PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Young, B; Dunstone, RL; Senden, TJ; Young, GC				Young, Ben; Dunstone, Robert L.; Senden, Timothy J.; Young, Gavin C.			A Gigantic Sarcopterygian (Tetrapodomorph Lobe-Finned Fish) from the Upper Devonian of Gondwana (Eden, New South Wales, Australia)	PLOS ONE			English	Article							FAMENNIAN EVIEUX FORMATION; TRISTICHOPTERID SARCOPTERYGII; NORTH-AMERICA; EAST GONDWANA; VICTORIA; OSTEOLEPIFORMES; RHIZODONTIDS; CANOWINDRA; BELGIUM; ANATOMY	Edenopteron keithcrooki gen. et sp. nov. is described from the Famennian Worange Point Formation; the holotype is amongst the largest tristichopterids and sarcopterygians documented by semi-articulated remains from the Devonian Period. The new taxon has dentary fangs and premaxillary tusks, features assumed to be derived for large Northern Hemisphere tristichopterids (Eusthenodon, Hyneria, Langlieria). It resembles Eusthenodon in ornament, but is distinguished by longer proportions of the parietal compared to the post-parietal shield, and numerous differences in shape and proportions of other bones. Several characters (accessory vomers in the palate, submandibulars overlapping ventral jaw margin, scales ornamented with widely-spaced deep grooves) are recorded only in tristichopterids from East Gondwana (Australia-Antarctica). On this evidence Edenopteron gen. nov. is placed in an endemic Gondwanan subfamily Mandageriinae within the Tristichopteridae; it differs from the nominal genotype Mandageria in its larger size, less pointed skull, shape of the orbits and other skull characters. The hypothesis that tristichopterids evolved in Laurussia and later dispersed into Gondwana, and a derived subgroup of large Late Devonian genera dispersed from Gondwana, is inconsistent with the evidence of the new taxon. Using oldest fossil and most primitive clade criteria the most recent phylogeny resolves South China and Gondwana as areas of origin for all tetrapodomorphs. The immediate outgroup to tristichopterids remains unresolved - either Spodichthys from Greenland as recently proposed, or Marsdenichthys from Gondwana, earlier suggested to be the sister group to all tristichopterids. Both taxa combine two characters that do not co-occur in other tetrapodomorphs (extratemporal bone in the skull; non-cosmoid round scales with an internal boss). Recently both 'primitive' and 'derived' tristichopterids have been discovered in the late Middle Devonian of both hemispheres, implying extensive ghost lineages within the group. Resolving their phylogeny and biogeography will depend on a comprehensive new phylogenetic analysis.	[Young, Ben] Lithicon Australia Pty Ltd, Canberra, ACT, Australia; [Young, Ben; Dunstone, Robert L.; Young, Gavin C.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Senden, Timothy J.] Australian Natl Univ, Res Sch Phys & Engn, Canberra, ACT, Australia	Australian National University; Australian National University	Young, GC (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	Gavin.Young@anu.edu.au	Senden, Tim J/A-7319-2008	Senden, Tim J/0000-0001-6808-7219	Australian Research Council [DP0558499, DP0772138]; Australian National University [10MEC15]	Australian Research Council(Australian Research Council); Australian National University(Australian National University)	This research was supported by Australian Research Council [www.arc.gov.au] Discovery Grants DP0558499 ('Australia's exceptional Palaeozoic fossil fishes, and a Gondwana origin for land vertebrates') and DP0772138 ('Old brains, new data-early evolution of structural complexity in the vertebrate head'). Surface scanning and 3D printing equipment was partly financed by an Australian National University [www.anu.edu.au] Major Equipment Grant (10MEC15). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Ahlberg PE, 2001, J VERTEBR PALEONTOL, V21, P1, DOI 10.1671/0272-4634(2001)021[0001:TLDLSS]2.0.CO;2; Ahlberg PE, 1997, J VERTEBR PALEONTOL, V17, P653, DOI 10.1080/02724634.1997.10011015; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P391; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; [Anonymous], AM MUS NOVIT; Bishop P, 2012, MEMOIRS QUE IN PRESS, V56; Clement G, 2002, PALAEONTOLOGY, V45, P577, DOI 10.1111/1475-4983.00250; Clement G, 2009, PALAEONTOLOGY, V52, P823, DOI 10.1111/j.1475-4983.2009.00876.x; Cope E. D., 1889, AM NAT, V23, P849, DOI DOI 10.1086/275018; Daeschler E, 2007, J VERTEBR PALEONTOL, V27, p65A; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Holland Timothy, 2010, Memoirs of Museum Victoria, V67, P35; Holland T, 2010, J VERTEBR PALEONTOL, V30, P68, DOI 10.1080/02724630903409105; HUXLEY T. H., 1880, P ZOOL SOC LOND, P649; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jarvik E., 1985, GEOSCIENCE, V13, P1; Jarvik E., 1942, ZOOL BIDR UPPS, V21, P235; Jarvik E., 1980, BASIC STRUCTURE EVOL, DOI [10.1126/science.214.4519.431.b, DOI 10.1126/SCIENCE.214.4519.431.B]; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; JARVIK ERIK, 1948, K SVENSKA VETENSKAPSAKAD HANDL, V25, P1; Jarvik E., 1944, K SVENSKA VETENSKAPSAKAD HANDL, V21, P1; Jarvik Erik, 1996, P285; Jeffery JE, 2003, T ROY SOC EDIN-EARTH, V93, P255, DOI 10.1017/S0263593300000432; Johanson Z, 2003, PALAEONTOLOGY, V46, P271, DOI 10.1111/1475-4983.00298; Johanson Z, 2001, T ROY SOC EDIN-EARTH, V92, P43, DOI 10.1017/S0263593300000043; Johanson Z, 1997, T ROY SOC EDIN-EARTH, V88, P39, DOI 10.1017/S0263593300002303; Johanson Z, 2004, RECENT ADV ORIGIN EA, P287; JOHANSON Z, 2000, GEOWISSENSCHAFTLICHE, V3, P111; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; LONG JA, 1990, LETHAIA, V23, P157, DOI 10.1111/j.1502-3931.1990.tb01357.x; LONG JA, 1985, ALCHERINGA, V9, P1, DOI 10.1080/03115518508618955; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; ROMER AS, 1955, NATURE, V176, P126, DOI 10.1038/176126a0; Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055; Schultze HP, 2012, HIST BIOL, V24, P425, DOI 10.1080/08912963.2012.673599; SCHULTZE HP, 1969, PALAEONTOGRAPHIA ITA, V65, P63; Snitting D, 2008, J VERTEBR PALEONTOL, V28, P637, DOI 10.1671/0272-4634(2008)28[637:AROTAO]2.0.CO;2; Snitting D, 2009, ACTA ZOOL-STOCKHOLM, V90, P273, DOI 10.1111/j.1463-6395.2008.00376.x; Swartz B, 2012, PLOS ONE, V7, P1; Thomson K. S., 1968, Postilla, VNo. 124, P1; Thomson K. S., 1967, ZOOL J LINN SOC-LOND, V46, P223; Vorobeva E.I., 1977, Trudy Paleontologicheskogo Instituta, V163, P1; Vorobyeva E. I., 1962, T PALEONTOLOGICHESKO, V94, P1; VOROBYEVA EI, 1959, T PALEONTOLOGISCHESK, V3, P95; Young GC, 2008, ALCHERINGA, V32, P321, DOI 10.1080/03115510802104368; Young GC, 2007, AUST J EARTH SCI, V54, P991, DOI 10.1080/08120090701488313; Young G.C., 2003, Records of the Western Australian Museum Supplement, V65, P1; Young G. C., 1992, REC AUST MUS, V14, P1, DOI [10.3853/j.0812-7387.14.1992.90, DOI 10.3853/J.0812-7387.14.1992.90]; Young Gavin C., 2003, Courier Forschungsinstitut Senckenberg, V242, P169; Young Gavin C., 2010, P85; Young Gavin C., 2010, Palaeoworld, V19, P160, DOI 10.1016/j.palwor.2009.10.001; Young Gavin C., 2010, Palaeoworld, V19, P55, DOI 10.1016/j.palwor.2009.11.005; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; YOUNG GC, 2006, ALCHERINGA S, V30, P409	58	13	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e53871	10.1371/journal.pone.0053871	http://dx.doi.org/10.1371/journal.pone.0053871			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483884	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100002
J	Hung, M; Niedziela-Majka, A; Jin, DB; Wong, M; Leavitt, S; Brendza, KM; Liu, XH; Sakowicz, R				Hung, Magdeleine; Niedziela-Majka, Anita; Jin, Debi; Wong, Melanie; Leavitt, Stephanie; Brendza, Katherine M.; Liu, Xiaohong; Sakowicz, Roman			Large-Scale Functional Purification of Recombinant HIV-1 Capsid	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ASSEMBLY IN-VITRO; TERMINAL DOMAIN; TYPE-1 CORE; CA PROTEIN; POLYMERIZATION; INHIBITOR; COMPLEX; TUBULIN	During human immunodeficiency virus type-1 (HIV-1) virion maturation, capsid proteins undergo a major rearrangement to form a conical core that protects the viral nucleoprotein complexes. Mutations in the capsid sequence that alter the stability of the capsid core are deleterious to viral infectivity and replication. Recently, capsid assembly has become an attractive target for the development of a new generation of anti-retroviral agents. Drug screening efforts and subsequent structural and mechanistic studies require gram quantities of active, homogeneous and pure protein. Conventional means of laboratory purification of Escherichia coli expressed recombinant capsid protein rely on column chromatography steps that are not amenable to large-scale production. Here we present a function-based purification of wild-type and quadruple mutant capsid proteins, which relies on the inherent propensity of capsid protein to polymerize and depolymerize. This method does not require the packing of sizable chromatography columns and can generate double-digit gram quantities of functionally and biochemically well-behaved proteins with greater than 98% purity. We have used the purified capsid protein to characterize two known assembly inhibitors in our in-house developed polymerization assay and to measure their binding affinities. Our capsid purification procedure provides a robust method for purifying large quantities of a key protein in the HIV-1 life cycle, facilitating identification of the next generation anti-HIV agents.	[Hung, Magdeleine; Niedziela-Majka, Anita; Jin, Debi; Wong, Melanie; Leavitt, Stephanie; Brendza, Katherine M.; Liu, Xiaohong; Sakowicz, Roman] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Sakowicz, R (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	roman.sakowicz@gilead.com						Abdurahman S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-34; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Dam J, 2004, METHOD ENZYMOL, V384, P185; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; EHRLICH LS, 1990, AIDS RES HUM RETROV, V6, P1169, DOI 10.1089/aid.1990.6.1169; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Khaki AR, 2010, J MOL BIOL, V400, P354, DOI 10.1016/j.jmb.2010.04.065; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Laue T.M., 1992, COMPUTER AIDED INTER; Lemke CT, 2012, J VIROL, V86, P6643, DOI 10.1128/JVI.00493-12; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; Prevelige PE, 2011, J MOL BIOL, V410, P634, DOI 10.1016/j.jmb.2011.03.074; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Tsiang M, 2012, BIOCHEMISTRY; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051	29	19	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58035	10.1371/journal.pone.0058035	http://dx.doi.org/10.1371/journal.pone.0058035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472130	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900074
J	Malan-Muller, S; Hemmings, SMJ; Spies, G; Kidd, M; Fennema-Notestine, C; Seedat, S				Malan-Mueller, Stefanie; Hemmings, Sian Megan Joanna; Spies, Georgina; Kidd, Martin; Fennema-Notestine, Christine; Seedat, Soraya			Shorter Telomere Length - A Potential Susceptibility Factor for HIV-Associated Neurocognitive Impairments in South African Woman	PLOS ONE			English	Article							CHILDHOOD TRAUMA QUESTIONNAIRE; OXIDATIVE DNA-DAMAGE; REVERSE-TRANSCRIPTASE; NUCLEAR EXPORT; T-CELLS; BLOOD; DISORDERS; DISEASE; STRESS; OLDER	The neuropathogenesis of the human immunodeficiency virus (HIV) may manifest as various neurocognitive impairments (NCI). HIV-positive individuals also have significantly shorter telomere length (TL) in peripheral blood mononuclear cells (PBMCs) and CD8+ T cells compared to HIV-negative individuals. Additionally, reduced TL has been found to be associated with chronic psychological stress. This study focused on the effects of HIV-infection and chronic stress associated with childhood trauma on telomere length, and investigated whether leukocyte TL (LTL), in particular, represents a risk factor for NCI. Eighty-three HIV-positive and 45 HIV-negative women were assessed for childhood trauma and were subjected to detailed neurocognitive testing. Blood from each participant was used to extract Deoxyribonucleic acid (DNA). Relative LTL were determined by performing real time quantitative PCR reactions as described by Cawthon et al. (2002). As expected, relative LTL in the HIV-positive individuals was significantly shorter than that of HIV-negative individuals (F = 51.56, p= <0.01). Notably, a significant positive correlation was evident between relative LTL and learning performance in the HIV-positive group. In addition, a significant negative correlation was observed between relative LTL and verbal fluency, but this association was only evident in HIV-positive individuals who had experienced trauma. Our results suggest that reduced LTL is associated with worse learning performance in HIV-positive individuals, indicating that TL could act as a susceptibility factor in increasing neurocognitive decline in HIV-infected individuals.	[Malan-Mueller, Stefanie; Hemmings, Sian Megan Joanna; Spies, Georgina; Seedat, Soraya] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Psychiat, Cape Town, South Africa; [Hemmings, Sian Megan Joanna] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Med Res Council,South Africa Ctr Mol & Cellular B, Cape Town, South Africa; [Kidd, Martin] Univ Stellenbosch, Dept Stat & Actuarial Sci, Ctr Stat Consultat, ZA-7600 Stellenbosch, South Africa; [Fennema-Notestine, Christine] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Fennema-Notestine, Christine] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA	Stellenbosch University; South African Medical Research Council; Stellenbosch University; Stellenbosch University; University of California System; University of California San Diego; University of California System; University of California San Diego	Malan-Muller, S (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Psychiat, Cape Town, South Africa.	smalan@sun.ac.za		Seedat, Soraya/0000-0002-5118-786X; Malan-Muller, Stefanie/0000-0003-0639-0129; Fennema-Notestine, Christine/0000-0002-6527-6361; Hemmings, Sian/0000-0001-8461-1017	Harry Crossley Foundation; National Institutes of Health CFAR Developmental Award [10316485]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER	Harry Crossley Foundation; National Institutes of Health CFAR Developmental Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	1. Harry Crossley Foundation (http://www.afterschoolafrica.com/2011/09/harry-crossley-foundation-research.html). 2. National Institutes of Health CFAR Developmental Award, Grant no: PO# 10316485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Bremner J Douglas, 2002, Semin Clin Neuropsychiatry, V7, P104, DOI 10.1053/scnp.2002.31787; Callen E, 2004, MUTAT RES-REV MUTAT, V567, P85, DOI 10.1016/j.mrrev.2004.06.003; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Effros RB, 2000, MICROBES INFECT, V2, P69, DOI 10.1016/S1286-4579(00)00283-5; Epel ES, 2009, AGING-US, V1, P81; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Glass Daniel, 2010, Biol Psychiatry, V68, pe21, DOI 10.1016/j.biopsych.2010.02.026; Gleissner U, 2001, CORTEX, V37, P55, DOI 10.1016/S0010-9452(08)70557-4; Grant I, 2008, INT REV PSYCHIATR, V20, P33, DOI 10.1080/09540260701877894; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Irie M, 2003, BIOCHEM BIOPH RES CO, V311, P1014, DOI 10.1016/j.bbrc.2003.10.105; Irie M, 2002, PSYCHOTHER PSYCHOSOM, V71, P90, DOI 10.1159/000049351; Joska JA, 2010, AIDS BEHAV, V14, P371, DOI 10.1007/s10461-009-9538-x; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kurosaka D, 2006, J RHEUMATOL, V33, P1102; Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078; Nakamura KI, 2007, EXP GERONTOL, V42, P944, DOI 10.1016/j.exger.2007.05.003; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; Obana N, 2003, INTERNAL MED, V42, P150, DOI 10.2169/internalmedicine.42.150; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Thurnher D, 2001, HEAD NECK-J SCI SPEC, V23, P1049, DOI 10.1002/hed.1150; Tsuboi H, 2004, J PSYCHOSOM RES, V56, P53, DOI 10.1016/S0022-3999(03)00567-1; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; Wu KD, 2001, EXP DERMATOL, V10, P329, DOI 10.1034/j.1600-0625.2001.100505.x	45	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58351	10.1371/journal.pone.0058351	http://dx.doi.org/10.1371/journal.pone.0058351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472184	gold, Green Published			2022-12-27	WOS:000315637900130
J	Sun, SQ; Wu, YH; Wang, GX; Zhou, J; Yu, D; Bing, HJ; Luo, J				Sun, Shou-Qin; Wu, Yan-Hong; Wang, Gen-Xu; Zhou, Jun; Yu, Dong; Bing, Hai-Jian; Luo, Ji			Bryophyte Species Richness and Composition along an Altitudinal Gradient in Gongga Mountain, China	PLOS ONE			English	Article							PLANT COMMUNITY RESPONSES; VASCULAR PLANTS; MONTANE FORESTS; DIVERSITY; ASSEMBLAGES; PATTERNS; PHOTOSYNTHESIS; ESTABLISHMENT; GERMINATION; ECOSYSTEMS	An investigation of terrestrial bryophyte species diversity and community structure along an altitudinal gradient from 2,001 to 4,221 m a.s.l. in Gongga Mountain in Sichuan, China was carried out in June 2010. Factors which might affect bryophyte species composition and diversity, including climate, elevation, slope, depth of litter, vegetation type, soil pH and soil Eh, were examined to understand the altitudinal feature of bryophyte distribution. A total of 14 representative elevations were chosen along an altitudinal gradient, with study sites at each elevation chosen according to habitat type (forests, grasslands) and accessibility. At each elevation, three 100 mx2 m transects that are 50 m apart were set along the contour line, and three 50 cmx50 cm quadrats were set along each transect at an interval of 30 m. Species diversity, cover, biomass, and thickness of terrestrial bryophytes were examined. A total of 165 species, including 42 liverworts and 123 mosses, are recorded in Gongga mountain. Ground bryophyte species richness does not show any clear elevation trend. The terrestrial bryophyte cover increases with elevation. The terrestrial bryophyte biomass and thickness display a clear humped relationship with the elevation, with the maximum around 3,758 m. At this altitude, biomass is 700.3 g m(-2) and the maximum thickness is 8 cm. Bryophyte distribution is primarily associated with the depth of litter, the air temperature and the precipitation. Further studies are necessary to include other epiphytes types and vascular vegetation in a larger altitudinal range.	[Sun, Shou-Qin; Wu, Yan-Hong; Wang, Gen-Xu; Zhou, Jun; Yu, Dong; Bing, Hai-Jian; Luo, Ji] Chinese Acad Sci, Key Lab Mt Surface Proc & Ecol Regulat, Inst Mt Hazards & Environm, Chengdu, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS	Sun, SQ (corresponding author), Chinese Acad Sci, Key Lab Mt Surface Proc & Ecol Regulat, Inst Mt Hazards & Environm, Chengdu, Peoples R China.	shouqinsun@imde.ac.cn	Bing, Haijian/N-7625-2017; Sun, Shou-Qin/AAC-5884-2020; , 周俊/J-6152-2012	Bing, Haijian/0000-0002-9813-6939; Sun, Shou-Qin/0000-0003-0022-5982; , 周俊/0000-0001-7315-6645	National Natural Science Foundation of China [41273096, 30900201]; Knowledge Innovation Project of the Chinese Academy of Sciences [KZCX2-EW-QN310, KZCX2-YW-BR-20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	The present work was supported by the "National Natural Science Foundation of China" (Grant No. 41273096, 30900201) and the "Knowledge Innovation Project of the Chinese Academy of Sciences" (Grant No. KZCX2-EW-QN310, KZCX2-YW-BR-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Peng C, 2007, DIVERS DISTRIB, V13, P654, DOI 10.1111/j.1472-4642.2007.00393.x; Andrew NR, 2003, J BIOGEOGR, V30, P731, DOI 10.1046/j.1365-2699.2003.00849.x; Bardat J, 2007, BIOL CONSERV, V139, P47, DOI 10.1016/j.biocon.2007.06.004; Batty K, 2003, CAN J BOT, V81, P439, DOI [10.1139/b03-039, 10.1139/B03-039]; Belnap J., 2003, BIOL SOIL CRUSTS STR, P3; Bergamini A, 2009, DIVERS DISTRIB, V15, P871, DOI 10.1111/j.1472-4642.2009.00595.x; Beringer J, 2001, J CLIMATE, V14, P3324, DOI 10.1175/1520-0442(2001)014<3324:TROASI>2.0.CO;2; Bruun HH, 2006, J VEG SCI, V17, P37, DOI 10.1111/j.1654-1103.2006.tb02421.x; Corrales A, 2010, BRYOLOGIST, V113, P8, DOI 10.1639/0007-2745-113.1.8; Delach A, 2002, BRYOLOGIST, V105, P249, DOI 10.1639/0007-2745(2002)105[0249:TEOPPO]2.0.CO;2; Frahm J. -P., 2001, TROPICAL BRYOLOGY, V20, P117, DOI DOI 10.11646/BDE.20.1.20; FRAHM JP, 1991, J BIOGEOGR, V18, P669, DOI 10.2307/2845548; Frego KA, 2007, FOREST ECOL MANAG, V242, P65, DOI 10.1016/j.foreco.2007.01.030; Gao Q, 2003, ILLUSTRATIONS BRYOPH; Gao Q, 1994, FLORA BRYOPHYTORUM S; Gao Q, 2008, FLORA BRYOPHYTORUM S; Gao Q, 1994, FLORA BRYOPHYTORUM S; Gao Q, 2003, FLORA BRYOPHYTORUM S; Gignac LD, 2001, BRYOLOGIST, V104, P410, DOI 10.1639/0007-2745(2001)104[0410:BAIOCC]2.0.CO;2; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Grytnes JA, 2006, ACTA OECOL, V29, P241, DOI 10.1016/j.actao.2005.10.007; Hu R., 2005, FLORA BRYOPHYTORUM S, VVII; Huo CF, 2010, J FOREST RES-JPN, V15, P176, DOI 10.1007/s10310-009-0173-1; Ingerpuu N, 2001, BIODIVERS CONSERV, V10, P2153, DOI 10.1023/A:1013141609742; Insightful Corp, 2007, INS S PLUS 8 0; Jagerbrand AK, 2009, OECOLOGIA, V161, P601, DOI 10.1007/s00442-009-1392-z; Jeschke M, 2008, FLORA, V203, P557, DOI 10.1016/j.flora.2007.09.006; Jonsdottir IS, 2005, GLOBAL CHANGE BIOL, V11, P553, DOI 10.1111/j.1365-2486.2005.00928.x; Kuusipalo J., 1983, Silva Fennica, V17, P245; Leps J, 2003, MULTIVARIATE ANAL EC; Li, 2000, FLORA BRYOPHYTORUM S, V3; Li X.J., 2006, FLORA BRYOPHYTORUM S, V4; Li ZH, 2010, J GUIZHOU NORMAL U N, V28, P156; Maestre FT, 2008, J VEG SCI, V19, P261, DOI 10.3170/2007-8-18366; Mandl NA, 2009, PLANT ECOL DIVERS, V2, P313, DOI 10.1080/17550870903341877; Marialigeti S, 2009, BIODIVERS CONSERV, V18, P2223, DOI 10.1007/s10531-009-9586-6; OSHEA BJ, 2003, TROPICAL BRYOLOGY RE, V4, P1; Peintinger M, 2006, PLANT ECOL, V185, P1, DOI 10.1007/s11258-005-9079-y; Pentecost A, 1998, GLOBAL ECOL BIOGEOGR, V7, P273, DOI 10.2307/2997601; Pharo EJ, 2002, BRYOLOGIST, V105, P11, DOI 10.1639/0007-2745(2002)105[0011:TABSVA]2.0.CO;2; Porley R., 2005, MOSSES LIVERWORTS; RINCON E, 1988, J BRYOL, V15, P209, DOI 10.1179/jbr.1988.15.1.209; Shields JA, 2007, FOREST ECOL MANAG, V252, P222, DOI 10.1016/j.foreco.2007.06.048; SKRE O, 1981, OECOLOGIA, V48, P50, DOI 10.1007/BF00346987; Startsev N, 2008, J VEG SCI, V19, P253, DOI 10.3170/2008-8-18367; Steel JB, 2004, OIKOS, V104, P479, DOI 10.1111/j.0030-1299.2004.12840.x; Stehn SE, 2010, CAN J FOREST RES, V40, P2164, DOI 10.1139/X10-156; SWARTZMAN G, 1992, CAN J FISH AQUAT SCI, V49, P1366, DOI 10.1139/f92-152; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; Tusiime FM, 2007, AFR J ECOL, V45, P79, DOI 10.1111/j.1365-2028.2007.00862.x; Uchida M, 2002, ARCT ANTARCT ALP RES, V34, P287, DOI 10.2307/1552486; Vellak K, 2003, SILVA FENN, V37, P3, DOI 10.14214/sf.508; Virtanen R, 2010, PLANT ECOL DIVERS, V3, P77, DOI 10.1080/17550874.2010.492403; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; [王长宝 Wang Changbao], 2007, [中国野生植物资源, Chinese Wild Plant Resources], V26, P35; Weibull H, 2005, BIOL CONSERV, V122, P71, DOI 10.1016/j.biocon.2004.07.001; Wigginton M. J., 2004, TROPICAL BRYOLOGY RE, V5, P1; Wu P., 2004, FLORA BRYOPHYTORUM S, VVIII; Wu P. C., 2002, FLORA BRYOPHYTORUM S, VVI; Zhang, 2009, FRONTIERS BIOL CHINA, V4, P143, DOI [10.1007/s11515-008-0104-0, DOI 10.1007/S11515-008-0104-0]	62	52	62	6	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58131	10.1371/journal.pone.0058131	http://dx.doi.org/10.1371/journal.pone.0058131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472146	Green Published, gold			2022-12-27	WOS:000315637900092
J	Wei, X; Zhang, Y; Fu, Z; Zhang, L				Wei, Xin; Zhang, Yuan; Fu, Zheng; Zhang, Luo			The Association between Polymorphisms in the MRPL4 and TNF-alpha Genes and Susceptibility to Allergic Rhinitis	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; FACTOR-KAPPA-B; ENDOTHELIAL-CELLS; UP-REGULATION; ATOPIC MARCH; MAST-CELLS; ASTHMA; EXPRESSION; DISEASE; EOSINOPHILIA	Background: Allergic rhinitis (AR) is a chronic inflammatory disease of the nasal mucosa, involving a complex interaction between genetic and environmental factors. Evidence suggests that polymorphisms in the gene coding for mitochondrial ribosomal protein L4 (MRPL4), located in close proximity to intercellular adhesion molecule-1 (ICAM-1) gene on chromosome location 19p13.2, may influence the risk factor for the development of AR. Objective: The aim of our study was to investigate any association between AR susceptibility and polymorphisms in ICAM-1 gene, as well as associations between AR risk and polymorphisms in MRPL4, nuclear factor-kappaB (NF-kappa B) and tumor necrosis factor alpha(TNF-alpha) genes, associated with ICAM-1 expression. Methods: A cohort of 414 patients with AR and 293 healthy controls was enrolled from the Han Chinese population in Beijing, China. Blood was drawn for DNA extraction and total serum immunoglobulin E (IgE). A total of 14 single nucleotide polymorphisms (SNPs) in ICAM-1, NF-kappa B, TNF-alpha, and MRPL4 genes were selected using the CHB genotyping data from the International Haplotype Mapping (HapMap) and assessed for differences in frequencies of the alleles and genotypes between the AR patients and control subjects. Results: TNF-alpha SNP rs1799964 and MRPL4 SNP rs11668618 were found to occur in significantly greater frequencies in the AR group compared to control group. There were no significant associations between SNPs in NF-kappa B, ICAM-1 and AR. The SNP-SNP interaction information analysis further indicated that there were no synergistic effects among the selected sets of polymorphisms. Conclusions: Our results suggest a strong association between AR risk and polymorphisms of MRPL4 and TNF-alpha genes in Han Chinese population.	[Wei, Xin; Zhang, Yuan; Zhang, Luo] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Wei, Xin; Zhang, Yuan; Zhang, Luo] Beijing Inst Otorhinolaryngol, Minist Educ China, Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Wei, Xin; Fu, Zheng] Peoples Hosp Hainan Prov, Dept Otolaryngol Head & Neck Surg, Haikou, Peoples R China	Capital Medical University; Ministry of Education, China	Zhang, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	National Science Fund for Distinguished Young Scholars [81025007]; National Natural Science Foundation of China [30973282, 81100706]; Beijing Natural Science Foundation [7102030]; Special Fund of Sanitation Elite Reconstruction of Beijing [2009-2-007]; Beijing Science and Technology program [Z111107055311040, KZ201110025027]; Beijing Nova Program [2010B022]; Hainan Provincial Health Department [2011K-19]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Special Fund of Sanitation Elite Reconstruction of Beijing; Beijing Science and Technology program; Beijing Nova Program(Beijing Municipal Science & Technology Commission); Hainan Provincial Health Department	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (81025007), the National Natural Science Foundation of China (30973282 and 81100706), the Beijing Natural Science Foundation (7102030), the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007), the Beijing Science and Technology program (Z111107055311040 and KZ201110025027), and the Beijing Nova Program (2010B022) to LZ, YZ and DH, and Hainan Provincial Health Department program (2011K-19) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andiappan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019719; Asakura K, 1996, INT ARCH ALLERGY IMM, V111, P156, DOI 10.1159/000237361; Azzolina A, 2003, BBA-MOL CELL RES, V1643, P75, DOI 10.1016/j.bbamcr.2003.09.003; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batikhan H, 2010, EUR ARCH OTO-RHINO-L, V267, P903, DOI 10.1007/s00405-009-1167-5; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Canonica GW, 2009, CLIN EXP IMMUNOL, V158, P260, DOI 10.1111/j.1365-2249.2009.04017.x; Chai OH, 2011, EXP MOL MED, V43, P35, DOI 10.3858/emm.2011.43.1.004; Chen BY, 2012, PAEDIATR PERINAT EP, V26, P146, DOI 10.1111/j.1365-3016.2011.01203.x; CIPRANDI G, 1994, J ALLERGY CLIN IMMUN, V94, P738, DOI 10.1016/0091-6749(94)90182-1; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; El-Shazly AE, 2011, INT IMMUNOPHARMACOL, V11, P1864, DOI 10.1016/j.intimp.2011.07.017; Gentile DA, 2004, HUM IMMUNOL, V65, P347, DOI 10.1016/j.humimm.2004.01.014; Gilain L, 2000, Ann Otolaryngol Chir Cervicofac, V117, P91; Gorska-Ciebiada M, 2006, ANN ALLERG ASTHMA IM, V97, P66, DOI 10.1016/S1081-1206(10)61372-5; Hon KLE, 2012, IRAN J ALLERGY ASTHM, V11, P73, DOI 011.01/ijaai.7377; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Krasznai M, 2011, EUR ARCH OTO-RHINO-L, V268, P561, DOI 10.1007/s00405-010-1424-7; Li Yanzhong, 2006, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V20, P315; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minhas K, 2010, J INVEST ALLERG CLIN, V20, P563; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Osada R, 2003, RHINOLOGY, V41, P80; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; von Kobyletzki LB, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-11; Widegren H, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-15; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yang CR, 2005, J IMMUNOL, V174, P1647, DOI 10.4049/jimmunol.174.3.1647; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306; Zhao Jiandong, 2008, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V22, P57; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67; Zhu SK, 2000, AM J RESP CRIT CARE, V161, P1655, DOI 10.1164/ajrccm.161.5.9906086	38	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57981	10.1371/journal.pone.0057981	http://dx.doi.org/10.1371/journal.pone.0057981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472126	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900069
J	Wolf, C; Sidhu, J; Otoul, C; Morris, DL; Cnops, J; Taubel, J; Bennett, B				Wolf, Christian; Sidhu, Jagdev; Otoul, Christian; Morris, Dexter L.; Cnops, Jennifer; Taubel, Jorg; Bennett, Barbara			Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ALPHA-4-BETA-1 INTEGRIN; ANTIBODY NATALIZUMAB; IN-VIVO; B-CELLS; INFLAMMATION; RESPONSES; CD49D; MOBILIZATION; MIGRATION	Background: Lymphocyte inhibition by antagonism of alpha 4 integrins is a validated therapeutic approach for relapsing multiple sclerosis (RMS). Objective: Investigate the effect of CDP323, an oral alpha(4)-integrin inhibitor, on lymphocyte biomarkers in RMS. Methods: Seventy-one RMS subjects aged 18-65 years with Expanded Disability Status Scale scores <= 6.5 were randomized to 28-day treatment with CDP323 100 mg twice daily (bid), 500 mg bid, 1000 mg once daily (qd), 1000 mg bid, or placebo. Results: Relative to placebo, all dosages of CDP323 significantly decreased the capacity of lymphocytes to bind vascular adhesion molecule-1 (VCAM-1) and the expression of alpha(4)-integrin on VCAM-1-binding cells. All but the 100-mg bid dosage significantly increased total lymphocytes and naive B cells, memory B cells, and T cells in peripheral blood compared with placebo, and the dose-response relationship was shown to be linear. Marked increases were also observed in natural killer cells and hematopoietic progenitor cells, but only with the 500-mg bid and 1000-mg bid dosages. There were no significant changes in monocytes. The number of samples for regulator and inflammatory T cells was too small to draw any definitive conclusions. Conclusions: CDP323 at daily doses of 1000 or 2000 mg induced significant increases in total lymphocyte count and suppressed VCAM-1 binding by reducing unbound very late antigen-4 expression on lymphocytes.	[Wolf, Christian] Lycalis Sprl, Clin Dev, Brussels, Belgium; [Sidhu, Jagdev] CSL Ltd, Clin Pharmacol Early Dev, Melbourne, Vic, Australia; [Otoul, Christian] UCB Pharma, Exploratory Stat, Brabant, Belgium; [Morris, Dexter L.] UCB Biosci Inc, Drug Dev, Raleigh, NC USA; [Cnops, Jennifer] Vrije Univ Brussel, Dept Cellular & Mol Immunol, Brussels, Belgium; [Taubel, Jorg] Richmond Pharmacol, London, England; [Bennett, Barbara] BABennett Consulting, Marietta, GA USA	CSL; UCB Pharma SA; Vrije Universiteit Brussel	Morris, DL (corresponding author), UCB Biosci Inc, Drug Dev, Raleigh, NC USA.	tony.morris@ucb.com	Taubel, Jorg/I-1286-2019	Taubel, Jorg/0000-0002-0010-207X; Wolf, Christian/0000-0002-4683-0507	UCB Pharma; Biogen Idec Inc.; Infusion Communications	UCB Pharma(UCB Pharma SA); Biogen Idec Inc.(Biogen); Infusion Communications	This study was sponsored by UCB Pharma and Biogen Idec Inc. The funders, in consultation with the authors, were included in discussions relating to study design and provided assistance with data analysis. They had no role in data collection or the decision to publish, and contributions to manuscript preparation were restricted to authors employed by the funders and financing of editorial support provided by Infusion Communications.; This study was funded by UCB Pharma and Biogen Idec, which were jointly developing CDP323 as a potential treatment for multiple sclerosis. Dr. Morris has been an employee of and holds stock in GlaxoSmithKline and is currently employed by and has received stock options from UCB Biosciences Inc. Among my coauthors, Dr. Wolf was a salaried employee of UCB Pharma S. A. during the time the study was conducted and has been a consultant for Novartis and Synthon. Dr. Sidhu was a salaried employee of and received stock in UCB Pharma during the time the study was conducted. Dr. Otoul is an employee of UCB Pharma. Dr. Taubel is employed by Richmond Pharmacology, which received financial remuneration for their clinical involvement in this study. Dr. Bennett was a salaried employee of UCB Biosciences Inc. during the time the study was conducted and is now an independent consultant. Dr. Cnops reports no conflicts of interest. This does not alter the authors' adherence to all of the PLOS ONE policies on sharing data and materials.	Baker M, 2006, MULT SCLER, V12, pS106; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; CHAN PY, 1993, J BIOL CHEM, V268, P24655; D'hooghe MB, 2010, MULT SCLER J, V16, P773, DOI 10.1177/1352458510367721; Davenport RJ, 2007, DRUG DISCOV TODAY, V12, P569, DOI 10.1016/j.drudis.2007.05.001; FERGUSON TA, 1991, P NATL ACAD SCI USA, V88, P8072, DOI 10.1073/pnas.88.18.8072; Jing D, 2010, BONE MARROW TRANSPL, V45, P1489, DOI 10.1038/bmt.2009.381; KENT SJ, 1995, J NEUROIMMUNOL, V58, P1, DOI 10.1016/0165-5728(94)00165-K; Kenyon NJ, 2009, EUR J PHARMACOL, V603, P138, DOI 10.1016/j.ejphar.2008.11.063; Kong L, 2005, PHARM STAT, V4, P25, DOI 10.1002/pst.148; Kovarik JM, 2004, J CLIN PHARMACOL, V44, P532, DOI 10.1177/0091270004264165; Krumbholz M, 2008, NEUROLOGY, V71, P1350, DOI 10.1212/01.wnl.0000327671.91357.96; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Lichterfeld M, 2000, BRIT J HAEMATOL, V110, P71, DOI 10.1046/j.1365-2141.2000.02130.x; Miller D, 2001, MULT SCLER, V7, pS16; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Muro F, 2008, BIOORGAN MED CHEM, V16, P9991, DOI 10.1016/j.bmc.2008.10.020; Neumann F, 2009, EXPERT OPIN BIOL TH, V9, P1099, DOI 10.1517/14712590903055011; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; Polman C, 2010, 62 ANN M AM AC NEUR; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Putzki N, 2010, EUR NEUROL, V63, P311, DOI 10.1159/000302687; Radue EW, 2010, J NEUROL SCI, V292, P28, DOI 10.1016/j.jns.2010.02.012; Rudick Richard A, 2004, Expert Rev Neurother, V4, P571, DOI 10.1586/14737175.4.4.571; SoiluHanninen M, 1997, J NEUROIMMUNOL, V72, P95, DOI 10.1016/S0165-5728(96)00158-0; Stadelmann C, 2011, BBA-MOL BASIS DIS, V1812, P275, DOI 10.1016/j.bbadis.2010.07.007; Vanderslice P, 2010, BIOCHEM BIOPH RES CO, V400, P619, DOI 10.1016/j.bbrc.2010.08.114; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zohren F, 2008, BLOOD, V111, P3893, DOI 10.1182/blood-2007-10-120329	29	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58438	10.1371/journal.pone.0058438	http://dx.doi.org/10.1371/journal.pone.0058438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472197	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000315637900143
J	Nara, M; Teshima, K; Watanabe, A; Ito, M; Iwamoto, K; Kitabayashi, A; Kume, M; Hatano, Y; Takahashi, N; Iida, S; Sawada, K; Tagawa, H				Nara, Miho; Teshima, Kazuaki; Watanabe, Atsushi; Ito, Mitsugu; Iwamoto, Keiko; Kitabayashi, Atsushi; Kume, Masaaki; Hatano, Yoshiaki; Takahashi, Naoto; Iida, Shinsuke; Sawada, Kenichi; Tagawa, Hiroyuki			Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; AURORA KINASES; POLYCOMB GENE; INHIBITION; PROTEIN; LINES; ESTABLISHMENT; PROTEASOME; COMPLEX; PHENOTYPE	Side population (SP) cells in cancers, including multiple myeloma, exhibit tumor-initiating characteristics. In the present study, we isolated SP cells from human myeloma cell lines and primary tumors to detect potential therapeutic targets specifically expressed in SP cells. We found that SP cells from myeloma cell lines (RPMI 8226, AMO1, KMS-12-BM, KMS-11) express CD138 and that non-SP cells include a CD138-negative population. Serial transplantation of SP and non-SP cells into NOD/Shi-scid IL-2 gamma nul mice revealed that clonogenic myeloma SP cells are highly tumorigenic and possess a capacity for self-renewal. Gene expression analysis showed that SP cells from five MM cell lines (RPMI 8226, AMO1, KMS-12-BM, KMS-11, JJN3) express genes involved in the cell cycle and mitosis (e. g., CCNB1, CDC25C, CDC2, BIRC5, CENPE, SKA1, AURKB, KIFs, TOP2A, ASPM), polycomb (e. g., EZH2, EPC1) and ubiquitin-proteasome (e. g., UBE2D3, UBE3C, PSMA5) more strongly than do non-SP cells. Moreover, CCNB1, AURKB, EZH2 and PSMA5 were also upregulated in the SPs from eight primary myeloma samples. On that basis, we used an aurora kinase inhibitor (VX-680) and a proteasome inhibitor (bortezomib) with RPMI 8226 and AMO1 cells to determine whether these agents could be used to selectively target the myeloma SP. We found that both these drugs reduced the SP fraction, though bortezomib did so more effectively than VX-680 due to its ability to reduce levels of both phospho-histone H3 (p-hist. H3) and EZH2; VX-680 reduced only p-hist. H3. This is the first report to show that certain oncogenes are specifically expressed in the myeloma SP, and that bortezomib effectively downregulates expression of their products. Our approach may be useful for screening new agents with which to target a cell population possessing strong tumor initiating potential in multiple myeloma.	[Nara, Miho; Teshima, Kazuaki; Watanabe, Atsushi; Ito, Mitsugu; Iwamoto, Keiko; Takahashi, Naoto; Sawada, Kenichi; Tagawa, Hiroyuki] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan; [Watanabe, Atsushi] Akita Kumiai Gen Hosp, Dept Internal Med, Akita, Japan; [Kume, Masaaki] Hiraka Gen Hosp, Dept Internal Med, Yokote, Japan; [Hatano, Yoshiaki] Yamamoto Kumiai Gen Hosp, Dept Internal Med, Noshiro, Akita, Japan; [Iida, Shinsuke] Nagoya City Univ, Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan	Akita University; Nagoya City University	Tagawa, H (corresponding author), Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan.	htagawa0279jp@yahoo.co.jp			Japan Society for the Promotion of Science; International Myeloma Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); International Myeloma Foundation	This work is supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (H. T) and The Award in Aki's Memory established by International Myeloma Foundation (for H. T). We wish to express our appreciation to Mss. E. Kobayashi, H. Kataho and Y. Abe for their outstanding technical assistance, Dr. T. Nanjo (Akita Univ., Akita, Japan) and Dr. R. Ichinohasama (Tohoku Univ., Sendai, Japan) for their histological and/or clinical diagnosis of MM. Drs. Y. Kameoka (Akita Univ.), Y. Michishita (Akita Univ.), Y. Saitoh (Hiraka General Hospital) and H. Oyagi (Hiraka General Hospital) for collection of primary MM samples and constructive discussion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Chng WJ, 2008, BLOOD, V111, P1603, DOI 10.1182/blood-2007-06-097774; Chng WJ, 2006, BLOOD, V107, P3669, DOI 10.1182/blood-2005-09-3810; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Gu ZJ, 1996, BLOOD, V88, P3972, DOI 10.1182/blood.V88.10.3972.bloodjournal88103972; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan P, 2009, GENE DEV, V23, P2237, DOI 10.1101/gad.536109; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; LUPAS A, 1993, ENZYME PROTEIN, V47, P252, DOI 10.1159/000468684; McKenna RW, 2008, WHO CLASSIFICATION T, P200; Mitsiades CS, 2011, J CLIN ONCOL, V29, P1916, DOI 10.1200/JCO.2010.34.0760; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oh Su-Jin, 2012, Immune Netw, V12, P66, DOI 10.4110/in.2012.12.2.66; Otsuki T, 2004, BRIT J HAEMATOL, V127, P292, DOI 10.1111/j.1365-2141.2004.05205.x; Pascreau Gaetan, 2003, Prog Cell Cycle Res, V5, P369; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SHIMIZU S, 1993, LEUKEMIA, V7, P274; Stankunas K, 1998, DEVELOPMENT, V125, P4055; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; TAGAWA S, 1990, LEUKEMIA, V4, P600; TAKAHIRA H, 1994, EXP HEMATOL, V22, P261; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Woods LK, 1982, P AM ASSOC CANC RES, V33, P126; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhu YX, 2011, BLOOD, V117, P3847, DOI 10.1182/blood-2010-08-304022	46	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e56954	10.1371/journal.pone.0056954	http://dx.doi.org/10.1371/journal.pone.0056954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469177	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900010
J	Shen, L; Ling, M; Li, Y; Xu, Y; Zhou, Y; Ye, J; Pang, Y; Zhao, Y; Jiang, RR; Zhang, JP; Liu, QZ				Shen, Lu; Ling, Min; Li, Yuan; Xu, Yuan; Zhou, Yun; Ye, Jing; Pang, Ying; Zhao, Yue; Jiang, Rongrong; Zhang, Jianping; Liu, Qizhan			Feedback Regulations of miR-21 and MAPKs via Pdcd4 and Spry1 Are Involved in Arsenite-Induced Cell Malignant Transformation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PDCD4; FACTOR-KAPPA-B; DOWN-REGULATION; UP-REGULATION; MICRORNA-21 TARGETS; CYCLIN D1; C-JUN; EXPRESSION; TUMORIGENESIS; ACTIVATION	Objective: To establish the functions of miR-21 and the roles of two feedback regulation loops, miR-21-Spry1-ERK/NF-kappa B and miR-21-Pdcd4-JNK/c-Jun, in arsenite-transformed human embryo lung fibroblast (HELF) cells. Methods: For arsenite-transformed HELF cells, apoptosis, clonogenicity, and capacity for migration were determined by Hoechst staining, assessment of their capacity for anchorage-independent growth, and wound-healing, respectively, after blockage, with inhibitors or with siRNAs, of signal pathways for JNK/c-Jun or ERK/NF-kappa B. Decreases of miR-21 levels were determined with anti-miR-21, and the up-regulation of Pdcd4 and Spry1 was assessed in transfected cells; these cells were molecularly characterized by RT-PCR, qRT-PCR, Western blots, and immunofluorescence assays. Results: MiR-21 was highly expressed in arsenite-transformed HELF cells and normal HELF cells acutely treated with arsenite, an effect that was concomitant with activation of JNK/c-Jun and ERK/NF-kappa B and down-regulation of Pdcd4 and Spry1 protein levels. However, there were no significant changes in mRNA levels for Pdcd4 and Spry1, which suggested that miR21 regulates the expressions of Pdcd4 and Spry1 through translational repression. In arsenite-transformed HELF cells, blockages of JNK/c-Jun or ERK/NF-kappa B with inhibitors or with siRNAs prevented the increases of miR-21 and the decreases of the protein levels but not the mRNA levels of Pdcd4 and Spry1. Down-regulation of miR-21 and up-regulations of Pdcd44 or Spry1 blocked the arsenite-induced activations of JNK/c-Jun or ERK/NF-kappa B, indicating that knockdown of miR-21 inhibits feedback of ERK activation and JNK activation via increases of Pdcd4 and Spry1 protein levels, respectively. Moreover, in arsenite-transformed HELF cells, inhibition of miR-21 promoted cell apoptosis, inhibited clonogenicity, and reduced migration. Conclusion: The results indicate that miR-21 is both a target and a regulator of ERK/NF-kappa B and JNK/c-Jun and the feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1, respectively, are involved in arsenite-induced malignant transformation of HELF cells.	[Shen, Lu; Ling, Min; Li, Yuan; Xu, Yuan; Pang, Ying; Zhao, Yue; Jiang, Rongrong; Liu, Qizhan] Sch Publ Hlth, Inst Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Shen, Lu; Li, Yuan; Xu, Yuan; Pang, Ying; Zhao, Yue; Jiang, Rongrong; Liu, Qizhan] Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Zhou, Yun; Ye, Jing; Zhang, Jianping] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Ling, Min] Jiangsu Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Zhang, JP (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	zhang_jp64@yahoo.com.cn; drqzliu@hotmail.com			Natural Science Foundations of China [81072327, 81273114, 81272713]; Research Fund for the Doctoral Program of Higher Education of China [20103234110005]; Key Program of Educational Commission of Jiangsu Province of China [11KJA330002]; Priority Academic Program Development of Jiangsu Higher Education Institutions [2010]	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Program of Educational Commission of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Natural Science Foundations of China (81072327, 81273114, and 81272713), Research Fund for the Doctoral Program of Higher Education of China (20103234110005), Key Program of Educational Commission of Jiangsu Province of China (11KJA330002), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Cantor KP, 2007, TOXICOL APPL PHARM, V222, P252, DOI 10.1016/j.taap.2007.01.026; Carpenter RL, 2011, BIOCHEM BIOPH RES CO, V414, P533, DOI 10.1016/j.bbrc.2011.09.102; Chen BL, 2013, CELL CYCLE, V12, P112, DOI 10.4161/cc.23030; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Fischer N, 2012, BIOCHEM BIOPH RES CO, V417, P29, DOI 10.1016/j.bbrc.2011.11.035; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Gao A, 2007, TOXICOL LETT, V170, P30, DOI 10.1016/j.toxlet.2007.02.008; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Grunder E, 2011, EUR J CANCER, V47, P2479, DOI 10.1016/j.ejca.2011.06.041; Guo Xiaoling, 2011, Genes Cancer, V2, P818, DOI 10.1177/1947601911431082; Han L, 2012, CNS NEUROSCI THER, V18, P573, DOI 10.1111/j.1755-5949.2012.00344.x; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He XQ, 2007, TOXICOL APPL PHARM, V220, P18, DOI 10.1016/j.taap.2006.12.021; Heck JE, 2009, ENVIRON HEALTH PERSP, V117, P1718, DOI 10.1289/ehp.0900566; Huang CS, 2004, MOL CELL BIOCHEM, V255, P57, DOI 10.1023/B:MCBI.0000007261.04684.78; Huang CS, 2001, MOL CELL BIOCHEM, V222, P29, DOI 10.1023/A:1017974131948; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P1; Itani S, 2012, J CANCER RES CLIN, V138, P1501, DOI 10.1007/s00432-012-1223-1; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jiang YG, 2011, TOXICOL SCI, V119, P50, DOI 10.1093/toxsci/kfq306; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lee JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021300; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Li GW, 2011, J CELL PHYSIOL, V226, P3225, DOI 10.1002/jcp.22683; Li Y, 2011, TOXICOL LETT, V206, P113, DOI 10.1016/j.toxlet.2011.06.024; Li YA, 2010, ENVIRON HEALTH PERSP, V118, P936, DOI 10.1289/ehp.0901677; Ling M, 2012, FREE RADICAL BIO MED, V52, P1508, DOI 10.1016/j.freeradbiomed.2012.02.020; Liu LH, 2010, TOXICOL IN VITRO, V24, P1168, DOI 10.1016/j.tiv.2010.02.016; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Macia A, 2012, ONCOGENE, V31, P3961, DOI 10.1038/onc.2011.556; Miller KA, 2009, CANCER RES, V69, P3689, DOI 10.1158/0008-5472.CAN-09-0024; Moghaddam SM, 2012, J ONCOL, V2012, DOI 10.1155/2012/373826; Narasimhan M, 2013, ALCOHOL CLIN EXP RES, V37, P96, DOI 10.1111/j.1530-0277.2012.01850.x; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Ouyang W, 2006, CARCINOGENESIS, V27, P864, DOI 10.1093/carcin/bgi321; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Rettig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042012; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Schaaf G, 2010, CANCER RES, V70, P762, DOI 10.1158/0008-5472.CAN-09-2532; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Shin EHH, 2012, MOL MED, V18, P861, DOI 10.2119/molmed.2012.00111; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang Q, 2012, BBA-MOL CELL RES, V1823, P1807, DOI 10.1016/j.bbamcr.2012.07.004; Wang ZS, 2012, ENVIRON HEALTH PERSP, V120, P92, DOI 10.1289/ehp.1104061; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhu Q, 2012, ONCOL REP, V27, P1660, DOI 10.3892/or.2012.1682	65	18	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57652	10.1371/journal.pone.0057652	http://dx.doi.org/10.1371/journal.pone.0057652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469214	gold, Green Submitted, Green Published			2022-12-27	WOS:000315897100029
J	Wang, JW; Zheng, W; Liu, JB; Chen, Y; Cao, LH; Luo, RZ; Li, AH; Zhou, JH				Wang, Jian-Wei; Zheng, Wei; Liu, Ji-Bin; Chen, Yao; Cao, Long-Hui; Luo, Rong-Zhen; Li, An-Hua; Zhou, Jian-Hua			Assessment of Early Tumor Response to Cytotoxic Chemotherapy with Dynamic Contrast-Enhanced Ultrasound in Human Breast Cancer Xenografts	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COLOR DOPPLER ULTRASOUND; NEOADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; HEPATOCELLULAR-CARCINOMA; QUANTITATIVE-EVALUATION; IMAGING TECHNIQUES; PERFUSION; US; ANGIOGENESIS	There is a strong need to assess early tumor response to chemotherapy in order to avoid adverse effects from unnecessary chemotherapy and allow early transition to second-line therapy. This study was to quantify tumor perfusion changes with dynamic contrast-enhanced ultrasound (CEUS) in the evaluation of early tumor response to cytotoxic chemotherapy. Sixty nude mice bearing with MCF-7 breast cancer were administrated with either adriamycin or sterile saline. CEUS was performed on days 0, 2, 4 and 6 of the treatment, in which time-signal intensity (SI) curves were obtained from the intratumoral and depth-matched liver parenchyma. Four perfusion parameters including peak enhancement (PE), area under the curve of wash-in (WiAUC), wash-in rate (WiR) and wash-in perfusion index (WiPI) were calculated from perfusion curves and normalized with respect to perfusion of adjacent liver parenchyma. Histopathological analysis was conducted to evaluate tumor perfusion, tumor cell density, microvascular density (MVD) and proliferating cell density. Significant decreases of tumor normalized perfusion parameters (i.e., nPE, nWiAUC, nWiR and nWiPI) were noticed between adriamycin-treated and control groups (P<0.01) 2 days after therapy. There were significant differences of tumor volumes between control and treated groups on day 6 (P<0.001) while there were no significant differences in tumor volume on days 0, 2 and 4 (P>0.05). Significant decreases of tumor perfusion, tumor cell density, MVD and proliferating cell density were seen in adrianycin-treated group 2 days after therapy when compared to control group (P<0.001). Dynamic CEUS for quantification of tumor perfusion could be used for early detection of cancer response to cytotoxic chemotherapy prior to notable tumor shrinkage.	[Wang, Jian-Wei; Zheng, Wei; Chen, Yao; Li, An-Hua; Zhou, Jian-Hua] Sun Yat Sen Univ, Ctr Canc, Dept Ultrasound, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Ji-Bin] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Cao, Long-Hui] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Rong-Zhen] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Jefferson University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Li, AH (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Ultrasound, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	anhuali@hotmail.com; zjh96421@hotmail.com		Zhou, Jian-hua/0000-0003-2096-8126	National Natural Science Foundation of China [30900369, 81071168, 81271578]; Fundamental Research Funds for the Central Universities [09ykpy56]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Funds for Pearl River Science & Technology Star of Guangzhou City	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Funds for Pearl River Science & Technology Star of Guangzhou City	This research was supported National Natural Science Foundation of China (No. 30900369, No. 81071168 and No. 81271578), the Fundamental Research Funds for the Central Universities (NO. 09ykpy56), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry and Funds for Pearl River Science & Technology Star of Guangzhou City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-See MLW, 2008, CLIN CANCER RES, V14, P6580, DOI 10.1158/1078-0432.CCR-07-4310; Bellomi M, 2007, RADIOLOGY, V244, P486, DOI 10.1148/radiol.2442061189; Bertolotto M, 2006, INVEST RADIOL, V41, P15, DOI 10.1097/01.rli.0000188363.93670.45; Bosch AM, 2003, EUR J RADIOL, V48, P285, DOI 10.1016/S0720-048X(03)00081-0; Bramer JAM, 2004, PEDIATR RADIOL, V34, P614, DOI 10.1007/s00247-004-1210-z; Craciunescu OI, 2009, INT J HYPERTHER, V25, P405, DOI 10.1080/02656730903022700; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Emmenegger U, 2004, CANCER RES, V64, P3994, DOI 10.1158/0008-5472.CAN-04-0580; Molins IG, 2010, WORLD J RADIOL, V2, P455, DOI 10.4329/wjr.v2.i12.455; Greco P, 1997, ACTA OBSTET GYN SCAN, V76, P169, DOI 10.3109/00016349709050075; Groheux D, 2011, EUR J NUCL MED MOL I, V38, P419, DOI 10.1007/s00259-010-1660-5; Guibal A, 2010, RADIOLOGY, V254, P420, DOI 10.1148/radiol.09090728; Guo WJ, 2002, WORLD J GASTROENTERO, V8, P476, DOI 10.3748/wjg.v8.i3.476; Gwyther SJ, 2008, EUR J CANCER, V44, P39, DOI 10.1016/j.ejca.2007.10.010; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Imuta N, 1997, ULTRASOUND MED BIOL, V23, P813, DOI 10.1016/S0301-5629(97)00068-9; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Lassau N, 2011, RADIOLOGY, V258, P291, DOI 10.1148/radiol.10091870; Lavisse S, 2008, INVEST RADIOL, V43, P100, DOI 10.1097/RLI.0b013e3181577cfc; Le-Petross HC, 2010, MAGN RESON IMAGING C, V18, P249, DOI 10.1016/j.mric.2010.02.008; Marcus CD, 2009, CRIT REV ONCOL HEMAT, V72, P217, DOI 10.1016/j.critrevonc.2008.07.012; Miller JC, 2005, JNCI-J NATL CANCER I, V97, P172, DOI 10.1093/jnci/dji023; Park MS, 2009, RADIOLOGY, V250, P110, DOI 10.1148/radiol.2493080226; Pritt B, 2004, MODERN PATHOL, V17, P905, DOI 10.1038/modpathol.3800138; Schoder H, 2005, J CLIN ONCOL, V23, P4643, DOI 10.1200/JCO.2005.12.072; Singh G, 2010, EUR J RADIOL, V75, pE158, DOI 10.1016/j.ejrad.2009.12.027; Singh Seema, 2005, Breast Cancer, V12, P45, DOI 10.2325/jbcs.12.45; Tardy I, 2010, INVEST RADIOL, V45, P573, DOI 10.1097/RLI.0b013e3181ee8b83; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wang JW, 2009, AM J ROENTGENOL, V193, P1090, DOI 10.2214/AJR.08.1367; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Zhou JH, 2011, BRIT J RADIOL, V84, P826, DOI 10.1259/bjr/14335925; Zhou JH, 2011, RADIOLOGY, V259, P406, DOI 10.1148/radiol.10101339; Zhou JH, 2011, AM J ROENTGENOL, V196, P13, DOI 10.2214/AJR.10.4734	35	39	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58274	10.1371/journal.pone.0058274	http://dx.doi.org/10.1371/journal.pone.0058274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469274	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100069
J	Gong, XL; Liu, YC; Zhang, XQ; Wei, ZY; Huo, R; Shen, L; He, L; Qin, SY				Gong, Xueli; Liu, Yichen; Zhang, Xiaoqing; Wei, Zhiyun; Huo, Ran; Shen, Lu; He, Lin; Qin, Shengying			Systematic Functional Study of Cytochrome P450 2D6 Promoter Polymorphisms in the Chinese Han Population	PLOS ONE			English	Article							SEQUENCE VARIATIONS; GENE-EXPRESSION; CYP2D6; AP2-ALPHA; BINDING; HEAD; 2D6	The promoter polymorphisms of drug-metabolizing genes can lead to interindividual differences in gene expression, which may result in adverse drug effects and therapeutic failure. Based on the database of CYP2D6 gene polymorphisms in the Chinese Han population established by our group, we functionally characterized the single nucleotide polymorphisms (SNPs) of the promoter region and corresponding haplotypes in this population. Using site-directed mutagenesis, all the five SNPs identified and ten haplotypes with a frequency equal to or greater than 0.01 in the population were constructed on a luciferase reporter system. Dual luciferase reporter systems were used to analyze regulatory activity. The activity produced by Haplo3(-2183G>A, -1775A>G, -1589G>C, -1431C>T, -1000G>A, -678A>G), Haplo8(-2065G>A, -2058T>G, -1775A>G, -1589G>C, -1235G>A, -678A>G) and MU3(-498C>A) was 0.7-, 0.7-, 1.2- times respectively compared with the wild type in human hepatoma cell lines(p < 0.05). These findings might be useful for optimizing pharmacotherapy and the design of personalized medicine.	[Gong, Xueli; Liu, Yichen; Wei, Zhiyun; Huo, Ran; Shen, Lu; He, Lin; Qin, Shengying] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiatr Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Gong, Xueli; Liu, Yichen; Wei, Zhiyun; Huo, Ran; Shen, Lu; He, Lin; Qin, Shengying] Shanghai Genome Pilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [Zhang, Xiaoqing] Shanghai Pulm Hosp, Shanghai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Qin, SY (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiatr Disorders, Minist Educ, Shanghai 200030, Peoples R China.	chinsir@sjtu.edu.cn	gong, xue/GYQ-8649-2022; liu, yichen/GVT-6262-2022; liu, yang/HHY-8583-2022; Wei, Zhiyun/E-2008-2016	Wei, Zhiyun/0000-0002-3554-4142	863 Program [2012AA02A515]; 973 Program [2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [30900799, 30972823, 81273596, 81121001]; Shanghai Jiao Tong University Med-X Fund [YG2010MS61]; Public Science and Technology Research Funds [201210056]; Shanghai Jiao Tong University Interdisciplinary Research fund; Shanghai Committee of Science and Technology [11dz1950300]; Shanghai Leading Academic Discipline Project [B205]	863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University Med-X Fund; Public Science and Technology Research Funds; Shanghai Jiao Tong University Interdisciplinary Research fund; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 863 Program (2012AA02A515), the 973 Program (2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Nature Science Foundation of China (30900799, 30972823, 81273596,81121001), the Shanghai Jiao Tong University Med-X Fund (YG2010MS61), the Public Science and Technology Research Funds(201210056), the Shanghai Jiao Tong University Interdisciplinary Research fund, the Major Program of the Shanghai Committee of Science and Technology (11dz1950300) and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranska M, 2012, PHARMACOL REP, V64, P336; Begbie M, 1999, DNA CELL BIOL, V18, P165, DOI 10.1089/104454999315556; Begg EJ, 2012, PHARMACOGENOMICS, V13, P83, DOI [10.2217/PGS.11.134, 10.2217/pgs.11.134]; Bennett KL, 2009, INT J CANCER, V124, P1285, DOI 10.1002/ijc.24087; Berezikov E, 2008, EXPLORING CONSERVATI, P437; Debieve F, 2011, MOL HUM REPROD, V17, P702, DOI 10.1093/molehr/gar045; Guzey C, 2004, CURR TOP MED CHEM, V4, P1409; Ho MT, 2011, ANN HEPATOL, V10, P327, DOI 10.1016/S1665-2681(19)31545-5; JOHANSSON I, 1994, MOL PHARMACOL, V46, P452; Morales-Lazaro SL, 2010, J NEUROCHEM, V112, P474, DOI 10.1111/j.1471-4159.2009.06467.x; Moon UY, 2010, J CELL BIOCHEM, V110, P1386, DOI 10.1002/jcb.22655; Paine MJI, 1996, ARCH BIOCHEM BIOPHYS, V328, P143, DOI 10.1006/abbi.1996.0154; Qin SY, 2008, GENOMICS, V92, P152, DOI 10.1016/j.ygeno.2008.05.004; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shukla P, 2012, J CANCER RES THER, V8, P40, DOI 10.4103/0973-1482.95172; Soyama Akiko, 2004, Drug Metab Pharmacokinet, V19, P313, DOI 10.2133/dmpk.19.313; Tamasi V, 2003, INFLAMM RES, V52, P322, DOI 10.1007/s00011-003-1186-4; Thum T, 2000, FASEB J, V14, P740, DOI 10.1096/fasebj.14.5.740; Wang HH, 2009, PHARMACOGENOMICS, V10, P359, DOI 10.2217/14622416.10.3.359; Zanger UM, 2001, PHARMACOGENETICS, V11, P573, DOI 10.1097/00008571-200110000-00004; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000	22	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57764	10.1371/journal.pone.0057764	http://dx.doi.org/10.1371/journal.pone.0057764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469064	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900162
J	Lu, X; Jiang, WM; Zhang, L; Zhang, F; Zhang, FY; Shen, Q; Wang, GF; Tang, KX				Lu, Xu; Jiang, Weimin; Zhang, Ling; Zhang, Fei; Zhang, Fangyuan; Shen, Qian; Wang, Guofeng; Tang, Kexuan			AaERF1 Positively Regulates the Resistance to Botrytis cinerea in Artemisia annua	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PATHOGEN RESISTANCE; GCC-BOX; DISEASE RESISTANCE; METHYL JASMONATE; ARABIDOPSIS MYC; BINDING PROTEIN; GENE-EXPRESSION; ERF; ACTIVATOR	Plants are sessile organisms, and they can not move away under abiotic or biotic stresses. Thus plants have evolved a set of genes that response to adverse environment to modulate gene expression. In this study, we characterized and functionally studied an ERF transcription factor from Artemisia annua, AaERF1, which plays an important role in biotic stress responses. The AaERF1 promoter had been cloned and GUS staining results of AaERF1 promoter-GUS transgenic A. annua showed that AaERF1 is expressed ubiquitiously in all organs. Several putative cis-acting elements such as W-box, TGA-box and Py-rich element, which are involved in defense responsiveness, are present in the promoter. The expression of AaERF1 can be induced vigorously by methyl jasmonate as well as by ethephon and wounding, implying that AaERF1 may activate some of the defense genes via the jasmonic acid and ethylene signaling pathways of A. annua. The results of electrophoretic mobility shift assay (EMSA) and yeast one-hybrid experiments showed that AaERF1 was able to bind to the GCC box cis-acting element in vitro and in yeast. Ectopic expression of AaERF1 could enhance the expression levels of the defense marker genes PLANT DEFENSIN1.2 (PDF1.2) and BASIC CHITINASE (ChiB), and increase the resistance to Botrytis cinerea in the 35S::AaERF1 transgenic Arabidopsis. The down-regulated expression level of AaERF1 evidently reduced the resistance to B. cinerea in A. annua. The overall results showed that AaERF1 positively regulated the resistance to B. cinerea in A. annua.	[Lu, Xu; Jiang, Weimin; Zhang, Ling; Zhang, Fei; Zhang, Fangyuan; Shen, Qian; Wang, Guofeng; Tang, Kexuan] Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, Sch Agr & Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Tang, KX (corresponding author), Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, Sch Agr & Biol, Shanghai 200030, Peoples R China.	kxtang@sjtu.edu.cn	SHEN, QIAN/O-6347-2015; Tang, Kexuan/E-3555-2013	SHEN, QIAN/0000-0002-4621-4659; Tang, Kexuan/0000-0002-8748-9624; Jiang, Weimin/0000-0002-2546-5256	Ministry of Education [2011AA100605, 2011ZX08002-001]	Ministry of Education	This work was funded by China "863'' Program (grant no. 2011AA100605), China Transgenic Research Program (grant no. 2011ZX08002-001), Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Cao YF, 2005, PHYSIOL MOL PLANT P, V67, P202, DOI 10.1016/j.pmpp.2006.01.004; dePater S, 1997, PLANT MOL BIOL, V34, P169, DOI 10.1023/A:1005898823105; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Fischer U, 2004, MOL PLANT MICROBE IN, V17, P1162, DOI 10.1094/MPMI.2004.17.10.1162; Hiraga S, 2000, PLANT CELL PHYSIOL, V41, P165, DOI 10.1093/pcp/41.2.165; Jarvis W.R., 1980, BIOL BOTRYTIS, P181; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Klotz KL, 1996, PLANT MOL BIOL, V31, P565, DOI 10.1007/BF00042229; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Liang HX, 2008, J EXP BOT, V59, P3111, DOI 10.1093/jxb/ern165; Liu DH, 2010, RUSS J PLANT PHYSL+, V57, P882, DOI 10.1134/S102144371006018X; Liu WY, 2011, J PLANT PHYSIOL, V168, P375, DOI 10.1016/j.jplph.2010.07.006; Mazarei M, 2002, MOL PLANT MICROBE IN, V15, P577, DOI 10.1094/MPMI.2002.15.6.577; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Qin J, 2006, J BIOSCIENCES, V31, P255, DOI 10.1007/BF02703918; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakuma Y, 2002, PLANT CELL, V12, P393; Schilmiller AL, 2008, PLANT J, V54, P702, DOI 10.1111/j.1365-313X.2008.03432.x; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Ye R, 2004, PLANT J, V38, P348, DOI 10.1111/j.1365-313X.2004.02037.x; Yu ZX, 2012, MOL PLANT, V5, P353, DOI 10.1093/mp/ssr087; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zhang F, 2010, J EXP BOT, V61, P3599, DOI 10.1093/jxb/erq173; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3; Zhang HB, 2007, PLANT MOL BIOL, V63, P63, DOI 10.1007/s11103-006-9072-4; Zhang L, 2009, BIOTECHNOL APPL BIOC, V52, P199, DOI 10.1042/BA20080068; Zhang W, 2010, PLANT PHYSIOL BIOCH, V48, P45, DOI 10.1016/j.plaphy.2009.10.002; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang ZY, 2007, J EXP BOT, V58, P2993, DOI 10.1093/jxb/erm151; Zuo KJ, 2007, GENE, V391, P80, DOI 10.1016/j.gene.2006.12.019	47	27	35	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57657	10.1371/journal.pone.0057657	http://dx.doi.org/10.1371/journal.pone.0057657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469042	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900141
J	Trapon, ML; Pratchett, MS; Hoey, AS				Trapon, Melanie L.; Pratchett, Morgan S.; Hoey, Andrew S.			Spatial Variation in Abundance, Size and Orientation of Juvenile Corals Related to the Biomass of Parrotfishes on the Great Barrier Reef, Australia	PLOS ONE			English	Article							POSTSETTLEMENT MORTALITY; SCLERACTINIAN CORALS; COMMUNITY STRUCTURE; LARVAL DISPERSAL; LIFE-HISTORIES; RECRUITMENT; PATTERNS; SETTLEMENT; DYNAMICS; GROWTH	For species with complex life histories such as scleractinian corals, processes occurring early in life can greatly influence the number of individuals entering the adult population. A plethora of studies have examined settlement patterns of coral larvae, mostly on artificial substrata, and the composition of adult corals across multiple spatial and temporal scales. However, relatively few studies have examined the spatial distribution of small (<= 50 mm diameter) sexually immature corals on natural reef substrata. We, therefore, quantified the variation in the abundance, composition and size of juvenile corals (<= 50 mm diameter) among 27 sites, nine reefs, and three latitudes spanning over 1000 km on Australia's Great Barrier Reef. Overall, 2801 juveniles were recorded with a mean density of 6.9 (+/- 0.3 SE) ind.m(-2), with Acropora, Pocillopora, and Porites accounting for 84.1% of all juvenile corals surveyed. Size-class structure, orientation on the substrate and taxonomic composition of juvenile corals varied significantly among latitudinal sectors. The abundance of juvenile corals varied both within (6-13 ind.m(-2)) and among reefs (2.8-11.1 ind.m(-2)) but was fairly similar among latitudes (6.1-8.2 ind.m(-2)), despite marked latitudinal variation in larval supply and settlement rates previously found at this scale. Furthermore, the density of juvenile corals was negatively correlated with the biomass of scraping and excavating parrotfishes across all sites, revealing a potentially important role of parrotfishes in determining distribution patterns of juvenile corals on the Great Barrier Reef. While numerous studies have advocated the importance of parrotfishes for clearing space on the substrate to facilitate coral settlement, our results suggest that at high biomass they may have a detrimental effect on juvenile coral assemblages. There is, however, a clear need to directly quantify rates of mortality and growth of juvenile corals to understand the relative importance of these mechanisms in shaping juvenile, and consequently adult, coral assemblages.	[Trapon, Melanie L.; Pratchett, Morgan S.; Hoey, Andrew S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University	Trapon, ML (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	melanie.trapon@my.jcu.edu.au	Pratchett, Morgan S/A-9256-2010; Pratchett, Morgan/AAW-5179-2020; Hoey, Andrew S/B-5457-2015	Pratchett, Morgan S/0000-0002-1862-8459; Pratchett, Morgan/0000-0002-1862-8459; Hoey, Andrew/0000-0002-4261-5594	ARC Centre of Excellence for Coral Reef Studies, Townsville; Australian Coral Reef Society	ARC Centre of Excellence for Coral Reef Studies, Townsville(Australian Research Council); Australian Coral Reef Society	This project was supported by the ARC Centre of Excellence for Coral Reef Studies, Townsville, and the Australian Coral Reef Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alino PM, 1985, P 5 INT COR REEF C, V4, P279; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Babcock R, 1985, P 5 INT COR REEF S, V4, P355; Babcock RC, 2003, ZOOL STUD, V42, P211; Baird AH, 2003, MAR ECOL PROG SER, V252, P289, DOI 10.3354/meps252289; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Banks SA, 1996, CORAL REEFS, V15, P225, DOI 10.1007/BF01787456; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Bonaldo RM, 2008, MAR ECOL PROG SER, V360, P237, DOI 10.3354/meps07413; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Christiansen NA, 2009, CORAL REEFS, V28, P47, DOI 10.1007/s00338-008-0429-9; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; DOHERTY PJ, 1988, OCEANOGR MAR BIOL, V26, P487; DOHERTY PJ, 1985, ENVIRON BIOL FISH, V12, P81, DOI 10.1007/BF00002761; Dunstan PK, 1998, CORAL REEFS, V17, P71, DOI 10.1007/s003380050098; Edmunds PJ, 2000, MAR ECOL PROG SER, V202, P113, DOI 10.3354/meps202113; Fitzhardinge R.C., 1988, P673; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; HARRIOTT VJ, 1988, AUST J MAR FRESH RES, V39, P409; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hoey AS, 2010, MAR BIOL, V157, P189, DOI 10.1007/s00227-009-1309-8; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hoey AS, 2004, OECOLOGIA, V139, P23, DOI 10.1007/s00442-004-1489-3; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; JONES GP, 1990, ECOLOGY, V71, P1691, DOI 10.2307/1937578; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mundy C, 2000, MAR ECOL PROG SER, V198, P109, DOI 10.3354/meps198109; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; Oren U, 1997, MAR BIOL, V127, P499, DOI 10.1007/s002270050038; Penin L, 2011, HYDROBIOLOGIA, V663, P259, DOI 10.1007/s10750-010-0569-0; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Roth MS, 2009, MAR ECOL PROG SER, V376, P133, DOI 10.3354/meps07787; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; RYLAARSDAM KW, 1983, MAR ECOL PROG SER, V13, P249, DOI 10.3354/meps013249; Sammarco PW, 1985, P 5 INT COR REEF C, V4, P391; SATO M, 1985, CORAL REEFS, V4, P27, DOI 10.1007/BF00302201; Schmitt RJ, 1996, MAR FRESHWATER RES, V47, P449, DOI 10.1071/MF9960449; SMITH SR, 1992, AM ZOOL, V32, P663; VANMOORSEL GWNM, 1988, MAR ECOL PROG SER, V50, P127, DOI 10.3354/meps050127; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; Wilson J, 2005, CORAL REEFS, V24, P418, DOI 10.1007/s00338-005-0033-1; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; WITTENBERG M, 1992, MAR BIOL, V112, P131, DOI 10.1007/BF00349736	58	30	30	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57788	10.1371/journal.pone.0057788	http://dx.doi.org/10.1371/journal.pone.0057788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469067	Green Published, gold, Green Accepted			2022-12-27	WOS:000315524900165
J	Taylor, JA; Mitchenall, LA; Rejzek, M; Field, RA; Maxwell, A				Taylor, James A.; Mitchenall, Lesley A.; Rejzek, Martin; Field, Robert A.; Maxwell, Anthony			Application of a Novel Microtitre Plate-Based Assay for the Discovery of New Inhibitors of DNA Gyrase and DNA Topoisomerase VI	PLOS ONE			English	Article							ARCHAEON SULFOLOBUS-SHIBATAE; DOUBLE-STRAND BREAKS; N-TERMINAL FRAGMENT; ESCHERICHIA-COLI; II TOPOISOMERASES; ANTIBACTERIAL DRUGS; CRYSTAL-STRUCTURE; NALIDIXIC-ACID; COUMARIN DRUGS; MECHANISM	DNA topoisomerases are highly exploited targets for antimicrobial drugs. The spread of antibiotic resistance represents a significant threat to public health and necessitates the discovery of inhibitors that target topoisomerases in novel ways. However, the traditional assays for topoisomerase activity are not suitable for the high-throughput approaches necessary for drug discovery. In this study we validate a novel assay for screening topoisomerase inhibitors. A library of 960 compounds was screened against Escherichia coli DNA gyrase and archaeal Methanosarcina mazei DNA topoisomerase VI. Several novel inhibitors were identified for both enzymes, and subsequently characterised in vitro and in vivo. Inhibitors from the M. mazei topoisomerase VI screen were tested for their ability to inhibit Arabidopsis topoisomerase VI in planta. The data from this work present new options for antibiotic drug discovery and provide insight into the mechanism of topoisomerase VI.	[Taylor, James A.; Mitchenall, Lesley A.; Rejzek, Martin; Field, Robert A.; Maxwell, Anthony] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Maxwell, A (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Colney Lane, Norwich NR4 7UH, Norfolk, England.	tony.maxwell@jic.ac.uk		Field, Rob/0000-0001-8574-0275; Mitchenall, Lesley/0000-0002-0063-1991; Taylor, James/0000-0003-0916-7344; Maxwell, Anthony/0000-0002-5756-6430	BBSRC-CASE studentship; Biotechnological and Biological Science Research Council; Plant Bioscience Ltd; BBSRC [BB/J004561/1]; John Innes Foundation; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201, BBS/E/J/000C0618] Funding Source: researchfish	BBSRC-CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnological and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Plant Bioscience Ltd; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JAT was supported by a BBSRC-CASE studentship funded by the Biotechnological and Biological Science Research Council and Plant Bioscience Ltd; the work was supported by grant BB/J004561/1 from BBSRC and the John Innes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Bates A. D., 2005, DNA TOPOLOGY; Bates AD, 2007, BIOCHEMISTRY-US, V46, P7929, DOI 10.1021/bi700789g; Bates AD, 2011, NUCLEIC ACIDS RES, V39, P6327, DOI 10.1093/nar/gkr258; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BERGERAT A, 1994, J BIOL CHEM, V269, P27663; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOJANOWSKI K, 1992, P NATL ACAD SCI USA, V89, P3025, DOI 10.1073/pnas.89.7.3025; Bradbury BJ, 2008, CURR OPIN PHARMACOL, V8, P574, DOI 10.1016/j.coph.2008.04.009; Buhler C, 1998, NUCLEIC ACIDS RES, V26, P5157, DOI 10.1093/nar/26.22.5157; Buhler C, 2001, J BIOL CHEM, V276, P37215, DOI 10.1074/jbc.M101823200; Burrell MR, 2010, METHODS MOL BIOL, V613, P257, DOI 10.1007/978-1-60327-418-0_16; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chauhan PMS, 2001, CURR MED CHEM, V8, P1535, DOI 10.2174/0929867013371851; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Corbett KD, 2007, NAT STRUCT MOL BIOL, V14, P611, DOI 10.1038/nsmb1264; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Edwards MJ, 2011, BIOCHEMISTRY-US, V50, P3432, DOI 10.1021/bi101691k; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; FIGGITT D, 1992, ANTIMICROB AGENTS CH, V36, P1644, DOI 10.1128/AAC.36.8.1644; FINLAY GJ, 1989, EUR J CANCER CLIN ON, V25, P1695, DOI 10.1016/0277-5379(89)90337-4; Finlay GJ, 1999, ONCOL RES, V11, P249; Flament-Saillour M, 1999, AM J RESP CRIT CARE, V160, P587, DOI 10.1164/ajrccm.160.2.9901012; Flatman RH, 2005, ANTIMICROB AGENTS CH, V49, P1093, DOI 10.1128/AAC.49.3.1093-1100.2005; Funatsuki K, 1998, BIOL PHARM BULL, V21, P667; Gadelle D, 2005, NUCLEIC ACIDS RES, V33, P2310, DOI 10.1093/nar/gki526; Gadelle D, 2006, BIOCHEM PHARMACOL, V72, P1207, DOI 10.1016/j.bcp.2006.07.040; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Graille M, 2008, STRUCTURE, V16, P360, DOI 10.1016/j.str.2007.12.020; Hartung F, 2000, NUCLEIC ACIDS RES, V28, P1548, DOI 10.1093/nar/28.7.1548; Hartung F, 2002, CURR BIOL, V12, P1787, DOI 10.1016/S0960-9822(02)01218-6; Harvey AL, 2007, CURR OPIN CHEM BIOL, V11, P480, DOI 10.1016/j.cbpa.2007.08.012; Heide L, 2002, MICROBIAL SECONDARY; Jordan KL, 1999, METH MOL B, V94, P41; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; KRAAL JH, 1979, J DENT RES, V58, P2125, DOI 10.1177/00220345790580111501; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Maxwell A, 1999, METH MOL B, V94, P135; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; MAXWELL A, 1993, MOL MICROBIOL, V9, P681, DOI 10.1111/j.1365-2958.1993.tb01728.x; Maxwell A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gk1054; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NELSON EM, 1984, P NATL ACAD SCI-BIOL, V81, P1361, DOI 10.1073/pnas.81.5.1361; NIERMAN MM, 1961, J INDIANA ST MED ASS, V54, P614; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pierrat OA, 2005, BIOCHEMISTRY-US, V44, P4204, DOI 10.1021/bi0478751; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; REECE RJ, 1989, J BIOL CHEM, V264, P19648; Rice LB, 2003, CURR OPIN PHARMACOL, V3, P459, DOI 10.1016/j.coph.2003.05.001; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; SANDER M, 1983, J BIOL CHEM, V258, P8421; Schrappe M, 2010, LANCET, V376, P1968, DOI 10.1016/S0140-6736(10)62194-0; Shaner DL, 2011, PEST MANAG SCI; SMITH PJ, 1990, BIOCHEM PHARMACOL, V40, P2069, DOI 10.1016/0006-2952(90)90237-F; STEIN CA, 1993, CANCER RES, V53, P2239; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Sturm A, 2007, MED MICROBIOL IMMUN, V196, P127, DOI 10.1007/s00430-007-0044-3; Sugimoto-Shirasu K, 2005, P NATL ACAD SCI USA, V102, P18736, DOI 10.1073/pnas.0505883102; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Sugimoto-Shirasu K, 2002, CURR BIOL, V12, P1782, DOI 10.1016/S0960-9822(02)01198-3; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; Swift LP, 2008, CANCER CHEMOTH PHARM, V61, P739, DOI 10.1007/s00280-007-0528-2; Taylor JA, 2012, METHODS MOL BIOL, V815, P229, DOI 10.1007/978-1-61779-424-7_17; THIELMANN HW, 1991, J CANCER RES CLIN, V117, P19, DOI 10.1007/BF01613191; Tse-Dinh Y. -C., 2007, Infectious Disorders - Drug Targets, V7, P3, DOI 10.2174/187152607780090748; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	83	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e58010	10.1371/journal.pone.0058010	http://dx.doi.org/10.1371/journal.pone.0058010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469129	Green Published, gold, Green Submitted			2022-12-27	WOS:000315561400051
J	Karachanak, S; Grugni, V; Fornarino, S; Nesheva, D; Al-Zahery, N; Battaglia, V; Carossa, V; Yordanov, Y; Torroni, A; Galabov, AS; Toncheva, D; Semino, O				Karachanak, Sena; Grugni, Viola; Fornarino, Simona; Nesheva, Desislava; Al-Zahery, Nadia; Battaglia, Vincenza; Carossa, Valeria; Yordanov, Yordan; Torroni, Antonio; Galabov, Angel S.; Toncheva, Draga; Semino, Ornella			Y-Chromosome Diversity in Modern Bulgarians: New Clues about Their Ancestry	PLOS ONE			English	Article							MUTATION-RATE; GENE FLOW; HAPLOGROUPS; DIFFUSION; ASIA	To better define the structure and origin of the Bulgarian paternal gene pool, we have examined the Y-chromosome variation in 808 Bulgarian males. The analysis was performed by high-resolution genotyping of biallelic markers and by analyzing the STR variation within the most informative haplogroups. We found that the Y-chromosome gene pool in modern Bulgarians is primarily represented by Western Eurasian haplogroups with, similar to 40% belonging to haplogroups E-V13 and I-M423, and 20% to R-M17. Haplogroups common in the Middle East (J and G) and in South Western Asia (R-L23*) occur at frequencies of 19% and 5%, respectively. Haplogroups C, N and Q, distinctive for Altaic and Central Asian Turkic-speaking populations, occur at the negligible frequency of only 1.5%. Principal Component analyses group Bulgarians with European populations, apart from Central Asian Turkic-speaking groups and South Western Asia populations. Within the country, the genetic variation is structured in Western, Central and Eastern Bulgaria indicating that the Balkan Mountains have been permeable to human movements. The lineage analysis provided the following interesting results: (i) R-L23* is present in Eastern Bulgaria since the post glacial period; (ii) haplogroup E-V13 has a Mesolithic age in Bulgaria from where it expanded after the arrival of farming; (iii) haplogroup J-M241 probably reflects the Neolithic westward expansion of farmers from the earliest sites along the Black Sea. On the whole, in light of the most recent historical studies, which indicate a substantial proto-Bulgarian input to the contemporary Bulgarian people, our data suggest that a common paternal ancestry between the proto-Bulgarians and the Altaic and Central Asian Turkic-speaking populations either did not exist or was negligible.	[Karachanak, Sena; Nesheva, Desislava; Toncheva, Draga] Med Univ Sofia, Dept Med Genet, Sofia, Bulgaria; [Karachanak, Sena; Grugni, Viola; Fornarino, Simona; Al-Zahery, Nadia; Battaglia, Vincenza; Carossa, Valeria; Torroni, Antonio; Semino, Ornella] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Yordanov, Yordan] Bulgarian Acad Sci, Inst Expt Morphol & Anthropol Museum, Sofia, Bulgaria; [Galabov, Angel S.] Bulgarian Acad Sci, Stephan Angeloff Inst Microbiol, Sofia, Bulgaria	Medical University Sofia; University of Pavia; Bulgarian Academy of Sciences; Bulgarian Academy of Sciences; Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences	Toncheva, D (corresponding author), Med Univ Sofia, Dept Med Genet, Sofia, Bulgaria.	dragatoncheva@gmail.com; ornella.semino@unipv.it	Torroni, Antonio/E-1557-2011; Battaglia, Vincenza/F-6950-2017; Yordanov, Yordan/M-4526-2016; Al-Zahery, Nadia/AAV-5878-2020; Karachanak-Yankova, Sena/AAL-2721-2021	Torroni, Antonio/0000-0002-4163-4478; Karachanak-Yankova, Sena/0000-0001-6441-629X; Nesheva, Desislava/0000-0002-8574-8477; Toncheva, Draga/0000-0002-7451-6363; SEMINO, Ornella/0000-0002-9675-9403	National Science Fund of Bulgaria [DOO 2-110/22.05.2009]; Fondazione Alma Mater Ticinensis; Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; Institute of International Education	National Science Fund of Bulgaria(National Science Fund of Bulgaria); Fondazione Alma Mater Ticinensis; Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; Institute of International Education	This study was supported by the National Science Fund of Bulgaria, project "Characterization of the anthropo-genetic identity of Bulgarians", contract number DOO 2-110/22.05.2009, and Fondazione Alma Mater Ticinensis (to OS and AT), the Italian Ministry of the University: Progetti Ricerca Interesse Nazionale 2009 (to OS and AT). NA-Z was supported by a fellowship from the Institute of International Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Bazin L, 1974, THESIS PARIS U LILLE; Beshevliev V, 1993, 1 BULGARIAN INSCRIPT; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cholov P, 2008, VOLGA BULGARIA 7 16; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Daskalov R, 2011, AMAZING WORLD PROTOB; Dimitrov B, 2005, 12 MYTHS BULGARIAN H, P38; DOBREV P, 2005, GOLDEN CORE BULGARIA; Dobrev P, 1998, CRUCIFIED HIST 1; Dobrev P, 1994, WORLD PROTOBULGARIAN; Dobrev PD, 1991, PROTOBULGARIANS ORIG; Dujchev I, 1963, MEDIEVAL TRANSLATION; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fol A, 2000, BULGARIANS; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Gimbutas M., 1970, INDOEUROPEAN INDOEUR, P155; Haefs H, 2009, GOLDENE REICH PAMIR; Karachanak S, 2012, INT J LEGAL MED; Kozlowski JK, 2007, DIOGENES, V54, P134, DOI 10.1177/0392192107077648; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Malyarchuk B, 2011, J HUM GENET, V56, P583, DOI 10.1038/jhg.2011.64; Manchen-Helfen O, 1973, WORLD HUNS STUDIES T; Marjanovic D, 2005, ANN HUM GENET, V69, P757, DOI 10.1111/j.1529-8817.2005.00190.x; Menges K.H., 1995, VER FFENTLICHUNGEN S; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nitecki M.H., 1994, ORIGINS ANATOMICALLY; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Petrov P, 1979, CHRESTOMATHY BULGARI, VI, P88; Pritsak O., 1955, BULGARISCHE FURSTENL; Rashev R, 1993, ORIGIN PROTOBULGARIA; Ray N., 2001, INTERNET ARCHAEOL, V11; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Stamatov A, 1997, TEMPORA INCOGNITA EA; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Wozniak M, 2010, AM J PHYS ANTHROPOL, V142, P540, DOI 10.1002/ajpa.21253; Yordanov Yordan Al, 2006, ANTHR BULGARIAN POPU; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	49	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56779	10.1371/journal.pone.0056779	http://dx.doi.org/10.1371/journal.pone.0056779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483890	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100008
J	Jin, M; He, YQ; Li, HY; Huang, PW; Zhong, WM; Yang, H; Zhang, HL; Tan, M; Duan, ZJ				Jin, Miao; He, Yaqing; Li, Huiying; Huang, Pengwei; Zhong, Weiming; Yang, Hong; Zhang, Hailong; Tan, Ming; Duan, Zhao-jun			Two Gastroenteritis Outbreaks Caused by GII Noroviruses: Host Susceptibility and HBGA Phenotypes	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; NORWALK VIRUS-INFECTION; CAPSID PROTEIN FORMS; VIRAL GASTROENTERITIS; BINDING SPECIFICITY; NONSENSE MUTATION; STRUCTURAL BASIS; UNITED-STATES; P-DOMAIN; STRAIN	Noroviruses (NoVs) cause epidemic acute gastroenteritis, in which histo-blood group antigens (HBGAs) may play an important role in the host susceptibility. To further explore this issue, two outbreaks of acute gastroenteritis caused by a GII.4 and a GII.3 NoV, respectively, in China in 2009 were studied. Stool and saliva samples from symptomatic patients and water samples from the outbreak facilities were collected. RT-PCR showed that 23 out of 33 (GII.4 outbreak) and 12 out of 13 (GII.3outbreak) stool samples were NoV positive. For the GII.4 outbreak the NoV sequences of stool and water samples were from an identical GII.4 strain, while the same GII.3 NoV sequences were found in five stool samples from the GII.3 outbreak. The HBGA phenotypes (A, B, Le(a), Le(b), Le(x), and Le(y)) of all saliva samples were determined, which revealed both secretors and nonsecretors in the symptomatic groups of the two outbreaks. In the GII.3 outbreak, type O individuals appeared less susceptible, while the type A may be more at risk of infection. However, No preference of HBGAs was observed in the GII. 4 outbreak. The observation that nonsecretors were infected in both outbreaks differed from the previous results that nonsecretors are resistant to these two GII NoVs.	[Jin, Miao; Li, Huiying; Duan, Zhao-jun] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Jin, Miao; Huang, Pengwei; Zhong, Weiming; Tan, Ming] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Tan, Ming] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [He, Yaqing; Yang, Hong; Zhang, Hailong] Shenzhen Ctr Dis Control & Prevent, Major Infect Dis Control Key Lab, Shenzhen, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Shenzhen Center for Disease Control & Prevention (SZCDC)	Tan, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA.	Ming.Tan@cchmc.org; zhaojund@126.com			National Institute of Allergy and Infectious Diseases [R21 AI092434-01A1]; Institutional Clinical and Translational Science Award (NIH/NCRR) [1UL1RR026314-01]; National Natural Science Foundation of China [81000727]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092434] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institutional Clinical and Translational Science Award (NIH/NCRR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this article was supported by the National Institute of Allergy and Infectious Diseases (R21 AI092434-01A1), Institutional Clinical and Translational Science Award (NIH/NCRR Grant Number 1UL1RR026314-01) and National Natural Science Foundation of China (Grant number: 81000727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Bucardo F, 2009, J MED VIROL, V81, P728, DOI 10.1002/jmv.21426; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Chan MCW, 2008, J INFECT DIS, V198, P940, DOI 10.1086/588707; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514; GREEN KY, 2001, FIELDS VIROLOGY, P841; Halperin T, 2008, J INFECT DIS, V197, P63, DOI 10.1086/524145; Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; Jin M, 2008, J MED VIROL, V80, P1997, DOI 10.1002/jmv.21308; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Kindberg E, 2007, J CLIN MICROBIOL, V45, P2720, DOI 10.1128/JCM.00162-07; Le Guyader FS, 2010, J CLIN MICROBIOL, V48, P915, DOI 10.1128/JCM.01664-09; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Nordgren J, 2010, EMERG INFECT DIS, V16, P81, DOI 10.3201/eid1601.090633; Rockx BHG, 2005, J INFECT DIS, V191, P749, DOI 10.1086/427779; Rydell GE, 2009, GLYCOBIOLOGY, V19, P309, DOI 10.1093/glycob/cwn139; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2004, J MED VIROL, V74, P641, DOI 10.1002/jmv.20228; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2008, VIROLOGY, V379, P324, DOI 10.1016/j.virol.2008.06.041; Tan M, 2008, J INFECT DIS, V198, P940, DOI 10.1086/589810; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Tan M, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P111; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005058; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	55	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58605	10.1371/journal.pone.0058605	http://dx.doi.org/10.1371/journal.pone.0058605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472212	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900158
J	Nitta, M; Imamura, M; Inoue, Y; Kunitomo, Y; Lin, ZYC; Ogawa, T; Yogo, K; Ishida-Kitagawa, N; Fukunaga, N; Okano, H; Sato, E; Takeya, T; Miyoshi, J				Nitta, Mai; Imamura, Masanori; Inoue, Yu; Kunitomo, Yasuo; Lin, Zachary Yu-Ching; Ogawa, Takuya; Yogo, Keiichiro; Ishida-Kitagawa, Norihiro; Fukunaga, Noritaka; Okano, Hideyuki; Sato, Eimei; Takeya, Tatsuo; Miyoshi, Jun			Aberrant Gene Expression and Sexually Incompatible Genomic Imprinting in Oocytes Derived from XY Mouse Embryonic Stem Cells In Vitro	PLOS ONE			English	Article							FETAL GERM-CELLS; FOLLICLE DEVELOPMENT; PRIMORDIAL FOLLICLES; OVARIAN STRUCTURES; GRANULOSA-CELLS; Y-CHROMOSOME; MATURATION; MICE; GROWTH; DIFFERENTIATION	Mouse embryonic stem cells (ESCs) have the potential to differentiate into germ cells (GCs) in vivo and in vitro. Interestingly, XY ESCs can give rise to both male and female GCs in culture, irrespective of the genetic sex. Recent studies showed that ESC-derived primordial GCs contributed to functional gametogenesis in vivo; however, in vitro differentiation techniques have never succeeded in generating mature oocytes from ESCs due to cryptogenic growth arrest during the preantral follicle stages of development. To address this issue, a mouse ESC line, capable of producing follicle-like structures (FLSs) efficiently, was established to investigate their properties using conventional molecular biological methods. The results revealed that the ESC-derived FLSs were morphologically similar to ovarian primary-to-secondary follicles but never formed an antrum; instead, the FLSs eventually underwent abnormal development or cell death in culture, or formed teratomas when transplanted under the kidney capsule in mice. Gene expression analyses demonstrated that the FLSs lacked transcripts for genes essential to late folliculogenesis, including gonadotropin receptors and steroidogenic enzymes, whereas some other genes were overexpressed in FLSs compared to the adult ovary. The E-Cadherin protein, which is involved in cell-to-cell interactions, was also expressed ectopically. Remarkably, it was seen that oocyte-like cells in the FLSs exhibited androgenetic genomic imprinting, which is ordinarily indicative of male GCs. Although the FLSs did not express male GC marker genes, the DNA methyltransferase, Dnmt3L, was expressed at an abnormally high level. Furthermore, the expression of sex determination factors was ambiguous in FLSs as both male and female determinants were expressed weakly. These data suggest that the developmental dysfunction of the ESC-derived FLSs may be attributable to aberrant gene expression and genomic imprinting, possibly associated with uncertain sex determination in culture.	[Nitta, Mai; Inoue, Yu; Kunitomo, Yasuo; Ogawa, Takuya; Ishida-Kitagawa, Norihiro; Takeya, Tatsuo] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan; [Nitta, Mai; Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan; [Imamura, Masanori; Lin, Zachary Yu-Ching; Okano, Hideyuki] Keio Univ, Dept Physiol, Tokyo, Japan; [Yogo, Keiichiro] Shizuoka Univ, Lab Anim Reprod & Physiol, Shizuoka, Japan; [Fukunaga, Noritaka; Sato, Eimei] Tohoku Univ, Lab Anim Reprod, Sendai, Miyagi 980, Japan	Nara Institute of Science & Technology; Osaka Medical Center for Cancer & Cardiovascular Diseases; Keio University; Shizuoka University; Tohoku University	Imamura, M (corresponding author), Keio Univ, Dept Physiol, Tokyo, Japan.	imamura@a5.keio.jp; ttakeya@bs.naist.jp	Okano, Hideyuki/I-7584-2019; Ogawa, Takuya/ABC-9628-2020; Imamura, Masanori/AAV-5743-2021	Ogawa, Takuya/0000-0001-9194-3079; Imamura, Masanori/0000-0001-7609-2026; Inoue, Yu/0000-0002-7540-6940; Yogo, Keiichiro/0000-0003-2051-6891	Japan Society for the Promotion of Science [JSPS-16108003]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for World-leading Innovative R&D in Science and Technology (FIRST); Keio University; Grants-in-Aid for Scientific Research [25860222] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-leading Innovative R&D in Science and Technology (FIRST); Keio University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS-16108003); grant-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to J.M., for period 2004-2010); the Funding Program for World-leading Innovative R&D in Science and Technology (FIRST); and Keio University Grant-in-Aid for Encouragement of Young Medical Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian B, 2006, REPRODUCTION, V132, P699, DOI 10.1530/REP-06-0022; Alton M, 2008, REPRODUCTION, V135, P241, DOI 10.1530/REP-07-0383; Arnaud P, 2010, REPRODUCTION, V140, P411, DOI 10.1530/REP-10-0173; Binelli M, 2010, REPROD FERT DEVELOP, V22, P1, DOI 10.1071/RD09218; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Bowles J, 2010, REPRODUCTION, V139, P943, DOI 10.1530/REP-10-0075; Britt KL, 2002, J ENDOCRINOL, V175, P269, DOI 10.1677/joe.0.1750269; Durcova-Hills G, 2004, DEV BIOL, V268, P105, DOI 10.1016/j.ydbio.2003.12.018; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; EVANS EP, 1977, NATURE, V267, P430, DOI 10.1038/267430a0; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Isotani A, 2005, P NATL ACAD SCI USA, V102, P4039, DOI 10.1073/pnas.0406769102; Kageyama S, 2007, REPRODUCTION, V133, P85, DOI 10.1530/REP-06-0025; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kerjean A, 2003, EUR J HUM GENET, V11, P493, DOI 10.1038/sj.ejhg.5200990; Kidder GM, 2002, REPRODUCTION, V123, P613, DOI 10.1530/rep.0.1230613; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kumar TR, 2005, REPRODUCTION, V130, P293, DOI 10.1530/rep.1.00660; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lavagnolli TMC, 2009, DIFFERENTIATION, V78, P124, DOI 10.1016/j.diff.2009.07.003; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; MCLAREN A, 1981, J REPROD FERTIL, V61, P461, DOI 10.1530/jrf.0.0610461; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Nicholas CR, 2009, ENDOCR REV, V30, P264, DOI 10.1210/er.2008-0034; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Picton HM, 2008, REPRODUCTION, V136, P703, DOI 10.1530/REP-08-0290; Psathaki OE, 2011, STEM CELLS DEV, V20, P2205, DOI 10.1089/scd.2010.0575; Qing TT, 2007, DIFFERENTIATION, V75, P902, DOI 10.1111/j.1432-0436.2007.00181.x; Salha O, 1998, HUM REPROD UPDATE, V4, P816, DOI 10.1093/humupd/4.6.816; Salvador LM, 2008, METHODS, V45, P172, DOI 10.1016/j.ymeth.2008.03.004; Shen W, 2007, REPRODUCTION, V134, P223, DOI 10.1530/REP-06-0378; Shen W, 2006, BIOL REPROD, V75, P615, DOI 10.1095/biolreprod.106.051482; Soyal SM, 2000, DEVELOPMENT, V127, P4645; SPEARS N, 1994, HUM REPROD, V9, P527, DOI 10.1093/oxfordjournals.humrep.a138539; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Tedesco M, 2011, INT J DEV BIOL, V55, P215, DOI 10.1387/ijdb.103108mt; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vanderhyden BC, 1997, BIOL REPROD, V57, P641, DOI 10.1095/biolreprod57.3.641; Villemure M, 2007, DEV BIOL, V301, P1, DOI 10.1016/j.ydbio.2006.10.034; West FD, 2010, HUM REPROD, V25, P168, DOI 10.1093/humrep/dep338; Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739; Young JC, 2010, BIOL REPROD, V82, P390, DOI 10.1095/biolreprod.109.078493; Yu Z, 2009, J MOL CELL BIOL, V1, P93, DOI 10.1093/jmcb/mjp026; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	59	5	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58555	10.1371/journal.pone.0058555	http://dx.doi.org/10.1371/journal.pone.0058555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472205	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900151
J	Paul, C; Pohnert, G				Paul, Carsten; Pohnert, Georg			Induction of Protease Release of the Resistant Diatom Chaetoceros didymus in Response to Lytic Enzymes from an Algicidal Bacterium	PLOS ONE			English	Article							GROWTH; PHYTOPLANKTON; GYMNODINIUM; PLANKTON; ALGAE; SEA; BAY	Marine lytic bacteria can have a substantial effect on phytoplankton and are even capable to terminate blooms of microalgae. The bacterium Kordia algicida was reported to lyse cells of the diatom Skeletonema costatum and several other diatoms by a quorum sensing controlled excretion of proteases. However the diatom Chaetoceros didymus is fully resistant against the bacterial enzymes. We show that the growth curve of this diatom is essentially unaffected by addition of bacterial filtrates that are active against other diatoms. By monitoring proteases from the medium using zymography and fluorescence based activity assays we demonstrate that C. didymus responds to the presence of the lytic bacteria with the induced production of algal proteases. These proteases exhibit a substantially increased activity compared to the bacterial counterparts. The induction is also triggered by signals in the supernatant of a K. algicida culture. Size fractionation shows that only the >30 kD fraction of the bacterial exudates acts as an inducing cue. Implications for a potential induced defense of the diatom C. didymus are discussed.	[Paul, Carsten; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem, Dept Bioorgan Analyt, Jena, Germany	Friedrich Schiller University of Jena	Pohnert, G (corresponding author), Univ Jena, Inst Inorgan & Analyt Chem, Dept Bioorgan Analyt, Jena, Germany.	Georg.Pohnert@uni-jena.de	Pohnert, Georg/D-3721-2013	Pohnert, Georg/0000-0003-2351-6336	VolkswagenFoundation; Jena School for Microbial Communication	VolkswagenFoundation(Volkswagen); Jena School for Microbial Communication	The study was funded by the VolkswagenFoundation in the framework of a LichtenbergProfessorship (http://www.volkswagen-stiftung.de/) and the Jena School for Microbial Communication (http://www.jsmc.uni-jena.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; Ask J, 2006, J PLANKTON RES, V28, P683, DOI 10.1093/plankt/fbl005; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Bruckner CG, 2011, ENVIRON MICROBIOL, V13, P1052, DOI 10.1111/j.1462-2920.2010.02411.x; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Doucette GJ, 1999, J PHYCOL, V35, P1447, DOI 10.1046/j.1529-8817.1999.3561447.x; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; Ferrier M, 2002, J APPL MICROBIOL, V92, P706, DOI 10.1046/j.1365-2672.2002.01576.x; Gardes A, 2011, ISME J, V5, P436, DOI 10.1038/ismej.2010.145; GARCIACARRENO FL, 1993, J FOOD BIOCHEM, V17, P97, DOI 10.1111/j.1745-4514.1993.tb00864.x; Grossart HP, 2007, AQUAT MICROB ECOL, V47, P163, DOI 10.3354/ame047163; Horner RA, 2005, PROG OCEANOGR, V67, P286, DOI 10.1016/j.pocean.2005.09.005; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Jones LJ, 1997, ANAL BIOCHEM, V251, P144, DOI 10.1006/abio.1997.2259; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; MAIER I, 1994, BOT ACTA, V107, P451, DOI 10.1111/j.1438-8677.1994.tb00820.x; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mayali X, 2008, J PHYCOL, V44, P923, DOI 10.1111/j.1529-8817.2008.00549.x; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Paul C, 2009, MAR ECOL PROG SER, V389, P61, DOI 10.3354/meps08162; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; Roth PB, 2008, HARMFUL ALGAE, V7, P682, DOI 10.1016/j.hal.2008.02.002; Seyedsayamdost MR, 2011, J AM CHEM SOC, V133, P18343, DOI 10.1021/ja207172s; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Tilman D., 1982, Monographs in Population Biology, pi; Vanelslander B, 2012, P NATL ACAD SCI USA, V109, P2412, DOI 10.1073/pnas.1108062109; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94	33	25	29	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57577	10.1371/journal.pone.0057577	http://dx.doi.org/10.1371/journal.pone.0057577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469204	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900028
J	Saito, TH; Uda, S; Tsuchiya, T; Ozaki, Y; Kuroda, S				Saito, Takeshi H.; Uda, Shinsuke; Tsuchiya, Takaho; Ozaki, Yu-ichi; Kuroda, Shinya			Temporal Decoding of MAP Kinase and CREB Phosphorylation by Selective Immediate Early Gene Expression	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PC12 CELLS; SIGNALING PATHWAYS; NEURONAL DIFFERENTIATION; NEGATIVE FEEDBACK; ERK OSCILLATIONS; ACTIVATION; NETWORKS; SPECIFICITY; MECHANISMS	A wide range of growth factors encode information into specific temporal patterns of MAP kinase (MAPK) and CREB phosphorylation, which are further decoded by expression of immediate early gene products (IEGs) to exert biological functions. However, the IEG decoding system remain unknown. We built a data-driven based on time courses of MAPK and CREB phosphorylation and IEG expression in response to various growth factors to identify how signal is processed. We found that IEG expression uses common decoding systems regardless of growth factors and expression of each IEG differs in upstream dependency, switch-like response, and linear temporal filters. Pulsatile ERK phosphorylation was selectively decoded by expression of EGR1 rather than c-FOS. Conjunctive NGF and PACAP stimulation was selectively decoded by synergistic JUNB expression through switch-like response to c-FOS. Thus, specific temporal patterns and combinations of MAPKs and CREB phosphorylation can be decoded by selective IEG expression via distinct temporal filters and switch-like responses. The data-driven modeling is versatile for analysis of signal processing and does not require detailed prior knowledge of pathways.	[Saito, Takeshi H.; Uda, Shinsuke; Tsuchiya, Takaho; Ozaki, Yu-ichi; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan; [Kuroda, Shinya] Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Kuroda, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan.	skuroda@bi.s.u-tokyo.ac.jp			CREST, from the Japan Science and Technology (JST); KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [21240025]; JST; Human Frontier Science Project (HFSP) [RGP0061/2011]	CREST, from the Japan Science and Technology (JST); KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST(Japan Science & Technology Agency (JST)); Human Frontier Science Project (HFSP)(Human Frontier Science Program)	This work was supported by The Dynamic Mechanisms of and Fundamental Technology for Biological Systems, and the Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, from the Japan Science and Technology (JST); by a KAKENHI Scientific Research grant (A) (#21240025) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); by the Strategic International Cooperative Program (Research Exchange Type), JST, and by a Human Frontier Science Project (HFSP) grant (RGP0061/2011). T. H. S. is a research fellow of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albeck JG, 2012, MOL CELL; Beaujean D, 2003, EXP NEUROL, V184, P348, DOI 10.1016/j.expneurol.2003.07.007; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Canossa M, 2001, EMBO J, V20, P1640, DOI 10.1093/emboj/20.7.1640; Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279; Chung JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009011; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Hashimoto H, 2000, J NEUROCHEM, V74, P501, DOI 10.1046/j.1471-4159.2000.740501.x; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hill A.V, 1910, J PHYSL, V40; HUNTER IW, 1986, BIOL CYBERN, V55, P135; Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Lijung L., 1987, SYSTEM IDENTIFICATIO; Ljung L, 2010, ANNU REV CONTROL, V34, P1, DOI 10.1016/j.arcontrol.2009.12.001; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ozaki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009955; Price ND, 2007, CURR OPIN BIOTECH, V18, P365, DOI 10.1016/j.copbio.2007.07.009; PSHENICHKIN SP, 1995, J BIOL CHEM, V270, P5994, DOI 10.1074/jbc.270.11.5994; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Sakai Y, 2001, BIOCHEM BIOPH RES CO, V285, P656, DOI 10.1006/bbrc.2001.5244; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Takei N, 2000, EUR J NEUROSCI, V12, P2273, DOI 10.1046/j.1460-9568.2000.00118.x; Torocsik B, 2000, BIOCHEM BIOPH RES CO, V278, P550, DOI 10.1006/bbrc.2000.3836; Torocsik B, 2000, EUR J NEUROSCI, V12, P527, DOI 10.1046/j.1460-9568.2000.00933.x; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Watanabe K, 2012, J CELL SCI, V125, P2198, DOI 10.1242/jcs.097709; Weber TJ, 2010, J INVEST DERMATOL, V130, P1444, DOI 10.1038/jid.2009.383; Yuhara A, 2003, BIOCHEM BIOPH RES CO, V301, P344, DOI 10.1016/S0006-291X(02)03037-1	46	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57037	10.1371/journal.pone.0057037	http://dx.doi.org/10.1371/journal.pone.0057037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469182	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900012
J	Carleton, RN; Thibodeau, MA; Teale, MJN; Welch, PG; Abrams, MP; Robinson, T; Asmundson, GJG				Carleton, R. Nicholas; Thibodeau, Michel A.; Teale, Michelle J. N.; Welch, Patrick G.; Abrams, Murray P.; Robinson, Thomas; Asmundson, Gordon J. G.			The Center for Epidemiologic Studies Depression Scale: A Review with a Theoretical and Empirical Examination of Item Content and Factor Structure	PLOS ONE			English	Article							CES-D SCALE; CONFIRMATORY FACTOR-ANALYSIS; SHORT VERSION; CHRONIC PAIN; CROSS-VALIDATION; POSITIVE AFFECT; INVENTORY-II; OLDER-ADULTS; SHORT-FORM; VALIDITY	Background: The Center for Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) is a commonly used freely available self-report measure of depressive symptoms. Despite its popularity, several recent investigations have called into question the robustness and suitability of the commonly used 4-factor 20-item CES-D model. The goal of the current study was to address these concerns by confirming the factorial validity of the CES-D. Methods and Findings: Differential item functioning estimates were used to examine sex biases in item responses, and confirmatory factor analyses were used to assess prior CES-D factor structures and new models heeding current theoretical and empirical considerations. Data used for the analyses included undergraduate (n = 948; 74% women), community (n = 254; 71% women), rehabilitation (n = 522; 53% women), clinical (n = 84; 77% women), and National Health and Nutrition Examination Survey (NHANES; n = 2814; 56% women) samples. Differential item functioning identified an item as inflating CES-D scores in women. Comprehensive comparison of the several models supported a novel, psychometrically robust, and unbiased 3-factor 14-item solution, with factors (i.e., negative affect, anhedonia, and somatic symptoms) that are more in line with current diagnostic criteria for depression. Conclusions: Researchers and practitioners may benefit from using the novel factor structure of the CES-D and from being cautious in interpreting results from the originally proposed scale. Comprehensive results, implications, and future research directions are discussed.	[Carleton, R. Nicholas; Thibodeau, Michel A.; Teale, Michelle J. N.; Welch, Patrick G.; Abrams, Murray P.; Asmundson, Gordon J. G.] Univ Regina, Dept Psychol, Anxiety & Illness Behav Lab, Regina, SK S4S 0A2, Canada; [Robinson, Thomas] Regina QuAppelle Hlth Reg, Funct Rehabil Program, Regina, SK, Canada	University of Regina	Carleton, RN (corresponding author), Univ Regina, Dept Psychol, Anxiety & Illness Behav Lab, Regina, SK S4S 0A2, Canada.	Nick.Carleton@uregina.ca	Carleton, R. Nicholas/A-2349-2009					American Psychiatric Association, 1968, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boey KW, 1999, INT J GERIATR PSYCH, V14, P608, DOI 10.1002/(SICI)1099-1166(199908)14:8<608::AID-GPS991>3.0.CO;2-Z; Boisvert JA, 2003, DEPRESS ANXIETY, V17, P19, DOI 10.1002/da.10080; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; BURNAM MA, 1988, MED CARE, V26, P775, DOI 10.1097/00005650-198808000-00004; Bush BA, 2004, J CLIN PSYCHOL MED S, V11, P195, DOI 10.1023/B:JOCS.0000037613.69367.d4; Byrne B. M., 2001, STRUCTURAL EQUATION; CALLAHAN CM, 1994, MED CARE, V32, P341, DOI 10.1097/00005650-199404000-00003; Carpenter J S, 1998, Issues Ment Health Nurs, V19, P481; Cheng ST, 2006, INT J GERIATR PSYCH, V21, P333, DOI 10.1002/gps.1467; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cole JC, 2004, PSYCHOL ASSESSMENT, V16, P360, DOI 10.1037/1040-3590.16.4.360; Embretson S, 2000, MULTIVARIATE APPL BO; FLOR H, 1987, J PSYCHOSOM RES, V31, P251, DOI 10.1016/0022-3999(87)90082-1; Fountoulakis KN, 2007, J AFFECT DISORDERS, V97, P187, DOI 10.1016/j.jad.2006.06.015; Freedle R, 1997, INTELLIGENCE, V24, P417, DOI 10.1016/S0160-2896(97)90058-1; Hambleton RK, 1989, APPL MEAS EDUC, V2, P313, DOI [10.1207/s15324818ame0204_4, DOI 10.1207/S15324818AME0204_4]; Herrero J, 2006, COMPUT HUM BEHAV, V22, P830, DOI 10.1016/j.chb.2004.03.007; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Hunter JE, 2000, PSYCHOL PUBLIC POL L, V6, P151, DOI 10.1037/1076-8971.6.1.151; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee AEY, 2008, INT J GERIATR PSYCH, V23, P592, DOI 10.1002/gps.1944; Lee SW, 2008, J PERS ASSESS, V90, P175, DOI 10.1080/00223890701845385; Meyer JP, 2011, JMETRIK 2 1 0 COMPUT; Morley S, 2002, PAIN, V99, P289, DOI 10.1016/S0304-3959(02)00137-9; Nevitt J, 2001, STRUCT EQU MODELING, V8, P353, DOI 10.1207/S15328007SEM0803_2; Novak D, 1995, J AM DIET ASSOC, V95, pA56; Nutt D, 2007, J PSYCHOPHARMACOL, V21, P461, DOI 10.1177/0269881106069938; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Osborne J.W., 2008, BEST PRACT QUANT MET, DOI DOI 10.4135/9781412995627.D18; Peterson CC, 2004, J PEDIATR PSYCHOL, V29, P331, DOI 10.1093/jpepsy/jsh037; Pool JJM, 2009, QUAL QUANT, V43, P773, DOI 10.1007/s11135-008-9203-x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Rivera-Medina CL, 2010, J CONSULT CLIN PSYCH, V78, P398, DOI 10.1037/a0019054; ROBERTS RE, 1991, J AM ACAD CHILD PSY, V30, P58, DOI 10.1097/00004583-199101000-00009; Rouch-Leroyer I, 2000, AGING-CLIN EXP RES, V12, P228, DOI 10.1007/BF03339840; SANTOR DA, 1995, PSYCHOL ASSESSMENT, V7, P131, DOI 10.1037/1040-3590.7.2.131; Santor DA, 1997, PSYCHOL ASSESSMENT, V9, P233, DOI 10.1037/1040-3590.9.3.233; Schroevers MJ, 2000, QUAL LIFE RES, V9, P1015, DOI 10.1023/A:1016673003237; SCHULBERG HC, 1985, ARCH GEN PSYCHIAT, V42, P1164; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; SHROUT PE, 1989, J CLIN EPIDEMIOL, V42, P69, DOI 10.1016/0895-4356(89)90027-9; Snarski M., 2006, PSYCHOTHERAPY DEPRES, P45; Stansbury JP, 2006, J PERS ASSESS, V86, P10, DOI 10.1207/s15327752jpa8601_03; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; TURK DC, 1994, BEHAV RES THER, V32, P9, DOI 10.1016/0005-7967(94)90078-7; Tuunainen A, 2001, PSYCHIAT RES, V103, P261, DOI 10.1016/S0165-1781(01)00278-5; Urbina S., 2004, ESSENTIALS PSYCHOL T, V1st ed; Vanheule S, 2008, ASSESSMENT, V15, P177, DOI 10.1177/1073191107311261; Ward LC, 2006, PSYCHOL ASSESSMENT, V18, P81, DOI 10.1037/1040-3590.18.1.81; Warner R.M., 2012, APPL STAT BIVARIATE; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Williams CD, 2007, PSYCHIAT RES, V150, P173, DOI 10.1016/j.psychres.2006.02.007; Yang FM, 2007, J CLIN EPIDEMIOL, V60, P1195, DOI 10.1016/j.jclinepi.2007.02.008; Yen S, 2000, J CONSULT CLIN PSYCH, V68, P993, DOI 10.1037/0022-006X.68.6.993; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2; Zumbo B. D., 2007, LANG ASSESS Q, V4, P223, DOI DOI 10.1080/15434300701375832	69	260	265	7	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58067	10.1371/journal.pone.0058067	http://dx.doi.org/10.1371/journal.pone.0058067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103EI	23469262	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100059
J	Dovzhenok, A; Park, C; Worth, RM; Rubchinsky, LL				Dovzhenok, Andrey; Park, Choongseok; Worth, Robert M.; Rubchinsky, Leonid L.			Failure of Delayed Feedback Deep Brain Stimulation for Intermittent Pathological Synchronization in Parkinson's Disease	PLOS ONE			English	Article							EXTERNAL GLOBUS-PALLIDUS; SUBTHALAMIC NUCLEUS; BETA OSCILLATIONS; MODEL; SUPPRESSION; PATTERNS; NETWORK; RHYTHM	Suppression of excessively synchronous beta-band oscillatory activity in the brain is believed to suppress hypokinetic motor symptoms of Parkinson's disease. Recently, a lot of interest has been devoted to desynchronizing delayed feedback deep brain stimulation (DBS). This type of synchrony control was shown to destabilize the synchronized state in networks of simple model oscillators as well as in networks of coupled model neurons. However, the dynamics of the neural activity in Parkinson's disease exhibits complex intermittent synchronous patterns, far from the idealized synchronous dynamics used to study the delayed feedback stimulation. This study explores the action of delayed feedback stimulation on partially synchronized oscillatory dynamics, similar to what one observes experimentally in parkinsonian patients. We employ a computational model of the basal ganglia networks which reproduces experimentally observed fine temporal structure of the synchronous dynamics. When the parameters of our model are such that the synchrony is unphysiologically strong, the feedback exerts a desynchronizing action. However, when the network is tuned to reproduce the highly variable temporal patterns observed experimentally, the same kind of delayed feedback may actually increase the synchrony. As network parameters are changed from the range which produces complete synchrony to those favoring less synchronous dynamics, desynchronizing delayed feedback may gradually turn into synchronizing stimulation. This suggests that delayed feedback DBS in Parkinson's disease may boost rather than suppress synchronization and is unlikely to be clinically successful. The study also indicates that delayed feedback stimulation may not necessarily exhibit a desynchronization effect when acting on a physiologically realistic partially synchronous dynamics, and provides an example of how to estimate the stimulation effect.	[Dovzhenok, Andrey; Park, Choongseok; Worth, Robert M.; Rubchinsky, Leonid L.] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA; [Dovzhenok, Andrey; Park, Choongseok; Worth, Robert M.; Rubchinsky, Leonid L.] Indiana Univ Purdue Univ, Ctr Math Biosci, Indianapolis, IN 46202 USA; [Worth, Robert M.] Indiana Univ Sch Med, Dept Neurosurg, Indianapolis, IN USA; [Rubchinsky, Leonid L.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Dovzhenok, A (corresponding author), Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA.	andrey.dovzhenok@uc.edu	Rubchinsky, Leonid/L-1896-2017	Rubchinsky, Leonid/0000-0002-6596-4594	National Institutes of Health (NSF/NIH CRCNS) [R01NS067200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067200] Funding Source: NIH RePORTER	National Institutes of Health (NSF/NIH CRCNS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are supported by National Institutes of Health grant R01NS067200 (NSF/NIH CRCNS program), http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016201; Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551; Best J, 2007, J COMPUT NEUROSCI, V23, P217, DOI 10.1007/s10827-007-0029-7; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Dorval AD, 2008, J NEUROPHYSIOL, V100, P2807, DOI 10.1152/jn.90763.2008; Eusebio A, 2009, EXP NEUROL, V217, P1, DOI 10.1016/j.expneurol.2009.02.003; Grill WM, 2004, NEUROREPORT, V15, P1137, DOI 10.1097/00001756-200405190-00011; Guo YX, 2011, NEURAL NETWORKS, V24, P602, DOI 10.1016/j.neunet.2011.03.010; Hahn PJ, 2008, EXP NEUROL, V211, P243, DOI 10.1016/j.expneurol.2008.01.032; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Hauptmann C, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066003; Hauptmann C, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056008; Hurtado JA, 2005, J NEUROPHYSIOL, V93, P1569, DOI 10.1152/jn.00829.2004; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Park C, 2011, CHAOS, V21, DOI 10.1063/1.3633078; Park C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042901; Park C, 2010, J NEUROPHYSIOL, V103, P2707, DOI 10.1152/jn.00724.2009; Pessiglione M, 2005, J NEUROSCI, V25, P1523, DOI 10.1523/JNEUROSCI.4056-04.2005; Popovych OV, 2006, BIOL CYBERN, V95, P69, DOI 10.1007/s00422-006-0066-8; Popovych OV, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026204; Popovych OV, 2008, J BIOL PHYS, V34, P367, DOI 10.1007/s10867-008-9068-1; Popovych OV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164102; Rosenblum M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041904; Rosenblum MG, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.114102; Rosenblum M, 2006, INT J BIFURCAT CHAOS, V16, P1989, DOI 10.1142/S0218127406015842; Rubchinsky LL, 2012, NONLINEAR DYNAM, V68, P329, DOI 10.1007/s11071-011-0223-z; Schiff SJ, 2010, PHILOS T R SOC A, V368, P2269, DOI 10.1098/rsta.2010.0050; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tukhlina N, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011918; Tukhlina N, 2008, J BIOL PHYS, V34, P301, DOI 10.1007/s10867-008-9081-4; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Umemura A, 2003, J NEUROSURG, V98, P779, DOI 10.3171/jns.2003.98.4.0779; Wichmann T, 2006, NEURON, V52, P197, DOI 10.1016/j.neuron.2006.09.022; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009	41	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58264	10.1371/journal.pone.0058264	http://dx.doi.org/10.1371/journal.pone.0058264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469272	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100068
J	Gimenez, L; Jenkins, SR				Gimenez, Luis; Jenkins, Stuart R.			Combining Traits and Density to Model Recruitment of Sessile Organisms	PLOS ONE			English	Article							POPULATION-DYNAMICS; HABITAT SELECTION; GROWTH-RATE; MARINE; SIZE; SETTLEMENT; COMPETITION; BARNACLES; COMMUNITY; PERFORMANCE	We propose an integrative approach that explains patterns of recruitment to adult populations in sessile organisms by considering the numbers of individuals and their body size. A recruitment model, based on a small number of parameters, was developed for sessile organisms and tested using the barnacle Semibalanus balanoides, a marine invertebrate inhabiting North Atlantic intertidal shores. Incorporating barnacle body size improved model fit beyond that based on density alone, showing that growth played an important role in how resource limitation affected survival. Our approach uncovered the following: First, changes in the shape of the recruitment curve resulted from the balance between individual growth and mortality. Second, recruitment was limited by the least plastic trait used to characterise body size, operculum area. Basal area, a trait that responded to increases in barnacle density, did not contribute significantly to explain patterns of recruitment. Third, some temporal variation is explained by changes in the amount of space occupied by shells of dead barnacles: at high cover barnacles are densely packed and these shells remain long after death. Fourth, seasonal variation and spatial variation in survival can be separated from that resulting from resource limitation; survival was predicted for two different shores and four sampling times using a single recruitment model. We conclude that applying this integrative approach to recruitment will lead to a considerable advance in understanding patterns of mortality of early stages of sessile organisms.	[Gimenez, Luis; Jenkins, Stuart R.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Gwynedd, Wales	Bangor University	Gimenez, L (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Gwynedd, Wales.	l.gimenez@bangor.ac.uk	Jenkins, Stuart R/D-2032-2010	Jenkins, Stuart R/0000-0002-2299-6318	CCCR consortium (Catchment to Coast Wales); NERC [NE/H006702/1] Funding Source: UKRI; Natural Environment Research Council [NE/H006702/1] Funding Source: researchfish	CCCR consortium (Catchment to Coast Wales); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	LG thanks CCCR consortium (Catchment to Coast Wales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SE, 1996, ECOL MONOGR, V66, P259, DOI 10.2307/2963518; Anger K., 2001, BIOL DECAPOD CRUSTAC; BARNES H, 1950, J ANIM ECOL, V19, P175, DOI 10.2307/1526; Barnes M, 2000, OCEANOGR MAR BIOL, V38, P157; Bertness M.D., 2001, MARINE COMMUNITY ECO; Bertness MD, 1998, ECOLOGY, V79, P1382, DOI 10.2307/176750; Boaventura D, 2003, J ANIM ECOL, V72, P435, DOI 10.1046/j.1365-2656.2003.00713.x; Burgess SC, 2011, J ANIM ECOL, V80, P681, DOI 10.1111/j.1365-2656.2010.01802.x; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Carr MH, 2003, ECOL APPL, V13, pS90; Caswell, 2000, MATRIX POPULATION MO; Charmantier G, 1998, INVERTEBR REPROD DEV, V33, P177, DOI 10.1080/07924259.1998.9652630; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; Claessen D, 2002, ECOLOGY, V83, P1660, DOI 10.2307/3071986; Cole SWB, 2011, J SEA RES, V65, P33, DOI 10.1016/j.seares.2010.06.006; CRISP DJ, 1960, J ANIM ECOL, V29, P95, DOI 10.2307/2273; De Roos AM, 2001, OIKOS, V94, P51, DOI 10.1034/j.1600-0706.2001.11313.x; Doherty P.J., 1982, Proceedings of the International Coral Reef Symposium, P465; Donahue MJ, 2004, MAR ECOL PROG SER, V267, P219, DOI 10.3354/meps267219; Fukaya K, 2010, J ANIM ECOL, V79, P1270, DOI 10.1111/j.1365-2656.2010.01727.x; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Getz WM, 1996, ECOLOGY, V77, P2014, DOI 10.2307/2265697; Gimenez L, 2004, MAR ECOL PROG SER, V283, P303, DOI 10.3354/meps283303; Gimenez L, 2010, ECOLOGY, V91, P1401, DOI 10.1890/09-1028.1; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Hoogenboom MO, 2008, ECOLOGY, V89, P1144, DOI 10.1890/07-1272.1; Huss M, 2012, ECOLOGY, V93, P847, DOI 10.1890/11-1254.1; Jarrett JN, 2008, J CRUSTACEAN BIOL, V28, P16, DOI 10.1651/07-2851R.1; Jarrett JN, 1997, ECOLOGY, V78, P1262, DOI 10.1890/0012-9658(1997)078[1262:TVICQA]2.0.CO;2; Jarrett JN, 2003, ECOLOGY, V84, P384, DOI 10.1890/0012-9658(2003)084[0384:SVILCA]2.0.CO;2; Jenkins SR, 2005, J ANIM ECOL, V74, P893, DOI 10.1111/j.1365-2656.2005.00985.x; Jenkins SR, 2000, J EXP MAR BIOL ECOL, V243, P209, DOI 10.1016/S0022-0981(99)00121-5; Jenkins SR, 2008, J ANIM ECOL, V77, P573, DOI 10.1111/j.1365-2656.2008.01366.x; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Knights AM, 2010, MAR ECOL PROG SER, V404, P79, DOI 10.3354/meps08480; Miller LP, 2007, MAR ECOL PROG SER, V349, P227, DOI 10.3354/meps07099; Needle CL, 2001, REV FISH BIOL FISHER, V11, P95, DOI 10.1023/A:1015208017674; PACALA SW, 1985, AM NAT, V125, P385, DOI 10.1086/284349; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; PETRAITIS PS, 1995, ECOLOGY, V76, P1337, DOI 10.2307/1940940; PIELOU E C, 1969, P286; Pineda J, 2006, MAR ECOL PROG SER, V320, P233, DOI 10.3354/meps320233; QIAN PY, 1990, J EXP MAR BIOL ECOL, V142, P63, DOI 10.1016/0022-0981(90)90137-2; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Royama T., 1992, ANAL POPULATION ECOL; SANFORD E, 1994, MAR ECOL PROG SER, V104, P49, DOI 10.3354/meps104049; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Tremblay R, 2007, MAR ECOL PROG SER, V340, P1, DOI 10.3354/meps340001; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; West-Eberhard Mary Jane, 2003, pi; WETHEY DS, 1986, ECOLOGY ROCKY COASTS, P194; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Zuidema PA, 2009, AM NAT, V174, P709, DOI 10.1086/605981	54	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57849	10.1371/journal.pone.0057849	http://dx.doi.org/10.1371/journal.pone.0057849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469247	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100046
J	Lee, IC; Lin, CH; Huang, YH; Huo, TI; Su, CW; Hou, MC; Huang, HC; Lee, KC; Chan, CC; Lin, MW; Lin, HC; Lee, SD				Lee, I-Cheng; Lin, Chen-Hao; Huang, Yi-Hsiang; Huo, Teh-Ia; Su, Chien-Wei; Hou, Ming-Chih; Huang, Hui-Chun; Lee, Kuei-Chuan; Chan, Che-Chang; Lin, Ming-Wei; Lin, Han-Chieh; Lee, Shou-Dong			IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B	PLOS ONE			English	Article							C VIRUS-INFECTION; SPONTANEOUS CLEARANCE; NATURAL-HISTORY; GENETIC-VARIATION; INTERFERON-ALPHA; VIRAL LOAD; GENOTYPE; ASSOCIATION; MANAGEMENT; MUTATIONS	Background & Aims: The clinical relevance of single nucleotide polymorphisms (SNPs) near the IL28B gene is controversial in patients with hepatitis B virus (HBV) infection. This study aimed to investigate the role of viral and host factors, including IL28B genotypes, in the natural course of chronic hepatitis B (CHB). Methods: The study enrolled consecutive 115 treatment-naive CHB patients. HBV viral loads, genotypes, precore and basal core promotor mutations, serum hepatitis B surface antigen (HBsAg) and interferon-gamma inducible protein 10 (IP-10) levels as well as four SNPs of IL28B were determined. Serial alanine transaminase (ALT) levels in the previous one year before enrollment at an interval of three months were recorded. Factors associated with active hepatitis, defined as persistent ALT >2x upper limit of normal (ULN) or a peak ALT level >5x ULN, were evaluated. Results: The prevalence of rs8105790 TT, rs12979860 CC, rs8099917 TT, and rs10853728 CC genotypes were 88.3%, 87.4%, 88.4% and 70.9%, respectively. In HBeAg-positive patients (n = 48), HBV viral load correlated with active hepatitis, while in HBeAg-negative patients (n = 67), rs10853728 CC genotype (p = 0.032) and a trend of higher IP-10 levels (p = 0.092) were associated with active hepatitis. In multivariate analysis, high viral load (HBV DNA >10(8) IU/mL, p = 0.042, odds ratio = 3.946) was significantly associated with HBeAg-positive hepatitis, whereas rs10853728 CC genotype (p = 0.019, odds ratio = 3.927) was the only independent factor associated with active hepatitis in HBeAg-negative population. Conclusions: HBV viral load and IL28B rs10853728 CC genotype correlated with hepatitis activity in HBeAg-positive and HBeAg-negative CHB, respectively. Both viral and host factors play roles in disease activity during different phases of CHB.	[Lee, I-Cheng; Lin, Chen-Hao; Huang, Yi-Hsiang; Huo, Teh-Ia; Su, Chien-Wei; Hou, Ming-Chih; Huang, Hui-Chun; Lee, Kuei-Chuan; Chan, Che-Chang; Lin, Han-Chieh] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Hou, Ming-Chih] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan; [Lee, I-Cheng; Lin, Chen-Hao; Huang, Yi-Hsiang; Su, Chien-Wei; Lee, Kuei-Chuan; Chan, Che-Chang] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, I-Cheng] Natl Yang Ming Univ Hosp, Dept Med, Ilan, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital	Huang, YH (corresponding author), Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan.	yhhuang@vghtpe.gov.tw	Su, Chien-Wei/AHC-8307-2022; Su, Chien-Wei/C-1521-2012; Lee, I-Cheng/AAF-5650-2020	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Huang, Yi-Hsiang/0000-0001-5241-5425	National Science Council [NSC100-2314-B-010-024]; Taipei Veterans General Hospital [V99C1-075, V100C-104, V101C-417]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The study was supported by grants from the National Science Council (NSC100-2314-B-010-024) and Taipei Veterans General Hospital (V99C1-075, V100C-104 and V101C-417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chu CJ, 2003, HEPATOLOGY, V38, P619, DOI 10.1053/jhep.2003.50352; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Huang YH, 2006, J VIRAL HEPATITIS, V13, P336, DOI 10.1111/j.1365-2893.2005.00688.x; Huang YH, 2003, J VIRAL HEPATITIS, V10, P277, DOI 10.1046/j.1365-2893.2003.00428.x; Jaroszewicz J, 2011, ANTIVIR THER, V16, P915, DOI 10.3851/IMP1866; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lampertico P, 2012, HEPATOLOGY, DOI [10.1002/hep.25749, DOI 10.1002/HEP.25749.]; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee IC, 2011, CLIN NUTR, V30, P647, DOI 10.1016/j.clnu.2011.05.001; Li WY, 2011, LIVER INT, V31, P1118, DOI 10.1111/j.1478-3231.2011.02507.x; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2011, HEPATOLOGY, V53, P2121, DOI 10.1002/hep.24364; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Lin CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018322; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Peng LJ, 2012, TISSUE ANTIGENS, V79, P302, DOI 10.1111/j.1399-0039.2011.01835.x; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; Pharm DT, 2012, HEPATOLOGY, V56, P361; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Ren S, 2012, CANCER IMMUNOL IMMUN, V61, P1433, DOI 10.1007/s00262-012-1203-y; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tan AT, 2010, J HEPATOL, V52, P330, DOI 10.1016/j.jhep.2009.12.015; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Wu XP, 2012, ANTIVIR RES, V93, P297, DOI 10.1016/j.antiviral.2011.12.009; Wursthorn K, 2011, J CLIN VIROL, V50, P292, DOI 10.1016/j.jcv.2010.12.008; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yotsuyanagi H, 2002, J HEPATOL, V37, P355, DOI 10.1016/S0168-8278(02)00180-0; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	43	21	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58071	10.1371/journal.pone.0058071	http://dx.doi.org/10.1371/journal.pone.0058071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469142	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900233
J	Conover, MD; Davis, C; Ferrara, E; McKelvey, K; Menczer, F; Flammini, A				Conover, Michael D.; Davis, Clayton; Ferrara, Emilio; McKelvey, Karissa; Menczer, Filippo; Flammini, Alessandro			The Geospatial Characteristics of a Social Movement Communication Network	PLOS ONE			English	Article							MEDIA	Social movements rely in large measure on networked communication technologies to organize and disseminate information relating to the movements' objectives. In this work we seek to understand how the goals and needs of a protest movement are reflected in the geographic patterns of its communication network, and how these patterns differ from those of stable political communication. To this end, we examine an online communication network reconstructed from over 600,000 tweets from a thirty-six week period covering the birth and maturation of the American anticapitalist movement, Occupy Wall Street. We find that, compared to a network of stable domestic political communication, the Occupy Wall Street network exhibits higher levels of locality and a hub and spoke structure, in which the majority of non-local attention is allocated to high-profile locations such as New York, California, and Washington D. C. Moreover, we observe that information flows across state boundaries are more likely to contain framing language and references to the media, while communication among individuals in the same state is more likely to reference protest action and specific places and times. Tying these results to social movement theory, we propose that these features reflect the movement's efforts to mobilize resources at the local level and to develop narrative frames that reinforce collective purpose at the national level.	[Conover, Michael D.; Davis, Clayton; Ferrara, Emilio; McKelvey, Karissa; Menczer, Filippo; Flammini, Alessandro] Indiana Univ, Ctr Complex Networks & Syst Res, Sch Informat & Comp, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Conover, MD (corresponding author), Indiana Univ, Ctr Complex Networks & Syst Res, Sch Informat & Comp, Bloomington, IN 47405 USA.	midconov@indiana.edu	Ferrara, Emilio/F-6136-2012	Ferrara, Emilio/0000-0002-1942-2831; Menczer, Filippo/0000-0003-4384-2876	National Science Foundation [CCF-1101743]; DARPA [W911NF-12-1-0037]; McDonnell Foundation; Direct For Computer & Info Scie & Enginr [1101743] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); McDonnell Foundation; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors gratefully acknowledge support from the National Science Foundation [http://www.nsf.gov/] (grant CCF-1101743), DARPA [http://www.darpa.mil/] (grant W911NF-12-1-0037), and the McDonnell Foundation [http://www.jsmf.org/]. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, HDB INTERNET CRIME; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Benford RD, 2000, ANNU REV SOCIOL, V26, P611, DOI 10.1146/annurev.soc.26.1.611; Bennett W., 2003, INFORM COMMUN SOC, V6, P143, DOI [DOI 10.1080/1369118032000093860A, 10.1080/1369118032000093860]; Bennett W.L., 2007, CHANGING CITIZENSHIP, P1; Boyd D., 2010, 43 HAW INT C SYST SC, V2010, P1, DOI DOI 10.1109/HICSS.2010.412; Castillo C., 2011, P 20 INT C WORLD WID, P675, DOI [DOI 10.1145/1963405.1963500, 10.1145/1963405.1963500]; Cha M., 2010, P 4 INT AAAI C WEBL; Chomsky Noam, 2012, OCCUPY; Choudhary A, 2012, COMMUN ACM, V55, P74, DOI 10.1145/2160718.2160736; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; Conover M., 2021, P INT AAAI C WEB SOC, V5, P89, DOI 10.1021/ja202932e; De Choudhury Munmun, 2012, P 6 INT AAAI C WEBL; Frahm K, 2012, EUROPEAN PHYS J B, V85, P1; Garrett R. K., 2006, Information Communication & Society, V9, P202, DOI 10.1080/13691180600630773; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Goodman A., 2012, OCCUPY HDB, P256; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Huberman BA, 2008, 1 MONDAY, V14, P1, DOI [DOI 10.5210/FM.V14I1.2317, 10.2139/ssrn.1313405]; Jansen BJ, 2009, J AM SOC INF SCI TEC, V60, P2169, DOI 10.1002/asi.21149; Java Akshay, 2007, P JOINT 9 WEBKDD 1 S, P56, DOI 10.1145/1348549.1348556; Krishnamurthy B., 2008, PROC 1 WORKSHOP ONLI, P19, DOI DOI 10.1145/1397735.1397741; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lotan G., 2011, INT J COMMUNICATION, V5; Mathiesen J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00814; MCCARTHY JD, 1977, AM J SOCIOL, V82, P1212, DOI 10.1086/226464; MotherJones website, WE AR 99 PERC CREAT; MYERS DJ, 1994, SOC SCI COMPUT REV, V12, P250, DOI 10.1177/089443939401200209; Onnela J, 2011, GEOGRAPHIC CONSTRAIN; RATCLIFF JW, 1988, DR DOBBS J, V13, P46; Rosenquist J., 2021, P INT AAAI C WEB SOC, V5, P554; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Weng L., 2012, SCI REPORTS, V2; Wray S., 1999, PEACE REV, V11, P107, DOI 10.1080/1040265990842623; Wu S., 2011, P 20 INT C WORLD WID, V20, P705, DOI [DOI 10.1145/1963405.1963504, 10.1145/1963405.1963504]	37	87	90	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e55957	10.1371/journal.pone.0055957	http://dx.doi.org/10.1371/journal.pone.0055957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483885	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100003
J	Martin, JA; Parekh, P; Kim, Y; Morey, TE; Sefah, K; Gravenstein, N; Dennis, DM; Tan, WH				Martin, Jennifer A.; Parekh, Parag; Kim, Youngmi; Morey, Timothy E.; Sefah, Kwame; Gravenstein, Nikolaus; Dennis, Donn M.; Tan, Weihong			Selection of an Aptamer Antidote to the Anticoagulant Drug Bivalirudin	PLOS ONE			English	Article							DIRECT THROMBIN INHIBITORS; RNA APTAMERS; MOLECULES; SELEX; DNA; CHROMATOGRAPHY; PHARMACOLOGY; COAGULATION; LIGANDS; BINDS	Adverse drug reactions, including severe patient bleeding, may occur following the administration of anticoagulant drugs. Bivalirudin is a synthetic anticoagulant drug sometimes employed as a substitute for heparin, a commonly used anticoagulant that can cause a condition called heparin-induced thrombocytopenia (HIT). Although bivalrudin has the advantage of not causing HIT, a major concern is lack of an antidote for this drug. In contrast, medical professionals can quickly reverse the effects of heparin using protamine. This report details the selection of an aptamer to bivalirudin that functions as an antidote in buffer. This was accomplished by immobilizing the drug on a monolithic column to partition binding sequences from nonbinding sequences using a low-pressure chromatography system and salt gradient elution. The elution profile of binding sequences was compared to that of a blank column (no drug), and fractions with a chromatographic difference were analyzed via real-time PCR (polymerase chain reaction) and used for further selection. Sequences were identified by 454 sequencing and demonstrated low micromolar dissociation constants through fluorescence anisotropy after only two rounds of selection. One aptamer, JPB5, displayed a dose-dependent reduction of the clotting time in buffer, with a 20 mu M aptamer achieving a nearly complete antidote effect. This work is expected to result in a superior safety profile for bivalirudin, resulting in enhanced patient care.	[Martin, Jennifer A.; Parekh, Parag; Kim, Youngmi; Sefah, Kwame; Tan, Weihong] Univ Florida, Dept Chem, Shands Canc Ctr, Gainesville, FL 32611 USA; [Martin, Jennifer A.; Parekh, Parag; Kim, Youngmi; Sefah, Kwame; Tan, Weihong] Univ Florida, Dept Physiol & Funct Genom, Shands Canc Ctr, Gainesville, FL USA; [Martin, Jennifer A.; Parekh, Parag; Kim, Youngmi; Sefah, Kwame; Tan, Weihong] Univ Florida, Ctr Res Bio Nano Interface, Gainesville, FL USA; [Morey, Timothy E.; Gravenstein, Nikolaus; Dennis, Donn M.] Univ Florida, Dept Anesthesiol & Pharmacol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tan, WH (corresponding author), Univ Florida, Dept Chem, Shands Canc Ctr, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Tan, Weihong/AAA-4536-2020; Parekh, Parag/ABE-2100-2021; Tan, Weihong/A-5412-2008	Tan, Weihong/0000-0002-8066-1524; Morey, Timothy/0000-0003-2922-8984	National Institutes of Health; National Science Foundation; State of Florida Board of Governors	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); State of Florida Board of Governors	This work was supported by grants through the National Institutes of Health, National Science Foundation, and the State of Florida Board of Governors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker RC, 2005, THROMB HAEMOSTASIS, V93, P1014, DOI 10.1160/TH04-12-0790; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fanikos J, 2007, AM J CARDIOL, V100, P1465, DOI 10.1016/j.amjcard.2007.06.041; Gal SW, 1998, EUR J BIOCHEM, V252, P553, DOI 10.1046/j.1432-1327.1998.2520553.x; Giovannini R, 1998, ANAL CHEM, V70, P3348, DOI 10.1021/ac980390w; Glickman JF, 2002, J BIOMOL SCREEN, V7, P3, DOI 10.1177/108705710200700102; Gopinath SCB, 2008, THROMB RES, V122, P838, DOI 10.1016/j.thromres.2007.10.022; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Heckel A, 2006, ANGEW CHEM INT EDIT, V45, P6748, DOI 10.1002/anie.200602346; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Ishizuka N, 2002, J CHROMATOGR A, V960, P85, DOI 10.1016/S0021-9673(01)01580-1; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Joachimi A, 2007, J AM CHEM SOC, V129, P3036, DOI 10.1021/ja0677822; Kam PCA, 2005, ANAESTHESIA, V60, P565, DOI 10.1111/j.1365-2044.2005.04192.x; Kim YM, 2009, P NATL ACAD SCI USA, V106, P6489, DOI 10.1073/pnas.0812402106; Oney S, 2007, OLIGONUCLEOTIDES, V17, P265, DOI 10.1089/oli.2007.0089; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Roberts MWH, 2009, J SEP SCI, V32, P2485, DOI 10.1002/jssc.200900309; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2000, THROMB HAEMOSTASIS, V84, P841; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Sciulli TM, 2002, ANN PHARMACOTHER, V36, P1028; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Tang ZW, 2009, CLIN CHEM, V55, P813, DOI 10.1373/clinchem.2008.113514; Tok JBH, 2008, CHEM COMMUN, P1883, DOI 10.1039/b717936g; Weitz JI, 2002, THROMB RES, V106, pV275, DOI 10.1016/S0049-3848(02)00093-2; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275	31	9	12	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57341	10.1371/journal.pone.0057341	http://dx.doi.org/10.1371/journal.pone.0057341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483901	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100018
J	Granke, M; Gourrier, A; Rupin, F; Raum, K; Peyrin, F; Burghammer, M; Saied, A; Laugier, P				Granke, Mathilde; Gourrier, Aurelien; Rupin, Fabienne; Raum, Kay; Peyrin, Francoise; Burghammer, Manfred; Saied, Amena; Laugier, Pascal			Microfibril Orientation Dominates the Microelastic Properties of Human Bone Tissue at the Lamellar Length Scale	PLOS ONE			English	Article							MINERALIZATION DENSITY DISTRIBUTION; SCANNING ACOUSTIC MICROSCOPY; RAY-SCATTERING ANALYSIS; CORTICAL BONE; ELASTIC PROPERTIES; HIERARCHICAL STRUCTURE; MECHANICAL-PROPERTIES; COLLAGEN; NANOINDENTATION; ANISOTROPY	The elastic properties of bone tissue determine the biomechanical behavior of bone at the organ level. It is now widely accepted that the nanoscale structure of bone plays an important role to determine the elastic properties at the tissue level. Hence, in addition to the mineral density, the structure and organization of the mineral nanoparticles and of the collagen microfibrils appear as potential key factors governing the elasticity. Many studies exist on the role of the organization of collagen microfibril and mineral nanocrystals in strongly remodeled bone. However, there is no direct experimental proof to support the theoretical calculations. Here, we provide such evidence through a novel approach combining several high resolution imaging techniques: scanning acoustic microscopy, quantitative scanning small-Angle X-ray scattering imaging and synchrotron radiation computed microtomography. We find that the periodic modulations of elasticity across osteonal bone are essentially determined by the orientation of the mineral nanoparticles and to a lesser extent only by the particle size and density. Based on the strong correlation between the orientation of the mineral nanoparticles and the collagen molecules, we conclude that the microfibril orientation is the main determinant of the observed undulations of microelastic properties in regions of constant mineralization in osteonal lamellar bone. This multimodal approach could be applied to a much broader range of fibrous biological materials for the purpose of biomimetic technologies.	[Granke, Mathilde; Rupin, Fabienne; Saied, Amena; Laugier, Pascal] Univ Paris 06, Lab Imagerie Parametr, UMR 7623, Paris, France; [Granke, Mathilde; Rupin, Fabienne; Saied, Amena; Laugier, Pascal] CNRS, Lab Imagerie Parametr, UMR 7623, Paris, France; [Gourrier, Aurelien] Univ Grenoble 1, Lab Interdisciplinaire Phys, UMR CNRS 5588, St Martin Dheres, France; [Gourrier, Aurelien; Peyrin, Francoise; Burghammer, Manfred] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Raum, Kay] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Raum, Kay] Charite, Berlin Brandenburg Sch Regenerat Therapies, D-13353 Berlin, Germany; [Peyrin, Francoise] Univ Lyon, INSA Lyon, CREATIS, INSERM,U1044,CNRS 5220, Villeurbanne, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Synchrotron Radiation Facility (ESRF); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Granke, M (corresponding author), Univ Paris 06, Lab Imagerie Parametr, UMR 7623, Paris, France.	mathilde.granke@gmail.com	Laugier, Pascal/P-1658-2017; Peyrin, Francoise/G-2823-2013; Raum, Kay/A-5576-2013	Laugier, Pascal/0000-0002-7498-0262; Peyrin, Francoise/0000-0002-1988-3435; Raum, Kay/0000-0003-0573-1622	Deutsche Forschungsgemeinshaft [SPP1420, Ra1380/7, Ge1894/3]	Deutsche Forschungsgemeinshaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinshaft (SPP1420, grants Ra1380/7 and Ge1894/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCENZI A, 1967, ANAT REC, V158, P375, DOI 10.1002/ar.1091580403; ASCENZI A, 1990, J BIOMECH, V23, P763, DOI 10.1016/0021-9290(90)90023-V; ASCENZI A, 1968, ANAT REC, V161, P377, DOI 10.1002/ar.1091610309; ASCENZI A, 1994, J BIOMECH, V27, P875, DOI 10.1016/0021-9290(94)90260-7; Ascenzi MG, 2012, FRONT BIOSCI-LANDMRK, V17, P1551, DOI 10.2741/4003; Ascenzi MG, 2003, J STRUCT BIOL, V141, P22, DOI 10.1016/S1047-8477(02)00578-6; Bala Y, 2011, J MECH BEHAV BIOMED, V4, P1473, DOI 10.1016/j.jmbbm.2011.05.017; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Blanton TN, 1995, POWDER DIFFR, V10, P91, DOI DOI 10.1017/S0885715600014421; Boivin G, 2009, OSTEOPOROSIS INT, V20, P1023, DOI 10.1007/s00198-009-0861-x; Chen PY, 2011, CALCIFIED TISSUE INT, V88, P351, DOI 10.1007/s00223-011-9462-8; Currey J.D., 2002, BONES STRUCTURE MECH; Faingold A, 2012, J MECH BEHAV BIOMED, V9, P198, DOI 10.1016/j.jmbbm.2012.01.014; FRATZL P, 1992, J BONE MINER RES, V7, P329; Fratzl P, 1996, Connect Tissue Res, V34, P247, DOI 10.3109/03008209609005268; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Fratzl-Zelman N, 2009, CALCIFIED TISSUE INT, V85, P335, DOI 10.1007/s00223-009-9289-8; Fratzl-Zelman N, 2009, BONE, V44, P1043, DOI 10.1016/j.bone.2009.02.021; Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; Glimcher M J, 1987, Instr Course Lect, V36, P49; Gourrier A, 2007, J APPL CRYSTALLOGR, V40, pS78, DOI 10.1107/S0021889807006693; Gourrier A, 2010, J APPL CRYSTALLOGR, V43, P1385, DOI 10.1107/S0021889810035090; Gupta HS, 2006, J MATER RES, V21, P1913, DOI 10.1557/JMR.2006.0234; Hellmich C, 2004, BIOMECH MODEL MECHAN, V2, P219, DOI [10.1007/s10237-004-0040-0, 10.1007/S10237-004-0040-0]; Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; Hofmann T, 2006, J BIOMECH, V39, P2282, DOI 10.1016/j.jbiomech.2005.07.009; Kazanci M, 2007, BONE, V41, P456, DOI 10.1016/j.bone.2007.04.200; Kerschnitzki M, 2011, CELLS TISSUES ORGANS, V194, P119, DOI 10.1159/000324467; Lakshmanan S, 2007, IEEE T ULTRASON FERR, V54, P1560, DOI 10.1109/TUFFC.2007.426; Landis W J, 1999, Gravit Space Biol Bull, V12, P15; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; Langer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035691; Liu YF, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012031; Liu YF, 2010, J BONE MINER RES, V25, P2029, DOI 10.1002/jbmr.84; McNally EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029258; Nuzzo S, 2002, MED PHYS, V29, P2672, DOI 10.1118/1.1513161; POROD G, 1952, KOLLOID Z Z POLYM, V125, P51, DOI 10.1007/BF01519615; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; Preininger B, 2011, ULTRASOUND MED BIOL, V37, P474, DOI 10.1016/j.ultrasmedbio.2010.12.007; Raum K, 2006, PHYS MED BIOL, V51, P747, DOI 10.1088/0031-9155/51/3/018; Raum K, 2006, PHYS MED BIOL, V51, P733, DOI 10.1088/0031-9155/51/3/017; Raum K, 2003, IEEE T ULTRASON FERR, V50, P507, DOI 10.1109/TUFFC.2003.1201463; Raum K, 2008, IEEE T ULTRASON FERR, V55, P1417, DOI 10.1109/TUFFC.2008.817; Reisinger AG, 2011, BIOMECH MODEL MECHAN, V10, P67, DOI 10.1007/s10237-010-0218-6; Rey C, 2007, MATERIALWISS WERKST, V38, P996, DOI 10.1002/mawe.200700229; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Rho JY, 1999, BONE, V25, P295, DOI 10.1016/S8756-3282(99)00163-5; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Rinnerthaler S, 1999, CALCIFIED TISSUE INT, V64, P422, DOI 10.1007/PL00005824; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Roschger P, 2001, BONE, V29, P185, DOI 10.1016/S8756-3282(01)00485-9; Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7; Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736; Seidel R, 2012, BIOINSPIR BIOMIM NAN, V1, P123, DOI 10.1680/bbn.11.00014; Seto J, 2008, ADV FUNCT MATER, V18, P1905, DOI 10.1002/adfm.200800214; Seto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047338; Spiesz EM, 2012, J MECH BEHAV BIOMED, V12, P20, DOI 10.1016/j.jmbbm.2012.03.004; Spiesz EM, 2011, J STRUCT BIOL, V176, P302, DOI 10.1016/j.jsb.2011.09.009; Utku FS, 2008, J STRUCT BIOL, V162, P361, DOI 10.1016/j.jsb.2008.01.004; Wagermaier W, 2006, BIOINTERPHASES, V1, P1, DOI 10.1116/1.2178386; Wagermaier W, 2007, J APPL CRYSTALLOGR, V40, P115, DOI 10.1107/S0021889806044888; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107; Weiner S, 1997, BONE, V20, P509, DOI 10.1016/S8756-3282(97)00053-7; Xu J, 2003, J BIOMED MATER RES A, V67A, P719, DOI 10.1002/jbm.a.10109; ZIMMERMAN MC, 1994, J BIOMED MATER RES, V28, P931, DOI 10.1002/jbm.820280812	68	53	53	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58043	10.1371/journal.pone.0058043	http://dx.doi.org/10.1371/journal.pone.0058043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472132	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900076
J	Mao, LY; Zhou, QJ; Zhou, SF; Wilbur, RR; Li, XT				Mao, Luyi; Zhou, Qiongjie; Zhou, Shufeng; Wilbur, Rhonda R.; Li, Xiaotian			Roles of Apolipoprotein E (ApoE) and Inducible Nitric Oxide Synthase (iNOS) in Inflammation and Apoptosis in Preeclampsia Pathogenesis and Progression	PLOS ONE			English	Article							DEFICIENT MICE; NO SYNTHASE; EXPRESSION; PREGNANCY; DISEASE; ASSOCIATION; INHIBITION; ALPHA; WOMEN; VIVO	Objectives: To investigate potential roles of inducible nitric oxide synthase (iNOS) and apolipoprotein (apoE) in inflammation and apoptosis promoting pathological changes in preeclampsia in pregnant mice with apoE and/or iNOS knock out. Methods: B6.129 mice were crossed to produce WT, apoE(-/-), apoE(+/-), iNOS(-/-), iNOS(+/-) and apoE(-/-)iNOS(-/-) groups. Variants were confirmed by PCR. Serum lipid parameters (triglycerides, TG; total cholesterol, TC; high density lipoprotein, HDL; and low density lipoprotein, LDL), NO levels and placental electronic microscopic ultrastructures were evaluated, and blood pressure (BP), 24-hour urine protein and pregnancy outcomes were recorded for pregnant F1 generation mice. Placental expressions of inflammatory (tumor necrosis factor-alpha, TNF-alpha; interleukin-6, IL-6; nuclear factor-kappa B, NF-kappa b) and apoptotic markers (Bcl-2 associated X protein, Bax, B-cell lymphoma/leukemia-2, Bcl-2, and Caspase-3) were evaluated via Western blot. Results: Serum lipids, BP and 24-hour urine protein levels were shown to be significantly higher and parturition and placenta weights were lower in apoE(-/-) and apoE(-/-) iNOS(-/-) groups (p<0.05). NO levels were lower in the apoE(-/-) iNOS(-/-) group. In addition, inflammatory/apoptosis parameters, including TNF-alpha, IL-6, NF-kappa b, Bax, Bcl-2 and Caspase-3 in the apoE(-/-) iNOS(-/-) group (p < 0.01), as well as in the apoE(-/-) group (p < 0.05), and NF-kappa B, Bax in iNOS(-/-) group (p < 0.05) were higher compared with WT group. However, most of the inflammatory/apoptosis parameters in the iNOS(+/-) and the apoE(+/-) groups (p > 0.05) showed no differences. In addition, placenta vascular endothelial and trophoblast cell morphological changes were demonstrated in both the apoE(-/-) iNOS(-/-) and apoE(-/-) groups. Conclusion: Elevated lipid metabolism and inflammatory/apoptosis parameters suggest a potentially significant role of apoE in preeclampsia pathology, as well as a relationship between iNOS and preeclampsia progression.	[Mao, Luyi; Zhou, Qiongjie; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Zhou, Shufeng; Wilbur, Rhonda R.] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA; [Li, Xiaotian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Xiaotian] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China	Fudan University; State University System of Florida; University of South Florida; Fudan University	Zhou, SF (corresponding author), Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA.	szhou@health.usf.edu; xiaotianli555@163.com	Li, Xiaotian/ABI-3309-2020	Li, Xiaotian/0000-0002-2051-4581	National Science Fund of China [30872777]; Key Projects in the National Science & Technology Pillar Program in the Eleventh Five-year Plan Period [2006BAI05A05]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program in the Eleventh Five-year Plan Period	This work was partly supported by grants from the National Science Fund of China (30872777) and the Key Projects in the National Science & Technology Pillar Program in the Eleventh Five-year Plan Period (2006BAI05A05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; Banning AP, 1999, ATHEROSCLEROSIS, V145, P17, DOI 10.1016/S0021-9150(99)00010-6; Belo L, 2004, EUR J OBSTET GYN R B, V112, P9, DOI 10.1016/S0301-2115(03)00240-9; Belo L, 2002, ATHEROSCLEROSIS, V162, P425, DOI 10.1016/S0021-9150(01)00734-1; Benyo DF, 2001, J CLIN ENDOCR METAB, V86, P2505, DOI 10.1210/jc.86.6.2505; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chen YC, 2005, CANCER RES, V65, P331; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Curtiss LK, 2000, CURR OPIN LIPIDOL, V11, P243, DOI 10.1097/00041433-200006000-00004; DEWOLF F, 1975, AM J OBSTET GYNECOL, V123, P164, DOI 10.1016/0002-9378(75)90522-0; Eissa NT, 2001, AM J RESP CELL MOL, V24, P616, DOI 10.1165/ajrcmb.24.5.4324; Correa PBF, 2007, J NEUROIMMUNOL, V183, P17, DOI 10.1016/j.jneuroim.2006.10.021; Faxen M., 2001, Archives of Gynecology and Obstetrics, V265, P45, DOI 10.1007/s004040000152; Galijasevic S, 2003, P NATL ACAD SCI USA, V100, P14766, DOI 10.1073/pnas.2435008100; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Gratacos E, 2000, EUR J OBSTET GYN R B, V92, P63, DOI 10.1016/S0301-2115(00)00427-9; Henriksen T, 2000, SEMIN PERINATOL, V24, P29, DOI 10.1016/S0146-0005(00)80051-8; Hubel CA, 1998, METABOLISM, V47, P1281, DOI 10.1016/S0026-0495(98)90337-7; Kashinakunti S. V., 2010, Al Ameen Journal of Medical Sciences, V3, P38; Kim YM, 1998, J BIOL CHEM, V273, P31437, DOI 10.1074/jbc.273.47.31437; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Lee SC, 1999, J NEUROPATH EXP NEUR, V58, P1163, DOI 10.1097/00005072-199911000-00006; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Leist M, 1999, EXP CELL RES, V249, P396, DOI 10.1006/excr.1999.4514; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mi S, 2009, CHINA ACAD J ELECT P, V36, P217; Moffett A, 2007, PLACENTA, V28, pS51, DOI 10.1016/j.placenta.2006.11.008; Mohrschladt MF, 2000, ATHEROSCLEROSIS, V148, P413, DOI 10.1016/S0021-9150(99)00316-0; Moncada S., 1991, PHARM REV, V43, P109; Nagy B, 1998, J CLIN PATHOL, V51, P324, DOI 10.1136/jcp.51.4.324; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; ROSSELLI M, 1995, HYPERTENSION, V25, P848, DOI 10.1161/01.HYP.25.4.848; Scalia R, 1998, ARTERIOSCL THROM VAS, V18, P1093, DOI 10.1161/01.ATV.18.7.1093; Schiessl B, 2005, J HISTOCHEM CYTOCHEM, V53, P1441, DOI 10.1369/jhc.4A6480.2005; Schiessl B, 2006, ARCH MED RES, V37, P967, DOI 10.1016/j.arcmed.2006.03.011; Shesely EG, 2001, AM J OBSTET GYNECOL, V185, P1198, DOI 10.1067/mob.2001.118142; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Stokes KY, 2002, FREE RADICAL BIO MED, V33, P1026, DOI 10.1016/S0891-5849(02)01015-8; Svenungsson E, 2003, LUPUS, V12, P454, DOI 10.1191/0961203303lu412oa; Thomson AJ, 1997, HUM REPROD, V12, P2546, DOI 10.1093/humrep/12.11.2546; Thorns V, 1998, EXP NEUROL, V150, P14, DOI 10.1006/exnr.1997.6751; TILG H, 1994, BLOOD, V83, P113; Tranquilli AL, 2005, ACTA OBSTET GYN SCAN, V84, P849, DOI 10.1111/j.0001-6349.2005.00756.x; Wong J M, 1995, Adv Pharmacol, V34, P155; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123	49	18	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58168	10.1371/journal.pone.0058168	http://dx.doi.org/10.1371/journal.pone.0058168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472151	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900097
J	Mongilardi, N; Montori, V; Riveros, A; Bernabe-Ortiz, A; Loza, J; Malaga, G				Mongilardi, Nicole; Montori, Victor; Riveros, Alejandro; Bernabe-Ortiz, Antonio; Loza, Javier; Malaga, German			Clinicians' Involvement of Patients in Decision Making. A Video Based Comparison of Their Behavior in Public vs. Private Practice	PLOS ONE			English	Article							OPTION SCALE; CARE; CONSULTATIONS	Background: Little is known about the extent to which Peruvian physicians seek to involve patients in shared decision making, or about the variation in these efforts across different settings. Objective: To measure the extent to which Peruvian clinicians involve their patients in decision making and to explore the differences between clinicians' behavior in private vs. public practice. Design: Videographic analysis. Participants and Setting: Seven academic physicians who provided care to patients in a public and a private setting participate in this study. All the encounters in both settings were filmed on one random day of February 2012. Approach: Two raters, working independently and in duplicate used the 12-item OPTION scale to quantify the extent of physician effort to involve patients in shared decision making (with 0 indicating no effort and 100 maximum possible effort) in 58 video recordings of usual clinical encounters in private and public practice. Results: The mean OPTION score was 14.3 (SD 7.0). Although the OPTION score in the private setting (mean 16.5, SD 7.3) was higher than in the public setting (mean 12.3 SD 6.1) this difference was not statistically significant (p = .09). Conclusion: Peruvian academic physicians in this convenience sample barely sought to involve their patients in shared decision making. Additional studies are required to confirm these results which suggest that patient-centered care remains an unfulfilled promise and a source of inequity within and across the private and the public sectors in Peru.	[Mongilardi, Nicole; Montori, Victor; Loza, Javier; Malaga, German] Univ Peruana Cayetano Heredia, Dept Med, Unidad Conocimiento & Evidencia CONEVID, Lima, Peru; [Mongilardi, Nicole; Riveros, Alejandro; Loza, Javier; Malaga, German] Univ Peruana Cayetano Heredia, Dept Med, Sch Med, Lima, Peru; [Montori, Victor] Mayo Clin, Coll Med, Div Endocrinol & Internal Med, Knowledge & Encounter Res Unit, Rochester, MN USA; [Bernabe-Ortiz, Antonio; Loza, Javier] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol Unit, Lima, Peru; [Bernabe-Ortiz, Antonio; Loza, Javier] Univ Peruana Cayetano Heredia, Cron Ctr Excellence Chron Dis, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Mayo Clinic; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Mongilardi, N (corresponding author), Univ Peruana Cayetano Heredia, Dept Med, Unidad Conocimiento & Evidencia CONEVID, Lima, Peru.	nicolemongilardi@gmail.com	mongilardi, nicole/AGR-0899-2022	Bernabe-Ortiz, Antonio/0000-0002-6834-1376; Riveros Grimaldi, Alejandro/0000-0002-9031-2627; Montori, Victor/0000-0003-0595-2898; Malaga, German/0000-0002-7828-300X				Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Brinkman WB, 2011, ARCH PEDIAT ADOL MED, V165, P1013, DOI 10.1001/archpediatrics.2011.154; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Elwyn G, 2005, HEALTH EXPECT, V8, P34, DOI 10.1111/j.1369-7625.2004.00311.x; Elwyn G, 2003, QUAL SAF HEALTH CARE, V12, P93, DOI 10.1136/qhc.12.2.93; Golin C, 2002, J GEN INTERN MED, V17, P866, DOI 10.1046/j.1525-1497.2002.20120.x; Goss C, 2008, BRIT J PSYCHIAT, V193, P416, DOI 10.1192/bjp.bp.107.048728; Gossey JT, 2011, PATIENT PREFER ADHER, V5, P397, DOI 10.2147/PPA.S19995; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; Montori V, 2008, JAMA EVIDENCE USERS, P643; Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x; Nicolai J, 2012, Z EVIDENZ FORTBILD Q, V106, P264, DOI 10.1016/j.zefq.2012.03.002; Pellerin MA, 2011, ACAD MED, V86, P1010, DOI 10.1097/ACM.0b013e31822220c5; Vaillancourt H, 2012, HLTH EXPECT, V19, P1369; Valdivia M, 2002, EC SOC; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076; Young HN, 2008, ARCH INTERN MED, V168, P1404, DOI 10.1001/archinte.168.13.1404	17	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58085	10.1371/journal.pone.0058085	http://dx.doi.org/10.1371/journal.pone.0058085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472136	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900081
J	Perez-Sampietro, M; Casas, C; Herrero, E				Perez-Sampietro, Maria; Casas, Celia; Herrero, Enrique			The AMPK Family Member Snf1 Protects Saccharomyces cerevisiae Cells upon Glutathione Oxidation	PLOS ONE			English	Article							SPINDLE POSITION CHECKPOINT; YEAST SNF1; SELENIUM-COMPOUNDS; BETA-SUBUNITS; KINASE SNF1; ACTIVATION; TOLERANCE; PHOSPHORYLATION; PHOSPHATASES; TRANSPORTER	The AMPK/Snf1 kinase has a central role in carbon metabolism homeostasis in Saccharomyces cerevisiae. In this study, we show that Snf1 activity, which requires phosphorylation of the Thr210 residue, is needed for protection against selenite toxicity. Such protection involves the Elm1 kinase, which acts upstream of Snf1 to activate it. Basal Snf1 activity is sufficient for the defense against selenite, although Snf1 Thr210 phosphorylation levels become increased at advanced treatment times, probably by inhibition of the Snf1 dephosphorylation function of the Reg1 phosphatase. Contrary to glucose deprivation, Snf1 remains cytosolic during selenite treatment, and the protective function of the kinase does not require its known nuclear effectors. Upon selenite treatment, a null snf1 mutant displays higher levels of oxidized versus reduced glutathione compared to wild type cells, and its hypersensitivity to the agent is rescued by overexpression of the glutathione reductase gene GLR1. In the presence of agents such as diethyl maleate or diamide, which cause alterations in glutathione redox homeostasis by increasing the levels of oxidized glutathione, yeast cells also require Snf1 in an Elm1-dependent manner for growth. These observations demonstrate a role of Snf1 to protect yeast cells in situations where glutathione-dependent redox homeostasis is altered to a more oxidant intracellular environment and associates AMPK to responses against oxidative stress.	[Perez-Sampietro, Maria; Casas, Celia; Herrero, Enrique] Univ Lleida, Dept Ciencies Med Basiques, IRBLleida, Lleida, Spain	Universitat de Lleida	Herrero, E (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, IRBLleida, Lleida, Spain.	enric.herrero@cmb.udl.cat	Casas, Celia/B-4963-2010; Herrero, Enrique/B-5592-2009	Casas, Celia/0000-0003-4140-5533; Herrero, Enrique/0000-0002-6763-111X	Ministerio de Economia y Competitividad (Spain) [BFU2010-17656, CSD2007-0020]; Generalitat de Catalunya [2009/SGR/196]; Generalitat de Catalunya	Ministerio de Economia y Competitividad (Spain)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Generalitat de Catalunya(Generalitat de Catalunya)	This work was funded by Ministerio de Economia y Competitividad (Spain) (grants BFU2010-17656 and CSD2007-0020) and Generalitat de Catalunya (grant 2009/SGR/196). MPS is the recipient of a predoctoral fellowship from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Bouquin N, 2000, J CELL SCI, V113, P1435; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; Casamayor A, 2012, BIOCHEM J, V444, P39, DOI 10.1042/BJ20112099; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Castrillo JI, 2003, PHYTOCHEMISTRY, V62, P929, DOI 10.1016/S0031-9422(02)00713-6; Caydasi AK, 2010, J CELL BIOL, V190, P975, DOI 10.1083/jcb.201006151; Celik HA, 2007, BIOL TRACE ELEM RES, V117, P65, DOI 10.1007/BF02698084; Dubacq C, 2004, MOL CELL BIOL, V24, P2560, DOI 10.1128/MCB.24.6.2560-2572.2004; Fasolo J, 2011, GENE DEV, V25, P767, DOI 10.1101/gad.1998811; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hedbacker K, 2006, EUKARYOT CELL, V5, P1950, DOI 10.1128/EC.00256-06; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hwang JT, 2006, CANCER RES, V66, P10057, DOI 10.1158/0008-5472.CAN-06-1814; Izquierdo A, 2010, MICROBIOL-SGM, V156, P2608, DOI 10.1099/mic.0.039719-0; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Lazard M, 2011, FEBS J, V278, P4112, DOI 10.1111/j.1742-4658.2011.08318.x; Lazard M, 2010, J BIOL CHEM, V285, P32029, DOI 10.1074/jbc.M110.139865; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Moore JK, 2010, J CELL BIOL, V191, P493, DOI 10.1083/jcb.201006092; Ohdate T, 2010, GENES CELLS, V15, P59, DOI 10.1111/j.1365-2443.2009.01365.x; Orlova M, 2008, YEAST, V25, P745, DOI 10.1002/yea.1628; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Plummer J L, 1981, Methods Enzymol, V77, P50; Portillo F, 2005, FEBS LETT, V579, P512, DOI 10.1016/j.febslet.2004.12.019; Rubenstein EM, 2006, EUKARYOT CELL, V5, P620, DOI 10.1128/EC.5.4.620-627.2006; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Ruiz A, 2011, P NATL ACAD SCI USA, V108, P6349, DOI 10.1073/pnas.1102758108; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; Sanz P, 2003, BIOCHEM SOC T, V31, P178; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Usaite R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.67; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Ye T, 2008, MICROBIOL-SGM, V154, P2814, DOI 10.1099/mic.0.2008/020149-0; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685	52	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58283	10.1371/journal.pone.0058283	http://dx.doi.org/10.1371/journal.pone.0058283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472170	gold, Green Published			2022-12-27	WOS:000315637900116
J	Yao, LM; Wang, B; Cheng, LJ; Wu, TL				Yao, Lu-Ming; Wang, Biao; Cheng, Lin-Jing; Wu, Tian-Long			Identification of Key Drought Stress-Related Genes in the Hyacinth Bean	PLOS ONE			English	Article							EXPRESSION; RESPONSES; PROTEIN; L.; TOLERANCE; SALINITY; GENOMICS; REVEALS; LABLAB	Hyacinth bean (Lablab purpureus [Linn.] Sweet) possesses excellent characteristics for field production, but the response of this plant to drought stress has not been described at the molecular level. Suppression subtraction hybridization (SSH) is an effective way to exploit key factors for plant responses to drought stress that are involved in transcriptional and metabolic activities. In this study, forward and reverse SSH libraries were generated from root tissues of the drought-tolerant hyacinth bean genotype MEIDOU 2012 under water-stress conditions. A total of 1,287 unigenes (94 contigs and 1,193 singletons) were derived from sequence alignment and cluster assembly of 1400 ESTs, and 80.6% of those hit against NCBI non-redundant (nr) database with E value <1E206. BLASTX analysis revealed that the majority top matches were proteins form Glycine max (L.) Merrill. (61.5%). According to a gene ontology (GO) functional classification, 816 functionally annotated unigenes were assigned to the biological process category (74.1%), and 83.9% of them classified into molecular function and 69.2% involved in cellular component. A total of 168 sequences were further annotated with 207 Enzyme Commission (EC) codes and mapped to 83 different KEGG pathways. Seventeen functionally relevant genes were found to be overrepresented under drought stress using enrichment analysis. Differential expression of unigenes were confirmed by quantitative real-time PCR assays, and their transcript profiles generally divided into three patterns, depending on the expression peaked levels after 6, 8 or 10 days dehydration, which indicated that these genes are functionally associated in the drought-stress response.	[Yao, Lu-Ming; Wang, Biao; Cheng, Lin-Jing; Wu, Tian-Long] Shanghai Jiao Tong Univ, Dept Plant Sci, Sch Agr & Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, B (corresponding author), Shanghai Jiao Tong Univ, Dept Plant Sci, Sch Agr & Biol, Shanghai 200030, Peoples R China.	wangbiao@sjtu.edu.cn			National Natural Science Foundation of China [31071435]; Ministry of Education Fund on New Staff [20100073120059]; '948' project [2011-G1(2)-16]; Shanghai Horticulture Key Discipline Construction Fund [B209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Fund on New Staff; '948' project(Ministry of Agriculture & Rural Affairs); Shanghai Horticulture Key Discipline Construction Fund	This work was supported by the National Natural Science Foundation of China (No. 31071435), Ministry of Education Fund on New Staff (No. 20100073120059), '948' project (No. 2011-G1(2)-16), and Shanghai Horticulture Key Discipline Construction Fund (B209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour H, 2012, J PLANT PHYSIOL, V169, P704, DOI 10.1016/j.jplph.2012.01.014; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bae H, 2011, PLANT SCI, V180, P775, DOI 10.1016/j.plantsci.2011.02.008; Ballizany WL, 2012, FUNCT PLANT BIOL, V39, P167, DOI 10.1071/FP11193; Bluthgen Nils, 2005, Genome Inform, V16, P106; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'souza MR, 2011, INDIAN J BIOTECHNOL, V10, P130; D'Souza MR, 2010, ACTA PHYSIOL PLANT, V32, P341, DOI 10.1007/s11738-009-0412-2; Deokar AA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-70; Des Marais DL, 2012, PLANT CELL, V24, P893, DOI 10.1105/tpc.112.096180; Ebrahimian E, 2012, J FOOD AGRIC ENVIRON, V10, P1026; Eyidogan F, 2007, ACTA PHYSIOL PLANT, V29, P485, DOI 10.1007/s11738-007-0059-9; Falgueras J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-38; Gaur PM, 2008, PLANT PROD SCI, V11, P3, DOI 10.1626/pps.11.3; Gholizadeh A., 2011, Australian Journal of Basic and Applied Sciences, V5, P952; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Huang JY, 2011, MOL BIOL REP, V38, P1055, DOI 10.1007/s11033-010-0202-3; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Jaleel CA, 2009, INT J AGRIC BIOL, V11, P100; Kim SH, 2011, PLOS ONE, V6; Klosterman SJ, 2011, PHYSIOL MOL PLANT P, V76, P48, DOI 10.1016/j.pmpp.2011.05.003; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Liu HX, 2011, FUNCT INTEGR GENOMIC, V11, P431, DOI 10.1007/s10142-011-0228-1; Lorenz WW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-264; Murphy A M, 1999, Livestock Research for Rural Development, V11, P96; Novillo F, 2012, J EXP BOT, V63, P293, DOI 10.1093/jxb/err279; Peng H, 2010, MOL BIOTECHNOL, V44, P30, DOI 10.1007/s12033-009-9202-8; Peng T, 2012, GENE, V492, P220, DOI 10.1016/j.gene.2011.10.025; Perdiguero P, 2012, PLANT PHYSIOL BIOCH, V50, P44, DOI 10.1016/j.plaphy.2011.09.022; Perrone I, 2012, PLANTA, V235, P1383, DOI 10.1007/s00425-011-1581-y; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Rani A, 2012, GENE, V495, P205, DOI 10.1016/j.gene.2011.12.029; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Swindell S R, 1997, Methods Mol Biol, V70, P75, DOI 10.1385/0-89603-358-9:75; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Wang L, 2009, PLANT BIOLOGY, V11, P837, DOI 10.1111/j.1438-8677.2008.00187.x; Wang SC, 2011, PLANT MOL BIOL REP, V29, P125, DOI 10.1007/s11105-010-0221-1; Wang YH, 2012, PLANT MOL BIOL, V78, P275, DOI 10.1007/s11103-011-9861-2; Wisniewska A, 2012, PLANT PHYSIOL BIOCH, V50, P54, DOI 10.1016/j.plaphy.2011.09.017; Zhang X, 2011, PLANT MOL BIOL REP, V29, P626, DOI 10.1007/s11105-010-0269-y; Zou XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-189	41	21	22	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58108	10.1371/journal.pone.0058108	http://dx.doi.org/10.1371/journal.pone.0058108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472143	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900088
J	Rasmussen, LD; Kronborg, G; Larsen, CS; Pedersen, C; Gerstoft, J; Obel, N				Rasmussen, Line D.; Kronborg, Gitte; Larsen, Carsten S.; Pedersen, Court; Gerstoft, Jan; Obel, Niels			Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							PREDICTIVE-VALUE; DOUBLE-BLIND; ATORVASTATIN; MARKERS; INFLAMMATION; METAANALYSIS; ASSOCIATION; ACTIVATION; ADHERENCE; DIAGNOSES	Background: Recent studies have suggested that statins possess diverse immune modulatory and anti-inflammatory properties. As statins might attenuate inflammation, statin therapy has been hypothesized to reduce mortality in HIV-infected individuals. We therefore used a Danish nationwide cohort of HIV-infected individuals to estimate the impact of statin use on mortality before and after a diagnosis of cardiovascular disease, chronic kidney disease or diabetes. Methods: We identified all Danish HIV-infected individuals (1,738) who initiated HAART after 1 January 1998, and achieved virological suppression within 180 days. Date of first redemption of a prescription of statin was obtained from the Danish National Prescription Registry. We used Poisson regression analysis to assess adjusted mortality rate ratios (aMRR). First, time was censored at date of virological failure (VL > 500 copies/ml). Second, time was not censored at virological failure. All analyses were adjusted for potential confounders. Results: In the analyses confined to observation time without virological failure (+ censoring) statin therapy was associated with a non-statistically significant reduced rate of death (aMRR 0.75; 95% CI: 0.33-1.68). No difference was observed in the analysis with no censoring (aMRR 1.17; 95% CI: 0.66-2.07). Use of statin seemed to reduce mortality in individuals after a diagnosis of comorbidity {(+ censoring: aMRR: 0.34; 95% CI: 0.11-1.04), (-censoring: aMRR: 0.64; 95% CI: 0.32-1.29)}. No difference in rate of death could be detected before first date of diagnosis of comorbidity {(+ censoring: aMRR: 1.12; 95% CI: 0.34-3.62), (-censoring: aMRR: 0.90; 95% CI: 0.28-2.88)}. Conclusion: Statin therapy might reduce all-cause mortality in HIV-infected individuals, but the impact on individuals with no comorbidity seems small or absent. An unambiguous proof of a causal relation can only be obtained in a randomized controlled trial, but the sample size predicted may be prohibitive for its conduct.	[Rasmussen, Line D.; Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Kronborg, Gitte] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Larsen, Carsten S.] Aarhus Univ Hosp, Dept Infect Dis, Skejby, Denmark; [Gerstoft, Jan; Obel, Niels] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen	Rasmussen, LD (corresponding author), Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.	linedahlerup@hotmail.com; niels.obel@rh.regionh.dk		Obel, Niels/0000-0002-5031-0045	NOVO Nordic Foundation; University of Southern Denmark; Clinical Institute of Copenhagen University; Roche; Bristol-Myers Squibb; Merck Sharp Dohme; GlaxoSmithKline; Abbott; Boehringer Ingelheim; Janssen-Cilag; Swedish Orphan Drugs; Gilead; Pharmasia; Baxter; Crucell/SBL vaccines	NOVO Nordic Foundation(Novo Nordisk Foundation); University of Southern Denmark; Clinical Institute of Copenhagen University; Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Swedish Orphan Drugs; Gilead(Gilead Sciences); Pharmasia; Baxter; Crucell/SBL vaccines	The authors thank the NOVO Nordic Foundation, University of Southern Denmark and the Clinical Institute of Copenhagen University for financial support of the Danish HIV cohort study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NO has received research funding from Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Abbott, Boehringer Ingelheim, Janssen-Cilag and Swedish Orphan Drugs. CP has received research funding from Abbott, Gilead and Merck Sharp & Dohme. JG has received research funding from Abbott, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, Pharmasia, GlaxoSmithKline, Swedish Orphan Drugs and Boehringer Ingelheim. CSL has received research funding from Baxter and Crucell/SBL vaccines. GK and LDR report no conflicts of interest. The potential conflicts of interest described above do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Andersen TF, 1999, DAN MED BULL, V46, P263; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; De Wit S, 2011, AIDS, V25, P1332, DOI 10.1097/QAD.0b013e328347c083; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V61, P774, DOI 10.1093/jac/dkn019; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Janda S, 2010, J CRIT CARE, V25; Janda S, 2009, CHEST, V136, P734, DOI 10.1378/chest.09-0194; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klein M, 2005, SURVIVAL ANAL, P403; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Lawes CMM, 2012, PRIM CARE RESP J, V21, P35, DOI 10.4104/pcrj.2011.00095; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021843; Obel N, 2009, INT J EPIDEMIOL, V38, P1202, DOI 10.1093/ije/dyn192; Patrick AR, 2011, VALUE HEALTH, V14, P513, DOI 10.1016/j.jval.2010.10.033; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; PEDERSEN TR, 1994, LANCET, V344, P1383; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P649; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004	43	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e52828	10.1371/journal.pone.0052828	http://dx.doi.org/10.1371/journal.pone.0052828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469159	gold, Green Submitted, Green Published			2022-12-27	WOS:000315634900001
J	Takase, K; Oda, S; Kuroda, M; Funato, H				Takase, Kenkichi; Oda, Satoko; Kuroda, Masaru; Funato, Hiromasa			Monoaminergic and Neuropeptidergic Neurons Have Distinct Expression Profiles of Histone Deacetylases	PLOS ONE			English	Article							MATERNAL-DEPRIVATION; BRAIN-FUNCTION; FOOD-INTAKE; RATS; PLASTICITY; STRESS; MEMORY; SLEEP; ACETYLATION; BEHAVIOR	Monoaminergic and neuropeptidergic neurons regulate a wide variety of behaviors, such as feeding, sleep/ wakefulness behavior, stress response, addiction, and social behavior. These neurons form neural circuits to integrate different modalities of behavioral and environmental factors, such as stress, maternal care, and feeding conditions. One possible mechanism for integrating environmental factors through the monoaminergic and neuropeptidergic neurons is through the epigenetic regulation of gene expression via altered acetylation of histones. Histone deacetylases (HDACs) play an important role in altering behavior in response to environmental factors. Despite increasing attention and the versatile roles of HDACs in a variety of brain functions and disorders, no reports have detailed the localization of the HDACs in the monoaminergic and neuropeptidergic neurons. Here, we examined the expression profile of the HDAC protein family from HDAC1 to HDAC11 in corticotropin-releasing hormone, oxytocin, vasopressin, agouti-related peptide (AgRP), pro-opiomelanocortin (POMC), orexin, histamine, dopamine, serotonin, and noradrenaline neurons. Immunoreactivities for HDAC1,- 2,- 3,- 5,- 6,- 7,- 9, and - 11 were very similar among the monoaminergic and neuropeptidergic neurons, while the HDAC4, - 8, and - 10 immunoreactivities were clearly different among neuronal groups. HDAC10 expression was found in AgRP neurons, POMC neurons, dopamine neurons and noradrenaline neurons but not in other neuronal groups. HDAC8 immunoreactivity was detected in the cytoplasm of almost all histamine neurons with a pericellular pattern but not in other neuropeptidergic and monoaminergic neurons. Thus, the differential expression of HDACs in monoaminergic and neuropeptidergic neurons may be crucial for the maintenance of biological characteristics and may be altered in response to environmental factors.	[Takase, Kenkichi; Oda, Satoko; Kuroda, Masaru; Funato, Hiromasa] Toho Univ, Dept Anat, Sch Med, Tokyo, Japan; [Funato, Hiromasa] Univ Tsukuba, Ctr Behav Mol Genet, Tsukuba, Ibaraki, Japan; [Funato, Hiromasa] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan	Toho University; University of Tsukuba; University of Tsukuba	Funato, H (corresponding author), Toho Univ, Dept Anat, Sch Med, Tokyo, Japan.	hiromasa.funato@med.toho-u.ac.jp	Satoko, Oda/J-8508-2016	Funato, Hiromasa/0000-0002-2787-9700	JSPS KAKENHI [22590228]; MEXT KAKENHI [23126526]; TANITA Healthy Weight Community Trust; University Graduate School of Medicine [12-02]; Toho University School of Medicine [21-3]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); TANITA Healthy Weight Community Trust; University Graduate School of Medicine; Toho University School of Medicine(Toho University)	This work was supported by JSPS KAKENHI Grant Number 22590228 to HF, MEXT KAKENHI Grant Number 23126526 to HF, the Research Grant from TANITA Healthy Weight Community Trust to HF, the Research Promotion Grant from Toho University Graduate School of Medicine (No. 12-02) to HF, and the Research Grant from Toho University School of Medicine (No. 21-3) to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Andretic R, 2008, ANNU REV GENET, V42, P361, DOI 10.1146/annurev.genet.42.110807.091541; Bonthuis PJ, 2011, ENDOCRINOLOGY, V152, P3172, DOI 10.1210/en.2010-1001; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Feng PF, 2007, BRAIN RES, V1154, P163, DOI 10.1016/j.brainres.2007.03.077; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Funato H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018950; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gao X, 2008, J NEUROENDOCRINOL, V20, P1242, DOI 10.1111/j.1365-2826.2008.01782.x; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwasaki S, 2000, PHYSIOL BEHAV, V70, P551, DOI 10.1016/S0031-9384(00)00305-X; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Lai IL, 2010, J BIOL CHEM, V285, P7187, DOI 10.1074/jbc.M109.061861; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Oda S, 2010, BRAIN RES, V1329, P89, DOI 10.1016/j.brainres.2010.03.011; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Ray S, 2008, NUCLEIC ACIDS RES, V36, P4510, DOI 10.1093/nar/gkn419; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Takase K, 2012, BEHAV BRAIN RES, V232, P306, DOI 10.1016/j.bbr.2012.04.016; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Vazquez-Palacios G, 2000, PHYSIOL BEHAV, V71, P23, DOI 10.1016/S0031-9384(00)00285-7; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Young KA, 2011, NEUROSCI BIOBEHAV R, V35, P498, DOI 10.1016/j.neubiorev.2010.06.004; Zylan Kathleen D., 1996, Physiology and Behavior, V59, P165, DOI 10.1016/0031-9384(95)02039-X	41	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58473	10.1371/journal.pone.0058473	http://dx.doi.org/10.1371/journal.pone.0058473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469282	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900090
J	Franzeck, FC; Ngwale, R; Msongole, B; Hamisi, M; Abdul, O; Henning, L; Letang, E; Mwaigomole, G; Battegay, M; Hatz, C; Tanner, M				Franzeck, Fabian C.; Ngwale, Ramadhani; Msongole, Bernadeta; Hamisi, Marian; Abdul, Omary; Henning, Lars; Letang, Emilio; Mwaigomole, Geoffrey; Battegay, Manuel; Hatz, Christoph; Tanner, Marcel			Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; B-VIRUS; ANTIRETROVIRAL TREATMENT; LIVER-DISEASE; COINFECTION; PREVALENCE; THERAPY	Background: Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in Sub-Saharan Africa. Screening for HBV surface antigen (HBsAg) before initiation of combination antiretroviral therapy (cART) is recommended. However, it is not part of diagnostic routines in HIV programs in many resource-limited countries although patients could benefit from optimized antiretroviral therapy covering both infections. Screening could be facilitated by rapid diagnostic tests for HBsAg. Operating experience with these point of care devices in HIV-positive patients in Sub-Saharan Africa is largely lacking. We determined the prevalence of HBV and Hepatitis C virus (HCV) infection as well as the diagnostic accuracy of the rapid test device Determine HBsAg in an HIV cohort in rural Tanzania. Methods: Prospectively collected blood samples from adult, HIV-1 positive and antiretroviral treatment-naive patients in the Kilombero and Ulanga antiretroviral cohort (KIULARCO) in rural Tanzania were analyzed at the point of care with Determine HBsAg, a reference HBsAg EIA and an anti-HCV EIA. Results: Samples of 272 patients were included. Median age was 38 years (interquartile range [IQR] 32-47), 169/272 (63%) subjects were females and median CD4+ count was 250 cells/mu L (IQR 97-439). HBsAg was detected in 25/272 (9.2%, 95% confidence interval [CI] 6.2-13.0%) subjects. Of these, 7/25 (28%) were positive for HBeAg. Sensitivity of Determine HBsAg was rated at 96% (95% CI 82.8-99.6%) and specificity at 100% (95% CI, 98.9-100%). Antibodies to HCV (anti-HCV) were found in 10/272 (3.7%, 95% CI 2.0-6.4%) of patients. Conclusion: This study reports a high prevalence of HBV in HIV-positive patients in a rural Tanzanian setting. The rapid diagnostic test Determine HBsAg is an accurate assay for screening for HBsAg in HIV-1 infected patients at the point of care and may further help to guide cART in Sub-Saharan Africa.	[Franzeck, Fabian C.; Henning, Lars; Letang, Emilio; Hatz, Christoph; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Franzeck, Fabian C.; Ngwale, Ramadhani; Msongole, Bernadeta; Hamisi, Marian; Abdul, Omary; Henning, Lars; Letang, Emilio; Mwaigomole, Geoffrey; Hatz, Christoph; Tanner, Marcel] Ifakara Hlth Inst, Ifakara, Tanzania; [Franzeck, Fabian C.; Henning, Lars; Letang, Emilio; Mwaigomole, Geoffrey; Battegay, Manuel; Hatz, Christoph; Tanner, Marcel] Univ Basel, Basel, Switzerland; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Msongole, Bernadeta; Hamisi, Marian; Abdul, Omary] St Francis Referral Hosp, Ifakara, Tanzania; [Letang, Emilio] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res, Barcelona, Spain	University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; University of Basel; University of Basel; University of Barcelona; Hospital Clinic de Barcelona	Franzeck, FC (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	fcfranzeck@gmail.com	Henning, Lars/ABG-9375-2020	Henning, Lars/0000-0003-3533-1515	SwissTPH; Canton of Basel-Stadt/Switzerland	SwissTPH; Canton of Basel-Stadt/Switzerland	This work was supported by the SwissTPH and funds from the Canton of Basel-Stadt/Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LANCET, V372, P293; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Chan ED, 2000, TUBERCLE LUNG DIS, V80, P131, DOI 10.1054/tuld.2000.0243; Davies J, 2010, T ROY SOC TROP MED H, V104, P162, DOI 10.1016/j.trstmh.2009.10.010; de Vries-Sluijs TEMS, 2010, GASTROENTEROLOGY, V139, P1934, DOI 10.1053/j.gastro.2010.08.045; EUROPEAN AIDS CLINICAL SOCIETY GUIDELINES (EACS), 2011, GUID CLIN MAN TREATM; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Hoffmann C J, 2012, Int J STD AIDS, V23, pe10, DOI 10.1258/ijsa.2009.009340; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Jaroszewicz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043143; Kew MC, 1996, GUT, V38, pS31, DOI 10.1136/gut.38.Suppl_2.S31; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Li JL, 2004, STAT MED, V23, P2537, DOI 10.1002/sim.1836; LOK ASF, 1993, HEPATOLOGY, V18, P497, DOI 10.1002/hep.1840180305; Martin-Carbonero L, 2011, AIDS, V25, P73, DOI 10.1097/QAD.0b013e328340fde2; Matthews GV, 2007, ANTIVIR THER, V12, P119; Ministry of Health and Social Welfare National AIDS Control Programme, 2012, NAT GUID MAN HIV AID; Ministry of Health and Social Welfare of Tanzania, 2009, NAT GUID MAN HIV AID; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Nagu TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-416; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; Randrianirina F, 2008, J VIROL METHODS, V151, P294, DOI 10.1016/j.jviromet.2008.03.019; Shivkumar S, 2012, AM J GASTROENTEROL; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; STAHEL E, 1984, E AFR MED J, V61, P806; Tess BH, 2000, AM J TROP MED HYG, V62, P138, DOI 10.4269/ajtmh.2000.62.138; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Thio CL, 2012, AIDS; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; WHO, 2010, ANT THER HIV INF AD; World Health Organisation, 2011, GLOB HIV AIDS RES EP; World Health Organization, 2008, HEP B FACTSH	35	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58468	10.1371/journal.pone.0058468	http://dx.doi.org/10.1371/journal.pone.0058468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469281	Green Published, Green Accepted, gold			2022-12-27	WOS:000315897100070
J	Kuo, CL; Lam, CM; Hewitt, JE; Scotting, PJ				Kuo, Cheng-Liang; Lam, Chi Man; Hewitt, Jane E.; Scotting, Paul J.			Formation of the Embryonic Organizer Is Restricted by the Competitive Influences of Fgf Signaling and the SoxB1 Transcription Factors	PLOS ONE			English	Article							BETA-CATENIN; ECTODERMAL FATE; EXPRESSION; XENOPUS; GROUCHO/TLE; INDUCTION; DOMAINS; CHORDIN; FAMILY; GENES	The organizer is one of the earliest structures to be established during vertebrate development and is crucial to subsequent patterning of the embryo. We have previously shown that the SoxB1 transcription factor, Sox3, plays a central role as a transcriptional repressor of zebrafish organizer gene expression. Recent data suggest that Fgf signaling has a positive influence on organizer formation, but its role remains to be fully elucidated. In order to better understand how Fgf signaling fits into the complex regulatory network that determines when and where the organizer forms, the relationship between the positive effects of Fgf signaling and the repressive effects of the SoxB1 factors must be resolved. This study demonstrates that both fgf3 and fgf8 are required for expression of the organizer genes, gsc and chd, and that SoxB1 factors (Sox3, and the zebrafish specific factors, Sox19a and Sox19b) can repress the expression of both fgf3 and fgf8. However, we also find that these SoxB1 factors inhibit the expression of gsc and chd independently of their repression of fgf expression. We show that ectopic expression of organizer genes induced solely by the inhibition of SoxB1 function is dependent upon the activation of fgf expression. These data allow us to describe a comprehensive signaling network in which the SoxB1 factors restrict organizer formation by inhibiting Fgf, Nodal and Wnt signaling, as well as independently repressing the targets of that signaling. The organizer therefore forms only where Nodal-induced Fgf signaling overlaps with Wnt signaling and the SoxB1 proteins are absent.	[Kuo, Cheng-Liang; Lam, Chi Man; Hewitt, Jane E.; Scotting, Paul J.] Univ Nottingham, Sch Biol, Ctr Genet & Genom, QMC, Nottingham NG7 2RD, England	University of Nottingham	Scotting, PJ (corresponding author), Univ Nottingham, Sch Biol, Ctr Genet & Genom, QMC, Nottingham NG7 2RD, England.	paul.scotting@nottingham.ac.uk		Kuo, Cheng-Liang/0000-0003-2401-9390				Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Araki I, 2001, GENESIS, V30, P157, DOI 10.1002/gene.1054; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dee CT, 2008, DEV BIOL, V320, P289, DOI 10.1016/j.ydbio.2008.05.542; Dee CT, 2007, INT J DEV BIOL, V51, P79, DOI 10.1387/ijdb.062204cd; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Fox MD, 2009, DEVELOPMENT, V136, P1675, DOI 10.1242/dev.031161; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Joubin K, 2001, INT J DEV BIOL, V45, P165; Jowett T, 1996, TRENDS GENET, V12, P387, DOI 10.1016/S0168-9525(96)90091-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudoh T, 2004, DEVELOPMENT, V131, P3581, DOI 10.1242/dev.01227; Maegawa S, 2006, DEVELOPMENT, V133, P3265, DOI 10.1242/dev.02483; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Okuda Y, 2006, DEV DYNAM, V235, P811, DOI 10.1002/dvdy.20678; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; Penzel R, 1997, INT J DEV BIOL, V41, P667; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Rogers CD, 2009, MECH DEVELOP, V126, P42, DOI 10.1016/j.mod.2008.10.005; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shih YH, 2010, DEVELOPMENT, V137, P2671, DOI 10.1242/dev.054130; Sun SK, 2007, DEV BIOL, V303, P675, DOI 10.1016/j.ydbio.2006.12.008; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Tsuji S, 2005, DEV GENES EVOL, V215, P275, DOI 10.1007/s00427-005-0474-0; Yan B, 2009, DEV BIOL, V329, P80, DOI 10.1016/j.ydbio.2009.02.019; Zhang C, 2004, DEV BIOL, V273, P23, DOI 10.1016/j.ydbio.2004.05.019; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57698	10.1371/journal.pone.0057698	http://dx.doi.org/10.1371/journal.pone.0057698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469052	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900151
J	Ladich, F; Schulz-Mirbach, T				Ladich, Friedrich; Schulz-Mirbach, Tanja			Hearing in Cichlid Fishes under Noise Conditions	PLOS ONE			English	Article							FRESH-WATER GOBIES; AMBIENT NOISE; ACOUSTIC COMMUNICATION; AUDITORY-SENSITIVITY; BACKGROUND-NOISE; SCIAENID FISHES; SOUND PRESSURE; THRESHOLDS; COD; PROPAGATION	Background: Hearing thresholds of fishes are typically acquired under laboratory conditions. This does not reflect the situation in natural habitats, where ambient noise may mask their hearing sensitivities. In the current study we investigate hearing in terms of sound pressure (SPL) and particle acceleration levels (PAL) of two cichlid species within the naturally occurring range of noise levels. This enabled us to determine whether species with and without hearing specializations are differently affected by noise. Methodology/Principal Findings: We investigated auditory sensitivities in the orange chromide Etroplus maculatus, which possesses anterior swim bladder extensions, and the slender lionhead cichlid Steatocranus tinanti, in which the swim bladder is much smaller and lacks extensions. E. maculatus was tested between 0.2 and 3 kHz and S. tinanti between 0.1 and 0.5 kHz using the auditory evoked potential (AEP) recording technique. In both species, SPL and PAL audiograms were determined in the presence of quiet laboratory conditions (baseline) and continuous white noise of 110 and 130 dB RMS. Baseline thresholds showed greatest hearing sensitivity around 0.5 kHz (SPL) and 0.2 kHz (PAL) in E. maculatus and 0.2 kHz in S. tinanti. White noise of 110 dB elevated the thresholds by 0-11 dB (SPL) and 7-11 dB (PAL) in E. maculatus and by 1-2 dB (SPL) and by 1-4 dB (PAL) in S. tinanti. White noise of 130 dB elevated hearing thresholds by 13-29 dB (SPL) and 26-32 dB (PAL) in E. maculatus and 6-16 dB (SPL) and 6-19 dB (PAL) in S. tinanti. Conclusions: Our data showed for the first time for SPL and PAL thresholds that the specialized species was masked by different noise regimes at almost all frequencies, whereas the non-specialized species was much less affected. This indicates that noise can limit sound detection and acoustic orientation differently within a single fish family.	[Ladich, Friedrich; Schulz-Mirbach, Tanja] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna	Ladich, F (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	friedrich.ladich@univie.ac.at			Austrian Science Fund (FWF) [22319]; German Academic Exchange Service (DAAD) [D/10/51727]; Austrian Science Fund (FWF) [P 22319] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF grant 22319 to FL) and the German Academic Exchange Service (DAAD, Postdoctoral fellowship D/10/51727 to TSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoser S, 2005, J EXP BIOL, V208, P3533, DOI 10.1242/jeb.01809; Amoser S, 2010, AQUAT SCI, V72, P371, DOI 10.1007/s00027-010-0136-9; Belanger AJ, 2010, J FISH BIOL, V77, P1488, DOI 10.1111/j.1095-8649.2010.02773.x; BUERKLE U, 1968, J FISH RES BOARD CAN, V25, P1155, DOI 10.1139/f68-101; BUERKLE U, 1969, J FISH RES BOARD CAN, V26, P1113, DOI 10.1139/f69-102; CHAPMAN CJ, 1973, HELGOLAND WISS MEER, V24, P371, DOI 10.1007/BF01609527; CHAPMAN CJ, 1973, J COMP PHYSIOL, V85, P147, DOI 10.1007/BF00696473; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; COOMBS S, 1979, J COMP PHYSIOL, V132, P203, DOI 10.1007/BF00614491; Fay R. R., 1988, HEARING VERTEBRATES; FAY RR, 1974, J COMP PHYSIOL PSYCH, V87, P708, DOI 10.1037/h0037002; FINE ML, 1995, MAR BIOL, V123, P401, DOI 10.1007/BF00349218; Frisch J. von., 1936, Biological Reviews Cambridge, V11, P210; Gutscher M, 2011, BIOACOUSTICS, V20, P117, DOI 10.1080/09524622.2011.9753639; Hawkins A.D., 1993, Fish and Fisheries Series, V7, P129; *ISO, 1983, 1683 ISO; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Ladich F, 1999, BRAIN BEHAV EVOLUT, V53, P288, DOI 10.1159/000006600; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F, 2000, PHILOS T ROY SOC B, V355, P1285, DOI 10.1098/rstb.2000.0685; Ladich F, 2012, ANIMAL COMM IN PRESS; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Lugli M, 2003, J ACOUST SOC AM, V114, P512, DOI 10.1121/1.1577561; Lugli M, 2003, J COMP PHYSIOL A, V189, P309, DOI 10.1007/s00359-003-0404-4; Lugli M, 2007, J ACOUST SOC AM, V122, P2881, DOI 10.1121/1.2783113; Lugli M, 2010, J COMP PHYSIOL A, V196, P439, DOI 10.1007/s00359-010-0528-2; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; Ramcharitar J, 2004, J ACOUST SOC AM, V116, P1687, DOI 10.1121/1.1771614; Ramcharitar J, 2001, BRAIN BEHAV EVOLUT, V58, P152, DOI 10.1159/000047269; Ramcharitar JU, 2006, J ACOUST SOC AM, V119, P439, DOI 10.1121/1.2139068; Rogers P.H., 1988, P131; Scholik AR, 2002, COMP BIOCHEM PHYS A, V133, P43, DOI 10.1016/S1095-6433(02)00108-3; Scholik AR, 2001, HEARING RES, V152, P17, DOI 10.1016/S0378-5955(00)00213-6; Scholz K, 2006, J FISH BIOL, V69, P892, DOI 10.1111/j.1095-8649.2006.01168.x; Schulz-Mirbach T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042292; Tavolga W.N., 1967, P233; Tavolga W. N., 1963, Bulletin of the American Museum of Natural History, V126, P177; Vasconcelos RO, 2007, J EXP BIOL, V210, P2104, DOI 10.1242/jeb.004317; Wysocki LE, 2005, JARO-J ASSOC RES OTO, V6, P28, DOI 10.1007/s10162-004-4043-4; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2002, HEARING RES, V169, P36, DOI 10.1016/S0378-5955(02)00336-2; Wysocki LE, 2007, J ACOUST SOC AM, V121, P2559, DOI 10.1121/1.2713661; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562	45	19	19	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57588	10.1371/journal.pone.0057588	http://dx.doi.org/10.1371/journal.pone.0057588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469032	gold, Green Published			2022-12-27	WOS:000315524900131
J	Trujillo, U; Vazquez-Rosa, E; Oyola-Robles, D; Stagg, LJ; Vassallo, DA; Vega, IE; Arold, ST; Baerga-Ortiz, A				Trujillo, Uldaeliz; Vazquez-Rosa, Edwin; Oyola-Robles, Delise; Stagg, Loren J.; Vassallo, David A.; Vega, Irving E.; Arold, Stefan T.; Baerga-Ortiz, Abel			Solution Structure of the Tandem Acyl Carrier Protein Domains from a Polyunsaturated Fatty Acid Synthase Reveals Beads-on-a-String Configuration	PLOS ONE			English	Article							POLYKETIDE; BIOSYNTHESIS; GENES; STREPTOMYCES	The polyunsaturated fatty acid (PUFA) synthases from deep-sea bacteria invariably contain multiple acyl carrier protein (ACP) domains in tandem. This conserved tandem arrangement has been implicated in both amplification of fatty acid production (additive effect) and in structural stabilization of the multidomain protein (synergistic effect). While the more accepted model is one in which domains act independently, recent reports suggest that ACP domains may form higher oligomers. Elucidating the three-dimensional structure of tandem arrangements may therefore give important insights into the functional relevance of these structures, and hence guide bioengineering strategies. In an effort to elucidate the three-dimensional structure of tandem repeats from deep-sea anaerobic bacteria, we have expressed and purified a fragment consisting of five tandem ACP domains from the PUFA synthase from Photobacterium profundum. Analysis of the tandem ACP fragment by analytical gel filtration chromatography showed a retention time suggestive of a multimeric protein. However, small angle X-ray scattering (SAXS) revealed that the multi-ACP fragment is an elongated monomer which does not form a globular unit. Stokes radii calculated from atomic monomeric SAXS models were comparable to those measured by analytical gel filtration chromatography, showing that in the gel filtration experiment, the molecular weight was overestimated due to the elongated protein shape. Thermal denaturation monitored by circular dichroism showed that unfolding of the tandem construct was not cooperative, and that the tandem arrangement did not stabilize the protein. Taken together, these data are consistent with an elongated beads-on-a-string arrangement of the tandem ACP domains in PUFA synthases, and speak against synergistic biocatalytic effects promoted by quaternary structuring. Thus, it is possible to envision bioengineering strategies which simply involve the artificial linking of multiple ACP domains for increasing the yield of fatty acids in bacterial cultures.	[Trujillo, Uldaeliz; Oyola-Robles, Delise; Vassallo, David A.; Baerga-Ortiz, Abel] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA; [Vazquez-Rosa, Edwin; Vega, Irving E.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Stagg, Loren J.; Arold, Stefan T.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Stagg, Loren J.; Arold, Stefan T.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Arold, Stefan T.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; King Abdullah University of Science & Technology	Arold, ST (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	STArold@mdanderson.org; abel.baerga@upr.edu	Arold, Stefan/T-2612-2019	Arold, Stefan T/0000-0001-5278-0668	National Science Foundation (NSF) [CHE0953254]; National Institutes of Health (NIH) [R25GM061838]; NIH [G12RR03051]; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA078586] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151, R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Science Foundation (NSF) grant CHE0953254 to ABO and National Institutes of Health (NIH) grant R25GM061838 (MBRS-RISE Program) to UT and DOR. Shared instrumentation was purchased with NIH Grant G12RR03051 (RCMI Program). This study was also supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant (CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bienkiewicz EA, 1997, BIOSPECTROSCOPY, V3, P171, DOI 10.1002/(SICI)1520-6343(1997)3:3<171::AID-BSPY1>3.3.CO;2-E; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Crawford JM, 2008, BIOORG CHEM, V36, P16, DOI 10.1016/j.bioorg.2007.11.002; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Gehring AM, 1997, CHEM BIOL, V4, P17, DOI 10.1016/S1074-5521(97)90233-7; Gu LC, 2011, ANGEW CHEM INT EDIT, V50, P2795, DOI 10.1002/anie.201005280; Jiang H, 2008, J AM CHEM SOC, V130, P6336, DOI 10.1021/ja801911t; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Orikasa Y, 2006, FEBS LETT, V580, P4423, DOI 10.1016/j.febslet.2006.07.008; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Rahman AS, 2005, J BIOL CHEM, V280, P6399, DOI 10.1074/jbc.M409814200; Shulse CN, 2011, ENVIRON MICROBIOL, V13, P684, DOI 10.1111/j.1462-2920.2010.02373.x; Udwary DW, 2002, J MOL BIOL, V323, P585, DOI 10.1016/S0022-2836(02)00972-5; YU JH, 1995, J BACTERIOL, V177, P4792, DOI 10.1128/jb.177.16.4792-4800.1995	22	18	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57859	10.1371/journal.pone.0057859	http://dx.doi.org/10.1371/journal.pone.0057859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469090	Green Published, gold			2022-12-27	WOS:000315524900186
J	Marchi, N; Bazarian, JJ; Puvenna, V; Janigro, M; Ghosh, C; Zhong, JH; Zhu, T; Blackman, E; Stewart, D; Ellis, J; Butler, R; Janigro, D				Marchi, Nicola; Bazarian, Jeffrey J.; Puvenna, Vikram; Janigro, Mattia; Ghosh, Chaitali; Zhong, Jianhui; Zhu, Tong; Blackman, Eric; Stewart, Desiree; Ellis, Jasmina; Butler, Robert; Janigro, Damir			Consequences of Repeated Blood-Brain Barrier Disruption in Football Players	PLOS ONE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; NEUROLOGICAL DISORDERS; PROFESSIONAL FOOTBALL; IMPACT BIOMECHANICS; ALZHEIMERS-DISEASE; SERUM S100-BETA; AUTOANTIBODIES; CONCUSSION	The acknowledgement of risks for traumatic brain injury in American football players has prompted studies for sideline concussion diagnosis and testing for neurological deficits. While concussions are recognized etiological factors for a spectrum of neurological sequelae, the consequences of sub-concussive events are unclear. We tested the hypothesis that blood-brain barrier disruption (BBBD) and the accompanying surge of the astrocytic protein S100B in blood may cause an immune response associated with production of auto-antibodies. We also wished to determine whether these events result in disrupted white matter on diffusion tensor imaging (DT) scans. Players from three college football teams were enrolled (total of 67 volunteers). None of the players experienced a concussion. Blood samples were collected before and after games (n = 57); the number of head hits in all players was monitored by movie review and post-game interviews. S100B serum levels and auto-antibodies against S100B were measured and correlated by direct and reverse immunoassays (n = 15 players; 5 games). A subset of players underwent DTI scans pre- and post-season and after a 6-month interval (n = 10). Cognitive and functional assessments were also performed. After a game, transient BBB damage measured by serum S100B was detected only in players experiencing the greatest number of sub-concussive head hits. Elevated levels of auto-antibodies against S100B were elevated only after repeated sub-concussive events characterized by BBBD. Serum levels of S100B auto-antibodies also predicted persistence of MRI-DTI abnormalities which in turn correlated with cognitive changes. Even in the absence of concussion, football players may experience repeated BBBD and serum surges of the potential autoantigen S100B. The correlation of serum S100B, auto-antibodies and DTI changes support a link between repeated BBBD and future risk for cognitive changes.	[Marchi, Nicola; Puvenna, Vikram; Ghosh, Chaitali; Stewart, Desiree; Ellis, Jasmina; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Puvenna, Vikram; Ghosh, Chaitali; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Puvenna, Vikram; Ghosh, Chaitali; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Cell & Mol Med, Cleveland, OH 44106 USA; [Janigro, Mattia; Janigro, Damir] Flocel Inc, Cleveland, OH USA; [Ellis, Jasmina] Baldwin Wallace Coll, Berea, OH USA; [Butler, Robert] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Bazarian, Jeffrey J.; Zhong, Jianhui; Zhu, Tong; Blackman, Eric] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Baldwin Wallace University; Cleveland Clinic Foundation; University of Rochester	Janigro, D (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	janigrd@ccf.org	Marchi, Nicola/J-8607-2016; Zhu, Tong/A-9402-2011; Zhong, Jianhui/AAE-6061-2020	Marchi, Nicola/0000-0001-9124-0226; Ghosh, Chaitali/0000-0003-4078-0278; Blackman, Eric/0000-0002-9405-8435; Zhu, Tong/0000-0002-0012-0091; Janigro, Damir/0000-0003-2165-5826	NINDS [R21HD057256]; Flocel, Inc; National Football League-Charities Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078307] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Flocel, Inc; National Football League-Charities Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was received from: NINDS R21HD057256; Salary for MJ supported by Flocel, Inc; National Football League-Charities Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankeny DP, 2010, TRENDS IMMUNOL, V31, P332, DOI 10.1016/j.it.2010.06.006; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Maetzler W, 2011, J ALZHEIMERS DIS, V26, P171, DOI 10.3233/JAD-2011-110221; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-34; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Pardini J, 2011, YOUMANS NEUROLOGICAL, P3380; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sorokina EG, 2010, ZH NEVROL PSIKHIATR, V110, P30; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Storace D, 2010, ARCH NEUROL-CHICAGO, V67, P867, DOI 10.1001/archneurol.2010.137; Taira BR, 2012, ANN EMERG MED, V60, P236, DOI 10.1016/j.annemergmed.2012.04.004; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	47	185	190	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56805	10.1371/journal.pone.0056805	http://dx.doi.org/10.1371/journal.pone.0056805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483891	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100009
J	Ferreira-Facio, CS; Milito, C; Botafogo, V; Fontana, M; Thiago, LS; Oliveira, E; da Rocha, AS; Werneck, F; Forny, DN; Dekermacher, S; de Azambuja, AP; Ferman, SE; de Faria, PAS; Land, MGP; Orfao, A; Costa, ES				Ferreira-Facio, Cristiane S.; Milito, Cristiane; Botafogo, Vitor; Fontana, Marcela; Thiago, Leandro S.; Oliveira, Elen; da Rocha-Filho, Ariovaldo S.; Werneck, Fernando; Forny, Danielle N.; Dekermacher, Samuel; de Azambuja, Ana Paula; Ferman, Sima Esther; Silvestre de Faria, Paulo Antonio; Land, Marcelo G. P.; Orfao, Alberto; Costa, Elaine S.			Contribution of Multiparameter Flow Cytometry Immunophenotyping to the Diagnostic Screening and Classification of Pediatric Cancer	PLOS ONE			English	Article							RESIDUAL NEUROBLASTOMA-CELLS; SOLID TUMOR PREPARATION; BONE-MARROW; PERIPHERAL-BLOOD; CHILDHOOD-CANCER; DNA; EXPRESSION; RHABDOMYOSARCOMA; HETEROGENEITY; NEOPLASMS	Pediatric cancer is a relatively rare and heterogeneous group of hematological and non-hematological malignancies which require multiple procedures for its diagnostic screening and classification. Until now, flow cytometry (FC) has not been systematically applied to the diagnostic work-up of such malignancies, particularly for solid tumors. Here we evaluated a FC panel of markers for the diagnostic screening of pediatric cancer and further classification of pediatric solid tumors. The proposed strategy aims at the differential diagnosis between tumoral vs. reactive samples, and hematological vs. non-hematological malignancies, and the subclassification of solid tumors. In total, 52 samples from 40 patients suspicious of containing tumor cells were analyzed by FC in parallel to conventional diagnostic procedures. The overall concordance rate between both approaches was of 96% (50/52 diagnostic samples), with 100% agreement for all reactive/inflammatory and non-infiltrated samples as well as for those corresponding to solid tumors (n = 35), with only two false negative cases diagnosed with Hodgkin lymphoma and anaplastic lymphoma, respectively. Moreover, clear discrimination between samples infiltrated by hematopoietic vs. non-hematopoietic tumor cells was systematically achieved. Distinct subtypes of solid tumors showed different protein expression profiles, allowing for the differential diagnosis of neuroblastoma (CD56(hi)/GD2(+)/CD81(hi)), primitive neuroectodermal tumors (CD271(hi)/CD99(+)), Wilms tumors (>1 cell population), rhabdomyosarcoma ((nu)MYOD1(+)/(nu)myogenin(+)), carcinomas (CD45(-)/EpCAM(+)), germ cell tumors (CD56(+)/CD45(-)/NG2(+)/CD10(+)) and eventually also hemangiopericytomas (CD45(-)/CD34(+)). In summary, our results show that multiparameter FC provides fast and useful complementary data to routine histopathology for the diagnostic screening and classification of pediatric cancer.	[Ferreira-Facio, Cristiane S.; Botafogo, Vitor; Fontana, Marcela; Thiago, Leandro S.; Oliveira, Elen; Forny, Danielle N.; Land, Marcelo G. P.; Costa, Elaine S.] Univ Fed Rio de Janeiro, Pediat Inst IPPMG, Rio De Janeiro, Brazil; [Milito, Cristiane] Univ Fed Rio de Janeiro, Dept Pathol, Fac Med, Rio De Janeiro, Brazil; [da Rocha-Filho, Ariovaldo S.; Werneck, Fernando; Dekermacher, Samuel] Servidores Estado Hosp HSE, Rio De Janeiro, Brazil; [Thiago, Leandro S.] Brazilian Natl Canc Inst INCa, Canc Res Ctr, Pediat Hematol & Oncol Program, Rio De Janeiro, Brazil; [de Azambuja, Ana Paula] Fed Univ Parana UFPR, Clin Hosp, Curitiba, Parana, Brazil; [Ferman, Sima Esther; Silvestre de Faria, Paulo Antonio] Brazilian Natl Canc Inst INCa, Dept Pediat Oncol, Rio De Janeiro, Brazil; [Orfao, Alberto] Univ Salamanca, Dept Med, Cytometry Serv, CSIC, E-37008 Salamanca, Spain; [Orfao, Alberto] Univ Salamanca, Canc Res Ctr, IBMCC, CSIC, E-37008 Salamanca, Spain; [Orfao, Alberto] Univ Salamanca, IBSAL, E-37008 Salamanca, Spain	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca); Universidade Federal do Parana; National Cancer Institute (Inca); Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Costa, ES (corresponding author), Univ Fed Rio de Janeiro, Pediat Inst IPPMG, Rio De Janeiro, Brazil.	elainesc@centroin.com.br	Thiago, Leandro/ABH-7607-2020; COSTA, ELAINE SOBRAL/AAE-9574-2021; land, marcelo g p/O-9286-2018; Thiago, Leandro/I-2678-2012; Sobral da Costa, Elaine/O-6523-2014	land, marcelo g p/0000-0001-9792-3167; DE AZAMBUJA, ANA PAULA/0000-0001-9884-4735; Thiago, Leandro/0000-0002-4003-3400; Sobral da Costa, Elaine/0000-0002-5340-5816	CNPq-Brazilian National Research Council (Brasilia, Brazil); FAPERJ-Research support foundation of Rio de Janeiro, (Rio de Janeiro, Brazil); CAPES/Ministerio da Educacao (Brasilia, Brazil)	CNPq-Brazilian National Research Council (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ-Research support foundation of Rio de Janeiro, (Rio de Janeiro, Brazil); CAPES/Ministerio da Educacao (Brasilia, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been partially supported by the following grants: EO was partially supported by grant from CNPq-Brazilian National Research Council (Brasilia, Brazil). MF was partially supported by a grant from FAPERJ-Research support foundation of Rio de Janeiro, (Rio de Janeiro, Brazil) and now she is partially supported by a grant from CAPES/Ministerio da Educacao (Brasilia, Brazil). VB was partially supported by FAPERJ-Research support foundation of Rio de Janeiro, (Rio de Janeiro, Brazil). ESC was partially supported by grant from CNPq-Brazilian National Research Council (Brasilia, Brazil) and FAPERJ-Research support foundation of Rio de Janeiro, (Rio de Janeiro, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BAKER DL, 1989, CANCER RES, V49, P4142; Barrena S, 2011, HISTOPATHOLOGY, V58, P906, DOI 10.1111/j.1365-2559.2011.03804.x; BIJMAN JT, 1985, CYTOMETRY, V6, P334; Bozzi F, 2008, ANTICANCER RES, V28, P1565; Bozzi F, 2006, ANTICANCER RES, V26, P3281; Bryson GJ, 2002, J CLIN PATHOL, V55, P535, DOI 10.1136/jcp.55.7.535; Chang A, 2003, AM J CLIN PATHOL, V119, P643, DOI 10.1309/FU3FDKYN8AU0891N; Corver WE, 2005, J PATHOL, V206, P233, DOI 10.1002/path.1765; Corver WE, 2002, CURR DIAGN PATHOL, V8, P249; Csathy L, 2011, CYTOM PART B-CLIN CY, V80B, P134, DOI 10.1002/cyto.b.20576; da Costa ES, 2010, CYTOM PART B-CLIN CY, V78B, P11, DOI 10.1002/cyto.b.20486; Dang-Tan T, 2007, CANCER-AM CANCER SOC, V110, P703, DOI 10.1002/cncr.22849; Dehner LP, 1998, MODERN PATHOL, V11, P669; DeZen L, 1997, J CLIN ONCOL, V15, P1198, DOI 10.1200/JCO.1997.15.3.1198; Domingues PH, 2012, AM J PATHOL, V181, P1749, DOI 10.1016/j.ajpath.2012.07.033; DuBois SG, 2010, PEDIATR BLOOD CANCER, V54, P13, DOI 10.1002/pbc.22245; ENSLEY JF, 1987, CYTOMETRY, V8, P488, DOI 10.1002/cyto.990080509; ENSLEY JF, 1987, CYTOMETRY, V8, P479, DOI 10.1002/cyto.990080508; Farinola MA, 2003, CANCER CYTOPATHOL, V99, P240, DOI 10.1002/cncr.11458; Gardner LI, 1998, VIRCHOWS ARCH, V40, P433; Gardner LJ, 1998, VIRCHOWS ARCH, V433, P35, DOI 10.1007/s004280050213; Gautam U, 2008, CANCER CYTOPATHOL, V114, P494, DOI 10.1002/cncr.23948; Ho R, 2011, CANCER LETT, V305, P76, DOI 10.1016/j.canlet.2011.02.029; Komada Y, 1998, CANCER, V82, P591, DOI 10.1002/(SICI)1097-0142(19980201)82:3<591::AID-CNCR23>3.3.CO;2-E; Konemann S, 2000, CYTOMETRY, V41, P172, DOI 10.1002/1097-0320(20001101)41:3<172::AID-CYTO3>3.0.CO;2-W; Laane E, 2005, CYTOM PART B-CLIN CY, V64B, P34, DOI 10.1002/cyto.b.20043; Leon ME, 2004, DIAGN CYTOPATHOL, V31, P147, DOI 10.1002/dc.20074; Lima M, 2001, AM J PATHOL, V159, P1861, DOI 10.1016/S0002-9440(10)63032-5; Lin Patrick P., 2011, Sarcoma, V2011, P276463, DOI 10.1155/2011/276463; LIPINSKI M, 1987, CANCER RES, V47, P183; Loeb DM, 2008, SURG CLIN N AM, V88, P615, DOI 10.1016/j.suc.2008.03.008; Mann G, 2006, PEDIATR HEMAT ONCOL, V23, P167, DOI 10.1080/08880010500506354; MECHTERSHEIMER G, 1991, CANCER RES, V51, P1300; Metsuyanim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006709; Mora J, 2001, BRIT J CANCER, V85, P182, DOI 10.1054/bjoc.2001.1849; Mora J, 2007, GENE CHROMOSOME CANC, V46, P385, DOI 10.1002/gcc.20421; Morotti RA, 2006, AM J SURG PATHOL, V30, P962, DOI 10.1097/00000478-200608000-00005; Nagai J, 2000, J PEDIAT HEMATOL ONC, V22, P20, DOI 10.1097/00043426-200001000-00004; Nap Marius, 2001, Virchows Archiv, V438, P425, DOI 10.1007/s004280000369; Okcu MF, 2005, PEDIATR BLOOD CANCER, V45, P787, DOI 10.1002/pbc.20428; Orfao A, 1999, CLIN CHEM, V45, P1708; Parham D M, 2001, Am J Clin Pathol, V115 Suppl, pS113; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Roshal Mikhail, 2011, Adv Hematol, V2011, P387034, DOI 10.1155/2011/387034; Rushton J, 2011, CANCER BIOMARK, V9, P211, DOI 10.3233/CBM-2011-0199; Sebire NJ, 2003, J CLIN PATHOL, V56, P412, DOI 10.1136/jcp.56.6.412; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; SMYTH CM, 1993, PATHOLOGY, V25, P388, DOI 10.3109/00313029309090865; Suarez L, 2001, HAEMATOLOGICA, V86, P1287; SUGIMOTO T, 1988, MED PEDIATR ONCOL, V16, P190, DOI 10.1002/mpo.2950160308; Swerdlow SH, 2008, WHO CLASSIFICATION T; Swerts K, 2004, CYTOM PART B-CLIN CY, V61B, P9, DOI 10.1002/cyto.b.20019; Terracini B, 2011, ENV HLTH, V10, pS1; Triche T.J., 2010, PRINCIPLES PRACTICES, V6th, P165; Tsang KS, 2003, CANCER, V97, P2887, DOI 10.1002/cncr.11389; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; VANDAM PA, 1990, J CLIN PATHOL, V43, P833, DOI 10.1136/jcp.43.10.833; Warzynski MJ, 2002, CYTOMETRY, V50, P298, DOI 10.1002/cyto.10159; Wick MR, 2012, ANN DIAGN PATHOL, V16, P71, DOI 10.1016/j.anndiagpath.2011.10.010; WILLIAMS DM, 1993, ARCH DIS CHILD, V68, P393, DOI 10.1136/adc.68.3.393	61	42	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e55534	10.1371/journal.pone.0055534	http://dx.doi.org/10.1371/journal.pone.0055534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472067	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900005
J	Leidner, RS; Li, L; Thompson, CL				Leidner, Rom S.; Li, Li; Thompson, Cheryl L.			Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer	PLOS ONE			English	Article							BLOOD-BASED MARKERS; EXPRESSION; SERUM; CELLS; RISK; RESISTANCE; BIOMARKER; TISSUES; TUMOR; GENE	Genome-wide platforms for high-throughput profiling of circulating miRNA (oligoarray or miR-Seq) offer enormous promise for agnostic discovery of circulating miRNA biomarkers as a pathway for development in breast cancer detection. By harmonizing data from 15 previous reports, we found widespread inconsistencies across prior studies. Whether this arises from differences in study design, such as sample source or profiling platform, is unclear. As a reproducibility experiment, we generated a genome-wide plasma miRNA dataset using the Illumina oligoarray and compared this to a publically available dataset generated using an identical sample size, substrate and profiling platform. Samples from 20 breast cancer patients, 20 mammography-screened controls, as well as 20 breast cancer patients after surgical resection and 10 female lung or colorectal cancer patients were included. After filtering for miRNAs derived from blood cells, and for low abundance miRNAs (non-detectable in over 10% of samples), a set of 522 plasma miRNAs remained, of which 46 were found to be differentially expressed between breast cancer patients and healthy controls (p<0.05), of which only 3 normalized to baseline levels in post-resection cases and were unique to breast cancer vs. lung or colorectal cancer (miR-708*, miR-92b* and miR-568, none previously reported). We were unable to demonstrate reproducibility by various measures between the two datasets. This finding, along with widespread inconsistencies across prior studies, highlight the need for better understanding of factors influencing circulating miRNA levels as prerequisites to progress in this area of translational research.	[Leidner, Rom S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Li, Li; Thompson, Cheryl L.] Case Western Reserve Univ, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA; [Li, Li; Thompson, Cheryl L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Leidner, Rom S.; Li, Li; Thompson, Cheryl L.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Thompson, CL (corresponding author), Case Western Reserve Univ, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA.	Cheryl.L.Thompson@case.edu		Leidner, Rom/0000-0003-0788-7938	National Cancer Institute (NCI) [K07CA136758]; Case Comprehensive Cancer Center [P30CA043703]; American Society of Clinical Oncology Young Investigator Award; NCI Clinical Oncology Research Career Development Award through the Case Comprehensive Cancer Center [K12CA076917]; NATIONAL CANCER INSTITUTE [K07CA136758, K12CA076917, P30CA043703] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Case Comprehensive Cancer Center; American Society of Clinical Oncology Young Investigator Award; NCI Clinical Oncology Research Career Development Award through the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this research was provided by the National Cancer Institute (NCI) (Grant number K07CA136758), The Case Comprehensive Cancer Center (P30CA043703), an American Society of Clinical Oncology Young Investigator Award and an NCI Clinical Oncology Research Career Development Award through the Case Comprehensive Cancer Center (Grant number: K12CA076917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appaiah HN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2943; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Gierisch JM, 2009, CANCER EPIDEMIOL, V33, P72, DOI 10.1016/j.cdp.2009.03.001; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kee F, 1992, Eur J Cancer Prev, V1, P311, DOI 10.1097/00008469-199206000-00006; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li XR, 2010, ENDOCRINOLOGY, V151, P2462, DOI 10.1210/en.2009-1150; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Meyer SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038946; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Ortiz AP, 2012, CANCER-AM CANCER SOC, V118, P1774, DOI 10.1002/cncr.26454; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Sieuwerts AM, 2011, CLIN CANCER RES, V17, P3600, DOI 10.1158/1078-0432.CCR-11-0255; Thompson CL, 2011, CANCER-AM CANCER SOC, V117, P841, DOI 10.1002/cncr.25507; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wu Q, 2012, CLIN CHIM ACTA, V413, P1058, DOI 10.1016/j.cca.2012.02.016; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	44	93	99	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57841	10.1371/journal.pone.0057841	http://dx.doi.org/10.1371/journal.pone.0057841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472110	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900049
J	Padilla-Torres, SD; Ferraz, G; Luz, SLB; Zamora-Perea, E; Abad-Franch, F				Padilla-Torres, Samael D.; Ferraz, Goncalo; Luz, Sergio L. B.; Zamora-Perea, Elvira; Abad-Franch, Fernando			Modeling Dengue Vector Dynamics under Imperfect Detection: Three Years of Site-Occupancy by Aedes aegypti and Aedes albopictus in Urban Amazonia	PLOS ONE			English	Article							POPULATION-DYNAMICS; PUERTO-RICO; TRANSMISSION; MOSQUITOS; CULICIDAE; DIPTERA; OVITRAP; BRAZIL; FEVER; INFESTATION	Aedes aegypti and Ae. albopictus are the vectors of dengue, the most important arboviral disease of humans. To date, Aedes ecology studies have assumed that the vectors are truly absent from sites where they are not detected; since no perfect detection method exists, this assumption is questionable. Imperfect detection may bias estimates of key vector surveillance/control parameters, including site-occupancy (infestation) rates and control intervention effects. We used a modeling approach that explicitly accounts for imperfect detection and a 38-month, 55-site detection/non-detection dataset to quantify the effects of municipality/state control interventions on Aedes site-occupancy dynamics, considering meteorological and dwelling-level covariates. Ae. aegypti site-occupancy estimates (mean 0.91; range 0.79-0.97) were much higher than reported by routine surveillance based on ` rapid larval surveys' (0.03; 0.02-0.11) and moderately higher than directly ascertained with oviposition traps (0.68; 0.50-0.91). Regular control campaigns based on breeding-site elimination had no measurable effects on the probabilities of dwelling infestation by dengue vectors. Site-occupancy fluctuated seasonally, mainly due to the negative effects of high maximum (Ae. aegypti) and minimum (Ae. albopictus) summer temperatures (June-September). Rainfall and dwelling-level covariates were poor predictors of occupancy. The marked contrast between our estimates of adult vector presence and the results from ` rapid larval surveys' suggests, together with the lack of effect of local control campaigns on infestation, that many Aedes breeding sites were overlooked by vector control agents in our study setting. Better sampling strategies are urgently needed, particularly for the reliable assessment of infestation rates in the context of control program management. The approach we present here, combining oviposition traps and site-occupancy models, could greatly contribute to that crucial aim.	[Padilla-Torres, Samael D.; Ferraz, Goncalo] Inst Nacl de Pesquisas da Amazonia, Grad Program Ecol, Manaus, Amazonas, Brazil; [Ferraz, Goncalo] Inst Nacl de Pesquisas da Amazonia, Smithsonian Trop Res Inst, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Luz, Sergio L. B.; Zamora-Perea, Elvira; Abad-Franch, Fernando] Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute; Fundacao Oswaldo Cruz	Abad-Franch, F (corresponding author), Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil.	fernando@amazonia.fiocruz.br	Abad-Franch, Fernando/AAB-6729-2021; Abad-Franch, Fernando/L-4741-2013; Ferraz, Gonçalo/C-3860-2008; Abad-Franch, Fernando/AAG-2432-2020	Ferraz, Gonçalo/0000-0001-8748-0462; Abad-Franch, Fernando/0000-0002-7715-0328	PDTSP-Dengue Program (Fiocruz-CNPq); Instituto Leonidas e Maria Deane; Fiocruz-Fapeam agreement; Brazilian National Research Council (CAPES/CNPq) [190023/10-4]; Research Program on Infectious Disease Ecology in the Amazon (RP-IDEA) of the Instituto Leonidas e Maria Deane - Fiocruz Amazonia [17]	PDTSP-Dengue Program (Fiocruz-CNPq); Instituto Leonidas e Maria Deane; Fiocruz-Fapeam agreement; Brazilian National Research Council (CAPES/CNPq); Research Program on Infectious Disease Ecology in the Amazon (RP-IDEA) of the Instituto Leonidas e Maria Deane - Fiocruz Amazonia	Research partially funded by the PDTSP-Dengue Program (Fiocruz-CNPq), the Instituto Leonidas e Maria Deane, the Fiocruz-Fapeam agreement, and the Brazilian National Research Council (CAPES/CNPq; scholarship 190023/10-4 to SDP-T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank RM Mota, DLN Leite, and AC Barbosa for field assistance. RS Rocha and the Manaus municipal and state Health Departments provided data on routine control-surveillance activities. We particularly thank the residents who participated in the study - and patiently let us keep running our vector monitoring system. SA Juliano, LL Bailey, RE Gurtler, and BW Nelson provided insightful comments on earlier versions of this manuscript. This work is contribution number 17 of the Research Program on Infectious Disease Ecology in the Amazon (RP-IDEA) of the Instituto Leonidas e Maria Deane - Fiocruz Amazonia.	Abad-Franch F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000620; Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; CHADEE D D, 1986, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V24, P199; Chadee DD, 2009, ACTA TROP, V109, P236, DOI 10.1016/j.actatropica.2008.12.001; da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x; Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942; Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Donatti JE, 2007, REV BRAS ENTOMOL, V51, P255, DOI 10.1590/S0085-56262007000200019; Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x; Favier C, 2006, TROP MED INT HEALTH, V11, P1104, DOI 10.1111/j.1365-3156.2006.01653.x; Fe NF, 2003, REV SAUDE PUBL, V37, P674, DOI 10.1590/S0034-89102003000500020; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; FUNASA, 2001, DENG INSTR PESS COMB; *FUNASA, 2002, PROGR NAC CONTR DENG; Fundacao de Vigilancia em Saude do Estado do Amazonas, 2008, REL FIN OP IMP CONTR; Fundacao de Vigilancia em Saude do Estado do Amazonas, 2009, REL FIN OP IMP 2 CON; FURLOW BM, 1970, MOSQ NEWS, V30, P468; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Gubler D. J., 1988, The arboviruses: epidemiology and ecology. Volume II., P223; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000427; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Hines J. E., 2006, PRESENCE 4 0 SOFTWAR; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Leisnham PT, 2009, OECOLOGIA, V160, P343, DOI 10.1007/s00442-009-1305-1; Lourenco-de-Oliveira R, 2008, J AM MOSQUITO CONTR, V24, P387, DOI 10.2987/5585.1; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2005, AUST NZ J STAT, V47, P65, DOI 10.1111/j.1467-842X.2005.00372.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MINISTERIO DA SAUDE, 2005, DIAGN RAP NOS MUN VI; MOGI M, 1990, J MED ENTOMOL, V27, P509, DOI 10.1093/jmedent/27.4.509; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Pilger D, 2011, TROP MED INT HEALTH, V16, P1143, DOI 10.1111/j.1365-3156.2011.02818.x; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; REITER P, 1991, J AM MOSQUITO CONTR, V7, P52; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Reiter Paul, 1997, P425; Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076; Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77; Taliberti H, 2010, REV PANAM SALUD PUBL, V27, P175, DOI 10.1590/S1020-49892010000300004; Tukey JW, 1977, EXPLORATORY DATA ANA; TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543; TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591; Who, 2006, SCI WORK GROUP REP D; WHO, 2012, GLOB AL RESP IMP DEN	60	12	13	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58420	10.1371/journal.pone.0058420	http://dx.doi.org/10.1371/journal.pone.0058420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472194	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900140
J	Eker, B; Meissner, R; Bertsch, A; Mehta, K; Renaud, P				Eker, Bilge; Meissner, Robert; Bertsch, Arnaud; Mehta, Kapil; Renaud, Philippe			Label-Free Recognition of Drug Resistance via Impedimetric Screening of Breast Cancer Cells	PLOS ONE			English	Article							MODEL; EXPRESSION; BIOMECHANICS; DOXORUBICIN; ADHESION; CADHERIN; MONITOR; KINASE	We present a novel study on label-free recognition and distinction of drug resistant breast cancer cells (MCF-7 DOX) from their parental cells (MCF-7 WT) via impedimetric measurements. Drug resistant cells exhibited significant differences in their dielectric properties compared to wild-type cells, exerting much higher extracellular resistance (R-extra). Immunostaining revealed that MCF-7 DOX cells gained a much denser F-actin network upon acquiring drug resistance indicating that remodeling of actin cytoskeleton is probably the reason behind higher R-extra, providing stronger cell architecture. Moreover, having exposed both cell types to doxorubicin, we were able to distinguish these two phenotypes based on their substantially different drug response. Interestingly, impedimetric measurements identified a concentration-dependent and reversible increase in cell stiffness in the presence of low non-lethal drug doses. Combined with a profound frequency analysis, these findings enabled distinguishing distinct cellular responses during drug exposure within four concentration ranges without using any labeling. Overall, this study highlights the possibility to differentiate drug resistant phenotypes from their parental cells and to assess their drug response by using microelectrodes, offering direct, real-time and noninvasive measurements of cell dependent parameters under drug exposure, hence providing a promising step for personalized medicine applications such as evaluation of the disease progress and optimization of the drug treatment of a patient during chemotherapy.	[Eker, Bilge; Meissner, Robert; Bertsch, Arnaud; Renaud, Philippe] Ecole Polytech Fed Lausanne, Lab Microsyst LMIS4, Stn 17, CH-1015 Lausanne, Switzerland; [Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Texas System; UTMD Anderson Cancer Center	Eker, B (corresponding author), Ecole Polytech Fed Lausanne, Lab Microsyst LMIS4, Stn 17, CH-1015 Lausanne, Switzerland.	bilge.eker@epfl.ch	Renaud, Philippe/AAQ-6205-2021; Bertsch, Arnaud/U-5753-2017; Renaud, P/A-6994-2011; Bertsch, Arnaud/AAA-7279-2020	Renaud, Philippe/0000-0001-5199-1252; Bertsch, Arnaud/0000-0002-1044-0478; Renaud, P/0000-0001-5199-1252; Bertsch, Arnaud/0000-0002-1044-0478	NanoTera Livesense project [20NAN1-123593]	NanoTera Livesense project	This study was financially supported by the NanoTera Livesense project no. 20NAN1-123593, http://www.nano-tera.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias L, 2010, BIOSENSORS BIOELECTR; Bagnaninchi PO, 2011, P NATL ACAD SCI USA, V108, P6462, DOI 10.1073/pnas.1018260108; Bartholoma P, 2005, J BIOMOL SCREEN, V10, P705, DOI 10.1177/1087057105277841; Besser A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/425; Bijman M, 2006, MOL CANC; BLOBE GC, 1993, J BIOL CHEM, V268, P10627; Chen J, 2011, LAB CHIP, V11, P3174, DOI 10.1039/c1lc20473d; Chen JSK, 2004, J CELL PHYSIOL, V200, P223, DOI 10.1002/jcp.20014; Chen JSK, 2002, BREAST CANCER RES TR, V71, P237, DOI 10.1023/A:1014461832403; Cole K. S., 1940, Cold Spring Harbor Symposia on Quantitative Biology, V8, P110; Coley HM, 2007, BBA-GEN SUBJECTS, V1770, P601, DOI 10.1016/j.bbagen.2006.12.002; Cross SE, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/215101; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; Debye PJW, 1929, POLAR MOL; Devarajan E, 2002, INT J ONCOL, V20, P913; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Gawad S, 2004, THESIS ECOLE POLYTEC; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Grimnes S, 2005, IEEE T BIO-MED ENG, V52, P132, DOI 10.1109/TBME.2004.836499; Grzanka A, 2005, NEOPLASMA; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Isambert H, 1998, PHYS REV LETT, V80, P3404, DOI 10.1103/PhysRevLett.80.3404; ITAKURA Y, 1989, BIOMATERIALS, V10, P489, DOI 10.1016/0142-9612(89)90091-4; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kitada S, 2002, ONCOGENE, V21, P3459, DOI 10.1038/sj.onc.1205327; Kols A., 2002, OUTLOOK, V19, P1; Lin SP, 2009, BIOMATERIALS, V30, P3110, DOI 10.1016/j.biomaterials.2009.03.017; Linderholm P, 2006, THESIS ECOLE POLYTEC; MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316; Meissner R, 2011, LAB CHIP, V11, P2352, DOI 10.1039/c1lc20212j; Mercanzini A, 2009, IEEE T BIO-MED ENG, V56, P1909, DOI 10.1109/TBME.2009.2018457; MITRA P, 1991, BIOTECHNIQUES, V11, P504; MOSCOW JA, 1993, CYTOTECHNOLOGY, V12, P155, DOI 10.1007/BF00744663; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; PAULY H, 1959, Z NATURFORSCH PT B, V14, P125; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PESSINA A, 1993, CYTOTECHNOLOGY, V12, P127, DOI 10.1007/BF00744661; Pierce RH, 2002, BIOCHEM PHARMACOL, V64, P413, DOI 10.1016/S0006-2952(02)01180-2; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rao J, 2004, CURRENT CANC DRUG TA; Satcher RL, 1996, BIOPHYS J, V71, P109, DOI 10.1016/S0006-3495(96)79206-8; Schwan HP, 1985, ANAL DIELECTRIC DATA, P913; Sharma SK, 2011, E-ADOPTION AND SOCIO-ECONOMIC IMPACTS: EMERGING INFRASTRUCTURAL EFFECTS, P1, DOI [10.4018/978-1-60960-597-1, 10.1057/9780230119208]; Stieglitz T, 2004, NEUROPROSTHETICS THE, P475; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Tu YP, 1996, BLOOD, V88, P1805, DOI 10.1182/blood.V88.5.1805.bloodjournal8851805; UEDA K, 1987, J BIOL CHEM, V262, P505; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Weldon C, 2012, EXPT BIOL MED CANC; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Winograd-Katz SE, 2011, EUR J CELL BIOL, V90, P143, DOI 10.1016/j.ejcb.2010.07.006; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	54	31	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57423	10.1371/journal.pone.0057423	http://dx.doi.org/10.1371/journal.pone.0057423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483910	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900018
J	Gibson, JM; Thomsen, J; Launay, F; Harder, E; DeFelice, N				Gibson, Jacqueline MacDonald; Thomsen, Jens; Launay, Frederic; Harder, Elizabeth; DeFelice, Nicholas			Deaths and Medical Visits Attributable to Environmental Pollution in the United Arab Emirates	PLOS ONE			English	Article							TOBACCO-SMOKE; LUNG-CANCER; ABU-DHABI; HEALTH; EXPOSURE; RISK; ASTHMA; MORTALITY; ASSOCIATION; QUALITY	Background: This study estimates the potential health gains achievable in the United Arab Emirates (UAE) with improved controls on environmental pollution. The UAE is an emerging economy in which population health risks have shifted rapidly from infectious diseases to chronic conditions observed in developed nations. The UAE government commissioned this work as part of an environmental health strategic planning project intended to address this shift in the nature of the country's disease burden. Methods and Findings: We assessed the burden of disease attributable to six environmental exposure routes outdoor air, indoor air, drinking water, coastal water, occupational environments, and climate change. For every exposure route, we integrated UAE environmental monitoring and public health data in a spatially resolved Monte Carlo simulation model to estimate the annual disease burden attributable to selected pollutants. The assessment included the entire UAE population (4.5 million for the year of analysis). The study found that outdoor air pollution was the leading contributor to mortality, with 651 attributable deaths (95% confidence interval [CI] 143-1,440), or 7.3% of all deaths. Indoor air pollution and occupational exposures were the second and third leading contributors to mortality, with 153 (95% CI 85-216) and 46 attributable deaths (95% CI 26-72), respectively. The leading contributor to health-care facility visits was drinking water pollution, to which 46,600 (95% CI 15,300-61,400) health-care facility visits were attributed (about 15% of the visits for all the diseases considered in this study). Major study limitations included (1) a lack of information needed to translate healthcare facility visits to quality-adjusted-life-year estimates and (2) insufficient spatial coverage of environmental data. Conclusions: Based on international comparisons, the UAE's environmental disease burden is low for all factors except outdoor air pollution. From a public health perspective, reducing pollutant emissions to outdoor air should be a high priority for the UAE's environmental agencies.	[Gibson, Jacqueline MacDonald; Harder, Elizabeth; DeFelice, Nicholas] Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Thomsen, Jens] Hlth Author Abu Dhabi, Abu Dhabi, U Arab Emirates; [Launay, Frederic] Environm Agcy Abu Dhabi, Abu Dhabi, U Arab Emirates	University of North Carolina; University of North Carolina Chapel Hill	Gibson, JM (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	jackie.macdonald@unc.edu	MacDonald Gibson, Jacqueline/D-3290-2013	Thomsen, Jens/0000-0002-2646-9494	Environment Agency-Abu Dhabi	Environment Agency-Abu Dhabi	This work was funded by the Environment Agency-Abu Dhabi (www.ead.ae). Staff from the funding organization provided environmental data to support this research but had no other role in the study design. One staff member from the funding organization (Dr. Launay) helped to prepare this manuscript and review it for accuracy. Otherwise, the funder had no role in the decision to publish this manuscript.	ANDRAE S, 1988, ARCH DIS CHILD, V63, P473, DOI 10.1136/adc.63.5.473; [Anonymous], 2007, Lancet, V369, P2052; [Anonymous], 2009, UAE LEADS BOTTL WAT; [Anonymous], 2001, NATL BURDEN DIS STUD; Antova T, 2008, J EPIDEMIOL COMMUN H, V62, P708, DOI 10.1136/jech.2007.065896; Australian Sports Commission, 2011, PART EX RECR SPORT 2; Badrinath P, 2002, MEASURING HLTH NATIO; Bartram J, 2007, PUBLIC HLTH, V15, P1; Cardenas VM, 1997, CANCER CAUSE CONTROL, V8, P57, DOI 10.1023/A:1018483121625; Darby S, 2006, SCAND J WORK ENV HEA, V32, P1; Davidson Christopher M., 2005, UNITED ARAB EMIRATES; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Folley TJ, 2012, AM J IND MED, V55, P940, DOI 10.1002/ajim.22043; Friborg JT, 2008, CANCER-AM CANCER SOC, V113, P1676, DOI 10.1002/cncr.23788; Gibson JM, 2012, ENVIRON HEALTH PERSP, V120, P681, DOI 10.1289/ehp.1104064; He J, 1999, EUR HEART J, V20, P1764, DOI 10.1053/euhj.1999.1825; Hill SE, 2007, AM J EPIDEMIOL, V165, P530, DOI 10.1093/aje/kwk043; Jaakkola MS, 2002, ENVIRON HEALTH PERSP, V110, P543, DOI 10.1289/ehp.02110543; Kapiszewski Andrzej, 2001, NATL EXPATRIATES POP; Kasim K, 2005, EPIDEMIOLOGY, V16, P672, DOI 10.1097/01.ede.0000173039.79207.80; Koornneef EJ, 2012, HEALTH POLICY, V108, P115, DOI 10.1016/j.healthpol.2012.08.026; Li JS, 1999, PEDIATR PULM, V27, P5, DOI 10.1002/(SICI)1099-0496(199901)27:1<5::AID-PPUL3>3.0.CO;2-5; Li Y, 2010, SCI TOTAL ENVIRON, V408, P5784, DOI 10.1016/j.scitotenv.2010.08.017; LINDFORS A, 1995, ARCH DIS CHILD, V73, P408, DOI 10.1136/adc.73.5.408; McMichael A., 2004, COMP QUANTIFICATION, V2, P1543; Morgan M.G., 1990, UNCERTAINTY GUIDE DE; MORRIS RD, 1992, AM J PUBLIC HEALTH, V82, P955, DOI 10.2105/AJPH.82.7.955; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Ostro B., 2004, ENV BURDEN DIS SERIE; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Pruss-Ustun A., 2003, INTRO METHODS ASSESS; Rumchev K, 2004, THORAX, V59, P746, DOI 10.1136/thx.2003.013680; Thomopoulos N., 2013, ESSENTIALS MONTE CAR, DOI [10.1007/978-1-4614-6022-0, DOI 10.1007/978-1-4614-6022-0]; Trumbo CW, 2007, RISK ANAL, V27, P337, DOI 10.1111/j.1539-6924.2007.00886.x; United Nations Development Programme, 2011, HUM DEV REP; Vetter P, 2012, HEALTH POLICY, V108, P105, DOI 10.1016/j.healthpol.2012.08.009; Vork KL, 2007, ENVIRON HEALTH PERSP, V115, P1394, DOI 10.1289/ehp.10155; Wade TJ, 2006, ENVIRON HEALTH PERSP, V114, P24, DOI 10.1289/ehp.8273; Walters TN, 2006, MIDDLE E REV, V10, P77; Wilk R., 2006, Journal of Consumer Culture, V6, P303, DOI 10.1177/1469540506068681; Willis HH, 2010, RISK ANAL, V30, P1842, DOI 10.1111/j.1539-6924.2010.01463.x; World Bank, 2001, WORLD DAT; World Health Organization, 2009, COUNTR PROF ENV BURD; Yeatts KB, 2012, ENVIRON HEALTH PERSP, V120, P687, DOI 10.1289/ehp.1104090	45	16	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57536	10.1371/journal.pone.0057536	http://dx.doi.org/10.1371/journal.pone.0057536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099PY	23469200	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900026
J	Tsurim, I; Silberbush, A; Ovadia, O; Blaustein, L; Margalith, Y				Tsurim, Ido; Silberbush, Alon; Ovadia, Ofer; Blaustein, Leon; Margalith, Yoel			Inter- and Intra-Specific Density-Dependent Effects on Life History and Development Strategies of Larval Mosquitoes	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; PITCHER-PLANT MOSQUITO; YELLOW-FEVER MOSQUITO; INTRASPECIFIC COMPETITION; CULISETA-LONGIAREOLATA; NUTRITIONAL RESERVES; POPULATION-DYNAMICS; ECDYSTEROID LEVELS; PUPAL COMMITMENT; CULICIDAE	We explored how inter- and intra-specific competition among larvae of two temporary-pool mosquito species, Culiseta longiareolata and Ochlerotatus caspius, affect larval developmental strategy and life history traits. Given that their larvae have similar feeding habits, we expected negative reciprocal inter-specific interactions. In a microcosm experiment, we found sex-specific responses of larval survival and development to both intra-and inter-specific larval competition. C. longiareolata was the superior competitor, reducing adult size and modifying larval developmental time of O. caspius. We observed two distinct waves of adult emergence in O. caspius, with clear sex-specific responses to its inter-specific competitor. In males, this pattern was not affected by C. longiareolata, but in females, the timing and average body size of the second wave strongly varied with C. longiareolata density. Specifically, in the absence of C. longiareolata, the second wave immediately followed the first wave. However, as C. longiareolata abundance increased, the second wave was progressively delayed and the resulting females tended to be larger. This study improves our understanding of the way intra-and inter-specific competition combine to influence the life histories of species making up temporary pond communities. It also provides strong evidence that not all individuals of a cohort employ the same strategies in response to competition.	[Tsurim, Ido; Silberbush, Alon; Ovadia, Ofer; Margalith, Yoel] Ben Gurion Univ Negev, Dept Life Sci, Ctr Biol Control, IL-84105 Beer Sheva, Israel; [Tsurim, Ido] Achva Acad Coll, Dept Life Sci, Mobile Post Shikmim, Israel; [Blaustein, Leon] Univ Haifa, Kadas Green Roofs Ecol Ctr, IL-31999 Haifa, Israel; [Blaustein, Leon] Univ Haifa, Inst Evolut, Community Ecol Lab, IL-31999 Haifa, Israel; [Blaustein, Leon] Univ Haifa, Fac Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	Ben Gurion University; University of Haifa; University of Haifa; University of Haifa	Tsurim, I (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Ctr Biol Control, IL-84105 Beer Sheva, Israel.	tsurim@bgu.ac.il	Silberbush, Alon/AAD-3650-2021; Silberbush, Alon/GPP-6599-2022	Silberbush, Alon/0000-0002-8762-6836; Ovadia, Ofer/0000-0002-4941-4947; Tsurim, Ido/0000-0002-8510-3089				Agnew P, 2000, J MED ENTOMOL, V37, P732, DOI 10.1603/0022-2585-37.5.732; AGUDELOSILVA F, 1984, AM J TROP MED HYG, V33, P1267, DOI 10.4269/ajtmh.1984.33.1267; Al-Jaran TKH, 2001, AQUAT INSECT, V23, P11, DOI 10.1076/aqin.23.1.11.4928; AL-SAADI M, 1988, Journal of Biological Sciences Research, V19, P339; ALFORD RA, 1988, AM NAT, V131, P91, DOI 10.1086/284775; [Anonymous], 1992, BIOL MOSQUITOES DEV; BARBOSA P, 1973, ENTOMOL EXP APPL, V16, P146, DOI 10.1007/BF00290687; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; BENJAMIN SN, 1994, ANN ENTOMOL SOC AM, V87, P331, DOI 10.1093/aesa/87.3.331; Bevins SN, 2008, BIOL INVASIONS, V10, P1109, DOI 10.1007/s10530-007-9188-8; Bevins SN, 2007, J VECTOR ECOL, V32, P252, DOI 10.3376/1081-1710(2007)32[252:TORIAL]2.0.CO;2; BLAUSTEIN L, 1993, ECOL ENTOMOL, V18, P104, DOI 10.1111/j.1365-2311.1993.tb01190.x; Blaustein L, 1996, J ANIM ECOL, V65, P77, DOI 10.2307/5701; BLAUSTEIN L, 1994, J ANIM ECOL, V63, P841, DOI 10.2307/5261; BLAUSTEIN L, 1995, J ARID ENVIRON, V29, P199, DOI 10.1016/S0140-1963(05)80090-4; Blaustein L, 2009, PHENOTYPIC PLASTICIT, P263; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bozicic-Lothrop B., 1996, Acta Entomologica Serbica, V2, P31; Bradshaw WE, 1997, ECOLOGY, V78, P969, DOI 10.1890/0012-9658(1997)078[0969:HODTAP]2.0.CO;2; Brown MR, 2006, AM J TROP MED HYG, V75, P265; Carron A., 2007, European Mosquito Bulletin, P4; FRANK JH, 1977, MOSQ NEWS, V37, P200; Gad AM, 1999, J MED ENTOMOL, V36, P709, DOI 10.1093/jmedent/36.6.709; Gilbert B, 2008, OIKOS, V117, P944, DOI 10.1111/j.0030-1299.2008.16300.x; Gleiser RM, 2000, ENTOMOL EXP APPL, V95, P135, DOI 10.1023/A:1003994321769; Hosmer D. W., 1999, APPL SURVIVAL ANAL; IKESHOJI T, 1974, ENVIRON ENTOMOL, V3, P482, DOI 10.1093/ee/3.3.482; ISTOCK CA, 1975, EVOLUTION, V29, P296, DOI [10.2307/2407218, 10.1111/j.1558-5646.1975.tb00210.x]; JULIANO SA, 1994, OECOLOGIA, V97, P369, DOI 10.1007/BF00317327; Juliano SA, 2007, J AM MOSQUITO CONTR, V23, P265, DOI 10.2987/8756-971X(2007)23[265:PD]2.0.CO;2; Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Legendre P., 2012, NUMERICAL ECOLOGY; LEGENDRE P, 2001, MODEL 2 REGRESSION U; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; Leisnham PT, 2009, OECOLOGIA, V160, P343, DOI 10.1007/s00442-009-1305-1; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204; MARGALIT J, 1987, B ENTOMOL RES, V77, P477, DOI 10.1017/S0007485300011962; MARGALIT J, 1973, ISRAEL J ZOOL, V22, P27; MARGALIT J, 1988, ARCH HYDROBIOL, V112, P233; Metge G, 1998, J AM MOSQUITO CONTR, V14, P283; Moll JD, 2008, AM NAT, V171, P839, DOI 10.1086/587517; MOORE CG, 1969, ANN ENTOMOL SOC AM, V62, P1325, DOI 10.1093/aesa/62.6.1325; Moreau J.-P., 1976, Medecine trop, V36, P441; MORI A, 1979, Tropical Medicine, V21, P85; Orshan L, 2008, J MED ENTOMOL, V45, P939, DOI 10.1603/0022-2585(2008)45[939:MVOWNF]2.0.CO;2; PETERS TM, 1969, MOSQ NEWS, V29, P667; PFENNIG DW, 1991, ECOLOGY, V72, P2240, DOI 10.2307/1941574; RAJAGOPALAN PK, 1976, INDIAN J MED RES, V64, P688; Rasband WS, 2011, IMAGEJ; REISEN WK, 1975, MOSQ NEWS, V35, P473; REISEN WK, 1984, MOSQ NEWS, V44, P385; Roberts DM, 2001, MED VET ENTOMOL, V15, P215, DOI 10.1046/j.0269-283x.2001.00303.x; SALIT AM, 1994, J U KUWAIT-SCI, V21, P77; Shaalan EA, 2012, J ENTOMOLOGY, P1; Shaalan EAS, 2009, TROP BIOMED, V26, P223; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SIDDIQUI T F, 1976, Tropical Medicine, V18, P195; Silberbush A, 2005, HYDROBIOLOGIA, V548, P1, DOI 10.1007/s10750-004-8336-8; Silberbush A, 2004, EFFECTS SALINITY PRE; Stav G, 2010, ISR J ECOL EVOL, V56, P9, DOI 10.1560/IJEE.56.1.9; SULEMAN M, 1982, MOSQ NEWS, V42, P347; Telang A, 2007, J EXP BIOL, V210, P854, DOI 10.1242/jeb.02715; Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009; WASHBURN JO, 1991, SCIENCE, V253, P185, DOI 10.1126/science.1906637; White K, 1987, KEYS ADULTS MALE HYP; Wilson RS, 2011, J ANIMAL ECOLOGY; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	71	16	18	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57875	10.1371/journal.pone.0057875	http://dx.doi.org/10.1371/journal.pone.0057875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469250	gold, Green Submitted, Green Published			2022-12-27	WOS:000315634900050
J	Bousbia, S; Papazian, L; Saux, P; Forel, JM; Auffray, JP; Martin, C; Raoult, D; La Scola, B				Bousbia, Sabri; Papazian, Laurent; Saux, Pierre; Forel, Jean-Marie; Auffray, Jean-Pierre; Martin, Claude; Raoult, Didier; La Scola, Bernard			Serologic Prevalence of Amoeba-Associated Microorganisms in Intensive Care Unit Pneumonia Patients	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; VENTILATOR-ASSOCIATED PNEUMONIA; ATYPICAL BACTERIAL PNEUMONIA; MASSILIENSIS SP-NOV; RESISTING BACTERIA; MYCOPLASMA-PNEUMONIAE; NOSOCOMIAL INFECTION; ANTIGEN MICROARRAY; MIMIVIRUS; SERODIAGNOSIS	Background: Patients admitted to intensive care units are frequently exposed to pathogenic microorganisms present in their environment. Exposure to these microbes may lead to the development of hospital-acquired infections that complicate the illness and may be fatal. Amoeba-associated microorganisms (AAMs) are frequently isolated from hospital water networks and are reported to be associated to cases of community and hospital-acquired pneumonia. Methodology/Principal Findings: We used a multiplexed immunofluorescence assay to test for the presence of antibodies against AAMs in sera of intensive care unit (ICU) pneumonia patients and compared to patients at the admission to the ICU (controls). Our results show that some AAMs may be more frequently detected in patients who had hospital-acquired pneumonia than in controls, whereas other AAMs are ubiquitously detected. However, ICU patients seem to exhibit increasing immune response to AAMs when the ICU stay is prolonged. Moreover, concomitant antibodies responses against seven different microorganisms (5 Rhizobiales, Balneatrix alpica, and Mimivirus) were observed in the serum of patients that had a prolonged ICU stay. Conclusions/Significance: Our work partially confirms the results of previous studies, which show that ICU patients would be exposed to water amoeba-associated microorganisms, and provides information about the magnitude of AAM infection in ICU patients, especially patients that have a prolonged ICU stay. However, the incidence of this exposure on the development of pneumonia remains to assess.	[Bousbia, Sabri; Papazian, Laurent; Raoult, Didier; La Scola, Bernard] Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France; [Papazian, Laurent; Forel, Jean-Marie] Hop Nord Marseille, Serv Reanimat Med, Marseille, France; [Saux, Pierre; Auffray, Jean-Pierre] Hop Enfants La Timone, Dept Anesthesie Reanimat, Marseille, France; [Martin, Claude] Hop Nord Marseille, Dept Anesthesie Reanimat, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	La Scola, B (corresponding author), Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	bernard.lascola@univmed.fr	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704	Programme Hospitalier de Recherche Clinique	Programme Hospitalier de Recherche Clinique	This work was supported by a grant from the Programme Hospitalier de Recherche Clinique 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Berger P, 2006, EMERG INFECT DIS, V12, P248; Birtles RJ, 1997, LANCET, V349, P925, DOI 10.1016/S0140-6736(05)62701-8; Bonhomme CJ, 2008, EUR J CLIN MICROBIOL, V27, P959, DOI 10.1007/s10096-008-0528-0; Bonhomme CJ, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-59; BUENOCAVANILLAS A, 1994, CRIT CARE MED, V22, P55, DOI 10.1097/00003246-199401000-00013; Casson N, 2007, J CLIN MICROBIOL, V45, P234, DOI 10.1128/JCM.01867-06; DAUGA C, 1993, RES MICROBIOL, V144, P35, DOI 10.1016/0923-2508(93)90213-L; Gouriet F, 2008, CLIN MICROBIOL INFEC, V14, P1119, DOI 10.1111/j.1469-0691.2008.02119.x; Gouriet F, 2008, CLIN MICROBIOL INFEC, V14, P1112, DOI 10.1111/j.1469-0691.2008.02094.x; Gouriet F, 2006, ANN NY ACAD SCI, V1078, P530, DOI 10.1196/annals.1374.104; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2002, EMERG INFECT DIS, V8, P625; Greub G, 2003, ANN NY ACAD SCI, V990, P311, DOI 10.1111/j.1749-6632.2003.tb07381.x; GROSS PA, 1980, AM J MED, V68, P219, DOI 10.1016/0002-9343(80)90357-5; Higashigawa M, 2009, PEDIATR INT, V51, P684, DOI 10.1111/j.1442-200X.2009.02858.x; Khan M, 2007, MICROB PATHOGENESIS, V42, P56, DOI 10.1016/j.micpath.2006.08.004; La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538; La Scola B, 2005, J HOSP INFECT, V59, P74, DOI 10.1016/j.jhin.2004.07.011; La Scola B, 2003, EMERG INFECT DIS, V9, P815, DOI 10.3201/eid0907.030065; La Scola B, 2003, INT J SYST EVOL MICR, V53, P15, DOI 10.1099/ijs.0.02127-0; La Scola B, 2002, INFECT CONT HOSP EP, V23, P462, DOI 10.1086/502086; La Scola B, 2002, INT J SYST EVOL MICR, V52, P1773, DOI [10.1099/ijs.0.02149-0, 10.1099/00207713-52-5-1773]; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; Lieberman D, 1997, AM J RESP CRIT CARE, V156, P578, DOI 10.1164/ajrccm.156.2.9608081; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Marrie TJ, 2001, EMERG INFECT DIS, V7, P1026, DOI 10.3201/eid0706.010619; Martins TB, 2009, J IMMUNOL METHODS, V342, P98, DOI 10.1016/j.jim.2008.12.003; Martins TB, 2009, CLIN VACCINE IMMUNOL, V16, P55, DOI 10.1128/CVI.00351-08; Mezzasoma L, 2002, CLIN CHEM, V48, P121; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Pagnier I, 2008, ENVIRON MICROBIOL, V10, P1135, DOI 10.1111/j.1462-2920.2007.01530.x; Raoult D, 2006, ANN INTERN MED, V144, P702, DOI 10.7326/0003-4819-144-9-200605020-00025; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Takahashi T, 2009, J INFECT CHEMOTHER, V15, P243, DOI 10.1007/s10156-009-0692-x; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Thomas VPerneger, 1998, BRIT MED J, P316; Thomas VPerneger, 1998, BRIT MED J, P7139; Vincent A, 2009, CRIT CARE MED, V37, P111, DOI 10.1097/CCM.0b013e318192fa8b; Vincent A, 2010, INTERVIROLOGY, V53, P304, DOI 10.1159/000312915; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639	43	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58111	10.1371/journal.pone.0058111	http://dx.doi.org/10.1371/journal.pone.0058111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469263	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100060
J	Jin, YNN; Yu, YXV; Gundemir, S; Jo, C; Cui, M; Tieu, K; Johnson, GVW				Jin, Youngnam N.; Yu, Yanxun V.; Gundemir, Soner; Jo, Chulman; Cui, Mei; Tieu, Kim; Johnson, Gail V. W.			Impaired Mitochondrial Dynamics and Nrf2 Signaling Contribute to Compromised Responses to Oxidative Stress in Striatal Cells Expressing Full-Length Mutant Huntingtin	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; CREB-BINDING-PROTEIN; TISSUE TRANSGLUTAMINASE; MOTOR-NEURON; ACTIVATION; AUTOPHAGY; DISEASE; FISSION; KEAP1; DEGRADATION	Huntington disease (HD) is an inherited neurodegenerative disease resulting from an abnormal expansion of polyglutamine in huntingtin (Htt). Compromised oxidative stress defense systems have emerged as a contributing factor to the pathogenesis of HD. Indeed activation of the Nrf2 pathway, which plays a prominent role in mediating antioxidant responses, has been considered as a therapeutic strategy for the treatment of HD. Given the fact that there is an interrelationship between impairments in mitochondrial dynamics and increased oxidative stress, in this present study we examined the effect of mutant Htt (mHtt) on these two parameters. STHdh(Q111/Q111) cells, striatal cells expressing mHtt, display more fragmented mitochondria compared to STHdh(Q7/Q7) cells, striatal cells expressing wild type Htt, concurrent with alterations in the expression levels of Drp1 and Opa1, key regulators of mitochondrial fission and fusion, respectively. Studies of mitochondrial dynamics using cell fusion and mitochondrial targeted photo-switchable Dendra revealed that mitochondrial fusion is significantly decreased in STHdh(Q111/Q111) cells. Oxidative stress leads to dramatic increases in the number of STHdh(Q111/Q111) cells containing swollen mitochondria, while STHdh(Q7/Q7) cells just show increases in the number of fragmented mitochondria. mHtt expression results in reduced activity of Nrf2, and activation of the Nrf2 pathway by the oxidant tBHQ is significantly impaired in STHdh(Q111/Q111) cells. Nrf2 expression does not differ between the two cell types, but STHdh(Q111/Q111) cells show reduced expression of Keap1 and p62, key modulators of Nrf2 signaling. In addition, STHdh(Q111/Q111) cells exhibit increases in autophagy, whereas the basal level of autophagy activation is low in STHdh(Q7/Q7) cells. These results suggest that mHtt disrupts Nrf2 signaling which contributes to impaired mitochondrial dynamics and may enhance susceptibility to oxidative stress in STHdh(Q111/Q111) cells.	[Jin, Youngnam N.; Johnson, Gail V. W.] Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA; [Jin, Youngnam N.; Johnson, Gail V. W.] Univ Rochester, Dept Physiol, Rochester, NY 14642 USA; [Yu, Yanxun V.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Gundemir, Soner; Jo, Chulman; Johnson, Gail V. W.] Univ Rochester, Dept Anesthesiol, Rochester, NY 14627 USA; [Cui, Mei; Tieu, Kim] Univ Rochester, Dept Neurol, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Johnson, GVW (corresponding author), Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA.	gail_johnsonvoll@urmc.rochester.edu	Tieu, Kim/F-5426-2012; Tieu, Kim/AAG-7336-2019	Tieu, Kim/0000-0001-6606-4371; Tieu, Kim/0000-0001-6606-4371; Gundemir, Soner/0000-0002-9997-3552	National Institutes of Health [NS041744, NS065825]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065825, R01NS041744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS041744 and NS065825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/1523086041798114; Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Browne SE, 1999, BRAIN PATHOL, V9, P147; Calkins MJ, 2010, EXP NEUROL, V224, P307, DOI 10.1016/j.expneurol.2010.04.008; Chae JI, 2012, BIOCHEM J, V446, P359, DOI 10.1042/BJ20111495; Chen YC, 2012, MOL NEUROBIOL; Chun WJ, 2001, J CELL BIOL, V153, P25, DOI 10.1083/jcb.153.1.25; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; del Hoyo P, 2006, NEUROCHEM RES, V31, P1103, DOI 10.1007/s11064-006-9110-2; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Ellrichmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016172; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Greco T, 2010, J BIOENERG BIOMEMBR, V42, P491, DOI 10.1007/s10863-010-9312-9; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jin YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030406; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Johnson D, 2012, AM J PHYSIOL-CELL PH, V302, pC1045, DOI 10.1152/ajpcell.00411.2011; Johri A, 2012, BBA-MOL BASIS DIS, V1822, P664, DOI 10.1016/j.bbadis.2011.11.014; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Klein B, 2011, APOPTOSIS, V16, P1101, DOI 10.1007/s10495-011-0642-9; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Long JD, 2012, NEUROBIOL DIS, V46, P625, DOI 10.1016/j.nbd.2012.02.012; MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Milakovic T, 2004, J BIOL CHEM, V279, P8715, DOI 10.1074/jbc.M308479200; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Milea D, 2010, CURR OPIN NEUROL, V23, P24, DOI 10.1097/WCO.0b013e3283347b27; Mimoto T, 2012, BRAIN RES, V1446, P109, DOI 10.1016/j.brainres.2011.12.064; Molina-Jijon E, 2011, FREE RADICAL BIO MED, V51, P1543, DOI 10.1016/j.freeradbiomed.2011.07.018; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Pehar M, 2007, J NEUROSCI, V27, P7777, DOI 10.1523/JNEUROSCI.0823-07.2007; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Quintanilla RA, 2009, BRAIN RES BULL, V80, P242, DOI 10.1016/j.brainresbull.2009.07.010; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sagredo O, 2011, J NEUROSCI RES, V89, P1509, DOI 10.1002/jnr.22682; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Solesio M. E., 2012, BIOCH BIOPHYS ACTA; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; van Roon-Mom WMC, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-84; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	76	74	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57932	10.1371/journal.pone.0057932	http://dx.doi.org/10.1371/journal.pone.0057932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469253	gold, Green Published			2022-12-27	WOS:000315897100050
J	McGuire, KL; Payne, SG; Palmer, MI; Gillikin, CM; Keefe, D; Kim, SJ; Gedallovich, SM; Discenza, J; Rangamannar, R; Koshner, JA; Massmann, AL; Orazi, G; Essene, A; Leff, JW; Fierer, N				McGuire, Krista L.; Payne, Sara G.; Palmer, Matthew I.; Gillikin, Caitlyn M.; Keefe, Dominique; Kim, Su Jin; Gedallovich, Seren M.; Discenza, Julia; Rangamannar, Ramya; Koshner, Jennifer A.; Massmann, Audrey L.; Orazi, Giulia; Essene, Adam; Leff, Jonathan W.; Fierer, Noah			Digging the New York City Skyline: Soil Fungal Communities in Green Roofs and City Parks	PLOS ONE			English	Article							PSEUDALLESCHERIA; MICROORGANISMS; GENERATION; DISPERSAL; DIVERSITY; BACTERIAL; BIOMASS; SEARCH; FIELD	In urban environments, green roofs provide a number of benefits, including decreased urban heat island effects and reduced energy costs for buildings. However, little research has been done on the non-plant biota associated with green roofs, which likely affect their functionality. For the current study, we evaluated whether or not green roofs planted with two native plant communities in New York City functioned as habitats for soil fungal communities, and compared fungal communities in green roof growing media to soil microbial composition in five city parks, including Central Park and the High Line. Ten replicate roofs were sampled one year after planting; three of these roofs were more intensively sampled and compared to nearby city parks. Using Illumina sequencing of the fungal ITS region we found that green roofs supported a diverse fungal community, with numerous taxa belonging to fungal groups capable of surviving in disturbed and polluted habitats. Across roofs, there was significant biogeographical clustering of fungal communities, indicating that community assembly of roof microbes across the greater New York City area is locally variable. Green roof fungal communities were compositionally distinct from city parks and only 54% of the green roof taxa were also found in the park soils. Phospholipid fatty acid analysis revealed that park soils had greater microbial biomass and higher bacterial to fungal ratios than green roof substrates. City park soils were also more enriched with heavy metals, had lower pH, and lower quantities of total bases (Ca, K, and Mg) compared to green roof substrates. While fungal communities were compositionally distinct across green roofs, they did not differentiate by plant community. Together, these results suggest that fungi living in the growing medium of green roofs may be an underestimated component of these biotic systems functioning to support some of the valued ecological services of green roofs.	[McGuire, Krista L.; Payne, Sara G.; Gillikin, Caitlyn M.; Keefe, Dominique; Kim, Su Jin; Gedallovich, Seren M.; Discenza, Julia; Rangamannar, Ramya; Koshner, Jennifer A.; Orazi, Giulia] Columbia Univ, Barnard Coll, Dept Biol, New York, NY 10027 USA; [Palmer, Matthew I.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Massmann, Audrey L.] Columbia Univ, Barnard Coll, Dept Environm Sci, New York, NY USA; [Essene, Adam] Fordham Univ, Dept Biol, Bronx, NY 10458 USA; [Leff, Jonathan W.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	Columbia University; Columbia University; Columbia University; Fordham University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McGuire, KL (corresponding author), Columbia Univ, Barnard Coll, Dept Biol, New York, NY 10027 USA.	kmcguire@barnard.columbia.edu		Orazi, Giulia/0000-0001-5228-2992; Payne, Sara/0000-0002-3572-9112; Massmann, Audrey/0000-0002-2104-207X; FIERER, NOAH/0000-0002-6432-4261; McGuire Meliora, Krista/0000-0002-8970-8827	Barnard College Presidential Research Award	Barnard College Presidential Research Award	This project was funded by the Barnard College Presidential Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; April TM, 1998, CAN J MICROBIOL, V44, P270, DOI 10.1139/cjm-44-3-270; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Beijerinck M, 1913, JAARBOEK KONINKLIJKE; Bellemain E, 2010, BMC MICROBIOL, V10, P9; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Brenneisen Stephan, 2006, Urban Habitats, V4, P27; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carter T, 2007, LANDSCAPE URBAN PLAN, V80, P84, DOI 10.1016/j.landurbplan.2006.06.005; Chillrud SN, 1999, ENVIRON SCI TECHNOL, V33, P657, DOI 10.1021/es9807892; De Deyn GB, 2005, TRENDS ECOL EVOL, V20, P625, DOI 10.1016/j.tree.2005.08.009; Del Barrio EP, 1998, ENERG BUILDINGS, V27, P179; Dickie IA, 2012, ECOL LETT, V15, P133, DOI 10.1111/j.1461-0248.2011.01722.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FIERER N, 2008, ACCESSING UNCULTIVAT, P95; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Hallenberg N, 2001, NORD J BOT, V21, P431, DOI 10.1111/j.1756-1051.2001.tb00793.x; Kaltseis J, 2009, MED MYCOL, V47, P398, DOI 10.1080/13693780802585317; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li HY, 2012, FUNGAL ECOL, V5, P309, DOI 10.1016/j.funeco.2011.06.002; Lundholm J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009677; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; Mentens J, 2006, LANDSCAPE URBAN PLAN, V77, P217, DOI 10.1016/j.landurbplan.2005.02.010; Monterusso MA, 2005, HORTSCIENCE, V40, P391, DOI 10.21273/HORTSCI.40.2.391; Nagase A, 2011, LANDSCAPE URBAN PLAN, V103, P230, DOI 10.1016/j.landurbplan.2011.07.012; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Ockinger E, 2009, LANDSCAPE URBAN PLAN, V93, P31, DOI 10.1016/j.landurbplan.2009.05.021; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Peay KG, 2010, ECOLOGY, V91, P3631, DOI 10.1890/09-2237.1; RESCHKE C., 1990, ECOLOGICAL COMMUNITI; STALTER R, 1987, B TORREY BOT CLUB, V114, P330, DOI 10.2307/2996472; Strohbach MW, 2009, ECOL SOC, V14; VanWoert ND, 2005, J ENVIRON QUAL, V34, P1036, DOI 10.2134/jeq2004.0364; Villarreal EL, 2005, ECOL ENG, V25, P1, DOI 10.1016/j.ecoleng.2004.11.008	45	129	135	9	232	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58020	10.1371/journal.pone.0058020	http://dx.doi.org/10.1371/journal.pone.0058020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469260	Green Published, gold			2022-12-27	WOS:000315897100057
J	Wang, ZH; Yan, AZ; Lin, YX; Xie, HH; Zhou, CY; Lan, FH				Wang, Zhihong; Yan, Aizhen; Lin, Yuxiang; Xie, Haihua; Zhou, Chunyan; Lan, Fenghua			Familial Skewed X Chromosome Inactivation in Adrenoleukodystrophy Manifesting Heterozygotes from a Chinese Pedigree	PLOS ONE			English	Article							FEMALE CARRIERS; XIST GENE; SYMPTOMS; EXPRESSION; PHENOTYPE; PATTERNS; MUTATION; ALLELE	Background: X-linked adrenoleukodystrophy (X-ALD) is an inherited neurodegenerative disorder caused by mutations in the ABCD1 gene. Approximately 20% of X-ALD female carriers may develop neurological symptoms. Skewed X chromosome inactivation (XCI) has been proposed to influence the manifestation of symptoms in X-ALD carriers, but data remain conflicting so far. We identified a three generation kindred, with five heterozygous females, including two manifesting carriers. XCI pattern and the ABCD1 allele expression were assessed in order to determine if symptoms in X-ALD carriers could be related to skewed XCI and whether skewing within this family is more consistent with genetically influenced or completely random XCI. Results: We found a high frequency of skewing in this family. Four of five females had skewed XCI, including two manifesting carriers favoring the mutant allele, one asymptomatic carrier favoring the normal allele, and one female who was not an X-ALD carrier. Known causes of skewing, such as chromosomal abnormalities, selection against deleterious alleles, XIST promoter mutations, were not consistent with our results. Conclusions: Our data support that skewed XCI in favor of the mutant ABCD1 allele would be associated with the manifestation of heterozygous symptoms. Furthermore, XCI skewing in this family is genetically influenced. However, the underlying mechanism remains to be substantiated by further experiments.	[Wang, Zhihong; Yan, Aizhen; Lin, Yuxiang; Xie, Haihua; Zhou, Chunyan; Lan, Fenghua] Fuzhou Gen Hosp, Res Ctr Mol Diag Genet Dis, Fuzhou, Peoples R China		Lan, FH (corresponding author), Fuzhou Gen Hosp, Res Ctr Mol Diag Genet Dis, Fuzhou, Peoples R China.	fhlan@mail.fjmu.edu.cn			National Science Foundation for Young Scientists of China [31200932]; Natural Science Foundation of Fujian Province, China [2012J05158]	National Science Foundation for Young Scientists of China; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	This work was supported by the National Science Foundation for Young Scientists of China (Grant No. 31200932) and the Natural Science Foundation of Fujian Province, China (No. 2012J05158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Kristiansen M, 2003, NEUROMUSCULAR DISORD, V13, P468, DOI 10.1016/S0960-8966(03)00067-1; Maier EM, 2002, ANN NEUROL, V52, P683, DOI 10.1002/ana.10376; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; Minks J, 2008, J CLIN INVEST, V118, P20, DOI 10.1172/JCI34470; Morrone A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e103; Naumova AK, 1998, EUR J HUM GENET, V6, P552, DOI 10.1038/sj.ejhg.5200255; Pereira LV, 1999, AM J MED GENET, V87, P86, DOI 10.1002/(SICI)1096-8628(19991105)87:1<86::AID-AJMG19>3.3.CO;2-A; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Renault NK, 2007, EUR J HUM GENET, V15, P628, DOI 10.1038/sj.ejhg.5201799; Salsano E, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-10; Schmidt S, 2001, J NEUROL, V248, P36, DOI 10.1007/s004150170267; Shaikh MG, 2008, J MED GENET, V45, DOI 10.1136/jmg.2007.055129; WATKISS E, 1993, J MED GENET, V30, P651, DOI 10.1136/jmg.30.8.651	16	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57977	10.1371/journal.pone.0057977	http://dx.doi.org/10.1371/journal.pone.0057977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469258	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100055
J	Devenish-Nelson, ES; Stephens, PA; Harris, S; Soulsbury, C; Richards, SA				Devenish-Nelson, Eleanor S.; Stephens, Philip A.; Harris, Stephen; Soulsbury, Carl; Richards, Shane A.			Does Litter Size Variation Affect Models of Terrestrial Carnivore Extinction Risk and Management?	PLOS ONE			English	Article							FOX VULPES-VULPES; DEMOGRAPHIC STOCHASTICITY; SIMULATION-MODEL; CLUTCH-SIZE; COUNT DATA; POPULATIONS; RABIES; FECUNDITY; STRATEGIES; PARAMETERS	Background: Individual variation in both survival and reproduction has the potential to influence extinction risk. Especially for rare or threatened species, reliable population models should adequately incorporate demographic uncertainty. Here, we focus on an important form of demographic stochasticity: variation in litter sizes. We use terrestrial carnivores as an example taxon, as they are frequently threatened or of economic importance. Since data on intraspecific litter size variation are often sparse, it is unclear what probability distribution should be used to describe the pattern of litter size variation for multiparous carnivores. Methodology/Principal Findings: We used litter size data on 32 terrestrial carnivore species to test the fit of 12 probability distributions. The influence of these distributions on quasi-extinction probabilities and the probability of successful disease control was then examined for three canid species - the island fox Urocyon littoralis, the red fox Vulpes vulpes, and the African wild dog Lycaon pictus. Best fitting probability distributions differed among the carnivores examined. However, the discretised normal distribution provided the best fit for the majority of species, because variation among litter-sizes was often small. Importantly, however, the outcomes of demographic models were generally robust to the distribution used. Conclusion/Significance: These results provide reassurance for those using demographic modelling for the management of less studied carnivores in which litter size variation is estimated using data from species with similar reproductive attributes.	[Devenish-Nelson, Eleanor S.; Stephens, Philip A.; Richards, Shane A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Soulsbury, Carl] Lincoln Univ, Sch Life Sci, Lincoln, England	Durham University; University of Bristol; University of Lincoln	Devenish-Nelson, ES (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	e.s.nelson@durham.ac.uk	Stephens, Philip/B-8397-2008; Soulsbury, Carl D./F-3137-2010; Soulsbury, Carl/P-1492-2019	Stephens, Philip/0000-0001-5849-788X; Soulsbury, Carl D./0000-0001-8808-5210; Soulsbury, Carl/0000-0001-8808-5210; Richards, Shane/0000-0002-9638-5827; Devenish-Nelson, Eleanor/0000-0002-9029-4772	Durham University; Dulverton Trust	Durham University; Dulverton Trust	ESDN was funded by a Durham University Doctoral Fellowship and SH was funded by the Dulverton Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKCAKAYA HR, 1991, ECOL MODEL, V54, P133; Akû║akaya H.R., 1999, APPL POPULATION ECOL; ALLEN SH, 1983, J WILDLIFE MANAGE, V47, P860, DOI 10.2307/3808627; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Beja P, 2008, J ANIM ECOL, V77, P335, DOI 10.1111/j.1365-2656.2007.01312.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Bohning-Gaese K, 2000, EVOL ECOL RES, V2, P823; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Bywater KA, 2010, MAMMAL REV, V40, P212, DOI 10.1111/j.1365-2907.2010.00160.x; Cardillo M, 2002, J ANIM ECOL, V71, P79, DOI 10.1046/j.0021-8790.2001.00577.x; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; CHARNOV EL, 1974, IBIS, V116, P217, DOI 10.1111/j.1474-919X.1974.tb00241.x; Chautan M, 2000, MAMMALIA, V64, P391, DOI 10.1515/mamm.2000.64.4.391; Clifford DL, 2006, BIOL CONSERV, V131, P230, DOI 10.1016/j.biocon.2006.04.029; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; CRESSWELL WJ, 1992, PHILOS T ROY SOC B, V338, P393, DOI 10.1098/rstb.1992.0157; Elmeros M, 2003, MAMM BIOL, V68, P391, DOI 10.1078/1616-5047-00108; Englund J., 1970, Viltrevy, V8, P1; Ewer, 1998, CARNIVORES; Gallizzi K, 2008, OIKOS, V117, P223, DOI 10.1111/j.2007.0030-1299.16172.x; Gese EM, 2001, CONSERV BIOL SER, V5, P372; Ginsberg Joshua R., 1997, P75; Hamilton W. J. jr., 1964, Journal of Mammalogy, V45, P242, DOI 10.2307/1376987; Harris S. E., UNPUB; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; Kendall BE, 2003, CONSERV BIOL, V17, P1170, DOI 10.1046/j.1523-1739.2003.02411.x; Kendall BE, 2010, AM NAT, V175, P461, DOI 10.1086/650724; Kerley LL, 2003, J MAMMAL, V84, P288, DOI 10.1644/1545-1542(2003)084<0288:RPOWFA>2.0.CO;2; Kohlmann S. G., 2005, ECOLOGICAL MODELLING, V183, P77; KULESZA G, 1990, IBIS, V132, P407, DOI 10.1111/j.1474-919X.1990.tb01059.x; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Miller Sterling D., 2003, Ursus (Knoxville), V14, P130; Mokkonen M, 2011, SCIENCE, V334, P972, DOI 10.1126/science.1208708; Morris W. F., 2002, QUANTITATIVE CONSERV; Nakaoka M, 1997, OIKOS, V79, P59, DOI 10.2307/3546090; Neal E.G., 1977, BADGERS; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; SHINE R, 1991, EVOLUTION, V45, P1696, DOI 10.1111/j.1558-5646.1991.tb02675.x; Sibly RM, 2009, AM NAT, V173, pE185, DOI 10.1086/598680; Sikes RS, 1998, OIKOS, V83, P452, DOI 10.2307/3546673; SLADE NA, 1984, THEOR POPUL BIOL, V26, P361, DOI 10.1016/0040-5809(84)90039-X; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; SMITH GC, 1991, PHILOS T ROY SOC B, V334, P459, DOI 10.1098/rstb.1991.0127; Sokal R.R., 1987, INTRO BIOSTATISTICS, V2nd; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Vial F, 2006, BIOL CONSERV, V131, P180, DOI 10.1016/j.biocon.2006.04.005; VOS A, 1995, ANN ZOOL FENN, V32, P93; Watts HE, 2008, J ZOOL, V276, P402, DOI 10.1111/j.1469-7998.2008.00506.x; Wilson AJ, 2005, EVOLUTION, V59, P451	58	6	6	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58060	10.1371/journal.pone.0058060	http://dx.doi.org/10.1371/journal.pone.0058060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469140	Green Accepted, Green Published, gold			2022-12-27	WOS:000315524900231
J	Estep, LK; McClure, CJW; Vander Kelen, P; Burkett-Cadena, ND; Sickerman, S; Hernandez, J; Jinright, J; Hunt, B; Lusk, J; Hoover, V; Armstrong, K; Stark, LM; Hill, GE; Unnasch, TR				Estep, Laura K.; McClure, Christopher J. W.; Vander Kelen, Patrick; Burkett-Cadena, Nathan D.; Sickerman, Stephen; Hernandez, Jose; Jinright, Joseph; Hunt, Brenda; Lusk, John; Hoover, Victor; Armstrong, Keith; Stark, Lillian M.; Hill, Geoffrey E.; Unnasch, Thomas R.			Risk of Exposure to Eastern Equine Encephalomyelitis Virus Increases with the Density of Northern Cardinals	PLOS ONE			English	Article							WEST-NILE-VIRUS; HOST-FEEDING PATTERNS; ENCEPHALITIS-VIRUS; DISEASE RISK; INFECTIOUS-DISEASE; SPECIES-DIVERSITY; AVIAN DIVERSITY; UNITED-STATES; TRANSMISSION; BIODIVERSITY	For a variety of infectious diseases, the richness of the community of potential host species has emerged as an important factor in pathogen transmission, whereby a higher richness of host species is associated with a lowered disease risk. The proposed mechanism driving this pattern is an increased likelihood in species-rich communities that infectious individuals will encounter dead-end hosts. Mosquito-borne pathogen systems potentially are exceptions to such "dilution effects" because mosquitoes vary their rates of use of vertebrate host species as bloodmeal sources relative to host availabilities. Such preferences may violate basic assumptions underlying the hypothesis of a dilution effect in pathogen systems. Here, we describe development of a model to predict exposure risk of sentinel chickens to eastern equine encephalitis virus (EEEV) in Walton County, Florida between 2009 and 2010 using avian species richness as well as densities of individual host species potentially important to EEEV transmission as candidate predictor variables. We found the highest support for the model that included the density of northern cardinals, a highly preferred host of mosquito vectors of EEEV, as a predictor variable. The highest-ranking model also included Culiseta melanura abundance as a predictor variable. These results suggest that mosquito preferences for vertebrate hosts influence pathogen transmission.	[Estep, Laura K.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [McClure, Christopher J. W.; Hill, Geoffrey E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Vander Kelen, Patrick; Burkett-Cadena, Nathan D.; Unnasch, Thomas R.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL USA; [Sickerman, Stephen; Hernandez, Jose; Jinright, Joseph] South Walton Cty Mosquito Control Dist, Santa Rosa Beach, FL USA; [Hunt, Brenda; Lusk, John; Hoover, Victor; Armstrong, Keith] North Walton Cty Mosquito Control Dist, Defuniak Springs, FL USA; [Stark, Lillian M.] Bur Labs Tampa, Florida Dept Hlth, Tampa, FL USA	Oregon State University; Auburn University System; Auburn University; State University System of Florida; University of South Florida; Florida Department of Health	Estep, LK (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	estepl@science.oregonstate.edu	McClure, Christopher/J-2712-2019; Hill, Geoffrey E./R-7354-2019	McClure, Christopher/0000-0003-1216-7425; Hill, Geoffrey E./0000-0001-8864-6495; Burkett-Cadena, Nathan/0000-0001-6168-1637	National Institute of Allergy and Infectious Diseases [R01AI049724]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049724] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by a grant from the National Institute of Allergy and Infectious Diseases, Project # R01AI049724 to TRU and GEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Begon Michael, 2008, P12; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHAMBERLAIN RW, 1954, AM J HYG, V60, P278, DOI 10.1093/oxfordjournals.aje.a119721; Chaves LF, 2004, ACTA TROP, V92, P245, DOI 10.1016/j.actatropica.2004.08.004; Cohen SB, 2009, AM J TROP MED HYG, V81, P452, DOI 10.4269/ajtmh.2009.81.452; Cupp EW, 2004, J MED ENTOMOL, V41, P495, DOI 10.1603/0022-2585-41.3.495; Cupp EW, 2003, AM J TROP MED HYG, V68, P495, DOI 10.4269/ajtmh.2003.68.495; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Day JF, 1996, J MED ENTOMOL, V33, P132, DOI 10.1093/jmedent/33.1.132; Day JF, 1989, J FLA ANTIMOSQ ASS, V60, P58; Diuk-Wasser MA, 2010, AM J TROP MED HYG, V82, P337, DOI 10.4269/ajtmh.2010.09-0506; Eastern Equine Encephalitis U.S. Department of Health and Human Services Centers for Disease Control and Prevention, 2012, E EQ ENC EP GEOGR DI; EDMAN JD, 1972, J MED ENTOMOL, V9, P429, DOI 10.1093/jmedent/9.5.429; Estep LK, 2011, AM J TROP MED HYG, V84, P718, DOI 10.4269/ajtmh.2011.10-0586; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Florida Department of Health, 2012, SURV CONTR SEL MOSQ; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; HESS AD, 1970, AM J TROP MED HYG, V19, P327, DOI 10.4269/ajtmh.1970.19.327; Hines J.E., 2006, WILDLIFE SOC B; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Kushwaha S. P. S., 2002, Tropical Ecology, V43, P137; Kutner M., 2004, APPL LINEAR STAT MOD; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Loss SR, 2009, OECOLOGIA, V159, P415, DOI 10.1007/s00442-008-1224-6; McKenzie VJ, 2010, ECOHEALTH, V7, P439, DOI 10.1007/s10393-010-0360-8; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Molaei G, 2006, AM J TROP MED HYG, V75, P1140, DOI 10.4269/ajtmh.2006.75.1140; Morris C. D., 1988, The arboviruses: epidemiology and ecology. Volume III., P1; Ralph C. John, 1995, U S Forest Service General Technical Report PSW, V149, P161; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Scott T. W., 1989, Advances in Virus Research, V37, P277, DOI 10.1016/S0065-3527(08)60838-6; Simpson JE, 2011, P R SOC B, V279, P925; Smith JP, 2008, TECH B FLA MOSQ CONT, V8, P10; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Vander Kelen PT, 2012, J MED ENTOMOL, V49, P746, DOI 10.1603/ME11224; VILLARI P, 1995, AM J TROP MED HYG, V52, P8, DOI 10.4269/ajtmh.1995.52.8	48	12	12	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57879	10.1371/journal.pone.0057879	http://dx.doi.org/10.1371/journal.pone.0057879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469095	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900191
J	Noguchi, Y; Shinozaki, Y; Fujishita, K; Shibata, K; Imura, Y; Morizawa, Y; Gachet, C; Koizumi, S				Noguchi, Yusuke; Shinozaki, Youichi; Fujishita, Kayoko; Shibata, Keisuke; Imura, Yoshio; Morizawa, Yosuke; Gachet, Christian; Koizumi, Schuichi			Astrocytes Protect Neurons against Methylmercury via ATP/P2Y(1) Receptor-Mediated Pathways in Astrocytes	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; NITRIC-OXIDE SYNTHASE; INDUCED NEUROTOXICITY; OXIDATIVE STRESS; IL-6 RELEASE; EXTRACELLULAR ATP; P2Y(1) RECEPTOR; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL CULTURES; POSSIBLE INVOLVEMENT	Methylmercury (MeHg) is a well known environmental pollutant that induces serious neuronal damage. Although MeHg readily crosses the blood-brain barrier, and should affect both neurons and glial cells, how it affects glia or neuron-to-glia interactions has received only limited attention. Here, we report that MeHg triggers ATP/P2Y(1) receptor signals in astrocytes, thereby protecting neurons against MeHg via interleukin-6 (IL-6)-mediated pathways. MeHg increased several mRNAs in astrocytes, among which IL-6 was the highest. For this, ATP/P2Y(1) receptor-mediated mechanisms were required because the IL-6 production was (i) inhibited by a P2Y(1) receptor antagonist, MRS2179, (ii) abolished in astrocytes obtained from P2Y(1) receptor-knockout mice, and (iii) mimicked by exogenously applied ATP. In addition, (iv) MeHg released ATP by exocytosis from astrocytes. As for the intracellular mechanisms responsible for IL-6 production, p38 MAP kinase was involved. MeHg-treated astrocyte-conditioned medium (ACM) showed neuro-protective effects against MeHg, which was blocked by anti-IL6 antibody and was mimicked by the application of recombinant IL-6. As for the mechanism of neuro-protection by IL-6, an adenosine A1 receptor-mediated pathway in neurons seems to be involved. Taken together, when astrocytes sense MeHg, they release ATP that autostimulates P2Y(1) receptors to upregulate IL-6, thereby leading to A1 receptor-mediated neuroprotection against MeHg.	[Noguchi, Yusuke; Shinozaki, Youichi; Fujishita, Kayoko; Shibata, Keisuke; Imura, Yoshio; Morizawa, Yosuke; Koizumi, Schuichi] Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi, Japan; [Shinozaki, Youichi; Shibata, Keisuke; Koizumi, Schuichi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Gachet, Christian] Univ Strasbourg, UMR INSERM S949, Etab Francais Sang Alsace, Strasbourg, France	University of Yamanashi; Japan Science & Technology Agency (JST); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Koizumi, S (corresponding author), Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi, Japan.	skoizumi@yamanashi.ac.jp	Shinozaki, Youichi/E-8594-2010; Shinozaki, Youichi/AAC-9431-2019; Koizumi, Schuichi/E-8568-2010; Gachet, Christian/H-9156-2016	Shinozaki, Youichi/0000-0002-6448-1304; Shinozaki, Youichi/0000-0002-6448-1304; Koizumi, Schuichi/0000-0001-6184-3106; 	Study (Group) of the Health Effects of Heavy Metals	Study (Group) of the Health Effects of Heavy Metals	This work was supported by Study (Group) of the Health Effects of Heavy Metals Organized by Ministry of the Environment, Japan (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ALI SF, 1992, NEUROTOXICOLOGY, V13, P637; Allen JW, 2002, NEUROTOXICOLOGY, V23, P755, DOI 10.1016/S0161-813X(01)00076-6; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Aschner M, 1996, NEUROTOXICOLOGY, V17, P663; Aschner M, 2000, CELL MOL BIOL, V46, P843; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhat NR, 1998, J NEUROSCI, V18, P1633; Biber K, 2001, NEUROPSYCHOPHARMACOL, V24, P86, DOI 10.1016/S0893-133X(00)00169-X; Biber K, 2008, NEUROPSYCHOPHARMACOL, V33, P2237, DOI 10.1038/sj.npp.1301612; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Braun N, 1998, J NEUROSCI, V18, P4891; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Carlson NG, 1999, J IMMUNOL, V163, P3963; Ceccatelli S, 2010, CHEM-BIOL INTERACT, V188, P301, DOI 10.1016/j.cbi.2010.04.007; Chang JY, 2007, NEUROSCI LETT, V416, P217, DOI 10.1016/j.neulet.2007.01.076; Chang JY, 2011, NEUROSCI LETT, V496, P152, DOI 10.1016/j.neulet.2011.04.004; Chang JY, 2009, NEUROSCI LETT, V461, P85, DOI 10.1016/j.neulet.2009.06.004; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; DEFORGE LE, 1991, BIOCHEM BIOPH RES CO, V174, P18, DOI 10.1016/0006-291X(91)90478-P; Farina M, 2011, LIFE SCI, V89, P555, DOI 10.1016/j.lfs.2011.05.019; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Fiebich BL, 2001, J NEUROCHEM, V79, P950, DOI 10.1046/j.1471-4159.2001.00652.x; Fujishita K, 2009, CELL MOL NEUROBIOL, V29, P1121, DOI 10.1007/s10571-009-9403-5; Fujita T, 2009, GLIA, V57, P244, DOI 10.1002/glia.20749; Gallagher CJ, 2003, J NEUROSCI, V23, P6728; Gasso S, 2001, J NEUROSCI RES, V66, P135, DOI 10.1002/jnr.1205; Harris JE, 2007, J LEUKOCYTE BIOL, V81, P548, DOI 10.1189/jlb.0806512; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Hua LWL, 2002, J NEUROIMMUNOL, V126, P180, DOI 10.1016/S0165-5728(02)00055-3; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Koizumi S, 1997, BRIT J PHARMACOL, V122, P51, DOI 10.1038/sj.bjp.0701344; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Lapham LW, 1995, NEUROTOXICOLOGY, V16, P689; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Liu HT, 2008, CELL RES, V18, P558, DOI 10.1038/cr.2008.49; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; LuKuo JM, 1996, J BIOL CHEM, V271, P22169, DOI 10.1074/jbc.271.36.22169; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Moro S, 1998, J MED CHEM, V41, P1456, DOI 10.1021/jm970684u; Mundy WR, 2000, NEUROTOXICOLOGY, V21, P1135; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Ni MW, 2011, GLIA, V59, P810, DOI 10.1002/glia.21153; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; Obara Y, 2005, MOL PHARMACOL, V68, P670, DOI 10.1124/mol.105.012922; Oberbach A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010882; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Peng YP, 2005, NEUROSCI LETT, V374, P192, DOI 10.1016/j.neulet.2004.10.069; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Sheng WS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-51; Shinozaki Y, 2005, GLIA, V49, P288, DOI 10.1002/glia.20118; Shinozaki Y, 2006, GLIA, V54, P606, DOI 10.1002/glia.20408; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Van Wagoner NJ, 2000, J NEUROCHEM, V75, P563, DOI 10.1046/j.1471-4159.2000.0750563.x; Wang L, 2009, TOXICOL SCI, V107, P135, DOI 10.1093/toxsci/kfn201; Yamada K, 1997, BRAIN RES BULL, V43, P573, DOI 10.1016/S0361-9230(96)00336-X; Yee S, 1996, NEUROTOXICOLOGY, V17, P17; Yuan YK, 2012, NEUROTOXICOLOGY, V33, P119, DOI 10.1016/j.neuro.2011.12.014; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	73	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57898	10.1371/journal.pone.0057898	http://dx.doi.org/10.1371/journal.pone.0057898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469098	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900194
J	Arunasri, K; Adil, M; Charan, KV; Suvro, C; Reddy, SH; Shivaji, S				Arunasri, Kotakonda; Adil, Mohammed; Charan, Katari Venu; Suvro, Chatterjee; Reddy, Seerapu Himabindu; Shivaji, Sisinthy			Effect of Simulated Microgravity on E. coli K12 MG1655 Growth and Gene Expression	PLOS ONE			English	Article							SHEAR MODELED MICROGRAVITY; ESCHERICHIA-COLI; SPACE-FLIGHT; MICROARRAY ANALYSIS; STRESS-RESPONSE; SALMONELLA; VIRULENCE; CLINOROTATION; BACTERIA; ALTERS	This study demonstrates the effects of simulated microgravity on E. coli K 12 MG1655 grown on LB medium supplemented with glycerol. Global gene expression analysis indicated that the expressions of hundred genes were significantly altered in simulated microgravity conditions compared to that of normal gravity conditions. Under these conditions genes coding for adaptation to stress are up regulated (sufE and ssrA) and simultaneously genes coding for membrane transporters (ompC, exbB, actP, mgtA, cysW and nikB) and carbohydrate catabolic processes (ldcC, ptsA, rhaD and rhaS) are down regulated. The enhanced growth in simulated gravity conditions may be because of the adequate supply of energy/reducing equivalents and up regulation of genes involved in DNA replication (srmB) and repression of the genes encoding for nucleoside metabolism (dfp, pyrD and spoT). In addition, E. coli cultured in LB medium supplemented with glycerol (so as to protect the cells from freezing temperatures) do not exhibit multiple stress responses that are normally observed when cells are exposed to microgravity in LB medium without glycerol.	[Arunasri, Kotakonda; Adil, Mohammed; Charan, Katari Venu; Shivaji, Sisinthy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Suvro, Chatterjee; Reddy, Seerapu Himabindu] Anna Univ, Vasc Biol Lab, Madras 600025, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Anna University; Anna University Chennai	Shivaji, S (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	shivas@ccmb.res.in		shivaji, sisinthy/0000-0003-0376-4658; Kotakonda, Arunasri/0000-0001-6870-2541	ISRO, India	ISRO, India	The project was funded by ISRO, India up to March 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P. W., 2005, BIOFILMS, V2, P1, DOI DOI 10.1017/S1479050504001437; Baker PW, 2006, ADV SPACE RES, V38, P1152, DOI 10.1016/j.asr.2006.05.014; Baker PW, 2004, MICROGRAVITY SCI TEC, V15, P35, DOI 10.1007/BF02870950; Benoit M, 2005, MICROBIOL-SGM, V151, P69, DOI 10.1099/mic.0.27062-0; Benoit MR, 2007, ADV SPACE RES, V39, P1225, DOI 10.1016/j.asr.2006.10.009; Berry BJ, 2010, APPL ENVIRON MICROB, V76, P2377, DOI 10.1128/AEM.02147-09; BOULOC P, 1991, J GEN MICROBIOL, V137, P2839, DOI 10.1099/00221287-137-12-2839; Brown RB, 2002, MICROGRAVITY SCI TEC, V13, P24, DOI 10.1007/BF02881678; Chen SL, 1997, APPL ENVIRON MICROB, V63, P2442, DOI 10.1128/AEM.63.6.2442-2445.1997; Chopra V, 2006, J TOXICOL ENV HEAL A, V69, P1345, DOI 10.1080/15287390500361792; Crabbe A, 2011, APPL ENVIRON MICROB, V77, P1221, DOI 10.1128/AEM.01582-10; Dalman MR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S11; Gao H, 1997, MICROGRAVITY SCI TEC, V10, P154; Gao Q, 2001, APPL MICROBIOL BIOT, V56, P384, DOI 10.1007/s002530100610; Gruener R, 1994, Biol Sci Space, V8, P79; Haga RA, 2011, AER C 2011 IEEE, P5; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Huijser RH, 2000, FSMG0017; IKENAKA K, 1986, J BIOL CHEM, V261, P9316; Jagessar KL, 2010, RNA, V16, P1386, DOI 10.1261/rna.2015610; Klaus D, 1997, MICROBIOL-SGM, V143, P449, DOI 10.1099/00221287-143-2-449; Leys NMEJ, 2004, J BIOL REG HOMEOS AG, V18, P193; McLean RJC, 2001, FEMS MICROBIOL LETT, V195, P115, DOI 10.1016/S0378-1097(00)00549-8; Mechold U, 1996, J BACTERIOL, V178, P1401, DOI 10.1128/jb.178.5.1401-1411.1996; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2003, J MICROBIOL METH, V54, P1, DOI 10.1016/S0167-7012(03)00018-6; Nickerson CA, 2000, INFECT IMMUN, V68, P3147, DOI 10.1128/IAI.68.6.3147-3152.2000; Parekh BS, 1997, J BACTERIOL, V179, P2086, DOI 10.1128/jb.179.6.2086-2088.1997; Ranquet C, 2007, J BACTERIOL, V189, P4872, DOI 10.1128/JB.01838-06; Rosenzweig JA, 2010, APPL MICROBIOL BIOT, V85, P885, DOI 10.1007/s00253-009-2237-8; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; SPITZER ED, 1988, J BACTERIOL, V170, P872, DOI 10.1128/jb.170.2.872-876.1988; Tucker DL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-15; Vukanti R, 2008, MICROGRAVITY SCI TEC, V20, P41, DOI 10.1007/s12217-008-9012-9; Vukanti R, 2012, MICROGRAVITY SCI TEC, V24, P267, DOI 10.1007/s12217-012-9310-0; Vukanti R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-4; WILSON HR, 1990, J BACTERIOL, V172, P3208, DOI 10.1128/jb.172.6.3208-3213.1990; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Yamazaki T, 2012, MICROBIOL IMMUNOL, V56, P441, DOI 10.1111/j.1348-0421.2012.00471.x; Yuan LH, 2005, INFECT IMMUN, V73, P4146, DOI 10.1128/IAI.73.7.4146-4154.2005	46	49	53	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57860	10.1371/journal.pone.0057860	http://dx.doi.org/10.1371/journal.pone.0057860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472115	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900054
J	Henriksen, L; Grandal, MV; Knudsen, SLJ; van Deurs, B; Grovdal, LM				Henriksen, Lasse; Grandal, Michael Vibo; Knudsen, Stine Louise Jeppe; van Deurs, Bo; Grovdal, Lene Melsaether			Internalization Mechanisms of the Epidermal Growth Factor Receptor after Activation with Different Ligands	PLOS ONE			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; EGF RECEPTOR; MEDIATED ENDOCYTOSIS; FACTOR-ALPHA; MACROPINOCYTOSIS; PATHWAYS	The epidermal growth factor receptor (EGFR) regulates normal growth and differentiation, but dysregulation of the receptor or one of the EGFR ligands is involved in the pathogenesis of many cancers. There are eight ligands for EGFR, however most of the research into trafficking of the receptor after ligand activation focuses on the effect of epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha). For a long time it was believed that clathrin-mediated endocytosis was the major pathway for internalization of the receptor, but recent work suggests that different pathways exist. Here we show that clathrin ablation completely inhibits internalization of EGF- and TGF-alpha-stimulated receptor, however the inhibition of receptor internalization in cells treated with heparin-binding EGF-like growth factor (HB-EGF) or betacellulin (BTC) was only partial. In contrast, clathrin knockdown fully inhibits EGFR degradation after all ligands tested. Furthermore, inhibition of dynamin function blocked EGFR internalization after stimulation with all ligands. Knocking out a number of clathrin-independent dynamin-dependent pathways of internalization had no effect on the ligand-induced endocytosis of the EGFR. We suggest that EGF and TGF-alpha lead to EGFR endocytosis mainly via the clathrin-mediated pathway. Furthermore, we suggest that HB-EGF and BTC also lead to EGFR endocytosis via a clathrin-mediated pathway, but can additionally use an unidentified internalization pathway or better recruit the small amount of clathrin remaining after clathrin knockdown.	[Henriksen, Lasse; Grandal, Michael Vibo; Knudsen, Stine Louise Jeppe; van Deurs, Bo; Grovdal, Lene Melsaether] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark	University of Copenhagen	Grovdal, LM (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark.	lenemg@sund.ku.dk			Eva og Henry Fraenkels Mindefond [2011-1-14-89]; Danish Cancer Society [DP08104]; Lundbeck Foundation [R67-A6299]; Danish Medical Research Council [271-06-0505]; Danish Cancer Research Foundation; Novo Nordic Foundation; John and Birthe Meyer Foundation; Arvid Nilssons Foundation; Vera & Carl Johan Michaelsens grant	Eva og Henry Fraenkels Mindefond; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); John and Birthe Meyer Foundation; Arvid Nilssons Foundation; Vera & Carl Johan Michaelsens grant	This work is funded by Eva og Henry Fraenkels Mindefond (grant number 2011-1-14-89; http://www.fraenkelsmindefond.org), The Danish Cancer Society (grant number DP08104; http://www.cancer.dk/), The Lundbeck Foundation (grant number R67-A6299; http://www.lundbeckfonden.com/), The Danish Medical Research Council (grant number 271-06-0505; http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-researchcouncils/medical-sciences), The Danish Cancer Research Foundation (http://www.dansk-kraeftforsknings-fond.dk), The Novo Nordic Foundation (http://www.novonordiskfonden.dk), The John and Birthe Meyer Foundation, The Arvid Nilssons Foundation, and The Vera & Carl Johan Michaelsens grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; DECKER SJ, 1990, BIOCHEM BIOPH RES CO, V166, P615, DOI 10.1016/0006-291X(90)90853-F; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; EBNER R, 1991, CELL REGUL, V2, P599, DOI 10.1091/mbc.2.8.599; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Grandal MV, 2012, TRAFFIC, V13, P576, DOI 10.1111/j.1600-0854.2011.01322.x; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Kazazic M, 2006, TRAFFIC, V7, P1518, DOI 10.1111/j.1600-0854.2006.00487.x; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; LUND KA, 1990, J BIOL CHEM, V265, P15713; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918	30	94	96	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58148	10.1371/journal.pone.0058148	http://dx.doi.org/10.1371/journal.pone.0058148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472148	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900094
J	Herberg, S; Shi, XM; Johnson, MH; Hamrick, MW; Isales, CM; Hill, WD				Herberg, Samuel; Shi, Xingming; Johnson, Maribeth H.; Hamrick, Mark W.; Isales, Carlos M.; Hill, William D.			Stromal Cell-Derived Factor-1 beta Mediates Cell Survival through Enhancing Autophagy in Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; SIGNALING PATHWAYS; SERUM-DEPRIVATION; PROGENITOR CELLS; APOPTOSIS; DEATH; ACTIVATION; MECHANISM; BECLIN-1; PROTEIN	Bone marrow-derived mesenchymal stem/stromal cells (BMSCs) hold great potential for cell-based therapy, yet the therapeutic efficacy remains uncertain. Transplanted BMSCs often fail to engraft within the bone marrow (BM), in part due to the poor survival of donor cells in response to inflammatory reactions, hypoxia, oxidative stress, or nutrient starvation. Two basic cell processes, apoptosis and autophagy, could potentially be responsible for the impaired survival of transplanted BMSCs. However, the functional relationship between apoptosis and autophagy in BMSC homeostasis is complex and not well understood. The stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor 4 (CXCR4) signaling axis appears to be critical in maintaining proliferation and survival of BM stem cell populations through improving cell proliferation and survival in response to stress; however, the exact mechanisms remain unclear. We recently described novel genetically engineered Tet-Off-SDF-1 beta BMSCs, which over-express SDF-1 beta under tight doxycycline-control, thus providing an ideal model system to investigate the isolated effects of SDF-1 beta. In this study we tested the hypothesis that SDF-1 beta can mediate cell survival of BMSCs in vitro through increasing autophagy. We found that SDF-1 beta had no effect on BMSC proliferation; however, SDF-1 beta significantly protected genetically engineered BMSCs from H2O2-induced cell death through increasing autophagy and decreasing caspase-3-dependent apoptosis. Taken together, we provide novel evidence that the SDF-1/CXCR4 axis, specifically activated by the SDF-1 beta isoform, plays a critical role in regulating BMSC survival under oxidative stress through increasing autophagy.	[Herberg, Samuel; Hill, William D.] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Herberg, Samuel; Hamrick, Mark W.; Isales, Carlos M.; Hill, William D.] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Johnson, Maribeth H.] Georgia Regents Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Hamrick, Mark W.; Isales, Carlos M.; Hill, William D.] Georgia Regents Univ, Dept Orthopaed Surg, Augusta, GA USA; [Shi, Xingming] Georgia Regents Univ, Dept Pathol, Augusta, GA USA; [Shi, Xingming; Hamrick, Mark W.; Isales, Carlos M.; Hill, William D.] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA USA; [Shi, Xingming; Hamrick, Mark W.; Isales, Carlos M.; Hill, William D.] Georgia Regents Univ, Inst Regenerat & Reparat Med, Augusta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Hill, WD (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA USA.	whill@gru.edu	Herberg, Samuel/I-3811-2019; Isales, Carlos/J-9902-2013; Hamrick, Mark/K-1131-2016	Herberg, Samuel/0000-0001-7196-2010; Isales, Carlos/0000-0002-4480-3484; 	United States Department of Veterans Affairs; National Institutes of Health [NIA-AG036675-01]; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	United States Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the United States Department of Veterans Affairs (VA Merit to WDH) and the National Institutes of Health (NIA-AG036675-01, WDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davis DA, 2005, BLOOD, V105, P4561, DOI 10.1182/blood-2004-12-4618; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Herberg S, 2013, TISSUE ENG PT A, V19, P1, DOI [10.1089/ten.tea.2012.0085, 10.1089/ten.TEA.2012.0085]; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hou Z, 1999, P NATL ACAD SCI USA, V96, P7294, DOI 10.1073/pnas.96.13.7294; Kessel D, 2007, CANCER LETT, V249, P294, DOI 10.1016/j.canlet.2006.09.009; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kucia M, 2004, J MOL HISTOL, V35, P233; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Lee YJ, 2012, J CELL BIOCH; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271; Marquez-Curtis L, 2008, STEM CELLS, V26, P1211, DOI 10.1634/stemcells.2007-0725; Nilsson SK, 1999, J EXP MED, V189, P729, DOI 10.1084/jem.189.4.729; Nobukuni T, 2007, CURR OPIN CELL BIOL, V19, P135, DOI 10.1016/j.ceb.2007.02.019; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oliver L, 2012, STEM CELLS DEV, V21, P2779, DOI 10.1089/scd.2012.0124; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sierra MD, 2004, BLOOD, V103, P2452; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Xu RX, 2008, J CELL BIOCHEM, V103, P256, DOI 10.1002/jcb.21402; Zhang J, 2010, J MOL CELL CARDIOL, V48, P1060, DOI 10.1016/j.yjmcc.2009.11.020; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200	47	57	63	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58207	10.1371/journal.pone.0058207	http://dx.doi.org/10.1371/journal.pone.0058207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472159	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900105
J	Liu, XY; He, YL; Xiao, K; White, JR; Fusco, DN; Papanicolaou, GA				Liu, Xinyan; He, Yaling; Xiao, Kun; White, Julie R.; Fusco, Dahlene N.; Papanicolaou, Genovefa A.			Effect of Linezolid on Clinical Severity and Pulmonary Cytokines in a Murine Model of Influenza A and Staphylococcus aureus Coinfection	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; COMBINATION ANTIBIOTIC-THERAPY; INTERFERON-GAMMA; NOSOCOMIAL PNEUMONIA; BACTERIAL PNEUMONIA; VIRUS-INFECTION; UNITED-STATES; MORTALITY; CELLS; IL-10	Excessive inflammation contributes to the severity of post influenza pneumonia caused by methicillin resistant S. aureus (MRSA). Linezolid, vancomycin, and clindamycin are antibiotics used for MRSA infections. Linezolid has immunomodulatory properties. We report on the effects of the three antibiotics on microbial clearance, pulmonary cytokines and clinical course in a murine model of influenza and MRSA coinfection. Methods: B6 mice were infected with influenza A virus and 3 days later with MRSA, both intranasally. Treatment with placebo, linezolid, vancomycin or clindamycin started immediately after MRSA infection and continued for 72 hours. Bacterial and viral titers as well as cytokine concentrations in the lungs were assessed 4 and 24 hours after MRSA coinfection. Mice were weighted daily for 13 days. Results: Coinfected mice had increased pulmonary IL-1 beta, TNF-alpha and mKC at 4 and 24 hours, IL-6, IL-10 and IL-12 at 4 hours and IFN-gamma at 24 hours after MRSA coinfection (all P<0.05). Compared to placebo, coinfected mice treated with linezolid, vancomycin or clindamycin had decreased pulmonary IL-6 and mKC at 4 hours and IFN-gamma at 24 hours after MRSA coinfection (all P<0.05). IL-1 beta, TNF-alpha and IL-12 were similar in antibiotic-treated and placebo groups. All antibiotics similarly reduced MRSA without effect on influenza titers. Linezolid-treated mice had less weight loss on days 4-6 after influenza infection compared to placebo (all P, 0.05). On all other days weight change was similar among all groups. Conclusions: This is the first report comparing the effects of antibiotics on cytokines and clinical outcome in a murine model of influenza and MRSA coinfection. Compared to placebo, antibiotic treatment reduced maximum concentration of IL-6, mKC and IFN-gamma in the lungs without any difference among antibiotics. During treatment, only linezolid delayed weight loss compared to placebo.	[Liu, Xinyan; He, Yaling; Xiao, Kun; Fusco, Dahlene N.; Papanicolaou, Genovefa A.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA; [White, Julie R.] Mem Sloan Kettering Canc Ctr, Lab Comparat Pathol, New York, NY 10021 USA; [Fusco, Dahlene N.; Papanicolaou, Genovefa A.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Papanicolaou, GA (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA.	papanicg@mskcc.org		Xiao, Kun/0000-0001-9373-7084; Papanicolaou, Genovefa/0000-0002-2891-079X	Pfizer, Inc; Weill Cornell Medical College Clinical and Translational Science Center; NIH [UL1 RR024996]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER	Pfizer, Inc(Pfizer); Weill Cornell Medical College Clinical and Translational Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a research grant from Pfizer, Inc (GAP) and a Pilot Award from the Weill Cornell Medical College Clinical and Translational Science Center, NIH Award Number UL1 RR024996 (GAP, DNF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Clinical and Translational Science Center, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aoki Naoko, 2004, Expert Opin Emerg Drugs, V9, P223, DOI 10.1517/14728214.9.2.223; Baddour LM, 2004, AM J RESP CRIT CARE, V170, P440, DOI 10.1164/rccm.200311-1578OC; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; Barman TK, 2009, INT J ANTIMICROB AG, V33, P280, DOI 10.1016/j.ijantimicag.2008.08.025; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Danin J, 2003, ORAL SURG ORAL MED O, V96, P492, DOI 10.1016/S1079-2104(03)00059-3; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Fusco D, 2010, VACCINE, V28, P3956, DOI 10.1016/j.vaccine.2010.03.047; Garcia-Roca P, 2006, ARCH MED RES, V37, P31, DOI 10.1016/j.arcmed.2005.05.022; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; HENNET T, 1992, J IMMUNOL, V149, P932; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Karlstrom A, 2009, J INFECT DIS, V199, P311, DOI 10.1086/596051; Leach KL, 2011, ANN NY ACAD SCI, V1222, P49, DOI 10.1111/j.1749-6632.2011.05962.x; Lee MH, 2010, J INFECT DIS, V201, P508, DOI 10.1086/650204; Lijek RS, 2012, CURR OPIN IMMUNOL, V24, P417, DOI 10.1016/j.coi.2012.05.005; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; MARKS JD, 1990, AM REV RESPIR DIS, V141, P94, DOI 10.1164/ajrccm/141.1.94; Martinez FJ, 2004, CLIN INFECT DIS, V38, pS328, DOI 10.1086/382689; Mufson MA, 2006, CLIN INFECT DIS, V42, P304, DOI 10.1086/499110; Murray RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008705; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nguyen JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031006; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pogue M., 2007, Morbidity and Mortality Weekly Report, V56, P325; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tessier PR, 2012, ANTIMICROB AGENTS CH, V56, P2342, DOI 10.1128/AAC.06427-11; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; van der Sluijs KF, 2010, CRIT CARE, V14, DOI 10.1186/cc8893; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Welshman IR, 2001, BIOPHARM DRUG DISPOS, V22, P91, DOI 10.1002/bdd.255; Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378/chest.124.5.1789; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC; Yao L, 1997, INFECT IMMUN, V65, P3889, DOI 10.1128/IAI.65.9.3889-3895.1997; Zhao YX, 1998, IMMUNOLOGY, V93, P80	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57483	10.1371/journal.pone.0057483	http://dx.doi.org/10.1371/journal.pone.0057483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23478252	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900025
J	Yagi, Y; Hayashi, S; Kobayashi, K; Hirayama, T; Nakamura, T				Yagi, Yusuke; Hayashi, Shimpei; Kobayashi, Keiko; Hirayama, Takashi; Nakamura, Takahiro			Elucidation of the RNA Recognition Code for Pentatricopeptide Repeat Proteins Involved in Organelle RNA Editing in Plants	PLOS ONE			English	Article							PPR-DYW PROTEINS; PHYSCOMITRELLA-PATENS; CHLOROPLAST TRANSCRIPTS; MITOCHONDRIAL GENOMES; GENE-EXPRESSION; EVOLUTION; SITES; REVEALS; NUCLEAR; INSIGHT	Pentatricopeptide repeat (PPR) proteins are eukaryotic RNA-binding proteins that are commonly found in plants. Organelle transcript processing and stability are mediated by PPR proteins in a gene-specific manner through recognition by tandem arrays of degenerate 35-amino-acid repeating units, the PPR motifs. However, the sequence-specific RNA recognition mechanism of the PPR protein remains largely unknown. Here, we show the principle underlying RNA recognition for PPR proteins involved in RNA editing. The distance between the PPR-RNA alignment and the editable C was shown to be conserved. Amino acid variation at 3 particular positions within the motif determined recognition of a specific RNA in a programmable manner, with a 1-motif to 1-nucleotide correspondence, with no gap sequence. Data from the decoded nucleotide frequencies for these 3 amino acids were used to assign accurate interacting sites to several PPR proteins for RNA editing and to predict the target site for an uncharacterized PPR protein.	[Yagi, Yusuke; Kobayashi, Keiko; Nakamura, Takahiro] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Yagi, Yusuke; Kobayashi, Keiko; Nakamura, Takahiro] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan; [Hayashi, Shimpei] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Ibaraki, Japan; [Hirayama, Takashi] Okayama Univ, Inst Plant Sci & Resources, Okayama, Japan; [Nakamura, Takahiro] Kyushu Univ, Biotron Applicat Ctr, Fukuoka 812, Japan	Kyushu University; Kyushu University; National Institute of Agrobiological Sciences - Japan; Okayama University; Kyushu University	Nakamura, T (corresponding author), Kyushu Univ, Fac Agr, Fukuoka 812, Japan.	tnaka@agr.kyushu-u.ac.jp	HIRAYAMA, Takashi/B-2496-2011	HIRAYAMA, Takashi/0000-0002-3868-2380	Program for Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) from the Bio-oriented Technology Research Advancement Institution; Kyushu University Research Superstar Program from Kyushu University; Ministry of Education, Culture, Sports, Science, and Technology [22681028, 22380008, 20570050, 21112521, 23112715]; Grants-in-Aid for Scientific Research [22681028] Funding Source: KAKEN	Program for Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) from the Bio-oriented Technology Research Advancement Institution; Kyushu University Research Superstar Program from Kyushu University; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Program for Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) from the Bio-oriented Technology Research Advancement Institution (T.N.; http://www.naro.affrc.go.jp/english/index.html); the Kyushu University Research Superstar Program (T.N.; http://www.srp.kyushu-u.ac.jp/ssp_home/e_top.html) from Kyushu University; and Grants-in-Aid 22681028 and 22380008 (T.N.) and 20570050, 21112521, and 23112715 (T. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bhattacharya D, 2007, BIOESSAYS, V29, P1239, DOI 10.1002/bies.20671; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Castandet B, 2011, BIOCHEMISTRY-MOSCOW+, V76, P924, DOI 10.1134/S0006297911080086; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hegeman CE, 2005, NUCLEIC ACIDS RES, V33, P1454, DOI 10.1093/nar/gki286; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Lenz H, 2010, CURR GENET, V56, P189, DOI 10.1007/s00294-009-0283-5; Lipinski KA, 2011, MOL BIOL EVOL, V28, P2935, DOI 10.1093/molbev/msr120; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Murayama M, 2012, J EXP BOT, V63, P5301, DOI 10.1093/jxb/ers188; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; Nishida K, 2009, NUCLEIC ACIDS RES, V37, P939, DOI 10.1093/nar/gkn1019; Ohtani S, 2010, PLANT CELL PHYSIOL, V51, P1942, DOI 10.1093/pcp/pcq142; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; Rubinson EH, 2012, CURR OPIN STRUC BIOL, V22, P101, DOI 10.1016/j.sbi.2011.11.005; Rudinger M, 2011, PLANT J, V67, P370, DOI 10.1111/j.1365-313X.2011.04600.x; Rudinger M, 2009, MOL GENET GENOMICS, V281, P473, DOI 10.1007/s00438-009-0424-z; Sasaki T, 2006, PLANT J, V47, P802, DOI 10.1111/j.1365-313X.2006.02825.x; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; Uchida M, 2011, FEBS LETT, V585, P2367, DOI 10.1016/j.febslet.2011.06.009	34	205	217	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57286	10.1371/journal.pone.0057286	http://dx.doi.org/10.1371/journal.pone.0057286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472078	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900016
J	Chung, CM; Wang, RY; Fann, CSJ; Chen, JW; Jong, YS; Jou, YS; Yang, HC; Kang, CS; Chen, CC; Chang, HC; Pan, WH				Chung, Chia-Min; Wang, Ruey-Yun; Fann, Cathy S. J.; Chen, Jaw-Wen; Jong, Yuh-Shiun; Jou, Yuh-Shan; Yang, Hsin-Chou; Kang, Chih-Sen; Chen, Chien-Chung; Chang, Huan-Cheng; Pan, Wen-Harn			Fine-Mapping Angiotensin-Converting Enzyme Gene: Separate QTLs Identified for Hypertension and for ACE Activity	PLOS ONE			English	Article							INSERTION-DELETION POLYMORPHISM; BLOOD-PRESSURE; DISEASE; ASSOCIATION; HAPLOTYPE; LOCUS; HEART; SERUM; METAANALYSIS; LINKAGE	Angiotensin-converting enzyme (ACE) has been implicated in multiple biological system, particularly cardiovascular diseases. However, findings associating ACE insertion/deletion polymorphism with hypertension or other related traits are inconsistent. Therefore, in a two-stage approach, we aimed to fine-map ACE in order to narrow-down the function-specific locations. We genotyped 31 single nucleotide polymorphisms (SNPs) of ACE from 1168 individuals from 305 young-onset (age <= 40) hypertension pedigrees, and found four linkage disequilibrium (LD) blocks. A tag-SNP, rs1800764 on LD block 2, upstream of and near the ACE promoter, was significantly associated with young-onset hypertension (p = 0.04). Tag-SNPs on all LD blocks were significantly associated with ACE activity (p-value: 10(-16) to <10(-33)). The two regions most associated with ACE activity were found between exon13 and intron18 and between intron 20 and 3'UTR, as revealed by measured haplotype analysis. These two major QTLs of ACE activity and the moderate effect variant upstream of ACE promoter for young-onset hypertension were replicated by another independent association study with 842 subjects.	[Chung, Chia-Min; Fann, Cathy S. J.; Jou, Yuh-Shan; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chung, Chia-Min; Pan, Wen-Harn] Natl Hlth Res Inst, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan; [Wang, Ruey-Yun] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Jong, Yuh-Shiun] Tao Yuan Gen Hosp, Dept Cardiol, Dept Hlth, Tao Yuan, Taiwan; [Yang, Hsin-Chou] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Kang, Chih-Sen] Min Sheng Hosp, Dept Cardiol, Tao Yuan, Taiwan; [Chen, Chien-Chung; Chang, Huan-Cheng] Lin Shin Hosp, Dept Cardiol, Chungli, Taiwan	Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan	Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	pan@ibms.sinica.edu.tw	Jou, Yuh-Shan/O-5921-2018; Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Fann, Cathy SJ/F-9410-2010	Jou, Yuh-Shan/0000-0001-5090-3732; Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Fann, Cathy SJ/0000-0001-9025-2276	Department of Health [DOH90- TD-1037]; National Science Council [NSC91-3112-P-001-025-YGPCP91-25]; Academia Sinica in Taiwan [AS91IBMS2PP-A]	Department of Health; National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica in Taiwan(Academia Sinica - Taiwan)	This research was supported by the Department of Health (DOH90- TD-1037), the National Science Council (NSC91-3112-P-001-025-YGPCP91-25), and by Academia Sinica (AS91IBMS2PP-A) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barley J, 1996, J HUM HYPERTENS, V10, P31; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouzekri N, 2004, EUR J HUM GENET, V12, P460, DOI 10.1038/sj.ejhg.5201166; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Corvol P WT, 1998, HDB PROTEOLYTIC ENZY, P1066; Corvol P WT, 1995, METHODS ENZYMOLOGY, P283; Cox R, 2002, HUM MOL GENET, V11, P2969, DOI 10.1093/hmg/11.23.2969; Danilczyk U, 2006, CIRC RES, V98, P463, DOI 10.1161/01.RES.0000205761.22353.5f; Fujimura T, 1997, AM J HYPERTENS, V10, P1384, DOI 10.1016/S0895-7061(97)00323-3; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glaab WE, 1999, MUTAT RES-FUND MOL M, V430, P1, DOI 10.1016/S0027-5107(99)00147-5; KASAHARA Y, 1981, CLIN CHEM, V27, P1922; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; Liu XF, 2001, J BIOL CHEM, V276, P33518, DOI 10.1074/jbc.M101495200; McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077; Ng DPK, 2006, DIABETES, V55, P2660, DOI 10.2337/db06-0496; Niu TH, 2002, DRUGS, V62, P977, DOI 10.2165/00003495-200262070-00001; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Pan WH, 2006, GENET EPIDEMIOL, V30, P143, DOI 10.1002/gepi.20136; Pusch W, 2002, PHARMACOGENOMICS, V3, P537, DOI 10.1517/14622416.3.4.537; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; Schurmann Manfred, 2003, Am J Pharmacogenomics, V3, P233; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Soubrier F, 2002, EUR J HUM GENET, V10, P553, DOI 10.1038/sj.ejhg.5200847; Wang RY, 2008, HUM HERED, V65, P85, DOI 10.1159/000108940; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhu XF, 2000, AM J HUM GENET, V67, P1144; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e56119	10.1371/journal.pone.0056119	http://dx.doi.org/10.1371/journal.pone.0056119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469169	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900004
J	Kornfield, R; Donohue, J; Berndt, ER; Alexander, GC				Kornfield, Rachel; Donohue, Julie; Berndt, Ernst R.; Alexander, G. Caleb			Promotion of Prescription Drugs to Consumers and Providers, 2001-2010	PLOS ONE			English	Article							OF-INTEREST; QUALITY	Background: Pharmaceutical firms heavily promote their products and may have changed marketing strategies in response to reductions in new product approvals, restrictions on some forms of promotion, and the expanding role of biologic therapies. Methods: We used descriptive analyses of annual cross-sectional data from 2001 through 2010 to examine direct-to-consumer advertising (DTCA) (Kantar Media) and provider-targeted promotion (IMS Health and SDI), including: (1) inflation-adjusted total promotion spending ($ and percent of sales); (2) distribution by channel (consumer v. provider); and (3) provider specialty both for the industry as a whole and for top-selling biologic and small molecule therapies. Results: Total promotion peaked in 2004 at US$36.1 billion (13.4% of sales). By 2010 it had declined to $27.7B (9.0% of sales). Between 2006 and 2010, similar declines were seen for promotion to providers and DTCA (both by 25%). DTCA's share of total promotion increased from 12% in 2002 to 18% in 2006, but then declined to 16% and remains highly concentrated. Number of products promoted to providers peaked in 2004 at over 3000, and then declined 20% by 2010. In contrast to top-selling small molecule therapies having an average of $ 370 million (8.8% of sales) spent on promotion, top biologics were promoted less, with only $ 33 million (1.4% of sales) spent per product. Little change occurred in the composition of promotion between primary care physicians and specialists from 2001-2010. Conclusions: These findings suggest that pharmaceutical companies have reduced promotion following changes in the pharmaceutical pipeline and patent expiry for several blockbuster drugs. Promotional strategies for biologic drugs differ substantially from small molecule therapies.	[Kornfield, Rachel; Alexander, G. Caleb] Univ Chicago, Dept Med, Gen Internal Med Sect, Chicago, IL 60637 USA; [Donohue, Julie] Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Donohue, Julie] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Berndt, Ernst R.] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; [Berndt, Ernst R.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Alexander, G. Caleb] Johns Hopkins Med, Dept Med, Baltimore, MD USA; [Alexander, G. Caleb] Univ Illinois, Chicago Sch Pharm, Dept Pharm Practice, Chicago, IL USA	University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alexander, GC (corresponding author), Univ Chicago, Dept Med, Gen Internal Med Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	galexand@jhsph.edu	Kornfield, Rachel/Q-4992-2019	Donohue, Julie/0000-0003-2418-6017	Agency for Healthcare Research and Quality [RO1 HS0189960]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Ms. Kornfield and Dr. Alexander were supported by the Agency for Healthcare Research and Quality (RO1 HS0189960). The funding sources had no role in study design or conduct; collection, management, analysis, or interpretation of the data; or preparation, review, or final manuscript approval.	Aggarwal S, 2010, NAT BIOTECHNOL, V28, P1165, DOI 10.1038/nbt1110-1165; Aitken M, 2009, HEALTH AFFAIR, V28, pW151, DOI 10.1377/hlthaff.28.1.w151; American Association of Medical Colleges, 2008, PROT PAT PRES INT AD; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2010, ARCH INTERN MED, V170, P1820, DOI 10.1001/archinternmed.2010.383; Campbell S, 2009, PROMOTIONAL SPENDING; Chimonas S, 2010, HEALTH SERV RES, V45, P98, DOI 10.1111/j.1475-6773.2009.01048.x; Donohue JM, 2004, J PUBLIC POLICY MARK, V23, P115, DOI 10.1509/jppm.23.2.115.51395; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Eichler HG, 2008, NAT REV DRUG DISCOV, V7, P818, DOI 10.1038/nrd2664; Fugh-Berman A, 2011, ACAD MED, V86, P649, DOI 10.1097/ACM.0b013e318212e8d4; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Groves KEM, 2003, J CLIN PHARM THER, V28, P259, DOI 10.1046/j.1365-2710.2003.00481.x; Hensley Scott, 2005, Wall St J (East Ed); Iizuka T, 2005, J ECON MANAGE STRAT, V14, P701, DOI 10.1111/j.1530-9134.2005.00079.x; IMS Institute for Healthcare Informatics, 2011, US MED US REV 2010; Institute of Medicine, 2009, CONFL INT MED RES ED; Kolata G., 2008, NY TIMES; Korenstein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023336; Liang BA, 2011, JAMA-J AM MED ASSOC, V305, P824, DOI 10.1001/jama.2011.203; Mullins CD, 2005, HEALTH AFFAIR, V24, P1117, DOI 10.1377/hlthaff.24.4.1117; O'Reilly K, 2009, AM MED NEWS     0323; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; Rader RA, 2011, TOP 50 BIOPHARMA PRO; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; Rosenthal MB, 2003, FRONTIERS HLTH POLIC, V6, P1; Rothman DJ, 2008, JAMA-J AM MED ASSOC, V300, P1067, DOI 10.1001/jama.300.9.1067; Rothman DJ, 2010, JAMA-J AM MED ASSOC, V304, P2294, DOI 10.1001/jama.2010.1714; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Trusheim MR, 2010, 16014 NAT BUR EC RES; United States Food and Drug Administration, 2011, SUMM NDA APPR REC 19; United States Food and Drug Administration, 2011, CTR DRUG EV RES DRUG	32	62	62	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e55504	10.1371/journal.pone.0055504	http://dx.doi.org/10.1371/journal.pone.0055504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099PY	23469165	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000315634900003
J	Piednoel, M; Donnart, T; Esnault, C; Graca, P; Higuet, D; Bonnivard, E				Piednoel, Mathieu; Donnart, Tifenn; Esnault, Caroline; Graca, Paula; Higuet, Dominique; Bonnivard, Eric			LTR-Retrotransposons in R. exoculata and Other Crustaceans: The Outstanding Success of GalEa-Like Copia Elements	PLOS ONE			English	Article							DEEP-SEA VENT; TRANSPOSABLE ELEMENTS; DIRS1-LIKE RETROTRANSPOSONS; MOBILE ELEMENTS; GENOME SIZE; EVOLUTION; DNA; EXPRESSION; RETROELEMENTS; ACTIVATION	Transposable elements are major constituents of eukaryote genomes and have a great impact on genome structure and stability. They can contribute to the genetic diversity and evolution of organisms. Knowledge of their distribution among several genomes is an essential condition to study their dynamics and to better understand their role in species evolution. LTR-retrotransposons have been reported in many diverse eukaryote species, describing a ubiquitous distribution. Given their abundance, diversity and their extended ranges in C-values, environment and life styles, crustaceans are a great taxon to investigate the genomic component of adaptation and its possible relationships with TEs. However, crustaceans have been greatly underrepresented in transposable element studies. Using both degenerate PCR and in silico approaches, we have identified 35 Copia and 46 Gypsy families in 15 and 18 crustacean species, respectively. In particular, we characterized several full-length elements from the shrimp Rimicaris exoculata that is listed as a model organism from hydrothermal vents. Phylogenic analyses show that Copia and Gypsy retrotransposons likely present two opposite dynamics within crustaceans. The Gypsy elements appear relatively frequent and diverse whereas Copia are much more homogeneous, as 29 of them belong to the single GalEa clade, and species-or lineage-dependent. Our results also support the hypothesis of the Copia retrotransposon scarcity in metazoans compared to Gypsy elements. In such a context, the GalEa-like elements present an outstanding wide distribution among eukaryotes, from fishes to red algae, and can be even highly predominant within a large taxon, such as Malacostraca. Their distribution among crustaceans suggests a dynamics that follows a "domino days spreading'' branching process in which successive amplifications may interact positively.	[Piednoel, Mathieu; Donnart, Tifenn; Esnault, Caroline; Graca, Paula; Higuet, Dominique; Bonnivard, Eric] Univ Paris 06, Equipe Genet & Evolut, UMR Systemat Adaptat Evolut 7138, Paris, France; [Piednoel, Mathieu] Univ Munich LMU, Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Munich	Bonnivard, E (corresponding author), Univ Paris 06, Equipe Genet & Evolut, UMR Systemat Adaptat Evolut 7138, Paris, France.	eric.bonnivard@upmc.fr	Camarinha-Matos, Luis/D-5011-2009; Esnault, Caroline/C-7221-2015	Camarinha-Matos, Luis/0000-0003-0594-1961; 				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arkhipova IR, 2006, SYST BIOL, V55, P875, DOI 10.1080/10635150601077683; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bonnivard E, 2009, GENOME, V52, P524, DOI [10.1139/G09-027, 10.1139/g09-027]; Brookfield JF, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-67; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Capy P, 1997, GENETICA, V100, P63, DOI 10.1023/A:1018300721953; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; CASACUBERTA JM, 1993, NUCLEIC ACIDS RES, V21, P2087, DOI 10.1093/nar/21.9.2087; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Cottin D, 2010, MAR GENOM, V3, P71, DOI 10.1016/j.margen.2010.05.002; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; de la Chaux N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-154; de la Vega E, 2007, FISH SHELLFISH IMMUN, V23, P1072, DOI 10.1016/j.fsi.2007.05.001; Desbruyeres D., 1997, HDB DEEP SEA HYDROTH; Devic M, 1997, PLANT PHYSIOL BIOCH, V35, P331; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Dziak RP, 2002, SCIENCE, V296, P1406, DOI 10.1126/science.1072075; Fablet Marie, 2011, Biomol Concepts, V2, P333, DOI 10.1515/BMC.2011.035; Fedoroff NV, 1999, ANN NY ACAD SCI, V870, P251, DOI 10.1111/j.1749-6632.1999.tb08886.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025; FLAVELL AJ, 1992, NUCLEIC ACIDS RES, V20, P3639, DOI 10.1093/nar/20.14.3639; Gaill F, 2007, INTERRIDGE NEWS, V16; Gilbert C, 2010, M S-MED SCI, V26, P1025, DOI 10.1051/medsci/201026121025; Giribet G, 2012, ANNU REV ENTOMOL, V57, P167, DOI 10.1146/annurev-ento-120710-100659; Goodwin TJD, 2002, MOL GENET GENOMICS, V267, P481, DOI 10.1007/s00438-002-0679-0; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hizer SE, 2008, ANIM GENET, V39, P363, DOI 10.1111/j.1365-2052.2008.01739.x; Huang SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-242; Jollivet D, 2004, INTERRIDGE NEWS, V13, P20; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-44; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kelly LJ, 2011, CHROMOSOME RES, V19, P939, DOI 10.1007/s10577-011-9246-z; Koyama T, 2013, MAR BIOTECHNOL, V15, P115, DOI 10.1007/s10126-012-9474-z; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Llorens C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-41; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Melayah D, 2001, PLANT J, V28, P159, DOI 10.1046/j.1365-313X.2001.01141.x; Montagne N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-62; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Nogare DED, 2002, MOL BIOL EVOL, V19, P247, DOI 10.1093/oxfordjournals.molbev.a004078; Ohbayashi F, 1998, GENES GENET SYST, V73, P345, DOI 10.1266/ggs.73.345; Ohshima K, 2005, CYTOGENET GENOME RES, V110, P475, DOI 10.1159/000084981; Oliver KR, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-8; Oliver KR, 2009, BIOESSAYS, V31, P703, DOI 10.1002/bies.200800219; Pagan HJT, 2012, GENOME BIOL EVOL, V4, P575, DOI 10.1093/gbe/evs038; Peterson-Burch BD, 2002, MOL BIOL EVOL, V19, P1832, DOI 10.1093/oxfordjournals.molbev.a004008; Piednoel M, 2012, MOL BIOL EVOL, V29, P3601, DOI 10.1093/molbev/mss168; Piednoel M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-621; Piednoel M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-86; Piskurek O, 2011, MOL BIOL EVOL, V28, P2727, DOI 10.1093/molbev/msr115; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Ravaux J, 2003, J EXP BIOL, V206, P2345, DOI 10.1242/jeb.00419; Ravaux J, 2009, MAR ECOL PROG SER, V396, P153, DOI 10.3354/meps08293; Rees DJ, 2008, GENOME, V51, P159, DOI 10.1139/g07-108; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rho MN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-425; Rho MN, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp752; Rohr CJB, 2002, MOL BIOL EVOL, V19, P149, DOI 10.1093/oxfordjournals.molbev.a004067; Roy-Engel AM, 2012, FRONT BIOSCI-LANDMRK, V17, P1345, DOI 10.2741/3991; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarradin PM, 1999, CAH BIOL MAR, V40, P93; Sarrazin J, 2006, INTERRIDGE NEWS, V15, P24; Schon I, 2006, GENE, V371, P296, DOI 10.1016/j.gene.2005.12.007; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Sun C, 2012, GENOME BIOL EVOL, V4, P168, DOI 10.1093/gbe/evr139; Tagmount A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009327; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Terrat Y, 2009, CARACTERISATION RETR; Terrat Y, 2008, MOL GENET GENOMICS, V279, P63, DOI 10.1007/s00438-007-0295-0; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vieira C, 2002, MOL BIOL EVOL, V19, P1154, DOI 10.1093/oxfordjournals.molbev.a004173; VOYTAS DF, 1992, P NATL ACAD SCI USA, V89, P7124, DOI 10.1073/pnas.89.15.7124; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; YOSHIOKA K, 1992, GENE, V120, P191; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	88	13	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57675	10.1371/journal.pone.0057675	http://dx.doi.org/10.1371/journal.pone.0057675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469217	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900035
J	Carraro, DM; Folgueira, MAAK; Lisboa, BC; Olivieri, EH; Krepischi, AC; de Carvalho, AF; Mota, LD; Puga, RD; Maciel, MD; Michelli, RAD; de Lyra, EC; Grosso, SHG; Soares, FA; Achatz, MIADW; Brentani, H; Moreira, CA; Brentani, MM				Carraro, Dirce Maria; Azevedo Koike Folgueira, Maria Aparecida; Garcia Lisboa, Bianca Cristina; Ribeiro Olivieri, Eloisa Helena; Vitorino Krepischi, Ana Cristina; de Carvalho, Alex Fiorini; de Carvalho Mota, Louise Danielle; Puga, Renato David; Maciel, Maria do Socorro; Depieri Michelli, Rodrigo Augusto; de Lyra, Eduardo Carneiro; Giorgi Grosso, Stana Helena; Soares, Fernando Augusto; de Souza Waddington Achatz, Maria Isabel Alves; Brentani, Helena; Moreira-Filho, Carlos Alberto; Brentani, Maria Mitzi			Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil	PLOS ONE			English	Article							WOMEN LESS-THAN-35 YEARS; YOUNG-WOMEN; GENE-EXPRESSION; SURVIVAL; FEATURES; RISK; AGE; POPULATION; PREVALENCE; PROGNOSIS	Germline mutations in BRCA1, BRCA2 and TP53 genes have been identified as one of the most important disease-causing issues in young breast cancer patients worldwide. The specific defective biological processes that trigger germline mutation-associated and -negative tumors remain unclear. To delineate an initial portrait of Brazilian early-onset breast cancer, we performed an investigation combining both germline and tumor analysis. Germline screening of the BRCA1, BRCA2, CHEK2 (c.1100delC) and TP53 genes was performed in 54 unrelated patients <35 y; their tumors were investigated with respect to transcriptional and genomic profiles as well as hormonal receptors and HER2 expression/amplification. Germline mutations were detected in 12 out of 54 patients (22%) [7 in BRCA1 (13%), 4 in BRCA2 (7%) and one in TP53 (2%) gene]. A cancer familial history was present in 31.4% of the unrelated patients, from them 43.7% were carriers for germline mutation (37.5% in BRCA1 and in 6.2% in the BRCA2 genes). Fifty percent of the unrelated patients with hormone receptor-negative tumors carried BRCA1 mutations, percentage increasing to 83% in cases with familial history of cancer. Over-representation of DNA damage-, cellular and cell cycle-related processes was detected in the up-regulated genes of BRCA1/2-associated tumors, whereas cell and embryo development-related processes were over-represented in the up-regulated genes of BRCA1/2-negative tumors, suggesting distinct mechanisms driving the tumorigenesis. An initial portrait of the early-onset breast cancer patients in Brazil was generated pointing out that hormone receptor-negative tumors and positive familial history are two major risk factors for detection of a BRCA1 germline mutation. Additionally, the data revealed molecular factors that potentially trigger the tumor development in young patients.	[Carraro, Dirce Maria; Garcia Lisboa, Bianca Cristina; Ribeiro Olivieri, Eloisa Helena; de Carvalho, Alex Fiorini; de Carvalho Mota, Louise Danielle] AC Camargo Hosp, Lab Genom & Mol Biol, Sao Paulo, Brazil; [Azevedo Koike Folgueira, Maria Aparecida; Brentani, Maria Mitzi] Univ Sao Paulo, Fac Med, Radiol & Oncol Dept, Sao Paulo, Brazil; [Vitorino Krepischi, Ana Cristina] AC Camargo Hosp, Lab Struct Genom, Sao Paulo, Brazil; [Puga, Renato David] AC Camargo Hosp, Lab Bioinformat & Bioestat, Sao Paulo, Brazil; [Maciel, Maria do Socorro] AC Camargo Hosp, Dept Mastol, Sao Paulo, Brazil; [Depieri Michelli, Rodrigo Augusto] Hosp Canc Barretos, Dept Oncogenet, Sao Paulo, Brazil; [de Lyra, Eduardo Carneiro] IBCC, Dept Mastol, Sao Paulo, Brazil; [Soares, Fernando Augusto] AC Camargo Hosp, Dept Invest Pathol, Sao Paulo, Brazil; [de Souza Waddington Achatz, Maria Isabel Alves] AC Camargo Hosp, Dept Mol Oncogenet, Sao Paulo, Brazil; [Brentani, Helena] Univ Sao Paulo, Fac Med, Dept Psychiat, Sao Paulo, Brazil; [Moreira-Filho, Carlos Alberto] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Carraro, Dirce Maria; Vitorino Krepischi, Ana Cristina; de Souza Waddington Achatz, Maria Isabel Alves] Natl Inst Sci & Technol Oncogenom INCITO, Sao Paulo, Brazil	A.C.Camargo Cancer Center; Universidade de Sao Paulo; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Carraro, DM (corresponding author), AC Camargo Hosp, Lab Genom & Mol Biol, Sao Paulo, Brazil.	dirce.carraro@cipe.accamargo.org.br	Achatz, Maria Isabel/C-5751-2013; Krepischi, Ana C V/E-4976-2012; carraro, dirce/C-9179-2009; Lisboa, Bianca/N-6649-2013; Folgueira, Maria Aparecida A K/D-8288-2012; Brentani, Helena/G-6839-2011; moreira-filho, carlos alberto/J-2551-2014; Olivieri, Eloisa R/A-3484-2014; Folgueira, Maria Aparecida Koike/V-3139-2019; Brentani, Maria Mitzi/E-8017-2012; Cancer, Cepid/I-4384-2013	Achatz, Maria Isabel/0000-0001-6894-1219; Krepischi, Ana C V/0000-0003-2931-8605; carraro, dirce/0000-0001-5667-1418; Lisboa, Bianca/0000-0002-2687-5011; Folgueira, Maria Aparecida A K/0000-0001-9269-8052; Brentani, Helena/0000-0001-5192-4682; moreira-filho, carlos alberto/0000-0003-3433-4714; Olivieri, Eloisa R/0000-0001-7027-5550; Folgueira, Maria Aparecida Koike/0000-0001-9269-8052; Soares, Fernando/0000-0002-1212-9093; Soares, Fernando Augusto/0000-0003-1647-7842	National Institute of Science and Technology in Oncogenomics (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [FAPESP 2008/57887-9]; National Institute of Science and Technology in Oncogenomics (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [CNPq 573589/08-9]; Centro de Pesquisa, Inovacao e Difusao - CEPID [FAPESP 98/14335-2]; FAPESP [2009/10088-7]	National Institute of Science and Technology in Oncogenomics (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); National Institute of Science and Technology in Oncogenomics (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Centro de Pesquisa, Inovacao e Difusao - CEPID; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from the National Institute of Science and Technology in Oncogenomics (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP 2008/57887-9; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq 573589/08-9), Centro de Pesquisa, Inovacao e Difusao - CEPID (FAPESP 98/14335-2), and FAPESP 2009/10088-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Anders CK, 2011, CANCER-AM CANCER SOC, V117, P1602, DOI 10.1002/cncr.25746; Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Bacchi LM, 2010, BREAST, V19, P137, DOI 10.1016/j.breast.2010.01.002; Bayraktar S, 2011, BREAST CANCER RES TR, V130, P145, DOI 10.1007/s10549-011-1711-z; Bonadona V, 2005, GENE CHROMOSOME CANC, V43, P404, DOI 10.1002/gcc.20199; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brekelmans CTM, 2007, EUR J CANCER, V43, P867, DOI 10.1016/j.ejca.2006.12.009; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cancello G, 2010, ANN ONCOL, V21, P1974, DOI 10.1093/annonc/mdq072; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Colleoni M, 2002, ANN ONCOL, V13, P273, DOI 10.1093/annonc/mdf039; da Costa ECB, 2008, CANCER GENET CYTOGEN, V184, P62, DOI 10.1016/j.cancergencyto.2008.03.011; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; de Carvalho LV, 2010, REV ASSOC MED BRAS, V56, P278; Dutra MC, 2009, REV BRAS GINECOL OBS, V31, P54, DOI 10.1590/S0100-72032009000200002; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Fernandopulle SM, 2006, PATHOLOGY, V38, P219, DOI 10.1080/00313020600699268; Figueiredo JC, 2007, BREAST CANCER RES TR, V105, P69, DOI 10.1007/s10549-006-9433-3; Folgueira MAAK, 2005, CLIN CANCER RES, V11, P7434; Garritano S, 2010, HUM MUTAT, V31, P143, DOI 10.1002/humu.21151; Gentilini O, 2010, BREAST, V19, P55, DOI 10.1016/j.breast.2009.11.001; Ginsburg OM, 2009, FAM CANCER, V8, P563, DOI 10.1007/s10689-009-9287-z; Gomes MCB, 2007, BREAST CANCER RES TR, V103, P349, DOI 10.1007/s10549-006-9378-6; Gonzalez-Angulo AM, 2005, CANCER-AM CANCER SOC, V103, P2466, DOI 10.1002/cncr.21070; Haffty BG, 2009, ANN ONCOL, V20, P1653, DOI 10.1093/annonc/mdp051; Han W, 2010, BREAST CANCER RES TR, V119, P193, DOI 10.1007/s10549-009-0388-z; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Krepischi ACV, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3109; Lakhani SR, 2000, CLIN CANCER RES, V6, P782; Lalloo F, 2006, EUR J CANCER, V42, P1143, DOI 10.1016/j.ejca.2005.11.032; Loizidou M, 2007, CLIN GENET, V71, P165, DOI 10.1111/j.1399-0004.2007.00747.x; Lourenco JJ, 2004, GENET MOL BIOL, V27, P500, DOI 10.1590/S1415-47572004000400006; Oldenburg RA, 2006, CLIN CANCER RES, V12, P1693, DOI 10.1158/1078-0432.CCR-05-2230; Jacome GPO, 2010, J TOXICOL ENV HEAL A, V73, P858, DOI 10.1080/15287391003744773; Palacios J, 2005, BREAST CANCER RES TR, V90, P5, DOI 10.1007/s10549-004-1536-0; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peng RJ, 2011, BREAST, V20, P568, DOI 10.1016/j.breast.2011.07.012; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Robertson L, 2012, BRIT J CANCER, V106, P1234, DOI 10.1038/bjc.2012.31; Sidoni A, 2003, BREAST, V12, P247, DOI 10.1016/S0960-9776(03)00095-X; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Uhrhammer Nancy, 2008, Int J Med Sci, V5, P197; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Young SR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-86	50	58	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57581	10.1371/journal.pone.0057581	http://dx.doi.org/10.1371/journal.pone.0057581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469205	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100024
J	Caruana, G; Farlie, PG; Hart, AH; Bagheri-Fam, S; Wallace, MJ; Dobbie, MS; Gordon, CT; Miller, KA; Whittle, B; Abud, HE; Arkell, RM; Cole, TJ; Harley, VR; Smyth, IM; Bertram, JF				Caruana, Georgina; Farlie, Peter G.; Hart, Adam H.; Bagheri-Fam, Stefan; Wallace, Megan J.; Dobbie, Michael S.; Gordon, Christopher T.; Miller, Kerry A.; Whittle, Belinda; Abud, Helen E.; Arkell, Ruth M.; Cole, Timothy J.; Harley, Vincent R.; Smyth, Ian M.; Bertram, John F.			Genome-Wide ENU Mutagenesis in Combination with High Density SNP Analysis and Exome Sequencing Provides Rapid Identification of Novel Mouse Models of Developmental Disease	PLOS ONE			English	Article							DNA-LIGASE-I; ETHYL-N-NITROSOUREA; INDUCED MUTATIONS; BLEBBED PHENOTYPE; SEX DETERMINATION; CELL-DEVELOPMENT; HIGH-THROUGHPUT; FRASER-SYNDROME; SCREEN; GENE	Background: Mice harbouring gene mutations that cause phenotypic abnormalities during organogenesis are invaluable tools for linking gene function to normal development and human disorders. To generate mouse models harbouring novel alleles that are involved in organogenesis we conducted a phenotype-driven, genome-wide mutagenesis screen in mice using the mutagen N-ethyl-N-nitrosourea (ENU). Methodology/Principal Findings: ENU was injected into male C57BL/6 mice and the mutations transmitted through the germ-line. ENU-induced mutations were bred to homozygosity and G3 embryos screened at embryonic day (E) 13.5 and E18.5 for abnormalities in limb and craniofacial structures, skin, blood, vasculature, lungs, gut, kidneys, ureters and gonads. From 52 pedigrees screened 15 were detected with anomalies in one or more of the structures/organs screened. Using single nucleotide polymorphism (SNP)-based linkage analysis in conjunction with candidate gene or next-generation sequencing (NGS) we identified novel recessive alleles for Fras1, Ift140 and Lig1. Conclusions/Significance: In this study we have generated mouse models in which the anomalies closely mimic those seen in human disorders. The association between novel mutant alleles and phenotypes will lead to a better understanding of gene function in normal development and establish how their dysfunction causes human anomalies and disease.	[Caruana, Georgina; Farlie, Peter G.; Hart, Adam H.; Bagheri-Fam, Stefan; Abud, Helen E.; Harley, Vincent R.; Smyth, Ian M.; Bertram, John F.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Farlie, Peter G.; Gordon, Christopher T.; Miller, Kerry A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Craniofacial Dev Lab, Parkville, Vic 3052, Australia; [Bagheri-Fam, Stefan; Harley, Vincent R.] Prince Henrys Inst Med Res, Mol Genet & Dev Div, Clayton, Vic, Australia; [Wallace, Megan J.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Wallace, Megan J.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Dobbie, Michael S.; Whittle, Belinda] Australian Natl Univ, Australian Phen Facil, Canberra, ACT, Australia; [Arkell, Ruth M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Cole, Timothy J.; Smyth, Ian M.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Prince Henry's Institute of Medical Research; Monash University; Monash University; Australian National University; Australian National University; Monash University	Caruana, G (corresponding author), Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia.	georgina.caruana@monash.edu	Hart, Adam/C-1196-2011; Dobbie, Michael/AAY-7345-2021; arkell, ruth m/D-1525-2009; Arkell, Ruth/AAR-8471-2021; Harley, Vincent/B-8092-2018; Gordon, Chris/F-1267-2017; Bertram, John F/I-2588-2014	Hart, Adam/0000-0001-8129-3877; arkell, ruth m/0000-0002-6213-7323; Arkell, Ruth/0000-0002-6213-7323; Harley, Vincent/0000-0002-2405-1262; Gordon, Chris/0000-0002-9300-8399; Bertram, John F/0000-0001-5863-6464; Abud, Helen/0000-0003-3792-4023; Wallace, Megan/0000-0001-5785-5120; Smyth, Ian/0000-0002-1727-7829	Australian Government's National Collaborative Research Infrastructure Strategy; Faculty of Medicine, Nursing and Health Sciences at Monash University; Victorian Government's Operational Infrastructure Support Program; NHMRC	Australian Government's National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Faculty of Medicine, Nursing and Health Sciences at Monash University; Victorian Government's Operational Infrastructure Support Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was enabled by the Australian Phenomics Network and partly supported by funding from the Australian Government's National Collaborative Research Infrastructure Strategy, a Strategic Grant from the Faculty of Medicine, Nursing and Health Sciences at Monash University, and the Victorian Government's Operational Infrastructure Support Program. IS acknowledges support through the NH&MRC R. Douglas Wright and ARC Future Fellowship schemes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2007, AM J PHYSIOL-RENAL, V292, pF1560, DOI 10.1152/ajprenal.00213.2006; Anderson KV, 2000, TRENDS GENET, V16, P99, DOI 10.1016/S0168-9525(99)01921-6; Anderson NM, 2012, EXP HEMATOL, V40, P48, DOI 10.1016/j.exphem.2011.09.007; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Ashe A, 2012, HUM MOL GENET, V21, P1808, DOI 10.1093/hmg/ddr613; Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; Bogani D, 2005, P NATL ACAD SCI USA, V102, P12477, DOI 10.1073/pnas.0500584102; Bogani D, 2004, GENESIS, V40, P109, DOI 10.1002/gene.20071; Boles MK, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-12; Brown FC, 2012, BLOOD CELLS MOL DIS, V2012; Buac K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000177; Cameron DA, 2009, DEV DYNAM, V238, P1140, DOI 10.1002/dvdy.21926; Ching YH, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-106; Clark AT, 2004, BIOL REPROD, V70, P1317, DOI 10.1095/biolreprod.103.020628; Clark AT, 2004, GENETICA, V122, P51, DOI 10.1007/s10709-004-1436-6; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Ermakov A, 2009, DEV DYNAM, V238, P581, DOI 10.1002/dvdy.21874; Fairfield H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r86; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Gimpel C, 2010, PEDIATR NEPHROL, V25, P1679, DOI 10.1007/s00467-010-1523-0; Hagarman JA, 2009, GENESIS, V47, P392, DOI 10.1002/dvg.20510; Hentges KE, 2006, GENE EXPR PATTERNS, V6, P653, DOI 10.1016/j.modgep.2005.11.015; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Hooper SB, 2006, CLIN EXP PHARMACOL P, V33, P273, DOI 10.1111/j.1440-1681.2006.04358.x; Hooper SB, 2004, LUNG DEV AGING ENV, P131; Hoyne GF, 2006, IMMUNOL REV, V210, P27, DOI 10.1111/j.0105-2896.2006.00363.x; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kamp A, 2010, HUM MOL GENET, V19, P3105, DOI 10.1093/hmg/ddq211; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kennedy CL, 2005, MOL HUM REPROD, V11, P871, DOI 10.1093/molehr/gah251; Kerecuk L, 2008, NAT CLIN PRACT NEPHR, V4, P312, DOI 10.1038/ncpneph0807; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Matera I, 2008, HUM MOL GENET, V17, P2118, DOI 10.1093/hmg/ddn110; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Miyazaki Y, 2003, PEDIATR INT, V45, P598, DOI 10.1046/j.1442-200X.2003.01777.x; Munger SC, 2009, GENE DEV, V23, P2521, DOI 10.1101/gad.1835809; Nhung N, 2011, AM J PHYSIOL-GASTR L, V300, pG1, DOI 10.1152/ajpgi.00343.2010; O'Sullivan Gerard J, 2006, Drug Discov Today Technol, V3, P173, DOI 10.1016/j.ddtec.2006.06.005; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Patterson VL, 2009, HUM MOL GENET, V18, P1719, DOI 10.1093/hmg/ddp075; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Pieles G, 2007, J ANAT, V211, P132, DOI 10.1111/j.1469-7580.2007.00746.x; Rastan S, 2004, GENETICA, V122, P47, DOI 10.1007/s10709-004-1930-x; Sabrautzki S, 2012, MAMM GENOME, V23, P416, DOI 10.1007/s00335-012-9397-z; Sandell LL, 2011, GENESIS, V49, P342, DOI 10.1002/dvg.20727; Smyth I, 2005, HUM MOL GENET, V14, pR269, DOI 10.1093/hmg/ddi262; Srivastava AK, 2003, BONE, V33, P179, DOI 10.1016/S8756-3282(03)00156-X; Stottmann RW, 2011, GENETICS, V188, P615, DOI 10.1534/genetics.111.126862; Sun M, 2012, G3-GENES GENOM GENET, V2, P143, DOI 10.1534/g3.111.001669; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Takahasi KR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-52; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; Wansleeben C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019357; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; WHO, 2003, WHO REG M CRAN AN BA; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Woolf AS, 2004, J AM SOC NEPHROL, V15, P998, DOI 10.1097/01.ASN.0000113778.06598.6F; Yu Q, 2004, DEVELOPMENT, V131, P6211, DOI 10.1242/dev.01543; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P3219, DOI 10.1073/pnas.0813400106; Zohn IE, 2005, BIRTH DEFECTS RES A, V73, P583, DOI 10.1002/bdra.20164	71	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e55429	10.1371/journal.pone.0055429	http://dx.doi.org/10.1371/journal.pone.0055429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469164	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100005
J	Cheang, CC; Tsang, LM; Chu, KH; Cheng, IJ; Chan, BKK				Cheang, Chi Chiu; Tsang, Ling Ming; Chu, Ka Hou; Cheng, I-Jiunn; Chan, Benny K. K.			Host-Specific Phenotypic Plasticity of the Turtle Barnacle Chelonibia testudinaria: A Widespread Generalist Rather than a Specialist	PLOS ONE			English	Article							ACORN BARNACLE; TETRACLITA-JAPONICA; WAVE-EXPOSURE; GENOME-SCAN; SEA-TURTLE; CIRRIPEDIA; DIFFERENTIATION; SPECIATION; CORAL; LENGTH	Turtle barnacles are common epibionts on marine organisms. Chelonibia testudinaria is specific on marine turtles whereas C. patula is a host generalist, but rarely found on turtles. It has been questioned why C. patula, being abundant on a variety of live substrata, is almost absent from turtles. We evaluated the genetic (mitochondrial COI, 16S and 12S rRNA, and amplified fragment length polymorphism (AFLP)) and morphological differentiation of C. testudinaia and C. patula from different hosts, to determine the mode of adaptation exhibited by Chelonibia species on different hosts. The two taxa demonstrate clear differences in shell morphology and length of 4-6 th cirri, but very similar in arthropodal characters. Moreover, we detected no genetic differentiation in mitochondrial DNA and AFLP analyses. Outlier detection infers insignificant selection across loci investigated. Based on combined morphological and molecular evidence, we proposed that C. testudinaria and C. patula are conspecific, and the two morphs with contrasting shell morphologies and cirral length found on different host are predominantly shaped by developmental plasticity in response to environmental setting on different hosts. Chelonibia testudinaria is, thus, a successful general epibiotic fouler and the phenotypic responses postulated can increase the fitness of the animals when they attach on hosts with contrasting life-styles.	[Cheang, Chi Chiu; Chan, Benny K. K.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Cheang, Chi Chiu; Tsang, Ling Ming; Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Simon FS Li Marine Sci Lab, Shatin, Hong Kong, Peoples R China; [Cheng, I-Jiunn] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan	Academia Sinica - Taiwan; Chinese University of Hong Kong; National Taiwan Ocean University	Chan, BKK (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	chankk@gate.sinica.edu.tw	Cheang, Chi Chiu/C-3064-2013; Chu, Ka Hou/B-8010-2011; Tsang, Ling Ming/Q-7628-2018	Cheang, Chi Chiu/0000-0003-3554-6647; Chu, Ka Hou/0000-0001-8107-5415; Tsang, Ling Ming/0000-0002-5029-5690; Chan, Benny/0000-0001-9479-024X	National Science Council [NSC-99-2621-B-001-007-MY3]; Career Development Award, Academia Sinica [AS-98-CDA-L15]; Group Research Scheme of the Research Committee, the Chinese University of Hong Kong	National Science Council(Ministry of Science and Technology, Taiwan); Career Development Award, Academia Sinica; Group Research Scheme of the Research Committee, the Chinese University of Hong Kong	BKK Chan would like to acknowledge the support of a research grant from the National Science Council (NSC-99-2621-B-001-007-MY3) and Career Development Award, Academia Sinica (AS-98-CDA-L15). KH Chu is supported by a grant from the Group Research Scheme of the Research Committee, the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; Chan BKK, 2008, J ZOOL, V275, P294, DOI 10.1111/j.1469-7998.2008.00441.x; Chan BKK, 2007, B MAR SCI, V81, P101; Chan BKK, 2007, ZOOL STUD, V46, P46; Chan BKK, 2005, J CRUSTACEAN BIOL, V25, P329, DOI 10.1651/C-2535; Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crandall KA, 1996, SYST BIOL, V45, P1; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; Dai A., 1991, P1; Darwin C., 1854, MONOGRAPH SUBCLASS C; Espinoza EO, 2007, ARCHAEOMETRY, V49, P685, DOI 10.1111/j.1475-4754.2007.00328.x; ESPINOZA J, 1987, J EXP MAR BIOL ECOL, V110, P183, DOI 10.1016/0022-0981(87)90027-X; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foll M., 2010, BAYESCAN V2 0 USER M; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRAZIER JG, 1990, CRUSTACEANA, V59, P213, DOI 10.1163/156854090X00688; FRICK M.G., 2001, MAR TURT NEWSL, V94, P16; Ge DY, 2011, P ROY SOC B-BIOL SCI, V278, P2133, DOI 10.1098/rspb.2010.1500; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Glen F, 2001, J MAR BIOL ASSOC UK, V81, P683, DOI 10.1017/S0025315401004374; Hayashi R, 2012, J MAR BIOL ASS UK; Hayashi R, 2008, ECOL RES, V23, P121, DOI 10.1007/s11284-007-0349-0; JOHANNESSON K, 1993, EVOLUTION, V47, P1770, DOI 10.1111/j.1558-5646.1993.tb01268.x; Josileen J, 2005, CRUSTACEANA, V78, P1, DOI 10.1163/1568540054024556; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitsos MS, 2003, CRUSTACEANA, V76, P403, DOI 10.1163/156854003322033816; Li NK, 2004, BIOL BULL-US, V206, P121, DOI 10.2307/1543635; LIVELY CM, 1986, EVOLUTION, V40, P232, DOI 10.1111/j.1558-5646.1986.tb00466.x; Lively CM, 2000, ECOLOGY, V81, P1240, DOI 10.1890/0012-9658(2000)081[1240:PIDVFI]2.0.CO;2; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Marchinko KB, 2003, ZOOLOGY, V106, P127, DOI 10.1078/0944-2006-00107; Marchinko KB, 2003, EVOLUTION, V57, P1281; MATHER K, 1976, HEREDITY, V36, P41, DOI 10.1038/hdy.1976.4; Mokady O, 2001, MOL BIOL EVOL, V18, P975, DOI 10.1093/oxfordjournals.molbev.a003898; Mokady O, 1999, J MOL EVOL, V49, P367, DOI 10.1007/PL00006560; Mokady Ofer, 1994, Molecular Marine Biology and Biotechnology, V3, P158; MONROE R, 1979, CRUSTACEANA, V36, P108, DOI 10.1163/156854079X00267; Newman W.A., 1976, REVISION BALANOMORPH; Parsons KE, 1997, OECOLOGIA, V110, P461, DOI 10.1007/s004420050181; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANGUAGE ENV STAT; Rawson PD, 2003, MOL ECOL, V12, P2697, DOI 10.1046/j.1365-294X.2003.01940.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross A, 1967, EOCENE BALANIDAE FLO; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schmidt PS, 1999, EVOLUTION, V53, P135, DOI 10.1111/j.1558-5646.1999.tb05339.x; Schmidt PS, 2000, P ROY SOC B-BIOL SCI, V267, P379, DOI 10.1098/rspb.2000.1012; SEIGEL RA, 1983, AM MIDL NAT, V109, P34, DOI 10.2307/2425512; Stamatakis A, 2005, RAXML OMP EFFICIENT; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; Tsang LM, 2008, MOL ECOL, V17, P4151, DOI 10.1111/j.1365-294X.2008.03907.x; Tsang LM, 2009, MOL ECOL, V18, P1463, DOI 10.1111/j.1365-294X.2009.04090.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; VEKEMANS X, 2002, AFLP SURV VERSION 1; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x; Williams LM, 2011, MOL BIOL EVOL, V28, P1817, DOI 10.1093/molbev/msr004; Wood HM, 2008, MOL ECOL, V17, P3123, DOI 10.1111/j.1365-294X.2008.03755.x; Zardus JD, 2004, J CRUSTACEAN BIOL, V24, P409, DOI 10.1651/C-2476	69	42	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57592	10.1371/journal.pone.0057592	http://dx.doi.org/10.1371/journal.pone.0057592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469208	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100026
J	Pedersen, DJ; Diakanastasis, B; Stockli, J; Schmitz-Peiffer, C				Pedersen, David J.; Diakanastasis, Barbara; Stoeckli, Jacqueline; Schmitz-Peiffer, Carsten			Protein Kinase C epsilon Modulates Insulin Receptor Localization and Trafficking in Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							PKC-EPSILON; INHIBITION; CELLS; LIVER; CEACAM1; ENDOCYTOSIS; CLEARANCE; MUSCLE	We have previously shown that deletion of protein kinase C epsilon (PKC epsilon) in mice results in protection against glucose intolerance caused by a high fat diet. This was in part due to reduced insulin uptake by hepatocytes and insulin clearance, which enhanced insulin availability. Here we employed mouse embryonic fibroblasts (MEFs) derived from wildtype (WT) and PKC epsilon-deficient (PKC epsilon(-/-)) mice to examine this mechanistically. PKC epsilon(-/-) MEFs exhibited reduced insulin uptake which was associated with decreased insulin receptor phosphorylation, while downstream signalling through IRS-1 and Akt was unaffected. Cellular fractionation demonstrated that PKC epsilon deletion changed the localization of the insulin receptor, a greater proportion of which co-fractionated with flotillin-1, a marker of membrane microdomains. Insulin stimulation resulted in redistribution of the receptor in WT cells, while this was markedly reduced in PKC epsilon(-/-) cells. These alterations in insulin receptor trafficking were associated with reduced expression of CEACAM1, a receptor substrate previously shown to modulate insulin clearance. Virally-mediated reconstitution of PKC epsilon in MEFs increased CEACAM1 expression and partly restored the sensitivity of the receptor to insulin-stimulated redistribution. These data indicate that PKC epsilon can affect insulin uptake in MEFs through promotion of receptor-mediated endocytosis, and that this may be mediated by regulation of CEACAM1 expression.	[Pedersen, David J.; Diakanastasis, Barbara; Stoeckli, Jacqueline; Schmitz-Peiffer, Carsten] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW, Australia; [Stoeckli, Jacqueline; Schmitz-Peiffer, Carsten] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Schmitz-Peiffer, C (corresponding author), Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW, Australia.	c.schmitz-peiffer@garvan.org.au	Stoeckli, Jacqueline/Z-4443-2019; Stoeckli, Jacqueline/D-7053-2016	Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350	National Health and Medical Research Council of Australia [535917, 481387]; Diabetes Australia Research Trust [Y11-SCHC]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by funding from the National Health and Medical Research Council of Australia (project grant 535917 to CSP; postgraduate training scholarship 481387 to DJP) and the Diabetes Australia Research Trust (general research grant (Y11-SCHC to CSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberger AM, 2006, CARCINOGENESIS, V27, P483, DOI 10.1093/carcin/bgi275; Bergman RN, 2000, DIABETOLOGIA, V43, P946, DOI 10.1007/s001250051474; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Cazzolli R, 2002, AM J PHYSIOL-ENDOC M, V282, pE1204, DOI 10.1152/ajpendo.00487.2001; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Formisano P, 1998, J BIOL CHEM, V273, P13197, DOI 10.1074/jbc.273.21.13197; Kampfer S, 1998, EMBO J, V17, P4046, DOI 10.1093/emboj/17.14.4046; Najjar SM, 1998, J BIOL CHEM, V273, P12923, DOI 10.1074/jbc.273.21.12923; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Raddatz K, 2011, DIABETOLOGIA, V54, P1447, DOI 10.1007/s00125-011-2073-0; Rubio ME, 2008, NEUROSCIENCE, V154, P99, DOI 10.1016/j.neuroscience.2007.12.016; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012	17	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58046	10.1371/journal.pone.0058046	http://dx.doi.org/10.1371/journal.pone.0058046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469261	gold, Green Submitted, Green Published			2022-12-27	WOS:000315897100058
J	Herrera, VL; Pasion, KA; Tan, GA; Ruiz-Opazo, N				Herrera, Victoria L.; Pasion, Khristine A.; Tan, Glaiza A.; Ruiz-Opazo, Nelson			Dahl (S x R) Rat Congenic Strain Analysis Confirms and Defines a Chromosome 17 Spatial Navigation Quantitative Trait Locus to < 10 Mbp	PLOS ONE			English	Article							RECOGNITION MEMORY	A quantitative trait locus (QTL) linked with ability to find a platform in the Morris Water Maze (MWM) was located on chromosome 17 (Nav-5 QTL) using intercross between Dahl S and Dahl R rats. We developed two congenic strains, S.R17A and S.R17B introgressing Dahl R-chromosome 17 segments into Dahl S chromosome 17 region spanning putative Nav-5 QTL. Performance analysis of S.R17A, S.R17B and Dahl S rats in the Morris water maze (MWM) task showed a significantly decreased spatial navigation performance in S.R17B congenic rats when compared with Dahl S controls (P = 0.02). The S.R17A congenic segment did not affect MWM performance delimiting Nav-5 to the chromosome 17 65.02-74.66 Mbp region. Additional fine mapping is necessary to identify the specific gene variant accounting for Nav-5 effect on spatial learning and memory in Dahl rats.	[Herrera, Victoria L.; Pasion, Khristine A.; Tan, Glaiza A.; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA	Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.	nruizo@bu.edu		Ruiz-Opazo, Nelson/0000-0001-8234-1332; Herrera, Victoria/0000-0001-8991-2134	NIH [RO1 HL086532]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086532] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH grant RO1 HL086532 to N.R-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Deng AY, 2001, MAMM GENOME, V12, P612, DOI 10.1007/s00335-001-2054-6; Duke LM, 2000, NEUROPSYCHOL REV, V10, P75, DOI 10.1023/A:1009096603879; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; LAI ZC, 1995, NEUROBIOL AGING, V16, P947, DOI 10.1016/0197-4580(95)02014-4; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; MARKOWSKA AL, 1989, NEUROBIOL AGING, V10, P31, DOI 10.1016/S0197-4580(89)80008-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Panegyres PK, 2004, QJM-INT J MED, V97, P555, DOI 10.1093/qjmed/hch096; Rapp PR, 1997, NEUROREPORT, V8, P1923, DOI 10.1097/00001756-199705260-00026; Ruiz-Opazo N, 2004, MOL MED, V10, P36, DOI 10.2119/2003-00044.Herrera; Ruiz-Opazo N, 2004, PHYSIOL GENOMICS, V16, P329, DOI 10.1152/physiolgenomics.00162.2003; Ruiz-Opazo N, 2004, HYPERTENSION, V43, P797, DOI 10.1161/01.HYP.0000120153.04064.8d; Ruiz-Opazo N, 2006, PHYSIOL GENOMICS, V26, P145, DOI 10.1152/physiolgenomics.00019.2006; UTTL B, 1993, PSYCHOL AGING, V8, P257, DOI 10.1037/0882-7974.8.2.257; Wilkniss SM, 1997, PSYCHOL AGING, V12, P372, DOI 10.1037/0882-7974.12.2.372; Wu PR, 2011, CELL DEATH DIFFER, V18, P1507, DOI 10.1038/cdd.2011.2; Yu WD, 2012, HUM MOL GENET, V21, P1384, DOI 10.1093/hmg/ddr576	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58280	10.1371/journal.pone.0058280	http://dx.doi.org/10.1371/journal.pone.0058280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469157	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900248
J	Rossi, EA; Achtman, RL; Guidon, A; Williams, DR; Roorda, A; Bavelier, D; Carroll, J				Rossi, Ethan A.; Achtman, Rebecca L.; Guidon, Arnaud; Williams, David R.; Roorda, Austin; Bavelier, Daphne; Carroll, Joseph			Visual Function and Cortical Organization in Carriers of Blue Cone Monochromacy	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; GANGLION-CELL DENSITY; RETINOTOPIC ORGANIZATION; CHROMATIC ABERRATION; CONTRAST SENSITIVITY; MAGNIFICATION FACTOR; HUMAN RETINA; GENE ARRAY; HUMAN-EYE; CORTEX	Carriers of blue cone monochromacy have fewer cone photoreceptors than normal. Here we examine how this disruption at the level of the retina affects visual function and cortical organization in these individuals. Visual resolution and contrast sensitivity was measured at the preferred retinal locus of fixation and visual resolution was tested at two eccentric locations (2.5 degrees and 8 degrees) with spectacle correction only. Adaptive optics corrected resolution acuity and cone spacing were simultaneously measured at several locations within the central fovea with adaptive optics scanning laser ophthalmoscopy (AOSLO). Fixation stability was assessed by extracting eye motion data from AOSLO videos. Retinotopic mapping using fMRI was carried out to estimate the area of early cortical regions, including that of the foveal confluence. Without adaptive optics correction, BCM carriers appeared to have normal visual function, with normal contrast sensitivity and visual resolution, but with AO-correction, visual resolution was significantly worse than normal. This resolution deficit is not explained by cone loss alone and is suggestive of an associated loss of retinal ganglion cells. However, despite evidence suggesting a reduction in the number of retinal ganglion cells, retinotopic mapping showed no reduction in the cortical area of the foveal confluence. These results suggest that ganglion cell density may not govern the foveal overrepresentation in the cortex. We propose that it is not the number of afferents, but rather the content of the information relayed to the cortex from the retina across the visual field that governs cortical magnification, as under normal viewing conditions this information is similar in both BCM carriers and normal controls.	[Rossi, Ethan A.; Roorda, Austin] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Achtman, Rebecca L.; Guidon, Arnaud; Bavelier, Daphne] Univ Rochester, Rochester Ctr Brain Imaging, Rochester, NY USA; [Williams, David R.; Bavelier, Daphne] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Williams, David R.; Bavelier, Daphne] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Guidon, Arnaud] Duke Univ, Brain Imaging & Anal Ctr, Durham, NC USA; [Carroll, Joseph] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Carroll, Joseph] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Carroll, Joseph] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	University of California System; University of California Berkeley; University of Rochester; University of Rochester; University of Rochester; Duke University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Rossi, EA (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.	erossi@cvs.rochester.edu	Rossi, Ethan/A-7933-2013; Rossi, Ethan/AAC-6204-2019	Rossi, Ethan/0000-0003-3210-0551; Rossi, Ethan/0000-0003-3210-0551; Bavelier, Daphne/0000-0002-5904-1240; Williams, David R/0000-0003-3227-8333	NIH [P30EY001319, R01EY014375, P30EY001931, R01EY017607, RO1EY016880]; Research to Prevent Blindness; NSF Center for Adaptive Optics [AST-9876783]; NATIONAL EYE INSTITUTE [R01EY016880, P30EY001319, P30EY001931, R01EY017607, R01EY014375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NSF Center for Adaptive Optics; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH Grant's P30EY001319, R01EY014375, P30EY001931, R01EY017607, RO1EY016880, unrestricted departmental grants from Research to Prevent Blindness, and the NSF Center for Adaptive Optics under cooperative agreement AST-9876783 managed by UC Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2003, J NEUROSCI, V23, P3771; *AM NAT STAND I, 2000, AM NAT STAND SAF US; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Ayyagari R, 1999, MOL VIS, V5; AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; BARON WS, 1973, J OPT SOC AM, V63, P212, DOI 10.1364/JOSA.63.000212; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; Bennett A.G., 1989, CLIN VISUAL OPTICS, V2nd ed.; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; BERSON EL, 1986, AM J OPHTHALMOL, V102, P254, DOI 10.1016/0002-9394(86)90154-6; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; Carroll J, 2010, VISION RES, V50, P1989, DOI 10.1016/j.visres.2010.07.009; Carroll J, 2002, J VISION, V2, DOI 10.1167/2.8.1; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; GOTTLOB I, 1994, INVEST OPHTH VIS SCI, V35, P3556; Grieve K, 2006, OPT EXPRESS, V14, P12230, DOI 10.1364/OE.14.012230; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Krill A, 1977, KRILLS HEREDITARY RE, VII, P355; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Mizrahi-Meissonnier L, 2010, INVEST OPHTH VIS SCI, V51, P3884, DOI 10.1167/iovs.09-4592; NATHANS J, 1993, AM J HUM GENET, V53, P987; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POKORNY J., 1979, CONGENITAL ACQUIRED; Polyak S. L., 1941, RETINA-J RET VIT DIS; Popovic Z, 2001, VISION RES, V41, P1313, DOI 10.1016/S0042-6989(00)00290-X; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; Rossi EA, 2007, J VISION, V7, DOI 10.1167/7.8.14; Rossi EA, 2010, J VISION, V10, DOI 10.1167/10.12.11; Rossi EA, 2010, NAT NEUROSCI, V13, P156, DOI 10.1038/nn.2465; Schneider KA, 2004, J NEUROSCI, V24, P8975, DOI 10.1523/JNEUROSCI.2413-04.2004; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SIMONET P, 1990, VISION RES, V30, P187, DOI 10.1016/0042-6989(90)90035-J; SPIVEY B E, 1964, Doc Ophthalmol, V18, P367, DOI 10.1007/BF00160588; Steinman RM, 2003, SPATIAL VISION, V16, P225, DOI 10.1163/156856803322467509; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; STENSAAS SS, 1974, J NEUROSURG, V40, P747, DOI 10.3171/jns.1974.40.6.0747; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; THIBOS LN, 1990, VISION RES, V30, P33, DOI 10.1016/0042-6989(90)90126-6; von dem Hagen EAH, 2005, EUR J NEUROSCI, V22, P2475, DOI 10.1111/j.1460-9568.2005.04433.x; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; WASSLE H, 1990, VISION RES, V30, P1897, DOI 10.1016/0042-6989(90)90166-I; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WESTHEIMER G, 1982, VISION RES, V22, P157, DOI 10.1016/0042-6989(82)90177-8; WESTHEIMER G, 1975, J OPT SOC AM, V65, P847, DOI 10.1364/JOSA.65.000847; WESTHEIMER G, 2003, ADLERS PHYSL EYE CLI, P453; Wildsoet C.F., 1993, CLIN EXP OPTOM, V76, P119; WILLIAMS D, 1993, P NATL ACAD SCI USA, V90, P9770, DOI 10.1073/pnas.90.21.9770; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; ZHANG XX, 1991, OPTOMETRY VISION SCI, V68, P456, DOI 10.1097/00006324-199106000-00007; ZHANG XX, 1993, J OPT SOC AM A, V10, P213, DOI 10.1364/JOSAA.10.000213; Zhang Y, 2006, J BIOMEDICAL OPTICS, V11; Zhang YH, 2006, OPT LETT, V31, P1268, DOI 10.1364/OL.31.001268; Zworykin VP, 1981, ARCH ANAT HISTOL EMB, V10; Zworykin VP, 1980, ARCH ANAT HISTOL EMB, V3	67	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57956	10.1371/journal.pone.0057956	http://dx.doi.org/10.1371/journal.pone.0057956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469117	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900211
J	Burri, A; Maercker, A; Krammer, S; Simmen-Janevska, K				Burri, Andrea; Maercker, Andreas; Krammer, Sandy; Simmen-Janevska, Keti			Childhood Trauma and PTSD Symptoms Increase the Risk of Cognitive Impairment in a Sample of Former Indentured Child Laborers in Old Age	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DEMENTIA; MEMORY; MOOD; NEUROBIOLOGY; PERFORMANCE; EXPERIENCES; DEPRESSION; INTERVIEW; VALIDITY	A growing body of evidence suggests a link between early childhood trauma, post-traumatic stress disorder (PTSD) and higher risk for dementia in old age. The aim of the present study was to investigate the association between childhood trauma exposure, PTSD and neurocognitive function in a unique cohort of former indentured Swiss child laborers in their late adulthood. To the best of our knowledge this is the first study ever conducted on former indentured child laborers and the first to investigate the relationship between childhood versus adulthood trauma and cognitive function. According to PTSD symptoms and whether they experienced childhood trauma (CT) or adulthood trauma (AT), participants (n = 96) were categorized as belonging to one of four groups: CT/PTSD+, CT/PTSD-, AT/PTSD+, AT/PTSD-. Information on cognitive function was assessed using the Structured Interview for Diagnosis of Dementia of Alzheimer Type, Multi-infarct Dementia and Dementia of other Etiology according to ICD-10 and DSM-III-R, the Mini-Mental State Examination, and a vocabulary test. Depressive symptoms were investigated as a potential mediator for neurocognitive functioning. Individuals screening positively for PTSD symptoms performed worse on all cognitive tasks compared to healthy individuals, independent of whether they reported childhood or adulthood adversity. When controlling for depressive symptoms, the relationship between PTSD symptoms and poor cognitive function became stronger. Overall, results tentatively indicate that PTSD is accompanied by cognitive deficits which appear to be independent of earlier childhood adversity. Our findings suggest that cognitive deficits in old age may be partly a consequence of PTSD or at least be aggravated by it. However, several study limitations need to considered. Consideration of cognitive deficits when treating PTSD patients and victims of lifespan trauma (even without a diagnosis of a psychiatric condition) is crucial. Furthermore, early intervention may prevent long-term deficits in memory function and development of dementia in adulthood.	[Burri, Andrea; Maercker, Andreas; Krammer, Sandy; Simmen-Janevska, Keti] Univ Zurich, Dept Psychol, Zurich, Switzerland	University of Zurich	Burri, A (corresponding author), Univ Zurich, Dept Psychol, Zurich, Switzerland.	andrea.burri@kcl.ac.uk; maercker@psychologie.uzh.ch	Maercker, Andreas/D-2814-2017	Maercker, Andreas/0000-0001-6925-3266; Burri, Andrea/0000-0002-4705-3551	Swiss National Science Foundation SNF [100014_124535]	Swiss National Science Foundation SNF(Swiss National Science Foundation (SNSF))	The authors acknowledge financial support from Swiss National Science Foundation SNF 100014_124535. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Bickel H, 2007, PSYCHIAT PRAX, V34, P139, DOI 10.1055/s-2006-951973; Bohnert KM, 2011, INT J METH PSYCH RES, V20, pE1, DOI 10.1002/mpr.331; Bremner JD, 1995, PSYCHIAT RES, V59, P97; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Busse A, 2002, Z GERONTOL GERIATR, V35, P565, DOI 10.1007/s00391-002-0068-7; Conover WJ, 1999, WILEY SERIES PROBABI, P592; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Dretsch MN, 2012, BRAIN BEHAV, V2, P357, DOI 10.1002/brb3.53; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forstmeier S, 2009, US NEUROLOGY, V5, P18; Gauggel S, 1999, Z KLIN PSYCHOL-FORSC, V28, P18, DOI 10.1026//0084-5345.28.1.18; Goodwin GM, 1997, J PSYCHOPHARMACOL, V11, P115, DOI 10.1177/026988119701100204; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Kuhlmann K, 2013, SEVERE CHILDHOOD TRA; Leuenberger LSM, 2008, VERSORGT VERGESSEN, P314; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maercker A, 2008, NERVENARZT, V79, P577, DOI 10.1007/s00115-008-2467-5; Maercker A, 2004, BRIT J PSYCHIAT, V184, P482, DOI 10.1192/bjp.184.6.482; Majer M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-61; McAllister-Williams RH, 1998, PSYCHOL MED, V28, P573, DOI 10.1017/S0033291798006680; Perlis ML, 2001, J SLEEP RES, V10, P93, DOI 10.1046/j.1365-2869.2001.00247.x; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Raven J.C., 1998, ADV PROGR MATRICES; Ravona-Springer R, 2011, J ALZHEIMERS DIS, V23, P709, DOI 10.3233/JAD-2010-101327; RUBINOW DR, 1984, ARCH GEN PSYCHIAT, V41, P279; Saigh PA, 2006, J ABNORM PSYCHOL, V115, P332, DOI 10.1037/0021-843X.115.2.332; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Siegrist P, 2010, TRAUMA GEWALT, V4, P208; Solas M, 2010, NEUROPSYCHOPHARMACOL, V35, P1664, DOI 10.1038/npp.2010.13; Steil A, 2000, POSTTRAUMATISCHE DIA; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Subica AM, 2012, SCHIZOPHR RES, V136, P104, DOI 10.1016/j.schres.2011.10.018; Tsolaki M, 2010, PSYCHIAT RES, V176, P51, DOI 10.1016/j.psychres.2009.06.001; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; World Health Organization, 2007, COMP INT DIAGN INT C; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yasik AE, 2007, BIOL PSYCHIAT, V61, P382, DOI 10.1016/j.biopsych.2006.06.005; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; ZAUDIG M, 1991, PSYCHOL MED, V21, P225, DOI 10.1017/S0033291700014811	45	58	60	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57826	10.1371/journal.pone.0057826	http://dx.doi.org/10.1371/journal.pone.0057826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098PO	23469076	gold, Green Accepted, Green Published			2022-12-27	WOS:000315561400047
J	Ferreira, MT; Manso, AS; Gaspar, P; Pinho, MG; Neves, AR				Ferreira, Maria Teresa; Manso, Ana S.; Gaspar, Paula; Pinho, Mariana G.; Neves, Ana Rute			Effect of Oxygen on Glucose Metabolism: Utilization of Lactate in Staphylococcus Aureus as Revealed by In Vivo NMR Studies	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ANAEROBIC GENE-EXPRESSION; LACTOCOCCUS-LACTIS; VIRULENCE GENES; DEHYDROGENASE; TRANSPORT; DEFICIENT; MANNITOL; KINETICS; STRAIN	The ability to successfully adapt to changing host conditions is crucial for full virulence of bacterial pathogens. Staphylococcus aureus has to cope with fluctuating oxygen concentrations during the course of infection. Hence, we studied the effect of oxygen on glucose metabolism in non-growing S. aureus COL-S cells by in vivo C-13-NMR. Glucose catabolism was probed at different oxygen concentrations in suspensions of cells grown aerobically (direct effects on metabolism) or anaerobically (transcriptional adjustment to oxygen deprivation). In aerobically-grown cells, the rate of glucose consumption diminished progressively with decreasing oxygen concentrations. Additionally, oxygen deprivation resulted in biphasic glucose consumption, with the second phase presenting a higher rate. The fructose-1,6-bisphosphate pool peaked while glucose was still abundant, but the transient maximum varied with the oxygen concentration. As oxygen became limiting mannitol/mannitol-1-phosphate were detected as products of glucose catabolism. Under anoxic conditions, accumulation of mannitol-1-phosphate ceased with the switch to higher glucose consumption rates, which implies the activation of a more efficient means by which NAD(+) can be regenerated. The distribution of end-products deriving from glucose catabolism was dramatically affected by oxygen: acetate increased and lactate decreased with the oxygen concentration; ethanol was formed only anaerobically. Moreover, oxygen promoted the energetically favourable conversion of lactate into acetate, which was particularly noticeable under fully oxygenated conditions. Interestingly, under aerobiosis growing S. aureus cells also converted lactate to acetate, used simultaneously glucose and lactate as substrates for growth, and grew considerably well on lactate-medium. We propose that the efficient lactate catabolism may endow S. aureus with a metabolic advantage in its ecological niche.	[Ferreira, Maria Teresa; Manso, Ana S.; Gaspar, Paula; Neves, Ana Rute] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Lact Acid Bacteria & Vivo NMR, Oeiras, Portugal; [Ferreira, Maria Teresa; Manso, Ana S.; Pinho, Mariana G.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Biol, Oeiras, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	Neves, AR (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.	rute@biosustain.dtu.dk	Ferreira, Teresa/C-9785-2012; Pinho, Mariana/B-9192-2008; Ferreira, Maria Teresa/F-7731-2015	Ferreira, Teresa/0000-0002-3900-1460; Pinho, Mariana/0000-0002-7132-8842; Ferreira, Maria Teresa/0000-0002-8446-5600	Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FEDER [PTDC/BIA-MIC/67845/2006, PTDC/BIA-MIC/099963/2008, PTDC/BIA-BCM/099152/2008, PEst-OE/EQB/LA0004/2011]; National NMR Network [REDE/1517/RMN/2005]; Programa Operacional Ciencia e Inovacao (POCTI); FCT [SFRH/BPD/31251/2006]	Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); National NMR Network; Programa Operacional Ciencia e Inovacao (POCTI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and FEDER, projects PTDC/BIA-MIC/67845/2006, PTDC/BIA-MIC/099963/2008, PTDC/BIA-BCM/099152/2008, and through grant PEst-OE/EQB/LA0004/2011. The NMR spectrometers are part of The National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010'' and FCT. P. Gaspar acknowledges FCT for the award of a post-doc grant (SFRH/BPD/31251/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Castro R, 2009, MOL MICROBIOL, V71, P795, DOI 10.1111/j.1365-2958.2008.06564.x; COLLINS FM, 1962, J GEN MICROBIOL, V29, P531, DOI 10.1099/00221287-29-3-531; EDWARDS KG, 1981, J BACTERIOL, V146, P1020, DOI 10.1128/JB.146.3.1020-1029.1981; Exley RM, 2007, INFECT IMMUN, V75, P1318, DOI 10.1128/IAI.01530-06; EZRA FS, 1983, BIOCHEMISTRY-US, V22, P3841, DOI 10.1021/bi00285a020; Ferain T, 1996, J BACTERIOL, V178, P7311, DOI 10.1128/jb.178.24.7311-7315.1996; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; FUTAI M, 1977, J BIOL CHEM, V252, P5820; GARDNER JF, 1962, J GEN MICROBIOL, V29, P157, DOI 10.1099/00221287-29-1-157; GARRARD W, 1968, J BACTERIOL, V95, P152, DOI 10.1128/JB.95.1.152-156.1968; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Gaspar P, 2004, APPL ENVIRON MICROB, V70, P1466, DOI 10.1128/AEM.70.3.1466-1474.2004; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; Gaupp R, 2010, J BACTERIOL, V192, P2385, DOI 10.1128/JB.01472-09; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; Goffin P, 2004, J BACTERIOL, V186, P6661, DOI 10.1128/JB.186.19.6661-6666.2004; Gould IM, 2009, INT J ANTIMICROB AG, V34, pS8, DOI 10.1016/S0924-8579(09)70542-4; Hecker M, 2010, INT J MED MICROBIOL, V300, P76, DOI 10.1016/j.ijmm.2009.10.006; Jojima T, 2010, APPL MICROBIOL BIOT, V87, P159, DOI 10.1007/s00253-010-2493-7; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Liang CG, 2011, PROTEOMICS, V11, P1915, DOI 10.1002/pmic.201000151; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Meyer H, 2010, ANAL BIOCHEM, V401, P250, DOI 10.1016/j.ab.2010.03.003; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Neves AR, 2000, EUR J BIOCHEM, V267, P3859, DOI 10.1046/j.1432-1327.2000.01424.x; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Nunez MF, 2002, BIOCHEM BIOPH RES CO, V290, P824, DOI 10.1006/bbrc.2001.6255; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Pereira SFF, 2007, J BACTERIOL, V189, P3525, DOI 10.1128/JB.00044-07; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; RIVERS DB, 1987, J GEN MICROBIOL, V133, P3159; SANTOS H, 1986, J MAGN RESON, V68, P345, DOI 10.1016/0022-2364(86)90251-9; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Stansen C, 2005, APPL ENVIRON MICROB, V71, P5920, DOI 10.1128/AEM.71.10.5920-5928.2005; STRASTERS KC, 1963, J GEN MICROBIOL, V33, P213, DOI 10.1099/00221287-33-2-213; Tynecka Z, 1999, RES MICROBIOL, V150, P555, DOI 10.1016/S0923-2508(99)00102-3	42	47	51	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58277	10.1371/journal.pone.0058277	http://dx.doi.org/10.1371/journal.pone.0058277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472168	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900114
J	Udofa, EA; Stringer, BW; Gade, P; Mahony, D; Buzza, MS; Kalvakolanu, DV; Antalis, TM				Udofa, Ekemini A.; Stringer, Brett W.; Gade, Padmaja; Mahony, Donna; Buzza, Marguerite S.; Kalvakolanu, Dhananjaya V.; Antalis, Toni M.			The Transcription Factor C/EBP-beta Mediates Constitutive and LPS-Inducible Transcription of Murine SerpinB2	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CCAAT/ENHANCER-BINDING-PROTEINS; STIMULATED HUMAN MONOCYTES; ALPHA-INDUCED APOPTOSIS; PAI-2 MESSENGER-RNA; PHORBOL ESTER; GENE-EXPRESSION; TYPE-2 GENE	SerpinB2 or plasminogen activator inhibitor type 2 (PAI-2) is highly induced in macrophages in response to inflammatory stimuli and is linked to the modulation of innate immunity, macrophage survival, and inhibition of plasminogen activators. Lipopolysaccharide (LPS), a potent bacterial endotoxin, can induce SerpinB2 expression via the toll-like receptor 4 (TLR4) by,similar to 1000-fold over a period of 24 hrs in murine macrophages. To map the LPS-regulated SerpinB2 promoter regions, we transfected reporter constructs driven by the similar to 5 kb 5'-flanking region of the murine SerpinB2 gene and several deletion mutants into murine macrophages. In addition, we compared the DNA sequence of the murine 59 flanking sequence with the sequence of the human gene for homologous functional regulatory elements and identified several regulatory cis-acting elements in the human SERPINB2 promoter conserved in the mouse. Mutation analyses revealed that a CCAAT enhancer binding (C/EBP) element, a cyclic AMP response element (CRE) and two activator protein 1 (AP-1) response elements in the murine SerpinB2 proximal promoter are essential for optimal LPS-inducibility. Electrophoretic mobility shift (EMSA) and chromatin immunoprecipitation (ChIP) assays demonstrated that LPS induces the formation of C/EBP- beta containing complexes with the SerpinB2 promoter. Importantly, both constitutive and LPS-induced SerpinB2 expression was severely abrogated in C/EBP-beta-null mouse embryonic fibroblasts (MEFs) and primary C/EBP-beta-deficient peritoneal macrophages. Together, these data provide new insight into C/EBP-beta-dependent regulation of inflammation-associated SerpinB2 expression.	[Udofa, Ekemini A.; Buzza, Marguerite S.; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Stringer, Brett W.; Mahony, Donna] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Gade, Padmaja; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Gade, Padmaja; Kalvakolanu, Dhananjaya V.; Antalis, Toni M.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; QIMR Berghofer Medical Research Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Antalis, TM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu	Stringer, Brett/GZB-1390-2022	Stringer, Brett/0000-0003-4552-9736; Riley, Ekemini/0000-0001-7040-5191	National Institutes of Health [CA-098369, CA-78282, CA-105005]; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [R56CA098369, R01CA105005, R01CA078282, R01CA098369, P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants CA-098369(TMA), CA-78282 (DVK), CA-105005 (DVK) and the National Health and Medical Research Council of Australia (TMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANTALIS TM, 1992, EUR J BIOCHEM, V205, P203, DOI 10.1111/j.1432-1033.1992.tb16769.x; ANTALIS TM, 1988, P NATL ACAD SCI USA, V85, P985, DOI 10.1073/pnas.85.4.985; Antalis TM, 1996, BLOOD, V88, P3686, DOI 10.1182/blood.V88.10.3686.bloodjournal88103686; ANTALIS TM, 1993, GENE, V134, P201, DOI 10.1016/0378-1119(93)90094-J; Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; BERGONZELLI GE, 1992, ENDOCRINOLOGY, V131, P1467, DOI 10.1210/en.131.3.1467; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; Bird P I, 1998, Results Probl Cell Differ, V24, P63; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2007, AM J PHYSIOL-CELL PH, V293, pC1788, DOI 10.1152/ajpcell.00141.2007; Chang S, 1999, J LEUKOCYTE BIOL, V66, P528, DOI 10.1002/jlb.66.3.528; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Costelloe EO, 1999, J LEUKOCYTE BIOL, V66, P172, DOI 10.1002/jlb.66.1.172; COUSIN E, 1991, NUCLEIC ACIDS RES, V19, P3881, DOI 10.1093/nar/19.14.3881; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Darnell GA, 2003, MOL CELL BIOL, V23, P6520, DOI 10.1128/MCB.23.18.6520-6532.2003; Dear AE, 1997, FEBS LETT, V402, P265, DOI 10.1016/S0014-5793(97)00002-1; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Dickinson JL, 1998, CELL DEATH DIFFER, V5, P163, DOI 10.1038/sj.cdd.4400324; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; GAN HX, 1995, J IMMUNOL, V155, P1304; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; HIBINO T, 1988, FEBS LETT, V231, P202, DOI 10.1016/0014-5793(88)80731-2; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jensen PJ, 1996, CELL GROWTH DIFFER, V7, P1793; Kalvakolanu DV, 2005, J INTERF CYTOK RES, V25, P757, DOI 10.1089/jir.2005.25.757; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; KUMAR S, 1991, J BIOL CHEM, V266, P20960; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lian XH, 2004, BIOL CELL, V96, P109, DOI 10.1016/j.biolcel.2003.09.007; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Maurer F, 1999, NUCLEIC ACIDS RES, V27, P1664, DOI 10.1093/nar/27.7.1664; Maurer F, 1996, J BIOL CHEM, V271, P26074, DOI 10.1074/jbc.271.42.26074; Medcalf RL, 2011, METHOD ENZYMOL, V499, P105, DOI 10.1016/B978-0-12-386471-0.00006-7; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Roy SK, 2005, J BIOL CHEM, V280, P24462, DOI 10.1074/jbc.M413661200; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; SAMIA JA, 1990, GENOMICS, V6, P159, DOI 10.1016/0888-7543(90)90461-3; SCHLEUNING WD, 1987, MOL CELL BIOL, V7, P4564, DOI 10.1128/MCB.7.12.4564; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schroder WA, 2010, PARASITE IMMUNOL, V32, P764, DOI 10.1111/j.1365-3024.2010.01241.x; Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; SCHUSTER WA, 1994, FIBRINOLYSIS, V8, P113, DOI 10.1016/S0268-9499(05)80028-1; SCHWARTZ BS, 1992, J BIOL CHEM, V267, P7089; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09; Shafren DR, 1999, J VIROL, V73, P7193, DOI 10.1128/JVI.73.9.7193-7198.1999; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Spooner CJ, 2007, CYTOKINE, V37, P119, DOI 10.1016/j.cyto.2007.03.001; Stasinopoulos S, 2010, FEBS J, V277, P1331, DOI 10.1111/j.1742-4658.2010.07563.x; Stringer B, 2012, J BIOL CHEM; Suzuki T, 2000, BLOOD, V96, P2584; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tierney MJ, 2001, J BIOL CHEM, V276, P13675, DOI 10.1074/jbc.M010627200; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Varro A, 2004, CANCER RES, V64, P1695, DOI 10.1158/0008-5472.CAN-03-2399; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; WEBB AC, 1987, J EXP MED, V166, P77, DOI 10.1084/jem.166.1.77; Xiao GW, 1999, P NATL ACAD SCI USA, V96, P3700, DOI 10.1073/pnas.96.7.3700; YE RD, 1987, J BIOL CHEM, V262, P3718; Yu H, 2002, BLOOD, V99, P2810, DOI 10.1182/blood.V99.8.2810	81	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57855	10.1371/journal.pone.0057855	http://dx.doi.org/10.1371/journal.pone.0057855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472114	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900053
J	Urao, N; Sudhahar, V; Kim, SJ; Chen, GF; McKinney, RD; Kojda, G; Fukai, T; Ushio-Fukai, M				Urao, Norifumi; Sudhahar, Varadarajan; Kim, Seok-Jo; Chen, Gin-Fu; McKinney, Ronald D.; Kojda, Georg; Fukai, Tohru; Ushio-Fukai, Masuko			Critical Role of Endothelial Hydrogen Peroxide in Post-Ischemic Neovascularization	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NADPH OXIDASE; BONE-MARROW; ANGIOTENSIN-II; GLUTATHIONE-PEROXIDASE; PROGENITOR CELLS; SMOOTH-MUSCLE; UP-REGULATION; MICE LACKING; ANGIOGENESIS	Background: Reactive oxygen species (ROS) play an important role in angiogenesis in endothelial cells (ECs) in vitro and neovascularization in vivo. However, little is known about the role of endogenous vascular hydrogen peroxide (H2O2) in postnatal neovascularization. Methodology/Principal Findings: We used Tie2-driven endothelial specific catalase transgenic mice (Cat-Tg mice) and hindlimb ischemia model to address the role of endogenous H2O2 in ECs in post-ischemic neovascularization in vivo. Here we show that Cat-Tg mice exhibit significant reduction in intracellular H2O2 in ECs, blood flow recovery, capillary formation, collateral remodeling with larger extent of tissue damage after hindlimb ischemia, as compared to wild-type (WT) littermates. In the early stage of ischemia-induced angiogenesis, Cat-Tg mice show a morphologically disorganized microvasculature. Vascular sprouting and tube elongation are significantly impaired in isolated aorta from Cat-Tg mice. Furthermore, Cat-Tg mice show a decrease in myeloid cell recruitment after hindlimb ischemia. Mechanistically, Cat-Tg mice show significant decrease in eNOS phosphorylation at Ser1177 as well as expression of redox-sensitive vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemotactic protein-1 (MCP-1) in ischemic muscles, which is required for inflammatory cell recruitment to the ischemic tissues. We also observed impaired endothelium-dependent relaxation in resistant vessels from Cat-Tg mice. Conclusions/Significance: Endogenous ECs-derived H2O2 plays a critical role in reparative neovascularization in response to ischemia by upregulating adhesion molecules and activating eNOS in ECs. Redox-regulation in ECs is a potential therapeutic strategy for angiogenesis-dependent cardiovascular diseases.	[Urao, Norifumi; Kim, Seok-Jo; McKinney, Ronald D.; Ushio-Fukai, Masuko] Univ Illinois, Dept Pharmacol, Ctr Lung & Vasc Biol, Cardiovasc Res Ctr, Chicago, IL 60607 USA; [Sudhahar, Varadarajan; Chen, Gin-Fu; Fukai, Tohru] Univ Illinois, Dept Med, Cardiovasc Res Ctr, Chicago, IL USA; [Sudhahar, Varadarajan; Chen, Gin-Fu; Fukai, Tohru] Univ Illinois, Dept Pharmacol, Cardiovasc Res Ctr, Chicago, IL USA; [Urao, Norifumi; Sudhahar, Varadarajan; McKinney, Ronald D.; Fukai, Tohru] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA; [Kojda, Georg] Univ Hosp Dusseldorf, Inst Pharmacol & Clin Pharmacol, Dusseldorf, Germany	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Ushio-Fukai, M (corresponding author), Univ Illinois, Dept Pharmacol, Ctr Lung & Vasc Biol, Cardiovasc Res Ctr, Chicago, IL 60607 USA.	mfukai@uic.edu	Varadarajan, Sudhahar/AAJ-6910-2021; Urao, Norifumi/O-7313-2015	Varadarajan, Sudhahar/0000-0002-9675-0097; Chen, Gin-Fu/0000-0003-2015-9943; Urao, Norifumi/0000-0001-9750-8406	National Institutes of Health (NIH) R01 Heart and Lung [(HL)077524, HL077524-S1, HL070187]; Department of Veterans Affairs Merit Review Grant [1I01BX001232]; American Heart Association (AHA) [0755805Z]; AHA National Center Research Program (NCRP) Innovative Research Grant [0970336N]; AHA SDG [12SDG12060100]; AHA [09POST2250151, 11POST5740006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070187, R01HL077524] Funding Source: NIH RePORTER	National Institutes of Health (NIH) R01 Heart and Lung(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); American Heart Association (AHA)(American Heart Association); AHA National Center Research Program (NCRP) Innovative Research Grant; AHA SDG(American Heart Association); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds from National Institutes of Health (NIH) R01 Heart and Lung (HL)077524, HL077524-S1 (to MU-F) and HL070187 (to TF), Department of Veterans Affairs Merit Review Grant 1I01BX001232 (to TF), American Heart Association (AHA) Grant-In-Aid 0755805Z (to MU-F), AHA National Center Research Program (NCRP) Innovative Research Grant 0970336N (to MU-F) and AHA SDG grant 12SDG12060100 and AHA Post-doctoral Fellowship 09POST2250151 (to NU) and 11POST5740006 (to VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arderiu G, 2011, ARTERIOSCL THROM VAS, V31, P2607, DOI 10.1161/ATVBAHA.111.233536; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Brandes RP, 2008, CURR OPIN LIPIDOL, V19, P513, DOI 10.1097/MOL.0b013e32830c91e3; Cai H, 2004, J MOL CELL CARDIOL, V37, P121, DOI 10.1016/j.yjmcc.2004.04.012; COHEN G, 1963, BIOCHEMISTRY-US, V2, P1420, DOI 10.1021/bi00906a038; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Fulton D, 2005, J BIOL CHEM, V280, P35943, DOI 10.1074/jbc.M504606200; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Groleau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023308; Haddad P, 2011, ATHEROSCLEROSIS, V217, P340, DOI 10.1016/j.atherosclerosis.2011.03.038; Haddad P, 2009, ARTERIOSCL THROM VAS, V29, P1522, DOI 10.1161/ATVBAHA.109.191437; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5; Hodara R, 2011, ARTERIOSCL THROM VAS, V31, P2203, DOI 10.1161/ATVBAHA.111.233247; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Isner JM, 1999, NAT MED, V5, P491, DOI 10.1038/8374; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Langston W, 2007, FREE RADICAL BIO MED, V42, P720, DOI 10.1016/j.freeradbiomed.2006.12.010; Larsen BT, 2009, ARTERIOSCL THROM VAS, V29, P739, DOI 10.1161/ATVBAHA.108.169367; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lauer N, 2005, CARDIOVASC RES, V65, P254, DOI 10.1016/j.cardiores.2004.09.010; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Liu YP, 2003, CIRC RES, V93, P573, DOI 10.1161/01.RES.0000091261.19387.AE; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Morikawa K, 2003, J CLIN INVEST, V112, P1871, DOI 10.1172/JCI200319351; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nathan C, 2010, CELL, V140, DOI 10.1016/j.cell.2010.03.008; NICOSIA RF, 1990, LAB INVEST, V63, P115; Okuno Y, 2012, NAT MED; Oshikawa J, 2012, AM J PHYSIOL-HEART C, V302, pH724, DOI 10.1152/ajpheart.00739.2011; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Ozumi K, 2012, HYPERTENSION, V60, P476, DOI 10.1161/HYPERTENSIONAHA.111.189571; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Rafii S, 2003, ANN NY ACAD SCI, V996, P49, DOI 10.1111/j.1749-6632.2003.tb03232.x; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Suvorava T, 2005, CIRCULATION, V112, P2487, DOI 10.1161/CIRCULATIONAHA.105.543157; Suvorava T, 2010, FREE RADICAL RES, V44, P199, DOI 10.3109/10715760903402898; Suvorava T, 2009, BBA-BIOENERGETICS, V1787, P802, DOI 10.1016/j.bbabio.2009.04.005; Takaki A, 2008, J EXP MED, V205, P2053, DOI 10.1084/jem.20080106; Takaki A, 2008, J CARDIOVASC PHARM, V52, P510, DOI 10.1097/FJC.0b013e318190358b; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463; Turgeon J, 2012, ATHEROSCLEROSIS, V223, P122, DOI 10.1016/j.atherosclerosis.2012.05.003; Urao N, 2012, FREE RADIC BIOL MED; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Urao N, 2012, STEM CELLS, V30, P923, DOI 10.1002/stem.1048; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Urbich C, 2002, FASEB J, V16, P706, DOI 10.1096/fj.01-0637fje; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Velasquez-Castano JC, 2008, ARTERIOSCL THROM VAS, V28, P4, DOI 10.1161/ATVBAHA.107.155978; Waeckel L, 2005, CIRC RES, V96, P576, DOI 10.1161/01.RES.0000159389.55544.20; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Yun J, 2009, ANTIOXID REDOX SIGN, V11, P1961, DOI 10.1089/ARS.2009.2476	75	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57618	10.1371/journal.pone.0057618	http://dx.doi.org/10.1371/journal.pone.0057618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472092	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900031
J	Whale, AS; Cowen, S; Foy, CA; Huggett, JF				Whale, Alexandra S.; Cowen, Simon; Foy, Carole A.; Huggett, Jim F.			Methods for Applying Accurate Digital PCR Analysis on Low Copy DNA Samples	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; REAL-TIME PCR; GENE-EXPRESSION; HIGH-THROUGHPUT; MULTIPLEX PCR; NUMBER VARIATIONS; FORENSIC SAMPLES; NUCLEIC-ACIDS; SINGLE-CELL; QUANTIFICATION	Digital PCR (dPCR) is a highly accurate molecular approach, capable of precise measurements, offering a number of unique opportunities. However, in its current format dPCR can be limited by the amount of sample that can be analysed and consequently additional considerations such as performing multiplex reactions or pre-amplification can be considered. This study investigated the impact of duplexing and pre-amplification on dPCR analysis by using three different assays targeting a model template (a portion of the Arabidopsis thaliana alcohol dehydrogenase gene). We also investigated the impact of different template types (linearised plasmid clone and more complex genomic DNA) on measurement precision using dPCR. We were able to demonstrate that duplex dPCR can provide a more precise measurement than uniplex dPCR, while applying pre-amplification or varying template type can significantly decrease the precision of dPCR. Furthermore, we also demonstrate that the pre-amplification step can introduce measurement bias that is not consistent between experiments for a sample or assay and so could not be compensated for during the analysis of this data set. We also describe a model for estimating the prevalence of molecular dropout and identify this as a source of dPCR imprecision. Our data have demonstrated that the precision afforded by dPCR at low sample concentration can exceed that of the same template post pre-amplification thereby negating the need for this additional step. Our findings also highlight the technical differences between different templates types containing the same sequence that must be considered if plasmid DNA is to be used to assess or control for more complex templates like genomic DNA.	[Whale, Alexandra S.; Cowen, Simon; Foy, Carole A.; Huggett, Jim F.] LGC Ltd, Mol & Cell Biol Team, Teddington, Middx, England	LGC Genomics	Whale, AS (corresponding author), LGC Ltd, Mol & Cell Biol Team, Teddington, Middx, England.	alexandra.whale@lgcgroup.com	; Huggett, Jim/N-9316-2013	Cowen, Simon/0000-0002-3305-369X; Huggett, Jim/0000-0002-0945-1911	UK National Measurement System	UK National Measurement System	The work described in this manuscript was funded by the UK National Measurement System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DIG PCR AN SOFTW VER; Barber AL, 2006, J FORENSIC SCI, V51, P1344, DOI 10.1111/j.1556-4029.2006.00262.x; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Bhat S, 2011, ANALYST, V136, P724, DOI 10.1039/c0an00484g; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Burrell A, 2006, 2004 2007 MFB MEASUR; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceulemans S, 2012, METHODS MOL BIOL, V838, P311, DOI 10.1007/978-1-61779-507-7_15; Coudry R, 2006, PREAMPLIFICATION SAM; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Devonshire AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-118; Dhanasekaran S, 2010, J IMMUNOL METHODS, V354, P34, DOI 10.1016/j.jim.2010.01.004; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Elenitoba-Johnson KSJ, 2001, NAT MED, V7, P249, DOI 10.1038/84708; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Ferruelo A, 2011, INT J CLIN EXP PATHO, V4, P156; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fox BC, 2012, ANAL BIOCHEM, V427, P178, DOI 10.1016/j.ab.2012.05.010; Gancberg D, 2008, CLIN CHEM LAB MED, V46, P463, DOI 10.1515/CCLM.2008.093; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Kim J, 2011, BIOANALYSIS, V3, P227, DOI 10.4155/BIO.10.172; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Levenson VV, 2007, BBA-GEN SUBJECTS, V1770, P847, DOI 10.1016/j.bbagen.2007.01.017; Meng YA, 2012, J AGR FOOD CHEM, V60, P23, DOI 10.1021/jf2034972; Noutsias M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-3; Peano C, 2006, EXPERT REV MOL DIAGN, V6, P465, DOI 10.1586/14737159.6.3.465; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Pienaar E, 2006, COMPUT BIOL CHEM, V30, P102, DOI 10.1016/j.compbiolchem.2005.11.002; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Ratcliff RM, 2007, CURR ISSUES MOL BIOL, V9, P87; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Schaerli Y, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq795; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Swango KL, 2007, FORENSIC SCI INT, V170, P35, DOI 10.1016/j.forsciint.2006.09.002; Vermeulen Joelle, 2009, BMC Res Notes, V2, P235, DOI 10.1186/1756-0500-2-235; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	42	99	105	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58177	10.1371/journal.pone.0058177	http://dx.doi.org/10.1371/journal.pone.0058177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472156	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900102
J	Wilson, HM; Hall, JS; Flint, PL; Franson, JC; Ely, CR; Schmutz, JA; Samuel, MD				Wilson, Heather M.; Hall, Jeffery S.; Flint, Paul L.; Franson, J. Christian; Ely, Craig R.; Schmutz, Joel A.; Samuel, Michael D.			High Seroprevalence of Antibodies to Avian Influenza Viruses among Wild Waterfowl in Alaska: Implications for Surveillance	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; MIGRATORY BEHAVIOR; MUTE SWANS; H5N1; BIRDS; GEESE; DUCKS; SUSCEPTIBILITY; TRANSMISSION; PREVALENCE	We examined seroprevalence (presence of detectable antibodies in serum) for avian influenza viruses (AIV) among 4,485 birds, from 11 species of wild waterfowl in Alaska (1998-2010), sampled during breeding/molting periods. Seroprevalence varied among species (highest in eiders (Somateria and Polysticta species), and emperor geese (Chen canagica)), ages (adults higher than juveniles), across geographic locations (highest in the Arctic and Alaska Peninsula) and among years in tundra swans (Cygnus columbianus). All seroprevalence rates in excess of 60% were found in marine-dependent species. Seroprevalence was much higher than AIV infection based on rRT-PCR or virus isolation alone. Because pre-existing AIV antibodies can infer some protection against highly pathogenic AIV (HPAI H5N1), our results imply that some wild waterfowl in Alaska could be protected from lethal HPAIV infections. Seroprevalence should be considered in deciphering patterns of exposure, differential infection, and rates of AIV transmission. Our results suggest surveillance programs include species and populations with high AIV seroprevalences, in addition to those with high infection rates. Serologic testing, including examination of serotype-specific antibodies throughout the annual cycle, would help to better assess spatial and temporal patterns of AIV transmission and overall disease dynamics.	[Wilson, Heather M.] US Fish & Wildlife Serv, Anchorage, AK USA; [Hall, Jeffery S.; Franson, J. Christian] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Flint, Paul L.; Ely, Craig R.; Schmutz, Joel A.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Wilson, HM (corresponding author), US Fish & Wildlife Serv, Anchorage, AK USA.	heather_wilson@fws.gov		Franson, J/0000-0002-0251-4238; Flint, Paul/0000-0002-8758-6993; Hall, Jeffrey/0000-0001-5599-2826	United States Fish and Wildlife Service, Office of Migratory Bird Management (Region 7) Avian Influenza Surveillance Program in Alaska; United States Geological Survey; United States Geological Survey and National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700007C]	United States Fish and Wildlife Service, Office of Migratory Bird Management (Region 7) Avian Influenza Surveillance Program in Alaska; United States Geological Survey(United States Geological Survey); United States Geological Survey and National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services	Funding for this project was provided by the United States Fish and Wildlife Service, Office of Migratory Bird Management (Region 7) Avian Influenza Surveillance Program in Alaska, with special thanks to Kim Trust and the United States Geological Survey. Additional support was provided via federal funds from the United States Geological Survey and National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Brown JD, 2010, J WILDLIFE DIS, V46, P1040, DOI 10.7589/0090-3558-46.3.1040; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; Dau CP, 2002, WATERBIRDS, V25, P241; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; Dzubin A.X., 1994, BIRDS N AM; Ely CR, 1996, AUK, V113, P889, DOI 10.2307/4088866; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fereidouni SR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-43; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Flint PL, 2009, CONDOR, V111, P591, DOI 10.1525/cond.2009.090100; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Granter A, 2010, VIRUS GENES, V41, P224, DOI 10.1007/s11262-010-0504-5; Hars J, 2008, J WILDLIFE DIS, V44, P811, DOI 10.7589/0090-3558-44.4.811; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Henaux V, 2013, J APPL ECOL, V50, P223, DOI 10.1111/1365-2664.12031; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henaux V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010997; Hoye BJ, 2012, P ROY SOC B-BIOL SCI, V279, P529, DOI 10.1098/rspb.2011.0958; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Khalenkov A, 2009, VIROLOGY, V383, P32, DOI 10.1016/j.virol.2008.09.026; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Nagy A, 2007, VET MICROBIOL, V120, P9, DOI 10.1016/j.vetmic.2006.10.004; Niqueux E, 2010, AVIAN DIS, V54, P502, DOI 10.1637/8804-040109-ResNote.1; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Pybus OG, 2012, PARASITOLOGY, V139, P1914, DOI 10.1017/S0031182012000261; Ramey AM, 2011, ARCH VIROL, V156, P1813, DOI 10.1007/s00705-011-1059-z; SAZONOV AA, 1977, ARCH VIROL, V53, P1, DOI 10.1007/BF01314842; Smietanka K, 2008, B VET I PULAWY, V52, P491; Spackman E, 2009, AVIAN DIS, V53, P276, DOI 10.1637/8520-111708-Reg.1; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Uchida Y, 2008, EMERG INFECT DIS, V14, P1427, DOI 10.3201/eid1409.080655; [USFWS USGS], 2009, SAMPL HIGHL PATH AS; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Winker K, 2007, EMERG INFECT DIS, V13, P547, DOI 10.3201/eid1304.061072	48	32	32	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58308	10.1371/journal.pone.0058308	http://dx.doi.org/10.1371/journal.pone.0058308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472177	Green Published, gold			2022-12-27	WOS:000315637900123
J	Wu, MP; Weng, SF; Hsu, YW; Wang, JJ; Kuo, HC				Wu, Ming-Ping; Weng, Shih-Feng; Hsu, Ya-Wen; Wang, Jhi-Joung; Kuo, Hann-Chorng			Medical Attendance for Lower Urinary Tract Symptoms Is Associated with Subsequent Increased Risk of Outpatient Visits and Hospitalizations Based on a Nationwide Population-Based Database	PLOS ONE			English	Article							QUALITY-OF-LIFE; OVERACTIVE BLADDER; CARDIOVASCULAR RISK; INCONTINENCE; PREVALENCE; MEN; IMPACT; BOTHER; CONTINENCE; COMMITTEE	Introduction: Lower urinary tract symptoms (LUTS), which encompass storage, voiding, and postmicturition symptoms, are highly prevalent and recognized globally. Based on a nationwide population-based database, this study tests the hypothesis that medical attendance for LUTS is associated with a subsequent increase in the number of outpatient visits and hospitalizations, with differences among medical specialties and age groups. Methods: Participants were selected from a random population sample of approximately one million people as a representative cohort of National Health Insurance (NHI) enrollees in Taiwan. Participants had at least three outpatient service claims with a coding of LUTS during the recruitment period 2001-2004. Both the LUTS group and non-LUTS control group were monitored for subsequent outpatient visits and hospitalizations, excluding LUTS-related healthcare services, for 2 years following the index date. The results were categorized based on medical specialty and age group. Results: The outpatient visit rates (no. per person-year) and adjusted incidence rate ratios (IRRs) (95% confidence interval (CI) were significantly higher in urology (4.51, 95% CI 4.15-4.91) and gynecology (1.82, 95% CI 1.76-1.89) for the LUTS group. They were also significantly high in other departments, including internal medicine (1.25), general practice (1.13), Chinese medicine (1.77), family medicine (1.19), surgery (1.38), and psychiatry (1.98). Similarly, the hospitalization rate (no. per 1000 person-year) and adjusted IRRs (95% CI) were significantly higher in urology (5.50, 95% CI = 4.60-6.50) and gynecology (1.60, 95% CI = 1.35-1.90), as well as in internal medicine (1.55) and surgery (1.56), but not in psychiatry (1.12). Furthermore, the IRRs differed among 3 age groups. Conclusions: A significantly higher number of outpatient visits and hospitalizations were observed for individuals with LUTS, compared to the control group, and the effects differed with the advancement of age. This study broadens understanding of LUTS by viewing their impact on healthcare services with multiple and overlapping systems, rather than considering them exclusively as symptoms of traditional diseases of the bladder and urethra.	[Wu, Ming-Ping] Chi Mei Fdn Hosp, Dept Obstet & Gynecol, Div Urogynecol, Tainan, Taiwan; [Wu, Ming-Ping] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Weng, Shih-Feng; Hsu, Ya-Wen] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Weng, Shih-Feng; Hsu, Ya-Wen; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw		Weng, Shih-Feng/0000-0001-8684-3487				Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.109; Charness N, 2008, HUM FACTORS, V50, P548, DOI 10.1518/001872008X312161; Chen GD, 2003, NEUROUROL URODYNAM, V22, P109, DOI 10.1002/nau.10010; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Coyne KS, 2011, BJU INT, V108, P1459, DOI 10.1111/j.1464-410X.2010.10013.x; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.x; Girman CJ, 1998, UROLOGY, V51, P428, DOI 10.1016/S0090-4295(97)00717-6; Heaton JPW, 2006, BRIT J PHARMACOL, V147, pS2, DOI 10.1038/sj.bjp.0706620; Hsiao SM, 2012, INT UROGYNECOL J, V23, P935, DOI 10.1007/s00192-012-1715-1; Hu TW, 2005, BJU INT, V96, P43, DOI 10.1111/j.1464-410X.2005.05654.x; Irwin DE, 2006, BJU INT, V97, P96, DOI 10.1111/j.1464-410X.2005.05889.x; Irwin DE, 2008, EUR UROL, V53, P1029, DOI 10.1016/j.eururo.2008.01.027; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Irwin DE, 2009, EUR UROL, V56, P14, DOI 10.1016/j.eururo.2009.02.026; Kannan H, 2009, UROLOGY, V74, P34, DOI 10.1016/j.urology.2008.12.077; Karatas OF, 2010, INT J CARDIOL, V144, P452, DOI 10.1016/j.ijcard.2009.03.099; Lee YS, 2011, WORLD J UROL, V29, P185, DOI 10.1007/s00345-009-0490-1; Liao CH, 2011, UROLOGY, V78, P1373, DOI 10.1016/j.urology.2011.04.076; Liu HT, 2011, NEUROUROL URODYNAM, V30, P1525, DOI 10.1002/nau.21118; Lunenfeld B, 2008, GYNECOL ENDOCRINOL, V24, P1, DOI 10.1080/09513590701718364; Malmsten UGH, 2010, EUR UROL, V58, P149, DOI 10.1016/j.eururo.2010.03.014; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Michel MC, 2004, J UROLOGY, V172, P1390, DOI 10.1097/01.ju.0000139995.85780.d8; Ng C. F., 2007, Hong Kong Medical Journal, V13, P421; Parsons JK, 2010, CURR BLADDER DYSFUNC, V5, P212, DOI 10.1007/s11884-010-0067-2; Ponholzer A, 2006, EUR UROL, V50, P581, DOI 10.1016/j.eururo.2006.01.031; Rotar M, 2011, NEUROUROL URODYNAM, V30, P1315, DOI 10.1002/nau.21013; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Tai HC, 2010, J CLIN ENDOCR METAB, V95, P1143, DOI 10.1210/jc.2009-1492; Terai A, 2004, UROLOGY, V63, P487, DOI 10.1016/j.urology.2003.09.070; Wehrberger C, 2011, UROLOGY, V78, P1063, DOI 10.1016/j.urology.2011.05.065; Wu MP, 2008, INT UROGYNECOL J, V19, P1639, DOI 10.1007/s00192-008-0697-5; Wu MP, 2013, UROLOGY, V81, P61, DOI 10.1016/j.urology.2012.08.033; Yazici H, 2012, BULL HOSP JT DIS, V70, P95	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57825	10.1371/journal.pone.0057825	http://dx.doi.org/10.1371/journal.pone.0057825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472108	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900047
J	Byrne, S; Czaban, A; Studer, B; Panitz, F; Bendixen, C; Asp, T				Byrne, Stephen; Czaban, Adrian; Studer, Bruno; Panitz, Frank; Bendixen, Christian; Asp, Torben			Genome Wide Allele Frequency Fingerprints (GWAFFs) of Populations via Genotyping by Sequencing	PLOS ONE			English	Article								Genotyping-by-Sequencing (GBS) is an excellent tool for characterising genetic variation between plant genomes. To date, its use has been reported only for genotyping of single individuals. However, there are many applications where resolving allele frequencies within populations on a genome-wide scale would be very powerful, examples include the breeding of outbreeding species, varietal protection in outbreeding species, monitoring changes in population allele frequencies. This motivated us to test the potential to use GBS to evaluate allele frequencies within populations. Perennial ryegrass is an outbreeding species, and breeding programs are based upon selection on populations. We tested two restriction enzymes for their efficiency in complexity reduction of the perennial ryegrass genome. The resulting profiles have been termed Genome Wide Allele Frequency Fingerprints (GWAFFs), and we have shown how these fingerprints can be used to distinguish between plant populations. Even at current costs and throughput, using sequencing to directly evaluate populations on a genome-wide scale is viable. GWAFFs should find many applications, from varietal development in outbreeding species right through to playing a role in protecting plant breeders' rights.	[Byrne, Stephen; Czaban, Adrian; Asp, Torben] Aarhus Univ, Dept Mol Biol & Genet, Res Ctr Flakkebjerg, Slagelse, Denmark; [Panitz, Frank; Bendixen, Christian] Aarhus Univ, Dept Mol Biol & Genet, Res Ctr Foulum, Tjele, Denmark; [Studer, Bruno] ETH, Inst Agr Sci, Zurich, Switzerland	Aarhus University; Aarhus University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Byrne, S (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Res Ctr Flakkebjerg, Slagelse, Denmark.	stephen.byrne@agrsci.dk	Studer, Bruno/O-2237-2017; Byrne, Stephen/L-3572-2019; Panitz, Frank/A-3281-2017	Byrne, Stephen/0000-0002-1179-2272; Panitz, Frank/0000-0002-6909-5162; Studer, Bruno/0000-0001-8795-0719	Danish Ministry for Food, Agriculture and Fisheries [3412-09-02602]	Danish Ministry for Food, Agriculture and Fisheries	This research was funded by the Danish Ministry for Food, Agriculture and Fisheries (Grant number 3412-09-02602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Bennett MD, 2011, ANN BOT-LONDON, V107, P467, DOI 10.1093/aob/mcq258; Chiang CWK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000866; Connolly V, 2001, BREEDING IMPORVED VA; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gaj P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035307; Gilliland TJ, 2010, SUSTAINABLE USE OF GENETIC DIVERSITY IN FORAGE AND TURF BREEDING, P261, DOI 10.1007/978-90-481-8706-5_37; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kirov G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-27; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; Mondal K, 2011, GENOMICS, V98, P260, DOI 10.1016/j.ygeno.2011.04.004; Narvel JM, 2000, MOL BREEDING, V6, P175, DOI 10.1023/A:1009637119947; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Postlethwait JH, STACKS BUILDING GENO; R Core Team, 2012, R LANG ENV STAT COMP; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172	22	64	64	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57438	10.1371/journal.pone.0057438	http://dx.doi.org/10.1371/journal.pone.0057438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469194	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900021
J	Hart, Y; Mayo, AE; Shoval, O; Alon, U				Hart, Yuval; Mayo, Avraham E.; Shoval, Oren; Alon, Uri			Comparing Apples and Oranges: Fold-Change Detection of Multiple Simultaneous Inputs	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; RECEPTOR; SENSITIVITY; ADAPTATION; ROBUSTNESS; RESPONSES; SYMMETRY; MODEL	Sensory systems often detect multiple types of inputs. For example, a receptor in a cell-signaling system often binds multiple kinds of ligands, and sensory neurons can respond to different types of stimuli. How do sensory systems compare these different kinds of signals? Here, we consider this question in a class of sensory systems - including bacterial chemotaxis-which have a property known as fold-change detection: their output dynamics, including amplitude and response time, depends only on the relative changes in signal, rather than absolute changes, over a range of several decades of signal. We analyze how fold-change detection systems respond to multiple signals, using mathematical models. Suppose that a step of fold F-1 is made in input 1, together with a step of F-2 in input 2. What total response does the system provide? We show that when both input signals impact the same receptor with equal number of binding sites, the integrated response is multiplicative: the response dynamics depend only on the product of the two fold changes, F1F2. When the inputs bind the same receptor with different number of sites n(1) and n(2), the dynamics depend on a product of power laws, F-1(n1) F-2(n2). Thus, two input signals which vary over time in an inverse way can lead to no response. When the two inputs affect two different receptors, other types of integration may be found and generally the system is not constrained to respond according to the product of the fold-change of each signal. These predictions can be readily tested experimentally, by providing cells with two simultaneously varying input signals. The present study suggests how cells can compare apples and oranges, namely by comparing each to its own background level, and then multiplying these two fold-changes.	[Hart, Yuval; Mayo, Avraham E.; Shoval, Oren; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	Hart, Yuval/HGD-6424-2022; mayo, avi/N-3756-2019	mayo, avi/0000-0002-4479-3423	European Research Council under the European Union [249919]; Israel Science Foundation [ISF 675/09]	European Research Council under the European Union(European Research Council (ERC)); Israel Science Foundation(Israel Science Foundation)	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 249919 and the Israel Science Foundation (ISF 675/09). Uri Alon is the incumbent of the Abisch-Frenkel Professorial Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Bargmann C. I., 2006, WORMBOOK; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Celani A, 2011, J STAT PHYS, V144, P219, DOI 10.1007/s10955-011-0251-6; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Eisenbach M, 2004, CHEMOTAXIS, DOI DOI 10.1142/P303; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; Keener J., 1998, MATH PHYSL; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Lazova MD, 2011, P NATL ACAD SCI USA, V108, P13870, DOI 10.1073/pnas.1108608108; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Masson JB, 2012, P NATL ACAD SCI USA, V109, P1802, DOI 10.1073/pnas.1116772109; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; Mello BA, 2007, BIOPHYS J, V92, P2329, DOI 10.1529/biophysj.106.097808; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Russo G, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041929; Shoval O, 2011, SIAM J APPL DYN SYST, V10, P857, DOI 10.1137/100818078; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Sontag E.D., 1998, MATH CONTROL THEORY; Sontag ED, 2003, SYST CONTROL LETT, V50, P119, DOI 10.1016/S0167-6911(03)00136-1; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; Weber E.H., 1996, EH WEBER TACTILE SEN; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	33	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57455	10.1371/journal.pone.0057455	http://dx.doi.org/10.1371/journal.pone.0057455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469195	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900022
J	Joy, N; Asha, S; Mallika, V; Soniya, EV				Joy, Nisha; Asha, Srinivasan; Mallika, Vijayan; Soniya, Eppurathu Vasudevan			De novo Transcriptome Sequencing Reveals a Considerable Bias in the Incidence of Simple Sequence Repeats towards the Downstream of 'Pre-miRNAs' of Black Pepper	PLOS ONE			English	Article							SMALL RNAS; MICRORNAS; IDENTIFICATION; DNA; PLANT; MICROSATELLITES; POLYMORPHISM; ANNOTATION; GENOMICS; CLEAVAGE	Next generation sequencing has an advantageon transformational development of species with limited available sequence data as it helps to decode the genome and transcriptome. We carried out the de novo sequencing using illuminaHiSeq (TM) 2000 to generate the first leaf transcriptome of black pepper (Piper nigrum L.), an important spice variety native to South India and also grown in other tropical regions. Despite the economic and biochemical importance of pepper, a scientifically rigorous study at the molecular level is far from complete due to lack of sufficient sequence information and cytological complexity of its genome. The 55 million raw reads obtained, when assembled using Trinity program generated 2,23,386 contigs and 1,28,157 unigenes. Reports suggest that the repeat-rich genomic regions give rise to small non-coding functional RNAs. MicroRNAs (miRNAs) are the most abundant type of non-coding regulatory RNAs. In spite of the widespread research on miRNAs, little is known about the hair-pin precursors of miRNAs bearing Simple Sequence Repeats (SSRs). We used the array of transcripts generated, for the in silico prediction and detection of '43 pre-miRNA candidates bearing different types of SSR motifs'. The analysis identified 3913 different types of SSR motifs with an average of one SSR per 3.04 MB of thetranscriptome. About 0.033% of the transcriptome constituted 'pre-miRNA candidates bearing SSRs'. The abundance, type and distribution of SSR motifs studied across the hair-pin miRNA precursors, showed a significant bias in the position of SSRs towards the downstream of predicted 'pre-miRNA candidates'. The catalogue of transcripts identified, together with the demonstration of reliable existence of SSRs in the miRNA precursors, permits future opportunities for understanding the genetic mechanism of black pepper and likely functions of 'tandem repeats' in miRNAs.	[Joy, Nisha; Asha, Srinivasan; Mallika, Vijayan; Soniya, Eppurathu Vasudevan] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Soniya, EV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India.	evsoniya@rgcb.res.in	Joy, Nisha/Q-8867-2019	Joy, Nisha/0000-0002-4883-7323; Srinivasan, Asha/0000-0002-2621-4205; Vijayanathan, Mallika/0000-0001-9806-3736	Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR), Govt. of India	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Department of Biotechnology (DBT) and Council of Scientific and Industrial Research (CSIR), Govt. of India for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Ahmad N, 2010, PLANT CELL TISS ORG, V102, P129, DOI 10.1007/s11240-010-9712-x; AKKAYA MS, 1992, GENETICS, V132, P1131; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bajgain P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-370; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BECKMANN JS, 1990, BIO-TECHNOL, V8, P930, DOI 10.1038/nbt1090-930; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Bennett MD, 2010, PLANT DNAC VALUES DA; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen M, 2010, MOL BIOL EVOL, V27, P2227, DOI 10.1093/molbev/msq100; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cloutier S, 2009, THEOR APPL GENET, V119, P53, DOI 10.1007/s00122-009-1016-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Gordo SMC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-168; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; Hisano H, 2007, DNA RES, V14, P271, DOI 10.1093/dnares/dsm025; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Joy N, 2012, FUNCT INTEGR GENOMIC, V12, P387, DOI 10.1007/s10142-012-0267-2; Joy N, 2011, GENETICA, V139, P1033, DOI 10.1007/s10709-011-9605-x; Joy N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-42; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim TS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-31; Krishnan NM, 2011, CURRENT SCI, V101, P12; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Maju T. T., 2012, International Journal of Medicinal and Aromatic Plants, V2, P178; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAGL W, 1983, BIOL ZBL, V102, P129; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; PHILIP VJ, 1992, PLANT CELL REP, V12, P41, DOI 10.1007/BF00232421; Ravindran PN, 1991, THESIS U CALICUT; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Roy NC, 1994, INT PEPPER NOIS B, V18, P7; Shamina A, 2001, J PLANTATION CROPS, V29, P22; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zuker M, 1999, NATO ASI SERIES	56	28	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e56694	10.1371/journal.pone.0056694	http://dx.doi.org/10.1371/journal.pone.0056694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469176	Green Submitted, gold, Green Published			2022-12-27	WOS:000315634900009
J	Liberman, A; Esser, M; Marx, N; Burgmaier, M				Liberman, Ana; Esser, Melanie; Marx, Nikolaus; Burgmaier, Mathias			Glucagon-Like Peptide-1(9-36) Inhibits Chemokine-Induced Migration of Human CD4-Positive Lymphocytes	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; GLP-1 (9-36)AMIDE; GLUCOSE-UPTAKE; METABOLITE; RECEPTOR; ACTIVATION; DISEASE; CELLS; AMIDE; DOGS	Introduction: Inhibitors of dipeptidyl peptidase-IV (DPP-IV), which decrease the degradation of glucose-lowering GLP-1(7-36) to the metabolically inactive GLP-1(9-36), are current new treatment options for patients with type 2 diabetes mellitus, a high-risk population for cardiovascular disease. However, the effects of the metabolite GLP-1(9-36) on atherosclerosis are unknown. Thus, the present study examined the effect of GLP-1(9-36) on chemokine-induced CD4-positive lymphocyte migration as one of the early and critical steps in atherogenesis. Methods and Results: Stimulation of isolated human CD4-positive lymphocytes with SDF-1 led to a 3.4 fold (p<0.001; n = 7) increase in cell migration. Pretreatment of cells with GLP-1(9-36) reduced this effect in a concentration-dependent manner by 41% to a 2.0 fold induction at 10 nmol/L GLP-1(9-36) (p<0.001 compared to SDF-1-treated cells, n = 7). Similar effects were obtained when RANTES was used as a chemokine to induce cell migration. The action of GLP-1(9-36) on CD4-positive lymphocyte migration was mediated through an early inhibition of chemokine-induced PI-3 kinase activity. Downstream in the PI-3 kinase signaling pathway, GLP-1(9-36) inhibited SDF-1-induced phosphorylation of MLC and cofilin and decreased f-actin formation as well as ICAM3 translocation as shown by Western blotting, flow cytometry and immunohistochemistry, respectively. However, the effect of GLP-1(9-36) on PI-3 kinase signaling was not associated with increased intracellular levels of cAMP. Furthermore, experiments with siRNA demonstrated that the inhibitory effect of GLP-1(9-36) on SDF-1-induced ICAM3-translocation was preserved in human CD4-positive lymphocytes lacking the GLP-1 receptor, suggesting signaling independent of the known GLP-1 receptor. Conclusion: Thus, GLP-1(9-36) inhibits chemokine-induced CD4-positive lymphocyte migration by inhibition of the PI3-kinase pathway independent of cAMP and GLP-1 receptor signaling. Further studies are needed to assess whether such effects may be clinically relevant for patients with type 2 diabetes treated with DPP-IV inhibitors.	[Liberman, Ana; Esser, Melanie; Marx, Nikolaus; Burgmaier, Mathias] Univ Hosp Aachen, Dept Internal Med Cardiol 1, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Marx, N (corresponding author), Univ Hosp Aachen, Dept Internal Med Cardiol 1, Aachen, Germany.	nmarx@ukaachen.de			Novartisstiftung fur therapeutische Forschung; German Research Foundation (DFG) [MA2047/4-1]; German Heart Foundation/German Foundation of Heart Research; Ernst and Berta Grimmke-Stiftung	Novartisstiftung fur therapeutische Forschung; German Research Foundation (DFG)(German Research Foundation (DFG)); German Heart Foundation/German Foundation of Heart Research; Ernst and Berta Grimmke-Stiftung	This work was supported by grants of the Novartisstiftung fur therapeutische Forschung and the German Research Foundation (DFG;MA2047/4-1) to Prof. Dr. Nikolaus Marx, as well as by a grant from the Karl und Lore Klein-Stiftung, the German Heart Foundation/German Foundation of Heart Research and the Ernst and Berta Grimmke-Stiftung to Dr. Mathias Burgmaier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aoukaty A, 1999, J IMMUNOL, V162, P3249; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Ban K, 2010, ENDOCRINOLOGY, V151, P1520, DOI 10.1210/en.2009-1197; Burgmaier M, 2012, DIABET MED; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Egan JM, 2002, J CLIN ENDOCR METAB, V87, P3768, DOI 10.1210/jc.87.8.3768; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Knudsen LB, 1996, EUR J PHARMACOL, V318, P429, DOI 10.1016/S0014-2999(96)00795-9; Marx N, 2010, CELL MOL LIFE SCI, V67, P3549, DOI 10.1007/s00018-010-0396-5; Nauck MA, 1996, DIABETOLOGIA, V39, P1546, DOI 10.1007/s001250050613; Nikolaidis LA, 2005, AM J PHYSIOL-HEART C, V289, pH2401, DOI 10.1152/ajpheart.00347.2005; Parker JC, 2006, J ENDOCRINOL, V191, P93, DOI 10.1677/joe.1.06904; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Walcher D, 2004, DIABETES, V53, P1664, DOI 10.2337/diabetes.53.7.1664; Wettergren A, 1998, PEPTIDES, V19, P877, DOI 10.1016/S0196-9781(98)00020-5	18	10	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58445	10.1371/journal.pone.0058445	http://dx.doi.org/10.1371/journal.pone.0058445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469279	Green Published, gold			2022-12-27	WOS:000315634900087
J	Maisels, F; Strindberg, S; Blake, S; Wittemyer, G; Hart, J; Williamson, EA; Aba'a, R; Abitsi, G; Ambahe, RD; Amsini, F; Bakabana, PC; Hicks, TC; Bayogo, RE; Bechem, M; Beyers, RL; Bezangoye, AN; Boundja, P; Bout, N; Akou, ME; Bene, LB; Fosso, B; Greengrass, E; Grossmann, F; Ikamba-Nkulu, C; Ilambu, O; Inogwabini, BI; Iyenguet, F; Kiminou, F; Kokangoye, M; Kujirakwinja, D; Latour, S; Liengola, I; Mackaya, Q; Madidi, J; Madzoke, B; Makoumbou, C; Malanda, GA; Malonga, R; Mbani, O; Mbendzo, VA; Ambassa, E; Ekinde, A; Mihindou, Y; Morgan, BJ; Motsaba, P; Moukala, G; Mounguengui, A; Mowawa, BS; Ndzai, C; Nixon, S; Nkumu, P; Nzolani, F; Pintea, L; Plumptre, A; Rainey, H; de Semboli, BB; Serckx, A; Stokes, E; Turkalo, A; Vanleeuwe, H; Vosper, A; Warren, Y				Maisels, Fiona; Strindberg, Samantha; Blake, Stephen; Wittemyer, George; Hart, John; Williamson, Elizabeth A.; Aba'a, Rostand; Abitsi, Gaspard; Ambahe, Ruffin D.; Amsini, Fidel; Bakabana, Parfait C.; Hicks, Thurston Cleveland; Bayogo, Rosine E.; Bechem, Martha; Beyers, Rene L.; Bezangoye, Anicet N.; Boundja, Patrick; Bout, Nicolas; Akou, Marc Ella; Bene, Lambert Bene; Fosso, Bernard; Greengrass, Elizabeth; Grossmann, Falk; Ikamba-Nkulu, Clement; Ilambu, Omari; Inogwabini, Bila-Isia; Iyenguet, Fortune; Kiminou, Franck; Kokangoye, Max; Kujirakwinja, Deo; Latour, Stephanie; Liengola, Innocent; Mackaya, Quevain; Madidi, Jacob; Madzoke, Bola; Makoumbou, Calixte; Malanda, Guy-Aime; Malonga, Richard; Mbani, Olivier; Mbendzo, Valentin A.; Ambassa, Edgar; Ekinde, Albert; Mihindou, Yves; Morgan, Bethan J.; Motsaba, Prosper; Moukala, Gabin; Mounguengui, Anselme; Mowawa, Brice S.; Ndzai, Christian; Nixon, Stuart; Nkumu, Pele; Nzolani, Fabian; Pintea, Lilian; Plumptre, Andrew; Rainey, Hugo; de Semboli, Bruno Bokoto; Serckx, Adeline; Stokes, Emma; Turkalo, Andrea; Vanleeuwe, Hilde; Vosper, Ashley; Warren, Ymke			Devastating Decline of Forest Elephants in Central Africa	PLOS ONE			English	Article							NATIONAL-PARK; GENOMIC DISSOCIATION; CONGO; RAINFALL; DUNG; DETERMINES; GOVERNANCE; DEFECATION; CYCLOTIS; RESERVE	African forest elephants-taxonomically and functionally unique-are being poached at accelerating rates, but we lack range-wide information on the repercussions. Analysis of the largest survey dataset ever assembled for forest elephants (80 foot-surveys; covering 13,000 km; 91,600 person-days of fieldwork) revealed that population size declined by ca. 62% between 2002-2011, and the taxon lost 30% of its geographical range. The population is now less than 10% of its potential size, occupying less than 25% of its potential range. High human population density, hunting intensity, absence of law enforcement, poor governance, and proximity to expanding infrastructure are the strongest predictors of decline. To save the remaining African forest elephants, illegal poaching for ivory and encroachment into core elephant habitat must be stopped. In addition, the international demand for ivory, which fuels illegal trade, must be dramatically reduced.	[Maisels, Fiona; Strindberg, Samantha; Blake, Stephen; Hart, John; Aba'a, Rostand; Abitsi, Gaspard; Ambahe, Ruffin D.; Amsini, Fidel; Bakabana, Parfait C.; Bechem, Martha; Boundja, Patrick; Bout, Nicolas; Fosso, Bernard; Greengrass, Elizabeth; Grossmann, Falk; Ikamba-Nkulu, Clement; Ilambu, Omari; Inogwabini, Bila-Isia; Iyenguet, Fortune; Kiminou, Franck; Kokangoye, Max; Kujirakwinja, Deo; Latour, Stephanie; Liengola, Innocent; Mackaya, Quevain; Madidi, Jacob; Madzoke, Bola; Makoumbou, Calixte; Malanda, Guy-Aime; Malonga, Richard; Mbani, Olivier; Mbendzo, Valentin A.; Ambassa, Edgar; Ekinde, Albert; Mihindou, Yves; Motsaba, Prosper; Moukala, Gabin; Mowawa, Brice S.; Ndzai, Christian; Nkumu, Pele; Nzolani, Fabian; Plumptre, Andrew; Rainey, Hugo; Stokes, Emma; Turkalo, Andrea; Vanleeuwe, Hilde; Warren, Ymke] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA; [Maisels, Fiona; Williamson, Elizabeth A.; Morgan, Bethan J.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Wittemyer, George] Save Elephants, Nairobi, Kenya; [Vosper, Ashley] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Hicks, Thurston Cleveland] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Bayogo, Rosine E.; de Semboli, Bruno Bokoto] Minist Eaux Forets Chasse & Peche, Bangui, Cent Afr Republ; [Beyers, Rene L.] Univ British Columbia, Beatty Biodivers Ctr, Vancouver, BC V5Z 1M9, Canada; [Bezangoye, Anicet N.; Akou, Marc Ella; Kokangoye, Max] Minist Eaux & Forets, Direct Gest Faune & Chasse, Libreville, Gabon; [Bene, Lambert Bene; Mbendzo, Valentin A.; Mounguengui, Anselme] World Wildlife Fund, Cent Africa Reg Programme Off, Yaounde, Cameroon; [Latour, Stephanie; Pintea, Lilian] Jane Goodall Inst, Arlington, VA USA; [Morgan, Bethan J.] Zool Soc San Diego, Cent Africa Program, Yaounde, Cameroon; [Nixon, Stuart] Zool Soc London, London, England; [Serckx, Adeline] Univ Liege, Behav Biol Unit, Liege, Belgium; [Vosper, Ashley] African Wildlife Fdn, Kinshasa, DEM REP CONGO	Wildlife Conservation Society; University of Stirling; Colorado State University; University of Amsterdam; University of British Columbia; Zoological Society of San Diego; Zoological Society of London; University of Liege	Maisels, F (corresponding author), Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA.	fmaisels@wcs.org	Maisels, Fiona/E-7382-2015; Wittemyer, George/AFQ-1840-2022; Plumptre, Andrew J./X-3145-2019; Williamson, Elizabeth/B-9090-2011; Hicks, Thurston/AAP-4835-2021; Williamson, Elizabeth/E-4727-2016; Williamson, Elizabeth/N-8958-2019	Maisels, Fiona/0000-0002-0778-0615; Plumptre, Andrew J./0000-0002-9333-4047; Williamson, Elizabeth/0000-0001-6848-9154; Williamson, Elizabeth/0000-0001-6848-9154; Inogwabini, Bila-Isia/0000-0002-6897-2477	African Wildlife Foundation; Beneficia Foundation; Busch Gardens; Columbus Zoo; Conservation International; Daniel K. Thorne Foundation; Diane Fossey Gorilla Foundation International; Especes Phares (European Union), Ecosystemes Forestiers d'Afrique Centrale (ECOFAC); Fauna and Flora International; Frankfurt Zoological Society; IUCN Netherlands; John D. and Catherine T. MacArthur Foundation; KFW; Operation Loango; Prince Bernhard Wildlife Fund; RAPAC; The Arcus Foundation; The Aspinall Foundation; The Born Free Foundation; The Institute for Biodiversity; Ecosystem Dynamics at The University of Amsterdam; The Jane Goodall Institute; The Liz Claiborne; Art Ortenberg Foundation; Lucie Burgers Foundation; The Wasmoeth Wildlife Foundation; Total Gabon; United States Agency for International Development (USAID CARPE); USFWS Great Ape Conservation Fund; USFWS African Elephant Conservation Fund; Wildlife Conservation Society; World Wildlife Fund and the Zoological Society of London	African Wildlife Foundation; Beneficia Foundation; Busch Gardens; Columbus Zoo; Conservation International; Daniel K. Thorne Foundation; Diane Fossey Gorilla Foundation International; Especes Phares (European Union), Ecosystemes Forestiers d'Afrique Centrale (ECOFAC); Fauna and Flora International; Frankfurt Zoological Society; IUCN Netherlands; John D. and Catherine T. MacArthur Foundation; KFW; Operation Loango; Prince Bernhard Wildlife Fund; RAPAC; The Arcus Foundation; The Aspinall Foundation; The Born Free Foundation; The Institute for Biodiversity; Ecosystem Dynamics at The University of Amsterdam; The Jane Goodall Institute; The Liz Claiborne; Art Ortenberg Foundation; Lucie Burgers Foundation; The Wasmoeth Wildlife Foundation; Total Gabon(Total SA); United States Agency for International Development (USAID CARPE)(United States Agency for International Development (USAID)); USFWS Great Ape Conservation Fund; USFWS African Elephant Conservation Fund; Wildlife Conservation Society; World Wildlife Fund and the Zoological Society of London	For funding of the survey work the authors thank (in alphabetical order) Nancy Abraham, the African Wildlife Foundation, Beneficia Foundation, Busch Gardens, Columbus Zoo, Conservation International, Daniel K. Thorne Foundation, Diane Fossey Gorilla Foundation International, Especes Phares (European Union), Ecosystemes Forestiers d'Afrique Centrale (ECOFAC), Fauna and Flora International, Frankfurt Zoological Society, IUCN Netherlands, John D. and Catherine T. MacArthur Foundation, KFW, LifeWeb (Spain), National Fund for Scientific Research (FNRS, Belgium), Offield Family Foundation, Operation Loango, Prince Bernhard Wildlife Fund, RAPAC, The Arcus Foundation, The Aspinall Foundation, The Born Free Foundation, The Institute for Biodiversity and Ecosystem Dynamics at The University of Amsterdam, The Jane Goodall Institute, The Liz Claiborne and Art Ortenberg Foundation, The Lucie Burgers Foundation, The Wasmoeth Wildlife Foundation and Karl Ammann, Total Gabon, United States Agency for International Development (USAID CARPE), USFWS Great Ape Conservation Fund, USFWS African Elephant Conservation Fund, Wildlife Conservation Society, World Wildlife Fund and the Zoological Society of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AfESG, 2003, STAT TAX EXT LOX, P2; [Anonymous], 2012, POL UNC 700 ILL WILD; ANPN, 2013, WILDL POACH ASS NE G, P23; Barnes R.F.W., 1987, TECH B, V1, P1; Barnes RFW, 2002, AFR J ECOL, V40, P159, DOI 10.1046/j.1365-2028.2002.00362.x; Barnes RFW, 1997, AFR J ECOL, V35, P39, DOI 10.1111/j.1365-2028.1997.061-89061.x; Barrett CB, 2006, CONSERV BIOL, V20, P1358, DOI 10.1111/j.1523-1739.2006.00521.x; Beyers RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027129; Blake S, 2002, ECOLOGY FOREST ELEPH, P319; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; BLANC J, 2008, LOXODONTA AFRICANA; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Blom A, 2004, BIODIVERS CONSERV, V13, P2661, DOI 10.1007/s10531-004-2138-1; Bouche P, 2012, ENVIRON MONIT ASSESS, V184, P7001, DOI 10.1007/s10661-011-2475-y; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Brandt AL, 2012, MOL ECOL, V21, P1175, DOI 10.1111/j.1365-294X.2012.05461.x; Breuer T, 2007, PACHYDERM, P43; Buckland S.T., 2001, pi; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Campos-Arceiz A, 2011, ACTA OECOL, V37, P542, DOI 10.1016/j.actao.2011.01.014; [CIAT CIESIN], 2005, GRIDD POP WORLD VERS; CITES, 2012, 5321 CITES COP16, P10; CITES, 2010, AFR EL ACT PLAN DOC; CITES, 2011, 442 CITES SC61; CITES, 2012, 461 CITES SC62, P29; CITES-China, 2012, CONV INT TRAD END SP; Clark CJ, 2009, CONSERV BIOL, V23, P1281, DOI 10.1111/j.1523-1739.2009.01243.x; CMS, 2012, APP 1 2 CONV CONS AP; Cuvillier-Fleury H, 1904, THESIS PARIS U PARIS, V290; de Boer WF, 2013, BIOL CONSERV, V159, P468, DOI 10.1016/j.biocon.2012.10.015; Department US, 2012, US EFF COMB WILDL TR; Department US, 2012, CLIN PARTN M COMB WI; Douglas-Hamilton I., 1987, Oryx, V6, P11; Douglas-Hamilton I, 1979, AFRICAN ELEPHANT IVO, P138; Fay JM, 2001, CONSERV ECOL, P207; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Government U, 2012, WILDL CRIM ENV AUD C; Grubb Peter, 2000, Elephant, V2, P1; Hall JS, 1998, INT J PRIMATOL, V19, P207, DOI 10.1023/A:1020375430965; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; House of Commons Environmental Audit Committee, 2012, 3 HOUS COMM ENV AUD, VII, P94; INTERPOL, 2012, INTERPOL GROUP EXP C; INTERPOL, 2012, ENV CRIM INT; Iremonger S, 1997, STAT ANAL GLOBAL FOR; Ishida Y, 2011, J HERED, V102, P610, DOI 10.1093/jhered/esr073; Ishida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020642; IUCN, 2011, GUID US IUCN RED LIS; IUCN, 2012, WCC2012RES133EN IUCN, P2; IUCN, 2012, IUCN RED LIST THREAT; IUCN/SSC, 2008, AFR EL LOX AFR FURTH; IUCN/SSC, 2008, STRAT PLANN SPEC CON, P104; Klaus G, 1998, J TROP ECOL, V14, P829, DOI 10.1017/S0266467498000595; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; Lemieux AM, 2009, BRIT J CRIMINOL, V49, P451, DOI 10.1093/bjc/azp030; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Martin E., 2011, IVORY DYNASTY REPORT; MICHELMORE F, 1994, AFR J ECOL, V32, P89, DOI 10.1111/j.1365-2028.1994.tb00561.x; MIKE, 2005, MON ILL KILL EL CENT; MILNERGULLAND EJ, 1993, P ROY SOC B-BIOL SCI, V252, P29, DOI 10.1098/rspb.1993.0042; Platt J, 2012, CAMEROON SENDS ARMY; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Roca AL, 2005, CURR OPIN GENET DEV, V15, P652, DOI 10.1016/j.gde.2005.09.014; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Roca AL, 2007, QUATERN INT, V169, P4, DOI 10.1016/j.quaint.2006.08.008; Rohland N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000564; Senelwa K, 2012, BIOENERGY FOR SUSTAINABLE DEVELOPMENT IN AFRICA, P237, DOI 10.1007/978-94-007-2181-4_20; SHORT J, 1981, MAMMALIA, V45, P177, DOI 10.1515/mamm.1981.45.2.177; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Stiles D, 2011, ELEPHANT MEAT TRADE, P104; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Tchamba M, 2008, TOTAL AERIAL COUNT E, P75; TCHAMBA MN, 1992, MAMMALIA, V56, P155; Theuerkauf J, 2010, ANN ZOOL FENN, V47, P398, DOI 10.5735/086.047.0603; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Transparency International, 2011, CORR PERC IND 2011; Turkalo Andrea, 1995, Pachyderm, V20, P45; U.S. Embassy, 2012, REG WILDL WORKSH CHA; Underwood FM, 2012, 16 M C PART CITES, P30; UNODC, 2012, CORR ENV UN CONV COR, P94; Vigne L, 2011, PACHYDERM, P79; WCS/CIESIN, 2005, LAST WILD DAT VERS 2; WHITE LJT, 1993, AFR J ECOL, V31, P181, DOI 10.1111/j.1365-2028.1993.tb00532.x; Wittemyer G, 2011, NATURE, V476, P282, DOI 10.1038/476282c; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; WWF, 2012, CAM SENDS ARM DEF BO; Yackulic CB, 2011, ECOL APPL, V21, P1296, DOI 10.1890/09-1099.1; Yasuko I, 2012, EVOLUTIONARY APPL, V6, P253	93	215	219	3	257	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e59469	10.1371/journal.pone.0059469	http://dx.doi.org/10.1371/journal.pone.0059469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469289	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900100
J	Kearns, T; Clucas, D; Connors, C; Currie, BJ; Carapetis, JR; Andrews, RM				Kearns, Therese; Clucas, Danielle; Connors, Christine; Currie, Bart J.; Carapetis, Jonathan R.; Andrews, Ross M.			Clinic Attendances during the First 12 Months of Life for Aboriginal Children in Five Remote Communities of Northern Australia	PLOS ONE			English	Article							DISEASE; TERRITORY	Background: The vast majority (>75%) of Aboriginal people in the Northern Territory (NT) live in remote or very remote locations. Children in these communities have high attendance rates at local Primary Health Care (PHC) centres but there is a paucity of studies documenting the reason and frequency of attendance. Such data can be used to help guide public health policy and practice. Methods and Findings: Clinic presentations during the first year of life were reviewed for 320 children born from 1 January 2001-31 December 2006. Data collected included reason for infectious presentation, antibiotic prescription and referral to hospital. The median number of presentations per child in the first year of life was 21 (IQR 15-29) with multiple reasons for presentation. The most prominent infectious presentations per child during the first year of life were upper respiratory tract infections (median 6, IQR 3-10); diarrhoea (median 3, IQR 1-5); ear disease (median 3, IQR 1-5); lower respiratory tract infection (median 3, IQR 2-5); scabies (median 3, IQR 1-5); and skin sores (median 3, IQR 2-5). Conclusions: Infectious diseases of childhood are strongly linked with poverty, poor living conditions and overcrowding. The data reported in our study were collected through manual review, however many remote communities now have established electronic health record systems, use the Key Performance Indicator System and are engaged in CQI (continuous quality improvement) processes. Building on these recent initiatives, there is an opportunity to incorporate routine monitoring of a range of infectious conditions (we suggest diarrhoea, LRTI, scabies and skin sores) using both the age at first presentation and the median number of presentations per child during the first year of life as potential indicators of progress in addressing health inequities in remote communities.	[Kearns, Therese; Currie, Bart J.; Andrews, Ross M.] Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Darwin, NT 0909, Australia; [Clucas, Danielle] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Connors, Christine; Currie, Bart J.] No Terr Dept Hlth & Families, Darwin, NT, Australia; [Carapetis, Jonathan R.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia	Charles Darwin University; Menzies School of Health Research; University of Melbourne; Telethon Kids Institute; University of Western Australia	Kearns, T (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Darwin, NT 0909, Australia.	therese.kearns@menzies.edu.au	Carapetis, Jonathan R/H-8933-2014; Kearns, Therese/N-2308-2013	Carapetis, Jonathan R/0000-0002-1182-9792; Kearns, Therese/0000-0003-0862-7572	Cooperative Research Council for Aboriginal Health; Rio Tinto Aboriginal Foundation; Ian Potter Foundation; Australian Government Office of Aboriginal and Torres Strait Islander Health	Cooperative Research Council for Aboriginal Health; Rio Tinto Aboriginal Foundation; Ian Potter Foundation; Australian Government Office of Aboriginal and Torres Strait Islander Health(Australian Government)	This work was supported by the Cooperative Research Council for Aboriginal Health (http://www.lowitja.org.au/), Rio Tinto Aboriginal Foundation (http://www.riotinto.com/), Ian Potter Foundation (http://www.ianpotter.org.au/), and the Australian Government Office of Aboriginal and Torres Strait Islander Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin TT, 2011, RURAL REMOTE HEALTH, V11; Andrews RM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000554; Austrailian Institute of Health and Welfare, 2015, AB TORR STRAIT ISL H; Australian Government, 2012, CLOS GAP MIN REP; Carapetis JR, 1996, MED J AUSTRALIA, V164, P146, DOI 10.5694/j.1326-5377.1996.tb122012.x; Carville KS, 2007, PEDIATR INFECT DIS J, V26, P210, DOI 10.1097/01.inf.0000254148.09831.7f; Clucas DB, 2008, B WORLD HEALTH ORGAN, V86, P241; Fischer K, 2012, ADV PARASIT, V79, P339, DOI 10.1016/B978-0-12-398457-9.00005-6; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; McMeniman E, 2011, AUSTRALAS J DERMATOL, V52, P270, DOI 10.1111/j.1440-0960.2011.00806.x; MUNOZ E, 1992, MED J AUSTRALIA, V156, P529, DOI 10.5694/j.1326-5377.1992.tb121412.x; StataCorpLP, 2012, STAT IC 12 1 WIND	12	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58231	10.1371/journal.pone.0058231	http://dx.doi.org/10.1371/journal.pone.0058231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469270	Green Published, gold			2022-12-27	WOS:000315897100067
J	Kok, R; Hoving, JL; Smits, PBA; Ketelaar, SM; van Dijk, FJH; Verbeek, JH				Kok, Rob; Hoving, Jan L.; Smits, Paul B. A.; Ketelaar, Sarah M.; van Dijk, Frank J. H.; Verbeek, Jos H.			A Clinically Integrated Post-Graduate Training Programme in Evidence-Based Medicine versus 'No Intervention' for Improving Disability Evaluations: A Cluster Randomised Clinical Trial	PLOS ONE			English	Article							INTRACLUSTER CORRELATION; IMPLEMENTATION; KNOWLEDGE; EDUCATION; EFFICACY; QUALITY; ADVICE	Background: Although several studies have shown that teaching EBM is effective in improving knowledge, at present, there is no convincing evidence that teaching EBM also changes professional behaviour in practice. Therefore, the primary aim of this study was to evaluate the effectiveness of a clinically integrated post-graduate training programme in EBM on evidence-based disability evaluation. Methods and Findings: In a cluster randomised controlled trial, fifty-four case-based learning groups consisting of 132 physicians and 1680 patients were randomly assigned to the intervention or control groups. A clinically integrated, postgraduate, 5-day training programme in evidence-based medicine, consisting of (home) assignments, peer teaching, interactive training in searching databases, lectures and brainstorming sessions was provided to the intervention group. The control group received no training. The primary outcome was evidence-based disability evaluation, as indicated by the frequency in use of evidence of sufficient quality in disability evaluation reports. There are no general EBM behaviour outcome measures available. Therefore, we followed general guidelines for constructing performance indicators and defined an a priori cut-off for determination of sufficient quality as recommended for evaluating EB training. Physicians trained in EBM performed more evidence-based disability evaluations compared to physicians in the control group (difference in absolute proportion 9.7%, 95% CI 3.5 to 15.9). The primary outcome differences between groups remained significant after both cluster-adjusted analysis and additional sensitivity analyses accounting for subjects lost to follow-up. Conclusions: A EBM programme successfully improved the use of evidence in a non-hospital based medical specialty. Our findings support the general recommendations to use multiple educational methods to change physician behaviour. In addition, it appeared important that the professional context of the intervention was very supportive in the sense that searches in databases, using and applying guidelines and other forms of evidence are considered standard practice and are encouraged by colleagues and management.	[Kok, Rob; Hoving, Jan L.; Smits, Paul B. A.; Ketelaar, Sarah M.; van Dijk, Frank J. H.; Verbeek, Jos H.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1105 AZ Amsterdam, Netherlands; [Kok, Rob; Hoving, Jan L.; Ketelaar, Sarah M.; van Dijk, Frank J. H.] Univ Amsterdam, Acad Med Ctr, Res Ctr Insurance Med, NL-1105 AZ Amsterdam, Netherlands; [Verbeek, Jos H.] Finnish Inst Occupat Hlth, Cochrane Occupat Safety & Hlth Review Grp, Kuopio, Finland	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Finnish Institute of Occupational Health	Kok, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.kok@amc.uva.nl	Verbeek, Jos H.A.M./F-8382-2013; Hoving, Jan/C-3744-2017; Hoving, Jan L/O-2235-2013	Verbeek, Jos H.A.M./0000-0002-6537-6100; Hoving, Jan L/0000-0002-0461-4013	National Institute of Benefit Schemes (UWV) as part of the Research Center for Insurance Medicine	National Institute of Benefit Schemes (UWV) as part of the Research Center for Insurance Medicine	The project was financed by the National Institute of Benefit Schemes (UWV) as part of the Research Center for Insurance Medicine. However, no funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON CM, 1994, MED CARE, V32, P755, DOI 10.1097/00005650-199408000-00001; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Campbell MK, 2001, STAT MED, V20, P391, DOI 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z; Coomarasamy A, 2004, BMJ-BRIT MED J, V329, P1017, DOI 10.1136/bmj.329.7473.1017; Cosby RH, 2003, FAM PRACT, V20, P77, DOI 10.1093/fampra/20.1.77; Davis D, 2010, CAN MED ASSOC J, V182, pE89, DOI 10.1503/cmaj.081241; Dawes Martin, 2005, BMC Med Educ, V5, P1; De Vries H, 1998, PSYCHOL HEALTH, V13, P369, DOI 10.1080/08870449808406757; DEBOER WEL, 2007, PRATIQUES ORG SOINS, V38, P205; Dickersin Kay, 2007, BMJ, V334 Suppl 1, ps10, DOI 10.1136/bmj.39062.639444.94; Eldridge S, 2012, PRACTICAL GUIDE CLUS; Forsetlund Louise, 2003, BMC Med Educ, V3, P2, DOI 10.1186/1472-6920-3-2; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Glasziou Paul, 2011, Evid Based Med, V16, P129, DOI 10.1136/ebm-2011-100099; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Hugenholtz NIR, 2008, INT ARCH OCC ENV HEA, V82, P107, DOI 10.1007/s00420-008-0315-3; Hugenholtz NIR, 2008, OCCUP MED-OXFORD, V58, P370, DOI 10.1093/occmed/kqn053; Kok R, 2008, OCCUP MED-OXFORD, V58, P83, DOI 10.1093/occmed/kqm151; Kok R, 2011, SCAND J WORK ENV HEA, V37, P494, DOI 10.5271/sjweh.3165; Kunz Regina, 2010, Open Med, V4, pe3; Marinopoulos Spyridon S, 2007, Evid Rep Technol Assess (Full Rep), P1; PALMER RH, 1982, MED CARE, V20, P758, DOI 10.1097/00005650-198208000-00002; Ramos KD, 2003, BRIT MED J, V326, P319, DOI 10.1136/bmj.326.7384.319; Rubenstein LV, 2000, MED CARE, V38, pS129; Schaafsma F, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-59; Schaafsma F, 2007, SCAND J WORK ENV HEA, V33, P368, DOI 10.5271/sjweh.1156; Schaafsma F, 2007, INT ARCH OCC ENV HEA, V80, P239, DOI 10.1007/s00420-006-0126-3; Shaneyfelt T, 2006, JAMA-J AM MED ASSOC, V296, P1116, DOI 10.1001/jama.296.9.1116; Shuval K, 2007, J EVAL CLIN PRACT, V13, P581, DOI 10.1111/j.1365-2753.2007.00859.x; Slawson DC, 2005, ACAD MED, V80, P685, DOI 10.1097/00001888-200507000-00014; Strauss S, 2005, EVIDENCE BASED MED P, V3rd; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; van Dijk FJH, 2010, J OCCUP ENVIRON MED, V52, P1262, DOI 10.1097/JOM.0b013e318202f2c5; Verbeek J, 2008, BRIT MED J, V336, P519, DOI 10.1136/bmj.39472.451134.80; Wiseman-Hakes C, 2010, NEUROREHABILITATION, V26, P355, DOI 10.3233/NRE-2010-0573	36	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57256	10.1371/journal.pone.0057256	http://dx.doi.org/10.1371/journal.pone.0057256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469188	gold, Green Submitted, Green Published			2022-12-27	WOS:000315897100018
J	Lee, RSC; Hermens, DF; Redoblado-Hodge, MA; Naismith, SL; Porter, MA; Kaur, M; White, D; Scott, EM; Hickie, IB				Lee, Rico S. C.; Hermens, Daniel F.; Redoblado-Hodge, M. Antoinette; Naismith, Sharon L.; Porter, Melanie A.; Kaur, Manreena; White, Django; Scott, Elizabeth M.; Hickie, Ian B.			Neuropsychological and Socio-Occupational Functioning in Young Psychiatric Outpatients: A Longitudinal Investigation	PLOS ONE			English	Article							RATING-SCALE; SCHIZOPHRENIA; DISABILITY; DISORDERS; REMISSION; PEOPLE; NEUROCOGNITION; PREDICTORS; DEPRESSION; PSYCHOSIS	Background: Clinical symptoms and neuropsychological deficits are longitudinally associated with functional outcome in chronic psychiatric cohorts. The current study extended these findings to young and early-course psychiatric outpatients, with the aim of identifying cognitive markers that predict later socio-occupational functioning. Methods: At baseline, 183 young psychiatric outpatients were assessed. Ninety-three returned for follow-up (M = 21.6 years old; SD = 4.5) with an average re-assessment interval of 21.6 months (SD = 7.0), and primary diagnoses of major depressive disorder (n = 34), bipolar disorder (n = 29), or psychosis (n = 30). The primary outcome measure was cross-validated with various other functional measures and structural equation modelling was used to map out the interrelationships between predictors and later functional outcome. Results: Good socio-occupational functioning at follow-up was associated with better quality of life, less disability, current employment and being in a romantic relationship. The final structural equation model explained 47.5% of the variability in functional outcome at follow-up, with baseline neuropsychological functioning (a composite of memory, working memory and attentional switching) the best independent predictor of later functional outcome. Notably, depressive and negative symptoms were only associated with functioning cross-sectionally. Diagnosis at follow-up was not associated with functional outcome. Conclusions: Neuropsychological functioning was the single best predictor of later socio-occupational outcome among young psychiatric outpatients. Therefore, framing psychiatric disorders along a neuropsychological continuum is likely to be more useful in predicting functional trajectory than traditional symptom-based classification systems. The current findings also have implications for early intervention utilising cognitive remediation approaches.	[Lee, Rico S. C.; Hermens, Daniel F.; Naismith, Sharon L.; Kaur, Manreena; White, Django; Scott, Elizabeth M.; Hickie, Ian B.] Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia; [Lee, Rico S. C.; Porter, Melanie A.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Redoblado-Hodge, M. Antoinette] Childrens Hosp Westmead, Child Dev Unit, Sydney, NSW, Australia	University of Sydney; Macquarie University; University of Sydney	Lee, RSC (corresponding author), Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia.	sze.lee@sydney.edu.au	Hickie, Ian B/K-8975-2015; Lee, Rico Sze Chun/B-6693-2015	Hickie, Ian B/0000-0001-8832-9895; Naismith, Sharon/0000-0001-9076-2778; Porter, Melanie/0000-0003-3281-1732; Hermens, Daniel/0000-0002-8570-2663	NHMRC [566529]; Australian Fellowship [511921]; NSW Health Mental Health and Drug Alcohol Office; NHMRC Clinical Research Fellowship [402864]; Wyeth; Eli Lily; Servier; Pfizer; Astra Zeneca; Eli-Lily; Novartis	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Fellowship; NSW Health Mental Health and Drug Alcohol Office; NHMRC Clinical Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wyeth(Wyeth); Eli Lily; Servier(Servier); Pfizer(Pfizer); Astra Zeneca(AstraZeneca); Eli-Lily; Novartis(Novartis)	IBH was funded by an NHMRC Program Grant (No. 566529) and Australian Fellowship (No. 511921). DFH was supported by a grant from NSW Health Mental Health and Drug & Alcohol Office. SLN was funded by an NHMRC Clinical Research Fellowship (No. 402864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. IBH was funded by an NHMRC Program Grant and Australia Fellowship. DFH was supported by a grant from NSW Health Mental Health and Drug & Alcohol Office. SLN was funded by an NHMRC Career Development Award. IBH has led projects for health professionals and the community supported by governmental, community agency, and drug industry partners (Wyeth, Eli Lily, Servier, Pfizer, Astra Zeneca) for the identification and management of depression and anxiety. He has served on advisory boards convened by the drug industry in relation to specific antidepressants, including nefazodone, duloxetine, and desvenlafaxine, and has participated in a multicenter clinical trial of agomelatine effects on sleep architecture in depression. He has participated in Servier-sponsored educational programs related to circadian-based therapies. DFH has previously received honoraria for educational seminars from Janssen-Cilag. MARH has received financial support from Eli-Lily for a multisite trial of cognitive remediation in psychosis, and is a co-investigator in an Australian Rotary funded project investigating the synergistic effects of cognitive remediation and vocational training in psychosis. She was also a co-investigator in a drug trial with Novartis pharmaceutical who sponsored overseas travel in 2011, and was also involved in NHMRC funded trials in psychosis. EMS has received honoraria for educational seminars related to the clinical management of depressive disorders supported by Servier and Eli-Lilly pharmaceuticals. She has also participated in a national advisory board for the antidepressant compound Pristiq, manufactured by Pfizer. These funding agencies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Addington J, 2010, J PSYCHIATR NEUROSCI, V35, P49, DOI 10.1503/jpn.080039; Allott K, 2011, SCHIZOPHR RES, V125, P221, DOI 10.1016/j.schres.2010.11.001; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Arbuckle J, 2011, IBM SPSS AMOS 20 USE; Baca-Garcia E, 2007, BRIT J PSYCHIAT, V190, P210, DOI 10.1192/bjp.bp.106.024026; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BENTLER PM, 1989, PSYCHOL BULL, V106, P315, DOI 10.1037/0033-2909.106.2.315; Bowie CR, 2008, BIOL PSYCHIAT, V63, P505, DOI 10.1016/j.biopsych.2007.05.022; Bowie CR, 2010, AM J PSYCHIAT, V167, P1116, DOI 10.1176/appi.ajp.2010.09101406; Burdock EI, 2006, PERS PSYCHOL, V16, P373; Chwastiak LA, 2003, J CLIN EPIDEMIOL, V56, P507, DOI 10.1016/S0895-4356(03)00051-9; DINGEMANS PMAJ, 1995, PSYCHOPHARMACOLOGY, V122, P263, DOI 10.1007/BF02246547; Fagiolini A, 2005, BIPOLAR DISORD, V7, P281, DOI 10.1111/j.1399-5618.2005.00207.x; Franzen M., 1990, 9 ANN CONV NAT AC NE; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Hafner H, 2008, EUR ARCH PSY CLIN N, V258, P85, DOI 10.1007/s00406-008-2011-4; Hallmayer JF, 2003, MOL PSYCHIATR, V8, P511, DOI 10.1038/sj.mp.4001273; Hatton SN, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-45; Hermens DF, 2011, J INT NEUROPSYCH SOC, V17, P267, DOI 10.1017/S1355617710001566; Jaeger J, 2006, PSYCHIAT RES, V145, P39, DOI 10.1016/j.psychres.2005.11.011; Kaur M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051871; Kozak J., 1998, COMPENDIUM NEUROPSYC, V2nd; Lee RSC, 2013, PSYCHOL MED, V43, P1161, DOI 10.1017/S0033291712002127; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Lin A, 2011, SCHIZOPHR RES, V132, P1, DOI 10.1016/j.schres.2011.06.014; Lucas S, 2008, PSYCHIAT RES, V161, P11, DOI 10.1016/j.psychres.2007.10.004; Martino DJ, 2009, J AFFECT DISORDERS, V116, P37, DOI 10.1016/j.jad.2008.10.023; McGorry PD, 2008, WORLD PSYCHIATRY, V7, P148; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Oorschot M, 2012, BRIT J PSYCHIAT, V201, P215, DOI 10.1192/bjp.bp.111.104414; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Robertson G, 2006, WIDE RANGE ACHIEVEME; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Scott EM, 2013, J AFFECT DISORDERS, V144, P208, DOI 10.1016/j.jad.2012.06.031; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; Senior G., 1998, 4 ANN C COLL CLIN NE; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simonsen C, 2010, J INT NEUROPSYCH SOC, V16, P771, DOI 10.1017/S1355617710000573; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Spreen O., 1977, NEUROSENSORY CTR COM; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Taylor E.M., 1959, PSYCHOL APPRAISAL CH; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Torres IJ, 2011, PSYCHOL MED, V41, P971, DOI 10.1017/S0033291710001613; Torres IJ, 2010, J CLIN PSYCHIAT, V71, P1234, DOI 10.4088/JCP.08m04997yel; VENTURA J, 1993, INT J METH PSYCH RES, V3, P221; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Withall A, 2009, PSYCHOL MED, V39, P393, DOI 10.1017/S0033291708003620; Zimmerman M, 2012, J CLIN PSYCHIAT, V73, P790, DOI 10.4088/JCP.11m07203	55	97	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58176	10.1371/journal.pone.0058176	http://dx.doi.org/10.1371/journal.pone.0058176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103EI	23469268	gold, Green Published, Green Submitted			2022-12-27	WOS:000315897100065
J	Ulla, M; Bonny, JM; Ouchchane, L; Rieu, I; Claise, B; Durif, F				Ulla, Miguel; Bonny, Jean Marie; Ouchchane, Lemlih; Rieu, Isabelle; Claise, Beatrice; Durif, Franck			Is R-2* a New MRI Biomarker for the Progression of Parkinson's Disease? A Longitudinal Follow-Up	PLOS ONE			English	Article							TRANSVERSE-RELAXATION RATE; BASAL GANGLIA IRON; MAGNETIC-RESONANCE; BRAIN IRON; SUBSTANTIA-NIGRA; IN-VIVO; AGE; DEPOSITION; FERRITIN; NEURODEGENERATION	Purpose: To study changes of iron content in basal ganglia in Parkinson's disease (PD) through a three-year longitudinal follow-up of the effective transverse relaxation rate R-2*, a validated MRI marker of brain iron content which can be rapidly measured under clinical conditions. Methods: Twenty-seven PD patients and 26 controls were investigated by a first MRI (t(0)). Longitudinal analysis was conducted among the 18 controls and 14 PD patients who underwent a second MRI (t(1)) 3 years after. The imaging protocol consisted in 6 gradient echo images obtained at different echo-times for mapping R-2*. Quantitative exploration of basal ganglia was performed by measuring the variation of R-2* [R-2*(t(1)) - R-2*(t(0))] in several regions of interest. Results: During the three-year evolution of PD, R-2* increased in Substantia nigra (SN) (by 10.2% in pars compacta, p = 0.001, and 8.1% in pars reticulata, p = 0.013) and in the caudal putamen (11.4%, p = 0.011), without significant change in controls. Furthermore, we showed a positive correlation between the variation of R-2* and the worsening of motor symptoms of PD (p = 0.028). Conclusion: Significant variation of R-2* was longitudinally observed in the SN and caudal putamen of patients with PD evolving over a three-year period, emphasizing its interest as a biomarker of disease progression. Our results suggest that R-2* MRI follow-up could be an interesting tool for individual assessment of neurodegeneration due to PD, and also be useful for testing the efficiency of disease-modifying treatments.	[Ulla, Miguel; Rieu, Isabelle; Durif, Franck] CHU Clermont Ferrand, Serv Neurol A, Clermont Ferrand, France; [Ulla, Miguel; Rieu, Isabelle; Claise, Beatrice; Durif, Franck] Univ Clermont 1, EA3845, Clermont Ferrand, France; [Bonny, Jean Marie] INRA, Qualite Prod Anim UR370, F-63122 St Genes Champanelle, France; [Ouchchane, Lemlih] CHU Clermont Ferrand, Unite Biostat Informat Med & Technol Commun, Clermont Ferrand, France; [Ouchchane, Lemlih] Univ Clermont1, Lab Biostat Informat Med & Technol Commun, Clermont Ferrand, France; [Claise, Beatrice] CHU Clermont Ferrand, Serv Radiol B, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); INRAE; CHU Clermont Ferrand; CHU Clermont Ferrand	Ulla, M (corresponding author), CHU Clermont Ferrand, Serv Neurol A, Clermont Ferrand, France.	mulla@chu-clermontferrand.fr	Durif, Franck/CAA-1077-2022					AGID Y, 1991, LANCET, V337, P1321, DOI 10.1016/0140-6736(91)92989-F; Bartzokis G, 1997, MAGN RESON IMAGING, V15, P29, DOI 10.1016/S0730-725X(96)00234-2; Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6; Bartzokis G, 2007, NEUROBIOL AGING, V28, P414, DOI 10.1016/j.neurobiolaging.2006.02.005; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; Behnke S, 2009, NEUROIMAGE, V47, P1237, DOI 10.1016/j.neuroimage.2009.05.072; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; Eapen M, 2011, AM J NEURORADIOL, V32, P688, DOI 10.3174/ajnr.A2355; Evans JR, 2011, J NEUROL NEUROSUR PS, V82, P1112, DOI 10.1136/jnnp.2011.240366; Fahn S., 1987, RECENT DEV PARKINSON, P153; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; Gerlach M, 2006, J NEURAL TRANSM-SUPP, P133; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; He Y, 2003, FREE RADICAL BIO MED, V35, P540, DOI 10.1016/S0891-5849(03)00385-X; Hirsch EC, 2006, J NEURAL TRANSM-SUPP, P201; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Kosta P, 2006, J NEUROL, V253, P26, DOI 10.1007/s00415-005-0914-9; Ma JF, 1996, J MAGN RESON SER B, V111, P61, DOI 10.1006/jmrb.1996.0060; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Martin WRW, 1998, CAN J NEUROL SCI, V25, P44, DOI 10.1017/S0317167100033473; Michaeli S, 2007, MOVEMENT DISORD, V22, P334, DOI 10.1002/mds.21227; Mitsumori F, 2009, MAGN RESON MED, V62, P1326, DOI 10.1002/mrm.22097; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Punwani S, 1997, ADV EXP MED BIOL, V413, P129; RYVLIN P, 1995, ARCH NEUROL-CHICAGO, V52, P583, DOI 10.1001/archneur.1995.00540300057013; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Siemonsen S, 2008, AM J NEURORADIOL, V29, P950, DOI 10.3174/ajnr.A0951; Thobois S, 2006, CLIN THER, V28, P1, DOI 10.1016/j.clinthera.2005.12.003; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Xu X, 2008, NEUROIMAGE, V40, P35, DOI 10.1016/j.neuroimage.2007.11.017; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	39	109	110	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57904	10.1371/journal.pone.0057904	http://dx.doi.org/10.1371/journal.pone.0057904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469252	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100049
J	van Oudenhove, L; Cerda, X; Bernstein, C				van Oudenhove, Louise; Cerda, Xim; Bernstein, Carlos			An Evolutionary Dynamics Model Adapted to Eusocial Insects	PLOS ONE			English	Article							INTERFERENCE COMPETITION; COMMUNITY ORGANIZATION; CLONAL REPRODUCTION; ANT COMMUNITY; WORKER SIZE; TRADE-OFF; SEED SIZE; DIVERSITY; CASTE; SPECIALIZATION	This study aims to better understand the evolutionary processes allowing species coexistence in eusocial insect communities. We develop a mathematical model that applies adaptive dynamics theory to the evolutionary dynamics of eusocial insects, focusing on the colony as the unit of selection. The model links long-term evolutionary processes to ecological interactions among colonies and seasonal worker production within the colony. Colony population dynamics is defined by both worker production and colony reproduction. Random mutations occur in strategies, and mutant colonies enter the community. The interactions of colonies at the ecological timescale drive the evolution of strategies at the evolutionary timescale by natural selection. This model is used to study two specific traits in ants: worker body size and the degree of collective foraging. For both traits, trade-offs in competitive ability and other fitness components allows to determine conditions in which selection becomes disruptive. Our results illustrate that asymmetric competition underpins diversity in ant communities.	[van Oudenhove, Louise; Bernstein, Carlos] Univ Lyon, Lyon, France; [van Oudenhove, Louise; Bernstein, Carlos] Univ Lyon 1, F-69622 Villeurbanne, France; [van Oudenhove, Louise; Bernstein, Carlos] CNRS, UMR5558, Lab Biometrie & Biol Evolut, Villeurbanne, France; [van Oudenhove, Louise; Cerda, Xim] CSIC, Estn Biol Donana, E-41080 Seville, Spain	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	van Oudenhove, L (corresponding author), Univ Lyon, Lyon, France.	louise@thomasvo.net	Cerda, Xim/P-6461-2014	Cerda, Xim/0000-0002-3222-2471	French Ministry of Research; French Ministry of Foreign affairs	French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Ministry of Foreign affairs	This study has been financed by the French Ministry of Research (Research grant for doctoral student) and the French Ministry of Foreign affairs (Research grant Lavoisier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2007, AM NAT, V169, P323, DOI 10.1086/510759; Adler FR, 2000, ECOLOGY, V81, P3226, DOI 10.2307/177412; Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; Armbrecht I, 2004, SCIENCE, V304, P284, DOI 10.1126/science.1094981; Arnan X, 2012, OECOLOGIA, V170, P489, DOI 10.1007/s00442-012-2315-y; Aron S, 2012, MYRMECOL NEWS, V17, P63; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Bestelmeyer BT, 1997, J ARID ENVIRON, V35, P297, DOI 10.1006/jare.1996.0147; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Cerda X, 1997, J ANIM ECOL, V66, P363, DOI 10.2307/5982; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; CHRISTIANSEN FB, 1991, AM NAT, V138, P37, DOI 10.1086/285203; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; DAVIDSON DW, 1978, AM NAT, V112, P523, DOI 10.1086/283294; DAVIDSON DW, 1977, ECOLOGY, V58, P711, DOI 10.2307/1936208; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Dieckmann U, 1997, TRENDS ECOL EVOL, V12, P128, DOI 10.1016/S0169-5347(97)01004-5; Dobata S, 2009, P ROY SOC B-BIOL SCI, V276, P567, DOI 10.1098/rspb.2008.1215; Feener DJ, 2000, OIKOS, V90, P79, DOI 10.1034/j.1600-0706.2000.900108.x; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Franks NR, 1985, METHODS, V31, P91; Geritz SAH, 2000, P ROY SOC B-BIOL SCI, V267, P1671, DOI 10.1098/rspb.2000.1194; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Hammond RL, 2004, PLOS BIOL, V2, P1472, DOI 10.1371/journal.pbio.0020248; Hartmann A, 2003, P NATL ACAD SCI USA, V100, P12836, DOI 10.1073/pnas.2132993100; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kaspari M, 1996, OECOLOGIA, V105, P397, DOI 10.1007/BF00328743; Kisdi E, 1999, J THEOR BIOL, V197, P149, DOI 10.1006/jtbi.1998.0864; Law R, 1997, EVOL ECOL, V11, P485, DOI 10.1023/A:1018441108982; Lawton J., 2000, COMMUNITY ECOLOGY CH; Lebrun EG, 2007, J ANIM ECOL, V76, P58, DOI 10.1111/j.1365-2656.2006.01173.x; Lecoutey E, 2011, BEHAV ECOL, V22, P108, DOI 10.1093/beheco/arq182; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; MACEVICZ S, 1976, BEHAV ECOL SOCIOBIOL, V1, P265, DOI 10.1007/BF00300068; Metz J, 1996, STOCHAST SPATIAL STR, P183; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Oster G.F., 1978, Monographs in Population Biology, pi; Peeters C, 2010, ANT ECOLOGY, P159; Planque R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011664; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RETANA J, 1994, OIKOS, V71, P261, DOI 10.2307/3546274; Rueffler C, 2006, AM NAT, V167, P81, DOI 10.1086/498275; Rueffler C, 2012, J MATH BIOL, P1, DOI [10.1007/s00285-012-0509-x, DOI 10.1007/S00285-012-0509-X:1-55]; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Rueffler C, 2012, P NATL ACAD SCI USA, V109, pE326, DOI 10.1073/pnas.1110521109; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Oudenhove L, 2011, NATURWISSENSCHAFTEN, V98, P1009, DOI 10.1007/s00114-011-0852-6; WILSON DS, 1986, AM NAT, V127, P835, DOI 10.1086/284528; Wittman SE, 2010, OIKOS, V119, P551, DOI 10.1111/j.1600-0706.2009.17792.x	63	2	2	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e55159	10.1371/journal.pone.0055159	http://dx.doi.org/10.1371/journal.pone.0055159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469162	gold, Green Published, Green Submitted			2022-12-27	WOS:000315897100003
J	Wang, Z; Griffin, M				Wang, Zhuo; Griffin, Martin			The Role of TG2 in Regulating S100A4-Mediated Mammary Tumour Cell Migration	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE TG2; 2 CROSS-LINKING; S100 PROTEINS; CANCER-CELLS; FIBRONECTIN; PROGRESSION; METASTASIS; ADHESION; INVASION; EXPRESSION	The importance of S100A4, a Ca2+-binding protein, in mediating tumour cell migration, both intracellularly and extracellularly, is well documented. Tissue transglutaminase (TG2) a Ca2+-dependent protein crosslinking enzyme, has also been shown to enhance cell migration. Here by using the well characterised non-metastatic rat mammary R37 cells (transfected with empty vector) and highly metastatic KP1 cells (R37 cells transfected with S100A4), we demonstrate that inhibition of TG2 either by TG2 inhibitors or transfection of cells with TG2 shRNA block S100A4-accelerated cell migration in the KP1cells and in R37 cells treated with exogenous S100A4. Cell migration was also blocked by the treatment with the non-cell permeabilizing TG2 inhibitor R294, in the human breast cancer cell line MDA-MB-231 (Clone 16, which has a high level of TG2 expression). Inhibition was paralleled by a decrease in S100A4 polymer formation. In vitro co-immunoprecipitation and Far Western blotting assays and cross-linking assays showed not only the direct interaction between TG2 and S100A4, but also confirmed S100A4 as a substrate for TG2. Using specific functional blocking antibodies, a targeting peptide and a recombinant protein as a competitive treatment, we revealed the involvement of syndecan-4 and alpha 5 beta 1 integrin co-signalling pathways linked by activation of PKC alpha in this TG2 and S100A4-mediated cell migration. We propose a mechanism for TG2-regulated S100A4-related mediated cell migration, which is dependent on TG2 crosslinking.	[Wang, Zhuo; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.griffin@aston.ac.uk		Griffin, Martin/0000-0003-3824-306X; WANG, ZHUO/0000-0002-2212-8318	European Commission Marie Curie ITN Project TRANSPATH contract [PITN-GA-2011-289964 MRTN-CT-2006-036032]; European Commission Marie Curie IAPP TRANSCOM contract [PIA-GA-2010-251506]	European Commission Marie Curie ITN Project TRANSPATH contract; European Commission Marie Curie IAPP TRANSCOM contract	This work was supported by European Commission Marie Curie ITN Project TRANSPATH contract PITN-GA-2011-289964 MRTN-CT-2006-036032 and by European Commission Marie Curie IAPP TRANSCOM contract PIA-GA-2010-251506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Alea MP, 2009, ANAL BIOCHEM, V389, P150, DOI 10.1016/j.ab.2009.03.029; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Baumgartner W, 2004, HISTOCHEM CELL BIOL, V122, P17, DOI 10.1007/s00418-004-0668-y; Chen DS, 1997, J BIOL CHEM, V272, P20283, DOI 10.1074/jbc.272.32.20283; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fischer J, 2013, J INVEST DERMATOL; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Ismail NI, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-12; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Jones RA, 2012, AMINO ACIDS; Kim TH, 2009, MOL CANCER RES, V7, P1605, DOI 10.1158/1541-7786.MCR-09-0102; Kiryushko D, 2006, MOL CELL BIOL, V26, P3625, DOI 10.1128/MCB.26.9.3625-3638.2006; Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1; Kotsakis P, 2011, AMINO ACIDS, V41, P909, DOI 10.1007/s00726-010-0790-1; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Ruse M, 2001, BIOCHEMISTRY-US, V40, P3167, DOI 10.1021/bi0019747; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Scarpellini A, 2009, J BIOL CHEM; Schaertl S, 2010, J BIOMOL SCREEN, V15, P478, DOI 10.1177/1087057110366035; Telci D, 2008, FIBRONECTIN TISSUE T; Verhaar R, 2011, NEUROCHEM INT; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; Wang GZ, 2005, ONCOGENE, V24, P1445, DOI 10.1038/sj.onc.1208291; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703	39	31	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57017	10.1371/journal.pone.0057017	http://dx.doi.org/10.1371/journal.pone.0057017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469180	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100013
J	Cacciotto, C; Addis, MF; Coradduzza, E; Carcangiu, L; Nuvoli, AM; Tore, G; Dore, GM; Pagnozzi, D; Uzzau, S; Chessa, B; Pittau, M; Alberti, A				Cacciotto, Carla; Addis, Maria Filippa; Coradduzza, Elisabetta; Carcangiu, Laura; Nuvoli, Anna Maria; Tore, Gessica; Dore, Gian Mario; Pagnozzi, Daniela; Uzzau, Sergio; Chessa, Bernardo; Pittau, Marco; Alberti, Alberto			Mycoplasma agalactiae MAG_5040 is a Mg2+-Dependent, Sugar-Nonspecific SNase Recognised by the Host Humoral Response during Natural Infection	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED NUCLEASE; STAPHYLOCOCCAL NUCLEASE; ANTIGENIC CHARACTERIZATION; CRYSTAL-STRUCTURE; COMPLETE GENOME; SEQUENCE; EXPRESSION; PENETRANS; CLONING; PURIFICATION	In this study the enzymatic activity of Mycoplasma agalactiae MAG_5040, a magnesium-dependent nuclease homologue to the staphylococcal SNase was characterized and its antigenicity during natural infections was established. A UGA corrected version of MAG_5040, lacking the region encoding the signal peptide, was expressed in Escherichia coli as a GST fusion protein. Recombinant GST-MAG_5040 exhibits nuclease activity similar to typical sugar-nonspecific endo- and exonucleases, with DNA as the preferred substrate and optimal activity in the presence of 20 mM MgCl2 at temperatures ranging from 37 to 45 degrees C. According to in silico analyses, the position of the gene encoding MAG_5040 is consistently located upstream an ABC transporter, in most sequenced mycoplasmas belonging to the Mycoplasma hominis group. In M. agalactiae, MAG_5040 is transcribed in a polycistronic RNA together with the ABC transporter components and with MAG_5030, which is predicted to be a sugar solute binding protein by 3D modeling and homology search. In a natural model of sheep and goats infection, anti-MAG_5040 antibodies were detected up to 9 months post infection. Taking into account its enzymatic activity, MAG_5040 could play a key role in Mycoplasma agalactiae survival into the host, contributing to host pathogenicity. The identification of MAG_5040 opens new perspectives for the development of suitable tools for the control of contagious agalactia in small ruminants.	[Cacciotto, Carla; Coradduzza, Elisabetta; Carcangiu, Laura; Nuvoli, Anna Maria; Tore, Gessica; Dore, Gian Mario; Chessa, Bernardo; Pittau, Marco; Alberti, Alberto] Univ Sassari, Dipartimento Med Vet, I-07100 Sassari, Italy; [Addis, Maria Filippa; Pagnozzi, Daniela; Uzzau, Sergio] Porto Conte Ric Srl, Alghero, SS, Italy; [Uzzau, Sergio] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy	University of Sassari; Porto Conte Ricerche; University of Sassari	Alberti, A (corresponding author), Univ Sassari, Dipartimento Med Vet, I-07100 Sassari, Italy.	alberti@uniss.it	CACCIOTTO, Carla/J-5076-2018; Coradduzza, Elisabetta/GRS-3669-2022; Addis, Maria Filippa/I-5381-2019; Uzzau, Sergio/F-3233-2015; Coradduzza, Elisabetta/AAA-4886-2020	CACCIOTTO, Carla/0000-0001-7725-9430; Coradduzza, Elisabetta/0000-0001-6942-3296; Addis, Maria Filippa/0000-0001-6934-7748; Uzzau, Sergio/0000-0001-6246-2794; Coradduzza, Elisabetta/0000-0001-6942-3296; DORE, Gian Mario/0000-0001-7171-4156; Pagnozzi, Daniela/0000-0001-7764-1867; PITTAU, Marco/0000-0001-9222-8835; Alberti, Alberto/0000-0002-1708-9473	Regione Sardegna [Ricerca Sanitaria 4 Finalizzata, Anno 2007, UPB S02.04.010, Cap SC02.1106]	Regione Sardegna(Regione Sardegna)	This work was supported by "Regione Sardegna", grant "Ricerca Sanitaria 4 Finalizzata, Anno 2007, UPB S02.04.010, Cap SC02.1106". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2006, J VET DIAGN INVEST, V18, P41, DOI 10.1177/104063870601800106; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendjennat M, 1997, J BACTERIOL, V179, P2210, DOI 10.1128/jb.179.7.2210-2220.1997; Bendjennat M, 1999, INFECT IMMUN, V67, P4456, DOI 10.1128/IAI.67.9.4456-4462.1999; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Cacciotto C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-225; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; COTTON FA, 1979, P NATL ACAD SCI USA, V76, P2551, DOI 10.1073/pnas.76.6.2551; Denison AM, 2005, INFECT IMMUN, V73, P2033, DOI 10.1128/IAI.73.4.2033-2039.2005; Fleury B, 2002, INFECT IMMUN, V70, P5612, DOI 10.1128/IAI.70.10.5612-5621.2002; Glew MD, 2002, J BACTERIOL, V184, P5987, DOI 10.1128/JB.184.21.5987-5998.2002; Glew MD, 2000, INFECT IMMUN, V68, P4539, DOI 10.1128/IAI.68.8.4539-4548.2000; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; HYNES TR, 1991, PROTEINS, V10, P92, DOI 10.1002/prot.340100203; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Jarvill-Taylor KJ, 1999, J BACTERIOL, V181, P1853, DOI 10.1128/JB.181.6.1853-1860.1999; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li LB, 2010, J BACTERIOL, V192, P4876, DOI 10.1128/JB.00401-10; LOLL PJ, 1989, PROTEINS, V5, P183, DOI 10.1002/prot.340050302; MINION FC, 1986, INFECT IMMUN, V51, P352, DOI 10.1128/IAI.51.1.352-354.1986; MINION FC, 1993, J BACTERIOL, V175, P7842, DOI 10.1128/JB.175.24.7842-7847.1993; MITCHELL A, 1977, J BACTERIOL, V130, P1047, DOI 10.1128/JB.130.3.1047-1054.1977; MUHLRADT PF, 1994, INFECT IMMUN, V62, P3801; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; Paddenberg R, 1998, CELL DEATH DIFFER, V5, P517, DOI 10.1038/sj.cdd.4400380; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rosati S, 2000, VET MICROBIOL, V71, P201, DOI 10.1016/S0378-1135(99)00164-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; Schmidt JA, 2007, J BACTERIOL, V189, P3414, DOI 10.1128/JB.01835-06; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Sokolova IA, 1998, IMMUNOL CELL BIOL, V76, P526, DOI 10.1046/j.1440-1711.1998.00781.x; Somarajan SR, 2010, CELL MICROBIOL, V12, P1821, DOI 10.1111/j.1462-5822.2010.01513.x; Stryer L, 2001, FREEMAN WH CO BIOCH, P704; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANIUCHI H, 1967, J BIOL CHEM, V242, P4752; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tola S, 2001, FEMS MICROBIOL LETT, V202, P45, DOI 10.1111/j.1574-6968.2001.tb10778.x; Wang LY, 2001, MOL MICROBIOL, V42, P1065, DOI 10.1046/j.1365-2958.2001.02700.x	43	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57775	10.1371/journal.pone.0057775	http://dx.doi.org/10.1371/journal.pone.0057775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469065	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900163
J	Erer, HB; Guvenc, TS; Kemik, AS; Yilmaz, HY; Kul, S; Altay, S; Sayar, N; Kaya, Y; Eren, M				Erer, Hatice Betul; Guvenc, Tolga Sinan; Kemik, Ahu Sarbay; Yilmaz, Hale Yaka; Kul, Seref; Altay, Servet; Sayar, Nurten; Kaya, Yuksel; Eren, Mehmet			Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; NEUROMUSCULAR DISORDERS; NON-COMPACTION; MYOCARDIUM	Ventricular hypertrabeculation/noncompaction is a morphologic and functional anomaly of myocardium characterized by prominent trabeculae accompanied by deep recessus. Dilated cardiomyopathy with left ventricular failure is observed in these patients, while the cause or pathophysiologic nature of this complication is not known. Anti-troponin antibodies are formed against circulating cardiac troponins after an acute coronary event or conditions associated with chronic myocyte necrosis, such as dilated cardiomyopathy. In present study, we aimed to investigate cardiac troponins and anti troponin autoantibodies in ventricular noncompaction/hypertrabeculation patients with/without reduced ejection fraction. A total of 50 patients with ventricular noncompaction and 23 healthy volunteers were included in this study. Noncompaction/hypertrabeculation was diagnosed with two-dimensional echocardiography using appropriate criteria. Depending on ejection fraction, patients were grouped into noncompaction with preserved EF (LVEF >50%, n = 24) and noncompaction with reduced EF (LVEF <35%, n = 26) groups. Troponin I, troponin T, anti-troponin I IgM and anti-troponin T IgM were measured with sandwich immunoassay method using a commercially available kit. Patients with noncompaction had significantly higher troponin I (28.98 +/- 9.21 ng/ml in NCNE group and 28.11 +/- 10.42 ng/ml in NCLE group), troponin T (22.17 +/- 6.97 pg/ml in NCNE group and 22.78 +/- 7.76 pg/ml in NCLE group) and antitroponin I IgM (1.92 +/- 0.43 mu g/ml in NCNE group and 1.79 +/- 0.36 mu g/ml in NCLE group) levels compared to control group, while antitroponin T IgM and IgG were only elevated in patients with noncompaction and reduced EF (15.81 +/- 6.52 mu g/ml for IgM and 16.46 +/- 6.25 mu g/ml for IgG). Elevated cardiac troponins and anti-troponin I autoantibodies were observed in patients with noncompaction preceding the decline in systolic function and could indicate ongoing myocardial damage in these patients.	[Erer, Hatice Betul; Yilmaz, Hale Yaka; Kul, Seref; Altay, Servet; Sayar, Nurten; Eren, Mehmet] Dr Siyami Ersek Cardiovasc & Thorac Surg Res & Tr, Dept Cardiol, Istanbul, Turkey; Kafkas Univ, Sch Med, Dept Cardiol, Kars, Turkey; [Kemik, Ahu Sarbay] Istanbul Univ, Cerrahpasa Fac Med, Dept Biochem, Istanbul, Turkey; [Kul, Seref] Bezmialem Vakif Univ, Fac Med, Istanbul, Turkey	Dr. Siyami Ersek Cardiac & Vascular Surgery Training & Research Hospital; Kafkas University; Istanbul University; Istanbul University - Cerrahpasa; Bezmialem Vakif University	Guvenc, TS (corresponding author), Kafkas Univ, Sch Med, Dept Cardiol, Kars, Turkey.	tsguvenc@gmail.com	Altay, Servet/C-1387-2018; Yilmaz, Hale/AAE-1109-2021; Eren, Mehmet/ACD-8031-2022; Güvenç, Tolga Sinan/AAK-6020-2020	Altay, Servet/0000-0001-7112-3970; Yilmaz, Hale/0000-0002-6365-2423; Eren, Mehmet/0000-0002-5570-705X; Güvenç, Tolga Sinan/0000-0002-6738-266X				Adamczyk M, 2010, CLIN CHEM, V56, P676, DOI 10.1373/clinchem.2009.138099; DUSEK J, 1975, ARCH PATHOL, V99, P312; Endberding R, 2010, DTSCH ARZTEBL INT, V107, P206; Finsterer J, 2007, CLIN RES CARDIOL, V96, P109, DOI 10.1007/s00392-006-0467-7; Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664; Halley CM, 2011, J CARD FAIL, V17, P359, DOI 10.1016/j.cardfail.2011.01.003; Hofer M, 2007, INT J CARDIOL, V121, P296, DOI 10.1016/j.ijcard.2006.08.065; Jenni R, 2007, HEART, V93, P11, DOI 10.1136/hrt.2005.082271; Kawahara C, 2011, CIRC J, V75, P656, DOI 10.1253/circj.CJ-10-0837; Leuschner F, 2008, EUR HEART J, V29, P1949, DOI 10.1093/eurheartj/ehn268; Mann DL, 2011, BRAUNWALDS HEART DIS, P487; Miettinen KH, 2008, J CARD FAIL, V14, P481, DOI 10.1016/j.cardfail.2008.02.009; Nagavalli S, 2010, SOUTH MED J, V103, P662, DOI 10.1097/SMJ.0b013e3181e2b377; Nellessen U, 2006, CLIN CARDIOL, V29, P219, DOI 10.1002/clc.4960290510; Nussinovitch U, 2010, HEART, V96, P1518, DOI 10.1136/hrt.2010.195255; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Sato Y, 2001, CIRCULATION, V103, P369; Shmilovich H, 2007, INT J CARDIOL, V117, P198, DOI 10.1016/j.ijcard.2006.04.077; Stollberger C, 2002, AM J CARDIOL, V90, P899, DOI 10.1016/S0002-9149(02)02723-6; Yoshikawa T, 2009, CIRC J, V73, P602, DOI 10.1253/circj.CJ-08-1151; Yousef ZR, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-37	21	4	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57648	10.1371/journal.pone.0057648	http://dx.doi.org/10.1371/journal.pone.0057648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469039	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900138
J	Estill, J; Egger, M; Johnson, LF; Gsponer, T; Wandeler, G; Davies, MA; Boulle, A; Wood, R; Garone, D; Stringer, JSA; Hallett, TB; Keiser, O				Estill, Janne; Egger, Matthias; Johnson, Leigh F.; Gsponer, Thomas; Wandeler, Gilles; Davies, Mary-Ann; Boulle, Andrew; Wood, Robin; Garone, Daniela; Stringer, Jeffrey S. A.; Hallett, Timothy B.; Keiser, Olivia		IeDEA Southern Africa	Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; VIRAL LOAD; FOLLOW-UP; TREATMENT FAILURE; PATIENTS LOST; MUTATIONS; INFECTION; CAMEROON; OUTCOMES	Objective: Mortality in patients starting antiretroviral therapy (ART) is higher in Malawi and Zambia than in South Africa. We examined whether different monitoring of ART (viral load [VL] in South Africa and CD4 count in Malawi and Zambia) could explain this mortality difference. Design:: Mathematical modelling study based on data from ART programmes. Methods: We used a stochastic simulation model to study the effect of VL monitoring on mortality over 5 years. In baseline scenario A all parameters were identical between strategies except for more timely and complete detection of treatment failure with VL monitoring. Additional scenarios introduced delays in switching to second-line ART (scenario B) or higher virologic failure rates (due to worse adherence) when monitoring was based on CD4 counts only (scenario C). Results are presented as relative risks (RR) with 95% prediction intervals and percent of observed mortality difference explained. Results: RRs comparing VL with CD4 cell count monitoring were 0.94 (0.74-1.03) in scenario A, 0.94 (0.77-1.02) with delayed switching (scenario B) and 0.80 (0.44-1.07) when assuming a 3-times higher rate of failure (scenario C). The observed mortality at 3 years was 10.9% in Malawi and Zambia and 8.6% in South Africa (absolute difference 2.3%). The percentage of the mortality difference explained by VL monitoring ranged from 4% (scenario A) to 32% (scenarios B and C combined, assuming a 3-times higher failure rate). Eleven percent was explained by non-HIV related mortality. Conclusions: VL monitoring reduces mortality moderately when assuming improved adherence and decreased failure rates.	[Estill, Janne; Egger, Matthias; Gsponer, Thomas; Wandeler, Gilles; Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Johnson, Leigh F.; Davies, Mary-Ann; Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, CIDER, ZA-7925 Cape Town, South Africa; [Wandeler, Gilles] Univ Hosp Bern, Infect Dis Clin, CH-3010 Bern, Switzerland; [Wood, Robin] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Garone, Daniela] Med Sans Frontieres, Khayelitsha ART Programme, Cape Town, South Africa; [Stringer, Jeffrey S. A.] CIDRZ, Lusaka, Zambia; [Stringer, Jeffrey S. A.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	University of Bern; University of Cape Town; University of Bern; University Hospital of Bern; University of Cape Town; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Imperial College London	Estill, J (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	jestill@ispm.unibe.ch	Boulle, Andrew/C-1413-2008; Stringer, Jeffrey S. A./AAU-2342-2021; Wandeler, Gilles/ABB-2961-2020	Boulle, Andrew/0000-0002-7713-8062; Stringer, Jeffrey/0000-0002-9590-7216; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132; Hallett, Timothy/0000-0002-9681-0424	National Institute of Allergy and Infectious Diseases (NIAID) [5U01-AI069924-05]; PROSPER fellowship; Swiss National Science Foundation [32333B_131629]; Swiss School of Public Health; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [G0600719B, MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PROSPER fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss School of Public Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), grant 5U01-AI069924-05, a PROSPER fellowship to O.K. supported by the Swiss National Science Foundation (grant 32333B_131629) and a PhD student fellowship to J.E. from the Swiss School of Public Health. This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), grant 5U01-AI069924-05, a PROSPER fellowship to O.K. supported by the Swiss National Science Foundation (grant 32333B_131629) and a PhD student fellowship to J.E. from the Swiss School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA2008 MOD; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Beadles WI, 2009, TROP DOCT, V39, P78, DOI 10.1258/td.2008.080213; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Eshun-Wilson Ingrid, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P104, DOI 10.1177/1545109710361537; Estill J, 2012, AIDS, V26, P1403, DOI 10.1097/QAD.0b013e3283536988; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Kimmel AD, 2010, JAIDS-J ACQ IMM DEF, V54, P258, DOI 10.1097/QAI.0b013e3181d0db97; Koethe JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009680; Kouanfack C, 2009, CLIN INFECT DIS, V48, P1318, DOI 10.1086/597779; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mermin J, 2011, BRIT MED J, V343; Orrell C, 2007, ANTIVIR THER, V12, P83; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tsiodras S, 2000, ARCH INTERN MED, V160, P2050, DOI 10.1001/archinte.160.13.2050; WHO, 2010, ANT THER HIV INF AD; WHO, 2012, WHO HIV DRUG RES REP; World Health Organization Joint United Nations Programme on HIV/AIDS (UNAIDS) UNICEF, 2010, UN ACC SCAL PRIO HIV	32	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57611	10.1371/journal.pone.0057611	http://dx.doi.org/10.1371/journal.pone.0057611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469035	Green Published, gold			2022-12-27	WOS:000315524900134
J	Fu, N; Wang, Q; Shen, HL				Fu, Nan; Wang, Qian; Shen, Huo-Lin			De Novo Assembly, Gene Annotation and Marker Development Using Illumina Paired-End Transcriptome Sequences in Celery (Apium graveolens L.)	PLOS ONE			English	Article							MICROSATELLITE MARKERS; SSR-MARKERS; RAPID TRANSCRIPTOME; ROOT TRANSCRIPTOME; HEVEA-BRASILIENSIS; GENERATION; IDENTIFICATION; INHERITANCE; CULTIVARS; DATABASE	Background: Celery is an increasing popular vegetable species, but limited transcriptome and genomic data hinder the research to it. In addition, a lack of celery molecular markers limits the process of molecular genetic breeding. High-throughput transcriptome sequencing is an efficient method to generate a large transcriptome sequence dataset for gene discovery, molecular marker development and marker-assisted selection breeding. Principal Findings: Celery transcriptomes from four tissues were sequenced using Illumina paired-end sequencing technology. De novo assembling was performed to generate a collection of 42,280 unigenes (average length of 502.6 bp) that represent the first transcriptome of the species. 78.43% and 48.93% of the unigenes had significant similarity with proteins in the National Center for Biotechnology Information (NCBI) non-redundant protein database (Nr) and Swiss-Prot database respectively, and 10,473 (24.77%) unigenes were assigned to Clusters of Orthologous Groups (COG). 21,126 (49.97%) unigenes harboring Interpro domains were annotated, in which 15,409 (36.45%) were assigned to Gene Ontology(GO) categories. Additionally, 7,478 unigenes were mapped onto 228 pathways using the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG). Large numbers of simple sequence repeats (SSRs) were indentified, and then the rate of successful amplication and polymorphism were investigated among 31 celery accessions. Conclusions: This study demonstrates the feasibility of generating a large scale of sequence information by Illumina paired-end sequencing and efficient assembling. Our results provide a valuable resource for celery research. The developed molecular markers are the foundation of further genetic linkage analysis and gene localization, and they will be essential to accelerate the process of breeding.	[Fu, Nan; Wang, Qian; Shen, Huo-Lin] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China	China Agricultural University	Shen, HL (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	SHL1606@cau.edu.cn	Shen, Huolin/AAI-1644-2019		Chinese Universities Scientific Fund [2012QJ134]	Chinese Universities Scientific Fund	This work was supported by Chinese Universities Scientific Fund (No. 2012QJ134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2006, MOL ECOL NOTES, V6, P1080, DOI 10.1111/j.1471-8286.2006.01440.x; Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; ARUS P, 1984, J HERED, V75, P11, DOI 10.1093/oxfordjournals.jhered.a109854; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Cardle L, 2000, GENETICS, V156, P847; Chang L, 2011, AFR J BIOTECHNOL, V10, P12147; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Domblides Arthur, 2008, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V62, P219, DOI 10.2478/v10046-009-0003-z; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Edwards CE, 2012, DNA RES, V19, P1, DOI 10.1093/dnares/dsr037; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu XingFang, 2005, Acta Horticulturae Sinica, V32, P108; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Guo YanMei, 2003, Acta Horticulturae Sinica, V30, P409; Hao DC, 2012, SCI CHINA LIFE SCI, V55, P452, DOI 10.1007/s11427-012-4319-6; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042081; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; HUESTIS GM, 1993, THEOR APPL GENET, V85, P889, DOI 10.1007/BF00225034; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Ju J, 2007, CHINESE AGR SCI B, V23, P120; Kabelka E, 2002, PHYTOPATHOLOGY, V92, P504, DOI 10.1094/PHYTO.2002.92.5.504; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Latrasse D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016592; Lesser MR, 2012, MOL ECOL RESOUR, V12, P448, DOI 10.1111/j.1755-0998.2011.03102.x; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li GY, 2000, HORTSCIENCE, V35, P726, DOI 10.21273/HORTSCI.35.4.726; Li Ying, 2010, Yaoxue Xuebao, V45, P524; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Ma ZhiHu, 2011, China Cucurbits and Vegetables, V24, P20; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Miao Han, 2010, Scientia Agricultura Sinica, V43, P4027; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Muminovic Jasmina, 2004, Plant Genetic Resources Characterization and Utilization, V2, P189, DOI 10.1079/PGR200450; Mutasa-Gottgens ES, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq012; Mutasa-Gottgens E, 2009, TRANSGENIC RES, V18, P301, DOI 10.1007/s11248-008-9211-6; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Noh YS, 2003, PLANT CELL, V15, P1671, DOI 10.1105/tpc.012161; Nothnagel T, 2003, PLANT BREEDING, V122, P339, DOI 10.1046/j.1439-0523.2003.00884.x; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Parra-Gonzalez LB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-425; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; QUIROS CF, 1987, THEOR APPL GENET, V74, P203, DOI 10.1007/BF00289969; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Sampson S, 2006, CHINESE CELERY HAS R; Shahin Arwa, 2012, BMC Res Notes, V5, P79, DOI 10.1186/1756-0500-5-79; Shen HuoLin, 2006, Acta Horticulturae Sinica, V33, P856; [宋小俊 SONG Xiaojun], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P6360; Song XJ, 2008, J ANHUI AGR SCI, V36, P6395; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Takahashi T, 1998, PLANT MOL BIOL, V37, P587, DOI 10.1023/A:1005924817190; [唐粉芳 Tang Fenfang], 2007, [食品科学, Food Science], V28, P322; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; TOWNSEND GR, 1946, PHYTOPATHOLOGY, V36, P980; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang S., 2010, ACTA AGR BOR SIN, V25, P119, DOI 10.7668/hbnxb.2010.S2.027; Wang SA, 2011, SCI HORTIC-AMSTERDAM, V129, P1, DOI 10.1016/j.scienta.2011.03.020; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Weir B.S., 1990, GENETIC DATA ANAL ME; YANG X, 1993, THEOR APPL GENET, V86, P205, DOI 10.1007/BF00222080; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhou XJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-169	78	74	76	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57686	10.1371/journal.pone.0057686	http://dx.doi.org/10.1371/journal.pone.0057686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469050	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900149
J	Takeichi, M; Nimura, K; Mori, M; Nakagami, H; Kaneda, Y				Takeichi, Makiko; Nimura, Keisuke; Mori, Masaki; Nakagami, Hironori; Kaneda, Yasufumi			The Transcription Factors Tbx18 and Wt1 Control the Epicardial Epithelial-Mesenchymal Transition through Bi-Directional Regulation of Slug in Murine Primary Epicardial Cells	PLOS ONE			English	Article							BETA 4 TREATMENT; MYOCARDIAL-INFARCTION; SIGNALING PATHWAYS; DEVELOPING HEART; DAMAGED HEART; RXR-ALPHA; DIFFERENTIATION; MORPHOGENESIS; PROGENITORS; MUSCLE	During cardiac development, a subpopulation of epicardial cells migrates into the heart as part of the epicardial epithelial-mesenchymal transition (EMT) and differentiates into smooth muscle cells and fibroblasts. However, the roles of transcription factors in the epicardial EMT are poorly understood. Here, we show that two transcription factors expressed in the developing epicardium, T-box18 (Tbx18) and Wilms' tumor 1 homolog (Wt1), bi-directionally control the epicardial EMT through their effects on Slug expression in murine primary epicardial cells. Knockdown of Wt1 induced the epicardial EMT, which was accompanied by an increase in the migration and expression of N-cadherin and a decrease in the expression of ZO-1 as an epithelial marker. By contrast, knockdown of Tbx18 inhibited the mesenchymal transition induced by TGF beta 1 treatment and Wt1 knockdown. The expression of Slug but not Snail decreased as a result of Tbx18 knockdown, but Slug expression increased following knockdown of Wt1. Knockdown of Slug also attenuated the epicardial EMT induced by TGF beta 1 treatment and Wt1 knockdown. Furthermore, in normal murine mammary gland-C7 (NMuMG-C7) cells, Tbx18 acted to increase Slug expression, while Wt1 acted to decrease Slug expression. Chromatin immunoprecipitation and promoter assay revealed that Tbx18 and Wt1 directly bound to the Slug promoter region and regulated Slug expression. These results provide new insights into the regulatory mechanisms that control the epicardial EMT.	[Takeichi, Makiko; Nimura, Keisuke; Mori, Masaki; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Suita, Osaka, Japan; [Mori, Masaki] Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Nakagami, Hironori] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka, Japan	Osaka University; Harvard University; Boston Children's Hospital; Osaka University	Nakagami, H (corresponding author), Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka, Japan.	nakagami@gts.med.osaka-u.ac.jp; kaneday@gts.med.osaka-u.ac.jp	Nakagami, Hironori/GLU-0570-2022; Nimura, Keisuke/AAE-9925-2020	Nakagami, Hironori/0000-0003-4494-3601; 	Ministry of Education, Culture, Sports, Science and Technology; Japan Heart Association; SENSHIN Medical Research Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Heart Association; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, and Japan Heart Association. This study was also supported by grants from SENSHIN Medical Research Foundation and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Guadix JA, 2011, DEVELOPMENT, V138, P1093, DOI 10.1242/dev.044594; Bax NAM, 2011, BASIC RES CARDIOL, V106, P829, DOI 10.1007/s00395-011-0181-0; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai XQ, 2011, DEV BIOL, V360, P381, DOI 10.1016/j.ydbio.2011.09.023; Casanova JC, 2013, GENESIS, V51, P32, DOI 10.1002/dvg.22353; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Christoffels V, 2011, NATURE, V474, P585, DOI 10.1038/474585a; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Compton LA, 2006, DEV DYNAM, V235, P82, DOI 10.1002/dvdy.20629; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; Dokic D, 2006, DEV BIOL, V299, P489, DOI 10.1016/j.ydbio.2006.08.054; Greulich F, 2012, CARDIOVASC RES, V96, P476, DOI 10.1093/cvr/cvs277; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Ishii Y, 2010, DEV CELL, V19, P307, DOI 10.1016/j.devcel.2010.07.017; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Kispert A, 2012, J MOL CELL CARDIOL, V52, P10, DOI 10.1016/j.yjmcc.2011.10.004; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Limana F, 2011, PHARMACOL THERAPEUT, V129, P82, DOI 10.1016/j.pharmthera.2010.09.002; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Miller-Hodges E, 2012, J PATHOL, V226, P229, DOI 10.1002/path.2977; Moore AW, 1999, DEVELOPMENT, V126, P1845; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Mori M, 2009, MOL BIOL CELL, V20, P3115, DOI 10.1091/mbc.E09-01-0046; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Plageman TF, 2005, DEV DYNAM, V232, P11, DOI 10.1002/dvdy.20201; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, METHODS; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; SPRINGHORN JP, 1989, BIOCHEM J, V258, P73, DOI 10.1042/bj2580073; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Zeng B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-67; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2012, J MOL CELL CARDIOL, V52, P43, DOI 10.1016/j.yjmcc.2011.08.020; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	56	46	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57829	10.1371/journal.pone.0057829	http://dx.doi.org/10.1371/journal.pone.0057829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469079	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900175
J	Mero, IL; Gustavsen, MW; Saether, HS; Flam, ST; Berg-Hansen, P; Sondergaard, HB; Jensen, PEH; Berge, T; Bjolgerud, A; Muggerud, A; Aarseth, JH; Myhr, KM; Celius, EG; Sellebjerg, F; Hillert, J; Alfredsson, L; Olsson, T; Oturai, AB; Kockum, I; Lie, BA; Andreassen, BK; Harbo, HF				Mero, Inger-Lise; Gustavsen, Marte W.; Saether, Hanne S.; Flam, Siri T.; Berg-Hansen, Pal; Sondergaard, Helle B.; Jensen, Poul Erik H.; Berge, Tone; Bjolgerud, Anja; Muggerud, Aslaug; Aarseth, Jan H.; Myhr, Kjell-Morten; Celius, Elisabeth G.; Sellebjerg, Finn; Hillert, Jan; Alfredsson, Lars; Olsson, Tomas; Oturai, Annette Bang; Kockum, Ingrid; Lie, Benedicte A.; Andreassen, Bettina Kulle; Harbo, Hanne F.		Int Multiple Sclerosis Genetics	Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; DIAGNOSTIC-CRITERIA; CLINICAL-FEATURES; INTERFERON-BETA; SUSCEPTIBILITY; POPULATION; HLA-DRB1; GENOMEWIDE; DISABILITY; GUIDELINES	The presence of oligoclonal bands (OCB) in cerebrospinal fluid (CSF) is a typical finding in multiple sclerosis (MS). We applied data from Norwegian, Swedish and Danish (i.e. Scandinavian) MS patients from a genome-wide association study (GWAS) to search for genetic differences in MS relating to OCB status. GWAS data was compared in 1367 OCB positive and 161 OCB negative Scandinavian MS patients, and nine of the most associated SNPs were genotyped for replication in 3403 Scandinavian MS patients. HLA-DRB1 genotypes were analyzed in a subset of the OCB positive (n = 2781) and OCB negative (n = 292) MS patients and compared to 890 healthy controls. Results from the genome-wide analyses showed that single nucleotide polymorphisms (SNPs) from the HLA complex and six other loci were associated to OCB status. In SNPs selected for replication, combined analyses showed genome-wide significant association for two SNPs in the HLA complex; rs3129871 (p = 5.7x10(-15)) and rs3817963 (p = 5.7x10(-10)) correlating with the HLA-DRB1*15 and the HLA-DRB1*04 alleles, respectively. We also found suggestive association to one SNP in the Calsyntenin-2 gene (p = 8.83x10(-7)). In HLA-DRB1 analyses HLA-DRB1*15:01 was a stronger risk factor for OCB positive than OCB negative MS, whereas HLA-DRB1*04:04 was associated with increased risk of OCB negative MS and reduced risk of OCB positive MS. Protective effects of HLA-DRB1*01:01 and HLA-DRB1*07:01 were detected in both groups. The groups were different with regard to age at onset (AAO), MS outcome measures and gender. This study confirms both shared and distinct genetic risk for MS subtypes in the Scandinavian population defined by OCB status and indicates different clinical characteristics between the groups. This suggests differences in disease mechanisms between OCB negative and OCB positive MS with implications for patient management, which need to be further studied.	[Mero, Inger-Lise; Gustavsen, Marte W.; Saether, Hanne S.; Berg-Hansen, Pal; Berge, Tone; Bjolgerud, Anja; Muggerud, Aslaug; Celius, Elisabeth G.; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Mero, Inger-Lise; Saether, Hanne S.; Flam, Siri T.; Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Mero, Inger-Lise; Saether, Hanne S.; Flam, Siri T.; Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Sondergaard, Helle B.; Jensen, Poul Erik H.; Sellebjerg, Finn; Oturai, Annette Bang] Rigshosp, Dept Neurol, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark; [Berge, Tone] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Aarseth, Jan H.; Myhr, Kjell-Morten] Norwegian Multiple Sclerosis Registry, Bergen, Norway; [Aarseth, Jan H.; Myhr, Kjell-Morten] Haukeland Hosp, Dept Neurol, Biobank, N-5021 Bergen, Norway; [Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway; [Hillert, Jan] Karolinska Inst, Dept Clin Neurosci, Multiple Sclerosis Res Grp, Ctr Mol Med, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Olsson, Tomas; Kockum, Ingrid] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Res Grp, Stockholm, Sweden; [Andreassen, Bettina Kulle] Univ Oslo, Inst Clin Med, Dept Clin Mol Biol & Lab Sci EpiGen, Oslo, Norway; [Andreassen, Bettina Kulle] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Gustavsen, Marte W.; Berg-Hansen, Pal; Bjolgerud, Anja; Muggerud, Aslaug; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Rigshospitalet; University of Copenhagen; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Oslo; University of Oslo; University of Oslo	Harbo, HF (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	h.f.harbo@medisin.uio.no	Zipp, Frauke/C-9968-2015; Kockum, Ingrid/O-8781-2018; Alfredsson, Lars/AAC-9007-2019; Myhr, Kjell-Morten/H-1528-2018; Celius, Elisabeth Gulowsen/S-1387-2019; Goris, An/F-2943-2010; Saarela, Janna S/E-5369-2014; Goris, An/L-5852-2019; D'Alfonso, Sandra/K-7295-2014	Zipp, Frauke/0000-0002-1231-1928; Kockum, Ingrid/0000-0002-0867-4726; Alfredsson, Lars/0000-0003-1688-6697; Myhr, Kjell-Morten/0000-0002-0980-510X; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Goris, An/0000-0002-1276-6682; Goris, An/0000-0002-1276-6682; D'Alfonso, Sandra/0000-0002-3983-9925; Sondergaard, Helle Bach/0000-0001-9435-0658; Saarela, Janna/0000-0002-0853-6219; Olsson, Tomas/0000-0002-2938-1877; Comabella Lopez, Manuel/0000-0002-2373-6657; Sellebjerg, Finn/0000-0002-1333-9623	South-Eastern Norway Regional Health Authority; Research Council of Norway; Odd Fellow MS society; Danish Multiple Sclerosis Society; Swedish Medical Research Council; AFA foundation; Knut and Alice and Wallenbergs foundations; Council for Working Life and Social Research; Wellcome Trust, as part of the Wellcome Trust Case Control Consortium2 project [085475/B/08/Z, 085475/Z/08/Z]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Odd Fellow MS society; Danish Multiple Sclerosis Society; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AFA foundation; Knut and Alice and Wallenbergs foundations; Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Wellcome Trust, as part of the Wellcome Trust Case Control Consortium2 project; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for Health Research(National Institute for Health Research (NIHR))	The current study is funded by grants from the South-Eastern Norway Regional Health Authority, the Research Council of Norway, the Odd Fellow MS society, the Danish Multiple Sclerosis Society, the Swedish Medical Research Council, the AFA foundation, Knut and Alice and Wallenbergs foundations and Council for Working Life and Social Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all patients and healthy controls for their participation. The International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium2 provided the genotypes used in the screening phase of this study. We acknowledge the collaboration and principal funding for the genome-wide study provided by the Wellcome Trust, as part of the Wellcome Trust Case Control Consortium2 project (085475/B/08/Z and 085475/Z/08/Z). We thank all contributors to the collection of samples and clinical data in the Norwegian MS Registry and Biobank. The Norwegian Bone Marrow Donor Registry, Rikshospitalet, Oslo University Hospital are acknowledged for providing Norwegian controls. The Centre for Integrative Genetics; CIGENE, Norwegian University of Life Sciences (UMB) Aas is thanked for performing Sequenom analyses.	ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Annunziata P, 2006, J NEUROL SCI, V244, P97, DOI 10.1016/j.jns.2006.01.004; Ballerini C, 2004, J NEUROIMMUNOL, V150, P178, DOI 10.1016/j.jneuroim.2004.01.015; Balnyte R, 2011, MEDICINA-LITHUANIA, V47, P368, DOI 10.3390/medicina47070052; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Buck D, 2012, ANN NEUROL; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Idiman E, 2009, J NEUROIMMUNOL, V212, P121, DOI 10.1016/j.jneuroim.2009.04.014; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; Imrell K, 2009, J NEUROIMMUNOL, V210, P128, DOI 10.1016/j.jneuroim.2009.03.005; JERSILD C, 1972, LANCET, V1, P1240; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Kikuchi S, 2003, NEUROLOGY, V60, P647, DOI 10.1212/01.WNL.0000048202.09147.9E; Lechner-Scott J, 2011, MULT SCLER; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Link J, 2010, J NEUROIMMUNOL, V226, P172, DOI 10.1016/j.jneuroim.2010.07.006; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; Lorentzen AR, 2009, ANN NEUROL, V65, P658, DOI 10.1002/ana.21695; Lourenco P, 2012, MULT SCLER; Lundkvist M, 2010, MULT SCLER J, V16, P796, DOI 10.1177/1352458510373112; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romero-Pinel L, 2011, EUR J NEUROL, V18, P1258, DOI 10.1111/j.1468-1331.2011.03379.x; SaruhanDireskeneli G, 1997, HUM IMMUNOL, V55, P59, DOI 10.1016/S0198-8859(97)00086-4; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; Sedille-Mostafaie N, 2012, J NEURAL TRANSM, V119, P77, DOI 10.1007/s00702-011-0667-9; Siritho S, 2009, J NEUROL SCI, V279, P21, DOI 10.1016/j.jns.2008.12.029; Tintore M, 2009, MULT SCLER J, V15, P407, DOI 10.1177/1352458509104581; Wu JS, 2010, J NEUROL SCI, V288, P63, DOI 10.1016/j.jns.2009.10.005; Zhang QO, 2011, AUTOIMMUN REV, V10, P474, DOI 10.1016/j.autrev.2011.03.003	42	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58352	10.1371/journal.pone.0058352	http://dx.doi.org/10.1371/journal.pone.0058352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472185	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900131
J	Rodriguez, JE; Ramirez, AS; Salas, LP; Helguera-Repetto, C; Gonzalez-y-Merchand, J; Soto, CY; Hernandez-Pando, R				Rodriguez, Jimmy E.; Ramirez, Ana S.; Salas, Laura P.; Helguera-Repetto, Cecilia; Gonzalez-y-Merchand, Jorge; Soto, Carlos Y.; Hernandez-Pando, Rogelio			Transcription of Genes Involved in Sulfolipid and Polyacyltrehalose Biosynthesis of Mycobacterium tuberculosis in Experimental Latent Tuberculosis Infection	PLOS ONE			English	Article							NONREPLICATING PERSISTENCE; CELL-WALL; DIFFERENTIAL EXPRESSION; PULMONARY TUBERCULOSIS; HYPOXIC CONDITIONS; NEUTRAL-RED; VIRULENCE; SULFOGLYCOLIPIDS; ACYLTRANSFERASES; BIOGENESIS	The Influence of trehalose-based glycolipids in the virulence of Mycobacterium tuberculosis (Mtb) is recognised; however, the actual role of these cell-wall glycolipids in latent infection is unknown. As an initial approach, we determined by two-dimensional thin-layer chromatography the sulfolipid (SL) and diacyltrehalose/polyacyltrehalose (DAT/PAT) profile of the cell wall of hypoxic Mtb. Then, qRT-PCR was extensively conducted to determine the transcription profile of genes involved in the biosynthesis of these glycolipids in non-replicating persistent 1 (NRP1) and anaerobiosis (NRP2) models of hypoxia (Wayne model), and murine models of chronic and progressive pulmonary tuberculosis. A diminished content of SL and increased amounts of glycolipids with chromatographic profile similar to DAT were detected in Mtb grown in the NRP2 stage. A striking decrease in the transcription of mmpL8 and mmpL10 transporter genes and increased transcription of the pks (polyketidesynthase) genes involved in SL and DAT biosynthesis were detected in both the NRP2 stage and the murine model of chronic infection. All genes were found to be up-regulated in the progressive disease. These results suggest that SL production is diminished during latent infection and the DAT/PAT precursors can be accumulated inside tubercle bacilli and are possibly used in reactivation processes.	[Rodriguez, Jimmy E.; Ramirez, Ana S.; Soto, Carlos Y.] Univ Nacl Colombia, Fac Ciencias, Dept Quim, Bogota, Colombia; [Salas, Laura P.; Helguera-Repetto, Cecilia; Gonzalez-y-Merchand, Jorge] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Microbiol Mol, Mexico City, DF, Mexico; [Hernandez-Pando, Rogelio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Secc Patol Expt, Mexico City, DF, Mexico	Universidad Nacional de Colombia; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Hernandez-Pando, R (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Secc Patol Expt, Mexico City, DF, Mexico.	rhdezpando@hotmail.com	Ramirez, Ana S./AAS-9922-2021	Ramirez, Ana S./0000-0002-1619-0721; Hernandez-Pando, Rogelio/0000-0003-1292-3833; Helguera Repetto, A Cecilia/0000-0001-6715-9671; Soto Ospina, Carlos Yesid/0000-0001-8694-7489	Division de Investigacion Bogota, Vicerrectoria de Investigacion, Universidad Nacional de Colombia [8003272, 16060]; CONACyT [84456, CB-2010-01-156347]; 7th Framework Program, European Commission [HEALTH-F3-2008-200999]	Division de Investigacion Bogota, Vicerrectoria de Investigacion, Universidad Nacional de Colombia; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 7th Framework Program, European Commission	This work was supported by Division de Investigacion Bogota, Vicerrectoria de Investigacion, Universidad Nacional de Colombia [Grants number 8003272 and 16060]; CONACyT [contract 84456 and grant number CB-2010-01-156347] and the 7th Framework Program, European Commission [contract number HEALTH-F3-2008-200999].	Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Badillo-Lopez C, 2010, INT MICROBIOL, V13, P9, DOI 10.2436/20.1501.01.106; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cardona PJ, 2006, MICROBES INFECT, V8, P183, DOI 10.1016/j.micinf.2005.06.011; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Fritz C, 2002, INFECT IMMUN, V70, P286, DOI 10.1128/IAI.70.1.286-291.2002; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GonzalezyMerchand JA, 1996, MICROBIOL-UK, V142, P667, DOI 10.1099/13500872-142-3-667; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Hernandez-Pando R, 2001, EXP TOXICOL PATHOL, V53, P257, DOI 10.1078/0940-2993-00182; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kim SY, 2008, J MED MICROBIOL, V57, P1473, DOI 10.1099/jmm.0.2008/001545-0; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Layre E, 2011, J LIPID RES, V52, P1098, DOI 10.1194/jlr.M013482; LUQUIN M, 1991, INT J SYST BACTERIOL, V41, P390, DOI 10.1099/00207713-41-3-390; Munoz M, 1997, FEMS MICROBIOL LETT, V157, P251, DOI 10.1016/S0378-1097(97)00483-7; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Soto CY, 2000, FEMS MICROBIOL LETT, V187, P103, DOI 10.1016/S0378-1097(00)00183-X; Soto CY, 2002, J CLIN MICROBIOL, V40, P3021, DOI 10.1128/JCM.40.8.3021-3024.2002; Starck J, 2004, MICROBIOL-SGM, V150, P3821, DOI 10.1099/mic.0.27284-0; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WHO, 2011, WHO GLOBAL TUBERCULO; Yu GH, 2011, GENE, V489, P21, DOI 10.1016/j.gene.2011.08.019	43	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58378	10.1371/journal.pone.0058378	http://dx.doi.org/10.1371/journal.pone.0058378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472191	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900137
J	Catteau, X; Simon, P; Vanhaeverbeek, M; Noel, JC				Catteau, Xavier; Simon, Philippe; Vanhaeverbeek, Michel; Noel, Jean-Christophe			Variable Stromal Periductular Expression of CD34 and Smooth Muscle Actin (SMA) in Intraductal Carcinoma of the Breast	PLOS ONE			English	Article							LYMPH-NODE BIOPSY; IN-SITU; EXTRACELLULAR-MATRIX; DUCTAL CARCINOMA; MYOFIBROBLAST DIFFERENTIATION; FIBROCYTES; ANTIGEN; TISSUE; CELLS; FIBROBLASTS	In breast carcinoma, the stromal loss of CD34 expression and acquisition of SMA myofibroblastic features may constitute a prerequisite for tumor invasiveness. However, this hypothesis remains controversial, with some authors describing the loss of CD34 fibrocytes in the absence of SMA myofibroblastic-like cells in the stroma of invasive carcinoma. Others have also described the disappearance of CD34 fibrocytes from in situ carcinoma. To clarify this issue, we compared the distribution of CD34 fibrocytes and SMA reactive myofibroblasts between stromal areas of tumor-free mammary tissue, ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). In addition to 28 IDC, 300 normal duct-lobular units and 600 ducts with DCIS (158 low-grade, 266 intermediate, and 176 high-grade) were scored. The relationships between staining patterns and different histological features (grade of DCIS and presence or absence of necrosis) were compared. Loss of CD34 expression and acquisition of SMA expression were more frequent in high-grade in situ lesions than in intermediate and low-grade lesions (p<0.001). When necrosis was found in association with grade 2 or 3 DCIS, the decrease in CD34 expression was higher than in lesions without necrosis and that independently of the grade of DCIS (p<0.05). Necrosis did not appear to play a significant role in the expression of SMA (p = 0.35). In all cases, the stroma of invasive carcinomas showed a complete loss of CD34 fibrocytes. Future research on both CD34 fibrocytes and mechanisms stromal changes are essential in the future and may potentially lead to new treatment approaches.	[Catteau, Xavier] Inst Pathol & Genet, Gosselies, Belgium; [Simon, Philippe] Erasmes Univ Hosp ULB, Unit Gynaecol, Brussels, Belgium; [Vanhaeverbeek, Michel] Univ Libre Brussels, Andre Vesale Hosp, CHU Charleroi, Expt Med Lab, Montignies le Tilleul, Belgium; [Noel, Jean-Christophe] Univ Libre Brussels, Erasmes Univ Hosp, Dept Pathol, Unit Gynaecopathol, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles	Catteau, X (corresponding author), Inst Pathol & Genet, Gosselies, Belgium.	xavier.catteau06@gmail.com	SIMON, Philippe/GXZ-4688-2022					Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Barth PJ, 2005, VIRCHOWS ARCH, V446, P532, DOI 10.1007/s00428-005-1256-9; Barth PJ, 2004, VIRCHOWS ARCH, V444, P231, DOI 10.1007/s00428-003-0965-1; Barth PJ, 2002, VIRCHOWS ARCH, V440, P298, DOI 10.1007/s004280100530; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Catteau X, 2012, PATHOL RES PRACT, V208, P217, DOI 10.1016/j.prp.2012.02.003; Chauhan H, 2003, J CLIN PATHOL, V56, P271, DOI 10.1136/jcp.56.4.271; Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307; Cimpean Anca Maria, 2005, Rom J Morphol Embryol, V46, P123; Espana EM, 2004, INVEST OPHTH VIS SCI, V45, P2985, DOI 10.1167/iovs.04-0201; HOWLETT AR, 1993, EPITHELIAL CELL BIOL, V2, P79; Humphreys TR, 2000, DERMATOL SURG, V26, P200, DOI 10.1046/j.1524-4725.2000.09207.x; LAGIOS MD, 1995, CANCER LETT, V90, P97, DOI 10.1016/0304-3835(94)03683-A; Liang XQ, 2009, PROTEOMICS, V9, P182, DOI 10.1002/pmic.200700957; Moore T, 2001, HISTOPATHOLOGY, V38, P62, DOI 10.1046/j.1365-2559.2001.01053.x; Rubin R, 2008, RUBINS PATHOLOGY CLI, V12, P1341; Satish L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-113; Schwartz GF, 2002, CANCER, V94, P2542, DOI 10.1002/cncr.10539; Sircar K, 1999, AM J SURG PATHOL, V23, P377, DOI 10.1097/00000478-199904000-00002; Suster S, 1997, AM J SURG PATHOL, V21, P195, DOI 10.1097/00000478-199702000-00009; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Valenti MT, 2001, HISTOCHEM J, V33, P499, DOI 10.1023/A:1014927305775; Weinberg Robert, 2006, Cancer Res, V66, P11550, DOI 10.1158/0008-5472.CAN-06-3149; Wessel C, 2008, VIRCHOWS ARCH, V453, P485, DOI 10.1007/s00428-008-0667-9; YAMAZAKI K, 1995, J SUBMICR CYTOL PATH, V27, P309; Yen TWF, 2005, J AM COLL SURGEONS, V200, P516, DOI 10.1016/j.jamcollsurg.2004.11.012	27	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57773	10.1371/journal.pone.0057773	http://dx.doi.org/10.1371/journal.pone.0057773			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469238	gold, Green Published, Green Submitted			2022-12-27	WOS:000315897100041
J	Liu, J; Bombera, R; Leroy, L; Roupioz, Y; Baganizi, DR; Marche, PN; Haguet, V; Mailley, P; Livache, T				Liu, Jie; Bombera, Radoslaw; Leroy, Loic; Roupioz, Yoann; Baganizi, Dieudonne R.; Marche, Patrice N.; Haguet, Vincent; Mailley, Pascal; Livache, Thierry			Selective Individual Primary Cell Capture Using Locally Bio-Functionalized Micropores	PLOS ONE			English	Article							AFFINITY-CHROMATOGRAPHY; MICROFLUIDIC CHAMBERS; CYTOMETRY PLATFORM; COULTER-COUNTER; TUMOR-CELLS; SEPARATION; SINGLE; BLOOD; LYMPHOCYTES; SURFACES	Background: Solid-state micropores have been widely employed for 6 decades to recognize and size flowing unlabeled cells. However, the resistive-pulse technique presents limitations when the cells to be differentiated have overlapping dimension ranges such as B and T lymphocytes. An alternative approach would be to specifically capture cells by solid-state micropores. Here, the inner wall of 15-mu m pores made in 10 mu m-thick silicon membranes was covered with antibodies specific to cell surface proteins of B or T lymphocytes. The selective trapping of individual unlabeled cells in a bio-functionalized micropore makes them recognizable just using optical microscopy. Methodology/Principal Findings: We locally deposited oligodeoxynucleotide (ODN) and ODN-conjugated antibody probes on the inner wall of the micropores by forming thin films of polypyrrole-ODN copolymers using contactless electro-functionalization. The trapping capabilities of the bio-functionalized micropores were validated using optical microscopy and the resistive-pulse technique by selectively capturing polystyrene microbeads coated with complementary ODN. B or T lymphocytes from a mouse splenocyte suspension were specifically immobilized on micropore walls functionalized with complementary ODN-conjugated antibodies targeting cell surface proteins. Conclusions/Significance: The results showed that locally bio-functionalized micropores can isolate target cells from a suspension during their translocation throughout the pore, including among cells of similar dimensions in complex mixtures.	[Liu, Jie; Bombera, Radoslaw; Leroy, Loic; Roupioz, Yoann; Baganizi, Dieudonne R.; Mailley, Pascal; Livache, Thierry] UJF, CEA, CNRS, Inst Nanosci & Cryogenie,UMR5819, Grenoble, France; [Baganizi, Dieudonne R.; Marche, Patrice N.] UJF, INSERM, U823, Inst Albert Bonniot, La Tronche, France; [Haguet, Vincent] UJF, CEA, INSERM, Inst Rech Technol & Sci Vivant,U1038, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Livache, T (corresponding author), UJF, CEA, CNRS, Inst Nanosci & Cryogenie,UMR5819, Grenoble, France.	thierry.livache@cea.fr	Marche, Patrice N/K-5060-2013; Haguet, Vincent/AAM-3326-2020	Marche, Patrice N/0000-0002-8930-9340; Haguet, Vincent/0000-0002-1325-5278; Baganizi, Dieudonne/0000-0001-6826-9864; Leroy, Loic/0000-0003-0641-264X; Mailley, Pascal/0000-0001-6601-1624	French ANR agency under the PNANO program [PRECIS ANR-08-NANO-049-02]; Nanosciences Foundation (Grenoble, France)	French ANR agency under the PNANO program(French National Research Agency (ANR)); Nanosciences Foundation (Grenoble, France)	This work was supported by the French ANR agency under the PNANO program (grant PRECIS ANR-08-NANO-049-02). PhD funding of RB was provided by the Nanosciences Foundation (Grenoble, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2003, CELLULAR MOL IMMUNOL; Adams AA, 2008, J AM CHEM SOC, V130, P8633, DOI 10.1021/ja8015022; Belov L, 2001, CANCER RES, V61, P4483; Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026; BIANCO C, 1970, J EXP MED, V132, P702, DOI 10.1084/jem.132.4.702; Bombera R, 2012, BIOSENS BIOELECTRON, V33, P10, DOI 10.1016/j.bios.2011.11.034; Bouchet A, 2009, SMALL, V5, P2297, DOI 10.1002/smll.200900482; Brewster JD, 2003, J MICROBIOL METH, V55, P287, DOI 10.1016/S0167-7012(03)00163-5; CHANG TW, 1983, J IMMUNOL METHODS, V65, P217; Cheng XH, 2007, LAB CHIP, V7, P170, DOI 10.1039/b612966h; Coulter W. H., 1953, US Patent, Patent No. [US 2656508 A, 2656508]; DEBLOIS RW, 1977, J VIROL, V23, P227, DOI 10.1128/JVI.23.2.227-233.1977; Dharmasiri U, 2011, ANAL CHEM, V83, P2301, DOI 10.1021/ac103172y; Diamond E, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00131; Gabriel M, 2008, P 12 MICROTAS C SAN, V2, P1600; Gabriel M, 2009, P 13 MICROTAS C JEJ, V1, P278; Goubault C, 2003, P MICR TOT AN SYST T, V1, P239; Gyurcsanyi RE, 2008, TRAC-TREND ANAL CHEM, V27, P627, DOI 10.1016/j.trac.2008.06.002; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heng JB, 2004, BIOPHYS J, V87, P2905, DOI 10.1529/biophysj.104.041814; HERZENBERG LA, 1976, SCI AM, V234, P108, DOI 10.1038/scientificamerican0376-108; ISHIDA Y, 1992, J CELL PHYSIOL, V150, P484, DOI 10.1002/jcp.1041500308; Juncker D, 2005, NAT MATER, V4, P622, DOI 10.1038/nmat1435; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Li P, 2012, ANAL CHEM, V84, P8140, DOI 10.1021/ac302002a; Liu J, 2012, SMALL, V8, P1345, DOI 10.1002/smll.201102327; Liu J, 2012, ANAL CHEM, V84, P3254, DOI 10.1021/ac2033744; MANDRUSOV E, 1995, BIOTECHNOL PROGR, V11, P208, DOI 10.1021/bp00032a013; Mittal S, 2012, BIOPHYS J, V102, P721, DOI 10.1016/j.bpj.2011.12.044; MOESSMER G, 1990, BIORHEOLOGY, V27, P829; MOLLOY P, 1995, J APPL BACTERIOL, V78, P359, DOI 10.1111/j.1365-2672.1995.tb03418.x; Murthy SK, 2004, LANGMUIR, V20, P11649, DOI 10.1021/la048047b; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; NIEMEYER CM, 1994, NUCLEIC ACIDS RES, V22, P5530, DOI 10.1093/nar/22.25.5530; Nieuwenhuis JH, 2004, SENSOR ACTUAT B-CHEM, V102, P44, DOI 10.1016/j.snb.2003.10.017; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Patel, 2001, SEPARATING CELLS; Picollet-D'hahan N, 2004, SENS LETT, V2, P91, DOI 10.1166/sl.2004.031; Plouffe BD, 2009, FASEB J, V23, P3309, DOI 10.1096/fj.09-130260; POUTREL B, 1983, J DAIRY SCI, V66, P2575, DOI 10.3168/jds.S0022-0302(83)82129-8; Pratt ED, 2011, CHEM ENG SCI, V66, P1508, DOI 10.1016/j.ces.2010.09.012; REMBAUM A, 1980, SCIENCE, V208, P364, DOI 10.1126/science.6768131; Revzin A, 2005, LAB CHIP, V5, P30, DOI 10.1039/b405557h; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Roupioz Y, 2009, SMALL, V5, P1493, DOI 10.1002/smll.200801941; Rubakhin SS, 2011, NAT METHODS, V8, pS20, DOI [10.1038/NMETH.1549, 10.1038/nmeth.1549]; Safarik I, 1999, J CHROMATOGR B, V722, P33, DOI 10.1016/S0378-4347(98)00338-7; Shi QH, 2012, P NATL ACAD SCI USA, V109, P419, DOI 10.1073/pnas.1110865109; Sin A, 2005, BIOTECHNOL BIOENG, V91, P816, DOI 10.1002/bit.20556; Ujam LB, 2003, BIOTECHNOL BIOENG, V83, P554, DOI 10.1002/bit.10703; Uram JD, 2006, ANGEW CHEM INT EDIT, V45, P2281, DOI 10.1002/anie.200502862; Vogel A, 2007, METHOD CELL BIOL, V82, P153, DOI 10.1016/S0091-679X(06)82005-4; Wacker R, 2004, ANAL BIOCHEM, V330, P281, DOI 10.1016/j.ab.2004.03.017; Wang K, 2008, ANAL CHEM, V80, P2118, DOI 10.1021/ac702553w; Wang K, 2007, ANAL CHIM ACTA, V601, P1, DOI 10.1016/j.aca.2007.08.029; Wang YL, 2008, LAB CHIP, V8, P734, DOI 10.1039/b800286j; Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b; Zhou KM, 2011, J AM CHEM SOC, V133, P1618, DOI 10.1021/ja108228x; Zhu H, 2008, COLLOID SURFACE B, V64, P260, DOI 10.1016/j.colsurfb.2008.02.010; Zhu H, 2008, ANAL CHIM ACTA, V608, P186, DOI 10.1016/j.aca.2007.12.021; Zhu H, 2009, ANAL CHEM, V81, P8150, DOI 10.1021/ac901390j	61	7	8	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57717	10.1371/journal.pone.0057717	http://dx.doi.org/10.1371/journal.pone.0057717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469221	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100032
J	Williamson, K; Schneider, V; Jordan, RA; Mueller, JE; Pozzi, MH; Bryk, M				Williamson, Kelly; Schneider, Victoria; Jordan, Rachel A.; Mueller, John E.; Pozzi, Michelle Henderson; Bryk, Mary			Catalytic and Functional Roles of Conserved Amino Acids in the SET Domain of the S. cerevisiae Lysine Methyltransferase Set1	PLOS ONE			English	Article							MIXED LINEAGE LEUKEMIA; HISTONE H3; SACCHAROMYCES-CEREVISIAE; PRODUCT SPECIFICITY; GENE-EXPRESSION; STRUCTURAL BASIS; METHYL TRANSFER; PROTEIN; COMPLEX; MECHANISM	In S. cerevisiae, the lysine methyltransferase Set1 is a member of the multiprotein complex COMPASS. Set1 catalyzes mono-, di- and trimethylation of the fourth residue, lysine 4, of histone H3 using methyl groups from S-adenosylmethionine, and requires a subset of COMPASS proteins for this activity. The methylation activity of COMPASS regulates gene expression and chromosome segregation in vivo. To improve understanding of the catalytic mechanism of Set1, single amino acid substitutions were made within the SET domain. These Set1 mutants were evaluated in vivo by determining the levels of K4-methylated H3, assaying the strength of gene silencing at the rDNA and using a genetic assessment of kinetochore function as a proxy for defects in Dam1 methylation. The findings indicate that no single conserved active site base is required for H3K4 methylation by Set1. Instead, our data suggest that a number of aromatic residues in the SET domain contribute to the formation of an active site that facilitates substrate binding and dictates product specificity. Further, the results suggest that the attributes of Set1 required for trimethylation of histone H3 are those required for Pol II gene silencing at the rDNA and kinetochore function.	[Schneider, Victoria] Texas A&M Univ Syst Hlth Sci Ctr, College Stn, TX USA; [Mueller, John E.] Lynntech, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bryk, M (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	bryk@tamu.edu		Williamson, Kelly/0000-0002-7529-0220	NSF REU Site in Biochemistry at Texas A&M University, NSF [DBI-0552822]; National Institutes of Health [RO1 GM70930]; Texas AgriLife Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070930] Funding Source: NIH RePORTER	NSF REU Site in Biochemistry at Texas A&M University, NSF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AgriLife Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the contribution of Kimberly Onyirioha, an undergraduate student who was funded through NSF REU Site in Biochemistry at Texas A&M University, NSF DBI-0552822. This work was supported by National Institutes of Health grant RO1 GM70930 and Texas AgriLife Research to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Canaani E, 2004, BRIT J CANCER, V90, P756, DOI 10.1038/sj.bjc.6601639; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; CURCIO MJ, 1992, MOL CELL BIOL, V12, P2813, DOI 10.1128/MCB.12.6.2813; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; Del Rizzo PA, 2011, EPIGENETICS, V6; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Justin N, 2010, CURR OPIN STRUC BIOL, V20, P730, DOI 10.1016/j.sbi.2010.09.012; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Li CH, 2006, MOL BIOL CELL, V17, P3848, DOI 10.1091/mbc.E06-03-0205; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Mersman DP, 2012, J BIOL CHEM, V287, P2652, DOI 10.1074/jbc.M111.280867; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rose MD., 1990, METHODS YEAST GENETI; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105; Zhang X, 2007, BIOCHEMISTRY-US, V46, P14838, DOI 10.1021/bi7014579; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	59	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57974	10.1371/journal.pone.0057974	http://dx.doi.org/10.1371/journal.pone.0057974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469257	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100054
J	Yang, LJ; Meng, Y; Bao, C; Liu, WH; Ma, CZ; Li, AB; Xuan, Z; Shan, G; Jia, Y				Yang, Lijian; Meng, Yan; Bao, Chun; Liu, Wangheng; Ma, Chengzhang; Li, Anbang; Xuan, Zhan; Shan, Ge; Jia, Ya			Robustness and Backbone Motif of a Cancer Network Regulated by miR-17-92 Cluster during the G1/S Transition	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; BOOLEAN NETWORK; DIFFERENT ROLES; FEEDBACK LOOPS; S-PHASE; EXPRESSION; ATTRACTOR; MICRORNA; E2F; TRANSCRIPTION	Based on interactions among transcription factors, oncogenes, tumor suppressors and microRNAs, a Boolean model of cancer network regulated by miR-17-92 cluster is constructed, and the network is associated with the control of G1/S transition in the mammalian cell cycle. The robustness properties of this regulatory network are investigated by virtue of the Boolean network theory. It is found that, during G1/S transition in the cell cycle process, the regulatory networks are robustly constructed, and the robustness property is largely preserved with respect to small perturbations to the network. By using the unique process-based approach, the structure of this network is analyzed. It is shown that the network can be decomposed into a backbone motif which provides the main biological functions, and a remaining motif which makes the regulatory system more stable. The critical role of miR-17-92 in suppressing the G1/S cell cycle checkpoint and increasing the uncontrolled proliferation of the cancer cells by targeting a genetic network of interacting proteins is displayed with our model.	[Yang, Lijian; Meng, Yan; Bao, Chun; Liu, Wangheng; Ma, Chengzhang; Li, Anbang; Xuan, Zhan; Jia, Ya] Cent China Normal Univ, Inst Biophys, Wuhan, Peoples R China; [Yang, Lijian; Meng, Yan; Bao, Chun; Liu, Wangheng; Ma, Chengzhang; Li, Anbang; Xuan, Zhan; Jia, Ya] Cent China Normal Univ, Dept Phys, Wuhan, Peoples R China; [Bao, Chun; Shan, Ge] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Central China Normal University; Central China Normal University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Shan, G (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China.	shange@ustc.edu.cn; jiay@phy.ccnu.edu.cn	杨, 利建/ABF-5198-2020; Shan, Ge/B-7323-2016; Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022; Jia, Ya/J-6121-2017	Shan, Ge/0000-0002-3561-2088; Jia, Ya/0000-0002-2818-9074; Chengzhang, Ma/0000-0003-2742-1174; Li, Anbang/0000-0001-8063-1862; Yang, Lijian/0000-0003-2363-9168	state key development programme for Basic research of China [2011CBA01103]; National Natural Science Foundation of China [11105058, 81171074, 11105059, 11175068]; self-determined research funds of CCNU from the colleges' basic research and operation of Ministry of Education [CCNU12A01011]	state key development programme for Basic research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); self-determined research funds of CCNU from the colleges' basic research and operation of Ministry of Education	This work was supported by the state key development programme for Basic research of China (2011CBA01103) to GS, the National Natural Science Foundation of China under 11105058 (LJY), 81171074 (GS), 11105059(ZX), 11175068 (YJ), and the self-determined research funds of CCNU from the colleges' basic research and operation of Ministry of Education: No. CCNU12A01011 (ZX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2003, CELL CYCLE, V2, P538, DOI 10.4161/cc.2.6.550; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Akutsu T, 2012, IEEE ACM T COMPUT BI, V9, P1410, DOI 10.1109/TCBB.2012.87; Akutsu T, 2011, J COMPUT BIOL, V18, P1275, DOI 10.1089/cmb.2010.0281; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Choi M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003363; Chow A., 2010, NEW ED, V3, P7; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Fortuna MA, 2007, J THEOR BIOL, V247, P331, DOI 10.1016/j.jtbi.2007.03.017; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hu SS, 2012, INT J BIOCHEM CELL B, V44, P1847, DOI 10.1016/j.biocel.2012.07.013; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kitano H, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100039; Kohn KW, 1998, ONCOGENE, V16, P1065, DOI 10.1038/sj.onc.1201608; Krawitz P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158701; LEES E, 1992, GENE DEV, V6, P1874, DOI 10.1101/gad.6.10.1874; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lin M, 2012, CHINESE SCI BULL, V57, P959, DOI 10.1007/s11434-011-4917-x; Liu HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2071; Lomazzi M, 2002, NAT GENET, V31, P190, DOI 10.1038/ng891; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MILTENBERGER RJ, 1995, MOL CELL BIOL, V15, P2527; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Shan G, 2010, INT J BIOCHEM CELL B, V42, P1243, DOI 10.1016/j.biocel.2009.04.023; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Verdicchio MP, 2011, BIOCOMPUT-PAC SYM, P350; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang GY, 2010, P NATL ACAD SCI USA, V107, P10478, DOI 10.1073/pnas.0914180107; Yang M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056105; Zhang SQ, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/20180	57	21	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57009	10.1371/journal.pone.0057009	http://dx.doi.org/10.1371/journal.pone.0057009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469179	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100012
J	Bernardini, C; Censi, F; Lattanzi, W; Barba, M; Calcagnini, G; Giuliani, A; Tasca, G; Sabatelli, M; Ricci, E; Michetti, F				Bernardini, Camilla; Censi, Federica; Lattanzi, Wanda; Barba, Marta; Calcagnini, Giovanni; Giuliani, Alessandro; Tasca, Giorgio; Sabatelli, Mario; Ricci, Enzo; Michetti, Fabrizio			Mitochondrial Network Genes in the Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients	PLOS ONE			English	Article							PRINCIPAL COMPONENTS; MOTOR-NEURONS; MOUSE MODEL; EXPRESSION; ATROPHY; DEGENERATION; CELLS; ATROGIN-1; LOCALIZATION; MICE	Recent evidence suggested that muscle degeneration might lead and/or contribute to neurodegeneration, thus it possibly play a key role in the etiopathogenesis and progression of amyotrophic lateral sclerosis (ALS). To test this hypothesis, this study attempted to categorize functionally relevant genes within the genome-wide expression profile of human ALS skeletal muscle, using microarray technology and gene regulatory network analysis. The correlation network structures significantly change between patients and controls, indicating an increased inter-gene connection in patients compared to controls. The gene network observed in the ALS group seems to reflect the perturbation of muscle homeostasis and metabolic balance occurring in affected individuals. In particular, the network observed in the ALS muscles includes genes (PRKR1A, FOXO1, TRIM32, ACTN3, among others), whose functions connect the sarcomere integrity to mitochondrial oxidative metabolism. Overall, the analytical approach used in this study offer the possibility to observe higher levels of correlation (i.e. common expression trends) among genes, whose function seems to be aberrantly activated during the progression of muscle atrophy.	[Bernardini, Camilla; Lattanzi, Wanda; Barba, Marta; Michetti, Fabrizio] Univ Cattolica Sacro Cuore, Sch Med, Inst Anat & Cell Biol, Rome, Italy; [Censi, Federica; Calcagnini, Giovanni] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [Giuliani, Alessandro] Ist Super Sanita, Dept Environm & Hlth, I-00161 Rome, Italy; [Tasca, Giorgio] Don Carlo Gnocchi Onlus Fdn, Milan, Italy; [Sabatelli, Mario; Ricci, Enzo] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IRCCS Fondazione Don Carlo Gnocchi Onlus; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bernardini, C (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Anat & Cell Biol, Rome, Italy.	camilla.bernardini@rm.unicatt.it	CALCAGNINI, GIOVANNI/E-3711-2015; Lattanzi, Wanda/K-5978-2016; Tasca, Giorgio/J-5153-2018; Barba, Marta/K-5966-2016; Ricci, Enzo/AAC-4448-2020; Giuliani, Alessandro/AAF-1740-2020; CENSI, FEDERICA/E-3712-2015; Giuliani, Alessandro/K-7589-2016	Lattanzi, Wanda/0000-0003-3092-4936; Tasca, Giorgio/0000-0003-0849-9144; Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; RICCI, Enzo/0000-0003-3092-3597; Sabatelli, Mario/0000-0001-6635-4985; Barba, Marta/0000-0001-6084-7666				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barradeau S, 2001, P NATL ACAD SCI USA, V98, P5037, DOI 10.1073/pnas.081393598; Bernardini C, 2010, GENE EXPRESSION, V14, P345, DOI 10.3727/105221610X12718619643013; Bernardini C, 2010, GENE EXPRESSION, V15, P27, DOI 10.3727/105221610X12819686555097; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Censi F, 2011, IEEE T BIO-MED ENG, V58, P2943, DOI 10.1109/TBME.2011.2150747; CHURCHILL GA, 1994, GENETICS, V138, P963; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Comi GP, 2001, ANN NEUROL, V50, P202, DOI 10.1002/ana.1095; Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; Giuliani A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S2; Gizak A, 2003, HISTOL HISTOPATHOL, V18, P135, DOI 10.14670/HH-18.135; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gorban AN, 2010, PHYSICA A, V389, P3193, DOI 10.1016/j.physa.2010.03.035; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kennel PF, 1996, NEUROREPORT, V7, P1427, DOI 10.1097/00001756-199605310-00021; Lattanzi W, 2007, J NEUROCHEM, V100, P1688, DOI 10.1111/j.1471-4159.2006.04331.x; Lattanzi W, 2013, BONE, V52, P474, DOI 10.1016/j.bone.2012.09.004; Leger B, 2006, FASEB J, V20, P583, DOI 10.1096/fj.05-5249fje; Marcuzzo S, 2011, EXP NEUROL, V231, P30, DOI 10.1016/j.expneurol.2011.05.007; Noble D, 2008, PHILOS T R SOC A, V366, P3001, DOI 10.1098/rsta.2008.0086; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Pradat PF, 2012, NEURODEGENER DIS, V9, P38, DOI 10.1159/000329723; Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005; Roden JC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-194; Romanello V, 2012, J MOL CELL CARDIOL; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Romualdi C, 2009, OMICS, V13, P173, DOI 10.1089/omi.2009.0003; Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1; Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339; Wilkins AS, 2007, BIOESSAYS, V29, P1179, DOI 10.1002/bies.20685; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106	43	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57739	10.1371/journal.pone.0057739	http://dx.doi.org/10.1371/journal.pone.0057739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469062	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900160
J	Lamparter, J; Aliyeva, S; Schulze, A; Berres, M; Pfeiffer, N; Hoffmann, EM				Lamparter, Julia; Aliyeva, Shakhsanam; Schulze, Andreas; Berres, Manfred; Pfeiffer, Norbert; Hoffmann, Esther M.			Standard Automated Perimetry versus Matrix Frequency Doubling Technology Perimetry in Subjects with Ocular Hypertension and Healthy Control Subjects	PLOS ONE			English	Article							VISUAL-FIELD LOSS; OPEN-ANGLE GLAUCOMA; VARIABILITY; BONFERRONI; THRESHOLD; PATTERN; DEFECTS; LOSSES; DAMAGE; EYES	Background: To evaluate the relationship and agreement between standard automated perimetry (SAP) and Matrix frequency doubling technology (Matrix-FDT) in subjects with ocular hypertension and healthy control subjects. Methods: Forty-four eyes of 44 ocular hypertensive subjects and 29 eyes of 29 healthy age-matched control subjects were included in this prospective study. All participants underwent complete ophthalmic examination, including slit-lamp biomicroscopy, intraocular pressure measurement, pachymetry, and dilated fundus examination, and showed reliable visual field tests. One randomly selected eye of each participant was examined with SAP (Swedish Interactive Threshold Algorithm [SITA] Standard 24-2 test) and Matrix-FDT (24-2 threshold test), in random order. Correlations between global indices (MD, PSD), regions (2 hemifields, 4 quadrants, 6 sectors) and 52 single field positions were analyzed using Spearman's rank correlation coefficient. Results: In both groups, mean deviation values of SAP and Matrix-FDT correlated significantly (OHT subjects: r = 0.47, p<0.005; healthy subjects: r = 0.68; p<0.001, respectively). Pattern standard deviation of SAP and Matrix-FDT showed no significant correlation in healthy subjects but correlated significantly in ocular hypertensive subjects (r = 0.45, p<0.005). In healthy subjects, a significant correlation between SAP and Matrix-FDT was shown in the supero-temporal and infero-temporal sectors of the disc (r = 0.40 and r = 0.38, p<0.05, respectively). In OHT subjects, supero-temporal, supero-nasal and nasal sectors correlated significantly (r = 0.49, 0.62 and 0.38, p <= 0.01, respectively). The correlation pattern of individual visual field test locations appeared heterogeneous in both groups. Conclusions: In both, ocular hypertensive and healthy subjects SAP and Matrix-FDT correlate well. In ocular hypertensive subjects, both techniques showed good correlation in the supero-temporal, supero-nasal, and nasal sectors of the disc. Poor agreement was found in the temporal, infero-temporal and infero-nasal disc sectors. This missing correlation might be related to early retinal nerve fiber layer damage in these regions of the disc, recognized by one of the visual field	[Lamparter, Julia; Aliyeva, Shakhsanam; Schulze, Andreas; Pfeiffer, Norbert; Hoffmann, Esther M.] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Berres, Manfred] Univ Med Ctr Mainz, Inst Med Biometry Epidemiol & Informat, Mainz, Germany; [Berres, Manfred] Univ Appl Sci Koblenz, Remagen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Hoffmann, EM (corresponding author), Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany.	ehoffman@uni-mainz.de	Hoffmann, Esther/AAO-5968-2021; Hoffmann, Esther/AAY-3575-2020; Pfeiffer, Norbert/AAO-7586-2020	Hoffmann, Esther/0000-0002-0949-4268; 				Artes PH, 2005, INVEST OPHTH VIS SCI, V46, P2451, DOI 10.1167/iovs.05-0135; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bozkurt B, 2008, J GLAUCOMA, V17, P203, DOI 10.1097/IJG.0b013e31815a3493; Cellini M, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-33; Cello KE, 2000, AM J OPHTHALMOL, V129, P314, DOI 10.1016/S0002-9394(99)00414-6; Clement CI, 2009, BRIT J OPHTHALMOL, V93, P582, DOI 10.1136/bjo.2007.119909; Fukushima A, 2004, J GLAUCOMA, V13, P114, DOI 10.1097/00061198-200404000-00006; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; JOHNSON CA, 1995, OPTOMETRY VISION SCI, V72, P359, DOI 10.1097/00006324-199506000-00003; Johnson CA, 1997, INVEST OPHTH VIS SCI, V38, P413; Johnson CA, 1999, OPTOMETRY VISION SCI, V76, P571, DOI 10.1097/00006324-199908000-00026; Kim TW, 2007, OPHTHALMOLOGY, V114, P1053, DOI 10.1016/j.ophtha.2006.09.015; Lamparter J, 2012, INVEST OPHTH VIS SCI, V53, P7553, DOI 10.1167/iovs.12-10892; Leeprechanon N, 2007, AM J OPHTHALMOL, V143, P263, DOI 10.1016/j.ajo.2006.10.033; Medeiros FA, 2004, AM J OPHTHALMOL, V137, P863, DOI 10.1016/j.ajo.2003.12.009; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakagawa S, 2012, J GLAUCOMA, V21, P22, DOI 10.1097/IJG.0b013e318202777e; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Quigley HA, 1998, AM J OPHTHALMOL, V125, P819, DOI 10.1016/S0002-9394(98)00046-4; Sample PA, 2000, INVEST OPHTH VIS SCI, V41, P1783; Spry PGD, 2001, INVEST OPHTH VIS SCI, V42, P1404; Spry PGD, 2005, J GLAUCOMA, V14, P11, DOI 10.1097/01.ijg.0000145813.46848.b8; Spry PGD, 2005, BRIT J OPHTHALMOL, V89, P1031, DOI 10.1136/bjo.2004.057778; Spry PGD, 2002, J GLAUCOMA, V11, P315, DOI 10.1097/00061198-200208000-00007; Weinreb RN, 2011, INVEST OPHTH VIS SCI, V52, P7842, DOI 10.1167/iovs.11-7895; Zarkovic A, 2007, CLIN EXP OPHTHALMOL, V35, P808, DOI 10.1111/j.1442-9071.2007.01629.x	28	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57663	10.1371/journal.pone.0057663	http://dx.doi.org/10.1371/journal.pone.0057663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469043	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900142
J	Reiter, G; Reiter, U; Wagner, T; Kozma, N; Roland, J; Schollnast, H; Ebner, F; Lanzer, G				Reiter, Gert; Reiter, Ursula; Wagner, Thomas; Kozma, Noemi; Roland, Joerg; Schoellnast, Helmut; Ebner, Franz; Lanzer, Gerhard			Thermometry of Red Blood Cell Concentrate: Magnetic Resonance Decoding Warm Up Process	PLOS ONE			English	Article							MR-THERMOMETRY; FREQUENCY-SHIFT; TEMPERATURE-CHANGES; STORAGE; IDENTIFICATION; TRANSPORT; ABLATION; QUALITY	Purpose: Temperature is a key measure in human red blood cell concentrate (RBC) quality control. A precise description of transient temperature distributions in RBC units removed from steady storage exposed to ambient temperature is at present unknown. Magnetic resonance thermometry was employed to visualize and analyse RBC warm up processes, to describe time courses of RBC mean, surface and core temperatures by an analytical model, and to determine and investigate corresponding model parameters. Methods: Warm-up processes of 47 RBC units stored at 1-6 degrees C and exposed to 21.25 degrees C ambient temperature were investigated by proton resonance frequency thermometry. Temperature distributions were visualized and analysed with dedicated software allowing derivation of RBC mean, surface and core temperature-time courses during warm up. Time-dependence of mean temperature was assumed to fulfil a lumped capacitive model of heat transfer. Time courses of relative surface and core temperature changes to ambient temperature were similarly assumed to follow shifted exponential decays characterized by a time constant and a relative time shift, respectively. Results: The lumped capacitive model of heat transfer and shifted exponential decays described time-dependence of mean, surface and core temperatures close to perfect (mean R-2 were 0.999 +/- 0.001, 0.996 +/- 0.004 and 0.998 +/- 0.002, respectively). Mean time constants were tau(mean) = 55.3 +/- 3.7 min, tau(surface) = 41.4 +/- 2.9 min and tau(core) = 76.8 +/- 7.1 min, mean relative time shifts were Delta(surface) = 0.07 +/- 0.02 and Delta(core) = 0.04 +/- 0.01. None of the constants correlated significantly with temperature differences between ambient and storage temperature. Conclusion: Lumped capacitive model of heat transfer and shifted exponential decays represent simple analytical formulas to describe transient mean, surface and core temperatures of RBC during warm up, which might be a helpful tool in RBC temperature monitoring and quality control. Independence of constants on differences between ambient and storage temperature suggests validity of models for arbitrary storage and ambient temperatures.	[Reiter, Gert] Siemens AG, Healthcare Sect, Graz, Austria; [Reiter, Ursula; Schoellnast, Helmut; Ebner, Franz] Med Univ Graz, Dept Radiol, Graz, Austria; [Wagner, Thomas; Kozma, Noemi; Lanzer, Gerhard] Med Univ Graz, Dept Blood Grp Serol & Transfus Med, Graz, Austria; [Roland, Joerg] Siemens AG, Healthcare Sect, Erlangen, Germany	Siemens AG; Medical University of Graz; Medical University of Graz; Siemens AG; Siemens Germany	Reiter, G (corresponding author), Siemens AG, Healthcare Sect, Graz, Austria.	gert.reiter@siemens.com	Reiter, Ursula/P-7259-2016	Schoellnast, Helmut/0000-0003-1442-9118				American Association of Blood Banks, 2009, STANDARDS BLOOD BANK; [Anonymous], WHO TECHN REP SER; Brunskill S, 2012, TRANSFUS MED REV, V26, P209, DOI 10.1016/j.tmrv.2011.09.005; Council of Europe, 2009, GUID PREP US QUAL AS; Davis R, 2009, VOX SANG, V97, P50, DOI 10.1111/j.1423-0410.2009.01174.x; de Senneville BD, 2012, NMR BIOMED, V25, P556, DOI 10.1002/nbm.1771; Gellermann J, 2006, MED PHYS, V33, P3912, DOI 10.1118/1.2348761; Granryd E, 2009, HEAT TRANSFER COLLEC; Grissom WA, 2010, MED PHYS, V37, P5014, DOI 10.1118/1.3475943; HAMILL TR, 1990, TRANSFUSION, V30, P58, DOI 10.1046/j.1537-2995.1990.30190117632.x; Hancock V, 2011, TRANSFUSION MED, V21, P325, DOI 10.1111/j.1365-3148.2011.01083.x; Holman J., 2001, HEAT TRANSFER; Johnson V, 2006, AM J CLIN PATHOL, V126, P406, DOI 10.1309/QD8H135A6D72Y22N; Kickhefel A, 2010, PHYS MEDICA, V26, P192, DOI 10.1016/j.ejmp.2009.11.006; Klose T, 2010, VOX SANG, V99, P44, DOI 10.1111/j.1423-0410.2009.01302.x; Kozma N, 2011, TRANSFUSION, V51, P2384, DOI 10.1111/j.1537-2995.2011.03169.x; Lee SC, 2012, TRANSFUSION, V52, P195, DOI 10.1111/j.1537-2995.2011.03242.x; McDannold N, 2005, INT J HYPERTHER, V21, P533, DOI 10.1080/02656730500096073; Perry HE, 2010, TRANSFUSION, V50, P174, DOI 10.1111/j.1537-2995.2009.02384.x; Peters RD, 1999, MAGNET RESON MED, V41, P909, DOI 10.1002/(SICI)1522-2594(199905)41:5<909::AID-MRM9>3.0.CO;2-N; Peters RD, 1998, MAGNET RESON MED, V40, P454, DOI 10.1002/mrm.1910400316; PICK P, 1971, TRANSFUSION, V11, P213, DOI 10.1111/j.1537-2995.1971.tb04403.x; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Reiter U, 2011, VOX SANG, V101, P10, DOI 10.1111/j.1423-0410.2010.01452.x; Reiter U, 2013, TRANSFUSION, V53, P167, DOI 10.1111/j.1537-2995.2012.03798.x; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Sharma RR, 2004, LAB MED, V35, P616, DOI 10.1309/AUHE16WN6MJC4V67; Thomas S, 2011, TRANSFUSION, V51, P442, DOI 10.1111/j.1537-2995.2010.02927.x; Wu T, 2000, MED PHYS, V27, P221, DOI 10.1118/1.598864	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57931	10.1371/journal.pone.0057931	http://dx.doi.org/10.1371/journal.pone.0057931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469108	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900203
J	Yang, FW; Zhang, XJ; Sun, Y; Wang, BY; Zhou, CB; Luo, YA; Ge, PF				Yang, Fuwei; Zhang, Xiaojie; Sun, Ying; Wang, Boyu; Zhou, Chuibing; Luo, Yinan; Ge, Pengfei			Ischemic Postconditioning Decreases Cerebral Edema and Brain Blood Barrier Disruption Caused by Relief of Carotid Stenosis in a Rat Model of Cerebral Hypoperfusion	PLOS ONE			English	Article							REDUCES INFARCT SIZE; REPERFUSION INJURY; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; MATRIX-METALLOPROTEINASE-9 EXPRESSION; FOCAL ISCHEMIA; FREE-RADICALS; PROTECTS; ARTERY; INHIBITOR	Background and Purpose: Complications due to brain edema and breakdown of blood brain barrier are an important factor affecting the treatment effects of patients with severe carotid stenosis. In this study, we investigated the protective effects of ischemic postconditioning on brain edema and disruption of blood brain barrier via establishing rat model of hypoperfusion due to severe carotid stenosis. Methods: Wistar rat model of hypoperfusion due to severe carotid stenosis was established by binding a stainless microtube to both carotid arteries. Ischemic postconditioning procedure consisted of three cycles of 30 seconds ischemia and 30 seconds reperfusion. Brain edema was evaluated by measuring cerebral water content, and blood brain barrier permeability was assayed by examining cerebral concentration of Evans' Blue (EB) and fluorescein sodium (NaF). ELISA was used to analyze the expression of MMP-9, claudin-5 and occludin. The activity and location of MMP-9 was analyzed by gelatin zymography and in situ zymography, respectively. The distribution of tight junction proteins claudin-5 and occludin was observed by immunohistochemistry. Results: The increased brain water content and cerebral concentration of EB and NaF were suppressed by administration of ischemic postconditioning prior to relief of carotid stenosis. Zymographic studies showed that MMP-9 was mainly located in the cortex and its activity was significantly improved by relief of carotid stenosis and, but the elevated MMP-9 activity was inhibited markedly by ischemic postconditioning. Immunohistochemistry revealed that ischemic postconditioning improved the discontinuous distribution of claudin-5 and occludin. ELISA detected that the expression of up-regulated MMP-9 and down-regulated claudin-5 and occludin caused by carotid relief were all attenuated by ischemic postconditioning. Conclusions: Ischemic postconditioning is an effective method to prevent brain edema and improve BBB permeability and could be used during relief of severe carotid stenosis.	[Yang, Fuwei; Wang, Boyu; Luo, Yinan; Ge, Pengfei] Jilin Univ, Bethune Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China; [Zhang, Xiaojie; Zhou, Chuibing] Changchun Children Hosp, Dept Neurosurg, Changchun, Peoples R China; [Sun, Ying] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China	Jilin University; Harbin Medical University	Ge, PF (corresponding author), Jilin Univ, Bethune Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China.	pengfeige@gmail.com			National Nature and Science Foundation of China [81171234, 30973110]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature and Science Foundation of China (Nos. 81171234 and 30973110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annambhotla S, 2012, J VASC SURG, V56, P1296, DOI 10.1016/j.jvs.2012.05.070; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Chen YH, 2012, INT J CARDIOL, V157, P104, DOI 10.1016/j.ijcard.2011.10.086; Cho AH, 2009, EUR J NEUROL, V16, P1066, DOI 10.1111/j.1468-1331.2009.02650.x; Dong X, 2009, CURR NEUROPHARMACOL, V7, P269, DOI 10.2174/157015909790031157; Duan W, 2011, ACTA NEUROBIOL EXP, V71, P233; Feng CS, 2012, INT J MOL SCI, V13, P13338, DOI 10.3390/ijms131013338; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Ivens S, 2010, J NEUROL, V257, P615, DOI 10.1007/s00415-009-5384-z; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Karapanayiotides T, 2005, STROKE, V36, P21, DOI 10.1161/01.STR.0000149946.86087.e5; Kokuzawa J, 2010, NEUROL MED-CHIR, V50, P250, DOI 10.2176/nmc.50.250; Landgraff NC, 2010, J NEUROL, V257, P982, DOI 10.1007/s00415-009-5449-z; Lee CZ, 2004, STROKE, V35, P1715, DOI 10.1161/01.STR.0000129334.05181.b6; Lee H, 2009, NEUROBIOL DIS, V34, P189, DOI 10.1016/j.nbd.2008.12.012; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Li ZY, 2012, J INT MED RES, V40, P954, DOI 10.1177/147323001204000314; Liu H, 2012, CURR NEUROVASC RES, V9, P152, DOI 10.2174/156720212801619027; Liu KX, 2009, INTENS CARE MED, V35, P933, DOI 10.1007/s00134-009-1428-1; Liu KH, 2005, FREE RADICAL BIO MED, V39, P71, DOI 10.1016/j.freeadbiomed.2005.03.033; Liu XR, 2012, CNS NEUROSCI THER, V18, P855, DOI 10.1111/j.1755-5949.2012.00366.x; Liu XH, 2007, BIOCHEM BIOPH RES CO, V359, P628, DOI 10.1016/j.bbrc.2007.05.129; Lok J, 2012, TRANSL STROKE RES, V3, pS119, DOI 10.1007/s12975-012-0157-x; Loukogeorgakis SP, 2006, CIRCULATION, V113, P1015, DOI 10.1161/CIRCULATIONAHA.105.590398; Lukic-Panin V, 2010, CURR NEUROVASC RES, V7, P319, DOI 10.2174/156720210793180747; Ma XJ, 2006, SCAND CARDIOVASC J, V40, P327, DOI 10.1080/14017430601047864; Marnane M, 2011, NEUROLOGY, V77, P738, DOI 10.1212/WNL.0b013e31822b00cf; Meng FR, 2011, BRAIN RES, V1391, P93, DOI 10.1016/j.brainres.2011.03.010; Moulakakis KG, 2009, J VASC SURG, V49, P1060, DOI 10.1016/j.jvs.2008.11.026; Panickar KS, 2011, INT J MOL SCI, V12, P8181, DOI 10.3390/ijms12118181; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; Rehni AK, 2012, CYTOKINE, V60, P83, DOI 10.1016/j.cyto.2012.05.009; Roach DM, 2002, EUR J VASC ENDOVASC, V23, P260, DOI 10.1053/ejvs.2002.1598; Switzer JA, 2011, STROKE, V42, P2633, DOI 10.1161/STROKEAHA.111.618215; Taussky P, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11222; Thuny F, 2012, J AM COLL CARDIOL, V59, P2175, DOI 10.1016/j.jacc.2012.03.026; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang Q, 2011, ANESTH ANALG, V113, P1180, DOI 10.1213/ANE.0b013e31822b885f; Wu TY, 2012, J NEUROL NEUROSUR PS, V83, P543, DOI 10.1136/jnnp-2011-301162; Xu B, 2011, J SURG RES, V166, pE157, DOI 10.1016/j.jss.2010.11.902; Yan JH, 2011, EXP NEUROL, V230, P240, DOI 10.1016/j.expneurol.2011.04.022; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Young KC, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1143; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017; Zhang WQ, 2011, J CLIN NEUROSCI, V18, P685, DOI 10.1016/j.jocn.2010.08.027; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhou CF, 2011, NEUROCHEM INT, V59, P749, DOI 10.1016/j.neuint.2011.08.008; Zhou Z, 2012, NEUROSCIENCE, V219, P137, DOI 10.1016/j.neuroscience.2012.05.060	52	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57869	10.1371/journal.pone.0057869	http://dx.doi.org/10.1371/journal.pone.0057869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469092	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900188
J	Li, H; Lui, N; Cheng, T; Tseng, HHK; Yue, DS; Giroux-Leprieur, E; Do, HT; Sheng, Q; Jin, JQ; Luh, TW; Jablons, DM; He, BA				Li, Hui; Lui, Natalie; Cheng, Tiffany; Tseng, Hsin-Hui K.; Yue, Dongsheng; Giroux-Leprieur, Etienne; Do, Hanh T.; Sheng, Qing; Jin, Joy Q.; Luh, Thomas W.; Jablons, David M.; He, Biao			Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; TGF-BETA; ACTIVATION; MECHANISMS; GENE	Malignant pleural mesothelioma (MPM) is a highly aggressive tumor with poor prognosis. Current treatment is rarely curative, thus novel meaningful therapies are urgently needed. Inhibition of Hedgehog (Hh) signaling at the cell membrane level in several cancers has shown anti-cancer activity in recent clinical studies. Evidence of Hh-independent Gli activation suggests Gli as a more potent therapeutic target. The current study is aimed to evaluate the potential of Gli as a therapeutic target to treat MPM. The expression profiles of Gli factors and other Hh signaling components were characterized in 46 MPM patient tissue samples by RT-PCR and immunohistochemistry. Cultured cell lines were employed to investigate the requirement of Gli activation in tumor cell growth by inhibiting Gli through siRNA or a novel small molecule Gli inhibitor (Gli-I). A xenograft model was used to evaluate Gli-I in vivo. In addition, a side by side comparison between Gli and Smoothened (Smo) inhibition was conducted in vitro using siRNA and small molecule inhibitors. Our study reported aberrant Gli1 and Gli2 activation in a large majority of tissues. Inhibition of Gli by siRNAs or Gli-I suppressed cell growth dramatically both in vitro and in vivo. Inhibition of Gli exhibited better cytotoxicity than that of Smo by siRNA and small molecule inhibitors vismodegib and cyclopamine. Combination of Gli-I and pemetrexed, as well as Gli-I and vismodegib demonstrated synergistic effects in suppression of MPM proliferation in vitro. In summary, Gli activation plays a critical role in MPM. Inhibition of Gli function holds strong potential to become a novel, clinically effective approach to treat MPM.	[Li, Hui; Lui, Natalie; Cheng, Tiffany; Tseng, Hsin-Hui K.; Yue, Dongsheng; Giroux-Leprieur, Etienne; Do, Hanh T.; Sheng, Qing; Jin, Joy Q.; Luh, Thomas W.; Jablons, David M.; He, Biao] Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA 94143 USA; [Sheng, Qing] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yue, Dongsheng] TianJin Med Univ, Dept Lung Canc, Lung Canc Ctr, Canc Inst & Hosp, Tianjin, Peoples R China	University of California System; University of California San Francisco; Zhejiang Sci-Tech University; Tianjin Medical University	He, BA (corresponding author), Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA 94143 USA.	biao.he@ucsfmedctr.org	Tseng, Hsin-Hui Katty/AAG-1941-2019; Leprieur, Etienne Giroux/H-6345-2015	Jin, Joy/0000-0002-1283-4665; Giroux Leprieur, Etienne/0000-0001-8441-1701	NIH/NCI [R01CA125030, R01CA132566]; Eileen D. Ludwig Endowed for Thoracic Oncology Research; Bonnie J. Addario Lung Cancer Foundation; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation; Paul and Michelle Zygielbaum; Honeywell Foundation; Jeffrey and Karen Peterson Family Foundation; NATIONAL CANCER INSTITUTE [R01CA125030, R01CA132566] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eileen D. Ludwig Endowed for Thoracic Oncology Research; Bonnie J. Addario Lung Cancer Foundation; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation; Paul and Michelle Zygielbaum; Honeywell Foundation; Jeffrey and Karen Peterson Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI grant R01CA125030; the Eileen D. Ludwig Endowed for Thoracic Oncology Research (to BH); NIH/NCI grant R01CA132566; the Bonnie J. Addario Lung Cancer Foundation; the Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley & Oberman Foundation; Paul and Michelle Zygielbaum; the Honeywell Foundation; and the Jeffrey and Karen Peterson Family Foundation (to DMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; Carbone M, 2012, CLIN CANCER RES, V18, P598, DOI 10.1158/1078-0432.CCR-11-2259; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Crispi S, 2010, CURR CANCER DRUG TAR, V10, P19, DOI 10.2174/156800910790980232; Dennler S, 2009, J INVEST DERMATOL, V129, pS85; Dlugosz A, 2012, NAT REV DRUG DISCOV, V11, P437, DOI 10.1038/nrd3753; Dodge ME, 2011, ANNU REV PHARMACOL, V51, P289, DOI 10.1146/annurev-pharmtox-010510-100558; Greillier L, 2011, ANTI-CANCER DRUG, V22, P199, DOI 10.1097/CAD.0b013e328341ccdd; He BNF, 2010, United States patent, Patent No. [US 6,885,550, 6885550]; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Sekido Y, 2010, CANCER SCI, V101, P1, DOI 10.1111/j.1349-7006.2009.01336.x; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Shi YD, 2012, CLIN CANCER RES, V18, P4646, DOI 10.1158/1078-0432.CCR-12-0599; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stanton BZ, 2010, MOL BIOSYST, V6, P44, DOI 10.1039/b910196a; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Zucali PA, 2011, CANCER TREAT REV, V37, P543, DOI 10.1016/j.ctrv.2011.01.001	35	26	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57346	10.1371/journal.pone.0057346	http://dx.doi.org/10.1371/journal.pone.0057346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483902	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100019
J	Vasiljevic, M; Crisp, RJ				Vasiljevic, Milica; Crisp, Richard J.			Tolerance by Surprise: Evidence for a Generalized Reduction in Prejudice and Increased Egalitarianism through Novel Category Combination	PLOS ONE			English	Article							EPISTEMIC MOTIVATIONS; STEREOTYPE CHANGE; NORTHERN-IRELAND; SELF-REGULATION; NEED; CONTACT; MIND; CLOSURE; BIAS; IDENTIFICATION	Prejudices towards different groups are interrelated, but research has yet to find a way to promote tolerance towards multiple outgroups. We devise, develop and implement a new cognitive intervention for achieving generalized tolerance based on scientific studies of social categorization. In five laboratory experiments and one field study the intervention led to a reduction of prejudice towards multiple outgroups (elderly, disabled, asylum seekers, HIV patients, gay men), and fostered generalized tolerance and egalitarian beliefs. Importantly, these effects persisted outside the laboratory in a context marked by a history of violent ethnic conflict, increasing trust and reconciliatory tendencies towards multiple ethnic groups in the Former Yugoslav Republic of Macedonia. We discuss the implications of these findings for intervention strategies focused on reducing conflict and promoting peaceful intergroup relations.	[Vasiljevic, Milica] Univ Kent, Ctr Study Grp Proc, Sch Psychol, Canterbury, Kent, England; [Crisp, Richard J.] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England	University of Kent; University of Sheffield	Vasiljevic, M (corresponding author), Univ Kent, Ctr Study Grp Proc, Sch Psychol, Canterbury, Kent, England.	m.d.vasiljevic@gmail.com; r.crisp@sheffield.ac.uk		Vasiljevic, Milica/0000-0001-7454-7744				Aiken L. S., 1991, MULTIPLE REGRESSION; Allport G. W., 1954, NATURE PREJUDICE; [Anonymous], 1972, ETHNOCENTRISM; Armor DA, 2003, PERS SOC PSYCHOL B, V29, P86, DOI 10.1177/0146167202238374; Brewer M., 1988, ADV SOCIAL COGNITION, P1; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; Calogero RM, 2008, THESIS U KENT CANTER; COHEN A R, 1955, J Abnorm Psychol, V51, P291, DOI 10.1037/h0042761; Cohen AR., 1957, ORDER PRESENTATION P, P79; Crisp RJ, 2011, PSYCHOL BULL, V137, P242, DOI 10.1037/a0021840; Crisp RJ, 2009, AM PSYCHOL, V64, P231, DOI 10.1037/a0014718; Crisp RJ, 2009, RES000222033 ESRC; De Bono E., 1967, USE LATERAL THINKING; de Dreu CKW, 1999, PERS SOC PSYCHOL B, V25, P348, DOI 10.1177/0146167299025003007; Deschamps Jean-Claude, 1978, DIFFERENTIATION SOCI, P141; Devine PG, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P339; Fiske S. T., 1990, ADV EXPT SOCIAL PSYC, V3, P1, DOI DOI 10.1016/S0065-2601(08)60317-2; FREUND T, 1985, PERS SOC PSYCHOL B, V11, P479, DOI 10.1177/0146167285114013; Gagne FM, 2001, J PERS SOC PSYCHOL, V81, P85, DOI 10.1037/0022-3514.81.1.85; Golebiowska EA, 2001, J POLIT, V63, P1017, DOI 10.1111/0022-3816.00099; Hall NR, 2005, PERS SOC PSYCHOL B, V31, P1435, DOI 10.1177/0146167205276084; Halperin E, 2011, SCIENCE, V333, P1767, DOI 10.1126/science.1202925; HAMILTON DL, 1994, HDB SOCIAL COGNITION, V2, P1; Harwood J, 2011, BRIT J SOC PSYCHOL, V50, P180, DOI 10.1348/014466610X524263; HASTIE R, 1990, B PSYCHONOMIC SOC, V28, P242; HEATON AW, 1991, PERS SOC PSYCHOL B, V17, P161, DOI 10.1177/014616729101700207; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; Hodson G, 2009, J EXP SOC PSYCHOL, V45, P974, DOI 10.1016/j.jesp.2009.02.010; Hutter RRC, 2005, PERS SOC PSYCHOL B, V31, P647, DOI 10.1177/0146167204271575; Judd C. M., 2011, DATA ANAL MODEL COMP; KATZ I, 1988, J PERS SOC PSYCHOL, V55, P893, DOI 10.1037/0022-3514.55.6.893; KRUGLANSKI AW, 1988, SOC COGNITION, V6, P1, DOI 10.1521/soco.1988.6.1.1; Kruglanski AW, 1996, PSYCHOL REV, V103, P263, DOI 10.1037/0033-295X.103.2.263; KUNDA Z, 1990, COGNITIVE SCI, V14, P551, DOI 10.1207/s15516709cog1404_3; KUNDA Z, 1995, J PERS SOC PSYCHOL, V68, P565, DOI 10.1037/0022-3514.68.4.565; MAYSELESS O, 1987, ORGAN BEHAV HUM DEC, V39, P162, DOI 10.1016/0749-5978(87)90036-7; Monteith M J, 1998, Pers Soc Psychol Rev, V2, P63, DOI 10.1207/s15327957pspr0201_4; MONTEITH MJ, 1993, J PERS SOC PSYCHOL, V65, P469, DOI 10.1037/0022-3514.65.3.469; Monteith MJ, 1998, J EXP SOC PSYCHOL, V34, P355, DOI 10.1006/jesp.1998.1355; Morrison KR, 2010, PERS SOC PSYCHOL B, V36, P1648, DOI 10.1177/0146167210386118; Nadler A, 2002, PEACE EDUCATION, P127; NEUBERG SL, 1993, J PERS SOC PSYCHOL, V65, P113, DOI 10.1037/0022-3514.65.1.113; Park B, 2001, J EXP SOC PSYCHOL, V37, P325, DOI 10.1006/jesp.2000.1460; Petty RE, 2002, J PERS SOC PSYCHOL, V82, P722, DOI 10.1037//0022-3514.82.5.722; Plaut VC, 2010, PSYCHOL INQ, V21, P77, DOI 10.1080/10478401003676501; Richards Z, 2001, PERS SOC PSYCHOL REV, V5, P52, DOI 10.1207/S15327957PSPR0501_4; Rokeach M., 1973, NATURE HUMAN VALUES; Rosenthal L, 2010, SOC ISS POLICY REV, V4, P215, DOI 10.1111/j.1751-2409.2010.01022.x; Rosenthal R., 2000, CONTRASTS EFFECT SIZ; Sanchez-Burks J, 2007, BASIC APPL SOC PSYCH, V29, P257, DOI 10.1080/01973530701503184; Sassenberg K, 2005, J EXP SOC PSYCHOL, V41, P506, DOI 10.1016/j.jesp.2004.10.002; Shah JY, 1998, J PERS SOC PSYCHOL, V75, P383, DOI 10.1037/0022-3514.75.2.383; Sherman JW, 2000, PERS SOC PSYCHOL B, V26, P26, DOI 10.1177/0146167200261003; Stapel DA, 2001, J EXP SOC PSYCHOL, V37, P134, DOI 10.1006/jesp.2000.1440; Stroop J. R., 1935, J EXP PSYCHOL, V12, P242; Sumner W. G., 1906, FOLKWAYS; Tam T, 2009, PERS SOC PSYCHOL B, V35, P45, DOI 10.1177/0146167208325004; Tausch N, 2007, BRIT J SOC PSYCHOL, V46, P541, DOI 10.1348/014466606X155150; TAYLOR SE, 1995, J PERS SOC PSYCHOL, V69, P213, DOI 10.1037/0022-3514.69.2.213; Thomas WI, 1912, AM J SOCIOL, V17, P725, DOI 10.1086/212034; Thomas WI, 1907, AM J SOCIOL, V12, P435, DOI 10.1086/211517; Thomas WI, 1904, AM J SOCIOL, V9, P593, DOI 10.1086/211245; TOOBY J, 1990, ETHOL SOCIOBIOL, V11, P375, DOI 10.1016/0162-3095(90)90017-Z; Turner J.C., 1987, REDISCOVERING SOCIAL; Vanbeselaere, 1991, EUROPEAN REV SOCIAL, V2, P247, DOI DOI 10.1080/14792779143000088; WEBER R, 1983, J PERS SOC PSYCHOL, V45, P961, DOI 10.1037/0022-3514.45.5.961; Williams RM., 1979, UNDERSTANDING HUMAN, P15; Wright SC, 1997, J PERS SOC PSYCHOL, V73, P73, DOI 10.1037/0022-3514.73.1.73	68	48	48	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57106	10.1371/journal.pone.0057106	http://dx.doi.org/10.1371/journal.pone.0057106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483895	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100013
J	Hosseinzadeh, R; Khorsandi, K; Hemmaty, S				Hosseinzadeh, Reza; Khorsandi, Khatereh; Hemmaty, Syavash			Study of the Effect of Surfactants on Extraction and Determination of Polyphenolic Compounds and Antioxidant Capacity of Fruits Extracts	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PHENOLIC-COMPOUNDS; SEPARATION; MICELLES; RADICALS; BROMIDE; TANNINS	Micelle/water mixed solutions of different surface active agents were studied for their effectiveness in the extraction of polyphenolic compounds from various varieties of apples from west Azerbaijan province in Iran. The total content of polyphenolic compound in fruit extracts were determined using ferrous tartrate and Folin-Ciocalteu assays methods and chromatographic methods and compared with theme. High performance liquid chromatography is one of the most common and important methods in biochemical compound identification. The effect of pH, ionic strength, surfactant type, surfactant concentration, extraction time and common organic solvent in the apple polyphenolics extractions was studied using HPLC-DAD. Mixtures of surfactants, water and methanol at various ratios were examined and micellar-water solutions of Brij surfactant showed the highest polyphenol extraction efficiency. Optimum conditions for the extraction of polyphenolic compounds from apple occurred at 7 mM Brij35, pH 3. Effect of ionic strength on extraction was determined and 2% (W/V) potassium Chloride was determined to be the optimum salt concentration. The procedure worked well with an ultrasound bath. Total antioxidant capacity also was determined in this study. The method can be safely scaled up for pharmaceutical applications.	[Hosseinzadeh, Reza; Hemmaty, Syavash] Univ Urmia, Urmia Branch, Acad Ctr Educ Culture & Res, Food & Chem Anal Res Lab, Orumiyeh, Iran; [Hosseinzadeh, Reza; Khorsandi, Khatereh] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR); Urmia University; University of Tehran	Hosseinzadeh, R (corresponding author), Univ Urmia, Urmia Branch, Acad Ctr Educ Culture & Res, Food & Chem Anal Res Lab, Orumiyeh, Iran.	chem.reza@gmail.com	Hosseinzadeh, Reza/N-5330-2017	Hosseinzadeh, Reza/0000-0003-2524-176X; Hemmaty, Syavash/0000-0002-7944-0118				Alonso-Salces RM, 2001, J CHROMATOGR A, V933, P37, DOI 10.1016/S0021-9673(01)01212-2; Alvarez-Suarez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025878; Antolovich M, 2000, ANALYST, V125, P989, DOI 10.1039/b000080i; Berthod A, 2000, CHROMATOGR SCI SERIE; Bordbar AK, 2007, J THERM ANAL CALORIM, V87, P453, DOI 10.1007/s10973-005-6906-2; Bordbar AK, 2006, COLLOID SURFACE B, V53, P288, DOI 10.1016/j.colsurfb.2006.09.019; Cam M, 2010, FOOD CHEM, V123, P878, DOI 10.1016/j.foodchem.2010.05.011; Cao DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021071; COSETENG MY, 1987, J FOOD SCI, V52, P985, DOI 10.1111/j.1365-2621.1987.tb14257.x; Cudina O, 2005, COLLOID SURFACE A, V256, P225, DOI 10.1016/j.colsurfa.2005.01.023; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; DESHPANDE SS, 1986, CRC CR REV FOOD SCI, V24, P401, DOI 10.1080/10408398609527441; Escarpa A, 1998, J CHROMATOGR A, V823, P331, DOI 10.1016/S0021-9673(98)00294-5; German J B, 1999, Adv Exp Med Biol, V459, P23; Guyot S, 1997, PHYTOCHEMISTRY, V44, P351, DOI 10.1016/S0031-9422(96)00480-3; Guyot S, 1998, J AGR FOOD CHEM, V46, P1698, DOI 10.1021/jf970832p; Hagerman AE, 1997, ACS SYM SER, V662, P209, DOI 10.1021/bk-1997-0662.ch012; Hosseinzadeh R, 2011, COLLOID SURFACE B, V84, P13, DOI 10.1016/j.colsurfb.2010.11.036; Hosseinzadeh R, 2009, COLLECT CZECH CHEM C, V74, P503, DOI 10.1135/cccc2008021; Hosseinzadeh R, 2009, COLLOID SURFACE B, V68, P213, DOI 10.1016/j.colsurfb.2008.10.012; JACKMAN RL, 1987, J FOOD BIOCHEM, V11, P279, DOI 10.1111/j.1745-4514.1987.tb00128.x; Khaledi MG, 1997, J CHROMATOGR A, V780, P3, DOI 10.1016/S0021-9673(97)00610-9; Kulikov A., 2007, METHODS OBJECTS CH 1, V92, P92; MAKKAR HPS, 1989, J AGR FOOD CHEM, V37, P1197, DOI 10.1021/jf00088a083; Markham K., 1975, FLAVONOIDS, P1; McBain TW, 1912, J CHEM SOC, V101, P2042; Ozyurt D, 2007, TALANTA, V71, P1155, DOI 10.1016/j.talanta.2006.06.015; Perez Ilzarbe J, 1997, Z UNTERS FORSCH, V204, P52; Porter L J., 1989, METHODS PLANT BIOCH, P389; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rosen M. J., 1978, SURFACTANTS INTERFAC, DOI DOI 10.1002/0471670561; SCALBERT A, 1989, J AGR FOOD CHEM, V37, P1324, DOI 10.1021/jf00089a026; SCALBERT A, 1992, BASIC LIFE SCI, V59, P259; Seoud OA, 1989, ADV COLLOID INTERFAC, V30, P1; Shahidi F., 2004, PHENOLICS FOOD NUTRA; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Sulaiman SF, 2001, J FOOD COMPOS ANAL, V24, P506; TEMPEL AS, 1982, J CHEM ECOL, V8, P1289, DOI 10.1007/BF00987762; Texter J, 1999, SURFACTANTS: A PRACTICAL HANDBOOK, P1; Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vermerris W, 2006, PHENOLIC COMPOUND BI; Vertuani S, 2004, CURR PHARM DESIGN, V10, P1677, DOI 10.2174/1381612043384655; Wu T, 2012, FOOD CHEM, V133, P1292, DOI 10.1016/j.foodchem.2011.08.002; Zarena AS, 2012, FOOD CHEM, V130, P203, DOI 10.1016/j.foodchem.2011.07.007; Zhang GW, 2011, INNOV FOOD SCI EMERG, V12, P18, DOI 10.1016/j.ifset.2010.12.003	48	49	50	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57353	10.1371/journal.pone.0057353	http://dx.doi.org/10.1371/journal.pone.0057353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472082	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900020
J	Teraoka, Y; Ide, K; Morimoto, H; Tahara, H; Ohdan, H				Teraoka, Yoshifumi; Ide, Kentaro; Morimoto, Hiroshi; Tahara, Hiroyuki; Ohdan, Hideki			Expression of Recipient CD47 on Rat Insulinoma Cell Xenografts Prevents Macrophage-Mediated Rejection through SIRP alpha Inhibitory Signaling in Mice	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; NEGATIVE REGULATION; T-CELL; PHAGOCYTOSIS; LYMPHOCYTES; ADHESION; RECEPTOR; XENOTRANSPLANTATION; TRANSPLANTATION; BABOONS	We have previously proven that the interspecies incompatibility of CD47 is responsible for in vitro phagocytosis of xenogeneic cells by host macrophages. Utilizing an in vivo model in the present study, we investigated whether genetically engineered expression of mouse CD47 in rat insulinoma cells (INS-1E) could inhibit macrophage-mediated xenograft rejection. INS-1E cells transfected with the pRc/CMV-mouse CD47 vector (mCD47-INS-1E) induced SIRP alpha-tyrosine phosphorylation in mouse macrophages in vitro, whereas cells transfected with the control vector (cont-INS-1E) did not. When these cells were injected into the peritoneal cavity of streptozotocin-induced diabetic Rag2(-/-)gamma chain(-/-) mice, which lack T, B, and NK cells, the expression of mouse CD47 on the INS-1E cells markedly reduced the susceptibility of these cells to phagocytosis by macrophages. Moreover, these mice became normoglycemic after receiving mCD47-INS-1E, whereas the mice that received cont-INS-1E failed to achieve normoglycemia. Furthermore, injection of an anti-mouse SIRP alpha blocking monoclonal antibody into the mouse recipients of mCD47-INS-1E cells prevented achievement of normoglycemia. These results demonstrate that interspecies incompatibility of CD47 significantly contributes to in vivo rejection of xenogeneic cells by macrophages. Thus, genetic induction of the expression of recipient CD47 on xenogeneic donor cells could provide inhibitory signals to recipient macrophages via SIPR alpha; this constitutes a novel approach for preventing macrophage-mediated xenograft rejection.	[Teraoka, Yoshifumi; Ide, Kentaro; Morimoto, Hiroshi; Tahara, Hiroyuki; Ohdan, Hideki] Hiroshima Univ, Dept Surg, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci, Hiroshima, Japan	Hiroshima University	Ide, K (corresponding author), Hiroshima Univ, Dept Surg, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci, Hiroshima, Japan.	ideken@hiroshima-u.ac.jp; hohdan@hiroshima-u.ac.jp	Ide, Kentaro/G-4757-2019; Ohdan, Hideki/G-4719-2019	Ide, Kentaro/0000-0002-2293-1688; Ohdan, Hideki/0000-0002-9066-1288	Japan Society for the Promotion of Science; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was carried out at the Natural Science Center for Basic Research and Development, Hiroshima University, and was supported by Grant-in-Aid for Sciences Research (A) from the Japan Society for the Promotion of Science, Grand-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science, and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Cooper DKC, 2002, ANNU REV MED, V53, P133, DOI 10.1146/annurev.med.53.082901.103900; Ide K, 2005, XENOTRANSPLANTATION, V12, P181, DOI 10.1111/j.1399-3089.2005.00222.x; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; McKenzie I F, 1994, Transpl Immunol, V2, P81, DOI 10.1016/0966-3274(94)90032-9; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Nilsson A, 2012, BIOCHEM BIOPH RES CO, V417, P1304, DOI 10.1016/j.bbrc.2011.12.137; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; Shahein YEA, 2002, IMMUNOLOGY, V106, P564, DOI 10.1046/j.1365-2567.2002.01465.x; Simon AR, 1999, IMMUNOL TODAY, V20, P323, DOI 10.1016/S0167-5699(99)01485-1; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Tahara H, 2010, XENOTRANSPLANTATION, V17, P188, DOI 10.1111/j.1399-3089.2010.00575.x; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Waern JM, 2012, HEPATOLOGY, V56, P1479, DOI 10.1002/hep.25816; Wang H, 2007, BLOOD, V109, P836, DOI 10.1182/blood-2006-04-019794; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wu GS, 2000, XENOTRANSPLANTATION, V7, P214, DOI 10.1034/j.1399-3089.2000.00071.x; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099; Yoshida H, 2002, J IMMUNOL, V168, P3213, DOI 10.4049/jimmunol.168.7.3213	31	10	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58359	10.1371/journal.pone.0058359	http://dx.doi.org/10.1371/journal.pone.0058359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472187	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900133
J	Planert, H; Berger, TK; Silberberg, G				Planert, Henrike; Berger, Thomas K.; Silberberg, Gilad			Membrane Properties of Striatal Direct and Indirect Pathway Neurons in Mouse and Rat Slices and Their Modulation by Dopamine	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; FAST-SPIKING INTERNEURONS; PROJECTION NEURONS; IN-VIVO; TRANSMITTER RELEASE; ELECTROPHYSIOLOGICAL PROPERTIES; SYNAPTIC-TRANSMISSION; RECEPTOR ACTIVATION; PYRAMIDAL NEURONS; CAUDATE-NUCLEUS	D1 and D2 receptor expressing striatal medium spiny neurons (MSNs) are ascribed to striatonigral ("direct") and striatopallidal ("indirect") pathways, respectively, that are believed to function antagonistically in motor control. Glutamatergic synaptic transmission onto the two types is differentially affected by Dopamine (DA), however, less is known about the effects on MSN intrinsic electrical properties. Using patch clamp recordings, we comprehensively characterized the two pathways in rats and mice, and investigated their DA modulation. We identified the direct pathway by retrograde labeling in rats, and in mice we used transgenic animals in which EGFP is expressed in D1 MSNs. MSNs were subjected to a series of current injections to pinpoint differences between the populations, and in mice also following bath application of DA. In both animal models, most electrical properties were similar, however, membrane excitability as measured by step and ramp current injections consistently differed, with direct pathway MSNs being less excitable than their counterparts. DA had opposite effects on excitability of D1 and D2 MSNs, counteracting the initial differences. Pronounced changes in AP shape were seen in D2 MSNs. In direct pathway MSNs, excitability increased across experimental conditions and parameters, and also when applying DA or the D1 agonist SKF-81297 in presence of blockers of cholinergic, GABAergic, and glutamatergic receptors. Thus, DA induced changes in excitability were D1 R mediated and intrinsic to direct pathway MSNs, and not a secondary network effect of altered synaptic transmission. DAergic modulation of intrinsic properties therefore acts in a synergistic manner with previously reported effects of DA on afferent synaptic transmission and dendritic processing, supporting the antagonistic model for direct vs. indirect striatal pathway function.	[Planert, Henrike; Silberberg, Gilad] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Planert, Henrike] Charite, Dept Expt Neurol, D-13353 Berlin, Germany; [Berger, Thomas K.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Berkeley	Planert, H (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	Henrike.Planert@ki.se; Gilad.Silberberg@ki.se	Silberberg, Gilad/A-1048-2012	Silberberg, Gilad/0000-0001-9964-505X; Berger, Thomas/0000-0001-9358-1315	European Commission Coordination Action ENINET [LSHM-CT-2005-19063]; Human Frontier Science Program (HFSP); Swedish Science Research Council (VRM); Jeanssons Stiftelse; EU Marie Curie Actions (CORTEX) [19729]; EU FP7 (Select and Act)	European Commission Coordination Action ENINET(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Swedish Science Research Council (VRM); Jeanssons Stiftelse; EU Marie Curie Actions (CORTEX); EU FP7 (Select and Act)	This work was supported by the European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063), the Human Frontier Science Program (HFSP), the Swedish Science Research Council (VRM), Jeanssons Stiftelse, the EU Marie Curie Actions (CORTEX, project No 19729), and EU FP7 (Select and Act). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE A, 1987, BRAIN RES, V418, P262, DOI 10.1016/0006-8993(87)90094-1; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andre VM, 2010, EUR J NEUROSCI, V31, P14, DOI 10.1111/j.1460-9568.2009.07047.x; Bertran-Gonzalez J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00136; Blomeley C, 2005, J PHYSIOL-LONDON, V569, P715, DOI 10.1113/jphysiol.2005.098269; Blomeley CP, 2009, EUR J NEUROSCI, V29, P1604, DOI 10.1111/j.1460-9568.2009.06725.x; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Browning KN, 1999, AM J PHYSIOL-HEART C, V276, pH1263, DOI 10.1152/ajpheart.1999.276.4.H1263; Cepeda C, 2008, EUR J NEUROSCI, V27, P671, DOI 10.1111/j.1460-9568.2008.06038.x; Chan CS, 2012, J NEUROSCI, V32, P9124, DOI 10.1523/JNEUROSCI.0229-12.2012; Costa RM, 2007, ANN NY ACAD SCI, V1104, P172, DOI 10.1196/annals.1390.015; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Doig NM, 2010, J NEUROSCI, V30, P14610, DOI 10.1523/JNEUROSCI.1623-10.2010; ElMansari M, 1997, NEUROPHARMACOLOGY, V36, P577, DOI 10.1016/S0028-3908(97)00035-X; ELMANSARI M, 1994, EUR J PHARMACOL, V261, P171, DOI 10.1016/0014-2999(94)90316-6; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Ford CP, 2009, J NEUROSCI, V29, P13344, DOI 10.1523/JNEUROSCI.3546-09.2009; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gonon F, 1997, J NEUROSCI, V17, P5972; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; GREIF GJ, 1995, J NEUROSCI, V15, P4533; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Hori T, 2009, J PHYSIOL-LONDON, V587, P2987, DOI 10.1113/jphysiol.2009.168765; Janssen MJ, 2009, J NEUROSCI, V29, P5116, DOI 10.1523/JNEUROSCI.4737-08.2009; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kiyatkin EA, 1998, BRAIN RES, V812, P14, DOI 10.1016/S0006-8993(98)00814-2; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Mahon S, 2001, CEREB CORTEX, V11, P360, DOI 10.1093/cercor/11.4.360; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Michael A. C., 2007, ELECTROCHEMICAL METH; Moyer JT, 2007, J NEUROPHYSIOL, V98, P3731, DOI 10.1152/jn.00335.2007; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nicola SM, 1998, J NEUROPHYSIOL, V79, P1768, DOI 10.1152/jn.1998.79.4.1768; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Rumberger A, 1998, EXP BRAIN RES, V119, P375, DOI 10.1007/s002210050353; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SUTOR B, 1990, NEUROSCI LETT, V116, P287, DOI 10.1016/0304-3940(90)90088-Q; Tecuapetla F, 2009, J NEUROSCI, V29, P8977, DOI 10.1523/JNEUROSCI.6145-08.2009; TSENG GF, 1991, J NEUROSCI METH, V37, P121, DOI 10.1016/0165-0270(91)90122-G; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Waszczak BL, 1998, P NATL ACAD SCI USA, V95, P11440, DOI 10.1073/pnas.95.19.11440; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wu XS, 2004, ANESTHESIOLOGY, V100, P663, DOI 10.1097/00000542-200403000-00029; Wu Y, 2000, NEUROSCI RES, V38, P49, DOI 10.1016/S0168-0102(00)00140-1; Yang YM, 2006, J NEUROSCI, V26, P5698, DOI 10.1523/JNEUROSCI.4889-05.2006; Yasumoto S, 2002, J NEUROPHYSIOL, V87, P1234, DOI 10.1152/jn.00514.2001; Zhu J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001032	70	88	88	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57054	10.1371/journal.pone.0057054	http://dx.doi.org/10.1371/journal.pone.0057054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469183	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100014
J	Chen, KJ; Tseng, CK; Chang, FR; Yang, JL; Yeh, CC; Chen, WC; Wu, SF; Chang, HW; Lee, JC				Chen, Kuan-Jen; Tseng, Chin-Kai; Chang, Fang-Rong; Yang, Jin-long; Yeh, Chi-Chen; Chen, Wei-Chun; Wu, Shou-Fang; Chang, Hsueh-Wei; Lee, Jin-Ching			Aqueous Extract of the Edible Gracilaria tenuistipitata Inhibits Hepatitis C Viral Replication via Cyclooxygenase-2 Suppression and Reduces Virus-Induced Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; ORAL-CANCER CELLS; HUMAN CYTOMEGALOVIRUS; ANTIVIRAL ACTIVITY; RNA REPLICATION; DNA-DAMAGE; EXPRESSION; COX-2; INFECTION; ALGAE	Hepatitis C virus (HCV) is an important human pathogen leading to hepatocellular carcinoma. Using an in vitro cell-based HCV replicon and JFH-1 infection system, we demonstrated that an aqueous extract of the seaweed Gracilaria tenuistipitata (AEGT) concentration-dependently inhibited HCV replication at nontoxic concentrations. AEGT synergistically enhanced interferon-alpha (IFN-alpha) anti-HCV activity in a combination treatment. We found that AEGT also significantly suppressed virus-induced cyclooxygenase-2 (COX-2) expression at promoter transactivation and protein levels. Notably, addition of exogenous COX-2 expression in AEGT-treated HCV replicon cells gradually abolished AEGT anti-HCV activity, suggesting that COX-2 down-regulation was responsible for AEGT antiviral effects. Furthermore, we highlighted the inhibitory effect of AEGT in HCV-induced pro-inflammatory gene expression such as the expression of tumour necrosis factor-alpha, interleukin-1 beta, inducible nitrite oxide synthase and COX-2 in a concentration-dependent manner to evaluate the potential therapeutic supplement in the management of patients with chronic HCV infections.	[Chen, Kuan-Jen; Tseng, Chin-Kai; Chen, Wei-Chun; Lee, Jin-Ching] Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan; [Chang, Fang-Rong; Yeh, Chi-Chen; Wu, Shou-Fang; Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan; [Yang, Jin-long] Natl Kaohsiung Marine Univ, Dept Seafood Sci, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Ctr Canc, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chang, HW (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Ctr Canc, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	changhw@kmu.edu.tw; jclee@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009	Chang, Hsueh-Wei/0000-0003-0068-2366; Chang, Fang-Rong/0000-0003-2549-4193; Lee, Jin-Ching/0000-0003-0729-9589	National Science Council of Taiwan [NSC 101-2311-B-037-002-MY3, NSC 101-2622-B-037-001-CC3]; Kaohsiung Medical University Research Foundation, Taiwan [KMUER014]; Department of Health, Executive Yuan, Taiwan [DOH102-TD-C-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research Foundation, Taiwan; Department of Health, Executive Yuan, Taiwan	National Science Council of Taiwan (NSC 101-2311-B-037-002-MY3; NSC 101-2622-B-037-001-CC3) http://web1.nsc.gov.tw/, Kaohsiung Medical University Research Foundation, Taiwan (KMUER014) http://www2.kmu.edu.tw/index.phtml and Department of Health, Executive Yuan, Taiwan (DOH102-TD-C-111-002) http://www.doh.gov.tw/EN2006/index_EN.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes JL, 2010, PLANTA MED, V76, P339, DOI 10.1055/s-0029-1186144; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dang HT, 2008, J NAT PROD, V71, P232, DOI 10.1021/np070452q; de Almeida CLF, 2011, INT J MOL SCI, V12, P4550, DOI 10.3390/ijms12074550; Domitrovic R, 2011, TOXICOLOGY, V280, P33, DOI 10.1016/j.tox.2010.11.005; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Ferreira SD, 2010, BRAZ J INFECT DIS, V14, P330, DOI 10.1590/S1413-86702010000400003; Freudenburg W, 2010, J GEN VIROL, V91, P2278, DOI 10.1099/vir.0.022665-0; Ganesan P, 2008, BIORESOURCE TECHNOL, V99, P2717, DOI 10.1016/j.biortech.2007.07.005; Gee J, 2008, UROL ONCOL-SEMIN ORI, V26, P641, DOI 10.1016/j.urolonc.2007.05.015; Ghosh N, 2010, PHARMACOL REP, V62, P233, DOI 10.1016/S1734-1140(10)70262-0; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; Halfon P, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02716.x; Jiang YF, 2011, CELL BIOL INT, V35, P1225, DOI 10.1042/CBI20110102; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lee HJ, 2009, ARCH PHARM RES, V32, P453, DOI 10.1007/s12272-009-1320-0; Lee JC, 2011, J VIRAL HEPATITIS, V18, pE315, DOI 10.1111/j.1365-2893.2010.01424.x; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Lee SMY, 2011, INFLUENZA OTHER RESP, V5, P230, DOI 10.1111/j.1750-2659.2011.00218.x; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Liu TS, 2005, VIROLOGY, V343, P12, DOI 10.1016/j.virol.2005.08.012; Makarenkova I. D., 2010, Voprosy Virusologii, V55, P41; Morinaga S, 2007, J GASTROEN HEPATOL, V22, P1249, DOI 10.1111/j.1440-1746.2006.04367.x; Nunez O, 2004, GUT, V53, P1665, DOI 10.1136/gut.2003.038364; Okamoto Mika, 2009, Antivir Chem Chemother, V20, P47, DOI 10.3851/IMP1372; Ozeki I, 2011, J GASTROENTEROL, V46, P929, DOI 10.1007/s00535-011-0411-0; Park CM, 2010, FOOD CHEM TOXICOL, V48, P1255, DOI 10.1016/j.fct.2010.02.019; Reynolds AE, 2006, REV MED VIROL, V16, P393, DOI 10.1002/rmv.519; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Steer P, 2003, LIPIDS, V38, P15, DOI 10.1007/s11745-003-1025-9; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; Trujillo-Murillo K, 2008, HEPATOLOGY, V47, P1462, DOI 10.1002/hep.22215; Tung WH, 2010, CELL SIGNAL, V22, P234, DOI 10.1016/j.cellsig.2009.09.018; Verma S, 2011, J GEN VIROL, V92, P507, DOI 10.1099/vir.0.026716-0; Vijayavel K, 2010, J MED FOOD, V13, P1494, DOI 10.1089/jmf.2009.0287; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Ward SM, 2007, J HEPATOL, V47, P316, DOI 10.1016/j.jhep.2007.03.023; Yang JI, 2012, MOLECULES, V17, P7241, DOI 10.3390/molecules17067241; Yangthong M, 2009, PLANT FOOD HUM NUTR, V64, P218, DOI 10.1007/s11130-009-0127-y; Yeh CC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-142; Yeh CC, 2012, MOLECULES, V17, P10916, DOI 10.3390/molecules170910916; Yeh ST, 2010, FISH SHELLFISH IMMUN, V28, P887, DOI 10.1016/j.fsi.2010.02.005; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799	49	54	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57704	10.1371/journal.pone.0057704	http://dx.doi.org/10.1371/journal.pone.0057704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469054	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900153
J	Li, BW; Wan, XJ; Zhu, Q; Li, L; Zeng, Y; Hu, DM; Qian, YQ; Lu, LG; Wang, XP; Meng, XJ				Li, Baiwen; Wan, Xinjian; Zhu, Qi; Li, Lei; Zeng, Yue; Hu, Duanmin; Qian, Yueqin; Lu, Lungen; Wang, Xingpeng; Meng, Xiangjun			Net Expression Inhibits the Growth of Pancreatic Ductal Adenocarcinoma Cell PL45 In Vitro and In Vivo	PLOS ONE			English	Article							DOMAIN TRANSCRIPTION FACTORS; C-FOS TRANSCRIPTION; COMPLEX FACTOR NET; KINASE ACTIVATION; CDK INHIBITORS; CANCER; PROTEIN; AP-1; ELK-1; PROLIFERATION	Pancreatic ductal adenocarcinoma has a poor prognosis due to late diagnosis and a lack of effective therapeutic options. Thus, it is important to better understand its molecular mechanisms and to develop more effective treatments for the disease. The ternary complex factor Net, which exerts its strong inhibitory function on transcription of proto-oncogene gene c-fos by forming ternary complexes with a second transcription factor, has been suspected of being involved in pancreatic cancer and other tumors biology. In this study, we found that the majority of pancreatic ductal adenocarcinoma tissues and cell lines had weak or no expression of Net, whereas significantly high level of Net expression occurred in paired adjacent normal tissues we studied. Furthermore, using in vitro and in vivo model systems, we found that overexpression of Net inhibited cell growth and survival and induced cell apoptosis in human pancreatic ductal adenocarcinoma cell PL45; the mechanisms by which Net inhibited the cell cycle progression were mainly through P21-Cyclin D1/CDK4 Pathway. Our data thus suggested that Net might play an important role in pancreatic carcinogenesis, possibly by acting as a tumor suppressor gene.	[Li, Baiwen; Wan, Xinjian; Li, Lei; Zeng, Yue; Qian, Yueqin; Lu, Lungen; Wang, Xingpeng; Meng, Xiangjun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Zhu, Qi; Hu, Duanmin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, XP (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200030, Peoples R China.	wangxp1965@yahoo.com.cn; xiangjunmeng@yahoo.com.cn	li, bz/GVR-7133-2022		Natural Science Fund of Shanghai of China [11ZR1429000]; Pujiang Talent Program Fund [10PJ1408500]	Natural Science Fund of Shanghai of China; Pujiang Talent Program Fund	This work is supported by Natural Science Fund of Shanghai of China (#11ZR1429000, http://www.stcsm.gov.cn) and Pujiang Talent Program Fund (#10PJ1408500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Ben QW, 2010, ANN SURG ONCOL, V17, P2213, DOI 10.1245/s10434-010-0955-x; Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618; Brasiuniene B, 2007, MEDICINA-LITHUANIA, V43, P716, DOI 10.3390/medicina43090093; Brasiuniene Birute, 2005, Medicina (Kaunas), V41, P382; Buchwalter DB, 2005, ENVIRON SCI TECHNOL, V39, P498, DOI 10.1021/es0404421; Buchwalter G, 2005, MOL CELL BIOL, V25, P10853, DOI 10.1128/MCB.25.24.10853-10862.2005; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cao HX, 2009, BIOCHEM BIOPH RES CO, V380, P11, DOI 10.1016/j.bbrc.2008.12.171; D'Emilio A, 2010, HISTOL HISTOPATHOL, V25, P21, DOI 10.14670/HH-25.21; Demir O, 2011, BBA-MOL BASIS DIS, V1812, P652, DOI 10.1016/j.bbadis.2011.02.012; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gross C, 2008, ONCOGENE, V27, P1333, DOI 10.1038/sj.onc.1210736; Guo XZ, 2005, PANCREAS, V31, P13, DOI 10.1097/01.mpa.0000168220.97967.d1; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Kasza A, 2005, J BIOL CHEM, V280, P1149, DOI 10.1074/jbc.M411161200; Li BW, 2008, TOHOKU J EXP MED, V216, P139, DOI 10.1620/tjem.216.139; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Liu TZ, 2006, FOOD CHEM TOXICOL, V44, P227, DOI 10.1016/j.fct.2005.07.003; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; Nakade K, 2004, MOL CELL BIOL, V24, P1132, DOI 10.1128/MCB.24.3.1132-1142.2004; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; Shaib YH, 2006, ALIMENT PHARM THER, V24, P87, DOI 10.1111/j.1365-2036.2006.02961.x; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHORE P, 1995, NUCLEIC ACIDS RES, V23, P4698, DOI 10.1093/nar/23.22.4698; Stinson J, 2003, NUCLEIC ACIDS RES, V31, P4717, DOI 10.1093/nar/gkg689; van Riggelen J, 2005, J BIOL CHEM, V280, P3286, DOI 10.1074/jbc.M409915200; Vickers ER, 2004, MOL CELL BIOL, V24, P10340, DOI 10.1128/MCB.24.23.10340-10351.2004; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Yang SH, 1997, BIOCHEM SOC T, V25, pS153, DOI 10.1042/bst025153s	39	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57818	10.1371/journal.pone.0057818	http://dx.doi.org/10.1371/journal.pone.0057818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469073	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900170
J	Zhao, GH; Cong, MM; Bian, QQ; Cheng, WY; Wang, RJ; Qi, M; Zhang, LX; Lin, Q; Zhu, XQ				Zhao, Guang-Hui; Cong, Mei-Mei; Bian, Qing-Qing; Cheng, Wen-Yu; Wang, Rong-Jun; Qi, Meng; Zhang, Long-Xian; Lin, Qing; Zhu, Xing-Quan			Molecular Characterization of Cyclospora-like Organisms from Golden Snub-nosed Monkeys in Qinling Mountain in Shaanxi Province, Northwestern China	PLOS ONE			English	Article							CAYETANENSIS INFECTION; INTESTINAL PATHOGEN; EPIDEMIOLOGY; DIARRHEA; APICOMPLEXA; PREVALENCE; EIMERIIDAE; OUTBREAKS; PRIMATES	Cyclospora spp. have been identified as one of the most important intestinal pathogens causing protracted diarrhea in animals and human beings. To determine the Cyclospora species in the non-human primate Rhinopithecus roxellanae, a total of 71 fecal samples from 19 endangered snub-nosed monkeys in Shaanxi province were collected and examined using Sheater's sugar flotation technique and by sequencing the fragments of 18S rDNA. Only two Cyclospora isolates from 2 golden snub-nosed monkeys (R. roxellanae) were obtained and identified between July 2011 and August of 2012. The sequences of the 18S rDNA for the two Cyclospora isolates were 477 bp, with no nucleotide variation between them. Phylogenetic analysis based on the 18S rDNA sequences revealed that the two Cyclospora isolates were posited into the clade Cyclospora spp. and sistered to C. colobi. These results first showed that Cyclospora infection occurred in R. roxellanae in hot and rainy weather, which would provide useful information for further understanding the molecular epidemiology of Cyclospora spp. and the control of Cyclospora infection in non-human primates as well as in human beings.	[Zhao, Guang-Hui; Cong, Mei-Mei; Bian, Qing-Qing; Cheng, Wen-Yu; Lin, Qing] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Rong-Jun; Qi, Meng; Zhang, Long-Xian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Northwest A&F University - China; Henan Agricultural University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Lin, Q (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi Provinc, Peoples R China.	yllinqing@126.com; xingquanzhu1@hotmail.com	Zhang, Longxian/R-7799-2019; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/I-9223-2019	Zhang, Longxian/0000-0002-5706-131X	National Natural Science Foundation of China [31101805, 31101138, 30960280]; Fund for Basic scientific research [ZD2012010, QN2012018]; Open Funds of the State Key Laboratory of Veterinary Etiological Biology; Lanzhou Veterinary Research Institute; Chinese Academy of Agricultural Sciences [SKLVEB2011KFKT011]; Special Funds for Talents in Northwest A F University [Z109021107, 2010BSJJ015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Basic scientific research; Open Funds of the State Key Laboratory of Veterinary Etiological Biology; Lanzhou Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Special Funds for Talents in Northwest A F University	This work was supported, in part, by the National Natural Science Foundation of China (Grant No. 31101805, 31101138, 30960280), the Fund for Basic scientific research (Grant No. ZD2012010 and QN2012018), the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant No. SKLVEB2011KFKT011), and the Special Funds for Talents in Northwest A & F University (Grant Nos. Z109021107 and 2010BSJJ015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFORD RW, 1979, ANN TROP MED PARASIT, V73, P497, DOI 10.1080/00034983.1979.11687291; Bern C, 2002, EMERG INFECT DIS, V8, P581, DOI 10.3201/eid0806.01-0331; Bern C, 1999, EMERG INFECT DIS, V5, P766, DOI 10.3201/eid0506.990604; Chacin-Bonilla L, 2003, AM J TROP MED HYG, V68, P304, DOI 10.4269/ajtmh.2003.68.304; Chacin-Bonilla L, 2007, T ROY SOC TROP MED H, V101, P1018, DOI 10.1016/j.trstmh.2007.05.008; Chacin-Bonilla L, 2010, ACTA TROP, V115, P181, DOI 10.1016/j.actatropica.2010.04.001; CHILTON NB, 1995, INT J PARASITOL, V25, P647, DOI 10.1016/0020-7519(94)00171-J; Chu DMT, 2004, AM J TROP MED HYG, V71, P373, DOI 10.4269/ajtmh.2004.71.373; Cordon GP, 2008, VET PARASITOL, V156, P302, DOI 10.1016/j.vetpar.2008.05.023; Eberhard ML, 1999, AM J TROP MED HYG, V60, P584, DOI 10.4269/ajtmh.1999.60.584; Eberhard ML, 1999, EMERG INFECT DIS, V5, P651, DOI 10.3201/eid0505.990505; Eberhard ML, 2001, J PARASITOL, V87, P1394, DOI 10.1645/0022-3395(2001)087[1394:ASFCSI]2.0.CO;2; Ferreira MS, 2000, MEM I OSWALDO CRUZ, V95, P159, DOI 10.1590/S0074-02762000000700026; Gao Zhen-yong, 2010, Zhongguo Shouyi Kexue, V40, P30; GarciaLopez HL, 1996, EMERG INFECT DIS, V2, P356, DOI 10.3201/eid0204.960414; HART AS, 1990, LANCET, V335, P169, DOI 10.1016/0140-6736(90)90042-4; Herwaldt BL, 2000, CLIN INFECT DIS, V31, P1040, DOI 10.1086/314051; HOGE CW, 1993, LANCET, V341, P1175, DOI 10.1016/0140-6736(93)91002-4; Kimura Kenji, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1371; Koumans EHA, 1998, AM J TROP MED HYG, V59, P235, DOI 10.4269/ajtmh.1998.59.235; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P103, DOI 10.1590/S0074-02762005000200001; Li GQ, 2007, PARASITOL RES, V100, P955, DOI 10.1007/s00436-006-0380-z; LONG EG, 1990, J CLIN MICROBIOL, V28, P1101, DOI 10.1128/JCM.28.6.1101-1104.1990; LONG EG, 1991, J INFECT DIS, V164, P199, DOI 10.1093/infdis/164.1.199; Madico G, 1997, CLIN INFECT DIS, V24, P977, DOI 10.1093/clinids/24.5.977; Mansfield LS, 2004, VET PARASITOL, V126, P73, DOI 10.1016/j.vetpar.2004.09.011; Nimri LF, 2003, INT MICROBIOL, V6, P131, DOI 10.1007/s10123-003-0121-4; ORTEGA YR, 1994, J PARASITOL, V80, P625, DOI 10.2307/3283201; ORTEGA YR, 1993, NEW ENGL J MED, V328, P1308, DOI 10.1056/NEJM199305063281804; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Relman DA, 1996, J INFECT DIS, V173, P440, DOI 10.1093/infdis/173.2.440; Schneider A., 1881, ARCH ZOOLOGIE EXPT G, V9, P387; Sherchand J B, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P143; Shields JA, 2003, INT J PARASITOL, V33, P371, DOI 10.1016/S0020-7519(02)00268-0; Smith HV, 1996, VET REC, V138, P528; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turgay N, 2007, MED SCI MONITOR, V13, pCR34; Wang KX, 2002, WORLD J GASTROENTERO, V8, P1144, DOI 10.3748/wjg.v8.i6.1144; WURTZ R, 1994, CLIN INFECT DIS, V18, P620, DOI 10.1093/clinids/18.4.620; Xing WL, 2002, CHIN J PARASIT DIS C, V15, P320; Yai Lucia Eiko Oishi, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P177, DOI 10.1590/S0036-46651997000300011; ZERPA R, 1995, J TROP MED HYG, V98, P325; Zhao GH, 2009, VET PARASITOL, V162, P67, DOI 10.1016/j.vetpar.2009.02.022; Zhao GH, 2011, INFECT GENET EVOL, V11, P610, DOI 10.1016/j.meegid.2011.01.015; Zhou Y, 2011, EMERG INFECT DIS, V17, P1887, DOI 10.3201/eid1710.101296	45	16	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58216	10.1371/journal.pone.0058216	http://dx.doi.org/10.1371/journal.pone.0058216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469155	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900246
J	Auersperger, I; Skof, B; Leskosek, B; Knap, B; Jerin, A; Lainscak, M				Auersperger, Irena; Skof, Branko; Leskosek, Bojan; Knap, Bojan; Jerin, Ales; Lainscak, Mitja			Exercise-Induced Changes in Iron Status and Hepcidin Response in Female Runners	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; SERUM HEPCIDIN; FERRIC CARBOXYMALTOSE; TRANSFERRIN RECEPTOR; HEART-FAILURE; DOUBLE-BLIND; DEFICIENCY; INFLAMMATION; SUPPLEMENTATION; POPULATION	Background and Aims: Exercise-induced iron deficiency is a common finding in endurance athletes. It has been suggested recently that hepcidin may be an important mediator in this process. Objective: To determine hepcidin levels and markers of iron status during long-term exercise training in female runners with depleted and normal iron stores. Methods: Fourteen runners were divided into two groups according to iron status. Blood samples were taken during a period of eight weeks at baseline, after training and after ten days' recovery phase. Results: Of 14 runners, 7 were iron deficient at baseline and 10 after training. Hepcidin was lower at recovery compared with baseline (p<0.05). The mean cell haemoglobin content, haemoglobin content per reticulocyte and total iron binding capacity all decreased, whereas soluble transferrin receptor and hypochromic red cells increased after training and recovery (p<0.05 for all). Conclusion: The prevalence of depleted iron stores was 71% at the end of the training phase. Hepcidin and iron stores decreased during long-term running training and did not recover after ten days, regardless of baseline iron status.	[Auersperger, Irena; Skof, Branko; Leskosek, Bojan] Univ Ljubljana, Fac Sport, Ljubljana, Slovenia; [Knap, Bojan] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia; [Jerin, Ales] Univ Med Ctr Ljubljana, Inst Clin Chem & Biochem, Ljubljana, Slovenia; [Lainscak, Mitja] Univ Clin Golnik, Div Cardiol, Golnik, Slovenia; [Lainscak, Mitja] Campus Virchow Klinikum, Charite, Dept Cardiol, Berlin, Germany	University of Ljubljana; University Medical Centre Ljubljana; University Medical Centre Ljubljana; University Clinic Golnik; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lainscak, M (corresponding author), Univ Clin Golnik, Div Cardiol, Golnik, Slovenia.	mitja.lainscak@guest.arnes.si			Heart Failure Association Research Fellowship	Heart Failure Association Research Fellowship	ML received a Heart Failure Association Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Babic Z, 2001, J SPORT MED PHYS FIT, V41, P399; Beard J, 2000, AM J CLIN NUTR, V72, p594S, DOI 10.1093/ajcn/72.2.594S; Bourque SP, 1997, J AM DIET ASSOC, V97, P1116, DOI 10.1016/S0002-8223(97)00272-1; Clement D B, 1982, Phys Sportsmed, V10, P37, DOI 10.1080/00913847.1982.11947181; Comin-Colet J, 2013, EUR HEART J, V34, P30, DOI 10.1093/eurheartj/ehr504; Costa E, 2009, ACTA HAEMATOL-BASEL, V122, P226, DOI 10.1159/000253590; CUSTER EM, 1995, J LAB CLIN MED, V126, P88; Dallalio G, 2003, BRIT J HAEMATOL, V122, P996, DOI 10.1046/j.1365-2141.2003.04516.x; Deruisseau KC, 2004, MED SCI SPORT EXER, V36, P241, DOI 10.1249/01.MSS.0000113483.13339.7B; DeRuisseau KC, 2002, INT J SPORT NUTR EXE, V12, P428, DOI 10.1123/ijsnem.12.4.428; Di Santolo M, 2008, EUR J APPL PHYSIOL, V102, P703, DOI 10.1007/s00421-007-0647-9; Edwards S, 1996, HEART ZONE TRAINING, P114; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Hinton PS, 2007, EUR J CLIN NUTR, V61, P30, DOI 10.1038/sj.ejcn.1602479; Janssen P, 2001, LACTATE THRESHOLD TR, P34; Karl JP, 2010, AM J CLIN NUTR, V92, P93, DOI 10.3945/ajcn.2010.29185; Malczewska J, 2000, INT J SPORT NUTR, V10, P260, DOI 10.1123/ijsnem.10.3.260; McClung JP, 2009, AM J CLIN NUTR, V90, P124, DOI 10.3945/ajcn.2009.27774; Murray-Kolb LE, 2007, AM J CLIN NUTR, V85, P778, DOI 10.1093/ajcn/85.3.778; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Ostojic SM, 2008, J SPORT MED PHYS FIT, V48, P398; Pasricha SR, 2011, HAEMATOL-HEMATOL J, V96, P1099, DOI 10.3324/haematol.2010.037960; Peeling P, 2008, EUR J APPL PHYSIOL, V103, P381, DOI 10.1007/s00421-008-0726-6; Peeling P, 2009, INT J SPORT NUTR EXE, V19, P583, DOI 10.1123/ijsnem.19.6.583; Peeling P, 2009, MED SCI SPORT EXER, V41, P1138, DOI 10.1249/MSS.0b013e318192ce58; Peeling P, 2009, EUR J APPL PHYSIOL, V106, P51, DOI 10.1007/s00421-009-0988-7; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Reinke S, 2012, INT J CARDIOL, V156, P186, DOI 10.1016/j.ijcard.2010.10.139; Roecker L, 2005, EUR J APPL PHYSIOL, V95, P569, DOI 10.1007/s00421-005-0055-y; Schumacher YO, 2002, BRIT J SPORT MED, V36, P195, DOI 10.1136/bjsm.36.3.195; Schumacher YO, 2002, MED SCI SPORT EXER, V34, P869; Stupnicki R, 2003, BRIT J SPORT MED, V37, P267, DOI 10.1136/bjsm.37.3.267; Thomas C, 2002, CLIN CHEM, V48, P1066; Troadec MB, 2009, EUR J APPL PHYSIOL, V106, P435, DOI 10.1007/s00421-009-1031-8; Zoller H, 2004, NUTRITION, V20, P615, DOI 10.1016/j.nut.2004.04.006	36	32	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58090	10.1371/journal.pone.0058090	http://dx.doi.org/10.1371/journal.pone.0058090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472137	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900082
J	Chan, YT; Lin, YC; Lin, RJ; Kuo, HH; Thang, WC; Chiu, KP; Yu, AL				Chan, Yu-Tzu; Lin, You-Chin; Lin, Ruey-Jen; Kuo, Huan-Hsien; Thang, Wai-Cheng; Chiu, Kuo-Ping; Yu, Alice L.			Concordant and Discordant Regulation of Target Genes by miR-31 and Its Isoforms	PLOS ONE			English	Article							MICRORNA TARGETS; MESSENGER-RNA; DICER; EXPRESSION; CELLS; REVEALS; CANCER; NEUROBLASTOMA; BIOGENESIS; DROSHA	It has been shown that imprecise cleavage of a primary or precursor RNA by Drosha or Dicer, respectively, may yield a group of microRNA (miRNA) variants designated as "isomiR". Variations in the relative abundance of isoforms for a given miRNA among different species and different cell types beg the question whether these isomiRs might regulate target genes differentially. We compared the capacity of three miR-31 isoforms (miR-31-H, miR-31-P, and miR-31-M), which differ only slightly in their 5'- and/or 3'-end sequences, to regulate several known targets and a predicted target, Dicer. Notably, we found isomiR-31s displayed concordant and discordant regulation of 6 known target genes. Furthermore, we validated a predicted target gene, Dicer, to be a novel target of miR-31 but only miR-31-P could directly repress Dicer expression in both MCF-7 breast cancer cells and A549 lung cancer cells, resulting in their enhanced sensitivity to cisplatin, a known attribute of Dicer knockdown. This was further supported by reporter assay using full length 3'-untranslated region (UTR) of Dicer. Our findings not only revealed Dicer to be a direct target of miR-31, but also demonstrated that isomiRs displayed similar and disparate regulation of target genes in cell-based systems. Coupled with the variations in the distribution of isomiRs among different cells or conditions, our findings support the possibility of fine-tuning gene expression by miRNAs.	[Chan, Yu-Tzu] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chan, Yu-Tzu; Lin, You-Chin; Lin, Ruey-Jen; Kuo, Huan-Hsien; Thang, Wai-Cheng; Chiu, Kuo-Ping; Yu, Alice L.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Yu, Alice L.] Univ Calif San Diego, Med Ctr, Dept Pediat Hematol Oncol, San Diego, CA 92103 USA	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; University of California System; University of California San Diego	Yu, AL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	ayu@gate.sinica.edu.tw	Chiu, Kuo-Ping/AAG-8855-2020; Thang, Wai Cheng/D-6097-2017	Chiu, Kuo-Ping/0000-0001-9144-0674; Lin, Ruey-Jen/0000-0001-5586-1770; yu, alice/0000-0003-2444-0505; Thang, Wai Cheng/0000-0002-1480-3563	Academia Sinica; National Science Council of Taiwan [98-2320-B-001-001- (2009)]	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by Academia Sinica and grant 98-2320-B-001-001- (2009) from National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bu Y, 2009, ONCOL REP, V21, P13, DOI 10.3892/or_00000183; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Felice KM, 2009, BIOCHEM J, V422, P329, DOI 10.1042/BJ20090534; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Warf MB, 2011, RNA, V17, P563, DOI 10.1261/rna.2432311; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200	50	29	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58169	10.1371/journal.pone.0058169	http://dx.doi.org/10.1371/journal.pone.0058169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472152	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900098
J	Gold, JI; Martini, JS; Hullmann, J; Gao, E; Chuprun, JK; Lee, L; Tilley, DG; Rabinowitz, JE; Bossuyt, J; Bers, DM; Koch, WJ				Gold, Jessica I.; Martini, Jeffrey S.; Hullmann, Jonathan; Gao, Erhe; Chuprun, J. Kurt; Lee, Linda; Tilley, Douglas G.; Rabinowitz, Joseph E.; Bossuyt, Julie; Bers, Donald M.; Koch, Walter J.			Nuclear Translocation of Cardiac G Protein-Coupled Receptor Kinase 5 Downstream of Select Gq-Activating Hypertrophic Ligands Is a Calmodulin-Dependent Process	PLOS ONE			English	Article							CALCIUM SENSOR PROTEINS; HEART-FAILURE; IN-VIVO; HISTONE DEACETYLASE-5; TRANSCRIPTION FACTOR; CLINICAL-OUTCOMES; TRANSGENIC MICE; EXPRESSION; BINDING; GRK5	G protein-Coupled Receptors (GPCRs) kinases (GRKs) play a crucial role in regulating cardiac hypertrophy. Recent data from our lab has shown that, following ventricular pressure overload, GRK5, a primary cardiac GRK, facilitates maladaptive myocyte growth via novel nuclear localization. In the nucleus, GRK5's newly discovered kinase activity on histone deacetylase 5 induces hypertrophic gene transcription. The mechanisms governing the nuclear targeting of GRK5 are unknown. We report here that GRK5 nuclear accumulation is dependent on Ca2+/calmodulin (CaM) binding to a specific site within the amino terminus of GRK5 and this interaction occurs after selective activation of hypertrophic Gq-coupled receptors. Stimulation of myocytes with phenylephrine or angiotensinII causes GRK5 to leave the sarcolemmal membrane and accumulate in the nucleus, while the endothelin-1 does not cause nuclear GRK5 localization. A mutation within the amino-terminus of GRK5 negating CaM binding attenuates GRK5 movement from the sarcolemma to the nucleus and, importantly, overexpression of this mutant does not facilitate cardiac hypertrophy and related gene transcription in vitro and in vivo. Our data reveal that CaM binding to GRK5 is a physiologically relevant event that is absolutely required for nuclear GRK5 localization downstream of hypertrophic stimuli, thus facilitating GRK5-dependent regulation of maladaptive hypertrophy.	[Gold, Jessica I.; Martini, Jeffrey S.; Hullmann, Jonathan; Koch, Walter J.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Gao, Erhe; Chuprun, J. Kurt; Tilley, Douglas G.; Rabinowitz, Joseph E.; Koch, Walter J.] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19122 USA; [Tilley, Douglas G.; Rabinowitz, Joseph E.; Koch, Walter J.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA; [Lee, Linda; Bossuyt, Julie; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California Davis	Koch, WJ (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA.	Walter.Koch@temple.edu		Bossuyt, Julie/0000-0001-8874-4765; Tilley, Douglas/0000-0002-9681-3377; Bers, Donald/0000-0002-2237-9483	United States National Institutes of Health [P01 HL091799, P01 HL07544]; American Heart Association Great Rivers Affiliate; National Institutes of Health [P01-HL080101, R01HL103933-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101, R01HL103933, P01HL091799] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Great Rivers Affiliate(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by United States National Institutes of Health grants P01 HL091799 (to WJK) and P01 HL07544 Project 2 (to WJK) and a Pre-Doctoral Fellowship Award from the American Heart Association Great Rivers Affiliate (to JIG). This work was also supported in part by National Institutes of Health grants NIH grant P01-HL080101 (to DMB) and R01HL103933-01 (to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Anand I, 2004, LANCET, V364, P347, DOI 10.1016/S0140-6736(04)16723-8; ASANO M, 1989, J PHARMACOL EXP THER, V251, P764; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Barker BL, 2011, BIOCHEMISTRY-US, V50, P6933, DOI 10.1021/bi2005202; Bonita RE, 2010, CTS-CLIN TRANSL SCI, V3, P14, DOI 10.1111/j.1752-8062.2010.00176.x; Bossuyt J, 2011, J BIOL CHEM, V286, P33390, DOI 10.1074/jbc.M111.246447; Brinks H, 2011, FUTUR CARDIOL, V7, P547, DOI [10.2217/FCA.11.36, 10.2217/fca.11.36]; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen XQ, 2010, J BIOL CHEM, V285, P12823, DOI 10.1074/jbc.M109.094243; Chuang TT, 1996, J BIOL CHEM, V271, P28691, DOI 10.1074/jbc.271.45.28691; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Dzimiri N, 2004, EUR J PHARMACOL, V489, P167, DOI 10.1016/j.ejphar.2004.03.015; Dzimiri N, 2002, CLIN EXP PHARMACOL P, V29, P181, DOI 10.1046/j.1440-1681.2002.03625.x; Eckhart AD, 2000, CIRC RES, V86, P43, DOI 10.1161/01.RES.86.1.43; Fogari R, 2012, DIABETIC MED, V29, P24, DOI 10.1111/j.1464-5491.2011.03383.x; Galasinski SC, 2002, J BIOL CHEM, V277, P19618, DOI 10.1074/jbc.M201174200; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Hata Jonathan A, 2003, Mol Interv, V3, P264, DOI 10.1124/mi.3.5.264; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang Z.M., 2012, FRONT BIOSCI, V17, P3047; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Iacovelli L, 1999, FASEB J, V13, P1; INGLESE J, 1993, J BIOL CHEM, V268, P23735; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Li X, 2011, CIRCULATION, V124, P572, DOI 10.1161/CIRCULATIONAHA.111.021352; Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750; Liu P, 2010, BRAIN RES, V1307, P134, DOI 10.1016/j.brainres.2009.10.036; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Michal AM, 2012, J BIOL CHEM, V287, P6928, DOI 10.1074/jbc.M111.298034; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Patial S, 2010, BIOCHEM J, V425, P169, DOI 10.1042/BJ20090908; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; Sallese M, 2000, BBA-MOL CELL RES, V1498, P112, DOI 10.1016/S0167-4889(00)00088-4; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Yamamoto K, 2011, HYPERTENS RES, V34, P325, DOI 10.1038/hr.2010.237; Yi XP, 2005, ANAT REC PART A, V282A, P13, DOI 10.1002/ar.a.20143; Yi YP, 2002, HYPERTENSION, V39, P1058, DOI 10.1161/01.HYP0000019130.09167.3B; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563	61	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57324	10.1371/journal.pone.0057324	http://dx.doi.org/10.1371/journal.pone.0057324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472081	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900019
J	Jayakumar, C; Ranganathan, P; Devarajan, P; Krawczeski, CD; Looney, S; Ramesh, G				Jayakumar, Calpurnia; Ranganathan, Punithavathi; Devarajan, Prasad; Krawczeski, Catherine D.; Looney, Stephen; Ramesh, Ganesan			Semaphorin 3A Is a New Early Diagnostic Biomarker of Experimental and Pediatric Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; EARLY PREDICTIVE BIOMARKER; ISCHEMIA-REPERFUSION INJURY; CRITICALLY-ILL PATIENTS; CARDIAC-SURGERY; URINARY BIOMARKERS; RIFLE CRITERIA; CHILDREN; MORTALITY; NGAL	Background: Semaphorin 3A is a secreted protein that regulates cell motility and attachment in axon guidance, vascular growth, immune cell regulation and tumor progression. However, nothing is known about its role in kidney pathophysiology. Here, we determined whether semaphorin3A is induced after acute kidney injury (AKI) and whether urinary semaphorin 3A can predict AKI in humans undergoing cardiopulmonary bypass (CPB). Methods and Principal Findings: In animals, semaphorin 3A is localized in distal tubules of the kidney and excretion increased within 3 hr after reperfusion of the kidney whereas serum creatinine was significantly raised at 24 hr. In humans, using serum creatinine, AKI was detected on average only 48 hours after CPB. In contrast, urine semaphorin increased at 2 hours after CPB, peaked at 6 hours (2596 +/- 591 pg/mg creatinine), and was no longer significantly elevated 12 hours after CPB. The predictive power of semaphorin 3A as demonstrated by area under the receiver-operating characteristic curve for diagnosis of AKI at 2, 6, and 12 hours after CPB was 0.88, 0.81, and 0.74, respectively. The 2-hour urine semaphorin measurement strongly correlated with duration and severity of AKI, as well as length of hospital stay. Adjusting for CPB time and gender, the 2-hour semaphorin remained an independent predictor of AKI, with an odds ratio of 2.19. Conclusion: Our results suggest that semaphorin 3A is an early, predictive biomarker in experimental and pediatric AKI, and may allow for the reliable early diagnosis and prognosis of AKI after CPB, much before the rise in serum creatinine.	[Jayakumar, Calpurnia; Ranganathan, Punithavathi; Ramesh, Ganesan] Georgia Hlth Sci Univ, Dept Med, Augusta, GA USA; [Jayakumar, Calpurnia; Ranganathan, Punithavathi; Ramesh, Ganesan] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA; [Devarajan, Prasad] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Dept Hypertens & Nephrol, Cincinnati, OH USA; [Krawczeski, Catherine D.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH USA; [Looney, Stephen] Georgia Hlth Sci Univ, Dept Biostat, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Georgia; Augusta University	Ramesh, G (corresponding author), Georgia Hlth Sci Univ, Dept Med, Augusta, GA USA.	gramesh@georgiahealth.edu	Ramesh, Ganesan/C-9134-2014	Ramesh, Ganesan/0000-0002-8968-0721; Devarajan, Prasad/0000-0002-7847-8552	National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) [1R01DK083379 - 01A3]; Georgia Health Sciences University; National Institutes of Health [RO1-DK069749, RO1-HL08676, UO1-DK082185, P50 DK096418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK082185, P50DK096418, R01DK069749, R01DK083379] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Georgia Health Sciences University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GR is supported by an R01 grant from National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) (1R01DK083379 - 01A3) and a startup grant from Georgia Health Sciences University. PD is supported by grants from the National Institutes of Health (RO1-DK069749, RO1-HL08676, UO1-DK082185, P50 DK096418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Allgren RL, 1997, NEW ENGL J MED, V336, P828, DOI 10.1056/NEJM199703203361203; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Coca SG, 2008, CLIN J AM SOC NEPHRO, V3, P481, DOI 10.2215/CJN.03520807; de Lemos JA, 2008, NEW ENGL J MED, V358, P2172, DOI 10.1056/NEJMe0801721; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Doi K, 2011, CRIT CARE MED, V39, P2464, DOI 10.1097/CCM.0b013e318225761a; Goldstein SL, 2006, PEDIATR NEPHROL, V21, P891, DOI 10.1007/s00467-006-0173-8; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hirsch R, 2007, PEDIATR NEPHROL, V22, P2089, DOI 10.1007/s00467-007-0601-4; Hirschberg R, 1999, KIDNEY INT, V55, P2423, DOI 10.1046/j.1523-1755.1999.00463.x; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Liu KD, 2009, CRIT CARE, V13, DOI 10.1186/cc7940; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Nguyen MT, 2008, PEDIATR NEPHROL, V23, P1317, DOI 10.1007/s00467-008-0827-9; Noiri E, 2009, AM J PHYSIOL-RENAL, V296, pF669, DOI 10.1152/ajprenal.90513.2008; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Parikh CR, 2006, AM J TRANSPLANT, V6, P1639, DOI 10.1111/j.1600-6143.2006.01352.x; Ramesh G, 2010, CLIN J AM SOC NEPHRO, V5, P395, DOI 10.2215/CJN.05140709; Robert B, 2000, AM J PHYSIOL-RENAL, V279, pF275, DOI 10.1152/ajprenal.2000.279.2.F275; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Slater MB, 2012, KIDNEY INT, V81, P791, DOI 10.1038/ki.2011.466; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Thakar CV, 2005, KIDNEY INT, V67, P1112, DOI 10.1111/j.1523-1755.2005.00177.x; Tufro A, 2008, MECH DEVELOP, V125, P558, DOI 10.1016/j.mod.2007.12.003; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Villegas G, 2002, MECH DEVELOP, V119, pS149, DOI 10.1016/S0925-4773(03)00108-4; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007	43	35	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58446	10.1371/journal.pone.0058446	http://dx.doi.org/10.1371/journal.pone.0058446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469280	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900088
J	Manek, AK; Ferrari, MCO; Pollock, RJ; Vicente, D; Weber, LP; Chivers, DP				Manek, Aditya K.; Ferrari, Maud C. O.; Pollock, Robyn J.; Vicente, Daniel; Weber, Lynn P.; Chivers, Douglas P.			Within and between Population Variation in Epidermal Club Cell Investment in a Freshwater Prey Fish: A Cautionary Tale for Evolutionary Ecologists	PLOS ONE			English	Article							ALARM SUBSTANCE CELLS; ULTRAVIOLET-RADIATION; SHOALMATE FAMILIARITY; FATHEAD MINNOWS; SEASONAL LOSS; THREAT; AVOIDANCE; RESPONSES; CUES; PROLIFERATION	Many prey fishes possess large club cells in their epidermis. The role of these cells has garnered considerable attention from evolutionary ecologists. These cells likely form part of the innate immune system of fishes, however, they also have an alarm function, releasing chemical cues that serve to warn nearby conspecifics of danger. Experiments aimed at understanding the selection pressures leading to the evolution of these cells have been hampered by a surprisingly large intraspecific variation in epidermal club cell (ECC) investment. The goal of our current work was to explore the magnitude and nature of this variation in ECC investment. In a field survey, we documented large differences in ECC investment both within and between several populations of minnows. We then tested whether we could experimentally reduce variation in mean ECC number by raising fish under standard laboratory conditions for 4 weeks. Fish from different populations responded very differently to being held under standard laboratory conditions; some populations showed an increase in ECC investment while others remained unchanged. More importantly, we found some evidence that we could reduce within population variation in ECC investment through time, but could not reduce among-population variation in mean ECC investment. Given the large variation we observed in wild fish and our limited ability to converge mean cell number by holding the fish under standard conditions, we caution that future studies may be hard pressed to find subtle effects of various experimental manipulations; this will make elucidating the selection pressures leading to the evolution of the cells challenging.	[Manek, Aditya K.; Pollock, Robyn J.; Vicente, Daniel; Chivers, Douglas P.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Ferrari, Maud C. O.; Weber, Lynn P.] WCVM Univ Saskatchewan, Dept Biomed Sci, Saskatoon, SK, Canada	University of Saskatchewan	Manek, AK (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	aditya.manek@usask.ca		Chivers, Douglas/0000-0002-9497-4329; Weber, Lynn/0000-0002-9631-464X	University of Saskatchewan; Natural Sciences and Engineering Research Council	University of Saskatchewan; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by the University of Saskatchewan and Natural Sciences and Engineering Research Council Discovery Grants to DPC, MCOF and LPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts MT, 2000, LIMNOL OCEANOGR, V45, P292, DOI 10.4319/lo.2000.45.2.0292; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Brown GE, 2011, ANIM BEHAV, V81, P1249, DOI 10.1016/j.anbehav.2011.03.013; Carreau-Green ND, 2008, J FISH BIOL, V73, P2390, DOI 10.1111/j.1095-8649.2008.02092.x; Chivers DP, 2008, EVOL ECOL, V22, P561, DOI 10.1007/s10682-007-9182-8; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; Chivers DP, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P127; Chivers DP, 1996, AM NAT, V148, P649, DOI 10.1086/285945; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Commens AM, 1999, J FISH BIOL, V55, P1359, DOI 10.1006/jfbi.1999.1132; Ferrari MCO, 2006, BEHAV ECOL SOCIOBIOL, V60, P522, DOI 10.1007/s00265-006-0195-z; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Halbgewachs CF, 2009, BIOL J LINN SOC, V98, P891, DOI 10.1111/j.1095-8312.2009.01328.x; Hugie D.M, 1990, THESIS U SASKATCHEWA; Hunter GW, 1938, J PARASITOL, V24, P475; James CT, 2009, BIOL J LINN SOC, V98, P884, DOI 10.1111/j.1095-8312.2009.01327.x; Krause J, 1996, ETHOLOGY, V102, P40, DOI 10.1111/j.1439-0310.1996.tb01102.x; Lonnstedt OM, 2011, ANIM BEHAV, V82, P213, DOI 10.1016/j.anbehav.2011.04.015; Manek AK, 2012, BIOL J LINN SOC, V105, P832, DOI 10.1111/j.1095-8312.2011.01829.x; MATHIS A, 1995, AM NAT, V145, P994, DOI 10.1086/285780; Mathis Alicia, 2009, P323, DOI 10.1201/b10189-12; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; MICHALAK T, 2006, THESIS U SASKATCHEWA; PFEIFFER W, 1977, COPEIA, P653, DOI 10.2307/1443164; PFEIFFER W, 1985, J FISH BIOL, V27, P553, DOI 10.1111/j.1095-8649.1985.tb03201.x; Pickering A. D., 1994, SALMON SAPROLEGNIASI, P67; Pollock MS, 2005, CHEMOECOLOGY, V15, P205, DOI 10.1007/s00049-005-0314-8; Pollock RJ, 2011, THESIS U SASKATCHEWA; Smith R.J.F., 1992, Reviews in Fish Biology and Fisheries, V2, P33, DOI 10.1007/BF00042916; SMITH RJF, 1983, COPEIA, P822; SMITH RJF, 1973, CAN J ZOOL, V51, P875, DOI 10.1139/z73-130; SMITH RJF, 1976, CAN J ZOOL, V54, P1172, DOI 10.1139/z76-134; Stabell OB, 1997, ENVIRON BIOL FISH, V49, P145, DOI 10.1023/A:1007368815511; STEEDMAN RJ, 1991, T AM FISH SOC, V120, P494, DOI 10.1577/1548-8659(1991)120&lt;0494:OAECOB&gt;2.3.CO;2; von Frisch K, 1938, NATURWISSENSCHAFTEN, V26, P601; von Frisch K, 1941, Z VERGL PHYSIOL, V29, P46; Wisenden BD, 2003, BEHAV ECOL SOCIOBIOL, V54, P485, DOI 10.1007/s00265-003-0653-9; WISENDEN BD, 1995, ECOSCIENCE, V2, P116, DOI 10.1080/11956860.1995.11682275; Wisenden BD, 1998, J FISH BIOL, V53, P841; Wisenden BD, 1997, J FISH BIOL, V50, P799, DOI 10.1111/j.1095-8649.1997.tb01973.x; Zhao XX, 2006, BEHAVIOUR, V143, P1103, DOI 10.1163/156853906778607408	43	9	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e56689	10.1371/journal.pone.0056689	http://dx.doi.org/10.1371/journal.pone.0056689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469175	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900008
J	Kiadaliri, AA; Jarl, J; Gavriilidis, G; Gerdtham, UG				Kiadaliri, Aliasghar Ahmad; Jarl, Johan; Gavriilidis, Georgios; Gerdtham, Ulf-G			Alcohol Drinking Cessation and the Risk of Laryngeal and Pharyngeal Cancers: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ESOPHAGEAL CANCER; ORAL-CAVITY; TREND ESTIMATION; TOBACCO SMOKING; DIETARY FACTORS; NECK-CANCER; HEAD; HYPOPHARYNGEAL; CONSUMPTION; DISEASE	Objective: To evaluate the effect of alcohol cessation on the risk of developing laryngeal and pharyngeal cancers, combining available evidence in the scientific literature in a meta-analysis. Methods: A systematic literature review was conducted, and a meta-analysis was applied on the retrieved studies. The generalised least squares method was used to estimate the trend from dose-response data to assess changes in the risks of laryngeal and pharyngeal cancers after drinking cessation. Results: A total of 9 case-control studies were included in the meta-analysis (4 and 8 estimates for laryngeal and pharyngeal cancers, respectively). On average, alcohol drinking cessation was associated with a 2% yearly reduction in the risk of developing laryngeal and pharyngeal cancers. There was a considerable heterogeneity between the studies of pharyngeal cancer, but this was mostly due to two studies. The increased risk of laryngeal and pharyngeal cancers caused by alcohol was reversible; the time periods until the risks became equal to those of never drinkers were 36 (95% CI 11-106) and 39 (95% CI 13-103) years, respectively. Moreover, 5 years of drinking cessation was associated with a reduction of around 15% in the alcohol-related elevated risk of laryngeal and pharyngeal cancers. Conclusion: Although a long time period is required to completely eliminate the alcohol-related elevated risk of laryngeal and pharyngeal cancers, a substantial risk reduction can be seen in the short term (5-10 years), and drinking cessation should therefore be encouraged to reduce the incidence of these cancers.	[Kiadaliri, Aliasghar Ahmad; Jarl, Johan; Gavriilidis, Georgios; Gerdtham, Ulf-G] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Div Hlth Econ, Malmo, Sweden; [Kiadaliri, Aliasghar Ahmad] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran; [Kiadaliri, Aliasghar Ahmad; Jarl, Johan; Gerdtham, Ulf-G] Lund Univ, Inst Econ Res, Malmo, Sweden; [Gerdtham, Ulf-G] Lund Univ, Dept Econ, Lund, Sweden	Lund University; Skane University Hospital; Tehran University of Medical Sciences; Lund University; Lund University	Kiadaliri, AA (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Div Hlth Econ, Malmo, Sweden.	aliasghar.ahmad_kiadaliri@med.lu.se	Gerdtham, Ulf-Göran/I-6766-2018; Kiadaliri, Ali/E-8685-2017	Gerdtham, Ulf-Göran/0000-0002-0647-7817; Kiadaliri, Ali/0000-0002-4254-9099; Jarl, Johan/0000-0002-9274-2479	Swedish Research Council [2009-3094]; Swedish Council for Working Life and Social Research (FAS) [2006-1660]; Government Grant for Clinical Research (ALF); Region Skane (Gerdtham)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Government Grant for Clinical Research (ALF); Region Skane (Gerdtham)	Financial support from the Swedish Research Council (dnr 2009-3094) is gratefully acknowledged. The Health Economics Program (HEP) at Lund University also receives core funding from the Swedish Council for Working Life and Social Research (FAS; dnr. 2006-1660), the Government Grant for Clinical Research (ALF), and Region Skane (Gerdtham). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri A, 2005, ORAL ONCOL, V41, P956, DOI 10.1016/j.oraloncology.2005.02.004; Altieri A, 2002, BRIT J CANCER, V87, P1227, DOI 10.1038/sj.bjc.6600638; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Balaram P, 2002, INT J CANCER, V98, P440, DOI 10.1002/ijc.10200; BLOT WJ, 1988, CANCER RES, V48, P3282; Castellsague X, 2004, INT J CANCER, V108, P741, DOI 10.1002/ijc.11627; DAY GL, 1994, J NATL CANCER I, V86, P131, DOI 10.1093/jnci/86.2.131; De Stefani E, 2004, CANC THER, V2, P99; Deeks J, 1996, BANDOLIER, V3, P6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J., 2004, IARC CANCERBASE; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franceschi S, 2000, INT J CANCER, V85, P787, DOI 10.1002/(SICI)1097-0215(20000315)85:6&lt;787::AID-IJC8&gt;3.0.CO;2-6; Freemantle N., 1998, EVID-BASED MENT HEAL, V1, P102; Garrote LF, 2001, BRIT J CANCER, V85, P46, DOI 10.1054/bjoc.2000.1825; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Gulliver SB, 2006, ALCOHOL RES HEALTH, V29, P208; Gutjahr E, 2001, EUR ADDICT RES, V7, P117, DOI 10.1159/000050729; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Hayes RB, 1999, CANCER CAUSE CONTROL, V10, P27, DOI 10.1023/A:1008876115797; Heckley GA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-446; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Islami F, 2010, ORAL ONCOL, V46, P802, DOI 10.1016/j.oraloncology.2010.07.015; Jarl J, 2012, ADDICTION, V107, P1234, DOI 10.1111/j.1360-0443.2011.03772.x; Kjaerheim K, 1998, CANCER CAUSE CONTROL, V9, P99, DOI 10.1023/A:1008809706062; de Souza DLB, 2011, CANCER EPIDEMIOL, V35, P510, DOI 10.1016/j.canep.2011.02.012; Lee CH, 2005, INT J CANCER, V113, P475, DOI 10.1002/ijc.20619; Marron M, 2010, INT J EPIDEMIOL, V39, P182, DOI 10.1093/ije/dyp291; MARTINEZ I, 1969, J NATL CANCER I, V42, P1069; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mukamal KJ, 2001, ALCOHOL RES HEALTH, V25, P255; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206; Rehm J, 2007, INT J CANCER, V121, P1132, DOI 10.1002/ijc.22798; StataCorp, 2011, STAT STAT SOFTW REL; Szymanska K, 2011, CANCER CAUSE CONTROL, V22, P1037, DOI 10.1007/s10552-011-9779-7; Takezaki T, 1996, JPN J CANCER RES, V87, P555, DOI 10.1111/j.1349-7006.1996.tb00259.x; Takezaki T, 2000, CANCER CAUSE CONTROL, V11, P597, DOI 10.1023/A:1008909129756; Tramacere I, 2010, ORAL ONCOL, V46, P497, DOI 10.1016/j.oraloncology.2010.03.024; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII	43	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58158	10.1371/journal.pone.0058158	http://dx.doi.org/10.1371/journal.pone.0058158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469267	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100064
J	Fiorelli, T; Kirouac, L; Padmanabhan, J				Fiorelli, Tina; Kirouac, Lisa; Padmanabhan, Jaya			Altered Processing of Amyloid Precursor Protein in Cells Undergoing Apoptosis	PLOS ONE			English	Article							DNA TOPOISOMERASE-I; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; CASPASE CLEAVAGE; NEURONAL APOPTOSIS; FAMILY-MEMBERS; BETA; APP; DEATH; DAMAGE	Altered proteolysis of amyloid precursor protein is an important determinant of pathology development in Alzheimer's disease. Here, we describe the detection of two novel fragments of amyloid precursor protein in H4 neuroglioma cells undergoing apoptosis. Immunoreactivity of these 25-35 kDa fragments to two different amyloid precursor protein antibodies suggests that they contain the amyloid-beta region and an epitope near the C-terminus of amyloid precursor protein. Generation of these fragments is associated with cleavage of caspase-3 and caspase-7, suggesting activation of these caspases. Studies in neurons undergoing DNA damage-induced apoptosis also showed similar results. Inclusion of caspase inhibitors prevented the generation of these novel fragments, suggesting that they are generated by a caspase-dependent mechanism. Molecular weight prediction and immunoreactivity of the fragments generated suggested that such fragments could not be generated by cleavage at any previously identified caspase, secretase, or calpain site on amyloid precursor protein. Bioinformatic analysis of the amino acid sequence of amyloid precursor protein revealed that fragments fitting the observed size and immunoreactivity could be generated by either cleavage at a novel, hitherto unidentified, caspase site or at a previously identified matrix metalloproteinase site in the extracellular domain. Proteolytic cleavage at any of these sites leads to a decrease in the generation of a-secretase cleaved secreted APP, which has both anti-apoptotic and neuroprotective properties, and thus may contribute to neurodegeneration in Alzheimer's disease.	[Fiorelli, Tina; Kirouac, Lisa; Padmanabhan, Jaya] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33620 USA; [Fiorelli, Tina; Kirouac, Lisa; Padmanabhan, Jaya] Univ S Florida, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Padmanabhan, J (corresponding author), Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33620 USA.	jpadmana@health.usf.edu	Padmanabhan, Jaya/A-4226-2012; Kirouac, Lisa/J-5092-2014	Padmanabhan, Jaya/0000-0003-2019-5135; 	Alzheimer's Association [IIRG-08-90842]; National Institute on Aging [1R21AG031429-01A2]; USF Health Byrd Alzheimer's Institute; Department of Molecular Medicine; University of South Florida; NATIONAL INSTITUTE ON AGING [R21AG031429] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); USF Health Byrd Alzheimer's Institute; Department of Molecular Medicine; University of South Florida; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work in JP's lab is supported by grants from Alzheimer's Association (IIRG-08-90842), the National Institute on Aging (1R21AG031429-01A2), and start-up funds from USF Health Byrd Alzheimer's Institute, the Department of Molecular Medicine and a SIPIN small research grant program from University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Armstrong RC, 1997, J NEUROSCI, V17, P553; Ayala-Grosso C, 2002, BRAIN PATHOL, V12, P430; Bertrand E, 2001, MOL CELL NEUROSCI, V18, P503, DOI 10.1006/mcne.2001.1030; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bravarenko NI, 2006, EUR J NEUROSCI, V23, P129, DOI 10.1111/j.1460-9568.2005.04549.x; Cattepoel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018296; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chan SL, 2002, NEUROMOL MED, V2, P167, DOI 10.1385/NMM:2:2:167; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; Cuesta A, 2009, BIOCHEM J, V418, P643, DOI 10.1042/BJ20081793; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; D'Onofrio G, 2011, BIOCHEM PHARMACOL, V81, P194, DOI 10.1016/j.bcp.2010.09.019; Edelmann B, 2011, EMBO J, V30, P379, DOI 10.1038/emboj.2010.326; Fein JA, 2008, AM J PATHOL, V172, P1683, DOI 10.2353/ajpath.2008.070829; Fiorelli T, 2011, ALFOMINE INT J RES D, V1, P1; Galvan V, 2002, J NEUROCHEM, V82, P283, DOI 10.1046/j.1471-4159.2002.00970.x; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hart MJ, 2012, ANAL BIOCHEM, V421, P467, DOI 10.1016/j.ab.2011.11.020; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Judge M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-80; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li HL, 1997, J NEUROBIOL, V32, P469, DOI 10.1002/(SICI)1097-4695(199705)32:5<469::AID-NEU3>3.3.CO;2-5; Li X, 2000, EXP CELL RES, V255, P125, DOI 10.1006/excr.1999.4796; Liu P, 2011, J ALZHEIMERS DIS, V26, P657, DOI 10.3233/JAD-2011-110383; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Mattson MP, 2001, BIOCHEM SOC SYMP, V67, P151, DOI 10.1042/bss0670151; McDonald AC, 1998, BRIT J CANCER, V78, P745, DOI 10.1038/bjc.1998.571; Milligan CE, 2000, NAT MED, V6, P385, DOI 10.1038/74644; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Nguyen TVV, 2008, J NEUROCHEM, V104, P1065, DOI 10.1111/j.1471-4159.2007.05031.x; NITSCH RM, 1995, ARZNEIMITTEL-FORSCH, V45-1, P435; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Padmanabhan Jaya, 2009, V523, P311, DOI 10.1007/978-1-59745-190-1_21; Park DS, 1998, J NEUROSCI, V18, P830; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Pompl PN, 2003, ARCH NEUROL-CHICAGO, V60, P369, DOI 10.1001/archneur.60.3.369; Portelius E, 2009, NEURODEGENER DIS, V6, P87, DOI 10.1159/000203774; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; SIMAN R, 1990, J NEUROSCI, V10, P2400; Soriano S, 2001, J BIOL CHEM, V276, P29045, DOI 10.1074/jbc.M102456200; Su JH, 2002, ACTA NEUROPATHOL, V104, P1, DOI 10.1007/s00401-002-0548-2; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Zhao M, 2003, NEUROBIOL DIS, V14, P391, DOI 10.1016/j.nbd.2003.07.006	56	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57979	10.1371/journal.pone.0057979	http://dx.doi.org/10.1371/journal.pone.0057979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469123	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900216
J	Guo, ZH; Grimm, C; Becker, L; Ricci, AJ; Heller, S				Guo, Zhaohua; Grimm, Christian; Becker, Lars; Ricci, Anthony J.; Heller, Stefan			A Novel Ion Channel Formed by Interaction of TRPML3 with TRPV5	PLOS ONE			English	Article							EPITHELIAL CA2+ CHANNEL; VARITINT-WADDLER PHENOTYPE; MONOVALENT CATION CURRENTS; HELIX-BREAKING MUTATION; CONSTITUTIVE ACTIVITY; HAIR-CELLS; EXPRESSION; DEAFNESS; MOUSE; LEADS	TRPML3 and TRPV5 are members of the mucolipin (TRPML) and TRPV subfamilies of transient receptor potential (TRP) cation channels. Based on sequence similarities of the pore forming regions and on structure-function evidence, we hypothesized that the pore forming domains of TRPML and TRPV5/TRPV6 channels have similarities that indicate possible functional interactions between these TRP channel subfamilies. Here we show that TRPML3 and TRPV5 associate to form a novel heteromeric ion channel. This novel conductance is detectable under conditions that do not activate either TRPML3 or TRPV5. It has pharmacological similarity with TRPML3 and requires functional TRPML3 as well as functional TRPV5. Single channel analyses revealed that TRPML3 and TRPV5 heteromers have different features than the respective homomers, and furthermore, that they occur in potentially distinct stoichiometric configurations. Based on overlapping expression of TRPML3 and TRPV5 in the kidney and the inner ear, we propose that TRPML3 and TRPV5 heteromers could have a biological function in these organs.	[Guo, Zhaohua; Becker, Lars; Ricci, Anthony J.; Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol HNS, Palo Alto, CA 94304 USA; [Guo, Zhaohua; Becker, Lars; Ricci, Anthony J.; Heller, Stefan] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Grimm, Christian] Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany; [Grimm, Christian] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany	Stanford University; Stanford University; University of Munich; University of Munich	Heller, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol HNS, Palo Alto, CA 94304 USA.	hellers@stanford.edu	Grimm, Christian/ABF-9121-2020	Grimm, Christian/0000-0002-0177-5559; ricci, anthony/0000-0002-1706-8904	National Institutes of Health [R01 DC004563, P30 DC010363]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004563, R01DC003896, P30DC010363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants R01 DC004563 and P30 DC010363 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Castiglioni AJ, 2011, J COMP NEUROL, V519, P1095, DOI 10.1002/cne.22554; Cha SK, 2007, J MEMBRANE BIOL, V220, P79, DOI 10.1007/s00232-007-9076-2; Corey DP, 2006, J PHYSIOL-LONDON, V576, P23, DOI 10.1113/jphysiol.2006.116582; Cuajungco MP, 2007, BBA-MOL BASIS DIS, V1772, P1022, DOI 10.1016/j.bbadis.2007.01.002; Curcio-Morelli C, 2010, J CELL PHYSIOL, V222, P328, DOI 10.1002/jcp.21956; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Ermakov YA, 2010, BIOPHYS J, V98, P1018, DOI 10.1016/j.bpj.2009.11.044; Grimm C, 2012, J PHARM EXP THER; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2012, J BIOL CHEM, V287, P22701, DOI 10.1074/jbc.M112.368876; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Jors S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014317; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; KROESE ABA, 1980, NATURE, V283, P395, DOI 10.1038/283395a0; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Lee KP, 2010, CELL CALCIUM, V48, P275, DOI 10.1016/j.ceca.2010.09.007; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Nilius B, 2001, BRIT J PHARMACOL, V134, P453, DOI 10.1038/sj.bjp.0704272; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Takumida M, 2009, ACTA OTO-LARYNGOL, P1; Takumida M, 2009, ACTA OTO-LARYNGOL, V129, P1340, DOI 10.3109/00016480902725254; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yamauchi Daisuke, 2010, BMC Physiology, V10, P1, DOI 10.1186/1472-6793-10-1; ZEEVI DA, 2009, J PATHOL; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; Zeevi DA, 2010, J CELL SCI, V123, P3112, DOI 10.1242/jcs.067330	42	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58174	10.1371/journal.pone.0058174	http://dx.doi.org/10.1371/journal.pone.0058174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469151	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900242
J	Chen, X; Kang, JH; Fu, CJ; Tan, WC				Chen, Xi; Kang, Jianhong; Fu, Ceji; Tan, Wenchang			Modeling Calcium Wave Based on Anomalous Subdiffusion of Calcium Sparks in Cardiac Myocytes	PLOS ONE			English	Article							HEART; ACTIVATION; CURRENTS; RELEASE	Ca2+ sparks and Ca2+ waves play important roles in calcium release and calcium propagation during the excitation-contraction (EC) coupling process in cardiac myocytes. Although the classical Fick's law is widely used to model Ca2+ sparks and Ca2+ waves in cardiac myocytes, it fails to reasonably explain the full-width at half maximum(FWHM) paradox. However, the anomalous subdiffusion model successfully reproduces Ca2+ sparks of experimental results. In this paper, in the light of anomalous subdiffusion of Ca2+ sparks, we develop a mathematical model of calcium wave in cardiac myocytes by using stochastic Ca2+ release of Ca2+ release units (CRUs). Our model successfully reproduces calcium waves with physiological parameters. The results reveal how Ca2+ concentration waves propagate from an initial firing of one CRU at a corner or in the middle of considered region, answer how large in magnitude of an anomalous Ca2+ spark can induce a Ca2+ wave. With physiological Ca2+ currents (2pA) through CRUs, it is shown that an initial firing of four adjacent CRUs can form a Ca2+ wave. Furthermore, the phenomenon of calcium waves collision is also investigated.	[Tan, Wenchang] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; Peking Univ, Dept Mech & Aerosp Engn, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University	Tan, WC (corresponding author), Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	tanwch@mech.pku.edu.cn	Tan, Wenchang/I-9949-2014; Fu, Ceji/C-3262-2012		National Natural Science Foundation of China [11272014, 10825208]; National Key Basic Research Program of China [2013CB531200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 11272014 and No. 10825208), and National Key Basic Research Program of China (Grant No. 2013CB531200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylor SM, 1998, J GEN PHYSIOL, V112, P297, DOI 10.1085/jgp.112.3.297; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; Cheng H, 1996, CELL CALCIUM, V20, P129, DOI 10.1016/S0143-4160(96)90102-5; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; GIRARD S, 1992, BIOPHYS J, V61, P509, DOI 10.1016/S0006-3495(92)81855-6; Izu LT, 2001, BIOPHYS J, V80, P103, DOI 10.1016/S0006-3495(01)75998-X; Izu LT, 2001, BIOPHYS J, V80, P88, DOI 10.1016/S0006-3495(01)75997-8; John C, 1978, J CELL BIOL, V76, P448, DOI DOI 10.1083/JCB.76.2.448; Keizer J, 1998, BIOPHYS CHEM, V72, P87, DOI 10.1016/S0301-4622(98)00125-2; LAKATTA EG, 1993, J CARDIOVASC ELECTR, V4, P473, DOI 10.1111/j.1540-8167.1993.tb01285.x; Li KT, 2011, CELL MOL BIOENG, V4, P457, DOI 10.1007/s12195-011-0174-y; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Lu LY, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026005; Tadjeran C, 2006, J COMPUT PHYS, V213, P205, DOI 10.1016/j.jcp.2005.08.008; TAKAMATSU T, 1990, FASEB J, V4, P1519, DOI 10.1096/fasebj.4.5.2307330; Tan WC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805208	19	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57093	10.1371/journal.pone.0057093	http://dx.doi.org/10.1371/journal.pone.0057093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483894	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100012
J	Bisoffi, Z; Tinto, H; Sirima, BS; Gobbi, F; Angheben, A; Buonfrate, D; Van den Ende, J				Bisoffi, Zeno; Tinto, Halidou; Sirima, Bienvenu Sodiomon; Gobbi, Federico; Angheben, Andrea; Buonfrate, Dora; Van den Ende, Jef			Should Malaria Treatment Be Guided by a Point of Care Rapid Test? A Threshold Approach to Malaria Management in Rural Burkina Faso	PLOS ONE			English	Article							COST-BENEFIT-ANALYSIS; INTERMITTENT PREVENTIVE TREATMENT; UNCOMPLICATED FALCIPARUM-MALARIA; DIAGNOSTIC-TESTS; DECISION-MAKING; SULFADOXINE-PYRIMETHAMINE; ANEURYSM REPAIR; AMODIAQUINE; SULFADOXINE/PYRIMETHAMINE; RECOMMENDATIONS	Background: In Burkina Faso, rapid diagnostic tests for malaria have been made recently available. Previously, malaria was managed clinically. This study aims at assessing which is the best management option of a febrile patient in a hyperendemic setting. Three alternatives are: treating presumptively, testing, or refraining from both test and treatment. The test threshold is the tradeoff between refraining and testing, the test-treatment threshold is the tradeoff between testing and treating. Only if the disease probability lies between the two should the test be used. Methods and Findings: Data for this analysis was obtained from previous studies on malaria rapid tests, involving 5220 patients. The thresholds were calculated, based on disease risk, treatment risk and cost, test accuracy and cost. The thresholds were then matched against the disease probability. For a febrile child under 5 in the dry season, the pre-test probability of clinical malaria (3.2%), was just above the test/treatment threshold. In the rainy season, that probability was 63%, largely above the test/treatment threshold. For febrile children>5 years and adults in the dry season, the probability was 1.7%, below the test threshold, while in the rainy season it was higher (25.1%), and situated between the two thresholds (3% and 60.9%), only if costs were not considered. If they were, neither testing nor treating with artemisinin combination treatments (ACT) would be recommended. Conclusions: A febrile child under 5 should be treated presumptively. In the dry season, the probability of clinical malaria in adults is so low, that neither testing nor treating with any regimen should be recommended. In the rainy season, if costs are considered, a febrile adult should not be tested, nor treated with ACT, but a possible alternative would be a presumptive treatment with amodiaquine plus sulfadoxine-pyrimethamine. If costs were not considered, testing would be recommended.	[Bisoffi, Zeno; Gobbi, Federico; Angheben, Andrea; Buonfrate, Dora] S Cuore Hosp, Ctr Trop Dis, Verona, Italy; [Tinto, Halidou] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Sirima, Bienvenu Sodiomon] Minist Hlth, Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Van den Ende, Jef] Prince Leopold Inst Trop Med, Dept Clin Sci, Antwerp, Belgium	Centre Muraz; Institute of Tropical Medicine (ITM)	Bisoffi, Z (corresponding author), S Cuore Hosp, Ctr Trop Dis, Verona, Italy.	zeno.bisoffi@sacrocuore.it	Buonfrate, Dora/ABG-7386-2020; Bisoffi, Zeno/B-6438-2013; Gobbi, Federico/ABG-7554-2020; Buonfrate, Dora/N-2965-2016; Angheben, Andrea/H-6248-2019; Angheben, Andrea/C-9167-2013	Buonfrate, Dora/0000-0003-0108-6822; Bisoffi, Zeno/0000-0001-9530-8742; Gobbi, Federico/0000-0002-6899-4545; Buonfrate, Dora/0000-0003-0108-6822; Angheben, Andrea/0000-0003-4545-8034; Tinto, Halidou/0000-0002-0472-3586				[Anonymous], MAL ART RES E AFR; Anoop P, 2009, PEDIATR BLOOD CANCER, V52, P429, DOI 10.1002/pbc.21846; Bailey RH, 2000, ENDOCRIN METAB CLIN, V29, P91, DOI 10.1016/S0889-8529(05)70118-3; Basinga P, 2007, MED DECIS MAKING, V27, P53, DOI 10.1177/0272989X06297104; Bent S, 2003, DM-DIS MON, V49, P83, DOI 10.1067/mda.2003.9; Bisoffi Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-226; Bisoffi Z, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-192; Boland MV, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-20; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; Brown JB, 2004, DIABETES CARE, V27, P1535, DOI 10.2337/diacare.27.7.1535; Bualombai P., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P322; Buclin T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018578; Capodanno D, 2010, AM HEART J, V159, P103, DOI 10.1016/j.ahj.2009.10.021; Carpenter CR, 2011, ACAD EMERG MED, V18, P782, DOI [10.1111/j.1553-2712.2011.01121.x, 10.1111/j.1553-2712.2011.01096.x]; Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Cucherat M, 1998, EUR J EPIDEMIOL, V14, P23, DOI 10.1023/A:1007423730270; de Sousa A, 2012, J INFECT DIS, V205, pS82, DOI 10.1093/infdis/jir799; Demyttenaere S, 2001, CLIN J PAIN, V17, P173, DOI 10.1097/00002508-200106000-00010; Eltoum IA, 2006, CANCER CYTOPATHOL, V108, P93, DOI 10.1002/cncr.21719; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; Karkos CD, 2003, CARDIOVASC SURG, V11, P6, DOI 10.1016/S0967-2109(02)00110-2; Karthikesalingam A, 2012, J ENDOVASC THER, V19, P200, DOI 10.1583/11-3762R.1; Kelly CM, 2011, ANN ONCOL, V22, P2387, DOI 10.1093/annonc/mdq786; Kopelman RI, 1999, NEW ENGL J MED, V341, P435, DOI 10.1056/NEJM199908053410608; LeCroy CJ, 2008, VASC ENDOVASC SURG, V42, P113, DOI 10.1177/1538574407312656; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; McAlister FA, 1998, CAN J CARDIOL, V14, P47; McAlister FA, 2000, CAN MED ASSOC J, V163, P403; Moons KGM, 1997, MED DECIS MAKING, V17, P447, DOI 10.1177/0272989X9701700410; Moreira J, 2008, TROP MED INT HEALTH, V13, P68, DOI 10.1111/j.1365-3156.2007.01975.x; Mosha JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008707; NEASE RF, 1989, MED DECIS MAKING, V9, P91, DOI 10.1177/0272989X8900900204; Obonyo CO, 2007, T ROY SOC TROP MED H, V101, P117, DOI 10.1016/j.trstmh.2006.07.001; Okura M, 2009, ORAL ONCOL, V45, P908, DOI 10.1016/j.oraloncology.2009.03.013; Orton LC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004912.pub3; Ost DE, 2012, AM J RESP CRIT CARE, V185, P363, DOI 10.1164/rccm.201104-0679CI; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; PAUKER SG, 1975, NEW ENGL J MED, V293, P229, DOI 10.1056/NEJM197507312930505; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; Richards RJ, 1997, HOSP PRACT, V32, P15, DOI 10.1080/21548331.1997.11443589; Richards RJ, 1997, HOSP PRACT MINNEAP, V32, P25; Rolland E, 2006, TROP MED INT HEALTH, V11, P398, DOI 10.1111/j.1365-3156.2006.01580.x; Saylor PJ, 2010, J UROLOGY, V183, P2200, DOI 10.1016/j.juro.2010.02.022; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008492.pub2; Stevens TP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003063.pub3; Swain Geoffrey R, 2004, Clin Med Res, V2, P29; Uzochukwu BSC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-265; Van den Ende J, 2007, J EVAL CLIN PRACT, V13, P374, DOI 10.1111/j.1365-2753.2006.00710.x; Van den Ende J, 2010, J EVAL CLIN PRACT, V16, P499, DOI 10.1111/j.1365-2753.2009.01150.x; van Dijk MR, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-1; WHO, 2011, INT DRUG PRIC IND GU; WHO, 2010, GUID TREATM MAL, V2nd; Yukich J, 2010, AM J TROP MED HYG, V83, P61, DOI 10.4269/ajtmh.2010.09-0632; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x	60	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58019	10.1371/journal.pone.0058019	http://dx.doi.org/10.1371/journal.pone.0058019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472129	Green Published, gold			2022-12-27	WOS:000315637900073
J	Bradshaw, CS; Walker, J; Fairley, CK; Chen, MY; Tabrizi, SN; Donovan, B; Kaldor, JM; McNamee, K; Urban, E; Walker, S; Currie, M; Birden, H; Bowden, F; Garland, S; Pirotta, M; Gurrin, L; Hocking, JS				Bradshaw, Catriona S.; Walker, Jennifer; Fairley, Christopher K.; Chen, Marcus Y.; Tabrizi, Sepehr N.; Donovan, Basil; Kaldor, John M.; McNamee, Kathryn; Urban, Eve; Walker, Sandra; Currie, Marian; Birden, Hudson; Bowden, Francis; Garland, Suzanne; Pirotta, Marie; Gurrin, Lyle; Hocking, Jane S.			Prevalent and Incident Bacterial Vaginosis Are Associated with Sexual and Contraceptive Behaviours in Young Australian Women	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; TRANSMITTED-DISEASE; RISK-FACTORS; GRAM STAIN; CHLAMYDIA-TRACHOMATIS; ACQUISITION; INFECTION; LESBIANS; HEALTH; RACE	Background: To determine prevalence and incidence of bacterial vaginosis (BV) and risk factors in young sexually-active Australian women. Methods: 1093 women aged 16-25 years were recruited from primary-care clinics. Participants completed 3-monthly questionnaires and self-collected vaginal smears 6-monthly for 12-months. The primary endpoint was a Nugent Score = 7-10 (BV) and the secondary endpoint was a NS = 4-10 (abnormal flora [AF]). BV and AF prevalence estimates and 95% confidence intervals (95% CI) were derived, and adjusted odds ratios (AOR) calculated to explore epidemiological associations with prevalent BV and AF. Proportional-hazards regression models were used to examine factors associated with incident BV and AF. Results: At baseline 129 women had BV [11.8% (95% CI: 9.4-14.2)] and 188 AF (17.2%; 15.1-19.5). Prevalent BV was associated with having a recent female partner [AOR = 2.1; 1.0-4.4] and lack of tertiary-education [AOR = 1.9; 1.2-3.0]; use of an oestrogen-containing contraceptive (OCC) was associated with reduced risk [AOR = 0.6; 0.4-0.9]. Prevalent AF was associated with the same factors, and additionally with >5 male partners (MSP) in 12-months [AOR = 1.8; 1.2-2.5)], and detection of C. trachomatis or M. genitalium [AOR = 2.1; 1.0-4.5]. There were 82 cases of incident BV (9.4%; 7.7-11.7/100 person-years) and 129 with incident AF (14.8%; 12.5-17.6/100 person-years). Incident BV and AF were associated with a new MSP [adjusted rate ratio (ARR) = 1.5; 1.1-2.2 and ARR = 1.5; 1.1-2.0], respectively. OCC-use was associated with reduced risk of incident AF [ARR = 0.7; 0.5-1.0]. Conclusion: This paper presents BV and AF prevalence and incidence estimates from a large prospective cohort of young Australian women predominantly recruited from primary-care clinics. These data support the concept that sexual activity is strongly associated with the development of BV and AF and that use of an OCC is associated with reduced risk.	[Bradshaw, Catriona S.; Fairley, Christopher K.; Chen, Marcus Y.] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bradshaw, Catriona S.; Fairley, Christopher K.; Chen, Marcus Y.; Urban, Eve; Walker, Sandra] Univ Melbourne, Sexual Hlth Unit, Sch Populat Hlth, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Walker, Jennifer] Univ Melbourne, Rural Hlth Acad Ctr, Melbourne Med Sch, Ctr Excellence Rural Sexual Hlth, Melbourne, Vic, Australia; [Walker, Jennifer; Hocking, Jane S.] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Womens Hlth Gender & Soc, Melbourne, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne] Royal Womens Hosp, Dept Microbiol & Infect Dis, Dept Mol Microbiol, Melbourne, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Donovan, Basil; Kaldor, John M.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Donovan, Basil; Kaldor, John M.] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [McNamee, Kathryn] Family Planning Victoria, Melbourne, Vic, Australia; [McNamee, Kathryn] Monash Med Ctr, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Currie, Marian; Bowden, Francis] Australian Natl Univ, Canberra, ACT, Australia; [Birden, Hudson] Univ Sydney, Univ Ctr Rural Hlth, Lismore, NSW, Australia; [Birden, Hudson] Univ Sydney, Sydney Inst Emerging Infect Dis & Biosecur, Sydney Sch Publ Hlth, Lismore, NSW, Australia; [Pirotta, Marie] Univ Melbourne, Dept Gen Practice, Primary Care Res Unit, Melbourne, Vic, Australia; [Gurrin, Lyle] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia	University of Melbourne; Monash University; University of Melbourne; University of Melbourne; University of Melbourne; University of New South Wales Sydney; Kirby Institute; Monash University; Australian National University; University of Sydney; University of Sydney; University of Melbourne; University of Melbourne	Bradshaw, CS (corresponding author), Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.	cbradshaw@mshc.org.au; j.hocking@unimelb.edu.au	Hocking, Jane/AAD-5203-2021; Donovan, Basil J/K-1246-2012; Birden, Hudson H/Q-7151-2016	Hocking, Jane/0000-0001-9329-8501; Donovan, Basil J/0000-0001-8851-4126; Birden, Hudson H/0000-0001-5134-7408; bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664; Gurrin, Lyle/0000-0001-7052-1969; McIntosh, Jennifer/0000-0002-6655-0940	Commonwealth of Australia; Australian National Health and Research Council [509144]; Australian National Health and Medical Research Council [456164, 566576]; Primary Health Care Research Evaluation and Development Mid-Career Fellowship, Department of Health and Aging	Commonwealth of Australia(Australian Government); Australian National Health and Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Primary Health Care Research Evaluation and Development Mid-Career Fellowship, Department of Health and Aging	This work was supported by the Commonwealth of Australia, as part of a National Chlamydia Pilot Program and the Australian National Health and Research Council (research grant number 509144). CSB, and JSH were supported by research fellowships issued by the Australian National Health and Medical Research Council (fellowship numbers 456164 and 566576 respectively). MP was supported by a Primary Health Care Research Evaluation and Development Mid-Career Fellowship, Department of Health and Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Allsworth JE, 2010, SEX TRANSM DIS, V37, P137, DOI 10.1097/OLQ.0b013e3181d36bdc; AVONTS D, 1990, SEX TRANSM DIS, V17, P23; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2013, CLIN INFECT IN PRESS; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592; Calzolari E, 2000, INT J GYNECOL OBSTET, V70, P341, DOI 10.1016/S0020-7292(00)00217-4; Carlin JB, 1999, STAT MED, V18, P2655, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2655::AID-SIM202>3.0.CO;2-#; Cherpes TL, 2007, SEX TRANSM INFECT, V84, P57, DOI 10.1136/sti.2007.026625; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Fethers KA, 2011, SEX TRANSM DIS; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fethers KA, 2009, J INFECT DIS, V200, P1662, DOI 10.1086/648092; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gallo MF, 2012, ANN EPIDEMIOL, V22, P213, DOI 10.1016/j.annepidem.2011.11.005; Gallo Maria F, 2011, Infect Dis Obstet Gynecol, V2011, P842652, DOI 10.1155/2011/842652; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hellberg D, 2000, INT J STD AIDS, V11, P603, DOI 10.1258/0956462001916461; Hocking JS, 2008, MED J AUSTRALIA, V188, P106, DOI 10.5694/j.1326-5377.2008.tb01533.x; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Lamont RF, 2000, INT J STD AIDS, V11, P495, DOI 10.1258/0956462001916371; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; McClelland RS, 2005, J INFECT DIS, V191, P333, DOI 10.1086/427262; Nagot N, 2007, SEX TRANSM INFECT, V83, P365, DOI 10.1136/sti.2007.024794; Nelson DB, 2003, J CLIN EPIDEMIOL, V56, P862, DOI 10.1016/S0895-4356(03)00073-8; Ness RB, 2006, SEX TRANSM DIS; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; Riggs M, 2007, SEX TRANSM DIS, V34, P954, DOI 10.1097/OLQ.0b013e31811ed0e4; Schwebke JR, 1997, SEX TRANSM DIS, V24, P236, DOI 10.1097/00007435-199704000-00009; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Shoubnikova M, 1997, CONTRACEPTION, V55, P355, DOI 10.1016/S0010-7824(97)00044-9; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P106, DOI 10.1111/j.1467-842X.2003.tb00797.x; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Thoma ME, 2011, SEX TRANSM DIS, V38, P1040, DOI 10.1097/OLQ.0b013e3182275499; Thoma ME, 2011, SEX TRANSM DIS, V38, P111, DOI 10.1097/OLQ.0b013e3181f0bdd0; Walker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037778; Walker J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-156; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Yoshida T, 2002, J CLIN MICROBIOL, V40, P1451, DOI 10.1128/JCM.40.4.1451-1455.2002	45	40	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57688	10.1371/journal.pone.0057688	http://dx.doi.org/10.1371/journal.pone.0057688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472099	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900038
J	Cahill, F; Shahidi, M; Shea, J; Wadden, D; Gulliver, W; Randell, E; Vasdev, S; Sun, G				Cahill, Farrell; Shahidi, Mariam; Shea, Jennifer; Wadden, Danny; Gulliver, Wayne; Randell, Edward; Vasdev, Sudesh; Sun, Guang			High Dietary Magnesium Intake Is Associated with Low Insulin Resistance in the Newfoundland Population	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; METABOLIC SYNDROME; RISK; OBESITY; SENSITIVITY; WOMEN; FAT; QUESTIONNAIRE	Background: Magnesium plays a role in glucose and insulin homeostasis and evidence suggests that magnesium intake is associated with insulin resistance (IR). However, data is inconsistent and most studies have not adequately controlled for critical confounding factors. Objective: The study investigated the association between magnesium intake and IR in normal-weight (NW), overweight (OW) and obese (OB) along with pre- and post-menopausal women. Design: A total of 2295 subjects (590 men and 1705 women) were recruited from the CODING study. Dietary magnesium intake was computed from the Willett Food Frequency Questionnaire (FFQ). Adiposity (NW, OW and OB) was classified by body fat percentage (%BF) measured by Dual-energy X-ray absorptiometry according to the Bray criteria. Multiple regression analyses were used to test adiposity-specific associations of dietary magnesium intake on insulin resistance adjusting for caloric intake, physical activity, medication use and menopausal status. Results: Subjects with the highest intakes of dietary magnesium had the lowest levels of circulating insulin, HOMA-IR, and HOMA-beta and subjects with the lowest intake of dietary magnesium had the highest levels of these measures, suggesting a dose effect. Multiple regression analysis revealed a strong inverse association between dietary magnesium with IR. In addition, adiposity and menopausal status were found to be critical factors revealing that the association between dietary magnesium and IR was stronger in OW and OB along with Pre-menopausal women. Conclusion: The results of this study indicate that higher dietary magnesium intake is strongly associated with the attenuation of insulin resistance and is more beneficial for overweight and obese individuals in the general population and pre-menopausal women. Moreover, the inverse correlation between insulin resistance and dietary magnesium intake is stronger when adjusting for %BF than BMI.	[Cahill, Farrell; Shahidi, Mariam; Shea, Jennifer; Wadden, Danny; Gulliver, Wayne; Vasdev, Sudesh; Sun, Guang] Mem Univ Newfoundland, Fac Med, Div Med, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Fac Med, Discipline Lab Med, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Sun, G (corresponding author), Mem Univ Newfoundland, Fac Med, Div Med, St John, NF, Canada.	gsun@mun.ca		Shea, Jennifer/0000-0002-6586-2061	Canadian Foundation for Innovation (CFI); Canadian Institute for Health Research [OOP-77984]	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	None of the authors had a personal or financial conflict of interest. This study was supported in part by the Canadian Foundation for Innovation (CFI) and the Canadian Institute for Health Research (operating grant: OOP-77984 to Guang Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2007, ANN NUTR METAB, V51, P402, DOI 10.1159/000108108; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Barbagallo M, 2007, ARCH BIOCHEM BIOPHYS, V458, P40, DOI 10.1016/j.abb.2006.05.007; Bergman BC, 2012, DIABETES; Bray GA., 2003, CONT DIAGNOSIS MANAG; Buse J, 2008, TYPE 2 DIABETES MELL; Canadian Diabetes Association, 2010, COST DIAB NEWF LABR, P1; Canadian Diabetes Association, 2009, PREV COSTS DIAB FACT; DYCKNER T, 1985, ACTA MED SCAND, V218, P443; Fox C, 2001, SOUTH MED J, V94, P1195, DOI 10.1097/00007611-200112000-00013; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Green KK, 2010, CLIN MED INSIGHTS-EN, V3, P25; Guerrero-Romero F, 2004, DIABETES METAB, V30, P253, DOI 10.1016/S1262-3636(07)70116-7; He K, 2006, CIRCULATION, V113, P1675, DOI 10.1161/CIRCULATIONAHA.105.588327; Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701; Hopping BN, 2010, J NUTR, V140, P68, DOI 10.3945/jn.109.112441; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Kennedy AP, 2009, OBESITY, V17, P2094, DOI 10.1038/oby.2009.101; Kim DJ, 2010, DIABETES CARE, V33, P2604, DOI 10.2337/dc10-0994; KOLTERMAN OG, 1981, J CLIN INVEST, V68, P957, DOI 10.1172/JCI110350; Leslie WD, 2010, J CLIN ENDOCR METAB, V95, P3272, DOI 10.1210/jc.2009-2794; Lima MD, 2009, DIABETES RES CLIN PR, V83, P257, DOI 10.1016/j.diabres.2008.11.019; Ma B, 2006, AM J EPIDEMIOL, V164, P449, DOI 10.1093/aje/kwj246; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKeown NM, 2008, EUR J NUTR, V47, P210, DOI 10.1007/s00394-008-0715-x; Nanri A, 2010, EUR J CLIN NUTR, V64, P1244, DOI 10.1038/ejcn.2010.138; Organization WH, 2011, WHO DIAB FACT SHEET; Paradisi G, 1999, DIABETES CARE, V22, P1310, DOI 10.2337/diacare.22.8.1310; Rattarasarn C, 2003, DIABETES RES CLIN PR, V60, P87, DOI 10.1016/S0168-8227(03)00017-2; Rob PM, 1996, NEPHRON, V72, P59, DOI 10.1159/000188807; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rumawas ME, 2006, J AM COLL NUTR, V25, P486, DOI 10.1080/07315724.2006.10719563; Shea JL, 2011, NUTR METAB CARDIOVAS; Simmons D, 2010, DIABETES RES CLIN PR, V87, P261, DOI 10.1016/j.diabres.2009.11.003; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Ur E, 2008, CANADIAN J DIABET S1, pS17; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	40	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58278	10.1371/journal.pone.0058278	http://dx.doi.org/10.1371/journal.pone.0058278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472169	Green Published, gold, Green Accepted			2022-12-27	WOS:000315637900115
J	Harrison-Uy, SJ; Siegenthaler, JA; Faedo, A; Rubenstein, JLR; Pleasure, SJ				Harrison-Uy, Susan J.; Siegenthaler, Julie A.; Faedo, Andrea; Rubenstein, John L. R.; Pleasure, Samuel J.			CoupTFI Interacts with Retinoic Acid Signaling during Cortical Development	PLOS ONE			English	Article							PROMOTER-TRANSCRIPTION FACTORS; NEURAL PROGENITOR CELLS; CAJAL-RETZIUS CELLS; DEVELOPING NEOCORTEX; NUCLEAR RECEPTORS; ORPHAN RECEPTOR; TFI; DIFFERENTIATION; NEUROGENESIS; NEURONS	We examined the role of the orphan nuclear hormone receptor CoupTFI in mediating cortical development downstream of meningeal retinoic acid signaling. CoupTFI is a regulator of cortical development known to collaborate with retinoic acid (RA) signaling in other systems. To examine the interaction of CoupTFI and cortical RA signaling we utilized Foxc1-mutant mice in which defects in meningeal development lead to alterations in cortical development due to a reduction of RA signaling. By analyzing CoupTFI(-)/(-); Foxc1(H/L) double mutant mice we provide evidence that CoupTFI is required for RA rescue of the ventricular zone and the neurogenic phenotypes in Foxc1-mutants. We also found that overexpression of CoupTFI in Foxc1-mutants is sufficient to rescue the Foxc1-mutant cortical phenotype in part. These results suggest that CoupTFI collaborates with RA signaling to regulate both cortical ventricular zone progenitor cell behavior and cortical neurogenesis.	[Harrison-Uy, Susan J.; Siegenthaler, Julie A.; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Faedo, Andrea; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Rubenstein, John L. R.; Pleasure, Samuel J.] Univ Calif San Francisco, Program Neurosci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Rubenstein, John L. R.; Pleasure, Samuel J.] Univ Calif San Francisco, Program Dev Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pleasure, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	sam.pleasure@ucsf.edu	faedo, andrea/AAA-4319-2021	Faedo, Andrea/0000-0002-2227-0656; , Julie/0000-0003-3700-6441	National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) [R01 DA017627]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099099, R01NS034661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017627] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) R01 DA017627. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Choe Y, 2012, NEURON, V73, P698, DOI 10.1016/j.neuron.2011.11.036; Diez del Corral R, 2003, NEURON, V40, P65; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Faedo A, 2008, CEREB CORTEX, V18, P2117, DOI 10.1093/cercor/bhm238; FENG JQ, 1995, J BIOL CHEM, V270, P28364, DOI 10.1074/jbc.270.47.28364; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Harrison SJ, 2008, CEREB CORTEX, V18, P1604, DOI 10.1093/cercor/bhm191; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Li SW, 2008, DIFFERENTIATION, V76, P897, DOI 10.1111/j.1432-0436.2008.00269.x; Liu Q, 2000, J NEUROSCI, V20, P7682; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Qiu Y, 1996, J STEROID BIOCHEM, V56, P81, DOI 10.1016/0960-0760(95)00225-1; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Rajaii F, 2008, DEV BIOL, V316, P371, DOI 10.1016/j.ydbio.2008.01.041; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Stumm RK, 2003, J NEUROSCI, V23, P5123; Subramanian L, 2009, SEMIN CELL DEV BIOL, V20, P712, DOI 10.1016/j.semcdb.2009.04.001; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; Tomassy GS, 2010, P NATL ACAD SCI USA, V107, P3576, DOI 10.1073/pnas.0911792107; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; van den Bout CJ, 2002, MECH DEVELOP, V110, P179, DOI 10.1016/S0925-4773(01)00597-4; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	46	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58219	10.1371/journal.pone.0058219	http://dx.doi.org/10.1371/journal.pone.0058219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472160	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900106
J	Jiang, L; Li, TZ; Boye, SE; Hauswirth, WW; Frederick, JM; Baehr, W				Jiang, Li; Li, Tansy Z.; Boye, Shannon E.; Hauswirth, William W.; Frederick, Jeanne M.; Baehr, Wolfgang			RNAi-Mediated Gene Suppression in a GCAP1(L151F) Cone-Rod Dystrophy Mouse Model	PLOS ONE			English	Article							CYCLASE-ACTIVATING PROTEINS; GUANYLATE-CYCLASE; RETINITIS-PIGMENTOSA; RETINAL DISEASE; KNOCKOUT MICE; HOMEOBOX GENE; MUTATION; PHOTORECEPTOR; GCAP1; DEGENERATION	Dominant mutations occurring in the high-affinity Ca2+-binding sites (EF-hands) of the GUCA1A gene encoding guanylate cyclase-activating protein 1 (GCAP1) cause slowly progressing cone-rod dystrophy (CORD) in a dozen families worldwide. We developed a nonallele-specific adeno-associated virus (AAV)-based RNAi knockdown strategy to rescue the retina degeneration caused by GCAP1 mutations. We generated three genomic transgenic mouse lines expressing wildtype (WT) and L151F mutant mouse GCAP1 with or without a C-terminal GFP fusion. Under control of endogenous regulatory elements, the transgenes were expressed specifically in mouse photoreceptors. GCAP1(L151F) and GCAP1(L151F)-GFP transgenic mice presented with a late onset and slowly progressive photoreceptor degeneration, similar to that observed in human GCAP1-CORD patients. Transgenic expression of WT GCAP1-EGFP in photoreceptors had no adverse effect. Toward therapy development, a highly effective anti-mGCAP1 shRNA, mG1hp4, was selected from four candidate shRNAs using an in-vitro screening assay. Subsequently a self-complementary (sc) AAV serotype 2/8 expressing mG1hp4 was delivered subretinally to GCAP1(L151F)-GFP transgenic mice. Knockdown of the GCAP1(L151F)-GFP transgene product was visualized by fluorescence live imaging in the scAAV2/8-mG1hp4-treated retinas. Concomitant with the mutant GCAP1-GFP fusion protein, endogenous GCAP1 decreased as well in treated retinas. We propose nonallele-specific RNAi knockdown of GCAP1 as a general therapeutic strategy to rescue any GCAP1-based dominant cone-rod dystrophy in human patients.	[Jiang, Li; Li, Tansy Z.; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Dept Ophthalmol & Visual Sci, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Boye, Shannon E.; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jiang, L (corresponding author), Univ Utah, Dept Ophthalmol & Visual Sci, Hlth Sci Ctr, Salt Lake City, UT 84112 USA.	li.jiang@hsc.utah.edu; wbaehr@hsc.utah.edu		hauswirth, william/0000-0002-3244-4947; Boye, Shannon/0000-0002-7312-3197	National Institutes of Health [EY08123, EY019298, EY021721]; National Institutes of Health (National Eye Institute) [EY014800-039003]; Foundation Fighting Blindness, Inc.; Research to Prevent Blindness; Foundation Fighting Blindness; Macula Vision Research Foundation; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [P30EY021721, R01EY008123, P30EY014800, R01EY019298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (National Eye Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness, Inc.; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Macula Vision Research Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grants EY08123 and EY019298 (WB), Grant EY014800-039003 (National Eye Institute core grant), EY021721 (to WWH); a Center Grant from the Foundation Fighting Blindness, Inc. (http://www.blindness.org/), to the University of Utah; and unrestricted grants to the Department of Ophthalmology at the University of Utah from Research to Prevent Blindness. WB is a recipient of a Research to Prevent Blindness (http://www.rpbusa.org/rpb/) Senior Investigator Award. WWH was supported by grants from the Foundation Fighting Blindness (http://www.blindness.org/), Macula Vision Research Foundation (http://www.mvrf.org/index.php), and Research to Prevent Blindness, Inc.(http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigoni FI, 2011, EUR J HUM GENET, V19, P131, DOI 10.1038/ejhg.2010.147; Baehr W., 2007, V45, P71; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Baehr W, 2009, EXP EYE RES, V89, P2, DOI 10.1016/j.exer.2008.12.016; Buch PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018089; Chen SM, 2002, HUM MOL GENET, V11, P873, DOI 10.1093/hmg/11.8.873; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Jacobson SG, 2011, INVEST OPHTH VIS SCI, V52, P70, DOI 10.1167/iovs.10-6127; Jiang L, 2005, MOL VIS, V11, P143; Jiang L, 2008, VISION RES, V48, P2425, DOI 10.1016/j.visres.2008.07.016; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Jiang L, 2010, ADV EXP MED BIOL, V664, P273, DOI 10.1007/978-1-4419-1399-9_31; Karan S, 2010, MOL CELL BIOCHEM, V334, P141, DOI 10.1007/s11010-009-0322-z; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122; Pennesi ME, 2003, P NATL ACAD SCI USA, V100, P6783, DOI 10.1073/pnas.1130102100; Pras E, 2009, MOL VIS, V15, P1709; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Yang RB, 1996, GENOMICS, V31, P367, DOI 10.1006/geno.1996.0060; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	40	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57676	10.1371/journal.pone.0057676	http://dx.doi.org/10.1371/journal.pone.0057676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472098	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900037
J	Nakanishi, Y; Iida, S; Ueoka-Nakanishi, H; Niimi, T; Tomioka, R; Maeshima, M				Nakanishi, Yoichi; Iida, Syuntaro; Ueoka-Nakanishi, Hanayo; Niimi, Tomoaki; Tomioka, Rie; Maeshima, Masayoshi			Exploring Dynamics of Molybdate in Living Animal Cells by a Genetically Encoded FRET Nanosensor	PLOS ONE			English	Article							ESCHERICHIA-COLI; FLUORESCENT INDICATORS; H+-PYROPHOSPHATASE; MOLYBDENUM INTAKE; BINDING-PROTEIN; TRANSPORT; MODE; OXYANION; SULFATE; HUMANS	Molybdenum (Mo) is an essential trace element for almost all living organisms including animals. Mo is used as a catalytic center of molybdo-enzymes for oxidation/reduction reactions of carbon, nitrogen, and sulfur metabolism. Whilst living cells are known to import inorganic molybdate oxyanion from the surrounding environment, the in vivo dynamics of cytosolic molybdate remain poorly understood as no appropriate indicator is available for this trace anion. We here describe a genetically encoded Forester-resonance-energy-transfer (FRET)-based nanosensor composed of CFP, YFP and the bacterial molybdate-sensor protein ModE. The nanosensor MolyProbe containing an optimized peptide-linker responded to nanomolar-range molybdate selectively, and increased YFP: CFP fluorescence intensity ratio by up to 109%. By introduction of the nanosensor, we have been able to successfully demonstrate the real-time dynamics of molybdate in living animal cells. Furthermore, time course analyses of the dynamics suggest that novel oxalate-sensitive-and sulfate-resistanttransporter(s) uptake molybdate in a model culture cell.	[Nakanishi, Yoichi; Iida, Syuntaro; Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Nagoya, Aichi 4648601, Japan; [Ueoka-Nakanishi, Hanayo] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan; [Ueoka-Nakanishi, Hanayo] Nagoya Univ, Div Phys, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Niimi, Tomoaki; Tomioka, Rie] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Aichi Medical University; Nagoya University; Nagoya University	Nakanishi, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Nagoya, Aichi 4648601, Japan.	nakanish@agr.nagoya-u.ac.jp	Maeshima, Masayoshi/D-3073-2013	Maeshima, Masayoshi/0000-0002-1611-5481; zhong xi, hua dai/0000-0001-8619-9513	Ministry of Education, Culture, Sports, Science and Technology [20200031]; Japan Society for the Promotion of Science [22780089]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (20200031) from The Ministry of Education, Culture, Sports, Science and Technology (to Y.N.), and by Grant-in-Aid for Young Scientists B (22780089) from Japan Society for the Promotion of Science (to Y.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 1997, EUR J BIOCHEM, V246, P119, DOI 10.1111/j.1432-1033.1997.00119.x; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Blanco-Penedo I, 2006, ENVIRON INT, V32, P901, DOI 10.1016/j.envint.2006.05.012; CARDIN CJ, 1976, BIOCHIM BIOPHYS ACTA, V455, P937, DOI 10.1016/0005-2736(76)90062-6; Cauvi D, 2003, CAN J PHYSIOL PHARM, V81, P1131, DOI 10.1139/Y03-120; De Angelis DA, 2002, PROTEIN PROTEIN INTE, P215; Delarbre L, 2001, J MOL BIOL, V308, P1063, DOI 10.1006/jmbi.2001.4636; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Gourley DG, 2001, J BIOL CHEM, V276, P20641, DOI 10.1074/jbc.M100919200; Grunden AM, 1999, J BIOL CHEM, V274, P24308, DOI 10.1074/jbc.274.34.24308; Hattori H, 2004, J NUTR SCI VITAMINOL, V50, P404, DOI 10.3177/jnsv.50.404; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Hirono M, 2005, J BIOCHEM, V138, P183, DOI 10.1093/jb/mvi112; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Ivanov VM, 2002, J ANAL CHEM+, V57, P758, DOI 10.1023/A:1020015521584; Iversen BS, 1998, ANALYST, V123, P81, DOI 10.1039/a706565e; Kiyokawa E, 2011, ANNU REV PHARMACOL, V51, P337, DOI 10.1146/annurev-pharmtox-010510-100234; Lopez Pcorcuera Guillermo, 1993, Journal of General Microbiology, V139, P1869; Mendel RR, 2012, BBA-MOL CELL RES, V1823, P1568, DOI 10.1016/j.bbamcr.2012.02.007; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Mitchell PCE, 2012, DATABASE MOLYBDENUM; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; RYAN J, 1987, ANN RECH VET, V18, P47; Schuttelkopf AW, 2003, J MOL BIOL, V326, P761, DOI 10.1016/S0022-2836(02)01358-X; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Self WT, 2001, RES MICROBIOL, V152, P311, DOI 10.1016/S0923-2508(01)01202-5; Stiefel EL, 2002, MET IONS BIOL SYST, V39, P1; Tao H, 2005, ARCH MICROBIOL, V184, P225, DOI 10.1007/s00203-005-0039-7; Tejada-Jimenez M, 2007, P NATL ACAD SCI USA, V104, P20126, DOI 10.1073/pnas.0704646104; Tejada-Jimenez M, 2011, P NATL ACAD SCI USA, V108, P6420, DOI 10.1073/pnas.1100700108; Tomatsu H, 2007, P NATL ACAD SCI USA, V104, P18807, DOI 10.1073/pnas.0706373104; Turnlund JR, 2004, J NUTR BIOCHEM, V15, P90, DOI 10.1016/j.jnutbio.2003.10.003; Turnlund JR, 2002, MET IONS BIOL SYST, V39, P727; VANHOE H, 1989, ANAL CHEM, V61, P1851, DOI 10.1021/ac00192a014; Yoo YC, 2002, J HEALTH SCI, V48, P186; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	43	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58175	10.1371/journal.pone.0058175	http://dx.doi.org/10.1371/journal.pone.0058175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472155	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900101
J	Pei, XH; Yang, WY; Wang, SN; Zhu, B; Wu, JQ; Zhu, J; Zhao, WH				Pei, Xiaohua; Yang, Wanyuan; Wang, Shengnan; Zhu, Bei; Wu, Jianqing; Zhu, Jin; Zhao, Weihong			Using Mathematical Algorithms to Modify Glomerular Filtration Rate Estimation Equations	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COLLABORATION CKD-EPI; CYSTATIN-C; CHINESE PATIENTS; SERUM CREATININE; GFR; RISK; CLASSIFICATION; PREVALENCE; MORTALITY	Background: The equations provide a rapid and low-cost method of evaluating glomerular filtration rate (GFR). Previous studies indicated that the Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease-Epidemiology (CKD-EPI) and MacIsaac equations need further modification for application in Chinese population. Thus, this study was designed to modify the three equations, and compare the diagnostic accuracy of the equations modified before and after. Methodology: With the use of (99) Tc-m-DTPA renal dynamic imaging as the reference GFR (rGFR), the MDRD, CKD-EPI and MacIsaac equations were modified by two mathematical algorithms: the hill-climbing and the simulated-annealing algorithms. Results: A total of 703 Chinese subjects were recruited, with the average rGFR 77.14 +/- 25.93 ml/min. The entire modification process was based on a random sample of 80% of subjects in each GFR level as a training sample set, the rest of 20% of subjects as a validation sample set. After modification, the three equations performed significant improvement in slop, intercept, correlated coefficient, root mean square error (RMSE), total deviation index (TDI), and the proportion of estimated GFR (eGFR) within 10% and 30% deviation of rGFR (P-10 and P-30). Of the three modified equations, the modified CKD-EPI equation showed the best accuracy. Conclusions: Mathematical algorithms could be a considerable tool to modify the GFR equations. Accuracy of all the three modified equations was significantly improved in which the modified CKD-EPI equation could be the optimal one.	[Pei, Xiaohua; Zhu, Bei; Zhao, Weihong] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Div Nephrol, Nanjing, Jiangsu, Peoples R China; [Yang, Wanyuan; Wang, Shengnan; Zhu, Jin] Nanjing Univ Sci & Technol, Sch Comp Sci, Inst Pattern Recognit & Machine Intelligence, Nanjing, Jiangsu, Peoples R China; [Wu, Jianqing] Nanjing Med Univ, Affiliated Hosp 1, Div Respirat, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University of Science & Technology; Nanjing Medical University	Zhao, WH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Div Nephrol, Nanjing, Jiangsu, Peoples R China.	zhaoweihong_1@medmail.com.cn			Jiangsu Province [BL2012066]; National Natural Science Foundation of China [H0511-810705]; Major State Basic Research Development Program of China [2013CB530803]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Innovation of Science and Technology Achievement Transformation Fund of Jiangsu Province BL2012066, the National Natural Science Foundation of China H0511-810705, and the grants from the Major State Basic Research Development Program of China 2013CB530803, a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions JX10231801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2012, INT J CIRC THEO APPL; Chudleigh RA, 2009, DIABETOLOGIA, V52, P1274, DOI 10.1007/s00125-009-1379-7; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; Delanaye P, 2005, NEPHROL DIAL TRANSPL, V20, P2024, DOI 10.1093/ndt/gfh983; Du X, 2011, RENAL FAILURE, V33, P859, DOI 10.3109/0886022X.2011.605533; Earley A, 2012, ANN INTERN MED; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; GATES GF, 1984, J NUCL MED, V25, P613; Geddes CC, 2008, NEPHROL DIAL TRANSPL, V23, P4, DOI 10.1093/ndt/gfm662; Georgia E, 2010, BMC MED RES METHODOL; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; GOLDFELD SM, 1966, ECONOMETRICA, V34, P541, DOI 10.2307/1909768; GRUBB A, 1985, ACTA MED SCAND, V218, P499; Heikkinen JO, 2001, NUCL MED COMMUN, V22, P987, DOI 10.1097/00006231-200109000-00008; Jaisuresh K, 2012, EXP CLIN TRANSPLANT, V10, P14, DOI 10.6002/ect.2011.0101; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Leung TK, 2010, KIDNEY INT, V77, P729, DOI 10.1038/ki.2009.549; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu X, 2012, INTERN MED J, V42, pe59, DOI 10.1111/j.1445-5994.2010.02398.x; MacIsaac RJ, 2006, DIABETOLOGIA, V49, P1686, DOI 10.1007/s00125-006-0275-7; Mellit A, 2009, RENEW SUST ENERG REV, V13, P406, DOI 10.1016/j.rser.2008.01.006; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Pei XH, 2012, J NEPHROL; Pei XH, 2012, SCAND J UROL NEPHROL, V46, P223, DOI 10.3109/00365599.2012.660985; Pei XH, 2012, INT UROL NEPHROL, V44, P1877, DOI 10.1007/s11255-012-0278-x; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Ribas I, 2010, COMPUT OPER RES, V37, P1439, DOI 10.1016/j.cor.2009.11.001; Rule AD, 2009, AM J KIDNEY DIS, V53, P932, DOI 10.1053/j.ajkd.2009.02.011; Stevens LA, 2011, AM J KIDNEY DIS, V57, pS9, DOI 10.1053/j.ajkd.2010.11.007; Stevens LA, 2010, CURR OPIN NEPHROL HY, V19, P298, DOI 10.1097/MNH.0b013e32833893e2; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027359; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	40	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57852	10.1371/journal.pone.0057852	http://dx.doi.org/10.1371/journal.pone.0057852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472113	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900052
J	Saxena, A; Prabhakar, MC				Saxena, Amrish; Prabhakar, Manish Chandra			Performance of DHI Score as a Predictor of Benign Paroxysmal Positional Vertigo in Geriatric Patients with Dizziness/Vertigo: A Cross-Sectional Study	PLOS ONE			English	Article							ELDERLY-PATIENTS; EPIDEMIOLOGY; POPULATION; PREVALENCE	Background: Dizziness/vertigo is one of the most common complaint and handicapping condition among patients aged 65 years and older (Geriatric patients). This study was conducted to assess the impact of dizziness/vertigo on the quality of life in the geriatric patients attending a geriatric outpatient clinic. Settings and Design: A cross-sectional study was performed in a geriatric outpatient clinic of a rural teaching tertiary care hospital in central India. Materials and Methods: In all consecutive geriatric patients with dizziness/vertigo attending geriatric outpatient clinic, DHI questionnaire was applied to assess the impact of dizziness/vertigo and dizziness associated handicap in the three areas of a patients' life: physical, functional and emotional domain. Later, each patient was evaluated and underwent Dix-Hallpike maneuver by the physician who was blind of the DHI scoring of the patient. Statistical Analysis Used: We compared means and proportions of variables across two categories of benign paroxysmal positional vertigo (BPPV) and non-BPPV. For these comparisons we used Student's t-test to test for continuous variables, chi-square test for categorical variables and Fisher's exact test in the case of small cell sizes (expected value <5). Results: The magnitude of dizziness/vertigo was 3%. Of the 88 dizziness/vertigo patients, 19 (22%) and 69(78%) cases, respectively, were attributed to BPPV and non-BPPV group. The association of DHI score >= 50 with the BPPV was found to be statistically significant with x(2) value = 58.2 at P < 0.01. Conclusion: DHI Score is a useful tool for the prediction of benign paroxysmal positional vertigo. Correct diagnosis of BPPV is 16 times greater if the DHI Score is greater than or equal to 50. The physical, functional and emotional investigation of dizziness, through the DHI, has demonstrated to be a valuable and useful instrument in the clinical routine.	[Saxena, Amrish; Prabhakar, Manish Chandra] Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India	Mahatma Gandhi Institute of Medical Sciences, Sevagram	Saxena, A (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India.	dramrishsaxena@rediffmail.com	Prabhakar, Manish Chandra/J-6326-2013	Prabhakar, Manish Chandra/0000-0002-6131-7146	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This study was partly funded by the Indian Council of Medical Research, New Delhi, India. Manish Chandra Prabhakar, a medical student, was awarded the short term studentship (2010) to conduct this study (URL: http://www.icmr.nic.in/shortr.htm). The Indian Council of Medical Research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; BLESSING R, 1986, LARYNGO RHINO OTOL, V65, P455, DOI 10.1055/s-2007-1008013; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cohen HS, 2004, ORL J OTO-RHINO-LARY, V66, P11, DOI 10.1159/000077227; COLLEDGE NR, 1994, AGE AGEING, V23, P117, DOI 10.1093/ageing/23.2.117; Colledge NR, 1996, BMJ-BRIT MED J, V313, P788; DAY JJ, 1990, AGE AGEING, V19, P144, DOI 10.1093/ageing/19.2.144; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; Andre APD, 2010, BRAZ J OTORHINOLAR, V76, P300, DOI 10.1590/S1808-86942010000300005; ENSRUD KE, 1992, ARCH INTERN MED, V152, P1058, DOI 10.1001/archinte.152.5.1058; EVANS JG, 1990, AGE AGEING, V19, P43, DOI 10.1093/ageing/19.1.43; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Furman JM, 1999, NEW ENGL J MED, V341, P1590, DOI 10.1056/NEJM199911183412107; Hajioff D, 2002, CLIN OTOLARYNGOL, V27, P27, DOI 10.1046/j.0307-7772.2001.00517.x; Hanley K, 2002, BRIT J GEN PRACT, V52, P809; HERRGARD E, 1995, ACTA PAEDIATR, V84, P1160, DOI 10.1111/j.1651-2227.1995.tb13517.x; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Korres S, 2002, OTOL NEUROTOL, V23, P926, DOI 10.1097/00129492-200211000-00019; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; Maarsingh OR, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-2; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Perez P, 2012, OTOL NEUROTOL, V33, P437, DOI 10.1097/MAO.0b013e3182487f78; Ryan H, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/918368; SLOANE P, 1989, J AM GERIATR SOC, V37, P101, DOI 10.1111/j.1532-5415.1989.tb05867.x; Sloane PD, 2001, ANN INTERN MED, V134, P823, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00005; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420	29	19	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58106	10.1371/journal.pone.0058106	http://dx.doi.org/10.1371/journal.pone.0058106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472142	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900087
J	Waidyatilaka, I; Lanerolle, P; Wickremasinghe, R; Atukorala, S; Somasundaram, N; de Silva, A				Waidyatilaka, Indu; Lanerolle, Pulani; Wickremasinghe, Rajitha; Atukorala, Sunethra; Somasundaram, Noel; de Silva, Angela			Sedentary Behaviour and Physical Activity in South Asian Women: Time to Review Current Recommendations?	PLOS ONE			English	Article							TELEVISION VIEWING TIME; LIFE-STYLE; DIABETES PREVENTION; OBESITY; ASSOCIATIONS; PREVALENCE; MORTALITY; PROGRAM; CHINA	Objective: Our aims were to describe activity and sedentary behaviours in urban Asian women, with dysglycaemia (diagnosed at recruitment), and without dysglycaemia and examine the relative contribution of these parameters to their glycaemic status. Methods: 2800 urban women (30-45 years) were selected by random cluster sampling and screened for dysglycaemia for a final sample of 272 newly diagnosed, drug naive dysglycaemic and 345 normoglycaemic women. Physical activity and sedentary behaviours were assessed by the International Physical Activity Questionnaire (IPAQ). Demographic data, diet and anthropometry were recorded. Logistic regression analysis assessed contribution of all parameters to dysglycaemia and exposure attributable fractions were calculated. Results: The mean energy expenditure on walking (2648.5 +/- 1023.7 MET-min/week) and on moderate and vigorous physical activity (4342.3 +/- 1768.1 MET-min/week) for normoglycemic women and dysglycaemic women (walking; 1046.4 +/- 728.4 MET-min/week, moderate and vigorous physical activity; 1086.7 +/- 1184.4 MET-min/week) was above the recommended amount of physical activity per week. 94.3% of women spent >1000 MET-minutes/week on activity. Mean sitting and TV time for normoglycaemic and dysglycaemic women were 154.3 +/- 62.8, 38.4 +/- 31.9, 312.6 +/- 116.7 and 140.2 +/- 56.5 minutes per day respectively. Physical activity and sedentary behaviour contributed to dysglycaemia after adjustment for family history, diet, systolic blood pressure and Body Mass Index. Exposure attributable fractions for dysglycaemia were; lower physical activity: 78%, higher waist circumference: 94%, and TV viewing time: 85%. Conclusions: Urban South Asian women are at risk of dysglycaemia at lower levels of sedentary behaviour and greater physical activity than western populations, indicating the need for re-visiting current physical activity guidelines for South Asians.	[Waidyatilaka, Indu; Lanerolle, Pulani; Atukorala, Sunethra] Univ Colombo, Dept Biochem & Mol Biol, Fac Med, Colombo, Sri Lanka; [Wickremasinghe, Rajitha] Univ Kelaniya, Fac Med, Dept Publ Hlth, Ragama, Sri Lanka; [Somasundaram, Noel] Univ Colombo, Endocrine Unit, Natl Hosp Colombo, Colombo, Sri Lanka; [de Silva, Angela] Univ Colombo, Dept Physiol, Fac Med, Colombo, Sri Lanka	University of Colombo; University Kelaniya; University of Colombo; University of Colombo	de Silva, A (corresponding author), Univ Colombo, Dept Physiol, Fac Med, Colombo, Sri Lanka.	desilva.angela@gmail.com			International Atomic Energy Agency (IAEA) [RC 15920]	International Atomic Energy Agency (IAEA)(International Atomic Energy Agency)	This research was funded by International Atomic Energy Agency (IAEA) - RC 15920. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Arambepola C, 2004, THESIS; Balagopal P, 2008, DIABETES CARE, V31, P1097, DOI 10.2337/dc07-1680; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Bowman SA, 2006, PREV CHRONIC DIS; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Gill JMR, 2011, DIABETES CARE, V34, P1214, DOI 10.2337/dc10-2313; Inoue S, 2012, J EPIDEMIOL, V22, P50, DOI 10.2188/jea.JE20110054; Janssen I, 2012, INT J EPIDEMIOL, P1; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lear SA, 2007, OBESITY, V15, P2817, DOI 10.1038/oby.2007.334; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Merom D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-90; Organization for Economic Co-Operative and Development, 2007, COMM OUTL; Owen N, 2009, BRIT J SPORT MED, V43, P81, DOI 10.1136/bjsm.2008.055269; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Stewart A., 2011, INT STANDARDS ANTHRO, V137; Sugiyama T, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-35; Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; World Health Organisation, 2010, GLOB EC PHYS ACT HLT; World Health Organization, 2010, GLOBAL TUBERCULOSIS	30	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58328	10.1371/journal.pone.0058328	http://dx.doi.org/10.1371/journal.pone.0058328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472180	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900126
J	Yang, BY; Liu, YY; Li, YF; Fan, SJ; Zhi, XY; Lu, XX; Wang, D; Zheng, QM; Wang, YN; Wang, YX; Sun, GF				Yang, Boyi; Liu, Yuyan; Li, Yongfang; Fan, Shujun; Zhi, Xueyuan; Lu, Xiangxiang; Wang, Da; Zheng, Quanmei; Wang, Yinuo; Wang, Yanxun; Sun, Guifan			Geographical Distribution of MTHFR C677T, A1298C and MTRR A66G Gene Polymorphisms in China: Findings from 15357 Adults of Han Nationality	PLOS ONE			English	Article							METHIONINE SYNTHASE REDUCTASE; NEURAL-TUBE DEFECTS; BREAST-CANCER RISK; METHYLENETETRAHYDROFOLATE REDUCTASE; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; HIGH PREVALENCE; PLASMA HOMOCYSTEINE; ETHNIC POPULATIONS; COMMON MUTATION; INCREASES RISK	Background: Methylenetetrahydrofolate reductase (MTHFR) C677T, A1298C and methionine synthase reductase (MTRR) A66G polymorphisms are important genetic determinants for homocysteine (Hcy) levels, and are associated with several disorders. These polymorphisms are heterogeneously distributed worldwide. Our objective was to explore the geographical distributions of these polymorphisms in China. Methodologies: 15357 healthy adults were recruited from 10 regions. Buccal samples were collected and genomic DNA was isolated. Genotyping was performed using the fluorogenic 5'-nuclease assay. Principal Findings: The prevalence of the three polymorphisms among different populations from China varied significantly and showed apparent geographical gradients. For MTHFR C677T, the frequencies of the 677T allele and the 677TT genotype were significantly higher among northern populations and ranged from the lowest values (24.0% and 6.4%, respectively) in Hainan (southern) to the highest values (63.1% and 40.8%, respectively) in Shandong (northern). For MTHFR A1298C, the 1298C allele and the 1298CC genotype frequencies were significantly higher among southern populations and increased from low values (13.1% and 1.4%, respectively) in Shandong to high values (25.7% and 6.7%, respectively) in Hainan. For A66G, the 66G allele and the 66GG genotype frequencies increased from lower values (23.7% and 5.4%, respectively) in Shandong to higher values (29.2% and 8.6%, respectively) in Hainan. The overall frequency of the 677T allele, 677TT genotype, 1298C allele, 1298CC genotype, 66G allele and 66GG genotype in the Chinese Han population was 45.2%, 23.2%, 18.6%, 3.9%, 25.7%, and 6.6%, respectively. No gender differences were found in the prevalence of both the MTHFR C677T and MTRR A66G polymorphisms. Conclusions: This study indicates that there are marked geographical variations in the prevalence of the three polymorphisms among Chinese Han populations. Our baseline data may be useful for future researches in related fields.	[Yang, Boyi; Liu, Yuyan; Li, Yongfang; Fan, Shujun; Zhi, Xueyuan; Lu, Xiangxiang; Wang, Da; Zheng, Quanmei; Sun, Guifan] China Med Univ, Coll Publ Hlth, Dept Occupat & Environm Hlth, Shenyang, Peoples R China; [Wang, Yinuo; Wang, Yanxun] Shanghai Inst Targeted Therapy & Mol Med, Shanghai, Peoples R China	China Medical University	Sun, GF (corresponding author), China Med Univ, Coll Publ Hlth, Dept Occupat & Environm Hlth, Shenyang, Peoples R China.	sungf@mail.cmu.edu.cn			National Natural Science Foundation of China (NSFC) [81072243]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by a grant (No. 81072243) from the National Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botto LD, 2000, AM J EPIDEMIOL, V151, P862; BRANDA RF, 1978, SCIENCE, V201, P625, DOI 10.1126/science.675247; Brown CA, 2000, J CARDIOVASC RISK, V7, P197; Brustolin S, 2010, BRAZ J MED BIOL RES, V43, P1, DOI 10.1590/S0100-879X2009007500021; Chen L, 2012, DNA CELL BIOL, V31, P238, DOI 10.1089/dna.2011.1281; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Cordain L, 2006, AM J CLIN NUTR, V84, P1243, DOI 10.1093/ajcn/84.5.1243; De Marco P, 2002, J HUM GENET, V47, P319, DOI 10.1007/s100380200043; Diamond J, 2005, NATURE, V435, P283, DOI 10.1038/435283a; Eloualid A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034111; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gaughan DJ, 2001, ATHEROSCLEROSIS, V157, P451, DOI 10.1016/S0021-9150(00)00739-5; Gueant-Rodriguez RM, 2006, AM J CLIN NUTR, V83, P701, DOI 10.1093/ajcn.83.3.701; Gueant-Rodriguez RM, 2003, NEUROSCI LETT, V344, P189, DOI 10.1016/S0304-3940(03)00468-3; Han D, 2012, MOL BIOL REP, V39, P805, DOI 10.1007/s11033-011-0802-6; Hao L, 2003, J NUTR, V133, P3630, DOI 10.1093/jn/133.11.3630; Huang J, 2011, J GERIATR CARDIOL, V8, P72, DOI 10.3724/SP.J.1263.2011.00072; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jiang Y, 2012, CELL BIOCHEM BIOPHYS, V62, P203, DOI 10.1007/s12013-011-9283-4; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Lajin B, 2012, ASIAN J PSYCHIATR, V5, P144, DOI 10.1016/j.ajp.2012.03.002; Lajin B, 2012, MOL CELL PROBE, V26, P16, DOI 10.1016/j.mcp.2011.10.005; Li Ya-jie, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P820; Li ZW, 2006, BIRTH DEFECTS RES A, V76, P237, DOI 10.1002/bdra.20248; Mansoor A, 2009, GENET TEST MOL BIOMA, V13, P521, DOI 10.1089/gtmb.2009.0012; Mao RF, 2008, CELL BIOCHEM FUNCT, V26, P352, DOI 10.1002/cbf.1450; McKinley MC, 2001, AM J CLIN NUTR, V73, P759; McNulty H, 2006, CIRCULATION, V113, P74, DOI 10.1161/CIRCULATIONAHA.105.580332; Mutchinick OM, 1999, MOL GENET METAB, V68, P461, DOI 10.1006/mgme.1999.2939; Ng MCY, 2004, GENOMICS, V83, P559, DOI 10.1016/j.ygeno.2003.09.008; Olteanu H, 2002, BIOCHEMISTRY-US, V41, P13378, DOI 10.1021/bi020536s; Palomino-Morales R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2989; Pepe G, 1998, AM J HUM GENET, V63, P917, DOI 10.1086/302015; Rady PL, 2002, AM J MED GENET, V107, P162, DOI 10.1002/ajmg.10122; Ren A, 2007, PUBLIC HEALTH NUTR, V10, P762, DOI 10.1017/S1368980007246786; Richter B, 2001, J HUM GENET, V46, P105, DOI 10.1007/s100380170096; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rome: International Center for Birth Defects, 2010, INT CLEAR HOUS BIRTH; Rosenberg N, 2002, AM J HUM GENET, V70, P758, DOI 10.1086/338932; Rozen R, 1999, AM J MED GENET, V83, P142, DOI 10.1002/(SICI)1096-8628(19990312)83:2<142::AID-AJMG12>3.0.CO;2-Y; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Sabbagh AS, 2008, GENET TEST, V12, P75, DOI 10.1089/gte.2007.0064; Saraswathy KN, 2012, MOL BIOL REP, V39, P5025, DOI 10.1007/s11033-011-1299-8; Sazci A, 2005, CELL BIOCHEM FUNCT, V23, P51, DOI 10.1002/cbf.1132; Shrubsole MJ, 2006, CANCER EPIDEM BIOMAR, V15, P586, DOI 10.1158/1055-9965.EPI-05-0576; Stolzenberg-Solomon RZ, 2003, CANCER EPIDEM BIOMAR, V12, P1222; The World Bank, 2011, HLTH HARM LIF CHIN S; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Van der Linden IJM, 2006, J MOL MED, V84, P1047, DOI 10.1007/s00109-006-0093-x; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Vijaya LS, 2011, J ATHEROSCLER THROMB, V18, P56; Wald DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016473; Wang D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-925; Wang XW, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.021; Weiner AS, 2012, CANCER EPIDEMIOL, V36, pE95, DOI 10.1016/j.canep.2011.11.010; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Yakub M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033222; Zeng W, 2011, GENET MOL RES, V10, P2597, DOI 10.4238/2011.October.25.7; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc; Zhu HP, 2003, MOL GENET METAB, V78, P216, DOI 10.1016/S1096-7192(03)00008-8	62	77	96	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57917	10.1371/journal.pone.0057917	http://dx.doi.org/10.1371/journal.pone.0057917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472119	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900062
J	McGovern, G; Jeffrey, M				McGovern, Gillian; Jeffrey, Martin			Membrane Toxicity of Abnormal Prion Protein in Adrenal Chromaffin Cells of Scrapie Infected Sheep	PLOS ONE			English	Article							ELECTRON-MICROSCOPIC OBSERVATIONS; NERVOUS-SYSTEM; PRP ACCUMULATION; MEDULLA; NEURONS; DISEASE; STRAIN; BRAIN; PATHOGENESIS; INNERVATION	Transmissible spongiform encephalopathies (TSEs) or prion diseases are associated with accumulations of disease specific PrP (PrPd) in the central nervous system (CNS) and often the lymphoreticular system (LRS). Accumulations have additionally been recorded in other tissues including the peripheral nervous system and adrenal gland. Here we investigate the effect of sheep scrapie on the morphology and the accumulation of PrPd in the adrenal medulla of scrapie affected sheep using light and electron microscopy. Using immunogold electron microscopy, non-fibrillar forms of PrPd were shown to accumulate mainly in association with chromaffin cells, occasional nerve endings and macrophages. PrPd accumulation was associated with distinctive membrane changes of chromaffin cells including increased electron density, abnormal linearity and invaginations. Internalisation of PrPd from the chromaffin cell plasma membrane occurred in association with granule recycling following hormone exocytosis. PrPd accumulation and internalisation from membranes is similarly associated with perturbations of membrane structure and trafficking in CNS neurons and tingible body macrophages of the LRS. These data suggest that a major toxic effect of PrPd is at the level of plasma membranes. However, the precise nature of PrPd-membrane toxicity is tissue and cell specific suggesting that the normal protein may act as a multi-functional scaffolding molecule. We further suggest that the co-localisation of PrPd with exocytic granules of the hormone trafficking system may provide an additional source of infectivity in blood.	[McGovern, Gillian; Jeffrey, Martin] Anim Hlth & Vet Labs Agcy, Lasswade Lab, Penicuik, Midlothian, Scotland		McGovern, G (corresponding author), Anim Hlth & Vet Labs Agcy, Lasswade Lab, Pentlands Sci Pk, Penicuik, Midlothian, Scotland.		McGOVERN, GILLIAN/C-3441-2011; Jeffrey, Martin/D-2251-2009	McGOVERN, GILLIAN/0000-0001-5344-5909; 	Defra [SE1957]	Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This study was funded by Defra grant SE1957. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE DK, 1985, P NATL ACAD SCI USA, V82, P4702, DOI 10.1073/pnas.82.14.4702; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Beekes M, 2000, NEUROSCI LETT, V278, P181, DOI 10.1016/S0304-3940(99)00934-9; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; Bencsik A, 2001, J NEUROVIROL, V7, P447, DOI 10.1080/135502801753170309; Bondiolotti G, 2010, NEUROBIOL DIS, V37, P114, DOI 10.1016/j.nbd.2009.09.014; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; COUPLAND RE, 1965, J ANAT, V99, P231; COUPLAND RE, 1965, J ANAT, V99, P255; DAGERLIND A, 1995, NEUROSCIENCE, V69, P1019, DOI 10.1016/0306-4522(95)00305-3; Ersdal C, 2009, NEUROPATH APPL NEURO, V35, P259, DOI 10.1111/j.1365-2990.2008.00988.x; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Gayrard V, 2000, ENDOCRINOLOGY, V141, P988, DOI 10.1210/en.141.3.988; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Hijazi N, 2005, J BIOL CHEM, V280, P17057, DOI 10.1074/jbc.M411314200; Hoffmann C, 2007, J GEN VIROL, V88, P1048, DOI 10.1099/vir.0.82186-0; Jeffrey M, 2000, J PATHOL, V191, P323, DOI 10.1002/1096-9896(200007)191:3&lt;323::AID-PATH629&gt;3.0.CO;2-Z; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; Jeffrey M, 2011, ACTA NEUROPATHOL, V121, P113, DOI 10.1007/s00401-010-0700-3; Johnston AR, 1998, EXP NEUROL, V151, P326, DOI 10.1006/exnr.1998.6817; Kovacs GG, 2002, BRAIN PATHOL, V12, P1; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Maignien T, 1999, J GEN VIROL, V80, P3035, DOI 10.1099/0022-1317-80-11-3035; Manson J., 1992, Neurodegeneration, V1, P45; McGovern G, 2004, J COMP PATHOL, V130, P181, DOI 10.1016/j.jcpa.2003.11.001; McGovern G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008186; McGovern G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001304; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Mravec B, 2005, AUTON NEUROSCI-BASIC, V120, P10, DOI 10.1016/j.autneu.2005.04.005; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Okada H, 2012, J HISTOCHEM CYTOCHEM, V60, P290, DOI 10.1369/0022155412437218; Ryan JBN, 1988, VET REC, P638; Schelcher F, 1999, ENDOCRINOLOGY, V140, P2422, DOI 10.1210/en.140.5.2422; Siso S, 2011, NEUROPATH APPL NEURO, V37, P484, DOI 10.1111/j.1365-2990.2010.01152.x; TOMLINSON A, 1990, J ANAT, V169, P209; van Keulen LJM, 2000, ARCH VIROL, P57; Voigtlander T, 2006, EUR J NEUROSCI, V23, P2723, DOI 10.1111/j.1460-9568.2006.04801.x; Wilesmith J W, 1991, Curr Top Microbiol Immunol, V172, P21; Ye X, 1996, J COMP PATHOL, V114, P291, DOI 10.1016/S0021-9975(96)80051-X	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58620	10.1371/journal.pone.0058620	http://dx.doi.org/10.1371/journal.pone.0058620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469286	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900095
J	Mondal, R; Ghosh, SK; Choudhury, JH; Seram, A; Sinha, K; Hussain, M; Laskar, RS; Rabha, B; Dey, P; Ganguli, S; NathChoudhury, M; Talukdar, FR; Chaudhuri, B; Dhar, B				Mondal, Rosy; Ghosh, Sankar Kumar; Choudhury, Javed Hussain; Seram, Anil; Sinha, Kavita; Hussain, Marine; Laskar, Ruhina Shirin; Rabha, Bijuli; Dey, Pradip; Ganguli, Sabitri; NathChoudhury, Monisha; Talukdar, Fazlur Rahman; Chaudhuri, Biswadeep; Dhar, Bishal			Mitochondrial DNA Copy Number and Risk of Oral Cancer: A Report from Northeast India	PLOS ONE			English	Article							SMOKELESS TOBACCO; SOUTHERN ASSAM; MTDNA CONTENT; HEAD; MUTATIONS; DEPLETION; SUSCEPTIBILITY; GSTM1; POLYMORPHISM; INFECTION	Background: Oral squamous cell carcinoma (OSCC) is the sixth most common cancer globally. Tobacco consumption and HPV infection, both are the major risk factor for the development of oral cancer and causes mitochondrial dysfunction. Genetic polymorphisms in xenobiotic-metabolizing enzymes modify the effect of environmental exposures, thereby playing a significant role in gene-environment interactions and hence contributing to the individual susceptibility to cancer. Here, we have investigated the association of tobacco - betel quid chewing, HPV infection, GSTM1-GSTT1 null genotypes, and tumour stages with mitochondrial DNA (mtDNA) content variation in oral cancer patients. Methodology/Principal Findings: The study comprised of 124 cases of OSCC and 140 control subjects to PCR based detection was done for high-risk HPV using a consensus primer and multiplex PCR was done for detection of GSTM1-GSTT1 polymorphism. A comparative Delta Ct method was used for determination of mtDNA content. The risk of OSCC increased with the ceased mtDNA copy number (P-trend = 0.003). The association between mtDNA copy number and OSCC risk was evident among tobacco - betel quid chewers rather than tobacco - betel quid non chewers; the interaction between mtDNA copy number and tobacco - betel quid was significant (P = 0.0005). Significant difference was observed between GSTM1 - GSTT1 null genotypes (P = 0.04, P = 0.001 respectively) and HPV infection (P<0.001) with mtDNA content variation in cases and controls. Positive correlation was found with decrease in mtDNA content with the increase in tumour stages (P<0.001). We are reporting for the first time the association of HPV infection and GSTM1-GSTT1 null genotypes with mtDNA content in OSCC. Conclusion: Our results indicate that the mtDNA content in tumour tissues changes with tumour stage and tobacco-betel quid chewing habits while low levels of mtDNA content suggests invasive thereby serving as a biomarker in detection of OSCC.	[Mondal, Rosy; Ghosh, Sankar Kumar; Choudhury, Javed Hussain; Seram, Anil; Sinha, Kavita; Hussain, Marine; Laskar, Ruhina Shirin; Rabha, Bijuli; Dey, Pradip; Ganguli, Sabitri; NathChoudhury, Monisha; Talukdar, Fazlur Rahman; Chaudhuri, Biswadeep; Dhar, Bishal] Assam Univ, Dept Biotechnol, Silchar, Assam, India	Assam University	Ghosh, SK (corresponding author), Assam Univ, Dept Biotechnol, Silchar, Assam, India.	drsankarghosh@gmail.com	Talukdar, Fazlur Rahman/S-5928-2019; mondal, rosy/J-7808-2017; Talukdar, Fazlur Rahman/GWV-3782-2022; Choudhury, Javed H/ABF-7723-2021	Talukdar, Fazlur Rahman/0000-0002-6558-5543; mondal, rosy/0000-0002-5556-0799; Laskar, Ruhina Shirin/0000-0001-6455-094X; Choudhury, Dr. Javed Hussain/0000-0002-3080-3600; Dhar, Bishal/0000-0001-9268-4662				AbdelRahman SZ, 1996, CANCER LETT, V107, P229, DOI 10.1016/0304-3835(96)04832-X; Agrawal D, 2010, ONCOLOGY-BASEL, V79, P181, DOI 10.1159/000318533; Anantharaman D, 2007, CARCINOGENESIS, V28, P1455, DOI 10.1093/carcin/bgm038; Bagchi M, 1999, FREE RADICAL BIO MED, V26, P992, DOI 10.1016/S0891-5849(98)00286-X; Bai RK, 2011, J ONCOL, V2011, DOI 10.1155/2011/496189; Bhattacharjee A, 2006, INDIAN J OTOLARYNGOL, V58, P15, DOI 10.1007/BF02907731; BLOT WJ, 1988, CANCER RES, V48, P3282; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chopra M, 2000, CLIN CHEM, V46, P1818; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Evans MF, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-10; Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322; Ghosh SK, 2011, ASIAN PAC J CANCER P, V12, P749; Ghosh SK, 2012, INT J GYNECOL OBSTET, V118, P72, DOI 10.1016/j.ijgo.2012.02.006; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Jayalekshmi PA, 2009, BRIT J CANCER, V100, P848, DOI 10.1038/sj.bjc.6604907; Jiang WW, 2006, CLIN CANCER RES, V12, P1564, DOI 10.1158/1078-0432.CCR-05-1471; Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147; Keusch GT, 2003, J NUTR, V133, p336S, DOI 10.1093/jn/133.1.336S; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2001, MUTAT RES-GEN TOX EN, V493, P67, DOI 10.1016/S1383-5718(01)00160-7; Liao LM, 2011, CANCER EPIDEM BIOMAR, V20, P1944, DOI 10.1158/1055-9965.EPI-11-0379; Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002; Mahimkar MB, 2001, MUTAT RES-GEN TOX EN, V491, P111, DOI 10.1016/S1383-5718(01)00133-4; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Mehrotra R, 2006, Indian J Cancer, V43, P60; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Mondal R, 2013, MITOCHONDR DNA, V24, P432, DOI 10.3109/19401736.2012.760551; Mondal R, 2013, ORAL ONCOL, V49, P345, DOI 10.1016/j.oraloncology.2012.11.003; Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001; NAIR UJ, 1992, ENVIRON HEALTH PERSP, V98, P203, DOI 10.2307/3431271; Nair UJ, 1999, CARCINOGENESIS, V20, P743, DOI 10.1093/carcin/20.5.743; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pena Gonzalez A, 2006, REV CUBANA ESTOMATOL, V43; Poljsak B, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/194586; Purdue MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043149; RENIS M, 1989, J NEUROCHEM, V52, P750, DOI 10.1111/j.1471-4159.1989.tb02518.x; Ruwali M, 2011, XENOBIOTICA, V41, P1122, DOI 10.3109/00498254.2011.614020; Selvanayagam P, 1996, LAB INVEST, V74, P592; Sen S, 2011, ACS SYM SER, V1083, P1; Sharan RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042759; Sharma H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-34; Shukla S, 2009, INDIAN J MED RES, V130, P222; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759; Tan DJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-93; Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; Verma Mukesh, 2007, Cancer Res, V67, P437, DOI 10.1158/0008-5472.CAN-06-4119; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015; Wen CP, 2010, CANCER CAUSE CONTROL, V21, P1427, DOI 10.1007/s10552-010-9570-1; Wong LJC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013532; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002; Yu M, 2001, MITOCHONDRIAL DNA CO; Yu M, 2012, TRANSL RES; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zheng SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031322	63	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57771	10.1371/journal.pone.0057771	http://dx.doi.org/10.1371/journal.pone.0057771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469236	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900044
J	Starks, AM; Martin, DN; Dorsey, TH; Boersma, BJ; Wallace, TA; Ambs, S				Starks, Adrienne M.; Martin, Damali N.; Dorsey, Tiffany H.; Boersma, Brenda J.; Wallace, Tiffany A.; Ambs, Stefan			Household Income Is Associated with the p53 Mutation Frequency in Human Breast Tumors	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TP53 GENE-MUTATIONS; AFRICAN-AMERICAN; CANCER PATIENTS; MOLECULAR PATHOGENESIS; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; EPITHELIAL-CELLS; SUPPRESSOR GENE; POOR-PROGNOSIS	Background: A study from Scotland reported that the p53 mutation frequency in breast tumors is associated with socioeconomic deprivation. Methods: We analyzed the association of the tumor p53 mutational status with tumor characteristics, education, and self-reported annual household income (HI) among 173 breast cancer patients from the greater Baltimore area, United States. Results: p53 mutational frequency was significantly associated with HI. Patients with < $15,000 HI had the highest p53 mutation frequency (21%), followed by the income group between $15,000 and $60,000 (18%), while those above $60,000 HI had the fewest mutations (5%). When dichotomized at $60,000, 26 out of 135 patients in the low income category had acquired a p53 mutation, while only 2 out of 38 with a high income carried a mutation (P<0.05). In the adjusted logistic regression analysis with 3 income categories (trend test), the association between HI and p53 mutational status was independent of tumor characteristics, age, race/ethnicity, tobacco smoking and body mass. Further analyses revealed that HI may impact the p53 mutational frequency preferentially in patients who develop an estrogen receptor (ER)-negative disease. Within this group, 42% of the low income patients (<$15,000 HI) carried a mutation, followed by the middle income group (21%), while those above $60,000 HI did not carry mutations (P-trend < 0.05). Conclusions: HI is associated with the p53 mutational frequency in patients who develop an ER-negative disease. Furthermore, high income patients may acquire fewer p53 mutations than other patients, suggesting that lifetime exposures associated with socio-economic status may impact breast cancer biology.	[Starks, Adrienne M.; Dorsey, Tiffany H.; Boersma, Brenda J.; Wallace, Tiffany A.; Ambs, Stefan] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Martin, Damali N.] NCI, Epidemiol & Genet Res Program, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambs, S (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	ambss@mail.nih.gov	Boersma, Brenda/A-9270-2009	Boersma, Brenda/0000-0002-8992-2735; Starks, Adrienne/0000-0002-2640-6928; Ambs, Stefan/0000-0001-7651-9309	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America; NATIONAL CANCER INSTITUTE [ZIABC010887] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Ahrendt SA, 1999, P NATL ACAD SCI USA, V96, P7382, DOI 10.1073/pnas.96.13.7382; Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Albain KS, 2009, JNCI-J NATL CANCER I, V101, P984, DOI 10.1093/jnci/djp175; Ambs S, 1999, J NATL CANCER I, V91, P86, DOI 10.1093/jnci/91.1.86; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Baker L, 2010, BRIT J CANCER, V102, P719, DOI 10.1038/sj.bjc.6605540; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Bernstein Leslie, 2003, Cancer, V97, P222, DOI 10.1002/cncr.11014; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Calza S, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1517; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chlebowski RT, 2005, JNCI-J NATL CANCER I, V97, P439, DOI 10.1093/jnci/dji064; Colomer A, 2003, APPL IMMUNOHISTO M M, V11, P130, DOI 10.1097/00129039-200306000-00007; Coombs N J, 1999, Nucleic Acids Res, V27, pe12, DOI 10.1093/nar/27.16.e12; Curtis E, 2008, CANCER-AM CANCER SOC, V112, P171, DOI 10.1002/cncr.23131; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Fernandez SV, 2006, INT J CANCER, V118, P1862, DOI 10.1002/ijc.21590; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Freudenheim JL, 2004, CARCINOGENESIS, V25, P931, DOI 10.1093/carcin/bgh088; Glynn SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-626; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; GORDON NH, 1995, AM J EPIDEMIOL, V142, P796, DOI 10.1093/oxfordjournals.aje.a117718; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hermes GL, 2009, P NATL ACAD SCI USA, V106, P22393, DOI 10.1073/pnas.0910753106; Hershman D, 2005, J CLIN ONCOL, V23, P6639, DOI 10.1200/JCO.2005.12.633; Hussain SP, 1999, MUTAT RES-FUND MOL M, V428, P23, DOI 10.1016/S1383-5742(99)00028-9; Igarashi H, 2010, CLIN EXP IMMUNOL, V161, P71, DOI 10.1111/j.1365-2249.2010.04163.x; Jones BA, 2004, CANCER, V101, P1293, DOI 10.1002/cncr.20500; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Narod SA, 2011, NAT REV CLIN ONCOL, V8, P669, DOI 10.1038/nrclinonc.2011.110; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pan D, 2011, CANCER RES, V71, P6360, DOI 10.1158/0008-5472.CAN-11-0362; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Piao CQ, 1999, CARCINOGENESIS, V20, P1529, DOI 10.1093/carcin/20.8.1529; SASA M, 1994, J SURG ONCOL, V56, P46, DOI 10.1002/jso.2930560110; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Thomson CS, 2001, J EPIDEMIOL COMMUN H, V55, P308, DOI 10.1136/jech.55.5.308; THOR AD, 1992, JNCI-J NATL CANCER I, V84, P845, DOI 10.1093/jnci/84.11.845; van Ravesteyn NT, 2011, CANCER EPIDEM BIOMAR, V20, P112, DOI 10.1158/1055-9965.EPI-10-0944; Vaninetti NM, 2008, MOL CARCINOGEN, V47, P275, DOI 10.1002/mc.20382; Wallace TA, 2011, CARCINOGENESIS, V32, P1107, DOI 10.1093/carcin/bgr066	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57361	10.1371/journal.pone.0057361	http://dx.doi.org/10.1371/journal.pone.0057361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469190	gold, Green Submitted, Green Published			2022-12-27	WOS:000315897100019
J	Kaundun, SS; Bailly, GC; Dale, RP; Hutchings, SJ; McIndoe, E				Kaundun, Shiv Shankhar; Bailly, Geraldine C.; Dale, Richard P.; Hutchings, Sarah-Jane; McIndoe, Eddie			A Novel W1999S Mutation and Non-Target Site Resistance Impact on Acetyl-CoA Carboxylase Inhibiting Herbicides to Varying Degrees in a UK Lolium multiflorum Population	PLOS ONE			English	Article							GRASS ALOPECURUS-MYOSUROIDES; BLACK-GRASS; TARGET-SITE; ACETOLACTATE-SYNTHASE; MULTIPLE RESISTANCE; CONFER RESISTANCE; CROSS-RESISTANCE; GENETIC-CONTROL; COENZYME; RIGIDUM	Background: Acetyl-CoA carboxylase (ACCase) inhibiting herbicides are important products for the post-emergence control of grass weed species in small grain cereal crops. However, the appearance of resistance to ACCase herbicides over time has resulted in limited options for effective weed control of key species such as Lolium spp. In this study, we have used an integrated biological and molecular biology approach to investigate the mechanism of resistance to ACCase herbicides in a Lolium multiflorum Lam. from the UK (UK21). Methodology/Principal Findings: The study revealed a novel tryptophan to serine mutation at ACCase codon position 1999 impacting on ACCase inhibiting herbicides to varying degrees. The W1999S mutation confers dominant resistance to pinoxaden and partially recessive resistance to cycloxydim and sethoxydim. On the other hand, plants containing the W1999S mutation were sensitive to clethodim and tepraloxydim. Additionally population UK21 is characterised by other resistance mechanisms, very likely non non-target site based, affecting several aryloxyphenoxyproprionate (FOP) herbicides but not the practical field rate of pinoxaden. The positive identification of wild type tryptophan and mutant serine alleles at ACCase position 1999 could be readily achieved with an original DNA based derived cleaved amplified polymorphic sequence (dCAPS) assay that uses the same PCR product but two different enzymes for positively identifying the wild type tryptophan and mutant serine alleles identified here. Conclusion/Significance: This paper highlights intrinsic differences between ACCase inhibiting herbicides that could be exploited for controlling ryegrass populations such as UK21 characterised by compound-specific target site and non-target site resistance.	[Kaundun, Shiv Shankhar; Bailly, Geraldine C.; Dale, Richard P.; Hutchings, Sarah-Jane; McIndoe, Eddie] Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England	Syngenta	Kaundun, SS (corresponding author), Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England.	deepak.kaundun@syngenta.com	Kaundun, Shiv/AIB-0473-2022		Syngenta, Jealott's Hill International Research Centre	Syngenta, Jealott's Hill International Research Centre	All authors are employed by Syngenta, Jealott's Hill International Research Centre, the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alarcon-Reverte R, 2008, Commun Agric Appl Biol Sci, V73, P899; Alarcon-Reverte R, 2012, WEED RES IN PRESS; Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Beckie HJ, 2012, WEED SCI, V60, P10, DOI 10.1614/WS-D-11-00110.1; Busi R, 2011, HEREDITY, V106, P817, DOI 10.1038/hdy.2010.124; CHRISTOPHER JT, 1992, PLANT PHYSIOL, V100, P1909, DOI 10.1104/pp.100.4.1909; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2005, WEED RES, V45, P323, DOI 10.1111/j.1365-3180.2005.00467.x; Delye C, 2005, PLANT PHYSIOL, V137, P794, DOI 10.1104/pp.104.046144; Delye C, 2011, WEED RES, V51, P433, DOI 10.1111/j.1365-3180.2011.00864.x; Delye C, 2011, WEED RES, V51, P353, DOI 10.1111/j.1365-3180.2011.00852.x; Delye C, 2010, NEW PHYTOL, V186, P1005, DOI 10.1111/j.1469-8137.2010.03233.x; Devine MD, 1997, PESTIC SCI, V51, P259, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;259::AID-PS644&gt;3.0.CO;2-S; Heap I, 1982, J AUSTR I AGR SCI, V48, P156; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; Herbert D, 1997, PESTIC SCI, V50, P67, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;67::AID-PS552&gt;3.0.CO;2-#; Hofer U, 2006, J PLANT DIS PROTECT, P989; Incledon BJ, 1997, PESTIC BIOCHEM PHYS, V57, P255, DOI 10.1006/pest.1997.2279; Kaundun SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039759; Kaundun SS, 2010, PEST MANAG SCI, V66, P1249, DOI 10.1002/ps.2003; Kaundun SS, 2006, WEED RES, V46, P34, DOI 10.1111/j.1365-3180.2006.00487.x; Kaundun SS, 2008, COMP PINOXADENS RESI; Kaundun SS, 2012, IMPORTANCE NOVEL P10; KONISHI T, 1994, P NATL ACAD SCI USA, V91, P3598, DOI 10.1073/pnas.91.9.3598; Konishi T, 1996, PLANT CELL PHYSL, V37, P2, DOI DOI 10.1093/OXFORDJOURNALS.PCP.A028920; Liu WJ, 2007, P NATL ACAD SCI USA, V104, P3627, DOI 10.1073/pnas.0611572104; Malone J, 2010, SPREAD HERBICIDE RES, P258; Menchari Y, 2008, J APPL ECOL, V45, P939, DOI 10.1111/j.1365-2664.2008.01462.x; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Neve P, 2005, THEOR APPL GENET, V110, P1154, DOI 10.1007/s00122-005-1947-2; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Petit C, 2010, PLANT SCI, V178, P501, DOI 10.1016/j.plantsci.2010.03.007; Petit C, 2010, PEST MANAG SCI, V66, P168, DOI 10.1002/ps.1851; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Preston C, 1996, PESTIC BIOCHEM PHYS, V54, P123, DOI 10.1006/pest.1996.0016; Preston C, 2003, WEED SCI, V51, P4, DOI 10.1614/0043-1745(2003)051[0004:IALOMB]2.0.CO;2; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Scarabel L, 2011, PEST MANAG SCI, V67, P932, DOI 10.1002/ps.2133; SHORROSH BS, 1994, P NATL ACAD SCI USA, V91, P4323, DOI 10.1073/pnas.91.10.4323; Spafford Jacob H, 2002, EXPERIENCE HERBICIDE, P660; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2005, NEW PHYTOL, V167, P787, DOI 10.1111/j.1469-8137.2005.01465.x; Yu Q, 2007, PLANT PHYSIOL, V145, P547, DOI 10.1104/pp.107.105262	45	45	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58012	10.1371/journal.pone.0058012	http://dx.doi.org/10.1371/journal.pone.0058012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469130	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900222
J	Longbottom, D; Livingstone, M; Maley, S; van der Zon, A; Rocchi, M; Wilson, K; Wheelhouse, N; Dagleish, M; Aitchison, K; Wattegedera, S; Nath, M; Entrican, G; Buxton, D				Longbottom, David; Livingstone, Morag; Maley, Stephen; van der Zon, Arjan; Rocchi, Mara; Wilson, Kim; Wheelhouse, Nicholas; Dagleish, Mark; Aitchison, Kevin; Wattegedera, Sean; Nath, Mintu; Entrican, Gary; Buxton, David			Intranasal Infection with Chlamydia abortus Induces Dose-Dependent Latency and Abortion in Sheep	PLOS ONE			English	Article							OVINE ENZOOTIC ABORTION; BLOOD MONONUCLEAR-CELLS; CHLAMYDOPHILA-ABORTUS; PSITTACI INFECTION; PLACENTAL TISSUES; IMMUNE-RESPONSES; PREGNANT SHEEP; PATHOGENESIS; IDENTIFICATION; KINETICS	Background: Latency is a key feature of the animal pathogen Chlamydia abortus, where infection remains inapparent in the non-pregnant animal and only becomes evident during a subsequent pregnancy. Often the first sign that an animal is infected is abortion occurring late in gestation. Despite this, little is understood of the underlying mechanisms that control latency or the recrudescence of infection that occurs during subsequent pregnancy. The aim of this study was to develop an experimental model of latency by mimicking the natural route of infection through the intranasal inoculation of nonpregnant sheep with C. abortus. Methodology/Principal Findings: Three groups of sheep (groups 1, 2 and 3) were experimentally infected with different doses of C. abortus (5x10(3), 5x10(5) and 5x10(7) inclusion forming units (IFU), respectively) prior to mating and monitored over 2 breeding cycles for clinical, microbiological, pathological, immunological and serological outcomes. Two further groups received either negative control inoculum (group 4a,b) or were inoculated subcutaneously on day 70 of gestation with 2x10(6) IFU C. abortus (group 5). Animals in groups 1, 2 and 5 experienced an abortion rate of 50-67%, while only one animal aborted in group 3 and none in group 4a, b. Pathological, microbiological, immunological and serological analyses support the view that the maternal protective immune response is influenced by initial exposure to the bacterium. Conclusions/Significance: The results show that intranasal administration of non-pregnant sheep with a low/medium dose of C. abortus results in a latent infection that leads in a subsequent pregnancy to infection of the placenta and abortion. In contrast a high dose stimulates protective immunity, resulting in a much lower abortion rate. This model will be useful in understanding the mechanisms of infection underlying latency and onset of disease, as well as in the development of novel therapeutics and vaccines for controlling infection.	[Longbottom, David; Livingstone, Morag; Maley, Stephen; Rocchi, Mara; Wilson, Kim; Wheelhouse, Nicholas; Dagleish, Mark; Aitchison, Kevin; Wattegedera, Sean; Entrican, Gary; Buxton, David] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [van der Zon, Arjan] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Nath, Mintu] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland	Moredun Research Institute; Utrecht University; James Hutton Institute	Longbottom, D (corresponding author), Moredun Res Inst, 408 Gilmerton Rd, Edinburgh EH17 7JH, Midlothian, Scotland.	david.longbottom@moredun.ac.uk	Nath, M/J-3777-2013; Longbottom, David/GWZ-8448-2022	Longbottom, David/0000-0003-0086-8443; Wattegedera, Sean/0000-0002-2218-5144; Wheelhouse, Nick/0000-0002-2803-0055	Scottish Government Rural and Environment Science and Analytical Services Division; Biotechnology and Biological Sciences Research Council [BB/E018939/1]; BBSRC [BB/E018939/1] Funding Source: UKRI	Scottish Government Rural and Environment Science and Analytical Services Division; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Scottish Government Rural and Environment Science and Analytical Services Division (http://www.scotland.gov.uk) and by grant number BB/E018939/1 from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken ID., 2007, DIS SHEEP, V4, P105, DOI [10.1002/9780470753316.ch16, DOI 10.1002/9780470753316.CH16]; ANDERSON IE, 1986, VET MICROBIOL, V12, P213, DOI 10.1016/0378-1135(86)90050-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buxton D, 2002, J COMP PATHOL, V127, P133, DOI 10.1053/jcpa.2002.0573; Buxton D, 1996, J COMP PATHOL, V114, P221, DOI 10.1016/S0021-9975(96)80044-2; Buxton D., 2001, Research in Veterinary Science, V70, P22; BUXTON D, 1990, J COMP PATHOL, V102, P221, DOI 10.1016/S0021-9975(08)80127-2; Caro MR, 2009, VET MICROBIOL, V135, P103, DOI 10.1016/j.vetmic.2008.09.029; DAWSON M, 1986, RES VET SCI, V40, P59, DOI 10.1016/S0034-5288(18)30487-9; Entrican G, 2012, COMP IMMUNOL MICROB, V35, P271, DOI 10.1016/j.cimid.2011.12.001; Gutierrez J, 2011, VET MICROBIOL, V147, P119, DOI 10.1016/j.vetmic.2010.06.015; JONES GE, 1988, RES VET SCI, V44, P260, DOI 10.1016/S0034-5288(18)30852-X; Kerr K, 2005, RES VET SCI, V78, P1, DOI 10.1016/j.rvsc.2004.08.004; LITTLEJOHN A I, 1950, Vet Rec, V62, P571; Livingstone M, 2005, CLIN DIAGN LAB IMMUN, V12, P770, DOI 10.1128/CDLI.12.6.770-777.2005; Livingstone M, 2009, VET MICROBIOL, V135, P134, DOI 10.1016/j.vetmic.2008.09.033; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Maley SW, 2009, VET MICROBIOL, V135, P122, DOI 10.1016/j.vetmic.2008.09.031; MCCLENAGHAN M, 1984, INFECT IMMUN, V45, P384, DOI 10.1128/IAI.45.2.384-389.1984; McEWEN A. D., 1951, VET REC, V63, P197; McEWEN A. D., 1951, VET REC, V63, P489; Navarro JA, 2004, VET PATHOL, V41, P498, DOI 10.1354/vp.41-5-498; NOVILLA MN, 1970, AM J VET RES, V31, P1983; Papp JR, 1996, INFECT IMMUN, V64, P1116, DOI 10.1128/IAI.64.4.1116-1125.1996; Rocchi MS, 2009, VET MICROBIOL, V135, P112, DOI 10.1016/j.vetmic.2008.09.030; Sammin DJ, 2006, J COMP PATHOL, V135, P83, DOI 10.1016/j.jcpa.2006.04.005; SPENCER WN, 1983, VET REC, V113, P535; STAMP J. T., 1950, VET REC, V62, P251; Stanley AC, 2004, VACCINE, V22, P3929, DOI 10.1016/j.vaccine.2004.04.022; Stanley AC, 2001, J COMP PATHOL, V125, P262, DOI 10.1053/jcpa.2001.0506; STUDDERT MJ, 1968, RES VET SCI, V9, P57; Wattegedera S, 2008, J REPROD IMMUNOL, V77, P171, DOI 10.1016/j.jri.2007.07.003; Wattegedera S, 2004, VET IMMUNOL IMMUNOP, V102, P67, DOI 10.1016/j.vetimm.2004.06.006; Wattegedera SR, 2010, VET IMMUNOL IMMUNOP, V136, P34, DOI 10.1016/j.vetimm.2010.02.004; WILSMORE AJ, 1984, BRIT VET J, V140, P380, DOI 10.1016/0007-1935(84)90130-1; Wilson K, 2009, VET MICROBIOL, V135, P38, DOI 10.1016/j.vetmic.2008.09.043	36	48	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57950	10.1371/journal.pone.0057950	http://dx.doi.org/10.1371/journal.pone.0057950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469113	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900208
J	Reed, GW; Choi, H; Lee, SY; Lee, M; Kim, Y; Park, H; Lee, J; Zhan, X; Kang, H; Hwang, S; Carroll, M; Cai, Y; Cho, SN; Barry, CE; Via, LE; Kornfeld, H				Reed, George W.; Choi, Hongjo; Lee, So Young; Lee, Myungsun; Kim, Youngran; Park, Hyemi; Lee, Jongseok; Zhan, Xin; Kang, Hyeungseok; Hwang, SooHee; Carroll, Matthew; Cai, Ying; Cho, Sang-Nae; Barry, Clifton E., III; Via, Laura E.; Kornfeld, Hardy			Impact of Diabetes and Smoking on Mortality in Tuberculosis	PLOS ONE			English	Article							TREATMENT OUTCOMES; PULMONARY TUBERCULOSIS; SUSCEPTIBILITY; RISK	Background: Diabetes mellitus is a risk factor for tuberculosis (TB) disease. There is evidence that diabetes also influences TB severity and treatment outcomes but information is incomplete and some published results have been inconsistent. Methods: A longitudinal cohort study was conducted at the National Masan Tuberculosis Hospital in the Republic of Korea. Subjects presenting with a first episode of TB or for retreatment of TB were followed from enrollment through completion of treatment. Demographic, clinical, and microbiological variables were recorded, along with assessment of outcomes. Results were compared in TB patients with and without diabetes or smoking history. Data were adjusted for gender, age, cohort, educational level and alcohol consumption. Results: The combined cohorts comprised 657 subjects. Diabetes was present in 25% and was associated with greater radiographic severity and with recurrent or relapsed TB. Diabetes and cigarette smoking independently increased the risk of death in the first 12 months after enrollment. Estimating the combined impact of diabetes and smoking yielded a hazard ratio of 5.78. Only 20% of diabetic subjects were non-smokers; 54% smoked >= 1 pack daily. In this cohort, the impact of diabetes on mortality was greater in patients younger than 50 years, compared to older patients. Conclusions: In this cohort of Korean patients, diabetes exacerbated the severity of TB disease. Diabetic subjects who smoked >= 1 pack of cigarettes daily were at particularly high risk of death from TB. Strategies to improve TB outcomes could productively focus resources for patient education and TB prevention on the vulnerable population of younger diabetics, particularly those who also smoke.	[Reed, George W.] Univ Massachusetts, Sch Med, Dept Prevent & Behav Med, Worcester, MA USA; [Choi, Hongjo; Lee, So Young; Lee, Myungsun; Kim, Youngran; Park, Hyemi; Lee, Jongseok; Cho, Sang-Nae] Int TB Res Ctr, Chang Won, South Korea; [Cho, Sang-Nae] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Zhan, Xin] Univ Massachusetts, Sch Med, Informat Serv Dept, Worcester, MA USA; [Kang, Hyeungseok; Hwang, SooHee] Natl Masan TB Hosp, Chang Won, South Korea; [Carroll, Matthew; Cai, Ying; Barry, Clifton E., III; Via, Laura E.] NIAID, TB Res Sect, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Yonsei University; Yonsei University Health System; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Massachusetts System; University of Massachusetts Worcester	Kornfeld, H (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	hardy.kornfeld@umassmed.edu	Via, Laura/AAD-3917-2021; Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Kornfeld, Hardy/AAS-2903-2021	Via, Laura/0000-0001-6074-9521; Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; 	University of Massachusetts Medical School Office of Global Health; Intramural Research Division of the National Institute of Allergy and Infectious Diseases (National Institutes of Health); Korean Ministry of Health and Welfare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001067] Funding Source: NIH RePORTER	University of Massachusetts Medical School Office of Global Health; Intramural Research Division of the National Institute of Allergy and Infectious Diseases (National Institutes of Health); Korean Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by the University of Massachusetts Medical School Office of Global Health, the Intramural Research Division of the National Institute of Allergy and Infectious Diseases (National Institutes of Health), and the Korean Ministry of Health and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baker MA, 2012, CLIN INFECT DIS, V53, P818; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Cleveland WS, 1993, VISUALIZING DATA, P86; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Jee SH, 2009, AM J EPIDEMIOL, V170, P1478, DOI 10.1093/aje/kwp308; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; LONG ER, 1952, AM REV TUBERC PULM, V65, P494; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Menzies D, 2011, INDIAN J MED RES, V133, P257; Oursler KK, 2002, CLIN INFECT DIS, V34, P752, DOI 10.1086/338784; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Wang CS, 2008, INFECTION, V36, P335, DOI 10.1007/s15010-008-7199-8; Wang CS, 2009, EPIDEMIOL INFECT, V137, P203, DOI 10.1017/S0950268808000782; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; World Health Organization, 2011, WHO PUBL; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x	25	69	73	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58044	10.1371/journal.pone.0058044	http://dx.doi.org/10.1371/journal.pone.0058044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469139	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900230
J	Webb, JS; Nikolakakis, KC; Willett, JLE; Aoki, SK; Hayes, CS; Low, DA				Webb, Julia S.; Nikolakakis, Kiel C.; Willett, Julia L. E.; Aoki, Stephanie K.; Hayes, Christopher S.; Low, David A.			Delivery of CdiA Nuclease Toxins into Target Cells during Contact-Dependent Growth Inhibition	PLOS ONE			English	Article							OUTER-MEMBRANE BIOGENESIS; ESCHERICHIA-COLI; 2-PARTNER SECRETION; PHASE VARIATION; OMP85 FAMILY; PROTEINS; ADHESIN; YAET; IDENTIFICATION; MATURATION	Bacterial contact-dependent growth inhibition (CDI) is mediated by the CdiB/CdiA family of two-partner secretion proteins. CDI systems deploy a variety of distinct toxins, which are contained within the polymorphic C-terminal region (CdiA-CT) of CdiA proteins. Several CdiA-CTs are nucleases, suggesting that the toxins are transported into the target cell cytoplasm to interact with their substrates. To analyze CdiA transfer to target bacteria, we used the CDI system of uropathogenic Escherichia coli 536 (UPEC536) as a model. Antibodies recognizing the amino- and carboxyl-termini of CdiA(UPEC536) were used to visualize transfer of CdiA from CDIUPEC536+ inhibitor cells to target cells using fluorescence microscopy. The results indicate that the entire CdiA(UPEC536) protein is deposited onto the surface of target bacteria. CdiA(UPEC536) transfer to bamA101 mutants is reduced, consistent with low expression of the CDI receptor BamA on these cells. Notably, our results indicate that the C-terminal CdiA-CT toxin region of CdiA(UPEC536) is translocated into target cells, but the N-terminal region remains at the cell surface based on protease sensitivity. These results suggest that the CdiA-CT toxin domain is cleaved from CdiA(UPEC536) prior to translocation. Delivery of a heterologous Dickeya dadantii CdiA-CT toxin, which has DNase activity, was also visualized. Following incubation with CDI+ inhibitor cells targets became anucleate, showing that the D. dadantii CdiA-CT was delivered intracellularly. Together, these results demonstrate that diverse CDI toxins are efficiently translocated across target cell envelopes.	[Webb, Julia S.; Willett, Julia L. E.; Aoki, Stephanie K.; Hayes, Christopher S.; Low, David A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Nikolakakis, Kiel C.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.; Low, David A.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Low, DA (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	david.low@lifesci.ucsb.edu	Willett, Julia/AAP-8740-2021	Willett, Julia/0000-0002-0524-8289	National Institutes of Health [GM078634, U54AI065359]; National Science Foundation [0642052]; TriCounty Blood Bank of Santa Barbara; NSF Graduate Research fellowship [DGE-1144085]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); TriCounty Blood Bank of Santa Barbara; NSF Graduate Research fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM078634 (to C.S.H.) and U54AI065359 (to D.A.L.) from the National Institutes of Health, and grant 0642052 (to D.A.L.) from the National Science Foundation. J.S.W. is supported by a grant from the TriCounty Blood Bank of Santa Barbara, and J.L.E.W. is supported by NSF Graduate Research fellowship DGE-1144085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Aiyar A, 1996, Methods Mol Biol, V57, P177; Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BASSFORD PJ, 1979, J BACTERIOL, V139, P19, DOI 10.1128/JB.139.1.19-31.1979; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Bonsor DA, 2008, BIOCHEM SOC T, V36, P1409, DOI 10.1042/BST0361409; BRAATEN BA, 1994, CELL, V76, P577, DOI 10.1016/0092-8674(94)90120-1; Buscher AZ, 2006, MOL MICROBIOL, V61, P470, DOI 10.1111/j.1365-2958.2006.05236.x; Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Diner EJ, 2012, GENE DEV, V26, P515, DOI 10.1101/gad.182345.111; Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; Fuchs S, 1999, MICROB PATHOGENESIS, V27, P13, DOI 10.1006/mpat.1999.0279; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Grass S, 2000, MOL MICROBIOL, V36, P55, DOI 10.1046/j.1365-2958.2000.01812.x; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; KNAPP S, 1986, J BACTERIOL, V168, P22, DOI 10.1128/jb.168.1.22-30.1986; Mazar J, 2006, MOL MICROBIOL, V62, P641, DOI 10.1111/j.1365-2958.2006.05392.x; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nikolakakis K, 2012, MOL MICROBIOL; NOU XW, 1995, EMBO J, V14, P5785, DOI 10.1002/j.1460-2075.1995.tb00267.x; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; ZHAO S, 1993, J BACTERIOL, V175, P2799, DOI 10.1128/JB.175.10.2799-2808.1993	40	59	61	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57609	10.1371/journal.pone.0057609	http://dx.doi.org/10.1371/journal.pone.0057609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469034	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900133
J	Wijesinghe, R; Solomon, SG; Camp, AJ				Wijesinghe, Rajiv; Solomon, Samuel G.; Camp, Aaron J.			Noise Normalizes Firing Output of Mouse Lateral Geniculate Nucleus Neurons	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CA2+ CHANNELS; IN-VITRO; CALCIUM CHANNELS; THALAMIC NEURONS; GAIN MODULATION; RELAY NEURONS; CELLS; BURST; INHIBITION	The output of individual neurons is dependent on both synaptic and intrinsic membrane properties. While it is clear that the response of an individual neuron can be facilitated or inhibited based on the summation of its constituent synaptic inputs, it is not clear whether subthreshold activity, (e.g. synaptic "noise"-fluctuations that do not change the mean membrane potential) also serve a function in the control of neuronal output. Here we studied this by making whole-cell patch-clamp recordings from 29 mouse thalamocortical relay (TC) neurons. For each neuron we measured neuronal gain in response to either injection of current noise, or activation of the metabotropic glutamate receptor-mediated cortical feedback network (synaptic noise). As expected, injection of current noise via the recording pipette induces shifts in neuronal gain that are dependent on the amplitude of current noise, such that larger shifts in gain are observed in response to larger amplitude noise injections. Importantly we show that shifts in neuronal gain are also dependent on the intrinsic sensitivity of the neuron tested, such that the gain of intrinsically sensitive neurons is attenuated divisively in response to current noise, while the gain of insensitive neurons is facilitated multiplicatively by injection of current noise-effectively normalizing the output of the dLGN as a whole. In contrast, when the cortical feedback network was activated, only multiplicative gain changes were observed. These network activation-dependent changes were associated with reductions in the slow after-hyperpolarization (sAHP), and were mediated at least in part, by T-type calcium channels. Together, this suggests that TC neurons have the machinery necessary to compute multiple output solutions to a given set of stimuli depending on the current level of network stimulation.	[Camp, Aaron J.] Univ Sydney, Sydney Med Sch, Sch Med Sci, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Camp, AJ (corresponding author), Univ Sydney, Sydney Med Sch, Sch Med Sci, Sydney, NSW 2006, Australia.	Aaron.Camp@sydney.edu.au		Wijesinghe, Rajiv/0000-0002-6215-6719; Solomon, Samuel/0000-0001-5321-0288	National Health and Medical Research Council of Australia [457337, 511967]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Grants 457337 and 511967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camp AJ, 2010, NEUROSCIENCE, V170, P348, DOI 10.1016/j.neuroscience.2010.06.040; Camp AJ, 2009, J NEUROSCI, V29, P5009, DOI 10.1523/JNEUROSCI.0219-09.2009; Camp AJ, 2006, J NEUROPHYSIOL, V95, P3208, DOI 10.1152/jn.01001.2005; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; COULTER DA, 1989, J PHYSIOL-LONDON, V414, P587, DOI 10.1113/jphysiol.1989.sp017705; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Crunelli V, 2005, J PHYSIOL-LONDON, V562, P121, DOI 10.1113/jphysiol.2004.076273; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; Crunelli V, 2006, CELL CALCIUM, V40, P175, DOI 10.1016/j.ceca.2006.04.022; Denning KS, 2005, J NEUROSCI, V25, P3531, DOI 10.1523/JNEUROSCI.4417-04.2005; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Erisir A, 1997, P NATL ACAD SCI USA, V94, P1517, DOI 10.1073/pnas.94.4.1517; Flores-Herr N, 2001, J NEUROSCI, V21, P4852, DOI 10.1523/JNEUROSCI.21-13-04852.2001; Godwin DW, 1996, J NEUROSCI, V16, P8181; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Govindaiah G, 2006, J NEUROSCI, V26, P13443, DOI 10.1523/JNEUROSCI.3578-06.2006; Guido W, 1998, VISUAL NEUROSCI, V15, P231, DOI 10.1017/S0952523898152033; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; Gutierrez C, 2001, J NEUROSCI, V21, P1022, DOI 10.1523/JNEUROSCI.21-03-01022.2001; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; Higgs MH, 2006, J NEUROSCI, V26, P8787, DOI 10.1523/JNEUROSCI.1792-06.2006; Hobai IA, 2000, AM J PHYSIOL-HEART C, V279, pH692, DOI 10.1152/ajpheart.2000.279.2.H692; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; Isope P, 2012, CEREBELLUM, V11, P651, DOI 10.1007/s12311-010-0195-4; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; JOHNSTON AR, 1994, J PHYSIOL-LONDON, V481, P61, DOI 10.1113/jphysiol.1994.sp020419; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Rivadulla C, 2002, J NEUROSCI, V22, P2956, DOI 10.1523/JNEUROSCI.22-07-02956.2002; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Uebachs M, 2006, J PHYSIOL-LONDON, V571, P519, DOI 10.1113/jphysiol.2005.103614; Van Horn SC, 2004, J COMP NEUROL, V475, P406, DOI 10.1002/cne.20187; Wang X, 2007, NEURON, V55, P465, DOI 10.1016/j.neuron.2007.06.039; Williams SR, 1996, J PHYSIOL-LONDON, V490, P129, DOI 10.1113/jphysiol.1996.sp021131; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591; Wolfart J, 2002, J NEUROSCI, V22, P3404; Yanai Y, 2006, BJU INT, V97, P182, DOI 10.1111/j.1464-410X.2006.05894.x; Zhan XJ, 1999, J NEUROPHYSIOL, V81, P2360, DOI 10.1152/jn.1999.81.5.2360	48	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57961	10.1371/journal.pone.0057961	http://dx.doi.org/10.1371/journal.pone.0057961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469120	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900213
J	Baker, NE				Baker, Nicholas E.			Developmental Regulation of Nucleolus Size during Drosophila Eye Differentiation	PLOS ONE			English	Article							POLARITY GENE HEDGEHOG; CELL-CYCLE PROGRESSION; MORPHOGENETIC FURROW; PATTERN-FORMATION; PRONEURAL GENE; PROLIFERATION; GROWTH; PROTEIN; DPP; COORDINATION	When cell cycle withdrawal accompanies terminal differentiation, biosynthesis and cellular growth are likely to change also. In this study, nucleolus size was monitored during cell fate specification in the Drosophila eye imaginal disc using fibrillarin antibody labeling. Nucleolus size is an indicator of ribosome biogenesis and can correlate with cellular growth rate. Nucleolar size was reduced significantly during cell fate specification and differentiation, predominantly as eye disc cells entered a cell cycle arrest that preceded cell fate specification. This reduction in nucleolus size required Dpp and Hh signaling. A transient enlargement of the nucleolus accompanied cell division in the Second Mitotic Wave. Nucleoli continued to diminish in postmitotic cells following fate specification. These results suggest that cellular growth is regulated early in the transition from proliferating progenitor cells to terminal cell fate specification, contemporary with regulation of the cell cycle, and requiring the same extracellular signals.	[Baker, Nicholas E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	nbaker@aecom.yu.edu			NIH [GM047892, EY021614]; Chinese Academy of Sciences; Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences; NATIONAL EYE INSTITUTE [R01EY021614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by grants from the NIH (GM047892 and EY021614), by a Visiting Professorship from the Chinese Academy of Sciences, and by an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Baker NE, 2001, CELL, V104, P699, DOI 10.1016/S0092-8674(02)06076-2; Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Baker NE, 2007, CURR OPIN GENET DEV, V17, P287, DOI 10.1016/j.gde.2007.05.005; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Cagan R, 2009, CURR TOP DEV BIOL, V89, P115, DOI 10.1016/S0070-2153(09)89005-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V; Dominguez M, 1999, DEVELOPMENT, V126, P2345; Escudero LM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-13; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Firth LC, 2005, DEV CELL, V8, P541, DOI 10.1016/j.devcel.2005.01.017; Firth LC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-28; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Greenwood S, 1999, DEVELOPMENT, V126, P5795; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Horsfield J, 1998, DEVELOPMENT, V125, P5069; Icreverzi A, 2012, CELL CYCLE, V11, P554, DOI 10.4161/cc.11.3.19062; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Killip LE, 2012, DEV BIOL, V371, P191, DOI 10.1016/j.ydbio.2012.08.020; Kumar JP, 2011, DEV NEUROBIOL, V71, P1133, DOI 10.1002/dneu.20921; Lopes CS, 2010, DEV BIOL, V339, P78, DOI 10.1016/j.ydbio.2009.12.020; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Navarro FJ, 2012, CURR OPIN CELL BIOL, V24, P833, DOI 10.1016/j.ceb.2012.10.015; Neufeld TP, 2002, RES PRO CEL, V37, P107; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Penton A, 1997, SCIENCE, V275, P203, DOI 10.1126/science.275.5297.203; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; RAFTERY LA, 1995, GENETICS, V139, P241; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; SEKELSKY JJ, 1995, GENETICS, V139, P1347; SELLECK SB, 1992, NATURE, V355, P253, DOI 10.1038/355253a0; Slavov N, 2012, MOL BIOL CELL, V23, P1986, DOI 10.1091/mbc.E11-11-0961; THOMAS BJ, 1994, CELL, V77, P1003, DOI 10.1016/0092-8674(94)90440-5; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; TOMLINSON A, 1985, J EMBRYOL EXP MORPH, V89, P313; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Wolff Tanya, 1993, P1277; Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145; XU T, 1993, DEVELOPMENT, V117, P1223; Yang LH, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-8; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669	54	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58266	10.1371/journal.pone.0058266	http://dx.doi.org/10.1371/journal.pone.0058266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472166	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900112
J	Kato-Maeda, M; Ho, C; Passarelli, B; Banaei, N; Grinsdale, J; Flores, L; Anderson, J; Murray, M; Rose, G; Kawamura, LM; Pourmand, N; Tariq, MA; Gagneux, S; Hopewell, PC				Kato-Maeda, Midori; Ho, Christine; Passarelli, Ben; Banaei, Niaz; Grinsdale, Jennifer; Flores, Laura; Anderson, Jillian; Murray, Megan; Rose, Graham; Kawamura, L. Masae; Pourmand, Nader; Tariq, Muhammad A.; Gagneux, Sebastien; Hopewell, Philip C.			Use of Whole Genome Sequencing to Determine the Microevolution of Mycobacterium tuberculosis during an Outbreak	PLOS ONE			English	Article							SAN-FRANCISCO; UNITED-STATES; SURVEILLANCE	Rationale: Current tools available to study the molecular epidemiology of tuberculosis do not provide information about the directionality and sequence of transmission for tuberculosis cases occurring over a short period of time, such as during an outbreak. Recently, whole genome sequencing has been used to study molecular epidemiology of Mycobacterium tuberculosis over short time periods. Objective: To describe the microevolution of M. tuberculosis during an outbreak caused by one drug-susceptible strain. Method and Measurements: We included 9 patients with tuberculosis diagnosed during a period of 22 months, from a population-based study of the molecular epidemiology in San Francisco. Whole genome sequencing was performed using Illumina's sequencing by synthesis technology. A custom program written in Python was used to determine single nucleotide polymorphisms which were confirmed by PCR product Sanger sequencing. Main results: We obtained an average of 95.7% (94.1-96.9%) coverage for each isolate and an average fold read depth of 73 (1 to 250). We found 7 single nucleotide polymorphisms among the 9 isolates. The single nucleotide polymorphisms data confirmed all except one known epidemiological link. The outbreak strain resulted in 5 bacterial variants originating from the index case A1 with 0-2 mutations per transmission event that resulted in a secondary case. Conclusions: Whole genome sequencing analysis from a recent outbreak of tuberculosis enabled us to identify microevolutionary events observable during transmission, to determine 0-2 single nucleotide polymorphisms per transmission event that resulted in a secondary case, and to identify new epidemiologic links in the chain of transmission.	[Kato-Maeda, Midori; Flores, Laura; Anderson, Jillian; Hopewell, Philip C.] Univ Calif San Francisco, Curry Int TB Ctr, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Ho, Christine; Grinsdale, Jennifer; Kawamura, L. Masae] San Francisco Dept Publ Hlth, TB Control Sect, San Francisco, CA USA; [Ho, Christine] Ctr Dis Control & Prevent CDC, Div TB Eliminat, Field Serv & Evaluat Branch CDC DTBE FSEB, Atlanta, GA USA; [Passarelli, Ben] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA; [Banaei, Niaz] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rose, Graham] Natl Inst Med Res, MRC, London NW7 1AA, England; [Pourmand, Nader; Tariq, Muhammad A.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland	University of California System; University of California San Francisco; San Francisco Department of Public Health; Centers for Disease Control & Prevention - USA; Stanford University; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; MRC National Institute for Medical Research; University of California System; University of California Santa Cruz; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Kato-Maeda, M (corresponding author), Univ Calif San Francisco, Curry Int TB Ctr, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	midori.kato-maeda@ucsf.edu	Tariq, Muhammad/ABC-2204-2020; Gagneux, Sebastien/ABE-7909-2020	Tariq, Muhammad/0000-0002-8239-9339; Rose, Graham/0000-0002-5097-5426; Pourmand, Nader/0000-0003-0251-9060; Banaei, Niaz/0000-0001-8501-3000; Gagneux, Sebastien/0000-0001-7783-9048	National Institutes of Health [AI034238, P01-35HG000205]; Medical Research Council UK [U117588500]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grants numbers AI034238 and P01-35HG000205) and the Medical Research Council UK (U117588500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDC was not engaged in human subject research as CDC staff provided technical support that did not involve possession or analysis of identifiable data.	Beaulieu AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015120; Bifani P, 2009, METHODS MOL BIOL, V551, P173, DOI 10.1007/978-1-60327-999-4_14; Cattamanchi A, 2006, INT J TUBERC LUNG D, V10, P297; Chaves F, 1996, J CLIN MICROBIOL, V34, P1118, DOI 10.1128/JCM.34.5.1118-1123.1996; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Ghosh S, 2012, INFECT GENET EVOL, V12, P782, DOI 10.1016/j.meegid.2011.10.013; Jombart T, HEREDITY, V106, P383; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Mitruka K, 2011, EMERG INFECT DIS, V17, P425, DOI 10.3201/eid1703.101550; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pio A, 2009, INT J TUBERC LUNG D, V13, P670; Reitmanova S, 2009, LANCET INFECT DIS, V9, P584, DOI 10.1016/S1473-3099(09)70237-3; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Schurch AC, 2010, INFECT GENET EVOL, V10, P108, DOI 10.1016/j.meegid.2009.10.002; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Starck J, 2004, MICROBIOL-SGM, V150, P3821, DOI 10.1099/mic.0.27284-0; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Walker TM, 2012, LANCET INFECT DIS; Wu BH, 2010, J BIOL CHEM, V285, P40081, DOI 10.1074/jbc.M110.184457	29	62	63	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58235	10.1371/journal.pone.0058235	http://dx.doi.org/10.1371/journal.pone.0058235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472164	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900110
J	Lee, HJ; Park, S; Kim, CI; Choi, DW; Lee, JS; Oh, SM; Cho, E; Park, HK; Kwon, KI; Oh, SW				Lee, Hae-Jeung; Park, Sangshin; Kim, Cho-il; Choi, Doo-won; Lee, Jung Sun; Oh, Sun Min; Cho, Eunyoung; Park, Hye Kyung; Kwon, Kwang-il; Oh, Sang Woo			The Association between Disturbed Eating Behavior and Socioeconomic Status: The Online Korean Adolescent Panel Survey (OnKAPS)	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; BODY-IMAGE; DISORDER SYMPTOMS; ATTITUDES TEST; PREVALENCE; GIRLS; OBESITY; RISK; BOYS	Background: A limited amount of research, primarily conducted in Western countries, has suggested that higher socioeconomic status (SES) is associated with higher risk of eating disorders (EDs). However, little is known about this association in Asian countries. We examined the association of SES with disturbed eating behavior (DEB) and related factors in Korean adolescents. Subjects: A nationwide online panel survey was conducted in a sample of adolescents (n = 6,943, 49.9% girls). DEB was measured with the 26-item Eating Attitudes Test (EAT-26). Participants who scored >= 20 on the EAT-26 were considered to have DEB. Participants' SES was determined based on self-reported household economic status. Results: The prevalence of DEB was 12.7%: 10.5% among boys and 14.8% among girls. Both boys and girls with DEB were more likely to perceive themselves as obese, experience higher levels of stress, and have lower academic achievement. The risk for DEB was significantly higher in boys of higher SES than in those of middle SES (OR = 1.45, 95%CI = 1.05-1.99 for high SES; OR = 5.16, 95%CI: 3.50-7.61 for highest SES). Among girls, higher risk of DEB was associated with the highest and lowest SES (OR = 1.52, 95%CI: 1.13-2.06 for lowest SES; OR = 2.22, 95%CI: 1.34-3.68 for highest SES). Conclusions: Despite the lower prevalence of obesity in Korea compared with Western countries, the prevalence of DEB in Korean adolescents was high, especially among girls. Moreover, the association between SES and DEB followed a U-shaped curve for girls and a J-shaped curve for boys.	[Lee, Hae-Jeung; Cho, Eunyoung] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Lee, Hae-Jeung; Cho, Eunyoung] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Lee, Hae-Jeung; Kim, Cho-il] Korea Hlth Ind Dev Inst, Ctr Nutr Policy & Promot, Osong, Chungcheongbuk, South Korea; [Park, Sangshin] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA; [Choi, Doo-won] Embrain Co Ltd, Seoul, South Korea; [Lee, Jung Sun] Univ Georgia, Dept Food & Nutr, Athens, GA 30602 USA; [Oh, Sun Min] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Hye Kyung; Kwon, Kwang-il] Korea Food & Drug Adm, Nutr Policy Div, Osong, Chungcheongbuk, South Korea; [Oh, Sang Woo] Dongguk Univ, Ilsan Hosp, Ctr Obes Metab & Nutr, Dept Family Med, Goyang Si, Gyeonggi Do, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Texas A&M University System; Texas A&M University College Station; University System of Georgia; University of Georgia; Yonsei University; Yonsei University Health System; Dongguk University; NHIS Ilsan Hospital	Oh, SW (corresponding author), Dongguk Univ, Ilsan Hosp, Ctr Obes Metab & Nutr, Dept Family Med, Goyang Si, Gyeonggi Do, South Korea.	osw6021@yahoo.co.kr	Cho, Eunyoung/AAV-4469-2020; Park, Sangshin/K-6889-2014; Kim, Cho-il/B-5961-2011	Cho, Eunyoung/0000-0001-6594-2582; Park, Sangshin/0000-0003-2407-0962; Oh, Sang Woo/0000-0002-5623-6720; Lee, Hae-Jeung/0000-0001-8353-3619	Korea Food & Drug Administration [09082KFDA904]	Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant (09082KFDA904) from Korea Food & Drug Administration in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, J ADOLESCENT HEALTH, V44, P206; [Anonymous], 2008, INT AS PAC REG COMP; BARTELS LM, 1999, POLITICAL ANAL, V0008; Chisuwa N, 2010, APPETITE, V54, P5, DOI 10.1016/j.appet.2009.11.008; Choi JH, 1998, KOREAN J CHILD ADOL, V9, P91; Clinton JD, 2001, PANEL BIAS ATTRITION; Crisp AH, 1976, COMMON IS ANOREXIA N; D'Souza CM, 2005, J ADOLESCENT HEALTH, V36, P208, DOI 10.1016/j.jadohealth.2004.01.014; Darby A, 2007, INT J OBESITY, V31, P876, DOI 10.1038/sj.ijo.0803501; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; DeLeel ML, 2009, PSYCHOL SCHOOLS, V46, P767, DOI 10.1002/pits.20415; Dorian BJ, 1999, PSYCHIAT ANN, V29, P187, DOI 10.3928/0048-5713-19990401-05; Dotti A, 1998, Eat Weight Disord, V3, P188; DOYLE J, 2000, ANOREXIA NERVOSA REL, P41; Fan YO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-314; FOX KC, 1976, NEW ZEAL MED J, V84, P309; Galesic M, 2009, PUBLIC OPIN QUART, V73, P349, DOI 10.1093/poq/nfp031; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Gibbons P, 2001, NUTR NOTEWORTHY, V4; Haines J, 2006, HEALTH EDUC RES, V21, P770, DOI 10.1093/her/cyl094; Haines J, 2011, J SCHOOL HEALTH, V81, P530, DOI 10.1111/j.1746-1561.2011.00623.x; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; HOEK HW, 1995, EATING DISORDERS OBE, P207; Jones JM, 2001, CAN MED ASSOC J, V165, P547; Korea CDC, 2009, 2009 KOR NAT HLTH NU; Makino Mariko, 2004, MedGenMed, V6, P49; Miotto P, 2003, PSYCHIAT RES, V119, P145, DOI 10.1016/s0165-1781(03)00128-8; Moya T, 2006, J ADOLESCENCE, V29, P313, DOI 10.1016/j.adolescence.2005.05.006; Muise AM, 2003, J ADOLESCENT HEALTH, V33, P427, DOI 10.1016/S1054-139X(03)00060-0; Neumark-Sztainer D, 1999, PREV MED, V28, P40, DOI 10.1006/pmed.1998.0373; Palma-Coca O, 2011, J ADOLESCENT HLTH OF; Power Yuri, 2008, Eat Disord, V16, P136, DOI 10.1080/10640260801887261; Preti A, 2007, AUST NZ J PSYCHIAT, V41, P525, DOI 10.1080/00048670701332292; Rogers L, 1997, INT J EAT DISORDER, V22, P15, DOI 10.1002/(SICI)1098-108X(199707)22:1&lt;15::AID-EAT2&gt;3.0.CO;2-5; Rosen DS, 2010, PEDIATRICS, V126, P1240, DOI 10.1542/peds.2010-2821; STORY M, 1995, INT J EAT DISORDER, V18, P173, DOI 10.1002/1098-108X(199509)18:2&lt;173::AID-EAT2260180210&gt;3.0.CO;2-Q; Striegel-Moore Rh, 2007, RISK FACTORS EATING; Tam CK, 2007, J PAEDIATR CHILD H, V43, P811, DOI 10.1111/j.1440-1754.2007.01195.x; Thomas CL, 2002, INT J EAT DISORDER, V31, P92, DOI 10.1002/eat.10000; Thompson JK, 2002, BODY IMAGE EATING DI; Tsai MR, 2011, ASIA PAC J CLIN NUTR, V20, P196; Wardle J, 2001, J EPIDEMIOL COMMUN H, V55, P185, DOI 10.1136/jech.55.3.185; Wassenaar D, 2000, EUR EAT DISORD REV, V8, P225, DOI 10.1002/(SICI)1099-0968(200005)8:3<225::AID-ERV324>3.0.CO;2-P; WILLIAMS P, 1982, PSYCHOL MED, V12, P431, DOI 10.1017/S003329170004678X; Williams R, 2012, SOCIAL PSYCHIAT PSYC, P1; Wong YC, 2011, J AM COLL NUTR, V30, P126, DOI 10.1080/07315724.2011.10719951; Yang SJ, 2010, YONSEI MED J, V51, P302, DOI 10.3349/ymj.2010.51.3.302; 문진수, 2008, Clinical and Experimental Pediatrics, V51, P1	48	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57880	10.1371/journal.pone.0057880	http://dx.doi.org/10.1371/journal.pone.0057880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472117	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900057
J	Longo, G; Trovato, M; Mazzei, V; Ferrante, M; Conti, GO				Longo, Guglielmo; Trovato, Michelanna; Mazzei, Veronica; Ferrante, Margherita; Conti, Gea Oliveri			Ligia italica (Isopoda, Oniscidea) as Bioindicator of Mercury Pollution of Marine Rocky Coasts	PLOS ONE			English	Article							GULF-OF-TRIESTE; PORCELLIO-SCABER; HEAVY-METALS; HEPATOPANCREAS; CONTAMINATION; BIOMARKERS; BIOACCUMULATION; ULTRASTRUCTURE; LOCALIZATION; INDICATORS	In this study, we evaluated the possible role of Ligia italica as a bioindicator for the monitoring of heavy metals pollution in the suppralittoral zone of marine rocky coasts. Between 2004 and 2011 specimens of L. italica were collected along the Eastern Sicilian coasts from sites known for their high pollution levels as they are near to an area where in September 2001 a refinery plant discharged into the sea some waste containing Hg. Other specimens were collected from the Vendicari Natural Reserve located about 30 miles from the polluted sites and used as control area. On a consistent number of animals, the concentration in toto of As, Cd, Cr, Hg, Ni, Pb, V, was determined by Atomic Absorption Spectrometry. On other animals, investigations were carried out in order to check for ultrastructural alterations of the hepatopancreas, that is the main metals storage organ in isopods. Results revealed the presence, in the animals collected in 2004 from the polluted sites, of considerable concentrations of Hg and of lower concentrations of other metals such as As, Pb and V. The Hg bioaccumulation resulted in remarkable ultrastructural alterations of the two cellular types (B and S cells) in the epithelium of the hepatopancreas. Surprisingly, a moderate amount of Hg was also found in specimens collected in 2004 from the Vendicari Natural Reserve, proving that the Hg pollution can also spread many miles away. Animals collected from the polluted sites in the following years showed a progressively decreasing Hg content, reaching very low levels in those from the last sampling. Also, the ultrastructural alterations found in the hepatopancreas of the animals from the last sample were quite irrelevant. In conclusion, Ligia italica can represent a good bioindicator and the ultrastructure of the hepatopancreas could be used as ultrastructural biomarker of heavy metals pollution in the supralittoral zones.	[Longo, Guglielmo; Trovato, Michelanna; Mazzei, Veronica] Univ Catania, Dipartimento Sci Biol Geol & Ambientali, Catania, Italy; [Ferrante, Margherita; Conti, Gea Oliveri] Univ Catania, Dipartimento Anat Biol & Genet Med Legale Neurosc, Catania, Italy	University of Catania; University of Catania	Ferrante, M (corresponding author), Univ Catania, Dipartimento Anat Biol & Genet Med Legale Neurosc, Catania, Italy.	marfer@unict.it	Oliveri Conti, Gea/N-4034-2016; Ferrante, Margherita/B-2781-2011	Ferrante, Margherita/0000-0001-7596-2464; Oliveri Conti, Gea/0000-0003-1857-8612				ANDERSEN JT, 1988, AQUAT TOXICOL, V13, P309; [Anonymous], 1987, ENVIRON HEALTH PERSP, V74, P3; Bazairi H, 2010, MEDITERRANEAN SEA BI, P1; Belashov E, 1998, METAL IONS BIOL MED, V5, P317; Besse G, 1976, THESIS U POITIERS; Bianca S, 2003, REPROD TOXICOL, V17, P539, DOI 10.1016/S0890-6238(03)00099-6; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bianchi Fabrizio, 2004, Epidemiol Prev, V28, P87; Boero F, 2003, STATE KNOWLEDGE MARI; Braeckman B, 1999, TISSUE CELL, V31, P223, DOI 10.1054/tice.1999.0021; Carefoot Thomas H., 1995, Crustacean Issues, V9, P47; CLIFFORD B, 1971, J MORPHOL, V135, P335, DOI 10.1002/jmor.1051350307; Conti GO, 2012, B ENVIRON CONTAM TOX, V88, P946, DOI 10.1007/s00128-012-0611-1; Copat C, 2012, ECOTOX ENVIRON SAFE, V86, P31, DOI 10.1016/j.ecoenv.2012.09.006; Copat C, 2012, J ENVIRON MONITOR, V14, P187, DOI 10.1039/c1em10575b; Covelli S, 2001, APPL GEOCHEM, V16, P541, DOI 10.1016/S0883-2927(00)00042-1; DALLINGER R, 1992, OECOLOGIA, V89, P32, DOI 10.1007/BF00319012; De Domenico E, 2011, AQUAT TOXICOL, V105, P688, DOI 10.1016/j.aquatox.2011.08.026; Di Leonardo R, 2007, SCI TOTAL ENVIRON, V388, P168, DOI 10.1016/j.scitotenv.2007.08.009; Faganeli J, 2003, SCI TOTAL ENVIRON, V304, P315, DOI 10.1016/S0048-9697(02)00578-8; Fitzgerald WF, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P107; Hopkin S.P., 1989, MONIT ZOOL ITAL MONO, V4, P477; HOPKIN SP, 1986, ENVIRON POLLUT B, V11, P271, DOI 10.1016/0143-148X(86)90045-5; Hunsaker CN, 1990, EPA6003060; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; ISERENTANT R, 1976, Memoires de la Societe Royale de Botanique de Belgique, V7, P15; Kohler HR, 1996, APPL SOIL ECOL, V3, P1, DOI 10.1016/0929-1393(95)00073-9; Kouba A, 2010, WATER AIR SOIL POLL, V211, P5, DOI 10.1007/s11270-009-0273-8; Marigomez I, 1996, ARCH ENVIRON CON TOX, V31, P54, DOI 10.1007/BF00203907; Martin M.H., 1982, BIOL MONITORING HEAV; Mazzariol S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019417; Nicosia E, 2007, ATT GIORN GEOGR RISC; Paoletti MG, 1999, AGR ECOSYST ENVIRON, V74, P157, DOI 10.1016/S0167-8809(99)00035-3; RAES H, 1991, PROG HISTOCHEM CYTOC, V23, P316; Ramistella EM, 1990, B ACC GIOENIA SCI NA, V23, P437; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; SATO T, 1973, STAIN TECHNOL, V48, P223, DOI 10.3109/10520297309116628; Sciacca S, 2009, MEDITERR J NUTR META, V2, P157, DOI 10.1007/s12349-009-0052-5; Souty-Grosset C, 2005, EUR J SOIL BIOL, V41, P109, DOI 10.1016/j.ejsobi.2005.09.009; STORCH V, 1980, ZOOL ANZ, V204, P137; Storch V., 1984, Symposia of the Zoological Society of London, P167; STORCH V, 1982, ZOOMORPHOLOGY, V100, P131, DOI 10.1007/BF00310359; STRUS J, 1985, HELGOLANDER MEERESUN, V39, P367; Tomasello B, 2012, ECOTOX ENVIRON SAFE, V86, P168, DOI 10.1016/j.ecoenv.2012.09.012; WIESER W, 1976, OECOLOGIA, V23, P107, DOI 10.1007/BF00557849; Youn SeJin, 2010, Journal of Applied Sciences and Environmental Management, V14, P71; Zagar D, 2007, MAR CHEM, V107, P64, DOI 10.1016/j.marchem.2007.02.007	47	51	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58548	10.1371/journal.pone.0058548	http://dx.doi.org/10.1371/journal.pone.0058548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472204	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900150
J	Qu, QH; Chen, J; Wang, YZ; Gui, WJ; Wang, L; Fan, ZS; Jiang, T				Qu, Qianhui; Chen, Jun; Wang, Yizhi; Gui, Wenjun; Wang, Li; Fan, Zusen; Jiang, Tao			Structural Characterization of the Self-Association of the Death Domain of p75(NTR)	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; MOLECULAR REPLACEMENT; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; GROWTH-FACTOR; CELL-DEATH; COMPLEX; MODEL; INFLAMMATION; SUPERFAMILY	The neurotrophin receptor p75(NTR) conveys multiple signals via its intracellular death domain. However, how the death domain is activated and interacts with downstream adaptors remains unclear. Here, we report two crystal structures of the p75(NTR) death domain in the form of a non-covalent asymmetric dimer and a Cys379-Cys379 disulfide bond linked symmetric dimer, respectively. These two dimer arrangements have not previously been observed in other death domain-containing proteins. Further analysis shows that both the Cys379-Cys379 disulfide linked and non-covalent full-length p75(NTR) dimers are present on the cell surface. These observations suggest that various oligomers may exist simultaneously on the cell surface, and that p75(NTR) activation and signalling may be modulated by neurotrophins or other factors via inducing a shift of the equilibrium between different oligomeric states.	[Qu, Qianhui; Wang, Yizhi; Gui, Wenjun; Jiang, Tao] Chinese Acad Sci, Inst Biophys, Natl Key Lab Biomacromol, Beijing 100080, Peoples R China; [Chen, Jun; Wang, Li; Fan, Zusen] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Qu, Qianhui; Chen, Jun; Wang, Yizhi; Gui, Wenjun; Wang, Li] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, T (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Key Lab Biomacromol, Beijing 100080, Peoples R China.	tjiang@ibp.ac.cn	qu, qianhui/N-9321-2015	qu, qianhui/0000-0002-5753-2599	Chinese Ministry of Science and Technology "973" grant [2011CB910302]; National Natural Science Foundation of China [31021062, 31025009]	Chinese Ministry of Science and Technology "973" grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by the Chinese Ministry of Science and Technology "973" grant (Grant 2011CB910302) and the National Natural Science Foundation of China (Grants 31021062, 31025009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2004, ANTICANCER RES, V24, P2997; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Ben-Zvi A, 2007, J NEUROSCI, V27, P13000, DOI 10.1523/JNEUROSCI.3373-07.2007; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Coulson EJ, 1999, MOL NEUROBIOL, V20, P29, DOI 10.1007/BF02741363; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Frossard N, 2004, EUR J PHARMACOL, V500, P453, DOI 10.1016/j.ejphar.2004.07.044; Fujii Takashi, 2009, Curr Mol Pharmacol, V2, P70; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krygier S, 2001, ANTICANCER RES, V21, P3749; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Mi W, 2008, BIOCHEM BIOPH RES CO, V368, P919, DOI 10.1016/j.bbrc.2008.02.021; Mi ZP, 2009, J NEUROCHEM, V110, P295, DOI 10.1111/j.1471-4159.2009.06137.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordell VL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-58; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pranovich S, 2005, INT J ARCHIT COMPUT, V3, P75, DOI 10.1260/1478077053739685; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Tyurina YY, 2005, AGING CELL, V4, P187, DOI 10.1111/j.1474-9726.2005.00160.x; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wang JJL, 2000, J NEUROSCI RES, V60, P587, DOI 10.1002/(SICI)1097-4547(20000601)60:5<587::AID-JNR3>3.0.CO;2-1; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, FEBS LETT, V492, P171, DOI 10.1016/S0014-5793(01)02162-7; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zeng F, 2011, BIOCH PHARM; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220	48	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57839	10.1371/journal.pone.0057839	http://dx.doi.org/10.1371/journal.pone.0057839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472109	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900048
J	Schwarze, U; Bingel, U; Badre, D; Sommer, T				Schwarze, Ulrike; Bingel, Ulrike; Badre, David; Sommer, Tobias			Ventral Striatal Activity Correlates with Memory Confidence for Old- and New-Responses in a Difficult Recognition Test	PLOS ONE			English	Article							DOPAMINERGIC MIDBRAIN; CORRECT RESPONSES; NUCLEUS-ACCUMBENS; ACTIVATION; RETRIEVAL; FMRI; RECOLLECTION; UNCERTAINTY; MECHANISMS; DECISIONS	Activity in the ventral striatum has frequently been associated with retrieval success, i.e., it is higher for hits than correct rejections. Based on the prominent role of the ventral striatum in the reward circuit, its activity has been interpreted to reflect the higher subjective value of hits compared to correct rejections in standard recognition tests. This hypothesis was supported by a recent study showing that ventral striatal activity is higher for correct rejections than hits when the value of rejections is increased by external incentives. These findings imply that the striatal response during recognition is context-sensitive and modulated by the adaptive significance of "oldness" or "newness" to the current goals. The present study is based on the idea that not only external incentives, but also other deviations from standard recognition tests which affect the subjective value of specific response types should modulate striatal activity. Therefore, we explored ventral striatal activity in an unusually difficult recognition test that was characterized by low levels of confidence and accuracy. Based on the human uncertainty aversion, in such a recognition context, the subjective value of all high confident decisions is expected to be higher than usual, i.e., also rejecting items with high certainty is deemed rewarding. In an accompanying behavioural experiment, participants rated the pleasantness of each recognition response. As hypothesized, ventral striatal activity correlated in the current unusually difficult recognition test not only with retrieval success, but also with confidence. Moreover, participants indicated that they were more satisfied by higher confidence in addition to perceived oldness of an item. Taken together, the results are in line with the hypothesis that ventral striatal activity during recognition codes the subjective value of different response types that is modulated by the context of the recognition test.	[Schwarze, Ulrike; Bingel, Ulrike; Sommer, Tobias] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Badre, David] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Brown University	Sommer, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	t.sommer@uke.de		Sommer, Tobias/0000-0002-3504-7357	Deutsche Forschungsgemeinschaft [DFG SO 952/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft to TS (DFG SO 952/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Butler AC, 2008, J EXP PSYCHOL LEARN, V34, P918, DOI 10.1037/0278-7393.34.4.918; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Chua EF, 2004, J COGNITIVE NEUROSCI, V16, P1131, DOI 10.1162/0898929041920568; Chua EF, 2009, PSYCHOL AGING, V24, P139, DOI 10.1037/a0014029; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Daniel R, 2012, NEUROIMAGE, V59, P3457, DOI 10.1016/j.neuroimage.2011.11.058; Daselaar SM, 2006, J NEUROSCI, V26, P5835, DOI 10.1523/JNEUROSCI.0258-06.2006; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Gluth S, 2012, J NEUROSCI, V32, P10686, DOI 10.1523/JNEUROSCI.0727-12.2012; Guitart-Masip M, 2010, J NEUROSCI, V30, P1721, DOI 10.1523/JNEUROSCI.5331-09.2010; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Han S, 2010, J NEUROSCI, V30, P4767, DOI 10.1523/JNEUROSCI.3077-09.2010; Hayes SM, 2011, J COGNITIVE NEUROSCI, V23, P3959, DOI 10.1162/jocn_a_00086; Hirsh JB, 2012, PSYCHOL REV, V119, P304, DOI 10.1037/a0026767; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kim H, 2013, HUM BRAIN M IN PRESS; Kim H, 2007, J NEUROSCI, V27, P12190, DOI 10.1523/JNEUROSCI.3408-07.2007; Kim H, 2009, BRAIN RES, V1282, P103, DOI 10.1016/j.brainres.2009.05.080; Levita L, 2009, NEUROIMAGE, V44, P1178, DOI 10.1016/j.neuroimage.2008.09.039; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; McDermott KB, 2009, NEUROPSYCHOLOGIA, V47, P2290, DOI 10.1016/j.neuropsychologia.2008.12.025; Moritz S, 2006, NEUROIMAGE, V33, P1188, DOI 10.1016/j.neuroimage.2006.08.003; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Roediger HL, 2010, TRENDS COGN SCI; Satterthwaite TD, 2012, NEUROIMAGE, V61, P723, DOI 10.1016/j.neuroimage.2012.03.060; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Schwarze U, 2012, J NEUROSCI, V32, P1481, DOI 10.1523/JNEUROSCI.4497-11.2012; Scimeca JM, 2012, NEURON, V75, P380, DOI 10.1016/j.neuron.2012.07.014; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006; Zink CF, 2003, J NEUROSCI, V23, P8092	40	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e54324	10.1371/journal.pone.0054324	http://dx.doi.org/10.1371/journal.pone.0054324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472064	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900002
J	Yang, SJ; Chen, CY; Chang, GD; Wen, HC; Chen, CY; Chang, SC; Liao, JF; Chang, CH				Yang, Su-Jung; Chen, Chen-Yu; Chang, Geen-Dong; Wen, Hui-Chin; Chen, Ching-Yu; Chang, Shi-Chuan; Liao, Jyh-Fei; Chang, Chung-Ho			Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1	PLOS ONE			English	Article							GROWTH-FACTOR-I; SMOOTH-MUSCLE-CELLS; NADPH-OXIDASE; TYROSINE KINASE; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; PPAR-GAMMA; SRC KINASE; C-SRC; INSULIN	Diabetes is characterized by chronic hyperglycemia, which in turn facilitates the formation of advanced glycation end products (AGEs). AGEs activate signaling proteins such as Src, Akt and ERK1/2. However, the mechanisms by which AGEs activate these kinases remain unclear. We examined the effect of AGEs on Akt activation in 3T3-L1 preadipocytes. Addition of AGEs to 3T3-L1 cells activated Akt in a dose- and time-dependent manner. The AGEs-stimulated Akt activation was blocked by a PI3-kinase inhibitor LY 294002, Src inhibitor PP2, an antioxidant NAC, superoxide scavenger Tiron, or nicotinamide adenine dinucleotide phosphate (NAD(P) H) oxidase inhibitor DPI, suggesting the involvement of Src and NAD(P) H oxidase in the activation of PI3-kinase-Akt pathway by AGEs. AGEs-stimulated Src tyrosine phosphorylation was inhibited by NAC, suggesting that Src is downstream of NAD(P) H oxidase. The AGEs-stimulated Akt activity was sensitive to Insulin-like growth factor 1 receptor (IGF-1R) kinase inhibitor AG1024. Furthermore, AGEs induced phosphorylation of IGF-1 receptor beta subunit (IGF-1R beta) on Tyr1135/1136, which was sensitive to PP2, indicating that AGEs stimulate Akt activity by transactivating IGF-1 receptor. In addition, the AGEs-stimulated Akt activation was attenuated by beta-methylcyclodextrin that abolishes the structure of caveolae, and by lowering caveolin-1 (Cav-1) levels with siRNAs. Furthermore, addition of AGEs enhanced the interaction of phospho-Cav-1 with IGF-1R beta and transfection of 3T3-L1 cells with Cav-1 Y14F mutants inhibited the activation of Akt by AGEs. These results suggest that AGEs activate NAD(P) H oxidase and Src which in turn phosphorylates IGF-1 receptor and Cav-1 leading to activation of IGF-1 receptor and the downstream Akt in 3T3-L1 cells. AGEs treatment promoted the differentiation of 3T3-L1 preadipocytes and addition of AG1024, LY 294002 or Akt inhibitor attenuated the promoting effect of AGEs on adipogenesis, suggesting that IGF-1 receptor, PI3-Kinase and Akt are involved in the facilitation of adipogenesis by AGEs.	[Yang, Su-Jung; Liao, Jyh-Fei] Natl Yang Ming Univ, Sch Med, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chen, Chen-Yu; Wen, Hui-Chin; Chang, Chung-Ho] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli, Taiwan; [Chang, Geen-Dong] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 10764, Taiwan; [Chen, Ching-Yu] Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Ching-Yu] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Ching-Yu] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Geriatr Res, Zhunan, Miaoli, Taiwan; [Chang, Shi-Chuan] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Inst Emergency & Crit Care Med, Chest Dept, Taipei 112, Taiwan; [Chang, Chung-Ho] China Med Univ, Coll Med, PhD Program Aging, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; China Medical University Taiwan	Chang, SC (corresponding author), Natl Yang Ming Univ, Taipei Vet Gen Hosp, Inst Emergency & Crit Care Med, Chest Dept, Taipei 112, Taiwan.	scchang@vghtpe.gov.tw; changch@nhri.org.tw	Chang, Chung-Ho/B-1068-2010	CHEN, CHING-YU/0000-0002-4095-4197	National Science Council [95-2314-B-309-007-MY3, 95-2314-B-309-003-MY3]; National Health Research Institutes [CSPP03]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by grants from the National Science Council (95-2314-B-309-007-MY3 and 95-2314-B-309-003-MY3) and by an intramural grant from the National Health Research Institutes (CSPP03) to C-HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouallegue A, 2009, CAN J PHYSIOL PHARM, V87, P1009, DOI 10.1139/Y09-056; Brizzi MF, 2002, DIABETES, V51, P3311, DOI 10.2337/diabetes.51.11.3311; Cassese A, 2008, J BIOL CHEM, V283, P36088, DOI 10.1074/jbc.M801698200; Catarzi S, 2005, BBA-MOL CELL RES, V1745, P166, DOI 10.1016/j.bbamcr.2005.03.004; Chen J, 2008, J CELL PHYSIOL, V217, P281, DOI 10.1002/jcp.21498; Chen ZJ, 2004, HYPERTENSION, V44, P963, DOI 10.1161/01.HYP.0000145859.94894.23; Coughlan MT, 2008, ANN NY ACAD SCI, V1126, P190, DOI 10.1196/annals.1433.018; Du J, 1996, BIOCHEM BIOPH RES CO, V218, P934, DOI 10.1006/bbrc.1996.0165; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Glait C, 2006, EXP CELL RES, V312, P3899, DOI 10.1016/j.yexcr.2006.08.016; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Guichard C, 2005, J BIOL CHEM, V280, P37021, DOI 10.1074/jbc.M506594200; Hallak H, 2002, HEPATOLOGY, V36, P1509, DOI 10.1053/jhep.2002.37138; Hamada Y, 1996, BIOCHEM BIOPH RES CO, V228, P539, DOI 10.1006/bbrc.1996.1695; Hong S, 2004, CELL DEATH DIFFER, V11, P714, DOI 10.1038/sj.cdd.4401405; Huo HR, 2003, J BIOL CHEM, V278, P11561, DOI 10.1074/jbc.M211785200; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Li HW, 2009, HYPERTENSION, V53, P1054, DOI 10.1161/HYPERTENSIONAHA.108.120642; Li LN, 2006, METABOLISM, V55, P1516, DOI 10.1016/j.metabol.2006.06.022; LI SW, 1994, J BIOL CHEM, V269, P32558; Li WQ, 2006, J BIOL CHEM, V281, P23785, DOI 10.1074/jbc.M605269200; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Matthews LC, 2008, ENDOCRINOLOGY, V149, P5199, DOI 10.1210/en.2007-1211; Mendez JD, 2010, MOL CELL BIOCHEM, V341, P33, DOI 10.1007/s11010-010-0434-5; Mercier I, 2009, LAB INVEST, V89, P614, DOI 10.1038/labinvest.2009.23; Nass N, 2007, Z GERONTOL GERIATR, V40, P349, DOI 10.1007/s00391-007-0484-9; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; PETERSON JE, 1994, J BIOL CHEM, V269, P27315; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Ramasamy R, 2007, MOL NUTR FOOD RES, V51, P1111, DOI 10.1002/mnfr.200700008; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Salani B, 2008, ENDOCRINOLOGY, V149, P461, DOI 10.1210/en.2007-0312; Santen RJ, 2009, STEROIDS, V74, P586, DOI 10.1016/j.steroids.2008.11.020; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Toure F, 2008, BIOCHEM J, V416, P255, DOI 10.1042/BJ20080054; Touyz RM, 2003, CAN J PHYSIOL PHARM, V81, P159, DOI 10.1139/Y02-164; Unoki H, 2007, DIABETES RES CLIN PR, V76, P236, DOI 10.1016/j.diabres.2006.09.016; Urata Y, 2002, FREE RADICAL BIO MED, V32, P688, DOI 10.1016/S0891-5849(01)00823-1; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Vetter M, 2003, HYPERTENSION, V41, P1136, DOI 10.1161/01.HYP.0000068201.48340.3B; WISE LS, 1979, J BIOL CHEM, V254, P273; Wong RKM, 2002, DIABETES, V51, P2846, DOI 10.2337/diabetes.51.9.2846; Wu CH, 2011, J AGR FOOD CHEM, V59, P7978, DOI 10.1021/jf201271y; Xu DZ, 2003, J BIOL CHEM, V278, P39349, DOI 10.1074/jbc.M302771200; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Yang BH, 2007, AM J PHYSIOL-HEART C, V292, pH954, DOI 10.1152/ajpheart.00758.2006; Zahradka P, 2004, ENDOCRINOLOGY, V145, P2978, DOI 10.1210/en.2004-0029	57	30	32	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58100	10.1371/journal.pone.0058100	http://dx.doi.org/10.1371/journal.pone.0058100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472139	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900084
J	Yu, Y; Zhang, J; Liu, J				Yu, Yang; Zhang, Jie; Liu, Jing			Biomedical Implementation of Liquid Metal Ink as Drawable ECG Electrode and Skin Circuit	PLOS ONE			English	Article								Background: Conventional ways of making bio-electrodes are generally complicated, expensive and unconformable. Here we describe for the first time the method of applying Ga-based liquid metal ink as drawable electrocardiogram (ECG) electrodes. Such material owns unique merits in both liquid phase conformability and high electrical conductivity, which provides flexible ways for making electrical circuits on skin surface and a prospective substitution of conventional rigid printed circuit boards (PCBs). Methods: Fundamental measurements of impedance and polarization voltage of the liquid metal ink were carried out to evaluate its basic electrical properties. Conceptual experiments were performed to draw the alloy as bio-electrodes to acquire ECG signals from both rabbit and human via a wireless module developed on the mobile phone. Further, a typical electrical circuit was drawn in the palm with the ink to demonstrate its potential of implementing more sophisticated skin circuits. Results: With an oxide concentration of 0.34%, the resistivity of the liquid metal ink was measured as 44.1 mu Omega.cm with quite low reactance in the form of straight line. Its peak polarization voltage with the physiological saline was detected as -0.73 V. The quality of ECG wave detected from the liquid metal electrodes was found as good as that of conventional electrodes, from both rabbit and human experiments. In addition, the circuit drawn with the liquid metal ink in the palm also runs efficiently. When the loop was switched on, all the light emitting diodes (LEDs) were lit and emitted colorful lights. Conclusions: The liquid metal ink promises unique printable electrical properties as both bio-electrodes and electrical wires. The implemented ECG measurement on biological surface and the successfully run skin circuit demonstrated the conformability and attachment of the liquid metal. The present method is expected to innovate future physiological measurement and biological circuit manufacturing technique in a large extent.	[Yu, Yang; Zhang, Jie; Liu, Jing] Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China; [Liu, Jing] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Cryogen, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS	Liu, J (corresponding author), Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China.	jliubme@tsinghua.edu.cn			Tsinghua University [20121088098]	Tsinghua University	This work is partially supported by Tsinghua University Grant No. 20121088098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; Cadwallader L. C., 2003, EN FAC CONTR GROUP E; Chen WC, 2012, INTERN EMERG MED, V7, P53, DOI 10.1007/s11739-011-0739-8; Cherepenin V, 2001, PHYSIOL MEAS, V22, P9, DOI 10.1088/0967-3334/22/1/302; Cherepenin VA, 2002, IEEE T MED IMAGING, V21, P662, DOI 10.1109/TMI.2002.800602; Chi Yu M., 2010, 2010 International Conference on Body Sensor Networks (BSN), P297, DOI 10.1109/BSN.2010.52; Chi YM, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P246, DOI 10.1109/P3644.51; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; Dean J.A., 1999, LANGES HDB CHEM, VFifteenth, P1291; Dunne SM, 2000, BRIT DENT J, V189, P310, DOI 10.1038/sj.bdj.4800755a; Gao Y, 2012, PLOS ONE, V7; HAGEMEISTER FB, 1990, CANCER, V65, P1090, DOI 10.1002/1097-0142(19900301)65:5<1090::AID-CNCR2820650509>3.0.CO;2-#; Ivanoff CS, 2012, FOOD CHEM TOXICOL, V50, P212, DOI 10.1016/j.fct.2011.10.041; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Li HY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4746397; Martens R. J., 2006, Proceedings of the 52nd Annual Convention of the American Association of Equine Practitioners, San Antonio, Texas, USA, 2-6 December, 2006, P219; MATULA RA, 1979, J PHYS CHEM REF DATA, V8, P1147, DOI 10.1063/1.555614; SCHWAN HP, 1966, BIOPHYSIK, V3, P181, DOI 10.1007/BF01191612; SELIGMAN PA, 1992, AM J HEMATOL, V41, P232, DOI 10.1002/ajh.2830410403; Thakor N. V., 1999, MEASUREMENT INSTRUME; Zhang Q, 2012, FRONT ENERGY, V6, P311, DOI 10.1007/s11708-012-0214-x	21	81	83	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58771	10.1371/journal.pone.0058771	http://dx.doi.org/10.1371/journal.pone.0058771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472220	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900167
J	Anklesaria, JH; Jagtap, DD; Pathak, BR; Kadam, KM; Joseph, S; Mahale, SD				Anklesaria, Jenifer H.; Jagtap, Dhanashree D.; Pathak, Bhakti R.; Kadam, Kaushiki M.; Joseph, Shaini; Mahale, Smita D.			Prostate Secretory Protein of 94 Amino Acids (PSP94) Binds to Prostatic Acid Phosphatase (PAP) in Human Seminal Plasma	PLOS ONE			English	Article							BETA-MICROSEMINOPROTEIN; IMMUNOHISTOCHEMICAL LOCALIZATION; IDENTIFICATION; PURIFICATION; TISSUES; INHIBIN; IMMUNOGLOBULIN; SPERMATOZOA; EXPRESSION; AFFINITY	Prostate Secretory Protein of 94 amino acids (PSP94) is one of the major proteins present in the human seminal plasma. Though several functions have been predicted for this protein, its exact role either in sperm function or in prostate pathophysiology has not been clearly defined. Attempts to understand the mechanism of action of PSP94 has led to the search for its probable binding partners. This has resulted in the identification of PSP94 binding proteins in plasma and seminal plasma from human. During the chromatographic separation step of proteins from human seminal plasma by reversed phase HPLC, we had observed that in addition to the main fraction of PSP94, other fractions containing higher molecular weight proteins also showed the presence of detectable amounts of PSP94. This prompted us to hypothesize that PSP94 could be present in the seminal plasma complexed with other protein/s of higher molecular weight. One such fraction containing a major protein of similar to 47 kDa, on characterization by mass spectrometric analysis, was identified to be Prostatic Acid Phosphatase (PAP). The ability of PAP present in this fraction to bind to PSP94 was demonstrated by affinity chromatography. Co-immunoprecipitation experiments confirmed the presence of PSP94-PAP complex both in the fraction studied and in the fresh seminal plasma. In silico molecular modeling of the PSP94-PAP complex suggests that beta-strands 1 and 6 of PSP94 appear to interact with domain 2 of PAP, while beta-strands 7 and 10 with domain 1 of PAP. This is the first report which suggests that PSP94 can bind to PAP and the PAP-bound PSP94 is present in human seminal plasma.	[Anklesaria, Jenifer H.; Jagtap, Dhanashree D.; Pathak, Bhakti R.; Mahale, Smita D.] Natl Inst Res Reprod Hlth, Div Struct Biol, Mumbai, Maharashtra, India; [Kadam, Kaushiki M.] Natl Inst Res Reprod Hlth, Prote Facil, Mumbai, Maharashtra, India; [Joseph, Shaini; Mahale, Smita D.] Natl Inst Res Reprod Hlth, ICMR Biomed Informat Ctr, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Mahale, SD (corresponding author), Natl Inst Res Reprod Hlth, Div Struct Biol, Mumbai, Maharashtra, India.	smitamahale@hotmail.com			Indian Council of Medical Research, New Delhi, India [NIRRH/MS/47/2012]; Department of Biotechnology, Government of India; Lady Tata Memorial Trust	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Lady Tata Memorial Trust	This work was financially supported by the Indian Council of Medical Research, New Delhi, India (NIRRH/MS/47/2012) and the Department of Biotechnology, Government of India. JHA is recipient of Junior Scholarship from the Lady Tata Memorial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baijal-Gupta M, 2000, J ENDOCRINOL, V165, P425, DOI 10.1677/joe.0.1650425; Brillard-Bourdet M, 2002, EUR J BIOCHEM, V269, P390, DOI 10.1046/j.0014-2956.2001.02667.x; Chao CF, 1996, BIOCHEM BIOPH RES CO, V218, P623, DOI 10.1006/bbrc.1996.0110; DUBE JY, 1987, J UROLOGY, V138, P883, DOI 10.1016/S0022-5347(17)43408-2; Franchi NA, 2008, REPRODUCTION, V136, P157, DOI 10.1530/REP-08-0032; Ghasriani H, 2006, J MOL BIOL, V362, P502, DOI 10.1016/j.jmb.2006.07.029; Hagerwall AMLE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002625; HYAKUTAKE H, 1993, PROSTATE, V22, P347, DOI 10.1002/pros.2990220409; Jagtap DD, 2007, BBA-PROTEINS PROTEOM, V1774, P723, DOI 10.1016/j.bbapap.2007.03.017; Jagtap DD, 2010, BBA-PROTEINS PROTEOM, V1804, P1889, DOI 10.1016/j.bbapap.2010.05.013; Kamada M, 1998, BBA-PROTEIN STRUCT M, V1388, P101, DOI 10.1016/S0167-4838(98)00164-2; Khan SA, 2009, REPRODUCTION, V138, P81, DOI 10.1530/REP-09-0052; Kumar A, 2010, J MOL BIOL, V397, P947, DOI 10.1016/j.jmb.2010.02.035; Lazure C, 2001, PROTEIN SCI, V10, P2207, DOI 10.1110/ps.06501; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; Marquinez AC, 2003, J PROTEIN CHEM, V22, P423, DOI 10.1023/B:JOPC.0000005457.29475.d7; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; OHKUBO I, 1995, INT J BIOCHEM CELL B, V27, P603, DOI 10.1016/1357-2725(95)00021-G; Parmar T, 2009, FERTIL STERIL, V92, P1091, DOI 10.1016/j.fertnstert.2008.07.1734; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Reeves JR, 2005, BIOCHEM J, V385, P105, DOI 10.1042/BJ20040290; RONNBERG L, 1981, INT J ANDROL, V4, P372, DOI 10.1111/j.1365-2605.1981.tb00721.x; SEIDAH NG, 1984, FEBS LETT, V175, P349, DOI 10.1016/0014-5793(84)80766-8; Starita-Geribaldi M, 2001, MOL HUM REPROD, V7, P715, DOI 10.1093/molehr/7.8.715; TAGA EM, 1983, PROSTATE, V4, P141, DOI 10.1002/pros.2990040205; Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083; THAKUR AN, 1978, INDIAN J EXP BIOL, V16, P854; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tsurusaki T, 1998, PROSTATE, V35, P109; Udby L, 2005, BIOCHEM BIOPH RES CO, V333, P555, DOI 10.1016/j.bbrc.2005.05.139; Udby L, 2005, J ANDROL, V26, P333, DOI 10.2164/jandrol.04132; ULVSBACK M, 1989, BIOCHEM BIOPH RES CO, V164, P1310, DOI 10.1016/0006-291X(89)91812-3; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; VIHKO P, 1978, CLIN CHEM, V24, P1783; VIHKO P, 1979, INVEST UROL, V16, P349; VONDERKAMMER H, 1993, UROL RES, V21, P227, DOI 10.1007/BF00590041; Wang ZJ, 2007, BIOL REPROD, V77, P476, DOI 10.1095/biolreprod.107.060194; WEIBER H, 1990, AM J PATHOL, V137, P593; Wojciak P, 2003, INT J BIOL MACROMOL, V32, P43, DOI 10.1016/S0141-8130(03)00024-2; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu DM, 2000, J CELL BIOCHEM, V76, P71, DOI 10.1002/(SICI)1097-4644(20000101)76:1<71::AID-JCB8>3.0.CO;2-B; Yadav VK, 2011, J SEP SCI, V34, P1076, DOI 10.1002/jssc.201000842	42	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58631	10.1371/journal.pone.0058631	http://dx.doi.org/10.1371/journal.pone.0058631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469287	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900097
J	Costea, PI; Lundeberg, J; Akan, P				Costea, Paul Igor; Lundeberg, Joakim; Akan, Pelin			TagGD: Fast and Accurate Software for DNA Tag Generation and Demultiplexing	PLOS ONE			English	Article							BARCODED PRIMERS; DISSECTION; ENHANCERS; DESIGN	Multiplexing is of vital importance for utilizing the full potential of next generation sequencing technologies. We here report TagGD (DNA-based Tag Generator and Demultiplexor), a fully-customisable, fast and accurate software package that can generate thousands of barcodes satisfying user-defined constraints and can guarantee full demultiplexing accuracy. The barcodes are designed to minimise their interference with the experiment. Insertion, deletion and substitution events are considered when designing and demultiplexing barcodes. 20,000 barcodes of length 18 were designed in 5 minutes and 2 million barcoded Illumina HiSeq-like reads generated with an error rate of 2% were demultiplexed with full accuracy in 5 minutes. We believe that our software meets a central demand in the current high-throughput biology and can be utilised in any field with ample sample abundance. The software is available on GitHub (https://github.com/pelinakan/UBD.git).	[Costea, Paul Igor; Lundeberg, Joakim; Akan, Pelin] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Solna, Sweden	Royal Institute of Technology	Akan, P (corresponding author), KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Solna, Sweden.	pelin.akan@scilifelab.se	Sahlen, Pelin/AAJ-1824-2021	Costea, Paul Igor/0000-0003-1645-3947	SSF- nanopore (Swedish Foundation for Strategic Research); EU [222913]	SSF- nanopore (Swedish Foundation for Strategic Research); EU(European Commission)	This work was funded by SSF- nanopore (Swedish Foundation for Strategic Research) and EU- digital seq (Digital Sequencing, EU FP7 grant agreement number 222913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butenhof D.R., 1997, PROGRAMMING POSIX TH; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Grassl Markus, 2007, BOUNDS MINIMUM DISTA; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; McDonald MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000622; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stahl PL, 2012, ANNU REV BIOCHEM, V81, P359, DOI 10.1146/annurev-biochem-060410-094158; Xu QK, 2009, P NATL ACAD SCI USA, V106, P2289, DOI 10.1073/pnas.0812506106; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	15	31	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57521	10.1371/journal.pone.0057521	http://dx.doi.org/10.1371/journal.pone.0057521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469199	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900025
J	Gacsi, M; Maros, K; Sernkvist, S; Farago, T; Miklosi, A				Gacsi, Marta; Maros, Katalin; Sernkvist, Sofie; Farago, Tamas; Miklosi, Adam			Human Analogue Safe Haven Effect of the Owner: Behavioural and Heart Rate Response to Stressful Social Stimuli in Dogs	PLOS ONE			English	Article							AINSWORTHS STRANGE SITUATION; CANIS-FAMILIARIS; PHYSIOLOGICAL-RESPONSES; ATTACHMENT BEHAVIOR; RATE-VARIABILITY; SALIVA CORTISOL; EVERYDAY LIFE; GUIDE DOGS; CUES; BOND	The secure base and safe haven effects of the attachment figure are central features of the human attachment theory. Recently, conclusive evidence for human analogue attachment behaviours in dogs has been provided, however, the owner's security-providing role in danger has not been directly supported. We investigated the relationship between the behavioural and cardiac response in dogs (N = 30) while being approached by a threatening stranger in separation vs. in the presence of the owner, presented in a balanced order. Non-invasive telemetric measures of heart rate (HR) and heart rate variability (HRV) data during the threatening approaches was compared to periods before and after the encounters. Dogs that showed distress vocalisation during separation (N = 18) and that growled or barked at the stranger during the threatening approach (N = 17) were defined as behaviourally reactive in the given situation. While characteristic stress vocalisations were emitted during separations, the absence of the owner did not have an effect on dogs' mean HR, but significantly increased the HRV. The threatening approach increased dogs' mean HR, with a parallel decrease in the HRV, particularly in dogs that were behaviourally reactive to the encounter. Importantly, the HR increase was significantly less pronounced when dogs faced the stranger in the presence of the owner. Moreover, the test order, whether the dog encountered the stranger first with or without its owner, also proved important: HR increase associated with the encounter in separation seemed to be attenuated in dogs that faced the stranger first in the presence of their owner. We provided evidence for human analogue safe haven effect of the owner in a potentially dangerous situation. Similarly to parents of infants, owners can provide a buffer against stress in dogs, which can even reduce the effect of a subsequent encounter with the same threatening stimuli later when the owner is not present.	[Gacsi, Marta] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary; [Maros, Katalin] Szent Istvan Univ, Dept Agri Environm Management, Godollo, Hungary; [Sernkvist, Sofie; Farago, Tamas; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary	MTA-ELTE Comparative Ethology Research Group; Hungarian University of Agriculture & Life Sciences; Eotvos Lorand University	Gacsi, M (corresponding author), MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary.		Faragó, Tamás/A-5386-2009; Miklosi, Adam/N-5147-2017	Faragó, Tamás/0000-0001-5987-2629; Miklosi, Adam/0000-0003-4831-8985; Gacsi, Marta/0000-0003-3080-7545	Hungarian Science Foundation [OTKA TO43763]; Hungarian Academy of Sciences [F01/031]	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The Hungarian Science Foundation (OTKA TO43763), and the Hungarian Academy of Sciences (F01/031) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M. D. S., 1969, DETERMIN INFANT BEH, V4, P111; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bergamasco L, 2010, APPL ANIM BEHAV SCI, V125, P56, DOI 10.1016/j.applanim.2010.03.002; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Bowlby J, 1972, ATTACHMENT; Camm AJ, 1996, EUR HEART J, V17, P354; Fallani G, 2007, PHYSIOL BEHAV, V90, P648, DOI 10.1016/j.physbeh.2006.12.001; Fallani G, 2006, APPL ANIM BEHAV SCI, V100, P241, DOI 10.1016/j.applanim.2005.12.005; FOX MW, 1975, PET ANIMALS SOC, P37; Friedman BH, 1998, J PSYCHOSOM RES, V44, P133, DOI 10.1016/S0022-3999(97)00202-X; Gacsi M, 2001, J COMP PSYCHOL, V115, P423, DOI 10.1037/0735-7036.115.4.423; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; Greiveldinger L, 2009, PSYCHONEUROENDOCRINO, V34, P805, DOI 10.1016/j.psyneuen.2008.10.025; Horvath Z, 2007, HORM BEHAV, V52, P621, DOI 10.1016/j.yhbeh.2007.08.001; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; KOSTARCZYK E, 1982, PHYSIOL BEHAV, V28, P27, DOI 10.1016/0031-9384(82)90096-8; LANG E, 1991, ACTA PHYSIOL HUNG, V78, P241; Magnusson MS, 1996, EUR J PSYCHOL ASSESS, V12, P112, DOI 10.1027/1015-5759.12.2.112; Maros K, 2008, APPL ANIM BEHAV SCI, V114, P159, DOI 10.1016/j.applanim.2008.01.022; Maros K, 2008, APPL ANIM BEHAV SCI, V109, P329, DOI 10.1016/j.applanim.2007.03.005; MARSTON LC, 2005, IWDBA C P, P132; McGreevy PD, 2005, ANTHROZOOS, V18, P236, DOI 10.2752/089279305785594045; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; Palestrini C, 2005, APPL ANIM BEHAV SCI, V94, P75, DOI 10.1016/j.applanim.2005.02.005; Palmer R, 2008, APPL ANIM BEHAV SCI, V109, P306, DOI 10.1016/j.applanim.2007.04.002; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; RAJECKI DW, 1978, BEHAV BRAIN SCI, V1, P417, DOI 10.1017/S0140525X00075816; Schalke E, 2007, APPL ANIM BEHAV SCI, V105, P369, DOI 10.1016/j.applanim.2006.11.002; Serpell JA, 1996, APPL ANIM BEHAV SCI, V47, P49, DOI 10.1016/0168-1591(95)01010-6; Shaver PR, 2012, NATURE DEV SOCIAL CO; SPANGLER G, 1993, CHILD DEV, V64, P1439, DOI 10.2307/1131544; SUOMI SJ, 1970, J ABNORM PSYCHOL, V76, P161, DOI 10.1037/h0029809; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Topal J., 2012, CROSSING BOUNDARIES, VVolume 8, P163, DOI [10.1163/9789004233041_010, DOI 10.1163/9789004233041_010]; Tuber DS, 1996, J COMP PSYCHOL, V110, P103, DOI 10.1037/0735-7036.110.1.103; Valsecchi P, 2010, APPL ANIM BEHAV SCI, V123, P43, DOI 10.1016/j.applanim.2009.12.012; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Vas J, 2008, APPL ANIM BEHAV SCI, V112, P331, DOI 10.1016/j.applanim.2007.09.002; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; WILSON CC, 1991, J NERV MENT DIS, V179, P482, DOI 10.1097/00005053-199108000-00006; Zupan M, 2012, PHYSIOL BEHAV, V106, P638, DOI 10.1016/j.physbeh.2012.04.025	48	96	96	4	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58475	10.1371/journal.pone.0058475	http://dx.doi.org/10.1371/journal.pone.0058475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469283	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000315634900091
J	Gu, LY; Dai, L; Cao, C; Zhu, J; Ding, CW; Xu, HB; Qiu, LH; Di, W				Gu, Liying; Dai, Lan; Cao, Cong; Zhu, Jing; Ding, Chuanwei; Xu, Hai-bo; Qiu, Lihua; Di, Wen			Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention	PLOS ONE			English	Article							INDUCED CELL-DEATH; WEAK INDUCER; ADENOCARCINOMA CELLS; MULTIPLE PATHWAYS; APOPTOSIS; TNF; PROLIFERATION; ANGIOGENESIS; ACTIVATION; NECROSIS	The aim of this current study was to investigate the expression of the tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) in human malignant ovarian tumors, and test TWEAK's potential role on tumor progression in cell models in-vitro. Using immunohistochemistry (IHC), we found that TWEAK and its receptor Fn14 were expressed in human malignant ovarian tumors, but not in normal ovarian tissues or in borderline/benign epithelial ovarian tumors. High levels of TWEAK expression was detected in the majority of malignant tumors (36 out of 41, 87.80%). Similarly, 35 out of 41 (85.37%) malignant ovarian tumors were Fn14 positive. In these malignant ovarian tumors, however, TWEAK/Fn14 expression was not corrected with patients' clinical subtype/stages or pathological features. In vitro, we demonstrated that TWEAK only inhibited ovarian cancer HO-8910PM cell proliferation in combination with tumor necrosis factor-alpha (TNF-alpha), whereas either TWEAK or TNF-alpha alone didn't affect HO-8910PM cell growth. TWEAK promoted TNF-alpha production in cultured THP-1 macrophages. Meanwhile, conditioned media from TWEAK-activated macrophages inhibited cultured HO-8910PM cell proliferation and invasion. Further, TWEAK increased monocyte chemoattractant protein-1 (MCP-1) production in cultured HO-8910PM cells to possibly recruit macrophages. Our results suggest that TWEAK/Fn14, by activating macrophages, could be ovarian tumor suppressors. The unique expression of TWEAK/Fn14 in malignant tumors indicates that it might be detected as a malignant ovarian tumor marker.	[Gu, Liying; Dai, Lan; Zhu, Jing; Ding, Chuanwei; Qiu, Lihua; Di, Wen] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gynecol & Obstet, Shanghai 200030, Peoples R China; [Gu, Liying; Dai, Lan; Zhu, Jing; Ding, Chuanwei; Qiu, Lihua; Di, Wen] Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China; [Cao, Cong] Soochow Univ, Affiliated Hosp 2, Suzhou, Peoples R China; [Xu, Hai-bo] Nantong Univ, Affiliated Tumor Hosp, Nantong, Peoples R China	Shanghai Jiao Tong University; Soochow University - China; Nantong University	Qiu, LH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gynecol & Obstet, Shanghai 200030, Peoples R China.	lilyqiulh@126.com; diwen163@163.com			International Collaborative Items of Ministry of Science and Technology of China [2006DFA32780]; Shanghai Municipal Inspiring Star Award [06QA14032]; Science and Technology Commission of Shanghai Municipality [11DZ2211002]; National Natural Science Foundation of China [81272884, 81072137]	International Collaborative Items of Ministry of Science and Technology of China; Shanghai Municipal Inspiring Star Award; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the International Collaborative Items of Ministry of Science and Technology of China (No. 2006DFA32780), Shanghai Municipal Inspiring Star Award(No. 06QA14032), Science and Technology Commission of Shanghai Municipality (No. 11DZ2211002) and National Natural Science Foundation of China (No. 81272884, No. 81072137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108, DOI 10.1002/jlb.63.1.108; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Dai L, 2009, CANCER LETT, V283, P159, DOI 10.1016/j.canlet.2009.03.036; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Kaduka Y, 2005, BIOCHEM BIOPH RES CO, V331, P384, DOI 10.1016/j.bbrc.2005.03.176; Kaptein A, 2000, FEBS LETT, V485, P135, DOI 10.1016/S0014-5793(00)02219-5; Kawakita T, 2005, INT J ONCOL, V26, P87; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; Lin BR, 2011, ANN SURG ONCOL; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Ma SL, 2009, J BIOL CHEM, V284, P24773, DOI 10.1074/jbc.M109.028621; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Michaelson JS, 2005, ONCOGENE, V24, P2613, DOI 10.1038/sj.onc.1208208; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Shenhua X, 1999, J EXP CLIN CANC RES, V18, P233; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Wang D, 2010, CANC LETT; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wilson CA, 2002, CELL DEATH DIFFER, V9, P1321, DOI 10.1038/sj.cdd.4401107; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005; Zou H, 2011, GYNECOL ONCOL	34	40	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57436	10.1371/journal.pone.0057436	http://dx.doi.org/10.1371/journal.pone.0057436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469193	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900020
J	Gao, ZF; Ding, XW; Yang, T; Liang, JY; Shui, RD				Gao, Zaifeng; Ding, Xiaowei; Yang, Tong; Liang, Junying; Shui, Rende			Coarse-to-Fine Construction for High-Resolution Representation in Visual Working Memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; NEURAL MECHANISMS; INFORMATION LOAD; FACE PERCEPTION; NUMBER; CAPACITY; STORAGE; ORGANIZATION; ALLOCATION; FEATURES	Background: This study explored whether the high-resolution representations created by visual working memory (VWM) are constructed in a coarse-to-fine or all-or-none manner. The coarse-to-fine hypothesis suggests that coarse information precedes detailed information in entering VWM and that its resolution increases along with the processing time of the memory array, whereas the all-or-none hypothesis claims that either both enter into VWM simultaneously, or neither does. Methodology/Principal Findings: We tested the two hypotheses by asking participants to remember two or four complex objects. An ERP component, contralateral delay activity (CDA), was used as the neural marker. CDA is higher for four objects than for two objects when coarse information is primarily extracted; yet, this CDA difference vanishes when detailed information is encoded. Experiment 1 manipulated the comparison difficulty of the task under a 500-ms exposure time to determine a condition in which the detailed information was maintained. No CDA difference was found between two and four objects, even in an easy-comparison condition. Thus, Experiment 2 manipulated the memory array's exposure time under the easy-comparison condition and found a significant CDA difference at 100 ms while replicating Experiment 1's results at 500 ms. In Experiment 3, the 500-ms memory array was blurred to block the detailed information; this manipulation reestablished a significant CDA difference. Conclusions/Significance: These findings suggest that the creation of high-resolution representations in VWM is a coarse-to-fine process.	[Gao, Zaifeng; Ding, Xiaowei; Yang, Tong; Liang, Junying; Shui, Rende] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Shui, RD (corresponding author), Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China.	rshui@zjuem.zju.edu.cn	Gao, Zaifeng/B-6398-2011	Gao, Zaifeng/0000-0001-9727-8524; Liang, Junying/0000-0002-3603-294X	National Natural Science Foundation of China [31170974, 31170975, 31271089]; Key Project of Humanities and Social Sciences, Ministry of Education [07JZD0029]; Research Fund for the Doctoral Program of Higher Education [20120101120085]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Humanities and Social Sciences, Ministry of Education; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (No. 31170974, 31170975, No. 31271089), Key Project of Humanities and Social Sciences, Ministry of Education (No. 07JZD0029), the Research Fund for the Doctoral Program of Higher Education (No.20120101120085), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Barton B, 2009, J EXP PSYCHOL HUMAN, V35, P1359, DOI 10.1037/a0015792; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Bentin S, 2006, J COGNITIVE NEUROSCI, V18, P1406, DOI 10.1162/jocn.2006.18.8.1406; Brady TF, 2011, J VISION, V11, DOI 10.1167/11.5.4; Chen Z, 2009, BOUNDARY CONDITIONS; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Curby KM, 2007, PSYCHON B REV, V14, P620, DOI 10.3758/BF03196811; Diamantopoulou S, 2011, EXP BRAIN RES, V209, P501, DOI 10.1007/s00221-011-2536-z; Drew TW, 2006, CLIN EEG NEUROSCI, V37, P286, DOI 10.1177/155005940603700405; Gao T, 2011, J EXP PSYCHOL HUMAN, V37, P1803, DOI 10.1037/a0025637; Gao ZF, 2011, J EXP PSYCHOL HUMAN, V37, P1051, DOI 10.1037/a0023091; Gao ZF, 2011, BIOL PSYCHOL, V87, P296, DOI 10.1016/j.biopsycho.2011.03.013; Gao ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014273; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; Goffaux V, 2011, CEREB CORTEX, V21, P467, DOI 10.1093/cercor/bhq112; Gratton G, 1998, PSYCHOPHYSIOLOGY, V35, P638, DOI 10.1111/1469-8986.3560638; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hyun JS, 2009, J EXP PSYCHOL HUMAN, V35, P1140, DOI 10.1037/a0015019; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Jiang YV, 2008, PERCEPT PSYCHOPHYS, V70, P1581, DOI 10.3758/PP.70.8.1581; Johnson JS, 2009, PSYCHOL SCI, V20, P568, DOI 10.1111/j.1467-9280.2009.02329.x; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Klaver P, 1999, NEUROREPORT, V10, P2001, DOI 10.1097/00001756-199907130-00002; Kyllingsbaek S, 2009, PSYCHON B REV, V16, P1000, DOI 10.3758/PBR.16.6.1000; Liu K, 2005, J VISION, V5, P650, DOI 10.1167/5.7.5; Loftus GR, 2004, J EXP PSYCHOL HUMAN, V30, P104, DOI 10.1037/0096-1523.30.1.104; Love BC, 1999, COGNITIVE PSYCHOL, V38, P291, DOI 10.1006/cogp.1998.0697; Luck S., 2008, VISUAL MEMORY; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luria R, 2011, NEUROPSYCHOLOGIA, V49, P1632, DOI 10.1016/j.neuropsychologia.2010.11.031; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Oh H, 2010, J COGNITIVE NEUROSCI, V22, P292, DOI 10.1162/jocn.2009.21250; Ruiz-Soler M, 2006, PSYCHOL RES-PSYCH FO, V70, P273, DOI 10.1007/s00426-005-0215-z; Scolari M, 2008, PSYCHON B REV, V15, P215, DOI 10.3758/PBR.15.1.215; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shen M, J COGN NEUR IN PRESS; Song JH, 2005, J VISION, V5, P322, DOI 10.1167/5.4.4; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Woodman GF, 2008, PSYCHON B REV, V15, P223, DOI 10.3758/PBR.15.1.223; Woodman GF, 2007, CEREB CORTEX, V17, pI118, DOI 10.1093/cercor/bhm065; Xu YD, 2009, TRENDS COGN SCI, V13, P167, DOI 10.1016/j.tics.2009.01.008; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Yin J, 2012, BIOL PSYCHOL, V90, P71, DOI 10.1016/j.biopsycho.2012.02.023; Yin J, 2012, PSYCHON B REV, V19, P218, DOI 10.3758/s13423-011-0201-y; Yin J, 2011, NEUROSCI LETT, V491, P26, DOI 10.1016/j.neulet.2011.01.001; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zhou JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023873	58	24	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57913	10.1371/journal.pone.0057913	http://dx.doi.org/10.1371/journal.pone.0057913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23469103	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900198
J	Jia, X; Zha, TS; Wu, B; Zhang, YQ; Chen, WJ; Wang, XP; Yu, HQ; He, GM				Jia, Xin; Zha, Tianshan; Wu, Bin; Zhang, Yuqing; Chen, Wenjing; Wang, Xiaoping; Yu, Haiqun; He, Guimei			Temperature Response of Soil Respiration in a Chinese Pine Plantation: Hysteresis and Seasonal vs. Diel Q(10)	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; BIOPHYSICAL CONTROLS; CO2 PRODUCTION; WATER-CONTENT; SENSITIVITY; RATES; PHOTOSYNTHESIS; DEPENDENCE; FOREST; FLOOR	Although the temperature response of soil respiration (R-s) has been studied extensively, several issues remain unresolved, including hysteresis in the R-s-temperature relationship and differences in the long- vs. short-term Rs sensitivity to temperature. Progress on these issues will contribute to reduced uncertainties in carbon cycle modeling. We monitored soil CO2 efflux with an automated chamber system in a Pinus tabulaeformis plantation near Beijing throughout 2011. Soil temperature at 10-cm depth (T-s) exerted a strong control over R-s, with the annual temperature sensitivity (Q(10)) and basal rate at 10 degrees C (R-s10) being 2.76 and 1.40 mu mol m(-2) s(-1), respectively. Both R-s and short-term (i.e., daily) estimates of R-s10 showed pronounced seasonal hysteresis with respect to T-s, with the efflux in the second half of the year being larger than that early in the season for a given temperature. The hysteresis may be associated with the confounding effects of microbial population dynamics and/or litter input. As a result, all of the applied regression models failed to yield unbiased estimates of R-s over the entire annual cycle. Lags between R-s and T-s were observed at the diel scale in the early and late growing season, but not in summer. The seasonality in these lags may be due to the use of a single T-s measurement depth, which failed to represent seasonal changes in the depth of CO2 production. Daily estimates of Q(10) averaged 2.04, smaller than the value obtained from the seasonal relationship. In addition, daily Q(10) decreased with increasing T-s, which may contribute feedback to the climate system under global warming scenarios. The use of a fixed, universal Q(10) is considered adequate when modeling annual carbon budgets across large spatial extents. In contrast, a seasonally-varying, environmentally-controlled Q(10) should be used when short-term accuracy is required.	[Jia, Xin; Zha, Tianshan; Wu, Bin; Zhang, Yuqing; Chen, Wenjing] Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China; [Wang, Xiaoping; Yu, Haiqun; He, Guimei] Beijing Forestry Carbon Adm, Beijing, Peoples R China	Beijing Forestry University	Zha, TS (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China.	tianshanzha@bjfu.edu.cn			Beijing Forestry University Young Scientist Fund [BLX2011008]; International Science and Technology Cooperation Program of China [2009DFA92900]; National Key Technology and Science Research and Development Program of China [2008BAD95B07]	Beijing Forestry University Young Scientist Fund; International Science and Technology Cooperation Program of China; National Key Technology and Science Research and Development Program of China	This study was financially supported by the Beijing Forestry University Young Scientist Fund (BLX2011008), International Science and Technology Cooperation Program of China (2009DFA92900), and National Key Technology and Science Research and Development Program of China (2008BAD95B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2005, FOREST ECOL MANAG, V210, P455, DOI 10.1016/j.foreco.2005.02.011; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; BhupinderpalSingh, 2003, PLANT CELL ENVIRON, V26, P1287, DOI 10.1046/j.1365-3040.2003.01053.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Cable JM, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001757; Cao J, 2011, THESIS BEIJING FORES; Chen H, 2005, J INTEGR PLANT BIOL, V47, P1288, DOI 10.1111/j.1744-7909.2005.00211.x; Curiel Yuste J, 2004, GLOBAL CHANGE BIOL, V10, P81; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Gaumont-Guay D, 2008, TREE PHYSIOL, V28, P161, DOI 10.1093/treephys/28.2.161; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Li HJ, 2008, AGR FOREST METEOROL, V148, P490, DOI 10.1016/j.agrformet.2007.10.009; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Moren AS, 2000, AGR FOREST METEOROL, V101, P1, DOI 10.1016/S0168-1923(99)00160-4; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P3102, DOI 10.1111/j.1365-2486.2011.02459.x; Phillips CL, 2011, GLOBAL CHANGE BIOL, V17, P515, DOI 10.1111/j.1365-2486.2010.02250.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Savage K, 2009, AGR FOREST METEOROL, V149, P2012, DOI 10.1016/j.agrformet.2009.07.008; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Tian DL, 2010, CHINESE SCI BULL, V55, P736, DOI 10.1007/s11434-009-0452-4; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Vargas R, 2010, GLOBAL CHANGE BIOL, V16, P1589, DOI 10.1111/j.1365-2486.2009.02111.x; Wang XH, 2010, SOIL BIOL BIOCHEM, V42, P1728, DOI 10.1016/j.soilbio.2010.06.008; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	36	323	329	6	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57858	10.1371/journal.pone.0057858	http://dx.doi.org/10.1371/journal.pone.0057858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469089	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900185
J	Nurminen, L; Kilpelainen, M; Vanni, S				Nurminen, Lauri; Kilpelainen, Markku; Vanni, Simo			Fovea-Periphery Axis Symmetry of Surround Modulation in the Human Visual System	PLOS ONE			English	Article							RANGE LATERAL INTERACTIONS; CLASSICAL RECEPTIVE-FIELD; SURFACE-BASED ANALYSIS; MACAQUE V1; SPATIAL INTERACTIONS; APPARENT CONTRAST; FUNCTIONAL MRI; SUPPRESSION; CORTEX; FMRI	A visual stimulus activates different sized cortical area depending on eccentricity of the stimulus. Here, our aim is to understand whether the visual field size of a stimulus or cortical size of the corresponding representation determines how strongly it interacts with other stimuli. We measured surround modulation of blood-oxygenation-level-dependent signal and perceived contrast with surrounds that extended either towards the periphery or the fovea from a center stimulus, centered at 6 degrees eccentricity. This design compares the effects of two surrounds which are identical in visual field size, but differ in the sizes of their cortical representations. The surrounds produced equally strong suppression, which suggests that visual field size of the surround determines suppression strength. A modeled population of neuronal responses, in which all the parameters were experimentally fixed, captured the pattern of results both in psychophysics and functional magnetic resonance imaging. Although the fovea-periphery anisotropy affects nearly all aspects of spatial vision, our results suggest that in surround modulation the visual system compensates for it.	[Nurminen, Lauri; Vanni, Simo] Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland; [Kilpelainen, Markku] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Vanni, Simo] Aalto Univ, Adv Magnet Imaging Ctr, AALTO NEUROIMAGING, Espoo, Finland	Aalto University; University of Helsinki; Aalto University	Nurminen, L (corresponding author), Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland.	lnurmin@neuro.hut.fi	Kilpeläinen, Markku/AAF-3420-2021; Kilpeläinen, Markku/C-7613-2011; Vanni, Simo/B-9590-2013	Kilpeläinen, Markku/0000-0002-4112-7548; Kilpeläinen, Markku/0000-0002-4112-7548; Vanni, Simo/0000-0002-6101-4129; Nurminen, Lauri/0000-0001-7480-7059	Finnish Graduate School of Neuroscience; National Doctoral Programme of Psychology; Ella and Georg Ehrnrooth Foundation; Academy of Finland [213464, 124698, 140726, 218054]	Finnish Graduate School of Neuroscience; National Doctoral Programme of Psychology; Ella and Georg Ehrnrooth Foundation; Academy of Finland(Academy of Finland)	LN was supported by the Finnish Graduate School of Neuroscience. http://www.brain-mind.fi/. MK was supported by the National Doctoral Programme of Psychology, http://www.dopsy.fi/, and The Ella and Georg Ehrnrooth Foundation, http://www.ellageorg.fi/en. SV was supported by the Academy of Finland grants 213464, 124698, 140726 and 218054 http://www.aka.fi/en-GB/A/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2002, J NEUROSCI, V22, P8633; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2005, CURR OPIN NEUROBIOL, V15, P459, DOI 10.1016/j.conb.2005.07.006; Bair W, 2003, J NEUROSCI, V23, P7690; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BOUMA H, 1973, VISION RES, V13, P767, DOI 10.1016/0042-6989(73)90041-2; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Bullier J, 2001, PROG BRAIN RES, V134, P193; CANNON MW, 1993, VISION RES, V33, P1685, DOI 10.1016/0042-6989(93)90034-T; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen CC, 2001, NEUROREPORT, V12, P655, DOI 10.1097/00001756-200103260-00008; Chen CC, 2002, J VISION, V2, DOI 10.1167/2.6.8; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; EJIMA Y, 1985, VISION RES, V25, P1223, DOI 10.1016/0042-6989(85)90036-7; Felsen G, 2005, NETWORK-COMP NEURAL, V16, P139, DOI 10.1080/09548980500463347; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Haak KV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037686; Henriksson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036859; Ichida JM, 2007, J NEUROPHYSIOL, V98, P2168, DOI 10.1152/jn.00298.2007; Jesmanowicz A, 1998, MAGNET RESON MED, V40, P754, DOI 10.1002/mrm.1910400517; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Levi DM, 2011, J VISION, V11, DOI 10.1167/11.1.10; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; Meese TS, 2007, J VISION, V7, DOI 10.1167/7.4.7; Meirovithz E, 2010, CEREB CORTEX, V20, P1293, DOI 10.1093/cercor/bhp191; Muller JR, 2003, J NEUROPHYSIOL, V90, P822, DOI 10.1152/jn.00005.2003; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Nurminen L, 2010, J VISION, V10, DOI 10.1167/10.13.9; Nurminen L, 2009, J NEUROPHYSIOL, V102, P2900, DOI 10.1152/jn.00201.2009; Olman CA, 2007, NEUROIMAGE, V34, P1126, DOI 10.1016/j.neuroimage.2006.08.045; Olzak LA, 1999, VISION RES, V39, P3983, DOI 10.1016/S0042-6989(99)00131-5; Parkes LM, 2005, MAGN RESON MED, V54, P1465, DOI 10.1002/mrm.20712; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Petrov Y, 2007, J VISION, V7, DOI 10.1167/7.2.12; Pihlaja M, 2008, HUM BRAIN MAPP, V29, P1001, DOI 10.1002/hbm.20442; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Schumacher JF, 2010, VISION RES, V50, P1214, DOI 10.1016/j.visres.2010.04.005; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; Schwabe L, 2010, NEUROIMAGE, V52, P777, DOI 10.1016/j.neuroimage.2010.01.032; Schwartz Eric L., 1994, Cerebral Cortex, V10, P359; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shushruth S, 2009, J NEUROPHYSIOL, V102, P2069, DOI 10.1152/jn.00512.2009; Sillito AM, 1996, J PHYSIOL-PARIS, V90, P205, DOI 10.1016/S0928-4257(97)81424-6; Snowden RJ, 1998, VISION RES, V38, P1935, DOI 10.1016/S0042-6989(97)00379-9; Tajima S, 2010, J NEUROSCI, V30, P3264, DOI 10.1523/JNEUROSCI.4473-09.2010; Vanni S, 2005, NEUROIMAGE, V27, P95, DOI 10.1016/j.neuroimage.2005.01.046; Vanni S, 2011, J COMPUT NEUROSCI, V30, P109, DOI 10.1007/s10827-010-0239-2; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wade AR, 2010, J NEUROSCI, V30, P5008, DOI 10.1523/JNEUROSCI.6260-09.2010; Williams AL, 2003, J NEUROPHYSIOL, V89, P525, DOI 10.1152/jn.00048.2002; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884; Zuiderbaan W, 2012, J VISION, V12, DOI 10.1167/12.3.10	68	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57906	10.1371/journal.pone.0057906	http://dx.doi.org/10.1371/journal.pone.0057906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469101	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900196
J	Saino, N; Romano, M; Rubolini, D; Teplitsky, C; Ambrosini, R; Caprioli, M; Canova, L; Wakamatsu, K				Saino, Nicola; Romano, Maria; Rubolini, Diego; Teplitsky, Celine; Ambrosini, Roberto; Caprioli, Manuela; Canova, Luca; Wakamatsu, Kazumasa			Sexual Dimorphism in Melanin Pigmentation, Feather Coloration and Its Heritability in the Barn Swallow (Hirundo rustica)	PLOS ONE			English	Article							HUMAN HAIR MELANINS; PASSER-DOMESTICUS; PLUMAGE COLOR; CHEMICAL-ANALYSIS; OXIDATIVE STRESS; MIGRATORY BIRD; HOUSE SPARROW; EVOLUTION; PHEOMELANIN; EUMELANIN	Melanin is the main pigment in animal coloration and considerable variation in the concentrations of the two melanin forms (pheo- and eumlanin) in pigmented tissues exists among populations and individuals. Melanin-based coloration is receiving increasing attention particularly in socio-sexual communication contexts because the melanocortin system has been hypothesized to provide a mechanistic basis for covariation between coloration and fitness traits. However, with few notable exceptions, little detailed information is available on inter-individual and inter-population variation in melanin pigmentation and on its environmental, genetic and ontogenetic components. Here, we investigate melanin-based coloration in an Italian population of a passerine bird, the barn swallow (Hirundo rustica rustica), its sex-and age-related variation, and heritability. The concentrations of eu- and pheomelanin in the throat (brown) and belly (white-to-brownish) feathers differed between sexes but not according to age. The relative concentration of either melanin (Pheo:Eu) differed between sexes in throat but not in belly feathers, and the concentrations in males compared to females were larger in belly than in throat feathers. There were weak correlations between the concentrations of melanins within as well as among plumage regions. Coloration of belly feathers was predicted by the concentration of both melanins whereas coloration of throat feathers was only predicted by pheomelanin in females. In addition, Pheo: Eu predicted coloration of throat feathers in females and that of belly feathers in males. Finally, we found high heritability of color of throat feathers. Melanization was found to differ from that recorded in Hirundo rustica rustica from Scotland or from H. r. erythrogaster from North America. Hence, present results show that pigmentation strategies vary in a complex manner according to sex and plumage region, and also among geographical populations, potentially reflecting adaptation to different natural and sexual selection regimes, and that some coloration components seem to be highly heritable.	[Saino, Nicola; Romano, Maria; Rubolini, Diego; Caprioli, Manuela] Univ Milan, Dept Biosci, Milan, Italy; [Teplitsky, Celine] CNRS MNHN UPMC, Dept Ecol & Gest Biodiversite UMR 7204, Paris, France; [Ambrosini, Roberto] Univ Milano Bicocca, Dept Biothecnol & Biosci, Milan, Italy; [Canova, Luca] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi, Japan	University of Milan; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Milano-Bicocca; University of Pavia; Fujita Health University	Saino, N (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	nicola.saino@unimi.it	Teplitsky, Celine/H-3621-2019; Canova, Luca/P-6066-2017; Rubolini, Diego/F-2851-2011; Wakamatsu, Kazumasa/AAZ-5877-2020; Ambrosini, Roberto/F-3188-2012	Teplitsky, Celine/0000-0001-9458-709X; Canova, Luca/0000-0002-5011-7413; Rubolini, Diego/0000-0003-2703-5783; Wakamatsu, Kazumasa/0000-0003-1748-9001; Ambrosini, Roberto/0000-0002-7148-1468; Saino, Nicola/0000-0002-0230-3967				Adachi K, 2010, COMP BIOCHEM PHYS A, V156, P184, DOI 10.1016/j.cbpa.2010.01.021; Antonov A, 2010, J EVOLUTION BIOL, V23, P1170, DOI 10.1111/j.1420-9101.2010.01982.x; Badyaev AV, 2000, BIOL J LINN SOC, V69, P153, DOI 10.1111/j.1095-8312.2000.tb01196.x; Bize P, 2006, EVOLUTION, V60, P2370; Commo S, 2012, INT J COSMETIC SCI, V34, P102, DOI 10.1111/j.1468-2494.2011.00691.x; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Cramp S, 1998, COMPLETE BIRDS W PAL; Dor R, 2012, J HERED, V103, P55, DOI 10.1093/jhered/esr114; Dreiss AN, 2010, BIOL J LINN SOC, V101, P689, DOI 10.1111/j.1095-8312.2010.01503.x; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Eikenaar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023288; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Fargallo JA, 2007, EVOL ECOL, V21, P157, DOI 10.1007/s10682-006-0020-1; Fitze PS, 2002, BEHAV ECOL, V13, P401, DOI 10.1093/beheco/13.3.401; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Galvan I, 2009, FUNCT ECOL, V23, P302, DOI 10.1111/j.1365-2435.2008.01504.x; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Gasparini J, 2009, J ANIM ECOL, V78, P608, DOI 10.1111/j.1365-2656.2008.01521.x; Ginn H. B., 1983, MOULT BIRDS BTO GUID; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Griffith SC, 2000, P ROY SOC B-BIOL SCI, V267, P1115, DOI 10.1098/rspb.2000.1116; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; HAASE E, 1992, J HERED, V83, P64, DOI 10.1093/oxfordjournals.jhered.a111160; HAASE E, 1995, PIGM CELL RES, V8, P164, DOI 10.1111/j.1600-0749.1995.tb00658.x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Hearing V. J., 1998, PIGMENTARY SYSTEM PH, P423; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Hill G. E., 2006, BIRD COLORATION, V2; Hill G. E., 2006, BIRD COLORATION, V1; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2005, HEREDITY, V94, P217, DOI 10.1038/sj.hdy.6800600; HOULE D, 1992, GENETICS, V130, P195; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; Ito S, 2000, PIGM CELL RES, V13, P103, DOI 10.1034/j.1600-0749.13.s8.19.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P63, DOI 10.1111/j.1755-148X.2010.00755.x; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Jensen H, 2006, OIKOS, V114, P212, DOI 10.1111/j.2006.0030-1299.14423.x; Johannesson K, 2002, BIOL J LINN SOC, V76, P137, DOI 10.1111/j.1095-8312.2002.tb01720.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lynch M., 1998, GENETICS ANAL QUANTI; Majerus M, 1998, MELANISM EVOLUTION A; Mathger LM, 2009, J R SOC INTERFACE, V6, pS149, DOI 10.1098/rsif.2008.0366.focus; McGraw KJ, 2005, FUNCT ECOL, V19, P816, DOI 10.1111/j.1365-2435.2005.01032.x; McGraw KJ, 2004, BEHAV ECOL, V15, P889, DOI 10.1093/beheco/arh109; McKenzie CA, 2007, BRIT J NUTR, V98, P159, DOI 10.1017/S0007114507694458; Meunier J, 2011, BEHAV ECOL SOCIOBIOL, V65, P559, DOI 10.1007/s00265-010-1092-z; Aparicio JM, 2012, BIOL J LINN SOC, V105, P925, DOI 10.1111/j.1095-8312.2011.01830.x; Moller AP, 2006, EVOLUTION, V60, P856; Moller AP, 1998, AM NAT, V151, P236, DOI 10.1086/286114; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Moller AP., 1994, SEXUAL SELECTION BAR; Niecke M, 2003, OECOLOGIA, V137, P153, DOI 10.1007/s00442-003-1307-3; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; Pike TW, 2011, FUNCT ECOL, V25, P297, DOI 10.1111/j.1365-2435.2010.01781.x; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Prota G., 1992, MELANINS MELANOGENES, P1; Roulin A, 2003, HEREDITY, V90, P359, DOI 10.1038/sj.hdy.6800260; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Roulin A, 2004, BIOL J LINN SOC, V81, P565, DOI 10.1111/j.1095-8312.2004.00308.x; Roulin A, 2011, J EVOLUTION BIOL, V24, P2241, DOI 10.1111/j.1420-9101.2011.02353.x; Roulin A, 2010, J EVOLUTION BIOL, V23, P2046, DOI 10.1111/j.1420-9101.2010.02086.x; Roulin A, 2008, ANIM BEHAV, V75, P1351, DOI 10.1016/j.anbehav.2007.09.007; Roulin A, 2010, ECOL LETT, V13, P616, DOI 10.1111/j.1461-0248.2010.01459.x; Rubolini D, 2002, J ZOOL, V258, P441, DOI 10.1017/S0952836902001590; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Saino N, 1997, EVOLUTION, V51, P562, DOI 10.1111/j.1558-5646.1997.tb02443.x; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2003, ITAL J ZOOL, V70, P167, DOI 10.1080/11250000309356511; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Saino N, 2012, J ANIM ECOL, V81, P1004, DOI 10.1111/j.1365-2656.2012.01989.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Siefferman L, 2005, EVOLUTION, V59, P1819, DOI 10.1111/j.0014-3820.2005.tb01828.x; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Singaravelan N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008708; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Turner A., 2006, BARN SWALLOW; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Vortman Y, 2011, BEHAV ECOL, V22, P1344, DOI 10.1093/beheco/arr139; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x	83	51	53	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58024	10.1371/journal.pone.0058024	http://dx.doi.org/10.1371/journal.pone.0058024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469134	Green Published, gold			2022-12-27	WOS:000315524900226
J	Saleem, H; Tovey, SC; Riley, AM; Potter, BVL; Taylor, CW				Saleem, Huma; Tovey, Stephen C.; Riley, Andrew M.; Potter, Barry V. L.; Taylor, Colin W.			Stimulation of Inositol 1,4,5-Trisphosphate (IP3) Receptor Subtypes by Adenophostin A and Its Analogues	PLOS ONE			English	Article							PENICILLIUM-BREVICOMPACTUM; MOLECULAR RECOGNITION; POTENT AGONISTS; CALCIUM-RELEASE; XENOPUS OOCYTES; CL-CURRENTS; I-CRAC; ACTIVATION; ADENINE; BINDING	Inositol 1,4,5-trisphosphate receptors (IP3R) are intracellular Ca2+ channels. Most animal cells express mixtures of the three IP3R subtypes encoded by vertebrate genomes. Adenophostin A (AdA) is the most potent naturally occurring agonist of IP3R and it shares with IP3 the essential features of all IP3R agonists, namely structures equivalent to the 4,5-bisphosphate and 6-hydroxyl of IP3. The two essential phosphate groups contribute to closure of the clam-like IP3-binding core (IBC), and thereby IP3R activation, by binding to each of its sides (the alpha- and beta-domains). Regulation of the three subtypes of IP3R by AdA and its analogues has not been examined in cells expressing defined homogenous populations of IP3R. We measured Ca2+ release evoked by synthetic adenophostin A (AdA) and its analogues in permeabilized DT40 cells devoid of native IP3R and stably expressing single subtypes of mammalian IP3R. The determinants of high-affinity binding of AdA and its analogues were indistinguishable for each IP3R subtype. The results are consistent with a cation-pi interaction between the adenine of AdA and a conserved arginine within the IBC alpha-domain contributing to closure of the IBC. The two complementary contacts between AdA and the alpha-domain (cation-pi interaction and 3 ''-phosphate) allow activation of IP3R by an analogue of AdA (3 ''-dephospho-AdA) that lacks a phosphate group equivalent to the essential 5-phosphate of IP3. These data provide the first structure-activity analyses of key AdA analogues using homogenous populations of all mammalian IP3R subtypes. They demonstrate that differences in the Ca2+ signals evoked by AdA analogues are unlikely to be due to selective regulation of IP3R subtypes.	[Saleem, Huma; Tovey, Stephen C.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Riley, Andrew M.; Potter, Barry V. L.] Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Cambridge; University of Bath	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	cwt1000@cam.ac.uk	Riley, Andrew M/F-3526-2013; Potter, Barry/AAX-4781-2020; Taylor, Colin/G-2447-2010	Riley, Andrew M/0000-0001-9003-3540; Taylor, Colin/0000-0001-7771-1044	Wellcome Trust [085295, 082837]; Jameel Family Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Jameel Family Trust	This work was supported by grants from the Wellcome Trust to CWT [085295], and BVLP and AMR [082837]. HS is supported by a research studentship from the Jameel Family Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird GS, 1999, J BIOL CHEM, V274, P20643, DOI 10.1074/jbc.274.29.20643; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Correa V, 2001, MOL PHARMACOL, V59, P1206, DOI 10.1124/mol.59.5.1206; DeLisle S, 1997, J BIOL CHEM, V272, P9956; Felemez M, 2000, NEW J CHEM, V24, P631, DOI 10.1039/b002457k; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gregory RB, 1999, BIOCHEM J, V341, P401, DOI 10.1042/0264-6021:3410401; Hartzell HC, 1997, MOL PHARMACOL, V51, P683, DOI 10.1124/mol.51.4.683; HIROSE K, 1994, NATURE, V372, P791; Hotoda H, 1999, BIOCHEMISTRY-US, V38, P9234, DOI 10.1021/bi990114r; HOTODA H, 1995, TETRAHEDRON LETT, V36, P5037, DOI 10.1016/0040-4039(95)00916-Z; Huang Y, 1998, J BIOL CHEM, V273, P31815, DOI 10.1074/jbc.273.48.31815; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jenkins DJ, 1997, CHEM COMMUN, P449, DOI 10.1039/a608208d; Machaca K, 1999, J BIOL CHEM, V274, P4824, DOI 10.1074/jbc.274.8.4824; Mak DOD, 2001, J GEN PHYSIOL, V117, P299, DOI 10.1085/jgp.117.4.299; Marchant JS, 1998, BIOCHEM J, V334, P505, DOI 10.1042/bj3340505; Marwood RD, 2000, J MED CHEM, V43, P4278, DOI 10.1021/jm000265o; Marwood RD, 2000, J CHEM SOC PERK T 1, P1935, DOI 10.1039/b001386m; Marwood RD, 1999, BIOORG MED CHEM LETT, V9, P453, DOI 10.1016/S0960-894X(99)00006-2; Marwood RD, 2000, TETRAHEDRON-ASYMMETR, V11, P397, DOI 10.1016/S0957-4166(99)00491-7; MUALLEM S, 1989, J BIOL CHEM, V264, P205; Nerou EP, 2001, BIOCHEM J, V355, P59, DOI 10.1042/bj3550059; Ott R. L., 2010, INTRO STAT METHODS D, P1273; Parekh AB, 2002, BIOCHEM J, V361, P133, DOI 10.1042/0264-6021:3610133; POLOKOFF MA, 1988, J BIOL CHEM, V263, P11922; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Rossi AM, 2010, BRIT J PHARMACOL, V161, P1070, DOI 10.1111/j.1476-5381.2010.00947.x; Rossi AM, 2010, CURR TOP MEMBR, V66, P209, DOI 10.1016/S1063-5823(10)66010-3; SAFRANY ST, 1991, FEBS LETT, V278, P252, DOI 10.1016/0014-5793(91)80128-P; Saleem H, 2012, PLOS ONE IN PRESS; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Shuto S, 1998, J ORG CHEM, V63, P8815, DOI 10.1021/jo980925l; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sureshan KM, 2012, J MED CHEM, V55, P1706, DOI 10.1021/jm201571p; Sureshan KM, 2009, CHEM COMMUN, P1204, DOI 10.1039/b819328b; TAKAHASHI M, 1993, J ANTIBIOT, V46, P1643, DOI 10.7164/antibiotics.46.1643; TAKAHASHI M, 1994, J BIOL CHEM, V269, P369; TAKAHASHI S, 1994, J ANTIBIOT, V47, P95, DOI 10.7164/antibiotics.47.95; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; TAYLOR CW, 1990, BIOCHEM J, V266, P189, DOI 10.1042/bj2660189; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Wilcox RA, 1998, TRENDS PHARMACOL SCI, V19, P467, DOI 10.1016/S0165-6147(98)01260-7; WILCOX RA, 1994, J BIOL CHEM, V269, P26815; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129	47	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58027	10.1371/journal.pone.0058027	http://dx.doi.org/10.1371/journal.pone.0058027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469136	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900227
J	Selmer, C; Hansen, ML; Olesen, JB; Merie, C; Lindhardsen, J; Olsen, AMS; Madsen, JC; Schmidt, U; Faber, J; Hansen, PR; Pedersen, OD; Torp-Pedersen, C; Gislason, GH				Selmer, Christian; Hansen, Morten Lock; Olesen, Jonas Bjerring; Merie, Charlotte; Lindhardsen, Jesper; Olsen, Anne-Marie Schjerning; Madsen, Jesper Clausager; Schmidt, Ulla; Faber, Jens; Hansen, Peter Riis; Pedersen, Ole Dyg; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar			New-Onset Atrial Fibrillation Is a Predictor of Subsequent Hyperthyroidism: A Nationwide Cohort Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; THYROID-FUNCTION; OVERT HYPERTHYROIDISM; HOSPITAL DISCHARGE; BETA-BLOCKERS; RISK; REGISTRY; ASSOCIATION; MORTALITY; STROKE	Aims: To examine the long-term risk of hyperthyroidism in patients admitted to hospital with new-onset AF. Hyperthyroidism is a well-known risk factor for atrial fibrillation (AF), but it is unknown whether new-onset AF predicts later-occurring hyperthyroidism. Methods and Results: All patients admitted with new-onset AF in Denmark from 1997-2009, and their present and subsequent use of anti-thyroid medication was identified by individual-level linkage of nationwide registries. Patients with previous thyroid diagnosis or thyroid medication use were excluded. Development of hyperthyroidism was assessed as initiation of methimazole or propylthiouracil up to a 13-year period. Risk of hyperthyroidism was analysed by Poisson regression models adjusted for important confounders such as amiodarone treatment. Non-AF individuals from the general population served as reference. A total of 145,623 patients with new-onset AF were included (mean age 66.4 years [SD 613.2] and 55.3% males) of whom 3% (4,620 events; 62.2% women) developed hyperthyroidism in the post-hospitalization period compared to 1% (48,609 events; 82% women) in the general population (n = 3,866,889). In both women and men we found a significantly increased risk of hyperthyroidism associated with new-onset AF compared to individuals in the general population. The highest risk was found in middle-aged men and was consistently increased throughout the 13-year period of observation. The results were confirmed in a substudy analysis of 527,352 patients who had thyroid screening done. Conclusion: New-onset AF seems to be a predictor of hyperthyroidism. Increased focus on subsequent risk of hyperthyroidism in patients with new-onset AF is warranted.	[Selmer, Christian; Hansen, Morten Lock; Olesen, Jonas Bjerring; Merie, Charlotte; Lindhardsen, Jesper; Olsen, Anne-Marie Schjerning; Hansen, Peter Riis; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Pedersen, Ole Dyg] Roskilde Univ Hosp, Dept Cardiol, Roskilde, Denmark; [Schmidt, Ulla; Faber, Jens] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark; [Madsen, Jesper Clausager] Copenhagen Gen Practitioners Lab, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Selmer, C (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	cselmer@gmail.com	Hansen, Peter Riis/AAR-7659-2020; Selmer, Christian/H-3314-2019; Gislason, Gunnar/B-7561-2009; Torp-Pedersen, Christian/E-5931-2013	Selmer, Christian/0000-0002-0534-3163; Gislason, Gunnar/0000-0002-0548-402X; Hansen, Peter Riis/0000-0002-9056-535X	Danish Heart Foundation [11-04-R84-A3483-22669]; Danish Thyroid Association; Agnes and Knut Mork Foundation; FUKAP Foundation, Gentofte University Hospital, Denmark; START Foundation, Gentofte University Hospital, Denmark	Danish Heart Foundation; Danish Thyroid Association; Agnes and Knut Mork Foundation; FUKAP Foundation, Gentofte University Hospital, Denmark; START Foundation, Gentofte University Hospital, Denmark	The study was funded in part by unrestricted grants from the The Danish Heart Foundation (Ref. no. 11-04-R84-A3483-22669), The Danish Thyroid Association, The Agnes and Knut Mork Foundation, and the FUKAP and START Foundations, Gentofte University Hospital, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Batcher EL, 2007, AM J MED, V120, P880, DOI 10.1016/j.amjmed.2007.04.022; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Biondi B, 2010, NAT REV ENDOCRINOL, V6, P431, DOI 10.1038/nrendo.2010.105; Brandt F, 2011, EUR J ENDOCRINOL, V165, P491, DOI 10.1530/EJE-11-0299; Buccelletti F, 2011, AM J EMERG MED, V29, P1158, DOI 10.1016/j.ajem.2010.06.010; Cerqueira C, 2009, J CLIN ENDOCR METAB, V94, P2400, DOI 10.1210/jc.2009-0123; Chen YC, 2002, J AM COLL CARDIOL, V39, P366, DOI 10.1016/S0735-1097(01)01731-4; Collet T-H, 2012, ARCH INTERN MED; Faber J, 2001, EUR J ENDOCRINOL, V145, P391, DOI 10.1530/eje.0.1450391; Friberg J, 2003, EPIDEMIOLOGY, V14, P666, DOI 10.1097/01.ede.0000091649.26364.c0; Frost L, 2006, NEUROEPIDEMIOLOGY, V26, P212, DOI 10.1159/000092795; Gammage MD, 2007, ARCH INTERN MED, V167, P928, DOI 10.1001/archinte.167.9.928; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Hansen ML, 2008, EUROPACE, V10, P395, DOI 10.1093/europace/eun011; Heeringa J, 2008, ARCH INTERN MED, V168, P2219, DOI 10.1001/archinte.168.20.2219; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Krahn AD, 1996, ARCH INTERN MED, V156, P2221, DOI 10.1001/archinte.156.19.2221; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Le Heuzey JY, 2010, AM J CARDIOL, V105, P687, DOI 10.1016/j.amjcard.2009.10.012; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Nabauer M, 2009, EUROPACE, V11, P423, DOI 10.1093/europace/eun369; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Nuttall M, 2006, J CLIN EPIDEMIOL, V59, P265, DOI 10.1016/j.jclinepi.2005.07.015; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Purtell K, 2010, INT J BIOCHEM CELL B, V42, P1767, DOI 10.1016/j.biocel.2010.07.013; Rasmussen LB, 2002, BRIT J NUTR, V87, P61, DOI 10.1079/BJN2001474; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Siu CW, 2009, AM J CARDIOL, V103, P540, DOI 10.1016/j.amjcard.2008.10.019; Stavrakis S, 2009, J AM COLL CARDIOL, V54, P1309, DOI 10.1016/j.jacc.2009.07.015; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83	39	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57893	10.1371/journal.pone.0057893	http://dx.doi.org/10.1371/journal.pone.0057893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469097	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900193
J	Brock, GR; Kim, G; Ingraffea, AR; Andrews, JC; Pianetta, P; van der Meulen, MCH				Brock, Garry R.; Kim, Grace; Ingraffea, Anthony R.; Andrews, Joy C.; Pianetta, Piero; van der Meulen, Marjolein C. H.			Nanoscale Examination of Microdamage in Sheep Cortical Bone Using Synchrotron Radiation Transmission X-Ray Microscopy	PLOS ONE			English	Article							MATRIX MICRODAMAGE; DIFFUSE DAMAGE; FATIGUE; ACCUMULATION	Microdamage occurs in bone through repeated and excessive loading. Accumulation of microdamage weakens bone, leading to a loss of strength, stiffness and energy dissipation in the tissue. Imaging techniques used to examine microdamage have typically been limited to the microscale. In the current study microdamage was examined at the nanoscale using transmission x-ray microscopy with an x-ray negative stain, lead-uranyl acetate. Microdamage was generated in notched and unnotched beams of sheep cortical bone (2x2x20 mm), with monotonic and fatigue loading. Bulk sections were removed from beams and stained with lead-uranyl acetate to identify microdamage. Samples were sectioned to 50 microns and imaged using transmission x-ray microscopy producing projection images of microdamage with nanoscale resolution. Staining indicated microdamage occurred in both the tensile and compressive regions. A comparison between monotonic and fatigue loading indicated a statistically significant greater amount of stain present in fatigue loaded sections. Microdamage occurred in three forms: staining to existing bone structures, cross hatch damage and a single crack extending from the notch tip. Comparison to microcomputed tomography demonstrated differences in damage morphology and total damage between the microscale and nanoscale. This method has future applications for understanding the underlying mechanisms for microdamage formation as well as three-dimensional nanoscale examination of microdamage.	[Brock, Garry R.; Kim, Grace; van der Meulen, Marjolein C. H.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Ingraffea, Anthony R.] Cornell Univ, Sch Civil & Environm Engn, Ithaca, NY 14853 USA; [Andrews, Joy C.; Pianetta, Piero] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [van der Meulen, Marjolein C. H.] Hosp Special Surg, Div Res, New York, NY 10021 USA	Cornell University; Cornell University	van der Meulen, MCH (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	mcv3@cornell.edu	ingraffea, anthony/AAU-6221-2021; van der Meulen, Marjolein C. H./D-1549-2010; Pianetta, Piero/GLS-9094-2022	van der Meulen, Marjolein C. H./0000-0001-6637-9808; Pianetta, Piero/0000-0002-4834-6014	National Institutes of Health [R01-AR053571, NIH R01-EB004321]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by National Institutes of Health R01-AR053571 and NIH R01-EB004321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JC, 2010, MICROSC MICROANAL, V16, P327, DOI 10.1017/S1431927610000231; Boyce TM, 1998, J ORTHOP RES, V16, P322, DOI 10.1002/jor.1100160308; Burr D, 2003, OSTEOPOROSIS INT, V14, pS67, DOI 10.1007/s00198-003-1476-2; BURR DB, 1990, CLIN ORTHOP RELAT R, P305, DOI 10.1097/00003086-199011000-00047; Burr DB, 1998, J BIOMECH, V21, P939; Donnelly E, 2006, J BIOMED MATER RES A, V77A, P426, DOI 10.1002/jbm.a.30633; Ebacher V, 2009, MATER RES SOC SYMP P, V1187, P141; Fazzalari NL, 1998, BONE, V23, P373, DOI 10.1016/S8756-3282(98)00111-2; GIMENEZMARTIN G, 1967, EXPERIENTIA, V23, P316, DOI 10.1007/BF02135708; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Jepsen KJ, 1999, J BIOMECH, V32, P303, DOI 10.1016/S0021-9290(98)00179-1; LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0; Landrigan MD, 2009, J BIOMECH, V42, P1212, DOI 10.1016/j.jbiomech.2009.03.016; Larrue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021297; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Leng HJ, 2008, J MECH BEHAV BIOMED, V1, P68, DOI 10.1016/j.jmbbm.2007.06.002; Liu YJ, 2012, OPT LETT, V37, P3708, DOI 10.1364/OL.37.003708; Liu YJ, 2012, J SYNCHROTRON RADIAT, V19, P281, DOI 10.1107/S0909049511049144; McMahon BK, 2011, AUST J CHEM, V64, P600, DOI 10.1071/CH11021; Muir P, 1999, BONE, V25, P571, DOI 10.1016/S8756-3282(99)00205-7; O'Brien FJ, 2007, INT J FATIGUE, V29, P1051, DOI 10.1016/j.ijfatigue.2006.09.017; O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6; Parsamian GP, 2001, J MATER SCI-MATER M, V12, P779, DOI 10.1023/A:1017916800421; Portero-Muzy NR, 2011, BONE, V49, P917, DOI 10.1016/j.bone.2011.07.001; Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050; Reilly GC, 2000, J BIOMECH, V33, P1131, DOI 10.1016/S0021-9290(00)00090-7; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2; Tang SY, 2007, BONE, V40, P1259, DOI 10.1016/j.bone.2006.10.031; Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003; Vashishth D, 2000, BONE, V26, P147, DOI 10.1016/S8756-3282(99)00253-7; Voide R, 2009, BONE, V45, P164, DOI 10.1016/j.bone.2009.04.248; Wang X, 2007, J BIOMECH, V40, P3397, DOI 10.1016/j.jbiomech.2007.05.009; Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zhang ZY, 2010, NANOSCALE, V2, P582, DOI 10.1039/b9nr00317g	37	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57942	10.1371/journal.pone.0057942	http://dx.doi.org/10.1371/journal.pone.0057942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472121	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900064
J	Bromley, SK; Larson, RP; Ziegler, SF; Luster, AD				Bromley, Shannon K.; Larson, Ryan P.; Ziegler, Steven F.; Luster, Andrew D.			IL-23 Induces Atopic Dermatitis-Like Inflammation Instead of Psoriasis-Like Inflammation in CCR2-Deficient Mice	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; HUMAN TH17 CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR (CCR)2; CHRONIC PLAQUE PSORIASIS; HUMAN EPITHELIAL-CELLS; T-CELLS; DENDRITIC CELLS; AIRWAY INFLAMMATION	Psoriasis is an immune-mediated chronic inflammatory skin disease, characterized by epidermal hyperplasia and infiltration of leukocytes into the dermis and epidermis. IL-23 is expressed in psoriatic skin, and IL-23 injected into the skin of mice produces IL-22-dependent dermal inflammation and acanthosis. The chemokine receptor CCR2 has been implicated in the pathogenesis of several inflammatory diseases, including psoriasis. CCR2-positive cells and the CCR2 ligand, CCL2 are abundant in psoriatic lesions. To examine the requirement of CCR2 in the development of IL-23-induced cutaneous inflammation, we injected the ears of wild-type (WT) and CCR2-deficient (CCR2(-)/(-)) mice with IL-23. CCR2(-)/(-) mice had increased ear swelling and epidermal thickening, which was correlated with increased cutaneous IL-4 levels and increased numbers of eosinophils within the skin. In addition, TSLP, a cytokine known to promote and amplify T helper cell type 2 (Th2) immune responses, was also increased within the inflamed skin of CCR2(-)/(-) mice. Our data suggest that increased levels of TSLP in CCR2(-)/(-) mice may contribute to the propensity of these mice to develop increased Th2-type immune responses.	[Bromley, Shannon K.; Luster, Andrew D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02115 USA; [Larson, Ryan P.; Ziegler, Steven F.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Larson, Ryan P.; Ziegler, Steven F.] Virginia Mason, Program Immunol, Benaroya Res Inst, Seattle, WA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Benaroya Research Institute; Virginia Mason Medical Center	Bromley, SK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02115 USA.	sbromley@helix.mgh.harvard.edu; aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	National Institutes of Health [R37-AI040618, R01-AR056113, K01-AR053715]; Claflin Distinguished Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053715, R01AR056113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claflin Distinguished Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Institutes of Health grant R37-AI040618 to ADL, R01-AR056113 to SFZ, and K01-AR053715 to SKB and a Claflin Distinguished Scholar Award to SKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bogiatzi SI, 2007, J IMMUNOL, V178, P3373, DOI 10.4049/jimmunol.178.6.3373; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Charo I F, 1999, Chem Immunol, V72, P30, DOI 10.1159/000058724; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Deleuran M, 1996, J DERMATOL SCI, V13, P228, DOI 10.1016/S0923-1811(96)00539-7; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; GILLITZER R, 1993, J INVEST DERMATOL, V101, P127, DOI 10.1111/1523-1747.ep12363613; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; HAMID Q, 1994, J CLIN INVEST, V94, P870, DOI 10.1172/JCI117408; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Indramohan M, 2012, INFECT IMMUNITY; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jessup HK, 2008, J IMMUNOL, V181, P4311, DOI 10.4049/jimmunol.181.6.4311; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Kim Y, 2001, J IMMUNOL, V166, P5183, DOI 10.4049/jimmunol.166.8.5183; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Li JO, 2010, J GENE MED, V12, P481, DOI 10.1002/jgm.1459; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Pan GH, 2001, J IMMUNOL, V167, P6559, DOI 10.4049/jimmunol.167.11.6559; Papp KA, 2012, J INVESTIGATIVE DERM; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Rampersad RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025833; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spadoni I, 2012, MUCOSAL IMMUNOL, V5, P184, DOI 10.1038/mi.2011.64; Szabo SK, 1998, J INVEST DERMATOL, V111, P1072, DOI 10.1046/j.1523-1747.1998.00419.x; Traynor TR, 2000, J IMMUNOL, V164, P2021, DOI 10.4049/jimmunol.164.4.2021; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wong CK, 2010, AM J RESP CELL MOL, V43, P305, DOI 10.1165/rcmb.2009-0168OC; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang Y, 2010, DERMATOLOGY, V221, P84, DOI 10.1159/000314154; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	66	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58196	10.1371/journal.pone.0058196	http://dx.doi.org/10.1371/journal.pone.0058196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472158	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900104
J	Chen, YL; Lehman, VN; Averette, AF; Perfect, JR; Heitman, J				Chen, Ying-Lien; Lehman, Virginia N.; Averette, Anna F.; Perfect, John R.; Heitman, Joseph			Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans	PLOS ONE			English	Article							COMBINATION THERAPY; FLUCONAZOLE; CALCINEURIN; RESISTANCE; INFECTION; CYCLOSPORINE; TACROLIMUS; MANAGEMENT; EVOLUTION; VIRULENCE	The object of this study was to test whether posaconazole, a broad-spectrum antifungal agent inhibiting ergosterol biosynthesis, exhibits synergy with the beta-1,3 glucan synthase inhibitor caspofungin or the calcineurin inhibitor FK506 against the human fungal pathogen Candida albicans. Although current drug treatments for Candida infection are often efficacious, the available antifungal armamentarium may not be keeping pace with the increasing incidence of drug resistant strains. The development of drug combinations or novel antifungal drugs to address emerging drug resistance is therefore of general importance. Combination drug therapies are employed to treat patients with HIV, cancer, or tuberculosis, and has considerable promise in the treatment of fungal infections like cryptococcal meningitis and C. albicans infections. Our studies reported here demonstrate that posaconazole exhibits in vitro synergy with caspofungin or FK506 against drug susceptible or resistant C. albicans strains. Furthermore, these combinations also show in vivo synergy against C. albicans strain SC5314 and its derived echinocandin-resistant mutants, which harbor an S645Y mutation in the CaFks1 beta-1,3 glucan synthase drug target, suggesting potential therapeutic applicability for these combinations in the future.	[Chen, Ying-Lien; Lehman, Virginia N.; Averette, Anna F.; Heitman, Joseph] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA; [Chen, Ying-Lien] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Lehman, Virginia N.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Perfect, John R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; National Taiwan University; Duke University; Duke University	Heitman, J (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021	Chen, Ying-Lien/0000-0002-1966-470X	Merck Co., Inc.; Astellas Pharma, Inc.; Duke University Center for AIDS Research (CFAR) [2P30 AI064518-06]; NIH/NIAID [AI50438]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, R01AI050438] Funding Source: NIH RePORTER	Merck Co., Inc.(Merck & Company); Astellas Pharma, Inc.(Astellas Pharmaceuticals); Duke University Center for AIDS Research (CFAR); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Pilot funds from Merck & Co., Inc. and Astellas Pharma, Inc., and in part by the Duke University Center for AIDS Research (CFAR) grant (2P30 AI064518-06 to Y.-L.C.) and NIH/NIAID R01 grant AI50438 (J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andes D, 2006, ANTIMICROB AGENTS CH, V50, P2374, DOI 10.1128/AAC.01053-05; Andes D, 2004, ANTIMICROB AGENTS CH, V48, P137, DOI 10.1128/AAC.48.1.137-142.2004; Berge M, 2009, THER DRUG MONIT, V31, P396, DOI 10.1097/FTD.0b013e31819de6fd; Billaud EM, 2010, MED MYCOL, V48, pS52, DOI 10.3109/13693786.2010.505203; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cacciapuoti A, 2006, ANTIMICROB AGENTS CH, V50, P2587, DOI 10.1128/AAC.00829-05; Calderone Richard A., 2002, P3; CALIENDO AM, 1994, CLIN INFECT DIS, V18, P516, DOI 10.1093/clinids/18.4.516; Chaturvedi V, 2011, ANTIMICROB AGENTS CH, V55, P1543, DOI 10.1128/AAC.01510-09; Chatzimoschou A, 2011, ANTIMICROB AGENTS CH, V55, P1968, DOI 10.1128/AAC.00959-10; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Chen YL, 2010, CURR FUNGAL INFECT R, V4, P244, DOI 10.1007/s12281-010-0027-5; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Dannaoui E, 2009, ANTIMICROB AGENTS CH, V53, P3549, DOI 10.1128/AAC.00184-09; Dolton MJ, 2012, ANTIMICROB AGENTS CH, V56, P2806, DOI 10.1128/AAC.05900-11; Firinu D, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/283239; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P112, DOI 10.1128/AAC.01162-08; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Graybill JR, 2003, ANTIMICROB AGENTS CH, V47, P2373, DOI 10.1128/AAC.47.7.2373-2375.2003; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Johnson MD, 2010, CURR FUNGAL INFECT R, V4, P87, DOI 10.1007/s12281-010-0018-6; Klepser ME, 1998, ANTIMICROB AGENTS CH, V42, P1387, DOI 10.1128/AAC.42.6.1387; Lewis RE, 2013, J INFECT DIS; Maesaki S, 1998, J ANTIMICROB CHEMOTH, V42, P747, DOI 10.1093/jac/42.6.747; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2932, DOI 10.1128/AAC.44.11.2932-2938.2000; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; MOERSCHELL RP, 1991, METHOD ENZYMOL, V194, P362; MOERSCHELL RP, 1988, P NATL ACAD SCI USA, V85, P524, DOI 10.1073/pnas.85.2.524; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Narreddy S, 2010, J ANTIMICROB CHEMOTH, V65, P701, DOI 10.1093/jac/dkq020; Ngai AL, 2011, INT J ANTIMICROB AG, V38, P540, DOI 10.1016/j.ijantimicag.2011.07.008; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Oliveira ER, 2005, ANTIMICROB AGENTS CH, V49, P3544, DOI 10.1128/AAC.49.8.3544-3545.2005; Onyewu C, 2006, ANTIMICROB AGENTS CH, V50, P3963, DOI 10.1128/AAC.00393-06; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Schuetzer-Muehlbauer M, 2003, MOL MICROBIOL, V48, P225, DOI 10.1046/j.1365-2958.2003.03430.x; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Vazquez JA, 2006, CLIN INFECT DIS, V42, P1179, DOI 10.1086/501457; White T C, 1997, Oral Dis, V3 Suppl 1, pS102; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; Worth LJ, 2008, INTERN MED J, V38, P521, DOI 10.1111/j.1445-5994.2008.01726.x; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044192; Zhang Jing, 2012, Commun Integr Biol, V5, P122, DOI 10.4161/cib.18833	46	44	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57672	10.1371/journal.pone.0057672	http://dx.doi.org/10.1371/journal.pone.0057672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472097	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900036
J	Chou, HJ; Lai, DM; Huang, CW; McLennan, IS; Wang, HD; Wang, PY				Chou, Hui-Ju; Lai, Dar-Ming; Huang, Cheng-Wen; McLennan, Ian S.; Wang, Horng-Dar; Wang, Pei-Yu			BMP4 Is a Peripherally-Derived Factor for Motor Neurons and Attenuates Glutamate-Induced Excitotoxicity In Vitro	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CILIARY NEUROTROPHIC FACTOR; SPINAL-CORD-INJURY; SCHWANN-CELLS; SCIATIC-NERVE; MOTONEURONS; SURVIVAL; MUSCLE; GROWTH; GENE	Bone morphogenetic proteins (BMPs), members of the transforming growth factor-beta (TGF-beta) superfamily, have been shown to play important roles in the nervous system, including neuronal survival and synaptogenesis. However, the physiological functions of BMP signaling in the mammalian neuromuscular system are not well understood. In this study, we found that proteins of the type II bone morphogenetic receptors (BMPRII) were detected at the neuromuscular junction (NMJ), and one of its ligands, BMP4, was expressed by Schwann cells and skeletal muscle fibers. In double-ligated nerves, BMP4 proteins accumulated at the proximal and distal portions of the axons, suggesting that Schwann cell-and muscle fiber-derived BMP4 proteins were anterogradely and retrogradely transported by motor neurons. Furthermore, BMP4 mRNA was down-regulated in nerves but up-regulated in skeletal muscles following nerve ligation. The motor neuron-muscle interactions were also demonstrated using differentiated C2C12 muscle cells and NG108-15 neurons in vitro. BMP4 mRNA and immunoreactivity were significantly up-regulated in differentiated C2C12 muscle cells when the motor neuron-derived factor, agrin, was present in the culture. Peripherally-derived BMP4, on the other hand, promotes embryonic motor neuron survival and protects NG108-15 neurons from glutamate-induced excitotoxicity. Together, these data suggest that BMP4 is a peripherally-derived factor that may regulate the survival of motor neurons.	[Chou, Hui-Ju; Huang, Cheng-Wen; Wang, Pei-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Chou, Hui-Ju; Wang, Pei-Yu] Natl Chengchi Univ, Inst Neurosci, Taipei 11623, Taiwan; [Chou, Hui-Ju; Wang, Pei-Yu] Natl Chengchi Univ, Res Ctr Mind Brain & Learning, Taipei 11623, Taiwan; [Lai, Dar-Ming] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Huang, Cheng-Wen; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [McLennan, Ian S.] Univ Otago, Dept Anat, Dunedin, New Zealand	National Taiwan University; National Chengchi University; National Chengchi University; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; University of Otago	Wang, PY (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan.	wangpeiyu@ntu.edu.tw		WANG, PEI-YU/0000-0002-1792-8935; Wang, Horng-Dar/0000-0001-9570-3611	National Science Council, Taiwan [NSC 98-2320-B-004-003-MY2, NSC 100-2311-B-002-017-MY3, NSC 101-2311-B-007-004-]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grants (NSC 98-2320-B-004-003-MY2 and NSC 100-2311-B-002-017-MY3) to P.-Y. Wang, and (NSC 101-2311-B-007-004-) to H.-D. Wang from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; CHOI DW, 1987, J NEUROSCI, V7, P369; Choi RCY, 1997, NEUROSCI LETT, V236, P167, DOI 10.1016/S0304-3940(97)00789-1; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; ISHII DN, 1989, P NATL ACAD SCI USA, V86, P2898, DOI 10.1073/pnas.86.8.2898; Jiang Y, 2000, NEUROSCIENCE, V97, P735, DOI 10.1016/S0306-4522(00)00084-1; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Lacazette E, 2003, J CELL BIOL, V161, P727, DOI 10.1083/jcb.200210156; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; LOWRIE MB, 1992, TRENDS NEUROSCI, V15, P80, DOI 10.1016/0166-2236(92)90014-Y; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Matsuura I, 2008, J NEUROCHEM, V105, P1471, DOI 10.1111/j.1471-4159.2008.05251.x; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McGeachie AB, 2001, NEUROSCIENCE, V104, P891, DOI 10.1016/S0306-4522(01)00129-4; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; Parikh P, 2011, P NATL ACAD SCI USA, V108, pE99, DOI 10.1073/pnas.1100426108; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Russell FD, 2000, NEUROSCIENCE, V97, P575, DOI 10.1016/S0306-4522(00)00079-8; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Sakamoto T, 2003, J NEUROSCI RES, V72, P54, DOI 10.1002/jnr.10558; SENDTNER M, 1992, J CELL BIOL, V118, P139, DOI 10.1083/jcb.118.1.139; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tan TW, 2012, J CELL PHYSIOL, V227, P2531, DOI 10.1002/jcp.22991; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Wang PY, 2007, MOL CELL NEUROSCI, V34, P653, DOI 10.1016/j.mcn.2007.01.008; Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106; Wang PY, 2005, P NATL ACAD SCI USA, V102, P16421, DOI 10.1073/pnas.0508304102; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	44	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58441	10.1371/journal.pone.0058441	http://dx.doi.org/10.1371/journal.pone.0058441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472198	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900144
J	van Bussel, BCT; Ferreira, I; van de Waarenburg, MPH; van Greevenbroek, MMJ; van der Kallen, CJH; Henry, RMA; Feskens, EJM; Stehouwer, CDA; Schalkwijk, CG				van Bussel, Bas C. T.; Ferreira, Isabel; van de Waarenburg, Marjo P. H.; van Greevenbroek, Marleen M. J.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Feskens, Edith J. M.; Stehouwer, Coen D. A.; Schalkwijk, Casper G.			Multiple Inflammatory Biomarker Detection in a Prospective Cohort Study: A Cross-Validation between Well-Established Single-Biomarker Techniques and an Electrochemiluminescense-Based Multi-Array Platform	PLOS ONE			English	Article							PUBLIC-HEALTH PRACTICE; LOW-GRADE INFLAMMATION; CARDIOVASCULAR-DISEASE; DEMING REGRESSION; RISK; ATHEROSCLEROSIS; CYTOKINES; MARKERS; MECHANISMS; PREDICTION	Background: In terms of time, effort and quality, multiplex technology is an attractive alternative for well-established single-biomarker measurements in clinical studies. However, limited data comparing these methods are available. Methods: We measured, in a large ongoing cohort study (n = 574), by means of both a 4-plex multi-array biomarker assay developed by MesoScaleDiscovery (MSD) and single-biomarker techniques (ELISA or immunoturbidimetric assay), the following biomarkers of low-grade inflammation: C-reactive protein (CRP), serum amyloid A (SAA), soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vascular cell adhesion molecule 1 (sVCAM-1). These measures were realigned by weighted Deming regression and compared across a wide spectrum of subjects' cardiovascular risk factors by ANOVA. Results: Despite that both methods ranked individuals' levels of biomarkers very similarly (Pearson's r all >= 0.755) absolute concentrations of all biomarkers differed significantly between methods. Equations retrieved by the Deming regression enabled proper realignment of the data to overcome these differences, such that intra-class correlation coefficients were then 0.996 (CRP), 0.711 (SAA), 0.895 (sICAM-1) and 0.858 (sVCAM-1). Additionally, individual biomarkers differed across categories of glucose metabolism, weight, metabolic syndrome and smoking status to a similar extent by either method. Conclusions: Multiple low-grade inflammatory biomarker data obtained by the 4-plex multi-array platform of MSD or by well-established single-biomarker methods are comparable after proper realignment of differences in absolute concentrations, and are equally associated with cardiovascular risk factors, regardless of such differences. Given its greater efficiency, the MSD platform is a potential tool for the quantification of multiple biomarkers of low-grade inflammation in large ongoing and future clinical studies.	[van Bussel, Bas C. T.; Ferreira, Isabel; van de Waarenburg, Marjo P. H.; van Greevenbroek, Marleen M. J.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Stehouwer, Coen D. A.; Schalkwijk, Casper G.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [van Bussel, Bas C. T.; Stehouwer, Coen D. A.] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht NUTRIM, Maastricht, Netherlands; [van Bussel, Bas C. T.; van de Waarenburg, Marjo P. H.; Henry, Ronald M. A.; Feskens, Edith J. M.; Stehouwer, Coen D. A.; Schalkwijk, Casper G.] TIFN, Wageningen, Netherlands; [Ferreira, Isabel] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, Maastricht, Netherlands; [Ferreira, Isabel] Maastricht Univ, CAPHRI, Maastricht, Netherlands; [Ferreira, Isabel; van Greevenbroek, Marleen M. J.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Stehouwer, Coen D. A.; Schalkwijk, Casper G.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Maastricht University; Maastricht University; Top Institute Food & Nutrition; Maastricht University; Maastricht University; Maastricht University; Wageningen University & Research	van Bussel, BCT (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands.	c.schalkwijk@maastrichtuniversity.nl	Ferreira, Isabel/B-6033-2008; Feskens, Edith/ABI-1446-2020; Stehouwer, Coen/AAB-3435-2021	Ferreira, Isabel/0000-0003-1434-0607; Feskens, Edith/0000-0001-5819-2488; van Greevenbroek, Marleen/0000-0002-2989-1631; van der Kallen, Carla/0000-0003-1468-8793; Schalkwijk, Casper G/0000-0003-0190-2690; Stehouwer, Coen/0000-0001-8752-3223	Top Institute Food and Nutrition (TIFN), Wageningen; Netherlands Diet & Endothelial Function [A1004]; Netherlands Heart Foundation [2006T050]; PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation	Top Institute Food and Nutrition (TIFN), Wageningen; Netherlands Diet & Endothelial Function; Netherlands Heart Foundation(Netherlands Heart Foundation); PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation	The present study received funding from Top Institute Food and Nutrition (TIFN), Wageningen, The Netherlands Diet & Endothelial Function (project A1004) (BCTvB, RMAH, EJMF, CDAS & CGS); a postdoctoral research grant (2006T050) from The Netherlands Heart Foundation (IF); and this research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), and supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation (CGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have any relationship with the manufacturer MesoScaleDiscovery, Gaithersburg, MD, USA, www.mesoscale.com.	Becker A, 2002, EUR J CLIN INVEST, V32, P1, DOI 10.1046/j.1365-2362.2002.00919.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Conen D, 2010, EUR HEART J, V31, P1730, DOI 10.1093/eurheartj/ehq146; Cull CA, 1997, CLIN CHEM, V43, P1913; Daniels LB, 2010, EUR HEART J, V31, P2980, DOI 10.1093/eurheartj/ehq336; de Koning L, 2012, CLIN BIOCHEM, DOI [10.1016/j.clinbiochem.2012.1004.1006, DOI 10.1016/J.CLINBIO-CHEM.2012.1004.1006]; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Du HD, 2008, AM J CLIN NUTR, V87, P655, DOI 10.1093/ajcn/87.3.655; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Gruson D, 2010, BIOMARKERS, V15, P289, DOI 10.3109/13547500903560065; Jacobs M, 2009, EUR J CLIN INVEST, V39, P437, DOI 10.1111/j.1365-2362.2009.02129.x; Jacobs M, 2011, EUR J CLIN INVEST, V41, P167, DOI 10.1111/j.1365-2362.2010.02392.x; Kaplan Robert C, 2008, J Stroke Cerebrovasc Dis, V17, P344, DOI 10.1016/j.jstrokecerebrovasdis.2008.04.006; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; Kruijshoop M, 2004, CLIN CHIM ACTA, V341, P33, DOI 10.1016/j.cccn.2003.10.033; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Linnet K, 1998, CLIN CHEM, V44, P1024; Maahs DM, 2011, CLIN J AM SOC NEPHRO, V6, P1952, DOI 10.2215/CJN.11271210; Marchese RD, 2009, CLIN VACCINE IMMUNOL, V16, P387, DOI 10.1128/CVI.00415-08; Martin RF, 2000, CLIN CHEM, V46, P100; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Oh ES, 2010, J ALZHEIMERS DIS, V21, P769, DOI 10.3233/JAD-2010-100456; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Prabhakar U, 2002, J IMMUNOL METHODS, V260, P207, DOI 10.1016/S0022-1759(01)00543-9; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schnabel RB, 2009, AM J CARDIOL, V104, P92, DOI 10.1016/j.amjcard.2009.02.053; Selvin E, 2010, J DIABETES, V2, P118, DOI 10.1111/j.1753-0407.2010.00070.x; Steffes M, 2005, CLIN CHEM, V51, P753, DOI 10.1373/clinchem.2004.042143; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thanabalasingham G, 2011, DIABETOLOGIA, V54, P2801, DOI 10.1007/s00125-011-2261-y; Thewissen MM, 2010, OBESITY SILVER SPRIN, V19, P1690; Twomey PJ, 2006, ANN CLIN BIOCHEM, V43, P124, DOI 10.1258/000456306776021616; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; van Bussel BC, 2011, HYPERTENSION, V58, P588, DOI 10.1161/HYPERTENSIONAHA.111.174557; van Bussel BCT, 2012, J HYPERTENS, V30, P744, DOI 10.1097/HJH.0b013e328350a487; van Greevenbroek MMJ, 2012, INT J CARDIOL, V154, P158, DOI 10.1016/j.ijcard.2010.09.017; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Wang TJ, 2010, J AM COLL CARDIOL, V55, P2092, DOI 10.1016/j.jacc.2010.02.019	41	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58576	10.1371/journal.pone.0058576	http://dx.doi.org/10.1371/journal.pone.0058576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472208	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900154
J	Benitez-Paez, A; Alvarez, M; Belda-Ferre, P; Rubido, S; Mira, A; Tomas, I				Benitez-Paez, Alfonso; Alvarez, Maximiliano; Belda-Ferre, Pedro; Rubido, Susana; Mira, Alex; Tomas, Inmaculada			Detection of Transient Bacteraemia following Dental Extractions by 16S rDNA Pyrosequencing: A Pilot Study	PLOS ONE			English	Article							PERIODONTAL-DISEASE; PCR; ENDOCARDITIS; CHILDREN; PREVALENCE; DNA; MICROORGANISMS; IDENTIFICATION; ALIGNMENTS; INTENSITY	Objective: The current manuscript aims to determine the prevalence, duration and bacterial diversity of bacteraemia following dental extractions using conventional culture-dependent methods and 16S rDNA pyrosequencing. Methods: The study group included 8 patients undergoing dental extractions under general anaesthesia. Peripheral venous blood samples were collected at baseline, 30 seconds and 15 minutes after the dental extractions. Blood samples were analysed for bacteraemia applying conventional microbiological cultures under aerobic and anaerobic conditions as well as pyrosequencing using universal bacterial primers that target the 16S ribosomal DNA gene. Results: Transient bacteremia was detected by culture-based methods in one sample at baseline time, in eight samples at 30 seconds, and in six samples at 15 minutes after surgical procedure; whereas bacteraemia was detected only in five blood samples at 30 seconds after dental extraction by using pyrosequencing. By applying conventional microbiological methods, a single microbial species was detected in six patients, and Streptococcus viridans was the most frequently cultured identified bacterium. By using pyrosequencing approaches however, the estimated blood microbial diversity after dental extractions was 13.4 +/- 1.7 bacterial families and 22.8 +/- 1.1 genera per sample. Conclusion: The application of 16S rDNA pyrosequencing underestimated the prevalence and duration of bacteraemia following dental extractions, presumably due to not reaching the minimum DNA required for PCR amplification. However, this molecular technique, unlike conventional culture-dependent methods, revealed an extraordinarily high bacterial diversity of post-extraction bacteraemia. We propose that microorganisms recovered by culture may be only the tip of an iceberg of a really diverse microbiota whose viability and potential pathogenicity should be further studied.	[Rubido, Susana; Tomas, Inmaculada] Univ Santiago de Compostela, Sch Med & Dent, Santiago De Compostela, Spain; [Benitez-Paez, Alfonso; Belda-Ferre, Pedro; Mira, Alex] Ctr Adv Res Publ Hlth CSISP, Genom & Hlth Dept, Valencia, Spain; [Alvarez, Maximiliano] Univ Hosp Complex, Inst Biomed Res, Dept Microbiol, Vigo, Spain	Universidade de Santiago de Compostela	Tomas, I (corresponding author), Univ Santiago de Compostela, Sch Med & Dent, Santiago De Compostela, Spain.	inmaculada.tomas@usc.es	Belda-Ferre, Pedro/C-9825-2010; Belda-Ferre, Pedro/E-7699-2013; Mira, Alex/A-7244-2010; TOMAS-CARMONA, INMACULADA/M-1135-2014; Benítez-Páez, Alfonso/AAY-7143-2020; Benitez-Paez, Alfonso/A-2018-2011	Belda-Ferre, Pedro/0000-0001-6532-1161; TOMAS-CARMONA, INMACULADA/0000-0002-3317-0853; Benítez-Páez, Alfonso/0000-0001-5707-4340; Benitez-Paez, Alfonso/0000-0001-5707-4340; Mira, Alex/0000-0002-9127-3877	Spanish Ministry of Science and Innovation [SAF2009-13032-C02-02, Consolider-Ingenio CSD2009-00006]; Spanish Institute of Health "Carlos III" [FIS 2011/PF004]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Institute of Health "Carlos III"(Instituto de Salud Carlos III)	This work was supported by projects SAF2009-13032-C02-02, Consolider-Ingenio CSD2009-00006 from the Spanish Ministry of Science and Innovation and by project FIS 2011/PF004 from Spanish Institute of Health "Carlos III". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bahrani-Mougeot FK, 2008, ORAL SURG ORAL MED O, V105, P720, DOI 10.1016/j.tripleo.2008.02.009; Barbeau J, 1996, APPL ENVIRON MICROB, V62, P3954, DOI 10.1128/AEM.62.11.3954-3959.1996; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Breijo-Marquez FR, 2012, ENDOCARDITIS, P19; Breton C, 2004, J AGR FOOD CHEM, V52, P531, DOI 10.1021/jf034588f; Brow CN, 2010, ENVIRON SCI TECHNOL, V44, P8243, DOI 10.1021/es101641y; Carmona IT, 2002, ORAL SURG ORAL MED O, V93, P660, DOI 10.1067/moe.2002.122338; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Diz P, 2011, PATOLOGIA PERIDONTAL, P159; ELLIOTT RH, 1968, ARCH DIS CHILD, V43, P451, DOI 10.1136/adc.43.230.451; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; HALL G, 1993, CLIN INFECT DIS, V17, P188, DOI 10.1093/clinids/17.2.188; HEIMDAHL A, 1990, J CLIN MICROBIOL, V28, P2205, DOI 10.1128/JCM.28.10.2205-2209.1990; Hill JE, 2010, APPL ENVIRON MICROB, V76, P4550, DOI 10.1128/AEM.01510-09; Horz HP, 2008, J MICROBIOL METH, V72, P98, DOI 10.1016/j.mimet.2007.10.007; Hryniewiecki T, 2002, J HEART VALVE DIS, V11, P870; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hung WL, 2011, ARCH MICROBIOL, V193, P407, DOI 10.1007/s00203-011-0689-6; Jordan JA, 2009, J CLIN MICROBIOL, V47, P368, DOI 10.1128/JCM.01991-08; Jordan JA, 2000, J CLIN MICROBIOL, V38, P2574, DOI 10.1128/JCM.38.7.2574-2578.2000; Kinane DF, 2005, J CLIN PERIODONTOL, V32, P708, DOI 10.1111/j.1600-051X.2005.00741.x; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Lai CC, 2011, J CLIN MICROBIOL, V49, P3329, DOI 10.1128/JCM.01241-11; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; MacGregor RR, 1999, J CLIN MICROBIOL, V37, P90, DOI 10.1128/JCM.37.1.90-94.1999; Castillo DM, 2011, J CLIN PERIODONTOL, V38, P418, DOI 10.1111/j.1600-051X.2011.01717.x; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Murray P, 1999, MANUAL CLIN MICROBIO, P283; Olsen I, 2008, TRANSFUS APHER SCI, V39, P173, DOI 10.1016/j.transci.2008.06.008; Parahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P46, DOI 10.1128/CMR.00028-08; Perez-Chaparro PJ, 2008, J CLIN PERIODONTOL, V35, P748, DOI 10.1111/j.1600-051X.2008.01296.x; Planes A, 2003, RECOMENDACIONES SOC; RAMFJORD SP, 1967, J PERIODONTOL, V38, P602, DOI 10.1902/jop.1967.38.6.602; Roberts GJ, 2006, HEART, V92, P1274, DOI 10.1136/hrt.2004.046581; Roberts GJ, 1997, PEDIATR CARDIOL, V18, P24, DOI 10.1007/s002469900103; Roberts Graham J., 1998, Pediatric Dentistry, V20, P28; Ruoff KL, 2002, J CLIN MICROBIOL, V40, P1129, DOI 10.1128/JCM.40.4.1129-1133.2002; Savarrio L, 2005, J DENT, V33, P293, DOI 10.1016/j.jdent.2004.09.008; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shah PM, 2000, J CLIN MICROBIOL, V38, P943; Shang SQ, 2003, CHINESE MED J-PEKING, V116, P129; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sonbol H, 2009, ORAL MICROBIOL IMMUN, V24, P177, DOI 10.1111/j.1399-302X.2008.00492.x; Tomas I, 2007, ORAL DIS, V13, P56, DOI 10.1111/j.1601-0825.2006.01247.x; Valdes C, 2008, ANAESTHESIA, V63, P588, DOI 10.1111/j.1365-2044.2008.05449.x; VICTOR T, 1993, EUR J CLIN CHEM CLIN, V31, P531; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	53	42	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57782	10.1371/journal.pone.0057782	http://dx.doi.org/10.1371/journal.pone.0057782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469240	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900046
J	Bousiges, O; Neidl, R; Majchrzak, M; Muller, MA; Barbelivien, A; de Vasconcelos, AP; Schneider, A; Loeffler, JP; Cassel, JC; Boutillier, AL				Bousiges, Olivier; Neidl, Romain; Majchrzak, Monique; Muller, Marc-Antoine; Barbelivien, Alexandra; de Vasconcelos, Anne Pereira; Schneider, Anne; Loeffler, Jean-Philippe; Cassel, Jean-Christophe; Boutillier, Anne-Laurence			Detection of Histone Acetylation Levels in the Dorsal Hippocampus Reveals Early Tagging on Specific Residues of H2B and H4 Histones in Response to Learning	PLOS ONE			English	Article							LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; BDNF GENE; FEAR MEMORY; MOUSE MODEL; NEUROTROPHIC FACTOR; COGNITIVE DEFICIT; PROTEIN-SYNTHESIS; CONDITIONED FEAR; RAT HIPPOCAMPUS	The recent literature provides evidence that epigenetic mechanisms such as DNA methylation and histone modification are crucial to gene transcription linked to synaptic plasticity in the mammalian brain - notably in the hippocampus - and memory formation. We measured global histone acetylation levels in the rat hippocampus at an early stage of spatial or fear memory formation. We found that H3, H4 and H2B underwent differential acetylation at specific sites depending on whether rats had been exposed to the context of a task without having to learn or had to learn about a place or fear therein: H3K9K14 acetylation was mostly responsive to any experimental conditions compared to naive animals, whereas H2B N-terminus and H4K12 acetylations were mostly associated with memory for either spatial or fear learning. Altogether, these data suggest that behavior/experience-dependent changes differently regulate specific acetylation modifications of histones in the hippocampus, depending on whether a memory trace is established or not: tagging of H3K9K14 could be associated with perception/processing of testing-related manipulations and context, thereby enhancing chromatin accessibility, while tagging of H2B N-terminus tail and H4K12 could be more closely associated with the formation of memories requiring an engagement of the hippocampus.	[Bousiges, Olivier; Neidl, Romain; Majchrzak, Monique; Muller, Marc-Antoine; Barbelivien, Alexandra; de Vasconcelos, Anne Pereira; Schneider, Anne; Cassel, Jean-Christophe; Boutillier, Anne-Laurence] Univ Strasbourg, CNRS, Fac Psychol, Lab Neurosci Cognit & Adaptat,UMR736,GDR 2905, Strasbourg, France; [Loeffler, Jean-Philippe] Univ Strasbourg, Lab Signalisat Mol & Neurodegenerescence, Fac Med, Inserm,U692,UMRS692, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Boutillier, AL (corresponding author), Univ Strasbourg, CNRS, Fac Psychol, Lab Neurosci Cognit & Adaptat,UMR736,GDR 2905, Strasbourg, France.	laurette@unistra.fr	LOEFFLER, Jean-Philippe/AAS-4401-2020; De Vasconcelos, Anne Pereira/M-3909-2017; BOUSIGES, Olivier/AAY-2458-2020	BOUSIGES, Olivier/0000-0001-6786-3191; Barbelivien, Alexandra/0000-0003-1220-0467	CNRS; INSERM; University of Strasbourg; ANR [ANR-12-MALZ-0002-01]; Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA) [10702]; LECMA; FORNASEP; Fondation Unistra-don Pierre Fabre	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; ANR(French National Research Agency (ANR)); Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA); LECMA; FORNASEP; Fondation Unistra-don Pierre Fabre	This work was supported by CNRS, INSERM, University of Strasbourg, ANR (ANR-12-MALZ-0002-01 to ALB) and granted by associations that the authors warmly thank: FRM-Alsace (to JCC and ALB), Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA project #10702 to ALB), Alsace Alzheimer 67 (to ALB and Dr. F. Blanc [FB], HUS, Strasbourg, France), as well as France Alzheimer Haut-Rhin (to JCC). OB received salary support from the LECMA, FORNASEP (to FB). RN and MAM were recipients of a doctoral fellowship from the French government, and RN received additional salary support from the LECMA. AS has been supported by the Fondation Unistra-don Pierre Fabre and ANR-12-MALZ-0002-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2013, NEUROPSYCHOPHARMACOL; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Chen GQ, 2010, J NEUROSCI, V30, P13066, DOI 10.1523/JNEUROSCI.2378-10.2010; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Fuchikami M, 2009, INT J NEUROPSYCHOPH, V12, P73, DOI 10.1017/S1461145708008997; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Igaz LM, 2002, J NEUROSCI, V22, P6781; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Keeley MB, 2006, LEARN MEMORY, V13, P135, DOI 10.1101/lm.86906; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lopez-Atalaya JP, 2011, EMBO J, V30, P4287, DOI 10.1038/emboj.2011.299; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Maharana C, 2010, NEUROSCIENCE, V167, P354, DOI 10.1016/j.neuroscience.2010.02.023; Marchand AR, 2003, J NEUROSCI METH, V126, P145, DOI 10.1016/S0165-0270(03)00076-1; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P840, DOI 10.1016/j.bbagrm.2010.08.012; Sharma SK, 2010, NEUROSCI BIOBEHAV R, V34, P1234, DOI 10.1016/j.neubiorev.2010.02.009; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Stilling RM, 2011, NEUROBIOL LEARN MEM, V96, P19, DOI 10.1016/j.nlm.2011.04.002; Takei S, 2011, J PSYCHIATR RES, V45, P460, DOI 10.1016/j.jpsychires.2010.08.009; Tian F, 2009, J NEUROCHEM, V109, P1375, DOI 10.1111/j.1471-4159.2009.06058.x; Valor LM, 2011, J NEUROSCI, V31, P1652, DOI 10.1523/JNEUROSCI.4737-10.2011	43	45	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57816	10.1371/journal.pone.0057816	http://dx.doi.org/10.1371/journal.pone.0057816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469244	Green Published, gold			2022-12-27	WOS:000315634900048
J	Lim, KH; Choi, HS; Park, YK; Park, ES; Shin, GC; Kim, DH; Ahn, SH; Kim, KH				Lim, Keo-Heun; Choi, Hyo Sun; Park, Yong Kwang; Park, Eun-Sook; Shin, Gu Choul; Kim, Doo Hyun; Ahn, Sung Hyun; Kim, Kyun-Hwan			HBx-Induced NF-kappa B Signaling in Liver Cells Is Potentially Mediated by the Ternary Complex of HBx with p22-FLIP and NEMO	PLOS ONE			English	Article							VIRUS-X-PROTEIN; RECEPTOR-INDUCED APOPTOSIS; FLICE-INHIBITORY PROTEINS; HEPATITIS-B; C-FLIP; HEPATOCELLULAR-CARCINOMA; CANCER DEVELOPMENT; ACTIVATION; DEATH; PATHWAY	Sustained activation of NF-kappa B is one of the causative factors for various liver diseases, including liver inflammation and hepatocellular carcinoma (HCC). It has been known that activating the NF-kappa B signal by hepatitis B virus X protein (HBx) is implicated in the development of HCC. However, despite numerous studies on HBx-induced NF-kappa B activation, the detailed mechanisms still remain unsolved. Recently, p22-FLIP, a cleavage product of c-FLIPL, has been reported to induce NF-kappa B activation through interaction with the I kappa B kinase (IKK) complex in primary immune cells. Since our previous report on the interaction of HBx with c-FLIPL, we explored whether p22-FLIP is involved in the modulation of HBx function. First, we identified the expression of endogenous p22-FLIP in liver cells. NF-kappa B reporter assay and electrophoretic mobility shift assay (EMSA) revealed that the expression of p22-FLIP synergistically enhances HBx-induced NF-kappa B activation. Moreover, we found that HBx physically interacts with p22-FLIP and NEMO and potentially forms a ternary complex. Knock-down of c-FLIP leading to the downregulation of p22-FLIP showed that endogenous p22-FLIP is involved in HBx-induced NF-kappa B activation, and the formation of a ternary complex is necessary to activate NF-kappa B signaling. In conclusion, we showed a novel mechanism of HBx-induced NF-kappa B activation in which ternary complex formation is involved among HBx, p22-FLIP and NEMO. Our findings will extend the understanding of HBx-induced NF-kappa B activation and provide a new target for intervention in HBV-associated liver diseases and in the development of HCC.	[Lim, Keo-Heun; Choi, Hyo Sun; Park, Yong Kwang; Park, Eun-Sook; Shin, Gu Choul; Kim, Doo Hyun; Ahn, Sung Hyun; Kim, Kyun-Hwan] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul, South Korea; [Lim, Keo-Heun; Choi, Hyo Sun; Park, Yong Kwang; Park, Eun-Sook; Shin, Gu Choul; Kim, Doo Hyun; Ahn, Sung Hyun; Kim, Kyun-Hwan] Konkuk Univ, Ctr Canc Res & Diagnost Med, IBST, Seoul, South Korea; [Lim, Keo-Heun; Kim, Kyun-Hwan] Konkuk Univ, Inst Funct Genom, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University	Kim, KH (corresponding author), Konkuk Univ, Sch Med, Dept Pharmacol, Seoul, South Korea.	khkim10@kku.ac.kr		Park, Eun-Sook/0000-0002-6652-9404; Kim, Kyun-Hwan/0000-0001-5266-072X; Shin, Gu-Choul/0000-0001-8200-9700	Konkuk University	Konkuk University	This work was supported by Konkuk University in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Dolcet X, 2005, LAB INVEST, V85, P885, DOI 10.1038/labinvest.3700286; Du XL, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-24; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hong A, 2012, BIOCHEM BIOPH RES CO, V423, P6, DOI 10.1016/j.bbrc.2012.05.021; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Jiao BY, 2011, ARCH VIROL, V156, P2015, DOI 10.1007/s00705-011-1099-4; Jin HS, 2009, CANCER RES, V69, P1782, DOI 10.1158/0008-5472.CAN-08-2256; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kim HR, 2010, FEBS LETT, V584, P525, DOI 10.1016/j.febslet.2009.11.091; Kim KH, 2003, EMBO J, V22, P2104, DOI 10.1093/emboj/cdg210; Kim SY, 2008, BMB REP, V41, P158, DOI 10.5483/BMBRep.2008.41.2.158; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Korkolopoulou P, 2007, HISTOPATHOLOGY, V51, P150, DOI 10.1111/j.1365-2559.2007.02723.x; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Li XG, 2001, BIOCHEM BIOPH RES CO, V286, P587, DOI 10.1006/bbrc.2001.5442; Lim KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022258; Liu YH, 2012, HEPATOLOGY, V56, P1015, DOI 10.1002/hep.25751; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Ohata K, 2003, FEBS LETT, V553, P304, DOI 10.1016/S0014-5793(03)01034-2; Rippo MR, 2004, ONCOGENE, V23, P7753, DOI 10.1038/sj.onc.1208051; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sorokina EM, 2004, J BIOL CHEM, V279, P13469, DOI 10.1074/jbc.M305250200; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Sun SC, 2011, CURR TOP MICROBIOL, V349, P197, DOI 10.1007/82_2010_108; Sylla BS, 1998, P NATL ACAD SCI USA, V95, P10106, DOI 10.1073/pnas.95.17.10106; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Yun C, 2002, CANCER LETT, V184, P97, DOI 10.1016/S0304-3835(02)00187-8; Zhou XD, 2004, CLIN SCI, V106, P397, DOI 10.1042/CS20030238	49	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57331	10.1371/journal.pone.0057331	http://dx.doi.org/10.1371/journal.pone.0057331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483900	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900015
J	Tleyjeh, IM; Bin Abdulhak, AA; Riaz, M; Garbati, MA; Al-Tannir, M; Alasmari, FA; AlGhamdi, M; Khan, AR; Erwin, PJ; Sutton, AJ; Baddour, LM				Tleyjeh, Imad M.; Bin Abdulhak, Aref A.; Riaz, Muhammad; Garbati, Musa A.; Al-Tannir, Mohamad; Alasmari, Faisal A.; AlGhamdi, Mushabab; Khan, Abdur Rahman; Erwin, Patricia J.; Sutton, Alex J.; Baddour, Larry M.			The Association between Histamine 2 Receptor Antagonist Use and Clostridium difficile Infection: A Systematic Review and Meta-analysis	PLOS ONE			English	Review							PROTON-PUMP INHIBITORS; GASTRIC-ACID SUPPRESSION; RISK-FACTORS; HOSPITALIZED-PATIENTS; FLUOROQUINOLONE USE; UNITED-STATES; DIARRHEA; DISEASE; OUTBREAK; COHORT	Background: Clostridium difficile infection (CDI) is a major health problem. Epidemiological evidence suggests that there is an association between acid suppression therapy and development of CDI. Purpose: We sought to systematically review the literature that examined the association between histamine 2 receptor antagonists (H2RAs) and CDI. Data source: We searched Medline, Current Contents, Embase, ISI Web of Science and Elsevier Scopus from 1990 to 2012 for all analytical studies that examined the association between H2RAs and CDI. Study selection: Two authors independently reviewed the studies for eligibility. Data extraction: Data about studies characteristics, adjusted effect estimates and quality were extracted. Data synthesis: Thirty-five observations from 33 eligible studies that included 201834 participants were analyzed. Studies were performed in 6 countries and nine of them were multicenter. Most studies did not specify the type or duration of H2RAs therapy. The pooled effect estimate was 1.44, 95% CI (1.22-1.7), I-2 = 70.5%. This association was consistent across different subgroups (by study design and country) and there was no evidence of publication bias. The pooled effect estimate for high quality studies was 1.39 (1.15-1.68), I2 = 72.3%. Meta-regression analysis of 10 study-level variables did not identify sources of heterogeneity. In a speculative analysis, the number needed to harm (NNH) with H2RAs at 14 days after hospital admission in patients receiving antibiotics or not was 58, 95% CI (37, 115) and 425, 95% CI (267, 848), respectively. For the general population, the NNH at 1 year was 4549, 95% CI (2860, 9097). Conclusion: In this rigorous systematic review and meta-analysis, we observed an association between H2RAs and CDI. The absolute risk of CDI associated with H2RAs is highest in hospitalized patients receiving antibiotics.	[Tleyjeh, Imad M.; Garbati, Musa A.; Alasmari, Faisal A.; AlGhamdi, Mushabab] King Fahad Med City, Dept Med, Riyadh, Saudi Arabia; [Tleyjeh, Imad M.; Baddour, Larry M.] Mayo Clin, Div Infect Dis, SW, Rochester, MN USA; [Tleyjeh, Imad M.] Mayo Clin, Div Epidemiol, SW, Rochester, MN USA; [Bin Abdulhak, Aref A.] Univ Missouri, Dept Internal Med, Sch Med, Kansas City, MO 64110 USA; [Riaz, Muhammad; Al-Tannir, Mohamad] King Fahad Med City, Res & Sci Publicat Ctr, Riyadh, Saudi Arabia; [Khan, Abdur Rahman] Univ Toledo, Med Ctr, Dept Internal Med, Toledo, OH 43606 USA; [Erwin, Patricia J.] Mayo Clin, Mayo Med Lib, SW, Rochester, MN USA; [Sutton, Alex J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	King Fahad Medical City; Mayo Clinic; Mayo Clinic; University of Missouri System; University of Missouri Kansas City; King Fahad Medical City; University System of Ohio; University of Toledo; Mayo Clinic; University of Leicester	Tleyjeh, IM (corresponding author), King Fahad Med City, Dept Med, Riyadh, Saudi Arabia.	tleyjeh.imad@mayo.edu	Alasmari, Faisal/AGW-9536-2022; alghamdi, Mushabab/AGR-6297-2022; Bin Abdulhak, Aref/AAM-9492-2020; Al-Ghamdi, Mohammed Ibrahim/I-3651-2018; Bin Abdulhak, Aref/AAK-4348-2020	Bin Abdulhak, Aref/0000-0001-9988-8609; Al-Ghamdi, Mohammed Ibrahim/0000-0002-9794-554X; Riaz, Muhammad/0000-0002-5512-1745; Sutton, Alexander/0000-0002-8934-9940; Garbati, Musa/0000-0003-3438-421X; Al-Tannir, Mohamad/0000-0002-7739-8446; Tleyjeh, Imad/0000-0002-5551-0353				Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Aseeri M, 2008, AM J GASTROENTEROL, V103, P2308, DOI 10.1111/j.1572-0241.2008.01975.x; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Beaulieu M, 2007, INFECT CONT HOSP EP, V28, P1305, DOI 10.1086/521664; Bliss DZ, 1998, ANN INTERN MED, V129, P1012, DOI 10.7326/0003-4819-129-12-199812150-00004; BROWN E, 1990, INFECT CONT HOSP EP, V11, P283; Cates Christopher J, 2002, BMC Med Res Methodol, V2, P1, DOI 10.1186/1471-2288-2-1; Coory MD, 2010, INT J EPIDEMIOL, V39, P932, DOI 10.1093/ije/dyp157; Dalton BR, 2009, ALIMENT PHARM THER, V29, P626, DOI 10.1111/j.1365-2036.2008.03924.x; Debast SB, 2009, CLIN MICROBIOL INFEC, V15, P427, DOI 10.1111/j.1469-0691.2009.02713.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshpande A, 2012, CLIN GASTROENTEROL H, V10, P225, DOI 10.1016/j.cgh.2011.09.030; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; Dial S, 2006, CAN MED ASSOC J, V175, P745, DOI 10.1503/cmaj.060284; Dubberke ER, 2007, CLIN INFECT DIS, V45, P1543, DOI 10.1086/523582; Dubberke ER, 2007, ARCH INTERN MED, V167, P1092, DOI 10.1001/archinte.167.10.1092; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emoto M, 1996, GYNECOL ONCOL, V61, P369, DOI 10.1006/gyno.1996.0158; Erwin J, 1997, BRIT J GEN PRACT, V47, P99; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Jarvis WR, 2009, AM J INFECT CONTROL, V37, P263, DOI 10.1016/j.ajic.2009.01.001; Jayatilaka S, 2007, ANN CLIN LAB SCI, V37, P241; Jump RLP, 2007, ANTIMICROB AGENTS CH, V51, P2883, DOI 10.1128/AAC.01443-06; Jung KS, 2010, GUT LIVER, V4, P332, DOI 10.5009/gnl.2010.4.3.332; Kazakova SV, 2006, ARCH INTERN MED, V166, P2518, DOI 10.1001/archinte.166.22.2518; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Kwok CS, 2012, AM J GASTROENTEROL, V107, P1011, DOI 10.1038/ajg.2012.108; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Lowe DO, 2006, CLIN INFECT DIS, V43, P1272, DOI 10.1086/508453; Manges AR, 2010, J INFECT DIS, V202, P1877, DOI 10.1086/657319; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McFarland LV, 2007, CLIN INFECT DIS, V45, P1141, DOI 10.1086/522187; Modena S, 2005, INFECT CONT HOSP EP, V26, P685, DOI 10.1086/502603; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Naggie S, 2011, AM J MED, V124, P276, DOI 10.1016/j.amjmed.2010.10.013; Nath S K, 1994, Can J Infect Dis, V5, P270; NETLAND PJ, 2011, HOSP PHARM, V46, P336, DOI DOI 10.1310/hpj4605-336; Novell MJ, 2010, ANN PHARMACOTHER, V44, P826, DOI 10.1345/aph.1M696; Peled N, 2007, INFECT CONT HOSP EP, V28, P377, DOI 10.1086/513723; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; SCHULLER I, 1995, ARCH DIS CHILD, V72, P219, DOI 10.1136/adc.72.3.219; Shah S, 2000, QJM-MON J ASSOC PHYS, V93, P175, DOI 10.1093/qjmed/93.3.175; Shi CW, 2004, AM J GASTROENTEROL, V99, P606, DOI 10.1111/j.1572-0241.2004.04130.x; Stevens V, 2011, PHARMACOEPIDEM DR S, V20, P1035, DOI 10.1002/pds.2198; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sundram F, 2009, J HOSP INFECT, V72, P111, DOI 10.1016/j.jhin.2009.02.020; Tleyjeh IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050836; U.S food and drug administration, PROT PUMP INH PPIS D; Wells G.A., NEWCASTLE OTTAWA SCA; Yip C, 2001, INFECT CONT HOSP EP, V22, P572, DOI 10.1086/501954; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	64	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e56498	10.1371/journal.pone.0056498	http://dx.doi.org/10.1371/journal.pone.0056498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469173	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900007
J	Van Dijck, G; Van Hulle, MM; Heiney, SA; Blazquez, PM; Meng, H; Angelaki, DE; Arenz, A; Margrie, TW; Mostofi, A; Edgley, S; Bengtsson, F; Ekerot, CF; Jorntell, H; Dalley, JW; Holtzman, T				Van Dijck, Gert; Van Hulle, Marc M.; Heiney, Shane A.; Blazquez, Pablo M.; Meng, Hui; Angelaki, Dora E.; Arenz, Alexander; Margrie, Troy W.; Mostofi, Abteen; Edgley, Steve; Bengtsson, Fredrik; Ekerot, Carl-Fredrik; Jorntell, Henrik; Dalley, Jeffrey W.; Holtzman, Tahl			Probabilistic Identification of Cerebellar Cortical Neurones across Species	PLOS ONE			English	Article							GOLGI CELLS; MOSSY FIBER; PURKINJE-CELLS; GRANULE CELLS; IN-VIVO; RECEPTIVE-FIELDS; PARALLEL FIBERS; RAT; INTERNEURONS; CORTEX	Despite our fine-grain anatomical knowledge of the cerebellar cortex, electrophysiological studies of circuit information processing over the last fifty years have been hampered by the difficulty of reliably assigning signals to identified cell types. We approached this problem by assessing the spontaneous activity signatures of identified cerebellar cortical neurones. A range of statistics describing firing frequency and irregularity were then used, individually and in combination, to build Gaussian Process Classifiers (GPC) leading to a probabilistic classification of each neurone type and the computation of equiprobable decision boundaries between cell classes. Firing frequency statistics were useful for separating Purkinje cells from granular layer units, whilst firing irregularity measures proved most useful for distinguishing cells within granular layer cell classes. Considered as single statistics, we achieved classification accuracies of 72.5% and 92.7% for granular layer and molecular layer units respectively. Combining statistics to form twin-variate GPC models substantially improved classification accuracies with the combination of mean spike frequency and log-interval entropy offering classification accuracies of 92.7% and 99.2% for our molecular and granular layer models, respectively. A cross-species comparison was performed, using data drawn from anaesthetised mice and decerebrate cats, where our models offered 80% and 100% classification accuracy. We then used our models to assess non-identified data from awake monkeys and rabbits in order to highlight subsets of neurones with the greatest degree of similarity to identified cell classes. In this way, our GPC-based approach for tentatively identifying neurones from their spontaneous activity signatures, in the absence of an established ground-truth, nonetheless affords the experimenter a statistically robust means of grouping cells with properties matching known cell classes. Our approach therefore may have broad application to a variety of future cerebellar cortical investigations, particularly in awake animals where opportunities for definitive cell identification are limited.	[Van Dijck, Gert; Van Hulle, Marc M.] KU Leuven Sch Med, Lab Neuro & Psychophysiol, Computat Neurosci Res Grp, Louvain, Belgium; [Heiney, Shane A.; Blazquez, Pablo M.] Washington Univ, Dept Otolaryngol, St Louis, MO USA; [Meng, Hui; Angelaki, Dora E.] Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO USA; [Arenz, Alexander; Margrie, Troy W.] Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; [Margrie, Troy W.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Mostofi, Abteen; Edgley, Steve; Holtzman, Tahl] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Bengtsson, Fredrik; Ekerot, Carl-Fredrik; Jorntell, Henrik] Lund Univ, Sect Neurosci, Dept Expt Med Sci, Lund, Sweden; [Jorntell, Henrik] NeuroNano Res Ctr, Lund, Sweden; [Dalley, Jeffrey W.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; [Van Dijck, Gert; Holtzman, Tahl] Univ Cambridge, Dept Psychol, Behav & Clin Neurosci Inst, Cambridge, England	KU Leuven; Washington University (WUSTL); Washington University (WUSTL); MRC National Institute for Medical Research; University of London; University College London; University of Cambridge; Lund University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Holtzman, T (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	th247@cam.ac.uk	Heiney, Shane/P-5646-2019	Heiney, Shane/0000-0001-9706-2133; Van Hulle, Marc/0000-0003-1060-7044; Dalley, Jeffrey/0000-0002-2282-3660	Medical Research Council, UK; Isaac Newton Trust; Trinity College, Cambridge; Wellcome Trust; School of Biological Sciences, Cambridge University; BBSRC [BBS/B/16984]; Michael and Morven Heller Research Fellowship in Computing Science at St Catharine's College, Cambridge; CREA of the K. U. Leuven [CREA/07/027]; Belgian Fund for Scientific Research - Flanders (FWO); Financing program of the K. U. Leuven [PFV/10/008]; Belgian Fund for Scientific Research - Flanders [G.0588.09]; Interuniversity Attraction Poles Programme [IUAP P7/21]; Flemish Regional Ministry of Education (Belgium) [GOA 10/019]; Flemish Agency for Innovation by Science and Technology; Medical Research Council, UK [MC_U1175975156];  [NINDS-R01NS065099]; Biotechnology and Biological Sciences Research Council [BBS/B/16984] Funding Source: researchfish; Medical Research Council [G0001354, G1000183B, G0001354B] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY012814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065099] Funding Source: NIH RePORTER	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Isaac Newton Trust; Trinity College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission); School of Biological Sciences, Cambridge University(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Michael and Morven Heller Research Fellowship in Computing Science at St Catharine's College, Cambridge; CREA of the K. U. Leuven; Belgian Fund for Scientific Research - Flanders (FWO)(FWO); Financing program of the K. U. Leuven; Belgian Fund for Scientific Research - Flanders(FWO); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Flemish Regional Ministry of Education (Belgium)(FWO); Flemish Agency for Innovation by Science and Technology; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Tahl Holtzman was supported by the Medical Research Council, UK, a grant from the Isaac Newton Trust, Trinity College, Cambridge and a Wellcome Trust VIP Award, School of Biological Sciences, Cambridge University. Work in awake rabbits with Abteen Mostofi and Steve Edgley was supported by the BBSRC (BBS/B/16984). Gert Van Dijck is supported by the Michael and Morven Heller Research Fellowship in Computing Science at St Catharine's College, Cambridge and was previously supported by the CREA financing (CREA/07/027) program of the K. U. Leuven and by the Belgian Fund for Scientific Research - Flanders (FWO) by means of a travel grant for a long stay abroad. Marc Van Hulle is supported by the CREA (CREA/07/027) and the Financing program (PFV/10/008) of the K. U. Leuven, the Belgian Fund for Scientific Research - Flanders (G.0588.09), the Interuniversity Attraction Poles Programme (IUAP P7/21), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), the Flemish Agency for Innovation by Science and Technology (TETRA project Spellbinder). Alexander Arenz and Troy W. Margrie were supported by the Wellcome Trust and The Medical Research Council, UK (MC_U1175975156). Pablo M. Blazquez and Shane Heiney are supported by NINDS-R01NS065099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bengtsson F, 2007, J NEUROPHYSIOL, V98, P1697, DOI 10.1152/jn.00057.2007; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Bhumbra G S, 2005, Cogn Process, V6, P157, DOI 10.1007/s10339-005-0006-x; Bhumbra GS, 2010, J NEUROENDOCRINOL, V22, P1239, DOI 10.1111/j.1365-2826.2010.02068.x; Bhumbra GS, 2009, J NEUROENDOCRINOL, V21, P935, DOI 10.1111/j.1365-2826.2009.01918.x; Bhumbra GS, 2005, J PHYSIOL-LONDON, V569, P257, DOI 10.1113/jphysiol.2005.097014; Bhumbra GS, 2005, J PHYSIOL-LONDON, V563, P291, DOI 10.1113/jphysiol.2004.079848; Bhumbra GS, 2004, J PHYSIOL-LONDON, V555, P281, DOI 10.1113/jphysiol.2003.053264; Bishop C. M, 2006, PATTERN RECOGNITION; BRAND S, 1976, EXP BRAIN RES, V26, P39; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chorev E, 2009, CURR OPIN NEUROBIOL, V19, P513, DOI 10.1016/j.conb.2009.08.005; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Davies RM, 2006, J NEUROPHYSIOL, V96, P906, DOI 10.1152/jn.01030.2005; Dino MR, 1999, J NEUROCYTOL, V28, P99, DOI 10.1023/A:1007072105919; Dorval AD, 2008, J NEUROSCI METH, V173, P129, DOI 10.1016/j.jneumeth.2008.05.013; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Fernandez FR, 2007, J NEUROPHYSIOL, V98, P278, DOI 10.1152/jn.00306.2007; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; Geurts FJ, 2003, CEREBELLUM, V2, P290, DOI 10.1080/14734220310011948; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Girolami M, 2006, NEURAL COMPUT, V18, P1790, DOI 10.1162/neco.2006.18.8.1790; GOLDBERG JM, 1990, J NEUROPHYSIOL, V63, P781, DOI 10.1152/jn.1990.63.4.781; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Heine SA, 2010, J NEUROSCI, V30, P17004, DOI 10.1523/JNEUROSCI.3513-10.2010; Hensbroek R. A., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Herfst L, 2012, J NEUROPHYSIOL, V108, P697, DOI 10.1152/jn.00910.2011; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Holtzman T, 2006, J PHYSIOL-LONDON, V577, P69, DOI 10.1113/jphysiol.2006.117218; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; Holtzman T, 2011, J PHYSIOL-LONDON, V589, P3837, DOI 10.1113/jphysiol.2011.207167; Holtzman T, 2009, EUR J NEUROSCI, V29, P328, DOI 10.1111/j.1460-9568.2008.06572.x; Jaarsma D, 1997, PROG BRAIN RES, V114, P67; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Katai S, 2010, EUR J NEUROSCI, V31, P1322, DOI 10.1111/j.1460-9568.2010.07150.x; Lansink CS, 2010, EUR J NEUROSCI, V32, P494, DOI 10.1111/j.1460-9568.2010.07293.x; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Miura K, 2006, NEURAL COMPUT, V18, P2359, DOI 10.1162/neco.2006.18.10.2359; Mostofi A, 2010, J NEUROSCI, V30, P8920, DOI 10.1523/JNEUROSCI.6117-09.2010; MUGNAINI E, 1983, J COMP NEUROL, V220, P7, DOI 10.1002/cne.902200103; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Pogosyan A, 2006, EXP NEUROL, V202, P271, DOI 10.1016/j.expneurol.2006.06.014; Prsa M, 2009, J NEUROSCI, V29, P250, DOI 10.1523/JNEUROSCI.4791-08.2009; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rees A, 1997, J NEUROPHYSIOL, V77, P2945, DOI 10.1152/jn.1997.77.6.2945; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; SCHULMAN JA, 1981, BRAIN RES, V210, P350, DOI 10.1016/0006-8993(81)90908-2; Shinomoto S, 2005, BIOSYSTEMS, V79, P67, DOI 10.1016/j.biosystems.2004.09.023; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; Simpson JI, 2005, PROG BRAIN RES, V148, P329, DOI 10.1016/S0079-6123(04)48026-1; Van Dijck G, 2012, INT J NEURAL SYST, V22, P1, DOI 10.1142/S0129065712003055; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vijayan S, 2010, J NEUROPHYSIOL, V103, P2074, DOI 10.1152/jn.00474.2009; Vos BP, 1999, EUR J NEUROSCI, V11, P2621, DOI 10.1046/j.1460-9568.1999.00678.x; Wang Y, 2008, ENDOCRINOLOGY, V149, P4938, DOI 10.1210/en.2008-0308; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182	70	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57669	10.1371/journal.pone.0057669	http://dx.doi.org/10.1371/journal.pone.0057669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469215	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900033
J	Li, K; Dias, SJ; Rimando, AM; Dhar, S; Mizuno, CS; Penman, AD; Lewin, JR; Levenson, AS				Li, Kun; Dias, Steven J.; Rimando, Agnes M.; Dhar, Swati; Mizuno, Cassia S.; Penman, Alan D.; Lewin, Jack R.; Levenson, Anait S.			Pterostilbene Acts through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate Cancer	PLOS ONE			English	Article							MTA1 MESSENGER-RNA; RESVERATROL SUPPRESSES; TRANS-RESVERATROL; EXPRESSION; APOPTOSIS; ANGIOGENESIS; INVASION; RATS; OVEREXPRESSION; CARCINOGENESIS	The development of natural product agents with targeted strategies holds promise for enhanced anticancer therapy with reduced drug-associated side effects. Resveratrol found in red wine, has anticancer activity in various tumor types. We reported earlier on a new molecular target of resveratrol, the metastasis-associated protein 1 (MTA1), which is a part of nucleosome remodeling and deacetylation (NuRD) co-repressor complex that mediates gene silencing. We identified resveratrol as a regulator of MTA1/NuRD complex and re-activator of p53 acetylation in prostate cancer (PCa). In the current study, we addressed whether resveratrol analogues also possess the ability to inhibit MTA1 and to reverse p53 deacetylation. We demonstrated that pterostilbene (PTER), found in blueberries, had greater increase in MTA1-mediated p53 acetylation, confirming superior potency over resveratrol as dietary epigenetic agent. In orthotopic PCa xenografts, resveratrol and PTER significantly inhibited tumor growth, progression, local invasion and spontaneous metastasis. Furthermore, MTA1-knockdown sensitized cells to these agents resulting in additional reduction of tumor progression and metastasis. The reduction was dependent on MTA1 signaling showing increased p53 acetylation, higher apoptotic index and less angiogenesis in vivo in all xenografts treated with the compounds, and particularly with PTER. Altogether, our results indicate MTA1 as a major contributor in prostate tumor malignant progression, and support the use of strategies targeting MTA1. Our strong pre-clinical data indicate PTER as a potent, selective and pharmacologically safe natural product that may be tested in advanced PCa.	[Li, Kun; Dias, Steven J.; Dhar, Swati; Levenson, Anait S.] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Rimando, Agnes M.; Mizuno, Cassia S.] ARS, USDA, Nat Prod Utilizat Res Unit, University, MS USA; [Penman, Alan D.] Univ Mississippi, Med Ctr, Ctr Biostat, Jackson, MS 39216 USA; [Lewin, Jack R.; Levenson, Anait S.] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; United States Department of Agriculture (USDA); University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Levenson, AS (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA.	alevenson@umc.edu	Dhar, Swati/V-9468-2019		University of Mississippi Medical Center [59927, 68100231012]	University of Mississippi Medical Center	The study was partially supported by the Intramural Research Support Program grants (#59927 and #68100231012) from University of Mississippi Medical Center to ASL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Banerjee S, 2002, CANCER RES, V62, P4945; Bavaresco L, 2003, DRUG EXP CLIN RES, V29, P181; Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje; Chakraborty A, 2010, TOXICOL IN VITRO, V24, P1215, DOI 10.1016/j.tiv.2010.02.007; Chang J, 2012, NEUROBIOL AGING, V33, P2062, DOI 10.1016/j.neurobiolaging.2011.08.015; Chiou YS, 2011, J AGR FOOD CHEM, V59, P2725, DOI 10.1021/jf2000103; Clement MV, 1998, BLOOD, V92, P996; Douillet-Breuil AC, 1999, J AGR FOOD CHEM, V47, P4456, DOI 10.1021/jf9900478; Feldman I, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.033; Ferrer P, 2005, NEOPLASIA, V7, P37, DOI 10.1593/neo.04337; Hofer MD, 2004, CANCER RES, V64, P825, DOI 10.1158/0008-5472.CAN-03-2755; Iguchi H, 2000, INT J ONCOL, V16, P1211; Jang KS, 2006, CANCER SCI, V97, P374, DOI 10.1111/j.1349-7006.2006.00186.x; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Juan ME, 2002, J NUTR, V132, P257, DOI 10.1093/jn/132.2.257; Kai L, 2011, PROSTATE, V71, P268, DOI 10.1002/pros.21240; Kai L, 2010, INT J CANCER, V126, P1538, DOI 10.1002/ijc.24928; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Kimura Y, 2001, J NUTR, V131, P1844, DOI 10.1093/jn/131.6.1844; Kondratyuk TP, 2011, MOL NUTR FOOD RES, V55, P1249, DOI 10.1002/mnfr.201100122; Kozuki Y, 2001, CANCER LETT, V167, P151, DOI 10.1016/S0304-3835(01)00476-1; Kuwajerwala N, 2002, CANCER RES, V62, P2488; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Lin HS, 2009, BIOMED CHROMATOGR, V23, P1308, DOI 10.1002/bmc.1254; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Marier JF, 2002, J PHARMACOL EXP THER, V302, P369, DOI 10.1124/jpet.102.033340; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mikstacka R, 2007, MOL NUTR FOOD RES, V51, P517, DOI 10.1002/mnfr.200600135; Mizuno CS, 2008, BIOORGAN MED CHEM, V16, P3800, DOI 10.1016/j.bmc.2008.01.051; Pan MH, 2008, J AGR FOOD CHEM, V56, P7502, DOI 10.1021/jf800820y; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Paul S, 2010, CARCINOGENESIS, V31, P1272, DOI 10.1093/carcin/bgq004; Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720; Remsberg CM, 2008, PHYTOTHER RES, V22, P169, DOI 10.1002/ptr.2277; Rimando AM, 2005, J AGR FOOD CHEM, V53, P3403, DOI 10.1021/jf0580364; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rimando AM, 2002, J AGR FOOD CHEM, V50, P3453, DOI 10.1021/jf0116855; Sasaki H, 2002, LUNG CANCER-J IASLC, V35, P149, DOI 10.1016/S0169-5002(01)00329-4; Toh Y, 1999, BRIT J CANCER, V79, P1723, DOI 10.1038/sj.bjc.6690274; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tolomeo M, 2005, INT J BIOCHEM CELL B, V37, P1709, DOI 10.1016/j.biocel.2005.03.004; Tseng SH, 2004, CLIN CANCER RES, V10, P2190, DOI 10.1158/1078-0432.CCR-03-0105; Wang TTY, 2010, MOL NUTR FOOD RES, V54, P335, DOI 10.1002/mnfr.200900143; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yu NW, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.061	48	71	76	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57542	10.1371/journal.pone.0057542	http://dx.doi.org/10.1371/journal.pone.0057542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469203	gold, Green Published, Green Submitted			2022-12-27	WOS:000315897100023
J	Begum, R; Powner, MB; Hudson, N; Hogg, C; Jeffery, G				Begum, Rana; Powner, Michael B.; Hudson, Natalie; Hogg, Chris; Jeffery, Glen			Treatment with 670 nm Light Up Regulates Cytochrome C Oxidase Expression and Reduces Inflammation in an Age-Related Macular Degeneration Model	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; EMITTING DIODE TREATMENT; NEAR-INFRARED LIGHT; AMYLOID-BETA; PHOTOBIOMODULATION; POLYMORPHISM; DYSFUNCTION; RADIATION; LESIONS; RETINA	Inflammation is an umbrella feature of ageing. It is present in the aged retina and many retinal diseases including age-related macular degeneration (AMD). In ageing and in AMD mitochondrial function declines. In normal ageing this can be manipulated by brief exposure to 670 nm light on the retina, which increases mitochondrial membrane potential and reduces inflammation. Here we ask if 670 nm exposure has the same ability in an aged mouse model of AMD, the complement factor H knockout (CFH-/-) where inflammation is a key feature. Further, we ask whether this occurs when 670 nm is delivered briefly in environmental lighting rather than directly focussed on the retina. Mice were exposed to 670 nm for 6 minutes twice a day for 14 days in the form of supplemented environmental light. Exposed animals had significant increase in cytochrome c oxidase (COX), which is a mitochondrial enzyme regulating oxidative phosphorylation. There was a significant reduction in complement component C3, an inflammatory marker in the outer retina. Vimetin and glial fibrillary acidic protein (GFAP) expression, which reflect retinal stress in Muller glia, were also significantly down regulated. There were also significant changes in outer retinal macrophage morphology. However, amyloid beta (A beta) load, which also increases with age in the outer retina and is pro-inflammatory, did not change. Hence, 670 nm is effective in reducing inflammation probably via COX activation in mice with a genotype similar to that in 50% of AMD patients even when brief exposures are delivered via environmental lighting. Further, inflammation can be reduced independent of A beta. The efficacy revealed here supports current early stage clinical trials of 670 nm in AMD patients.	[Begum, Rana; Powner, Michael B.; Hudson, Natalie; Hogg, Chris; Jeffery, Glen] UCL, Inst Ophthalmol, London, England; [Hogg, Chris] Moorfields Eye Hosp, London, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Jeffery, G (corresponding author), UCL, Inst Ophthalmol, London, England.	g.jeffery@ucl.ac.uk	Powner, Michael/CAG-7455-2022	Powner, Michael/0000-0003-4913-1004	Rosetrees Trust	Rosetrees Trust(Rosetrees Trust)	This study was funded by the Rosetrees Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin R, 2012, PHOTOCHEM PHOTOBIOL, V88, P1418, DOI 10.1111/j.1751-1097.2012.01130.x; Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Alonso-Fernandez Patricia, 2011, Curr Aging Sci, V4, P78; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Barot M, 2011, CURR EYE RES, V36, P1069, DOI 10.3109/02713683.2011.607536; Catchpole IR, 2011, ARVO M 2011, V262, P1778; Chiang PK, 2008, CURR MOL MED, V8, P580, DOI 10.2174/156652408785747951; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Cook HL, 2008, BRIT MED BULL, V85, P127, DOI 10.1093/bmb/ldn012; Cunea A, 2007, VISUAL NEUROSCI, V24, P151, DOI 10.1017/S0952523807070204; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Freund PR, 2011, DOC OPHTHALMOL, V122, P177, DOI 10.1007/s10633-011-9273-2; GRAYMORE CN, 1969, EXP EYE RES, V8, P375, DOI 10.1016/S0014-4835(69)80001-1; Hageman G.S., 2008, WEBVISION ORG RETINA; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Jackson GR, 2002, AGEING RES REV, V1, P381, DOI 10.1016/S1568-1637(02)00007-7; Kam JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013127; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lee V, 2012, NEUROBIOL AGING, V33, P2382, DOI 10.1016/j.neurobiolaging.2011.12.002; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Lim J, 2010, J PHOTOCH PHOTOBIO B, V99, P105, DOI 10.1016/j.jphotobiol.2010.03.002; Lim J, 2009, J BIOCHEM MOL TOXIC, V23, P1, DOI 10.1002/jbt.20257; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lutty G, 1999, MOL VIS, V5; Merry G., 2012, INVEST OPHTHALMOL VI, V53, P2049; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; PASSARELLA S, 1984, FEBS LETT, V175, P95, DOI 10.1016/0014-5793(84)80577-3; Pastore D, 2000, FEBS LETT, V470, P88, DOI 10.1016/S0014-5793(00)01292-8; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Puzzo D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.020; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Shaw VE, 2010, J COMP NEUROL, V518, P25, DOI 10.1002/cne.22207; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Wong-Riley MTT, 2001, NEUROREPORT, V12, P3033, DOI 10.1097/00001756-200110080-00011; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Yeh S, 2008, J AUTOIMMUN, V31, P91, DOI 10.1016/j.jaut.2008.05.001	53	89	100	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57828	10.1371/journal.pone.0057828	http://dx.doi.org/10.1371/journal.pone.0057828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469078	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315524900174
J	Cheng, DF; Zhang, ZL; He, XF; Liang, GW				Cheng, Daifeng; Zhang, Zhiling; He, Xiaofang; Liang, Guangwen			Validation of Reference Genes in Solenopsis invicta in Different Developmental Stages, Castes and Tissues	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; FIRE ANT; RT-PCR; HOUSEKEEPING GENES; APIS-MELLIFERA; EXPRESSION; SELECTION; IDENTIFICATION; QUANTIFICATION	To accurately assess gene expression levels, it is essential to normalize real-time quantitative PCR (RT-qPCR) data with suitable internal reference genes. For the red imported fire ant, Solenopsis invicta, reliable reference genes to assess the transcript expression levels of the target genes have not been previously investigated. In this study, we examined the expression levels of five candidate reference genes (rpl18, ef1-beta, act, GAPDH, and tbp) in different developmental stages, castes and tissues of S. invicta. To evaluate the suitability of these genes as endogenous controls, three software-based approaches (geNorm, BestKeeper and NormFinder) and one web-based comprehensive tool (RefFinder) were used to analyze and rank the tested genes. Furthermore, the optimal number of reference gene(s) was determined by the pairwise variation value. Our data showed that two of the five candidate genes, rpl18 and ef1-beta, were the most suitable reference genes because they have the most stable expression among different developmental stages, castes and tissues in S. invicta. Although widely used as reference gene in other species, in S. invicta the act gene has high variation in expression and was consequently excluded as a reliable reference gene. The two validated reference genes, rpl18 and ef1-beta, can be widely used for quantification of target gene expression with RT-qPCR technology in S. invicta.	[Cheng, Daifeng; Zhang, Zhiling; He, Xiaofang; Liang, Guangwen] South China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	He, XF (corresponding author), South China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	hexf@scau.edu.cn	Cheng, Daifeng/K-3071-2019		Natural Science Foundation of China [30900942]; Guangdong Science and Technology Plan [2011B031500017]; Guangdong College Students' Innovative Experiment Project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Plan; Guangdong College Students' Innovative Experiment Project	This work was supported by the Natural Science Foundation of China, www.nsfc.org.cn, (30900942); Guangdong Science and Technology Plan, www.pro.gdstc.gov.cn, (2011B031500017); and Guangdong College Students' Innovative Experiment Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Bagnall NH, 2010, MED VET ENTOMOL, V24, P176, DOI 10.1111/j.1365-2915.2010.00866.x; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Choi MY, 2011, J INSECT PHYSIOL, V57, P161, DOI 10.1016/j.jinsphys.2010.10.008; Cubero-Leon E, 2012, ENV SCI POLLUTTION R, DOI [10.1007/s11356-11012-10772-11359, DOI 10.1007/S11356-11012-10772-11359]; Dong MT, 2012, CURR GENET, V58, P13, DOI 10.1007/s00294-011-0361-3; Feng H, 2012, PLANT PHYSIOL BIOCH, V51, P116, DOI 10.1016/j.plaphy.2011.10.010; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Hunt BG, 2013, MOL BIOL EVOL, V30, P263, DOI 10.1093/molbev/mss234; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Kemp SF, 2000, J ALLERGY CLIN IMMUN, V105, P683, DOI 10.1067/mai.2000.105707; Kowalewska M, 2012, CLIN BIOCHEM, V45, P368, DOI 10.1016/j.clinbiochem.2012.01.001; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lofgren C.S., 1986, P227; Logan J., 2009, REAL TIME PCR CURREN; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Lu HL, 2011, INSECT MOL BIOL, V20, P637, DOI 10.1111/j.1365-2583.2011.01094.x; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Ometto L, 2012, MOL ECOL, V21, P2488, DOI 10.1111/j.1365-294X.2012.05544.x; Ometto L, 2011, MOL BIOL EVOL, V28, P1381, DOI 10.1093/molbev/msq322; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Ransbotyn V, 2006, LIMNOL OCEANOGR-METH, V4, P367, DOI 10.4319/lom.2006.4.367; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Tian HS, 2004, INSECT BIOCHEM MOLEC, V34, P937, DOI 10.1016/j.ibmb.2004.06.004; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r9; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Ye JW, 2010, J INSECT BEHAV, V23, P396, DOI 10.1007/s10905-010-9222-z; Zhou YH, 2012, APPL MICROBIOL BIOT, V93, P679, DOI 10.1007/s00253-011-3561-3; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	47	67	71	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57718	10.1371/journal.pone.0057718	http://dx.doi.org/10.1371/journal.pone.0057718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469057	Green Published, Green Submitted			2022-12-27	WOS:000315524900155
J	Muller, P; Alber, DG; Turnbull, L; Schlothauer, RC; Carter, DA; Whitchurch, CB; Harry, EJ				Mueller, Patrick; Alber, Dagmar G.; Turnbull, Lynne; Schlothauer, Ralf C.; Carter, Dee A.; Whitchurch, Cynthia B.; Harry, Elizabeth J.			Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus (MRSA)	PLOS ONE			English	Article							LEPTOSPERMUM-SCOPARIUM HONEY; PSEUDOMONAS-AERUGINOSA; MANUKA HONEY; NEW-ZEALAND; ANTIMICROBIAL ACTIVITY; ANTIBACTERIAL ACTIVITY; RNA-POLYMERASE; METHYLGLYOXAL; ANTIBIOTICS; WOUNDS	Skin and chronic wound infections caused by highly antibiotic resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) are an increasing and urgent health problem worldwide, particularly with sharp increases in obesity and diabetes. New Zealand manuka honey has potent broad-spectrum antimicrobial activity, has been shown to inhibit the growth of MRSA strains, and bacteria resistant to this honey have not been obtainable in the laboratory. Combinational treatment of chronic wounds with manuka honey and common antibiotics may offer a wide range of advantages including synergistic enhancement of the antibacterial activity, reduction of the effective dose of the antibiotic, and reduction of the risk of antibiotic resistance. The aim of this study was to investigate the effect of Medihoney in combination with the widely used antibiotic rifampicin on S. aureus. Using checkerboard microdilution assays, time-kill curve experiments and agar diffusion assays, we show a synergism between Medihoney and rifampicin against MRSA and clinical isolates of S. aureus. Furthermore, the Medihoney/rifampicin combination stopped the appearance of rifampicin-resistant S. aureus in vitro. Methylglyoxal (MGO), believed to be the major antibacterial compound in manuka honey, did not act synergistically with rifampicin and is therefore not the sole factor responsible for the synergistic effect of manuka honey with rifampicin. Our findings support the idea that a combination of honey and antibiotics may be an effective new antimicrobial therapy for chronic wound infections.	[Mueller, Patrick; Alber, Dagmar G.; Turnbull, Lynne; Whitchurch, Cynthia B.; Harry, Elizabeth J.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia; [Schlothauer, Ralf C.] Comvita NZ Ltd, Te Puke, New Zealand; [Carter, Dee A.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Technology Sydney; University of Sydney	Harry, EJ (corresponding author), Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia.	Elizabeth.Harry@uts.edu.au	Harry, Liz/AAT-9396-2020; Harry, Elizabeth/G-8123-2017; Carter, Dee/C-1331-2010; Whitchurch, Cynthia/A-5954-2008; Turnbull, Lynne/A-2605-2012	Carter, Dee/0000-0002-4638-0059; Whitchurch, Cynthia/0000-0003-2296-3791; Turnbull, Lynne/0000-0002-9255-9033; Harry, Elizabeth/0000-0003-0858-9473	Australian Research Council [LP0990949]; Australian National Health and Medical Research Council Senior Research Fellowship [571905]; University of Technology Sydney Chancellors Postdoctoral Fellowship	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Technology Sydney Chancellors Postdoctoral Fellowship	Sources of funding that supported the work: 1. Australian Research Council (http://www.arc.gov.au/) in the form of an Australian Research Council Linkage Project (LP0990949) to EJH, CBW, LT, DAC and RCS. (http://www.comvita.co.nz/) 2. CBW is supported by an Australian National Health and Medical Research Council Senior Research Fellowship (571905). 3. LT was supported by a University of Technology Sydney Chancellors Postdoctoral Fellowship (http://www.uts.edu.au). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Aubry-Damon H, 1998, ANTIMICROB AGENTS CH, V42, P2590, DOI 10.1128/AAC.42.10.2590; BALS MG, 1969, ARZNEI-FORSCHUNG, V19, P1285; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Braga LC, 2005, CAN J MICROBIOL, V51, P541, DOI 10.1139/W05-022; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cooper R, 2010, EUROPEAN J CLIN MICR, P1; Cooper RA, 2010, EUR J CLIN MICROBIOL, V29, P1237, DOI 10.1007/s10096-010-0992-1; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; ECDC E, 2009, BACT CHALL TIM REACT; EFEM SEE, 1988, BRIT J SURG, V75, P679, DOI 10.1002/bjs.1800750718; Eliopoulos GM, 1996, ANTIBIOTICS LAB MED; ENG RHK, 1985, J ANTIMICROB CHEMOTH, V15, P201, DOI 10.1093/jac/15.2.201; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Feklistov A, 2008, P NATL ACAD SCI USA, V105, P14820, DOI 10.1073/pnas.0802822105; GAL K, 1965, CAN MED ASSOC J, V93, P844; George NM, 2007, WOUNDS, V19, P231; Harbarth S, 2011, INT J ANTIMICROB AG, V37, P110, DOI 10.1016/j.ijantimicag.2010.10.022; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Iyer S, 2004, J AM ACAD DERMATOL, V50, P854, DOI 10.1016/j.jaad.2003.12.043; Jabar MA, 2010, AFRICAN J BIOTECHNOL, P6; Jenkins RE, 2012, J ANTIMICROBIAL CHEM; Jenkins R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045600; Jenkins R, 2011, J ANTIMICROB CHEMOTH, V66, P2536, DOI 10.1093/jac/dkr340; Jenkins R, 2011, INT J ANTIMICROB AG, V37, P373, DOI 10.1016/j.ijantimicag.2010.11.036; JENSEN K, 1969, Q J MED, V38, P91; Kwakman PHS, 2012, IUBMB LIFE, V64, P48, DOI 10.1002/iub.578; Kwakman PHS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017709; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; Lee JW, 2007, J MICROBIOL, V45, P350; Leibovici L, 2010, CLIN MICROBIOL INFEC, V16, P1736, DOI 10.1111/j.1469-0691.2010.03330.x; Lewis K, 2007, NATURE, V200, P6; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Merckoll P, 2009, SCAND J INFECT DIS, V41, P341, DOI 10.1080/00365540902849383; Molan PC, 2008, EXPLANATION WHY MGO; Mukherjee S, 2011, INDIAN J EXP BIOL, V49, P547; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Rahal JJ, 2006, CLIN INFECT DIS, V43, pS95, DOI 10.1086/504486; RIBNER B, 1976, CHEST, V70, P681, DOI 10.1378/chest.70.5.681; Saleem M, 2010, NAT PROD REP, V27, P238, DOI 10.1039/b916096e; Schierle CF, 2009, WOUND REPAIR REGEN, V17, P354, DOI 10.1111/j.1524-475X.2009.00489.x; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sherlock O, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-47; Shiota S, 2004, MICROBIOL IMMUNOL, V48, P67, DOI 10.1111/j.1348-0421.2004.tb03489.x; Taormina PJ, 2001, INT J FOOD MICROBIOL, V69, P217, DOI 10.1016/S0168-1605(01)00505-0; Tiwari RP, 2005, INDIAN J MED RES, V122, P80; TRACZEWSKI MM, 1983, ANTIMICROB AGENTS CH, V23, P571, DOI 10.1128/AAC.23.4.571; Villar M, 2011, J ANTIMICROB CHEMOTH, V66, P997, DOI 10.1093/jac/dkr059; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; WILLIX DJ, 1992, J APPL BACTERIOL, V73, P388, DOI 10.1111/j.1365-2672.1992.tb04993.x; Windsor S., 2012, J PHARMACOGN PHYTHER, V4, P6, DOI DOI 10.5897/JPP11.025; Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002	59	69	70	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57679	10.1371/journal.pone.0057679	http://dx.doi.org/10.1371/journal.pone.0057679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469049	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900148
J	Phillips, CD; Butler, B; Fondon, JW; Mantilla-Meluk, H; Baker, RJ				Phillips, Caleb D.; Butler, Boyd; Fondon, John W., III; Mantilla-Meluk, Hugo; Baker, Robert J.			Contrasting Evolutionary Dynamics of the Developmental Regulator PAX9, among Bats, with Evidence for a Novel Post-Transcriptional Regulatory Mechanism	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR EVOLUTION; TOOTH DEVELOPMENT; GENE-EXPRESSION; DIVERGENCE; MSX1; DIVERSIFICATION; PHYLLOSTOMIDAE; IDENTIFICATION; HYPOTHESIS	Morphological evolution can be the result of natural selection favoring modification of developmental signaling pathways. However, little is known about the genetic basis of such phenotypic diversity. Understanding these mechanisms is difficult for numerous reasons, yet studies in model organisms often provide clues about the major developmental pathways involved. The paired- domain gene, PAX9, is known to be a key regulator of development, particularly of the face and teeth. In this study, using a comparative genetics approach, we investigate PAX9 molecular evolution among mammals, focusing on craniofacially diversified (Phyllostomidae) and conserved (Vespertilionidae) bat families, and extend our comparison to other orders of mammal. Open- reading frame analysis disclosed signatures of selection, in which a small percentage of residues vary, and lineages acquire different combinations of variation through recurrent substitution and lineage specific changes. A few instances of convergence for specific residues were observed between morphologically convergent bat lineages. Bioinformatic analysis for unknown PAX9 regulatory motifs indicated a novel post- transcriptional regulatory mechanism involving a Musashi protein. This regulation was assessed through fluorescent reporter assays and gene knockdowns. Results are compatible with the hypothesis that the number of Musashi binding- elements in PAX9 mRNA proportionally regulates protein translation rate. Although a connection between morphology and binding element frequency was not apparent, results indicate this regulation would vary among craniofacially divergent bat species, but be static among conserved species. Under this model, Musashi's regulatory control of alternative human PAX9 isoforms would also vary. The presence of Musashi- binding elements within PAX9 of all mammals examined, chicken, zebrafish, and the fly homolog of PAX9, indicates this regulatory mechanism is ancient, originating basal to much of the animal phylogeny.	[Phillips, Caleb D.; Butler, Boyd; Mantilla-Meluk, Hugo; Baker, Robert J.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Fondon, John W., III] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	Texas Tech University System; Texas Tech University; University of Texas System; University of Texas Arlington	Phillips, CD (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	caleb.phillips@ttu.edu		Mantilla-Meluk, Hugo/0000-0001-8134-3694; Phillips, Caleb/0000-0001-9839-1510	Texas Biological Database program	Texas Biological Database program	Funding was provided by the Texas Biological Database program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RJ, 2012, CAM STUD MORPHOL MOL, P385; Bianchi FJ, 2007, J APPL ORAL SCI, V15, P382, DOI 10.1590/S1678-77572007000500002; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; Epstein CJ, 2008, OXFORD MONOGRAPHS ME; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Jameson NM, 2011, J HUM EVOL, V61, P295, DOI 10.1016/j.jhevol.2011.04.004; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Jonker L, 2004, MECH DEVELOP, V121, P1313, DOI 10.1016/j.mod.2004.07.002; Kong H, 2011, CELLS TISSUES ORGANS, V194, P156, DOI 10.1159/000324747; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Lack JB, 2010, J MAMMAL, V91, P1435, DOI 10.1644/09-MAMM-A-354.1; Lack JB, 2010, J MAMMAL, V91, P976, DOI 10.1644/09-MAMM-A-192.1; Lai EC, 1997, DEVELOPMENT, V124, P4847; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Lin DH, 2007, DEV DYNAM, V236, P1307, DOI 10.1002/dvdy.21127; Liu B, 2010, SEMIN CELL DEV BIOL, V21, P309, DOI 10.1016/j.semcdb.2009.09.002; Liu Y, 2012, MOL BIOL EVOL, V29, P1441, DOI 10.1093/molbev/msr310; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Londhe S M, 2008, Med J Armed Forces India, V64, P67, DOI 10.1016/S0377-1237(08)80153-0; Maddison W., 2018, MESQUITE MODULAR SYS; Mammoto T, 2011, DEV CELL, V21, P758, DOI 10.1016/j.devcel.2011.07.006; Matsui A, 2009, GENE, V441, P53, DOI 10.1016/j.gene.2008.08.024; Mendoza-Fandino GA, 2011, CLIN GENET, V80, P265, DOI 10.1111/j.1399-0004.2010.01529.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ogawa T, 2005, ARCH ORAL BIOL, V50, P141, DOI 10.1016/j.archoralbio.2004.09.011; Ogawa T, 2006, J BIOL CHEM, V281, P18363, DOI 10.1074/jbc.M601543200; Okano H, 2002, J CELL SCI, V115, P1355; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Ovcharenko I, 2004, GENOME RES, V14, P1191, DOI 10.1101/gr.1773104; Paixao-Cortes VR, 2011, ARCH ORAL BIOL, V56, P337, DOI 10.1016/j.archoralbio.2010.10.020; Pemberton TJ, 2007, DEV DYNAM, V236, P2245, DOI 10.1002/dvdy.21226; Pereira TV, 2006, P NATL ACAD SCI USA, V103, P5676, DOI 10.1073/pnas.0509562103; Perry GH, 2006, MOL BIOL EVOL, V23, P644, DOI 10.1093/molbev/msj072; Peters H, 1999, DEVELOPMENT, V126, P5399; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Santagati F, 2003, GENETICS, V165, P235; Sasaki Y, 2007, ARCH ORAL BIOL, V52, P260, DOI 10.1016/j.archoralbio.2006.09.012; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Su DM, 2001, DEV BIOL, V236, P316, DOI 10.1006/dbio.2001.0342; Suda N, 2011, J DENT RES, V90, P382, DOI 10.1177/0022034510390042; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Vorobyov E, 2006, J MOL EVOL, V63, P153, DOI 10.1007/s00239-005-0163-7; Wang W, 2010, GENES GENET SYST, V85, P193, DOI 10.1266/ggs.85.193; Wang Y, 2009, HUM MOL GENET, V18, P2863, DOI 10.1093/hmg/ddp221; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; Wuebben EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034827	60	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57649	10.1371/journal.pone.0057649	http://dx.doi.org/10.1371/journal.pone.0057649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469040	Green Published, gold			2022-12-27	WOS:000315524900139
J	Hua, WK; Chang, YI; Yao, CL; Hwang, SM; Chang, CY; Lin, WJ				Hua, Wei-Kai; Chang, Yuan-I; Yao, Chao-Ling; Hwang, Shiaw-Min; Chang, Chung-Yi; Lin, Wey-Jinq			Protein Arginine Methyltransferase 1 Interacts with and Activates p38 alpha to Facilitate Erythroid Differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; HEMATOPOIETIC STEM-CELL; P38 MAP-KINASE; MEGAKARYOCYTIC DIFFERENTIATION; METHYLATION; PRMT1; PHOSPHORYLATION; REGULATOR; MECHANISM; ERYTHROPOIETIN	Protein arginine methylation is emerging as a pivotal posttranslational modification involved in regulating various cellular processes; however, its role in erythropoiesis is still elusive. Erythropoiesis generates circulating red blood cells which are vital for body activity. Deficiency in erythroid differentiation causes anemia which compromises the quality of life. Despite extensive studies, the molecular events regulating erythropoiesis are not fully understood. This study showed that the increase in protein arginine methyltransferase 1 (PRMT1) levels, via transfection or protein transduction, significantly promoted erythroid differentiation in the bipotent human K562 cell line as well as in human primary hematopoietic progenitor CD34(+) cells. PRMT1 expression enhanced the production of hemoglobin and the erythroid surface marker glycophorin A, and also up-regulated several key transcription factors, GATA1, NF-E2 and EKLF, which are critical for lineage-specific differentiation. The shRNA-mediated knockdown of PRMT1 suppressed erythroid differentiation. The methyltransferase activity-deficient PRMT1G80R mutant failed to stimulate differentiation, indicating the requirement of arginine methylation of target proteins. Our results further showed that a specific isoform of p38 MAPK, p38 alpha, promoted erythroid differentiation, whereas p38 beta did not play a role. The stimulation of erythroid differentiation by PRMT1 was diminished in p38 alpha-but not p38 beta-knockdown cells. PRMT1 appeared to act upstream of p38 alpha, since expression of p38 alpha still promoted erythroid differentiation in PRMT1-knockdown cells, and expression of PRMT1 enhanced the activation of p38 MAPK. Importantly, we showed for the first time that PRMT1 was associated with p38 alpha in cells by co-immunoprecipitation and that PRMT1 directly methylated p38 alpha in in vitro methylation assays. Taken together, our findings unveil a link between PRMT1 and p38 alpha in regulating the erythroid differentiation program and provide evidence suggesting a novel regulatory mechanism for p38 alpha through arginine methylation.	[Hua, Wei-Kai; Chang, Yuan-I; Lin, Wey-Jinq] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Yao, Chao-Ling] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Chungli, Taiwan; [Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Chang, Chung-Yi] Cheng Hsin Gen Hosp, Ctr Heart, Taipei, Taiwan	National Yang Ming Chiao Tung University; Yuan Ze University; Cheng Hsin General Hospital	Lin, WJ (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.	wjlin@ym.edu.tw	Chang, Yuan-I/AAY-1711-2021; Yao, Chao-Ling/HDN-2709-2022	Yao, Chao-Ling/0000-0002-7196-5833	National Science Council, Taiwan [NSC 100-2311-B-010-002, NSC 99-2221-E-155-086-MY2, NSC-101-2221-E-155-044-MY3]; Ministry of Education, Aim for the Top University Plan; Cheng Hsin General Hospital and National Yang-Ming University [101F195CY19]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Cheng Hsin General Hospital and National Yang-Ming University	This work was supported by grants from the National Science Council, Taiwan (NSC 100-2311-B-010-002 to WJL; NSC 99-2221-E-155-086-MY2 and NSC-101-2221-E-155-044-MY3 to CLY), the Ministry of Education, Aim for the Top University Plan, and Cheng Hsin General Hospital and National Yang-Ming University (101F195CY19 to WJL and CYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Chang YI, 2011, BIOCHEM BIOPH RES CO, V404, P865, DOI 10.1016/j.bbrc.2010.12.076; Chang YI, 2010, ELECTROPHORESIS, V31, P3834, DOI 10.1002/elps.201000376; Chang YI, 2010, J BIOL CHEM, V285, P20595, DOI 10.1074/jbc.M109.092411; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cho JH, 2012, CELL DEATH DIFFER, V19, P859, DOI 10.1038/cdd.2011.168; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Duong FHT, 2005, J VIROL, V79, P15342, DOI 10.1128/JVI.79.24.15342-15350.2005; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lei NZ, 2009, NUCLEIC ACIDS RES, V37, P832, DOI 10.1093/nar/gkn941; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Pace BS, 2003, EXP HEMATOL, V31, P1089, DOI 10.1016/S0301-472X(03)00235-2; Park JI, 2001, CELL GROWTH DIFFER, V12, P481; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Sakamaki J, 2011, P NATL ACAD SCI USA, V108, P6085, DOI 10.1073/pnas.1015328108; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Tallack MR, 2009, HAEMATOLOGICA, V95, P144; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Wang D, 2005, APOPTOSIS, V10, P963, DOI 10.1007/s10495-005-1191-x; Wickrema A, 2007, ONCOGENE, V26, P6803, DOI 10.1038/sj.onc.1210763; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56715	10.1371/journal.pone.0056715	http://dx.doi.org/10.1371/journal.pone.0056715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483889	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100007
J	Chen, P; Guo, XF; Zhou, HD; Zhang, WL; Zeng, ZY; Liao, QJ; Li, XY; Xiang, B; Yang, JB; Ma, J; Zhou, M; Peng, SP; Xiang, JJ; Li, XL; Le, CW; Xiong, W; McCarthy, JB; Li, GY				Chen, Pan; Guo, Xiaofang; Zhou, Houde; Zhang, Wenling; Zeng, Zhaoyang; Liao, Qianjin; Li, Xiayu; Xiang, Bo; Yang, Jianbo; Ma, Jian; Zhou, Ming; Peng, Shuping; Xiang, Juanjuan; Li, Xiaoling; Le, Colvin Wanshura; Xiong, Wei; McCarthy, James B.; Li, Guiyuan			SPLUNC1 Regulates Cell Progression and Apoptosis through the miR-141-PTEN/p27 Pathway, but Is Hindered by LMP1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; NASOPHARYNGEAL CARCINOMA; SUSCEPTIBILITY LOCUS; CDNA MICROARRAY; INHERITED BREAST; CHROMOSOME 3P21; HOST-DEFENSE; PROTEIN; GENE	Little is known about the role of the host defensive protein short palate, lung and nasal epithelium clone 1 (SPLUNC1) in the carcinogenesis of nasopharyngeal carcinoma (NPC). Here we report that SPLUNC1 plays a role at a very early stage of NPC carcinogenesis. SPLUNC1 regulates NPC cell proliferation, differentiation and apoptosis through miR-141, which in turn regulates PTEN and p27 expression. This signaling axis is negatively regulated by the EBV-coded gene LMP1. Therefore we propose that SPLUNC1 suppresses NPC tumor formation and its inhibition by LMP1 provides a route for NPC tumorigenesis.	[Chen, Pan; Zeng, Zhaoyang; Xiang, Bo; Ma, Jian; Zhou, Ming; Peng, Shuping; Xiang, Juanjuan; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Chen, Pan; Zeng, Zhaoyang; Xiang, Bo; Ma, Jian; Zhou, Ming; Peng, Shuping; Xiang, Juanjuan; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Changsha, Hunan, Peoples R China; [Chen, Pan; Guo, Xiaofang; Zhou, Houde; Zhang, Wenling; Zeng, Zhaoyang; Liao, Qianjin; Xiang, Bo; Ma, Jian; Zhou, Ming; Peng, Shuping; Xiang, Juanjuan; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Key Lab Carcinogenesis, Minist Hlth, Canc Res Inst, Changsha, Hunan, Peoples R China; [Chen, Pan; Guo, Xiaofang; Zhou, Houde; Zhang, Wenling; Zeng, Zhaoyang; Liao, Qianjin; Xiang, Bo; Ma, Jian; Zhou, Ming; Peng, Shuping; Xiang, Juanjuan; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Key Lab Carcinogenesis & Canc Invas, Canc Res Inst, Minist Educ, Changsha, Hunan, Peoples R China; [Zeng, Zhaoyang; Li, Xiayu; Xiang, Bo; Ma, Jian; Zhou, Ming; Peng, Shuping; Xiang, Juanjuan; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Xiangya Hosp 3, Hunan Key Lab Nonresolving Inflammat, Changsha, Hunan, Peoples R China; [Zeng, Zhaoyang; Li, Xiayu; Yang, Jianbo; Ma, Jian; Zhou, Ming; Peng, Shuping; Xiang, Juanjuan; Xiong, Wei; Li, Guiyuan] Cent S Univ, Xiangya Hosp 3, Canc & Dis Genome Res Ctr, Changsha, Hunan, Peoples R China; [Yang, Jianbo; Le, Colvin Wanshura; McCarthy, James B.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Yang, Jianbo; Le, Colvin Wanshura; McCarthy, James B.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McCarthy, JB (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	mccar001@umn.edu; ligy@xysm.net	yang, jian/HIK-0188-2022; li, xia/HHZ-7468-2022	Zhou, Hou-De/0000-0001-9131-4141	National High Technology Research and Development Program of China [2012AA02A206]; National Natural Science Foundation of China [91229122, 81071644, 81101509, 81171934, 81172189, 81171930, 81272298, 81272254, 30971147]; 111 Project [111-2-12]; Hunan Province Natural Sciences Foundation of China [10JJ7003]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Hunan Province Natural Sciences Foundation of China(Natural Science Foundation of Hunan Province)	This study was supported by grants from the National High Technology Research and Development Program of China (2012AA02A206), the National Natural Science Foundation of China (91229122, 81071644, 81101509, 81171934, 81172189, 81171930, 81272298, 81272254 and 30971147), the 111 Project (111-2-12) and the Hunan Province Natural Sciences Foundation of China (10JJ7003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bingle CD, 2004, INT J BIOCHEM CELL B, V36, P2144, DOI 10.1016/j.biocel.2004.05.002; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Chen CC, 2010, CELL SIGNAL, V22, P1132, DOI 10.1016/j.cellsig.2010.03.008; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; DAWSON CW, 1990, NATURE, V344, P777, DOI 10.1038/344777a0; Fan HX, 2001, MOL DIAGN, V6, P279, DOI 10.1054/modi.2001.29161; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Guo Xiuchan, 2010, BMC Res Notes, V3, P212, DOI 10.1186/1756-0500-3-212; Hu LF, 2008, EUR J HUM GENET, V16, P343, DOI 10.1038/sj.ejhg.5201951; LeClair EE, 2003, J DENT RES, V82, P944, DOI 10.1177/154405910308201202; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014562; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Liu TR, 2011, CURR OPIN OTOLARYNGO, V19, P87, DOI 10.1097/MOO.0b013e3283448402; Marsh DJ, 2008, NAT CLIN PRACT ONCOL, V5, P357, DOI 10.1038/ncponc1112; Peng C, 2007, MOL CELL BIOCHEM, V303, P141, DOI 10.1007/s11010-007-9466-x; Ren ZF, 2010, CANCER EPIDEMIOL, V34, P419, DOI 10.1016/j.canep.2010.04.011; Rollins BM, 2010, CHANNELS, V4, P255, DOI 10.4161/chan.4.4.12255; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Schneider F, 2008, PLOS BIOL, V6, P86, DOI 10.1371/journal.pbio.0060008; Shirakata M, 2001, J VIROL, V75, P5059, DOI 10.1128/JVI.75.11.5059-5068.2001; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; Tang YL, 2008, BRAZ J MED BIOL RES, V41, P110, DOI 10.1590/S0100-879X2008000200006; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Vaysberg M, 2008, J BIOL CHEM, V283, P36573, DOI 10.1074/jbc.M802968200; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Yang YX, 2007, MOL IMMUNOL, V44, P984, DOI 10.1016/j.molimm.2006.03.013; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zeng ZY, 2011, SCI CHINA LIFE SCI, V54, P966, DOI 10.1007/s11427-011-4223-5; Zeng ZY, 2006, GENET MED, V8, P156, DOI 10.1097/01.gim.0000196821.87655.d0; Zhang BC, 2003, GENE CHROMOSOME CANC, V38, P80, DOI 10.1002/gcc.10247; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang WL, 2012, J MOL HISTOL, V43, P297, DOI 10.1007/s10735-012-9392-4; Zhang WL, 2009, ACTA BIOCH BIOPH SIN, V41, P414, DOI 10.1093/abbs/gmp025; Zheng MZ, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-36; Zheng Y, 2012, J INNATE IMMUN, V4, P387, DOI 10.1159/000336178; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou HD, 2006, HISTOCHEM CELL BIOL, V125, P315, DOI 10.1007/s00418-005-0070-4; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3	45	17	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e56929	10.1371/journal.pone.0056929	http://dx.doi.org/10.1371/journal.pone.0056929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472073	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900011
J	Chen, Q; Liu, WB; Sinha, KM; Yasuda, H; de Crombrugghe, B				Chen, Qin; Liu, Wenbin; Sinha, Krishna M.; Yasuda, Hideyo; de Crombrugghe, Benoit			Identification and Characterization of MicroRNAs Controlled by the Osteoblast-Specific Transcription Factor Osterix	PLOS ONE			English	Article							BONE-FORMATION; GENE-EXPRESSION; DIFFERENTIATION; WNT; MICE; SCLEROSTIN; RUNX2; DLX5; CHONDROCYTES; HEDGEHOG	Osterix (Osx) is an osteoblast-specific transcription factor which is essential for bone formation. MicroRNAs (miRNAs) have been previously shown to be involved in osteogenesis. However, it is unclear whether Osx is involved in the regulation of miRNA expression. In this study, we have identified groups of miRNAs that are differentially expressed in calvaria of the E18.5 Osx(-/-) embryos compared to wild type embryos. The correlation between the levels of miRNAs and Osx expression was further verified in cultured M-Osx cells in which over-expression of Osx is inducible. Our results suggest that Osx down-regulates expression of a group of miRNAs including mir-133a and -204/211, but up-regulates expression of another group of miRNAs such as mir-141/200a. Mir-133a and -204/211 are known to target the master osteogenic transcription factor Runx2. Further assays suggest that Sost, which encodes the Wnt signaling antagonist Sclerostin, and alkaline phosphatase (ALP) are two additional targets of mir-204/211. Mir-141/200a has been known to target the transcription factor Dlx5. Thus, we postulate that during the process of Osx-controlled osteogenesis, Osx has the ability to coordinately modulate Runx2, Sclerostin, ALP and Dlx5 proteins at levels appropriate for optimal osteoblast differentiation and function, at least in part, through regulation of specific miRNAs. Our study shows a tight correlation between Osx and the miRNAs involved in bone formation, and provides new information about molecular mechanisms of Osx-controlled osteogenesis.	[Chen, Qin; Yasuda, Hideyo; de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Liu, Wenbin] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Sinha, Krishna M.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	qchen1@mdanderson.org			National Institutes of Health [R01 AR49072, CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049072, R03AR061590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institutes of Health grants R01 AR49072 (B.d.C.) and CA016672 (MD Anderson's Cancer Center Support Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Hu R, 2010, EXPERT OPIN THER TAR, V14, P1109, DOI 10.1517/14728222.2010.512916; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Igarashi M, 2004, J MOL HISTOL, V35, P3, DOI 10.1023/B:HIJO.0000020883.33256.fe; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Storey JD, 2001, J COMPUT BIOL, V8, P549, DOI 10.1089/106652701753216530; Storey John D, 2003, Methods Mol Biol, V224, P149; Tadic T, 2002, J BONE MINER RES, V17, P1008, DOI 10.1359/jbmr.2002.17.6.1008; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Yang L, 2012, J BONE MINER RES, V27, P1598, DOI 10.1002/jbmr.1621; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; ZHAO GQ, 1994, DEV BIOL, V164, P37, DOI 10.1006/dbio.1994.1178; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	43	44	51	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58104	10.1371/journal.pone.0058104	http://dx.doi.org/10.1371/journal.pone.0058104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900086
J	Krishnamurthy, VM; Raman, VS; Mowery, RA; Hentz, M; Baleja, JD; Shaw, BF; Kumar, K				Krishnamurthy, Vijay M.; Raman, Venkata S.; Mowery, Richard A.; Hentz, Michelle; Baleja, James D.; Shaw, Bryan F.; Kumar, Krishna			Ligand-Induced Protein Mobility in Complexes of Carbonic Anhydrase II and Benzenesulfonamides with Oligoglycine Chains	PLOS ONE			English	Article							ENTHALPY-ENTROPY COMPENSATION; MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; BACKBONE DYNAMICS; HYDROGEN-EXCHANGE; DIFFUSION-COEFFICIENTS; BINDING; NMR; INHIBITORS; SURFACE	This paper describes a biophysical investigation of residual mobility in complexes of bovine carbonic anhydrase II (BCA) and para-substituted benzenesulfonamide ligands with chains of 1-5 glycine subunits, and explains the previously observed increase in entropy of binding with chain length. The reported results represent the first experimental demonstration that BCA is not the rigid, static globulin that has been typically assumed, but experiences structural fluctuations upon binding ligands. NMR studies with N-15-labeled ligands demonstrated that the first glycine subunit of the chain binds without stabilization or destabilization by the more distal subunits, and suggested that the other glycine subunits of the chain behave similarly. These data suggest that a model based on ligand mobility in the complex cannot explain the thermodynamic data. Hydrogen/deuterium exchange studies provided a global estimate of protein mobility and revealed that the number of exchanged hydrogens of BCA was higher when the protein was bound to a ligand with five glycine subunits than when bound to a ligand with only one subunit, and suggested a trend of increasing number of exchanged hydrogens with increasing chain length of the BCA-bound ligand, across the series. These data support the idea that the glycine chain destabilizes the structure of BCA in a length-dependent manner, causing an increase in BCA mobility. This study highlights the need to consider ligand-induced mobility of even "static" proteins in studies of protein-ligand binding, including rational ligand design approaches.	[Krishnamurthy, Vijay M.; Raman, Venkata S.; Kumar, Krishna] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Mowery, Richard A.; Hentz, Michelle; Shaw, Bryan F.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Baleja, James D.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Baleja, James D.; Kumar, Krishna] Tufts Univ, Med Ctr, Ctr Canc, Boston, MA 02111 USA	Tufts University; Baylor University; Tufts University; Tufts University	Krishnamurthy, VM (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	vijay.murthy@tufts.edu; krishna.kumar@tufts.edu	Shaw, Bryan/A-7001-2008; Kumar, Krishna/B-3151-2009	Kumar, Krishna/0000-0002-0548-5014	National Institutes of Health [GM65500]; Department of Defense Congressionally Directed Medical Research Program [AL100089]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM65500 to KK) and the Department of Defense Congressionally Directed Medical Research Program (AL100089 to BFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; ANDREWS PR, 1984, J MED CHEM, V27, P1648, DOI 10.1021/jm00378a021; Bai YW, 2006, CHEM REV, V106, P1757, DOI 10.1021/cr040432i; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Borsi V, 2010, J MED CHEM, V53, P4285, DOI 10.1021/jm901723z; BUNN AMC, 1994, J AM CHEM SOC, V116, P5063, DOI 10.1021/ja00091a006; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; CHENG XH, 1995, J AM CHEM SOC, V117, P8859, DOI 10.1021/ja00139a023; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferreira RS, 2009, J MED CHEM, V52, P5005, DOI 10.1021/jm9009229; GILLI P, 1994, J PHYS CHEM-US, V98, P1515, DOI 10.1021/j100056a024; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; HAYDUK W, 1974, AICHE J, V20, P611, DOI 10.1002/aic.690200329; JAIN A, 1994, J AM CHEM SOC, V116, P5057, DOI 10.1021/ja00091a005; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Krishnamurthy V.M., 2006, FRAGMENT BASED APPRO, P11, DOI DOI 10.1002/3527608761.CH2; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Krishnamurthy VM, 2006, J AM CHEM SOC, V128, P5802, DOI 10.1021/ja060070r; Lee AL, 1999, J BIOMOL NMR, V13, P101, DOI 10.1023/A:1008304220445; Lill MA, 2011, BIOCHEMISTRY-US, V50, P6157, DOI 10.1021/bi2004558; Ling Y, 2010, BIOORGAN MED CHEM, V18, P3448, DOI 10.1016/j.bmc.2010.03.077; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; Lu J, 2006, J CHEM ENG DATA, V51, P1593, DOI 10.1021/je0600754; Maity H, 2003, PROTEIN SCI, V12, P153, DOI 10.1110/ps.0225803; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MATTHEW JB, 1983, J BIOL CHEM, V258, P3039; Mecinovic J, 2011, J AM CHEM SOC, V133, P14017, DOI 10.1021/ja2045293; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; MORRIS KF, 1993, J AM CHEM SOC, V115, P4291, DOI 10.1021/ja00063a053; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Myslinski JM, 2011, J AM CHEM SOC, V133, P18518, DOI 10.1021/ja2068752; Nazare M, 2012, ANGEW CHEM INT EDIT, V51, P905, DOI 10.1002/anie.201107091; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PENG JW, 1991, J MAGN RESON, V94, P82, DOI 10.1016/0022-2364(91)90296-6; Polyansky AA, 2012, METHODS MOL BIOL, V819, P327, DOI 10.1007/978-1-61779-465-0_21; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; PRATT LR, 1977, J CHEM PHYS, V67, P3683, DOI 10.1063/1.435308; Sapienza PJ, 2010, CURR OPIN PHARMACOL, V10, P723, DOI 10.1016/j.coph.2010.09.006; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schnolzer M, 2007, INT J PEPT RES THER, V13, P31, DOI 10.1007/s10989-006-9059-7; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Shaw BF, 2010, J AM CHEM SOC, V132, P17411, DOI 10.1021/ja9067035; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Southall NT, 2002, J PHYS CHEM B, V106, P521, DOI 10.1021/jp015514e; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Starikov EB, 2007, J PHYS CHEM B, V111, P14431, DOI 10.1021/jp075784i; Stockmann H, 2008, J AM CHEM SOC, V130, P12420, DOI 10.1021/ja803755m; TANFORD C, 1979, P NATL ACAD SCI USA, V76, P4175, DOI 10.1073/pnas.76.9.4175; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; WAGNER G, 1993, CURR OPIN STRUC BIOL, V3, P748, DOI 10.1016/0959-440X(93)90059-T; Whitesides GM, 2005, Q REV BIOPHYS, V38, P385, DOI 10.1017/S0033583506004240; WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; WILLIAMS DH, 1991, J AM CHEM SOC, V113, P7020, DOI 10.1021/ja00018a047	70	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57629	10.1371/journal.pone.0057629	http://dx.doi.org/10.1371/journal.pone.0057629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472094	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900033
J	Lawless, N; Foroushani, ABK; McCabe, MS; O'Farrelly, C; Lynn, DJ				Lawless, Nathan; Foroushani, Amir B. K.; McCabe, Matthew S.; O'Farrelly, Cliona; Lynn, David J.			Next Generation Sequencing Reveals the Expression of a Unique miRNA Profile in Response to a Gram-Positive Bacterial Infection	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; IMMUNE-RESPONSE; SMALL RNAS; MICRORNAS; REPERTOIRE; TARGETS; INNATE; NORMALIZATION; DISCOVERY; CYTOKINES	MicroRNAs (miRNAs) are short, non-coding RNAs, which post-transcriptionally regulate gene expression and are proposed to play a key role in the regulation of innate and adaptive immunity. Here, we report a next generation sequencing (NGS) approach profiling the expression of miRNAs in primary bovine mammary epithelial cells (BMEs) at 1, 2, 4 and 6 hours post-infection with Streptococcus uberis, a causative agent of bovine mastitis. Analysing over 450 million sequencing reads, we found that 20% of the approximately 1,300 currently known bovine miRNAs are expressed in unchallenged BMEs. We also identified the expression of more than 20 potentially novel bovine miRNAs. There is, however, a significant dynamic range in the expression of known miRNAs. The top 10 highly expressed miRNAs account for >80% of all aligned reads, with the remaining miRNAs showing much lower expression. Twenty-one miRNAs were identified as significantly differentially expressed post-infection with S. uberis. Several of these miRNAs have characterised roles in the immune systems of other species. This miRNA response to the Gram-positive S. uberis is markedly different, however, to lipopolysaccharide (LPS) induced miRNA expression. Of 145 miRNAs identified in the literature as being LPS responsive, only 9 were also differentially expressed in response to S. uberis. Computational analysis has also revealed that the predicted target genes of miRNAs, which are down-regulated in BMEs following S. uberis infection, are statistically enriched for roles in innate immunity. This suggests that miRNAs, which potentially act as central regulators of gene expression responses to a Gram-positive bacterial infection, may significantly regulate the sentinel capacity of mammary epithelial cells to mobilise the innate immune system.	[Lawless, Nathan; Foroushani, Amir B. K.; McCabe, Matthew S.; Lynn, David J.] TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland; [Lawless, Nathan; O'Farrelly, Cliona] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Foroushani, Amir B. K.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Teagasc; Trinity College Dublin; Simon Fraser University	Lynn, DJ (corresponding author), TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland.	david.lynn@teagasc.ie		Lawless, Nathan/0000-0002-3120-1126; Foroushani, Amir/0000-0003-2748-3009; O'Farrelly, Cliona/0000-0002-0616-2874; Lynn, David/0000-0003-4664-1404	Teagasc [RMIS 6018]; Teagasc Walsh Fellowship Scheme	Teagasc; Teagasc Walsh Fellowship Scheme	This project was supported by Teagasc (RMIS 6018). NL and AF are supported by the Teagasc Walsh Fellowship Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERRY DP, 2005, DERIVATION HLTH SUBI; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Blatchford DR, 1999, J CELL PHYSIOL, V181, P304, DOI 10.1002/(SICI)1097-4652(199911)181:2<304::AID-JCP12>3.0.CO;2-5; Blatchford DR, 1999, ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 10, P141; Buermans HPJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-716; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Cui LB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/425939; Dilda F, 2012, VET J, V192, P514, DOI 10.1016/j.tvjl.2011.08.018; Enright AJ, 2004, GENOME BIOL, V5; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garmire LX, 2012, RNA, V18, P1279, DOI 10.1261/rna.030916.111; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Hogeveen H, 2011, NATL MASTITIS COUNCI; Hou QL, 2012, DNA CELL BIOL, V31, P739, DOI 10.1089/dna.2011.1402; Hsieh CH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-69; Huang HC, 2012, J LEUKOCYTE BIOL, V92, P171, DOI 10.1189/jlb.1211593; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khalkhali-Ellis Z, 2008, J CELL BIOCHEM, V105, P208, DOI 10.1002/jcb.21814; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-609; Liu PT, 2012, NAT MED, V18, P267, DOI 10.1038/nm.2584; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mackowiak Sebastian D, 2011, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1210s36; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Moyes KM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-542; Mukhopadhyay P, 2010, BIRTH DEFECTS RES A, V88, P511, DOI 10.1002/bdra.20684; Naeem A, 2012, J DAIRY SCI, V95, P1; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith KM, 2012, J IMMUNOL, V189, P1567, DOI 10.4049/jimmunol.1103171; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu GX, 2009, MOL CELL BIOCHEM, V332, P9, DOI 10.1007/s11010-009-0168-4; Yang RX, 2010, BREAST CANCER RES TR, V121, P693, DOI 10.1007/s10549-009-0633-5; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Yue X, 2012, ONCOL REP, V27, P1200, DOI 10.3892/or.2011.1588	69	75	100	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57543	10.1371/journal.pone.0057543	http://dx.doi.org/10.1371/journal.pone.0057543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472090	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900029
J	Li, DQ; Lei, H; Li, ZH; Li, HQ; Wang, Y; Lai, YP				Li, Dongqing; Lei, Hu; Li, Zhiheng; Li, Hongquan; Wang, Yue; Lai, Yuping			A Novel Lipopeptide from Skin Commensal Activates TLR2/CD36-p38 MAPK Signaling to Increase Antibacterial Defense against Bacterial Infection	PLOS ONE			English	Article							ALLERGIC DISEASES; LIPOTEICHOIC ACID; CD36; CD14; TOLL-LIKE-RECEPTOR-2; BETA-DEFENSIN-3; KERATINOCYTES; PHAGOCYTOSIS; TLR2	Staphylococcus epidermidis (S. epidermidis) plays important protective roles by directly producing or by stimulating hosts to produce antimicrobial peptides (AMPs) against pathogenic infections. Although several AMPs from S. epidermidis have been identified, molecules that stimulate hosts to produce AMPs remain largly unknown. Here we demonstrate that a new lipopeptide (named LP01) purified from S. epidermidis culture media has a unique structure with heneicosanoic acid (21 carbons) binding to lysine(11) of a peptide chain. In vitro LP01 increased the expression of beta-defensin 2(hBD2) and hBD3 in neonatal human epidermal keratinocytes(NHEK), leading to increased capacity of cell lysates to inhibit the growth of S. aureus. In vivo LP01 induced the expression of mouse b-defensin 4(mBD4) to decrease the survival of local S. aureus in skin and systemic S. aureus survival in liver. The induction of beta-defensins by LP01 was dependent on TLR2 as Tlr2-deficient mice had decreased mBD4. Furthermore, knockdown of CD36 decreased the expression of hBD2 and hBD3, and p38 MAPK inhibitor significantly inhibited the expression of hBDs induced by LP01. Taken together, these findings demonstrate that lipopeptide LP01 from normal commensal S. epidermidis increases antimicrobial peptide hBD2 and hBD3 expression via the activation of TLR2/CD36-p38 MAPK, thus enhancing antimicrobial defense against pathogenic infections.	[Li, Dongqing; Lei, Hu; Li, Zhiheng; Li, Hongquan; Wang, Yue; Lai, Yuping] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Lai, YP (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai 200062, Peoples R China.	yplai@bio.ecnu.edu.cn		lei, hu/0000-0003-3288-5205; Li, Xi/0000-0002-2977-2624; Lai, Yuping/0000-0001-7445-6738; Li, Dongqing/0000-0003-0588-9390	National Natural Science Foundation of China grants (NSFC) [81072422, 31222021, 31170867, 11QA1401900, 12ZZ039]; NSFC [31100109]; Shanghai Natural science Foundation [11ZR1409900]; program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions; Science and Technology Commission of Shanghai Municipality [11DZ2260300]; Johnson and Johnson	National Natural Science Foundation of China grants (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Natural science Foundation(Natural Science Foundation of Shanghai); program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA)	This work was supported by National Natural Science Foundation of China grants (NSFC) 81072422, 31222021&31170867, grants 11QA1401900, 12ZZ039 to Yuping Lai, NSFC grant 31100109 to Deming Jiang, Shanghai Natural science Foundation grant11ZR1409900 to Meiling Zhang, the program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions (Yuping Lai), and the Science and Technology Commission of Shanghai Municipality grant 11DZ2260300. Part of in-vitro studies was also supported by Johnson and Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Cogen AL, J INVEST DERMATOL, V130, P192; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DIXON RA, 1986, J ANTIMICROB CHEMOTH, V18, P557, DOI 10.1093/jac/18.5.557; EVANS CA, 1950, J INVEST DERMATOL, V15, P305, DOI 10.1038/jid.1950.105; FITZGERALD RJ, 1986, INFECT IMMUN, V54, P288, DOI 10.1128/IAI.54.2.288-290.1986; Guo Y, APPL ENV MICROBIOL, V78, P3156; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hormannsperger G, 2012, J ALLERGY CLIN IMMUN, V129, P1452, DOI 10.1016/j.jaci.2011.12.993; Kanda N, 2008, ENDOCRINOLOGY, V149, P5189, DOI 10.1210/en.2008-0343; Kim PI, 2004, J APPL MICROBIOL, V97, P942, DOI 10.1111/j.1365-2672.2004.02356.x; KLICH MA, 1994, MYCOPATHOLOGIA, V127, P123, DOI 10.1007/BF01103068; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lan CC, MOL MED, V17, P771; Li J, 2008, CHEM BIOL, V15, P118, DOI 10.1016/j.chembiol.2007.12.014; MARPLES MJ, 1969, BRIT J DERMATOL, VS 81, P2, DOI 10.1111/j.1365-2133.1969.tb12827.x; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; SAHL HG, 1987, ZBL BAKT-INT J MED M, V267, P173; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Sumikawa Y, 2006, MICROBES INFECT, V8, P1513, DOI 10.1016/j.micinf.2006.01.008; Tally FP, 2000, J ANTIMICROB CHEMOTH, V46, P523, DOI 10.1093/jac/46.4.523; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; Vasselon T, 2002, J LEUKOCYTE BIOL, V71, P503; Wanke I, J INVEST DERMATOL, V131, P382	32	43	51	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58288	10.1371/journal.pone.0058288	http://dx.doi.org/10.1371/journal.pone.0058288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472173	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900119
J	Xu, X; Wu, J; Mao, YQ; Zhu, Y; Hu, ZH; Xu, XL; Lin, YW; Chen, H; Zheng, XY; Qin, J; Xie, LP				Xu, Xin; Wu, Jian; Mao, Yeqing; Zhu, Yi; Hu, Zhenghui; Xu, Xianglai; Lin, Yiwei; Chen, Hong; Zheng, Xiangyi; Qin, Jie; Xie, Liping			Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies	PLOS ONE			English	Article							POPULATION-BASED COHORT; GROWTH-FACTOR-I; MORTALITY; BIAS	Objective: Diabetes is associated with increased risk of cancer at several sites, but its association with risk of bladder cancer is still controversial. We examined this association by conducting a systematic review and meta-analysis of cohort studies. Methods: Studies were identified by searching PubMed, EMBASE, Scopus, Web of Science, Cochrane register, and Chinese National Knowledge Infrastructure (CNKI) databases through April 29, 2012. Summary relative risks (SRRs) with their corresponding 95% confidence intervals (CIs) were calculated using a random-effects model. Results: A total of fifteen cohort studies were included in this meta-analysis. Analysis of all studies showed that diabetes was associated with a borderline statistically significant increased risk of bladder cancer (RR 1.11, 95% CI 1.00-1.23; p < 0.001 for heterogeneity; I-2 = 84%). When restricting the analysis to studies that had adjusted for cigarette smoking (n = 6) or more than three confounders (n = 7), the RRs were 1.32 (95% CI 1.18-1.49) and 1.20 (95% CI 1.02-1.42), respectively. There was no significant publication bias (p = 0.62 for Egger's regression asymmetry test). Conclusions: Our findings support that diabetes was associated with an increased risk of bladder cancer. More future studies are warranted to get a better understanding of the association and to provide convincing evidence for clinical practice in bladder cancer prevention.	[Xu, Xin; Wu, Jian; Mao, Yeqing; Zhu, Yi; Hu, Zhenghui; Xu, Xianglai; Lin, Yiwei; Chen, Hong; Zheng, Xiangyi; Qin, Jie; Xie, Liping] Zhejiang Univ, Dept Urol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xie, LP (corresponding author), Zhejiang Univ, Dept Urol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	xielp@zjuem.zju.edu.cn	zheng, xiang-yi/C-3752-2012; Xie, li/HGE-6052-2022		National Key Clinical Specialty Construction Project of China; Key medical disciplines of Zhejiang province; Combination of traditional Chinese and Western medicine key disciplines of Zhejiang Province [2012-XK-A23]; Health sector scientific research special project [201002010]; National Natural Science Foundation of China [30900552]; Zhejiang Provincial Natural Science Foundation of China [Z2090356]	National Key Clinical Specialty Construction Project of China; Key medical disciplines of Zhejiang province; Combination of traditional Chinese and Western medicine key disciplines of Zhejiang Province; Health sector scientific research special project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by grants from National Key Clinical Specialty Construction Project of China, Key medical disciplines of Zhejiang province, Combination of traditional Chinese and Western medicine key disciplines of Zhejiang Province (2012-XK-A23), Health sector scientific research special project (201002010), National Natural Science Foundation of China (Grant No. 30900552) and Zhejiang Provincial Natural Science Foundation of China (Z2090356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Attner B, 2012, CANCER CAUSE CONTROL, V23, P769, DOI 10.1007/s10552-012-9946-5; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Burger M, 2012, EUR UROL; Chaturvedi AK, 2008, ANN EPIDEMIOL, V18, P230, DOI 10.1016/j.annepidem.2007.10.005; Chen HS, 2012, UROLOGY, V79, P86, DOI 10.1016/j.urology.2011.07.1431; Clow WH, 1997, J NATL CANCER I, V89, P1453; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunn SE, 1997, CANCER RES, V57, P4667; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Funfstuck R, 2012, CLIN NEPHROL, V77, P40, DOI 10.5414/CN107216; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Jankovic S, 2007, TUMORI, V93, P4; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones ME, 1998, AM J EPIDEMIOL, V148, P1012; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253; Larsson SC, 2006, DIABETOLOGIA, V49, P2819, DOI 10.1007/s00125-006-0468-0; Larsson SC, 2011, DIABETOLOGIA, V54, P1013, DOI 10.1007/s00125-011-2051-6; Larsson SC, 2008, EUR J CANCER, V44, P2655, DOI 10.1016/j.ejca.2008.07.012; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lo SF, 2012, INT J CANC; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Murta-Nascimento C, 2007, WORLD J UROL, V25, P285, DOI 10.1007/s00345-007-0168-5; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; RAGOZZINO M, 1982, J CHRON DIS, V35, P13, DOI 10.1016/0021-9681(82)90025-X; Ren HB, 2011, CANCER CAUSE CONTROL, V22, P837, DOI 10.1007/s10552-011-9754-3; Rinaldi S, 2010, INT J CANCER, V126, P1702, DOI 10.1002/ijc.24927; Shu X, 2010, DIABETIC MED, V27, P791, DOI 10.1111/j.1464-5491.2010.03011.x; Swerdlow AJ, 2005, BRIT J CANCER, V92, P2070, DOI 10.1038/sj.bjc.6602611; Tripathi A, 2002, CANCER-AM CANCER SOC, V95, P2316, DOI 10.1002/cncr.10975; Tseng CH, 2011, DIABETOLOGIA, V54, P2009, DOI 10.1007/s00125-011-2171-z; Tseng CH, 2009, ANN MED, V41, P371, DOI 10.1080/07853890902729778; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Woolcott CG, 2011, CANCER EPIDEMIOL, V35, P551, DOI 10.1016/j.canep.2011.02.014; Wotton CJ, 2011, DIABETOLOGIA, V54, P527, DOI 10.1007/s00125-010-1987-2; Yang WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027326; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105; Zhao H, 2003, J UROLOGY, V169, P714, DOI 10.1016/S0022-5347(05)63999-7	49	24	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58079	10.1371/journal.pone.0058079	http://dx.doi.org/10.1371/journal.pone.0058079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472134	Green Published, gold			2022-12-27	WOS:000315637900079
J	Duecker, F; Sack, AT				Duecker, Felix; Sack, Alexander T.			Pre-Stimulus Sham TMS Facilitates Target Detection	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SIMPLE REACTION-TIME; OBJECTIVE MEASURES; SPATIAL ATTENTION; INFORMATION; NETWORK; MASKING; VISION	Transcranial magnetic stimulation (TMS) allows non-invasive manipulation of brain activity during active task performance. Because every TMS pulse is accompanied by non-neural effects such as a clicking sound and somato-sensation on the head, control conditions are required to ensure that changes in task behavior are indeed due to the induced neural effects. However, the non-neural effects of TMS in the context of a given task performance are largely unknown and, consequently, it is unclear what constitutes a valid control condition. We explored the non-neural effects of TMS on visual target detection. Participants received single pulse sham TMS to each hemisphere at different time points prior to target appearance during a visual target detection task. It was hypothesized that the clicking sound of a sham TMS pulse differentially affects performance depending on the location of the coil and the timing of the pulse. Our results show that, first, sham TMS caused a facilitation of reaction times when preceding the target stimulus by 150, 200, and 250 ms, whereas earlier and later time windows were not effective. Second, positioning the TMS coil ipsilateral instead of contralateral relative to the target stimulus improved reaction times. Third, infrequent noTMS trials that were interleaved with sham TMS trials had oddball-like properties resulting in increased reaction times during noTMS. The clicking sound produced by sham TMS influences task performance in multiple ways. These non-neural effects of TMS need to be controlled for in TMS research and the present findings provide an empirical basis for deciding what constitutes a valid control condition.	[Duecker, Felix; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Duecker, Felix; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Maastricht Brain Imaging Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University	Duecker, F (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	felix.duecker@maastrichtuniversity.nl		Sack, Alexander/0000-0002-1471-0885	European Research Council under the European Union [263472]; Netherlands Organization for Scientific Research (NWO) [400-07-230]	European Research Council under the European Union(European Research Council (ERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no [263472]; granted to A. T. S.), and the Netherlands Organization for Scientific Research (NWO; grant number 400-07-230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2005, BRAIN TOPOGR, V17, P193, DOI 10.1007/s10548-005-6028-y; [Anonymous], [No title captured]; de Graaf TA, 2011, NEUROSCI BIOBEHAV R, V35, P871, DOI 10.1016/j.neubiorev.2010.10.006; de Graaf TA, 2011, CONSCIOUS COGN, V20, P1244, DOI 10.1016/j.concog.2011.04.012; de Graaf TA, 2011, EXP BRAIN RES, V209, P19, DOI 10.1007/s00221-010-2512-z; de Graaf TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008307; FARAH MJ, 1989, NEUROPSYCHOLOGIA, V27, P461, DOI 10.1016/0028-3932(89)90051-1; Hackley SA, 2009, PSYCHOPHYSIOLOGY, V46, P225, DOI 10.1111/j.1469-8986.2008.00716.x; Jacobs C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048808; Jacobs C, 2012, NEUROIMAGE, V59, P616, DOI 10.1016/j.neuroimage.2011.07.090; Kirby N. H., 1980, REACTION TIMES, P129; Marzi CA, 1998, EXP BRAIN RES, V118, P435, DOI 10.1007/s002210050299; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Sawaki L, 1999, EXP BRAIN RES, V127, P402, DOI 10.1007/s002210050808; Schmitt M, 2000, Q J EXP PSYCHOL-A, V53, P105, DOI 10.1080/027249800390691; Schuhmann T, 2012, CEREB CORTEX, V22, P701, DOI 10.1093/cercor/bhr155; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Terao Y, 1997, EXP BRAIN RES, V115, P541, DOI 10.1007/PL00005724	19	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57765	10.1371/journal.pone.0057765	http://dx.doi.org/10.1371/journal.pone.0057765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469232	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900042
J	Renuart, AJ; Goldfarb, DM; Mokomane, M; Tawanana, EO; Narasimhamurthy, M; Steenhoff, AP; Silverman, JA				Renuart, Andrew J.; Goldfarb, David M.; Mokomane, Margaret; Tawanana, Ephraim O.; Narasimhamurthy, Mohan; Steenhoff, Andrew P.; Silverman, Jonathan A.			Microbiology of Urinary Tract Infections in Gaborone, Botswana	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE	Objective: The microbiology and epidemiology of UTI pathogens are largely unknown in Botswana, a high prevalence HIV setting. Using laboratory data from the largest referral hospital and a private hospital, we describe the major pathogens causing UTI and their antimicrobial resistance patterns. Methods: This retrospective study examined antimicrobial susceptibility data for urine samples collected at Princess Marina Hospital (PMH), Bokamoso Private Hospital (BPH), or one of their affiliated outpatient clinics. A urine sample was included in our dataset if it demonstrated pure growth of a single organism and accompanying antimicrobial susceptibility and subject demographic data were available. Results: A total of 744 samples were included. Greater than 10% resistance was observed for amoxicillin, co-trimoxazole, amoxicillin-clavulanate, and ciprofloxacin. Resistance of E. coli isolates to ampicillin and co-trimoxazole was greater than 60% in all settings. HIV status did not significantly impact the microbiology of UTIs, but did impact antimicrobial resistance to co-trimoxazole. Conclusions: Data suggests that antimicrobial resistance has already emerged to most oral antibiotics, making empiric management of outpatient UTIs challenging. Ampicillin, co-trimoxazole, and ciprofloxacin should not be used as empiric treatment for UTI in this context. Nitrofurantoin could be used for simple cystitis; aminoglycosides for uncomplicated UTI in inpatients.	[Renuart, Andrew J.; Goldfarb, David M.; Steenhoff, Andrew P.] Botswana UPenn Partnership, Gaborone, Botswana; [Renuart, Andrew J.; Steenhoff, Andrew P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Goldfarb, David M.] McMaster Univ, Hamilton, ON, Canada; [Goldfarb, David M.; Steenhoff, Andrew P.; Silverman, Jonathan A.] Univ Botswana, Sch Med, Dept Paediat & Adolescent Med, Gaborone, Botswana; [Mokomane, Margaret] Natl Hlth Lab, Gaborone, Botswana; [Tawanana, Ephraim O.] Princess Marina Hosp, Microbiol Lab, Gaborone, Botswana; [Narasimhamurthy, Mohan] Bokamoso Private Hosp, Gaborone, Botswana; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Silverman, Jonathan A.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA	University of Pennsylvania; Pennsylvania Medicine; McMaster University; University of Botswana; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle	Silverman, JA (corresponding author), Univ Botswana, Sch Med, Dept Paediat & Adolescent Med, Gaborone, Botswana.	jonathan.silverman@seattlechldrens.org	narasimahmurthy, mohan/AAM-8077-2021; Goldfarb, David/ABD-4623-2021	Goldfarb, David/0000-0003-0835-9504	Penn Center for AIDS Research (CFAR); NIH [P30 AI 045008]	Penn Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This publication was made possible through core services and support from the Penn Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboderin OA, 2009, J NATL MED ASSOC, V101, P1268, DOI 10.1016/S0027-9684(15)31138-X; Bosch FJ, 2011, SAMJ S AFR MED J, V101, P328, DOI 10.7196/SAMJ.4346; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Echols RM, 1999, CLIN INFECT DIS, V29, P113, DOI 10.1086/520138; Foxman B, 2002, AM J MED, V113, p5S; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Habte TM, 2009, SAMJ S AFR MED J, V99, P584; Johane K, 2009, STATS BRIEF PRELIMIN; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Omoregie R, 2009, BRIT J BIOMED SCI, V66, P190, DOI 10.1080/09674845.2009.11730272; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Talan DA, 2004, INT J ANTIMICROB AG, V23, pS54, DOI 10.1016/j.ijantimicag.2003.12.005; WHO, 2005, WHOFCHCAH0511	14	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57776	10.1371/journal.pone.0057776	http://dx.doi.org/10.1371/journal.pone.0057776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469239	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900045
J	Moomaw, EW; Hoffer, E; Moussatche, P; Salerno, JC; Grant, M; Immelman, B; Uberto, R; Ozarowski, A; Angerhofer, A				Moomaw, Ellen W.; Hoffer, Eric; Moussatche, Patricia; Salerno, John C.; Grant, Morgan; Immelman, Bridget; Uberto, Richard; Ozarowski, Andrew; Angerhofer, Alexander			Kinetic and Spectroscopic Studies of Bicupin Oxalate Oxidase and Putative Active Site Mutants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SEED STORAGE PROTEINS; OXALIC-ACID; BACILLUS-SUBTILIS; CERIPORIOPSIS-SUBVERMISPORA; SWISS-MODEL; MICROBIAL RELATIVES; CUPIN SUPERFAMILY; DECARBOXYLASE; ENZYME	Ceriporiopsis subvermispora oxalate oxidase (CsOxOx) is the first bicupin enzyme identified that catalyzes manganese-dependent oxidation of oxalate. In previous work, we have shown that the dominant contribution to catalysis comes from the monoprotonated form of oxalate binding to a form of the enzyme in which an active site carboxylic acid residue must be unprotonated. CsOxOx shares greatest sequence homology with bicupin microbial oxalate decarboxylases (OxDC) and the 241-244DASN region of the N-terminal Mn binding domain of CsOxOx is analogous to the lid region of OxDC that has been shown to determine reaction specificity. We have prepared a series of CsOxOx mutants to probe this region and to identify the carboxylate residue implicated in catalysis. The pH profile of the D241A CsOxOx mutant suggests that the protonation state of aspartic acid 241 is mechanistically significant and that catalysis takes place at the N-terminal Mn binding site. The observation that the D241S CsOxOx mutation eliminates Mn binding to both the N- and C-terminal Mn binding sites suggests that both sites must be intact for Mn incorporation into either site. The introduction of a proton donor into the N-terminal Mn binding site (CsOxOx A242E mutant) does not affect reaction specificity. Mutation of conserved arginine residues further support that catalysis takes place at the N-terminal Mn binding site and that both sites must be intact for Mn incorporation into either site.	[Moomaw, Ellen W.; Hoffer, Eric; Salerno, John C.; Grant, Morgan; Immelman, Bridget; Uberto, Richard] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA; [Moussatche, Patricia] Fdn Appl Mol Evolut, Gainesville, FL USA; [Ozarowski, Andrew] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Angerhofer, Alexander] Univ Florida, Dept Chem, Gainesville, FL 32611 USA	University System of Georgia; Kennesaw State University; State University System of Florida; Florida State University; State University System of Florida; University of Florida	Moomaw, EW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	emoomaw@kennesaw.edu	salerno, john c/A-2595-2014; Angerhofer, Alexander/E-3143-2010	Angerhofer, Alexander/0000-0002-8580-6024; Moomaw, Ellen/0000-0002-2341-1676; Moussatche, Patricia/0000-0003-4540-0609; Grant, Morgan/0000-0002-9796-4636	National Science Foundation [MCB-1041912, DMR-0654118]; NSF [CHE-0809725]; State of Florida; U.S. Department of Energy; Direct For Mathematical & Physical Scien [1213440] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); State of Florida; U.S. Department of Energy(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation (MCB-1041912) to EWM. Partial support was provided by NSF (CHE-0809725) to AA. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by National Science Foundation Cooperative Agreement No. DMR-0654118, the State of Florida, and the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 1999, ARCH BIOCHEM BIOPHYS, V366, P275, DOI 10.1006/abbi.1999.1216; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Angerhofer A, 2007, J PHYS CHEM B, V111, P5043, DOI 10.1021/jp0715326; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Burrell MR, 2007, BIOCHEMISTRY-US, V46, P12327, DOI 10.1021/bi700947s; Chang CH, 2005, J CHEM THEORY COMPUT, V1, P994, DOI 10.1021/ct050063d; CHIRIBOGA J, 1966, ARCH BIOCHEM BIOPHYS, V116, P516, DOI 10.1016/0003-9861(66)90057-9; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; Escutia MR, 2005, APPL ENVIRON MICROB, V71, P3608, DOI 10.1128/AEM.71.7.3608-3616.2005; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hassan AK, 2000, J MAGN RESON, V142, P300, DOI 10.1006/jmre.1999.1952; Hesse A, 1996, CLIN BIOCHEM, V29, P467, DOI 10.1016/0009-9120(96)00067-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honow R, 1997, CLIN CHIM ACTA, V261, P131, DOI 10.1016/S0009-8981(97)06521-2; Imaram W, 2011, FREE RADICAL BIO MED, V50, P1009, DOI 10.1016/j.freeradbiomed.2011.01.023; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Just VJ, 2007, BIOCHEM J, V407, P397, DOI 10.1042/BJ20070708; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Kotsira VP, 1997, ARCH BIOCHEM BIOPHYS, V340, P239, DOI 10.1006/abbi.1997.9896; Lane BG, 2000, BIOCHEM J, V349, P309, DOI 10.1042/0264-6021:3490309; LEEK AE, 1972, BIOCHEM J, V128, pP87; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moomaw EW, 2009, BIOCHEMISTRY-US, V48, P6116, DOI 10.1021/bi801856k; Moussatche P, 2011, ARCH BIOCHEM BIOPHYS, V509, P100, DOI 10.1016/j.abb.2011.02.022; OLIVARES JA, 1988, METHOD ENZYMOL, V158, P205, DOI 10.1016/0076-6879(88)58057-6; Opaleye O, 2006, J BIOL CHEM, V281, P6428, DOI 10.1074/jbc.M510256200; PUNDIR CS, 1993, INDIAN J BIOCHEM BIO, V30, P54; Requena L, 1999, BIOCHEM J, V343, P185, DOI 10.1042/0264-6021:3430185; RUTTIMANNJOHNSON C, 1993, APPL ENVIRON MICROB, V59, P1792; SATYAPAL, 1993, BIOCHIM BIOPHYS ACTA, V1161, P1, DOI 10.1016/0167-4838(93)90188-W; SCHUTTE H, 1976, EUR J BIOCHEM, V62, P151, DOI 10.1111/j.1432-1033.1976.tb10108.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHIMAZONO H, 1957, J BIOL CHEM, V227, P151; SHIMAZONO H, 1955, J BIOCHEM-TOKYO, V42, P321, DOI 10.1093/oxfordjournals.jbchem.a126533; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STRASSER H, 1994, FEMS MICROBIOL LETT, V119, P365, DOI 10.1111/j.1574-6968.1994.tb06914.x; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; Svedruzic D, 2007, ARCH BIOCHEM BIOPHYS, V464, P36, DOI 10.1016/j.abb.2007.03.016; Tabares LC, 2009, J PHYS CHEM B, V113, P9016, DOI 10.1021/jp9021807; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; THOMPSON C, 1995, EUPHYTICA, V85, P169, DOI 10.1007/BF00023945; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VARALAKSHMI P, 1992, BIOCHEM INT, V26, P153; Wei YD, 1998, PLANT MOL BIOL, V36, P101, DOI 10.1023/A:1005955119326; Whittaker MM, 2002, J BIOL INORG CHEM, V7, P136, DOI 10.1007/s007750100281	52	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57933	10.1371/journal.pone.0057933	http://dx.doi.org/10.1371/journal.pone.0057933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469254	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100051
J	Kadomatsu, T; Uragami, S; Akashi, M; Tsuchiya, Y; Nakajima, H; Nakashima, Y; Endo, M; Miyata, K; Terada, K; Todo, T; Node, K; Oike, Y				Kadomatsu, Tsuyoshi; Uragami, Shota; Akashi, Makoto; Tsuchiya, Yoshiki; Nakajima, Hiroo; Nakashima, Yukiko; Endo, Motoyoshi; Miyata, Keishi; Terada, Kazutoyo; Todo, Takeshi; Node, Koichi; Oike, Yuichi			A Molecular Clock Regulates Angiopoietin-Like Protein 2 Expression	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; BIOLOGICAL CLOCK; VASCULAR-DISEASE; PERIOD2 GENE; METABOLISM; TRANSCRIPTION; OBESITY; MICE; PHOSPHORYLATION; INFLAMMATION	Various physiological and behavioral processes exhibit circadian rhythmicity. These rhythms are usually maintained by negative feedback loops of core clock genes, namely, CLOCK, BMAL, PER, and CRY. Recently, dysfunction in the circadian clock has been recognized as an important foundation for the pathophysiology of lifestyle-related diseases, such as obesity, cardiovascular disease, and some cancers. We have reported that angiopoietin-like protein 2 (ANGPTL2) contributes to the pathogenesis of these lifestyle-related diseases by inducing chronic inflammation. However, molecular mechanisms underlying regulation of ANGPTL2 expression are poorly understood. Here, we assess circadian rhythmicity of ANGPTL2 expression in various mouse tissues. We observed that ANGPTL2 rhythmicity was similar to that of the PER2 gene, which is regulated by the CLOCK/BMAL1 complex. Promoter activity of the human ANGPTL2 gene was significantly induced by CLOCK and BMAL1, an induction markedly attenuated by CRY co-expression. We also identified functional E-boxes in the ANGPTL2 promoter and observed occupancy of these sites by endogenous CLOCK in human osteosarcoma cells. Furthermore, Cry-deficient mice exhibited arrhythmic Angptl2 expression. Taken together, these data suggest that periodic expression of ANGPTL2 is regulated by a molecular clock.	[Kadomatsu, Tsuyoshi; Uragami, Shota; Nakashima, Yukiko; Endo, Motoyoshi; Miyata, Keishi; Terada, Kazutoyo; Oike, Yuichi] Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Kumamoto, Japan; [Akashi, Makoto] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan; [Tsuchiya, Yoshiki] Kyoto Prefectural Univ Med, Dept Neurosci & Cell Biol, Kyoto, Japan; [Nakajima, Hiroo; Todo, Takeshi] Osaka Univ, Dept Radiat Biol & Med Genet, Grad Sch Med, Osaka, Japan; [Node, Koichi] Saga Univ, Dept Cardiovasc & Renal Med, Fac Med, Saga 840, Japan	Kumamoto University; Yamaguchi University; Kyoto Prefectural University of Medicine; Osaka University; Saga University	Kadomatsu, T (corresponding author), Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Kumamoto, Japan.	tkado@gpo.kumamoto-u.ac.jp; oike@gpo.kumamoto-u.ac.jp	Endo, Motoyoshi/T-5840-2019; Miyata, Keishi/HGF-1876-2022	Miyata, Keishi/0000-0003-0336-1859	Japan Society for the Promotion of Science (JSPS) [LS098]; Council for Science and Technology Policy (CSTP); Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Society for the Promotion of Science (JSPS) through the (sic)Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," (LS098) initiated by the Council for Science and Technology Policy (CSTP). The work was also supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Haupt CM, 2008, ATHEROSCLEROSIS, V201, P205, DOI 10.1016/j.atherosclerosis.2007.12.059; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Kadomatsu T, 2007, BIOCHEM BIOPH RES CO, V361, P516, DOI 10.1016/j.bbrc.2007.07.053; Kadomatsu T, 2011, FEBS J, V278, P559, DOI 10.1111/j.1742-4658.2010.07979.x; Kitazawa M, 2011, ENDOCRINOLOGY, V152, P2558, DOI 10.1210/en.2010-1407; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Marcheva B, 2009, J APPL PHYSIOL, V107, P1638, DOI 10.1152/japplphysiol.00698.2009; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shimizu F, 2007, J NEUROCHEM, V103, P1834, DOI 10.1111/j.1471-4159.2007.04900.x; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Suda T, 2005, CORNEA, V24, pS12, DOI 10.1097/01.ico.0000178742.98716.65; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takeda N, 2010, HYPERTENS RES, V33, P645, DOI 10.1038/hr.2010.68; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	37	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57921	10.1371/journal.pone.0057921	http://dx.doi.org/10.1371/journal.pone.0057921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469106	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900201
J	Kawatsu, K				Kawatsu, Kazutaka			Sexual Conflict over the Maintenance of Sex: Effects of Sexually Antagonistic Coevolution for Reproductive Isolation of Parthenogenesis	PLOS ONE			English	Article							RETICULITERMES-SPERATUS ISOPTERA; EULIMNADIA-TEXANA; CLAM SHRIMP; EVOLUTION; SELECTION; CONSTRAINTS; PERSPECTIVE; TRANSITION; PARASITES; BARRIERS	Sexual reproduction involves many costs. Therefore, females acquiring a capacity for parthenogenetic (or asexual) reproduction will gain a reproductive advantage over obligately sexual females. In contrast, for males, any trait coercing parthenogens into sexual reproduction (male coercion) increases their fitness and should be under positive selection because parthenogenesis deprives them of their genetic contribution to future generations. Surprisingly, although such sexual conflict is a possible outcome whenever reproductive isolation is incomplete between parthenogens and the sexual ancestors, it has not been given much attention in the studies of the maintenance of sex. Using two mathematical models, I show here that the evolution of male coercion substantially favours the maintenance of sex even though a female barrier against the coercion can evolve. First, the model based on adaptive-dynamics theory demonstrates that the resultant antagonistic coevolution between male coercion and a female barrier fundamentally ends in either the prevalence of sex or the co-occurrence of two reproductive modes. This is because the coevolution between the two traits additionally involves sex-ratio selection, that is, an increase in parthenogenetic reproduction leads to a female-biased population sex ratio, which will enhance reproductive success of more coercive males and directly promotes the evolution of the coercion among males. Therefore, as shown by the individual-based model, the establishment of obligate parthenogenesis in the population requires the simultaneous evolution of strong reproductive isolation between males and parthenogens. These findings should shed light on the interspecific diversity of reproductive modes as well as help to explain the prevalence of sexual reproduction.	Kyoto Univ, Lab Insect Ecol, Grad Sch Agr, Sakyo Ku, Kyoto, Japan	Kyoto University	Kawatsu, K (corresponding author), Kyoto Univ, Lab Insect Ecol, Grad Sch Agr, Sakyo Ku, Kitashirakawaoiwake Cho, Kyoto, Japan.	kazutakawatsu@gmail.com	Kawtasu, Kazutaka/B-1066-2010	Kawtasu, Kazutaka/0000-0003-4447-4761	Japan Society for the Promotion of Science [21-2115]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (No. 21-2115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Andersson Malte, 1994; Annila A, 2012, BIOSYSTEMS, V110, P156, DOI 10.1016/j.biosystems.2012.09.006; Arnqvist Goran, 2005, pUnpaginated; AVISE JC, 1992, EVOL BIOL, V26, P225; BEDFORD GO, 1978, ANNU REV ENTOMOL, V23, P125, DOI 10.1146/annurev.en.23.010178.001013; Bell G, 1982, MASTERPIECE NATURE E; CARSON HL, 1967, GENETICS, V55, P157; Corley LS, 1999, P ROY SOC B-BIOL SCI, V266, P471, DOI 10.1098/rspb.1999.0661; Dagg JL, 2006, OIKOS, V112, P232, DOI 10.1111/j.0030-1299.2006.14196.x; Dieckmann U., 1997, TRENDS ECOL EVOL, V23, P446; Doebeli M., 2011, ADAPTIVE DIVERSIFICA; Engelstadter J, 2008, BIOESSAYS, V30, P1138, DOI 10.1002/bies.20833; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hayashi TI, 2007, EVOLUTION, V61, P516, DOI 10.1111/j.1558-5646.2007.00059.x; Heethoff M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P241, DOI 10.1007/978-90-481-2770-2_12; HICKEY DA, 1982, GENETICS, V101, P519; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Huigens ME, 2003, CONT T ENT, P247; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; HURST LD, 1992, P ROY SOC B-BIOL SCI, V248, P135, DOI 10.1098/rspb.1992.0053; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Kramer MG, 2001, EVOLUTION, V55, P748, DOI [10.1554/0014-3820(2001)055[0748:LHCTAT]2.0.CO;2, 10.1111/j.0014-3820.2001.tb00811.x]; Kramer MG, 2002, EVOL DEV, V4, P223, DOI 10.1046/j.1525-142X.2002.02008.x; KUNO E, 1991, RES POPUL ECOL, V33, P33, DOI 10.1007/BF02514572; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Lehtonen J, 2012, TRENDS ECOL EVOL, V27, P172, DOI 10.1016/j.tree.2011.09.016; Lewis W M Jr, 1987, Experientia Suppl, V55, P33; Matsuura K, 2001, POPUL ECOL, V43, P119, DOI 10.1007/PL00012022; Matsuura K, 2007, APPL ENTOMOL ZOOL, V42, P241, DOI 10.1303/aez.2007.241; Matsuura K, 2009, SCIENCE, V323, P1687, DOI 10.1126/science.1169702; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; MOGIE M, 1986, BIOL J LINN SOC, V28, P321, DOI 10.1111/j.1095-8312.1986.tb01761.x; Normark BB, 2006, EVOLUTION, V60, P631; Otto S. P., 2006, BIOL GUIDE MATH MODE; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; OTTO SP, 1993, AM NAT, V141, P329, DOI 10.1086/285476; Rankin DJ, 2008, OIKOS, V117, P173, DOI 10.1111/j.2007.0030-1299.16271.x; Rankin DJ, 2011, AM NAT, V177, P780, DOI 10.1086/659947; Saitoh K, 2004, ZOOL SCI, V21, P795, DOI 10.2108/zsj.21.795; SASSAMAN C, 1993, AM NAT, V141, P314, DOI 10.1086/285475; Scali V, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P317, DOI 10.1007/978-90-481-2770-2_16; Schlupp I, 2005, ANNU REV ECOL EVOL S, V36, P399, DOI 10.1146/annurev.ecolsys.36.102003.152629; Schwander T, 2010, P ROY SOC B-BIOL SCI, V277, P1435, DOI 10.1098/rspb.2009.2113; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Singh RS, 2010, J HERED, V101, pS100, DOI 10.1093/jhered/esq006; SMITH JM, 1978, EVOLUTION SEX; STALKER HD, 1954, GENETICS, V39, P4; Templeton A.R., 1982, P75; TINTI F, 1993, CHROMOSOMA, V102, P403, DOI 10.1007/BF00360405; TINTI F, 1992, MOL REPROD DEV, V33, P235, DOI 10.1002/mrd.1080330302; Vrijenhoek RC, 1998, BIOSCIENCE, V48, P617, DOI 10.2307/1313421; VRIJENHOEK RC, 1994, ANNU REV ECOL SYST, V25, P71, DOI 10.1146/annurev.es.25.110194.000443; Weeks SC, 2000, EVOLUTION, V54, P878; Weeks SC, 2004, INVERTEBR BIOL, V123, P146; Weeks SC, 2008, ETHOLOGY, V114, P64, DOI 10.1111/j.1439-0310.2007.01446.x; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	66	19	19	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58141	10.1371/journal.pone.0058141	http://dx.doi.org/10.1371/journal.pone.0058141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469150	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900241
J	Mastroeni, C; Bergmann, TO; Rizzo, V; Ritter, C; Klein, C; Pohlmann, I; Brueggemann, N; Quartarone, A; Siebner, HR				Mastroeni, Claudia; Bergmann, Til Ole; Rizzo, Vincenzo; Ritter, Christoph; Klein, Christine; Pohlmann, Ines; Brueggemann, Norbert; Quartarone, Angelo; Siebner, Hartwig Roman			Brain-Derived Neurotrophic Factor - A Major Player in Stimulation-Induced Homeostatic Metaplasticity of Human Motor Cortex?	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST-STIMULATION; PAIRED-ASSOCIATIVE STIMULATION; BDNF VAL66MET POLYMORPHISM; CORTICAL PLASTICITY; SYNAPTIC PLASTICITY; CONSCIOUS HUMANS; CEREBRAL-CORTEX; UNIT RESPONSES; SURFACE EMG	Repetitive transcranial magnetic stimulation (rTMS) of the human motor hand area (M1(HAND)) can induce lasting changes in corticospinal excitability as indexed by a change in amplitude of the motor-evoked potential. The plasticity-inducing effects of rTMS in M1(HAND) show substantial inter-individual variability which has been partially attributed to the val(66)met polymorphism in the brain-derived neurotrophic factor (BDNF) gene. Here we used theta burst stimulation (TBS) to examine whether the BDNF val(66)met genotype can be used to predict the expression of TBS-induced homeostatic metaplasticity in human M1(HAND). TBS is a patterned rTMS protocol with intermittent TBS (iTBS) usually inducing a lasting increase and continuous TBS (cTBS) a lasting decrease in corticospinal excitability. In three separate sessions, healthy val(66)met (n = 12) and val(66)val (n = 17) carriers received neuronavigated cTBS followed by cTBS (n = 27), cTBS followed by iTBS (n = 29), and iTBS followed by iTBS (n = 28). Participants and examiner were blinded to the genotype at the time of examination. As expected, the first TBS intervention induced a decrease (cTBS) and increase (iTBS) in corticospinal excitability, respectively, at the same time priming the after effects caused by the second TBS intervention in a homeostatic fashion. Critically, val(66)met carriers and val(66)val carriers showed very similar response patterns to cTBS and iTBS regardless of the order of TBS interventions. Since none of the observed TBS effects was modulated by the BDNF val(66)met polymorphism, our results do not support the notion that the BDNF val(66)met genotype is a major player with regard to TBS-induced plasticity and metaplasticity in the human M1(HAND).	[Mastroeni, Claudia; Bergmann, Til Ole; Ritter, Christoph; Pohlmann, Ines; Siebner, Hartwig Roman] Univ Kiel, Dept Neurol, Kiel, Germany; [Mastroeni, Claudia; Rizzo, Vincenzo; Quartarone, Angelo] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol Sci, Messina, Italy; [Bergmann, Til Ole] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Njmegen, Netherlands; [Klein, Christine; Brueggemann, Norbert] Med Univ Lubeck, Sect Clin & Mol Neurogenet, Dept Neurol, D-23538 Lubeck, Germany; [Quartarone, Angelo] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Ritter, Christoph] Univ Hamburg, Dept Neurol, Hamburg, Germany; [Brueggemann, Norbert; Siebner, Hartwig Roman] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark	University of Kiel; University of Messina; Radboud University Nijmegen; University of Lubeck; New York University; University of Hamburg; University of Copenhagen	Siebner, HR (corresponding author), Univ Kiel, Dept Neurol, Kiel, Germany.	hartwig.siebner@drcmr.dk	Klein, Christine/AGK-8003-2022; Mastroeni, Claudia/AAC-1001-2019; Bergmann, Til Ole/F-9453-2010; Siebner, Hartwig R/G-4052-2016; QUARTARONE, Angelo/G-3264-2017	Bergmann, Til Ole/0000-0002-2282-6618; Klein, Christine/0000-0003-2102-3431; Ritter, Christoph/0000-0001-8899-6444; QUARTARONE, Angelo/0000-0003-1485-6590	Lundbeck Foundation on "Mapping, Modulation & Modeling the Control of Actions (ContAct)" [R59 A5399]; Deutsche Forschungsgemeinschaft [SFB654/A6]; Dutch BrainGain Smart Mix Programme (NWO) [056-14-011]; Lundbeck Foundation [R59-2010-5399] Funding Source: researchfish	Lundbeck Foundation on "Mapping, Modulation & Modeling the Control of Actions (ContAct)"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dutch BrainGain Smart Mix Programme (NWO); Lundbeck Foundation(Lundbeckfonden)	HRS was supported by a Grant of Excellence sponsored by The Lundbeck Foundation on "Mapping, Modulation & Modeling the Control of Actions (ContAct)" (grant no. R59 A5399). TOB was supported by the Deutsche Forschungsgemeinschaft (grant no. SFB654/A6, "Plasticity and Sleep") and the Dutch BrainGain Smart Mix Programme (NWO grant no. 056-14-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; AMASSIAN VE, 1987, NEUROSURGERY, V20, P74; Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Bergmann TO, 2009, J NEUROPHYSIOL, V102, P2303, DOI 10.1152/jn.00437.2009; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Butefisch CM, 2004, NEUROSCIENTIST, V10, P163, DOI 10.1177/1073858403262152; Cheeran BJ, 2009, NEUROSCIENCE, V164, P156, DOI 10.1016/j.neuroscience.2009.01.054; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; Di Lazzaro V, 2001, EXP BRAIN RES, V141, P121; Doeltgen SH, 2011, EXP BRAIN RES, V215, P199, DOI 10.1007/s00221-011-2886-6; Edwards MJ, 2008, LANCET NEUROL, V7, P827, DOI 10.1016/S1474-4422(08)70190-X; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Florian J, 2007, EUR J NEUROSCI, V25, P3461, DOI 10.1111/j.1460-9568.2007.05603.x; Fricke K, 2011, J NEUROPHYSIOL, V105, P1141, DOI 10.1152/jn.00608.2009; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gamboa OL, 2011, BRAIN STIMUL, V4, P145, DOI 10.1016/j.brs.2010.09.008; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Hamada M, 2012, CEREB CORTEX; Hamada M, 2008, J PHYSIOL-LONDON, V586, P3927, DOI 10.1113/jphysiol.2008.152793; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Ilic TV, 2005, ANN NY ACAD SCI, V1048, P175, DOI 10.1196/annals.1342.016; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; Iyer MB, 2003, J NEUROSCI, V23, P10867; Jayasekeran V, 2011, GASTROENTEROLOGY; Kamke MR, 2012, J NEUROSCI, V32, P7001, DOI 10.1523/JNEUROSCI.1028-12.2012; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Karabanov A, J PHYSL IN PRESS; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Lefaucheur JP, 2005, REV NEUROL-FRANCE, V161, P27, DOI 10.1016/S0035-3787(05)84971-9; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Missitzi J, 2011, J PHYSIOL-LONDON, V589, P297, DOI 10.1113/jphysiol.2010.200600; Mori F, 2012, J NEUROSCI, V32, P873, DOI 10.1523/JNEUROSCI.2531-11.2012; Murakami T, 2012, J PHYSL; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nakamura K, 2011, NEUROSCI LETT, V487, P264, DOI 10.1016/j.neulet.2010.10.034; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Potter-Nerger M, 2009, J NEUROPHYSIOL; Ragert P, 2009, J NEUROPHYSIOL, V102, P766, DOI 10.1152/jn.00274.2009; Sale MV, 2008, J NEUROSCI, V28, P8285, DOI 10.1523/JNEUROSCI.1963-08.2008; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P1815, DOI 10.1016/j.clinph.2007.05.062; Terney D, 2008, J NEUROSCI, V28, P14147, DOI 10.1523/JNEUROSCI.4248-08.2008; Todd G, 2009, EXP BRAIN RES, V195, P307, DOI 10.1007/s00221-009-1791-8; Voti PL, 2011, EXP BRAIN RES, V212, P91, DOI 10.1007/s00221-011-2700-5; Wankerl K, 2010, J NEUROSCI, V30, P6197, DOI 10.1523/JNEUROSCI.4673-09.2010; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; WERHAHN KJ, 1994, ELECTROEN CLIN NEURO, V93, P138, DOI 10.1016/0168-5597(94)90077-9; Weyh T, 2005, CLIN NEUROPHYSIOL, V116, P1477, DOI 10.1016/j.clinph.2005.02.002; Witte AV, 2012, J NEUROSCI, V32, P4553, DOI 10.1523/JNEUROSCI.6010-11.2012; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Zafar N, 2008, CLIN NEUROPHYSIOL, V119, P1393, DOI 10.1016/j.clinph.2008.02.006; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	69	51	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57957	10.1371/journal.pone.0057957	http://dx.doi.org/10.1371/journal.pone.0057957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469118	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900212
J	Shiga, H; Taki, J; Washiyama, K; Yamamoto, J; Kinase, S; Okuda, K; Kinuya, S; Watanabe, N; Tonami, H; Koshida, K; Amano, R; Furukawa, M; Miwa, T				Shiga, Hideaki; Taki, Junichi; Washiyama, Kohshin; Yamamoto, Junpei; Kinase, Sakae; Okuda, Koichi; Kinuya, Seigo; Watanabe, Naoto; Tonami, Hisao; Koshida, Kichiro; Amano, Ryohei; Furukawa, Mitsuru; Miwa, Takaki			Assessment of Olfactory Nerve by SPECT-MRI Image with Nasal Thallium-201 Administration in Patients with Olfactory Impairments in Comparison to Healthy Volunteers	PLOS ONE			English	Article							SUBSET EXPECTATION MAXIMIZATION; RESOLUTION RECOVERY; THALLIUM TRANSPORT; TRAUMATIC ANOSMIA; BULB; IDENTIFICATION; DYSFUNCTION; MUCOSA; MICE	Purpose: The aim of this study was to assess whether migration of thallium-201 (Tl-201) to the olfactory bulb were reduced in patients with olfactory impairments in comparison to healthy volunteers after nasal administration of Tl-201. Procedures: 10 healthy volunteers and 21 patients enrolled in the study (19 males and 12 females; 26-71 years old). The causes of olfactory dysfunction in the patients were head trauma (n = 7), upper respiratory tract infection (n = 7), and chronic rhinosinusitis (n = 7). (TlCl)-Tl-201 was administered unilaterally to the olfactory cleft, and SPECT-CT was conducted 24 h later. Separate MRI images were merged with the SPECT images. Tl-201 olfactory migration was also correlated with the volume of the olfactory bulb determined from MRI images, as well as with odor recognition thresholds measured by using T&T olfactometry. Results: Nasal Tl-201 migration to the olfactory bulb was significantly lower in the olfactory-impaired patients than in healthy volunteers. The migration of Tl-201 to the olfactory bulb was significantly correlated with odor recognition thresholds obtained with T&T olfactometry and correlated with the volume of the olfactory bulb determined from MRI images when all subjects were included. Conclusions: Assessment of the Tl-201 migration to the olfactory bulb was the new method for the evaluation of the olfactory nerve connectivity in patients with impaired olfaction.	[Shiga, Hideaki; Yamamoto, Junpei; Miwa, Takaki] Kanazawa Med Univ, Dept Otorhinolaryngol, Kanazawa, Ishikawa, Japan; [Shiga, Hideaki; Washiyama, Kohshin; Koshida, Kichiro; Amano, Ryohei] Kanazawa Univ, Grad Sch Med Sci, Dept Quantum Med Technol, Kanazawa, Ishikawa 9201192, Japan; [Taki, Junichi; Okuda, Koichi; Kinuya, Seigo] Kanazawa Univ, Grad Sch Med Sci, Dept Biotracer Med, Kanazawa, Ishikawa 9201192, Japan; [Kinase, Sakae] Japan Atom Energy Agcy, Nucl Safety Res Ctr, Risk Anal & Applicat Res Grp, Ibaraki, Japan; [Watanabe, Naoto; Tonami, Hisao] Kanazawa Med Univ, Dept Diagnost & Therapeut Radiol, Kanazawa, Ishikawa, Japan; [Furukawa, Mitsuru] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan	Kanazawa Medical University; Kanazawa University; Kanazawa University; Japan Atomic Energy Agency; Kanazawa Medical University; Kanazawa University	Shiga, H (corresponding author), Kanazawa Med Univ, Dept Otorhinolaryngol, Kanazawa, Ishikawa, Japan.	shigah@kanazawa-med.ac.jp	Okuda, Koichi/F-2780-2012; Shiga, Hideaki/E-6911-2018; Shiga, Hideaki/N-4624-2019; Kinase, Sakae/I-6526-2019	Okuda, Koichi/0000-0003-0010-6844; Shiga, Hideaki/0000-0001-7218-154X; Shiga, Hideaki/0000-0001-7218-154X; Kinase, Sakae/0000-0002-4677-6598	Ministry of Education, Science and Culture of Japan [C21592174]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (C21592174 to H. S.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; HASEGAWA S, 1986, ARCH OTO-RHINO-LARYN, V243, P112, DOI 10.1007/BF00453761; Holbrook EH, 2005, LARYNGOSCOPE, V115, P2144, DOI 10.1097/01.MLG.0000181493.83661.CE; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; Jafek BW., 1990, AM J RHINOL, V4, P91, DOI [10.2500/105065890782009497, DOI 10.2500/105065890782009497]; Kanayama Y, 2005, NUCL MED BIOL, V32, P505, DOI 10.1016/j.nucmedbio.2005.03.009; Ken S, 2007, MAGN RESON IMAGING, V25, P883, DOI 10.1016/j.mri.2007.02.003; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; Kinoshita Y, 2008, CHEM SENSES, V33, P73, DOI 10.1093/chemse/bjm066; MAIR RG, 1982, NEUROSCIENCE, V7, P3091, DOI 10.1016/0306-4522(82)90232-9; Menzel Hans-Georg, 2009, Ann ICRP, V39, P1, DOI 10.1016/j.icrp.2009.09.001; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rombaux P, 2006, LARYNGOSCOPE, V116, P436, DOI 10.1097/01.MLG.0000195291.36641.1E; Shiga H, 2008, CHEM SENSES, V33, P633, DOI 10.1093/chemse/bjn030; Shiga H, 2011, MOL IMAGING BIOL, V13, P1262, DOI 10.1007/s11307-010-0461-3; Shiga H, 2009, RHINOLOGY, V47, P460, DOI 10.4193/Rhin08.213; Stansfield EC, 2010, RADIOLOGY, V257, P793, DOI 10.1148/radiol.10100102; TAKAGI SF, 1987, ANN NY ACAD SCI, V510, P113; Washiyama K, 2011, J RADIAT RES, V52, P450, DOI 10.1269/jrr.10153; Zeintl J, 2010, J NUCL MED, V51, P921, DOI 10.2967/jnumed.109.071571	25	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57671	10.1371/journal.pone.0057671	http://dx.doi.org/10.1371/journal.pone.0057671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469046	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900145
J	Tolsgaard, MG; Todsen, T; Sorensen, JL; Ringsted, C; Lorentzen, T; Ottesen, B; Tabor, A				Tolsgaard, Martin G.; Todsen, Tobias; Sorensen, Jette L.; Ringsted, Charlotte; Lorentzen, Torben; Ottesen, Bent; Tabor, Ann			International Multispecialty Consensus on How to Evaluate Ultrasound Competence: A Delphi Consensus Survey	PLOS ONE			English	Article							ULTRASONOGRAPHY; SONOGRAPHY; CHECKLISTS	Objectives: To achieve international consensus across multiple specialties on a generic ultrasound rating scale using a Delphi technique. Methods: Ultrasound experts from Obstetrics-Gynaecology, Surgery, Urology, Radiology, Rheumatology, Emergency Medicine, and Gastro-Enterology representing North America, Australia, and Europe were identified. A multi-round survey was conducted to obtain consensus between these experts. Of 60 invited experts, 44 experts agreed to participate in the first Delphi round, 41 remained in the second round, and 37 completed the third Delphi round. Seven key elements of the ultrasound examination were identified from existing literature and recommendations from international ultrasound societies. All experts rated the importance of these seven elements on a five-point Likert scale in the first round and suggested potential new elements for the assessment of ultrasound skills. In the second round, the experts re-rated all elements and a third round was conducted to allow final comments. Agreement on which elements to include in the final rating scale was pre-defined as more than 80% of the experts rating an element four or five, on importance to the ultrasound examination. Results: Two additional elements were suggested by more than 10% of the experts in the first Delphi round. Consensus was obtained to include these two new elements along with five of the original elements in the final assessment instrument: 1) Indication for the examination 2) Applied knowledge of ultrasound equipment 3) Image optimization 4) Systematic examination 5) Interpretation of images 6) Documentation of examination and 7) Medical decision making. Conclusion: International multispecialty consensus was achieved on the content of a generic ultrasound rating scale. This is the first step to ensure valid assessment of clinicians in different medical specialties using ultrasound.	[Tolsgaard, Martin G.; Sorensen, Jette L.] Rigshosp, Copenhagen Univ Hosp, Dept Obstet, DK-2100 Copenhagen, Denmark; [Todsen, Tobias] Rigshosp, Copenhagen Univ Hosp, Ctr Clin Educ, DK-2100 Copenhagen, Denmark; [Ringsted, Charlotte] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Ringsted, Charlotte] Univ Hlth Network, Wilson Ctr, Toronto, ON, Canada; [Ringsted, Charlotte] UoT, Toronto, ON, Canada; [Lorentzen, Torben] Herlev Univ Hosp, Dept Radiol, DK-2730 Herlev, Denmark; [Ottesen, Bent] Rigshosp, Copenhagen Univ Hosp, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; [Tabor, Ann] Rigshosp, Copenhagen Univ Hosp, Juliane Marie Ctr, Dept Obstet, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Tolsgaard, MG (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Obstet, DK-2100 Copenhagen, Denmark.	martintolsgaard@gmail.com	Dixon, Thomas R/G-5822-2013; Sørensen, Jette Led/X-4556-2019; tolsgaard, Martin/AES-2153-2022; Ringsted, Charlotte/AAG-9389-2019; Sørensen, Jette Led/B-7286-2018	Sørensen, Jette Led/0000-0002-7320-2784; tolsgaard, Martin/0000-0001-9197-5564; Sørensen, Jette Led/0000-0002-7320-2784; Todsen, Tobias/0000-0003-3267-3560; Tabor, Ann/0000-0001-7450-1543	Juliane Marie Centre, Copenhagen University Hospital Rigshospitalet	Juliane Marie Centre, Copenhagen University Hospital Rigshospitalet	This study was funded by the Juliane Marie Centre, Copenhagen University Hospital Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, ACAD EMERG MED, V16, pS32, DOI 10.1111/j.1553-2712.2009.00589.x; [Anonymous], 2010, Ultraschall Med, V31, P426, DOI 10.1055/s-0030-1263214; Balslev T, 2010, PEDIATRICS, V125, pE570, DOI 10.1542/peds.2009-0438; Brown AK, 2006, ANN RHEUM DIS, V65, P629, DOI 10.1136/ard.2005.039974; Cheung JJH, 2012, REGION ANESTH PAIN M, V37, P329, DOI 10.1097/AAP.0b013e318246f63c; Crowley RS, 2003, J AM MED INFORM ASSN, V10, P39, DOI 10.1197/jamia.M1123; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; Dreyfus H. L., 1986, MIND MACH, P16; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hertzberg BS, 2000, AM J ROENTGENOL, V174, P1221, DOI 10.2214/ajr.174.5.1741221; Hodges B, 1999, ACAD MED, V74, P1129, DOI 10.1097/00001888-199910000-00017; Hodges B, 2003, MED EDUC, V37, P1012, DOI 10.1046/j.1365-2923.2003.01674.x; Hofer M, 2011, ULTRASCHALL MED, V32, P184, DOI 10.1055/s-0029-1246049; Jang T, 2004, AM J EMERG MED, V22, P439, DOI 10.1016/j.ajem.2004.07.025; Jang TB, 2012, J ULTRAS MED, V31, P515, DOI 10.7863/jum.2012.31.4.515; Jang TB, 2010, ACAD EMERG MED, V17, P1247, DOI 10.1111/j.1553-2712.2010.00909.x; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Krupinski EA, 2011, SEMIN NUCL MED, V41, P392, DOI 10.1053/j.semnuclmed.2011.05.002; Ma IWY, 2012, ADV HEALTH SCI EDUC, V17, P457, DOI 10.1007/s10459-011-9322-3; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Morgan PJ, 2007, CAN J ANAESTH, V54, P992, DOI 10.1007/BF03016633; Nathens AB, 2003, J TRAUMA, V54, P595, DOI 10.1097/01.TA.0000028044.43091.74; Nodine C. F., 1987, EYE MOVEMENTS PSYCHO, P572; Palter VN, 2012, SURGERY, V151, P391, DOI 10.1016/j.surg.2011.08.005; Palter VN, 2011, AM J SURG, V201, P251, DOI 10.1016/j.amjsurg.2010.01.031; Salvesen KA, 2010, ULTRASOUND OBST GYN, V36, P525, DOI 10.1002/uog.8851; Shah S, 2010, AM J EMERG MED, V28, P834, DOI 10.1016/j.ajem.2009.07.024; Streiner D.L, 2008, HLTH MEASUREMENT SCA, P248	32	96	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57687	10.1371/journal.pone.0057687	http://dx.doi.org/10.1371/journal.pone.0057687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23469051	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900150
J	Zhang, HB; Xia, WX; Lu, X; Sun, R; Wang, L; Zheng, LS; Ye, YF; Bao, YN; Xiang, YQ; Guo, X				Zhang, Haibo; Xia, Weixiong; Lu, Xing; Sun, Rui; Wang, Lin; Zheng, Lisheng; Ye, Yanfang; Bao, Yingna; Xiang, Yanqun; Guo, Xiang			A Novel Statistical Prognostic Score Model that Includes Serum CXCL5 Levels and Clinical Classification Predicts Risk of Disease Progression and Survival of Nasopharyngeal Carcinoma Patients	PLOS ONE			English	Article							PROSTATE-CANCER; INDEX SCORE; TUMOR; OVEREXPRESSION; ANGIOGENESIS; CHEMOKINES; MIGRATION	Background: Aberrant expression of C-X-C motif chemokine 5 (CXCL5) contributes to the progression of various cancers. This study analyzed the clinical significance of serum CXCL5 (sCXCL5) levels of nasopharyngeal carcinoma (NPC) patients, with the goal of building a novel prognostic score model. Experimental Design: Serum samples were collected prior to treatment from 290 NPC patients for the detection of sCXCL5 with ELISA. Half of the patients (n = 145) were randomly assigned to the training set to generate the sCXCL5 cutoff point using receiver operator characteristic (ROC) analysis, while the other half (n = 145) were assigned to the testing set for validation. Associations between sCXCL5 levels and clinical characteristics were analyzed. A prognostic score model was built using independent predictors derived from multivariate analysis. A concordance index (C-Index) was used to evaluate prognostic ability. Results: The sCXCL5 cutoff point was 0.805 ng/ml. Sex, age, histology, T classification, clinical classification and local recurrence were not associated with sCXCL5 levels. However, sCXCL5 levels were positively associated with N classification, distant metastasis and disease progression (P < 0.05). A high sCXCL5 level predicted poor 6-year overall survival (OS), poor 6-year distant metastasis-free survival (DMFS), and poor 6-year progression-free survival (PFS). A prognostic score model was subsequently constructed based on sCXCL5 levels and clinical classification (C-C model), which are independent predictors of OS, DMFS, and PFS, as confirmed by the multivariate analysis. Furthermore, this novel model successfully divided the patients into four risk subgroups in the training set, the testing set and the entire set of patients. The C-Indices were 0.751 and 0.762 for the training set and the testing set, respectively. Conclusions: sCXCL5 level was determined to be an independent prognostic factor for NPC patients. The novel statistical CC model, which includes sCXCL5 levels and clinical classification, could be helpful in predicting the prognosis of NPC patients.	[Zhang, Haibo; Xia, Weixiong; Lu, Xing; Sun, Rui; Wang, Lin; Ye, Yanfang; Xiang, Yanqun; Guo, Xiang] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Haibo; Xia, Weixiong; Lu, Xing; Sun, Rui; Wang, Lin; Zheng, Lisheng; Ye, Yanfang; Bao, Yingna; Xiang, Yanqun; Guo, Xiang] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China	Xiang, YQ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China.	xiangyq@sysucc.org.cn; guoxiang@sysucc.org.cn			National Natural Science Foundation of China [81172041, 81201630]; Natural Science Foundation of Guangdong Province [S2011010005312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (No: 81172041; 81201630) and Natural Science Foundation of Guangdong Province (No: S2011010005312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier PK, 2005, ANTICANCER RES, V25, P3581; Begley LA, 2008, NEOPLASIA, V10, P244, DOI 10.1593/neo.07976; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; Cao X, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-104; Cheng SH, 2006, INT J RADIAT ONCOL, V66, P992, DOI 10.1016/j.ijrobp.2006.06.006; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; FREGENE TA, 1993, ANTICANCER RES, V13, P2377; Jin Y, 2012, EUR J CANCER, V48, P882, DOI 10.1016/j.ejca.2011.09.004; Kawamura M, 2012, EUR J CANCER, V48, P2244, DOI 10.1016/j.ejca.2011.11.032; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; Kuo PL, 2011, J CELL PHYSIOL, V226, P1224, DOI 10.1002/jcp.22445; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Li AH, 2011, AM J PATHOL, V178, P1340, DOI 10.1016/j.ajpath.2010.11.058; Lu X, 2011, EUR J CANCER, V47, P339, DOI 10.1016/j.ejca.2010.09.025; Ma J, 2001, AI ZHENG, V20, P505; Mao Yan-Ping, 2009, Ai Zheng, V28, P1022; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Miyazaki H, 2006, CANCER RES, V66, P4279, DOI 10.1158/0008-5472.CAN-05-4398; Ong YK, 2003, EUR J CANCER, V39, P1535, DOI 10.1016/S0959-8049(03)00310-1; Park JY, 2007, J CANCER RES CLIN, V133, P835, DOI 10.1007/s00432-007-0225-x; Samoszuk M, 1996, CLIN CANCER RES, V2, P1867; Toh CK, 2005, BRIT J CANCER, V92, P1382, DOI 10.1038/sj.bjc.6602525; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; White ES, 2003, CLIN CANCER RES, V9, P853; Xu J, 2010, J CLIN ONCOL, V28, P5202, DOI 10.1200/JCO.2009.25.6552; Zhou SL, 2012, HEPATOLOGY IN PRESS	30	17	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57830	10.1371/journal.pone.0057830	http://dx.doi.org/10.1371/journal.pone.0057830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469080	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900176
J	Lucassen, EA; Zhao, XC; Rother, KI; Mattingly, MS; Courville, AB; de Jonge, L; Csako, G; Cizza, G				Lucassen, Eliane A.; Zhao, Xiongce; Rother, Kristina I.; Mattingly, Megan S.; Courville, Amber B.; de Jonge, Lilian; Csako, Gyorgy; Cizza, Giovanni		Sleep Extension Study Grp	Evening Chronotype Is Associated with Changes in Eating Behavior, More Sleep Apnea, and Increased Stress Hormones in Short Sleeping Obese Individuals	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS; FOOD-INTAKE; FREQUENCY; VALIDATION; EPIDEMIC; ADULTS; MORNINGNESS/EVENINGNESS; CONTRIBUTORS; POPULATION; METABOLISM	Background: Short sleep duration and decreased sleep quality are emerging risk factors for obesity and its associated morbidities. Chronotype, an attribute that reflects individual preferences in the timing of sleep and other behaviors, is a continuum from morningness to eveningness. The importance of chronotype in relation to obesity is mostly unknown. Evening types tend to have unhealthy eating habits and suffer from psychological problems more frequently than Morning types, thus we hypothesized that eveningness may affect health parameters in a cohort of obese individuals reporting sleeping less than 6.5 hours per night. Methodology and Principal Findings: Baseline data from obese (BMI: 38.5+/-6.4 kg/m(2)) and short sleeping (5.8+/-0.8 h/night by actigraphy) participants (n = 119) of the Sleep Extension Study were analyzed (www.ClinicalTrials.gov, identifier NCT00261898). Assessments included the Horne and Ostberg Morningness-Eveningness questionnaire, a three-day dietary intake diary, a 14-day sleep diary, 14 days of actigraphy, and measurements of sleep apnea. Twenty-four hour urinary free cortisol, 24 h urinary norepinephrine and epinephrine levels, morning plasma ACTH and serum cortisol, fasting glucose and insulin, and lipid parameters were determined. Eveningness was associated with eating later in the day on both working and non-working days. Progression towards eveningness was associated with an increase in BMI, resting heart rate, food portion size, and a decrease in the number of eating occasions and HDL-cholesterol. Evening types had overtly higher 24 h urinary epinephrine and morning plasma ACTH levels, and higher morning resting heart rate than Morning types. In addition, Evening types more often had sleep apnea, independent of BMI or neck circumference. Conclusions: Eveningness was associated with eating later and a tendency towards fewer and larger meals and lower HDL-cholesterol levels. In addition, Evening types had more sleep apnea and higher stress hormones. Thus, eveningness in obese, chronically sleep-deprived individuals compounds the cardiovascular risk associated with obesity.	[Lucassen, Eliane A.; Courville, Amber B.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Zhao, Xiongce] NIDDK, Intramural Res Program, NIH, Bethesda, MD USA; [Rother, Kristina I.] NIH, Sect Pediat Diabet & Metab, Bethesda, MD 20892 USA; [Mattingly, Megan S.; de Jonge, Lilian; Cizza, Giovanni] NIDDK, Sect Neuroendocrinol Obes, NIH, Bethesda, MD 20892 USA; [Csako, Gyorgy] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Cizza, G (corresponding author), NIDDK, Sect Neuroendocrinol Obes, NIH, Bethesda, MD 20892 USA.	cizzag@intra.niddk.nih.gov		de Jonge, Lilian/0000-0001-5900-0695	National Institutes of Health, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases; Fulbright; VSBfonds; Leiden University Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047054, ZIADK047049] Funding Source: NIH RePORTER	National Institutes of Health, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases; Fulbright; VSBfonds; Leiden University Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases. EAL received scholarships from Fulbright, VSBfonds and the Leiden University Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors had a conflict of interest.	Ayappa I, 2008, J CLIN SLEEP MED, V4, P26; Baron KG, 2011, OBESITY SILVER SPRIN, V19, P1347; Brennan IM, 2012, AM J PHYSIOL-GASTR L, V303, pG129, DOI 10.1152/ajpgi.00478.2011; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chapelot D, 2006, OBESITY, V14, P215, DOI 10.1038/oby.2006.28; Cizza G, 2005, SLEEP, V28, P1217, DOI 10.1093/sleep/28.10.1217; Cizza G, 2012, J ENDOCRINOL INVEST, V35, P236, DOI 10.3275/8182; Cizza G, 2011, J ENDOCRINOL INVEST, V34, P793, DOI 10.3275/7808; Cizza G, 2010, CLIN TRIALS, V7, P274, DOI 10.1177/1740774510368298; Coffee JC, 2006, J BODYW MOV THER, V10, P134, DOI 10.1016/j.jbmt.2005.07.003; de Castro JM, 2004, J NUTR, V134, P104, DOI 10.1093/jn/134.1.104; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fletcher EC, 2003, SLEEP, V26, P15, DOI 10.1093/sleep/26.1.15; Garaulet M, 2007, SLEEP MED REV, V11, P429; Gooley JJ, 2011, J CLIN ENDOCR METAB, V96, pE463, DOI 10.1210/jc.2010-2098; Henley DE, 2009, J CLIN ENDOCR METAB, V94, P4234, DOI 10.1210/jc.2009-1174; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hur YM, 2007, J SLEEP RES, V16, P17, DOI 10.1111/j.1365-2869.2007.00562.x; IRANMANESH A, 1990, J CLIN ENDOCR METAB, V71, P1276, DOI 10.1210/jcem-71-5-1276; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kanerva N, 2012, CHRONOBIOL INT, V29, P920, DOI 10.3109/07420528.2012.699128; KANT AK, 1995, INT J OBESITY, V19, P468; Kantermann T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040655; Keim NL, 1997, J NUTR, V127, P75, DOI 10.1093/jn/127.1.75; Lack L, 2009, NAT SCI SLEEP, V1, P1; Lichstein KL, 2006, SLEEP, V29, P232; Lucassen EA, 2012, CURR OBES REP, V1, P208, DOI 10.1007/s13679-012-0028-5; Martin JS, 2012, CHRONOBIOL INT, V29, P295, DOI 10.3109/07420528.2011.653656; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Meijer JH, 2012, PROG BRAIN RES, V199, P143, DOI 10.1016/B978-0-444-59427-3.00009-5; Merikanto I, 2012, CHRONOBIOL INT, V29, P311, DOI 10.3109/07420528.2012.655870; Mongrain V, 2005, SLEEP, V28, P819, DOI 10.1093/sleep/28.7.819; Natale V, 2002, PERS INDIV DIFFER, V32, P809, DOI 10.1016/S0191-8869(01)00085-X; Pabst SR, 2009, J ADOLESCENT HEALTH, V44, P554, DOI 10.1016/j.jadohealth.2008.11.012; PACK AI, 1992, J APPL PHYSIOL, V72, P985, DOI 10.1152/jappl.1992.72.3.985; Paine SJ, 2006, J BIOL RHYTHM, V21, P68, DOI 10.1177/0748730405283154; Randler C, 2011, INT J PSYCHOL, V46, P91, DOI 10.1080/00207594.2010.518237; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Roeser K, 2012, PHYSIOL BEHAV, V106, P151, DOI 10.1016/j.physbeh.2012.01.023; Sato-Mito N, 2011, INT J FOOD SCI NUTR, V62, P525, DOI 10.3109/09637486.2011.560563; Schakel SF, 2001, J FOOD COMPOS ANAL, V14, P315, DOI 10.1006/jfca.2001.0992; Schubert E, 2008, APPETITE, V51, P501, DOI 10.1016/j.appet.2008.03.018; Smeets AJ, 2008, BRIT J NUTR, V99, P1316, DOI 10.1017/S0007114507877646; Taillard J, 2004, J BIOL RHYTHM, V19, P76, DOI 10.1177/0748730403259849; Toth PP, 2005, CIRCULATION, V111, pE89, DOI 10.1161/01.CIR.0000154555.07002.CA; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; Vink JM, 2001, CHRONOBIOL INT, V18, P809, DOI 10.1081/CBI-100107516; Westbrook PR, 2005, CHEST, V128, P2166, DOI 10.1378/chest.128.4.2166	49	149	150	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56519	10.1371/journal.pone.0056519	http://dx.doi.org/10.1371/journal.pone.0056519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483886	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100004
J	Chaplin-Kramer, R; George, MR				Chaplin-Kramer, Rebecca; George, Melvin R.			Effects of Climate Change on Range Forage Production in the San Francisco Bay Area	PLOS ONE			English	Article							GRASSLAND RESPONSES; PRECIPITATION; QUANTITY; IMPACTS; CO2	The San Francisco Bay Area in California, USA is a highly heterogeneous region in climate, topography, and habitats, as well as in its political and economic interests. Successful conservation strategies must consider various current and future competing demands for the land, and should pay special attention to livestock grazing, the dominant non-urban land-use. The main objective of this study was to predict changes in rangeland forage production in response to changes in temperature and precipitation projected by downscaled output from global climate models. Daily temperature and precipitation data generated by four climate models were used as input variables for an existing rangeland forage production model (linear regression) for California's annual rangelands and projected on 244 12 km x 12 km grid cells for eight Bay Area counties. Climate model projections suggest that forage production in Bay Area rangelands may be enhanced by future conditions in most years, at least in terms of peak standing crop. However, the timing of production is as important as its peak, and altered precipitation patterns could mean delayed germination, resulting in shorter growing seasons and longer periods of inadequate forage quality. An increase in the frequency of extremely dry years also increases the uncertainty of forage availability. These shifts in forage production will affect the economic viability and conservation strategies for rangelands in the San Francisco Bay Area.	[Chaplin-Kramer, Rebecca] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA; [George, Melvin R.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Stanford University; University of California System; University of California Davis	George, MR (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	mrgeorge@ucdavis.edu		Chaplin-Kramer, Rebecca/0000-0002-1539-5231	California Energy Commission's Public Interest Energy Research (PIER) Program under the California Climate Change Center	California Energy Commission's Public Interest Energy Research (PIER) Program under the California Climate Change Center	The California Energy Commission's Public Interest Energy Research (PIER) Program provided support for this research under the California Climate Change Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cayan D., 2012, CALIFORNIA ENERGY CO; Cayan Dan, 2006, CLIMATE SCENARIOS CA; Chaplin-Kramer Rebecca, 2011, Rangelands, V33, P33; Chou WW, 2008, GLOBAL CHANGE BIOL, V14, P1382, DOI 10.1111/j.1365-2486.2008.01572.x; Cornwell W. K., 2012, CALIFORNIA ENERGY CO, VCEC-500-2012-023; FORERO L, 1992, J SOIL WATER CONSERV, V47, P475; George M, 2001, DIVISION AGR NATURAL; George M, 2001, DIVISION AGR NATURAL; GEORGE MR, 1988, J RANGE MANAGE, V41, P193, DOI 10.2307/3899166; GEORGE MR, 2010, RANGELANDS, V32, P16, DOI DOI 10.2111/RANGELANDS-D-10-00003.1; George MR, 1989, J RANGE MANAGE, V42, P509; Hahn G. L., 1985, Stress physiology in livestock. Volume II. Ungulates., P151; HANSON JD, 1993, AGR SYST, V41, P487, DOI 10.1016/0308-521X(93)90047-6; Harris NR, 2001, THESIS OREGON STATE; Howden SM, 2008, AUST J EXP AGR, V48, P780, DOI 10.1071/EA08033; HRC-GWRI, 2011, CEC5002010051 HRCGWR; Huntsinger L, 1996, J RANGE MANAGE, V49, P167, DOI 10.2307/4002689; Huntsinger L., 2007, GRAZING MANAGEMENT C, P233; Keshta N, 2012, HYDROL PROCESS, V26, P1321, DOI 10.1002/hyp.8215; LOGAN SH, 1983, J AM SOC HORTIC SCI, V108, P977; Milchunas DG, 2005, AGR ECOSYST ENVIRON, V111, P166, DOI 10.1016/j.agee.2005.06.014; MURPHY AH, 1970, J RANGE MANAGE, V23, P363, DOI 10.2307/3896168; Nader G., 2007, RANGELANDS, V29, P18, DOI [https://doi.org/10.2111/1551-501X(2007)29[18:PHITMO]2.0.CO;2, DOI 10.2111/1551-501X(2007)29[18:PHITMO]2.0.CO;2]; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Shaw MR, 2011, CLIMATIC CHANGE, V109, P465, DOI 10.1007/s10584-011-0313-4; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; USGS (U.S. Department of Interior Geological Survey), 2006, NAT MAP LANDFIRE NAT; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100	29	15	15	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57723	10.1371/journal.pone.0057723	http://dx.doi.org/10.1371/journal.pone.0057723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472102	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900041
J	Imai, S; Kano, M; Nonoyama, K; Ebihara, S				Imai, Saki; Kano, Makoto; Nonoyama, Keiko; Ebihara, Shizufumi			Behavioral Characteristics of Ubiquitin-Specific Peptidase 46-Deficient Mice	PLOS ONE			English	Article							GABA(A) RECEPTORS; SUCROSE PREFERENCE; STRESS; RESPONSES; SUBUNIT; ALCOHOL; SENSITIVITY; LACKING; MAP	We have previously identified Usp46, which encodes for ubiquitin-specific peptidase 46, as a quantitative trait gene affecting the immobility time of mice in the tail suspension test (TST) and forced swimming test. The mutation that we identified was a 3-bp deletion coding for lysine (Lys 92), and mice with this mutation (MT mice), as well as Usp46 KO mice exhibited shorter TST immobility times. Behavioral pharmacology suggests that the gamma aminobutyric acid A (GABA(A)) receptor is involved in regulating TST immobility time. In order to understand how far Usp46 controls behavioral phenotypes, which could be related to mental disorders in humans, we subjected Usp46 MT and KO mice to multiple behavioral tests, including the open field test, ethanol preference test, ethanol-induced loss of righting reflex test, sucrose preference test, novelty-suppressed feeding test, marble burying test, and novel object recognition test. Although behavioral phenotypes of the Usp46 MT and KO mice were not always identical, deficiency of Usp46 significantly affected performance in all these tests. In the open field test, activity levels were lower in Usp46 KO mice than wild type (WT) or MT mice. Both MT and KO mice showed lower ethanol preference and shorter recovery times after ethanol administration. Compared to WT mice, Usp46 MT and KO mice exhibited decreased sucrose preference, took longer latency periods to bite pellets, and buried more marbles in the sucrose preference test, novelty-suppressed feeding test, and marble burying test, respectively. In the novel object recognition test, neither MT nor KO mice showed an increase in exploration of a new object 24 hours after training. These findings indicate that Usp46 regulates a wide range of behavioral phenotypes that might be related to human mental disorders and provides insight into the function of USP46 deubiquitinating enzyme in the neural system.	[Imai, Saki; Kano, Makoto; Nonoyama, Keiko; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan	Nagoya University	Ebihara, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan.	ebihara@agr.nagoya-u.ac.jp			JSPS KAKENHI [22248033, 22658093]; Takeda Science Foundation; Life Science Foundation of Japan;  [22006714]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Life Science Foundation of Japan(Life Science Foundation of Japan); 	This research was supported by JSPS KAKENHI Grant Number 22248033, 22658093, Takeda Science Foundation, Life Science Foundation of Japan to SE and Grant-in-Aid for JSPS Fellows (22006714) to SI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albelda N, 2012, NEUROSCI BIOBEHAV R, V36, P47, DOI 10.1016/j.neubiorev.2011.04.006; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Blednov YA, 2003, J PHARMACOL EXP THER, V304, P30, DOI 10.1124/jpet.102.042960; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; Cai YQ, 2006, J NEUROSCI RES, V84, P255, DOI 10.1002/jnr.20884; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Egashira N, 2013, PSYCHOPHARMACOLOGY, V226, P295, DOI 10.1007/s00213-012-2904-9; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Hu JH, 2004, NEUROSCIENCE, V123, P807, DOI 10.1016/j.neuroscience.2003.11.018; Imai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039084; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Koob GF, 2004, BIOCHEM PHARMACOL, V68, P1515, DOI 10.1016/j.bcp.2004.07.031; Li X, 2012, ONCOGENE, DOI [10.1038/onc.2012.6632, DOI 10.1038/ONE.2012.6632]; Lobo IA, 2008, PHARMACOL BIOCHEM BE, V90, P90, DOI 10.1016/j.pbb.2008.03.006; Mamiya T, 1998, BRAIN RES, V783, P236, DOI 10.1016/S0006-8993(97)01406-6; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Miyamoto Y, 2002, J NEUROSCI, V22, P2335, DOI 10.1523/JNEUROSCI.22-06-02335.2002; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Shen QY, 2010, BIOL PSYCHIAT, V68, P512, DOI 10.1016/j.biopsych.2010.04.024; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Vollenweider I, 2011, BEHAV BRAIN RES, V217, P77, DOI 10.1016/j.bbr.2010.10.009; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026297	32	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58566	10.1371/journal.pone.0058566	http://dx.doi.org/10.1371/journal.pone.0058566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472206	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900152
J	Li, HH; Chen, Q; Liu, FC; Zhang, XM; Li, W; Liu, SP; Zhao, YY; Gong, YQ; Yan, CZ				Li, Honghao; Chen, Qi; Liu, Fuchen; Zhang, Xuemei; Li, Wei; Liu, Shuping; Zhao, Yuying; Gong, Yaoqin; Yan, Chuanzhu			Unfolded Protein Response and Activated Degradative Pathways Regulation in GNE Myopathy	PLOS ONE			English	Article							INCLUSION-BODY MYOSITIS; RIMMED VACUOLES; DISTAL MYOPATHY; 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; ENDOPLASMIC-RETICULUM; MUSCLE-FIBERS; ALPHA-DYSTROGLYCAN; AUTOPHAGY; PROTEASOME; NEURODEGENERATION	Although intracellular beta amyloid (A beta) accumulation is known as an early upstream event in the degenerative course of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) myopathy, the process by which A beta deposits initiate various degradative pathways, and their relationship have not been fully clarified. We studied the possible secondary responses after amyloid beta precursor protein (A beta PP) deposition including unfolded protein response (UPR), ubiquitin proteasome system (UPS) activation and its correlation with autophagy system. Eight GNE myopathy patients and five individuals with normal muscle morphology were included in this study. We performed immunofluorescence and immunoblotting to investigate the expression of A beta PP, phosphorylated tau (p-tau) and endoplasmic reticulum molecular chaperones. Proteasome activities were measured by cleavage of fluorogenic substrates. The expression of proteasome subunits and linkers between proteasomal and autophagy systems were also evaluated by immunoblotting and relative quantitative real-time RT-PCR. Four molecular chaperones, glucose-regulated protein 94 (GRP94), glucose-regulated protein 78 (GRP78), calreticulin and calnexin and valosin containing protein (VCP) were highly expressed in GNE myopathy. 20S proteasome subunits, three main proteasome proteolytic activities, and the factors linking UPS and autophagy system were also increased. Our study suggests that A beta PP deposition results in endoplasmic reticulum stress (ERS) and highly expressed VCP deliver unfolded proteins from endoplasmic reticulum to proteosomal system which is activated in endoplasmic reticulum associated degradation (ERAD) in GNE myopathy. Excessive ubiquitinated unfolded proteins are exported by proteins that connect UPS and autophagy to autophagy system, which is activated as an alternative pathway for degradation.	[Li, Honghao; Liu, Fuchen; Li, Wei; Liu, Shuping; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan 250100, Peoples R China; [Li, Honghao] Shandong Univ, Dept Neurol, Prov Hosp, Jinan 250100, Peoples R China; [Chen, Qi] Yantai Yuhuangding Hosp, Dept Neurol, Yantai, Peoples R China; [Zhang, Xuemei] Shandong Univ Hosp, Dept Gen Internal Med, Jinan, Peoples R China; [Gong, Yaoqin; Yan, Chuanzhu] Shandong Univ, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Peoples R China; [Gong, Yaoqin; Yan, Chuanzhu] Shandong Univ, Inst Med Genet, Sch Med, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Yan, CZ (corresponding author), Shandong Univ, Dept Neurol, Qilu Hosp, Jinan 250100, Peoples R China.	czyan@yahoo.cn	li, honghao/HGC-1028-2022		National Natural Science Foundation of China [30670744/C090301]; National Science Foundation [81171182]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the following funding sources: The National Natural Science Foundation of China General Projects (Grant No.30670744/C090301) and the National Science Foundation Research Grant (Grant no. 81171182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Broccolini A, 2005, NEUROMUSCULAR DISORD, V15, P177, DOI 10.1016/j.nmd.2004.10.001; D'Agostino C, 2011, ACTA NEUROPATHOL, V122, P627, DOI 10.1007/s00401-011-0874-3; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kayashima T, 2002, J HUM GENET, V47, P77, DOI 10.1007/s100380200004; Korolchuk VI, FEBS LETT, V584, P1393; Kumamoto T, 1998, INTERNAL MED, V37, P746, DOI 10.2169/internalmedicine.37.746; Li H, J HUM GENET, V56, P335; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2007, AUTOPHAGY, V3, P396, DOI 10.4161/auto.4270; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; Pandey UB, 2007, AUTOPHAGY, V3, P643, DOI 10.4161/auto.5050; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Sugarman MC, 2002, P NATL ACAD SCI USA, V99, P6334, DOI 10.1073/pnas.082545599; Tajima Y, 2005, AM J PATHOL, V166, P1121, DOI 10.1016/S0002-9440(10)62332-2; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsuruta Y, 2001, ACTA NEUROPATHOL, V101, P579; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6; Yang Y, 2005, MOL CELLS, V20, P173	34	24	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58116	10.1371/journal.pone.0058116	http://dx.doi.org/10.1371/journal.pone.0058116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472144	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900089
J	Lo, YC; Chuang, JH; Kuo, HW; Huang, WT; Hsu, YF; Liu, MT; Chen, CH; Huang, HH; Chang, CH; Chou, JH; Chang, FY; Lin, TY; Chiu, WT				Lo, Yi-Chun; Chuang, Jen-Hsiang; Kuo, Hung-Wei; Huang, Wan-Ting; Hsu, Yu-Fen; Liu, Ming-Tsan; Chen, Chang-Hsun; Huang, Hui-Hsun; Chang, Chi-Hsi; Chou, Jih-Haw; Chang, Feng-Yee; Lin, Tzou-Yien; Chiu, Wen-Ta			Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011-212 Season	PLOS ONE			English	Article							H1N1 2009; NEURAMINIDASE INHIBITORS; INCREASED RISK; B VIRUSES; OSELTAMIVIR; INFECTION; EFFICACY; SUSCEPTIBILITY; ASSOCIATION	Introduction The 2011-12 trivalent influenza vaccine contains a strain of influenza B/Victoria-lineage viruses. Despite free provision of influenza vaccine among target populations, an epidemic predominated by influenza B/Yamagata-lineage viruses occurred during the 2011-12 season in Taiwan. We characterized this vaccine-mismatched epidemic and estimated influenza vaccine effectiveness (VE). Methods: Influenza activity was monitored through sentinel viral surveillance, emergency department (ED) and outpatient influenza-like illness (ILI) syndromic surveillance, and case-based surveillance of influenza with complications and deaths. VE against laboratory-confirmed influenza was evaluated through a case-control study on ILI patients enrolled into sentinel viral surveillance. Logistic regression was used to estimate VE adjusted for confounding factors. Results: During July 2011-June 2012, influenza B accounted for 2,382 (72.5%) of 3,285 influenza-positive respiratory specimens. Of 329 influenza B viral isolates with antigen characterization, 287 (87.2%) were B/Yamagata-lineage viruses. Proportions of ED and outpatient visits being ILI-related increased from November 2011 to January 2012. Of 1,704 confirmed cases of influenza with complications, including 154 (9.0%) deaths, influenza B accounted for 1,034 (60.7%) of the confirmed cases and 103 (66.9%) of the deaths. Reporting rates of confirmed influenza with complications and deaths were 73.5 and 6.6 per 1,000,000, respectively, highest among those aged >= 65 years, 50-64 years, 3-6 years, and 0-2 years. Adjusted VE was -31% (95% CI: -80, 4) against all influenza, 54% (95% CI: 3, 78) against influenza A, and -66% (95% CI: -132, -18) against influenza B. Conclusions: This influenza epidemic in Taiwan was predominated by B/Yamagata-lineage viruses unprotected by the 2011-12 trivalent vaccine. The morbidity and mortality of this vaccine-mismatched epidemic warrants careful consideration of introducing a quadrivalent influenza vaccine that includes strains of both B lineages.	[Lo, Yi-Chun; Chuang, Jen-Hsiang; Kuo, Hung-Wei; Huang, Wan-Ting; Hsu, Yu-Fen; Liu, Ming-Tsan; Chen, Chang-Hsun; Huang, Hui-Hsun; Chang, Chi-Hsi; Chou, Jih-Haw; Chang, Feng-Yee] Ctr Dis Control, Taipei, Taiwan; [Chang, Feng-Yee] Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan; [Chang, Feng-Yee] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Tzou-Yien; Chiu, Wen-Ta] Dept Hlth, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Defense Medical Center; National Defense Medical Center	Chang, FY (corresponding author), Ctr Dis Control, Taipei, Taiwan.	fychang@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010; Huang, Wan-Ting/E-3497-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; Huang, Wan-Ting/0000-0002-4344-9567	Taiwan Field Epidemiology Training Program	Taiwan Field Epidemiology Training Program	This work was funded by the Taiwan Field Epidemiology Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; [Anonymous], 2010, WHO GUID PHARM MAN P; Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Belshe RB, 2010, VACCINE, V28, pD45, DOI 10.1016/j.vaccine.2010.08.028; Belshe RB, 2010, VACCINE, V28, P2149, DOI 10.1016/j.vaccine.2009.11.068; Bodewes R, 2012, VACCINE, V30, P7407, DOI 10.1016/j.vaccine.2012.04.086; Boivin G, 2002, ANTIVIR RES, V54, P143, DOI 10.1016/S0166-3542(01)00219-4; Bureau of National Health Insurance, 2012, NAT HLTH INS TAIW 20; Chapman WW, 2005, J AM MED INFORM ASSN, V12, P618, DOI 10.1197/jamia.M1841; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Crowcroft NS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-458; Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692; Ferraris O, 2005, ANTIVIR RES, V68, P43, DOI 10.1016/j.antiviral.2005.07.004; Hsieh Yu-Chia, 2005, Journal of Microbiology Immunology and Infection, V38, P238; Janjua NZ, 2012, J INFECT DIS, V205, P1858, DOI 10.1093/infdis/jis283; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; Jian JW, 2008, VIRUS RES, V131, P243, DOI 10.1016/j.virusres.2007.09.014; Jimenez-Jorge S, 2012, EURO SURVEILL, V17; KELLY H, 2010, EURO SURVEILL, V15; Kissling E, 2012, EUROSURVEILLANCE, V17; Kobinger GP, 2010, J INFECT DIS, V201, P1000, DOI 10.1086/651171; Lin JH, 2008, J MED VIROL, V80, P316, DOI 10.1002/jmv.21074; McCullers JA, 2004, J VIROL, V78, P12817, DOI 10.1128/JVI.78.23.12817-12828.2004; Mungall BA, 2004, VIRUS RES, V103, P195, DOI 10.1016/j.virusres.2004.02.033; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Shaw MW, 2002, VIROLOGY, V303, P1, DOI 10.1006/viro.2002.1719; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Skowronski DM, 2011, CLIN INFECT DIS, V52, P831, DOI 10.1093/cid/cir036; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Tsuchihashi Y, 2012, CLIN INFECT DIS, V54, P381, DOI 10.1093/cid/cir787; Tsui FC, 2003, J AM MED INFORM ASSN, V10, P399, DOI 10.1197/jamia.M1345; World Health Organization (WHO), 2011, WKLY EPIDEMIOL REC, V46, P86; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Yang JR, 2010, ANTIVIR RES, V88, P256, DOI 10.1016/j.antiviral.2010.09.014; Yang JR, 2010, VIRUS RES, V151, P33, DOI 10.1016/j.virusres.2010.03.011	38	45	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58222	10.1371/journal.pone.0058222	http://dx.doi.org/10.1371/journal.pone.0058222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472161	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900107
J	Mangiola, A; Saulnier, N; De Bonis, P; Orteschi, D; Sica, G; Lama, G; Pettorini, BL; Sabatino, G; Zollino, M; Lauriola, L; Colabianchi, A; Proietti, G; Kovacs, G; Maira, G; Anile, C				Mangiola, Annunziato; Saulnier, Nathalie; De Bonis, Pasquale; Orteschi, Daniela; Sica, Gigliola; Lama, Gina; Pettorini, Benedetta Ludovica; Sabatino, Giovanni; Zollino, Marcella; Lauriola, Libero; Colabianchi, Anna; Proietti, Gabriella; Kovacs, Gyula; Maira, Giulio; Anile, Carmelo			Gene Expression Profile of Glioblastoma Peritumoral Tissue: An Ex Vivo Study	PLOS ONE			English	Article							MALIGNANT GLIOMA; NESTIN EXPRESSION; NORMAL BRAIN; LUNG-CANCER; MULTIFORME; CELLS; TUMOR; ANGIOGENESIS; TAZ; CARCINOMA	The gene expression pattern of glioblastoma (GBM) is well documented but the expression profile of brain adjacent to tumor is not yet analysed. This may help to understand the oncogenic pathway of GBM development. We have established the genome-wide expression profiles of samples isolated from GBM tumor mass, white matter adjacent to tumor (apparently free of tumor cells), and white matter controls by using the Affymetrix HG-U133 arrays. Array-CGH (aCGH) was also performed to detect genomic alterations. Among genes dysregulated in peritumoral white matter, 15 were overexpressed, while 42 were down-regulated when compared to white matter controls. A similar expression profile was detected in GBM cells. Growth, proliferation and cell motility/adhesion-associated genes were up-regulated while genes involved in neurogenesis were down-regulated. Furthermore, several tumor suppressor genes along with the KLRC1 (a member of natural killer receptor) were also down-regulated in the peritumoral brain tissue. Several mosaic genomic lesions were detected by aCGH, mostly in tumor samples and several GBM-associated mosaic genomic lesions were also present in the peritumoral brain tissue, with a similar mosaicism pattern. Our data could be explained by a dilution of genes expressed from tumor cells infiltrating the peritumour tissue. Alternatively, these findings could be substained by a relevant amount of "apparently normal" cells presenting a gene profile compatible with a precancerous state or even "quiescent" cancer cells. Otherwise, the recurrent tumor may arise from both infiltrating tumor cells and from an interaction and recruitment of apparently normal cells in the peritumor tissue by infiltrating tumor cells.	[Mangiola, Annunziato; De Bonis, Pasquale; Pettorini, Benedetta Ludovica; Sabatino, Giovanni; Maira, Giulio; Anile, Carmelo] Univ Cattolica Sacro Cuore, Fac Med, Inst Neurosurg, Rome, Italy; [Saulnier, Nathalie] Univ Cattolica Sacro Cuore, Fac Med, Inst Human Anat, Rome, Italy; [Lauriola, Libero] Univ Cattolica Sacro Cuore, Fac Med, Inst Pathol, Rome, Italy; [Sica, Gigliola; Lama, Gina; Colabianchi, Anna; Proietti, Gabriella] Univ Cattolica Sacro Cuore, Fac Med, Inst Histol & Embryol, Rome, Italy; [Orteschi, Daniela; Zollino, Marcella] Univ Cattolica Sacro Cuore, Fac Med, Inst Genet, Rome, Italy; [Kovacs, Gyula] Heidelberg Univ, Fac Med, Heidelberg, Germany	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Ruprecht Karls University Heidelberg	De Bonis, P (corresponding author), Univ Cattolica Sacro Cuore, Fac Med, Inst Neurosurg, Rome, Italy.	debonisvox@gmail.com	de bonis, pasquale/K-8200-2016; Zollino, Marcella/AAC-3891-2022; Sabatino, Giovanni/J-9965-2018	de bonis, pasquale/0000-0002-9879-8940; Zollino, Marcella/0000-0003-4871-9519; Saulnier, Nathalie/0000-0003-0159-8414; SABATINO, Giovanni/0000-0002-4227-0434	FIRB (Fondo per Investimenti Ricerca di Base-Funding for Basic Research); Ministry of University and Research; PRIN (Programma di Ricerca Scientifica di Rilevante Interesse Nazionale-Scientific Research Program; Atena-Onlus	FIRB (Fondo per Investimenti Ricerca di Base-Funding for Basic Research); Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); PRIN (Programma di Ricerca Scientifica di Rilevante Interesse Nazionale-Scientific Research Program(Ministry of Education, Universities and Research (MIUR)); Atena-Onlus	This study was supported by grants FIRB (Fondo per Investimenti Ricerca di Base-Funding for Basic Research, by Ministry of University and Research), PRIN (Programma di Ricerca Scientifica di Rilevante Interesse Nazionale-Scientific Research Program with high national interest-by Ministry of University and Research), Atena-Onlus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RY, 2011, TRENDS MOL MED, V17, P301, DOI 10.1016/j.molmed.2011.01.011; Bakshi A, 1998, J NEUROL SCI, V155, P196, DOI 10.1016/S0022-510X(97)00315-8; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Boon K, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-39; BURGER PC, 1983, J NEUROSURG, V58, P159, DOI 10.3171/jns.1983.58.2.0159; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen PY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-2; Dahlback HSS, 2009, GENE CHROMOSOME CANC, V48, P908, DOI 10.1002/gcc.20690; De Micheli E, 2000, ADV EXP MED BIOL, V483, P621; Dehnhardt M, 2008, J TRACE ELEM MED BIO, V22, P17, DOI 10.1016/j.jtemb.2007.08.002; Donovan LK, 2012, CELL PROLIFERAT, V45, P527, DOI 10.1111/j.1365-2184.2012.00842.x; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Folsom AR, 2008, DIABETES CARE, V31, P905, DOI 10.2337/dc07-2131; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Hoi Sang U, 1995, J NEUROSURG, V82, P847; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kontani K, 2003, INT J MOL MED, V12, P767; Korosec B, 2006, CANCER GENET CYTOGEN, V171, P105, DOI 10.1016/j.cancergencyto.2006.06.016; Lal G, 2006, CANCER, V107, P2752, DOI 10.1002/cncr.22325; Lama G, 2007, INT J ONCOL, V30, P1333; Lee JH, 2007, CLIN CANCER RES, V13, P2584, DOI 10.1158/1078-0432.CCR-06-1785; Manara MC, 2006, MOL BIOL CELL, V17, P1910, DOI 10.1091/mbc.E05-10-0971; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; Mangiola A, 2008, CANCER-AM CANCER SOC, V113, P841, DOI 10.1002/cncr.23624; Mangiola A, 2010, EXPERT REV NEUROTHER, V10, P507, DOI [10.1586/ern.09.158, 10.1586/ERN.09.158]; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Mittelbronn M, 2007, J NEUROIMMUNOL, V189, P50, DOI 10.1016/j.jneuroim.2007.07.002; Nowacki P, 2001, FOLIA NEUROPATHOL, V39, P95; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Scotlandi K, 2007, ONCOGENE, V26, P6604, DOI 10.1038/sj.onc.1210481; Shih AH, 2006, NEOPLASIA, V8, P1072, DOI 10.1593/neo.06526; Sica G, 2011, INT J ONCOL, V38, P41, DOI 10.3892/ijo_00000822; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stefanova N, 2003, J NEUROSCI RES, V73, P334, DOI 10.1002/jnr.10662; Stevenson CB, 2008, NEUROSURGERY, V63, P560, DOI 10.1227/01.NEU.0000324896.26088.EF; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tzeng SF, 2001, J NEUROSCI RES, V66, P1161; Valli R, 2011, CANCER GENET-NY, V204, P216, DOI 10.1016/j.cancergen.2011.02.002; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; Wang HM, 2006, TECHNOL CANCER RES T, V5, P195, DOI 10.1177/153303460600500303; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	45	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57145	10.1371/journal.pone.0057145	http://dx.doi.org/10.1371/journal.pone.0057145			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472076	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900014
J	Savarese, G; Trimarco, B; Dellegrottaglie, S; Prastaro, M; Gambardella, F; Rengo, G; Leosco, D; Perrone-Filardi, P				Savarese, Gianluigi; Trimarco, Bruno; Dellegrottaglie, Santo; Prastaro, Maria; Gambardella, Francesco; Rengo, Giuseppe; Leosco, Dario; Perrone-Filardi, Pasquale			Natriuretic Peptide-Guided Therapy in Chronic Heart Failure: A Meta-Analysis of 2,686 Patients in 12 Randomized Trials	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; SYSTOLIC DYSFUNCTION; MANAGEMENT; BNP; GUIDELINES; SURVIVAL; MORBIDITY; MORTALITY; ADHERENCE; EVENTS	Background: The role of cardiac natriuretic peptides in the management of patients with chronic heart failure (HF) remains uncertain. The purpose of this study was to evaluate whether natriuretic peptide-guided therapy, compared to clinically-guided therapy, improves mortality and hospitalization rate in patients with chronic HF. Methodology/Principal Findings: MEDLINE, Cochrane, ISI Web of Science and SCOPUS databases were searched for articles reporting natriuretic peptide-guided therapy in HF until August 2012. All randomized trials reporting clinical end-points (all-cause mortality and/or HF-related hospitalization and/or all-cause hospitalization) were included. Meta-analysis was performed to assess the influence of treatment on outcomes. Sensitivity analysis was performed to test the influence of potential effect modifiers and of each trial included in meta-analysis on results. Twelve trials enrolling 2,686 participants were included. Natriuretic peptide-guided therapy (either B-type natriuretic peptide [BNP]- or N-terminal pro-B-type natriuretic peptide [NT-proBNP]-guided therapy) significantly reduced all-cause mortality (Odds Ratio [OR]:0.738; 95% Confidence Interval [CI]:0.596 to 0.913; p = 0.005) and HF-related hospitalization (OR:0.554; CI:0.399 to 0.769; p = 0.000), but not all-cause hospitalization (OR:0.803; CI:0.629 to 1.024; p = 0.077). When separately assessed, NT-proBNP-guided therapy significantly reduced all-cause mortality (OR:0.717; CI:0.563 to 0.914; p = 0.007) and HF-related hospitalization (OR:0.531; CI:0.347 to 0.811; p = 0.003), but not all-cause hospitalization (OR:0.779; CI:0.414 to 1.465; p = 0.438), whereas BNP-guided therapy did not significantly reduce all-cause mortality (OR:0.814; CI:0.518 to 1.279; p = 0.371), HF-related hospitalization (OR:0.599; CI:0.303 to 1.187; p = 0.142) or all-cause hospitalization (OR:0.726; CI:0.609 to 0.964; p = 0.077). Conclusions/Significance: Use of cardiac peptides to guide pharmacologic therapy significantly reduces mortality and HF related hospitalization in patients with chronic HF. In particular, NT-proBNP-guided therapy reduced all-cause mortality and HF-related hospitalization but not all-cause hospitalization, whereas BNP-guided therapy did not significantly reduce both mortality and morbidity.	[Savarese, Gianluigi; Trimarco, Bruno; Dellegrottaglie, Santo; Prastaro, Maria; Gambardella, Francesco; Perrone-Filardi, Pasquale] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Dellegrottaglie, Santo] Osped Med Chirurg Accreditato Villa dei Fiori, Div Cardiol, Naples, Italy; [Rengo, Giuseppe; Leosco, Dario] Univ Naples Federico II, Dept Med Translat Sci, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Perrone-Filardi, P (corresponding author), Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy.	fpperron@unina.it	Perrone Filardi, Pasquale/AAC-7590-2022; Rengo, Giuseppe/K-4963-2016; Rengo, Giuseppe/AAA-2870-2021; Trimarco, Bruno BT/K-7851-2016; Savarese, Gianluigi/K-6845-2016	Rengo, Giuseppe/0000-0002-9701-0437; Rengo, Giuseppe/0000-0002-9701-0437; Trimarco, Bruno BT/0000-0002-0701-6449; Savarese, Gianluigi/0000-0001-7732-0887; Leosco, Dario/0000-0002-6543-5721				Adams KF, 2010, HEART FAIL REV, V15, P351, DOI 10.1007/s10741-009-9139-9; Anguita M, 2010, MED CLIN-BARCELONA, V135, P435, DOI 10.1016/j.medcli.2009.11.048; Beck-da-Silva Luis, 2005, Congest Heart Fail, V11, P248, DOI 10.1111/j.1527-5299.2005.04239.x; Berger R, 2010, J AM COLL CARDIOL, V55, P645, DOI 10.1016/j.jacc.2009.08.078; Berry C, 2007, EUR J HEART FAIL, V9, P429, DOI 10.1016/j.ejheart.2006.10.005; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Costanzo P, 2009, J HYPERTENS, V27, P1136, DOI 10.1097/HJH.0b013e3283281254; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; Eurlings LWM, 2010, J AM COLL CARDIOL, V56, P2090, DOI 10.1016/j.jacc.2010.07.030; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Felker GM, 2009, AM HEART J, V158, P422, DOI 10.1016/j.ahj.2009.06.018; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; Hartmann F, 2004, CIRCULATION, V110, P1780, DOI 10.1161/01.CIR.0000143059.68996.A7; Hildebrandt P, 2010, EUR HEART J, V31, P1881, DOI 10.1093/eurheartj/ehq163; Iraqi W, 2009, CIRCULATION, V119, P2471, DOI 10.1161/CIRCULATIONAHA.108.809194; Januzzi JL, 2011, J AM COLL CARDIOL, V58, P1881, DOI 10.1016/j.jacc.2011.03.072; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Karlstrom P, 2011, EUR J HEART FAIL, V13, P1096, DOI 10.1093/eurjhf/hfr078; Komajda M, 2005, EUR HEART J, V26, P1653, DOI 10.1093/eurheartj/ehi251; Lainchbury JG, 2009, J AM COLL CARDIOL, V55, P53, DOI 10.1016/j.jacc.2009.02.095; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Metra M, 2011, J CARDIOVASC MED, V12, P76, DOI 10.2459/JCM.0b013e32834058d1; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Persson H, 2010, EUR J HEART FAIL, V12, P1300, DOI 10.1093/eurjhf/hfq169; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Porapakkham P, 2010, ARCH INTERN MED, V170, P507, DOI 10.1001/archinternmed.2010.35; Powell LH, 2010, JAMA-J AM MED ASSOC, V304, P1331, DOI 10.1001/jama.2010.1362; Prastaro M, 2011, EUR J ECHOCARDIOGR, V12, P506, DOI 10.1093/ejechocard/jer070; Savarese G, 2013, INT J CARDIOL, V167, P2482, DOI 10.1016/j.ijcard.2012.05.010; Savarese G, 2012, J AM COLL CARDIOL, V60, P1192, DOI 10.1016/j.jacc.2012.01.083; Schou M, 2013, EUR HEART J, V34, P432, DOI 10.1093/eurheartj/ehs235; Shah MR, 2011, J CARD FAIL, V17, P613, DOI 10.1016/j.cardfail.2011.04.012; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Sharp S, 1998, STATA TECH B REPRINT, V7, P100; Steiner J, 2008, INT J CARDIOL, V129, P5, DOI 10.1016/j.ijcard.2007.12.093; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.3305/NH.2010.25.2.4545; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; White Michel, 2009, Ther Adv Cardiovasc Dis, V3, P113, DOI 10.1177/1753944708103658; Whitehead A., 2002, METAANALYSIS CONTROL	46	122	134	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58287	10.1371/journal.pone.0058287	http://dx.doi.org/10.1371/journal.pone.0058287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472172	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900118
J	Tang, SW; Bao, HM; Zhang, Y; Yao, J; Yang, PY; Chen, X				Tang, Siwei; Bao, Huimin; Zhang, Yang; Yao, Jun; Yang, Pengyuan; Chen, Xian			14-3-3 epsilon Mediates the Cell Fate Decision-Making Pathways in Response of Hepatocellular Carcinoma to Bleomycin-Induced DNA Damage	PLOS ONE			English	Article							KINASE KINASE KINASE; 14-3-3 PROTEINS; IN-VIVO; HISTONE DEACETYLASE; NUCLEAR ANTIGEN; SIGNALING PATHWAYS; PROTEOMIC APPROACH; TAK1; BINDING; CANCER	Background: Lack of understanding of the response of hepatocellular carcinoma (HCC) to anticancer drugs causes the high mortality of HCC patients. Bleomycin (BLM) that induces DNA damage is clinically used for cancer therapy, while the mechanism underlying BLM-induced DNA damage response (DDR) in HCC cells remains ambiguous. Given that 14-3-3 proteins are broadly involved in regulation of diverse biological processes (BPs)/pathways, we investigate how a 14-3-3 isoform coordinates particular BPs/pathways in BLM-induced DDR in HCC. Methodology/Principal Findings: Using dual-tagging quantitative proteomic approach, we dissected the 14-3-3 epsilon interactome formed during BLM-induced DDR, which revealed that 14-3-3 epsilon via its associations with multiple pathway-specific proteins coordinates multiple pathways including chromosome remodeling, DNA/RNA binding/processing, DNA repair, protein ubiquitination/degradation, cell cycle arrest, signal transduction and apoptosis. Further, "zoom-in" investigation of the 14-3-3 epsilon interacting network indicated that the BLM-induced interaction between 14-3-3 epsilon and a MAP kinase TAK1 plays a critical role in determining cell propensity of apoptosis. Functional characterization of this interaction further revealed that BLM triggers site-specific phosphorylations in the kinase domain of TAK1. These BLM-induced changes of phosphorylations directly correlate to the strength of the TAK1 binding to 14-3-3 epsilon, which govern the phosphorylation-dependent TAK1 activation. The enhanced 14-3-3 epsilon-TAK1 association then inhibits the anti-apoptotic activity of TAK1, which ultimately promotes BLM-induced apoptosis in HCC cells. In a data-dependent manner, we then derived a mechanistic model where 14-3-3 epsilon plays the pivotal role in integrating diverse biological pathways for cellular DDR to BLM in HCC. Conclusions: Our data demonstrated on a systems view that 14-3-3 epsilon coordinates multiple biological pathways involved in BLM-induced DDR in HCC cells. Specifically, 14-3-3 epsilon associates with TAK1 in a phosphorylation-dependent manner to determine the cell fate of BLM-treated HCC cells. Not only individual proteins but also those critical links in the network could be the potential targets for BLM-mediated therapeutic intervention of HCC.	[Tang, Siwei; Bao, Huimin; Zhang, Yang; Yao, Jun; Yang, Pengyuan; Chen, Xian] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Tang, Siwei; Bao, Huimin; Zhang, Yang; Yao, Jun; Yang, Pengyuan; Chen, Xian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Chen, Xian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill	Chen, X (corresponding author), Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China.	xianc@email.unc.edu		Bao, Huimin/0000-0003-3115-9009	Shanghai Science and Technology Development Program [03DZ14024, 07ZR14010]; 863 High Technology Foundation of China [2006AA02A310]; National Institutes of Health (NIH) [NIH R01AI064806, NIH 1U24CA160035]; NATIONAL CANCER INSTITUTE [U24CA160035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064806] Funding Source: NIH RePORTER	Shanghai Science and Technology Development Program; 863 High Technology Foundation of China(National High Technology Research and Development Program of China); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Shanghai Science and Technology Development Program (Grants 03DZ14024 and 07ZR14010) and the 863 High Technology Foundation of China (Grant 2006AA02A310). This work is also supported in part by National Institutes of Health (NIH) grants to X. C. (NIH R01AI064806 and NIH 1U24CA160035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Balajee AS, 2001, NUCLEIC ACIDS RES, V29, P1341, DOI 10.1093/nar/29.6.1341; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Bayer R A, 1992, Semin Oncol, V19, P46; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Chong SS, 1996, GENOME RES, V6, P735, DOI 10.1101/gr.6.8.735; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Du YC, 2006, MOL CELL PROTEOMICS, V5, P1033, DOI 10.1074/mcp.M500327-MCP200; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Frouin I, 2003, J BIOL CHEM, V278, P39265, DOI 10.1074/jbc.C300098200; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; He YF, 2009, PROTEOMICS, V9, P5414, DOI 10.1002/pmic.200800864; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; JONES DH, 1995, FEBS LETT, V368, P55, DOI 10.1016/0014-5793(95)00598-4; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lee CL, 2003, PROTEOMICS, V3, P2472, DOI 10.1002/pmic.200300586; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Luk SCW, 1999, J CELL BIOCHEM, V73, P31, DOI 10.1002/(SICI)1097-4644(19990401)73:1<31::AID-JCB4>3.0.CO;2-X; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Martinez Jesse D, 2005, Future Oncol, V1, P631, DOI 10.2217/14796694.1.5.631; Matheos D, 2002, BBA-GENE STRUCT EXPR, V1578, P59, DOI 10.1016/S0167-4781(02)00497-9; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Rosenquist M, 2003, BRAZ J MED BIOL RES, V36, P403, DOI 10.1590/S0100-879X2003000400001; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Seow TK, 2000, ELECTROPHORESIS, V21, P1787, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1787::AID-ELPS1787>3.3.CO;2-1; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Thomas D, 2005, CURR TOP DEV BIOL, V67, P285, DOI 10.1016/S0070-2153(05)67009-3; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Wang TY, 2005, J PROTEOME RES, V4, P941, DOI 10.1021/pr050031z; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Xie L, 2009, ANAL CHEM, V81, P1411, DOI 10.1021/ac802161d; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yan J, 2004, ONCOGENE, V23, P1939, DOI 10.1038/sj.onc.1207306; Yang XL, 2010, J PROTEOME RES, V9, P1402, DOI 10.1021/pr900932y; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zuo SA, 2010, J PROTEOME RES, V9, P3465, DOI 10.1021/pr9011377	76	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e55268	10.1371/journal.pone.0055268	http://dx.doi.org/10.1371/journal.pone.0055268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472066	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900004
J	Urbino, C; Gutierrez, S; Antolik, A; Bouazza, N; Doumayrou, J; Granier, M; Martin, DP; Peterschmitt, M				Urbino, Cica; Gutierrez, Serafin; Antolik, Anna; Bouazza, Nabila; Doumayrou, Juliette; Granier, Martine; Martin, Darren P.; Peterschmitt, Michel			Within-Host Dynamics of the Emergence of Tomato Yellow Leaf Curl Virus Recombinants	PLOS ONE			English	Article							INDIAN-OCEAN ISLANDS; SARDINIA-VIRUS; MOSAIC-VIRUS; EVOLUTION; GEMINIVIRUSES; DISPLACEMENT; EPIDEMICS	Tomato yellow leaf curl virus (TYLCV) is a highly damaging begomovirus native to the Middle East. TYLCV has recently spread worldwide, recombining with other begomoviruses. Recent analysis of mixed infections between TYLCV and Tomato leaf curl Comoros begomovirus (ToLCKMV) has shown that, although natural selection preserves certain co-evolved intragenomic interactions, numerous and diverse recombinants are produced at 120 days post-inoculation (dpi), and recombinant populations from different tomato plants are very divergent. Here, we investigate the population dynamics that lead to such patterns in tomato plants co-infected with TYLCV and ToLCKMV either by agro-inoculation or using the natural whitefly vector Bemisia tabaci. We monitored the frequency of parental and recombinant genotypes independently in 35 plants between 18 and 330 dpi and identified 177 recombinants isolated at different times. Recombinants were detected from 18 dpi and their frequency increased over time to reach about 50% at 150 dpi regardless of the inoculation method. The distribution of breakpoints detected on 96 fully sequenced recombinants was consistent with a continuous generation of new recombinants as well as random and deterministic effects in their maintenance. A severe population bottleneck of around 10 genomes was estimated during early systemic infection-a phenomenon that could account partially for the heterogeneity in recombinant patterns observed among plants. The detection of the same recombinant genome in six of the thirteen plants analysed beyond 30 dpi supported the influence of selection on observed recombination patterns. Moreover, a highly virulent recombinant genotype dominating virus populations within one plant has, apparently, the potential to be maintained in the natural population according to its infectivity, within-host accumulation, and transmission efficiency -all of which were similar or intermediate to those of the parent genotypes. Our results anticipate the outcomes of natural encounters between TYLCV and ToLCKMV.	[Urbino, Cica; Gutierrez, Serafin; Antolik, Anna; Bouazza, Nabila; Granier, Martine; Peterschmitt, Michel] UMR BGPI CIRAD, Montpellier, France; [Gutierrez, Serafin] CNRS 5290 IRD 224 UM1 UM2, UMR Malad Infect & Vecteurs Ecol Genet Evolut & Co, Montpellier, France; [Doumayrou, Juliette] INRA, UMR BGPI, F-34060 Montpellier, France; [Martin, Darren P.] Univ Cape Town, Inst Infect Dis & Mol Med, Computat Biol Grp, Observatory, South Africa	CIRAD; Universite de Montpellier; INRAE; University of Cape Town	Urbino, C (corresponding author), UMR BGPI CIRAD, Montpellier, France.	cica.urbino@cirad.fr	Martin, Darren P/C-4599-2008; Martin, Darren/ABE-3614-2021	Gutierrez, Serafin/0000-0002-5277-7239	CIRAD ATP Emergence; Agence Nationale de la Recherche; French ANR [2010-BLAN-170401]	CIRAD ATP Emergence; Agence Nationale de la Recherche(French National Research Agency (ANR)); French ANR(French National Research Agency (ANR))	This work was funded by CIRAD ATP Emergence and by the project "BemisiaRisk'' within the program "Agriculture et Developpement Durable'' of the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/). Serafin Gutierrez acknowledges support from the grant No. 2010-BLAN-170401 from the French ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1990, ANAL CATEGORICAL DAT; [Anonymous], 2010, R LANG ENV STAT COMP; Bates D, 2012, LINEAR MIXED EFFECTS; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Davino S, 2006, EUR J PLANT PATHOL, V114, P293, DOI 10.1007/s10658-005-5805-5; Davino S, 2012, J GEN VIROL, V93, P2712, DOI 10.1099/vir.0.045773-0; Delatte H, 2005, J GEN VIROL, V86, P1533, DOI 10.1099/vir.0.80805-0; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Fabre F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002654; French R, 2003, ANNU REV PHYTOPATHOL, V41, P199, DOI 10.1146/annurev.phyto.41.052002.095559; Garcia-Andres S, 2007, VIROLOGY, V365, P210, DOI 10.1016/j.virol.2007.03.045; Gutierrez S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003009; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lemey P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-126; Martin DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002203; Monci F, 2002, VIROLOGY, V303, P317, DOI 10.1006/viro.2002.1633; Monsion B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000174; Morilla G, 2004, J VIROL, V78, P10715, DOI [10.1128/JVI.78.19.10715-10723.2004, 10.1128/jvi.78.19.10715-10723.2004]; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pico B, 1996, SCI HORTIC-AMSTERDAM, V67, P151, DOI 10.1016/S0304-4238(96)00945-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sacristan S, 2003, J VIROL, V77, P9906, DOI 10.1128/JVI.77.18.9906-9911.2003; Sanchez-Campos S, 1999, PHYTOPATHOLOGY, V89, P1038, DOI 10.1094/PHYTO.1999.89.11.1038; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Urbino C, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-135; Vuillaume F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002028; Zwart MP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002122	30	19	20	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58375	10.1371/journal.pone.0058375	http://dx.doi.org/10.1371/journal.pone.0058375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472190	Green Published, gold			2022-12-27	WOS:000315637900136
J	Benard, MR; Baskent, D				Benard, Michel Ruben; Baskent, Deniz			Perceptual Learning of Interrupted Speech	PLOS ONE			English	Article							TOP-DOWN INFLUENCES; PHONEMIC RESTORATION; REDUCED SPEECH; TIME-COURSE; BOTTOM-UP; INTELLIGIBILITY; RECOGNITION; INFORMATION; LISTENERS; CONTEXT	The intelligibility of periodically interrupted speech improves once the silent gaps are filled with noise bursts. This improvement has been attributed to phonemic restoration, a top-down repair mechanism that helps intelligibility of degraded speech in daily life. Two hypotheses were investigated using perceptual learning of interrupted speech. If different cognitive processes played a role in restoring interrupted speech with and without filler noise, the two forms of speech would be learned at different rates and with different perceived mental effort. If the restoration benefit were an artificial outcome of using the ecologically invalid stimulus of speech with silent gaps, this benefit would diminish with training. Two groups of normal-hearing listeners were trained, one with interrupted sentences with the filler noise, and the other without. Feedback was provided with the auditory playback of the unprocessed and processed sentences, as well as the visual display of the sentence text. Training increased the overall performance significantly, however restoration benefit did not diminish. The increase in intelligibility and the decrease in perceived mental effort were relatively similar between the groups, implying similar cognitive mechanisms for the restoration of the two types of interruptions. Training effects were generalizable, as both groups improved their performance also with the other form of speech than that they were trained with, and retainable. Due to null results and relatively small number of participants (10 per group), further research is needed to more confidently draw conclusions. Nevertheless, training with interrupted speech seems to be effective, stimulating participants to more actively and efficiently use the top-down restoration. This finding further implies the potential of this training approach as a rehabilitative tool for hearing-impaired/elderly populations.	[Benard, Michel Ruben] Pento Audiol Ctr Zwolle, Zwolle, Netherlands; [Benard, Michel Ruben; Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands; [Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen	Baskent, D (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands.	d.baskent@umcg.nl		Benard, Ruben/0000-0003-2146-1722; Baskent, Deniz/0000-0002-6560-1451	Netherlands Organization for Scientific Research (NWO) [016.096.397]; Netherlands Organization for Health Research and Development (ZonMw); University Medical Center Groningen; Pento Audiology Center Zwolle; Heinsius Houbolt Foundation	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); University Medical Center Groningen; Pento Audiology Center Zwolle; Heinsius Houbolt Foundation	Funding sources: 1) VIDI grant 016.096.397 from the Netherlands Organization for Scientific Research (NWO) and the Netherlands Organization for Health Research and Development (ZonMw). URL: http://www.nwo.nl/; http://www.zonmw.nl/. 2) Rosalind Franklin Fellowship from University Medical Center Groningen. URL: http://www.rug.nl/ggw/vacatures/RosalindFranklin/index. 3) Pento Audiology Center Zwolle. 4) Heinsius Houbolt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adank P, 2009, J ACOUST SOC AM, V126, P2649, DOI 10.1121/1.3216914; Alain C, 2001, J EXP PSYCHOL HUMAN, V27, P1072, DOI 10.1037/0096-1523.27.5.1072; BASHFORD JA, 1992, PERCEPT PSYCHOPHYS, V51, P211, DOI 10.3758/BF03212247; BASHFORD JA, 1979, J ACOUST SOC AM, V65, pS112, DOI 10.1121/1.2016950; Baskent D, 2012, JARO-J ASSOC RES OTO, V13, P683, DOI 10.1007/s10162-012-0334-3; Baskent D, 2010, HEARING RES, V270, P127, DOI 10.1016/j.heares.2010.08.011; Baskent D, 2010, J ACOUST SOC AM, V128, pE169, DOI 10.1121/1.3475794; Baskent D, 2010, HEARING RES, V260, P54, DOI 10.1016/j.heares.2009.11.007; Baskent D, 2009, J ACOUST SOC AM, V125, P3995, DOI 10.1121/1.3125329; Bhargava P, 2012, J ACOUST SOC AM, V131, pEL87, DOI 10.1121/1.3670000; Bregman A.S., 1994, AUDITORY SCENE ANAL; BRONKHORST AW, 1993, J ACOUST SOC AM, V93, P499, DOI 10.1121/1.406844; Chatterjee M, 2010, J ACOUST SOC AM, V127, pEL37, DOI 10.1121/1.3284544; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Davis MH, 2007, HEARING RES, V229, P132, DOI 10.1016/j.heares.2007.01.014; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; Eisner F, 2006, J ACOUST SOC AM, V119, P1950, DOI 10.1121/1.2178721; Fahle M, 2004, J VISION, V4, P879, DOI 10.1167/4.10.4; Francis AL, 2000, PERCEPT PSYCHOPHYS, V62, P1668, DOI 10.3758/BF03212164; Francis AL, 2007, J SPEECH LANG HEAR R, V50, P1445, DOI 10.1044/1092-4388(2007/100); Francis AL, 2009, ATTEN PERCEPT PSYCHO, V71, P1360, DOI 10.3758/APP.71.6.1360; Fu QJ, 2008, HEARING RES, V242, P198, DOI 10.1016/j.heares.2007.11.010; Fu QJ, 2003, J ACOUST SOC AM, V113, P1065, DOI 10.1121/1.1537708; Gilbert G, 2007, J ACOUST SOC AM, V122, P1336, DOI 10.1121/1.2756161; Gnansia D, 2010, HEARING RES, V265, P46, DOI 10.1016/j.heares.2010.02.012; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grossberg S, 2011, J ACOUST SOC AM, V130, P440, DOI 10.1121/1.3589258; Hervais-Adelman A, 2008, J EXP PSYCHOL HUMAN, V34, P460, DOI 10.1037/0096-1523.34.2.460; HUGGINS AWF, 1964, J ACOUST SOC AM, V36, P1055, DOI 10.1121/1.1919151; Janse E, 2011, J PHONETICS, V39, P330, DOI 10.1016/j.wocn.2011.03.005; Kashino M, 2006, ACOUST SCI TECHNOL, V27, P318, DOI 10.1250/ast.27.318; Loebach JL, 2009, EAR HEARING, V30, P662, DOI 10.1097/AUD.0b013e3181b9c92d; Magnuson JS, 2003, J EXP PSYCHOL GEN, V132, P202, DOI 10.1037/0096-3445.132.2.202; MAXWELL C, 1978, BRIT J CLIN PHARMACO, V6, P15, DOI 10.1111/j.1365-2125.1978.tb01676.x; MILLER GA, 1950, J ACOUST SOC AM, V22, P167, DOI 10.1121/1.1906584; MONTGOMERY AA, 1984, EAR HEARING, V5, P30, DOI 10.1097/00003446-198401000-00007; Nelson PB, 2004, J ACOUST SOC AM, V115, P2286, DOI 10.1121/1.1703538; Nygaard LC, 1998, PERCEPT PSYCHOPHYS, V60, P355, DOI 10.3758/BF03206860; PAAS FGWC, 1994, PERCEPT MOTOR SKILL, V79, P419, DOI 10.2466/pms.1994.79.1.419; POWERS GL, 1977, J ACOUST SOC AM, V61, P195, DOI 10.1121/1.381255; POWERS GL, 1973, J ACOUST SOC AM, V54, P661, DOI 10.1121/1.1913646; Samuel AG, 1997, COGNITIVE PSYCHOL, V32, P97, DOI 10.1006/cogp.1997.0646; SCHWAB EC, 1985, HUM FACTORS, V27, P395, DOI 10.1177/001872088502700404; Seitz AR, 2010, COGNITION, V115, P435, DOI 10.1016/j.cognition.2010.03.004; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sivonen P, 2006, BRAIN RES, V1121, P177, DOI 10.1016/j.brainres.2006.08.123; Srinivasan S, 2005, SPEECH COMMUN, V45, P63, DOI 10.1016/j.specom.2004.09.002; Stacey PC, 2008, J SPEECH LANG HEAR R, V51, P526, DOI 10.1044/1092-4388(2008/038); Sweetow Robert, 2005, J Am Acad Audiol, V16, P494, DOI 10.3766/jaaa.16.7.9; VERSCHUURE J, 1983, PERCEPT PSYCHOPHYS, V33, P232, DOI 10.3758/BF03202859; Versfeld NJ, 2000, J ACOUST SOC AM, V107, P1671, DOI 10.1121/1.428451; WARREN RM, 1974, PERCEPT PSYCHOPHYS, V16, P150, DOI 10.3758/BF03203268; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; WARREN RM, 1983, J AUDIO ENG SOC, V31, P623; WATSON CS, 1980, ANN OTO RHINOL LARYN, V89, P96; Winkler I, 2005, COGNITIVE BRAIN RES, V25, P291, DOI 10.1016/j.cogbrainres.2005.06.005; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262	57	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58149	10.1371/journal.pone.0058149	http://dx.doi.org/10.1371/journal.pone.0058149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103EI	23469266	gold, Green Submitted, Green Published			2022-12-27	WOS:000315897100063
J	Guillot, N; Kollins, D; Badimon, JJ; Schlondorff, D; Hutter, R				Guillot, Nicolas; Kollins, Dmitrij; Badimon, Juan J.; Schlondorff, Detlef; Hutter, Randolph			Accelerated Reendothelialization, Increased Neovascularization and Erythrocyte Extravasation after Arterial Injury in BAMBI(-/-) Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; MOUSE MODEL; NEOINTIMA FORMATION; DENUDATION INJURY; FACTOR-BETA; OVEREXPRESSION; ANGIOGENESIS; HYPERPLASIA; EXPRESSION	Background: Intimal injury rapidly activates TGF beta and enhances vascular repair by the growth of endothelial (EC) and vascular smooth muscle cells (VSMC). The response to the TGF beta family of growth factors can be modified by BAMBI (BMP, Activin, Membrane Bound Inhibitor) acting as a non-signaling, competitive antagonist of TGF beta type I receptors such as ALK 1 and 5. In vivo the effect of BAMBI will depend on its cell-specific expression and of that of the ALK type receptors. We recently reported EC restricted BAMBI expression and genetic elimination of BAMBI resulting in an in vitro and in vivo phenotype characterized by endothelial activation and proliferation involving alternative pathway activation by TGF beta through ALK 1. Methodology/Principal Findings: To test the hypothesis that BAMBI modulates arterial response to injury via its effects on endothelial repair and arterial wall neovascularization we used a model of femoral arterial denudation injury in wild type (WT) and BAMBI(-/-) mice. Arterial response was evaluated at 2 and 4 weeks after luminal endothelial denudation of femoral arteries. The BAMBI(-/-) genotype mice showed accelerated luminal endothelial repair at 2 weeks and a highly unusual increase in arterial wall neovascularization compared to WT mice. The exuberant intimal and medial neovessel formation with BAMBI(-/-) genotype was also associated with significant red blood cell extravasation. The bleeding into the neointima at 2 weeks transiently increased it's area in the BAMBI(-/-) genotype despite the faster luminal endothelial repair in this group. Vascular smooth muscle cells were decreased at 2 weeks in BAMBI(-/-) mice, but comparable to wild type at 4 weeks. Conclusions/Significance: The absence of BAMBI results in a highly unusual surge in arterial wall neovascularization that surprisingly mimiks features of intra-plaque hemorrhage of advanced atheroma in a mechanical injury model. This suggests important effects of BAMBI on arterial EC homeostasis that need to be further studied in a model of inflammatory atherosclerosis.	[Guillot, Nicolas; Kollins, Dmitrij; Schlondorff, Detlef] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Badimon, Juan J.; Hutter, Randolph] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Schlondorff, D (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	detlef.schlondorff@mssm.edu		Guillot, Nicolas/0000-0003-1096-6960	National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK081420-01, RO1-DK081420-02S1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081420] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases R01-DK081420-01 and RO1-DK081420-02S1 to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAHARA T, 1995, CIRCULATION, V92, P365, DOI 10.1161/01.CIR.92.9.365; CARSTAIRS KC, 1965, J PATHOL BACTERIOL, V90, P225, DOI 10.1002/path.1700900124; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Fay WP, 2004, TRENDS CARDIOVAS MED, V14, P196, DOI 10.1016/j.tcm.2004.03.002; Gallo R, 1998, CIRCULATION, V97, P581; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; GRAINGER DJ, 1994, BIOCHEM J, V299, P227, DOI 10.1042/bj2990227; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Guillot N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039406; Hutter R, 2004, CIRCULATION, V110, P2430, DOI 10.1161/01.CIR.0000145120.37891.8A; Hutter R, 2003, CIRCULATION, V107, P1658, DOI 10.1161/01.CIR.0000058169.21850.CE; Khan R, 2007, CARDIOVASC RES, V74, P223, DOI 10.1016/j.cardiores.2007.02.012; MADRI JA, 1989, LAB INVEST, V60, P755; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schulick AH, 1998, P NATL ACAD SCI USA, V95, P6983, DOI 10.1073/pnas.95.12.6983; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070	23	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58550	10.1371/journal.pone.0058550	http://dx.doi.org/10.1371/journal.pone.0058550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469285	gold, Green Submitted, Green Published			2022-12-27	WOS:000315897100071
J	He, RR; Li, Y; Li, XD; Yi, RN; Wang, XY; Tsoi, B; Lee, KKH; Abe, K; Yang, XS; Kurihara, H				He, Rong-Rong; Li, Yan; Li, Xiao-Di; Yi, Ruo-Nan; Wang, Xiao-Yu; Tsoi, Bun; Lee, Kenneth Ka Ho; Abe, Keiichi; Yang, Xuesong; Kurihara, Hiroshi			A New Oxidative Stress Model, 2,2-Azobis(2-Amidinopropane) Dihydrochloride Induces Cardiovascular Damages in Chicken Embryo	PLOS ONE			English	Article							INHIBITION	It is now well established that the developing embryo is very sensitive to oxidative stress, which is a contributing factor to pregnancy-related disorders. However, little is known about the effects of reactive oxygen species (ROS) on the embryonic cardiovascular system due to a lack of appropriate ROS control method in the placenta. In this study, a small molecule called 2,2-azobis(2-amidinopropane) dihydrochloride (AAPH), a free radicals generator, was used to study the effects of oxidative stress on the cardiovascular system during chick embryo development. When nine-day-old (stage HH 35) chick embryos were treated with different concentrations of AAPH inside the air chamber, it was established that the LD50 value for AAPH was 10 mu mol/egg. At this concentration, AAPH was found to significantly reduce the density of blood vessel plexus that was developed in the chorioallantoic membrane (CAM) of HH 35 chick embryos. Impacts of AAPH on younger embryos were also examined and discovered that it inhibited the development of vascular plexus on yolk sac in HH 18 embryos. AAPH also dramatically repressed the development of blood islands in HH 3+ embryos. These results implied that AAPH-induced oxidative stress could impair the whole developmental processes associated with vasculogenesis and angiogenesis. Furthermore, we observed heart enlargement in the HH 40 embryo following AAPH treatment, where the left ventricle and interventricular septum were found to be thickened in a dose-dependent manner due to myocardiac cell hypertrophy. In conclusion, oxidative stress, induced by AAPH, could lead to damage of the cardiovascular system in the developing chick embryo. The current study also provided a new developmental model, as an alternative for animal and cell models, for testing small molecules and drugs that have anti-oxidative activities.	[He, Rong-Rong; Li, Xiao-Di; Yi, Ruo-Nan; Tsoi, Bun; Kurihara, Hiroshi] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Li, Yan; Wang, Xiao-Yu; Yang, Xuesong] Jinan Univ, Coll Med, Div Histol & Embryol, Key Lab Regenerat Med,Minist Educ, Jinan, Peoples R China; [Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Hong Kong, Hong Kong, Peoples R China; [Abe, Keiichi] BRANDs Hlth Sci Ctr, Sci Res Div, Singapore, Singapore	Jinan University; University of Jinan; Chinese University of Hong Kong	Yang, XS (corresponding author), Jinan Univ, Coll Med, Div Histol & Embryol, Key Lab Regenerat Med,Minist Educ, Jinan, Peoples R China.	yang_xuesong@126.com; Hiroshi_Kurihara@163.com	Tsoi, Bun/AAH-9135-2019; Lee, Kenneth Ka Ho/H-6698-2013; Tsoi, Bun/P-4173-2019; Tsoi, Bun/C-7395-2014	Tsoi, Bun/0000-0003-4958-4222; Lee, Kenneth Ka Ho/0000-0002-6520-304X; Tsoi, Bun/0000-0002-7033-1732; Tsoi, Bun/0000-0002-7033-1732; Li, Xiaodi/0000-0002-7109-6770; HE, Rong-Rong/0000-0001-5505-5672	National Natural Science Foundation of China [30971493, 31071054, 81102485]; BRAND'S Centre for Health and Nutritional Sciences in Singapore	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BRAND'S Centre for Health and Nutritional Sciences in Singapore	This work was supported by the grant from National Natural Science Foundation of China (30971493, 31071054 & 81102485) and BRAND'S Centre for Health and Nutritional Sciences in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe C., 2009, B I TECHNOL SCI U TO, V54, P70; Abramov JP, 2011, TOXICOL SCI, V120, P428, DOI 10.1093/toxsci/kfr007; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; Dennery Phyllis A., 2007, Birth Defects Research, V81, P155, DOI 10.1002/bdrc.20098; Doukas Charlampos N, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2345; Gavaller H, 2011, ECHOCARDIOGR-J CARD, V28, P848, DOI 10.1111/j.1540-8175.2011.01469.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He RR, 2009, BIOL PHARM BULL, V32, P247, DOI 10.1248/bpb.32.247; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HIRAMOTO K, 1993, FREE RADICAL RES COM, V19, P323, DOI 10.3109/10715769309056521; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Landi L, 1997, FREE RADICAL BIO MED, V22, P329, DOI 10.1016/S0891-5849(96)00294-8; Li XD, 2011, CHINESE PHARMACOL B, V27, P5; Li XD, 2012, FOOD CHEM TOXICOL, V50, P1848, DOI 10.1016/j.fct.2012.03.037; Ma ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034278; Noguchi N, 1998, FREE RADICAL BIO MED, V24, P259, DOI 10.1016/S0891-5849(97)00230-X; Sarre A, 2010, PHARMACOL RES, V61, P85, DOI 10.1016/j.phrs.2009.09.007; Tang YZ, 2007, BIOORGAN MED CHEM, V15, P1903, DOI 10.1016/j.bmc.2007.01.007; Torry DS, 2004, AM J REPROD IMMUNOL, V51, P257, DOI 10.1111/j.1600-0897.2004.00154.x; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wan Joanne, 2006, Birth Defects Research, V78, P326, DOI 10.1002/bdrc.20080; Wang YM, 2009, TOXICOL IN VITRO, V23, P1354, DOI 10.1016/j.tiv.2009.06.028; Weseler AR, 2010, CURR HYPERTENS REP, V12, P154, DOI 10.1007/s11906-010-0103-9; YAMAMOTO Y, 1985, BIOCHIM BIOPHYS ACTA, V819, P29, DOI 10.1016/0005-2736(85)90192-0	27	42	45	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57732	10.1371/journal.pone.0057732	http://dx.doi.org/10.1371/journal.pone.0057732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469224	Green Submitted, gold, Green Published			2022-12-27	WOS:000315897100033
J	Scanferla, A; Zaher, H; Novas, FE; de Muizon, C; Cespedes, R				Scanferla, Agustin; Zaher, Hussam; Novas, Fernando E.; de Muizon, Christian; Cespedes, Ricardo			A New Snake Skull from the Paleocene of Bolivia Sheds Light on the Evolution of Macrostomatans	PLOS ONE			English	Article							SIDED GARTER SNAKE; MORPHOLOGY; PHYLOGENY; SERPENTES; SUPPORT; NUCLEAR	Macrostomatan snakes, one of the most diverse extant clades of squamates, display an impressive arsenal of cranial features to consume a vast array of preys. In the absence of indisputable fossil representatives of this clade with well-preserved skulls, the mode and timing of these extraordinary morphological novelties remain obscure. Here, we report the discovery of Kataria anisodonta n. gen. n. sp., a macrostomatan snake recovered in the Early Palaeocene locality of Tiupampa, Bolivia. The holotype consists of a partial, minute skull that exhibits a combination of booid and caenophidian characters, being the presence of an anisodont dentition and diastema in the maxilla the most distinctive trait. Phylogenetic analysis places Kataria basal to the Caenophidia+Tropidophiidae, and represents along with bolyeriids a distinctive clade of derived macrostomatans. The discovery of Kataria highlights the morphological diversity in the maxilla among derived macrostomatans, demonstrating the relevance of maxillary transformations in the evolution of this clade. Kataria represents the oldest macrostomatan skull recovered, revealing that the diversification of macrostomatans was well under way in early Tertiary times. This record also reinforces the importance of Gondwanan territories in the history of snakes, not only in the origin of the entire group but also in the evolution of ingroup clades.	[Scanferla, Agustin] Consejo Nacl Invest Cient & Tecn, Inst Bio & Geociencias NOA, Museo Ciencias Nat Salta, Salta, Argentina; [Zaher, Hussam] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [Novas, Fernando E.] Museo Argentino Ciencias Nat Bernardino Rivadav, Lab Anat Comparada & Evoluc Vertebrados, Buenos Aires, DF, Argentina; [de Muizon, Christian] CNRS, UMR 7207, Dept Hist Terre, Paris, France; [Cespedes, Ricardo] Museo Hist Nat Alcide DOrbigny, Cochabamba, Bolivia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Scanferla, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Bio & Geociencias NOA, Museo Ciencias Nat Salta, Salta, Argentina.	agustin_scanferla@yahoo.com.ar	Fapesp, Biota/F-8655-2017; Zaher, Hussam/ABC-1701-2021; De Muizon, Christian/P-4335-2017; Zaher, Hussam/D-4000-2012; De Muizon, Christian/Q-7986-2019	Fapesp, Biota/0000-0002-9887-8449; Zaher, Hussam/0000-0002-6994-489X; De Muizon, Christian/0000-0002-1247-8867; Zaher, Hussam/0000-0002-6994-489X; De Muizon, Christian/0000-0002-1247-8867; Scanferla, Agustin/0000-0002-9803-7842	Museo de Historia Natural de Cochabamba "Alcide dOrbigny"; National Geographic Society [7163-01]; Conicet [PIP 5153]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 13803, 53]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/50206-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303545/2010-0, 565046/2010-1]	Museo de Historia Natural de Cochabamba "Alcide dOrbigny"; National Geographic Society(National Geographic Society); Conicet(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Research was funded by Museo de Historia Natural de Cochabamba "Alcide dOrbigny", National Geographic Society (grant 7163-01), Conicet (grant PIP 5153), Agencia Nacional de Promocion Cientifica y Tecnologica (grants PICT 13803 and 53). HZ is supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/50206-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (303545/2010-0 and 565046/2010-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; Auge Marc, 2006, Annales de Paleontologie, V92, P235, DOI 10.1016/j.annpal.2005.09.001; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Caldwell MW, 1997, NATURE, V386, P705, DOI 10.1038/386705a0; Cundall David, 2000, P293, DOI 10.1016/B978-012632590-4/50010-1; Cundall David, 2008, Contributions to Herpetology, V23, P349; FRAZZETTA TH, 1966, J MORPHOL, V118, P217, DOI 10.1002/jmor.1051180206; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gelfo JN, 2009, PALAEONTOLOGY, V52, P251, DOI 10.1111/j.1475-4983.2008.00835.x; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GROOMBRIDGE B, 1979, J ZOOL, V189, P559; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Longrich NR, 2012, NATURE, V488, P205, DOI 10.1038/nature11227; Mahler D. Luke, 2006, Fieldiana Zoology, P1; Maisano JA, 2007, CASAREA DUSSUMIERI; Maisano JA, 2007, J MORPHOL, V268, P371, DOI 10.1002/jmor.10519; McDowell Samuel B., 2008, P467; MCDOWELL SB, 1986, J HERPETOL, V20, P353, DOI 10.2307/1564502; Monteiro Leandro R., 1998, Snake, V28, P51; Noonan BP, 2006, MOL PHYLOGENET EVOL, V40, P347, DOI 10.1016/j.ympev.2006.03.010; Rage J.C., 1999, Palaeontologia Africana, V35, P85; Rage Jean-Claude, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P503; Rage Jean-Claude, 1998, Palaeovertebrata (Montpellier), V27, P109; Rieppel O, 2007, ZOOL ANZ, V246, P177, DOI 10.1016/j.jcz.2007.04.001; ROSSMAN CE, 1980, HERPETOLOGICA, V36, P42; Scanlon JD, 2006, NATURE, V439, P839, DOI 10.1038/nature04137; Scanlon JD, 2000, NATURE, V403, P416, DOI 10.1038/35000188; Tchernov E, 2000, SCIENCE, V287, P2010, DOI 10.1126/science.287.5460.2010; Uetz P., 2012, REPTILE DATABASE; Vidal N, 2004, P ROY SOC B-BIOL SCI, V271, pS226, DOI 10.1098/rsbl.2003.0151; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; Vidal Nicolas, 2007, P27; Vidal Nicolas, 2009, P390; Vonk FJ, 2008, NATURE, V454, P630, DOI 10.1038/nature07178; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Wilson JA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000322; YOUNG BA, 1989, J ZOOL, V218, P365, DOI 10.1111/j.1469-7998.1989.tb02550.x; YOUNG BA, 1988, NETH J ZOOL, V38, P166; Zaher Hussam, 1999, American Museum Novitates, V3271, P1; Zaher H, 2012, ZOOL J LINN SOC-LOND, V164, P194, DOI 10.1111/j.1096-3642.2011.00755.x; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115	44	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57583	10.1371/journal.pone.0057583	http://dx.doi.org/10.1371/journal.pone.0057583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469206	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100025
J	Theodoridou, A; Penton-Voak, IS; Rowe, AC				Theodoridou, Angeliki; Penton-Voak, Ian S.; Rowe, Angela C.			A Direct Examination of the Effect of Intranasal Administration of Oxytocin on Approach-Avoidance Motor Responses to Emotional Stimuli	PLOS ONE			English	Article							FACIAL EXPRESSIONS; AUTOMATIC EVALUATION; ARM FLEXION; FACES; HUMANS; AMYGDALA; RECOGNITION; BEHAVIOR; FEAR; NEUROPEPTIDES	Oxytocin has been shown to promote a host of social behaviors in humans but the exact mechanisms by which it exerts its effects are unspecified. One prominent theory suggests that oxytocin increases approach and decreases avoidance to social stimuli. Another dominant theory posits that oxytocin increases the salience of social stimuli. Herein, we report a direct test of these hypotheses. In a double-blind, placebo-controlled study we examined approach-avoidance motor responses to social and non-social emotional stimuli. One hundred and twenty participants self-administered either 24 IU oxytocin or placebo and moved a lever toward or away from pictures of faces depicting emotional expressions or from natural scenes appearing before them on a computer screen. Lever movements toward stimuli decreased and movements away increased stimuli size producing the illusion that stimuli moved away from or approached participants. Reaction time data were recorded. The task produced the effects that were anticipated on the basis of the approach-avoidance literature in relation to emotional stimuli, yet the anticipated speeded approach and slowed avoidance responses to emotional faces by the oxytocin group were not observed. Interestingly, the oxytocin treatment group was faster to approach and avoid faces depicting disgust relative to the placebo group, suggesting a salience of disgust for the former group. Results also showed that within the oxytocin group women's reaction times to all emotional faces were faster than those of men, suggesting sex specific effects of oxytocin. The present findings provide the first direct evidence that intranasal oxytocin administration does not enhance approach/avoidance to social stimuli and does not exert a stronger effect on social vs. non-social stimuli in the context of processing of emotional expressions and scenes. Instead, our data suggest that oxytocin administration increases the salience of certain social stimuli and point to a possible role for oxytocin in behavioral prophylaxis.	[Theodoridou, Angeliki; Penton-Voak, Ian S.; Rowe, Angela C.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England	University of Bristol	Theodoridou, A (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	at4194@bristol.ac.uk		Penton-Voak, Ian/0000-0003-4232-0953	ESRC (Economic and Social Research Council) [PTA-031-2006-00552]; University of Bristol, United Kingdom	ESRC (Economic and Social Research Council); University of Bristol, United Kingdom	This work was financially supported by the ESRC (Economic and Social Research Council) (PTA-031-2006-00552) and the University of Bristol, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Alexopoulos T, 2007, J EXP SOC PSYCHOL, V43, P1010, DOI 10.1016/j.jesp.2006.10.017; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bech P, 1997, EUR PSYCHIAT, V12, P194, DOI 10.1016/S0924-9338(97)89104-3; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; CACIOPPO JT, 1993, J PERS SOC PSYCHOL, V65, P5; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Di Simplicio M, 2009, J PSYCHOPHARMACOL, V23, P241, DOI 10.1177/0269881108095705; Ditzen B, 2009, BIOL PSYCHIAT, V65, P728, DOI 10.1016/j.biopsych.2008.10.011; Domes G, 2007, BIOL PSYCHIAT, V62, P1187, DOI 10.1016/j.biopsych.2007.03.025; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; Evans S, 2010, NEUROPSYCHOPHARMACOL, V35, P2502, DOI 10.1038/npp.2010.110; Farah MJ, 2000, COGNITIVE NEUROPSYCH, V17, P117, DOI 10.1080/026432900380526; Feldman R, 2012, HORM BEHAV, V61, P380, DOI 10.1016/j.yhbeh.2012.01.008; Fischer-Shofty M, 2010, NEUROPSYCHOLOGIA, V48, P179, DOI 10.1016/j.neuropsychologia.2009.09.003; Fischer-Shofty M, 2013, SOC COGN AFFECT NEUR, V8, P313, DOI 10.1093/scan/nsr100; Galbally M, 2011, HARVARD REV PSYCHIAT, V19, P1, DOI 10.3109/10673229.2011.549771; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Kavaliers M, 2011, PSYCHOL SCI, V22, P1367, DOI 10.1177/0956797611420576; Kemp AH, 2011, CURR DIR PSYCHOL SCI, V20, P222, DOI 10.1177/0963721411417547; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P659, DOI 10.1001/jama.2011.117; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Leuine A, 2007, PEPTIDES, V28, P1162, DOI 10.1016/j.peptides.2007.04.016; Lewin K., 1935, DYNAMIC THEORY PERS; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Lischke A, 2012, PSYCHONEUROENDOCRINO, V37, P475, DOI 10.1016/j.psyneuen.2011.07.015; Liu JCJ, 2012, HORM BEHAV, V62, P585, DOI 10.1016/j.yhbeh.2012.09.002; Lundqvist D., 1998, KAROLINSKA DIRECTED; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Marsh AA, 2010, PSYCHOPHARMACOLOGY, V209, P225, DOI 10.1007/s00213-010-1780-4; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Norman GJ, 2011, J PSYCHOPHARMACOL, V25, P1313, DOI 10.1177/0269881110367452; Osgood C.E., 1953, METHOD THEORY EXPT P; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; SCHNEIRLA TC, 1959, NEBR SYM MOTIV, V7, P1; Schulze L, 2011, PSYCHONEUROENDOCRINO, V36, P1378, DOI 10.1016/j.psyneuen.2011.03.011; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steyer, 1997, MEHRDIMENSIONALE BEF; Taylor SE, 2006, CURR DIR PSYCHOL SCI, V15, P273, DOI 10.1111/j.1467-8721.2006.00451.x; Theodoridou A, 2009, HORM BEHAV, V56, P128, DOI 10.1016/j.yhbeh.2009.03.019; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	58	38	41	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58113	10.1371/journal.pone.0058113	http://dx.doi.org/10.1371/journal.pone.0058113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469148	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900239
J	Wang, JN; Diao, S; Tang, YJ; Hou, AJ; Yuan, HB; Zheng, Y; Zhou, YH				Wang, Jie-Ning; Diao, Shu; Tang, Yuan-Jun; Hou, An-Ji; Yuan, Hai-Bo; Zheng, Yan; Zhou, Yu-Hao			Intracoronary versus Intravenous Administration of Abciximab in Patients with Acute Coronary Syndrome: A Meta-Analysis	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIALS; BOLUS ABCIXIMAB; INTERVENTION; REVASCULARIZATION; ANGIOPLASTY	Background: Abciximab is a widely used adjunctive therapy for acute coronary syndrome (ACS). However, the effect of intracoronary (IC) administration of abciximab on cardiovascular events remains unclear when compared with intravenous (IV) therapy. Methodology and Principal Findings: We systematically searched the Medline, Embase, and Cochrane Central Register of Controlled Trials databases and reference lists of articles and proceedings of major meetings for obtaining relevant literature. All eligible trials included ACS patients who received either IC administration of abciximab or IV therapy. The primary outcome was major cardiovascular events, and secondary outcomes included total mortality, reinfarction, and any possible adverse events. Of 660 identified studies, we included 9 trials reporting data on 3916 ACS patients. Overall, IC administration of abciximab resulted in 45% reduction in relative risk for major cardiovascular events (RR; 95% confidence interval [CI], 24-60%), 41% reduction in RR for reinfarction (95% CI, 7-63%), and 44% reduction in RR for congestive heart failure relative to IV therapy (95% CI, 8-66%); however, compared to IV therapy, IC administration of abciximab had no effect on total mortality (RR, 0.69; 95% CI, 0.45-1.07). No other significant differences were identified between the effect of IC abciximab administration and IV therapy. Conclusions/Significance: IC administration of abciximab can reduce the risk of major cardiovascular events, reinfarction, and congestive heart failure when compared with IV therapy.	[Wang, Jie-Ning; Diao, Shu] Shanghai Seventh Peoples Hosp, Shanghai, Peoples R China; [Tang, Yuan-Jun] Second Mil Med Univ, Dept Pharmaceut Anal, Sch Pharm, Shanghai, Peoples R China; [Hou, An-Ji] Shanghai Seventh Peoples Hosp, Dept Oncol, Shanghai, Peoples R China; [Yuan, Hai-Bo; Zheng, Yan] Shanghai Seventh Peoples Hosp, Dept Sci, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China	Naval Medical University	Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	zhou_ly@126.com						Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Bailey SR, 1997, CATHETER CARDIO DIAG, V42, P181, DOI 10.1002/(SICI)1097-0304(199710)42:2<181::AID-CCD18>3.0.CO;2-R; Bartorelli AL, 1999, CATHETER CARDIO INTE, V48, P211, DOI 10.1002/(SICI)1522-726X(199910)48:2<211::AID-CCD20>3.0.CO;2-V; Bellandi F, 2004, CATHETER CARDIO INTE, V62, P186, DOI 10.1002/ccd.20041; De Luca G, 2012, ATHEROSCLEROSIS, V222, P426, DOI 10.1016/j.atherosclerosis.2012.02.041; Deibele AJ, 2010, CIRCULATION, V121, P784, DOI 10.1161/CIRCULATIONAHA.109.882746; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desch S, 2012, CLIN RES CARDIOL, V101, P117, DOI 10.1007/s00392-011-0372-6; Dominguez-Rodriguez A, 2009, ATHEROSCLEROSIS, V206, P523, DOI 10.1016/j.atherosclerosis.2009.03.011; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friedland S, 2011, AM J CARDIOL, V108, P1244, DOI 10.1016/j.amjcard.2011.06.039; Gu YL, 2010, CIRCULATION, V122, P2709, DOI 10.1161/CIRCULATIONAHA.110.002741; Huynh T, 2009, CIRCULATION, V119, P3101, DOI 10.1161/CIRCULATIONAHA.108.793745; Iversen A, 2008, CURR CARDIOL REV, V4, P293, DOI 10.2174/157340308786349480; Iversen AZ, 2011, CARDIOLOGY, V120, P43, DOI 10.1159/000333117; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Kakkar AK, 2004, CATHETER CARDIO INTE, V61, P31, DOI 10.1002/ccd.10730; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Osuna JGG, 2006, REV ESP CARDIOL, V59, P567; Romagnoli E, 2005, INT J CARDIOL, V105, P250, DOI 10.1016/j.ijcard.2004.11.037; Romagnoli E, 2007, J THROMB THROMBOLYS, V23, P57, DOI 10.1007/s11239-006-9000-0; Schroder R, 2004, CIRCULATION, V110, pE506, DOI 10.1161/01.CIR.0000147778.05979.E6; Thiele H, 2008, CIRCULATION, V118, P49, DOI 10.1161/CIRCULATIONAHA.107.747642; Thiele H, 2012, LANCET, V379, P923, DOI 10.1016/S0140-6736(11)61872-2; Werf FV, 2003, EUR HEART J, V24, P28, DOI DOI 10.1016/S0195-668X(02)00618-8; Wohrle J, 2003, CIRCULATION, V107, P1840, DOI 10.1161/01.CIR.0000066852.98038.D1; Zhu MM, 2001, AM J CARDIOL, V88, P297, DOI 10.1016/S0002-9149(01)01645-9	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58077	10.1371/journal.pone.0058077	http://dx.doi.org/10.1371/journal.pone.0058077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469144	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900235
J	Hadas, Y; Nitzan, N; Furley, AJW; Kozlov, SV; Klar, A				Hadas, Yoav; Nitzan, Noa; Furley, Andrew J. W.; Kozlov, Serguei V.; Klar, Avihu			Distinct Cis Regulatory Elements Govern the Expression of TAG1 in Embryonic Sensory Ganglia and Spinal Cord	PLOS ONE			English	Article							ADHESION MOLECULE TAG-1; HOMEODOMAIN TRANSCRIPTION FACTORS; COMMISSURAL AXON GUIDANCE; SECRETED PROTEIN AXONIN-1; MOTOR-NEURON; CELL-ADHESION; IN-VIVO; IMMUNOGLOBULIN SUPERFAMILY; GLYCOPROTEIN TAG-1; NEURITE OUTGROWTH	Cell fate commitment of spinal progenitor neurons is initiated by long-range, midline-derived, morphogens that regulate an array of transcription factors that, in turn, act sequentially or in parallel to control neuronal differentiation. Included among these are transcription factors that regulate the expression of receptors for guidance cues, thereby determining axonal trajectories. The Ig/FNIII superfamily molecules TAG1/Axonin1/CNTN2 (TAG1) and Neurofascin (Nfasc) are co-expressed in numerous neuronal cell types in the CNS and PNS - for example motor, DRG and interneurons - both promote neurite outgrowth and both are required for the architecture and function of nodes of Ranvier. The genes encoding TAG1 and Nfasc are adjacent in the genome, an arrangement which is evolutionarily conserved. To study the transcriptional network that governs TAG1 and Nfasc expression in spinal motor and commissural neurons, we set out to identify cis elements that regulate their expression. Two evolutionarily conserved DNA modules, one located between the Nfasc and TAG1 genes and the second directly 5' to the first exon and encompassing the first intron of TAG1, were identified that direct complementary expression to the CNS and PNS, respectively, of the embryonic hindbrain and spinal cord. Sequential deletions and point mutations of the CNS enhancer element revealed a 130bp element containing three conserved E-boxes required for motor neuron expression. In combination, these two elements appear to recapitulate a major part of the pattern of TAG1 expression in the embryonic nervous system.	[Hadas, Yoav; Nitzan, Noa; Klar, Avihu] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Med Neurobiol, IL-91010 Jerusalem, Israel; [Furley, Andrew J. W.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Kozlov, Serguei V.] SAIC Frederick Inc, Ctr Adv Preclin Res, FNLCR, Frederick, MD USA	Hebrew University of Jerusalem; University of Sheffield; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Furley, AJW (corresponding author), Univ Sheffield, Dept Biomed Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	a.j.furley@sheffield.ac.uk; kozlovse@mail.nih.gov; avihu@cc.huji.ac.il	Furley, Andrew J. W./D-4798-2013; Furley, Andrew JW/B-7316-2012; Klar, Avihu/AHC-4770-2022	Furley, Andrew JW/0000-0001-5549-8668; 	Israel Science Foundation [229/09]; Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation [1930/08]; Center of Excellence - Legacy Heritage Biomedical Science Partnership [1803/10]; Israel Ministry of Health; Medical Research Council, UK; EMBO	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation; Center of Excellence - Legacy Heritage Biomedical Science Partnership; Israel Ministry of Health; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO(European Molecular Biology Organization (EMBO))	A.K was supported by grants from Israel Science Foundation (grant No. 229/09), The Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation (grant No. 1930/08), Center of Excellence - Legacy Heritage Biomedical Science Partnership (grant No. 1803/10) and the Israel Ministry of Health. The work performed by A.J.W.F. was supported by core funding to NIMR from the Medical Research Council, UK. Part of S.V.K.'s work had been supported by EMBO Short Term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham O, 2010, J NEUROSCI, V30, P15546, DOI 10.1523/JNEUROSCI.2380-10.2010; Avraham Oshri, 2010, J Vis Exp, DOI 10.3791/1792; Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; Bizzoca A, 2003, DEVELOPMENT, V130, P29, DOI 10.1242/dev.00183; Bizzoca A, 2012, DEV BIOL, V365, P133, DOI 10.1016/j.ydbio.2012.02.011; Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4; Cangiano G, 1997, MOL BRAIN RES, V48, P279, DOI 10.1016/S0169-328X(97)00100-9; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Denaxa M, 2005, DEV BIOL, V288, P87, DOI 10.1016/j.ydbio.2005.09.021; Denaxa M, 2003, MOL BRAIN RES, V118, P91, DOI 10.1016/j.molbrainres.2003.07.004; Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055; Ding Q, 2012, P NATL ACAD SCI USA, V109, P1566, DOI 10.1073/pnas.1112392109; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Garcia-Frigola C, 2008, DEVELOPMENT, V135, P1833, DOI 10.1242/dev.020693; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONES FS, 1988, P NATL ACAD SCI USA, V85, P2186, DOI 10.1073/pnas.85.7.2186; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; KARAGOGEOS D, 1991, DEVELOPMENT, V112, P51; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; Law CO, 2008, DEVELOPMENT, V135, P2361, DOI 10.1242/dev.009019; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Mansour AA, 2011, MOL CELL NEUROSCI, V46, P187, DOI 10.1016/j.mcn.2010.09.002; Marcos-Mondejar P, 2012, J NEUROSCI, V32, P4372, DOI 10.1523/JNEUROSCI.5851-11.2012; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perrin FE, 2001, NEURON, V30, P707, DOI 10.1016/S0896-6273(01)00315-4; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; RATHJEN FG, 1984, EMBO J, V3, P461, DOI 10.1002/j.1460-2075.1984.tb01828.x; RUEGG MA, 1989, J CELL BIOL, V109, P2363, DOI 10.1083/jcb.109.5.2363; SHIGA T, 1991, J COMP NEUROL, V310, P234, DOI 10.1002/cne.903100208; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sittaramane V, 2009, DEV BIOL, V325, P363, DOI 10.1016/j.ydbio.2008.10.030; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; STOECKLI ET, 1991, J CELL BIOL, V112, P449, DOI 10.1083/jcb.112.3.449; Suster ML, 2009, DEV BIOL, V325, P422, DOI 10.1016/j.ydbio.2008.10.004; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Wolfer DP, 1998, ANAT EMBRYOL, V197, P177, DOI 10.1007/s004290050129	54	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57960	10.1371/journal.pone.0057960	http://dx.doi.org/10.1371/journal.pone.0057960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469119	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000315561400050
J	Whalley, HC; Sussmann, JE; Romaniuk, L; Stewart, T; Papmeyer, M; Sprooten, E; Hackett, S; Hall, J; Lawrie, SM; McIntosh, AM				Whalley, Heather C.; Sussmann, Jessika E.; Romaniuk, Liana; Stewart, Tiffany; Papmeyer, Martina; Sprooten, Emma; Hackett, Suzanna; Hall, Jeremy; Lawrie, Stephen M.; McIntosh, Andrew M.			Prediction of Depression in Individuals at High Familial Risk of Mood Disorders Using Functional Magnetic Resonance Imaging	PLOS ONE			English	Article							INSULAR CORTEX; RATING-SCALE; BIPOLAR; ACTIVATION; PERSONALITY; RELIABILITY; AMYGDALA; ILLNESS; FMRI	Objective: Bipolar disorder is a highly heritable condition. First-degree relatives of affected individuals have a more than a ten-fold increased risk of developing bipolar disorder (BD), and a three-fold risk of developing major depressive disorder (MDD) than the general population. It is unclear however whether differences in brain activation reported in BD and MDD are present before the onset of illness. Methods: We studied 98 young unaffected individuals at high familial risk of BD and 58 healthy controls using functional Magnetic Resonance Imaging (fMRI) scans and a task involving executive and language processing. Twenty of the high-risk subjects subsequently developed MDD after the baseline fMRI scan. Results: At baseline the high-risk subjects who later developed MDD demonstrated relatively increased activation in the insula cortex, compared to controls and high risk subjects who remained well. In the healthy controls and high-risk group who remained well, this region demonstrated reduced engagement with increasing task difficulty. The high risk subjects who subsequently developed MDD did not demonstrate this normal disengagement. Activation in this region correlated positively with measures of cyclothymia and neuroticism at baseline, but not with measures of depression. Conclusions: These results suggest that increased activation of the insula can differentiate individuals at high-risk of bipolar disorder who later develop MDD from healthy controls and those at familial risk who remain well. These findings offer the potential of future risk stratification in individuals at risk of mood disorder for familial reasons.	[Whalley, Heather C.; Sussmann, Jessika E.; Romaniuk, Liana; Stewart, Tiffany; Papmeyer, Martina; Sprooten, Emma; Hackett, Suzanna; Hall, Jeremy; Lawrie, Stephen M.; McIntosh, Andrew M.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland	University of Edinburgh	Whalley, HC (corresponding author), Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland.	heather.whalley@ed.ac.uk	Sprooten, Emma/N-3836-2017; Lawrie, Stephen MacGregor/AAD-1607-2021; McIntosh, Andrew M/B-9379-2008; Whalley, Heather C/N-1886-2019	Sprooten, Emma/0000-0002-1691-9105; Lawrie, Stephen MacGregor/0000-0002-2444-5675; McIntosh, Andrew M/0000-0002-0198-4588; Whalley, Heather C/0000-0002-4505-8869; Hall, Jeremy/0000-0002-0403-3278	Royal Society [DH080018]; Medical Research Council; Scottish Senior Clinical Fellowship; Wellcome Trust; Health Foundation through Clinician Scientist Fellowship [2268/4295]; Brain and Behaviour Research Foundation through NARSAD Independent Investigator Award; Scottish Funding Council Senior Clinical Fellowship; National Health Service (NHS) Research Scotland, through the Scottish Mental Health Research Network; Dr Mortimer and Theresa Sackler Foundation; Pfizer; SINAPSE (Scottish Imaging Network, a Platform for Scientific Excellence); MRC [G0600429] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-CSF2-McIntosh] Funding Source: researchfish; Medical Research Council [G0801418B, G0600429] Funding Source: researchfish	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Senior Clinical Fellowship; Wellcome Trust(Wellcome Trust); Health Foundation through Clinician Scientist Fellowship; Brain and Behaviour Research Foundation through NARSAD Independent Investigator Award; Scottish Funding Council Senior Clinical Fellowship; National Health Service (NHS) Research Scotland, through the Scottish Mental Health Research Network; Dr Mortimer and Theresa Sackler Foundation; Pfizer(Pfizer); SINAPSE (Scottish Imaging Network, a Platform for Scientific Excellence); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The author HCW is supported by a Dorothy Hodgkin Fellowship from the Royal Society (DH080018). MP and ES are supported by a studentship from the Medical Research Council. JH is supported by a Scottish Senior Clinical Fellowship. JES is supported by a Clinical Research Training Fellowship from the Wellcome Trust. AMM was supported by the Health Foundation through a Clinician Scientist Fellowship (Ref: 2268/4295), by the Brain and Behaviour Research Foundation through a NARSAD Independent Investigator Award and by a Scottish Funding Council Senior Clinical Fellowship. The investigators also acknowledge the financial support of National Health Service (NHS) Research Scotland, through the Scottish Mental Health Research Network (www.smhrn.org.uk) who provided assistance with subject recruitment and cognitive assessments. All imaging aspects also received financial support from the Dr Mortimer and Theresa Sackler Foundation. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.; HCW, LR, ES, JH, SML and AMM have received financial support from Pfizer (formerly Wyeth) in relation to imaging studies of people with schizophrenia and bipolar disorder. SML and AMM have done consultancy work for Roche Pharmaceuticals in connection with a possible new treatment for schizophrenia. SML has also received honoraria for lectures, chairing meetings, and consultancy work from Janssen in connection with brain imaging and therapeutic initiatives for psychosis. The authors MP, TS, SH, and JES have no competing interests to declare.; We would like to thank all of the participants who took part in the study and the radiographers who acquired the MRI scans. This study was conducted at the Brain Research Imaging Centre (http://www.bric.ed.ac.uk) which is supported by SINAPSE (Scottish Imaging Network, a Platform for Scientific Excellence, http://www.sinapse.ac.uk). The investigators also acknowledge the financial support of National Health Service (NHS) Research Scotland, through the Scottish Mental Health Research Network (www.smhrn.org.uk) who provided assistance with subject recruitment and cognitive assessments.	Akiskal HS, 2005, J AFFECT DISORDERS, V85, P45, DOI 10.1016/j.jad.2003.10.012; Ayuso-Mateos JL, 2006, GLOBAL BURDEN OF BIP; Beauregard M, 2006, NEUROREPORT, V17, P843, DOI 10.1097/01.wnr.0000220132.32091.9f; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bienvenu OJ, 2003, J PERS DISORD, V17, P139, DOI 10.1521/pedi.17.2.139.23991; BLOOM PA, 1980, MEM COGNITION, V8, P631, DOI 10.3758/BF03213783; Burgess P.W., 1997, HAYLING BRIXTON TEST; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; DelBello MP, 2001, BIPOLAR DISORD, V3, P325, DOI 10.1034/j.1399-5618.2001.30607.x; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Duffy A, 2010, BRIT J PSYCHIAT, V197, P341, DOI 10.1192/bjp.bp.110.079665; Feinstein JS, 2006, SOC COGN AFFECT NEUR, V1, P136, DOI 10.1093/scan/nsl016; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Glahn DC, 2012, BIOL PSYCHIAT, V71, P6, DOI 10.1016/j.biopsych.2011.08.022; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Gruber O, 2010, HUM BRAIN MAPP, V31, P115, DOI 10.1002/hbm.20849; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hillegers MH, 2005, BIPOLAR DISORD, V7, P344, DOI 10.1111/j.1399-5618.2005.00215.x; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; McIntosh A, 2008, SCHIZOPHR RES, V98, P40; McIntosh AM, 2008, AM J PSYCHIAT, V165, P378, DOI 10.1176/appi.ajp.2007.07020365; MUFSON EJ, 1981, NEUROSCIENCE, V6, P1231, DOI 10.1016/0306-4522(81)90184-6; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Ramautar JR, 2006, BRAIN RES, V1105, P143, DOI 10.1016/j.brainres.2006.02.091; Schosser A, 2010, MOL PSYCHIATR, V15, P844, DOI 10.1038/mp.2009.21; Schulze TG, 2012, WORLD J BIOL PSYCHIA; Sprengelmeyer R, 2011, J AFFECT DISORDERS, V133, P120, DOI 10.1016/j.jad.2011.04.004; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Whalley HC, 2008, J AFFECT DISORDERS, V109, P99, DOI 10.1016/j.jad.2007.11.009; Whalley HC, 2004, BRAIN, V127, P478, DOI 10.1093/brain/awh070; Whalley HC, 2011, BIOL PSYCHIAT, V70, P343, DOI 10.1016/j.biopsych.2011.04.007; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	36	26	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57357	10.1371/journal.pone.0057357	http://dx.doi.org/10.1371/journal.pone.0057357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483904	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100021
J	Brombo, G; Volpato, S; Secchiero, P; Passaro, A; Bosi, C; Zuliani, G; Zauli, G				Brombo, Gloria; Volpato, Stefano; Secchiero, Paola; Passaro, Angelina; Bosi, Cristina; Zuliani, Giovanni; Zauli, Giorgio			Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol	PLOS ONE			English	Article							BODY-MASS INDEX; HEART-FAILURE; ENDOTHELIAL-CELLS; ATHEROSCLEROSIS; BIOLOGY; MARKERS; MICE	Objective: Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL), in addition to having a prognostic value in patients with cardiovascular disease, seems to interact with adiposity, insulin resistance and other cardiovascular risk factors. However, the results of previous clinical studies, focused on the association of TRAIL with selected metabolic or anthropometric indices were inconclusive. The aim of this study was to further investigate how soluble TRAIL concentrations independently correlate with major cardiovascular risk factors, including lipid, glycemic and anthropometric features. Materials/Methods: We examined the associations between serum soluble TRAIL concentrations, measured by ELISA, and lipid, glycemic and anthropometric features in 199 subjects recruited at our Metabolic Outpatient Clinic. Results: Soluble TRAIL concentrations had a significant and direct correlation with total cholesterol (p = 0.046), LDL-cholesterol (p = 0.032), triglycerides (p = 0.01), body mass index (p = 0.046), waist circumference (p = 0.008), fat mass (p = 0.056) and insulin (p = 0.046) and an inverse correlation with HDL-cholesterol (p = 0.02). In multivariable regression analyses adjusted for potential confounders (age, gender, C-reactive protein, HDL-cholesterol, triglycerides, waist circumference, and insulin), TRAIL levels continued to have an independent correlation with LDL-cholesterol and waist circumference (r(2) = 0.04). Conclusions: Serum TRAIL levels were weakly but significantly and independently associated with waist circumference, a marker of visceral adiposity, and with LDL-cholesterol. Further studies are needed to clarify the biological basis of these relationships.	[Brombo, Gloria; Volpato, Stefano; Passaro, Angelina; Bosi, Cristina; Zuliani, Giovanni] Univ Ferrara, Dept Clin & Expt Med, Sect Internal Med Gerontol & Clin Nutr, I-44100 Ferrara, Italy; [Secchiero, Paola] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Zauli, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy	University of Ferrara; University of Ferrara; IRCCS Burlo Garofolo	Volpato, S (corresponding author), Univ Ferrara, Dept Clin & Expt Med, Sect Internal Med Gerontol & Clin Nutr, I-44100 Ferrara, Italy.	vlt@unife.it	Passaro, Angelina/P-3401-2015; Zauli, Giorgio/ABE-8001-2020; VOLPATO, STEFANO/H-2977-2014; secchiero, paola/G-9689-2015	Passaro, Angelina/0000-0001-8462-7000; VOLPATO, STEFANO/0000-0003-4335-6034; secchiero, paola/0000-0003-4101-7987; Bosi, Cristina/0000-0002-9443-1447; Zauli, Giorgio/0000-0002-3750-8698; Brombo, Gloria/0000-0003-3907-0770				Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Ashley DT, 2011, METABOLISM, V60, P994, DOI 10.1016/j.metabol.2010.10.001; Blake GJ, 2003, J AM COLL CARDIOL, V41, p37S, DOI 10.1016/S0735-1097(02)02953-4; Choi JW, 2004, ANN CLIN LAB SCI, V34, P400; Clark AL, 2011, J CARD FAIL, V17, P374, DOI 10.1016/j.cardfail.2011.01.009; Deftereos S, 2012, HEART, V98, P214, DOI 10.1136/heartjnl-2011-300339; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Kawano N, 2011, DIABETES RES CLIN PR, V91, P316, DOI 10.1016/j.diabres.2010.11.034; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Schoppet M, 2006, ATHEROSCLEROSIS, V184, P446, DOI 10.1016/j.atherosclerosis.2005.10.028; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Zauli G, 2003, CIRC RES, V92, P732, DOI 10.1161/01.RES.0000067928.83455.9C; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002	19	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58225	10.1371/journal.pone.0058225	http://dx.doi.org/10.1371/journal.pone.0058225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472162	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900108
J	Cossu, R; Wells, MG				Cossu, Remo; Wells, Mathew G.			The Interaction of Large Amplitude Internal Seiches with a Shallow Sloping Lakebed: Observations of Benthic Turbulence in Lake Simcoe, Ontario, Canada	PLOS ONE			English	Article							BOTTOM BOUNDARY-LAYER; COASTAL WATERS; MONO LAKE; WAVES; DENSITY; STRATIFICATION; DEGENERATION; TEMPERATURE; CALIFORNIA; STABILITY	Observations of the interactions of large amplitude internal seiches with the sloping boundary of Lake Simcoe, Canada show a pronounced asymmetry between up-and downwelling. Data were obtained during a 42-day period in late summer with an ADCP and an array of four thermistor chains located in a 5 km line at the depths where the thermocline intersects the shallow slope of the lakebed. The thermocline is located at depths of 12-14 m during the strongly stratified period of late summer. During periods of strong westerly winds the thermocline is deflected as much as 8 m vertically and interacts directly with the lakebed at depth between 14-18 m. When the thermocline was rising at the boundary, the stratification resembles a turbulent bore that propagates up the sloping lakebed with a speed of 0.05-0.15 m s(-1) and a Froude number close to unity. There were strong temperature overturns associated with the abrupt changes in temperature across the bore. Based on the size of overturns in the near bed stratification, we show that the inferred turbulent diffusivity varies by up to two orders of magnitude between up-and downwellings. When the thermocline was rising, estimates of turbulent diffusivity were high with K-Z similar to 10(-4) m 2 s(-1), whereas during downwelling events the near-bed stratification was greatly increased and the turbulence was reduced. This asymmetry is consistent with previous field observations and underlines the importance of shear-induced convection in benthic bottom boundary layers of stratified lakes.	[Cossu, Remo] Univ Toronto, Ctr Earth Sci, Dept Phys & Environm Sci, Toronto, ON, Canada; [Wells, Mathew G.] Univ Toronto, Dept Phys & Environm Sci, Toronto, ON, Canada	University of Toronto; University of Toronto	Cossu, R (corresponding author), Univ Toronto, Ctr Earth Sci, Dept Phys & Environm Sci, Toronto, ON, Canada.	remo.cossu@utoronto.ca	Cossu, Remo/C-6085-2016; wells, mathew G/A-7101-2012	Cossu, Remo/0000-0002-1712-6692; wells, mathew/0000-0003-3838-9202	Environment Canada through the "Lake Simcoe Clean up fund"; National Science and Engineering Research Council of Canada; Ontario Ministry of Economic Development and Innovation	Environment Canada through the "Lake Simcoe Clean up fund"; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Economic Development and Innovation	Funding for this project was provided by Environment Canada through the "Lake Simcoe Clean up fund" (http://www.ec.gc.ca/doc/eau-water/simcoe_e.html), the National Science and Engineering Research Council of Canada through their Discovery Grants awards (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp) and the Ontario Ministry of Economic Development and Innovation, through an Early Researcher Award (http://www.mri.gov.on.ca/english/news/ERA072511_toronto_bd.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghsaee P, 2010, J FLUID MECH, V659, P289, DOI 10.1017/S002211201000248X; Becherer JK, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007119; Boegman L, 2005, LIMNOL OCEANOGR, V50, P1620, DOI 10.4319/lo.2005.50.5.1620; Boegman L, 2003, LIMNOL OCEANOGR, V48, P895, DOI 10.4319/lo.2003.48.2.0895; Boegman L, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004411; Bouffard D, 2012, LIMNOL OCEANOGR, V57, P1201, DOI 10.4319/lo.2012.57.4.1201; Bourgault D, 2011, J PHYS OCEANOGR, V41, P586, DOI 10.1175/2010JPO4464.1; CAIRNS JL, 1967, J GEOPHYS RES, V72, P3563, DOI 10.1029/JZ072i014p03563; CHEN CT, 1977, LIMNOL OCEANOGR, V22, P158, DOI 10.4319/lo.1977.22.1.0158; Coman MA, 2012, CAN J FISH AQUAT SCI, V69, P282, DOI 10.1139/F2011-167; Cossu R, 2012, EUR J MECH B-FLUID, V32, P70, DOI 10.1016/j.euromechflu.2011.09.006; Evans DO, 1996, CAN J FISH AQUAT SCI, V53, P194, DOI 10.1139/cjfas-53-S1-194; Gloor M, 2000, J GEOPHYS RES-OCEANS, V105, P8629, DOI 10.1029/1999JC900303; Goudsmit GH, 1997, J GEOPHYS RES-OCEANS, V102, P27903, DOI 10.1029/97JC01861; Holtappels M, 2011, LIMNOL OCEANOGR-METH, V9, P29, DOI 10.4319/lom.2011.9.29; Horn DA, 2001, J FLUID MECH, V434, P181, DOI 10.1017/S0022112001003536; IMBERGER J, 1990, ADV APPL MECH, V27, P303, DOI 10.1016/ S0065- 2156( 08) 70199- 6; Lorke A, 2005, LIMNOL OCEANOGR, V50, P1612, DOI 10.4319/lo.2005.50.5.1612; Lorke A, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001154; Lorke A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034607; Lorke A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004008; Lorrai C, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007121; MacIntyre S, 1999, LIMNOL OCEANOGR, V44, P512, DOI 10.4319/lo.1999.44.3.0512; MacIntyre S, 2009, LIMNOL OCEANOGR, V54, P2255, DOI 10.4319/lo.2009.54.6.2255; Moum JN, 2004, J PHYS OCEANOGR, V34, P2189, DOI 10.1175/1520-0485(2004)034<2189:CDMITB>2.0.CO;2; PATTERSON JC, 1984, LIMNOL OCEANOGR, V29, P845, DOI 10.4319/lo.1984.29.4.0845; Preusse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041674; Preusse M, 2010, LIMNOL OCEANOGR, V55, P2353, DOI 10.4319/lo.2010.55.6.2353; Read JS, 2011, ENVIRON MODELL SOFTW, V26, P1325, DOI 10.1016/j.envsoft.2011.05.006; Rippeth TP, 2001, J PHYS OCEANOGR, V31, P2458, DOI 10.1175/1520-0485(2001)031<2458:TCOTDI>2.0.CO;2; ROBERTSON DM, 1994, INT REV GES HYDROBIO, V79, P159, DOI 10.1002/iroh.19940790202; Shih LH, 2005, J FLUID MECH, V525, P193, DOI 10.1017/S0022112004002587; Shin JO, 2004, J FLUID MECH, V521, P1, DOI 10.1017/S002211200400165X; Simpson J.H, 2000, INTERACTIONS ESTUARI, P57; Simpson JE, 1979, J FLUID MECH, V94, DOI [10.1017/S0022112079001142, DOI 10.1017/S0022112079001142]; Stainsby EA, 2011, J GREAT LAKES RES, V37, P55, DOI 10.1016/j.jglr.2011.04.001; THORPE SA, 1987, J GEOPHYS RES-OCEANS, V92, P5231, DOI 10.1029/JC092iC05p05231; THORPE SA, 1977, PHILOS T R SOC A, V286, P125, DOI 10.1098/rsta.1977.0112; TROWBRIDGE JH, 1991, J PHYS OCEANOGR, V21, P1171, DOI 10.1175/1520-0485(1991)021<1171:ABOAOB>2.0.CO;2; Troy CD, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007148; Umlauf L, 2011, J PHYS OCEANOGR, V41, P329, DOI 10.1175/2010JPO4438.1; van Haren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032535; Wain DJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008391; WEATHERLY GL, 1978, J PHYS OCEANOGR, V8, P557, DOI 10.1175/1520-0485(1978)008<0557:OTSADO>2.0.CO;2; Wells M, 2010, J PHYS OCEANOGR, V40, P2713, DOI 10.1175/2010JPO4225.1; WINANT CD, 1974, J GEOPHYS RES, V79, P4523, DOI 10.1029/JC079i030p04523; Wuest A, 2000, LIMNOL OCEANOGR, V45, P1388; Wuest A, 2003, ANNU REV FLUID MECH, V35, P373, DOI 10.1146/annurev.fluid.35.101101.161220; Wuest A., 2005, MARINE TURBULENCE TH, P139	49	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57444	10.1371/journal.pone.0057444	http://dx.doi.org/10.1371/journal.pone.0057444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472085	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900023
J	Lin, R; Charlesworth, J; Stankovich, J; Perreau, VM; Brown, MA; Taylor, BV				Lin, Rui; Charlesworth, Jac; Stankovich, Jim; Perreau, Victoria M.; Brown, Matthew A.; Taylor, Bruce V.		ANZgene Consortium	Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ZINC-FINGER PROTEIN; GENETIC DISSECTION; COMPLEX TRAITS; LOCI; EXPRESSION; FAMILY; SCANS; RISK; DETERMINANTS	Genome-wide association studies (GWAS) have identified around 60 common variants associated with multiple sclerosis (MS), but these loci only explain a fraction of the heritability of MS. Some missing heritability may be caused by rare variants that have been suggested to play an important role in the aetiology of complex diseases such as MS. However current genetic and statistical methods for detecting rare variants are expensive and time consuming. 'Population-based linkage analysis' (PBLA) or so called identity-by-descent (IBD) mapping is a novel way to detect rare variants in extant GWAS datasets. We employed BEAGLE fastIBD to search for rare MS variants utilising IBD mapping in a large GWAS dataset of 3,543 cases and 5,898 controls. We identified a genome-wide significant linkage signal on chromosome 19 (LOD = 4.65; p = 1.9x10(-6)). Network analysis of cases and controls sharing haplotypes on chromosome 19 further strengthened the association as there are more large networks of cases sharing haplotypes than controls. This linkage region includes a cluster of zinc finger genes of unknown function. Analysis of genome wide transcriptome data suggests that genes in this zinc finger cluster may be involved in very early developmental regulation of the CNS. Our study also indicates that BEAGLE fastIBD allowed identification of rare variants in large unrelated population with moderate computational intensity. Even with the development of whole-genome sequencing, IBD mapping still may be a promising way to narrow down the region of interest for sequencing priority.	[Lin, Rui; Charlesworth, Jac; Stankovich, Jim; Taylor, Bruce V.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Stankovich, Jim] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Perreau, Victoria M.] Univ Melbourne, Dept Anat & Neurosci, Ctr Neurosci, Melbourne, Vic, Australia; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia	University of Tasmania; Walter & Eliza Hall Institute; University of Melbourne; University of Queensland	Taylor, BV (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	Bruce.Taylor@utas.edu.au	Brown, Matthew A/E-5749-2010; Baxter, Alan G/A-1412-2010; Foote, Simon J/F-2802-2013; Charlesworth, Jac/J-7661-2014; Kermode, Allan/G-3568-2019; Lin, Rui/P-2742-2019; MOSCATO, PABLO ALBERTO/G-7668-2013; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	Brown, Matthew A/0000-0003-0538-8211; Baxter, Alan G/0000-0002-6960-9821; Charlesworth, Jac/0000-0001-6201-3518; Kermode, Allan/0000-0002-4476-4016; Lin, Rui/0000-0002-3846-9301; Perreau, Victoria/0000-0002-0773-7246; Wiley, James/0000-0001-9421-4154; Scott, Rodney/0000-0001-7724-3404; Kilpatrick, Trevor/0000-0003-3999-085X; Field, Judith/0000-0002-7089-0999; Vucic, Steve/0000-0002-8323-873X; Booth, David/0000-0001-8580-2384; Slee, Mark/0000-0003-4323-2453; Stankovich, Jim/0000-0001-9344-7749	National Health and Medical Research Council (NHMRC, Australia) [605511]; Australian Research Council [LP110100473]; NHMRC Senior Principal Research Fellowship	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC, Australia) [Project 605511]; and the Australian Research Council [LP110100473]. MAB was supported by an NHMRC Senior Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2010, R LANG ENV STAT COMP; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2010, GENES IMMUN, V11, P660, DOI 10.1038/gene.2010.36; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2008, GENETICS, V178, P2123, DOI 10.1534/genetics.107.084624; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fathi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022856; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Hansen T, 2005, MULT SCLER J, V11, P504, DOI 10.1191/1352458505ms1220oa; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; JERSILD C, 1975, TRANSPLANT REV, V22, P148; JERSILD C, 1972, ACTA NEUROL SCAND, V48, P377; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kang SJ, 2006, MOVEMENT DISORD, V21, P2175, DOI 10.1002/mds.21151; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lorenz P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-206; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Navratilova Pavla, 2009, Briefings in Functional Genomics & Proteomics, V8, P333, DOI 10.1093/bfgp/elp019; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; O'Gorman C, 2013, NEUROEPIDEMIOLOGY, V40, P1, DOI 10.1159/000341902; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Sabater L, 2002, BIOCHEM BIOPH RES CO, V293, P1066, DOI 10.1016/S0006-291X(02)00344-3; SADOVNICK AD, 1993, ANN NEUROL, V33, P281, DOI 10.1002/ana.410330309; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yu ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017951	56	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e56379	10.1371/journal.pone.0056379	http://dx.doi.org/10.1371/journal.pone.0056379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472070	Green Published, gold, Green Accepted			2022-12-27	WOS:000315637900008
J	Matthews, LT; Sibeko, S; Mansoor, LE; Yende-Zuma, N; Bangsberg, DR; Karim, QA				Matthews, Lynn T.; Sibeko, Sengeziwe; Mansoor, Leila E.; Yende-Zuma, Nonhlanhla; Bangsberg, David R.; Karim, Quarraisha Abdool			Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial	PLOS ONE			English	Article							CONTRACEPTIVE USE; MALE CIRCUMCISION; SOUTH-AFRICA; HORMONAL CONTRACEPTION; ANTIRETROVIRAL THERAPY; DOUBLE-BLIND; PREVENTION; INFECTION; COUPLES; MEN	Background: Antiretroviral prophylaxis may be a critical strategy to reduce periconception HIV transmission. Maximizing the benefit of periconception pharmacologic HIV risk-reduction requires an understanding of the links between pregnancy and adherence to this prevention strategy. Methods: We assessed study gel adherence among women with pregnancies compared to women without pregnancies enrolled in the CAPRISA 004 phase IIB trial of 1% vaginal tenofovir gel. Pregnancy was assessed with monthly urine tests. Adherence was measured monthly and defined as proportion of sex acts covered by two returned, used applicators based on pre- and post-coital dosing. High adherence was defined as a median adherence score of >80%, that is, more than 80% of sex acts were covered by two applications of study gel. A multivariate generalized estimating equations (GEE) model with a binomial distribution was used to assess covariates associated with high adherence (>80%) over time. Median adherence before and after pregnancy was compared using Wilcoxon signed rank test. Results: Among 868 women, 53 had at least 1 pregnancy (4.06 per 100 woman years, 95% CI: 3.04, 5.31). Women with pregnancies had lower median adherence compared to women without pregnancies (50% [IQR: 45-83] vs. 60% [IQR: 50-100], p = 0.02). Women with pregnancies also had a 48% lower odds of high adherence compared to women without pregnancies when adjusting for confounders (aOR 0.52, 95% CI: 0.41-0.66, p<0.0001). Among women with pregnancies, adherence before and after pregnancy was not different (50% [IQR: 46-83] vs. 55% [IQR: 20-100], p = 0.68). Conclusions: Women with pregnancies were less likely to have high adherence to study gel compared to women without pregnancies. Understanding these differences may inform findings from HIV prevention trials and future implementation of antiretroviral prophylaxis for at-risk women who choose to conceive. The protocol for the parent trial is registered on ClinicalTrials.gov, NCT00441298, http://www.clinicaltrials.gov/ct2/show/NCT00441298.	[Matthews, Lynn T.; Bangsberg, David R.] Massachusetts Gen Hosp, Div Infect Dis, Ctr Global Hlth, Boston, MA 02114 USA; [Matthews, Lynn T.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Matthews, Lynn T.; Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Sibeko, Sengeziwe; Mansoor, Leila E.; Yende-Zuma, Nonhlanhla; Karim, Quarraisha Abdool] Ctr AIDS Program Res South Africa CAPRISA, Durban, Kwazulu Natal, South Africa; [Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Karim, Quarraisha Abdool] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; Columbia University	Matthews, LT (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Ctr Global Hlth, Boston, MA 02114 USA.	ltmatthews@partners.org	Abdool Karim, Quarraisha/GVS-1160-2022; Sibeko, Sengeziwe/HCH-1293-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; 	United States Agency for International Development (USAID) [FHI360, GPO-A-00-05-00022-00, 132119]; Technology Innovation Agency (LIFElab) of the South African government's Department of Science Technology; Burroughs Wellcome Fund; American Society for Tropical Medicine and Hygiene;  [NIMH MH095655];  [NIMH MH087227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, K23MH095655] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Technology Innovation Agency (LIFElab) of the South African government's Department of Science Technology; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Society for Tropical Medicine and Hygiene; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The parent trial (CAPRISA 004) was supported by the United States Agency for International Development (USAID), FHI360 [ USAID co-operative agreement # GPO-A-00-05-00022-00, contract # 132119], and the Technology Innovation Agency (LIFElab) of the South African government's Department of Science & Technology. Tenofovir was provided by Gilead Sciences and the gel was manufactured and supplied for the CAPRISA 004 trial by CONRAD. Dr. Matthews is supported by a postdoctoral fellowship in infectious diseases from the Burroughs Wellcome Fund and the American Society for Tropical Medicine and Hygiene, and by a K23 award (NIMH MH095655). Dr. Bangsberg was supported by a K24 award (NIMH MH087227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Bekker L. G., 2011, Southern African Journal of HIV Medicine, V12, P31; Blish CA, 2011, AM J REPROD IMMUNOL, V65, P302, DOI 10.1111/j.1600-0897.2010.00930.x; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Donnell D, 2012, TENOFOVIR DISOPROXIL; Dyer SJ, 2002, HUM REPROD, V17, P1663, DOI 10.1093/humrep/17.6.1663; Forrest JI, 2009, AIDS BEHAV, V13, pS55, DOI 10.1007/s10461-009-9552-z; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Halpern V, 2011, CONTRACEPTION, V83, P436, DOI 10.1016/j.contraception.2010.08.018; Harrison A, 2010, AIDS BEHAV, V14, P991, DOI 10.1007/s10461-010-9687-y; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kharsany ABM, 2010, HIV MED, V11, P661, DOI 10.1111/j.1468-1293.2010.00838.x; Lampe MA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.026; MacPhail C, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-31; Mandelbrot L, 1997, LANCET, V349, P850, DOI 10.1016/S0140-6736(05)61754-0; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Matthews LT, 2011, AIDS BEHAV; Matthews LT, 2012, CURR OPIN HIV AIDS, V7, P569, DOI 10.1097/COH.0b013e328358bac9; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Matthews LT, 2009, AIDS BEHAV, V13, pS5, DOI 10.1007/s10461-009-9551-0; Microbicide Trials Network, 2011, MTN STAT DEC DISC US; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Morrison CS, 2012, AIDS, V26, P497, DOI 10.1097/QAD.0b013e32834fa13d; Mugo N, 2012, CROI 2012 SEATTL; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; National Department of Health SA, 2010, NAT ANT SENT HIV SYP; Nduna M, 2009, AIDS BEHAV, V13, pS62, DOI 10.1007/s10461-009-9545-y; Ngure K, 2012, AIDS 2012 WASH DC; Ngure K, 2012, AIDS, V26, P513, DOI 10.1097/QAD.0b013e32834f981c; Nicopoullos JDM, 2010, FERTIL STERIL, V94, P2458, DOI 10.1016/j.fertnstert.2010.03.074; Odutola A, 2012, SEX TRANSM INFECT, V88, P436, DOI 10.1136/sextrans-2011-050412; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Polis CB, 2012, AIDS; Polis CB, 2011, CONTRACEPTION, V83, P549, DOI 10.1016/j.contraception.2010.10.002; Polis CB, 2010, AIDS, V24, P1937, DOI 10.1097/QAD.0b013e32833b3282; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Richter L, 1996, SURVEY REPROD HLTH I; Schimmer B. P, 2011, GOODMAN GILMANS PHAR, P1209; Sibeko S, 2011, OBSTET GYNECOL, V118, P895, DOI 10.1097/AOG.0b013e31822be512; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith DJ, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000298101.56614.af; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2010, REP GLOB AIDS EP; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Varga C. A., 1996, AGENDA, V28, P31, DOI DOI 10.2307/4065754; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; Wood K, 1997, Gend Dev, V5, P41	54	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e56400	10.1371/journal.pone.0056400	http://dx.doi.org/10.1371/journal.pone.0056400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472071	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900009
J	Vergnaud, AC; Norat, T; Mouw, T; Romaguera, D; May, AM; Bueno-de-Mesquita, HB; van der Daphne, A; Agudo, A; Wareham, N; Khaw, KT; Romieu, I; Freisling, H; Slimani, N; Perquier, F; Boutron-Ruault, MC; Clavel-Chapelon, F; Palli, D; Berrino, F; Mattiello, A; Tumino, R; Ricceri, F; Rodriguez, L; Molina-Montes, E; Amiano, P; Barricarte, A; Chirlaque, MD; Crowe, FL; Orfanos, P; Naska, A; Trichopoulou, A; Teucher, B; Kaaks, R; Boeing, H; Buijsse, B; Johansson, I; Hallmans, G; Drake, I; Sonestedt, E; Jakobsen, MU; Overvad, K; Tjonneland, A; Halkjaer, J; Skeie, G; Braaten, T; Lund, E; Riboli, E; Peeters, PHM				Vergnaud, Anne-Claire; Norat, Teresa; Mouw, Traci; Romaguera, Dora; May, Anne M.; Bueno-de-Mesquita, H. Bas; van der Daphne, A.; Agudo, Antonio; Wareham, Nicholas; Khaw, Kay-Tee; Romieu, Isabelle; Freisling, Heinz; Slimani, Nadia; Perquier, Florence; Boutron-Ruault, Marie-Christine; Clavel-Chapelon, Francoise; Palli, Domenico; Berrino, Franco; Mattiello, Amalia; Tumino, Rosario; Ricceri, Fulvio; Rodriguez, Laudina; Molina-Montes, Esther; Amiano, Pilar; Barricarte, Aurelio; Chirlaque, Maria-Dolores; Crowe, Francesca L.; Orfanos, Philippos; Naska, Androniki; Trichopoulou, Antonia; Teucher, Birgit; Kaaks, Rudolf; Boeing, Heiner; Buijsse, Brian; Johansson, Ingeged; Hallmans, Goran; Drake, Isabel; Sonestedt, Emily; Jakobsen, Marianne Uhre; Overvad, Kim; Tjonneland, Anne; Halkjaer, Jytte; Skeie, Guri; Braaten, Tonje; Lund, Eiliv; Riboli, Elio; Peeters, Petra H. M.			Macronutrient Composition of the Diet and Prospective Weight Change in Participants of the EPIC-PANACEA Study	PLOS ONE			English	Article							LOW-FAT DIET; LOW-CARBOHYDRATE; PHYSICAL-ACTIVITY; PROTEIN-INTAKE; EUROPEAN COUNTRIES; GLYCEMIC-INDEX; UNITED-STATES; ENERGY-INTAKE; RISK-FACTORS; CANCER	Background: The effect of the macronutrient composition of the usual diet on long term weight maintenance remains controversial. Methods: 373,803 subjects aged 25-70 years were recruited in 10 European countries (1992-2000) in the PANACEA project of the EPIC cohort. Diet was assessed at baseline using country-specific validated questionnaires and weight and height were measured at baseline and self-reported at follow-up in most centers. The association between weight change after 5 years of follow-up and the iso-energetic replacement of 5% of energy from one macronutrient by 5% of energy from another macronutrient was assessed using multivariate linear mixed-models. The risk of becoming overweight or obese after 5 years was investigated using multivariate Poisson regressions stratified according to initial Body Mass Index. Results: A higher proportion of energy from fat at the expense of carbohydrates was not significantly associated with weight change after 5 years. However, a higher proportion of energy from protein at the expense of fat was positively associated with weight gain. A higher proportion of energy from protein at the expense of carbohydrates was also positively associated with weight gain, especially when carbohydrates were rich in fibre. The association between percentage of energy from protein and weight change was slightly stronger in overweight participants, former smokers, participants >= 60 years old, participants underreporting their energy intake and participants with a prudent dietary pattern. Compared to diets with no more than 14% of energy from protein, diets with more than 22% of energy from protein were associated with a 23-24% higher risk of becoming overweight or obese in normal weight and overweight subjects at baseline. Conclusion: Our results show that participants consuming an amount of protein above the protein intake recommended by the American Diabetes Association may experience a higher risk of becoming overweight or obese during adult life.	[Vergnaud, Anne-Claire; Norat, Teresa; Mouw, Traci; Romaguera, Dora; Riboli, Elio; Peeters, Petra H. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [May, Anne M.; Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [May, Anne M.; Bueno-de-Mesquita, H. Bas; van der Daphne, A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Agudo, Antonio] IDIBELL, Catalan Inst Oncol, Unit Nutr Environm & Canc, Barcelona, Spain; [Wareham, Nicholas] MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Romieu, Isabelle; Freisling, Heinz; Slimani, Nadia] Int Agcy Res Canc IARC WHO, Lyon, France; [Perquier, Florence; Boutron-Ruault, Marie-Christine; Clavel-Chapelon, Francoise] INSERM, ERI 20, EA 4045, Villejuif, France; [Perquier, Florence; Boutron-Ruault, Marie-Christine; Clavel-Chapelon, Francoise] Inst Gustave Roussy, Villejuif, France; [Palli, Domenico] CSPO Sci Inst Tuscany, Mol & Nutr Epidemiol Unit, Florence, Italy; [Berrino, Franco] IRCCS Fdn, Natl Canc Inst, Epidemiol & Prevent Unit, Milan, Italy; [Mattiello, Amalia] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Tumino, Rosario] Civile Mp Arezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile Mp Arezzo Hosp, Histopathol Unit, Ragusa, Italy; [Ricceri, Fulvio] HuGeF, Human Genet Fdn, Turin, Italy; [Rodriguez, Laudina] Hlth & Hlth Care Serv Council, Publ Hlth & Participat Directorate, Asturias, Spain; [Molina-Montes, Esther] Andalusian Sch Publ Hlth, Granada, Spain; [Amiano, Pilar] Basque Reg Hlth Dept, Publ Hlth Dept Gipuzkoa, San Sebastian, Spain; [Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Chirlaque, Maria-Dolores] Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Crowe, Francesca L.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Orfanos, Philippos; Naska, Androniki; Trichopoulou, Antonia] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Food & Nutr Policies, GR-11527 Athens, Greece; [Orfanos, Philippos; Naska, Androniki; Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Teucher, Birgit; Kaaks, Rudolf] German Canc Res Ctr, Div Clin Epidemiol, Heidelberg, Germany; [Boeing, Heiner; Buijsse, Brian] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Johansson, Ingeged] Umea Univ, Dept Odontol, Umea, Sweden; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Drake, Isabel; Sonestedt, Emily] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Cardiol Ctr, Cardiovasc Res Aalborg Hosp, Aalborg, Denmark; [Tjonneland, Anne; Halkjaer, Jytte] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Skeie, Guri; Braaten, Tonje; Lund, Eiliv] Univ Tromso, Inst Community Med, Tromso, Norway	Imperial College London; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Cambridge; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Naples Federico II; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Escuela Andaluza de Salud Publica; Public Health Institute of Navarra; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Umea University; Umea University; Lund University; Aarhus University; Aarhus University; Danish Cancer Society; UiT The Arctic University of Tromso	Vergnaud, AC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England.	a.vergnaud@imperial.ac.uk	Teucher, Birgit/J-6380-2015; Romaguera, Dora/ABE-7004-2020; May, Anne M/G-9183-2011; Ricceri, Fulvio/I-9910-2018; Sonestedt, Emily/I-3814-2016; Berrino, Franco/AAC-2364-2020; Orfanos, Philippos/AAL-2606-2021; Agudo, Antonio/J-1805-2016; Jakobsen, Marianne Uhre/I-8550-2018; Clavel-Chapelon, Francoise/G-6733-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Boutron-Ruault, Marie-Christine/H-3936-2014; Mattiello, Amalia AM/K-5112-2016; Romaguera, Dora/AAB-2852-2020; Khaw, Kay-Tee/AAZ-3209-2021; Huerta, Jose Maria/N-8654-2015	Romaguera, Dora/0000-0002-5762-8558; Ricceri, Fulvio/0000-0001-8749-9737; Sonestedt, Emily/0000-0002-0747-4562; Berrino, Franco/0000-0002-4858-1866; Agudo, Antonio/0000-0001-9900-5677; Jakobsen, Marianne Uhre/0000-0001-6518-4136; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Mattiello, Amalia AM/0000-0003-3676-7353; tumino, rosario/0000-0003-2666-414X; Gueranger, Anne-Claire/0000-0003-0728-9313; Molina-Montes, Esther/0000-0002-0428-2426; Skeie, Guri/0000-0003-2476-4251; Freisling, Heinz/0000-0001-8648-4998; Riboli, Elio/0000-0001-6795-6080; Orfanos, Philippos/0000-0002-9949-3137; PALLI, Domenico/0000-0002-5558-2437; Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921; Naska, Androniki/0000-0002-1610-1813; Drake, Isabel/0000-0002-6500-6310; Huerta, Jose Maria/0000-0002-9637-3869; Crowe, Francesca/0000-0003-4026-1726; Lund, Eiliv/0000-0002-8071-8711	European Union [2005328]; European Commission: Public Health and Consumer Protection Directorate; European Commission: Research Directorate-General; Ligue contre le Cancer (France); German Cancer Aid, German Cancer Research Center, Federal Ministry of Education and Research (Germany); Danish Cancer Society (Denmark); Health Research Fund (FIS) of the Spanish Ministry of Health (Spain); Cancer Research UK (United Kingdom); Medical Research Council (United Kingdom); Stroke Association (United Kingdom); British Heart Foundation (United Kingdom); Department of Health, Food Standards Agency (United Kingdom); Wellcome Trust (United Kingdom); Greek Ministry of Health and Social Solidarity (Greece); Hellenic Health Foundation (Greece); Stavros Niarchos Foundation (Greece); Italian Association for Research on Cancer (Italy); National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (The Netherlands); Dutch Ministry of Health (The Netherlands); Dutch Prevention Funds (The Netherlands); LK Research Funds (The Netherlands); Dutch ZON (Zorg Onderzoek Nederland) (The Netherlands); World Cancer Research Fund (WCRF) (The Netherlands); Swedish Cancer Society (Sweden); Swedish Scientific Council (Sweden); Regional Government of Skane (Sweden); Regional Government of Vasterbotten (Sweden); Norwegian Research Council (Norway); Societe 3M (France); Mutuelle Generale de l'Education Nationale (France); Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish	European Union(European Commission); European Commission: Public Health and Consumer Protection Directorate(European CommissionEuropean Commission Joint Research Centre); European Commission: Research Directorate-General(European CommissionEuropean Commission Joint Research Centre); Ligue contre le Cancer (France); German Cancer Aid, German Cancer Research Center, Federal Ministry of Education and Research (Germany); Danish Cancer Society (Denmark)(Danish Cancer Society); Health Research Fund (FIS) of the Spanish Ministry of Health (Spain)(Instituto de Salud Carlos III); Cancer Research UK (United Kingdom)(Cancer Research UK); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association (United Kingdom); British Heart Foundation (United Kingdom)(British Heart Foundation); Department of Health, Food Standards Agency (United Kingdom); Wellcome Trust (United Kingdom)(Wellcome Trust); Greek Ministry of Health and Social Solidarity (Greece); Hellenic Health Foundation (Greece); Stavros Niarchos Foundation (Greece); Italian Association for Research on Cancer (Italy)(Fondazione AIRC per la ricerca sul cancro); National Research Council (Italy)(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports (The Netherlands); Dutch Ministry of Health (The Netherlands); Dutch Prevention Funds (The Netherlands)(Netherlands Government); LK Research Funds (The Netherlands)(Netherlands Government); Dutch ZON (Zorg Onderzoek Nederland) (The Netherlands)(Netherlands Government); World Cancer Research Fund (WCRF) (The Netherlands)(Netherlands GovernmentWorld Cancer Research Fund International (WCRF)); Swedish Cancer Society (Sweden)(Swedish Cancer Society); Swedish Scientific Council (Sweden); Regional Government of Skane (Sweden); Regional Government of Vasterbotten (Sweden); Norwegian Research Council (Norway)(Research Council of Norway); Societe 3M (France)(3M); Mutuelle Generale de l'Education Nationale (France); Institut National de la Sante et de la Recherche Medicale (INSERM) (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This publication arises from the project PANACEA, which has received funding from the European Union, in the framework of the Public Health Programme (project number: 2005328). The work was further financially supported by the European Commission: Public Health and Consumer Protection Directorate 1993-2004; Research Directorate-General 2005-.''; Ligue contre le Cancer, Societe 3M, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center, Federal Ministry of Education and Research (Germany); Danish Cancer Society (Denmark); Health Research Fund (FIS) of the Spanish Ministry of Health, The participating regional governments and institutions (Spain); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, the Wellcome Trust (United Kingdom); Greek Ministry of Health and Social Solidarity, Hellenic Health Foundation and Stavros Niarchos Foundation (Greece); Italian Association for Research on Cancer, National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports, Dutch Ministry of Health, Dutch Prevention Funds, LK Research Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) (The Netherlands); Swedish Cancer Society, Swedish Scientific Council, Regional Government of Skane and Vasterbotten (Sweden); Norwegian Research Council (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NUTR CONTENT US FOOD; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Balanza R, 2007, PUBLIC HEALTH NUTR, V10, P168, DOI 10.1017/S1368980007246592; Beasley JM, 2010, J AM GERIATR SOC, V58, P1063, DOI 10.1111/j.1532-5415.2010.02866.x; Blanck Heidi Michels, 2006, MedGenMed, V8, P5; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Bruinsma J, 2003, 2015 2030 FAO PERSPE; Bujnowski D, 2011, J AM DIET ASSOC, V111, P1150, DOI 10.1016/j.jada.2011.05.002; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Elmadfa I, 2009, FORUM NUTR, V62, P1, DOI [10.1159/000244607, 10.1159/000242367]; Ferrari P, 2008, INT J EPIDEMIOL, V37, P368, DOI 10.1093/ije/dym242; Forouhi NG, 2009, AM J CLIN NUTR, V90, P1632, DOI 10.3945/ajcn.2009.27828; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Freisling H, 2012, BRIT J NUTR, V107, P910, DOI 10.1017/S0007114511003564; Fung TT, 2010, ANN INTERN MED, V153, P289, DOI 10.7326/0003-4819-153-5-201009070-00003; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Halkjaer J, 2010, INT J OBES LOND; Iqbal SI, 2006, OBESITY, V14, P106, DOI 10.1038/oby.2006.13; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383; Kramer M.S., 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000032, 10.1002/14651858]; Kroke A, 2002, INT J OBESITY, V26, P403, DOI 10.1038/sj.ijo.0801920; Layman DK, 2009, J NUTR, V139, P514, DOI 10.3945/jn.108.099440; Long SJ, 2000, APPETITE, V35, P79, DOI 10.1006/appe.2000.0332; Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Paddon-Jones D, 2008, AM J CLIN NUTR, V87, p1558S, DOI 10.1093/ajcn/87.5.1558S; Parker DR, 1997, INT J OBESITY, V21, P103, DOI 10.1038/sj.ijo.0800373; Pillot B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019107; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 2003, CANCER EPIDEM BIOMAR, V12, P784; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Stamatakis E, 2007, PREV MED, V45, P416, DOI 10.1016/j.ypmed.2006.12.014; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; van Bakel MME, 2009, J NUTR, V139, P568, DOI 10.3945/jn.108.097121; Vergnaud AC, 2010, AM J CLIN NUTR; Virtanen JK, 2006, NUTR METAB CARDIOVAS, V16, P113, DOI 10.1016/j.numecd.2005.05.005; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Wolever TMS, 2008, AM J CLIN NUTR, V87, P114, DOI 10.1093/ajcn/87.1.114; World Health Organization (WHO), 2003, REP JOINT FAO WHO EX, V916, P1; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	54	51	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57300	10.1371/journal.pone.0057300	http://dx.doi.org/10.1371/journal.pone.0057300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472080	Green Published, gold			2022-12-27	WOS:000315637900018
J	Beauche, F; Richard, FJ				Beauche, Fanny; Richard, Freddie-Jeanne			The Best Timing of Mate Search in Armadillidium vulgare (Isopoda, Oniscidea)	PLOS ONE			English	Article							TERRESTRIAL ISOPOD; ONISCUS-ASELLUS; AGGREGATION PHEROMONES; BEHAVIORAL EVIDENCE; CHEMICAL SIGNALS; REPRODUCTION; CRUSTACEA; COMMUNICATION; CALCIUM; LATREILLE	Mate choice is mediated by many components with the criteria varying across the animal kingdom. Chemical cues used for mate attractiveness can also reflect mate quality. Regarding the gregarious species Armadillidium vulgare (isopod crustacean), we tested whether individuals can discriminate conspecifics at two different levels (between sex and physiological status) based on olfactory perception. Tested conspecifics were individuals of the same or opposite sex, with the females at different moult stages. We found that the attractiveness of individuals was mediated by short-distance chemical cues and tested individuals were able to discriminate and prefer individuals of the opposite sex. Moreover, male preference to female increased during their moulting status as they matured. Males were particularly more attracted by females with appearing white calcium plates, which corresponds to the beginning of their higher receptivity period. These differences in attractiveness due to sex and physiological status are likely to shape the composition of aggregates and facilitate mate finding and optimize the reproductive success for both males and females. Thus aggregation pheromones could be linked to sex pheromones in terrestrial isopods.	[Beauche, Fanny; Richard, Freddie-Jeanne] Univ Poitiers, CNRS, Equipe Ecol Evolut Symbiose, Lab Ecol & Biol Interact,UMR 7267, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers	Richard, FJ (corresponding author), Univ Poitiers, CNRS, Equipe Ecol Evolut Symbiose, Lab Ecol & Biol Interact,UMR 7267, Poitiers, France.	Freddie.jeanne.richard@univ-poitiers.fr		Richard, Freddie-Jeanne/0000-0002-2796-1181				Ali JG, 2010, ANIM BEHAV, V80, P9, DOI 10.1016/j.anbehav.2010.03.014; BARTELT RJ, 1986, PHYSIOL ENTOMOL, V11, P367, DOI 10.1111/j.1365-3032.1986.tb00427.x; Bennett NC, 1996, P ROY SOC B-BIOL SCI, V263, P1599, DOI 10.1098/rspb.1996.0234; Blomquist G.J., 1985, P117; BLOOM HD, 1977, J EXP ZOOL, V199, P215, DOI 10.1002/jez.1401990206; Broly P, 2012, ZOOKEYS, P133, DOI 10.3897/zookeys.176.2258; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Caruso D, 1976, ANIMALIA CATANIA, V3, P17; Caubet Y, 1998, ETHOL ECOL EVOL, V10, P209, DOI 10.1080/08927014.1998.9522853; Caubet Y, 2008, P INT S TERR IS BIOL, V7, P137; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; Chang ES, 2011, CHEM COMMUNICATION C; CHARMANTIER G, 1980, GEN COMP ENDOCR, V41, P349, DOI 10.1016/0016-6480(80)90079-9; Conrad T, 2010, J EXP BIOL, V213, P4065, DOI 10.1242/jeb.038174; Costa J., 2006, OTHER INSECT SOC; Cullen DA, 2010, J INSECT PHYSIOL, V56, P937, DOI 10.1016/j.jinsphys.2010.04.023; Deneubourg JL, 2002, BIOL BULL-US, V202, P262, DOI 10.2307/1543477; Devigne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017389; DRACH P, 1967, VIE MILIEU A BIOL MA, V18, P595; Garcia C, 2009, AM J PRIMATOL, V71, P868, DOI 10.1002/ajp.20717; Ginzel MD, 2003, CHEMOECOLOGY, V13, P135, DOI 10.1007/s00049-003-0239-z; GRAVES BM, 1991, J COMP PSYCHOL, V105, P140; Green MC, 2005, CAN J ZOOL, V83, P683, DOI 10.1139/Z05-058; Guevara-Fiore P, 2010, ANIM BEHAV, V79, P1191, DOI 10.1016/j.anbehav.2010.02.027; Hardege JD, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P373, DOI 10.1007/978-0-387-77101-4_19; Hassall M, 2010, BEHAVIOUR, V147, P151, DOI 10.1163/000579509X12512861455834; Head ML, 2005, ACTA ETHOL, V8, P79, DOI 10.1007/s10211-005-0003-1; Henf C, 2008, P INT S TERR IS BIOL, P149; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Jormalainen V, 1998, Q REV BIOL, V73, P275, DOI 10.1086/420306; Koenig WD, 1998, AM NAT, V151, P243, DOI 10.1086/286115; Krang AS, 2004, J EXP MAR BIOL ECOL, V310, P195, DOI 10.1016/j.jembe.2004.04.010; KUENEN D. J., 1963, ENTOMOL EXPTL ET APPL, V6, P133; Lefebvre F, 1999, INVERTEBR REPROD DEV, V35, P55, DOI 10.1080/07924259.1999.9652367; Lefebvre F, 2000, CAN J ZOOL, V78, P1987, DOI 10.1139/cjz-78-11-1987; Lefebvre F, 2010, INVERTEBR REPROD DEV, V54, P177, DOI 10.1080/07924259.2010.9652331; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Marshall J, 1999, CURR BIOL, V9, P755, DOI 10.1016/S0960-9822(99)80336-4; Marshall NJ, 1996, J COMP PHYSIOL A, V179, P473; Mathews LM, 2003, BEHAV ECOL, V14, P63, DOI 10.1093/beheco/14.1.63; MEAD F, 1988, INT J INVER REP DEV, V14, P95, DOI 10.1080/01688170.1988.10510368; Moreau J, 2002, J CRUSTACEAN BIOL, V22, P353, DOI 10.1651/0278-0372(2002)022[0353:TSOCCD]2.0.CO;2; Moreau J, 2002, ANIM BEHAV, V64, P569, DOI 10.1006/anbe.2002.4000; Moreau J, 2000, OIKOS, V91, P477, DOI 10.1034/j.1600-0706.2000.910308.x; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; PARIS OH, 1962, ECOLOGY, V43, P229, DOI 10.2307/1931979; Popper AN, 2001, J COMP PHYSIOL A, V187, P83, DOI 10.1007/s003590100184; Rivault C, 1998, J INSECT PHYSIOL, V44, P909, DOI 10.1016/S0022-1910(98)00062-6; Roberts JA, 2005, ANIM BEHAV, V70, P217, DOI 10.1016/j.anbehav.2004.09.026; Rutledge JM, 2010, ANIM BEHAV, V80, P419, DOI 10.1016/j.anbehav.2010.05.027; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Sivalinghem S, 2010, BEHAV ECOL, V21, P1308, DOI 10.1093/beheco/arq150; Smigel JT, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4401; Stange N, 2008, P INT S TERR IS, P161; STEEL CGH, 1993, CAN J ZOOL, V71, P4, DOI 10.1139/z93-002; STEEL CGH, 1980, BIOL BULL, V159, P206, DOI 10.2307/1541019; Steel CGH, 1998, INVERTEBR REPROD DEV, V34, P187, DOI 10.1080/07924259.1998.9652652; STEEL CGH, 1982, CAN J ZOOL, V60, P429, DOI 10.1139/z82-058; Suzuki S, 2005, ARTHROPOD STRUCT DEV, V34, P441, DOI 10.1016/j.asd.2005.06.002; Takacs S, 2003, J APPL ENTOMOL, V127, P127, DOI 10.1046/j.1439-0418.2003.00724.x; Takeda N., 1984, Symposia of the Zoological Society of London, P381; Thiel Martin, 2007, P3; Tuck JM, 2005, BEHAV ECOL SOCIOBIOL, V58, P545, DOI 10.1007/s00265-005-0959-x; VAFOPOULOU X, 1995, INVERTEBR REPROD DEV, V28, P87, DOI 10.1080/07924259.1995.9672469; Verne S, 2007, J CRUSTACEAN BIOL, V27, P217, DOI 10.1651/S-2752.1; Ziegler A, 2005, MICRON, V36, P137, DOI 10.1016/j.micron.2004.09.006; Zimmer M, 2001, ANIM BEHAV, V62, P815, DOI 10.1006/anbe.2001.1845	68	24	25	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57737	10.1371/journal.pone.0057737	http://dx.doi.org/10.1371/journal.pone.0057737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469225	Green Published, gold			2022-12-27	WOS:000315897100034
J	Ogonowski, M; Duberg, J; Hansson, S; Gorokhova, E				Ogonowski, Martin; Duberg, Jon; Hansson, Sture; Gorokhova, Elena			Behavioral, Ecological and Genetic Differentiation in an Open Environment-A Study of a Mysid Population in the Baltic Sea	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; CHARR SALVELINUS-ALPINUS; STABLE-ISOTOPES; MIXTA CRUSTACEA; LAKE-SUPERIOR; COASTAL AREA; RESOURCE POLYMORPHISMS; CERCOPAGIS-PENGOI; TROPHIC POSITION; CARBON ISOTOPES	Diel vertical migration (DVM) is often assumed to encompass an entire population. However, bimodal nighttime vertical distributions have been observed in various taxa. Mysid shrimp populations also display this pattern with one group concentrated in the pelagia and the other near the bottom. This may indicate alternative migratory strategies, resembling the seasonal partial migrations seen in birds, fishes and amphibians, where only a subset of the population migrates. To assess the persistence of these alternative strategies, we analyzed the nitrogen and carbon stable isotope signatures (as proxies for diet), biochemical indices (as proxies for growth condition), and genetic population divergence in the Baltic mysid Mysis salemaai collected at night in the pelagia and close to the bottom. Stable isotope signatures were significantly different between migrants (pelagic samples) and residents (benthic samples), indicating persistent diet differences, with pelagic mysids having a more uniform and carnivorous diet. Sequencing of the mitochondrial cytochrome subunit I (COI) gene showed genetic differentiation attributable to geographic location but not between benthic and pelagic groups. Divergent migration strategies were however supported by significantly lower gene flow between benthic populations indicating that these groups have a lower predisposition for horizontal migrations compared to pelagic ones. Different migration strategies did not convey measurable growth benefits as pelagic and benthic mysids had similar growth condition indices. Thus, the combination of ecological, biochemical and genetic markers indicate that this partial migration may be a plastic behavioral trait that yields equal growth benefits.	[Ogonowski, Martin; Hansson, Sture] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; [Duberg, Jon; Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Ogonowski, M (corresponding author), Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden.	martin.ogonowski@aquabiota.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956; Ogonowski, Martin/0000-0002-7082-0990	Department of Systems Ecology, Stockholm University; Stockholm University Marine Research Centre (SMF); Stockholm University	Department of Systems Ecology, Stockholm University; Stockholm University Marine Research Centre (SMF); Stockholm University	The study was mainly funded by The Department of Systems Ecology, Stockholm University and to a minor extent by research grants from Stockholm University Marine Research Centre (SMF; http://www.smf.su.se) and Stockholm University's strategic marine environmental research program "Baltic Ecosystem Adaptive Management". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson J, 2004, AQUAT ECOL, V38, P457, DOI 10.1023/B:AECO.0000035163.30037.38; ANEER G, 1975, Merentutkimuslaitoksen Julkaisu, V239, P146; ARRHENIUS F, 1993, MAR ECOL PROG SER, V96, P125, DOI 10.3354/meps096125; Audzijonyte A, 2005, HYDROBIOLOGIA, V544, P89, DOI 10.1007/s10750-004-8337-7; Audzijonyte A, 2006, MOL ECOL, V15, P3287, DOI 10.1111/j.1365-294X.2006.02998.x; Axenrot T, 2004, ESTUAR COAST SHELF S, V60, P541, DOI 10.1016/j.ecss.2004.02.004; Benjamini Y, 2001, ANN STAT, V29, P1165; BERTHOLD P, 1991, TRENDS ECOL EVOL, V6, P254, DOI 10.1016/0169-5347(91)90072-6; Blomqvist S, 1996, HELGOLANDER MEERESUN, V50, P453, DOI 10.1007/BF02367160; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Boscarino BT, 2007, LIMNOL OCEANOGR, V52, P1599, DOI 10.4319/lo.2007.52.4.1599; BOWEN SH, 1995, ECOLOGY, V76, P899, DOI 10.2307/1939355; BOWERS JA, 1988, B MAR SCI, V43, P730; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; DAWIDOWICZ P, 1992, LIMNOL OCEANOGR, V37, P1589, DOI 10.4319/lo.1992.37.8.1589; DEMEESTER L, 1995, NATURE, V378, P483; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DODSON S, 1988, LIMNOL OCEANOGR, V33, P1431, DOI 10.4319/lo.1988.33.6_part_2.1431; Duffy MA, 2010, FRESHWATER BIOL, V55, P995, DOI 10.1111/j.1365-2427.2009.02336.x; Engqvist A, 2004, DEEP-SEA RES PT II, V51, P371, DOI 10.1016/j.dsr2.2003.09.003; Engqvist A, 2009, ESTUAR COAST SHELF S, V83, P159, DOI 10.1016/j.ecss.2007.11.029; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fanelli E, 2009, J SEA RES, V61, P174, DOI 10.1016/j.seares.2008.10.005; Feuchtmayr H, 2003, RAPID COMMUN MASS SP, V17, P2605, DOI 10.1002/rcm.1227; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; Gal G, 1999, CAN J FISH AQUAT SCI, V56, P311, DOI 10.1139/cjfas-56-2-311; Gorokhova E, 2004, ICES J MAR SCI, V61, P959, DOI 10.1016/j.icesjms.2004.06.016; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 1999, CAN J FISH AQUAT SCI, V56, P2203, DOI 10.1139/cjfas-56-11-2203; Grayson KL, 2011, ECOLOGY, V92, P1236, DOI 10.1890/11-0133.1; GROSSNICKLE NE, 1982, HYDROBIOLOGIA, V93, P101, DOI 10.1007/BF00008103; Hansen BB, 2010, CAN J ZOOL, V88, P1202, DOI 10.1139/Z10-086; HANSSON S, 1990, OECOLOGIA, V84, P430, DOI 10.1007/BF00329770; Hansson S, 1997, ECOLOGY, V78, P2249, DOI 10.2307/2265961; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; HINDAR K, 1982, CAN J FISH AQUAT SCI, V39, P1030, DOI 10.1139/f82-138; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Holliland PB, 2012, J PLANKTON RES, V34, P376, DOI 10.1093/plankt/fbs008; Johannsson OE, 2009, AQUAT BIOL, V5, P249, DOI 10.3354/ab00111; Johannsson OE, 2008, AQUAT BIOL, V4, P33, DOI 10.3354/ab00091; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; Lasenby D, 2004, CAN J ZOOL, V82, P525, DOI 10.1139/Z04-005; Lehtiniemi M, 2002, BOREAL ENVIRON RES, V7, P121; LUNDBERG P, 1987, J THEOR BIOL, V125, P351, DOI 10.1016/S0022-5193(87)80067-X; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; Mauchline J, 1980, ADV MAR BIOL, P1; Mehner T, 2011, J ANIM ECOL, V80, P761, DOI 10.1111/j.1365-2656.2011.01823.x; Mohammadian MA, 1997, MAR ECOL PROG SER, V150, P113, DOI 10.3354/meps150113; MORGAN MD, 1980, ECOLOGY, V61, P551, DOI 10.2307/1937421; NEILL WE, 1990, NATURE, V345, P524, DOI 10.1038/345524a0; NERO RW, 1982, CAN J FISH AQUAT SCI, V39, P349, DOI 10.1139/f82-048; Olsson IC, 2006, ECOL LETT, V9, P645, DOI 10.1111/j.1461-0248.2006.00909.x; Olsson K, 2008, CAN J FISH AQUAT SCI, V65, P2293, DOI 10.1139/F08-137; Parsons KJ, 2010, EVOL DEV, V12, P246, DOI 10.1111/j.1525-142X.2010.00410.x; Patwa Z, 2007, ENVIRON TOXICOL CHEM, V26, P1224, DOI 10.1897/06-441R.1; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Petersson JCE, 2001, J FISH BIOL, V58, P487, DOI 10.1111/j.1095-8649.2001.tb02267.x; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Ringelberg J, 2010, DIEL VERTICAL MIGRATION OF ZOOPLANKTON IN LAKES AND OCEANS: CAUSAL EXPLANATIONS AND ADAPTIVE SIGNIFICANCES, P1, DOI 10.1007/978-90-481-3093-1; Robillard MM, 2011, BIOL CONSERV, V144, P1931, DOI 10.1016/j.biocon.2011.03.022; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; RUDSTAM LG, 1990, ANN ZOOL FENN, V27, P259; RUDSTAM LG, 1992, MAR ECOL PROG SER, V80, P159, DOI 10.3354/meps080159; RUDSTAM LG, 1989, MAR BIOL, V101, P43, DOI 10.1007/BF00393476; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; SALEMAA H, 1986, OPHELIA, P239; Savage C, 2004, ECOL APPL, V14, P517, DOI 10.1890/02-5396; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheiner SM, 1993, DESIGN ANAL ECOLOGIC, P99; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sierszen ME, 2011, CAN J FISH AQUAT SCI, V68, P1051, DOI [10.1139/F2011-033, 10.1139/f2011-033]; Skov C, 2010, BEHAV ECOL, V21, P1140, DOI 10.1093/beheco/arq121; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Sommer U, 1989, PLANKTON ECOLOGY SUC; Spaak P, 1997, HYDROBIOLOGIA, V360, P177, DOI 10.1023/A:1003121520393; STICH HB, 1984, OECOLOGIA, V61, P192, DOI 10.1007/BF00396759; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; TSAO CHING-HSI, 1952, ANN ENT SOC AMER, V45, P585; Vainola R, 1998, HYDROBIOLOGIA, V368, P137, DOI 10.1023/A:1003237829779; Valiela I, 1995, MARINE ECOLOGICAL PR; Viherluoto M, 2000, MAR BIOL, V136, P553, DOI 10.1007/s002270050715; Viherluoto M., 2001, WALTER ANDREE NOTTBE, V23, P1; Viitasalo S, 2004, MAR ECOL PROG SER, V281, P155, DOI 10.3354/meps281155; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wysujack K, 2009, ECOL FRESHW FISH, V18, P52, DOI 10.1111/j.1600-0633.2008.00322.x	95	17	17	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57210	10.1371/journal.pone.0057210	http://dx.doi.org/10.1371/journal.pone.0057210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469185	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100015
J	Kumar, N; Kanchan, T; Unnikrishnan, B; Thapar, R; Mithra, P; Kulkarni, V; Papanna, MK; Holla, R; Sarathy, S				Kumar, Nithin; Kanchan, Tanuj; Unnikrishnan, Bhaskaran; Thapar, Rekha; Mithra, Prasanna; Kulkarni, Vaman; Papanna, Mohan Kumar; Holla, Ramesh; Sarathy, Saran			Profile of Substance Use among Patients Attending De-Addiction Centres in a Coastal City of Southern India	PLOS ONE			English	Article							PEER PRESSURE; BEHAVIOR	Drug dependence is still to be recognized in developing countries as a significant public health problem and literature on the magnitude of this problem is limited. The present research was planned to study the socio-demographic profile and the reasons for substance use among patients admitted at De-addiction centres in Mangalore, India. In this cross-sectional study, all the patients admitted at the De-addiction centres during the study period were interviewed. The data was analyzed and the results obtained were expressed in proportions. A total of 83 patients were included in the study, all of whom were males. A positive family history of substance use was evident in 63% of the respondents. The mean age of the study participants was 41.9 (SD +/- 11.2) years and the mean age for starting substance use was 20.9 (SD +/- 7.7) years. The most common substance used was alcohol (95.2%). Majority of the subjects (56.6%) cited peer pressure as a reason for initiating substance use. Our findings suggest that the initiation of substance use occurs during late teenage years and mostly due to peer pressure. Our observations point towards the vulnerability of younger age towards substance use and hence, it is proposed that the preventive health policies in this regard should be targeted specifically during teenage years.	[Kumar, Nithin; Unnikrishnan, Bhaskaran; Thapar, Rekha; Mithra, Prasanna; Kulkarni, Vaman; Papanna, Mohan Kumar; Holla, Ramesh] Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, Karnataka, India; [Kanchan, Tanuj] Manipal Univ, Kasturba Med Coll, Dept Forens Med, Mangalore, Karnataka, India; [Sarathy, Saran] Manipal Univ, Kasturba Med Coll, Mangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Kumar, N (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, Karnataka, India.	nithin.gatty@manipal.edu	Kumar, Nithin/P-2781-2015; Prasanna Mithra, MBBS/J-9621-2018; KANCHAN, TANUJ/L-8547-2015; Holla, Ramesh/P-2785-2015; Thapar, Rekha/A-7098-2016; Unnikrishnan, Bhaskaran/O-1025-2015	Kumar, Nithin/0000-0003-4665-9401; Prasanna Mithra, MBBS/0000-0002-7153-411X; KANCHAN, TANUJ/0000-0003-0346-1075; Holla, Ramesh/0000-0002-2296-3719; Thapar, Rekha/0000-0003-2278-1445; Unnikrishnan, Bhaskaran/0000-0003-0892-8551; Kulkarni, Vaman/0000-0002-6518-2277	Department of Community Medicine, Kasturba Medical college, Mangalore; Manipal University; FOGARTY INTERNATIONAL CENTER [D43TW008332] Funding Source: NIH RePORTER	Department of Community Medicine, Kasturba Medical college, Mangalore; Manipal University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors are grateful to the study participants who voluntarily took part in the study. We wish to acknowledge the support provided by the Department of Community Medicine, Kasturba Medical college, Mangalore and Manipal University for encouraging research and its publication in international journals of repute.	Ali H., 2011, Eastern Mediterranean Health Journal, V17, P41; Anil B, 2011, J BIOSCI TECH, V2, P258; Azad India Foundation, DRUG AB IND; Borsari B, 2001, J SUBST ABUSE, V13, P391, DOI 10.1016/S0899-3289(01)00098-0; BROWN BB, 1982, J YOUTH ADOLESCENCE, V11, P121, DOI 10.1007/BF01834708; BROWN BB, 1986, DEV PSYCHOL, V22, P521, DOI 10.1037/0012-1649.22.4.521; Goodarzi F., 2011, IRAN J TOXICOL, V4, P377; Kadri AM, 2003, INDIAN J COMMUNITY M, V28, P74; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Malhotra S, 2009, GER J PSYCHIAT, V12, P14; Ministry of Health and Family Welfare, 2005, NAT FAM HLTH SURV NF; Ponnudurai R, 1993, Indian J Psychiatry, V35, P167; Singh B, 2006, MEDICOLEGAL UPDATE, V6, P13; Tariq Zafar, 2002, International Journal of Drug Policy, V13, P121, DOI 10.1016/S0955-3959(02)00011-7; United Nations Office on Drugs and Crime Vienna, 2012, WORLD DRUG REP; Wani Z, 2004, JK PRACTITIONER, V11, P14; Winslow M, 2006, ANN ACAD MED SINGAP, V35, P451; World Health Organization, SUBSTANCE ABUSE; World Health Organization and United Nations Office on Drugs and Crime, 2008, PRINC DRUG DEP TREAT	19	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57824	10.1371/journal.pone.0057824	http://dx.doi.org/10.1371/journal.pone.0057824			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469075	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900172
J	Yu, SC; Klosterman, SM; Martin, AA; Gracheva, EO; Richmond, JE				Yu, Szi-Chieh; Klosterman, Susan M.; Martin, Ashley A.; Gracheva, Elena O.; Richmond, Janet E.			Differential Roles for Snapin and Synaptotagmin in the Synaptic Vesicle Cycle	PLOS ONE			English	Article							C-ELEGANS; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; SNARE COMPLEX; EXOCYTOSIS; FUSION; TRANSMISSION; PLASTICITY; BINDING; PROTEIN	Evoked synaptic transmission is dependent on interactions between the calcium sensor Synaptotagmin I and the SNARE complex, comprised of Syntaxin, SNAP-25, and Synaptobrevin. Recent evidence suggests that Snapin may be an important intermediate in this process, through simultaneous interactions of Snapin dimers with SNAP-25 and Synaptotagmin. In support of this model, cultured neurons derived from embryonically lethal Snapin null mutant mice exhibit desynchronized release and a reduced readily releasable vesicle pool. Based on evidence that a dimerization-defective Snapin mutation specifically disrupts priming, Snapin is hypothesized to stabilize primed vesicles by structurally coupling Synaptotagmin and SNAP-25. To explore this model in vivo we examined synaptic transmission in viable, adult C. elegans Snapin (snpn-1) mutants. The kinetics of synaptic transmission were unaffected at snpn-1 mutant neuromuscular junctions (NMJs), but the number of docked, fusion competent vesicles was significantly reduced. However, analyses of snt-1 and snt-1; snpn-1 double mutants suggest that the docking role of SNPN-1 is independent of Synaptotagmin. Based on these results we propose that the primary role of Snapin in C. elegans is to promote vesicle priming, consistent with the stabilization of SNARE complex formation through established interactions with SNAP-25 upstream of the actions of Synaptotagmin in calcium-sensing and endocytosis.	[Yu, Szi-Chieh; Klosterman, Susan M.; Martin, Ashley A.; Richmond, Janet E.] Univ Illinois, Chicago, IL 60607 USA; [Gracheva, Elena O.] Yale Univ, New Haven, CT USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University	Richmond, JE (corresponding author), Univ Illinois, Chicago, IL 60607 USA.	jer@uic.edu		Martin, Ashley/0000-0003-1896-306X; Gracheva, Elena O/0000-0002-0846-3427	NIH [R01 MH073156-03]; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073156] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH R01 MH073156-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The CGC was funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Augustine GJ, 1996, ANNU REV PHARMACOL, V36, P659, DOI 10.1146/annurev.pa.36.040196.003303; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Dickman DK, 2012, J NEUROSCI, V32, P8716, DOI 10.1523/JNEUROSCI.5465-11.2012; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hermann GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043043; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kim JSM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-23; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Matos MF, 2003, NEUROPHARMACOLOGY, V45, P777, DOI 10.1016/S0028-3908(03)00318-6; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Richmond J, 2009, J VIS EXP; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Striegel AR, 2012, J NEUROSCI, V32, P1253, DOI 10.1523/JNEUROSCI.4652-11.2012; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thakur P, 2004, J NEUROSCI, V24, P6476, DOI 10.1523/JNEUROSCI.0590-04.2004; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	41	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57842	10.1371/journal.pone.0057842	http://dx.doi.org/10.1371/journal.pone.0057842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469084	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900180
J	Faiz, A; Tjin, G; Harkness, L; Weckmann, M; Bao, SS; Black, JL; Oliver, BGG; Burgess, JK				Faiz, Alen; Tjin, Gavin; Harkness, Louise; Weckmann, Markus; Bao, Shisan; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.			The Expression and Activity of Cathepsins D, H and K in Asthmatic Airways	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; ANTIGEN PRESENTATION; PULMONARY-FIBROSIS; IV COLLAGEN; HUMAN LUNG; ANGIOGENESIS; CANCER; MACROPHAGES; INHIBITORS; TUMSTATIN	Tumstatin is an anti-angiogenic collagen IV alpha 3 fragment, levels of which are reduced in the airways of asthmatics. Its reduction may be due to the degradation by extracellular matrix (ECM) proteases. Cathepsins play a role in ECM remodelling, with cathepsin D, H and K (CTSD, CTSH and CTSK) being associated with lung diseases. CTSD modulates the NC1 domains of collagen molecules including tumstatin, while CTSH and CTSK are involved in ECM degradation. The role of these cathepsins in the regulation of tumstatin in the lung has not previously been examined. We demonstrated that CTSB, D, F, H, K, L and S mRNA was expressed in the airways. Quantification of immunohistochemistry showed that there is no difference in the global expression of CTSD, CTSH and CTSK between asthmatics and non-asthmatics. CTSD and CTSK, but not CTSH had the capacity to degrade tumstatin. No difference was observed in the activity of CTSD and H in bronchoalveolar lavage fluid of asthmatic and non-asthmatics, while CTSK was undetectable. This indicates that while CTSD possesses the potential to directly regulate tumstatin, and thus angiogenesis through this mechanism however, it is not likely to be involved in the dysregulation of tumstatin found in asthmatic airways.	[Faiz, Alen; Tjin, Gavin; Harkness, Louise; Weckmann, Markus; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Faiz, Alen; Tjin, Gavin; Bao, Shisan; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Harkness, Louise; Weckmann, Markus; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Weckmann, Markus; Bao, Shisan] Univ Sydney, Discipline Pathol, Sch Med Sci, Sydney, NSW 2006, Australia; [Weckmann, Markus; Bao, Shisan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Weckmann, Markus; Black, Judith L.; Oliver, Brian G. G.; Burgess, Janette K.] Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Faiz, A (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	afai4257@uni.sydney.edu.au	Burgess, Janette K/A-3597-2010; Faiz, Alen/HII-9884-2022; Oliver, Brian/E-7939-2010; Black, Judith L/C-6559-2008; Faiz, Alen/AAB-7132-2019; Burgess, Janette/M-7117-2019; Weckmann, Markus/GXG-3428-2022; Bao, Shisan/C-6072-2014; Bao, Shisan/AAF-6464-2020	Faiz, Alen/0000-0003-1740-3538; Oliver, Brian/0000-0002-7122-9262; Faiz, Alen/0000-0003-1740-3538; Weckmann, Markus/0000-0001-5342-979X; Bao, Shisan/0000-0002-6687-3846; Tjin, Gavin/0000-0002-7235-6909; Burgess, Janette/0000-0001-9868-9966	National Health and Medical Research Council, Australia [570867]; NHMRC [1032695, 571098, 1026880]; Australian Postgraduate Award (APA); Asthma Foundation of NSW Scholarship	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award (APA)(Australian Government); Asthma Foundation of NSW Scholarship	This work was supported by the National Health and Medical Research Council, Australia (Grant # 570867). J.K. Burgess is supported by a NHMRC Career Development Fellowship # 1032695 A. Faiz is supported by a Australian Postgraduate Award (APA) L. Harkness is supported by an Asthma Foundation of NSW Scholarship J.L. Black is supported by a NHMRC senior Principal Research Fellowship # 571098 B. G. G. Oliver is supported by a NHMRC Career Development Fellowship # 1026880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SR, 2009, PULM PHARMACOL THER, V22, P417, DOI 10.1016/j.pupt.2009.04.007; Baraket M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-11; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; BOUSQUET J., 1992, ALLERGY, V74, P3; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Brouillet JP, 1997, CANCER, V79, P2132, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2132::AID-CNCR10>3.3.CO;2-L; Buhling F, 2001, J PATHOL, V195, P375; Burgess JK, 2010, AM J RESP CRIT CARE, V181, P106, DOI 10.1164/rccm.200904-0631OC; Burgess JK, 2009, PULM PHARMACOL THER, V22, P379, DOI 10.1016/j.pupt.2008.12.007; Burgess JK, 2009, AM J RESP CRIT CARE, P106; Carroll NG, 1997, AM J RESP CRIT CARE, V155, P689, DOI 10.1164/ajrccm.155.2.9032214; Chilosi M, 2009, MODERN PATHOL, V22, P161, DOI 10.1038/modpathol.2008.189; Cimerman N, 2001, CLIN CHIM ACTA, V310, P113, DOI 10.1016/S0009-8981(01)00530-7; Deschamps K, 2011, AM J RESP CELL MOL, V45, P81, DOI 10.1165/rcmb.2009-0392OC; DIMENT S, 1990, J IMMUNOL, V145, P417; ERDEL M, 1990, J HISTOCHEM CYTOCHEM, V38, P1313, DOI 10.1177/38.9.2201737; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Gu QL, 2006, PROTEIN EXPRES PURIF, V47, P461, DOI 10.1016/j.pep.2006.01.011; HARGREAVE FE, 1986, J ALLERGY CLIN IMMUN, V78, P825, DOI 10.1016/0091-6749(86)90226-5; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Kasper M, 1996, VIRCHOWS ARCH, V428, P207; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Lau JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013360; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; MARAGOUDAKIS ME, 1993, KIDNEY INT, V43, P147, DOI 10.1038/ki.1993.24; Meier C, 2006, CLIN LAB, V52, P1; Minarowska A, 2008, FOLIA HISTOCHEM CYTO, V46, P23, DOI 10.2478/v10042-008-0003-x; Minarowska A, 2007, FOLIA HISTOCHEM CYTO, V45, P165; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Munoz-Torres M, 2009, MATURITAS, V64, P188, DOI 10.1016/j.maturitas.2009.09.011; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Oorni K, 2004, J BIOL CHEM, V279, P34776, DOI 10.1074/jbc.M310814200; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Schweiger A, 2000, BRIT J CANCER, V82, P782, DOI 10.1054/bjoc.1999.0999; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Srivastava M, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-54; Sudhakar A, 2008, PHARM RES-DORD, V25, P2731, DOI 10.1007/s11095-008-9634-z; van den Brule S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-84; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Woischnik M, 2008, EUR RESPIR J, V31, P1197, DOI 10.1183/09031936.00081207; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Xia Q, 2012, INT J CARDIOL, V154, P187, DOI 10.1016/j.ijcard.2011.10.093; Xiang XG, 2012, IMMUNOL CELL BIOL, V90, P611, DOI 10.1038/icb.2011.79	50	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57245	10.1371/journal.pone.0057245	http://dx.doi.org/10.1371/journal.pone.0057245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483898	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100016
J	Benkoe, T; Baumann, S; Weninger, M; Pones, M; Reck, C; Rebhandl, W; Oehler, R				Benkoe, Thomas; Baumann, Suzann; Weninger, Manfred; Pones, Mario; Reck, Carlos; Rebhandl, Winfried; Oehler, Rudolf			Comprehensive Evaluation of 11 Cytokines in Premature Infants with Surgical Necrotizing Enterocolitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MESSENGER-RNA EXPRESSION; CRITICALLY-ILL INFANTS; BIRTH-WEIGHT INFANTS; GENE-EXPRESSION; PRETERM INFANTS; INTERLEUKIN-10; SEPSIS; MORBIDITY; MORTALITY	Objective: A prospective study to investigate the pattern of pro-and anti-inflammatory cytokine responses in neonates with surgical necrotizing enterocolitis (NEC) and identify those cytokines being the most promising for future research. Methods: A panel of 11 different cytokines were measured in 9 infants with proven NEC and compared with 18 age-matched healthy neonates. Results: The serum concentrations of the interleukins (IL)-6, IL-8, and IL-10 were significantly (32-fold to 56-fold) higher in NEC infants compared with controls. In contrast, IL-5, IFN gamma, IL-4 and IL-2 showed slightly (1.4-fold to 5.9-fold) lower levels in the NEC samples. However, these cytokines showed a very low absolute concentration in infants with NEC and in controls. The sum of the serum concentrations of IL-6, IL-8 and IL-10 was able to clearly separate infants with NEC from control samples. IL-1 beta and TNF-alpha showed no statistically different levels. The serum levels of TNF-beta and IL-12p70 were below the detection limit in more than 50% of all samples per group. Conclusion: In spite of strong local inflammation only three out of eleven cytokines (IL-6, IL-8, and IL-10) showed strongly increased serum levels indicating an important role of them in the pathogenesis of NEC. At least two of these three cytokines were elevated in every single NEC patient. Thus, longitudinal monitoring of combined IL-8, IL-6, and IL-10 levels could reveal their potency in being clinical relevant markers in NEC.	[Benkoe, Thomas; Baumann, Suzann; Pones, Mario; Reck, Carlos; Rebhandl, Winfried] Med Univ Vienna, Dept Pediat Surg, Vienna, Austria; [Weninger, Manfred] Med Univ Vienna, Dept Pediat, Div Neonatol Intens Care & Neuropediat, Vienna, Austria; [Oehler, Rudolf] Med Univ Vienna, Surg Res Labs, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Benkoe, T (corresponding author), Med Univ Vienna, Dept Pediat Surg, Vienna, Austria.	thomas.benkoe@meduniwien.ac.at	Oehler, Rudolf/ABC-7836-2020; Burneo, Carlos Albert Reck/D-1099-2009	Oehler, Rudolf/0000-0003-2891-7155; Burneo, Carlos Albert Reck/0000-0003-4284-8969; rebhandl, winfried/0000-0002-9177-3564; Benkoe, Thomas/0000-0002-3428-9186				Benkoe T, 2012, J PEDIATR SURG, V47, P1548, DOI 10.1016/j.jpedsurg.2011.11.049; Berrington JE, 2012, J PEDIATR-US, V160, P49, DOI 10.1016/j.jpeds.2011.06.046; Chan KYY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036977; Chuang SL, 2009, PEDIAT ALLERG IMM-UK, V20, P45, DOI 10.1111/j.1399-3038.2008.00729.x; COMINELLI F, 1990, J CLIN INVEST, V86, P972, DOI 10.1172/JCI114799; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Emami CN, 2012, AM J SURG, V203, P428, DOI 10.1016/j.amjsurg.2011.08.016; Ford H R, 1996, Semin Pediatr Surg, V5, P155; Goepfert AR, 2004, AM J OBSTET GYNECOL, V191, P1375, DOI 10.1016/j.ajog.2004.06.086; Halpern MD, 2002, PEDIATR RES, V51, P733, DOI 10.1023/01.PDR.0000017480.64723.56; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; JORDAN M, 1995, J IMMUNOL, V154, P4081; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lane JS, 1997, SURGERY, V122, P288, DOI 10.1016/S0039-6060(97)90020-9; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Linch SN, 2012, AM J RESP CRIT CARE, V186, P246, DOI 10.1164/rccm.201201-0134OC; Lodha A, 2010, ACTA PAEDIATR, V99, P338, DOI 10.1111/j.1651-2227.2009.01600.x; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; MATTHES T, 1993, J EXP MED, V178, P521, DOI 10.1084/jem.178.2.521; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Nadler EP, 2001, J PEDIATR SURG, V36, P1122, DOI 10.1053/jpsu.2001.25726; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Rees CM, 2007, ARCH DIS CHILD-FETAL, V92, pF193, DOI 10.1136/adc.2006.099929; Romagnoli C, 2001, EUR J PEDIATR, V160, P345, DOI 10.1007/PL00008445; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P21, DOI 10.1016/0016-5085(95)90004-7; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Viscardi RM, 1997, PEDIATR PATHOL LAB M, V17, P547, DOI 10.1080/107710497174516; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; West GA, 1996, GASTROENTEROLOGY, V110, P1683, DOI 10.1053/gast.1996.v110.pm8964392	35	53	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58720	10.1371/journal.pone.0058720	http://dx.doi.org/10.1371/journal.pone.0058720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472217	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900163
J	Cyktor, JC; Carruthers, B; Beamer, GL; Turner, J				Cyktor, Joshua C.; Carruthers, Bridget; Beamer, Gillian L.; Turner, Joanne			Clonal Expansions of CD8(+) T Cells with IL-10 Secreting Capacity Occur during Chronic Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							GAMMA-INTERFERON; VIRUS-INFECTION; PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; PROGRAMMED DEATH-1; MELANOMA PATIENTS; VIRAL-INFECTION; CUTTING EDGE; C57BL/6 MICE; CBA/J MICE	The exact role of CD8(+) T cells during Mycobacterium tuberculosis (Mtb) infection has been heavily debated, yet it is generally accepted that CD8(+) T cells contribute to protection against Mtb. In this study, however, we show that the Mtb-susceptible CBA/J mouse strain accumulates large numbers of CD8(+) T cells in the lung as infection progresses, and that these cells display a dysfunctional and immunosuppressive phenotype (PD-1(+), Tim-3(+), CD122(+)). CD8(+) T cell expansions from the lungs of Mtb-infected CBA/J mice were also capable of secreting the immunosuppressive cytokine interleukin-10 (IL-10), although in vivo CD8(+) T cell depletion did not significantly alter Mtb burden. Further analysis revealed that pulmonary CD8(+) T cells from Mtb-infected CBA/J mice were clonally expanded, preferentially expressing T cell receptor (TcR) V beta chain 8 (8.2, 8.3) or V beta 14. Although V beta 8(+) CD8(+) T cells were responsible for the majority of IL-10 production, in vivo depletion of V beta 8(+) did not significantly change the outcome of Mtb infection, which we hypothesize was a consequence of their dual IL-10/IFN-gamma secreting profiles. Our data demonstrate that IL-10-secreting CD8(+) T cells can arise during chronic Mtb infection, although the significance of this T cell population in tuberculosis pathogenesis remains unclear.	[Cyktor, Joshua C.; Turner, Joanne] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Beamer, Gillian L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Cyktor, Joshua C.; Carruthers, Bridget; Beamer, Gillian L.; Turner, Joanne] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Turner, J (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	joanne.turner@osumc.edu	Turner, Joanne/F-4118-2015		National Institutes of Health (NIH) [AI-064522]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064522] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health (NIH) R01 (AI-064522; JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel M, 2006, HEPATOLOGY, V44, P1607, DOI 10.1002/hep.21438; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Beamer GL, 2008, CLIN VACCINE IMMUNOL, V15, P474, DOI 10.1128/CVI.00408-07; Beamer GL, 2012, EUR J IMMUNOL, V42, P870, DOI 10.1002/eji.201142054; Beamer GL, 2011, CELL IMMUNOL, V271, P53, DOI 10.1016/j.cellimm.2011.06.002; Beamer GL, 2005, ARCH IMMUNOL THER EX, V53, P469; Begum D, 2009, IMMUNOLOGY, V128, P556, DOI 10.1111/j.1365-2567.2009.03141.x; BEHLKE MA, 1986, P NATL ACAD SCI USA, V83, P767, DOI 10.1073/pnas.83.3.767; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bold TD, 2012, J IMMUNOL, V189, P2530, DOI 10.4049/jimmunol.1200994; Boom WH, 2007, J CLIN INVEST, V117, P2092, DOI 10.1172/JCI32933; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Chen JZ, 2009, J LEUKOCYTE BIOL, V86, P1305, DOI 10.1189/jlb.0609406; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; D'Souza CD, 2000, AM J RESP CELL MOL, V23, P188, DOI 10.1165/ajrcmb.23.2.4063; Dai HH, 2010, J IMMUNOL, V185, P803, DOI 10.4049/jimmunol.1000661; Dalakas MC, 2007, ANN NEUROL, V61, P466, DOI 10.1002/ana.21103; Du G, 2010, J IMMUNOL, V185, P3940, DOI 10.4049/jimmunol.1001222; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; FLYNN JAL, 1993, INFECT AGENT DIS, V2, P259; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Hofmeyer KA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/451694; Huang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030631; Itoh S, 2002, AM J HEMATOL, V69, P59, DOI 10.1002/ajh.10005; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; JOUVINMARCHE E, 1992, P NATL ACAD SCI USA, V89, P3232, DOI 10.1073/pnas.89.8.3232; Junqueira-Kipnis AP, 2005, IMMUNOLOGY, V115, P246, DOI 10.1111/j.1365-2567.2005.02136.x; Kang HS, 2010, J VIROL, V84, P2774, DOI 10.1128/JVI.01948-09; Kaufmann DE, 2008, CURR OPIN HIV AIDS, V3, P362, DOI 10.1097/COH.0b013e3282f9ae8b; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Lalvani A, 2002, AM J RESP CRIT CARE, V166, P789, DOI 10.1164/rccm.2206002; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; MULLER I, 1987, INFECT IMMUN, V55, P2037; Mumprecht S, 2009, BLOOD, V114, P1528, DOI 10.1182/blood-2008-09-179697; Rowbottom AW, 1999, IMMUNOLOGY, V98, P80; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Shams H, 2001, INFECT IMMUN, V69, P3497, DOI 10.1128/IAI.69.5.3497-3501.2001; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Silva RA, 2001, J IMMUNOL, V167, P1535, DOI 10.4049/jimmunol.167.3.1535; Sousa AO, 2000, P NATL ACAD SCI USA, V97, P4204, DOI 10.1073/pnas.97.8.4204; STAERZ UD, 1985, J IMMUNOL, V134, P3994; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Turner J, 2001, INFECT IMMUN, V69, P3264, DOI 10.1128/IAI.69.5.3264-3270.2001; Urdahl KB, 2003, J IMMUNOL, V170, P1987, DOI 10.4049/jimmunol.170.4.1987; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Vesosky B, 2006, INFECT IMMUN, V74, P3314, DOI 10.1128/IAI.01475-05; Wang J, 2004, J IMMUNOL, V173, P4590, DOI 10.4049/jimmunol.173.7.4590; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001	63	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58612	10.1371/journal.pone.0058612	http://dx.doi.org/10.1371/journal.pone.0058612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472214	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900160
J	Roche, EA; Brown, CR; Brown, MB; Lear, KM				Roche, Erin A.; Brown, Charles R.; Brown, Mary Bomberger; Lear, Kristen M.			Recapture Heterogeneity in Cliff Swallows: Increased Exposure to Mist Nets Leads to Net Avoidance	PLOS ONE			English	Article							STEROID-HORMONE LEVELS; CAPTURE-RECAPTURE; INDIVIDUAL HETEROGENEITY; POPULATION-SIZE; TRAP-RESPONSE; REPRODUCTIVE SUCCESS; ANNUAL SURVIVAL; ADULT SURVIVAL; MARKED ANIMALS; ABUNDANCE	Ecologists often use mark-recapture to estimate demographic variables such as abundance, growth rate, or survival for samples of wild animal populations. A common assumption underlying mark-recapture is that all animals have an equal probability of detection, and failure to meet or correct for this assumption-as when certain members of the population are either easier or more difficult to capture than other animals-can lead to biased and inaccurate demographic estimates. We built within-year and among-years Cormack-Jolly-Seber recaptures-only models to identify causes of capture heterogeneity for a population of colonially nesting cliff swallows (Petrochelidon pyrrhonota) caught using mist-netting as a part of a 20-year mark-recapture study in southwestern Nebraska, U. S. A. Daily detection of cliff swallows caught in stationary mist nets at their colony sites declined as the birds got older and as the frequency of netting at a site within a season increased. Experienced birds' avoidance of the net could be countered by sudden disturbances that startled them into a net, such as when we dropped a net over the side of a bridge or flushed nesting cliff swallows into a stationary net positioned at a colony entrance. Our results support the widely held, but seldom tested, belief that birds learn to avoid stationary mist nets over time, but also show that modifications of traditional field methods can reduce this source of recapture heterogeneity.	[Roche, Erin A.; Brown, Charles R.; Brown, Mary Bomberger; Lear, Kristen M.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	University of Tulsa	Roche, EA (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	roch042@gmail.com			National Science Foundation [DEB-1019423]; National Institutes of Health [AI057569]; National Geographic Society; Erna and Victor Hasselblad Foundation; American Philosophical Society; Princeton University; Yale University; University of Tulsa; Chapman Fund of the American Museum of Natural History; National Academy of Sciences; Sigma Xi; Alpha Chi; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057569] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Geographic Society(National Geographic Society); Erna and Victor Hasselblad Foundation; American Philosophical Society; Princeton University(Princeton University); Yale University; University of Tulsa; Chapman Fund of the American Museum of Natural History; National Academy of Sciences; Sigma Xi; Alpha Chi; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the National Science Foundation (most recently through grant DEB-1019423 to CRB), the National Institutes of Health (grant AI057569 to CRB), the National Geographic Society, the Erna and Victor Hasselblad Foundation, the American Philosophical Society, Princeton University, Yale University, the University of Tulsa, the Chapman Fund of the American Museum of Natural History, the National Academy of Sciences, Sigma Xi, and Alpha Chi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshartous D, 2010, COMPUT STAT DATA AN, V54, P2296, DOI 10.1016/j.csda.2010.04.011; AGRESTI A, 1994, BIOMETRICS, V50, P494, DOI 10.2307/2533391; Altwegg R, 2007, AM NAT, V169, P47, DOI 10.1086/510215; Anthony NM, 2005, WILDLIFE SOC B, V33, P1018, DOI 10.2193/0091-7648(2005)33[1018:CEOLAS]2.0.CO;2; Bart J, 1999, AUK, V116, P1147, DOI 10.2307/4089698; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; BOLLINGER EK, 1994, WILSON BULL, V106, P46; Bonter DN, 2008, J FIELD ORNITHOL, V79, P314, DOI 10.1111/j.1557-9263.2008.00179.x; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Bradford AL, 2006, MAR ECOL PROG SER, V315, P293, DOI 10.3354/meps315293; Brown C. R., 1996, COLONIALITY CLIFF SW; Brown C.R., 1998, SWALLOW SUMMER; Brown CR, 2008, ANIM BEHAV, V76, P1201, DOI 10.1016/j.anbehav.2008.03.028; Brown CR, 2007, VECTOR-BORNE ZOONOT, V7, P304, DOI 10.1089/vbz.2006.0646; Brown CR, 2005, ECOLOGY, V86, P1034, DOI 10.1890/04-0740; Brown CR, 2005, ECOLOGY, V86, P2904, DOI 10.1890/05-0246; Brown CR, 2000, J ANIM ECOL, V69, P133, DOI 10.1046/j.1365-2656.2000.00382.x; Brown CR, 2004, BEHAV ECOL SOCIOBIOL, V36, P221; Brown MB, 2009, AUK, V126, P853, DOI 10.1525/auk.2009.09048; BROWNIE C, 1983, BIOMETRICS, V39, P437, DOI 10.2307/2531015; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; Calvert AM, 2009, J APPL ECOL, V46, P610, DOI 10.1111/j.1365-2664.2009.01636.x; CAROTHERS AD, 1973, J ANIM ECOL, V42, P125, DOI 10.2307/3408; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chao A, 2000, BIOMETRICS, V56, P427, DOI 10.1111/j.0006-341X.2000.00427.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cooper CB, 2008, ECOLOGY, V89, P3349, DOI 10.1890/08-0315.1; Crespin L, 2008, POPUL ECOL, V50, P247, DOI 10.1007/s10144-008-0090-8; Cubaynes S, 2012, METHODS ECOL EVOL, V3, P564, DOI 10.1111/j.2041-210X.2011.00175.x; Cubaynes S, 2010, CONSERV BIOL, V24, P621, DOI 10.1111/j.1523-1739.2009.01431.x; Davis AK, 2005, J FIELD ORNITHOL, V76, P339, DOI 10.1648/0273-8570-76.4.339; Davis SA, 2003, J WILDLIFE MANAGE, V67, P634, DOI 10.2307/3802720; Desante DF, 1995, J APPL STAT, V22, P935, DOI 10.1080/02664769524720; DESLAURIERS JV, 1991, J FIELD ORNITHOL, V62, P107; Devineau O, 2006, WILDLIFE SOC B, V34, P1028, DOI 10.2193/0091-7648(2006)34[1028:PCSSPB]2.0.CO;2; Dieter CD, 2009, J WILDLIFE MANAGE, V73, P1223, DOI 10.2193/2008-438; Domenech J, 1998, J FIELD ORNITHOL, V69, P380; Drickamer LC, 1999, J MAMMAL, V80, P410, DOI 10.2307/1383289; Dunn Erica H., 2004, Studies in Avian Biology, P92; EBERHARDT LL, 1969, J WILDLIFE MANAGE, V33, P28, DOI 10.2307/3799647; Faaborg J, 2007, J FIELD ORNITHOL, V78, P270, DOI 10.1111/j.1557-9263.2007.00114.x; Fearnbach H, 2012, ECOL APPL, V22, P1689; Fletcher D, 2012, METHODS ECOL EVOL, V3, P206, DOI 10.1111/j.2041-210X.2011.00137.x; Gardali T, 2000, CONDOR, V102, P601, DOI 10.1650/0010-5422(2000)102[0601:DOADPO]2.0.CO;2; Gehrt SD, 1996, AM MIDL NAT, V135, P23, DOI 10.2307/2426868; Gilroy JJ, 2012, ECOLOGY, V93, P1509, DOI 10.1890/12-0124.1; Gimenez O, 2010, ECOLOGY, V91, P951, DOI 10.1890/09-1903.1; Gimenez O, 2008, AM NAT, V172, P441, DOI 10.1086/589520; Grosbois V, 2005, OIKOS, V109, P273, DOI 10.1111/j.0030-1299.2005.13774.x; Harris MP, 1997, J AVIAN BIOL, V28, P287, DOI 10.2307/3676941; Hein EW, 2000, SOUTHWEST NAT, V45, P67, DOI 10.2307/3672553; Hines JE, 2002, J APPL STAT, V29, P573, DOI 10.1080/02664760120108872; Huggins R, 2001, STAT PROBABIL LETT, V54, P147, DOI 10.1016/S0167-7152(00)00233-9; Jennings S, 2009, CONDOR, V111, P488, DOI 10.1525/cond.2009.080107; JENSEN TS, 1975, OIKOS, V26, P196, DOI 10.2307/3543709; Karr J.R., 1981, Studies in Avian Biology, P62; Koons DN, 2009, HERPETOL CONSERV BIO, V4, P221; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lee DE, 2008, AUK, V125, P316, DOI 10.1525/auk.2008.07007; Lefebvre L, 1996, BEHAVIOUR, V133, P241, DOI 10.1163/156853996X00134; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; MACARTHUR RH, 1974, P NATL ACAD SCI USA, V71, P3230, DOI 10.1073/pnas.71.8.3230; MARTEN GG, 1970, ECOLOGY, V51, P291, DOI 10.2307/1933666; McClintock BT, 2006, J AGR BIOL ENVIR ST, V11, P231, DOI 10.1198/108571106X129171; Moller AP, 1999, J ANIM ECOL, V68, P163, DOI 10.1046/j.1365-2656.1999.00274.x; NICHOLS JD, 1984, J WILDLIFE MANAGE, V48, P289, DOI 10.2307/3808491; Nur Nadav, 2004, Studies in Avian Biology, P63; Ogutu JO, 2006, J ZOOL, V269, P161, DOI 10.1111/j.1469-7998.2006.00058.x; Peach WJ, 1996, BIRD STUDY, V43, P142, DOI 10.1080/00063659609461007; Peron G, 2010, OIKOS, V119, P524, DOI 10.1111/j.1600-1706.2009.17882.x; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Pledger S, 2008, BIOMETRICAL J, V50, P1022, DOI 10.1002/bimj.200810446; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Pradel R, 1997, ECOLOGY, V78, P1431; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pradel R., 1993, P29; Prevot-Julliard AC, 1998, AUK, V115, P85; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Rexstad E., 2012, RMARK R CODE MARK AN; Roche EA, 2011, ANIM BEHAV, V82, P1275, DOI 10.1016/j.anbehav.2011.09.005; Roche EA, 2008, BIOL CONSERV, V141, P3079, DOI 10.1016/j.biocon.2008.09.014; Royle JA, 2008, BIOMETRICS, V64, P364, DOI 10.1111/j.1541-0420.2007.00891.x; Salewski V, 2007, J ORNITHOL, V148, P29, DOI 10.1007/s10336-006-0096-y; SENAR JC, 1988, J FIELD ORNITHOL, V59, P381; Seppanen JT, 2007, CURR BIOL, V17, P1248, DOI 10.1016/j.cub.2007.06.034; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; SILVY NJ, 1968, J WILDLIFE MANAGE, V32, P175, DOI 10.2307/3798252; Smout S, 2011, J APPL ECOL, V48, P364, DOI 10.1111/j.1365-2664.2010.01913.x; Spotswood EN, 2012, METHODS ECOL EVOL, V3, P29, DOI 10.1111/j.2041-210X.2011.00123.x; SUMMERLIN CT, 1973, ECOLOGY, V54, P1156, DOI 10.2307/1935584; Tanaka R., 1963, Researches on Population Ecology Japan, V5, P139, DOI 10.1007/BF02518838; Tavecchia G, 2001, ECOLOGY, V82, P165, DOI 10.1890/0012-9658(2001)082[0165:SAARVI]2.0.CO;2; Tuyttens FAM, 1999, J APPL ECOL, V36, P1051, DOI 10.1046/j.1365-2664.1999.00462.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehead H, 2001, MAR MAMMAL SCI, V17, P718, DOI 10.1111/j.1748-7692.2001.tb01295.x; Williams BL, 2011, J WILDLIFE MANAGE, V75, P432, DOI 10.1002/jwmg.64; Zabel RW, 2005, ECOL APPL, V15, P1427, DOI 10.1890/04-0940; [No title captured]	99	26	25	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58092	10.1371/journal.pone.0058092	http://dx.doi.org/10.1371/journal.pone.0058092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472138	gold, Green Published			2022-12-27	WOS:000315637900083
J	Yang, ZY; Yuan, JQ; Di, MY; Zheng, DY; Chen, JZ; Ding, H; Wu, XY; Huang, YF; Mao, C; Tang, JL				Yang, Zu-Yao; Yuan, Jin-Qiu; Di, Meng-Yang; Zheng, Da-Yong; Chen, Jin-Zhang; Ding, Hong; Wu, Xin-Yin; Huang, Ya-Fang; Mao, Chen; Tang, Jin-Ling			Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer: A Systematic Review with Meta-Analysis	PLOS ONE			English	Article							PHASE-III TRIAL; GROWTH-FACTOR RECEPTOR; COLONY-STIMULATING FACTOR; CLINICAL-TRIALS; COMBINATION; ADENOCARCINOMA; CHEMOTHERAPY; DOCETAXEL; SURVIVAL; MULTICENTER	Background: This study aims to comprehensively summarize the currently available evidences on the efficacy and safety of gemcitabine plus erlotinib for treating advanced pancreatic cancer. Methodology/Principal Findings: PubMed, EMBASE, The Cochrane Library and abstracts of recent major conferences were systematically searched to identify relevant publications. Studies that were conducted in advanced pancreatic cancer patients treated with gemcitabine plus erlotinib (with or without comparison with gemcitabine alone) and reporting objective response rate, disease control rate, progression-free survival, time-to-progression, overall survival, 1-year survival rate and/or adverse events were included. Data on objective response rate, disease control rate, 1-year survival rate and adverse events rate, respectively, were combined mainly by using Meta-Analyst software with a random-effects model. Data on progression-free survival, time-to-progression and overall survival were summarized descriptively. Sixteen studies containing 1,308 advanced pancreatic cancer patients treated with gemcitabine plus erlotinib were included. The reported median progression-free survival (or time-to-progression), median overall survival, 1-year survival rates, objective response rates and disease control rates were 2-9.6 months, 5-12.5 months, 20%-51%, 0%-28.6% and 25.0%-83.3%, respectively. The weighted 1-year survival rate, objective response rate and disease control rate based on studies reporting robust results were 27.9%, 9.1% and 57.0%, respectively. According to the studies with relevant data, the incidences of total and severe adverse events were 96.3% and 62.9%, respectively. The most frequently reported adverse events were leucopenia, rash, diarrhea, vomitting, neutropenia, thrombocytopenia, anaemia, stomatitis, drug-induced liver injury, fatigue and fever. Compared with gemcitabine alone, the progression-free survival and overall survival with gemcitabine plus erlotinib were significantly longer, but there were also more deaths and interstitial lung disease-like syndrome related to this treatment. Conclusions/Significance: Gemcitabine plus erlotinib represent a new option for the treatment of advanced pancreatic cancer, with mild but clinically meaningful additive efficacy compared with gemcitabine alone. Its safety profile is generally acceptable, although careful management is needed for some specific adverse events.	[Yang, Zu-Yao; Yuan, Jin-Qiu; Di, Meng-Yang; Wu, Xin-Yin; Huang, Ya-Fang; Mao, Chen; Tang, Jin-Ling] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Yang, Zu-Yao; Mao, Chen; Tang, Jin-Ling] Chinese Univ Hong Kong, Hong Kong Branch, Chinese Cochrane Ctr, Hong Kong, Hong Kong, Peoples R China; [Zheng, Da-Yong; Chen, Jin-Zhang] Southern Med Univ, Dept Oncol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Ding, Hong] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Mao, Chen; Tang, Jin-Ling] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen Municipal Key Lab Hlth Risk Anal, Shenzhen, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Southern Medical University - China; Southern Medical University - China; Chinese University of Hong Kong, Shenzhen	Mao, C (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China.	maochen@cuhk.edu.hk; jltang@cuhk.edu.hk	Yuan, Jinqiu/A-4867-2018; Tang, JL/G-1759-2013; Mao, Chen/G-9805-2013; Mao, Chen/AAW-2742-2020; Di, Mengyang/U-4847-2018	Mao, Chen/0000-0001-7471-1516; Mao, Chen/0000-0002-6537-6215; Di, Mengyang/0000-0001-6165-2617				Anderson KE, 2006, CANC EPIDEMIOLOGY PR; Androulakis N, 1999, J CLIN ONCOL, V17, P1779, DOI 10.1200/JCO.1999.17.6.1779; Aranda E, 2012, ANN ONCOL, V23, P1919, DOI 10.1093/annonc/mdr560; Ardavanis A, 2009, ANTICANCER RES, V29, P5211; Bengala C, 2009, PHASE 2 TRIAL ERLOTI; Berlin JD, 2002, J CLIN ONCOL, V20, P3270, DOI 10.1200/JCO.2002.11.149; Boeck S, 2010, ANTI-CANCER DRUG, V21, P94, DOI 10.1097/CAD.0b013e32833123ed; Bond-Smith G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2476; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cascinu S, 1999, ANN ONCOL, V10, P105, DOI 10.1023/A:1008205515591; Cheng Yue-Juan, 2010, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V32, P421, DOI 10.3881/j.issn.1000-503X.2010.04.013; Colucci G, 2002, CANCER, V94, P902, DOI 10.1002/cncr.10323.abs; Deeks JJ, COCHRANE HDB SYSTEMA; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dragovich T, 2007, CANCER CHEMOTH PHARM, V60, P295, DOI 10.1007/s00280-006-0389-0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feliu J, 2011, CANCER CHEMOTH PHARM, V67, P215, DOI 10.1007/s00280-010-1472-0; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fjallskog MLH, 2003, CLIN CANCER RES, V9, P1469; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim GP, 2011, RANDOMIZED PHASE 2 T; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Lynch TJ, 2007, ONCOLOGIST, V12, P610, DOI 10.1634/theoncologist.12-5-610; Milella M, 2010, PHASE 2 STUDY ERLOTI; Miller VA, 2000, SEMIN ONCOL, V27, P3; Modiano M, 2012, APRICOT P RANDOMIZED; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Munoz Llarena A, 2011, GEMCITABINE G FIXED; Oettle H, 2005, ANN ONCOL, V16, P1639, DOI 10.1093/annonc/mdi309; Okusaka T, 2011, CANCER SCI, V102, P425, DOI 10.1111/j.1349-7006.2010.01810.x; Perez-Soler R, 2005, J CLIN ONCOL, V23, P5235, DOI 10.1200/JCO.2005.00.6916; Philip PA, 2012, PHASE 1 RANDOMIZED P; Scheithauer W, 2003, ANN ONCOL, V14, P97, DOI 10.1093/annonc/mdg029; Stathopoulos GP, 2008, ANTICANCER RES, V28, P1303; Stathopoulos GP, 2001, ANN ONCOL, V12, P101, DOI 10.1023/A:1008310106171; Stuebs P, 2010, 1 LINE THERAPY ADV P; Tobita K, 2003, INT J MOL MED, V11, P305; Ueda S, 2004, PANCREAS, V29, pE1, DOI 10.1097/00006676-200407000-00061; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Xiong HQ, 2004, CANCER CHEMOTH PHARM, V54, pS69, DOI 10.1007/s00280-004-0890-2	45	32	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57528	10.1371/journal.pone.0057528	http://dx.doi.org/10.1371/journal.pone.0057528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472089	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900028
J	Gopinath, B; Schneider, J; McMahon, CM; Burlutsky, G; Leeder, SR; Mitchell, P				Gopinath, Bamini; Schneider, Julie; McMahon, Catherine M.; Burlutsky, George; Leeder, Stephen R.; Mitchell, Paul			Dual Sensory Impairment in Older Adults Increases the Risk of Mortality: A Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; BLUE-MOUNTAINS-EYE; HEALTH INTERVIEW SURVEY; HEARING-LOSS; VISUAL IMPAIRMENT; AUSTRALIAN POPULATION; COMMUNITY; AGE; PREVALENCE; CONSEQUENCES	Although concurrent vision and hearing loss are common in older adults, population-based data on their relationship with mortality is limited. This cohort study investigated the association between objectively measured dual sensory impairment (DSI) with mortality risk over 10 years. 2812 Blue Mountains Eye Study participants aged 55 years and older at baseline were included for analyses. Visual impairment was defined as visual acuity less than 20/40 (better eye), and hearing impairment as average pure-tone air conduction threshold greater than 25 dB HL (500-4000 Hz, better ear). Ten-year all-cause mortality was confirmed using the Australian National Death Index. After ten years, 64% and 11% of participants with DSI and no sensory loss, respectively, had died. After multivariable adjustment, participants with DSI (presenting visual impairment and hearing impairment) compared to those with no sensory impairment at baseline, had 62% increased risk of all-cause mortality, hazard ratio, HR, 1.62 (95% confidence intervals, CI, 1.16-2.26). This association was more marked in those with both moderate-severe hearing loss (. 40 dB HL) and presenting visual impairment, HR 1.84 (95% CI 1.19-2.86). Participants with either presenting visual impairment only or hearing impairment only, did not have an increased risk of mortality, HR 1.05 (95% CI 0.61-1.80) and HR 1.24 (95% CI 0.99-1.54), respectively. Concurrent best-corrected visual impairment and moderate-severe hearing loss was more strongly associated with mortality 10 years later, HR 2.19 (95% CI 1.20-4.03). Objectively measured DSI was an independent predictor of total mortality in older adults. DSI was associated with a risk of death greater than that of either vision loss only or hearing loss alone.	[Gopinath, Bamini; Burlutsky, George; Mitchell, Paul] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Gopinath, Bamini; Burlutsky, George; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Schneider, Julie; Leeder, Stephen R.] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia; [McMahon, Catherine M.] Univ Melbourne, HEARing Cooperat Res Ctr, Melbourne, Vic, Australia; [McMahon, Catherine M.] Macquarie Univ, Ctr Language Sci, Dept Linguist, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Melbourne; Macquarie University	Mitchell, P (corresponding author), Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia.	paul_mitchell@wmi.usyd.edu.au	Gopinath, Bamini/K-4286-2019; Mitchell, Paul/P-1498-2014; Schneider, Julie/GXV-0276-2022	Gopinath, Bamini/0000-0003-3573-359X; McMahon, Catherine/0000-0001-7312-6593	Australian National Health and Medical Research Council [974159, 991407, 211069, 262120]; National Health and Medical Research Council (NHMRC) Partnerships for Better Health [571449]; HEARing CRC under the Australian Government's Cooperative Research Centres Program; NHMRC Centre for Clinical Research Excellence [529923]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Partnerships for Better Health(National Health and Medical Research Council (NHMRC) of Australia); HEARing CRC under the Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC Centre for Clinical Research Excellence(National Health and Medical Research Council (NHMRC) of Australia)	The Blue Mountains Eye and Hearing Study were supported by the Australian National Health and Medical Research Council (Grant Nos. 974159, 991407, 211069, 262120). The authors also acknowledge the financial support of the National Health and Medical Research Council (NHMRC) Partnerships for Better Health (grant no. 571449) and the HEARing CRC, established and supported under the Australian Government's Cooperative Research Centres Program. Bamini Gopinath is supported by an NHMRC Centre for Clinical Research Excellence (grant no 529923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], 1994, AUSTR POPULATION CEN; Appollonio I, 1996, AGE AGEING, V25, P89, DOI 10.1093/ageing/25.2.89; APPOLLONIO I, 1995, AGE AGEING, V24, P30, DOI 10.1093/ageing/24.1.30; Arlinger S, 2003, INT J AUDIOL, V42, pS17; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Burlutsky G, 2012, AGE AGEING; CARABELLESE C, 1993, J AM GERIATR SOC, V41, P401, DOI 10.1111/j.1532-5415.1993.tb06948.x; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Chia EM, 2006, OPHTHAL EPIDEMIOL, V13, P371, DOI 10.1080/09286580600864794; Chia EM, 2004, INVEST OPHTH VIS SCI, V45, P71, DOI 10.1167/iovs.03-0661; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Cugati S, 2007, ARCH OPHTHALMOL-CHIC, V125, P917, DOI 10.1001/archopht.125.7.917; Dhital A, 2010, EYE, V24, P1437, DOI 10.1038/eye.2010.60; Evans JR, 2007, OPHTHALMOLOGY, V114, P283, DOI 10.1016/j.ophtha.2006.10.006; Feeny D, 2012, J CLIN EPIDEMIOL, V65, P764, DOI 10.1016/j.jclinepi.2012.01.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman EE, 2005, INVEST OPHTH VIS SCI, V46, P4040, DOI 10.1167/iovs.05-0687; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gopinath B, 2010, EAR HEARING, V31, P277, DOI 10.1097/AUD.0b013e3181c8e902; Gopinath B, 2012, MATURITAS, V72, P146, DOI 10.1016/j.maturitas.2012.03.010; Gopinath B, 2012, AGE AGEING, V41, P195, DOI 10.1093/ageing/afr155; Gopinath B, 2009, J AM GERIATR SOC, V57, P1306, DOI 10.1111/j.1532-5415.2009.02317.x; Gopinath B, 2009, ARCH INTERN MED, V169, P415, DOI 10.1001/archinternmed.2008.597; HANSON BS, 1989, AM J EPIDEMIOL, V130, P100, DOI 10.1093/oxfordjournals.aje.a115301; Heine C, 2002, DISABIL REHABIL, V24, P763, DOI 10.1080/09638280210129162; Karpa MJ, 2010, ANN EPIDEMIOL, V20, P452, DOI 10.1016/j.annepidem.2010.03.011; Karpa MJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P1347, DOI 10.1001/archophthalmol.2009.240; Keller BK, 1999, J AM GERIATR SOC, V47, P1319, DOI 10.1111/j.1532-5415.1999.tb07432.x; Laforge R.G., 1992, J AGING HEALTH, V4, P126, DOI [10.1177/089826439200400108, DOI 10.1177/089826439200400108]; Lam BL, 2006, ARCH OPHTHALMOL-CHIC, V124, P95, DOI 10.1001/archopht.124.1.95; Lee DJ, 2007, J AGING HEALTH, V19, P382, DOI 10.1177/0898264307300174; Lee DJ, 2005, J AGING HEALTH, V17, P531, DOI 10.1177/0898264305277956; LUTMAN M E, 1987, British Journal of Audiology, V21, P45, DOI 10.3109/03005368709077774; Magliano D, 2003, AUST NZ J PUBL HEAL, V27, P649, DOI 10.1111/j.1467-842X.2003.tb00615.x; Mitchell P, 2009, DIABETIC MED, V26, P483, DOI 10.1111/j.1464-5491.2009.02710.x; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Schneider J. M., 2011, J AGING HLTH; Schneider J, 2012, ANN EPIDEMIOL, V22, P295, DOI 10.1016/j.annepidem.2012.02.004; Schneider J, 2010, AGE AGEING, V39, P458, DOI 10.1093/ageing/afq051; Schneider JM, 2011, J AGING HEALTH, V23, P1309, DOI 10.1177/0898264311408418; Smith W, 1997, AUST NZ J PUBL HEAL, V21, P127, DOI 10.1111/j.1467-842X.1997.tb01671.x; Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248; Tay T, 2007, J AGING HEALTH, V19, P229, DOI 10.1177/0898264307299243; Tay T, 2006, GERONTOLOGY, V52, P386, DOI 10.1159/000095129; Taylor HR, 2005, MED J AUSTRALIA, V182, P565, DOI 10.5694/j.1326-5377.2005.tb06815.x; Viljanen A, 2009, J GERONTOL A-BIOL, V64, P312, DOI 10.1093/gerona/gln015; WHO, 1977, MAN INT STAT CLASS D, V1; Woodcock K, 2008, INT J REHABIL RES, V31, P297, DOI 10.1097/MRR.0b013e3282fb7d4d; World Health Organization, 1992, INT STAT CLASS DIS R	52	79	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e55054	10.1371/journal.pone.0055054	http://dx.doi.org/10.1371/journal.pone.0055054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099PY	23469161	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900002
J	Laurenzana, A; Balliu, M; Cellai, C; Romanelli, MN; Paoletti, F				Laurenzana, Anna; Balliu, Manjola; Cellai, Cristina; Romanelli, Maria Novella; Paoletti, Francesco			Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; CHROMATIN-STRUCTURE; ANDROGEN-RECEPTOR; TUMOR-CELLS; NUDE-MICE; EXPRESSION; GROWTH; ACETYLATION; APOPTOSIS; DIFFERENTIATION	Histone deacetylase inhibitors (HDACi) represent a promising class of epigenetic agents with anticancer properties. Here, we report that (S)-2, a novel hydroxamate-based HDACi, shown previously to be effective against acute myeloid leukemia cells, was also a potent inducer of apoptosis/differentiation in human prostate LNCaP and PC3 cancer cells. In LNCaP cells (S)-2 was capable of triggering H3/H4 histone acetylation, H2AX phosphorylation as a marker of DNA damage and producing G(0)/G(1) cell cycle arrest. Consistently, (S)-2 led to enhanced expression of both the protein and mRNA p21 levels in LNCaP cells but, contrary to SAHA, not in normal non-tumorigenic prostate PNT1A cells. Mechanistic studies demonstrated that (S)-2-induced apoptosis in LNCaP cells developed through the cleavage of pro-caspase 9 and 3 and of poly(ADP-ribose)polymerase accompanied by the dose-dependent loss of mitochondrial membrane potential. Indeed, the addition of the pan-caspase inhibitor Z-VAD-fmk greatly reduced drug-mediated apoptosis while the antioxidant N-acetyl-cysteine was virtually ineffective. Importantly, preliminary data with nude mice xenografted with LNCaP cells showed that (S)-2 prompted a decrease in the tumor volume and an increase in H2AX phosphorylation within the cancer cells. Moreover, the highly metastatic prostate cancer PC3 cells were also sensitive to (S)-2 that: i) induced growth arrest and moderate apoptosis; ii) steered cells towards differentiation and neutral lipid accumulation; iii) reduced cell invasiveness potential by decreasing the amount of MMP-9 activity and up-regulating TIMP-1 expression; and iv) inhibited cell motility and migration through the Matrigel. Overall, (S)-2 has proven to be a powerful HDACi capable of inducing growth arrest, cell death and/or differentiation of LNCaP and PC3 prostate cancer cells and, due to its low toxicity and efficacy in vivo, might also be of clinical interest to support conventional prostate cancer therapy.	[Laurenzana, Anna; Balliu, Manjola; Cellai, Cristina; Paoletti, Francesco] Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy; [Romanelli, Maria Novella] Univ Florence, Dept Pharmaceut Sci, Sesto Fiorentino, Italy	University of Florence; University of Florence	Balliu, M (corresponding author), Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy.	manjolaballiu@virgilio.it; francesco.paoletti@unifi.it	Dei, Silvia/FGV-3455-2022; Bartolucci, Gianluca/J-4545-2019	Dei, Silvia/0000-0003-0898-7148; Bartolucci, Gianluca/0000-0002-5631-8769; ROMANELLI, Maria Novella/0000-0002-5685-3403	MIUR [200606139]; University of Florence, Italy; Ente Cassa di Risparmio di Firenze (Florence, Italy); Associazione Italiana contro le Leucemie	MIUR(Ministry of Education, Universities and Research (MIUR)); University of Florence, Italy; Ente Cassa di Risparmio di Firenze (Florence, Italy)(Fondazione Cassa Risparmio Firenze); Associazione Italiana contro le Leucemie	This work was supported by grants from MIUR (Ministry of Education, Universities and Research PRIN 2006 to FP, #200606139), the University of Florence, Italy (ex 60% 2009 and 2010 to FP and MNR), Ente Cassa di Risparmio di Firenze 2007-9 (Florence, Italy; # 2007.1019 to FP) and Associazione Italiana contro le Leucemie, Linfomi e Mieloma (A.I.L.) sezione di Firenze to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNHARD EJ, 1994, P NATL ACAD SCI USA, V91, P4293, DOI 10.1073/pnas.91.10.4293; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Butler LM, 2000, CANCER RES, V60, P5165; Cellai C, 2006, BRIT J CANCER, V94, P1637, DOI 10.1038/sj.bjc.6603156; Cellai C, 2011, J CELL MOL MED; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; Constantinou AI, 1998, AM J CLIN NUTR, V68, p1426S, DOI 10.1093/ajcn/68.6.1426S; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; Geng L, 2006, CANCER RES, V66, P11298, DOI 10.1158/0008-5472.CAN-06-0049; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guandalini L, 2008, BIOORG MED CHEM LETT, V18, P5071, DOI 10.1016/j.bmcl.2008.07.119; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hua J, 1996, CANCER RES, V56, P5279; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ju R, 2003, CANCER RES, V63, P2891; Kawai H, 2003, INT J CANCER, V107, P353, DOI 10.1002/ijc.11403; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Laurenzana A, 2005, LEUKEMIA, V19, P390, DOI 10.1038/sj.leu.2403618; Leber TM, 1997, ANAL BIOCHEM, V249, P24, DOI 10.1006/abio.1997.2170; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; NAITO K, 1994, INT J CANCER, V58, P730, DOI 10.1002/ijc.2910580518; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Plumb JA, 2003, MOL CANCER THER, V2, P721; Rasheed WK, 2007, EXPERT OPIN INV DRUG, V16, P659, DOI 10.1517/13543784.16.5.659; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sato N, 1997, CANCER RES, V57, P1584; Sonoda H, 1996, ONCOGENE, V13, P143; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tsunezuka Y, 1996, CANCER RES, V56, P5678; Wang Q, 2001, BREAST CANCER RES TR, V67, P157, DOI 10.1023/A:1010643323268; Warren KE, 2008, CANCER CHEMOTH PHARM, V62, P433, DOI 10.1007/s00280-007-0622-5; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu WS, 2006, P NATL ACAD SCI USA, V103, P15540, DOI 10.1073/pnas.0607518103; Zhau HYE, 2011, CLIN CANCER RES, V17, P2159, DOI 10.1158/1078-0432.CCR-10-2523; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	50	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58267	10.1371/journal.pone.0058267	http://dx.doi.org/10.1371/journal.pone.0058267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469273	Green Published, gold			2022-12-27	WOS:000315634900080
J	Lee, SY; Chen, YC; Tsai, IC; Yen, CJ; Chueh, SN; Chuang, HF; Wu, HY; Chiang, CK; Cheng, HT; Hung, KY; Huang, JW				Lee, Szu-Ying; Chen, Yin-Cheng; Tsai, I-Chieh; Yen, Chung-Jen; Chueh, Shu-Neng; Chuang, Hsueh-Fang; Wu, Hon-Yen; Chiang, Chih-Kang; Cheng, Hui-Teng; Hung, Kuan-Yu; Huang, Jenq-Wen			Glycosylated Hemoglobin and Albumin-Corrected Fructosamine Are Good Indicators for Glycemic Control in Peritoneal Dialysis Patients	PLOS ONE			English	Article							GLUCOSE MONITORING-SYSTEM; CHRONIC-RENAL-FAILURE; DIABETIC-PATIENTS; HEMODIALYSIS-PATIENTS; GLYCATED ALBUMIN; CARBAMYLATED HEMOGLOBIN; CELL SURVIVAL; A(1C) LEVELS; ICODEXTRIN; COHORT	Purpose: Diabetes mellitus (DM) is the most common cause of end-stage renal disease and is an important risk factor for morbidity and mortality after dialysis. However, glycemic control among such patients is difficult to assess. The present study examined glycemic control parameters and observed glucose variation after refilling different kinds of fresh dialysate in peritoneal dialysis (PD) patients. Methods: A total of 25 DM PD patients were recruited, and continuous glucose monitoring system (CGMS) was applied to measure interstitial fluid (ISF) glucose levels at 5-min intervals for 3 days. Patients filled out diet and PD fluid exchange diaries. The records measured with CGMS were analyzed and correlated with other glycemic control parameters such as fructosamine, albumin-corrected fructosamine (AlbF), glycosylated hemoglobin (HbA1c), and glycated albumin levels. Results: There were significant correlations between mean ISF glucose and fructosamine (r = 0.45, P<0.05), AlbF (r = 0.54, P<0.01), and HbA1c (r = 0.51, P<0.01). The ISF glucose levels in glucose-containing dialysate increased from approximately 7-8 mg/dL within 1 hour of exchange in contrast to icodextrin dialysate which kept ISF glucose levels unchanged. Conclusion: HbA1c and AlbF significantly correlated with the mean ISF glucose levels, indicating that they are reliable indices of glycemic control in DM PD patients. Icodextrin dialysate seems to have a favorable glycemic control effect when compared to the other glucose-containing dialysates.	[Lee, Szu-Ying] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Taipei, Yunlin County, Taiwan; [Chen, Yin-Cheng; Tsai, I-Chieh] Taipei Hosp, Dept Hlth, Dept Internal Med, Taipei, Taiwan; [Yen, Chung-Jen; Wu, Hon-Yen; Hung, Kuan-Yu; Huang, Jenq-Wen] Natl Taiwan Univ Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan; [Chueh, Shu-Neng] Natl Taiwan Univ Hosp & Coll Med, Dept Nursing, Taipei, Taiwan; [Chuang, Hsueh-Fang] Natl Taiwan Univ Hosp, Dept Nursing, Bei Hu Branch, Taipei, Taiwan; [Wu, Hon-Yen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp & Coll Med, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Cheng, Hui-Teng] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, SY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Taipei, Yunlin County, Taiwan.	007378@ntuh.gov.tw	CHENG, HUI-TENG/AAD-9899-2020	CHENG, HUI-TENG/0000-0003-1544-7473; HUANG, JENQ-WEN/0000-0001-8011-2317; CHIANG, CHIH-KANG/0000-0001-9021-4616; YEN, CHUNG-JEN/0000-0001-5372-3657; HUNG, KUAN-YU/0000-0003-3472-5512	Department of Health, Taipei Hospital	Department of Health, Taipei Hospital	This work was supported by a grant from the Department of Health, Taipei Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS4, DOI 10.2337/dc10-S004; Babazono T, 2007, AM J NEPHROL, V27, P409, DOI 10.1159/000105123; BLUMENKRANTZ MJ, 1981, KIDNEY INT, V19, P593, DOI 10.1038/ki.1981.57; Bock HA, 2008, NEPHROL DIAL TRANSPL, V23, P301, DOI 10.1093/ndt/gfm579; CORONEL F, 1991, ADV PERIT D, V7, P253; Freedman BI, 2010, PERITON DIALYSIS INT, V30, P72, DOI 10.3747/pdi.2008.00243; Gillett Melissa J, 2009, Clin Biochem Rev, V30, P197; GOLDSTEIN DE, 1995, DIABETES CARE, V18, P896, DOI 10.2337/diacare.18.6.896; Gross T M, 2000, Diabetes Technol Ther, V2, P49, DOI 10.1089/152091500316737; Hung KY, 2000, ARTIF ORGANS, V24, P261, DOI 10.1046/j.1525-1594.2000.06478.x; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Joy MS, 2002, AM J KIDNEY DIS, V39, P297, DOI 10.1053/ajkd.2002.30549; Ly J, 2004, AM J KIDNEY DIS, V44, P715, DOI 10.1053/j.ajkd.2004.06.018; Marshall J, 2003, KIDNEY INT, V64, P1480, DOI 10.1046/j.1523-1755.2003.00209.x; McGahan Lynda, 2002, Issues Emerg Health Technol, P1; Mittman N, 2010, KIDNEY INT, V78, pS41, DOI 10.1038/ki.2010.193; Nakao T, 1998, INTERNAL MED, V37, P826, DOI 10.2169/internalmedicine.37.826; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Paniagua R, 2009, PERITON DIALYSIS INT, V29, P422; PANZER S, 1982, BLOOD, V59, P1348; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; Reach G, 2008, DIABETES TECHNOL THE, V10, P69, DOI 10.1089/dia.2007.0261; Reach G, 2008, CURR DIABETES REV, V4, P175, DOI 10.2174/157339908785294488; Riveline JP, 2009, NEPHROL DIAL TRANSPL, V24, P2866, DOI 10.1093/ndt/gfp181; SMITH WGJ, 1989, NEPHROL DIAL TRANSPL, V4, P96; Sulowicz W, 2007, CLIN J AM SOC NEPHRO, V2, P637, DOI 10.2215/CJN.03631006; Tzamaloukas AH, 1996, ADV PERIT D, V12, P171; Weykamp CW, 1999, CLIN CHEM, V45, P438; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Wu HY, 2008, AM J NEPHROL, V28, P765, DOI 10.1159/000128608; Wu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030337; Wu HY, 2010, PERITON DIALYSIS INT, V30, P448, DOI 10.3747/pdi.2009.00063	32	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57762	10.1371/journal.pone.0057762	http://dx.doi.org/10.1371/journal.pone.0057762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469230	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900041
J	Zhang, KP; Wang, JJ; Zhang, LY; Rong, CW; Zhao, FW; Peng, T; Li, HM; Cheng, DM; Liu, X; Qin, HJ; Zhang, AM; Tong, YP; Wang, DW				Zhang, Kunpu; Wang, Junjun; Zhang, Liyi; Rong, Chaowu; Zhao, Fengwu; Peng, Tao; Li, Huimin; Cheng, Dongmei; Liu, Xin; Qin, Huanju; Zhang, Aimin; Tong, Yiping; Wang, Daowen			Association Analysis of Genomic Loci Important for Grain Weight Control in Elite Common Wheat Varieties Cultivated with Variable Water and Fertiliser Supply	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BACKCROSS QTL ANALYSIS; ARRAYS TECHNOLOGY DART; TRITICUM-AESTIVUM L.; HEXAPLOID WHEAT; USE EFFICIENCY; KERNEL SIZE; LINKAGE DISEQUILIBRIUM; MOLECULAR-DETECTION; WIDE ASSOCIATION	Grain weight, an essential yield component, is under strong genetic control and markedly influenced by the environment. Here, by genome-wide association analysis with a panel of 94 elite common wheat varieties, 37 loci were found significantly associated with thousand-grain weight (TGW) in one or more environments differing in water and fertiliser levels. Five loci were stably associated with TGW under all 12 environments examined. Their elite alleles had positive effects on TGW. Four, two, three, and two loci were consistently associated with TGW in the irrigated and fertilised (IF), rainfed (RF), reduced nitrogen (RN), and reduced phosphorus (RP) environments. The elite alleles of the IF-specific loci enhanced TGW under well-resourced conditions, whereas those of the RF-, RN-, or RP-specific loci conferred tolerance to the TGW decrease when irrigation, nitrogen, or phosphorus were reduced. Moreover, the elite alleles of the environment-independent and -specific loci often acted additively to enhance TGW. Four additional loci were found associated with TGW in specific locations, one of which was shown to contribute to the TGW difference between two experimental sites. Further analysis of 14 associated loci revealed that nine affected both grain length and width, whereas the remaining loci influenced either grain length or width, indicating that these loci control grain weight by regulating kernel size. Finally, the elite allele of Xpsp3152 frequently co-segregated with the larger grain haplotype of TaGW2-6A, suggesting probable genetic and functional linkages between Xpsp3152 and GW2 that are important for grain weight control in cereal plants. Our study provides new knowledge on TGW control in elite common wheat lines, which may aid the improvement of wheat grain weight trait in further research.	[Zhang, Kunpu; Wang, Junjun; Rong, Chaowu; Liu, Xin; Qin, Huanju; Zhang, Aimin; Tong, Yiping; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Wang, Junjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhang, Liyi] Guizhou Inst Upland Crops, Guiyang, Peoples R China; [Zhao, Fengwu; Li, Huimin] Hebei Acad Agr & Forestry Sci, Dry Land Farming Inst, Hengshui, Peoples R China; [Peng, Tao; Cheng, Dongmei] Jiyuan Inst Agr Sci, Jiyuan, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hebei Academy of Agricultural & Forestry Sciences	Wang, DW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	dwwang@genetics.ac.cn		wang, dao wen/0000-0002-6230-8735	Ministry of Science and Technology of China [2009CB118300, 2011CB100300, 2011BAD07B02-2]; National Natural Science Foundation of China [30821061]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the Ministry of Science and Technology of China (2009CB118300, 2011CB100300 and 2011BAD07B02-2), and the National Natural Science Foundation of China (30821061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; Bonjean APA, 2010, CEREALS CHINA; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Bryan GJ, 1997, THEOR APPL GENET, V94, P557, DOI 10.1007/s001220050451; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Chardon F, 2012, J EXP BOT, V63, P3401, DOI 10.1093/jxb/err353; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; De Kok LJ., 2011, MOL PHYSL BASIS NUTR, P295; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Dixon J, 2009, WHEAT FACTS FUTURES; Dodig D, 2012, INT J MOL SCI, V13, P6167, DOI 10.3390/ijms13056167; Fan MS, 2012, J EXP BOT, V63, P13, DOI 10.1093/jxb/err248; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fontaine JX, 2009, THEOR APPL GENET, V119, P645, DOI 10.1007/s00122-009-1076-4; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Golabadi M, 2011, EUPHYTICA, V177, P207, DOI 10.1007/s10681-010-0242-8; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta PK, 2002, THEOR APPL GENET, V105, P413, DOI 10.1007/s00122-002-0865-9; Habash DZ, 2007, THEOR APPL GENET, V114, P403, DOI 10.1007/s00122-006-0429-5; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; He Z., 2001, HIST WHEAT BREEDING; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; KETATA H, 1976, CROP SCI, V16, P19, DOI 10.2135/cropsci1976.0011183X001600010005x; Kilian B, 2009, PLANT GENET GENOMICS, V7, P81, DOI 10.1007/978-0-387-77489-3_3; Kirigwi FM, 2007, MOL BREEDING, V20, P401, DOI 10.1007/s11032-007-9100-3; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Laperche A, 2007, THEOR APPL GENET, V115, P399, DOI 10.1007/s00122-007-0575-4; Li Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-143; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; Lincoln S, 1993, WHITEHEAD I BIOMED R; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu LiHua, 2010, Molecular Plant Breeding, V1, P5; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Mantovani P, 2008, MOL BREEDING, V22, P629, DOI 10.1007/s11032-008-9205-3; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; McIntyre CL, 2010, THEOR APPL GENET, V120, P527, DOI 10.1007/s00122-009-1173-4; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Nezhad KZ, 2012, EUPHYTICA, V186, P127, DOI 10.1007/s10681-011-0559-y; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Peleg Z, 2009, PLANT CELL ENVIRON, V32, P758, DOI 10.1111/j.1365-3040.2009.01956.x; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Pritchard JK, 2000, GENETICS, V155, P945; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; Roder MS, 1998, GENETICS, V149, P2007; Rohlf F.J., 2000, NTSYSPC NUMERICAL TA; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Snape JW, 2007, EUPHYTICA, V154, P401, DOI 10.1007/s10681-006-9208-2; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sorrells ME, 2009, PLANT GENET GENOMICS, V7, P655, DOI 10.1007/978-0-387-77489-3_22; Sourdille P, 2001, THEOR APPL GENET, V103, P346, DOI 10.1007/s00122-001-0542-4; Stephenson P, 1998, THEOR APPL GENET, V97, P946, DOI 10.1007/s001220050975; Su JY, 2009, PLANT SCI, V176, P824, DOI 10.1016/j.plantsci.2009.03.006; Su JY, 2006, PLANT SOIL, V281, P25, DOI 10.1007/s11104-005-3771-5; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tsilo TJ, 2010, THEOR APPL GENET, V121, P717, DOI 10.1007/s00122-010-1343-4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2010, THEOR APPL GENET, V121, P465, DOI 10.1007/s00122-010-1323-8; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Xie CJ, 2003, THEOR APPL GENET, V106, P341, DOI 10.1007/s00122-002-1022-1; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yang ZB, 2012, THEOR APPL GENET, V125, P1057, DOI 10.1007/s00122-012-1895-6; Yao J, 2009, GENETICA, V137, P67, DOI 10.1007/s10709-009-9351-5; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang J., 2011, J EXP BOT, V32, P1; Zhang KP, 2008, J INTEGR PLANT BIOL, V50, P941, DOI 10.1111/j.1744-7909.2008.00698.x; Zhang KunPu, 2009, Acta Agronomica Sinica, V35, P270, DOI 10.3724/SP.J.1006.2009.00270; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	92	55	58	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57853	10.1371/journal.pone.0057853	http://dx.doi.org/10.1371/journal.pone.0057853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469248	Green Submitted, gold, Green Published			2022-12-27	WOS:000315634900049
J	Pal, I; Nyitrai, G; Kardos, J; Heja, L				Ildiko Pal; Gabriella Nyitrai; Julianna Kardos; Laszlo Heja			Neuronal and Astroglial Correlates Underlying Spatiotemporal Intrinsic Optical Signal in the Rat Hippocampal Slice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VIVO MICRODIALYSIS; ANION CHANNELS; EXTRACELLULAR POTASSIUM; GLUTAMATE NEUROTOXICITY; SOMATOSENSORY CORTEX; SPREADING DEPRESSION; MOUSE HIPPOCAMPUS; EVOKED-POTENTIALS; PYRAMIDAL CELLS	Widely used for mapping afferent activated brain areas in vivo, the label-free intrinsic optical signal (IOS) is mainly ascribed to blood volume changes subsequent to glial glutamate uptake. By contrast, IOS imaged in vitro is generally attributed to neuronal and glial cell swelling, however the relative contribution of different cell types and molecular players remained largely unknown. We characterized IOS to Schaffer collateral stimulation in the rat hippocampal slice using a 464-element photodiode-array device that enables IOS monitoring at 0.6 ms time-resolution in combination with simultaneous field potential recordings. We used brief half-maximal stimuli by applying a medium intensity 50 Volt-stimulus train within 50 ms (20 Hz). IOS was primarily observed in the str. pyramidale and proximal region of the str. radiatum of the hippocampus. It was eliminated by tetrodotoxin blockade of voltage-gated Na+ channels and was significantly enhanced by suppressing inhibitory signaling with gamma-aminobutyric acid(A) receptor antagonist picrotoxin. We found that IOS was predominantly initiated by postsynaptic Glu receptor activation and progressed by the activation of astroglial Glu transporters and Mg2+-independent astroglial N-methyl-D-aspartate receptors. Under control conditions, role for neuronal K+/Cl- cotransporter KCC2, but not for glial Na+/K+/Cl- cotransporter NKCC1 was observed. Slight enhancement and inhibition of IOS through non-specific Cl- and volume-regulated anion channels, respectively, were also depicted. High-frequency IOS imaging, evoked by brief afferent stimulation in brain slices provide a new paradigm for studying mechanisms underlying IOS genesis. Major players disclosed this way imply that spatiotemporal IOS reflects glutamatergic neuronal activation and astroglial response, as observed within the hippocampus. Our model may help to better interpret in vivo IOS and support diagnosis in the future.	[Ildiko Pal; Gabriella Nyitrai; Julianna Kardos; Laszlo Heja] Hungarian Acad Sci, Dept Funct Pharmacol, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Pal, I (corresponding author), Hungarian Acad Sci, Dept Funct Pharmacol, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary.	pal.ildiko@ttk.mta.hu		Heja, Laszlo/0000-0002-0035-7005	 [ERA-Chemistry OTKA 102166];  [TECH-09-AI-2009-0117 NKFP NANOSEN9]	; 	This work was supported by grants ERA-Chemistry OTKA 102166 (http://www.otka.hu/) and TECH-09-AI-2009-0117 NKFP NANOSEN9 (http://www.nih.gov.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; ANDERSEN P, 1971, EXP BRAIN RES, V13, P208; ANDERSEN P, 1966, EXP BRAIN RES, V1, P236; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Andrew RD, 1999, METHODS, V18, P185, DOI 10.1006/meth.1999.0771; ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Balena T, 2008, BRAIN RES, V1205, P12, DOI 10.1016/j.brainres.2008.02.038; Barbaro NM, 2004, NEUROSCIENCE, V128, P655, DOI 10.1016/j.neuroscience.2004.07.007; Barbarosie M, 1997, J NEUROSCI, V17, P9308; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; Buchheim K, 2005, EUR J NEUROSCI, V22, P125, DOI 10.1111/j.1460-9568.2005.04203.x; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cerne R, 2002, NEUROSCI LETT, V317, P147, DOI 10.1016/S0304-3940(01)02453-3; Chang PY, 2003, J MEMBRANE BIOL, V196, P105, DOI 10.1007/s00232-003-0629-8; Chen-Bee CH, 2010, J NEUROSCI METH, V187, P171, DOI 10.1016/j.jneumeth.2010.01.009; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOI DW, 1987, J NEUROSCI, V7, P357; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Deitmer JW, 2010, BRAIN RES REV, V63, P113, DOI 10.1016/j.brainresrev.2009.10.006; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Dodt HU, 1998, HISTOCHEM J, V30, P141, DOI 10.1023/A:1003291218707; Dodt HU, 1996, NEUROREPORT, V7, P1553, DOI 10.1097/00001756-199607080-00004; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Eggermont J, 2001, CELL BIOCHEM BIOPHYS, V35, P263, DOI 10.1385/CBB:35:3:263; Fayuk D, 2002, J NEUROPHYSIOL, V87, P1924, DOI 10.1152/jn.00231.2001; FEDERICO P, 1994, NEUROSCIENCE, V58, P461, DOI 10.1016/0306-4522(94)90073-6; Fields RD, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00032; Fields RD, 2011, SEMIN CELL DEV BIOL, V22, P214, DOI 10.1016/j.semcdb.2011.02.009; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Gutschmidt KU, 1999, NEUROSCIENCE, V91, P1471, DOI 10.1016/S0306-4522(98)00700-3; Haas B, 2006, CEREB CORTEX, V16, P237, DOI 10.1093/cercor/bhi101; Haglund MM, 2008, J NEUROSURG, V109, P654, DOI 10.3171/JNS/2008/109/10/0654; Han BC, 2004, LIFE SCI, V76, P573, DOI 10.1016/j.lfs.2004.07.016; Hansson E, 2000, NEUROCHEM INT, V37, P317, DOI 10.1016/S0197-0186(00)00033-4; Heja L, 2006, CURR TOP MED CHEM, V6, P989, DOI 10.2174/156802606777323656; Holthoff K, 1998, BRAIN RES BULL, V47, P649, DOI 10.1016/S0361-9230(98)00135-X; Holthoff K, 1996, J NEUROSCI, V16, P2740, DOI 10.1523/jneurosci.16-08-02740.1996; Holtkamp M, 2011, NEUROBIOL DIS, V43, P220, DOI 10.1016/j.nbd.2011.03.014; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Jarvis CR, 1999, NEUROIMAGE, V10, P357, DOI 10.1006/nimg.1999.0473; Jinno S, 2011, NEUROSCIENCE, V180, P41, DOI 10.1016/j.neuroscience.2011.02.013; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kawauchi S, 2009, NEUROSCI LETT, V459, P152, DOI 10.1016/j.neulet.2009.05.014; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; Kohn A, 2000, NEUROSCIENCE, V95, P51; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; Kuo IYT, 2011, J PHYSIOL-LONDON, V589, P783, DOI 10.1113/jphysiol.2010.199497; Lasztoczi B, 2004, EUR J NEUROSCI, V19, P1361, DOI 10.1111/j.1460-9568.2004.03231.x; Lasztoczi B, 2009, J NEUROPHYSIOL, V102, P2538, DOI 10.1152/jn.91318.2008; Lozovaya N, 2004, BRAIN RES, V1011, P195, DOI 10.1016/j.brainres.2004.03.023; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Mane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043981; MASSIEU L, 1995, J NEUROCHEM, V64, P2262; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mc Loughlin NP, 1998, NEUROIMAGE, V7, P326, DOI 10.1006/nimg.1998.0329; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; Narayan S M, 1994, Neuroimage, V1, P181, DOI 10.1006/nimg.1994.1003; NARAYAN SM, 1994, CEREB CORTEX, V4, P195, DOI 10.1093/cercor/4.2.195; Nilius B, 2004, NEUROCHEM RES, V29, P3, DOI 10.1023/B:NERE.0000010430.23137.be; Nyitrai G, 2006, CURR TOP MED CHEM, V6, P935, DOI 10.2174/156802606777323674; Nyitrai G, 2010, BRAIN RES, V1309, P172, DOI 10.1016/j.brainres.2009.11.007; Otis TS, 2001, NEURON, V29, P11, DOI 10.1016/S0896-6273(01)00176-3; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PASANTESMORALES H, 1989, GLIA, V2, P45, DOI 10.1002/glia.440020105; Pouratian Nader, 2002, Neurosurg Focus, V13, pe1; Prakash N, 2009, NEUROIMAGE, V47, pT116, DOI 10.1016/j.neuroimage.2008.07.066; Ransom BR, 2012, METHODS MOL BIOL, V814, P3, DOI 10.1007/978-1-61779-452-0_1; Rector DM, 1997, J NEUROPHYSIOL, V78, P1707, DOI 10.1152/jn.1997.78.3.1707; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; SCHOUSBOE A, 1992, CAN J PHYSIOL PHARM, V70, pS356, DOI 10.1139/y92-283; Schwartz TH, 2004, NEUROREPORT, V15, P1527, DOI 10.1097/01.wnr.0000131006.59315.2f; SOMJEN GG, 1979, ANNU REV PHYSIOL, V41, P159, DOI 10.1146/annurev.ph.41.030179.001111; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Sul JY, 2004, NEURON GLIA BIOL, V1, P3, DOI 10.1017/S1740925X04000031; Sykova E, 2003, NEUROIMAGE, V18, P214, DOI 10.1016/S1053-8119(02)00014-9; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Verkhratsky A, 2000, BRAIN RES REV, V32, P380, DOI 10.1016/S0165-0173(99)00093-4; Viitanen T, 2010, J PHYSIOL-LONDON, V588, P1527, DOI 10.1113/jphysiol.2009.181826; Wankhede M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316299; WHITE SR, 1994, NEUROSCIENCE, V62, P41, DOI 10.1016/0306-4522(94)90313-1; Wu LJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-40; Zapeda A, 2004, J NEUROSCI METH, V136, P1, DOI 10.1016/j.jneumeth.2004.02.025; Zhu L, 2008, EPILEPSY RES, V79, P201, DOI 10.1016/j.eplepsyres.2008.02.005	93	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57694	10.1371/journal.pone.0057694	http://dx.doi.org/10.1371/journal.pone.0057694			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469218	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000315897100030
J	Qi, JH; Ebrahem, Q; Ali, M; Cutler, A; Bell, B; Prayson, N; Sears, J; Knauper, V; Murphy, G; Anand-Apte, B				Qi, Jian Hua; Ebrahem, Quteba; Ali, Mariya; Cutler, Alecia; Bell, Brent; Prayson, Nicholas; Sears, Jonathan; Knauper, Vera; Murphy, Gillian; Anand-Apte, Bela			Tissue Inhibitor of Metalloproteinases-3 Peptides Inhibit Angiogenesis and Choroidal Neovascularization in Mice	PLOS ONE			English	Article							SORSBYS-FUNDUS-DYSTROPHY; ENDOTHELIAL GROWTH-FACTOR; FUNCTIONAL DOMAINS; TIMP3; MUTATION; GENE; VEGF; LOCALIZATION; (TIMP)-3; BINDING	Tissue inhibitors of metalloproteinases (TIMPs) while originally characterized as inhibitors of matrix metalloproteinases (MMPs) have recently been shown to have a wide range of functions that are independent of their MMP inhibitory properties. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a potent inhibitor of VEGF-mediated angiogenesis and neovascularization through its ability to block the binding of VEGF to its receptor VEGFR-2. To identify and characterize the anti-angiogenic domain of TIMP-3, structure function analyses and synthetic peptide studies were performed using VEGF-mediated receptor binding, signaling, migration and proliferation. In addition, the ability of TIMP-3 peptides to inhibit CNV in a mouse model was evaluated. We demonstrate that the anti-angiogenic property resides in the COOH-terminal domain of TIMP-3 protein which can block the binding of VEGF specifically to its receptor VEGFR-2, but not to VEGFR-1 similar to the full-length wild-type protein. Synthetic peptides corresponding to putative loop 6 and tail region of TIMP-3 have anti-angiogenic properties as determined by inhibition of VEGF binding to VEGFR-2, VEGF-induced phosphorylation of VEGFR-2 and downstream signaling pathways as well as endothelial cell proliferation and migration in response to VEGF. In addition, we show that intravitreal administration of TIMP-3 peptide could inhibit the size of laser-induced choroidal neovascularization lesions in mice. Thus, we have identified TIMP-3 peptides to be efficient inhibitors of angiogenesis and have a potential to be used therapeutically in diseases with increased neovascularization.	[Qi, Jian Hua; Ebrahem, Quteba; Ali, Mariya; Cutler, Alecia; Prayson, Nicholas; Sears, Jonathan; Anand-Apte, Bela] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cole Eye Inst,Dept Ophthalmol, Cleveland, OH 44106 USA; [Anand-Apte, Bela] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; [Knauper, Vera] Cardiff Univ, Sch Dent, Matrix Biol & Tissue Repair Res Unit, Metalloproteinase Res Grp, Cardiff CF10 3AX, S Glam, Wales; [Murphy, Gillian] Li Ka Shing Ctr, Canc Res United Kingdom Cambridge Res Inst, Cambridge, England	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cardiff University; Cancer Research UK; CRUK Cambridge Institute	Anand-Apte, B (corresponding author), Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cole Eye Inst,Dept Ophthalmol, Cleveland, OH 44106 USA.	anandab@ccf.org		Knauper, Vera/0000-0002-3965-9924	US National Institute of Health [EY016490, CA106415, EY015638]; Research to Prevent Blindness (RPB); RPB Lew Wasserman award; NATIONAL CANCER INSTITUTE [R01CA106415] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY022768, R24EY015638, R01EY016490] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); RPB Lew Wasserman award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by US National Institute of Health EY016490, CA106415, EY015638, Research to Prevent Blindness (RPB) Challenge Grant and RPB Lew Wasserman award to BA-A. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amaral J, 2010, INVEST OPHTH VIS SCI, V51, P1318, DOI 10.1167/iovs.09-4455; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Barbazetto IA, 2005, ARCH OPHTHALMOL-CHIC, V123, P542, DOI 10.1001/archopht.123.4.542; BODDEN MK, 1994, J BIOL CHEM, V269, P18943; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Della NG, 1996, INVEST OPHTH VIS SCI, V37, P1921; Ebrahem Q, 2011, INVEST OPHTHALMOL VI; FELBOR U, 1995, HUM MOL GENET, V4, P2415, DOI 10.1093/hmg/4.12.2415; Felbor U, 1997, ARCH OPHTHALMOL-CHIC, V115, P1569, DOI 10.1001/archopht.1997.01100160739011; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; HOLZ FG, 1994, RETINA-J RET VIT DIS, V14, P329, DOI 10.1097/00006982-199414040-00006; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; JACOBSON SG, 1995, NAT GENET, V11, P27, DOI 10.1038/ng0995-27; KALMUS H, 1976, J MED GENET, V13, P271, DOI 10.1136/jmg.13.4.271; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Langton KP, 1998, J BIOL CHEM, V273, P16778, DOI 10.1074/jbc.273.27.16778; Langton KP, 2000, J BIOL CHEM, V275, P27027; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Lee MH, 2001, BIOCHEM BIOPH RES CO, V280, P945, DOI 10.1006/bbrc.2000.4192; Lin RJ, 2006, AM J OPHTHALMOL, V142, P839, DOI 10.1016/j.ajo.2006.06.003; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; POLKINGHORNE PJ, 1989, OPHTHALMOLOGY, V96, P1763; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qi JH, 2002, J BIOL CHEM, V277, P13394, DOI 10.1074/jbc.M110870200; Qi JH, 2009, J BIOL CHEM; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Smith G, 1999, BRIT J OPHTHALMOL, V83, P486, DOI 10.1136/bjo.83.4.486; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Tabata Y, 1998, HUM GENET, V103, P179, DOI 10.1007/PL00008707; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WILLIAMSON RA, 1990, BIOCHEM J, V268, P267, DOI 10.1042/bj2680267	41	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e55667	10.1371/journal.pone.0055667	http://dx.doi.org/10.1371/journal.pone.0055667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469166	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000315897100006
J	Ramirez-Gonzalez, R; Yu, DW; Bruce, C; Heavens, D; Caccamo, M; Emerson, BC				Ramirez-Gonzalez, Ricardo; Yu, Douglas W.; Bruce, Catharine; Heavens, Darren; Caccamo, Mario; Emerson, Brent C.			PyroClean: Denoising Pyrosequences from Protein-Coding Amplicons for the Recovery of Interspecific and Intraspecific Genetic Variation	PLOS ONE			English	Article							MICROBIAL DIVERSITY; SOIL; BACTERIAL; RARE; COMMUNITIES; BIOSPHERE; PRIMERS; PH	High-throughput parallel sequencing is a powerful tool for the quantification of microbial diversity through the amplification of nuclear ribosomal gene regions. Recent work has extended this approach to the quantification of diversity within otherwise difficult-to-study metazoan groups. However, nuclear ribosomal genes present both analytical challenges and practical limitations that are a consequence of the mutational properties of nuclear ribosomal genes. Here we exploit useful properties of protein-coding genes for cross-species amplification and denoising of 454 flowgrams. We first use experimental mixtures of species from the class Collembola to amplify and pyrosequence the 59 region of the COI barcode, and we implement a new algorithm called PyroClean for the denoising of Roche GS FLX pyrosequences. Using parameter values from the analysis of experimental mixtures, we then analyse two communities sampled from field sites on the island of Tenerife. Cross-species amplification success of target mitochondrial sequences in experimental species mixtures is high; however, there is little relationship between template DNA concentrations and pyrosequencing read abundance. Homopolymer error correction and filtering against a consensus reference sequence reduced the volume of unique sequences to approximately 5% of the original unique raw reads. Filtering of remaining non-target sequences attributed to PCR error, sequencing error, or numts further reduced unique sequence volume to 0.8% of the original raw reads. PyroClean reduces or eliminates the need for an additional, time-consuming step to cluster reads into Operational Taxonomic Units, which facilitates the detection of intraspecific DNA sequence variation. PyroCleaned sequence data from field sites in Tenerife demonstrate the utility of our approach for quantifying evolutionary diversity and its spatial structure. Comparison of our sequence data to public databases reveals that we are able to successfully recover both interspecific and intraspecific sequence diversity.	[Ramirez-Gonzalez, Ricardo; Heavens, Darren; Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [Yu, Douglas W.] Chinese Acad Sci, Kunming Inst Zool, Ecol Conservat & Environm Ctr, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Yu, Douglas W.; Bruce, Catharine] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	The Genome Analysis Centre (TGAC); Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia	Emerson, BC (corresponding author), CSIC, Isl Ecol & Evolut Res Grp, Inst Prod Nat & Agrobiol, Tenerife, Canary Islands, Spain.	bemerson@ipna.csic.es	Ramírez, Ricardo/H-4808-2019; Yu, Douglas W./D-2536-2009	Ramírez, Ricardo/0000-0001-5745-7085; Yu, Douglas W./0000-0001-8551-5609; Emerson, Brent/0000-0003-4067-9858; Heavens, Darren/0000-0001-5418-7868	Leverhulme Trust; Genome Analysis Centre (TGAC); University of East Anglia; Consejo Superior de Investigaciones Cientificas; Yunnan Province [20080A001]; Chinese Academy of Sciences [0902281081, KSCX2-YW-Z-1027, Y002731079]; National Natural Science Foundation of China [31170498]; Ministry of Science and Technology of China [2012FY110800]; State Key Laboratory of Genetic Resources and Evolution at the Kunming Institute of Zoology; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); Genome Analysis Centre (TGAC); University of East Anglia; Consejo Superior de Investigaciones Cientificas; Yunnan Province; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Key Laboratory of Genetic Resources and Evolution at the Kunming Institute of Zoology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Research Fellowship to Brent Emerson from The Leverhulme Trust, project support from The Genome Analysis Centre (TGAC), the University of East Anglia, and the Consejo Superior de Investigaciones Cientificas. Doug Yu was supported by Yunnan Province (20080A001), the Chinese Academy of Sciences (0902281081, KSCX2-YW-Z-1027, Y002731079), the National Natural Science Foundation of China (31170498), the Ministry of Science and Technology of China (2012FY110800), the University of East Anglia, and the State Key Laboratory of Genetic Resources and Evolution at the Kunming Institute of Zoology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Arechavaleta M., 2010, LISTA ESPECIES SILVE; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Emerson BC, 2011, PHILOS T R SOC B, V366, P2391, DOI 10.1098/rstb.2011.0057; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	32	15	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57615	10.1371/journal.pone.0057615	http://dx.doi.org/10.1371/journal.pone.0057615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469211	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100027
J	Bramall, AN; Szego, MJ; Pacione, LR; Chang, I; Diez, E; D'Orleans-Juste, P; Stewart, DJ; Hauswirth, WW; Yanagisawa, M; McInnes, RR				Bramall, Alexa N.; Szego, Michael J.; Pacione, Laura R.; Chang, Inik; Diez, Eduardo; D'Orleans-Juste, Pedro; Stewart, Duncan J.; Hauswirth, William W.; Yanagisawa, Masashi; McInnes, Roderick R.			Endothelin-2-Mediated Protection of Mutant Photoreceptors in Inherited Photoreceptor Degeneration	PLOS ONE			English	Article							ENDOTHELIN-CONVERTING ENZYME-1; LEUKEMIA INHIBITORY FACTOR; RETINAL DEGENERATION; GENE-EXPRESSION; RHODOPSIN MUTATION; MICE DEFICIENT; MULLER CELLS; RAT MODEL; RECEPTOR; ACTIVATION	Expression of the Endothelin-2 (Edn2) mRNA is greatly increased in the photoreceptors (PRs) of mouse models of inherited PR degeneration (IPD). To examine the role of Edn2 in mutant PR survival, we generated Edn2(-/-) mice carrying homozygous Pde6b(rd1) alleles or the Tg(RHO P347S) transgene. In the Edn2(-/-) background, PR survival increased 110% in Pde6b(rd1/rd1) mice at post-natal (PN) day 15, and 60% in Tg(RHO P347S) mice at PN40. In contrast, PR survival was not increased in retinal explants of Pde6b(rd1/rd1); Edn2(-/-) mice. This finding, together with systemic abnormalities in Edn2(-/-) mice, suggested that the increased survival of mutant PRs in the Edn2(-/-) background resulted at least partly from the systemic EDN2 loss of function. To examine directly the role of EDN2 in mutant PRs, we used a scAAV5-Edn2 cDNA vector to restore Edn2 expression in Pde6b(rd1/rd1); Edn2(-/-) PRs and observed an 18% increase in PR survival at PN14. Importantly, PR survival was also increased after injection of scAAV5-Edn2 into Pde6b(rd1/rd1) retinas, by 31% at PN15. Together, these findings suggest that increased Edn2 expression is protective to mutant PRs. To begin to elucidate Edn2-mediated mechanisms that contribute to PR survival, we used microarray analysis and identified a cohort of 20 genes with >4-fold increased expression in Tg(RHO P347S) retinas, including Fgf2. Notably, increased expression of the FGF2 protein in Tg(RHO P347S) PRs was ablated in Tg(RHO P347S); Edn2(-/-) retinas. Our findings indicate that the increased expression of PR Edn2 increases PR survival, and suggest that the Edn2-dependent increase in PR expression of FGF2 may contribute to the augmented survival.	[Bramall, Alexa N.; Szego, Michael J.; Pacione, Laura R.; McInnes, Roderick R.] Hosp Sick Children, Program Dev Biol, Res Inst, Toronto, ON M5G 1X8, Canada; [Bramall, Alexa N.; Szego, Michael J.; Pacione, Laura R.; McInnes, Roderick R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Diez, Eduardo; McInnes, Roderick R.] McGill Univ, Jewish Gen Hosp, Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada; [Chang, Inik; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Chang, Inik; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [D'Orleans-Juste, Pedro] Univ Sherbrooke, Fac Med, Dept Anat & Cell Biol, Sherbrooke, PQ, Canada; [Stewart, Duncan J.] Univ Ottawa, Regenerat Med Program, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Sherbrooke; University of Ottawa; Ottawa Hospital Research Institute; State University System of Florida; University of Florida	McInnes, RR (corresponding author), Hosp Sick Children, Program Dev Biol, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	rod.mcinnes@mcgill.ca		hauswirth, william/0000-0002-3244-4947; Pacione, Laura/0000-0002-6290-7412	Canadian Institutes of Health Research [MOP-7315, IOP-54037, MOP-74752]; Canadian Genetic Diseases Network; Macula Vision Research Foundation; National Institutes of Health [EY021721]; Foundation Fighting Blindness; Eldon Family Foundation; Vision for Children; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [P30EY021721] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Genetic Diseases Network; Macula Vision Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Eldon Family Foundation; Vision for Children; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the Canadian Institutes of Health Research to RRM [MOP-7315 and IOP-54037 to R.R.M., MOP-74752 to D.J.S.], the Canadian Genetic Diseases Network [to R.R.M.], the Macula Vision Research Foundation [to R.R.M. and W.W.H.], and by grants from the National Institutes of Health [EY021721 to W.W.H.], Foundation Fighting Blindness, Eldon Family Foundation, Vision for Children and Research to Prevent Blindness, Inc. for partial support of this work. W.W.H. and the University of Florida have a financial interest in the use of AAV therapies, and own equity in a company (AGTC Inc.) that might, in the future, commercialize some aspects of this work. R.R.M. holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta ML, 2005, MOL VIS, V11, P717; Adamus G, 2003, J AUTOIMMUN, V21, P121, DOI 10.1016/S0896-8411(03)00092-1; Al-Alem L, 2007, J ENDOCRINOL, V193, P383, DOI 10.1677/JOE-07-0089; Baguma-Nibasheka M, 2007, MOL CELL ENDOCRINOL, V267, P127, DOI 10.1016/j.mce.2007.01.008; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Braunger BM, 2013, NEUROBIOL DIS, V50, P1, DOI 10.1016/j.nbd.2012.09.008; Burgi S, 2009, MOL VIS, V15, P1631; Caffe AR, 2001, J CHEM NEUROANAT, V22, P263; Chen L, 2004, EXP EYE RES, V79, P239, DOI 10.1016/j.exer.2004.05.002; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Cottet S, 2006, FASEB J, V20, P2036, DOI 10.1096/fj.06-6211com; Dalkara D, 2011, MOL THER, V19, P1602, DOI 10.1038/mt.2011.62; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Gao H, 1996, EXP EYE RES, V62, P181, DOI 10.1006/exer.1996.0022; Gauthier R, 2005, INVEST OPHTH VIS SCI, V46, P3383, DOI 10.1167/iovs.05-0362; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Grimshaw MJ, 2004, CANCER RES, V64, P2461, DOI 10.1158/0008-5472.CAN-03-1069; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hauswirth WW, 2000, CLIN CHEM LAB MED, V38, P147, DOI 10.1515/CCLM.2000.022; Huang SP, 2004, J BIOMED SCI, V11, P37, DOI 10.1159/000075287; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Kamphuis W, 2007, MOL VIS, V13, P1020; Knee R, 1997, P NATL ACAD SCI USA, V94, P4943, DOI 10.1073/pnas.94.10.4943; Ko C, 2006, ENDOCRINOLOGY, V147, P1770, DOI 10.1210/en.2005-1228; Kong FS, 2010, EXP EYE RES, V90, P546, DOI 10.1016/j.exer.2010.01.011; Kotake-Nara E, 2007, BIOCHEM BIOPH RES CO, V357, P168, DOI 10.1016/j.bbrc.2007.03.118; Lambert GL, 2000, J MOL ENDOCRINOL, V24, P273, DOI 10.1677/jme.0.0240273; Lau D, 2000, INVEST OPHTH VIS SCI, V41, P3622; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Li YC, 1995, J MOL NEUROSCI, V6, P169, DOI 10.1007/BF02736763; Lin N, 1997, EXP EYE RES, V64, P239, DOI 10.1006/exer.1996.0208; Ling L, 2011, BR J PHARM; Liu GX, 2002, CHINESE MED J-PEKING, V115, P750; Meidan R, 2005, J BIOL CHEM, V280, P40867, DOI 10.1074/jbc.M505679200; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nakazawa T, 2011, INVEST OPHTH VIS SCI, V52, P1384, DOI 10.1167/iovs.10-6509; Neuner-Jehle M, 2000, HUM GENE THER, V11, P1875, DOI 10.1089/10430340050129495; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Okoye G, 2003, J NEUROSCI, V23, P4164; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; Prasanna G, 2003, MOL CELL BIOCHEM, V253, P71, DOI 10.1023/A:1026005418874; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Rohrer B, 2007, INVEST OPHTH VIS SCI, V48, P5282, DOI 10.1167/iovs.07-0282; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Saida K, 2000, GENOMICS, V64, P51, DOI 10.1006/geno.1999.6083; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; SANYAL S, 1981, EXP EYE RES, V33, P213, DOI 10.1016/S0014-4835(81)80070-X; Stitt AW, 1996, CURR EYE RES, V15, P111, DOI 10.3109/02713689609017618; Su WY, 2010, BIOCHEM BIOPH RES CO, V396, P177, DOI 10.1016/j.bbrc.2010.04.147; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Telemaque S, 1998, J CARDIOVASC PHARM, V31, pS548, DOI 10.1097/00005344-199800001-00158; Torbidoni V, 2006, EXP BIOL MED, V231, P1095; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; Valter K, 2005, INVEST OPHTH VIS SCI, V46, P1748, DOI 10.1167/iovs.04-0657; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Vlachantoni D, 2011, HUM MOL GENET, V20, P322, DOI 10.1093/hmg/ddq467; Wang X, 2009, EXP EYE RES, V88, P378, DOI 10.1016/j.exer.2008.09.009; WEN TC, 1995, NEUROSCIENCE, V65, P513, DOI 10.1016/0306-4522(94)00499-U; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Xia X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018282; Zacks DN, 2006, INVEST OPHTH VIS SCI, V47, P1691, DOI 10.1167/iovs.05-1209; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118	69	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58023	10.1371/journal.pone.0058023	http://dx.doi.org/10.1371/journal.pone.0058023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469133	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900225
J	Ghosh, MC; Ray, AK				Ghosh, Manik C.; Ray, Arun K.			Membrane Phospholipid Augments Cytochrome P4501a Enzymatic Activity by Modulating Structural Conformation during Detoxification of Xenobiotics	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; ENDOPLASMIC-RETICULUM STRESS; ANIONIC PHOSPHOLIPIDS; DRUG-METABOLISM; P450 REDUCTASE; HEPATIC DRUG; PROTEIN; CARBOFURAN; LIPIDS; LIVER	Cytochrome P450 is a superfamily of membrane-bound hemoprotein that gets involved with the degradation of xenobiotics and internal metabolites. Accumulated body of evidence indicates that phospholipids play a crucial role in determining the enzymatic activity of cytochrome P450 in the microenvironment by modulating its structure during detoxification; however, the structure-function relationship of cytochrome P4501A, a family of enzymes responsible for degrading lipophilic aromatic hydrocarbons, is still not well defined. Inducibility of cytochrome P4501A in cultured catfish hepatocytes in response to carbofuran, a widely used pesticide around the world, was studied earlier in our laboratory. In this present investigation, we observed that treating catfish with carbofuran augmented total phospholipid in the liver. We examined the role of phospholipid on the of cytochrome P4501A-marker enzyme which is known as ethoxyresorufin-O-deethylase (EROD) in the context of structure and function. We purified the carbofuran-induced cytochrome P4501A protein from catfish liver. Subsequently, we examined the enzymatic activity of purified P4501A protein in the presence of phospholipid, and studied how the structure of purified protein was influenced in the phospholipid environment. Membrane phospholipid appeared to accelerate the enzymatic activity of EROD by changing its structural conformation and thus controlling the detoxification of xenobiotics. Our study revealed the missing link of how the cytochrome P450 restores its enzymatic activity by changing its structural conformation in the phospholipid microenvironment.	[Ghosh, Manik C.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Ray, Arun K.] Bose Inst, Div Mol Med, Kolkata 700009, W Bengal, India	University of Tennessee System; University of Tennessee Health Science Center; Department of Science & Technology (India); Bose Institute	Ghosh, MC (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.	ghosh.manik7@gmail.com			Department of Biotechnology of India	Department of Biotechnology of India	The Department of Biotechnology of India is acknowledged for funding of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-2; Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; Agarwal PK, 2012, PHYS LIFE REV; Ahn T, 2005, BIOCHEMISTRY-US, V44, P9188, DOI 10.1021/bi050051e; Ahn T, 2007, CURR PROTEIN PEPT SC, V8, P496, DOI 10.2174/138920307782411392; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; Begum G, 2001, ENVIRON MONIT ASSESS, V70, P233, DOI 10.1023/A:1010775224753; BIDLACK WR, 1984, J AM DIET ASSOC, V84, P892; BIDLACK WR, 1986, FASEB J, V45, P142; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CAUSEY KM, 1990, MOL PHARMACOL, V38, P134; Cho EY, 2008, BIOCHEM BIOPH RES CO, V376, P584, DOI 10.1016/j.bbrc.2008.09.023; EDWARDS RJ, 1991, BIOCHEMISTRY-US, V30, P71, DOI 10.1021/bi00215a011; EDWARDS RJ, 1991, BIOCHEM J, V278, P749, DOI 10.1042/bj2780749; Elsherbiny ME, 2011, DRUG METAB REV, V43, P457, DOI 10.3109/03602532.2011.596204; Emoto Chie, 2009, Drug Metab Lett, V3, P207; Fernandez C, 2003, FEBS LETT, V555, P144, DOI 10.1016/S0014-5793(03)01155-4; Fleming CR, 2011, ECOTOXICOLOGY, V20, P1300, DOI 10.1007/s10646-011-0686-1; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Fu PP, 2012, J ENVIRON SCI HEAL C, V30, P1, DOI 10.1080/10590501.2012.653887; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Ghosh MC, 2012, J CELL COMMUN SIGNAL, V6, P37, DOI 10.1007/s12079-011-0143-1; Ghosh MC, 2000, J BIOCHEM MOL TOXIC, V14, P204, DOI 10.1002/(SICI)1099-0461(2000)14:4<204::AID-JBT4>3.3.CO;2-#; Ghosh MC, 2001, ENVIRON RES, V86, P167, DOI 10.1006/enrs.2001.4249; GOKSOYR A, 1985, BIOCHIM BIOPHYS ACTA, V840, P409, DOI 10.1016/0304-4165(85)90222-3; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GUPTA RC, 1994, J TOXICOL ENV HEALTH, V42, P451, DOI 10.1080/15287399409531895; GUPTA RC, 1994, J TOXICOL ENV HEALTH, V43, P383, DOI 10.1080/15287399409531931; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; IMAOKA S, 1992, BIOCHEMISTRY-US, V31, P6063, DOI 10.1021/bi00141a015; INGELMANSUNDBERG M, 1981, BIOCHEMISTRY-US, V20, P4100, DOI 10.1021/bi00517a024; Jang HH, 2010, ARCH BIOCHEM BIOPHYS, V493, P143, DOI 10.1016/j.abb.2009.10.012; Kim KH, 2007, ARCH BIOCHEM BIOPHYS, V468, P226, DOI 10.1016/j.abb.2007.10.003; Kim KH, 2003, BIOCHEMISTRY-US, V42, P15377, DOI 10.1021/bi035280k; Kisselev P, 1998, J BIOL CHEM, V273, P1380, DOI 10.1074/jbc.273.3.1380; Kisselev P, 2002, EUR J BIOCHEM, V269, P1799, DOI 10.1046/j.1432-1033.2002.02848.x; Kleinschmidt JH, 2003, CELL MOL LIFE SCI, V60, P1547, DOI 10.1007/s00018-003-3170-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Luthra A, 2011, ARCH BIOCHEM BIOPHYS, V507, P26, DOI 10.1016/j.abb.2010.12.008; NORRED W P, 1984, Drug-Nutrient Interactions, V3, P11; Nussio MR, 2010, CHEM PHYS LIPIDS, V163, P182, DOI 10.1016/j.chemphyslip.2009.11.003; Pagonis TA, 2008, CLIN TOXICOL, V46, P57, DOI 10.1080/15563650701590910; Ramanathan A, 2009, J PHYS CHEM B, V113, P16669, DOI 10.1021/jp9077213; Reed JR, 2010, METHODS MOL BIOL, V606, P11, DOI 10.1007/978-1-60761-447-0_2; Reed JR, 2006, DRUG METAB DISPOS, V34, P660, DOI 10.1124/dmd.105.006825; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sarasquete C, 2000, SCI TOTAL ENVIRON, V247, P313, DOI 10.1016/S0048-9697(99)00500-8; Sen A, 1998, J BIOCHEM MOL TOXIC, V12, P103, DOI 10.1002/(SICI)1099-0461(1998)12:2<103::AID-JBT5>3.0.CO;2-P; Shet MS, 1996, ARCH BIOCHEM BIOPHYS, V330, P199, DOI 10.1006/abbi.1996.0243; Snyder R, 2004, DRUG METAB REV, V36, P531, DOI 10.1081/DMR-200033445; STEGEMAN JJ, 1989, XENOBIOTICA, V19, P1093, DOI 10.3109/00498258909043164; SUZUKI K, 1993, BIOCHIM BIOPHYS ACTA, V1203, P215, DOI 10.1016/0167-4838(93)90086-7; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang SC, 2007, BIOCHEMISTRY-US, V46, P14557, DOI 10.1021/bi701073d; Yun CH, 1997, J BIOL CHEM, V272, P19725, DOI 10.1074/jbc.272.32.19725	57	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57919	10.1371/journal.pone.0057919	http://dx.doi.org/10.1371/journal.pone.0057919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469105	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900200
J	Giorgi, D; Farina, A; Grosso, V; Gennaro, A; Ceoloni, C; Lucretti, S				Giorgi, Debora; Farina, Anna; Grosso, Valentina; Gennaro, Andrea; Ceoloni, Carla; Lucretti, Sergio			FISHIS: Fluorescence In Situ Hybridization in Suspension and Chromosome Flow Sorting Made Easy	PLOS ONE			English	Article							INSITU HYBRIDIZATION; DNA-SEQUENCES; BREAD WHEAT; COMPLEX GENOMES; REPETITIVE DNA; PLANT GENOME; ORGANIZATION; BARLEY; IDENTIFICATION; DENATURATION	The large size and complex polyploid nature of many genomes has often hampered genomics development, as is the case for several plants of high agronomic value. Isolating single chromosomes or chromosome arms via flow sorting offers a clue to resolve such complexity by focusing sequencing to a discrete and self-consistent part of the whole genome. The occurrence of sufficient differences in the size and or base-pair composition of the individual chromosomes, which is uncommon in plants, is critical for the success of flow sorting. We overcome this limitation by developing a robust method for labeling isolated chromosomes, named Fluorescent In situ Hybridization In suspension (FISHIS). FISHIS employs fluorescently labeled synthetic repetitive DNA probes, which are hybridized, in a wash-less procedure, to chromosomes in suspension following DNA alkaline denaturation. All typical A, B and D genomes of wheat, as well as individual chromosomes from pasta (T. durum L.) and bread (T. aestivum L.) wheat, were flow-sorted, after FISHIS, at high purity. For the first time in eukaryotes, each individual chromosome of a diploid organism, Dasypyrum villosum (L.) Candargy, was flow-sorted regardless of its size or base-pair related content. FISHIS-based chromosome sorting is a powerful and innovative flow cytogenetic tool which can develop new genomic resources from each plant species, where microsatellite DNA probes are available and high quality chromosome suspensions could be produced. The joining of FISHIS labeling and flow sorting with the Next Generation Sequencing methodology will enforce genomics for more species, and by this mightier chromosome approach it will be possible to increase our knowledge about structure, evolution and function of plant genome to be used for crop improvement. It is also anticipated that this technique could contribute to analyze and sort animal chromosomes with peculiar cytogenetic abnormalities, such as copy number variations or cytogenetic aberrations.	[Giorgi, Debora; Farina, Anna; Grosso, Valentina; Lucretti, Sergio] CASACCIA Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, Rome, Italy; [Gennaro, Andrea; Ceoloni, Carla] Univ Tuscia, DAFNE, Viterbo, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Tuscia University	Lucretti, S (corresponding author), CASACCIA Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, Rome, Italy.	sergio.lucretti@enea.it	Ceoloni, Carla/AAB-2031-2020; Gennaro, Andrea/A-2774-2014	Gennaro, Andrea/0000-0002-3020-2637; CEOLONI, Carla/0000-0001-6354-8901	Italian Ministry of Agriculture "Progetto MAPPA 5A" [D.M. 7398/7303/08]	Italian Ministry of Agriculture "Progetto MAPPA 5A"	This work was supported by the Italian Ministry of Agriculture "Progetto MAPPA 5A" (D.M. 7398/7303/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brind'Amour J, 2011, NAT METHODS, V8, P484, DOI [10.1038/NMETH.1601, 10.1038/nmeth.1601]; Cantsilieris S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035255; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Cuadrado A, 2008, CYTOGENET GENOME RES, V120, P210, DOI 10.1159/000121069; Cuadrado A, 2007, CHROMOSOME RES, V15, P711, DOI 10.1007/s10577-007-1156-8; Cuadrado A, 2010, CHROMOSOMA, V119, P495, DOI 10.1007/s00412-010-0273-x; Darzynkiewicz Z, 2001, CURRENT PROTOCOLS CY; DOLEZEL J, 1994, CRIT REV PLANT SCI, V13, P275, DOI 10.1080/713608061; Dolezel J., 1999, Methods in Cell Science, V21, P95, DOI 10.1023/A:1009876621187; Dolezel J, 2009, GENETICS GENOMICS TR, P385; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Dolezel J, 2012, FUNCT INTEGR GENOMIC, V12, P397, DOI 10.1007/s10142-012-0293-0; DUDIN G, 1987, HUM GENET, V76, P290; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gill KS, 1999, THEOR APPL GENET, V98, P1248, DOI 10.1007/s001220051190; Gradzielewska A, 2006, EUPHYTICA, V152, P441, DOI 10.1007/s10681-006-9245-x; Grosso V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050151; Gualberti G, 1996, THEOR APPL GENET, V92, P744, DOI 10.1007/BF00226097; He H, 2001, INT J RADIAT BIOL, V77, P787, DOI 10.1080/09553000110047546; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; Hoffman RA, 2007, CHARACTERIZATION FLO; Jiang JM, 2006, GENOME, V49, P1057, DOI 10.1139/G06-076; Kubalakova M, 2005, GENETICS, V170, P823, DOI 10.1534/genetics.104.039180; Kubalakova M, 2002, THEOR APPL GENET, V104, P1362, DOI 10.1007/s00122-002-0888-2; Lucretti S, 1997, CYTOMETRY, V28, P236; Lucretti Sergio, 1999, Methods in Cell Science, V21, P155, DOI 10.1023/A:1009893008892; Ma YZ, 2005, GENES GENET SYST, V80, P35, DOI 10.1266/ggs.80.35; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Ng BL, 2006, CYTOM PART A, V69A, P1028, DOI 10.1002/cyto.a.20330; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; PICH U, 1995, PLANT J, V7, P1039, DOI 10.1046/j.1365-313X.1995.07061039.x; RAAP AK, 1986, CYTOMETRY, V7, P235, DOI 10.1002/cyto.990070303; Robertson KL, 2009, ANAL BIOCHEM, V390, P109, DOI 10.1016/j.ab.2009.04.026; Rosenfeld JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040294; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Sharma S, 2005, CYTOGENET GENOME RES, V109, P15, DOI 10.1159/000082377; Simkova H., 2008, BMC GENOMICS, V9; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Steinhaeuser U, 2002, J HISTOCHEM CYTOCHEM, V50, P1697, DOI 10.1177/002215540205001216; TRASK B, 1985, SCIENCE, V230, P1401, DOI 10.1126/science.2416058; VANDEKKEN H, 1990, CYTOMETRY, V11, P153, DOI 10.1002/cyto.990110118; VANDILLA MA, 1990, CYTOMETRY, V11, P208, DOI 10.1002/cyto.990110124; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vitulo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026421; Vrana J, 2000, GENETICS, V156, P2033; Wenzl P, 2010, THEOR APPL GENET, V121, P465, DOI 10.1007/s00122-010-1323-8; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629	56	63	65	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57994	10.1371/journal.pone.0057994	http://dx.doi.org/10.1371/journal.pone.0057994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469124	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900217
J	Jung, YR; Dziennis, S; Zhi, ZW; Reif, R; Wang, RKK				Jung, Yeongri; Dziennis, Suzan; Zhi, Zhongwei; Reif, Roberto; Wang, Ruikang K.			Tracking Dynamic Microvascular Changes during Healing after Complete Biopsy Punch on the Mouse Pinna Using Optical Microangiography	PLOS ONE			English	Article							BLOOD-FLOW; VASCULAR PERFUSION; MICRO-ANGIOGRAPHY; HUMAN SKIN; ANGIOGENESIS; DOPPLER; MICROCIRCULATION; DISEASE; SPECKLE; RETINA	Optical microangiography (OMAG) and Doppler optical microangiography (DOMAG) are two non-invasive techniques capable of determining the tissue microstructural content, microvasculature angiography, and blood flow velocity and direction. These techniques were used to visualize the acute and chronic microvascular and tissue responses upon an injury in vivo. A tissue wound was induced using a 0.5 mm biopsy punch on a mouse pinna. The changes in the microangiography, blood flow velocity and direction were quantified for the acute (<30 min) wound response and the changes in the tissue structure and microangiography were determined for the chronic wound response (30 min-60 days). The initial wound triggered recruitment of peripheral capillaries, as well as redirection of main arterial and venous blood flow within 3 min. The complex vascular networks and new vessel formation were quantified during the chronic response using fractal dimension. The highest rate of wound closure occurred between days 8 and 22. The vessel tortuosity increased during this time suggesting angiogenesis. Taken together, these data signify that OMAG has the capability to track acute and chronic changes in blood flow, microangiography and structure during wound healing. The use of OMAG has great potential to improve our understanding of vascular and tissue responses to injury in order to develop more effective therapeutics.	[Jung, Yeongri; Dziennis, Suzan; Zhi, Zhongwei; Reif, Roberto; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wang, RKK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	wangrk@u.washington.edu	Zhi, Zhongwei/H-4175-2015; Wang, Ruikang/L-3889-2019	Zhi, Zhongwei/0000-0001-8995-7287; Wang, Ruikang/0000-0001-5169-8822; Zheng, Ying/0000-0003-2723-9022	Niational Institutes of Health [RO1EB009682, RO1HL093140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009682] Funding Source: NIH RePORTER	Niational Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by research grants from the Niational Institutes of Health (RO1EB009682)(RO1HL093140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2008, OPT EXPRESS, V16, P11438, DOI 10.1364/OE.16.011438; An L, 2010, OPT EXPRESS, V18, P8220, DOI 10.1364/OE.18.008220; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Baum CL, 2005, DERMATOL SURG, V31, P674; Briers JD, 1999, J BIOMED OPT, V4, P164, DOI 10.1117/1.429903; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119; Cho CH, 2006, P NATL ACAD SCI USA, V103, P4946, DOI 10.1073/pnas.0506352103; Cobb MJ, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2388152; Davidson JM, 1998, ARCH DERMATOL RES, V290, pS1, DOI 10.1007/PL00007448; Demirdogen B, 2010, GROWTH FACTORS, V28, P426, DOI 10.3109/08977194.2010.508456; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Helbich TH, 2002, ACAD RADIOL, V9, pS145, DOI 10.1016/S1076-6332(03)80423-3; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kruglikov I. L., 2011, J COSMET DERMATOL SC, V1, P157; Lell M, 2005, EUR RADIOL, V15, P1514, DOI 10.1007/s00330-005-2770-5; Levy L, 2012, J DIABETES, V4, P68, DOI 10.1111/j.1753-0407.2011.00151.x; Lockwood GR, 1996, IEEE ENG MED BIOL, V15, P60, DOI 10.1109/51.544513; LOGERFO FW, 1984, NEW ENGL J MED, V311, P1615, DOI 10.1056/NEJM198412203112506; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Qin J, 2011, LASER SURG MED, V43, P122, DOI 10.1002/lsm.20977; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Rege A, 2012, ANGIOGENESIS, V15, P87, DOI 10.1007/s10456-011-9245-x; Rege A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3582334; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339; Sorg H, 2007, J ANAT, V211, P810, DOI 10.1111/j.1469-7580.2007.00822.x; Tomlins PH, 2005, J PHYS D APPL PHYS, V38, P2519, DOI 10.1088/0022-3727/38/15/002; Tsai TH, 2009, J DERMATOL SCI, V56, P1, DOI 10.1016/j.jdermsci.2009.06.008; Wang RKK, 2007, OPT EXPRESS, V15, P11402, DOI 10.1364/OE.15.011402; Wang RK, 2007, OPT EXPRESS, V15, P4083, DOI 10.1364/OE.15.004083; Wang RK, 2010, OPT LETT, V35, P1467, DOI 10.1364/OL.35.001467; Wang RK, 2009, OPT EXPRESS, V17, P8926, DOI 10.1364/OE.17.008926; Yao JJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3594786; Yeh AT, J BIOMEDICAL OPTICS, V9, P248; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220; Zhi ZW, 2011, OPT LETT, V36, P3169, DOI 10.1364/OL.36.003169; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P1059, DOI 10.1364/BOE.2.001059; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	42	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57976	10.1371/journal.pone.0057976	http://dx.doi.org/10.1371/journal.pone.0057976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469122	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900215
J	Skraban, J; Dzeroski, S; Zenko, B; Mongus, D; Gangl, S; Rupnik, M				Skraban, Jure; Dzeroski, Saso; Zenko, Bernard; Mongus, Domen; Gangl, Simon; Rupnik, Maja			Gut Microbiota Patterns Associated with Colonization of Different Clostridium difficile Ribotypes	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN FECAL MICROBIOTA; INTESTINAL MICROBIOTA; DIVERSITY; DIARRHEA; IDENTIFICATION; ELECTROPHORESIS; THERAPY; OBESITY; FUNGI	C. difficile infection is associated with disturbed gut microbiota and changes in relative frequencies and abundance of individual bacterial taxons have been described. In this study we have analysed bacterial, fungal and archaeal microbiota by denaturing high pressure liquid chromatography (DHPLC) and with machine learning methods in 208 faecal samples from healthy volunteers and in routine samples with requested C. difficile testing. The latter were further divided according to stool consistency, C. difficile presence or absence and C. difficile ribotype (027 or non-027). Lower microbiota diversity was a common trait of all routine samples and not necessarily connected only to C. difficile colonisation. Differences between the healthy donors and C. difficile positive routine samples were detected in bacterial, fungal and archaeal components. Bifidobacterium longum was the single most important species associated with C. difficile negative samples. However, by machine learning approaches we have identified patterns of microbiota composition predictive for C. difficile colonization. Those patterns also differed between samples with C. difficile ribotype 027 and other C. difficile ribotypes. The results indicate that not only the presence of a single species/group is important but that certain combinations of gut microbes are associated with C. difficile carriage and that some ribotypes (027) might be associated with more disturbed microbiota than the others.	[Skraban, Jure; Rupnik, Maja] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; [Rupnik, Maja] Inst Publ Hlth Maribor, Ctr Microbiol, Maribor, Slovenia; [Skraban, Jure; Dzeroski, Saso; Zenko, Bernard; Rupnik, Maja] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Dzeroski, Saso; Zenko, Bernard] Jozef Stefan Inst, Ljubljana, Slovenia; [Dzeroski, Saso] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Mongus, Domen; Gangl, Simon] Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia	University of Maribor; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Maribor	Rupnik, M (corresponding author), Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia.	maja.rupnik@zzv-mb.si	Dzeroski, Saso/ABH-2758-2021	Dzeroski, Saso/0000-0003-2363-712X	Slovenian Research Agency [1000-10-310160, J3-4298]; European Regional Development Fund [OP13.1.1.2.02.0005]; Slovenian Ministry of Higher Education, Science and Technology [OP13.1.1.2.02.0005]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Regional Development Fund(European Commission); Slovenian Ministry of Higher Education, Science and Technology	This work was supported by Slovenian Research Agency grants 1000-10-310160 and J3-4298 and Operation no. OP13.1.1.2.02.0005 financed by the European Regional Development Fund and the Slovenian Ministry of Higher Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbut F, 2012, CLIN INFECT DIS, V55, P1669, DOI 10.1093/cid/cis790; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Blockeel H., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P55; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; De La Cochetiere MF, 2008, MICROB ECOL, V56, P395, DOI 10.1007/s00248-007-9356-5; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; Domann E, 2003, J CLIN MICROBIOL, V41, P5500, DOI 10.1128/JCM.41.12.5500-5510.2003; Eckburg PB, 2003, INFECT IMMUN, V71, P591, DOI 10.1128/IAI.71.2.591-596.2003; Fujitani S, 2011, AM J INFECT CONTROL, V39, P188, DOI 10.1016/j.ajic.2010.10.024; Goldenberg O, 2005, J CLIN MICROBIOL, V43, P5912, DOI 10.1128/JCM.43.12.5912-5915.2005; Goldenberg O, 2007, J MICROBIOL METH, V68, P94, DOI 10.1016/j.mimet.2006.06.009; Graul T, 2009, MED HYPOTHESES, V73, P194, DOI 10.1016/j.mehy.2009.02.026; Ho N, 2011, J CLIN GASTROENTEROL, V45, P742, DOI 10.1097/MCG.0b013e31821b1094; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Manges AR, 2010, J INFECT DIS, V202, P1877, DOI 10.1086/657319; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; Mellow Mark H, 2011, J Okla State Med Assoc, V104, P89; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Peterfreund GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046966; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rea MC, 2012, J CLIN MICROBIOL, V50, P867, DOI 10.1128/JCM.05176-11; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Rousseau C, 2011, J MED MICROBIOL, V60, P1112, DOI 10.1099/jmm.0.029736-0; Rousseau C, 2011, J CLIN MICROBIOL, V49, P858, DOI 10.1128/JCM.01507-10; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Turenne CY, 1999, J CLIN MICROBIOL, V37, P1846, DOI 10.1128/JCM.37.6.1846-1851.1999; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wagner AO, 2009, APPL ENVIRON MICROB, V75, P956, DOI 10.1128/AEM.01411-08; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Witten IH, 2011, MOR KAUF D, P1; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zidaric V, 2008, ANAEROBE, V14, P325, DOI 10.1016/j.anaerobe.2008.10.001; Zwielehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028654	46	50	52	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58005	10.1371/journal.pone.0058005	http://dx.doi.org/10.1371/journal.pone.0058005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469128	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900221
J	Zhang, JS; Li, DM; Ma, Y; He, N; Gu, Q; Wang, FS; Jiang, SQ; Chen, BQ; Liu, JR				Zhang, Jing-Shu; Li, Da-Ming; Ma, Yue; He, Ning; Gu, Qing; Wang, Feng-Shan; Jiang, Shu-Qing; Chen, Bing-Qing; Liu, Jia-Ren			gamma-Tocotrienol Induces Paraptosis-Like Cell Death in Human Colon Carcinoma SW620 Cells	PLOS ONE			English	Article							HUMAN GASTRIC-CANCER; INDUCED APOPTOSIS; VITAMIN-E; DELTA-TOCOTRIENOL; IN-VIVO; SIGNALING PATHWAY; MAMMARY CARCINOGENESIS; RICH FRACTION; UP-REGULATION; TUMOR-GROWTH	Colorectal cancer is one of the most serious illnesses among diagnosed cancer. As a new type of anti-cancer composition from tocotrienol-rich fraction of palm oil, gamma-tocotrienol is widely used in anti-cancer research. The objectives of this study were to investigate the effects of gamma-tocotrienol on human colon cancer SW620 and HCT-8 cells. We showed that treatment with different concentrations of gamma-tocotrienol resulted in a dose dependent inhibition of cell growth. Cell death induced by gamma-tocotrienol was mediated by a paraptosis-like cell death in SW620 and HCT-8 cells. Real-time RT-PCR and western blot analyses showed that gamma-tocotrienol inhibited the expression level of beta-catenin, cyclin D1 and c-jun. These data suggest that a paraptosis-like cell death induced by gamma-tocotrienol in SW620 cells is associated with the suppression of the Wnt signaling pathway, which offers a novel tool for treating apoptosis-resistance colon cancer.	[Zhang, Jing-Shu; Li, Da-Ming; He, Ning; Gu, Qing; Wang, Feng-Shan; Jiang, Shu-Qing] Tianjin Ctr Dis Control & Prevent, Dept Toxicol, Tianjin, Peoples R China; [Zhang, Jing-Shu; Ma, Yue] Tianjin Med Univ, Coll Publ Hlth, Tianjin, Peoples R China; [Chen, Bing-Qing] Harbin Med Univ, Dept Nutr & Food Hyg, Coll Publ Hlth, Harbin, Peoples R China; [Liu, Jia-Ren] Harvard Univ, Sch Med, CHB, Boston, MA USA	Tianjin Center for Disease Control & Prevention; Tianjin Medical University; Harbin Medical University; Harvard University; Harvard Medical School	Chen, BQ (corresponding author), Harbin Med Univ, Dept Nutr & Food Hyg, Coll Publ Hlth, Harbin, Peoples R China.	bingqingchen@sina.com; Jia-Ren.Liu@childrens.harvard.edu	Liu, Jia-Ren/V-9031-2019; Liu, Jia-Ren/G-1455-2011	Liu, Jia-Ren/0000-0001-6653-0053	Chinese National Natural Science Foundation [30771801]; Science and Chinese Technology Foundation of Tianjin Health Bureau [07KZ73]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Chinese Technology Foundation of Tianjin Health Bureau	This research was supported by the Chinese National Natural Science Foundation (No. 30771801) and the Science and Chinese Technology Foundation of Tianjin Health Bureau (No. 07KZ73). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Bardhan J, 2011, CURR PHARM DESIGN, V17, P2196, DOI 10.2174/138161211796957472; Bi S, 2010, TOXICOLOGY, V274, P27, DOI 10.1016/j.tox.2010.05.002; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chen BQ, 2003, WORLD J GASTROENTERO, V9, P44, DOI 10.3748/wjg.v9.i1.44; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Constantinou C, 2012, NUTR CANCER, V64, P136, DOI 10.1080/01635581.2012.630167; Constantinou C, 2009, CURR CANCER DRUG TAR, V9, P717, DOI 10.2174/156800909789271512; Constantinou C, 2009, NUTR CANCER, V61, P864, DOI 10.1080/01635580903285130; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Dong YW, 2011, PAIN MED, V12, P1777, DOI 10.1111/j.1526-4637.2011.01265.x; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guo WJ, 2010, J X-RAY SCI TECHNOL, V18, P293, DOI 10.3233/XST-2010-0261; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Heath-Engel HM, 2012, BBA-MOL CELL RES, V1823, P335, DOI 10.1016/j.bbamcr.2011.11.020; Hsieh TC, 2010, ANTICANCER RES, V30, P2869; Hu M, 2012, ANTICANCER RES, V32, P4385; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hunter DD, 2004, MOL CELL NEUROSCI, V27, P477, DOI 10.1016/j.mcn.2004.08.003; Iida J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044418; Inoue A, 2011, NUTR CANCER, V63, P763, DOI 10.1080/01635581.2011.563030; James MA, 2011, MOL CARCINOGEN, V50, P1, DOI 10.1002/mc.20690; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji XM, 2011, J CELL BIOCHEM, V112, P2773, DOI 10.1002/jcb.23184; Jiang Q, 2012, INT J CANCER, V130, P685, DOI 10.1002/ijc.26054; Kannappan R, 2010, MOL CANCER THER, V9, P2196, DOI 10.1158/1535-7163.MCT-10-0277; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lavergne E, 2011, ONCOGENE, V30, P423, DOI 10.1038/onc.2010.432; Li BH, 2011, CANCER LETT, V301, P185, DOI 10.1016/j.canlet.2010.11.015; Li Y, 2011, J NUTR BIOCHEM, V22, P1127, DOI 10.1016/j.jnutbio.2010.09.012; Liu HK, 2010, J NUTR BIOCHEM, V21, P206, DOI 10.1016/j.jnutbio.2008.11.004; Liu JR, 2008, INT J CANCER, V122, P2689, DOI 10.1002/ijc.23453; Liu JR, 2004, WORLD J GASTROENTERO, V10, P348; Liu JR, 2010, NUTR CANCER, V62, P58, DOI 10.1080/01635580903191510; Liu JR, 2004, WORLD J GASTROENTERO, V10, P167; Liu JR, 2002, WORLD J GASTROENTERO, V8, P999, DOI 10.3748/wjg.v8.i6.999; Liu T, 2012, EXP THER MED, V4, P716, DOI 10.3892/etm.2012.647; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mahalingam D, 2011, EUR J CLIN NUTR, V65, P63, DOI 10.1038/ejcn.2010.184; Manu KA, 2012, CLIN CANCER RES, V18, P2220, DOI 10.1158/1078-0432.CCR-11-2470; Mathiasen IS, 2002, TRENDS MOL MED, V8, P212, DOI 10.1016/S1471-4914(02)02328-6; Nakagawa K, 2007, J NUTR, V137, P1938, DOI 10.1093/jn/137.8.1938; Nautiyal J, 2011, INT J CANCER, V128, P951, DOI 10.1002/ijc.25410; Nesaretnam K, 2004, LIPIDS, V39, P459, DOI 10.1007/s11745-004-1251-1; Patacsil D, 2012, J NUTR BIOCHEM, V23, P93, DOI 10.1016/j.jnutbio.2010.11.012; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Qurishi Y, 2011, FUTURE ONCOL, V7, P1007, DOI [10.2217/fon.11.69, 10.2217/FON.11.69]; Rajendran P, 2011, BRIT J PHARMACOL, V163, P283, DOI 10.1111/j.1476-5381.2010.01187.x; Rickmann M, 2007, GASTROENTEROLOGY, V132, P2518, DOI 10.1053/j.gastro.2007.03.107; Shenoy AK, 2012, CANC RES; Shun MC, 2004, NUTR CANCER, V48, P95, DOI 10.1207/s15327914nc4801_13; Sookwong P, 2010, J AGR FOOD CHEM, V58, P3350, DOI 10.1021/jf903663k; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Sun WG, 2008, BRIT J NUTR, V99, P1247, DOI 10.1017/S0007114507879128; Sun WG, 2009, J NUTR BIOCHEM, V20, P276, DOI 10.1016/j.jnutbio.2008.03.003; Suzuki Hiromu, 2005, Nihon Rinsho, V63, P707; Takahashi K, 2004, BIOCHEM PHARMACOL, V67, P315, DOI 10.1016/j.bcp.2003.07.015; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; Wada S, 2005, CANCER LETT, V229, P181, DOI 10.1016/j.canlet.2005.06.036; Wang H, 2010, WORLD J GASTROENTERO, V16, P5416, DOI 10.3748/wjg.v16.i43.5416; Weng-Yew W, 2009, NUTR CANCER, V61, P367, DOI 10.1080/01635580802582736; Wilankar C, 2011, CURR PHARM DESIGN, V17, P2176, DOI 10.2174/138161211796957463; Wu SJ, 2010, INTEGR CANCER THER, V9, P66, DOI 10.1177/1534735409357757; Xu WL, 2009, NUTRITION, V25, P555, DOI 10.1016/j.nut.2008.10.019; Yang G, 2012, BR J CANC; Yap SP, 2001, J PHARM PHARMACOL, V53, P67, DOI 10.1211/0022357011775208; Yoon MJ, 2010, FREE RADICAL BIO MED, V48, P713, DOI 10.1016/j.freeradbiomed.2009.12.016; Zhang JS, 2011, TOXICOLOGY, V285, P8, DOI 10.1016/j.tox.2011.03.011; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	73	41	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57779	10.1371/journal.pone.0057779	http://dx.doi.org/10.1371/journal.pone.0057779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469066	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900164
J	Zhou, J; Ye, YX; Zeng, SG; Zhou, Y; Mao, ZG; Song, XB; Ying, BW; Lu, XJ; Jiang, H; Wang, LL				Zhou, Juan; Ye, Yuanxin; Zeng, Shugen; Zhou, Yi; Mao, Zhigang; Song, Xingbo; Ying, Binwu; Lu, Xiaojun; Jiang, Hong; Wang, Lanlan			Impact of JAK2 V617F Mutation on Hemogram Variation in Patients with Non-Reactive Elevated Platelet Counts	PLOS ONE			English	Article							CHRONIC MYELOPROLIFERATIVE DISORDERS; TYROSINE KINASE JAK2; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; CLINICAL-SIGNIFICANCE; JAK2(V617F); ACTIVATION; JAK2V617F; MYELOFIBROSIS; GRANULOCYTES	Background: Non-reactive platelet counts elevation occurs mainly in myeloproliferative disorders (MPDs), which have been reported to be closely associated with JAK2 V617F mutation. Complete blood cell count (CBC) is essential in diagnosis of MPDs, however, the impact of JAK2 V617F mutation on the patients' hemogram variation remains not clear. Methods: JAK2 V617F mutation was detected by allele specific real-time quantitative fluorescence PCR (AS-qPCR). Results: Of the 402 non-reactive platelet elevating patients, JAK2 V617F mutation was detected in 222 (55.2%) patients. RBC counts, WBC counts, platelet-large contrast ratio (P-LCR), platelet distribution width (PDW) and mean platelet volume (MPV) were much higher in JAK2 V617F mutated patients, except platelet counts. In addition, when the patients were classified into subgroups by blood cell counts, it was found that JAK2 V617F mutation rate increased progressively with the increase of RBC counts and WBC counts, other than platelet counts. Furthermore, trilineage hyperplasia group showed highest JAK2 V617F mutation rate (93.26%), followed by the bilineage hyperplasia groups. Lastly, JAK2 V617F mutant allele burden was found much higher in polycythemia vera (PV) patients [median(P-25-P-75): 45.02%(35.12%-54.22%)] than in essential thrombocythemia (ET) patients [median(P-25-P-75): 28.23%(17.77%-41.66%)], and that it increased with WBC counts (r = 0.393, p = 0.000) and RBC counts(r = 0.215, p = 0.001), other than platelet counts (r = -0.051, p = 0.452). Further analysis revealed that in ET patients, JAK2 V617F mutant allele burden correlated with WBC counts and platelet counts positively, other than RBC counts, while in PV patients, it correlated with WBC counts and RBC counts positively, but not platelet counts. Conclusions: JAK2 V617F mutation occurs frequently in patients with non-reactive elevated platelet counts. The presence of JAK2 V617F mutation has great impact on hemogram variation, including RBC counts, WBC counts, platelet parameters and lineage hyperplasia, but not on platelet counts. Besides, JAK2 V617F mutant allele burden affects the blood cell proliferation pattern.	[Zhou, Juan; Ye, Yuanxin; Zeng, Shugen; Zhou, Yi; Mao, Zhigang; Song, Xingbo; Ying, Binwu; Lu, Xiaojun; Jiang, Hong; Wang, Lanlan] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Ying, BW (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	yingbinwu916@163.com; luxiaojun1972@163.com; Jiangh6656@hotmail.com; wangll_wch@163.com	Ying, Binwu/AAB-5934-2022	Ying, Binwu/0000-0001-8077-3908	National Natural Science Foundation of China [NSFC-81071425, NSFC-81101327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC-81071425 and NSFC-81101327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902; Arellano-Rodrigo E, 2012, PLATELETS, V23, P336, DOI 10.3109/09537104.2011.630112; Barbui T, 2012, BLOOD; Basquiera AL, 2009, HEMATOLOGY, V14, P323, DOI 10.1179/102453309X12473408860226; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Calzada AA, 2012, EXP HEMATOL; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Cervantes F, 2011, HEMATOL-AM SOC HEMAT, P215, DOI 10.1182/asheducation-2011.1.215; Chang CC, 2006, ARCH PATHOL LAB MED, V130, P1123; Finazzi G, 2012, LEUKEMIA, V26, P875, DOI 10.1038/leu.2011.306; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Godfrey AL, 2012, HEMATOL ONCOL CLIN N, V26, P993, DOI 10.1016/j.hoc.2012.07.003; Hermouet S, 2007, LEUKEMIA, V21, P1128, DOI 10.1038/sj.leu.2404588; Hsu Hui-Chi, 2007, J Chin Med Assoc, V70, P89; James C, 2005, TRENDS MOL MED, V11, P546, DOI 10.1016/j.molmed.2005.10.003; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; James Chloe, 2008, Hematology Am Soc Hematol Educ Program, P69, DOI 10.1182/asheducation-2008.1.69; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kaushansky Kenneth, 2009, Hematology Am Soc Hematol Educ Program, P147, DOI 10.1182/asheducation-2009.1.147; Fuentes AEK, 2012, MED CLIN-BARCELONA, V139, P373, DOI 10.1016/j.medcli.2012.03.032; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lasho TL, 2005, BRIT J HAEMATOL, V130, P797, DOI 10.1111/j.1365-2141.2005.05682.x; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Palandri F, 2011, ANN HEMATOL, V90, P933, DOI 10.1007/s00277-010-1154-3; Panova-Noeva M, 2011, BLOOD, V118, P2599, DOI 10.1182/blood-2011-02-339655; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Randhawa J, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-43; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Santos FP, 2012, HEMATOL ONCOL CLIN N; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Skoda Radek C, 2009, Hematology Am Soc Hematol Educ Program, P159, DOI 10.1182/asheducation-2009.1.159; Sokolowska B, 2011, FOLIA HISTOCHEM CYTO, V49, P267, DOI 10.5603/FHC.2011.0037; Tefferi A, 2005, MAYO CLIN PROC, V80, P947, DOI 10.4065/80.7.947; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Vannucchi AM, 2007, BLOOD, V110, P840, DOI 10.1182/blood-2006-12-064287	38	10	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57856	10.1371/journal.pone.0057856	http://dx.doi.org/10.1371/journal.pone.0057856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469088	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900184
J	Choyce, A; Yong, M; Narayan, S; Mattarollo, SR; Liem, A; Lambert, PF; Frazer, IH; Leggatt, GR				Choyce, Allison; Yong, Michelle; Narayan, Sharmal; Mattarollo, Stephen R.; Liem, Amy; Lambert, Paul F.; Frazer, Ian H.; Leggatt, Graham R.			Expression of a Single, Viral Oncoprotein in Skin Epithelium Is Sufficient to Recruit Lymphocytes	PLOS ONE			English	Article							NKT CELLS; CANCER; PROTEIN; INFLAMMATION; ANTAGONISTS; CARCINOMA; IMMUNITY; TISSUE	Established cancers are frequently associated with a lymphocytic infiltrate that fails to clear the tumour mass. In contrast, the importance of recruited lymphocytes during premalignancy is less well understood. In a mouse model of premalignant skin epithelium, transgenic mice that express the human papillomavirus type 16 (HPV16) E7 oncoprotein under a keratin 14 promoter (K14E7 mice) display epidermal hyperplasia and have a predominant infiltrate of lymphocytes consisting of both CD4 and CD8 T cells. Activated, but not naive T cells, were shown to preferentially traffic to hyperplastic skin with an increased frequency of proliferative CD8+ T cells and CD4+ T cells expressing CCR6 within the tissue. Disruption of the interaction between E7 protein and retinoblastoma tumour suppressor protein (pRb) led to reduced epithelial hyperplasia and T cell infiltrate. Finally, while K14E7 donor skin grafts are readily accepted onto syngeneic, non-transgenic recipients, these same skin grafts lacking skin-resident lymphocytes were rejected. Our data suggests that expression of a single oncoprotein in the epidermis is sufficient for lymphocyte trafficking (including immunosuppressive lymphocytes) to premalignant skin.	[Choyce, Allison; Yong, Michelle; Narayan, Sharmal; Mattarollo, Stephen R.; Frazer, Ian H.; Leggatt, Graham R.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Liem, Amy; Lambert, Paul F.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Queensland; University of Wisconsin System; University of Wisconsin Madison	Leggatt, GR (corresponding author), Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia.	g.leggatt@uq.edu.au	Mattarollo, Stephen/B-3671-2011; Leggatt, Graham/G-1924-2010; Frazer, Ian/A-1137-2007	Mattarollo, Stephen/0000-0003-3659-6507; Leggatt, Graham/0000-0002-4078-5653; Frazer, Ian/0000-0002-8002-4680	National Health and Medical Research Council of Australia [569938]; National Cancer Institute [5U01CA141583]; Cancer Council Queensland; Lions Medical Research Foundation; Australian Cancer Research Foundation; Queensland Government Premiers Fellowship; NATIONAL CANCER INSTITUTE [U01CA141583] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Council Queensland(Cancer Council Queensland); Lions Medical Research Foundation; Australian Cancer Research Foundation; Queensland Government Premiers Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council of Australia (Program grant 569938); National Cancer Institute (grant 5U01CA141583); Cancer Council Queensland; Lions Medical Research Foundation and the Australian Cancer Research Foundation. Ian H. Frazer was the recipient of a Queensland Government Premiers Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Balsitis S, 2005, J VIROL, V79, P11392, DOI 10.1128/JVI.79.17.11392-11402.2005; Bethwaite PB, 1996, PATHOLOGY, V28, P321, DOI 10.1080/00313029600169274; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Burger JA, 2009, EXPERT OPIN INV DRUG, V18, P481, DOI [10.1517/13543780902804249 , 10.1517/13543780902804249]; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Dunn LA, 1997, VIROLOGY, V235, P94, DOI 10.1006/viro.1997.8650; EDWARDS RP, 1995, CANCER-AM CANCER SOC, V76, P1411, DOI 10.1002/1097-0142(19951015)76:8<1411::AID-CNCR2820760817>3.0.CO;2-V; Frazer IH, 2011, ANNU REV IMMUNOL, V29, P111, DOI 10.1146/annurev-immunol-031210-101308; Frazer IH, 2001, J IMMUNOL, V167, P6180, DOI 10.4049/jimmunol.167.11.6180; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Junankar SR, 2006, J INVEST DERM SYMP P, V11, P36, DOI 10.1038/sj.jidsymp.5650024; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsumoto K, 2004, JNCI-J NATL CANCER I, V96, P1611, DOI 10.1093/jnci/djh301; Mattarollo SR, 2011, J IMMUNOL, V187, P1601, DOI 10.4049/jimmunol.1100756; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; McGargill MA, 2002, J IMMUNOL, V169, P2141, DOI 10.4049/jimmunol.169.4.2141; Narayan S, 2009, EUR J IMMUNOL, V39, P481, DOI 10.1002/eji.200838527; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Yan L, 2006, EUR J CANCER, V42, P793, DOI 10.1016/j.ejca.2006.01.013	32	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57798	10.1371/journal.pone.0057798	http://dx.doi.org/10.1371/journal.pone.0057798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469070	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400046
J	Zalepa-King, L; Citovsky, V				Zalepa-King, Lisa; Citovsky, Vitaly			A Plasmodesmal Glycosyltransferase-Like Protein	PLOS ONE			English	Article							VIRUS MOVEMENT PROTEIN; GENE-EXPRESSION; TUNNELING NANOTUBES; NUCLEAR IMPORT; TOBACCO; CALRETICULIN; TRANSFORMATION; TRANSIENT; IDENTIFICATION; LOCALIZATION	Plasmodesmata (Pd) are plant intercellular connections that represent cytoplasmic conduits for a wide spectrum of cellular transport cargoes, from ions to house-keeping proteins to transcription factors and RNA silencing signals; furthermore, Pd are also utilized by most plant viruses for their spread between host cells. Despite this central role of Pd in the plant life cycle, their structural and functional composition remains poorly characterized. In this study, we used a known Pd-associated calreticulin protein AtCRT1 as bait to isolate other Pd associated proteins in Arabidopsis thaliana. These experiments identified a beta-1,6-N-acetylglucosaminyl transferase-like enzyme (AtGnTL). Subcellular localization studies using confocal microscopy observed AtGnTL at Pd within living plant cells and demonstrated colocalization with a Pd callose-binding protein (AtPDCB1). That AtGnTL is resident in Pd was consistent with its localization within the plant cell wall following plasmolysis. Initial characterization of an Arabidopsis T-DNA insertional mutant in the AtGnTL gene revealed defects in seed germination and delayed plant growth.	[Zalepa-King, Lisa; Citovsky, Vitaly] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Citovsky, V (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	vitaly.citovsky@stonybrook.edu		Citovsky, Vitaly/0000-0003-2024-6844	National Institutes of Health (NIH); National Science Foundation (NSF); US Department of Energy (DOE); US-Israel Binational Science Foundation (BSF); National Institute of Food and Agriculture/US Department of Agriculture (NIFA/USDA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050224] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Energy (DOE)(United States Department of Energy (DOE)); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); National Institute of Food and Agriculture/US Department of Agriculture (NIFA/USDA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH), National Science Foundation (NSF), US Department of Energy (DOE), US-Israel Binational Science Foundation (BSF), National Institute of Food and Agriculture/US Department of Agriculture (NIFA/USDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ballas N, 1997, P NATL ACAD SCI USA, V94, P10723, DOI 10.1073/pnas.94.20.10723; Baluska F, 1999, PLANT J, V19, P481, DOI 10.1046/j.1365-313X.1999.00530.x; Baluska F, 2001, PLANT PHYSIOL, V126, P39, DOI 10.1104/pp.126.1.39; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; Benitez-Alfonso Y, 2010, MOL PLANT MICROBE IN, V23, P1403, DOI 10.1094/MPMI-05-10-0116; Boyko V, 2000, NAT CELL BIOL, V2, P826, DOI 10.1038/35041072; Chen MH, 2005, PLANT PHYSIOL, V138, P1866, DOI 10.1104/pp.105.064386; Choo KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S2; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Crawford KM, 2001, PLANT PHYSIOL, V125, P1802, DOI 10.1104/pp.125.4.1802; DeBolt S, 2009, PLANT PHYSIOL, V151, P78, DOI 10.1104/pp.109.140582; DING B, 1992, PROTOPLASMA, V169, P28, DOI 10.1007/BF01343367; DING B, 1992, PLANT CELL, V4, P915, DOI 10.1105/tpc.4.8.915; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fukuda M, 1994, MOL GLYCOBIOLOGY; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; HEINLEIN M, 1995, SCIENCE, V270, P1983, DOI 10.1126/science.270.5244.1983; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Iglesias VA, 2000, PLANT J, V21, P157, DOI 10.1046/j.1365-313x.2000.00658.x; Jo Y, 2011, PROTOPLASMA, V248, P191, DOI 10.1007/s00709-010-0251-4; Kaiser C., 1994, METHODS YEAST GENETI; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Kim JY, 2002, P NATL ACAD SCI USA, V99, P4103, DOI 10.1073/pnas.052484099; Kotlizky G, 2001, MOL PLANT MICROBE IN, V14, P895, DOI 10.1094/MPMI.2001.14.7.895; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Laporte C, 2003, PLANT CELL, V15, P2058, DOI 10.1105/tpc.013896; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; Levy A, 2007, PLANT J, V49, P669, DOI 10.1111/j.1365-313X.2006.02986.x; Li JX, 2005, P NATL ACAD SCI USA, V102, P5733, DOI 10.1073/pnas.0404118102; Magori S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002124; Maule AJ, 2011, CURR OPIN PLANT BIOL, V14, P683, DOI 10.1016/j.pbi.2011.07.007; Maule AJ, 2008, CURR OPIN PLANT BIOL, V11, P680, DOI 10.1016/j.pbi.2008.08.002; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nam J, 1999, MOL GEN GENET, V261, P429, DOI 10.1007/s004380050985; Oparka KJ, 1997, PLANT J, V12, P781, DOI 10.1046/j.1365-313X.1997.12040781.x; Overall RL, 2000, ACTIN DYNAMIC FRAMEW, P1; Park H, 1998, CHROMOSOMA, V107, P211, DOI 10.1007/s004120050299; Roberts AG, 2003, PLANT CELL ENVIRON, V26, P103, DOI 10.1046/j.1365-3040.2003.00950.x; Roberts IM, 2001, PROTOPLASMA, V218, P31, DOI 10.1007/BF01288358; Ruiz-Medrano R, 2004, CURR OPIN PLANT BIOL, V7, P641, DOI 10.1016/j.pbi.2004.09.012; Sagi G, 2005, PLANT CELL, V17, P1788, DOI 10.1105/tpc.105.031823; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; Siddiqui SF, 2005, CANCER EPIDEM BIOMAR, V14, P2517, DOI 10.1158/1055-9965.EPI-05-0464; Simpson C, 2009, PLANT CELL, V21, P581, DOI 10.1105/tpc.108.060145; Sutton A, 2001, MOL CELL BIOL, V21, P3514, DOI 10.1128/MCB.21.10.3514-3522.2001; Taoka K, 2007, PLANT CELL, V19, P1866, DOI 10.1105/tpc.107.052522; Thomas CL, 2008, PLOS BIOL, V6, P180, DOI 10.1371/journal.pbio.0060007; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Tzfira T, 2002, P NATL ACAD SCI USA, V99, P10435, DOI 10.1073/pnas.162304099; Tzfira T, 1997, PLANT MOL BIOL REP, V15, P219, DOI 10.1023/A:1007484917759; Ueki S, 2002, NAT CELL BIOL, V4, P478, DOI 10.1038/ncb806; Ueki S, 2005, P NATL ACAD SCI USA, V102, P12089, DOI 10.1073/pnas.0505927102; Ueki S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001201; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WHITE RG, 1994, PROTOPLASMA, V180, P169, DOI 10.1007/BF01507853; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Zaltsman A, 2005, PLANT J, V42, P609, DOI 10.1111/j.1365-313X.2005.02401.x; Zaltsman A, 2010, CELL HOST MICROBE, V7, P197, DOI 10.1016/j.chom.2010.02.009; Zambryski P, 2008, CURR BIOL, V18, pR324, DOI 10.1016/j.cub.2008.01.046	73	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e58025	10.1371/journal.pone.0058025	http://dx.doi.org/10.1371/journal.pone.0058025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469135	gold, Green Published, Green Submitted			2022-12-27	WOS:000315561400052
J	Asher, E; Dvir, S; Seidman, DS; Greenberg-Dotan, S; Kedem, A; Sheizaf, B; Reuveni, H				Asher, Elad; Dvir, Shay; Seidman, Daniel S.; Greenberg-Dotan, Sari; Kedem, Alon; Sheizaf, Boaz; Reuveni, Haim			Defensive Medicine among Obstetricians and Gynecologists in Tertiary Hospitals	PLOS ONE			English	Article							MALPRACTICE CLAIMS; RISK; ASSOCIATION; PHYSICIANS; DELIVERY	Objective: To describe the daily work practice under the threat of defensive medicine among obstetricians and gynecologists. Study Design: A prospective cross-sectional survey of obstetricians and gynecologists working at tertiary medical centers in Israel. Results: Among the 117 obstetricians and gynecologists who participated in the survey, representing 10% of the obstetricians and gynecologists registered by the Israel Medical Association, 113 (97%) felt that their daily work practice is influenced by concern about being sued for medical negligence and not only by genuine medical considerations. As a result, 102 (87%) physicians are more likely to offer the cesarean section option, even in the absence of a clear medical indication, 70 (60%) follow court rulings concerning medical practices, and 85 (73%) physicians mentioned that discussions about medical negligence court rulings are included in their departments' meetings. Conclusions: Defensive medicine is a well-embedded phenomenon affecting the medical decision process of obstetricians and gynecologists.	[Asher, Elad] Chaim Sheba Med Ctr, Ramat Gan, Israel; [Dvir, Shay; Seidman, Daniel S.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Seidman, Daniel S.; Kedem, Alon] Chaim Sheba Med Ctr, Div Obstet & Gynecol, Ramat Gan, Israel; [Greenberg-Dotan, Sari; Reuveni, Haim] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Sheizaf, Boaz] Soroka Med Ctr, Div Obstet & Gynecol, IL-84101 Beer Sheva, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Asher, E (corresponding author), Chaim Sheba Med Ctr, Ramat Gan, Israel.	El.asher@gmail.com	Asher, Elad/I-3544-2019	Asher, Elad/0000-0003-3381-605X				ACOG Task Force on Cesarean Delivery Rates, 2000, EV CES DEL; Amu O, 1998, BRIT MED J, V317, P463; Anderson RE, 1999, ARCH INTERN MED, V159, P2399, DOI 10.1001/archinte.159.20.2399; Asher E, 2007, EUR J INTERN MED, V18, P35, DOI 10.1016/j.ejim.2006.07.021; Asher E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042613; Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; Eddy DM, 1998, HEALTH AFFAIR, V17, P7, DOI 10.1377/hlthaff.17.4.7; Grobman WA, 2006, OBSTET GYNECOL, V108, P1058, DOI 10.1097/01.AOG.0000245092.16780.a6; HICKSON GB, 1992, JAMA-J AM MED ASSOC, V267, P1359, DOI 10.1001/jama.267.10.1359; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Mello MM, 2006, UNDERSTANDING MED MA, P1; Murthy K, 2007, OBSTET GYNECOL, V110, P1264, DOI 10.1097/01.AOG.0000287294.89148.23; OECD, OECD REV HLTH CAR QU; Pellegrino E D, 1993, Pharos Alpha Omega Alpha Honor Med Soc, V56, P34; Quinlivan JA, 1999, AUST NZ J OBSTET GYN, V39, P207, DOI 10.1111/j.1479-828X.1999.tb03375.x; Saar A, 2002, MED LAW, V27, P16; Samanta Ash, 2006, Med Law Rev, V14, P321, DOI 10.1093/medlaw/fwl010; Sclar David, 2003, HARV HLTH POLY REV, V4, P75; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Tussing AD, 1997, MED CARE, V35, P172, DOI 10.1097/00005650-199702000-00007; US Congress Office of Technology Assessment, 1994, US C PUBL, VOTA-H-602; Wagner VV, 2004, CANADIAN J MIDWIFERY, V3, P12; Zwecker P, 2011, AM J PERINAT, V28, P277, DOI 10.1055/s-0030-1271213	27	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57108	10.1371/journal.pone.0057108	http://dx.doi.org/10.1371/journal.pone.0057108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483896	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100014
J	Roberts, G				Roberts, Gilbert			When Punishment Pays	PLOS ONE			English	Article							STRONG RECIPROCITY; ALTRUISTIC PUNISHMENT; COSTLY PUNISHMENT; NEURAL BASIS; EVOLUTION; COOPERATION; BEHAVIOR; SELECTION; BENEFITS	Explaining cooperation in groups remains a key problem because reciprocity breaks down between more than two. Punishing individuals who contribute little provides a potential answer but changes the dilemma to why pay the costs of punishing which, like cooperation itself, provides a public good. Nevertheless, people are observed to punish others in behavioural economic games, posing a problem for existing theory which highlights the difficulty in explaining the spread and persistence of punishment. Here, I consider the apparent mismatch between theory and evidence and show by means of instructive analysis and simulation how much of the experimental evidence for punishment comes from scenarios in which punishers may expect to obtain a net benefit from punishing free-riders. In repeated games within groups, punishment works by imposing costs on defectors so that it pays them to switch to cooperating. Both punishers and non-punishers then benefit from the resulting increase in cooperation, hence investing in punishment can constitute a social dilemma. However, I show the conditions in which the benefits of increased cooperation are so great that they more than offset the costs of punishing, thereby removing the temptation to free-ride on others' investments and making punishment explicable in terms of direct self-interest. Crucially, this is because of the leveraging effect imposed in typical studies whereby people can pay a small cost to inflict a heavy loss on a punished individual. In contrast to previous models suggesting punishment is disadvantaged when rare, I show it can invade until it comes into a producer-scrounger equilibrium with non-punishers. I conclude that adding punishment to an iterated public goods game can solve the problem of achieving cooperation by removing the social dilemma.	Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Roberts, G (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.	Gilbert.Roberts@ncl.ac.uk	Roberts, Gilbert/K-5449-2019					Atkinson QD, 2011, EVOL HUM BEHAV, V32, P41, DOI 10.1016/j.evolhumbehav.2010.07.008; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barclay P, 2006, EVOL HUM BEHAV, V27, P325, DOI 10.1016/j.evolhumbehav.2006.01.003; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; Boehm C, 1999, HUM NATURE-INT BIOS, V10, P205, DOI 10.1007/s12110-999-1003-z; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Boyd R, 2007, SCIENCE, V316, P1858, DOI 10.1126/science.1144339; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Bshary A, 2010, CURR BIOL, V20, P2032, DOI 10.1016/j.cub.2010.10.027; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Burnham TC., 2005, ANAL KRITIK, V27, P113, DOI [10.1515/auk-2005-0107, DOI 10.1515/AUK-2005-0107]; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colman AM, 2006, NATURE, V440, P744, DOI 10.1038/440744b; DAWES RM, 1988, J ECON PERSPECT, V2, P187, DOI 10.1257/jep.2.3.187; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Frank SA, 2003, EVOLUTION, V57, P693; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; Johnson DDP, 2003, NATURE, V421, P911, DOI 10.1038/421912a; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lehmann L, 2007, AM NAT, V170, P21, DOI 10.1086/518568; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Mathew S, 2009, P R SOC B, V276, P1167, DOI 10.1098/rspb.2008.1623; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MULDER RA, 1993, ANIM BEHAV, V45, P830, DOI 10.1006/anbe.1993.1100; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Raihani NJ, 2010, SCIENCE, V327, P171, DOI 10.1126/science.1183068; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Rankin DJ, 2009, P NATL ACAD SCI USA, V106, pE135, DOI 10.1073/pnas.0911990107; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Roberts G, 2005, ANIM BEHAV, V70, P901, DOI 10.1016/j.anbehav.2005.02.006; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Sherratt T. N., 2009, FRONT BIOSCI E, VE1, P340; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; WILSON DS, 1990, OIKOS, V59, P135, DOI 10.2307/3545133; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106; Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103	62	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57378	10.1371/journal.pone.0057378	http://dx.doi.org/10.1371/journal.pone.0057378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483907	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100024
J	Al-Ubaydli, O; Houser, D; Nye, J; Paganelli, MP; Pan, XS				Al-Ubaydli, Omar; Houser, Daniel; Nye, John; Paganelli, Maria Pia; Pan, Xiaofei Sophia			The Causal Effect of Market Priming on Trust: An Experimental Investigation Using Randomized Control	PLOS ONE			English	Article							BEHAVIORAL-EXPERIMENTS; PREFERENCES; INCENTIVES; FAIRNESS	We report data from laboratory experiments where participants were primed using phrases related to markets and trade. Participants then participated in trust games with anonymous strangers. The decisions of primed participants are compared to those of a control group. We find evidence that priming for market participation affects positively the beliefs regarding the trustworthiness of anonymous strangers and increases trusting decisions.	[Al-Ubaydli, Omar] Bahrain Ctr Strateg Int & Energy Studies, Res Dept, Awali, Bahrain; [Al-Ubaydli, Omar; Houser, Daniel] George Mason Univ, Dept Econ, Fairfax, VA 22030 USA; [Al-Ubaydli, Omar; Houser, Daniel] George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA; [Al-Ubaydli, Omar; Nye, John] George Mason Univ, Mercatus Ctr, Arlington, VA USA; [Nye, John] Natl Res Univ, Higher Sch Econ, Int Lab Inst Anal Econ Reforms, Moscow, Russia; [Paganelli, Maria Pia] Trinity Univ, Dept Econ, San Antonio, TX USA; [Pan, Xiaofei Sophia] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	George Mason University; George Mason University; George Mason University; HSE University (National Research University Higher School of Economics); Trinity University; Harvard University	Pan, XS (corresponding author), Harvard Univ, Dept Econ, Cambridge, MA 02138 USA.	xpan@fas.harvard.edu		Houser, Daniel/0000-0003-3583-8201; Paganelli, Maria Pia/0000-0002-5796-4519				Algan Y, 2010, AM ECON REV, V100, P2060, DOI 10.1257/aer.100.5.2060; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Banerjee AV, 2009, ANNU REV ECON, V1, P151, DOI 10.1146/annurev.economics.050708.143235; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; BARGH JA, 1986, J PERS SOC PSYCHOL, V50, P869, DOI 10.1037/0022-3514.50.5.869; Benabou R, 2003, REV ECON STUD, V70, P489, DOI 10.1111/1467-937X.00253; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Benjamin DJ, 2010, AM ECON REV, V100, P1913, DOI 10.1257/aer.100.4.1913; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bicchieri C, 2011, POLIT PHILOS ECON, V10, P170, DOI 10.1177/1470594X10387260; Bowles S, 1998, J ECON LIT, V36, P75; Bowles S, 2011, PHILOS PUBLIC AFF, V39, P46, DOI 10.1111/j.1088-4963.2011.01201.x; Brandts J, 2011, EXP ECON, V14, P375, DOI 10.1007/s10683-011-9272-x; Burnham T, 2000, J ECON BEHAV ORGAN, V43, P57, DOI 10.1016/S0167-2681(00)00108-6; Chen D, 2010, MARKETS MORALI UNPUB; Cox JC, 2004, GAME ECON BEHAV, V46, P260, DOI 10.1016/S0899-8256(03)00119-2; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dufwenberg M, 2004, GAME ECON BEHAV, V47, P268, DOI 10.1016/j.geb.2003.06.003; Falk A, 2004, GAME ECON BEHAV, V54, P293; Falk A, 2006, AM ECON REV, V96, P1611, DOI 10.1257/aer.96.5.1611; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2009, J EUR ECON ASSOC, V7, P235, DOI 10.1162/JEEA.2009.7.2-3.235; Frey BS, 1997, AM ECON REV, V87, P746; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Hayek FA, 1945, AM ECON REV, V35, P519; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J., 2005, FDN HUMAN SOCIALITY; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hirshman H, 1977, PASSION INTERESTS PO; Hume David, 1985, ESSAYS MORAL POLITIC, P51; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Marx Karl, 2000, KAPITAL; Montesquieu Charles, 1989, SPIRIT LAWS; Mussweiler T., 1999, EUR REV SOC PSYCHOL, V10, P135, DOI DOI 10.1080/14792779943000044; North D. C., 1990, I I CHANGE EC PERFOR; Paine T., 1984, RIGHTS MAN; Reeson AF, 2010, ENVIRON RESOUR ECON, V47, P439, DOI 10.1007/s10640-010-9387-0; Smith A., 1759, THEORY MORAL SENTIME; SMITH VL, 1982, AM ECON REV, V72, P923; Veblen T, 1899, THEORY LEISURE CLASS; Zak PJ, 2001, ECON J, V111, P295, DOI 10.1111/1468-0297.00609	44	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e55968	10.1371/journal.pone.0055968	http://dx.doi.org/10.1371/journal.pone.0055968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472068	Green Published, gold			2022-12-27	WOS:000315637900006
J	Albertsen, HM; Chettier, R; Farrington, P; Ward, K				Albertsen, Hans M.; Chettier, Rakesh; Farrington, Pamela; Ward, Kenneth			Genome-Wide Association Study Link Novel Loci to Endometriosis	PLOS ONE			English	Article							MONOZYGOTIC TWINS; GENETICS; WOMEN; POPULATION; EXPRESSION; DIAGNOSIS; DISEASE; SAMPLE; DELAY; RISK	Endometriosis is a common gynecological condition with complex etiology defined by the presence of endometrial glands and stroma outside the womb. Endometriosis is a common cause of both cyclic and chronic pelvic pain, reduced fertility, and reduced quality-of-life. Diagnosis and treatment of endometriosis is, on average, delayed by 7-10 years from the onset of symptoms. Absence of a timely and non-invasive diagnostic tool is presently the greatest barrier to the identification and treatment of endometriosis. Twin and family studies have documented an increased relative risk in families. To identify genetic factors that contribute to endometriosis we conducted a two-stage genome-wide association study (GWAS) of a European cohort including 2,019 surgically confirmed endometriosis cases and 14,471 controls. Three of the SNPs we identify associated at P<5 x 10(-8) in our combined analysis belong to two loci: LINC00339-WNT4 on 1p36.12 (rs2235529; P = 8.65 x 10(-9), OR = 1.29, CI = 1.18-1.40) and RND3-RBM43 on 2q23.3 (rs1519761; P = 4.70 x 10(-8), OR = 1.20, Cl = 1.13-1.29, and rs6757804; P = 4.05 x 10(-8), OR = 1.20, Cl = 1.13-1.29). Using an adjusted Bonferoni significance threshold of 4.51 x 10(-7) we identify two additional loci in our meta-analysis that associate with endometriosis:, RNF144B-ID4 on 6p22.3 (rs6907340; P = 2.19 x 10(-7), OR = 1.20, Cl = 1.12-1.28), and HNRNPA3P1-LOC100130539 on 10q11.21 (rs10508881; P = 4.08 x 10(-7), OR = 1.19, Cl = 1.11-1.27). Consistent with previously suggested associations to WNT4 our study implicate a 150 kb region around WNT4 that also include LINC00339 and CDC42. A univariate analysis of documented infertility, age at menarche, and family history did not show allelic association with these SNP markers. Clinical data from patients in our study reveal an average delay in diagnosis of 8.4 years and confirm a strong correlation between endometriosis severity and infertility (n = 1182, P<0.001, OR = 2.18). This GWAS of endometriosis was conducted with high diagnostic certainty in cases, and with stringent handling of population substructure. Our findings broaden the understanding of the genetic factors that play a role in endometriosis.	[Albertsen, Hans M.; Chettier, Rakesh; Farrington, Pamela; Ward, Kenneth] Juneau Biosci LLC, Salt Lake City, UT USA		Ward, K (corresponding author), Juneau Biosci LLC, Salt Lake City, UT USA.	kenw@juneaubiosciences.com						Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Arruda MS, 2003, HUM REPROD, V18, P756, DOI 10.1093/humrep/deg136; Ballard K, 2006, FERTIL STERIL, V86, P1296, DOI 10.1016/j.fertnstert.2006.04.054; Canis M, 1997, FERTIL STERIL, V67, P817; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Goteri G, 2006, FERTIL STERIL, V86, P559, DOI 10.1016/j.fertnstert.2006.01.031; Grechukhina O, 2012, EMBO MOL MED; Hadfield RM, 1997, FERTIL STERIL, V68, P941, DOI 10.1016/S0015-0282(97)00359-2; Hansen KA, 2010, CLIN OBSTET GYNECOL, V53, P403, DOI 10.1097/GRF.0b013e3181db7ca1; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu WP, 2006, J CLIN ENDOCR METAB, V91, P228, DOI 10.1210/jc.2004-1594; Husby GK, 2003, ACTA OBSTET GYN SCAN, V82, P649, DOI 10.1034/j.1600-0412.2003.00168.x; Luong HT, 2012, HUM REPROD; MOEN MH, 1994, ACTA OBSTET GYN SCAN, V73, P59, DOI 10.3109/00016349409013396; Montgomery GW, 2008, HUM REPROD UPDATE, V14, P447, DOI 10.1093/humupd/dmn016; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nyholt DR, 2012, NAT GENET; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahmioglu N, 2012, CURR OBSTET GYNECOL, V1, P124, DOI 10.1007/s13669-012-0016-5; Santulli P, 2012, HUM REPROD, V27, P2001, DOI 10.1093/humrep/des154; Signorile PG, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-49; Stefanson H, 2002, HUM REPROD, V17, P555, DOI 10.1093/humrep/17.3.555; Treloar SA, 1999, FERTIL STERIL, V71, P701, DOI 10.1016/S0015-0282(98)00540-8; Treloar SA, 2005, AM J HUM GENET, V77, P365, DOI 10.1086/432960; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612	30	103	111	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58257	10.1371/journal.pone.0058257	http://dx.doi.org/10.1371/journal.pone.0058257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472165	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900111
J	Beck, KE; Thorne, L; Lockey, R; Vickery, CM; Terry, LA; Bujdoso, R; Spiropoulos, J				Beck, Katy E.; Thorne, Leigh; Lockey, Richard; Vickery, Christopher M.; Terry, Linda A.; Bujdoso, Raymond; Spiropoulos, John			Strain Typing of Classical Scrapie by Transgenic Mouse Bioassay Using Protein Misfolding Cyclic Amplification to Replace Primary Passage	PLOS ONE			English	Article							BOVINE SPONGIFORM; PRION PROTEIN; SHEEP; TRANSMISSION; CONVERSION; FEATURES; DISEASE; BRAIN; MICE; BSE	According to traditional murine bioassay methodology, prions must be serially passaged within a new host before a stable phenotype, and therefore a strain, can be assigned. Prions often transmit with difficulty from one species to another; a property termed the transmission barrier. Transgenic mouse lines that over express prion protein (PrP) genes of different species can circumvent the transmission barrier but serial passages may still be required, particularly if unknown strains are encountered. Here we sought to investigate whether protein misfolding cyclic amplification (PMCA), an in-vitro method of PrPSc replication, could be used to replace serial passage of VRQ/VRQ classical scrapie isolates undergoing strain typing in ovine transgenic tg338 mice. Two classical scrapie field isolates that do not readily transmit to wild-type mice underwent bioassay in tg338 mice pre- and post- PMCA and the phenotype of disease in inoculated mice was compared. For one of the sources investigated, the PMCA product gave rise to the same disease phenotypes in tg338 mice as traditional bioassay, as indicated by lesion profile, IHC analysis and Western blot, whilst the second source produced phenotypic characteristics which were not identical with those that arose through traditional bioassay. These data show that differences in the efficiency of PMCA as a strain-typing tool may vary between ovine classical scrapie isolates and therefore suggest that the ability of PMCA to replace serial passage of classical scrapie in tg338 mice may depend on the strain present in the initial source.	[Beck, Katy E.; Thorne, Leigh; Vickery, Christopher M.; Terry, Linda A.] Anim Hlth & Vet Labs Agcy, Transmissible Spongiform Encephalopathy Dept, Addlestone, Surrey, England; [Lockey, Richard; Spiropoulos, John] Anim Hlth & Vet Labs Agcy, Dept Pathol, Addlestone, Surrey, England; [Bujdoso, Raymond] Univ Cambridge, Dept Vet Med, Cambridge, England	Veterinary Laboratories Agency; Veterinary Laboratories Agency; University of Cambridge	Spiropoulos, J (corresponding author), Anim Hlth & Vet Labs Agcy, Dept Pathol, Addlestone, Surrey, England.	john.spiropoulos@ahvla.gsi.gov.uk	Beck, Katy/C-7990-2011; Thorne, Leigh/C-6500-2011; Spiropoulos, John/C-7991-2011		AHVLA [SC0250]	AHVLA	This project was supported by AHVLA grant SC0250. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck KE, 2010, J NEUROPATH EXP NEUR, V69, P483, DOI 10.1097/NEN.0b013e3181db2497; Beck KE, 2010, BRAIN PATHOL, V20, P313, DOI 10.1111/j.1750-3639.2009.00273.x; Beck KE, 2011, BRAIN PATHOL, P10; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Bossers A, 2000, J VIROL, V74, P1407, DOI 10.1128/JVI.74.3.1407-1414.2000; Brown DA, 2003, NEUROPATH APPL NEURO, V29, P262, DOI 10.1046/j.1365-2990.2003.00462.x; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; Bruce ME, 2003, RECENT PROGR TRANSMI, V29, P207; Garza MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027525; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; European Union RL, 2009, FIX TISS PROC HIST I; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Gotte DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027510; Gonzalez-Montalban N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041210; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Green R, 2005, J COMP PATHOL, V132, P117, DOI 10.1016/j.jcpa.2004.08.002; Makarava N, 2013, J BIOL CHEM, V288, P33, DOI 10.1074/jbc.M112.419531; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mazza M, 2010, RES VET SCI, V88, P478, DOI 10.1016/j.rvsc.2009.11.015; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; Thackray AM, 2008, J VIROL, V82, P11197, DOI 10.1128/JVI.01454-08; Thackray AM, 2012, EXP MOL PATHOL, V92, P167, DOI 10.1016/j.yexmp.2011.11.004; Thackray AM, 2011, J GEN VIROL; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0	34	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57851	10.1371/journal.pone.0057851	http://dx.doi.org/10.1371/journal.pone.0057851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472112	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900051
J	Cannuyer, J; Loriot, A; Parvizi, GK; De Smet, C				Cannuyer, Julie; Loriot, Axelle; Parvizi, Gregory K.; De Smet, Charles			Epigenetic Hierarchy within the MAGEA1 Cancer-Germline Gene: Promoter DNA Methylation Dictates Local Histone Modifications	PLOS ONE			English	Article							MELANOMA CELL-LINES; SILENCED GENES; STEM-CELLS; HYPOMETHYLATION; EXPRESSION; MAGE-A1; CPG; IMMUNOTHERAPY; DEMETHYLATION; TRANSCRIPTION	Gene MAGEA1 belongs to a group of human germline-specific genes that rely on DNA methylation for repression in somatic tissues. Many of these genes, termed cancer-germline (CG) genes, become demethylated and activated in a wide variety of tumors, where they encode tumor-specific antigens. The process leading to DNA demethylation of CG genes in tumors remains unclear. Previous data suggested that histone acetylation might be involved. Here, we investigated the relative contribution of DNA methylation and histone acetylation in the epigenetic regulation of gene MAGEA1. We show that MAGEA1 DNA hypomethylation in expressing melanoma cells is indeed correlated with local increases in histone H3 acetylation (H3ac). However, when MAGEA1-negative cells were exposed to a histone deacetylase inhibitor (TSA), we observed only short-term activation of the gene and detected no demethylation of its promoter. As a more sensitive assay, we used a cell clone harboring a methylated MAGEA1/hph construct, which confers resistance to hygromycin upon stable re-activation. TSA induced only transient de-repression of the transgene, and did not lead to the emergence of hygromycin-resistant cells. In striking contrast, transient depletion of DNA-methyltransferase-1 in the reporter cell clone gave rise to a hygromycin-resistant population, in which the re-activated MAGEA1/hph transgene displayed not only marked DNA hypomethylation, but also significant reversal of histone marks, including gains in H3ac and H3K4me2, and losses of H3K9me2. Collectively, our results indicate that DNA methylation has a dominant role in the epigenetic hierarchy governing MAGEA1 expression.	[Cannuyer, Julie; Loriot, Axelle; Parvizi, Gregory K.; De Smet, Charles] Catholic Univ Louvain, de Duve Inst, Grp Genet & Epigenet, B-1200 Brussels, Belgium	Universite Catholique Louvain	De Smet, C (corresponding author), Catholic Univ Louvain, de Duve Inst, Grp Genet & Epigenet, B-1200 Brussels, Belgium.	charles.desmet@uclouvain.be			FSR-FNRS-Televie grant; FSR-FNRS-FRIA; FSR-FNRS [3.4563.11]	FSR-FNRS-Televie grant(Fonds de la Recherche Scientifique - FNRS); FSR-FNRS-FRIA(Fonds de la Recherche Scientifique - FNRS); FSR-FNRS(Fonds de la Recherche Scientifique - FNRS)	JC is the recipient of a FSR-FNRS-Televie grant (http://www2.frs-fnrs.be/). GKP received a fellowship from FSR-FNRS-FRIA (http://www2.frs-fnrs.be/). This work was supported by a FRSM grant from the FSR-FNRS (ref. 3.4563.11, http://www2.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Anichini A, 1999, HUMAN CELL CULTURE, V1, P283; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Brasseur F, 1999, HUMAN CELL CULTURE, V1, P275; Campbell MJ, 2013, ADV EXP MED BIOL, V754, P81, DOI 10.1007/978-1-4419-9967-2_4; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; D'Alessio AC, 2007, MOL CELL BIOL, V27, P7462, DOI 10.1128/MCB.01120-07; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; De Smet C, 2013, ADV EXP MED BIOL, V754, P149, DOI 10.1007/978-1-4419-9967-2_7; De Smet Charles, 2010, Epigenetics, V5, P206; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Link PA, 2009, MOL CANCER RES, V7, P851, DOI 10.1158/1541-7786.MCR-08-0497; Loriot A, 2006, J BIOL CHEM, V281, P10118, DOI 10.1074/jbc.M510469200; Loriot A, 2003, INT J CANCER, V105, P371, DOI 10.1002/ijc.11104; Loriot A, 2012, BIOCHEM BIOPH RES CO, V417, P187, DOI 10.1016/j.bbrc.2011.11.120; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Rao M, 2011, CANCER RES, V71, P4192, DOI 10.1158/0008-5472.CAN-10-2442; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Steele N, 2009, BRIT J CANCER, V100, P758, DOI 10.1038/sj.bjc.6604932; Tilman G, 2009, ONCOGENE, V28, P1682, DOI 10.1038/onc.2009.23; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Wischnewski F, 2007, MOL CANCER RES, V5, P749, DOI 10.1158/1541-7786.MCR-06-0364; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07	39	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58743	10.1371/journal.pone.0058743	http://dx.doi.org/10.1371/journal.pone.0058743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472218	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900165
J	Kuang, Q; Li, LF; Peng, JZ; Sun, SL; Wang, XJ				Kuang, Qi; Li, Lingfei; Peng, Jianzong; Sun, Shulan; Wang, Xiaojing			Transcriptome Analysis of Gerbera hybrida Ray Florets: Putative Genes Associated with Gibberellin Metabolism and Signal Transduction	PLOS ONE			English	Article							CELL-PROLIFERATION; FLOWER DEVELOPMENT; FLORAL DEVELOPMENT; DELLA PROTEIN; RNA-SEQ; ARABIDOPSIS; RECEPTOR; RICE; IDENTIFICATION; BIOSYNTHESIS	In this study, the transcriptome of the Gerbera hybrida ray floret was constructed using a high-throughput Illumina sequencing platform. All 47,104 UniGenes with an average length of 845 nt and an N50 equaling 1321 nt were generated from 72,688,546 total primary reads after filtering and assembly. A total of 36,693 transcripts were annotated by comparison with non-redundant National Center for Biotechnology Information (NCBI) protein (Nr), non-redundant NCBI nucleotide (Nt), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases after removing exogenous contaminated sequences. The majority of the genes that are associated with gibberellin metabolism and signal transduction were identified. The targets for signal transduction of other plant hormones were also enumerated. Our study provides a systematic overview of the hormone signal transduction genes that are involved in ray floral development in Asteraceae and should facilitate further understanding of the crucial roles of phytohormones in plant growth.	[Kuang, Qi; Li, Lingfei; Peng, Jianzong; Sun, Shulan; Wang, Xiaojing] S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China	South China Normal University	Wang, XJ (corresponding author), S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China.	wangxj@scnu.edu.cn		Li, Lingfei/0000-0001-5115-5166	National Natural Science Foundation of China [31070261]; Natural Science Foundation of Guangdong Province [2011A020201008, 10151063101000023, 2011A020102007]; Doctoral Fund of MoE [20104407110005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Doctoral Fund of MoE	This study was supported by National Natural Science Foundation of China (Grant No. 31070261) and Natural Science Foundation of Guangdong Province (Grant No. 2011A020201008, 10151063101000023, 2011A020102007) and Doctoral Fund of MoE (Grant No. 20104407110005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Broholm SK, 2010, J EXP BOT, V61, P75, DOI 10.1093/jxb/erp279; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Chua LL, 2010, J INTEGR PLANT BIOL, V52, P410, DOI 10.1111/j.1744-7909.2010.00938.x; Csukasi F, 2011, NEW PHYTOL, V191, P376, DOI 10.1111/j.1469-8137.2011.03700.x; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; Elling AA, 2009, PLANT SIGNAL BEHAV, V4, P760, DOI 10.1105/tpc.109.065714; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; HELARIUTTA Y, 1993, PLANT MOL BIOL, V22, P183, DOI 10.1007/BF00014927; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Huang YY, 2012, FUNCT INTEGR GENOMIC, V12, P199, DOI 10.1007/s10142-011-0243-2; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kilian N., 2009, SYSTEMATICS EVOLUTIO; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Laitinen RAE, 2005, GENOME RES, V15, P475, DOI 10.1101/gr.3043705; Laitinen RAE, 2008, J EXP BOT, V59, P3691, DOI 10.1093/jxb/ern216; Laitinen RAE, 2007, PLANTA, V226, P347, DOI 10.1007/s00425-007-0486-2; Laitinen RAE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-11; Lange T, 2005, PLANT PHYSIOL, V139, P213, DOI 10.1104/pp.105.064162; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Masmoudi-Allouche F, 2009, PLANT CELL REP, V28, P1, DOI 10.1007/s00299-008-0611-0; Meng XC, 2004, J HORTIC SCI BIOTECH, V79, P131, DOI 10.1080/14620316.2004.11511725; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Nomura T, 2005, J BIOL CHEM, V280, P17873, DOI 10.1074/jbc.M414592200; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Ruokolainen S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-129; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Schilmiller AL, 2010, PLANT PHYSIOL, V153, P1212, DOI 10.1104/pp.110.157214; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Stephenson PG, 2009, P NATL ACAD SCI USA, V106, P7654, DOI 10.1073/pnas.0811684106; Teeri TH, 2006, J EXP BOT, V57, P3445, DOI 10.1093/jxb/erl181; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Weiss D, 1989, PLATA, V192, P489; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yu DY, 1999, PLANT J, V17, P51, DOI 10.1046/j.1365-313X.1999.00351.x; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang ZL, 2011, P NATL ACAD SCI USA, V108, P2160, DOI 10.1073/pnas.1012232108; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	53	23	28	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57715	10.1371/journal.pone.0057715	http://dx.doi.org/10.1371/journal.pone.0057715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472101	Green Published, gold			2022-12-27	WOS:000315637900040
J	Nglazi, MD; Kaplan, R; Orrell, C; Myer, L; Wood, R; Bekker, LG; Lawn, SD				Nglazi, Mweete D.; Kaplan, Richard; Orrell, Catherine; Myer, Landon; Wood, Robin; Bekker, Linda-Gail; Lawn, Stephen D.			Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TREATMENT PROGRAM; INCOME COUNTRIES; EARLY MORTALITY; THERAPY; OUTCOMES; ADULTS; DISCONTINUATION; TUBERCULOSIS; REASONS	Objectives: To determine the proportion, characteristics and outcomes of patients who transfer-out from an antiretroviral therapy (ART) service in a South African township. Methods: This retrospective cohort study included all patients aged >= 15 years who enrolled between September 2002 and December 2009. Follow-up data were censored in December 2010. Kaplan-Meier survival analysis was used to describe time to transfer-out and cox proportional hazard analysis was used to determine associated risk factors. Results: 4511 patients (4003 ART-naive and 508 non-naive at baseline) received ART during the study period. Overall, 597 (13.2%) transferred out. The probability of transferring out by one year of ART steadily increased from 1.4% in 2002/2004 cohort to 8.9% for the 2009 cohort. Independent risk factors for transfer-out were more recent calendar year of enrolment, younger age (<= 25 years) and being ART non-naive at baseline (i.e., having previously transferred into this clinic from another facility). The proportions of patients transferred out who had a CD4 cell count,200 cells/mu L and/or a viral load >= 1000 copies/mL were 19% and 20%, respectively. Conclusions: With scale-up of ART over time, an increasing proportion of patients are transferring between ART services and information systems are needed to track patients. Approximately one-fifth of these have viral loads > 1000 copies/mL around the time of transfer, suggesting the need for careful adherence counseling and assessment of medication supplies among those planning transfer.	[Nglazi, Mweete D.; Kaplan, Richard; Orrell, Catherine; Wood, Robin; Bekker, Linda-Gail; Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Nglazi, Mweete D.; Kaplan, Richard; Orrell, Catherine; Wood, Robin; Bekker, Linda-Gail; Lawn, Stephen D.] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Nglazi, Mweete D.] Int Union TB & Lung Dis, Paris, France; [Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England	University of Cape Town; University of Cape Town; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Nglazi, MD (corresponding author), Univ Cape Town, Desmond Tutu HIV Ctr, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Mweete.Nglazi@hiv-research.org.za	Orrell, Catherine/AAF-3405-2019; Bekker, Linda-Gail/AAZ-8929-2020	Orrell, Catherine/0000-0003-1134-7475; Kaplan, Richard/0000-0003-1565-4704; BEKKER, LINDA-GAIL/0000-0002-0755-4386	Cost-Effectiveness of Preventing AIDS Complications (CEPAC); National Institutes of Health (NIH) [5 R01AI058736-02]; National Institute of Allergy and Infectious Diseases (NIAID) [5U01AI069924-02]; USAID [CA 674 A 00 08 0000 700]; South African Centre for Epidemiological Modelling and Analysis (SACEMA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, R01AI058736] Funding Source: NIH RePORTER	Cost-Effectiveness of Preventing AIDS Complications (CEPAC); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USAID(United States Agency for International Development (USAID)); South African Centre for Epidemiological Modelling and Analysis (SACEMA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MDN is supported as an operational research fellow by the International Union Against Tuberculosis and Lung Disease, Paris, France. SDL is funded by the Wellcome Trust, London UK. RW is funded in part by the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) funded by the National Institutes of Health (NIH, 5 R01AI058736-02); International Epidemiologic Database to Evaluate Aids with a grant from the National Institute of Allergy and Infectious Diseases (NIAID: 5U01AI069924-02); USAID Right to Care (CA 674 A 00 08 0000 700) and the South African Centre for Epidemiological Modelling and Analysis (SACEMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NAT ANT TREATM GUID; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; CrimeSolutions.org, 2011, PROGRAM PROFILE COMM; Department of Health and Human Sevices Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, AUSTR COMM DHHS GUID; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2011, SAMJ S AFR MED J, V101, P258, DOI 10.7196/SAMJ.4392; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Mukora R, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-205; Mulamba D, 2010, DECENTRALIZING ANTIR; National Department of Health, 1997, WHIT PAP TRANSF HLTH; National Department of Health, 2010, HCT POL GUID MARCH 2; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Yu JKL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002065	23	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57907	10.1371/journal.pone.0057907	http://dx.doi.org/10.1371/journal.pone.0057907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472118	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000315637900061
J	Niu, XW; Liu, GX; Wu, RS; Chudasama, N; Zakharov, SI; Karlin, A; Marx, SO				Niu, Xiaowei; Liu, Guoxia; Wu, Roland S.; Chudasama, Neelesh; Zakharov, Sergey I.; Karlin, Arthur; Marx, Steven O.			Orientations and Proximities of the Extracellular Ends of Transmembrane Helices S0 and S4 in Open and Closed BK Potassium Channels	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; VOLTAGE-SENSOR; BETA-SUBUNIT; MOLECULAR-BASIS; SODIUM-CHANNELS; SCALE MOVEMENT; IONIC CURRENTS; ALPHA-SUBUNIT; CROSS-LINKING; RAT MUSCLE	The large-conductance potassium channel (BK) alpha subunit contains a transmembrane (TM) helix S0 preceding the canonical TM helices S1 through S6. S0 lies between S4 and the TM2 helix of the regulatory beta 1 subunit. Pairs of Cys were substituted in the first helical turns in the membrane of BK alpha S0 and S4 and in beta 1 TM2. One such pair, W22C in S0 and W203C in S4, was 95% crosslinked endogenously. Under voltage-clamp conditions in outside-out patches, this crosslink was reduced by DTT and reoxidized by a membrane-impermeant bis-quaternary ammonium derivative of diamide. The rate constants for this reoxidation were not significantly different in the open and closed states of the channel. Thus, these two residues are approximately equally close in the two states. In addition, 90% crosslinking of a second pair, R20C in S0 and W203C in S4, had no effect on the V-50 for opening. Taken together, these findings indicate that separation between residues at the extracellular ends of S0 and S4 is not required for voltage-sensor activation. On the contrary, even though W22C and W203C were equally likely to form a disulfide in the activated and deactivated states, relative immobilization by crosslinking of these two residues favored the activated state. Furthermore, the efficiency of recrosslinking of W22C and W203C on the cell surface was greater in the presence of the beta 1 subunit than in its absence, consistent with beta 1 acting through S0 to stabilize its immobilization relative to alpha S4.	[Niu, Xiaowei; Karlin, Arthur] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Biochem, New York, NY 10027 USA; [Niu, Xiaowei; Karlin, Arthur] Columbia Univ, Dept Physiol, Ctr Mol Recognit, Coll Phys & Surg, New York, NY 10027 USA; [Niu, Xiaowei; Karlin, Arthur] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Neurol, New York, NY USA; [Liu, Guoxia; Wu, Roland S.; Chudasama, Neelesh; Zakharov, Sergey I.; Marx, Steven O.] Columbia Univ, Coll Phys & Surg, Div Cardiol, Dept Med, New York, NY USA; [Marx, Steven O.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Karlin, A (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Biochem, New York, NY 10027 USA.	ak12@columbia.edu; sm460@columbia.edu		KARLIN, ARTHUR/0000-0002-4813-752X	National Institute of Neurological Disorders and Stroke [R01 NS054946]; National Heart, Lung, and Blood Institute [P01 HL081172]; Arlene and Arnold Goldstein Family Foundation; Lewis Katz Cardiovascular Research Prize; AHA Scientist Development Grant; National Institutes of Health [T32 HL07854]; Schering-Plough; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081172, T32HL007854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054946] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Arlene and Arnold Goldstein Family Foundation; Lewis Katz Cardiovascular Research Prize; AHA Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schering-Plough(Merck & CompanySchering Plough Corporation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by R01 NS054946 from National Institute of Neurological Disorders and Stroke and P01 HL081172 from National Heart, Lung, and Blood Institute, the Arlene and Arnold Goldstein Family Foundation, and the Lewis Katz Cardiovascular Research Prize. GL is supported by an AHA Scientist Development Grant. RW was supported by National Institutes of Health T32 HL07854 and Future Leaders in CV Medical Research award from Schering-Plough. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Aziz QH, 2002, J BIOL CHEM, V277, P42719, DOI 10.1074/jbc.M207258200; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Broomand A, 2008, NEURON, V59, P770, DOI 10.1016/j.neuron.2008.07.008; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Gruslova A, 2012, J GEN PHYSIOL, V139, P57, DOI 10.1085/jgp.201110698; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; KOSOWER EM, 1974, BIOCHEM BIOPH RES CO, V59, P347, DOI 10.1016/S0006-291X(74)80213-5; Koval OM, 2007, J GEN PHYSIOL, V129, P209, DOI 10.1085/jgp.200609662; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Liu GX, 2008, P NATL ACAD SCI USA, V105, P10727, DOI 10.1073/pnas.0805212105; Liu G, 2008, J GEN PHYSIOL, V131, P537, DOI 10.1085/jgp.200809968; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 1996, FEBS LETT, V385, P127; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Pantazis A, 2010, J GEN PHYSIOL, V136, P645, DOI 10.1085/jgp.201010503; Pantazis A, 2010, P NATL ACAD SCI USA, V107, P4459, DOI 10.1073/pnas.0911959107; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Savalli N, 2006, P NATL ACAD SCI USA, V103, P12619, DOI 10.1073/pnas.0601176103; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Semenova NP, 2009, J BIOL CHEM, V284, P10684, DOI 10.1074/jbc.M808891200; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang B, 2006, J GEN PHYSIOL, V127, P449, DOI 10.1085/jgp.200509436; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wu RS, 2009, J NEUROSCI, V29, P8321, DOI 10.1523/JNEUROSCI.6191-08.2009; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58335	10.1371/journal.pone.0058335	http://dx.doi.org/10.1371/journal.pone.0058335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472181	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900127
J	Rapp, C; Klerman, H; Levine, E; McClendon, CL				Rapp, Chaya; Klerman, Hadassa; Levine, Emily; McClendon, Christopher L.			Hydrogen Bond Strengths in Phosphorylated and Sulfated Amino Acid Residues	PLOS ONE			English	Article							FORCE-FIELD; TYROSINE SULFATION; MOLECULAR-DYNAMICS; RECOGNITION; PROTEINS; SH2	Post-translational modification by the addition of an oxoanion functional group, usually a phosphate group and less commonly a sulfate group, leads to diverse structural and functional consequences in protein systems. Building upon previous studies of the phosphoserine residue (pSer), we address the distinct nature of hydrogen bonding interactions in phosphotyrosine (pTyr) and sulfotyrosine (sTyr) residues. We derive partial charges for these modified residues and then study them in the context of molecular dynamics simulation of model tripeptides and sulfated protein complexes, potentials of mean force for interacting residue pairs, and a survey of the interactions of modified residues among experimental protein structures. Overall, our findings show that for pTyr, bidentate interactions with Arg are particularly dominant, as has been previously demonstrated for pSer. sTyr interactions with Arg are significantly weaker, even as compared to the same interactions made by the Glu residue. Our work sheds light on the distinct nature of these modified tyrosine residues, and provides a physical-chemical foundation for future studies with the goal of understanding their roles in systems of biological interest.	[Rapp, Chaya; Klerman, Hadassa; Levine, Emily] Yeshiva Univ, Stern Coll Women, Dept Chem & Biochem, New York, NY 10033 USA; [McClendon, Christopher L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Yeshiva University; University of California System; University of California San Diego	Rapp, C (corresponding author), Yeshiva Univ, Stern Coll Women, Dept Chem & Biochem, New York, NY 10033 USA.	rappc@yu.edu			United States National Institutes of Health [1R15GM098997-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM098997] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health grant 1R15GM098997-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MAESTR VERS 9 1 107; [Anonymous], PYMOL MOL GRAPH SYST; [Anonymous], 2007, MACR VERS 9 1 107; [Anonymous], 2007, JAG VERS 7 6; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Choe H, 2009, METHOD ENZYMOL, V461, P147, DOI 10.1016/S0076-6879(09)05407-X; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GETTINS P, 1989, J BIOL CHEM, V264, P3781; Grzesiek S, 2004, PROG NUCL MAG RES SP, V45, P275, DOI 10.1016/j.pnmrs.2004.08.001; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mandell DJ, 2007, J AM CHEM SOC, V129, P820, DOI 10.1021/ja063019w; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Schaefer SA, 2013, J MOL BIOL, V425, P222, DOI 10.1016/j.jmb.2012.11.011; Singer AU, 1997, PROTEIN SCI, V6, P1910, DOI 10.1002/pro.5560060912; Sun QX, 2011, FEBS LETT, V585, P281, DOI 10.1016/j.febslet.2010.11.060; Sychrovsky V, 2006, J AM CHEM SOC, V128, P6823, DOI 10.1021/ja0551180; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Zandarashvili L, 2011, J AM CHEM SOC, V133, P9192, DOI 10.1021/ja202219n	38	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57804	10.1371/journal.pone.0057804	http://dx.doi.org/10.1371/journal.pone.0057804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472106	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900045
J	Tang, YT; Dong, S; Cao, XK; Zhou, Q; Ding, GT; Jiang, CZ				Tang, Yitao; Dong, Shan; Cao, Xinkai; Zhou, Qing; Ding, Guitao; Jiang, Cizhong			H2A.Z Nucleosome Positioning Has No Impact on Genetic Variation in Drosophila Genome	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; RNA-POLYMERASE-II; TANDEM REPEATS; DNA-REPAIR; ORGANIZATION; PHOTOLYASE; REVEALS; DAMAGE; YEAST	Nucleosome occupancy results in complex sequence variation rate heterogeneity by either increasing mutation rate or inhibiting DNA repair in yeast, fish, and human. H2A.Z nucleosome is extensively involved in gene transcription activation and regulation. To test whether H2A.Z nucleosome has the similar impact on sequence variability in the Drosophila genome, we profiled the H2A.Z nucleosome occupancy and sequence variation rate at gene ends and splicing sites. Consistent with previous studies, H2A.Z nucleosome positioning helps to demarcate the borders of exons. Nucleosome occupancy is anticorrelated with sequence divergence rate in the regions flanking transcription start sites and splicing sites. However, there is no rate heterogeneity between the linker DNA and H2A.Z nucleosomal DNA regardless of nucleosome occupancy, fuzziness, positioning in promoter, coding, and intergenic regions, young or old genes. But the rate at intergenic nucleosomes and the flanking linker regions is higher than that at the genic counterparts. Further analyses found that the high sequence divergence rate in the promoter regions that are usually nucleosome depleted regions may be likely resulted from the high mutation rate in the enriched tandem repeats. Interestingly, within nucleosomes spanning splicing sites, sequence variability of nucleosomal DNA significantly increases from the end within exons to the other end protruding into introns. The relaxed functional constraint in introns contributes to the high rate of nucleosomal DNA residing in introns while the strict functional constraint in exons maintains the low rate of nucleosomal DNA residing in exons. Taken together, H2A.Z nucleosome occupancy has no effect on sequence variability of Drosophila genome, which is likely determined by local sequence composition and the concomitant selection pressure.	[Tang, Yitao; Dong, Shan; Cao, Xinkai; Zhou, Qing; Ding, Guitao; Jiang, Cizhong] Tongji Univ, Shanghai Peoples Hosp 10, Shanghai Key Lab Signaling & Dis Res, Dept Bioinformat,Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University	Jiang, CZ (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Shanghai Key Lab Signaling & Dis Res, Dept Bioinformat,Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn	DONG, Shan/GVS-5706-2022	Dong, Shan/0000-0001-9130-0225	Ministry of Science and Technology of China [2010CB944901, 2011CB965104, 2012AA020405]; National Natural Science Foundation of China [91019017, 31271373]; Pujiang Talent Project of Shanghai [10PJ1409500]; New Century Talent Project of Ministry of Education of China [NCET-10-0600]; Aurora Talent Project of Shanghai [10SG24]; Ministry of Education, China [IRT1168]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pujiang Talent Project of Shanghai; New Century Talent Project of Ministry of Education of China; Aurora Talent Project of Shanghai; Ministry of Education, China(Ministry of Education, China)	This work was supported by the Ministry of Science and Technology of China (2010CB944901, 2011CB965104, 2012AA020405 to CJ), the National Natural Science Foundation of China (91019017, 31271373 to CJ), Pujiang Talent Project of Shanghai (10PJ1409500 to CJ), New Century Talent Project of Ministry of Education of China (NCET-10-0600 to CJ), the Aurora Talent Project of Shanghai (10SG24 to CJ), and IRT1168 from the Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; BOULIKAS T, 1992, J MOL EVOL, V35, P156, DOI 10.1007/BF00183227; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Guzder SN, 1996, J BIOL CHEM, V271, P8903, DOI 10.1074/jbc.271.15.8903; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; LivingstoneZatchej M, 1997, NUCLEIC ACIDS RES, V25, P3795, DOI 10.1093/nar/25.19.3795; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Prendergast JGD, 2011, GENOME RES, V21, P1777, DOI 10.1101/gr.122275.111; Radwan A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-186; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Suter B, 2002, J MOL BIOL, V319, P395, DOI 10.1016/S0022-2836(02)00291-7; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; Tilgner H, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.3.11319; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; van Hoffen A, 2003, TOXICOLOGY, V193, P79, DOI 10.1016/j.tox.2003.06.001; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vishnoi A, 2010, GENOME RES, V20, P1574, DOI 10.1101/gr.109595.110; Washietl S, 2008, TRENDS GENET, V24, P583, DOI 10.1016/j.tig.2008.09.003; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	34	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58295	10.1371/journal.pone.0058295	http://dx.doi.org/10.1371/journal.pone.0058295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472174	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900120
J	Abdullah, A; Deris, S; Anwar, S; Arjunan, SNV				Abdullah, Afnizanfaizal; Deris, Safaai; Anwar, Sohail; Arjunan, Satya N. V.			An Evolutionary Firefly Algorithm for the Estimation of Nonlinear Biological Model Parameters	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; SYSTEMS BIOLOGY; DIFFERENTIAL EVOLUTION; GLOBAL OPTIMIZATION; P53 PATHWAY; SELECTION; DYNAMICS; STRATEGY; DESIGN; GROWTH	The development of accurate computational models of biological processes is fundamental to computational systems biology. These models are usually represented by mathematical expressions that rely heavily on the system parameters. The measurement of these parameters is often difficult. Therefore, they are commonly estimated by fitting the predicted model to the experimental data using optimization methods. The complexity and nonlinearity of the biological processes pose a significant challenge, however, to the development of accurate and fast optimization methods. We introduce a new hybrid optimization method incorporating the Firefly Algorithm and the evolutionary operation of the Differential Evolution method. The proposed method improves solutions by neighbourhood search using evolutionary procedures. Testing our method on models for the arginine catabolism and the negative feedback loop of the p53 signalling pathway, we found that it estimated the parameters with high accuracy and within a reasonable computation time compared to well-known approaches, including Particle Swarm Optimization, Nelder-Mead, and Firefly Algorithm. We have also verified the reliability of the parameters estimated by the method using an a posteriori practical identifiability test.	[Abdullah, Afnizanfaizal; Deris, Safaai] Univ Teknol Malaysia, Fac Comp, Artificial Intelligence & Bioinformat Grp, Johor Baharu, Malaysia; [Anwar, Sohail] Penn State Univ, Altoona, PA USA; [Arjunan, Satya N. V.] RIKEN Quantitat Biol Ctr, Lab Biochem Simulat, Osaka, Japan	Universiti Teknologi Malaysia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; RIKEN	Abdullah, A (corresponding author), Univ Teknol Malaysia, Fac Comp, Artificial Intelligence & Bioinformat Grp, Johor Baharu, Malaysia.	afnizanfaizal@utm.my; satya@riken.jp	Abdullah, Afnizanfaizal/E-8709-2013; Abdullah, Afnizanfaizal/AAI-9429-2020; Arjunan, Satya N. V./B-3441-2008; Arjunan, Satya/AAL-2433-2020	Abdullah, Afnizanfaizal/0000-0002-0280-565X; Abdullah, Afnizanfaizal/0000-0002-0280-565X; Arjunan, Satya N. V./0000-0002-2913-3347; Arjunan, Satya/0000-0002-2913-3347	Malaysia Ministry of Science, Technology and Innovation [07-05-MGI-GMB011, 73744]	Malaysia Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This research was supported by a grant from Malaysia Ministry of Science, Technology and Innovation, organized by Malaysia Genome Institute project number 07-05-MGI-GMB011 entitled "Design and Development of Microbial Cell Factories for Biomolecules Production and Secretion'' and managed by Research Management Centre, Universiti Teknologi Malaysia grant number 73744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Apgar JF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040030; Balsa-Canto E, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-26; Balsa-Canto E, 2012, ADV EXP MED BIOL, V736, P409, DOI 10.1007/978-1-4419-7210-1_24; Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; BELLMAN R, 1970, Mathematical Biosciences, V7, P329, DOI 10.1016/0025-5564(70)90132-X; Besozzi D, 2009, LECT NOTES COMPUT SC, V5483, P116, DOI 10.1007/978-3-642-01184-9_11; Boys RJ, 2008, STAT COMPUT, V18, P125, DOI 10.1007/s11222-007-9043-x; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Burrage K, 2011, DESIGN AND ANALYSIS OF BIOMOLECULAR CIRCUITS:ENGINEERING APPROACHES TO SYSTEMS AND SYNTHETIC BIOLOGY, P43, DOI 10.1007/978-1-4419-6766-4_2; Campbell KS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000560; Casey FP, 2007, IET SYST BIOL, V1, P190, DOI 10.1049/iet-syb:20060065; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012475; Das S, 2008, STUD COMPUT INTELL, V116, P1, DOI 10.1007/978-3-540-78297-1_1; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; Fu WL, 2010, LECT NOTES ARTIF INT, V6464, P313, DOI 10.1007/978-3-642-17432-2_32; Glover F, 2000, CONTROL CYBERN, V29, P653; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Ho WH, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/514756; Horst R., 2000, INTRO GLOBAL OPTIMIZ; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lillacci G, 2012, INT J ROBUST NONLIN, V22, P1065, DOI 10.1002/rnc.2794; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Lukasik S, 2009, COMPUT COLLECT INTEL, P197; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; Miao HY, 2009, BIOMETRICS, V65, P292, DOI 10.1111/j.1541-0420.2008.01059.x; Montanez R, 2008, AMINO ACIDS, V34, P223, DOI 10.1007/s00726-007-0502-7; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; OLSSON DM, 1975, TECHNOMETRICS, V17, P45, DOI 10.2307/1267998; Pascal VH, 2009, CONSTRAINT BASED LOC; Poovathingal SK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-414; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; Raue A, 2011, IET SYST BIOL, V5, P120, DOI 10.1049/iet-syb.2010.0061; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; Schaber J, 2011, CURR OPIN BIOTECH, V22, P109, DOI 10.1016/j.copbio.2010.09.014; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sun JY, 2012, IEEE ACM T COMPUT BI, V9, P185, DOI 10.1109/TCBB.2011.63; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Tashkova K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-159; Vilas C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-79; Villaverde AF, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-75; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14; YORK D, 1969, EARTH PLANET SC LETT, V5, P320; Zheng YT, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541609	53	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e56310	10.1371/journal.pone.0056310	http://dx.doi.org/10.1371/journal.pone.0056310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469172	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900006
J	Adams, AL; Dickinson, KJM; Robertson, BC; van Heezik, Y				Adams, Amy L.; Dickinson, Katharine J. M.; Robertson, Bruce C.; van Heezik, Yolanda			Predicting Summer Site Occupancy for an Invasive Species, the Common Brushtail Possum (Trichosurus vulpecula), in an Urban Environment	PLOS ONE			English	Article							NEW-ZEALAND; HOME-RANGE; FOREST; CONSEQUENCES; RESOURCES; PATTERNS; BIRDS; FRAGMENTATION; URBANIZATION; PREDATION	Invasive species are often favoured in fragmented, highly-modified, human-dominated landscapes such as urban areas. Because successful invasive urban adapters can occupy habitat that is quite different from that in their original range, effective management programmes for invasive species in urban areas require an understanding of distribution, habitat and resource requirements at a local scale that is tailored to the fine-scale heterogeneity typical of urban landscapes. The common brushtail possum (Trichosurus vulpecula) is one of New Zealand's most destructive invasive pest species. As brushtail possums traditionally occupy forest habitat, control in New Zealand has focussed on rural and forest habitats, and forest fragments in cities. However, as successful urban adapters, possums may be occupying a wider range of habitats. Here we use site occupancy methods to determine the distribution of brushtail possums across five distinguishable urban habitat types during summer, which is when possums have the greatest impacts on breeding birds. We collected data on possum presence/absence and habitat characteristics, including possible sources of supplementary food (fruit trees, vegetable gardens, compost heaps), and the availability of forest fragments from 150 survey locations. Predictive distribution models constructed using the programme PRESENCE revealed that while occupancy rates were highest in forest fragments, possums were still present across a large proportion of residential habitat with occupancy decreasing as housing density increased and green cover decreased. The presence of supplementary food sources was important in predicting possum occupancy, which may reflect the high nutritional value of these food types. Additionally, occupancy decreased as the proportion of forest fragment decreased, indicating the importance of forest fragments in determining possum distribution. Control operations to protect native birds from possum predation in cities should include well-vegetated residential areas; these modified habitats not only support possums but provide a source for reinvasion of fragments.	[Adams, Amy L.; Robertson, Bruce C.; van Heezik, Yolanda] Univ Otago, Dept Zool, Dunedin, New Zealand; [Dickinson, Katharine J. M.] Univ Otago, Dept Bot, Dunedin, New Zealand	University of Otago; University of Otago	Adams, AL (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	amylouiseadams@hotmail.com	Dickinson, Katharine J.M./M-1728-2017; van Heezik, Yolanda/I-2744-2019	Dickinson, Katharine J.M./0000-0001-6769-552X; van Heezik, Yolanda/0000-0003-0494-5311	University of Otago Zoology Department; University of Otago Postgraduate Scholarship	University of Otago Zoology Department; University of Otago Postgraduate Scholarship	This research was funded by the University of Otago Zoology Department. AA was supported by the University of Otago Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, HDB NZ MAMMALS; [Anonymous], 2004, P 4 INT S URB WILDL; ATTIWILL PM, 1987, FOREST SOILS NUTR CY; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Bamford J., 1970, Proc. N Z. ecol. Soc., V17, P118; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Brockie R., 1992, LIVING NZ FOREST; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clout Mick N., 2000, P1; COLEMAN JD, 1985, NEW ZEAL J ECOL, V8, P21; Cowan PE, 2001, J ROY SOC NEW ZEAL, V31, P15, DOI 10.1080/03014223.2001.9517636; COWAN PE, 1990, NEW ZEAL J ZOOL, V17, P549, DOI 10.1080/03014223.1990.10422953; Cowan Phil, 2000, P24; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Efford Murray, 2000, P47; ESRI, 2009, ARCGIS; Eyre Teresa J., 2004, P1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Freeland WJ, 1975, J CHEM ECOL, V1, P439; Freeman C, 2003, LANDSCAPE URBAN PLAN, V63, P161, DOI 10.1016/S0169-2046(02)00188-3; Ganzhorn JU, 2002, OECOLOGIA, V131, P427, DOI 10.1007/s00442-002-0891-y; GREEN WQ, 1986, NEW ZEAL J ECOL, V9, P57; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harper MJ, 2008, AUSTRAL ECOL, V33, P243, DOI 10.1111/j.1442-9993.2007.01689.x; Harper MJ, 2005, WILDLIFE RES, V32, P681, DOI 10.1071/WR04072; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Hill NJ, 2008, APPL ENVIRON MICROB, V74, P5549, DOI 10.1128/AEM.00809-08; Hines J., 2006, PRESENCE2 SOFTWARE E; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Jolly J.N., 1976, Proceedings of the New Zealand Ecological Society, V23, P70; Kerle A., 2001, POSSUMS BRUSHTAILS R; Kerle J.A., 1984, P115; Lepczyk CA, 2004, BIOL CONSERV, V115, P191, DOI 10.1016/S0006-3207(03)00107-1; MacArthur R.H., 1972, pvii; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Mackey BG, 2001, J BIOGEOGR, V28, P1147, DOI 10.1046/j.1365-2699.2001.00626.x; Matthews A, 2004, URBAN WILDLIFE MORE; Mcdonald-Madden E, 2000, AUST J ZOOL, V48, P155, DOI 10.1071/ZO99061; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meenken D, 2005, CONTAGION WAXT UNPUB; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; National Possum Control Agencies, 2010, POSS POP MON US WAXT; Nugent Graham, 2000, P10; Ogilvie S. C., 2006, New Zealand Plant Protection, V59, P28; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Paterson BM, 1995, NEW ZEAL VET J, V43, P281, DOI 10.1080/00480169./1995.35907; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pracy LT, 1974, INTRO LIBERATION OPO; Reunanen P, 2002, ECOL APPL, V12, P1188, DOI 10.1890/1051-0761(2002)012[1188:POFTSF]2.0.CO;2; Sadleir Richard, 2000, P126; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sol D, 2012, OECOLOGIA, V169, P553, DOI 10.1007/s00442-011-2203-x; Statham M, 1997, WILDLIFE RES, V24, P715, DOI 10.1071/WR96092; Strohbach MW, 2009, ECOLOGY SOC, V14; Sweetapple PJ, 1997, COMP RED DEER POSSUM, P61; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Thomas M, 2011, SOME NOTES IDENTIFIC, P6; Thomas MD, 2007, 20067 PEST CONTR RES; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; van Heezik Y, 2008, NEW ZEAL J ECOL, V32, P155; van Heezik Y, 2008, LANDSCAPE URBAN PLAN, V87, P223, DOI 10.1016/j.landurbplan.2008.06.004; Villard MA, 1999, CONSERV BIOL, V13, P774, DOI 10.1046/j.1523-1739.1999.98059.x; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; Warburton B., 1978, New Zealand Journal of Ecology, V1, P126; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; White PCL, 1996, J ANIM ECOL, V65, P121, DOI 10.2307/5705; Wintle BA, 2005, AUSTRAL ECOL, V30, P719, DOI 10.1111/j.1442-9993.2005.01514.x; World Bank, 2015, LEVERAGING URBANIZAT	78	8	8	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58422	10.1371/journal.pone.0058422	http://dx.doi.org/10.1371/journal.pone.0058422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469277	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900085
J	Vergara-Alert, J; Moreno, A; Zabala, JG; Bertran, K; Costa, TP; Cordon, I; Rivas, R; Majo, N; Busquets, N; Cordioli, P; Rodriguez, F; Darji, A				Vergara-Alert, Julia; Moreno, Ana; Zabala, Juliana G.; Bertran, Kateri; Costa, Taiana P.; Cordon, Ivan; Rivas, Raquel; Majo, Natalia; Busquets, Nuria; Cordioli, Paolo; Rodriguez, Fernando; Darji, Ayub			Exposure to a Low Pathogenic A/H7N2 Virus in Chickens Protects against Highly Pathogenic A/H7N1 Virus but Not against Subsequent Infection with A/H5N1	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; CROSS-PROTECTION; A VIRUS; H5N1; ANTIBODIES; HOST; VACCINES; SUBTYPES; STRAIN; TESTS	Recent evidences have demonstrated that the presence of low pathogenic avian influenza viruses (LPAIV) may play an important role in host ecology and transmission of avian influenza viruses (AIV). While some authors have clearly demonstrated that LPAIV can mutate to render highly pathogenic avian influenza viruses (HPAIV), others have shown that their presence could provide the host with enough immunological memory to resist re-infections with HPAIV. In order to experimentally study the role of pre-existing host immunity, chickens previously infected with H7N2 LPAIV were subsequently challenged with H7N1 HPAIV. Pre-infection of chickens with H7N2 LAPIV conferred protection against the lethal challenge with H7N1 HPAIV, dramatically reducing the viral shedding, the clinical signs and the pathological outcome. Correlating with the protection afforded, sera from chickens primed with H7N2 LPAIV reacted with the H7-AIV subtype in hemagglutination inhibition assay and specifically with the N2-neuraminidase antigen. Conversely, subsequent exposure to H5N1 HPAIV resulted in a two days-delay on the onset of disease but all chickens died by 7 days post-challenge. Lack of protection correlated with the absence of H5-hemagglutining inhibitory antibodies prior to H5N1 HPAIV challenge. Our data suggest that in naturally occurring outbreaks of HPAIV, birds with pre-existing immunity to LPAIV could survive lethal infections with HA-homologous HPAIV but not subsequent re-infections with HA-heterologous HPAIV. These results could be useful to better understand the dynamics of AIV in chickens and might help in future vaccine formulations.	[Vergara-Alert, Julia; Zabala, Juliana G.; Bertran, Kateri; Cordon, Ivan; Rivas, Raquel; Majo, Natalia; Busquets, Nuria; Rodriguez, Fernando; Darji, Ayub] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, Inst Recerca & Tecnol Agroalimentaries, Bellaterra, Cerdanyola Del, Spain; [Moreno, Ana; Cordioli, Paolo] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Costa, Taiana P.; Majo, Natalia] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Cerdanyola Del, Spain; [Darji, Ayub] Inst Recerca & Tecnol Agroalimentaries, Barcelona, Spain	Autonomous University of Barcelona; IRTA; IZS Lombardia e Emilia; Autonomous University of Barcelona; IRTA	Vergara-Alert, J (corresponding author), Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, Inst Recerca & Tecnol Agroalimentaries, Campus Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	vergaraa@staff.uni-marburg.de	Rodriguez, Fernando/GLN-3947-2022; Bertran, Kateri/H-3458-2019; Costa, Taiana/HHS-5800-2022; Vergara-Alert, Júlia/I-5010-2015; Costa, Taiana/O-9469-2019; Masferrer, Natàlia Majó/AAV-3696-2021; Moreno, Ana/Q-2173-2019; Busquets, Núria/T-8431-2017	Rodriguez, Fernando/0000-0001-7361-8408; Bertran, Kateri/0000-0002-6920-4154; Costa, Taiana/0000-0002-5010-4188; Vergara-Alert, Júlia/0000-0001-7484-444X; Costa, Taiana/0000-0002-5010-4188; Moreno, Ana/0000-0002-8497-9708; Majo, Natalia/0000-0003-0189-9751	Spanish Government [AGL2007-60434/GAN, AGL2010-22229-C03-01]; FPI-MICINN (FPI (Research Personnel Training) grant of the Spanish Science and Innovation Ministry) [BES-2008-00260]	Spanish Government(Spanish GovernmentEuropean Commission); FPI-MICINN (FPI (Research Personnel Training) grant of the Spanish Science and Innovation Ministry)	This work was supported by the Spanish Government Grants AGL2007-60434/GAN and AGL2010-22229-C03-01 (Ministry of Science and Innovation, MICINN). JV-A was supported by FPI-MICINN (FPI (Research Personnel Training) grant of the Spanish Science and Innovation Ministry) Training Grant BES-2008-00260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barral M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-50; Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; Busquets N, 2010, VET RES, V41, DOI 10.1051/vetres/2010046; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017821; Droebner K, 2008, VACCINE, V26, P6965, DOI 10.1016/j.vaccine.2008.09.051; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garamszegi LZ, 2007, P ROY SOC B-BIOL SCI, V274, P2003, DOI 10.1098/rspb.2007.0124; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kapczynski Darrell R, 2011, BMC Proc, V5 Suppl 4, pS13, DOI 10.1186/1753-6561-5-S4-S13; KIDA H, 1980, INFECT IMMUN, V30, P547; Lupiani B, 2009, COMP IMMUNOL MICROB, V32, P311, DOI 10.1016/j.cimid.2008.01.004; Ma WJ, 2010, J VIROL, V84, P2122, DOI 10.1128/JVI.01668-09; Moreno A, 2009, VACCINE, V27, P4967, DOI 10.1016/j.vaccine.2009.05.089; OIE, 2011, MANUAL DIAGNOSTIC TE; Sala G, 2003, AVIAN DIS, V47, P1057, DOI 10.1637/0005-2086-47.s3.1057; Schrauwen EJA, 2011, J GEN VIROL, V92, P1410, DOI 10.1099/vir.0.030379-0; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Swayne DE., 2008, AVIAN INFLUENZA, V1, P87, DOI 10.1002/9780813818634.ch5; Terregino C, 2010, AVIAN PATHOL, V39, P215, DOI 10.1080/03079451003781858; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Van Reeth K, 2009, VACCINE, V27, P6330, DOI 10.1016/j.vaccine.2009.03.021; Veits J, 2012, P NATL ACAD SCI USA, V109, P2579, DOI 10.1073/pnas.1109397109; Villegras P, 2008, LAB MANUAL ISOLATION, P217	31	6	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58692	10.1371/journal.pone.0058692	http://dx.doi.org/10.1371/journal.pone.0058692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469288	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900099
J	Goetz, SM; Truong, CN; Gerhofer, MG; Peterchev, AV; Herzog, HG; Weyh, T				Goetz, Stefan M.; Cong Nam Truong; Gerhofer, Manuel G.; Peterchev, Angel V.; Herzog, Hans-Georg; Weyh, Thomas			Analysis and Optimization of Pulse Dynamics for Magnetic Stimulation	PLOS ONE			English	Article							ELECTROCUTANEOUS NERVE-STIMULATION; SODIUM-CHANNEL; MOTOR CORTEX; ELECTRICAL-STIMULATION; CURRENT DIRECTIONS; ACTION-POTENTIALS; WAVE-FORMS; BRAIN; MODELS; FIELD	Magnetic stimulation is a standard tool in brain research and has found important clinical applications in neurology, psychiatry, and rehabilitation. Whereas coil designs and the spatial field properties have been intensively studied in the literature, the temporal dynamics of the field has received less attention. Typically, the magnetic field waveform is determined by available device circuit topologies rather than by consideration of what is optimal for neural stimulation. This paper analyzes and optimizes the waveform dynamics using a nonlinear model of a mammalian axon. The optimization objective was to minimize the pulse energy loss. The energy loss drives power consumption and heating, which are the dominating limitations of magnetic stimulation. The optimization approach is based on a hybrid global-local method. Different coordinate systems for describing the continuous waveforms in a limited parameter space are defined for numerical stability. The optimization results suggest that there are waveforms with substantially higher efficiency than that of traditional pulse shapes. One class of optimal pulses is analyzed further. Although the coil voltage profile of these waveforms is almost rectangular, the corresponding current shape presents distinctive characteristics, such as a slow low-amplitude first phase which precedes the main pulse and reduces the losses. Representatives of this class of waveforms corresponding to different maximum voltages are linked by a nonlinear transformation. The main phase, however, scales with time only. As with conventional magnetic stimulation pulses, briefer pulses result in lower energy loss but require higher coil voltage than longer pulses.	[Goetz, Stefan M.; Cong Nam Truong; Gerhofer, Manuel G.; Herzog, Hans-Georg; Weyh, Thomas] Tech Univ Munich, Inst Energy Convers, D-80290 Munich, Germany; [Goetz, Stefan M.; Peterchev, Angel V.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Goetz, Stefan M.; Peterchev, Angel V.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Goetz, Stefan M.; Peterchev, Angel V.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA	Technical University of Munich; Duke University; Duke University; Duke University	Goetz, SM (corresponding author), Tech Univ Munich, Inst Energy Convers, D-80290 Munich, Germany.	sgoetz@tum.de; weyh@tum.de	Peterchev, Angel V/I-1477-2019	Peterchev, Angel V/0000-0002-4385-065X	Rogue Research Inc. through Duke University	Rogue Research Inc. through Duke University	The authors are co-inventors on several patent applications on technology in the field of brain stimulation/modulation devices held by their currently or formerly employing institutions (DE 3930930, WO 1991004071, DE 19702841, DE 29814987, EP 0940157, EP 01273320, US 20040193002, EP 1671672, DE 102006024467, DE 102007013531, US 7753836, EP 2026871, WO 2007145838, US 7946973, DE 102009023855, WO 2010135425, DE 102010004307, DE 102012101921). Several patents and patent applications on magnetic stimulation are licensed to Rogue Research. AVP has recently received patent royalties (through Columbia University) and research support (through Duke University) from Rogue Research Inc. and equipment donations from Magstim Co., MagVenture A/S, and ANS/St. Jude Medical. None of those requested this work, had any influence on the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, the patents do not cover nor limit the results or techniques described in this paper. Therefore, the declared conflicts of interest do not alter the authors' adherence to the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	[Anonymous], 2011, FRONT NEUROENG, DOI DOI 10.3389/FNENG.2011.00015; BARKER AT, 1991, ELECTROEN CLIN NEURO, P227; Birdno MJ, 2012, J NEUROPHYSIOL, V107, P364, DOI 10.1152/jn.00906.2010; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; BUTIKOFER R, 1979, IEEE T BIO-MED ENG, V26, P69, DOI 10.1109/TBME.1979.326529; BUTIKOFER R, 1978, IEEE T BIO-MED ENG, V25, P526, DOI 10.1109/TBME.1978.326286; Butson CR, 2007, NEUROIMAGE, V34, P661, DOI 10.1016/j.neuroimage.2006.09.034; CADWELL J, 1991, ELECTROEN CLIN NEURO, P238; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CLAUS D, 1990, ELECTROEN CLIN NEURO, V75, P342, DOI 10.1016/0013-4694(90)90112-W; Davey K, 2000, IEEE T BIO-MED ENG, V47, P1493, DOI 10.1109/10.880101; DEAN D, 1985, IEEE T BIO-MED ENG, V32, P8, DOI 10.1109/TBME.1985.325644; Di Lazzaro V, 2001, J PHYSIOL-LONDON, V537, P1047, DOI 10.1113/jphysiol.2001.012572; Eberhart R., 1995, MHS'95. Proceedings of the Sixth International Symposium on Micro Machine and Human Science (Cat. No.95TH8079), P39, DOI 10.1109/MHS.1995.494215; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Gerstner W, 2009, SCIENCE, V326, P379, DOI 10.1126/science.1181936; Goetz SM, 2012, IEEE ENG MED BIO, P4700, DOI 10.1109/EMBC.2012.6347016; Goetz SM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056007; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; GORMAN PH, 1983, IEEE T BIO-MED ENG, V30, P407, DOI 10.1109/TBME.1983.325041; Grill WM, 2008, J COMPUT NEUROSCI, V24, P81, DOI 10.1007/s10827-007-0043-9; Grill WM, 1997, IEEE T BIO-MED ENG, V44, P1, DOI 10.1109/10.553708; Havel WJ, 1997, IEEE T MAGN, V33, P4269, DOI 10.1109/20.619732; HIWAKI O, 1991, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 13, PTS 1-5, P853, DOI 10.1109/IEMBS.1991.684228; Hsu KH, 2003, IEEE T BIO-MED ENG, V50, P1276, DOI 10.1109/TBME.2003.818473; Jezernik S, 2010, J NEURAL ENG, V52, P740; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; LORENZEN HW, 1992, IEEE T MAGN, V28, P1481, DOI 10.1109/20.123976; Maccabee PJ, 1998, J PHYSIOL-LONDON, V513, P571, DOI 10.1111/j.1469-7793.1998.571bb.x; MACHETANZ J, 1994, MUSCLE NERVE, V17, P1170, DOI 10.1002/mus.880171007; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MCROBBIE D, 1984, CLIN PHYS PHYSIOL M, V5, P67, DOI 10.1088/0143-0815/5/2/002; MCROBBIE D, 1985, J PHYS E SCI INSTRUM, V18, P74, DOI 10.1088/0022-3735/18/1/019; MOTZ H, 1986, NEUROSCIENCE, V18, P699, DOI 10.1016/0306-4522(86)90064-3; NAGARAJAN SS, 1993, IEEE T BIO-MED ENG, V40, P1175, DOI 10.1109/10.245636; Ni Z, 2011, J NEUROPHYSIOL, V105, P749, DOI 10.1152/jn.00640.2010; Niehaus L, 2000, CLIN NEUROPHYSIOL, V111, P75, DOI 10.1016/S1388-2457(99)00198-4; OBERG PA, 1973, MED BIOL ENG, V11, P55, DOI 10.1007/BF02477296; OFFNER F, 1946, J NEUROPHYSIOL, V9, P387, DOI 10.1152/jn.1946.9.5.387; Peterchev AV, 2008, IEEE T BIO-MED ENG, V55, P257, DOI 10.1109/TBME.2007.900540; Peterchev AV, 2011, I IEEE EMBS C NEUR E, P646, DOI 10.1109/NER.2011.5910631; Peterchev AV, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036016; Peterchev AV, 2011, CLIN NEUROPHYSIOLO S, V112, pS191; Pitcher JB, 2003, J PHYSIOL-LONDON, V546, P605, DOI 10.1113/jphysiol.2002.029454; POLSON MJR, 1982, MED BIOL ENG COMPUT, V20, P243, DOI 10.1007/BF02441362; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Powell MJD, 2003, MATH PROGRAM, V97, P605, DOI 10.1007/s10107-003-0430-6; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Reid G, 1999, J PHYSIOL-LONDON, V518, P681, DOI 10.1111/j.1469-7793.1999.0681p.x; REILLY JP, 1989, MED BIOL ENG COMPUT, V27, P101, DOI 10.1007/BF02446217; Richardson AG, 2000, MED BIOL ENG COMPUT, V38, P438, DOI 10.1007/BF02345014; Ruohonen J, 1997, ANN BIOMED ENG, V25, P840, DOI 10.1007/BF02684168; Ruohonen J, 1996, ELECTROMYOGR MOTOR C, V101, P167, DOI 10.1016/0924-980X(95)00237-F; Rushton WAH, 1932, J PHYSIOL-LONDON, V74, P424, DOI 10.1113/jphysiol.1932.sp002859; SAFRONOV BV, 1993, J PHYSIOL-LONDON, V460, P675, DOI 10.1113/jphysiol.1993.sp019493; Salinas FS, 2007, PHYS MED BIOL, V52, P2879, DOI 10.1088/0031-9155/52/10/016; SCHOLZ A, 1993, J NEUROPHYSIOL, V70, P1274, DOI 10.1152/jn.1993.70.3.1274; SCHWARZ JR, 1995, PFLUG ARCH EUR J PHY, V430, P283, DOI 10.1007/BF00374660; Skinner F, 2010, SPR SER COMPUT NEURO, V5, P399, DOI 10.1007/978-1-4419-0996-1_14; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Sotiropoulos SN, 2007, J NEURAL ENG, V4, P107, DOI 10.1088/1741-2560/4/2/011; Szecsi J, 2010, CLIN NEUROPHYSIOL, V121, P1589, DOI 10.1016/j.clinph.2010.03.023; Taylor JL, 2007, J AFFECT DISORDERS, V97, P271, DOI 10.1016/j.jad.2006.06.027; Tzoumaka E, 2000, J NEUROSCI RES, V60, P37, DOI 10.1002/(SICI)1097-4547(20000401)60:1<37::AID-JNR4>3.0.CO;2-W; UENO S, 1988, J APPL PHYS, V64, P5862, DOI 10.1063/1.342181; Waltz RA, 2006, MATH PROGRAM, V107, P391, DOI 10.1007/s10107-004-0560-5; Weber M, 2002, MUSCLE NERVE, V25, P160; Weyh T, 2005, CLIN NEUROPHYSIOL, V116, P1477, DOI 10.1016/j.clinph.2005.02.002; Weyh T, 1995, THESIS UAF MUNICH; Whitaker WRJ, 2001, MOL BRAIN RES, V88, P37, DOI 10.1016/S0169-328X(00)00289-8; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009; Wongsarnpigoon A, 2010, IEEE T NEUR SYS REH, V18, P319, DOI 10.1109/TNSRE.2010.2047610	74	19	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e55771	10.1371/journal.pone.0055771	http://dx.doi.org/10.1371/journal.pone.0055771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469168	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100008
J	McNamara, CR; Ahuja, R; Osafo-Addo, AD; Barrows, D; Kettenbach, A; Skidan, I; Teng, X; Cuny, GD; Gerber, S; Degterev, A				McNamara, Colleen R.; Ahuja, Ruchita; Osafo-Addo, Awo D.; Barrows, Douglas; Kettenbach, Arminja; Skidan, Igor; Teng, Xin; Cuny, Gregory D.; Gerber, Scott; Degterev, Alexei			Akt Regulates TNF alpha Synthesis Downstream of RIP1 Kinase Activation during Necroptosis	PLOS ONE			English	Article							AUTOPHAGIC CELL-DEATH; PROGRAMMED NECROSIS; INHIBITOR; PHOSPHORYLATION; IDENTIFICATION; APOPTOSIS; EFFICACY; 3-KINASE; PATHWAY; COMPLEX	Necroptosis is a regulated form of necrotic cell death that has been implicated in the pathogenesis of various diseases including intestinal inflammation and systemic inflammatory response syndrome (SIRS). In this work, we investigated the signaling mechanisms controlled by the necroptosis mediator receptor interacting protein-1 (RIP1) kinase. We show that Akt kinase activity is critical for necroptosis in L929 cells and plays a key role in TNF alpha production. During necroptosis, Akt is activated in a RIP1 dependent fashion through its phosphorylation on Thr308. In L929 cells, this activation requires independent signaling inputs from both growth factors and RIP1. Akt controls necroptosis through downstream targeting of mammalian Target of Rapamycin complex 1 (mTORC1). Akt activity, mediated in part through mTORC1, links RIP1 to JNK activation and autocrine production of TNF alpha. In other cell types, such as mouse lung fibroblasts and macrophages, Akt exhibited control over necroptosis-associated TNF alpha production without contributing to cell death. Overall, our results provide new insights into the mechanism of necroptosis and the role of Akt kinase in both cell death and inflammatory regulation.	[McNamara, Colleen R.] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Biochem, Boston, MA 02111 USA; [Ahuja, Ruchita; Osafo-Addo, Awo D.; Barrows, Douglas; Skidan, Igor; Degterev, Alexei] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Biochem, Boston, MA 02111 USA; [Kettenbach, Arminja; Gerber, Scott] Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Teng, Xin; Cuny, Gregory D.] Brigham & Womens Hosp, Harvard NeuroDiscovery Ctr, Lab Drug Discovery Neurodegenerat, Cambridge, MA USA; [Teng, Xin; Cuny, Gregory D.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Tufts University; Tufts University; Dartmouth College; Harvard University; Brigham & Women's Hospital; Harvard University	Degterev, A (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Biochem, Boston, MA 02111 USA.	alexei.degterev@tufts.edu		Kettenbach, Arminja/0000-0003-3979-4576; Cuny, Gregory/0000-0002-3188-4748; Gerber, Scott/0000-0002-2964-5051	NIGMS/NIH [GM084205]; Smith Family Award for Excellence in Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084205] Funding Source: NIH RePORTER	NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Smith Family Award for Excellence in Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the NIGMS/NIH to A. D. (GM084205) http://www.nigms.nih.gov/) and by Smith Family Award for Excellence in Biomedical Research (http://www.hria.org/tmfservices/tmfgrants/smith.html) to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Chen SY, 2011, AUTOPHAGY, V7, P217, DOI 10.4161/auto.7.2.14212; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dunai Z, 2011, PATHOL ONCOL RES, V17, P791, DOI 10.1007/s12253-011-9433-4; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tanemura S, 2009, J BIOCHEM, V145, P345, DOI 10.1093/jb/mvn172; Teng X, 2005, BIOORG MED CHEM LETT, V15, P5039, DOI 10.1016/j.bmcl.2005.07.077; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Wu YT, 2009, AUTOPHAGY, V5, P824, DOI 10.4161/auto.9099; Ye YC, 2011, J PHARMACOL SCI, V117, P160, DOI 10.1254/jphs.11105FP; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	52	47	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e56576	10.1371/journal.pone.0056576	http://dx.doi.org/10.1371/journal.pone.0056576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469174	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100010
J	Savergnini, SQ; Ianzer, D; Carvalho, MBL; Ferreira, AJ; Silva, GAB; Marques, FD; Peluso, AAB; Beiman, M; Cojocaru, G; Cohen, Y; Almeida, AP; Rotman, G; Santos, RAS				Savergnini, Silvia Q.; Ianzer, Danielle; Carvalho, Mariana B. L.; Ferreira, Anderson J.; Silva, Gerluza A. B.; Marques, Fulvia D.; Peluso, Antonio Augusto B.; Beiman, Merav; Cojocaru, Gady; Cohen, Yossi; Almeida, Alvair P.; Rotman, Galit; Santos, Robson A. S.			The Novel Mas agonist, CGEN-856S, Attenuates Isoproterenol-Induced Cardiac Remodeling and Myocardial Infarction Injury in Rats	PLOS ONE			English	Article							ANGIOTENSIN-(1-7) RECEPTOR MAS; HEART-FAILURE; ALDOSTERONE SYSTEM; NITRIC-OXIDE; IN-VIVO; HYPERTENSION; FIBROSIS; HYPERTROPHY; FIBROBLASTS; IMPAIRMENT	CGEN-856S is a novel Mas agonist. Herein, we examined the effects of this peptide on isoproterenol (ISO)-induced cardiac remodeling and myocardial infarction (MI) injury. We also sought to determine whether CGEN-856S activates the underlying mechanisms related to Mas receptor activation. Heart hypertrophy and fibrosis were induced by ISO (2 mg.kg(-1).day(-1)) in Wistar rats. After a 7-day treatment period with CGEN-856S (90 mu g.kg(-1).day(-1)) or vehicle, the cardiomyocyte diameter was evaluated in left ventricular sections stained with hematoxylin and eosin, and immunofluorescence labeling and quantitative confocal microscopy were used to quantify the deposition of type I and III collagen and fibronectin in the left ventricles. MI was induced by coronary artery ligation, and CGEN-856S (90 mu g.kg(-1).day(-1)) or saline was administered for 14 days. The Langendorff technique was used to evaluate cardiac function, and left ventricular sections were stained with Masson's trichrome dye to quantify the infarct area. Using Chinese hamster ovary cells stably transfected with Mas cDNA, we evaluated whether CGEN-856S alters AKT and endothelial nitric oxide synthase (eNOS) phosphorylation. CGEN-856S reduced the degree of ISO-induced hypertrophy (13.91 +/- 0.17 mu m vs. 12.41 +/- 0.16 mu m in the ISO+CGEN-856S group). In addition, the Mas agonist attenuated the ISO-induced increase in collagen I, collagen III, and fibronectin deposition. CGEN-856S markedly attenuated the MI-induced decrease in systolic tension, as well as in +dT/dt and -dT/dt. Furthermore, CGEN-856S administration significantly decreased the infarct area (23.68 +/- 2.78% vs. 13.95 +/- 4.37% in the MI+CGEN-856S group). These effects likely involved the participation of AKT and NO, as CGEN-856S administration increased the levels of p-AKT and p-eNOS. Thus, our results indicate that CGEN-856S exerts cardioprotective effects on ISO-induced cardiac remodeling and MI-mediated heart failure in rats through a mechanism likely involving the eNOS/AKT pathway.	[Savergnini, Silvia Q.; Ianzer, Danielle; Carvalho, Mariana B. L.; Marques, Fulvia D.; Peluso, Antonio Augusto B.; Almeida, Alvair P.; Santos, Robson A. S.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Ferreira, Anderson J.; Silva, Gerluza A. B.] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil; [Beiman, Merav; Cojocaru, Gady; Cohen, Yossi; Rotman, Galit] Compugen Ltd, Tel Aviv, Israel	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Santos, RAS (corresponding author), Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.	robsonsant@gmail.com	Santos, Robson A S/C-9336-2011	Santos, Robson A S/0000-0001-8738-5852; Peluso, Augusto/0000-0002-8653-2248	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Compugen Grant; Ministerio de Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)/Instituto Nacional de Ciencia e Tecnologia-INCT-NanoBiofar; Compugen Ltd.	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Compugen Grant; Ministerio de Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)/Instituto Nacional de Ciencia e Tecnologia-INCT-NanoBiofar; Compugen Ltd.	S.Q.S. was supported by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and F.D.M. was supported by a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). This study was supported by a Compugen Grant and by Ministerio de Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)/Instituto Nacional de Ciencia e Tecnologia-INCT-NanoBiofar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to declare that Merav Beiman, Gady Cojocaru, Yossi Cohen and Galit Rotman are affiliated to the commercial funders of this research (Compugen Ltd.) and this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Benter IF, 2006, AM J PHYSIOL-HEART C, V290, pH684, DOI 10.1152/ajpheart.00632.2005; BRILLA CG, 1991, CIRC RES, V69, P107, DOI 10.1161/01.RES.69.1.107; Castro CH, 2006, LIFE SCI, V80, P264, DOI 10.1016/j.lfs.2006.09.007; Deschamps AM, 2005, CURR OPIN CARDIOL, V20, P211, DOI 10.1097/01.hco.0000162397.44843.83; Dias-Peixoto MF, 2008, HYPERTENSION, V52, P542, DOI 10.1161/HYPERTENSIONAHA.108.114280; Ferreira AJ, 2007, LIFE SCI, V81, P916, DOI 10.1016/j.lfs.2007.07.022; Ferreira AJ, 2007, AM J PHYSIOL-HEART C, V292, pH1113, DOI 10.1152/ajpheart.00828.2006; Giani JF, 2007, AM J PHYSIOL-HEART C, V293, pH1154, DOI 10.1152/ajpheart.01395.2006; Gomes ERM, 2010, HYPERTENSION, V55, P153, DOI 10.1161/HYPERTENSIONAHA.109.143255; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; He JG, 2010, HEART VESSELS, V25, P438, DOI 10.1007/s00380-009-1213-7; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Kliger Y, 2008, BIOINFORMATICS, V24, P1049, DOI 10.1093/bioinformatics/btn084; Levonen AL, 2001, ANTIOXID REDOX SIGN, V3, P215, DOI 10.1089/152308601300185188; Lijnen PJ, 2003, METHOD FIND EXP CLIN, V25, P541, DOI 10.1358/mf.2003.25.7.778094; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; Nadu AP, 2008, J AM SOC HYPERTENS, V2, P341, DOI 10.1016/j.jash.2008.04.012; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Santiago NM, 2010, HYPERTENSION, V55, P889, DOI 10.1161/HYPERTENSIONAHA.110.149815; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Santos RAS, 2004, PHYSIOL GENOMICS, V17, P292, DOI 10.1152/physiolgenomics.00227.2003; Savergnini SQ, 2010, HYPERTENSION, V56, P112, DOI 10.1161/HYPERTENSIONAHA.110.152942; Shemesh R, 2008, J BIOL CHEM, V283, P34643, DOI 10.1074/jbc.M805181200; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Weber KT, 2000, CURR OPIN CARDIOL, V15, P264, DOI 10.1097/00001573-200007000-00010; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849	29	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57757	10.1371/journal.pone.0057757	http://dx.doi.org/10.1371/journal.pone.0057757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469229	Green Submitted, gold, Green Published			2022-12-27	WOS:000315897100036
J	Heijnen, BFJ; Nelissen, J; van Essen, H; Fazzi, GE; Tervaert, JWC; Peutz-Kootstra, CJ; Mullins, JJ; Schalkwijk, CG; Janssen, BJA; Struijker-Boudier, HAJ				Heijnen, Bart F. J.; Nelissen, Jelly; van Essen, Helma; Fazzi, Gregorio E.; Tervaert, Jan W. Cohen; Peutz-Kootstra, Carine J.; Mullins, John J.; Schalkwijk, Casper G.; Janssen, Ben J. A.; Struijker-Boudier, Harry A. J.			Irreversible Renal Damage after Transient Renin-Angiotensin System Stimulation: Involvement of an AT(1)-Receptor Mediated Immune Response	PLOS ONE			English	Article							CYP1A1-REN2 TRANSGENIC RATS; II-INDUCED HYPERTENSION; DEPENDENT MALIGNANT HYPERTENSION; CHRONIC KIDNEY-DISEASE; T-CELL; VASCULAR INFLAMMATION; OXIDATIVE STRESS; CARDIAC DAMAGE; ORGAN DAMAGE; INJURY	Transient activation of the renin-angiotensin system (RAS) induces irreversible renal damage causing sustained elevation in blood pressure (BP) in Cyp1a1-Ren2 transgenic rats. In our current study we hypothesized that activation of the AT(1)-receptor (AT(1)R) leads to a T-cell response causing irreversible impairment of renal function and hypertension. Cyp1a1-Ren2 rats harbor a construct for activation of the RAS by indole-3-carbinol (I3C). Rats were fed a I3C diet between 4-8 weeks of age to induce hypertension. Next, I3C was withdrawn and rats were followed-up for another 12 weeks. Additional groups received losartan (20 mg/kg/day) or hydralazine (100 mg/kg/day) treatment between 4-8 weeks. Rats were placed for 24h in metabolic cages before determining BP at week 8, 12 and 20. At these ages, subsets of animals were sacrificed and the presence of kidney T-cell subpopulations was investigated by immunohistochemistry and molecular marker analysis. The development of sustained hypertension was completely prevented by losartan, whereas hydralazine only caused a partial decrease in BP. Markers of renal damage: KIM-1 and osteopontin were highly expressed in urine and kidney samples of I3C-treated rats, even until 20 weeks of age. Additionally, renal expression of regulatory-T cells (Tregs) was highly increased in I3C-treated rats, whereas the expression of T-helper 1 (Th1) cells demonstrated a strong decrease. Losartan prevented these effects completely, whereas hydralazine was unable to affect these changes. In young Cyp1a1-Ren2 rats AT(1)R activation leads to induction of an immune response, causing a shift from Th1-cells to Tregs, contributing to the development of irreversible renal damage and hypertension.	[Heijnen, Bart F. J.; Nelissen, Jelly; van Essen, Helma; Fazzi, Gregorio E.; Janssen, Ben J. A.; Struijker-Boudier, Harry A. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol, Maastricht, Netherlands; [Tervaert, Jan W. Cohen] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Immunol, Maastricht, Netherlands; [Peutz-Kootstra, Carine J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Schalkwijk, Casper G.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands; [Mullins, John J.] Univ Edinburgh, Sch Med, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Edinburgh	Heijnen, BFJ (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol, Maastricht, Netherlands.	bart.heijnen@maastrichtuniversity.nl	tervaert, jan willem cohen/AAB-1111-2019	Schalkwijk, Casper G/0000-0003-0190-2690	Dutch Top Institute Pharma [T2301]	Dutch Top Institute Pharma	This work was performed within the framework of Dutch Top Institute Pharma, project "Renin-Angiotensin system blockade beyond Angiotensin II (T2301)". All the funding received for this study came from the Dutch Top Institute Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Baumann M, 2007, J HYPERTENS, V25, P207, DOI 10.1097/HJH.0b013e3280102bff; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; BROWN AJ, 1981, AM J PHYSIOL, V241, pH381, DOI 10.1152/ajpheart.1981.241.3.H381; Crowley SD, 2008, AM J PHYSIOL-RENAL, V295, pF515, DOI 10.1152/ajprenal.00527.2007; De Miguel C, 2011, AM J PHYSIOL-RENAL, V300, pF734, DOI 10.1152/ajprenal.00454.2010; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Devarajan P, 2010, ADV CHRONIC KIDNEY D, V17, P469, DOI 10.1053/j.ackd.2010.09.002; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Graciano ML, 2007, AM J PHYSIOL-RENAL, V292, pF1858, DOI 10.1152/ajprenal.00469.2006; GRIFFIN SA, 1991, HYPERTENSION, V17, P626, DOI 10.1161/01.HYP.17.5.626; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Heijnen BFJ, 2011, J HYPERTENS, V29, P2369, DOI 10.1097/HJH.0b013e32834cfcf4; Honetschlagerova Z, 2011, J HYPERTENS, V29, P1590, DOI 10.1097/HJH.0b013e328349062f; Howard CG, 2010, AM J MED SCI, V339, P543, DOI 10.1097/MAJ.0b013e3181d82a62; Huskova Z, 2010, J HYPERTENS, V28, P495, DOI 10.1097/HJH.0b013e3283345d69; Kantachuvesiri S, 2001, J BIOL CHEM, V276, P36727, DOI 10.1074/jbc.M103296200; Kasal DA, 2012, HYPERTENSION, V59, P324, DOI 10.1161/HYPERTENSIONAHA.111.181123; Kato T, 2010, BIOMED RES-TOKYO, V31, P363, DOI 10.2220/biomedres.31.363; Knier B, 2011, J HYPERTENS, V29, P1602, DOI 10.1097/HJH.0b013e32834840e8; Kvakan H, 2009, CIRCULATION, V119, P2904, DOI 10.1161/CIRCULATIONAHA.108.832782; Leibowitz A, 2011, CURR HYPERTENS REP, V13, P465, DOI 10.1007/s11906-011-0224-9; LEVER AF, 1993, J HYPERTENS, V11, pS27; Lorenzen JM, 2010, ATHEROSCLEROSIS, V209, P184, DOI 10.1016/j.atherosclerosis.2009.09.009; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Marvar PJ, 2010, CIRC RES, V107, P263, DOI 10.1161/CIRCRESAHA.110.217299; Mitchell KD, 2005, AM J PHYSIOL-RENAL, V289, pF1210, DOI 10.1152/ajprenal.00461.2004; Mitchell KD, 2006, J RENIN-ANGIO-ALDO S, V7, P74, DOI 10.3317/jraas.2006.013; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; Nataraj C, 1999, J CLIN INVEST, V104, P1693, DOI 10.1172/JCI7451; Nozaki Y, 2012, KIDNEY INT, V81, P844, DOI 10.1038/ki.2011.424; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; Peters B, 2008, J HYPERTENS, V26, P102, DOI 10.1097/HJH.0b013e3282f0ab66; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Schiffrin EL, 2010, CURR OPIN NEPHROL HY, V19, P181, DOI 10.1097/MNH.0b013e3283360a2e; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; TAKEICHI N, 1988, MICROBIOL IMMUNOL, V32, P1235, DOI 10.1111/j.1348-0421.1988.tb01487.x; Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927; Tervaert JWC, 2011, HYPERTENS RES, V34, P443, DOI 10.1038/hr.2011.15; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Vanourkova Z, 2006, J HYPERTENS, V24, P2465; Viel EC, 2010, AM J PHYSIOL-HEART C, V298, pH938, DOI 10.1152/ajpheart.00707.2009; Williams DE, 2010, AM J MED SCI, V339, P356, DOI 10.1097/MAJ.0b013e3181d2b0a8; Wolak T, 2009, KIDNEY INT, V76, P32, DOI 10.1038/ki.2009.90; Zhang JD, 2012, CIRC RES, V110, P1604, DOI 10.1161/CIRCRESAHA.111.261768	49	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57815	10.1371/journal.pone.0057815	http://dx.doi.org/10.1371/journal.pone.0057815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469072	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900169
J	Iwatsuki, K; Arai, T; Ota, H; Kato, S; Natsume, T; Kurimoto, S; Yamamoto, M; Hirata, H				Iwatsuki, Katsuyuki; Arai, Tetsuya; Ota, Hideyuki; Kato, Shuichi; Natsume, Tadahiro; Kurimoto, Shigeru; Yamamoto, Michiro; Hirata, Hitoshi			Targeting Anti-Inflammatory Treatment Can Ameliorate Injury-Induced Neuropathic Pain	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SLOW WALLERIAN DEGENERATION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-ALPHA; NERVE REGENERATION; TNF-ALPHA; RAT MODEL; T-CELLS; AXONAL REGENERATION; SENSORY NEURONS	Tumor necrosis factor-alpha plays important roles in immune system development, immune response regulation, and T-cell-mediated tissue injury. The present study assessed the net value of anti-tumor necrosis factor-alpha treatment in terms of functional recovery and inhibition of hypersensitivity after peripheral nerve crush injury. We created a right sciatic nerve crush injury model using a Sugita aneurysm clip. Animals were separated into 3 groups: the first group received only a skin incision; the second group received nerve crush injury and intraperitoneal vehicle injection; and the third group received nerve crush injury and intraperitoneal etanercept (6 mg/kg). Etanercept treatment improved recovery of motor nerve conduction velocity, muscle weight loss, and sciatic functional index. Plantar thermal and von Frey mechanical withdrawal thresholds recovered faster in the etanercept group than in the control group. On day 7 after crush injury, the numbers of ED-1-positive cells in crushed nerves of the control and etanercept groups were increased compared to that in the sham-treated group. After 21 days, ED-1-positive cells had nearly disappeared from the etanercept group. Etanercept reduced expression of interleukin-6 and monocyte chemotactic and activating factor-1 at the crushed sciatic nerve. These findings demonstrate the utility of etanercept, in terms of both enhancing functional recovery and suppressing hypersensitivity after nerve crush. Etanercept does not impede the onset or progression of Wallerian degeneration, but optimizes the involvement of macrophages and the secretion of inflammatory mediators.	[Iwatsuki, Katsuyuki; Arai, Tetsuya; Ota, Hideyuki; Kato, Shuichi; Natsume, Tadahiro; Kurimoto, Shigeru; Yamamoto, Michiro; Hirata, Hitoshi] Nagoya Univ, Dept Hand Surg, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Iwatsuki, K (corresponding author), Nagoya Univ, Dept Hand Surg, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan.	kiwatsuki@med.nagoya-u.ac.jp	Yamamoto, Michiro/M-5075-2014; Iwatsuki, Katsuyuki/M-4882-2014; KURIMOTO, Shigeru/J-3451-2015	Yamamoto, Michiro/0000-0002-6753-538X; KURIMOTO, Shigeru/0000-0003-1521-0038	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Health and Labour Sciences Research Grant on Intractable Diseases (Pathogenesis and Diagnostic Accuracy of Neuropathic Pain) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalbert R, 2005, EUR J NEUROSCI, V21, P271, DOI 10.1111/j.1460-9568.2004.03833.x; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Alshekhlee A, 2010, MUSCLE NERVE, V41, P723, DOI 10.1002/mus.21584; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Andreev YA, 2012, RECENT PATENTS INFLA, V6, P35, DOI 10.2174/187221312798889266; Antenor-Dorsey JAV, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-5; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; BAICHWAL RR, 1988, P NATL ACAD SCI USA, V85, P1701, DOI 10.1073/pnas.85.5.1701; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; BREDER CD, 1994, P NATL ACAD SCI USA, V91, P11393, DOI 10.1073/pnas.91.24.11393; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; BROWN MC, 1991, NEURON, V6, P359, DOI 10.1016/0896-6273(91)90245-U; Chattopadhyay S, 2007, BRAIN BEHAV IMMUN, V21, P561, DOI 10.1016/j.bbi.2006.10.015; Chen LE, 1996, NEUROCHEM INT, V29, P197; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Fainzilber M, 2006, NEURON, V50, P819, DOI 10.1016/j.neuron.2006.05.023; Fenrich K, 2004, CAN J NEUROL SCI, V31, P142, DOI 10.1017/S0317167100053798; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; George A, 2004, NEUROSCI LETT, V372, P215, DOI 10.1016/j.neulet.2004.09.075; Gillingwater TH, 2006, HUM MOL GENET, V15, P625, DOI 10.1093/hmg/ddi478; Golz G, 2006, EUR J NEUROSCI, V24, P2721, DOI 10.1111/j.1460-9568.2006.05155.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Horste GMZ, 2011, NEUROBIOL DIS, V42, P1, DOI 10.1016/j.nbd.2010.12.006; Jeon SM, 2011, NEUROSCIENCE, V190, P354, DOI 10.1016/j.neuroscience.2011.06.036; Jeon SM, 2009, BRAIN RES, V1251, P103, DOI 10.1016/j.brainres.2008.11.046; Kato K, 2009, NEUROSCIENCE, V160, P492, DOI 10.1016/j.neuroscience.2009.02.038; Kato K, 2010, J NEUROSCI RES, V88, P360, DOI 10.1002/jnr.22202; Kato N, 2002, J NEUROL SCI, V202, P69, DOI 10.1016/S0022-510X(02)00209-5; Laser H, 2006, MOL BIOL CELL, V17, P1075, DOI 10.1091/mbc.E05-04-0375; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Liefner M, 2000, J NEUROIMMUNOL, V108, P147, DOI 10.1016/S0165-5728(00)00262-9; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; Madhusudan S, 2005, J CLIN ONCOL, V23, P5950, DOI 10.1200/JCO.2005.04.127; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W; Murphy PG, 1999, J NEUROSCI, V19, P3791; Myers RR, 2011, J PERIPHER NERV SYST, V16, P277, DOI 10.1111/j.1529-8027.2011.00362.x; Noponen-Hietala N, 2005, PAIN, V114, P186, DOI 10.1016/j.pain.2004.12.015; Ohtori S., 2012, EUR SPINE J; Okui N, 2010, MUSCLE NERVE, V42, P570, DOI 10.1002/mus.21727; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; Orr-Urtreger A, 2005, NEUROREPORT, V16, P1123, DOI 10.1097/00001756-200507130-00018; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; PERRY VH, 1990, EUR J NEUROSCI, V2, P802, DOI 10.1111/j.1460-9568.1990.tb00472.x; Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020; Romagnoli R, 2008, EXPERT OPIN THER TAR, V12, P647, DOI 10.1517/14728222.12.5.647 ; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; SAID G, 1992, RES IMMUNOL, V143, P589, DOI 10.1016/0923-2494(92)80040-R; Sawada T, 2007, NEUROSCI LETT, V417, P55, DOI 10.1016/j.neulet.2007.02.028; Schafers M, 2003, J NEUROSCI, V23, P3028; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Skaper Stephen D, 2009, Cardiovasc Psychiatry Neurol, V2009, P861324, DOI 10.1155/2009/861324; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Smith D, 2009, J NEUROPATH EXP NEUR, V68, P691, DOI 10.1097/NEN.0b013e3181a7c14e; SOMMER C, 1995, J NEUROPATH EXP NEUR, V54, P635, DOI 10.1097/00005072-199509000-00004; Sommer C, 1998, BRAIN RES, V784, P154, DOI 10.1016/S0006-8993(97)01327-9; SPIES JM, 1995, BRAIN, V118, P857, DOI 10.1093/brain/118.4.857; Stuebgen JP, 2008, MUSCLE NERVE, V37, P281, DOI 10.1002/mus.20924; Subang MC, 2001, EUR J NEUROSCI, V13, P521, DOI 10.1046/j.1460-9568.2001.01425.x; Terada T, 2011, CAN J ANESTH, V58, P630, DOI 10.1007/s12630-011-9504-8; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Watanabe M, 2007, NEUROSCI LETT, V411, P228, DOI 10.1016/j.neulet.2006.09.068; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wishart TM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-148; Yamamoto M, 2011, J ANAT, V218, P413, DOI 10.1111/j.1469-7580.2011.01341.x; Yamamoto M, 2010, J ORTHOP RES, V28, P284, DOI 10.1002/jor.21004; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	96	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57721	10.1371/journal.pone.0057721	http://dx.doi.org/10.1371/journal.pone.0057721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469058	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900156
J	Carinci, F; Santoro, D; von Samson-Himmelstjerna, F; Lindel, TD; Dieringer, MA; Niendorf, T				Carinci, Flavio; Santoro, Davide; von Samson-Himmelstjerna, Federico; Lindel, Tomasz Dawid; Dieringer, Matthias Alexander; Niendorf, Thoralf			Characterization of Phase-Based Methods Used for Transmission Field Uniformity Mapping: A Magnetic Resonance Study at 3.0 T and 7.0 T	PLOS ONE			English	Article							PARALLEL EXCITATION; COIL	Knowledge of the transmission field (B-1(+)) of radio-frequency coils is crucial for high field (B-0 = 3.0 T) and ultrahigh field (B-0 >= 7.0 T) magnetic resonance applications to overcome constraints dictated by electrodynamics in the short wavelength regime with the ultimate goal to improve the image quality. For this purpose B-1(+) mapping methods are used, which are commonly magnitude-based. In this study an analysis of five phase-based methods for three-dimensional mapping of the B-1(+) field is presented. The five methods are implemented in a 3D gradient-echo technique. Each method makes use of different RF-pulses (composite or off-resonance pulses) to encode the effective intensity of the B-1(+) field into the phase of the magnetization. The different RF-pulses result in different trajectories of the magnetization, different use of the transverse magnetization and different sensitivities to B-1(+) inhomogeneities and frequency offsets, as demonstrated by numerical simulations. The characterization of the five methods also includes phantom experiments and in vivo studies of the human brain at 3.0 T and at 7.0 T. It is shown how the characteristics of each method affect the quality of the B-1(+) maps. Implications for in vivo B-1(+) mapping at 3.0 T and 7.0 T are discussed.	[Carinci, Flavio; Santoro, Davide; von Samson-Himmelstjerna, Federico; Lindel, Tomasz Dawid; Dieringer, Matthias Alexander; Niendorf, Thoralf] Max Delbruck Ctr Mol Med MDC, BUFF, Berlin, Germany; [Carinci, Flavio] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [von Samson-Himmelstjerna, Federico] Charite, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [von Samson-Himmelstjerna, Federico] Fraunhofer MEVIS, Inst Med Image Comp, Bremen, Germany; [Lindel, Tomasz Dawid] PTB, Dept Med Metrol, Berlin, Germany; [Dieringer, Matthias Alexander; Niendorf, Thoralf] ECRC, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB)	Santoro, D (corresponding author), Max Delbruck Ctr Mol Med MDC, BUFF, Berlin, Germany.	davide.santoro.73@gmail.com	Niendorf, Thoralf/H-7738-2013	Niendorf, Thoralf/0000-0001-7584-6527; Carinci, Flavio/0000-0001-5865-8786	Max Delbruck Centrum for Molecular Medicine	Max Delbruck Centrum for Molecular Medicine	This study was funded through institutional funding by the Max Delbruck Centrum for Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOKA S, 1993, MAGN RESON IMAGING, V11, P437, DOI 10.1016/0730-725X(93)90078-R; Allen SP, 2011, MAGN RESON MED, V65, P1126, DOI 10.1002/mrm.22700; [Anonymous], 2010, IEC60601233; Bloch F, 1940, PHYS REV, V57, P522, DOI 10.1103/PhysRev.57.522; Carinci F, 2011, P 28 ANN M ESMRMB LE, P46; Chang YLV, 2012, MAGN RESON MED, V67, P718, DOI 10.1002/mrm.23051; Cunningham CH, 2006, MAGN RESON MED, V55, P1326, DOI 10.1002/mrm.20896; Dowell NG, 2007, MAGN RESON MED, V58, P622, DOI 10.1002/mrm.21368; INSKO EK, 1993, J MAGN RESON SER A, V103, P82, DOI 10.1006/jmra.1993.1133; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Khalighi MM, 2011, P 19 SCI M INT SOC M, P4431; KLOSE U, 1992, MED PHYS, V19, P1099, DOI 10.1118/1.596828; Morrell GR, 2008, MAGN RESON MED, V60, P889, DOI 10.1002/mrm.21729; Morrell GR, 2010, PHYS MED BIOL, V55, P6157, DOI 10.1088/0031-9155/55/20/008; Mugler J.P.I., 2005, P 13 ANN M ISMRM MIA, P789; Mugler JPI, 2007, P 15 ANN M ISMRM, P351; Nehrke K, 2012, MAGN RESON MED; PARK HW, 1988, MAGNET RESON MED, V7, P340, DOI 10.1002/mrm.1910070311; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; Santoro D, 2010, P 18 ANN M ISMRM STO, P4943; Santoro D, 2009, P 17 ANN M ISMRM HON, P2611; Santoro D, 2011, MAGN RESON MED, V65, P1166, DOI 10.1002/mrm.22683; Saranathan M, 2011, P 19 ANN M ISMRM MON, P577; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Stollberger R, 1996, MAGNET RESON MED, V35, P246, DOI 10.1002/mrm.1910350217; Storey P, 2009, P 17 ANN M ISMRM HON, P374; Ullmann P, 2005, MAGNET RESON MED, V54, P994, DOI 10.1002/mrm.20646; Yang QX, 2004, MAGNET RESON MED, V52, P1418, DOI 10.1002/mrm.20303; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57982	10.1371/journal.pone.0057982	http://dx.doi.org/10.1371/journal.pone.0057982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472127	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315637900070
J	Kupper, N; Pelle, AJ; Szabo, BM; Denollet, J				Kupper, Nina; Pelle, Aline J.; Szabo, Balazs M.; Denollet, Johan			The Relationship between Type D Personality, Affective Symptoms and Hemoglobin Levels in Chronic Heart Failure	PLOS ONE			English	Article							KIDNEY-FUNCTION DECLINE; QUALITY-OF-LIFE; PSYCHOLOGICAL-FACTORS; MYOCARDIAL-INFARCTION; CANCER-PATIENTS; EPOETIN-ALPHA; RISK-FACTORS; ANEMIA; DEPRESSION; INFLAMMATION	Background: Anemia is associated with poor prognosis in heart failure (HF) patients. Contributors to the risk of anemia in HF include hemodilution, renal dysfunction and inflammation. Hemoglobin levels may also be negatively affected by alterations in stress regulatory systems. Therefore, psychological distress characterized by such alterations may adversely affect hemoglobin in HF. The association between hemoglobin and Type D personality and affective symptomatology in the context of HF is poorly understood. Aim: To examine the relationship between Type D personality and affective symptomatology with hemoglobin levels at inclusion and 12-month follow-up, controlling for relevant clinical factors. Methods: Plasma levels of hemoglobin and creatinine were assessed in 264 HF patients at inclusion and at 12-month follow-up. Type D personality and affective symptomatology were assessed at inclusion. Results: At inclusion, hemoglobin levels were similar for Type D and non-Type D HF patients (p=.23), and were moderately associated with affective symptomatology (r=-.14, p=.02). Multivariable regression showed that Type D personality (beta=-.15; p=.02), was independently associated with future hemoglobin levels, while controlling for renal dysfunction, gender, NYHA class, time since diagnosis, BMI, the use of angiotensin-related medication, and levels of affective symptomatology. Change in renal function was associated with Type D personality (beta=.20) and hemoglobin at 12 months (beta=-.25). Sobel mediation analysis showed significant partial mediation of the Type D - hemoglobin association by renal function deterioration (p=.01). Anemia prevalence increased over time, especially in Type D patients. Female gender, poorer baseline renal function, deterioration of renal function and a longer HF history predicted the observed increase in anemia prevalence over time, while higher baseline hemoglobin was protective. Conclusion: Type D personality, but not affective symptomatology, was associated with reduced future hemoglobin levels, independent of clinical factors. The relation between Type D personality and future hemoglobin levels was mediated by renal function deterioration.	[Kupper, Nina; Pelle, Aline J.; Denollet, Johan] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands; [Kupper, Nina] TweeSteden Hosp, Dept Cardiol, Tilburg, Netherlands; [Szabo, Balazs M.] St Elizabeth Hosp, Dept Cardiol, Tilburg, Netherlands	Tilburg University; Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ)	Kupper, N (corresponding author), Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.	h.m.kupper@tilburguniversity.edu	Kupper, Nina M/B-6337-2011; Kupper, Nina/B-7045-2011	Kupper, Nina M/0000-0001-8721-5239; 	Dutch Research Organization VICI grant [NWO 453-04-004]	Dutch Research Organization VICI grant	This work was supported by a Dutch Research Organization VICI grant (grant number: NWO 453-04-004; www.nwo.nl) awarded to Prof. Dr. J. Denollet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlbrecht C, 2008, EUR HEART J, V29, P2343, DOI 10.1093/eurheartj/ehn359; Adomaitiene V, 2008, EUR PSYCHIAT, V23, pS269, DOI 10.1016/j.eurpsy.2008.01.549; Anand IS, 2008, HEART FAIL REV, V13, P379, DOI 10.1007/s10741-008-9088-8; Anand IS, 2008, J AM COLL CARDIOL, V52, P501, DOI 10.1016/j.jacc.2008.04.044; Bansal N, 2007, AM J CARDIOL, V99, P1137, DOI 10.1016/j.amjcard.2006.11.055; CASADEVALL N, 1995, NEPHROL DIAL TRANSPL, V10, P27, DOI 10.1093/ndt/10.supp6.27; Comin-Colet J, 2012, EUR HEART J; de Jonge P, 2007, J PSYCHOSOM RES, V63, P477, DOI 10.1016/j.jpsychores.2007.06.002; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2008, BRAIN BEHAV IMMUN, V22, P736, DOI 10.1016/j.bbi.2007.10.015; Denollet J, 2006, PSYCHOTHER PSYCHOSOM, V75, P346, DOI 10.1159/000095440; Denollet J, 2009, AM J CARDIOL, V103, P399, DOI 10.1016/j.amjcard.2008.09.096; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Geiser F, 2007, SUPPORT CARE CANCER, V15, P273, DOI 10.1007/s00520-006-0132-8; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; He F, 2011, CELL BIOCHEM BIOPHYS, V61, P65, DOI 10.1007/s12013-011-9162-z; Heffner KL, 2011, IMMUNOL ALLERGY CLIN, V31, P95, DOI 10.1016/j.iac.2010.09.005; Hiramoto JS, 2012, AM J KIDNEY DIS, V60, P225, DOI 10.1053/j.ajkd.2012.02.335; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555; Kleijn L, 2012, HEART, V98, P1237, DOI 10.1136/heartjnl-2012-301954; Kourea K, 2008, EUR J CARDIOV PREV R, V15, P365, DOI 10.1097/HJR.0b013e3282f849d0; Kraai IH, 2012, INT J CARDIOL; Krishnan Gokul, 2006, BMC Pulm Med, V6, P23, DOI 10.1186/1471-2466-6-23; Kupper N, 2012, J AFFECT DISORDERS, V136, P567, DOI 10.1016/j.jad.2011.10.029; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lind M, 2002, BRIT J CANCER, V86, P1243, DOI 10.1038/sj.bjc.6600247; Lucca U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001920; Maas AJBM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-46; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P39, DOI 10.1093/ndt/17.suppl_11.39; MacMahon KMA, 2002, ARCH INTERN MED, V162, P509, DOI 10.1001/archinte.162.5.509; Martens EJ, 2007, J PSYCHOSOM RES, V63, P545, DOI 10.1016/j.jpsychores.2007.06.005; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; Members ATF, 2012, EUR HEART J; Messina A, 2011, ANN CLIN PSYCHIATRY, V23, P125; Molloy GJ, 2008, PSYCHOSOM MED, V70, P863, DOI 10.1097/PSY.0b013e3181842e0c; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Okonko DO, 2005, AM J CARDIOL, V96, P101, DOI 10.1016/j.amjcard.2005.02.053; Onder G, 2005, J GERONTOL A-BIOL, V60, P1168, DOI 10.1093/gerona/60.9.1168; Pelle AJ, 2010, INT J CARDIOL, V145, P82, DOI 10.1016/j.ijcard.2009.05.018; Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086; Pelle AJ, 2010, CIRC-HEART FAIL, V3, P261, DOI 10.1161/CIRCHEARTFAILURE.109.871483; Silverberg DS, 2009, CLIN EXP NEPHROL, V13, P101, DOI 10.1007/s10157-008-0074-1; SINGER JW, 1976, J CELL PHYSIOL, V88, P127, DOI 10.1002/jcp.1040880202; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666; Teng WF, 2008, BIOL TRACE ELEM RES, V121, P243, DOI 10.1007/s12011-007-8047-x; van der Meer P, 2009, HEART, V95, P1309, DOI 10.1136/hrt.2008.161091; von Haehling S, 2011, EUR J HEART FAIL, V13, P656, DOI 10.1093/eurjhf/hfr044; Wei CL, 2008, INT J HEMATOL, V88, P52, DOI 10.1007/s12185-008-0105-4; Whitehead DL, 2007, J PSYCHOSOM RES, V62, P419, DOI 10.1016/j.jpsychores.2006.11.005; WHO, 2011, WHONMHNHDMNM111; Williams L, 2011, PSYCHOL HEALTH, V26, P703, DOI 10.1080/08870446.2010.488265	57	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58370	10.1371/journal.pone.0058370	http://dx.doi.org/10.1371/journal.pone.0058370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472188	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900134
J	Moodley, K; Weiss, SFT				Moodley, Kiashanee; Weiss, Stefan F. T.			Downregulation of the Non-Integrin Laminin Receptor Reduces Cellular Viability by Inducing Apoptosis in Lung and Cervical Cancer Cells	PLOS ONE			English	Article							PROSTATE-CANCER; BINDING PROTEIN; EXPRESSION; PRECURSOR; VIRUS; IDENTIFICATION; LOCALIZATION; CARCINOMAS; CASPASE-3; ACYLATION	The non-integrin laminin receptor, here designated the 37-kDa/67-kDa laminin receptor (LRP/LR), is involved in many physiologically relevant processes, as well as numerous pathological conditions. The overexpression of LRP/LR on various cancerous cell lines plays critical roles in tumour metastasis and angiogenesis. This study investigated whether LRP/LR is implicated in the maintenance of cellular viability in lung and cervical cancer cell lines. Here we show a significant reduction in cellular viability in the aforementioned cell lines as a result of the siRNA-mediated downregulation of LRP. This reduction in cellular viability is due to increased apoptotic processes, reflected by the loss of nuclear integrity and the significant increase in the activity of caspase-3. These results indicate that LRP/LR is involved in the maintenance of cellular viability in tumorigenic lung and cervix uteri cells through the blockage of apoptosis. Knockdown of LRP/LR by siRNA might represent an alternative therapeutic strategy for the treatment of lung and cervical cancer.	[Moodley, Kiashanee; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, Gauteng, South Africa	University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, Gauteng, South Africa.	stefan.weiss@wits.ac.za			NRF, South Africa; MRC, South Africa	NRF, South Africa(National Research Foundation - South Africa); MRC, South Africa	NRF, South Africa. MRC, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qare AW, 2001, J TOXICOL ENV HEAL B, V4, P313, DOI 10.1080/109374001301419737; Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; AlSaleh W, 1997, J PATHOL, V181, P287, DOI 10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; CASTRONOVO V, 1991, BIOCHEM BIOPH RES CO, V177, P177, DOI 10.1016/0006-291X(91)91965-F; CIOCE V, 1991, J NATL CANCER I, V83, P29, DOI 10.1093/jnci/83.1.29; de Manzoni G, 1998, ONCOLOGY-BASEL, V55, P456, DOI 10.1159/000011895; Fontanini G, 1997, CLIN CANCER RES, V3, P227; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Khusal R, 2013, PLOS ONE IN PRESS; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; LIOTTA LA, 1985, EXP CELL RES, V156, P117, DOI 10.1016/0014-4827(85)90266-6; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; McKenna DJ, 2001, EXP EYE RES, V73, P81, DOI 10.1006/exer.2001.1013; MECHAM RP, 1989, J BIOL CHEM, V264, P16652; MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X; Nadji M, 1999, CANCER-AM CANCER SOC, V85, P432, DOI 10.1002/(SICI)1097-0142(19990115)85:2<432::AID-CNCR22>3.0.CO;2-J; Nikles D, 2008, BBA-MOL BASIS DIS, V1782, P335, DOI 10.1016/j.bbadis.2008.02.003; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Pelosi G, 1997, J PATHOL, V183, P62, DOI 10.1002/(SICI)1096-9896(199709)183:1<62::AID-PATH1095>3.0.CO;2-A; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Renvoize C, 1998, CELL BIOL TOXICOL, V14, P111, DOI 10.1023/A:1007429904664; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Robertson JD, 2000, J STRUCT BIOL, V129, P346, DOI 10.1006/jsbi.2000.4254; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Susantad T, 2008, CELL MOL BIOL LETT, V13, P452, DOI 10.2478/s11658-008-0017-6; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; VANDENBRULE FA, 1994, EUR J CANCER, V30A, P1096, DOI 10.1016/0959-8049(94)90464-2; Waltregny D, 1997, JNCI-J NATL CANCER I, V89, P1224, DOI 10.1093/jnci/89.16.1224; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Yin MC, 2009, J AGR FOOD CHEM, V57, P6468, DOI 10.1021/jf9004466; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	39	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57409	10.1371/journal.pone.0057409	http://dx.doi.org/10.1371/journal.pone.0057409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472084	Green Published, gold			2022-12-27	WOS:000315637900022
J	Song, WG; Kerr, CC; Lytton, WW; Francis, JT				Song, Weiguo; Kerr, Cliff C.; Lytton, William W.; Francis, Joseph T.			Cortical Plasticity Induced by Spike-Triggered Microstimulation in Primate Somatosensory Cortex	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; MOTOR CORTEX; INTRACORTICAL MICROSTIMULATION; STIMULUS LOCATION; STIMULATION; INFORMATION; NEURONS; AREA; SYNCHRONY; NETWORKS	Electrical stimulation of the nervous system for therapeutic purposes, such as deep brain stimulation in the treatment of Parkinson's disease, has been used for decades. Recently, increased attention has focused on using microstimulation to restore functions as diverse as somatosensation and memory. However, how microstimulation changes the neural substrate is still not fully understood. Microstimulation may cause cortical changes that could either compete with or complement natural neural processes, and could result in neuroplastic changes rendering the region dysfunctional or even epileptic. As part of our efforts to produce neuroprosthetic devices and to further study the effects of microstimulation on the cortex, we stimulated and recorded from microelectrode arrays in the hand area of the primary somatosensory cortex (area 1) in two awake macaque monkeys. We applied a simple neuroprosthetic microstimulation protocol to a pair of electrodes in the area 1 array, using either random pulses or pulses time-locked to the recorded spiking activity of a reference neuron. This setup was replicated using a computer model of the thalamocortical system, which consisted of 1980 spiking neurons distributed among six cortical layers and two thalamic nuclei. Experimentally, we found that spike-triggered microstimulation induced cortical plasticity, as shown by increased unit-pair mutual information, while random microstimulation did not. In addition, there was an increased response to touch following spike-triggered microstimulation, along with decreased neural variability. The computer model successfully reproduced both qualitative and quantitative aspects of the experimental findings. The physiological findings of this study suggest that even simple microstimulation protocols can be used to increase somatosensory information flow.	[Song, Weiguo; Kerr, Cliff C.; Lytton, William W.; Francis, Joseph T.] Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; [Song, Weiguo; Kerr, Cliff C.; Lytton, William W.; Francis, Joseph T.] Suny Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA; [Kerr, Cliff C.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Lytton, William W.] Kings Cty Hosp, Dept Neurol, Brooklyn, NY USA; [Lytton, William W.; Francis, Joseph T.] Suny Downstate Med Ctr, Robert Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Lytton, William W.; Francis, Joseph T.] Joint Grad Program Engn SUNY Downstate, Brooklyn, NY USA; [Lytton, William W.; Francis, Joseph T.] NYU POLY, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Sydney; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Kerr, CC (corresponding author), Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA.	cliffk@neurosim.downstate.edu		Francis, Joseph/0000-0002-2874-0452; Song, Weiguo/0000-0001-8415-9286; Lytton, William/0000-0002-3727-2849	DARPA REPAIR Contract [N66001-10-C-2008]	DARPA REPAIR Contract	This work was supported by DARPA REPAIR Contract #N66001-10-C-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; Alloway KD, 2002, EXP BRAIN RES, V147, P227, DOI 10.1007/s00221-002-1233-3; ASANUMA H, 1975, BRAIN RES, V98, P73, DOI 10.1016/0006-8993(75)90510-7; Baker SN, 2003, J PHYSIOL-LONDON, V550, P529, DOI 10.1113/jphysiol.2003.045674; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brockmeier AJ, 2011, IEEE ENG MED BIO, P1069, DOI 10.1109/IEMBS.2011.6090249; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Carnevale NT, 2006, NEURON BOOK; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; Chhatbar PY, 2010, J NEUROSCI METH, V188, P187, DOI 10.1016/j.jneumeth.2010.02.006; Choi JS, 2012, IEEE T NEUR SYS REH, V20, P161, DOI 10.1109/TNSRE.2011.2181417; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Clark KL, 2011, P ROY SOC B-BIOL SCI, V278, P1121, DOI 10.1098/rspb.2010.2211; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Fitzsimmons NA, 2007, J NEUROSCI, V27, P5593, DOI 10.1523/JNEUROSCI.5297-06.2007; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Griffin DM, 2011, J NEUROSCI, V31, P13088, DOI 10.1523/JNEUROSCI.6322-10.2011; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Heming E, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/064001; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; KELLER A, 1992, J NEUROPHYSIOL, V68, P295, DOI 10.1152/jn.1992.68.1.295; Kerr CC, 2012, IEEE T NEUR SYS REH, V20, P153, DOI 10.1109/TNSRE.2011.2178614; Leal-Campanario R, 2006, P NATL ACAD SCI USA, V103, P10052, DOI 10.1073/pnas.0603584103; LENZ FA, 1993, J NEUROPHYSIOL, V70, P200, DOI 10.1152/jn.1993.70.1.200; Li L., 2011, MACH LEARN SIGN PROC, V6, P1; Li L, 2011, I IEEE EMBS C NEUR E, P13, DOI 10.1109/NER.2011.5910478; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Liang SF, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045001; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; Lytton WW, 2008, NEURAL COMPUT, V20, P2745, DOI 10.1162/neco.2008.10-07-622; Lytton WW, 2005, INT J BIOELECTROMAGN, V7, P47; Magri C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-81; Marquez-Ruiz J, 2012, P NATL ACAD SCI USA, V109, P6710, DOI 10.1073/pnas.1121147109; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Neymotin S., 2011, 2011 IEEE SIGN PROC, P1, DOI DOI 10.1109/SPMB.2011.6120115; Neymotin SA, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00019; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Ollerenshaw DRZ, 2011, C P SOC NEUROSCI; Palomar FJ, 2011, MOVEMENT DISORD, V26, P2058, DOI 10.1002/mds.23779; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Patel S, 2006, J NEUROPHYSIOL, V95, P646, DOI 10.1152/jn.00756.2005; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petersen RS, 2002, BIOSYSTEMS, V67, P187, DOI 10.1016/S0303-2647(02)00076-X; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rebesco JM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/016011; Rebesco JM, 2010, FRONT SYS NEUROSCI, P4; Reed JL, 2008, P NATL ACAD SCI USA, V105, P10233, DOI 10.1073/pnas.0803800105; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Roy A, 2007, J NEUROPHYSIOL, V98, P1645, DOI 10.1152/jn.00522.2006; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Song WG, 2011, J NEUROSCI, V31, P3110, DOI 10.1523/JNEUROSCI.2335-10.2011; Song WG, 2011, C P SOC NEURAL CONTR; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Talathi SS, 2008, J COMPUT NEUROSCI, V25, P262, DOI 10.1007/s10827-008-0077-7; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Venkatraman S, 2009, IEEE T BIO-MED ENG, V56, P15, DOI 10.1109/TBME.2008.2005944; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	78	29	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57453	10.1371/journal.pone.0057453	http://dx.doi.org/10.1371/journal.pone.0057453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472086	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900024
J	van Dooren, FEP; Nefs, G; Schram, MT; Verhey, FRJ; Denollet, J; Pouwer, F				van Dooren, Fleur E. P.; Nefs, Giesje; Schram, Miranda T.; Verhey, Frans R. J.; Denollet, Johan; Pouwer, Francois			Depression and Risk of Mortality in People with Diabetes Mellitus: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CO-MORBID DEPRESSION; EUROPEAN DEPRESSION; MYOCARDIAL-INFARCTION; HEALTH OUTCOMES; ALL-CAUSE; ADULTS; PREVALENCE; SYMPTOMS; ASSOCIATION; TYPE-1	Objective: To examine the association between depression and all-cause and cardiovascular mortality in people with diabetes by systematically reviewing the literature and carrying out a meta-analysis of relevant longitudinal studies. Research Design and Methods: PUBMED and PSYCINFO were searched for articles assessing mortality risk associated with depression in diabetes up until August 16, 2012. The pooled hazard ratios were calculated using random-effects models. Results: Sixteen studies met the inclusion criteria, which were pooled in an overall all-cause mortality estimate, and five in a cardiovascular mortality estimate. After adjustment for demographic variables and micro-and macrovascular complications, depression was associated with an increased risk of all-cause mortality (HR = 1.46, 95% CI = 1.29-1.66), and cardiovascular mortality (HR = 1.39, 95% CI = 1.11-1.73). Heterogeneity across studies was high for all-cause mortality and relatively low for cardiovascular mortality, with an I-squared of respectively 78.6% and 39.6%. Subgroup analyses showed that the association between depression and mortality not significantly change when excluding three articles presenting odds ratios, yet this decreased heterogeneity substantially (HR = 1.49, 95% CI = 1.39-1.61, I-squared = 15.1%). A comparison between type 1 and type 2 diabetes could not be undertaken, as only one study reported on type 1 diabetes specifically. Conclusions: Depression is associated with an almost 1.5-fold increased risk of mortality in people with diabetes. Research should focus on both cardiovascular and non-cardiovascular causes of death associated with depression, and determine the underlying behavioral and physiological mechanisms that may explain this association.	[van Dooren, Fleur E. P.; Nefs, Giesje; Denollet, Johan; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands; [van Dooren, Fleur E. P.; Verhey, Frans R. J.] Maastricht Univ, MHeNS Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Dooren, Fleur E. P.; Schram, Miranda T.] Maastricht Univ, MUMC Maastricht Univ Med Ctr, Dept Med, Maastricht, Netherlands	Tilburg University; Maastricht University; Maastricht University	Pouwer, F (corresponding author), Tilburg Univ, Dept Med & Clin Psychol, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.	F.Pouwer@uvt.nl	Nefs, Giesje/C-9992-2018	Schram, Miranda/0000-0001-8113-7604; van Dooren, Fleur/0000-0002-6809-3819; Pouwer, Frans/0000-0002-8172-9818	Tilburg University; Maastricht University	Tilburg University; Maastricht University	Funded by Tilburg University and Maastricht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola AJ, 2012, DIABETOLOGIA, V55, P73, DOI 10.1007/s00125-011-2347-6; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x; Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822; Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974; Bot M, 2012, DIABETES CARE, V35, P503, DOI 10.2337/dc11-1749; Bot M, 2010, DIABETIC MED, V27, P1295, DOI 10.1111/j.1464-5491.2010.03119.x; Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; de Jonge P, 2010, NEUROSCI BIOBEHAV R, V35, P84, DOI 10.1016/j.neubiorev.2009.11.025; Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339; Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Halaris A, 2009, INT ANGIOL, V28, P92; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Iversen MM, 2009, DIABETES CARE, V32, P2193, DOI 10.2337/dc09-0651; Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9; Knol MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021248; Koopmans B, 2009, FAM PRACT, V26, P171, DOI 10.1093/fampra/cmp016; Kuo YF, 2004, DIABETES CARE, V27, P1630, DOI 10.2337/diacare.27.7.1630; Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002; LUSTMAN PJ, 1992, DIABETES CARE, V15, P1631, DOI 10.2337/diacare.15.11.1631; Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x; Mapppsy LKR, 2008, DIABETES CARE, V31, P880, DOI 10.2337/dc07-2215; Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007; Marshall SM, 2006, BMJ-BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80; Mastrogiannis D, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/794762; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414; Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176; Pieper L, 2011, BUNDESGESUNDHEITSBLA, V54, P98, DOI 10.1007/s00103-010-1181-1; Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x; Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214; Rosenthal MJ, 1998, DIABETES CARE, V21, P231, DOI 10.2337/diacare.21.2.231; Scherrer JF, 2011, DIABETES CARE, V34, P1729, DOI 10.2337/dc11-0031; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791; Thombs BD, 2008, DIABETES CARE, V31, pe55; Thombs Brett D, 2008, Diabetes Care, V31, pe55, DOI 10.2337/dc08-0446; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; Verger P, 2009, EUR J PUBLIC HEALTH, V19, P618, DOI 10.1093/eurpub/ckp057; Winkley K, 2012, DIABETOLOGIA, V55, P303, DOI 10.1007/s00125-011-2359-2; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089	52	237	240	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57058	10.1371/journal.pone.0057058	http://dx.doi.org/10.1371/journal.pone.0057058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472075	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900013
J	Seto, SW; Krishna, SM; Yu, HY; Liu, D; Khosla, S; Golledge, J				Seto, Sai Wang; Krishna, Smriti M.; Yu, Hongyou; Liu, David; Khosla, Surabhi; Golledge, Jonathan			Impaired Acetylcholine-Induced Endothelium-Dependent Aortic Relaxation by Caveolin-1 in Angiotensin II-Infused Apolipoprotein-E (ApoE(-/-)) Knockout Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MOLECULE EXPRESSION; DENSITY-LIPOPROTEIN; DEFICIENT MICE; BLOOD-PRESSURE; DYSFUNCTION; RECEPTOR; INCREASES; ATHEROSCLEROSIS; ADHESION	Objective: The angiotensin II (AngII)-infused apolipoprotein E-deficient (ApoE(-/-)) mouse model is widely used to study atherosclerosis and abdominal aortic aneurysm. An increase in blood pressure has been reported in this model however the underlying mechanism has not been fully explored. In this study, we investigated whether vasomotor dysfunction develops in AngII-infused ApoE(-/-) mice and the underlying mechanism involved. Methods: ApoE(-/-) mice were infused with vehicle (distilled water) or AngII subcutaneously for 14 days. Blood pressure and heart rate were measured using the non-invasive tail cuff method. Aortic vascular reactivity and expression of key proteins (endothelial nitric oxide synthase (eNOS), phospho-eNOS and caveolin-1) were assessed using tension myography and Western blotting respectively. Plasma nitric oxide (NO) level was estimated using a colorimetric assay. Results: AngII infusion caused a time-dependent increase in blood pressure (P<0.001). Aortas from AngII-infused mice were significantly less responsive to acetylcholine-induced endothelium-dependent relaxation when compared to aortas from mice infused with vehicle control (P<0.05). Contractile responses to phenylephrine (P<0.01) and potassium chloride (P<0.001) were significantly enhanced in aortas from AngII-infused mice. eNOS phosphorylation was significantly decreased in the aorta of AngII-infused mice (P<0.05). Aortic caveolin-1 protein expression was significantly increased in AngII-infused mice (P<0.05). Plasma nitrate/nitrite level was significantly reduced in AngII-infused mice (P<0.05). Pharmacological disruption of caveolae using methyl-beta-cyclodextrin (M beta CD) in isolated aortas from AngII-infused mice caused a significant leftward shift of the acetylcholine-induced relaxation concentration-response curve when compared to vehicle control (P<0.05). Conclusion: Upregulation of caveolin-1 protein expression and reduced NO bioavailability contributes to aortic endothelial dysfunction in AngII-infused ApoE(-/-) mice.	[Seto, Sai Wang; Krishna, Smriti M.; Yu, Hongyou; Liu, David; Khosla, Surabhi; Golledge, Jonathan] James Cook Univ, Queensland Res Ctr Peripheral Vasc Dis, Sch Med & Dent, Vasc Biol Unit, Townsville, Qld 4811, Australia	James Cook University	Golledge, J (corresponding author), James Cook Univ, Queensland Res Ctr Peripheral Vasc Dis, Sch Med & Dent, Vasc Biol Unit, Townsville, Qld 4811, Australia.	jonathan.golledge@jcu.edu.au	golledge, jonathan/I-2371-2013; KRISHNA, SMRITI/G-7791-2012	KRISHNA, SMRITI/0000-0002-0810-5144; Seto, Sai Wang/0000-0003-0236-4935	James Cook University Research Infrastructure Block Grant (RIBG); School Administered Grant (SAG) Scheme; British United Provident Association (BUPA) Foundation; Australia Government National Health and Medical Research Council (NHMRC); Australia Government National Health; Medical Research Council; National Heart Foundation, Australia; Queensland Government; National Health and Medical Research Council, Australia	James Cook University Research Infrastructure Block Grant (RIBG); School Administered Grant (SAG) Scheme; British United Provident Association (BUPA) Foundation; Australia Government National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australia Government National Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart Foundation, Australia(National Heart Foundation of Australia); Queensland Government; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was partially supported by the James Cook University Research Infrastructure Block Grant (RIBG) and School Administered Grant (SAG) Scheme (2011), by a grant from the British United Provident Association (BUPA) Foundation and by an Australia Government National Health and Medical Research Council (NHMRC) project grant. SW Seto is a recipient of a training fellowship from Australia Government National Health and Medical Research Council and S Khosla was supported by the summer scholarship from the National Heart Foundation, Australia. J Golledge is supported by fellowships from the Queensland Government and National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Barton M, 1998, P NATL ACAD SCI USA, V95, P14367, DOI 10.1073/pnas.95.24.14367; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bodor C, 2012, AM J PHYSIOL-CELL PH, V302, pC267, DOI 10.1152/ajpcell.00138.2011; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Crauwels HM, 2003, CARDIOVASC RES, V59, P189, DOI 10.1016/S0008-6363(03)00353-5; d'Uscio LV, 2001, ARTERIOSCL THROM VAS, V21, P1017, DOI 10.1161/01.ATV.21.6.1017; d'Uscio LV, 2001, STROKE, V32, P2658, DOI 10.1161/hs1101.097393; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Foudi N, 2009, AM J PHYSIOL-HEART C, V297, pH1882, DOI 10.1152/ajpheart.00092.2009; FUJIWARA T, 1993, J CARDIOVASC PHARM, V22, P58, DOI 10.1097/00005344-199307000-00010; Gao L, 2012, HYPERTENSION, V59, P158, DOI 10.1161/HYPERTENSIONAHA.111.181644; Gaspari T, 2011, DIABETES VASC DIS RE, V8, P117, DOI 10.1177/1479164111404257; Golledge J, 2010, CARDIOVASC DRUG THER, V24, P373, DOI 10.1007/s10557-010-6262-8; Golledge J, 2010, ATHEROSCLEROSIS, V210, P51, DOI 10.1016/j.atherosclerosis.2009.10.027; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Krishna SM, 2012, AM J PATHOL, V181, P706, DOI 10.1016/j.ajpath.2012.04.015; Lam TY, 2006, EUR J PHARMACOL, V546, P134, DOI 10.1016/j.ejphar.2006.07.003; Linder AE, 2005, J PHARMACOL EXP THER, V314, P9, DOI 10.1124/jpet.105.083634; MINOR RL, 1990, J CLIN INVEST, V86, P2109, DOI 10.1172/JCI114949; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Ricchiuti V, 2011, J ENDOCRINOL, V211, P47, DOI 10.1530/JOE-10-0458; Sharma A, 2011, EUR J PHARMACOL, V659, P206, DOI 10.1016/j.ejphar.2011.03.028; Testa A, 2012, AM J HYPERTENS, V25, P103, DOI 10.1038/ajh.2011.178; Trollope A, 2011, CARDIOVASC PATHOL, V20, P114, DOI 10.1016/j.carpath.2010.01.001; Vuagnat A, 2001, J MOL MED-JMM, V79, P175, DOI 10.1007/s001090100205; Wan JB, 2009, J AGR FOOD CHEM, V57, P6692, DOI 10.1021/jf900529w; Wang N, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-37; Xu Y, 2007, LIFE SCI, V80, P1678, DOI 10.1016/j.lfs.2007.01.041; Yaghoubi M, 2000, J CARDIOVASC PHARM, V36, P751, DOI 10.1097/00005344-200012000-00010; Yamashiro K, 2010, J CEREBR BLOOD F MET, V30, P1494, DOI 10.1038/jcbfm.2010.34; Yang Z, 2012, J MOL CELL CARDIOL, V52, P1155, DOI 10.1016/j.yjmcc.2012.01.019	36	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58481	10.1371/journal.pone.0058481	http://dx.doi.org/10.1371/journal.pone.0058481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469284	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000315634900093
J	Wang, ZL; Tang, XQ; Xu, W; Cao, Z; Sun, L; Li, WM; Li, QB; Zou, P; Zhao, ZG				Wang, Zhenling; Tang, Xiaoqiong; Xu, Wen; Cao, Zeng; Sun, Li; Li, Weiming; Li, Qiubai; Zou, Ping; Zhao, Zhigang			The Different Immunoregulatory Functions on Dendritic Cells between Mesenchymal Stem Cells Derived from Bone Marrow of Patients with Low-Risk or High-Risk Myelodysplastic Syndromes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; T-CELLS; INHIBIT; RESPONSES; CANCER; PROLIFERATION; MATURATION; LEUKEMIA; IMMUNITY	Myelodysplastic syndrome (MDS) is a group of progressive, clonal, neoplastic bone marrow disorders characterized by hematopoietic stem cell dysregulation and abnormalities in the immune system. Mesenchymal stem cells (MSC) appear to modulate the immune system at the very first step of the immune response through the inhibition of dendritic cells (DCs) differentiation and maturation. However, it is still unclear whether the effects of MSC on the development of DCs will be altered with disease state. In addition, it is not clear whether there are differences in the effects between low-risk and high-risk MDS-MSC on DCs development. In this study, our data confirm that MDS-MSC mediate a potent inhibition of DCs differentiation. Additionaly, MDS-MSC greatly alter DCs functions, including endocytosis, IL-12 secretion, their ability to inhibit T cell proliferation. Moreover, our results show that there are major differences in DCs development and function between low-risk and high-risk MDS-MSC. Compared to high-risk MDS-MSC, low-risk MDS-MSC is characterized by a poor ability to inhibit DCs differentiation and maturation; and correspondingly, less dysfunctional DC endocytosis, mildly decreased IL-12 secretion, and a reduction in DC-mediated inhibition of T cell proliferation. Finally, our results demonstrate that MDS-MSC derived TGF-beta 1 is largely responsible for the inhitory effects. These results elucidate the different immunoregulatory role of MSC in low-risk and high-risk MDS on DCs development, which may be important for understanding the pathogenesis of MDS and the development of novel immune therapies for the treatment of MDS.	[Wang, Zhenling; Xu, Wen; Zhao, Zhigang] Tianjin Med Univ, Oncol Hosp, Dept Hematol & Oncol, Tianjin, Peoples R China; [Tang, Xiaoqiong] Chongqing Med Univ, Dept Hematol, Inst Hematol, Chongqing, Peoples R China; [Cao, Zeng] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China; [Cao, Zeng] Chinese Acad Med Sci, Blood Dis Hosp, State Key Lab Expt Method Hematol, Tianjin, Peoples R China; [Cao, Zeng] Peking Union Med Coll, Tianjin, Peoples R China; [Sun, Li; Li, Weiming; Li, Qiubai; Zou, Ping] Huazhong Univ Sci & Technol, Dept Hematol, Inst Hematol, Tongji Med Coll, Wuhan 430074, Peoples R China	Tianjin Medical University; Chongqing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology	Zhao, ZG (corresponding author), Tianjin Med Univ, Oncol Hosp, Dept Hematol & Oncol, Tianjin, Peoples R China.	zhaodor001@gmail.com	Li, Qiubai/GWQ-9911-2022		National Natural Science Foundation [30801051, 81172833]; Tianjin Application Foundation; Advanced Technology Research Program [08JCYBJC06500, 09JCYBJC11000]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Application Foundation; Advanced Technology Research Program	This work is supported by grants from National Natural Science Foundation (30801051; 81172833) and Tianjin Application Foundation and Advanced Technology Research Program (08JCYBJC06500; 09JCYBJC11000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aggarwal S, 2011, BRIT J HAEMATOL, V153, P568, DOI 10.1111/j.1365-2141.2011.08683.x; Alfinito F, 2010, BRIT J HAEMATOL, V148, P90, DOI 10.1111/j.1365-2141.2009.07921.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Chan AC, 2010, LEUKEMIA, V24, P592, DOI 10.1038/leu.2009.279; Chen Wanjun, 2002, Curr Dir Autoimmun, V5, P62; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Epperson DE, 2001, LEUKEMIA RES, V25, P1075, DOI 10.1016/S0145-2126(01)00083-2; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Guo H, 2003, EXP HEMATOL, V31, P650, DOI 10.1016/S0301-472X(03)00087-0; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Kordasti SY, 2009, BRIT J HAEMATOL, V145, P64, DOI 10.1111/j.1365-2141.2009.07593.x; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Maciejewski JP, 2007, FOLIA HISTOCHEM CYTO, V45, P5; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Tauro S, 2002, LEUKEMIA, V16, P785, DOI 10.1038/sj.leu.2402440; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wlodarski MW, 2005, BLOOD, V106, P2769, DOI 10.1182/blood-2004-10-4045; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhao ZG, 2008, IMMUNOL INVEST, V37, P726, DOI 10.1080/08820130802349940; Zhao ZG, 2012, CANCER LETT, V317, P136, DOI 10.1016/j.canlet.2011.08.030; Zou P, 2008, LEUKEMIA LYMPHOMA, V9, P2187	33	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57470	10.1371/journal.pone.0057470	http://dx.doi.org/10.1371/journal.pone.0057470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469196	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900023
J	Lamb, MM; Simpson, MD; Seifert, J; Scott, FW; Rewers, M; Norris, JM				Lamb, Molly M.; Simpson, Melissa D.; Seifert, Jennifer; Scott, Fraser W.; Rewers, Marian; Norris, Jill M.			The Association between IgG4 Antibodies to Dietary Factors, Islet Autoimmunity and Type 1 Diabetes: The Diabetes Autoimmunity Study in the Young	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; BETA-CELL AUTOIMMUNITY; NEWLY-DIAGNOSED IDDM; COWS MILK; SUBCLASS ANTIBODIES; IMMUNOGLOBULIN-G; FOOD ANTIGENS; GENETIC RISK; T-CELLS; CHILDREN	Background: Infant dietary exposures have been linked to type 1 diabetes (T1D) development. IgG4 antibody responses to food antigens are associated with food intolerances but have not been explored prospectively in the period preceding T1D. Methods: Using a case-cohort design, IgG4 antibodies to beta-lactoglobulin, gluten, and ovalbumin were measured in plasma collected annually from 260 DAISY participants. Of those, 77 developed islet autoimmunity (IA), defined as positive for either insulin, GAD65 or IA-2 autoantibodies on two consecutive visits, and 22 developed T1D. Results: In mixed model analysis adjusting for HLA-DR status, T1D family history, age and ethnicity, higher beta-lactoglobulin IgG4 concentrations were associated with shorter breastfeeding duration (beta = -0.03, 95% Confidence Interval: -0.05, -0.006) and earlier first cow's milk exposure (beta = -0.04, 95% Confidence Interval: -0.08, 0.00). Higher gluten IgG4 was associated with older age at gluten introduction (beta = 0.06, 95% Confidence Interval: 0.00, 0.13). In proportional hazards analysis adjusting for HLA-DR status, T1D family history and ethnicity, IgG4 against individual or multiple dietary antigens throughout childhood were not associated with IA. In addition, mean antigen-specific IgG4 concentrations in infancy (age,2 years) were not associated with risk of IA nor progression to T1D. Higher ovalbumin IgG4 at first IA positive visit was marginally associated with progression to T1D (Hazard Ratio: 1.39, 95% Confidence Interval: 1.00, 1.92). Conclusion: We found no association between the IgG4 response to beta-lactoglobulin, gluten, and the development of either IA or T1D. The association between higher ovalbumin and progression to T1D in children with IA should be explored in other populations.	[Lamb, Molly M.; Simpson, Melissa D.; Seifert, Jennifer; Norris, Jill M.] Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO USA; [Scott, Fraser W.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Rewers, Marian] Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Ottawa; Ottawa Hospital Research Institute	Norris, JM (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO USA.	Jill.Norris@ucdenver.edu		Lamb, Molly/0000-0002-2331-2555	National Institutes of Health [DK49654, DK32493]; Diabetes Endocrine Research Center, Clinical Investigation & Bioinformatics Core [P30 DK 57516]; Children's Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032493, P30DK057516, R37DK032493, R01DK049654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrine Research Center, Clinical Investigation & Bioinformatics Core; Children's Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK49654 and DK32493, Diabetes Endocrine Research Center, Clinical Investigation & Bioinformatics Core P30 DK 57516, and The Children's Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Ahmed T, 1997, DIABETES CARE, V20, P74, DOI 10.2337/diacare.20.1.74; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Badami E, 2011, DIABETES, V60, P2120, DOI 10.2337/db10-1201; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bosi E, 2006, DIABETOLOGIA, V49, P2824, DOI 10.1007/s00125-006-0465-3; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; CATASSI C, 1987, LANCET, V2, P158; Couper JJ, 1999, DIABETES, V48, P2145, DOI 10.2337/diabetes.48.11.2145; DAHLQUIST G, 1992, DIABETOLOGIA, V35, P980, DOI 10.1007/BF00401429; Damci T, 2003, EUR J CLIN INVEST, V33, P397, DOI 10.1046/j.1365-2362.2003.01161.x; Duchen K, 1991, Adv Exp Med Biol, V310, P427; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Hayashibara Hiroshi, 1993, Acta Paediatrica Japonica, V35, P113; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P356, DOI 10.1067/mpd.2000.107582; Holmberg H, 2007, BRIT J NUTR, V97, P111, DOI 10.1017/S0007114507210189; Hummel M, 2002, DIABETES CARE, V25, P1111, DOI 10.2337/diacare.25.7.1111; Hummel M, 2000, DIABETES CARE, V23, P969, DOI 10.2337/diacare.23.7.969; Jenmalm MC, 1998, J ALLERGY CLIN IMMUN, V102, P671, DOI 10.1016/S0091-6749(98)70286-6; Jenmalm MC, 1999, PEDIATR ALLERGY IMMU, V10, P112, DOI 10.1034/j.1399-3038.1999.00015.x; Juvonen P, 1999, PEDIAT ALLERG IMM-UK, V10, P191, DOI 10.1034/j.1399-3038.1999.00030.x; KARJALAINEN J, 1992, NEW ENGL J MED, V327, P302, DOI 10.1056/NEJM199207303270502; Kimpimaki T, 2001, DIABETOLOGIA, V44, P63, DOI 10.1007/s001250051581; Klemetti P, 1998, SCAND J IMMUNOL, V47, P48; Knip M, 2010, AM J CLIN NUTR, V91, p1506S, DOI 10.3945/ajcn.2010.28701C; Kohno T, 2002, DIABETES RES CLIN PR, V55, P1, DOI 10.1016/S0168-8227(01)00250-9; LEE SI, 1986, MONOGR ALLERGY, V19, P108; Liu Z, 2005, ACTA PAEDIATR, V94, P386, DOI 10.1080/08035250410023304; Luopajarvi K, 2008, PEDIATR DIABETES, V9, P434, DOI 10.1111/j.1399-5448.2008.00413.x; Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x; Mojibian M, 2009, DIABETES, V58, P1789, DOI 10.2337/db08-1579; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Norris JM, 1996, JAMA-J AM MED ASSOC, V276, P609, DOI 10.1001/jama.276.8.609; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; SAUKKONEN T, 1994, DIABETES CARE, V17, P970, DOI 10.2337/diacare.17.9.970; SAVILAHTI E, 1993, DIABETES CARE, V16, P984, DOI 10.2337/diacare.16.7.984; Savilahti EM, 2010, EUR J NUTR, V49, P501, DOI 10.1007/s00394-010-0109-8; Secondulfo M, 2004, DIGEST LIVER DIS, V36, P35, DOI 10.1016/j.dld.2003.09.016; Simpson M, 2009, PEDIATR DIABETES, V10, P563, DOI 10.1111/j.1399-5448.2009.00541.x; Stene LC, 2006, PEDIATR DIABETES, V7, P247, DOI 10.1111/j.1399-5448.2006.00198.x; Teshima Christopher W, 2008, Curr Gastroenterol Rep, V10, P443, DOI 10.1007/s11894-008-0083-y; Tomicic S, 2009, PEDIAT ALLERG IMM-UK, V20, P35, DOI 10.1111/j.1399-3038.2008.00738.x; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; Virtanen SM, 2011, DIABETIC MED, V28, P965, DOI 10.1111/j.1464-5491.2011.03294.x; Wahlberg J, 2006, BRIT J NUTR, V95, P603, DOI 10.1079/BJN20051676; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Yu LP, 1996, J CLIN ENDOCR METAB, V81, P4264, DOI 10.1210/jc.81.12.4264; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	51	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57936	10.1371/journal.pone.0057936	http://dx.doi.org/10.1371/journal.pone.0057936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469110	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900205
J	Lin, CH; Wang, LH; Meng, PJ; Chen, CS; Tsai, SJ				Lin, Chiahsin; Wang, Li-Hsueh; Meng, Pei-Jie; Chen, Chii-Shiarng; Tsai, Sujune			Lipid Content and Composition of Oocytes from Five Coral Species: Potential Implications for Future Cryopreservation Efforts	PLOS ONE			English	Article							FATTY-ACIDS; MONTIPORA-DIGITATA; OKINAWAN CORALS	Given the previously documented importance of lipid concentration and composition in the successful cryopreservation of gorgonian corals, these parameters were assessed in oocytes of five species of scleractinian coral; Platygyra daedalea, Echinopora gemmacea, Echinophyllia aspera, Oxypora lacera and Astreopora expansa. Wax esters, phosphatidylethanolamine, phosphatidylcholine, and fatty acids were all measured at detectable levels, and the latter were produced at significantly elevated quantities in E. gemmacea, E. aspera, and O. lacera. On the other hand, phosphatidylethanolamine, phosphatidylcholine, and wax ester were found at significantly higher concentrations in A. expansa oocytes. Triacylglycerol was not present in any species. Interestingly, the total lipid content of oocytes from all five scleractinians was significantly lower than that of oocytes of two gorgonian species, Junceella juncea and Junceella fragilis. As higher total lipid concentrations may be correlated with greater degrees of cellular membrane fluidity at lower temperatures, it stands to reason that gorgonian coral oocytes may be more likely to survive the cryopreservation process than oocytes of scleractinian corals.	[Tsai, Sujune] Mingdao Univ, Dept Biotechnol, Peetow, Chang Hua, Taiwan; [Lin, Chiahsin; Wang, Li-Hsueh; Meng, Pei-Jie; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Lin, Chiahsin; Wang, Li-Hsueh; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Inst Marine Biotechnol, Checheng, Pingtung, Taiwan	Mingdao University; National Museum of Marine Biology & Aquarium; National Dong Hwa University	Tsai, SJ (corresponding author), Mingdao Univ, Dept Biotechnol, Peetow, Chang Hua, Taiwan.	stsai@mdu.edu.tw	Meng, PJ/AAC-3677-2021		Mingdao University; National Museum of Marine Biology Aquarium	Mingdao University; National Museum of Marine Biology Aquarium	Funding provided by Mingdao University and National Museum of Marine Biology & Aquarium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI T, 1993, CORAL REEFS, V12, P71; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; BATTEY JF, 1984, MAR BIOL, V79, P27, DOI 10.1007/BF00404982; Carballeira NM, 2002, COMP BIOCHEM PHYS B, V131, P83, DOI 10.1016/S1096-4959(01)00495-X; Dai C, 2009, SCLERACTINIA FAUNA T; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; HARLAND AD, 1993, MAR BIOL, V117, P113, DOI 10.1007/BF00346432; HEYWARD AJ, 1985, AUST J MAR FRESH RES, V36, P441; Imbs AB, 2006, LIPIDS, V41, P721, DOI 10.1007/s11745-006-5023-8; LAM NC, 1981, BIOL MORYA-VLAD+, P44; Lin C, 2012, THERIOGENOLOGY, V77, P1257, DOI 10.1016/j.theriogenology.2011.09.021; Lin C, 2011, CRYOLETTERS, V32, P141; Lin C, 2012, CRYOBIOLOGY IN PRESS; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038689; MEYERS PA, 1979, MAR BIOL LETT, V1, P69; Oku H, 2002, FISHERIES SCI, V68, P517, DOI 10.1046/j.1444-2906.2002.00456.x; Pekiner BD, 2002, J FAC PHARM, V31, P169; STIMSON JS, 1987, B MAR SCI, V41, P889; Tsai S, 2011, CRYOLETTERS, V32, P1; Tsai S, 2010, THERIOGENOLOGY, V73, P605, DOI 10.1016/j.theriogenology.2009.10.016; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Yamashiro H, 1999, COMP BIOCHEM PHYS B, V122, P397, DOI 10.1016/S0305-0491(99)00014-0	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57823	10.1371/journal.pone.0057823	http://dx.doi.org/10.1371/journal.pone.0057823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469074	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900171
J	Lin, CH; Lu, WY; Zhang, W; Londono-Joshi, AI; Buchsbaum, DJ; Bu, GJ; Li, YH				Lin, Cuihong; Lu, Wenyan; Zhang, Wei; Londono-Joshi, Angelina I.; Buchsbaum, Donald J.; Bu, Guojun; Li, Yonghe			The C-Terminal Region Mesd Peptide Mimics Full-Length Mesd and Acts as an Inhibitor of Wnt/beta-Catenin Signaling in Cancer Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; BETA-CATENIN; MOLECULAR-DYNAMICS; WNT PROTEINS; LRP6; PROSTATE; EXPRESSION; BINDING; LIGAND; GROWTH	While Mesd was discovered as a specialized molecular endoplasmic reticulum chaperone for the Wnt co-receptors LRP5 and LRP6, recombinant Mesd protein is able to bind to mature LRP5 and LRP6 on the cell surface and acts as a universal antagonist of LRP5/6 modulators. In our previous study, we found that the C-terminal region of Mesd, which is absent in sequences from invertebrates, is necessary and sufficient for binding to mature LRP6 on the cell surface. In the present studies, we further characterized the interaction between the C-terminal region Mesd peptide and LRP5/6. We found that Mesd C-terminal region-derived peptides block Mesd binding to LRP5 at the cell surface too. We also showed that there are two LRP5/6 binding sites within Mesd C-terminal region which contain several positively charged residues. Moreover, we demonstrated that the Mesd C-terminal region peptide, like the full-length Mesd protein, blocked Wnt 3A- and Rspodin1-induced Wnt/beta-catenin signaling in LRP5- and LRP6-expressing cells, suppressed Wnt/beta-catenin signaling in human breast HS578T cells and prostate cancer PC-3 cells, and inhibited cancer cell proliferation, although the full-length Mesd protein is more potent than its peptide. Finally, we found that treatment of the full-length Mesd protein and its C-terminal region peptide significantly increased chemotherapy agent Adriamycin-induced cytotoxicity in HS578T and PC-3 cells. Together, our results suggest that Mesd C-terminal region constitutes the major LRP5/6-binding domain, and that Mesd protein and its C-terminal region peptide have a potential therapeutic value in cancer.	[Lin, Cuihong; Lu, Wenyan; Zhang, Wei; Li, Yonghe] So Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA; [Lin, Cuihong] Fujian Med Univ, Affiliated Hosp 1, Dept Pharm, Fuzhou, Peoples R China; [Londono-Joshi, Angelina I.] Univ Alabama Birmingham, Dept Mol & Cellular Pathol, Birmingham, AL USA; [Buchsbaum, Donald J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Fujian Medical University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Mayo Clinic	Li, YH (corresponding author), So Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA.	y.li@southernresearch.org			National Institutes of Health [RO1CA124531]; National Cancer Institute [CA 13148]; NATIONAL CANCER INSTITUTE [R01CA124531, P30CA013148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health RO1CA124531 (to Y.L.) and National Cancer Institute grant CA 13148 (to the UAB Comprehensive Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Case D, 2006, AMBER 9; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Chen JL, 2011, STRUCTURE, V19, P313, DOI 10.1016/j.str.2011.01.010; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Chowdhury S, 2003, BIOPOLYMERS, V68, P63, DOI 10.1002/bip.10216; Culi J, 2004, EMBO J, V23, P1372, DOI 10.1038/sj.emboj.7600132; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Lin CH, 2011, FEBS LETT, V585, P3120, DOI 10.1016/j.febslet.2011.08.046; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Lu WY, 2008, FEBS LETT, V582, P643, DOI 10.1016/j.febslet.2008.01.035; Lu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029290; Lu WY, 2010, BIOCHEMISTRY-US, V49, P4635, DOI 10.1021/bi1001486; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145	49	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58102	10.1371/journal.pone.0058102	http://dx.doi.org/10.1371/journal.pone.0058102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469146	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900237
J	Nkosi, PJ; Targosz, BS; Labib, K; Sanchez-Diaz, A				Nkosi, Pedro Junior; Targosz, Bianca-Sabrina; Labib, Karim; Sanchez-Diaz, Alberto			Hof1 and Rvs167 Have Redundant Roles in Actomyosin Ring Function during Cytokinesis in Budding Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; CONTRACTILE RING; IN-VIVO; ACTIN CYTOSKELETON; FAMILY PROTEIN; F-ACTIN; ENDOCYTOSIS; DOMAIN; BAR	The Hof1 protein (Homologue of Fifteen) regulates formation of the primary septum during cytokinesis in the budding yeast Saccharomyces cerevisiae, whereas the orthologous Cdc15 protein in fission yeast regulates the actomyosin ring by using its F-BAR domain to recruit actin nucleators to the cleavage site. Here we show that budding yeast Hof1 also contributes to actin ring assembly in parallel with the Rvs167 protein. Simultaneous deletion of the HOF1 and RVS167 genes is lethal, and cells fail to assemble the actomyosin ring as they progress through mitosis. Although Hof1 and Rvs167 are not orthologues, they both share an analogous structure, with an F-BAR or BAR domain at the amino terminus, capable of inducing membrane curvature, and SH3 domains at the carboxyl terminus that bind to specific proline-rich targets. The SH3 domain of Rvs167 becomes essential for assembly of the actomyosin ring in cells lacking Hof1, suggesting that it helps to recruit a regulator of the actin cytoskeleton. This new function of Rvs167 appears to be independent of its known role as a regulator of the Arp2/3 actin nucleator, as actin ring assembly is not abolished by the simultaneous inactivation of Hof1 and Arp2/3. Instead we find that recruitment to the bud-neck of the Iqg1 actin regulator is defective in cells lacking Hof1 and Rvs167, though future studies will be needed to determine if this reflects a direct interaction between these factors. The redundant role of Hof1 in actin ring assembly suggests that the mechanism of actin ring assembly has been conserved to a greater extent across evolution than anticipated previously.	[Nkosi, Pedro Junior; Targosz, Bianca-Sabrina; Labib, Karim; Sanchez-Diaz, Alberto] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England	Paterson Institute for Cancer Research; University of Manchester	Labib, K (corresponding author), Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England.	klabib@picr.man.ac.uk; a.sanchezdiaz@unican.es	Sanchez-Diaz, Alberto/L-2320-2014	Sanchez-Diaz, Alberto/0000-0002-3308-4824	Cancer Research United Kingdom; Cantabria International Campus from the Spanish "Ministerio de Economia y Competitividad" [BFU2011-23193]; European Regional Development Fund; Ramon y Cajal contract	Cancer Research United Kingdom(Cancer Research UK); Cantabria International Campus from the Spanish "Ministerio de Economia y Competitividad"; European Regional Development Fund(European Commission); Ramon y Cajal contract(Spanish Government)	The authors are grateful to Cancer Research United Kingdom who funded this work. ASD joined the University of Cantabria as a recipient of a Ramon y Cajal contract (call 2010) and now receives funding from the Cantabria International Campus and via grant BFU2011-23193 from the Spanish "Ministerio de Economia y Competitividad" (co-funded by the European Regional Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carnahan RH, 2003, J CELL BIOL, V162, P851, DOI 10.1083/jcb.200305012; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Colwill K, 1999, GENETICS, V152, P881; Demeter J, 1998, J CELL BIOL, V143, P415, DOI 10.1083/jcb.143.2.415; Devrekanli A, 2012, J CELL SCI; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jendretzki A, 2009, MOL GENET GENOMICS, V282, P437, DOI 10.1007/s00438-009-0476-0; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08; Ko N, 2007, MOL BIOL CELL, V18, P5139, DOI 10.1091/mbc.E07-05-0509; Korinek WS, 2000, CURR BIOL, V10, P947, DOI 10.1016/S0960-9822(00)00626-6; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Meitinger F, 2011, GENE DEV, V25, P875, DOI 10.1101/gad.622411; Michelot A, 2010, CURR BIOL, V20, P1890, DOI 10.1016/j.cub.2010.10.016; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Nishihama R, 2009, J CELL BIOL, V185, P995, DOI 10.1083/jcb.200903125; Norden C, 2004, MOL MICROBIOL, V53, P469, DOI 10.1111/j.1365-2958.2004.04148.x; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Roberts-Galbraith RH, 2010, MOL CELL, V39, P86, DOI 10.1016/j.molcel.2010.06.012; Roberts-Galbraith RH, 2009, J CELL BIOL, V184, P113, DOI 10.1083/jcb.200806044; Roncero C, 2010, YEAST, V27, P521, DOI 10.1002/yea.1779; Sanchez-Diaz A, 2008, NAT CELL BIOL, V10, P395, DOI 10.1038/ncb1701; Sanchez-Diaz Alberto, 2004, Sci STKE, V2004, pPL8, DOI 10.1126/stke.2232004pl8; Soulard A, 2002, MOL CELL BIOL, V22, P7889, DOI 10.1128/MCB.22.22.7889-7906.2002; Takaine M, 2009, EMBO J, V28, P3117, DOI 10.1038/emboj.2009.252; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; Wachtler V, 2006, MOL BIOL CELL, V17, P3254, DOI 10.1091/mbc.E05-11-1086; Wloka C, 2012, CYTOSKELETON, V69, P710, DOI 10.1002/cm.21046; Wolfe BA, 2005, TRENDS CELL BIOL, V15, P10, DOI 10.1016/j.tcb.2004.11.006; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181	45	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57846	10.1371/journal.pone.0057846	http://dx.doi.org/10.1371/journal.pone.0057846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469085	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900181
J	Chowdhury, R; Rasheed, M; Keidel, D; Moussalem, M; Olson, A; Sanner, M; Bajaj, C				Chowdhury, Rezaul; Rasheed, Muhibur; Keidel, Donald; Moussalem, Maysam; Olson, Arthur; Sanner, Michel; Bajaj, Chandrajit			Protein-Protein Docking with F(2)Dock 2.0 and GB-Rerank	PLOS ONE			English	Article							SHAPE COMPLEMENTARITY; MOLECULAR-MECHANICS; FORCE-FIELD; SOLVATION; ELECTROSTATICS; REFINEMENT; POTENTIALS; PRINCIPLES; PREDICTION; ALGORITHM	Motivation: Computational simulation of protein-protein docking can expedite the process of molecular modeling and drug discovery. This paper reports on our new F-2 Dock protocol which improves the state of the art in initial stage rigid body exhaustive docking search, scoring and ranking by introducing improvements in the shape-complementarity and electrostatics affinity functions, a new knowledge-based interface propensity term with FFT formulation, a set of novel knowledge-based filters and finally a solvation energy (GBSA) based reranking technique. Our algorithms are based on highly efficient data structures including the dynamic packing grids and octrees which significantly speed up the computations and also provide guaranteed bounds on approximation error. Results: The improved affinity functions show superior performance compared to their traditional counterparts in finding correct docking poses at higher ranks. We found that the new filters and the GBSA based reranking individually and in combination significantly improve the accuracy of docking predictions with only minor increase in computation time. We compared F-2 Dock 2.0 with ZDock 3.0.2 and found improvements over it, specifically among 176 complexes in ZLab Benchmark 4.0, F-2 Dock 2.0 finds a near-native solution as the top prediction for 22 complexes; where ZDock 3.0.2 does so for 13 complexes. F-2 Dock 2.0 finds a near-native solution within the top 1000 predictions for 106 complexes as opposed to 104 complexes for ZDock 3.0.2. However, there are 17 and 15 complexes where F-2 Dock 2.0 finds a solution but ZDock 3.0.2 does not and vice versa; which indicates that the two docking protocols can also complement each other. Availability: The docking protocol has been implemented as a server with a graphical client (TexMol) which allows the user to manage multiple docking jobs, and visualize the docked poses and interfaces. Both the server and client are available for download. Server: http://www.cs.utexas.edu/similar to bajaj/cvc/software/f2dock.shtml. Client: http://www.cs.utexas.edu/similar to bajaj/cvc/software/f2dockclient.shtml.	[Chowdhury, Rezaul; Rasheed, Muhibur; Moussalem, Maysam] Univ Texas Austin, Dept Comp Sci, Inst Computat Engn & Sci, Austin, TX 78712 USA; [Keidel, Donald; Olson, Arthur; Sanner, Michel; Bajaj, Chandrajit] Scripps Res Inst, La Jolla, CA 92037 USA	University of Texas System; University of Texas Austin; Scripps Research Institute	Bajaj, C (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	bajaj@cs.utexas.edu		Bajaj, Chandrajit/0000-0002-9619-3278	National Science Foundation (NSF) [CNS-0540033]; National Institutes of Health (NIH) [R01-GM074258, R01-GM073087, R01-EB004873]; NSF Graduate Research Fellowship; NIH [R01-GM073087]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074258, R01GM073087] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research of C. B., R. C., M. M., and M. R. of University of Texas, was supported in part by National Science Foundation (NSF) grant CNS-0540033, and grants from the National Institutes of Health (NIH) R01-GM074258, R01-GM073087, R01-EB004873. The research of M. M. was additionally supported by an NSF Graduate Research Fellowship. The research of M. S. and A.O. of TSRI was supported in part by a subcontract on NIH grant R01-GM073087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Bajaj C, 2004, IEEE VISUALIZATION 2004, PROCEEEDINGS, P243, DOI 10.1109/VISUAL.2004.103; Bajaj C, 2011, BIOINFORMATICS, V27, P55, DOI 10.1093/bioinformatics/btq627; Bajaj C, 2011, IEEE ACM T COMPUT BI, V8, P45, DOI 10.1109/TCBB.2009.57; Bajaj C, 2010, SIAM J SCI COMPUT, V31, P4524, DOI 10.1137/090746173; Ben-Zeev E, 2003, PROTEINS, V52, P41, DOI 10.1002/prot.10392; Ben-Zeev E, 2003, PROTEINS, V52, P24, DOI 10.1002/prot.10391; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Castrillon-Candas J, 2005, 0544 ICES U TEX AUST; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Chowdhury RA, 2010, 1032 ICES U TEX AUST; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DUNCAN BS, 1993, BIOPOLYMERS, V33, P219, DOI 10.1002/bip.360330204; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Fruton J. S., 1999, PROTEINS ENZYMES GEN; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; GILSON MK, 1993, J PHYS CHEM-US, V97, P3591, DOI 10.1021/j100116a025; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Gu SY, 2012, PROTEINS, V80, P221, DOI 10.1002/prot.23192; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; HERMANN RB, 1972, J PHYS CHEM-US, V76, P2754, DOI 10.1021/j100663a023; Huang W, 2012, PROTEINS, V80, P691, DOI 10.1002/prot.23223; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; JACKINS CL, 1980, COMPUT VISION GRAPH, V14, P249, DOI 10.1016/0146-664X(80)90055-6; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kovacs JA, 2003, ACTA CRYSTALLOGR D, V59, P1371, DOI 10.1107/S0907444903011247; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; LATTMAN EA, 1972, ACTA CRYSTALL B-STRU, VB 28, P1065, DOI 10.1107/S0567740872003723; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Liu S, 2011, BMC BIOINFORMATICS, V12; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Martin ACR, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P33, DOI 10.1007/978-3-642-01147-4_3; MAX NL, 1988, IEEE COMPUT GRAPH, V8, P42, DOI 10.1109/38.7748; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Mitchell JC, 2008, SIAM J SCI COMPUT, V30, P525, DOI 10.1137/030601879; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Pierce B, 2007, COMPUTATIONAL METHOD, P109; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Ravikant DVS, 2010, PROTEINS, V78, P400, DOI 10.1002/prot.22550; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Ritchie DW, 1998, THESIS U ABERDEEN AB; SHARP K, 1991, J COMPUT CHEM, V12, P454, DOI 10.1002/jcc.540120407; SIMONSON T, 1994, J PHYS CHEM-US, V98, P4683, DOI 10.1021/j100068a033; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103; WANG HJ, 1991, J COMPUT CHEM, V12, P746, DOI 10.1002/jcc.540120612; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190	64	28	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e51307	10.1371/journal.pone.0051307	http://dx.doi.org/10.1371/journal.pone.0051307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483883	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100001
J	Garcin, G; Bordat, Y; Chuchana, P; Monneron, D; Law, HKW; Piehler, J; Uze, G				Garcin, Genevieve; Bordat, Yann; Chuchana, Paul; Monneron, Daniele; Law, Helen K. W.; Piehler, Jacob; Uze, Gilles			Differential Activity of Type I Interferon Subtypes for Dendritic Cell Differentiation	PLOS ONE			English	Article							CD8(+) T-CELLS; PBL-SCID MICE; APOPTOTIC CELLS; IFN-ALPHA; FUNCTIONAL-ACTIVITIES; COMPLEMENT RECEPTOR; EXPRESSION; PHAGOCYTOSIS; ACTIVATION; TOLERANCE	The type I interferon (IFN) family comprises 15 cytokines (in human 13 alpha, 1 beta, 1 omega), which exert several cellular functions through binding to a common receptor. Despite initial activation of the same Jak/Stat signalling pathway, the cellular response may differ depending on type I IFN subtype. We investigated the activity of six type I IFN subtypes -IFN alpha 1, alpha 2, alpha 8, alpha 21, omega and beta- to promote the differentiation of dendritic cells (DC). Transcriptome analyses identified two distinct groups, the IFN alpha/omega-DC and the IFN beta-DC. In addition, the expression level of seven chemokines and several cell surface markers characteristic of DC distinguished IFN alpha-DC and IFN beta-DC. These differences are unlikely to impact the efficacy of T cell functional response since IFN alpha 2-DC and IFN beta-DC were equipotent in inducing the proliferation and the polarization of allogenic naive CD4 T cells into Th1 cells and in stimulating autologous antigen specific CD4 or CD8 T cells. Of the functional parameters analysed, the only one that showed a modest differential was the phagocytic uptake of dead cells which was higher for IFN alpha 2-DC.	[Garcin, Genevieve; Bordat, Yann; Monneron, Daniele; Uze, Gilles] Univ Montpellier 2, Ctr Natl Rech Sci, Unite Mixte Rech 5235, Montpellier, France; [Chuchana, Paul] Inst Natl Sante & Rech Med 844, Inst Neurosci Montpellier, Montpellier, France; [Law, Helen K. W.] Inst Pasteur, Ctr Human Immunol, Paris, France; [Piehler, Jacob] Univ Osnabruck, Div Biophys, Osnabruck, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University Osnabruck	Uze, G (corresponding author), Univ Montpellier 2, Ctr Natl Rech Sci, Unite Mixte Rech 5235, Montpellier, France.	uze@univ-montp2.fr	Uzé, Gilles/O-6383-2019; LAW, Helen Ka-Wai/C-7345-2013	Garcin, Genevieve/0000-0001-9669-7057; LAW, Helen Ka-Wai/0000-0002-5579-9054; BORDAT, Yann/0000-0001-8616-6498; Uze, Gilles/0000-0002-4150-5772	European Community [223608]; Centre of Human Immunology	European Community(European Commission); Centre of Human Immunology	Funding was from the European Community's Seventh Framework Programme under grant agreement no 223608 (GU and JP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sandra Pellegrini, Mark Livingstone and Frederique Michel for critical reading of the manuscript, Maria Ferrantini, Stefano Santini, Caterina Lapenta, Sylvie van der Werf and Guillaume Cartron for helpful discussions, Christophe Duperray for his assistance in FACS sorting, Matthew Albert and the Centre of Human Immunology for support, Hella Kenneweg for protein production, Veronique Pantesco and the microarray core facility of IRB, Montpellier.	Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chuchana P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm093; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farkas A, 2011, BRIT J DERMATOL, V165, P247, DOI 10.1111/j.1365-2133.2011.10301.x; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Gorgani NN, 2008, J IMMUNOL, V181, P7902, DOI 10.4049/jimmunol.181.11.7902; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Lapenta C, 2003, J EXP MED, V198, P361, DOI 10.1084/jem.20021924; Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lorenzi S, 2011, J IMMUNOL, V186, P5142, DOI 10.4049/jimmunol.1004163; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Paquette RL, 1998, J LEUKOCYTE BIOL, V64, P358, DOI 10.1002/jlb.64.3.358; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Santini SM, 2005, METH MOLEC MED, V116, P167; Santini SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017364; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; UZE G, 1994, J MOL BIOL, V243, P245, DOI 10.1006/jmbi.1994.1651; Vermi W, 2011, J INVEST DERMATOL, V131, P426, DOI 10.1038/jid.2010.256; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600	46	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58465	10.1371/journal.pone.0058465	http://dx.doi.org/10.1371/journal.pone.0058465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472200	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900146
J	Kato, H; Lu, QP; Rapaport, D; Kozjak-Pavlovic, V				Kato, Hiroki; Lu, Qiping; Rapaport, Doron; Kozjak-Pavlovic, Vera			Tom70 Is Essential for PINK1 Import into Mitochondria	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; PARKINSONS-DISEASE; INTRACELLULAR MEMBRANES; QUALITY-CONTROL; PATHWAY; RECRUITMENT; BIOGENESIS; MECHANISMS; COMPLEX; BINDING	PTEN induced kinase 1 (PINK1) is a serine/threonine kinase in the outer membrane of mitochondria (OMM), and known as a responsible gene of Parkinson's disease (PD). The precursor of PINK1 is synthesized in the cytosol and then imported into the mitochondria via the translocase of the OMM (TOM) complex. However, a large part of PINK1 import mechanism remains unclear. In this study, we examined using cell-free system the mechanism by which PINK1 is targeted to and assembled into mitochondria. Surprisingly, the main component of the import channel, Tom40 was not necessary for PINK1 import. Furthermore, we revealed that the import receptor Tom70 is essential for PINK1 import. In addition, we observed that although PINK1 has predicted mitochondrial targeting signal, it was not processed by the mitochondrial processing peptidase. Thus, our results suggest that PINK1 is imported into mitochondria by a unique pathway that is independent of the TOM core complex but crucially depends on the import receptor Tom70.	[Kato, Hiroki; Lu, Qiping; Rapaport, Doron] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Kozjak-Pavlovic, Vera] Univ Wurzburg, Dept Microbiol, Bioctr, D-97070 Wurzburg, Germany	Eberhard Karls University of Tubingen; University of Wurzburg	Kato, H (corresponding author), Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan.	hmg1@tokyo-med.ac.jp	Kato, Hiroki/L-2346-2013; Kato, Hiroki/N-3495-2019; Kozjak-Pavlovic, Vera/E-1494-2013; Lu, Qiping/GLV-2085-2022	Kato, Hiroki/0000-0002-3292-2160; Kato, Hiroki/0000-0002-6529-659X; Kozjak-Pavlovic, Vera/0000-0001-9658-7018; lu, qi ping/0000-0002-5011-3762	Faculty of Medicine, University of Tubingen [Fortuene 1959-0-0]; Deutsche Forschungsgemeinschaft [KO3882/1-1]; UEHARA MEMORIAL FOUNDATION; German Academic Exchange Service	Faculty of Medicine, University of Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UEHARA MEMORIAL FOUNDATION(Uehara Memorial Foundation); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Faculty of Medicine, University of Tubingen (Fortuene 1959-0-0 to H. K.) and the Deutsche Forschungsgemeinschaft (KO3882/1-1 to V. K.-P.). This work was also supported by a postdoctoral fellowship from the UEHARA MEMORIAL FOUNDATION to H. K. and a fellowship from the German Academic Exchange Service to Q. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker D., 2012, J BIOL CHEM; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P228, DOI 10.1177/0891988710383572; Burbulla LF, 2011, J NEUROL SCI, V306, P1, DOI 10.1016/j.jns.2011.04.005; CONBOY JG, 1982, BIOCHEM BIOPH RES CO, V105, P1, DOI 10.1016/S0006-291X(82)80002-8; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; IWAHASHI J, 1994, J BIOCHEM-TOKYO, V116, P156, DOI 10.1093/oxfordjournals.jbchem.a124488; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kato H, 2008, BIOCHEM BIOPH RES CO, V369, P958, DOI 10.1016/j.bbrc.2008.02.150; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Luciano P, 1997, J MOL BIOL, V272, P213, DOI 10.1006/jmbi.1997.1231; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; OHBA M, 1987, EMBO J, V6, P2117, DOI 10.1002/j.1460-2075.1987.tb02478.x; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Papic D, 2011, J CELL BIOL, V194, P397, DOI 10.1083/jcb.201102041; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Yamamoto H, 2009, J BIOL CHEM, V284, P31635, DOI 10.1074/jbc.M109.041756; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	33	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58435	10.1371/journal.pone.0058435	http://dx.doi.org/10.1371/journal.pone.0058435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472196	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900142
J	Lai, WH; Ho, JCY; Chan, YC; Ng, JHL; Au, KW; Wong, LY; Siu, CW; Tse, HF				Lai, Wing-Hon; Ho, Jenny C. Y.; Chan, Yau-Chi; Ng, Joyce H. L.; Au, Ka-Wing; Wong, Lai-Yung; Siu, Chung-Wah; Tse, Hung-Fat			Attenuation of Hind-Limb Ischemia in Mice with Endothelial-Like Cells Derived from Different Sources of Human Stem Cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BONE-MARROW-CELLS; PROGENITOR CELLS; MOUSE MODEL; NEOVASCULARIZATION; GENERATION; TRANSPLANTATION; ANGIOGENESIS; IMPLANTATION; EFFICACY	Functional endothelial-like cells (EC) have been successfully derived from different cell sources and potentially used for treatment of cardiovascular diseases; however, their relative therapeutic efficacy remains unclear. We differentiated functional EC from human bone marrow mononuclear cells (BM-EC), human embryonic stem cells (hESC-EC) and human induced pluripotent stem cells (hiPSC-EC), and compared their in-vitro tube formation, migration and cytokine expression profiles, and in-vivo capacity to attenuate hind-limb ischemia in mice. Successful differentiation of BM-EC was only achieved in 1/6 patient with severe coronary artery disease. Nevertheless, BM-EC, hESC-EC and hiPSC-EC exhibited typical cobblestone morphology, had the ability of uptaking DiI-labeled acetylated low-density-lipoprotein, and binding of Ulex europaeus lectin. In-vitro functional assay demonstrated that hiPSC-EC and hESC-EC had similar capacity for tube formation and migration as human umbilical cord endothelial cells (HUVEC) and BM-EC (P>0.05). While increased expression of major angiogenic factors including epidermal growth factor, hepatocyte growth factor, vascular endothelial growth factor, placental growth factor and stromal derived factor-1 were observed in all EC cultures during hypoxia compared with normoxia (P<0.05), the magnitudes of cytokine up-regulation upon hypoxic were more dramatic in hiPSC-EC and hESC-EC (P<0.05). Compared with medium, transplanting BM-EC (n = 6), HUVEC (n = 6), hESC-EC (n = 8) or hiPSC-EC (n = 8) significantly attenuated severe hind-limb ischemia in mice via enhancement of neovascularization. In conclusion, functional EC can be generated from hECS and hiPSC with similar therapeutic efficacy for attenuation of severe hind-limb ischemia. Differentiation of functional BM-EC was more difficult to achieve in patients with cardiovascular diseases, and hESC-EC or iPSC-EC are readily available as "off-the-shelf'' format for the treatment of tissue ischemia.	[Lai, Wing-Hon; Ho, Jenny C. Y.; Chan, Yau-Chi; Ng, Joyce H. L.; Au, Ka-Wing; Wong, Lai-Yung; Siu, Chung-Wah; Tse, Hung-Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Ho, Jenny C. Y.; Siu, Chung-Wah; Tse, Hung-Fat] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Tse, HF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	hftse@hkucc.hku.hk	Chan, Yau Chi/C-4547-2009; Tse, Hung-Fat/C-4426-2009; Siu, Chung Wah/C-6947-2011	Tse, Hung-Fat/0000-0002-9578-7808; Tse, Hung Fat/0000-0003-4665-7887	Collaborative Research Fund of Hong Kong Research Grant Council [HKU 8/CRF/09]; Theme-Based Research Scheme of Hong Kong University Grants Committee [T12-705/11]; University of Hong Kong [201007176290]; Philip Wong Foundation Fund for Cardiac Stem Cell Research	Collaborative Research Fund of Hong Kong Research Grant Council; Theme-Based Research Scheme of Hong Kong University Grants Committee; University of Hong Kong(University of Hong Kong); Philip Wong Foundation Fund for Cardiac Stem Cell Research	This work was supported by the Collaborative Research Fund of Hong Kong Research Grant Council (HKU 8/CRF/09, http://ugc.edu.hk/eng/rgc/crf/crf.htm); Theme-Based Research Scheme of Hong Kong University Grants Committee (T12-705/11, http://www.ugc.edu.hk/eng/rgc/theme/theme.htm); CRCG Small Project Funding of University of Hong Kong (Project No. 201007176290, JCH, http://www.rss.hku.hk/fund/small-project-funding); and Mr. Philip Wong Foundation Fund for Cardiac Stem Cell Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhang SH, 2012, TISSUE ENG PT A, V18, P310, DOI [10.1089/ten.tea.2011.0193, 10.1089/ten.TEA.2011.0193]; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; Fortini C, 2011, J CELL MOL MED, V15, P1726, DOI 10.1111/j.1582-4934.2010.01195.x; Kang S, 2008, CORONARY ARTERY DIS, V19, P327, DOI 10.1097/MCA.0b013e328300dbd3; Kim MH, 2011, INT J CARDIOL; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Lai WH, 2010, CELL REPROGRAM, V12, P641, DOI 10.1089/cell.2010.0051; Li MF, 2011, DIABETES-METAB RES, V27, P185, DOI 10.1002/dmrr.1159; Li ZJ, 2011, STEM CELLS DEV, V20, P1701, DOI 10.1089/scd.2010.0426; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Novak A, 2010, CELL REPROGRAM, V12, P665, DOI 10.1089/cell.2010.0027; Schultz A, 1999, CIRCULATION, V100, P547, DOI 10.1161/01.CIR.100.5.547; Seifinejad A, 2010, STEM CELL REV REP, V6, P297, DOI 10.1007/s12015-010-9121-x; Siu CW, 2012, LANCET, V379, P870, DOI 10.1016/S0140-6736(12)60236-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Tse HF, 2007, EUR HEART J, V28, P2998, DOI 10.1093/eurheartj/ehm485; Tse HF, 2007, EUR J HEART FAIL, V9, P747, DOI 10.1016/j.ejheart.2007.03.008; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	26	47	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57876	10.1371/journal.pone.0057876	http://dx.doi.org/10.1371/journal.pone.0057876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472116	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900056
J	Mohammed, MA; Stevens, AJ				Mohammed, Mohammed A.; Stevens, Andrew J.			A Simple Insightful Approach to Investigating a Hospital Standardised Mortality Ratio: An Illustrative Case-Study	PLOS ONE			English	Article							CONTROL CHARTS; CASE-MIX; RATES; PERFORMANCE; CARE; SHIPMAN	Background: Despite methodological concerns Hospital Standardised Mortality Ratios (HSMRs) are promoted as measures of performance. Hospitals that experience an increase in their HSMR are presented with a serious challenge but with little guidance on how to investigate this complex phenomenon. We illustrate a simple penetrating approach. Methods: Retrospective analysis of routinely collected hospital admissions data comparing observed and expected deaths predicted by the Dr Foster Unit case mix adjustment method over three years (n = 74,860 admissions) in Shropshire and Telford NHS Trust Hospital (SaTH) constituting PRH (Princess Royal Hospital) and RSH (Royal Shrewsbury Hospital); whose HSMR increased from 99 in the year 2008/09 to 118 in the year 2009/10. Results: The step up in HSMR was primarily located in PRH (109 to 130 vs. 105 to 118 RSH). Disentangling the HSMR by plotting run charts of observed and expected deaths showed that observed deaths were stable in RSH and PRH but expected deaths, especially at PRH, had fallen. The fall in expected deaths has two possible explanations-genuinely lower risk admissions or that the case-mix adjustment model is underestimating the risk of admissions perhaps because of inadequate clinical coding. There was no evidence that the case-mix profile of admissions had changed but there was considerable evidence that clinical coding process at PRH was producing a lower depth of coding resulting in lower expected mortality. Conclusion: Knowing whether the change (increase/decrease) in HSMR is driven by the numerator or the denominator is a crucial pivotal first step in understanding a given HSMR and so such information should be an integral part of the HSMR reporting methodology.	[Mohammed, Mohammed A.; Stevens, Andrew J.] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham	Mohammed, MA (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	m.a.mohammed@bham.ac.uk						[Anonymous], 2011, FOST GOOD HOSP GUID; [Anonymous], TRUST RANKS BEST UK; Aylin P, 2004, BRIT MED J, V329, P825, DOI 10.1136/bmj.329.7470.825; Aylin P, 2003, LANCET, V362, P485, DOI 10.1016/S0140-6736(03)14077-9; Barker A, 2009, QUAL SAF HEALTH CARE, V18, P473, DOI 10.1136/qshc.2007.025601; Billett J, 2005, J PUBLIC HEALTH, V27, P270, DOI 10.1093/pubmed/fdi043; Black N, 2010, BMJ-BRIT MED J, V340, P933; Bottle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7116; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleveland WS., 1993, VISUALIZING DATA; Dr Foster Intelligence, HOSP GUID; Duckett SJ, 2007, MED J AUSTRALIA, V187, P571, DOI 10.5694/j.1326-5377.2007.tb01419.x; Hawkes N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2153; Heijink R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-73; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Keogh B, 2005, BRIT MED J, V330, P319, DOI 10.1136/bmj.330.7487.319; KOSTER M, 2008, LAKAR TIDNINGEN, V19, P1391; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford R, 2010, BMJ-BRIT MED J, V340, P955; Marshall T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-63; Miyata H, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-229; Mohammed MA, 2004, BMJ-BRIT MED J, V328, P1474, DOI 10.1136/bmj.328.7454.1474; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Parry G, 2006, QUAL SAF HEALTH CARE, V15, P144; Pitches DW, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-91; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396; The Canadian Institute for Health Information, 2007, HSMR NEW APPR MEAS H	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57845	10.1371/journal.pone.0057845	http://dx.doi.org/10.1371/journal.pone.0057845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472111	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900050
J	Onami, H; Nagai, N; Kaji, H; Nishizawa, M; Sato, Y; Osumi, N; Nakazawa, T; Abe, T				Onami, Hideyuki; Nagai, Nobuhiro; Kaji, Hirokazu; Nishizawa, Matsuhiko; Sato, Yasufumi; Osumi, Noriko; Nakazawa, Toru; Abe, Toshiaki			Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; GANCICLOVIR; RELEASE; PHARMACOKINETICS; PERMEABILITY; INFLIXIMAB; INDUCTION; IMPLANT	We established a sustained vasohibin-1 (a 42-kDa protein), delivery device by a novel method using photopolymerization of a mixture of polyethylene glycol dimethacrylate, triethylene glycol dimethacrylate, and collagen microparticles. We evaluated its effects in a model of rat laser-induced choroidal neovascularization (CNV) using a transscleral approach. We used variable concentrations of vasohibin-1 in the devices, and used an enzyme-linked immunosorbent assay and Western blotting to measure the released vasohibin-1 (0.31 nM/day when using the 10 mu M vasohibin-1 delivery device [ 10VDD]). The released vasohibin-1 showed suppression activity comparable to native effects when evaluated using endothelial tube formation. We also used pelletized vasohibin-1 and fluorescein isothiocyanate-labeled 40 kDa dextran as controls. Strong fluorescein staining was observed on the sclera when the device was used for drug delivery, whereas pellet use produced strong staining in the conjunctiva and surrounding tissue, but not on the sclera. Vasohibin-1 was found in the sclera, choroid, retinal pigment epithelium (RPE), and neural retina after device implantation. Stronger immunoreactivity at the RPE and ganglion cell layers was observed than in other retinal regions. Significantly lower fluorescein angiography (FA) scores and smaller CNV areas in the flat mounts of RPE-choroid-sclera were observed for the 10VDD, VDD (1 mu M vasohibin-1 delivery device), and vasohibin-1 intravitreal direct injection (0.24 mu M) groups when compared to the pellet, non-vasohibin-1 delivery device, and intravitreal vehicle injection groups. Choroidal neovascularization can be treated with transscleral sustained protein delivery using our novel device. We offer a safer sustained protein release for treatment of retinal disease using the transscleral approach.	[Onami, Hideyuki; Nagai, Nobuhiro; Abe, Toshiaki] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med ART, Div Clin Cell Therapy, Sendai, Miyagi 980, Japan; [Onami, Hideyuki; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Kaji, Hirokazu; Nishizawa, Matsuhiko] Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan; [Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi 980, Japan; [Osumi, Noriko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med ART, Div Dev Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Abe, T (corresponding author), Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med ART, Div Clin Cell Therapy, Sendai, Miyagi 980, Japan.	toshi@oph.med.tohoku.ac.jp	Osumi, Noriko/T-2823-2019; Sato, Yasufumi/AAF-3367-2019; Kaji, Hirokazu/T-2219-2019	Osumi, Noriko/0000-0003-0548-6452; Kaji, Hirokazu/0000-0003-2566-4172	Ministry of Education, Culture, Sports, Science, and Technology [21592214, 23680054]; Ministry of Health Labour and Welfare [H23-iryokiki-wakate-003, H23-kankaku-ippan-004, H24-nanchitoh-ippan-067]; Suzuken Memorial Foundation; Ichiro Kanehara Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Suzuken Memorial Foundation; Ichiro Kanehara Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (No. 21592214) and Young Scientists (A) (No. 23680054) from the Ministry of Education, Culture, Sports, Science, and Technology, Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare (No. H23-iryokiki-wakate-003, H23-kankaku-ippan-004, H24-nanchitoh-ippan-067), the Suzuken Memorial Foundation, and the Ichiro Kanehara Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral J, 2005, INVEST OPHTH VIS SCI, V46, P4383, DOI 10.1167/iovs.05-0492; [Anonymous], 1986, Arch Ophthalmol, V104, P694; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Cashman SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019078; Chan JW, 2003, SURV OPHTHALMOL, V48, P12, DOI 10.1016/S0039-6257(02)00416-2; Charles NC, 2002, AM J OPHTHALMOL, V133, P273, DOI 10.1016/S0002-9394(01)01307-1; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; de Carvalho RAP, 2006, INVEST OPHTH VIS SCI, V47, P4532, DOI 10.1167/iovs.06-0030; Eckardt C, 1999, GRAEF ARCH CLIN EXP, V237, P313, DOI 10.1007/s004170050239; Edelman JL, 2000, EXP EYE RES, V71, P523, DOI 10.1006/exer.2000.0907; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Hayreh SS, 2010, AM J OPHTHALMOL, V150, P940, DOI 10.1016/j.ajo.2010.08.011; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Ishikawa Y, 2012, ADV EXP MED BIOL, V723, P305, DOI 10.1007/978-1-4614-0631-0_40; Kawashima T, 2011, BIOMATERIALS, V32, P1950, DOI 10.1016/j.biomaterials.2010.11.006; Kim H, 2010, J CONTROL RELEASE, V142, P286, DOI 10.1016/j.jconrel.2009.10.031; Kim SH, 2008, PHARM RES-DORDR, V25, P512, DOI 10.1007/s11095-007-9408-z; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kondo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019911; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kunou N, 2000, J CONTROL RELEASE, V68, P263, DOI 10.1016/S0168-3659(00)00267-4; Lassota N, 2008, ACTA OPHTHALMOL, V86, P495, DOI [10.1111/j.1600-0420.2007.01127.x, 10.1111/j.1755-3768.2008.01412.x]; Lee SJ, 2010, INVEST OPHTH VIS SCI, V51, P5205, DOI 10.1167/iovs.10-5337; Lutty G, 1999, MOL VIS, V5; MARTIN DF, 1994, ARCH OPHTHALMOL-CHIC, V112, P1531, DOI 10.1001/archopht.1994.01090240037023; McHugh AJ, 2005, J CONTROL RELEASE, V109, P211, DOI 10.1016/j.jconrel.2005.09.038; MILLER JW, 1994, AM J PATHOL, V145, P574; Ohno S, 2004, J RHEUMATOL, V31, P1362; Olsen TW, 2011, INVEST OPHTH VIS SCI, V52, P4749, DOI 10.1167/iovs.10-6291; Onami H, 2012, RETINA-J RET VIT DIS, V32, P1204, DOI 10.1097/IAE.0b013e318233ad0b; Pilu S, 2008, AM J OPHTHALMOL, V145, P879, DOI 10.1016/j.ajo.2007.12.036; Raghava Swita, 2004, Expert Opin Drug Deliv, V1, P99, DOI 10.1517/17425247.1.1.99; Ranta VP, 2010, J CONTROL RELEASE, V148, P42, DOI 10.1016/j.jconrel.2010.08.028; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Reichel E, 1999, OPHTHALMOLOGY, V106, P1908, DOI 10.1016/S0161-6420(99)90400-1; Robinson MR, 2006, EXP EYE RES, V82, P479, DOI 10.1016/j.exer.2005.08.007; Sfikakis PP, 2001, LANCET, V358, P295, DOI 10.1016/S0140-6736(01)05497-6; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Smiddy WE, 2005, RETINA-J RET VIT DIS, V25, P751, DOI 10.1097/00006982-200509000-00011; Srivastava S, 2004, OPHTHAL SURG LAS IM, V35, P254, DOI 10.3928/1542-8877-20040501-16; Stefansson E, 2011, PROG RETIN EYE RES, V30, P72, DOI 10.1016/j.preteyeres.2010.09.003; THIRKILL CE, 1989, NEW ENGL J MED, V321, P1589, DOI 10.1056/NEJM198912073212307; THOMAS MA, 1992, OPHTHALMOLOGY, V99, P952; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Wakusawa R, 2011, INVEST OPHTH VIS SCI, V52, P3272, DOI 10.1167/iovs.10-6295; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003; Yu HG, 2008, INVEST OPHTH VIS SCI, V49, P2599, DOI 10.1167/iovs.07-1508	50	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58580	10.1371/journal.pone.0058580	http://dx.doi.org/10.1371/journal.pone.0058580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472209	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900155
J	Wilkins, MJ; Wrighton, KC; Nicora, CD; Williams, KH; McCue, LA; Handley, KM; Miller, CS; Giloteaux, L; Montgomery, AP; Lovley, DR; Banfield, JF; Long, PE; Lipton, MS				Wilkins, Michael J.; Wrighton, Kelly C.; Nicora, Carrie D.; Williams, Kenneth H.; McCue, Lee Ann; Handley, Kim M.; Miller, Chris S.; Giloteaux, Ludovic; Montgomery, Alison P.; Lovley, Derek R.; Banfield, Jillian F.; Long, Philip E.; Lipton, Mary S.			Fluctuations in Species-Level Protein Expression Occur during Element and Nutrient Cycling in the Subsurface	PLOS ONE			English	Article							IN-SITU; GEOBACTER-SULFURREDUCENS; URANIUM; BIOREMEDIATION; REDUCTION; GROWTH; METALLIREDUCENS; AVAILABILITY; PHYSIOLOGY; COMMUNITY	While microbial activities in environmental systems play a key role in the utilization and cycling of essential elements and compounds, microbial activity and growth frequently fluctuates in response to environmental stimuli and perturbations. To investigate these fluctuations within a saturated aquifer system, we monitored a carbon-stimulated in situ Geobacter population while iron reduction was occurring, using 16S rRNA abundances and high-resolution tandem mass spectrometry proteome measurements. Following carbon amendment, 16S rRNA analysis of temporally separated samples revealed the rapid enrichment of Geobacter-like environmental strains with strong similarity to G. bemidjiensis. Tandem mass spectrometry proteomics measurements suggest high carbon flux through Geobacter respiratory pathways, and the synthesis of anapleurotic four carbon compounds from acetyl-CoA via pyruvate ferredoxin oxidoreductase activity. Across a 40-day period where Fe(III) reduction was occurring, fluctuations in protein expression reflected changes in anabolic versus catabolic reactions, with increased levels of biosynthesis occurring soon after acetate arrival in the aquifer. In addition, localized shifts in nutrient limitation were inferred based on expression of nitrogenase enzymes and phosphate uptake proteins. These temporal data offer the first example of differing microbial protein expression associated with changing geochemical conditions in a subsurface environment.	[Wilkins, Michael J.; Nicora, Carrie D.; McCue, Lee Ann; Lipton, Mary S.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Wrighton, Kelly C.; Handley, Kim M.; Miller, Chris S.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Williams, Kenneth H.; Montgomery, Alison P.; Long, Philip E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Giloteaux, Ludovic; Lovley, Derek R.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Amherst	Wilkins, MJ (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	michael.wilkins@pnnl.gov	Giloteaux, Ludovic/L-6986-2015; Wrighton, Kelly C/ABD-6621-2021; Wilkins, Michael/A-9358-2013; Williams, Kenneth Hurst/O-5181-2014; Long, Philip E/F-5728-2013; Lipton, Mary S/H-3913-2012	Wrighton, Kelly C/0000-0003-0434-4217; Williams, Kenneth Hurst/0000-0002-3568-1155; Long, Philip E/0000-0003-4152-5682; Banfield, Jill/0000-0001-8203-8771; McCue, Lee Ann/0000-0003-4456-517X; Wilkins, Michael/0000-0002-3595-0853; Handley, Kim/0000-0003-0531-3009; Miller, Christopher/0000-0002-9448-8144	United States Department of Energy, Office of Science, Environmental Remediation Science Program through the Integrated Field Research Challenge Site at Rifle, Colorado [DE-AC05-76RL01830]; Integrated Field Research Challenge Site (IFRC) at Rifle, Colorado	United States Department of Energy, Office of Science, Environmental Remediation Science Program through the Integrated Field Research Challenge Site at Rifle, Colorado(United States Department of Energy (DOE)); Integrated Field Research Challenge Site (IFRC) at Rifle, Colorado	This research was funded by the United States Department of Energy, Office of Science, Environmental Remediation Science Program through the Integrated Field Research Challenge Site at Rifle, Colorado, under contract number DE-AC05-76RL01830 to Pacific Northwest National Laboratory. (http://science.energy.gov/ber/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the city of Rifle, CO, the Colorado Department of Public Health and Environment, and the U. S. Environmental Protection Agency, Region 8, for their cooperation in this study. Portions of this work were performed at the Environmental Molecular Sciences Laboratory, a DOE national scientific user facility located at the Pacific Northwest National Laboratory. This material is based upon work supported through the Integrated Field Research Challenge Site (IFRC) at Rifle, Colorado.	Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Barlett M, 2011, BIOGEOSCIENCES DISCU, V8, P11337; Bazylinski DA, 2000, ENVIRON MICROBIOL, V2, P266, DOI 10.1046/j.1462-2920.2000.00096.x; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Campbell KM, 2012, APPL GEOCHEM, V27, P1499, DOI 10.1016/j.apgeochem.2012.04.013; Coppi MV, 2005, MICROBIOL-SGM, V151, P1239, DOI 10.1099/mic.0.27535-0; Denef VJ, 2007, J PROTEOME RES, V6, P3152, DOI 10.1021/pr0701005; Ding YHR, 2008, BBA-PROTEINS PROTEOM, V1784, P1935, DOI 10.1016/j.bbapap.2008.06.011; Druhan JL, 2012, ENVIRON SCI TECHNOL, V46, P8895, DOI 10.1021/es302016p; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elifantz H, 2010, FEMS MICROBIOL ECOL, V73, P441, DOI 10.1111/j.1574-6941.2010.00907.x; Finneran KT, 2002, SOIL SEDIMENT CONTAM, V11, P339, DOI 10.1080/20025891106781; Holmes DE, 2007, ISME J, V1, P663, DOI 10.1038/ismej.2007.85; Holmes DE, 2009, ISME J, V3, P216, DOI 10.1038/ismej.2008.89; Holmes DE, 2013, APPL ENV MI IN PRESS; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Konopka A, ENCY MICROBIOLOGY, P91; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lin B, 2009, ENVIRON MICROBIOL, V11, P2425, DOI 10.1111/j.1462-2920.2009.01971.x; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; Mahadevan R, 2011, NAT REV MICROBIOL, V9, P39, DOI 10.1038/nrmicro2456; Mailloux BJ, 2003, APPL ENVIRON MICROB, V69, P3798, DOI 10.1128/AEM.69.7.3798-3808.2003; Miller CS, 2013, PLOS ONE IN PRESS; Mouser PJ, 2009, ENVIRON SCI TECHNOL, V43, P4386, DOI 10.1021/es8031055; N'Guessan AL, 2010, ISME J, V4, P253, DOI 10.1038/ismej.2009.115; Ortiz-Bernad I, 2004, APPL ENVIRON MICROB, V70, P3091, DOI 10.1128/AEM.70.5.3091-3095.2004; Pearce CI, 2009, ENVIRON TECHNOL, V30, P1313, DOI 10.1080/09593330902984751; Segura D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040036; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P3859, DOI 10.1128/AEM.02986-06; Tremblay PL, 2012, J BACTERIOL, V194, P2248, DOI 10.1128/JB.00044-12; Vrionis HA, 2005, APPL ENVIRON MICROB, V71, P6308, DOI 10.1128/AEM.71.10.6308-6318.2005; Wilkins MJ, 2011, MICROB BIOTECHNOL, V4, P55, DOI 10.1111/j.1751-7915.2010.00194.x; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	38	15	18	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57819	10.1371/journal.pone.0057819	http://dx.doi.org/10.1371/journal.pone.0057819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472107	Green Published, gold			2022-12-27	WOS:000315637900046
J	Patil, SD; Sharma, R; Srivastava, S; Navani, NK; Pathania, R				Patil, Supriya Deepak; Sharma, Rajnikant; Srivastava, Santosh; Navani, Naveen Kumar; Pathania, Ranjana			Downregulation of yidC in Escherichia coli by Antisense RNA Expression Results in Sensitization to Antibacterial Essential Oils Eugenol and Carvacrol	PLOS ONE			English	Article							INHIBITOR; GENES; DISCOVERY; SYNERGY; TARGETS; FABF	Background: The rising drug resistance in pathogenic bacteria and inefficiency of current antibiotics to meet clinical requirements has augmented the need to establish new and innovative approaches for antibacterial drug discovery involving identification of novel antibacterial targets and inhibitors. Being obligatory for bacterial growth, essential gene products are considered vital as drug targets. The bacterial protein YidC is highly conserved among pathogens and is essential for membrane protein insertion due to which it holds immense potential as a promising target for antibacterial therapy. Methods/Principal Findings: The aim of this study was to explore the feasibility and efficacy of expressed antisense-mediated gene silencing for specific downregulation of yidC in Escherichia coli. We induced RNA silencing of yidC which resulted in impaired growth of the host cells. This was followed by a search for antibacterial compounds sensitizing the YidC depleted cells as they may act as inhibitors of the essential protein or its products. The present findings affirm that reduction of YidC synthesis results in bacterial growth retardation, which warrants the use of this enzyme as a viable target in search of novel antibacterial agents. Moreover, yidC antisense expression in E. coli resulted in sensitization to antibacterial essential oils eugenol and carvacrol. Fractional Inhibitory Concentration Indices (FICIs) point towards high level of synergy between yidC silencing and eugenol/carvacrol treatment. Finally, as there are no known YidC inhibitors, the RNA silencing approach applied in this study put forward rapid means to screen novel potential YidC inhibitors. Conclusions/Significance: The present results suggest that YidC is a promising candidate target for screening antibacterial agents. High level of synergy reported here between yidC silencing and eugenol/carvacrol treatment is indicative of a potential antibacterial therapy. This is the first report indicating that the essential gene yidC is a therapeutic target of the antibacterial essential oils eugenol and carvacrol in E. coli.	[Patil, Supriya Deepak; Sharma, Rajnikant; Srivastava, Santosh; Navani, Naveen Kumar; Pathania, Ranjana] Indian Inst Technol, Dept Biotechnol, Chem Biol & Drug Discovery Lab, Roorkee, Uttarakhand, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Pathania, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Chem Biol & Drug Discovery Lab, Roorkee, Uttarakhand, India.	ranjanapathania@gmail.com	Patil, Supriya Deepak/AAL-6757-2020; Sharma, Rajnikant/AGO-9487-2022	Pathania, Ranjana/0000-0002-7965-8176	Department of Science and Technology (DST), New Delhi, India [SR/FT/LS-129/2008]; Council of Scientific and Industrial Research (CSIR); Ministry of Human Resource Development (MHRD), Government of India	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Human Resource Development (MHRD), Government of India(Ministry of Human Resource Development (MHRD), Government of India)	Financial support for this work has been provided by Department of Science and Technology (DST), New Delhi, India under Fast Track Scheme (grant no. SR/FT/LS-129/2008) awarded to RP. SDP is thankful to the Council of Scientific and Industrial Research (CSIR); RS and SS thank Ministry of Human Resource Development (MHRD), Government of India for financial support. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boberek JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013745; Bowlin TL, 2012, CURRENT OPINION PHAR; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chan Pan F., 2002, Current Drug Targets - Infectious Disorders, V2, P291, DOI 10.2174/1568005023342227; Davies J, 2007, EMBO REP, V8, P616, DOI 10.1038/sj.embor.7401022; Donald RGK, 2009, CHEM BIOL, V16, P826, DOI 10.1016/j.chembiol.2009.07.004; Dryselius R, 2003, OLIGONUCLEOTIDES, V13, P427, DOI 10.1089/154545703322860753; Dryselius R, 2005, J ANTIMICROB CHEMOTH, V56, P97, DOI 10.1093/jac/dki173; Dryselius R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-97; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Gill AO, 2006, INT J FOOD MICROBIOL, V111, P170, DOI 10.1016/j.ijfoodmicro.2006.04.046; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Hasona A, 2005, P NATL ACAD SCI USA, V102, P17466, DOI 10.1073/pnas.0508778102; Ji Y, 2006, FEMS MICROBIOLOGY LE, V231, P177; Kim BC, 2006, ENZYME MICROB TECH, V39, P440, DOI 10.1016/j.enzmictec.2005.11.032; Knudsen H, 1996, NUCLEIC ACIDS RES, V24, P494, DOI 10.1093/nar/24.3.494; Kropp H, 2006, ANN NY ACAD SCI, V235, P364; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Meng J, 2012, FEMS MICROBIOLOGY LE; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; Nakashima N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl697; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Olano C, 2008, METAB ENG, V10, P281, DOI 10.1016/j.ymben.2008.07.001; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Pathania R, 2008, BIOCHEM CELL BIOL, V86, P111, DOI 10.1139/O08-011; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Prabuseenivasan Seenivasan, 2006, BMC Complement Altern Med, V6, P39, DOI 10.1186/1472-6882-6-39; Projan SJ, 2002, CURR OPIN PHARMACOL, V2, P513, DOI 10.1016/S1471-4892(02)00197-2; Roemer T, 2012, NAT CHEM BIOL, V8, P46, DOI 10.1038/nchembio.744; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; Vergidis PI, 2008, CURR OPIN INVEST DR, V9, P176; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang J, 2007, P NATL ACAD SCI USA, V104, P7612, DOI 10.1073/pnas.0700746104; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10; Young K, 2006, ANTIMICROB AGENTS CH, V50, P519, DOI 10.1128/AAC.50.2.519-526.2006; Zhang YJ, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-290, 10.1186/1471-2148-9-137]	42	31	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57370	10.1371/journal.pone.0057370	http://dx.doi.org/10.1371/journal.pone.0057370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469191	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900016
J	Avidor, B; Turner, D; Mor, Z; Chalom, S; Riesenberg, K; Shahar, E; Pollack, S; Elbirt, D; Sthoeger, Z; Maayan, S; Olshtain-Pops, K; Averbuch, D; Chowers, M; Istomin, V; Anis, E; Mendelson, E; Ram, D; Levy, I; Grossman, Z				Avidor, Boaz; Turner, Dan; Mor, Zohar; Chalom, Shirley; Riesenberg, Klaris; Shahar, Eduardo; Pollack, Shimon; Elbirt, Daniel; Sthoeger, Zev; Maayan, Shlomo; Olshtain-Pops, Karen; Averbuch, Diana; Chowers, Michal; Istomin, Valery; Anis, Emilia; Mendelson, Ella; Ram, Daniela; Levy, Itzchak; Grossman, Zehava			Transmission Patterns of HIV-Subtypes A/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy	PLOS ONE			English	Article							VIRUS REVERSE-TRANSCRIPTASE; TYPE-1 DRUG-RESISTANCE; RESPONSE CURVE SLOPE; PROTEASE; INFECTION; MUTATIONS; EPIDEMIOLOGY; DIVERSITY; SUSCEPTIBILITY; EMTRICITABINE	Background: HIV subtypes A and CRF01_AE (A/AE) became prevalent in Israel, first through immigration of infected people, mostly intravenous-drug users (IVDU), from Former Soviet-Union (FSU) countries and then also by local spreading. We retrospectively studied virus-transmission patterns of these subtypes in comparison to the longer-established subtype B, evaluating in particular risk-group related differences. We also examined to what extent distinct drug-resistance patterns in subtypes A/AE versus B reflected differences in patient behavior and drug-treatment history. Methods: Reverse-transcriptase (RT) and protease sequences were retrospectively analyzed along with clinical and epidemiological data. MEGA, ClusalX, and Beast programs were used in a phylogenetic analysis to identify transmission networks. Results: 318 drug-naive individuals with A/AE or patients failing combination antiretroviral therapy (cART) were identified. 61% were IVDU. Compared to infected homosexuals, IVDU transmitted HIV infrequently and, typically, only to a single partner. 6.8% of drug-naive patients had drug resistance. Treatment-failing, regimen-stratified subtype-A/AE-and B-patients differed from each other significantly in the frequencies of the major resistance-conferring mutations T215FY, K219QE and several secondary mutations. Notably, failing boosted protease-inhibitors (PI) treatment was not significantly associated with protease or RT mutations in either subtype. Conclusions: While sizable transmission networks occur in infected homosexuals, continued HIV transmission among IVDU in Israel is largely sporadic and the rate is relatively modest, as is that of drug-resistance transmission. Deviation of drugnaive A/AE sequences from subtype-B consensus sequence, documented here, may subtly affect drug-resistance pathways. Conspicuous differences in overall drug-resistance that are manifest before regimen stratification can be largely explained in terms of treatment history, by the different efficacy/adherence limitations of older versus newer regimens. The phenomenon of treatment failure in boosted-PI-including regimens in the apparent absence of drug-resistance to any of the drugs, and its relation to adherence, require further investigation.	[Avidor, Boaz; Turner, Dan; Chalom, Shirley] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Crusaid Kobler AIDS Ctr, IL-69978 Tel Aviv, Israel; [Avidor, Boaz] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Lab Viruses & Mol Biol, IL-69978 Tel Aviv, Israel; [Mor, Zohar] Minist Hlth, Publ Hlth Serv, Ramle Dept Hlth, Ramla, Israel; [Riesenberg, Klaris] Soroka Med Ctr, IL-84101 Beer Sheva, Israel; [Shahar, Eduardo; Pollack, Shimon] Rambam Med Ctr, Haifa, Israel; [Elbirt, Daniel; Sthoeger, Zev] Kaplan Med Ctr, Rehovot, Israel; [Maayan, Shlomo; Olshtain-Pops, Karen; Averbuch, Diana] Hadassah Med Ctr, IL-91120 Jerusalem, Israel; [Chowers, Michal] Meir Med Ctr, Kefar Sava, Israel; [Istomin, Valery] Hillel Yaffe Med Ctr, Hadera, Israel; [Anis, Emilia] Minist Hlth, Dept Epidemiol, Publ Hlth Serv, Jerusalem, Israel; [Mendelson, Ella; Ram, Daniela] Minist Hlth, Cent Virol, Publ Hlth Labs, Ramat Gan, Israel; [Mendelson, Ella; Grossman, Zehava] Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel; [Levy, Itzchak] Sheba Med Ctr, Infect Dis Unit, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Soroka Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Chaim Sheba Medical Center	Grossman, Z (corresponding author), Tel Aviv Univ, Sch Publ Hlth, IL-69978 Tel Aviv, Israel.	zehava.grossman@gmail.com	RIESENBERG, KLARIS/F-1132-2012; Averbuch, Dina/ABA-6433-2020	Chowers, Michal/0000-0001-6148-254X	European Commission [LSHP-CT -2006-518211]; European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported in part by a European Commission grant (LSHP-CT -2006-518211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; Several sequences documented in the present study are shared with SPREAD, a scientific surveillance program supported by the European Commission [56].	ADLER MW, 1987, BMJ-BRIT MED J, V294, P1083, DOI 10.1136/bmj.294.6579.1083; Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007; Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bengtsson L, 2010, AIDS, V24, P2301, DOI 10.1097/QAD.0b013e32833d207d; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Central Bureau of Statistics Jerusalem the State of Israel, 2010, STAT ABSTR ISR; Chemtob D, 2004, INT J STD AIDS, V15, P691, DOI 10.1258/0956462041944321; Chemtob Daniel, 2008, Harefuah, V147, P634; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; Di Giambenedetto S, 2009, ANTIVIR THER, V14, P359; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Grossman Z, 2004, ANTIMICROB AGENTS CH, V48, P2159, DOI 10.1128/AAC.48.6.2159-2165.2004; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Grossman Z, 2001, AIDS, V15, P1453, DOI 10.1097/00002030-200108170-00001; Grossman Z, 2012, ANTIVIR THER S, V17, pA172; Gupta RK, 2010, AIDS, V24, P1651, DOI 10.1097/QAD.0b013e3283398216; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kantor R, 2001, NUCLEIC ACIDS RES, V29, P296, DOI 10.1093/nar/29.1.296; Kaplan E H, 1995, Public Health Rev, V23, P215; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Levy I, 2011, CLIN INFECT DIS, V52, P1363, DOI 10.1093/cid/cir244; Lohse N, 2006, ANTIVIR THER, V11, P591; Martinez-Cajas JL, 2012, J ANTIMICROB CHEMOTH, V67, P988, DOI 10.1093/jac/dkr582; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mor Z, 2011, HIV AIDS ISRAEL EPID; Nabatov AA, 2002, AIDS RES HUM RETROV, V18, P891, DOI 10.1089/08892220260190380; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; Rambaut A, 2010, FIGTREE V131; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Roudinskii NI, 2004, J VIROL, V78, P11276, DOI 10.1128/JVI.78.20.11276-11287.2004; Saad MD, 2006, AIDS RES HUM RETROV, V22, P796, DOI 10.1089/aid.2006.22.796; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Schupbach J, 2007, PLOS MED, V4, P1921, DOI 10.1371/journal.pmed.0040343; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; SLATER PE, 1993, ISRAEL J MED SCI, V29, P2; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Svicher V, 2010, JAIDS-J ACQ IMM DEF, V55, P336, DOI 10.1097/QAI.0b013e3181e6763f; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner D, 2012, HIV MED, V13, P202, DOI 10.1111/j.1468-1293.2011.00960.x; UNAIDS, 2011, 2010 GLOB REP; Vercauteren J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-12; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Wainberg MA, 2010, VIRUSES-BASEL, V2, P2493, DOI 10.3390/v2112493; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916	57	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57789	10.1371/journal.pone.0057789	http://dx.doi.org/10.1371/journal.pone.0057789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469241	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100042
J	Jena, B; Maiti, S; Huls, H; Singh, H; Lee, DA; Champlin, RE; Cooper, LJN				Jena, Bipulendu; Maiti, Sourindra; Huls, Helen; Singh, Harjeet; Lee, Dean A.; Champlin, Richard E.; Cooper, Laurence J. N.			Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials	PLOS ONE			English	Article							B-LINEAGE LEUKEMIA; SINGLE-CHAIN FV; ADOPTIVE IMMUNOTHERAPY; PERSISTENCE; CD19; SPECIFICITY; LYMPHOMA; EXPRESS; CLONES	Clinical trials targeting CD19 on B-cell malignancies are underway with encouraging anti-tumor responses. Most infuse T cells genetically modified to express a chimeric antigen receptor (CAR) with specificity derived from the scFv region of a CD19-specific mouse monoclonal antibody (mAb, clone FMC63). We describe a novel anti-idiotype monoclonal antibody (mAb) to detect CD19-specific CAR(+) T cells before and after their adoptive transfer. This mouse mAb was generated by immunizing with a cellular vaccine expressing the antigen-recognition domain of FMC63. The specificity of the mAb (clone no. 136.20.1) was confined to the scFv region of the CAR as validated by inhibiting CAR-dependent lysis of CD19(+) tumor targets. This clone can be used to detect CD19-specific CAR(+) T cells in peripheral blood mononuclear cells at a sensitivity of 1: 1,000. In clinical settings the mAb is used to inform on the immunophenotype and persistence of administered CD19-specific T cells. Thus, our CD19-specific CAR mAb (clone no. 136.20.1) will be useful to investigators implementing CD19-specific CAR(+) T cells to treat B-lineage malignancies. The methodology described to develop a CAR-specific anti-idiotypic mAb could be extended to other gene therapy trials targeting different tumor associated antigens in the context of CAR-based adoptive T-cell therapy.	[Jena, Bipulendu; Maiti, Sourindra; Huls, Helen; Singh, Harjeet; Lee, Dean A.; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Lee, Dean A.; Cooper, Laurence J. N.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Champlin, Richard E.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Cooper, LJN (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA.	ljncooper@mdanderson.org	Jena, Bipulendu/G-8206-2014; Lee, Dean Anthony/AAK-8443-2021	Lee, Dean Anthony/0000-0001-6693-5392	Cancer Center Core Grant [CA16672, CA148600, CA124782, CA120956, CA141303, CA116127, CA136411]; Department of Defense; Albert J Ward Foundation; Alex Lemonade Stand Foundation; Burroughs Wellcome Fund; Cancer Prevention Research Institute of Texas; Ann Parsons Memorial Foundation; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy, Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society; Lymphoma Research Foundation; Miller Foundation; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; William Lawrence and Blanche Hughes Children's Foundation; NATIONAL CANCER INSTITUTE [R01CA124782, R33CA116127, R01CA141303, P30CA016672, P01CA148600, P50CA136411, R01CA120956] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Cancer Center Core Grant; Department of Defense(United States Department of Defense); Albert J Ward Foundation; Alex Lemonade Stand Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Prevention Research Institute of Texas; Ann Parsons Memorial Foundation; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy, Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lymphoma Research Foundation; Miller Foundation; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; William Lawrence and Blanche Hughes Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study is supported by funding from following agencies; Cancer Center Core Grant (CA16672); P01 (CA148600); RO1 (CA124782, CA120956, CA141303); R33 (CA116127); SPORE (CA136411); Department of Defense; Albert J Ward Foundation; Alex Lemonade Stand Foundation; Burroughs Wellcome Fund; Cancer Prevention Research Institute of Texas; Ann Parsons Memorial Foundation; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; The Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy, Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society; Lymphoma Research Foundation; Miller Foundation; Mr. and Mrs. Joe H. Scales; Mr. Thomas Scott; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; William Lawrence and Blanche Hughes Children's Foundation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Cooper LJN, 2012, BLOOD, V119, P2700, DOI 10.1182/blood-2011-12-398719; Cooper LJN, 2003, BLOOD, V101, P1637, DOI 10.1182/blood-2002-07-1989; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Hombach A, 2010, GENE THER, V17, P1206, DOI 10.1038/gt.2010.91; Huls MH, 2013, JOVE-J VIS EXP, DOI 10.3791/50070; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Lamers CHJ, 2011, BLOOD, V117, P72, DOI 10.1182/blood-2010-07-294520; Ma QZ, 2004, PROSTATE, V61, P12, DOI 10.1002/pros.20073; Manuri PVR, 2010, HUM GENE THER, V21, P427, DOI 10.1089/hum.2009.114; Moeller M, 2005, BLOOD, V106, P2995, DOI 10.1182/blood-2004-12-4906; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2010, CANCER J, V16, P336, DOI 10.1097/PPO.0b013e3181eb3879; Nicholson IC, 1997, MOL IMMUNOL, V34, P1157, DOI 10.1016/S0161-5890(97)00144-2; O'Connor CM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00249; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rossig C, 2002, BLOOD, V99, P2009, DOI 10.1182/blood.V99.6.2009; Rossig C, 2001, INT J CANCER, V94, P228, DOI 10.1002/ijc.1457; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Vera J, 2006, BLOOD, V108, P3890, DOI 10.1182/blood-2006-04-017061; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989	32	82	121	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57838	10.1371/journal.pone.0057838	http://dx.doi.org/10.1371/journal.pone.0057838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469246	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100045
J	Crnigoj, M; Podlesek, Z; Zorko, M; Jerala, R; Anderluh, G; Ulrih, NP				Crnigoj, Miha; Podlesek, Zdravko; Zorko, Mateja; Jerala, Roman; Anderluh, Gregor; Ulrih, Natasa Poklar			Interactions of Archaeal Chromatin Proteins Alba1 and Alba2 with Nucleic Acids	PLOS ONE			English	Article							DNA-BINDING PROTEINS; EXPRESSION; SSH10B	Background: Architectural proteins have important roles in compacting and organising chromosomal DNA. There are two potential histone counterpart peptide sequences (Alba1 and Alba2) in the Aeropyrum pernix genome (APE1832.1 and APE1823). Methodology/Principal Findings: These two peptides were expressed and their interactions with various DNAs were studied using a combination of various experimental techniques: surface plasmon resonance, UV spectrophotometry, circular dichroism-spectropolarimetry, gel-shift assays, and isothermal titration calorimetry. Conclusions/Significance: Our data indicate that there are significant differences in the properties of the Alba1 and Alba2 proteins. Both of these Alba proteins can thermally stabilise DNA polynucleotides, as seen from UV melting curves. Alba2 and equimolar mixtures of Alba1/Alba2 have greater effects on the thermal stability of poly(dA-dT). poly(dA-dT). Surface plasmon resonance sensorgrams for binding of Alba1, Alba2, and equimolar mixtures of Alba1/Alba2 to DNA oligonucleotides show different binding patterns. Circular dichroism indicates that Alba2 has a less-ordered secondary structure than Alba1. The secondary structures of the Alba proteins are not significantly influenced by DNA binding, even at high temperatures. Based on these data, we conclude that Alba1, Alba2, and equimolar mixtures of Alba1/Alba2 show different properties in their binding to various DNAs.	[Crnigoj, Miha; Podlesek, Zdravko; Anderluh, Gregor; Ulrih, Natasa Poklar] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Zorko, Mateja; Jerala, Roman; Anderluh, Gregor] Natl Chem Inst Slovenia, Ljubljana, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Jerala, Roman] Ctr Excellence EN FIST, Ljubljana, Slovenia; [Ulrih, Natasa Poklar] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Ulrih, NP (corresponding author), Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.	natasa.poklar@bf.uni-lj.si	Ulrih, Natasa Poklar/B-2015-2008; Anderluh, Gregor/C-6905-2014; Jerala, Roman/H-9850-2015	Anderluh, Gregor/0000-0002-9916-8465; Jerala, Roman/0000-0002-6337-5251; Poklar Ulrih, Natasa/0000-0002-2731-9973	Centre of Excellence CipKeBiP; Centre of Excellence EN-FIST;  [P4-0121];  [P4-0176]	Centre of Excellence CipKeBiP; Centre of Excellence EN-FIST; ; 	This work was partially supported by Research Programme P4-0121 (Biochemical and Biophysical-Chemical Characterisation of Natural Compounds) and Centre of Excellence CipKeBiP. RJ and MZ were supported by Research Programme P4-0176 (Molecular Biotechnology) and by the Centre of Excellence EN-FIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Cantor C.R., 1980, BIOPHYS CHEM; Crnigoj M, 2011, CROAT CHEM ACTA, V84, P499, DOI 10.5562/cca1772; CROTHERS DM, 1971, BIOPOLYMERS, V10, P2147, DOI 10.1002/bip.360101110; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; Dame RT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002123; Dinger ME, 2000, MOL MICROBIOL, V36, P876, DOI 10.1046/j.1365-2958.2000.01904.x; Driessen RPC, 2013, NUCLEIC ACIDS RES, V41, P196, DOI 10.1093/nar/gks1053; Driessen RPC, 2011, BIOCHEM SOC T, V39, P116, DOI 10.1042/BST0390116; Edmondson SP, 2004, BIOCHEMISTRY-US, V43, P13026, DOI 10.1021/bi0491752; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; GROTE M, 1986, BIOCHIM BIOPHYS ACTA, V873, P405, DOI 10.1016/0167-4838(86)90090-7; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Hames BD., 1990, GEL ELECTROPHORESIS, P1; Hardy CD, 2008, EXTREMOPHILES, V12, P235, DOI 10.1007/s00792-007-0120-z; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Jelinska C, 2010, BIOCHEM J, V427, P49, DOI 10.1042/BJ20091841; Kahsai MA, 2005, BIOCHEMISTRY-US, V44, P2822, DOI 10.1021/bi047669t; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Luo X, 2007, J BACTERIOL, V189, P403, DOI 10.1128/JB.01246-06; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Riley M, 1966, J MOL BIOL, V20, P118; Sambrook J., 2001, MOL CLONING LAB MANU; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Tanaka T, 2012, J BIOL CHEM, V287, P10394, DOI 10.1074/jbc.M112.343210; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; White MF, 2002, TRENDS GENET, V18, P621, DOI 10.1016/S0168-9525(02)02808-1; Xuan JS, 2012, CURR PROTEIN PEPT SC, V13, P258, DOI 10.2174/138920312800785067; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000	33	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58237	10.1371/journal.pone.0058237	http://dx.doi.org/10.1371/journal.pone.0058237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469156	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900247
J	De Bond, JAP; Li, Q; Millar, RP; Clarke, IJ; Smith, JT				De Bond, Julie-Ann P.; Li, Qun; Millar, Robert P.; Clarke, Iain J.; Smith, Jeremy T.			Kisspeptin Signaling Is Required for the Luteinizing Hormone Response in Anestrous Ewes following the Introduction of Males	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; GNRH PULSE-GENERATOR; ARCUATE NUCLEUS; NEUROKININ B; PREOPTIC AREA; GONADOTROPIN-SECRETION; DYNORPHIN-A; MERINO EWES; NEURONS; SHEEP	The introduction of a novel male stimulates the hypothalamic-pituitary-gonadal axis of female sheep during seasonal anestrus, leading to the resumption of follicle maturation and ovulation. How this pheromone cue activates pulsatile secretion of gonadotropin releasing hormone (GnRH)/luteinizing hormone (LH) is unknown. We hypothesised that pheromones activate kisspeptin neurons, the product of which is critical for the stimulation of GnRH neurons and fertility. During the non-breeding season, female sheep were exposed to novel males and blood samples collected for analysis of plasma LH profiles. Females without exposure to males served as controls. In addition, one hour before male exposure, a kisspeptin antagonist (P-271) or vehicle was infused into the lateral ventricle and continued for the entire period of male exposure. Introduction of a male led to elevated mean LH levels, due to increased LH pulse amplitude and pulse frequency in females, when compared to females not exposed to a male. Infusion of P-271 abolished this effect of male exposure. Brains were collected after the male effect stimulus and we observed an increase in the percentage of kisspeptin neurons co-expressing Fos, by immunohistochemistry. In addition, the per-cell expression of Kiss1 mRNA was increased in the rostral and mid (but not the caudal) arcuate nucleus (ARC) after male exposure in both aCSF and P-271 treated ewes, but the per-cell content of neurokinin B mRNA was decreased. There was also a generalized increase in Fos positive cells in the rostral and mid ARC as well as the ventromedial hypothalamus of females exposed to males. We conclude that introduction of male sheep to seasonally anestrous female sheep activates kisspeptin neurons and other cells in the hypothalamus, leading to increased GnRH/LH secretion.	[De Bond, Julie-Ann P.; Li, Qun; Clarke, Iain J.; Smith, Jeremy T.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Millar, Robert P.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, Gauteng, South Africa; [Millar, Robert P.] Univ Cape Town, UCT MRC Receptor Biol Unit, ZA-7925 Cape Town, Western Cape, South Africa; [Millar, Robert P.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	Monash University; University of Pretoria; University of Cape Town; University of Edinburgh	Smith, JT (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia.	jeremy.smith@uwa.edu.au	Smith, Jeremy T/I-3401-2013	Smith, Jeremy T/0000-0002-3450-9505; Clarke, Iain/0000-0002-6613-2757; Millar, Robert P/0000-0003-3606-2708	National Health and Medical Research Council of Australia (NHMRC) [606538, 1024346]; Australian Research Council (ARC) [DP120100521, FT0990986]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	Supported by the National Health and Medical Research Council of Australia (NHMRC) Project Grants 606538 and 1024346 and the Australian Research Council (ARC) Discovery Project DP120100521 and Future Fellowship FT0990986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delgadillo JA, 2009, BEHAV BRAIN RES, V200, P304, DOI 10.1016/j.bbr.2009.02.004; Bakker J, 2010, HORM BEHAV, V57, P390, DOI 10.1016/j.yhbeh.2009.11.005; Billings HJ, 2010, ENDOCRINOLOGY, V151, P3836, DOI 10.1210/en.2010-0174; Boukhliq R, 1999, ENDOCRINOLOGY, V140, P5929, DOI 10.1210/en.140.12.5929; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Caraty A, 2007, ENDOCRINOLOGY, V148, P5258, DOI 10.1210/en.2007-0554; Chanvallon A, 2010, ANIM REPROD SCI, V119, P205, DOI 10.1016/j.anireprosci.2010.02.003; Clarke IJ, 2011, FRONT NEUROENDOCRIN, V32, P367, DOI 10.1016/j.yfrne.2011.01.001; Clarke IJ, 2009, PEPTIDES, V30, P154, DOI 10.1016/j.peptides.2008.08.022; COHEN-TANNOUDJI J, 1994, PHYSIOL BEHAV, V56, P955, DOI 10.1016/0031-9384(94)90329-8; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de St Jorre TJ, 2012, REPROD FERT DEVELOP, V24, P523, DOI 10.1071/RD11085; de Tassigny XD, 2008, ENDOCRINOLOGY, V149, P3926, DOI 10.1210/en.2007-1487; Estrada KM, 2006, J NEUROENDOCRINOL, V18, P806, DOI 10.1111/j.1365-2826.2006.01485.x; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Gelez H, 2006, NEUROSCIENCE, V140, P791, DOI 10.1016/j.neuroscience.2006.02.066; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Grachev P, 2012, ENDOCRINOLOGY, V153, P4894, DOI 10.1210/en.2012-1574; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hawken PAR, 2012, DOMEST ANIM ENDOCRIN, V43, P85, DOI 10.1016/j.domaniend.2012.03.005; Hawken PAR, 2009, ANIMAL, V3, P690, DOI 10.1017/S1751731109003954; Hawken PAR, 2009, BIOL REPROD, V80, P1146, DOI 10.1095/biolreprod.108.075341; Herbison AE, 2010, ENDOCRINOLOGY, V151, P312, DOI 10.1210/en.2009-0552; Hoffman GE, 2011, ENDOCRINOLOGY, V152, P214, DOI 10.1210/en.2010-0066; Hrabovszky E, 2012, ENDOCRINOLOGY, V153, P4978, DOI 10.1210/en.2012-1545; Jansen HT, 1998, BRAIN RES BULL, V45, P27, DOI 10.1016/S0361-9230(97)00279-7; Keller M, 2009, BEHAV BRAIN RES, V200, P268, DOI 10.1016/j.bbr.2009.01.020; Kinsey-Jones JS, 2012, ENDOCRINOLOGY, V153, P307, DOI 10.1210/en.2011-1641; LEE VWK, 1976, J REPROD FERTIL, V46, P1, DOI 10.1530/jrf.0.0460001; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; LEHMAN MN, 1986, J COMP NEUROL, V244, P19, DOI 10.1002/cne.902440103; Li Q, 2011, J NEUROENDOCRINOL, V23, P871, DOI 10.1111/j.1365-2826.2011.02195.x; Li Q, 2012, NEUROENDOCRINOLOGY; LINDSAY DR, 1975, PHYSIOL BEHAV, V15, P423, DOI 10.1016/0031-9384(75)90208-5; MARTIN GB, 1983, AUST J BIOL SCI, V36, P369; Murata K, 2011, J REPROD DEVELOP, V57, P197, DOI 10.1262/jrd.10-070E; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Okamura H, 2010, J NEUROENDOCRINOL, V22, P825, DOI 10.1111/j.1365-2826.2010.02037.x; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; POLKOWSKA J, 1980, CELL TISSUE RES, V208, P327, DOI 10.1007/BF00234880; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Ruiz-Pino F, 2012, ENDOCRINOLOGY, V153, P4818, DOI 10.1210/en.2012-1287; Sakamoto K, 2012, J REPROD DEV; SCHINCKEL P. G., 1954, AUSTRALIAN VET JOUR, V30, P189, DOI 10.1111/j.1751-0813.1954.tb08198.x; Scott CJ, 2000, ENDOCRINOLOGY, V141, P2951, DOI 10.1210/en.141.8.2951; Sebert ME, 2010, DOMEST ANIM ENDOCRIN, V38, P289, DOI 10.1016/j.domaniend.2010.01.001; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Smith JT, 2009, ENDOCRINOLOGY, V150, P5530, DOI 10.1210/en.2009-0712; Smith JT, 2008, ENDOCRINOLOGY, V149, P5770, DOI 10.1210/en.2008-0581; Smith JT, 2008, BRAIN RES REV, V57, P288, DOI 10.1016/j.brainresrev.2007.04.002; Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435; Smith JT, 2011, ENDOCRINOLOGY, V152, P1001, DOI 10.1210/en.2010-1225; Smith JT, 2009, PEPTIDES, V30, P94, DOI 10.1016/j.peptides.2008.08.013; Wagner GC, 2008, ENDOCRINOLOGY, V149, P32, DOI 10.1210/en.2007-0658; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010	59	43	43	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57972	10.1371/journal.pone.0057972	http://dx.doi.org/10.1371/journal.pone.0057972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469121	Green Published, gold			2022-12-27	WOS:000315524900214
J	Mutch, WAC; Patel, SR; Shahidi, AM; Kulasekara, SI; Fisher, JA; Duffin, J; Hudson, C				Mutch, W. Alan C.; Patel, Sunni R.; Shahidi, Ayda M.; Kulasekara, Susith I.; Fisher, Joseph A.; Duffin, James; Hudson, Christopher			Cerebral Oxygen Saturation: Graded Response to Carbon Dioxide with Isoxia and Graded Response to Oxygen with Isocapnia	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; EARLY VENTILATION; BRAIN-INJURY; HYPERVENTILATION; ANESTHESIA; VOLUME; METHODOLOGY; METABOLISM	Background: Monitoring cerebral saturation is increasingly seen as an aid to management of patients in the operating room and in neurocritical care. How best to manipulate cerebral saturation is not fully known. We examined cerebral saturation with graded changes in carbon dioxide tension while isoxic and with graded changes in oxygen tension while isocapnic. Methodology/Principal Findings: The study was approved by the Research Ethics Board of the University Health Network at the University of Toronto. Thirteen studies were undertaken in healthy adults with cerebral oximetry by near infrared spectroscopy. End-tidal gas concentrations were manipulated using a model-based prospective end-tidal targeting device. End-tidal carbon dioxide was altered +/- 15 mmHg from baseline in 5 mmHg increments with isoxia (clamped at 110 +/- 4 mmHg). End-tidal oxygen was changed to 300, 400, 500, 80, 60 and 50 mmHg under isocapnia (37 +/- 2 mmHg). Twelve studies were completed. The end-tidal carbon dioxide versus cerebral saturation fit a linear relationship (R-2 = 0.92 +/- 0.06). The end-tidal oxygen versus cerebral saturation followed log-linear behaviour and best fit a hyperbolic relationship (R-2 = 0.85 +/- 0.10). Cerebral saturation was maximized in isoxia at end-tidal carbon dioxide of baseline +15 mmHg (77 +/- 3 percent). Cerebral saturation was minimal in isocapnia at an end-tidal oxygen tension of 50 mmHg (61 +/- 3 percent). The cerebral saturation during normoxic hypocapnia was equivalent to normocapnic hypoxia of 60 mmHg. Conclusions/Significance: Hypocapnia reduces cerebral saturation to an extent equivalent to moderate hypoxia.	[Mutch, W. Alan C.] Univ Manitoba, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada; [Patel, Sunni R.; Shahidi, Ayda M.; Kulasekara, Susith I.; Hudson, Christopher] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Fisher, Joseph A.] Univ Toronto, Dept Anesthesia & Pain Management, Toronto, ON, Canada; [Duffin, James] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Manitoba; University of Toronto; University of Toronto; University of Toronto	Mutch, WAC (corresponding author), Univ Manitoba, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada.	wacmutch@shaw.ca		Duffin, James/0000-0003-2270-7392; Mutch, W. Alan/0000-0001-7174-7839	Internal Funding Department of Ophthalmology and Vision Sciences, University of Toronto	Internal Funding Department of Ophthalmology and Vision Sciences, University of Toronto	This study was funded by the Internal Funding Department of Ophthalmology and Vision Sciences, University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blockley NP, 2012, NEUROIMAGE, V60, P279, DOI 10.1016/j.neuroimage.2011.11.081; Bulte DP, 2012, NEUROIMAGE, V60, P582, DOI 10.1016/j.neuroimage.2011.12.017; Bulte D, 2007, J MAGN RESON IMAGING, V26, P894, DOI 10.1002/jmri.21096; Cenic A, 2002, ANESTH ANALG, V94, P661, DOI 10.1097/00000539-200203000-00033; Chiarelli PA, 2007, NEUROIMAGE, V37, P808, DOI 10.1016/j.neuroimage.2007.05.033; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Donahue MJ, 2009, J CEREBR BLOOD F MET, V29, P1856, DOI 10.1038/jcbfm.2009.107; Espenell AEG, 2010, CAN J ANESTH, V57, P903, DOI 10.1007/s12630-010-9356-7; Fedorow C, 2010, CURR OPIN ANESTHESIO, V23, P89, DOI 10.1097/ACO.0b013e3283346d10; Fujii N, 2012, AM J PHYSIOL-REG I, V303, pR975, DOI 10.1152/ajpregu.00169.2012; Goodwin JA, 2009, NEUROIMAGE, V47, P573, DOI 10.1016/j.neuroimage.2009.04.064; Han JS, 2011, STROKE, V42, P3047, DOI 10.1161/STROKEAHA.111.615955; Heyn C, 2010, AM J NEURORADIOL, V31, P862, DOI 10.3174/ajnr.A1922; Highton D, 2010, CURR OPIN ANESTHESIO, V23, P576, DOI 10.1097/ACO.0b013e32833e1536; Hoge RD, 2012, NEUROIMAGE, V62, P930, DOI 10.1016/j.neuroimage.2012.02.022; Ito H, 2000, J CEREBR BLOOD F MET, V20, P1264, DOI 10.1097/00004647-200008000-00011; Kasman N, 2011, PEDIATR ANESTH, V21, P473, DOI 10.1111/j.1460-9592.2011.03549.x; Kisilevsky M, 2008, INVEST OPHTH VIS SCI, V49, P5503, DOI 10.1167/iovs.08-1854; Mandell DM, 2008, STROKE, V39, P2021, DOI 10.1161/STROKEAHA.107.506709; Mardimae A, 2012, PFLUG ARCH EUR J PHY, V464, P345, DOI 10.1007/s00424-012-1148-1; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Pellicer A, 2011, SEMIN FETAL NEONAT M, V16, P42, DOI 10.1016/j.siny.2010.05.003; Rais-Bahrami K, 2006, J PERINATOL, V26, P628, DOI 10.1038/sj.jp.7211573; Rao GSU, 2011, CURR OPIN ANESTHESIO, V24, P487, DOI 10.1097/ACO.0b013e32834a8965; RINGAERT KRA, 1988, ANESTH ANALG, V67, P383; Schytz HW, 2012, NEUROCRIT CARE, V17, P139, DOI 10.1007/s12028-012-9720-2; Slessarev M, 2007, J PHYSIOL-LONDON, V581, P1207, DOI 10.1113/jphysiol.2007.129395; Smith M, 2009, ANESTH ANALG, V108, P1055, DOI 10.1213/ane.0b013e31819a0301; Zheng F, 2012, ANESTHESIA ANALGESIA, P1	33	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57881	10.1371/journal.pone.0057881	http://dx.doi.org/10.1371/journal.pone.0057881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469096	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900192
J	Taubert, F; Hartig, F; Dobner, HJ; Huth, A				Taubert, Franziska; Hartig, Florian; Dobner, Hans-Juergen; Huth, Andreas			On the Challenge of Fitting Tree Size Distributions in Ecology	PLOS ONE			English	Article							GENERAL QUANTITATIVE THEORY; POWER-LAW DISTRIBUTIONS; FLIGHT SEARCH PATTERNS; DIAMETER DISTRIBUTIONS; FOREST STRUCTURE; BEHAVIOR; MODELS; FIRES; COMMUNITIES; EXAMPLES	Patterns that resemble strongly skewed size distributions are frequently observed in ecology. A typical example represents tree size distributions of stem diameters. Empirical tests of ecological theories predicting their parameters have been conducted, but the results are difficult to interpret because the statistical methods that are applied to fit such decaying size distributions vary. In addition, binning of field data as well as measurement errors might potentially bias parameter estimates. Here, we compare three different methods for parameter estimation - the common maximum likelihood estimation (MLE) and two modified types of MLE correcting for binning of observations or random measurement errors. We test whether three typical frequency distributions, namely the power-law, negative exponential and Weibull distribution can be precisely identified, and how parameter estimates are biased when observations are additionally either binned or contain measurement error. We show that uncorrected MLE already loses the ability to discern functional form and parameters at relatively small levels of uncertainties. The modified MLE methods that consider such uncertainties (either binning or measurement error) are comparatively much more robust. We conclude that it is important to reduce binning of observations, if possible, and to quantify observation accuracy in empirical studies for fitting strongly skewed size distributions. In general, modified MLE methods that correct binning or measurement errors can be applied to ensure reliable results.	[Taubert, Franziska; Hartig, Florian; Huth, Andreas] Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Saxony, Germany; [Hartig, Florian] Univ Freiburg, Dept Biometry & Environm Syst Anal, Fac Forestry & Environm Sci, Freiburg, Baden Wuerttemb, Germany; [Dobner, Hans-Juergen] Univ Appl Sci, Fac Comp Sci Math & Nat Sci, Leipzig, Saxony, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg	Taubert, F (corresponding author), Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Saxony, Germany.	franziska.taubert@ufz.de	Hartig, Florian/G-4510-2010	Hartig, Florian/0000-0002-6255-9059; Taubert, Franziska/0000-0001-7594-8152	Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE); National Science Foundation [DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197]; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund	Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE); National Science Foundation(National Science Foundation (NSF)); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund	This work was kindly supported by Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute for providing field data of Barro Colorado Island (BCI) from the year 2000 used in this article. The BCI forest dynamics research project was made possible by National Science Foundation grants to Stephen P. Hubbell: DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, support from the Center for Tropical Forest Science, the Smithsonian Tropical Research Institute, the John D. and Catherine T. MacArthur Foundation, the Mellon Foundation, the Small World Institute Fund, and numerous private individuals, and through the hard work of over 100 people from 10 countries over the past two decades. The plot project is part the Center for Tropical Forest Science, a global network of large-scale demographic tree plots. The authors also want to thank the anonymous reviewers for valuable comments.	BAILEY RL, 1973, FOREST SCI, V19, P97; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Clar S, 1996, J PHYS-CONDENS MAT, V8, P6803, DOI 10.1088/0953-8984/8/37/004; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Condit R, 1998, TROPICAL FOREST CENS; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Gutenberg B., 1954, SEISMICITY EARTH ASS; Heath M.T., 2002, SCI COMPUTING INTRO; Hubbell S.P., 2005, BARRO COLORADO FORES; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; KIEFER J, 1953, P AM MATH SOC, V4, P502, DOI 10.2307/2032161; Kieseppa IA, 1997, BRIT J PHILOS SCI, V48, P21, DOI 10.1093/bjps/48.1.21; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; R Core Team, 2020, R LANG ENV STAT COMP; Reed WJ, 2002, ECOL MODEL, V150, P239, DOI 10.1016/S0304-3800(01)00483-5; RENNOLLS K, 1985, FORESTRY, V58, P57, DOI 10.1093/forestry/58.1.57; Reynolds AM, 2012, ECOLOGY, V93, P1228, DOI 10.1890/11-1815.1; Reynolds AM, 2009, BEHAV ECOL SOCIOBIOL, V64, P115, DOI 10.1007/s00265-009-0826-2; Shimano K, 2000, PLANT ECOL, V146, P207; Shinozaki K, 1964, ECOLOGICAL SOC JAPAN, V14, P133; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Stegen JC, 2008, ECOL LETT, V11, P1287, DOI 10.1111/j.1461-0248.2008.01242.x; Turcotte DL, 2004, PHYSICA A, V340, P580, DOI 10.1016/j.physa.2004.05.009; Virkar Y., 2012, ARXIV12083524; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007	37	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58036	10.1371/journal.pone.0058036	http://dx.doi.org/10.1371/journal.pone.0058036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469137	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900228
J	Koch, V; Peckham, H; Mancini, A; Eguchi, T				Koch, Volker; Peckham, Hoyt; Mancini, Agnese; Eguchi, Tomoharu			Estimating At-Sea Mortality of Marine Turtles from Stranding Frequencies and Drifter Experiments	PLOS ONE			English	Article							BAJA-CALIFORNIA-SUR; FISHERIES BYCATCH; BAHIA MAGDALENA; JELLYFISH; CONSERVATION; CONSUMPTION; POPULATION; PATTERNS	Strandings of marine megafauna can provide valuable information on cause of death at sea. However, as stranding probabilities are usually very low and highly variable in space and time, interpreting the results can be challenging. We evaluated the magnitude and distribution of at-sea mortality of marine turtles along the Pacific coast of Baja California Sur, Mexico during 2010-11, using a combination of counting stranded animals and drifter experiments. A total of 594 carcasses were found during the study period, with loggerhead (62%) and green turtles (31%) being the most common species. 87% of the strandings occurred in the southern Gulf of Ulloa, a known hotspot of loggerhead distribution in the Eastern Pacific. While only 1.8% of the deaths could be definitively attributed to bycatch (net marks, hooks), seasonal variation in stranding frequencies closely corresponded to the main fishing seasons. Estimated stranding probabilities from drifter experiments varied among sites and trials (0.05-0.8), implying that only a fraction of dead sea turtles can be observed at beaches. Total mortality estimates for 15-day periods around the floater trials were highest for PSL, a beach in the southern Gulf of Ulloa, ranging between 11 sea turtles in October 2011 to 107 in August 2010. Loggerhead turtles were the most numerous, followed by green and olive ridley turtles. Our study showed that drifter trials combined with beach monitoring can provide estimates for death at sea to measure the impact of small-scale fisheries that are notoriously difficult to monitor for by-catch. We also provided recommendations to improve the precision of the mortality estimates for future studies and highlight the importance of estimating impacts of small-scale fisheries on marine megafauna.	[Koch, Volker; Mancini, Agnese] Univ Autonoma Baja Calif Sur, Dept Marine Biol, La Paz, Baja Calif Sur, Mexico; [Koch, Volker] Invest Conservacio & El Desarrollo, La Paz, Baja Calif Sur, Mexico; [Koch, Volker] Leibniz Ctr Trop Marine Ecol, Dept Directorate, Bremen, Germany; [Peckham, Hoyt] Grp Tortuguero Calif AC, La Paz, Baja Calif Sur, Mexico; [Peckham, Hoyt] Stanford Univ, Ctr Ocean Solut, Pacific Grove, CA USA; [Mancini, Agnese] Boomerang Earth Conservat, Antony, France; [Eguchi, Tomoharu] NOAA, Protected Resources Div, Southwest Fisheries Sci Ctr, Natl Marine Fishery Serv, La Jolla, CA USA	Universidad Autonoma de Baja California; Leibniz Zentrum fur Marine Tropenforschung (ZMT); Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	Koch, V (corresponding author), Univ Autonoma Baja Calif Sur, Dept Marine Biol, La Paz, Baja Calif Sur, Mexico.	vokoch68@gmail.com	Koch, Volker/J-1587-2012		Western Pacific Regional Fishery Management Council pursuant to National Oceanic and Atmospheric Administration Award [NA10NMF4410219]	Western Pacific Regional Fishery Management Council pursuant to National Oceanic and Atmospheric Administration Award	This study was funded by the Western Pacific Regional Fishery Management Council pursuant to National Oceanic and Atmospheric Administration Award No. NA10NMF4410219 (http://wpcouncil.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro Shigueto Joanna, 2008, Endangered Species Research, V5, P129, DOI 10.3354/esr00142; Alfaro-Shigueto J, 2011, J APPL ECOL, V48, P1432, DOI 10.1111/j.1365-2664.2011.02040.x; Casale P, 2010, AQUAT CONSERV, V20, P611, DOI 10.1002/aqc.1133; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Eguchi T, 2002, MAR MAMMAL SCI, V18, P698, DOI 10.1111/j.1748-7692.2002.tb01067.x; Epperly SP, 1996, B MAR SCI, V59, P289; Espinosa-Carreon TL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002105; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Geraci Joseph R., 1999, P367; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; GILMAN E, 2009, P TECHN WORKSH MIT S; Godley Brendan, 1998, Zoology in the Middle East, V16, P49; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Hays GC, 2012, P ROY SOC B-BIOL SCI, V279, P465, DOI 10.1098/rspb.2011.0978; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Peckham SH, 2011, MAR ECOL PROG SER, V425, P269, DOI 10.3354/meps08995; *INEGI, 2005, AN EST EST BAJ CAL; IUCN, 2012, IUCN RED LIST THREAT; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Koch V, 2007, MAR BIOL, V153, P35, DOI 10.1007/s00227-007-0782-1; Legaard KR, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003282; Lewison RL, 2011, B MAR SCI, V87, P235, DOI 10.5343/bms.2010.1062; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lopez-Castro Melania C., 2010, Endangered Species Research, V11, P35, DOI 10.3354/esr00264; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MANCINI A, 2009, THESIS U AUTONOMA BC; Mancini A, 2012, ORYX, V46, P69, DOI 10.1017/S0030605310001833; Mancini A, 2011, HUM ECOL, V39, P743, DOI 10.1007/s10745-011-9425-8; Mancini Agnese, 2009, Endangered Species Research, V7, P1, DOI 10.3354/esr00165; Mangel JC, 2010, BIOL CONSERV, V143, P136, DOI 10.1016/j.biocon.2009.09.017; Mercuri M, 2008, THESIS I POLITECNICO; Monzon-Arguello C, 2012, J R SOC INTERFACE, V9, P1725, DOI 10.1098/rsif.2011.0788; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; NICHOLS WJ, 2004, CONSERVATION PRACTIC, V5, P30; NICHOLS WJ, 2003, THESIS U ARIZONA TUC; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Peckham S. Hoyt, 2008, Endangered Species Research, V5, P171, DOI 10.3354/esr00123; Petersen Samantha L., 2008, Endangered Species Research, V5, P117, DOI 10.3354/esr00132; Prellezo Raul, 2008, Endangered Species Research, V5, P335, DOI 10.3354/esr00140; RAFTERY AE, 1988, BIOMETRIKA, V75, P223, DOI 10.1093/biomet/75.2.223; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Secretaria de Agricultura Ganaderia Desarrollo Rural Pesca y Alimentacion (SAGARPA), 2010, AN PESC; Shanker K, 2004, BIOL CONSERV, V115, P149, DOI 10.1016/S0006-3207(03)00104-6; Sharifi M, 2007, INT AGROPHYS, V21, P391; Shaver D.J., 1990, Marine Turtle Newsletter, P25; Soykan Candan U., 2008, Endangered Species Research, V5, P91, DOI 10.3354/esr00175; Tomas Jesus, 2008, Endangered Species Research, V5, P161, DOI 10.3354/esr00116; Wallace BP, 2010, CONSERV LETT, V3, P1; Wingfield DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027874; WITHERINGTON BE, 1989, COPEIA, P696; Zaytsev O, 2003, J OCEANOGR, V59, P489, DOI 10.1023/A:1025544700632	54	45	48	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56776	10.1371/journal.pone.0056776	http://dx.doi.org/10.1371/journal.pone.0056776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23483880	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200157
J	Barboza, P; Vaillant, L; Mawudeku, A; Nelson, NP; Hartley, DM; Madoff, LC; Linge, JP; Collier, N; Brownstein, JS; Yangarber, R; Astagneau, P				Barboza, Philippe; Vaillant, Laetitia; Mawudeku, Abla; Nelson, Noele P.; Hartley, David M.; Madoff, Lawrence C.; Linge, Jens P.; Collier, Nigel; Brownstein, John S.; Yangarber, Roman; Astagneau, Pascal		Global Hlth Security Initiative	Evaluation of Epidemic Intelligence Systems Integrated in the Early Alerting and Reporting Project for the Detection of A/H5N1 Influenza Events	PLOS ONE			English	Article							EARLY WARNING SYSTEM; PROMED-MAIL; INTERNET; SURVEILLANCE; DISEASES; CLASSIFICATION; BIOCASTER; HEALTHMAP	The objective of Web-based expert epidemic intelligence systems is to detect health threats. The Global Health Security Initiative (GHSI) Early Alerting and Reporting (EAR) project was launched to assess the feasibility and opportunity for pooling epidemic intelligence data from seven expert systems. EAR participants completed a qualitative survey to document epidemic intelligence strategies and to assess perceptions regarding the systems performance. Timeliness and sensitivity were rated highly illustrating the value of the systems for epidemic intelligence. Weaknesses identified included representativeness, completeness and flexibility. These findings were corroborated by the quantitative analysis performed on signals potentially related to influenza A/H5N1 events occurring in March 2010. For the six systems for which this information was available, the detection rate ranged from 31% to 38%, and increased to 72% when considering the virtual combined system. The effective positive predictive values ranged from 3% to 24% and F1-scores ranged from 6% to 27%. System sensitivity ranged from 38% to 72%. An average difference of 23% was observed between the sensitivities calculated for human cases and epizootics, underlining the difficulties in developing an efficient algorithm for a single pathology. However, the sensitivity increased to 93% when the virtual combined system was considered, clearly illustrating complementarities between individual systems. The average delay between the detection of A/H5N1 events by the systems and their official reporting by WHO or OIE was 10.2 days (95% CI: 6.7-13.8). This work illustrates the diversity in implemented epidemic intelligence activities, differences in system's designs, and the potential added values and opportunities for synergy between systems, between users and between systems and users.	[Barboza, Philippe; Vaillant, Laetitia] Inst Veille Sanitaire, French Inst Publ Hlth Surveillance, Int Dept, St Maurice, France; [Mawudeku, Abla] Publ Hlth Agcy Canada, Situat Awareness Sect, Ottawa, ON, Canada; [Nelson, Noele P.] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA; [Hartley, David M.] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20007 USA; [Madoff, Lawrence C.] Int Soc Infect Dis, ProMED Mail, Boston, MA USA; [Linge, Jens P.] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy; [Collier, Nigel] Natl Inst Informat, Tokyo, Japan; [Brownstein, John S.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Yangarber, Roman] Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland; [Astagneau, Pascal] Univ Paris 06, Sch Med, Dept Publ Hlth, Paris, France	Institute of Public Health Surveillance; Public Health Agency of Canada; Georgetown University; Georgetown University; European Commission Joint Research Centre; EC JRC ISPRA Site; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Helsinki; UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte	Barboza, P (corresponding author), Inst Veille Sanitaire, French Inst Publ Hlth Surveillance, Int Dept, St Maurice, France.	p.barboza@invs.sante.fr	Astagneau, Pascal/AAF-3473-2020; Yangarber, Roman/H-4762-2016; Riccardo, Flavia/K-5215-2016	Hartley, David/0000-0001-5202-6278; Hartley, David/0000-0003-2589-2538; Riccardo, Flavia/0000-0002-1582-6329; Collier, Nigel/0000-0002-7230-4164; Yangarber, Roman/0000-0001-5264-9870; Declich, Silvia/0000-0002-5916-3889; Dente, Maria Grazia/0000-0002-0782-6564	GHSI	GHSI	Our thanks to the entire EAR working group for their participation and fruitful discussion raised by this manuscript. We gratefully acknowledge GHSI which supports the project and allow countries and institutions to provide human and financial supports for this project.	Bohigas PA, 2009, CLIN MICROBIOL INFEC, V15, P734, DOI 10.1111/j.1469-0691.2009.02875.x; Brownstein J., 2007, EUROSURVEILLANCE, V12, DOI DOI 10.2807/ESW.12.48.03322-EN5; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Brownstein John S., 2007, GLOBAL INFECT DIS SU, P122; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Chanlekha H, 2010, INT J MED INFORM, V79, P284, DOI 10.1016/j.ijmedinf.2010.01.014; Collier N, 2010, J BIOMEDICAL SEMANTI, V1; Collier N, 2011, J BIOMEDICAL SEMA S5, V2; Collier N, 2008, BIOINFORMATICS, V24, P2940, DOI 10.1093/bioinformatics/btn534; Conway M, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1323; Cowen P, 2006, JAVMA-J AM VET MED A, V229, P1090, DOI 10.2460/javma.229.7.1090; Dente MG, 2009, EUROSURVEILLANCE, V14; Formenty P, 2006, MED MALADIES INFECT, V36, P9, DOI 10.1016/j.medmal.2005.06.009; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Grishman R, 2002, J BIOMED INFORM, V35, P236, DOI 10.1016/S1532-0464(03)00013-3; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Kaiser R, 2006, EUROSURVEILLANCE, V11; Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114; Linge JP, 2009, EUROSURVEILLANCE, V14; Lyon A, 2012, TRANSBOUND EMERG DIS, V59, P223, DOI 10.1111/j.1865-1682.2011.01258.x; Madoff LC, 2005, ARCH MED RES, V36, P724, DOI 10.1016/j.arcmed.2005.06.005; Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003; Mawudeku A, 2008, GLOBAL PUBLIC HLTH I; Morse SS, 2007, HEALTH AFFAIR, V26, P1069, DOI 10.1377/hlthaff.26.4.1069; Nelson NP, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-4; NELSON NP, 2010, EURO SURVEILL, V15; Rortais A, 2010, FOOD RES INT, V43, P1553, DOI 10.1016/j.foodres.2010.04.009; Rotureau B, 2007, EMERG INFECT DIS, V13, P1590, DOI 10.3201/eid1310.070522; Steinberger R, 2008, NATO SCI PEACE SEC D, P295; Thomas CS, 2011, EMERGING HLTH THREAT, V4; Torii M, 2011, INT J MED INFORM, V80, P56, DOI 10.1016/j.ijmedinf.2010.10.015; Von Etter P, 2010, ASSESSMENT UTILITY W, P29; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Woodall J P, 2001, Cad Saude Publica, V17 Suppl, P147, DOI 10.1590/S0102-311X2001000700024; World Health Organization, 2008, INT HLTH REG 2005, V2nd; World Health Organization (WHO), 2016, INT HLTH REG 2005; Yangarber R, 2006, COMBINING INFORM EPI, P295; Zeldenrust ME, 2008, EURO SURVEILL, V13; Zhang ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015314	40	52	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57252	10.1371/journal.pone.0057252	http://dx.doi.org/10.1371/journal.pone.0057252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472077	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900015
J	de Busserolles, F; Fitzpatrick, JL; Paxton, JR; Marshall, NJ; Collin, SP				de Busserolles, Fanny; Fitzpatrick, John L.; Paxton, John R.; Marshall, N. Justin; Collin, Shaun P.			Eye-Size Variability in Deep-Sea Lanternfishes (Myctophidae): An Ecological and Phylogenetic Study	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; MESOPELAGIC FISHES; FAMILY MYCTOPHIDAE; RETINAL SPECIALIZATIONS; SPECIES COMPOSITION; BIOLUMINESCENCE; VISION; MORPHOLOGY; PATTERNS; SLOPE	One of the most common visual adaptations seen in the mesopelagic zone (200-1000 m), where the amount of light diminishes exponentially with depth and where bioluminescent organisms predominate, is the enlargement of the eye and pupil area. However, it remains unclear how eye size is influenced by depth, other environmental conditions and phylogeny. In this study, we determine the factors influencing variability in eye size and assess whether this variability is explained by ecological differences in habitat and lifestyle within a family of mesopelagic fishes characterized by broad intra-and interspecific variance in depth range and luminous patterns. We focus our study on the lanternfish family (Myctophidae) and hypothesise that lanternfishes with a deeper distribution and/or a reduction of bioluminescent emissions have smaller eyes and that ecological factors rather than phylogenetic relationships will drive the evolution of the visual system. Eye diameter and standard length were measured in 237 individuals from 61 species of lanternfishes representing all the recognised tribes within the family in addition to compiling an ecological dataset including depth distribution during night and day and the location and sexual dimorphism of luminous organs. Hypotheses were tested by investigating the relationship between the relative size of the eye (corrected for body size) and variations in depth and/or patterns of luminous-organs using phylogenetic comparative analyses. Results show a great variability in relative eye size within the Myctophidae at all taxonomic levels (from subfamily to genus), suggesting that this character may have evolved several times. However, variability in eye size within the family could not be explained by any of our ecological variables (bioluminescence and depth patterns), and appears to be driven solely by phylogenetic relationships.	[de Busserolles, Fanny; Collin, Shaun P.] Univ Western Australia, Sch Anim Biol, Neuroecol Grp, Crawley, WA, Australia; [de Busserolles, Fanny; Collin, Shaun P.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Fitzpatrick, John L.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia; [Fitzpatrick, John L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Paxton, John R.] Australian Museum, Sydney, NSW 2000, Australia; [Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, Sensory Neurobiol Grp, Brisbane, Qld, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Manchester; Australian Museum; University of Queensland	de Busserolles, F (corresponding author), Univ Western Australia, Sch Anim Biol, Neuroecol Grp, Crawley, WA, Australia.	debusf01@student.uwa.edu.au	Fitzpatrick, John/E-8766-2011; de Busserolles, Fanny/A-1769-2013; Collin, Shaun/K-8827-2012	de Busserolles, Fanny/0000-0002-4602-9840; Collin, Shaun/0000-0001-6236-0771; Marshall, Justin/0000-0001-9006-6713; Fitzpatrick, John/0000-0002-2834-4409	Australian Research Council; West Australian State Government; Australian Research Council Postdoctoral Fellowship	Australian Research Council(Australian Research Council); West Australian State Government; Australian Research Council Postdoctoral Fellowship(Australian Research Council)	This work was funded by the Australian Research Council (Discovery grant to SPC and a Linkage Grant to NJM and SPC) and the West Australian State Government. JLF is supported by an Australian Research Council Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom E.H., 1976, Report Calif Coop Oceanic Fish Invest, V18, P167; [Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Beebe William, 1944, ZOOLOGICA [NEW YORK], V29, P59; CASE JF, 1977, NATURE, V265, P179, DOI 10.1038/265179a0; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Collin SP, 1998, BRAIN BEHAV EVOLUT, V51, P291; Collin SP, 1996, J FISH BIOL, V49, P157, DOI 10.1111/j.1095-8649.1996.tb06073.x; Collin SP, 1997, BRAIN BEHAV EVOLUT, V50, P335, DOI 10.1159/000113345; DENTON EJ, 1990, LIGHT AND LIFE IN THE SEA, P127; EDWARDS AS, 1977, MAR BIOL, V41, P59, DOI 10.1007/BF00390582; Flynn A, 2012, DEEP SEA RES 1; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; GARTNER JV, 1987, FISH B-NOAA, V85, P81; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HANSEN K, 1977, J ZOOL, V182, P103; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HAYGOOD MG, 1994, J EXP ZOOL, V270, P225, DOI 10.1002/jez.1402700212; Herring P.J., 1985, Symposia of the Society for Experimental Biology, P323; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; HULLEY PA, 1981, ARCH FISCHEREIWISS, V31, P1; HULLEY PA, LIVING MARI IN PRESS; Kaartvedt S, 2012, MAR ECOL PROG SER, V456, P1, DOI 10.3354/meps09785; Karnella C, 1987, BIOL MIDWATER FISHES, V452, P51; Kawasaki K., 1978, Bulletin, Shinshu University Forests, P1; KINZER J, 1985, MAR BIOL, V85, P313, DOI 10.1007/BF00393252; Kristoffersen JB, 1998, SARSIA, V83, P95; Land M.F., 1981, HDB SENSORY PHYSL, Vvii; LAND MF, 1990, LIGHT AND LIFE IN THE SEA, P149; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LAWRY JV, 1974, NATURE, V247, P155, DOI 10.1038/247155a0; Linkowski TB, 1996, MAR BIOL, V124, P495, DOI 10.1007/BF00351031; Locket N. A., 1977, HDB SENSORY PHYSL  5, P67; Madison W., 2011, MESQUITE MODULAR SYS; Mahe J.-C., 2005, MANUEL PROTOCOLES CA; Mallefet J, 1995, MAR BIOL, V124, P381, DOI 10.1007/BF00363911; Marshall N. B., 1954, ASPECTS DEEP SEA BIO; MATTHIESSEN L, 1882, PFLUG ARCH GES PHYS, V38, P521; Matthiessen L., 1882, ARCH GESAMTE PHYSIOL, V27, P510, DOI DOI 10.1007/BF01802978; Moser H. G, 1970, Bull. Los Ang. Cty Mus. Sci., VNo. 7, P1; MOSER HG, 1974, FISH B-NOAA, V72, P391; MOSER HG, 1972, FISH BULL NATL OC AT, V70, P541; Munk O., 1965, GALATHEA REP, V8, P21; MUNK OLE, 1966, DANA REP CARLSBERG FOUND, V70, P5; Murray J, 1902, DEPTHS OCEAN; Nafpaktitis B. G, 1977, Memoirs Sears Fdn mem. Res., V1, P13; NAFPAKTITIS B G, 1978, Natural History Museum of Los Angeles County Science Bulletin, P1; Nafpaktitis B. G., 1969, Bulletin Los Angeles City Museum Sci, VNo. 5, P1; ODAY WT, 1976, MAR BIOL, V37, P187, DOI 10.1007/BF00389128; Olivar MP, 2012, DEEP-SEA RES PT I, V62, P53, DOI 10.1016/j.dsr.2011.12.014; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PANKHURST NW, 1987, ENVIRON BIOL FISH, V19, P269, DOI 10.1007/BF00003228; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paxton J.R., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P239; Paxton JR, 1972, SCI B LOS ANGELES CO, V13, P1; Poulsen JY, BMC EVOLUTI IN PRESS; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; ROBISON BH, 1972, COPEIA, P448; Ross SW, 2010, DEEP-SEA RES PT II, V57, P1926, DOI 10.1016/j.dsr2.2010.05.008; STEFANESCU C, 1992, Scientia Marina, V56, P69; TSUJI FI, 1971, NATURE, V233, P623, DOI 10.1038/233623a0; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; VILTER V, 1951, CR SOC BIOL, V145, P52; Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2; Wagner HJ, 2001, BRAIN BEHAV EVOLUT, V57, P117, DOI 10.1159/000047231; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant E, 2000, PHILOS T ROY SOC B, V355, P1155, DOI 10.1098/rstb.2000.0658; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Warrant Eric J., 2003, P303, DOI 10.1007/978-0-387-22628-6_16; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Williams A, 1997, MAR BIOL, V130, P259, DOI 10.1007/s002270050246; Zahuranec Bernard J., 2000, Smithsonian Contributions to Zoology, V607, P1	75	33	33	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58519	10.1371/journal.pone.0058519	http://dx.doi.org/10.1371/journal.pone.0058519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472203	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900149
J	Foster, HR; Fuerst, E; Lee, TH; Cousins, DJ; Woszczek, G				Foster, Holly R.; Fuerst, Elisabeth; Lee, Tak H.; Cousins, Davis J.; Woszczek, Grzegorz			Characterisation of P2Y(12) Receptor Responsiveness to Cysteinyl Leukotrienes	PLOS ONE			English	Article							ALLERGIC INFLAMMATION; PLATELET ACTIVATION; HUMAN MONOCYTES; ASTHMA; EXPRESSION; CELLS; D-4; IDENTIFICATION; AIRWAYS; E-4	Leukotriene E-4 (LTE4), the most stable of the cysteinyl leukotrienes (cysLTs), binds poorly to classical type 1 and 2 cysLT receptors although in asthmatic individuals it may potently induce bronchial constriction, airway hyperresponsiveness and inflammatory cell influx to the lung. A recent study has suggested that the purinergic receptor P2Y(12) is required for LTE4 mediated pulmonary inflammation in a mouse model of asthma and signals in response to cysLTs. The aim of the study was to characterise the responsiveness of human P2Y(12) to cysteinyl leukotrienes. Models of human CysLT(1), CysLT(2) and P2Y(12) overexpressed in HEK293, CHO cells and human platelets were used and responsiveness to different agonists was measured using intracellular calcium, cAMP and beta-arrestin recruitment assays. CysLTs induced concentration dependent calcium mobilisation in cells overexpressing CysLT(1) and CysLT(2) but failed to induce any calcium response in cells expressing P2Y(12) or P2Y(12)+ G alpha(16). In contrast, selective P2Y(12) agonists ADP and 2-MeS-ADP induced specific calcium flux in cells expressing P2Y(12)+ G alpha(16). Similarly, specific response to 2-MeS-ADP, but not to cysLTs was also observed in cells expressing P2Y(12) when intracellular cAMP and beta-arrestin signalling were analysed. Platelets were used as a model of human primary cells expressing P2Y(12) to analyse potential signalling and cell activation through P2Y(12) receptor or receptor heterodimers but no specific LTE4 responses were observed. These results show that LTE4 as well as other cysLTs do not activate intracellular signalling acting through P2Y(12) and suggest that another LTE4 specific receptor has yet to be identified.	[Woszczek, Grzegorz] Kings Coll London, MRC, London WC2R 2LS, England; Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, Dept Asthma Allergy & Resp Sci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Woszczek, G (corresponding author), Kings Coll London, MRC, London WC2R 2LS, England.	grzegorz.woszczek@kcl.ac.uk	Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059; Cousins, David/0000-0003-3821-9596; Foster, Holly/0000-0001-8118-9842	Medical Research Council [G0900536]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; MRC [G0900536] Funding Source: UKRI; Medical Research Council [G1000758] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Medical Research Council (G0900536) to Grzegorz Woszczek. The authors acknowledge support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baurand A, 2005, MOL PHARMACOL, V67, P721, DOI 10.1124/mol.104.004846; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; BUCKNER CK, 1990, J PHARMACOL EXP THER, V252, P77; Chen LY, 2011, ALLERGY, V66, P1304, DOI 10.1111/j.1398-9995.2011.02647.x; Diamant Z, 1997, AM J RESP CRIT CARE, V155, P1247, DOI 10.1164/ajrccm.155.4.9105062; Gauvreau GM, 2001, AM J RESP CRIT CARE, V164, P1495, DOI 10.1164/ajrccm.164.8.2102033; GRESELE P, 1993, J ALLERGY CLIN IMMUN, V91, P894, DOI 10.1016/0091-6749(93)90347-I; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Kowal K, 2006, CLIN EXP ALLERGY, V36, P426, DOI 10.1111/j.1365-2222.2006.02446.x; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; Lee TH, 2009, J ALLERGY CLIN IMMUN, V124, P417, DOI 10.1016/j.jaci.2009.04.020; Luttrell LM, 2002, J CELL SCI, V115, P455; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Nonaka Y, 2005, BIOCHEM BIOPH RES CO, V337, P281, DOI 10.1016/j.bbrc.2005.09.052; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Parmentier CN, 2012, J ALLERGY CLIN IMMUN, V129, P1136, DOI 10.1016/j.jaci.2012.01.057; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Pitchford SC, 2004, BLOOD, V103, P639, DOI 10.1182/blood-2003-05-1707; Pitchford SC, 2003, J ALLERGY CLIN IMMUN, V112, P109, DOI 10.1067/mai.2003.1514; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Woszczek G, 2008, J ALLERGY CLIN IMMUN, V121, P215, DOI 10.1016/j.jaci.2007.09.013; Woszczek G, 2007, J IMMUNOL, V178, P5262, DOI 10.4049/jimmunol.178.8.5262; YAMAMOTO H, 1993, J ALLERGY CLIN IMMUN, V91, P79, DOI 10.1016/0091-6749(93)90299-U	28	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58305	10.1371/journal.pone.0058305	http://dx.doi.org/10.1371/journal.pone.0058305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472176	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900122
J	Martinot, AJ; Meythaler, M; Pozzi, LA; Boisvert, KD; Knight, H; Walsh, D; Westmoreland, S; Anderson, DC; Kaur, A; O'Neil, SP				Martinot, Amanda J.; Meythaler, Mareike; Pozzi, Lu-Ann; Boisvert, Karen Dalecki; Knight, Heather; Walsh, Dennis; Westmoreland, Susan; Anderson, Daniel C.; Kaur, Amitinder; O'Neil, Shawn P.			Acute SIV Infection in Sooty Mangabey Monkeys Is Characterized by Rapid Virus Clearance from Lymph Nodes and Absence of Productive Infection in Germinal Centers	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; FOLLICULAR DENDRITIC CELLS; CD4(+) T-CELLS; ASYMPTOMATIC PATIENTS; HIV-1 REPLICATION; TYPE-1; AIDS; MACAQUES; LYMPHOCYTES; RESERVOIR	Lymphoid tissue immunopathology is a characteristic feature of chronic HIV/SIV infection in AIDS-susceptible species, but is absent in SIV-infected natural hosts. To investigate factors contributing to this difference, we compared germinal center development and SIV RNA distribution in peripheral lymph nodes during primary SIV infection of the natural host sooty mangabey and the non-natural host pig-tailed macaque. Although SIV-infected cells were detected in the lymph node of both species at two weeks post infection, they were confined to the lymph node paracortex in immune-competent mangabeys but were seen in both the paracortex and the germinal center of SIV-infected macaques. By six weeks post infection, SIV-infected cells were no longer detected in the lymph node of sooty mangabeys. The difference in localization and rate of disappearance of SIV-infected cells between the two species was associated with trapping of cell-free virus on follicular dendritic cells and higher numbers of germinal center CD4(+) T lymphocytes in macaques post SIV infection. Our data suggests that fundamental differences in the germinal center microenvironment prevent productive SIV infection within the lymph node germinal centers of natural hosts contributing to sustained immune competency.	[Martinot, Amanda J.; Boisvert, Karen Dalecki; Knight, Heather; Walsh, Dennis; Westmoreland, Susan; O'Neil, Shawn P.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA; [Meythaler, Mareike; Pozzi, Lu-Ann; Kaur, Amitinder] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Immunol, Southborough, MA 01772 USA; [Anderson, Daniel C.] Emory Univ, Yerkes Natl Primate Res Ctr, Div Res Resources, Atlanta, GA 30322 USA; [Meythaler, Mareike] Univ Erlangen Nurnberg, Inst Klin & Mol Virol, Erlangen, Germany	Harvard University; Harvard University; Emory University; University of Erlangen Nuremberg	Martinot, AJ (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA.	amanda_martinot@hms.harvard.edu			National Institutes of Health [RR000168, RR000165, AI049809, AI084810, R01-NS048831, P51OD011103, P51OD011132]; Emory Center for AIDS Research Grant [P30 AI50409]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI084810, R01AI049809, T32AI007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048831] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103, P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Center for AIDS Research Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research is supported by National Institutes of Health grants RR000168, RR000165, AI049809, AI084810, R01-NS048831, P51OD011103 and P51OD011132. Work by the Emory University Center for AIDS Research virology core was supported by Emory Center for AIDS Research Grant P30 AI50409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi A, 2009, SCIENCE, V325, P953, DOI 10.1126/science.1178752; Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Burton GF, 2002, SEMIN IMMUNOL, V14, P275, DOI 10.1016/S1044-5323(02)00060-X; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; CHAKRABARTI L, 1994, J VIROL, V68, P6634, DOI 10.1128/JVI.68.10.6634-6643.1994; CHAKRABARTI L, 1995, VIROLOGY, V213, P535, DOI 10.1006/viro.1995.0026; Chakrabarti LA, 2000, J VIROL, V74, P1209, DOI 10.1128/JVI.74.3.1209-1223.2000; CHALIFOUX LV, 1987, AM J PATHOL, V128, P104; Cumont MC, 2008, J VIROL, V82, P1175, DOI 10.1128/JVI.00450-07; Diop OM, 2000, J VIROL, V74, P7538, DOI 10.1128/JVI.74.16.7538-7547.2000; Dumaurier MJ, 2005, J GEN VIROL, V86, P3369, DOI 10.1099/vir.0.81133-0; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; EMBRETSON J, 1993, P NATL ACAD SCI USA, V90, P357, DOI 10.1073/pnas.90.1.357; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Folkvord JM, 2005, AIDS RES HUM RETROV, V21, P363, DOI 10.1089/aid.2005.21.363; FOX CH, 1991, J INFECT DIS, V164, P1051, DOI 10.1093/infdis/164.6.1051; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Gueye A, 2004, J MED PRIMATOL, V33, P83, DOI 10.1111/j.1600-0684.2004.00057.x; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Ho J, 2007, J IMMUNOL, V178, P6968, DOI 10.4049/jimmunol.178.11.6968; Kacani L, 2000, J VIROL, V74, P7997, DOI 10.1128/JVI.74.17.7997-8002.2000; Kaur A, 2008, J VIROL, V82, P1084, DOI 10.1128/JVI.02197-07; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; LAURENCE J, 1993, ANN NY ACAD SCI, V693, P52, DOI 10.1111/j.1749-6632.1993.tb26256.x; Ma CS, 2009, IMMUNITY, V31, P12, DOI 10.1016/j.immuni.2009.06.009; Meythaler M, 2011, J IMMUNOL, V186, P5151, DOI 10.4049/jimmunol.1004110; Meythaler M, 2009, J VIROL, V83, P572, DOI 10.1128/JVI.01715-08; Milush JM, 2007, J IMMUNOL, V179, P3047, DOI 10.4049/jimmunol.179.5.3047; O'Neil SP, 2004, AM J PATHOL, V164, P1157, DOI 10.1016/S0002-9440(10)63204-X; O'Neil SP, 2000, J INFECT DIS, V182, P1051, DOI 10.1086/315823; Ohba K, 2009, J IMMUNOL, V183, P524, DOI 10.4049/jimmunol.0900371; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Pallikkuth S, 2012, CYTOKINE GROWTH F R, V23, P173, DOI 10.1016/j.cytogfr.2012.05.004; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; PANTALEO G, 1994, IMMUNOL REV, V140, P105, DOI 10.1111/j.1600-065X.1994.tb00867.x; RACZ P, 1986, PROG ALLERGY, V37, P81; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Rey-Cuille MA, 1998, J VIROL, V72, P3872; Rosenberg YJ, 1997, EUR J IMMUNOL, V27, P3214, DOI 10.1002/eji.1830271219; SCHMITZ J, 1994, J IMMUNOL, V153, P1352; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Smith BA, 2001, J IMMUNOL, V166, P690, DOI 10.4049/jimmunol.166.1.690; SPIEGEL H, 1992, AM J PATHOL, V140, P15; Tenner-Racz K, 1998, J EXP MED, V187, P949, DOI 10.1084/jem.187.6.949; TENNERRACZ K, 1993, AM J PATHOL, V142, P1750; TENNERRACZ K, 1988, NEW ENGL J MED, V318, P49, DOI 10.1056/NEJM198801073180113; Thacker TC, 2009, J VIROL, V83, P150, DOI 10.1128/JVI.01652-08; van Nierop K, 2002, SEMIN IMMUNOL, V14, P251, DOI 10.1016/S1044-5323(02)00057-X; Yearley JH, 2008, DEV COMP IMMUNOL, V32, P1510, DOI 10.1016/j.dci.2008.06.006	53	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57785	10.1371/journal.pone.0057785	http://dx.doi.org/10.1371/journal.pone.0057785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472105	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900044
J	Venkatesh, T; Nagashri, MN; Swamy, SS; Mohiyuddin, SMA; Gopinath, KS; Kumar, A				Venkatesh, Thejaswini; Nagashri, Mathighatta Nagaraj; Swamy, Shivananda S.; Mohiyuddin, S. M. Azeem; Gopinath, Kodaganur S.; Kumar, Arun			Primary Microcephaly Gene MCPH1 Shows Signatures of Tumor Suppressors and Is Regulated by miR-27a in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CHROMOSOME ARM 8P; CENTROSOME AMPLIFICATION; ALLELIC IMBALANCE; MITOTIC ENTRY; EXPRESSION; PROTEIN; CANCER; MUTATIONS; IDENTIFICATION	Mutations in the MCPH1 (microcephalin 1) gene, located at chromosome 8p23.1, result in two autosomal recessive disorders: primary microcephaly and premature chromosome condensation syndrome. MCPH1 has also been shown to be downregulated in breast, prostate and ovarian cancers, and mutated in 1/10 breast and 5/41 endometrial tumors, suggesting that it could also function as a tumor suppressor (TS) gene. To test the possibility of MCPH1 as a TS gene, we first performed LOH study in a panel of 81 matched normal oral tissues and oral squamous cell carcinoma (OSCC) samples, and observed that 14/71 (19.72%) informative samples showed LOH, a hallmark of TS genes. Three protein truncating mutations were identified in 1/15 OSCC samples and 2/5 cancer cell lines. MCPH1 was downregulated at both the transcript and protein levels in 21/41 (51.22%) and 19/25 (76%) OSCC samples respectively. A low level of MCPH1 promoter methylation was also observed in 4/40 (10%) tumor samples. We further observed that overexpression of MCPH1 decreased cellular proliferation, anchorage-independent growth in soft agar, cell invasion and tumor size in nude mice, indicating its tumor suppressive function. Using bioinformatic approaches and luciferase assay, we showed that the 3'-UTR of MCPH1 harbors two non-overlapping functional seed regions for miR-27a which negatively regulated its level. The expression level of miR-27a negatively correlated with the MCPH1 protein level in OSCC. Our study indicates for the first time that, in addition to its role in brain development, MCPH1 also functions as a tumor suppressor gene and is regulated by miR-27a.	[Venkatesh, Thejaswini; Nagashri, Mathighatta Nagaraj; Kumar, Arun] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Swamy, Shivananda S.; Gopinath, Kodaganur S.] Bangalore Inst Oncol, Dept Surg Oncol, Bangalore, Karnataka, India; [Mohiyuddin, S. M. Azeem] RL Jalappa Hosp & Res Ctr, Dept Otolaryngol & Head & Neck Surg, Kolar, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kumar, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	karun@mrdg.iisc.ernet.in	Kumar, Arun/C-9149-2009; Venkatesh, Thejaswini/ABC-4002-2021; Mohiyuddin, S M Azeem/ABA-5063-2020	Kumar, Arun/0000-0001-8422-0219; Venkatesh, Thejaswini/0000-0002-5831-9255; Mohiyuddin, S M Azeem/0000-0002-0974-2057	Council for Scientific and Industrial Research, New Delhi [27(0192)/09/EMR-II]; University Grants Commission, New Delhi	Council for Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	This work was financially supported by a research grant (number 27(0192)/09/EMR-II) from the Council for Scientific and Industrial Research, New Delhi to AK and KSG, and a Junior Research Fellowship from the University Grants Commission, New Delhi, to TV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andressakis D, 2008, J LARYNGOL OTOL, V122, P1213, DOI 10.1017/S0022215108002636; Bajaj V, 2008, GENE, V424, P40, DOI 10.1016/j.gene.2008.07.032; Beder LB, 2006, J CANCER RES CLIN, V132, P19, DOI 10.1007/s00432-005-0033-0; Bhat V, 2011, CLIN GENET, V80, P532, DOI 10.1111/j.1399-0004.2011.01686.x; Bikeye SNN, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-1; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; Brown JAL, 2010, ONCOGENE, V29, P5537, DOI 10.1038/onc.2010.302; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Darvish H, 2010, J MED GENET, V47, P823, DOI 10.1136/jmg.2009.076398; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Farooq M, 2010, AM J MED GENET A, V152A, P495, DOI 10.1002/ajmg.a.33234; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Ghani-Kakhki M, 2012, MOL SYNDROMOL, V3, P6, DOI 10.1159/000338975; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Hague A, 2004, J PATHOL, V204, P175, DOI 10.1002/path.1630; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Hussain MS, 2012, CLIN GENET, V6, P9999; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jiang L, 2009, EUR J ORAL SCI, V117, P90, DOI 10.1111/j.1600-0722.2008.00599.x; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kubetzko FBB, 2004, CARCINOGENESIS, V25, P1839, DOI 10.1093/carcin/bgh190; Kumar A, 1998, HUM GENET, V103, P173; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Liu DW, 2005, EUR RESPIR J, V26, P1002, DOI 10.1183/09031936.05.00050205; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2007, WORLD J GASTROENTERO, V13, P1090, DOI 10.3748/wjg.v13.i7.1090; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; MACGROGAN D, 1994, GENE CHROMOSOME CANC, V10, P151, DOI 10.1002/gcc.2870100302; Michor F, 2010, CANCER PREV RES, V3, P1361, DOI 10.1158/1940-6207.CAPR-10-0234; Pan SA, 2010, CLIN CANCER RES, V16, P442, DOI 10.1158/1078-0432.CCR-09-2574; Peng G, 2009, CELL CYCLE, V8, P3071, DOI 10.4161/cc.8.19.9411; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Shi L, 2012, FEBS J, V279, P491, DOI 10.1111/j.1742-4658.2011.08441.x; Simmons ML, 2001, CANCER RES, V61, P1122; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; Tsai WC, 2006, MOL CANCER RES, V4, P539, DOI 10.1158/1541-7786.MCR-05-0266; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; White JS, 2007, ORAL ONCOL, V43, P701, DOI 10.1016/j.oraloncology.2006.09.001; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wu CL, 1997, GENE CHROMOSOME CANC, V20, P347, DOI 10.1002/(SICI)1098-2264(199712)20:4<347::AID-GCC5>3.0.CO;2-1; Xi S, 2003, J DENT RES, V82, P11, DOI 10.1177/154405910308200104; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Zemlyakova V. V., 2003, Molekulyarnaya Biologiya (Moscow), V37, P696	55	34	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e54643	10.1371/journal.pone.0054643	http://dx.doi.org/10.1371/journal.pone.0054643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472065	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000315637900003
J	Chapman, CH; Nazem-Zadeh, M; Lee, OE; Schipper, MJ; Tsien, CI; Lawrence, TS; Cao, Y				Chapman, Christopher H.; Nazem-Zadeh, Mohammad; Lee, Oliver E.; Schipper, Matthew J.; Tsien, Christina I.; Lawrence, Theodore S.; Cao, Yue			Regional Variation in Brain White Matter Diffusion Index Changes following Chemoradiotherapy: A Prospective Study Using Tract-Based Spatial Statistics	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RADIATION-INDUCED CHANGES; CENTRAL-NERVOUS-SYSTEM; CRANIAL IRRADIATION; RETINAL ISCHEMIA; LIMBIC CIRCUIT; RADIOTHERAPY; THERAPY; INJURY; GLIOMA	Purpose: There is little known about how brain white matter structures differ in their response to radiation, which may have implications for radiation-induced neurocognitive impairment. We used diffusion tensor imaging (DTI) to examine regional variation in white matter changes following chemoradiotherapy. Methods: Fourteen patients receiving two or three weeks of whole-brain radiation therapy (RT) +/- chemotherapy underwent DTI pre-RT, at end-RT, and one month post-RT. Three diffusion indices were measured: fractional anisotropy (FA), radial diffusivity (RD), and axial diffusivity (AD). We determined significant individual voxel changes of diffusion indices using tract-based spatial statistics, and mean changes of the indices within fourteen white matter structures of interest. Results: Voxels of significant FA decreases and RD increases were seen in all structures (p<0.05), with the largest changes (20-50%) in the fornix, cingula, and corpus callosum. There were highly significant between-structure differences in pre-RT to end-RT mean FA changes (p<0.001). The inferior cingula had a mean FA decrease from pre-RT to end-RT significantly greater than 11 of the 13 other structures (p<0.00385). Conclusions: Brain white matter structures varied greatly in their response to chemoradiotherapy as measured by DTI changes. Changes in FA and RD related to white matter demyelination were prominent in the cingula and fornix, structures relevant to radiation-induced neurocognitive impairment. Future research should evaluate DTI as a predictive biomarker of brain chemoradiotherapy adverse effects.	[Chapman, Christopher H.; Nazem-Zadeh, Mohammad; Schipper, Matthew J.; Tsien, Christina I.; Lawrence, Theodore S.; Cao, Yue] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Lee, Oliver E.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Cao, Yue] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Cao, Yue] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chapman, CH (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	chchap@med.umich.edu		Nazem-Zadeh, Mohammad-Reza/0000-0001-6831-1815	National Institutes of Health [RO1 NS064973, R21 CA113699]; NATIONAL CANCER INSTITUTE [T32CA083654, R21CA113699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grants RO1 NS064973 and R21 CA113699. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2001, NEUROL MED-CHIR, V41, P590, DOI 10.2176/nmc.41.590; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bokemeyer C, 1996, J CLIN ONCOL, V14, P2923, DOI 10.1200/JCO.1996.14.11.2923; CALVO W, 1988, BRIT J RADIOL, V61, P1043, DOI 10.1259/0007-1285-61-731-1043; Cao Y, 2005, MED PHYS, V32, P2136, DOI 10.1118/1.1999737; Cao Y, 2011, SEMIN RADIAT ONCOL, V21, P147, DOI 10.1016/j.semradonc.2010.11.001; Chapman CH, 2012, INT J RADIAT ONCOL, V82, P2033, DOI 10.1016/j.ijrobp.2011.01.068; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; CONSTINE LS, 1988, INT J RADIAT ONCOL, V15, P319, DOI 10.1016/S0360-3016(98)90011-6; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Dellani PR, 2008, J MAGN RESON IMAGING, V27, P1250, DOI 10.1002/jmri.21364; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Ghia A, 2007, INT J RADIAT ONCOL, V68, P971, DOI 10.1016/j.ijrobp.2007.02.016; Hattori T, 2012, AM J NEURORADIOL, V33, P97, DOI 10.3174/ajnr.A2706; Hodges H, 1998, BEHAV BRAIN RES, V91, P99, DOI 10.1016/S0166-4328(97)00108-3; Hsiao KY, 2010, INT J RADIAT ONCOL, V77, P722, DOI 10.1016/j.ijrobp.2009.06.080; Hua CH, 2012, INT J RADIAT ONCOL, V82, P2047, DOI 10.1016/j.ijrobp.2011.03.057; Khong PL, 2003, AM J NEURORADIOL, V24, P734; Lautin A., 2002, LIMBIC BRAIN; Lawrence YR, 2010, INT J RADIAT ONCOL, V76, pS20, DOI 10.1016/j.ijrobp.2009.02.091; Leung LHT, 2004, NEUROIMAGE, V21, P261, DOI 10.1016/j.neuroimage.2003.09.020; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marsh JC, 2011, J MED IMAG RADIAT ON, V55, P442, DOI 10.1111/j.1754-9485.2011.02282.x; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MiotNoirault E, 1996, AM J NEURORADIOL, V17, P907; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagesh V, 2008, INT J RADIAT ONCOL, V70, P1002, DOI 10.1016/j.ijrobp.2007.08.020; Nazem-Zadeh MR, 2012, MED PHYS, V39, P5603, DOI 10.1118/1.4745560; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; Okada S, 2001, NEUROPATHOLOGY, V21, P247, DOI 10.1046/j.1440-1789.2001.00408.x; Qiu D, 2007, INT J RADIAT ONCOL, V69, P846, DOI 10.1016/j.ijrobp.2007.04.041; Radiation Therapy Oncology Group; National Cancer Institute, 2010, AV HIPP WHOL BRAIN R; REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Shah A, 2012, J CLIN NEUROSCI, V19, P289, DOI 10.1016/j.jocn.2011.04.039; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Surma-aho O, 2001, NEUROLOGY, V56, P1285, DOI 10.1212/WNL.56.10.1285; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; VANDERKOGEL AJ, 1986, BRIT J CANCER, V53, P207; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Welzel T, 2008, AM J NEURORADIOL, V29, P379, DOI 10.3174/ajnr.A0797; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yu JB, 2007, INT J RADIAT ONCOL, V68, P621, DOI 10.1016/j.ijrobp.2006.12.004; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	54	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57768	10.1371/journal.pone.0057768	http://dx.doi.org/10.1371/journal.pone.0057768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469234	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900043
J	Dwivedi, S; AlKhedhairy, AA; Ahamed, M; Musarrat, J				Dwivedi, Sourabh; AlKhedhairy, Abdulaziz A.; Ahamed, Maqusood; Musarrat, Javed			Biomimetic Synthesis of Selenium Nanospheres by Bacterial Strain JS-11 and Its Role as a Biosensor for Nanotoxicity Assessment: A Novel Se-Bioassay	PLOS ONE			English	Article							ELEMENTAL RED SELENIUM; SILVER NANOPARTICLES; CARBON NANOTUBES; REDUCTION; SELENATE; BIOSYNTHESIS; TELLURITE; TOXICITY; GROWTH; PHENAZINE-1-CARBOXAMIDE	Selenium nanoparticles (Se-NPs) were synthesized by green technology using the bacterial isolate Pseudomonas aeruginosa strain JS-11. The bacteria exhibited significant tolerance to selenite (SeO32-) up to 100 mM concentration with an EC50 value of 140 mM. The spent medium (culture supernatant) contains the potential of reducing soluble and colorless SeO32- to insoluble red elemental selenium (Se-0) at 37 degrees C. Characterization of red Se degrees product by use of UV-Vis spectroscopy, X-ray diffraction (XRD), atomic force microscopy (AFM) and transmission electron microscopy (TEM) with energy dispersive X-ray spectrum (EDX) analysis revealed the presence of stable, predominantly monodispersed and spherical selenium nanoparticles (Se-NPs) of an average size of 21 nm. Most likely, the metabolite phenazine-1-carboxylic acid (PCA) released by strain JS-11 in culture supernatant along with the known redox agents like NADH and NADH dependent reductases are responsible for biomimetic reduction of SeO32- to Se degrees nanospheres. Based on the bioreduction of a colorless solution of SeO32- to elemental red Se-0, a high throughput colorimetric bioassay (Se-Assay) was developed for parallel detection and quantification of nanoparticles (NPs) cytotoxicity in a 96 well format. Thus, it has been concluded that the reducing power of the culture supernatant of strain JS-11 could be effectively exploited for developing a simple and environmental friendly method of Se-NPs synthesis. The results elucidated that the red colored Se degrees nanospheres may serve as a biosensor for nanotoxicity assessment, contemplating the inhibition of SeO32- bioreduction process in NPs treated bacterial cell culture supernatant, as a toxicity end point.	[Dwivedi, Sourabh; AlKhedhairy, Abdulaziz A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Ahamed, Maqusood] King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh, Saudi Arabia; [Musarrat, Javed] Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India	King Saud University; King Saud University; Aligarh Muslim University	Musarrat, J (corresponding author), Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India.	musarratj1@yahoo.com	Musarrat, Javed/N-4094-2019; Ahamed, Maqusood/R-8619-2017; Dwivedi, Sourabh/I-2060-2013; Al-Khedhairy, Abdulaziz A A/F-8327-2011; Musarrat, Javed/I-1942-2013	Ahamed, Maqusood/0000-0001-6025-1950; Al-Khedhairy, Abdulaziz A A/0000-0002-1210-6262; dwivedi, sourabh/0000-0002-7591-5358; Musarrat, Javed/0000-0001-5981-3813	National Plan for Sciences and Technology (NPST), King Saud University, Riyadh [10-NAN1115-02]	National Plan for Sciences and Technology (NPST), King Saud University, Riyadh	Financial support through the National Plan for Sciences and Technology (NPST Project No. 10-NAN1115-02), King Saud University, Riyadh, for this study, is greatly acknowledged. (http://npst.ksu.edu.sa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkar E, 2003, FEMS MICROBIOL LETT, V226, P107, DOI 10.1016/S0378-1097(03)00609-8; Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; Anjaiah V, 1998, MOL PLANT MICROBE IN, V11, P847, DOI 10.1094/MPMI.1998.11.9.847; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Avazeri C, 1997, MICROBIOL-SGM, V143, P1181, DOI 10.1099/00221287-143-4-1181; Binaeian E., 2012, WASET, V67, P1219, DOI [10.5281/zenodo.1077312, DOI 10.5281/ZENODO.1077312]; Bledsoe TL, 1999, APPL MICROBIOL BIOT, V51, P682, DOI 10.1007/s002530051452; Casey A, 2007, CARBON, V45, P34, DOI 10.1016/j.carbon.2006.08.009; DEMOLLDECKER H, 1993, ARCH MICROBIOL, V160, P241; Dhanjal S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-52; Dong Y, 2003, CANCER RES, V63, P52; Dudev T, 2010, J AM CHEM SOC, V132, P16533, DOI 10.1021/ja106600k; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Etezad SM, 2009, ENZYME MICROB TECH, V45, P1, DOI 10.1016/j.enzmictec.2009.04.004; EUSTICE DC, 1981, PLANT PHYSIOL, V67, P1054, DOI 10.1104/pp.67.5.1054; Euzeby J, 2008, INT J SYST EVOL MICR, V58, P1057; Fesharaki PJ, 2010, BRAZ J MICROBIOL, V41, P461, DOI [10.1590/S1517-83822010000200028, 10.1590/S1517-838220100002000028]; He SY, 2007, MATER LETT, V61, P3984, DOI 10.1016/j.matlet.2007.01.018; Hull RV, 2001, BIOPHYS CHEM, V90, P9, DOI 10.1016/S0301-4622(00)00239-8; Hunter WJ, 2007, CURR MICROBIOL, V55, P455, DOI 10.1007/s00284-007-9020-9; Hunter WJ, 2007, CURR MICROBIOL, V55, P344, DOI 10.1007/s00284-007-0202-2; Hunter WJ, 2009, CURR MICROBIOL, V58, P493, DOI 10.1007/s00284-009-9358-2; Hurt RH, 2006, CARBON, V44, P1028, DOI 10.1016/j.carbon.2005.12.023; Lin H, 2007, ORG BIOMOL CHEM, V5, P2541, DOI 10.1039/b706887e; Lin ZH, 2005, MATER CHEM PHYS, V92, P591, DOI 10.1016/j.matchemphys.2005.02.023; Lloyd-Jones G, 2006, J MICROBIOL METH, V67, P549, DOI 10.1016/j.mimet.2006.05.006; LORTIE L, 1992, APPL ENVIRON MICROB, V58, P4042, DOI 10.1128/AEM.58.12.4042-4044.1992; Losi ME, 1997, APPL ENVIRON MICROB, V63, P3079, DOI 10.1128/AEM.63.8.3079-3084.1997; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Monteiro-Riviere NA, 2006, CARBON, V44, P1070, DOI 10.1016/j.carbon.2005.11.004; Musarrat J, 2010, BIORESOURCE TECHNOL, V101, P8772, DOI 10.1016/j.biortech.2010.06.065; Narasingarao P, 2007, APPL ENVIRON MICROB, V73, P3519, DOI 10.1128/AEM.02737-06; OREMLAND RS, 1994, APPL ENVIRON MICROB, V60, P3011, DOI 10.1128/AEM.60.8.3011-3019.1994; OREMLAND RS, 1989, APPL ENVIRON MICROB, V55, P2333, DOI 10.1128/AEM.55.9.2333-2343.1989; OREMLAND RS, 1990, ENVIRON SCI TECHNOL, V24, P1157, DOI 10.1021/es00078a001; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; Prakash NT, 2009, BIOTECHNOL LETT, V31, P1857, DOI 10.1007/s10529-009-0096-0; Roux M, 2001, APPL ENVIRON MICROB, V67, P769, DOI 10.1128/AEM.67.2.769-773.2001; Sabaty M, 2001, APPL ENVIRON MICROB, V67, P5122, DOI 10.1128/AEM.67.11.5122-5126.2001; Sarret G, 2005, APPL ENVIRON MICROB, V71, P2331, DOI 10.1128/AEM.71.5.2331-2337.2005; TOMEI FA, 1992, CAN J MICROBIOL, V38, P1328, DOI 10.1139/m92-219; Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729; Turner RJ, 1998, BIOMETALS, V11, P223, DOI 10.1023/A:1009290213301; van Rij ET, 2004, MOL PLANT MICROBE IN, V17, P557, DOI 10.1094/MPMI.2004.17.5.557; Vinod Yadav, 2008, Biotechnology, V7, P299; Wang B, 2007, B ENVIRON CONTAM TOX, V78, P503, DOI 10.1007/s00128-007-9144-4; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; YANKE LJ, 1995, ANAEROBE, V1, P61, DOI 10.1016/S1075-9964(95)80457-9; Zhang J, 2004, CHINESE CHEM LETT, V15, P1345	50	69	74	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57404	10.1371/journal.pone.0057404	http://dx.doi.org/10.1371/journal.pone.0057404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483909	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900017
J	Gurzu, S; Szentirmay, Z; Toth, E; Bara, T; Bara, T; Jung, I				Gurzu, Simona; Szentirmay, Zoltan; Toth, Erika; Bara, Tivadar; Bara, Tivadar, Jr.; Jung, Ioan			Serrated Pathway Adenocarcinomas: Molecular and Immunohistochemical Insights into Their Recognition	PLOS ONE			English	Article							COLORECTAL ADENOCARCINOMAS; MICROSATELLITE INSTABILITY; CYTOKERATINS 7; BRAF; EXPRESSION; ADENOMAS; POLYPS; KRAS; MUTATIONS; PHENOTYPE	Introduction: Colorectal adenocarcinomas (CRC) developed through serrated pathway seem to present particular behavior compared with the non-serrated ones, but recognition of them is difficult to do. The aim of our paper was to establish some criteria to facilitate their identification. Materials and Methods: In 170 consecutive CRCs, we performed immunohistochemical staining with Cytokeratin 7 (CK7) and Cytokeratin 20 (CK20) and also with p53 and MLH-1. At the same time, we analyzed BRAF and K-ras mutations and the microsatellite status of CRC. Results: 26.47% of cases expressed CK7, and 16.47% were CK20-negative. Diffuse positivity for CK7 was associated in the proximal colon with CK20 negativity or weak positivity, BRAF mutations, lack of K-ras mutations, and p53 and MLH-1 negativity. All these cases were microsatellite-unstable and were diagnosed in stage II. Those cases from the distal colon and rectum that expressed CK7 were K-ras-mutated and had low p53 index and MLH-1 positivity, independent of the CK20 expression. Conclusions: CK7, associated with MLH-1 and p53 expression, and also with the microsatellite status, BRAF and K-ras pattern, might be used to identify the CRC potentially going through serrated pathway. The serrated pathway adenocarcinomas of the proximal colon that do not display the morphological features of this pattern are more frequent CK7+/p532/MLH-12/BRAF-mutated/K-ras-wt/MSI cases, but those located in the distal colorectal segments seem to be CK7+/CK20+/p532/MLH-1+/BRAF wt/K-ras-mutated/MSS cases.	[Gurzu, Simona; Jung, Ioan] Univ Med & Pharm Targu Mures, Dept Pathol, Targu Mures, Romania; [Szentirmay, Zoltan; Toth, Erika] Natl Inst Oncol, Dept Pathol, Budapest, Hungary; [Bara, Tivadar; Bara, Tivadar, Jr.] Univ Med & Pharm Targu Mures, Dept Surg, Targu Mures, Romania	George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures; National Institute of Oncology Hungary; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures	Gurzu, S (corresponding author), Univ Med & Pharm Targu Mures, Dept Pathol, Targu Mures, Romania.	simonagurzu@yahoo.com	GURZU, SIMONA/AAD-2710-2019	gurzu, simona/0000-0003-3968-5118	National Fellowship Unesco-L'Oreal 'For women in science	National Fellowship Unesco-L'Oreal 'For women in science	This work was partially supported by the National Fellowship Unesco-L'Oreal 'For women in science.	Bayrak R, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-9; Bayrak R, 2011, PATHOL RES PRACT, V207, P156, DOI 10.1016/j.prp.2010.12.005; Garcia-Solano J, 2010, HUM PATHOL, V41, P1359, DOI 10.1016/j.humpath.2010.04.002; Gurzu S, 2012, PATHOL RES PRACT, V208, P163, DOI 10.1016/j.prp.2012.01.003; Janavicius R, 2010, CLIN CHEM, V56, P1750, DOI 10.1373/clinchem.2010.150680; Jaramillo E, 2005, ENDOSCOPY, V37, P254, DOI 10.1055/s-2005-861007; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; LONGACRE TA, 1990, AM J SURG PATHOL, V14, P524, DOI 10.1097/00000478-199006000-00003; McGregor DK, 2004, AM J SURG PATHOL, V28, P712, DOI 10.1097/01.pas.0000126757.58474.12; Neumann J, 2012, PATHOLOGE, V33, P39, DOI 10.1007/s00292-011-1543-y; Noffsinger Amy E, 2010, Gastrointest Endosc Clin N Am, V20, P543, DOI 10.1016/j.giec.2010.03.012; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Oka S, 2004, GASTROINTEST ENDOSC, V59, P213, DOI 10.1016/S0016-5107(03)02693-2; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Saad RS, 2009, APPL IMMUNOHISTO M M, V17, P196, DOI 10.1097/PAI.0b013e31819268f2; Stefanius K, 2011, HISTOPATHOLOGY, V58, P679, DOI 10.1111/j.1365-2559.2011.03821.x; Tatsumi N, 2005, DIGEST DIS SCI, V50, P1741, DOI 10.1007/s10620-005-2928-7; Yang S, 2004, AM J SURG PATHOL, V28, P1452, DOI 10.1097/01.pas.0000141404.56839.6a	19	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57699	10.1371/journal.pone.0057699	http://dx.doi.org/10.1371/journal.pone.0057699			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469219	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900036
J	Michael, S; Sorg, H; Peck, CT; Koch, L; Deiwick, A; Chichkov, B; Vogt, PM; Reimers, K				Michael, Stefanie; Sorg, Heiko; Peck, Claas-Tido; Koch, Lothar; Deiwick, Andrea; Chichkov, Boris; Vogt, Peter M.; Reimers, Kerstin			Tissue Engineered Skin Substitutes Created by Laser-Assisted Bioprinting Form Skin-Like Structures in the Dorsal Skin Fold Chamber in Mice	PLOS ONE			English	Article							CAPILLARY-LIKE NETWORK; ATHYMIC MICE; CELL-TYPES; IN-VITRO; KERATINOCYTES; EQUIVALENT; TRANSPLANTATION; ANGIOGENESIS; REGENERATION; TECHNOLOGY	Tissue engineering plays an important role in the production of skin equivalents for the therapy of chronic and especially burn wounds. Actually, there exists no (cellularized) skin equivalent which might be able to satisfactorily mimic native skin. Here, we utilized a laser-assisted bioprinting (LaBP) technique to create a fully cellularized skin substitute. The unique feature of LaBP is the possibility to position different cell types in an exact three-dimensional (3D) spatial pattern. For the creation of the skin substitutes, we positioned fibroblasts and keratinocytes on top of a stabilizing matrix (Matriderm (R)). These skin constructs were subsequently tested in vivo, employing the dorsal skin fold chamber in nude mice. The transplants were placed into full-thickness skin wounds and were fully connected to the surrounding tissue when explanted after 11 days. The printed keratinocytes formed a multi-layered epidermis with beginning differentiation and stratum corneum. Proliferation of the keratinocytes was mainly detected in the suprabasal layers. In vitro controls, which were cultivated at the air-liquid-interface, also exhibited proliferative cells, but they were rather located in the whole epidermis. E-cadherin as a hint for adherens junctions and therefore tissue formation could be found in the epidermis in vivo as well as in vitro. In both conditions, the printed fibroblasts partly stayed on top of the underlying Matriderm (R) where they produced collagen, while part of them migrated into the Matriderm (R). In the mice, some blood vessels could be found to grow from the wound bed and the wound edges in direction of the printed cells. In conclusion, we could show the successful 3D printing of a cell construct via LaBP and the subsequent tissue formation in vivo. These findings represent the prerequisite for the creation of a complex tissue like skin, consisting of different cell types in an intricate 3D pattern.	[Michael, Stefanie; Sorg, Heiko; Peck, Claas-Tido; Vogt, Peter M.; Reimers, Kerstin] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany; [Koch, Lothar; Deiwick, Andrea; Chichkov, Boris] Laser Zentrum Hannover eV, Hannover, Germany	Hannover Medical School	Michael, S (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany.	Michael.Stefanie@mh-hannover.de	Vogt, Peter M./AAL-1332-2020; Chichkov, Boris/M-4112-2015; Chichkov, Boris/ABG-9694-2020	Chichkov, Boris/0000-0002-8129-7373; Chichkov, Boris/0000-0002-8129-7373; Sorg, Heiko/0000-0001-6827-0857	Deutsche Forschungsgemeinschaft [SFB TransRegio 37]; Deutsche Forschungsgemeinschaft, Rebirth Cluster of Excellence [Exc 62/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, Rebirth Cluster of Excellence	This study has been supported by Deutsche Forschungsgemeinschaft, SFB TransRegio 37 and Rebirth Cluster of Excellence (Exc 62/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034113; Auyeung RCY, 2001, CELL BY CELL CONSTRU, P698; BALLAUN C, 1995, J INVEST DERMATOL, V104, P7, DOI 10.1111/1523-1747.ep12613450; Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f; Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398; Black AF, 1998, FASEB J, V12, P1331, DOI 10.1096/fasebj.12.13.1331; Boland T, 2003, ANAT REC PART A, V272A, P497, DOI 10.1002/ar.a.10059; BORN C, 1992, BIOTECHNOL BIOENG, V40, P1004, DOI 10.1002/bit.260400903; BOYCE ST, 1993, J INVEST DERMATOL, V100, P360, DOI 10.1111/1523-1747.ep12471822; Catros S, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025001; Couet F, 2012, EXPERT REV MED DEVIC, V9, P233, DOI [10.1586/erd.12.15, 10.1586/ERD.12.15]; Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Goren I, 2009, J INVEST DERMATOL, V129, P752, DOI 10.1038/jid.2008.230; Gruene M, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/015005; Gruene M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-19; Guillotin B, 2010, BIOMATERIALS, V31, P7250, DOI 10.1016/j.biomaterials.2010.05.055; Hacker C, 2010, GROWTH FACTORS, V28, P178, DOI 10.3109/08977190903578660; Hopp B, 2005, TISSUE ENG, V11, P1817, DOI 10.1089/ten.2005.11.1817; Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001; Kalyanaraman B, 2009, J SURG RES, V152, P296, DOI 10.1016/j.jss.2008.04.001; Kirfel G, 2004, PROTOPLASMA, V223, P67, DOI 10.1007/s00709-003-0031-5; Klingenberg JM, 2010, J INVEST DERMATOL, V130, P587, DOI 10.1038/jid.2009.295; Koch L, 2010, TISSUE ENG C; Koch L, 2010, TISSUE ENG PART C-ME, V16, P847, DOI [10.1089/ten.tec.2009.0397, 10.1089/ten.TEC.2009.0397]; Koch L, 2012, BIOTECHNOL BIOENG, V109, P1855, DOI 10.1002/bit.24455; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Othon CM, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034101; Owczarczak AB, 2012, JOVE-J VIS EXP, DOI 10.3791/3681; Rasmussen CA, 2010, ANN SURG, V251, P368, DOI 10.1097/SLA.0b013e3181c1ab5f; Reimers K, 2012, BURNS J INT SOC BURN; Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843; Rochon MH, 2010, TISSUE ENG PT A, V16, P1457, DOI [10.1089/ten.tea.2009.0090, 10.1089/ten.TEA.2009.0090]; Schechner JS, 2003, FASEB J, V17, P2250, DOI 10.1096/fj.03-0257com; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Egana JT, 2009, TISSUE ENG PT A, V15, P1191, DOI 10.1089/ten.tea.2008.0097; Unger C, 2011, APPL PHYS A-MATER, V103, P271, DOI 10.1007/s00339-010-6030-4; Vogt PM, 2007, CHIRURG, V78, P335, DOI 10.1007/s00104-007-1325-5; Wilson WC, 2003, ANAT REC PART A, V272A, P491, DOI 10.1002/ar.a.10057; Xie JL, 2007, J PLAST RECONSTR AES, V60, P983, DOI 10.1016/j.bjps.2005.12.062; Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035; Zheng QA, 2011, ANAL BIOCHEM, V410, P171, DOI 10.1016/j.ab.2010.10.024	43	328	359	12	272	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57741	10.1371/journal.pone.0057741	http://dx.doi.org/10.1371/journal.pone.0057741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469227	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900040
J	Vernau, KM; Runstadler, JA; Brown, EA; Cameron, JM; Huson, HJ; Higgins, RJ; Ackerley, C; Sturges, BK; Dickinson, PJ; Puschner, B; Giulivi, C; Shelton, GD; Robinson, BH; DiMauro, S; Bollen, AW; Bannasch, DL				Vernau, Karen M.; Runstadler, Jonathan A.; Brown, Emily A.; Cameron, Jessie M.; Huson, Heather J.; Higgins, Robert J.; Ackerley, Cameron; Sturges, Beverly K.; Dickinson, Peter J.; Puschner, Birgit; Giulivi, Cecilia; Shelton, G. Diane; Robinson, Brian H.; DiMauro, Salvatore; Bollen, Andrew W.; Bannasch, Danika L.			Genome-Wide Association Analysis Identifies a Mutation in the Thiamine Transporter 2 (SLC19A3) Gene Associated with Alaskan Husky Encephalopathy	PLOS ONE			English	Article							BASAL GANGLIA DISEASE; MITOCHONDRIAL-FUNCTION; BIOTIN; DEFICIENCY; FAMILY; PRESERVATION; TOXICITY; LEIGH	Alaskan Husky Encephalopathy (AHE) has been previously proposed as a mitochondrial encephalopathy based on neuropathological similarities with human Leigh Syndrome (LS). We studied 11 Alaskan Husky dogs with AHE, but found no abnormalities in respiratory chain enzyme activities in muscle and liver, or mutations in mitochondrial or nuclear genes that cause LS in people. A genome wide association study was performed using eight of the affected dogs and 20 related but unaffected control AHs using the Illumina canine HD array. SLC19A3 was identified as a positional candidate gene. This gene controls the uptake of thiamine in the CNS via expression of the thiamine transporter protein THTR2. Dogs have two copies of this gene located within the candidate interval (SLC19A3.2 - 43.36-43.38 Mb and SLC19A3.1 - 43.411-43.419 Mb) on chromosome 25. Expression analysis in a normal dog revealed that one of the paralogs, SLC19A3.1, was expressed in the brain and spinal cord while the other was not. Subsequent exon sequencing of SLC19A3.1 revealed a 4bp insertion and SNP in the second exon that is predicted to result in a functional protein truncation of 279 amino acids (c. 624 insTTGC, c. 625 C>A). All dogs with AHE were homozygous for this mutation, 15/41 healthy AH control dogs were heterozygous carriers while 26/41 normal healthy AH dogs were wild type. Furthermore, this mutation was not detected in another 187 dogs of different breeds. These results suggest that this mutation in SLC19A3.1, encoding a thiamine transporter protein, plays a critical role in the pathogenesis of AHE.	[Vernau, Karen M.; Brown, Emily A.; Sturges, Beverly K.; Dickinson, Peter J.; Puschner, Birgit; Giulivi, Cecilia; Bannasch, Danika L.] Univ Calif Davis, Davis, CA 95616 USA; [Runstadler, Jonathan A.; Huson, Heather J.; Higgins, Robert J.] Univ Alaska Fairbanks, Fairbanks, AK USA; [Cameron, Jessie M.; Ackerley, Cameron; Robinson, Brian H.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Shelton, G. Diane] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Bollen, Andrew W.] Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of Alaska System; University of Alaska Fairbanks; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California San Diego; Columbia University; University of California System; University of California San Francisco	Vernau, KM (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	kmvernau@ucdavis.edu	Bannasch, Danika/GZL-8044-2022; Giulivi, Cecilia/AAV-6774-2021; Giulivi, Cecilia/ABB-7809-2020; Dickinson, Peter/GPT-0703-2022	Giulivi, Cecilia/0000-0003-1033-7435; Puschner, Birgit/0000-0001-6765-5085; Bannasch, Danika/0000-0002-7614-7207; Huson, Heather/0000-0001-8299-0447	Center for Companion Animal Health; School of Veterinary Medicine, UC Davis; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	Center for Companion Animal Health; School of Veterinary Medicine, UC Davis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant from The Center for Companion Animal Health, from the School of Veterinary Medicine, UC Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CJ, 2003, J VET INTERN MED, V17, P551, DOI 10.1892/0891-6640(2003)017&lt;0551:LAISBT&gt;2.3.CO;2; Baiker K, 2009, ACTA NEUROPATHOL, V118, P697, DOI 10.1007/s00401-009-0548-6; Brenner O, 2000, ACTA NEUROPATHOL, V100, P50, DOI 10.1007/s004010051192; Cerase A, 2011, RADIOL MED, V116, P319, DOI 10.1007/s11547-011-0618-x; Debs R, 2010, ARCH NEUROL-CHICAGO, V67, P126, DOI 10.1001/archneurol.2009.293; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P113, DOI 10.1016/j.cbi.2006.05.010; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P94, DOI 10.1016/j.cbi.2006.04.014; Dubowitz V, 2007, HISTOLOGICAL HISTOCH, P21; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013; Force A, 1999, GENETICS, V151, P1531; Ganapathy V, 2004, PFLUG ARCH EUR J PHY, V447, P641, DOI 10.1007/s00424-003-1068-1; GLERUM DM, 1988, FEBS LETT, V236, P100, DOI 10.1016/0014-5793(88)80293-X; Kono S, 2009, NEW ENGL J MED, V360, P1792, DOI 10.1056/NEJMc0809100; Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123; Matwichuk CL, 1999, AM J VET RES, V60, P88; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; READ DH, 1986, AM J VET RES, V47, P2281; ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027; ROBINSON BH, 1983, EUR J PEDIATR, V140, P98, DOI 10.1007/BF00441651; Steel RJS, 1997, AUST VET J, V75, P719, DOI 10.1111/j.1751-0813.1997.tb12252.x; Subramanian VS, 2006, AM J PHYSIOL-CELL PH, V291, pC851, DOI 10.1152/ajpcell.00105.2006; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Wakshlag JJ, 1999, J SMALL ANIM PRACT, V40, P585, DOI 10.1111/j.1748-5827.1999.tb03028.x; Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847; Yamada K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-171; Zeng WQ, 2005, AM J HUM GENET, V77, P16, DOI 10.1086/431216	28	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57195	10.1371/journal.pone.0057195	http://dx.doi.org/10.1371/journal.pone.0057195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469184	Green Published, gold			2022-12-27	WOS:000315634900013
J	Fu, XJ; Gao, XL; He, SF; Huang, D; Zhang, P; Wang, XL; Zhang, SX; Dang, RY; Yin, SH; Du, EQ; Yang, ZQ				Fu, Xiangjing; Gao, Xiaolong; He, Shengfang; Huang, Di; Zhang, Peng; Wang, Xinglong; Zhang, Shuxia; Dang, Ruyi; Yin, Shuanghui; Du, Enqi; Yang, Zengqi			Design and Selection of a Camelid Single-Chain Antibody Yeast Two-Hybrid Library Produced De Novo for the Cap Protein of Porcine Circovirus Type 2 (PCV2)	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; LIGHT-CHAINS; IN-VITRO; FRAGMENTS; IDENTIFICATION; SEQUENCE; DOMAIN; REPERTOIRE; EXPRESSION; ROTAVIRUS	Nanobodies (or variable domain of the heavy chain of the heavy-chain antibodies, VHHs) are single-domain antigen-binding fragments derived from camelid heavy chain antibodies. Their comparatively small size, monomeric behavior, high stability, high solubility, and ability to bind epitopes inaccessible to conventional antibodies make them especially suitable for many therapeutic and biotechnological applications. In this paper, for the first time, we created the immunized Camelus Bactrianus VHH yeast two-hybrid (Y2H) library according to the Clontech Mate & Plate library construction system. The transformation efficiency and titer of the VHH Y2H library were 7.26x10(6) cfu/3 mu g and 2x10(9) cfu/ml, which met the demand for Y2H library screening. Using as an example the porcine circovirus type 2 (PCV2) Cap protein as bait, we screened 21 positive Cap-specific VHH sequences. Among these sequences, 7 of 9 randomly selected clones were strongly positive as indicated by enzyme-linked immunosorbent assay, either using PCV2 viral lysis or purified Cap protein as coated antigen. Additionally, the immunocytochemistry results further indicated that the screened VHHs could specifically detected PCV2 in the infected cells. All this suggests the feasibility of in vivo VHH throughput screening based on Y2H strategy.	[Fu, Xiangjing; Gao, Xiaolong; He, Shengfang; Huang, Di; Zhang, Peng; Wang, Xinglong; Zhang, Shuxia; Dang, Ruyi; Du, Enqi; Yang, Zengqi] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Yin, Shuanghui] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Minist Agr, Key Lab Anim Virol,State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Du, EQ (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	duenqi227@126.com; yzq8162@163.com			Research Starting Foundation for Dr. Enqi Du, Northwest A F University [Z111021006]; Shaanxi "13115" Science & Technology Innovation Project [2010ZDKG-71]; National Natural Science Foundation of China, China [31101803/C1803]	Research Starting Foundation for Dr. Enqi Du, Northwest A F University; Shaanxi "13115" Science & Technology Innovation Project; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC))	This work was supported by the Research Starting Foundation for Dr. Enqi Du, Northwest A & F University (Grant No. Z111021006), Shaanxi "13115" Science & Technology Innovation Project (Grant No. 2010ZDKG-71) and National Natural Science Foundation of China (Grant No. 31101803/C1803), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chartier A, 2009, HUM MOL GENET, V18, P1849, DOI 10.1093/hmg/ddp101; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gillespie J, 2009, J VET INTERN MED, V23, P1151, DOI 10.1111/j.1939-1676.2009.0389.x; Hamel AL, 1998, J VIROL, V72, P5262, DOI 10.1128/JVI.72.6.5262-5267.1998; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Holcroft J, 2011, EUR J ORAL SCI, V119, P301, DOI 10.1111/j.1600-0722.2011.00870.x; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Huang LP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-188; Kastelic D, 2009, J IMMUNOL METHODS, V350, P54, DOI 10.1016/j.jim.2009.08.016; Koh WWL, 2010, J BIOL CHEM, V285, P19116, DOI 10.1074/jbc.M110.116699; Liu QG, 2001, VIROLOGY, V285, P91, DOI 10.1006/viro.2001.0922; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2001, J Biotechnol, V74, P277; Spinelli S, 2004, FEBS LETT, V564, P35, DOI 10.1016/S0014-5793(04)00304-7; Strokappe N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033298; Tanaka T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng023; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; Vascotto F, 2005, J IMMUNOL METHODS, V301, P31, DOI 10.1016/j.jim.2005.03.011; Vielemeyer O, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-59; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Wu PC, 2012, APPL MICROBIOL BIOTE; Zhou JY, 2005, J BIOTECHNOL, V118, P201, DOI 10.1016/j.jbiotec.2005.02.017	26	19	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e56222	10.1371/journal.pone.0056222	http://dx.doi.org/10.1371/journal.pone.0056222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469171	Green Published, gold			2022-12-27	WOS:000315897100009
J	Benson, J; Phillips, C; Kay, M; Webber, MT; Ratcliff, AJ; Correa-Velez, I; Lorimer, MF				Benson, Jill; Phillips, Christine; Kay, Margaret; Webber, Murray T.; Ratcliff, Alison J.; Correa-Velez, Ignacio; Lorimer, Michelle F.			Low Vitamin B12 Levels among Newly-Arrived Refugees from Bhutan, Iran and Afghanistan: A Multicentre Australian Study	PLOS ONE			English	Article							KENYAN SCHOOL-CHILDREN; MICRONUTRIENT DEFICIENCIES; PLASMA VITAMIN-B-12; METHYLMALONIC ACID; IRON-DEFICIENCY; HIGH PREVALENCE; PREGNANT-WOMEN; FOLIC-ACID; FOLATE; HOMOCYSTEINE	Background: Vitamin B12 deficiency is prevalent in many countries of origin of refugees. Using a threshold of 5% above which a prevalence of low Vitamin B12 is indicative of a population health problem, we hypothesised that Vitamin B12 deficiency exceeds this threshold among newly-arrived refugees resettling in Australia, and is higher among women due to their increased risk of food insecurity. This paper reports Vitamin B12 levels in a large cohort of newly arrived refugees in five Australian states and territories. Methods: In a cross-sectional descriptive study, we collected Vitamin B12, folate and haematological indices on all refugees (n = 916; response rate 94% of eligible population) who had been in Australia for less than one year, and attended one of the collaborating health services between July 2010 and July 2011. Results: 16.5% of participants had Vitamin B12 deficiency (<150 pmol/L). One-third of participants from Iran and Bhutan, and one-quarter of participants from Afghanistan had Vitamin B12 deficiency. Contrary to our hypothesis, low Vitamin B12 levels were more prevalent in males than females. A higher prevalence of low Vitamin B12 was also reported in older age groups in some countries. The sensitivity of macrocytosis in detecting Vitamin B12 deficiency was only 4.6%. Conclusion: Vitamin B12 deficiency is an important population health issue in newly-arrived refugees from many countries. All newly-arrived refugees should be tested for Vitamin B12 deficiency. Ongoing research should investigate causes, treatment, and ways to mitigate food insecurity, and the contribution of such measures to enhancing the health of the refugee communities.	[Benson, Jill] Univ Adelaide, Discipline Gen Practice, Adelaide, SA 5005, Australia; [Phillips, Christine] Australian Natl Univ, Social Fdn Med, Sch Med, Acton, Australia; [Kay, Margaret] Univ Queensland, Discipline Gen Practice, Brisbane, Qld, Australia; [Webber, Murray T.] HNE Local Hlth Dist, Hunter New England Hlth Refugee Hlth Program, Sydney, NSW, Australia; [Ratcliff, Alison J.] Royal Hobart Hosp, Hobart, Tas, Australia; [Correa-Velez, Ignacio] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Lorimer, Michelle F.] Univ Adelaide, Adelaide, SA 5005, Australia	University of Adelaide; Australian National University; University of Queensland; Royal Hobart Hospital; Queensland University of Technology (QUT); University of Adelaide	Benson, J (corresponding author), Univ Adelaide, Discipline Gen Practice, Adelaide, SA 5005, Australia.	jill.benson@adelaide.edu.au	Phillips, Christine/H-3041-2019	Phillips, Christine/0000-0001-5602-3664; Lorimer, Michelle/0000-0003-3785-4395; Correa-Velez, Ignacio/0000-0003-1800-4475	PHCRED scholarship at the University of Adelaide	PHCRED scholarship at the University of Adelaide	This research was funded in part through a PHCRED scholarship at the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdollahi Z, 2008, ANN NUTR METAB, V53, P143, DOI 10.1159/000170890; ADAMS WH, 1974, AM J CLIN NUTR, V27, P217, DOI 10.1093/ajcn/27.2.217; Benson J, 2010, AUST FAM PHYSICIAN, V39, P215; Bondevik GT, 2001, EUR J CLIN NUTR, V55, P856, DOI 10.1038/sj.ejcn.1601236; Carmel R, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013441; Cuevas-Nasu L, 2012, SALUD PUBLICA MEXICO, V54, P116, DOI 10.1590/S0036-36342012000200007; de la Jara GD, 2004, BMJ-BRIT MED J, V329, P156; Department of Immigration and Citizenship, 2011, ANN REP 2010 2011 PR; Department of Immigration and Citizenship, 2012, SETTL REP FAC; Department of Immigration and Citizenship, 2010, ANN REP 2009 2010 PR; Food and Agriculture Organization of the United Nations (FAO), 2011, STATE FOOD INSECURIT; Gallegos D, 2008, NUTR DIET, V65, P78, DOI 10.1111/j.1747-0080.2007.00175.x; Garcia-Casal MN, 2005, EUR J CLIN NUTR, V59, P1064, DOI 10.1038/sj.ejcn.1602212; Gladstone, 2000, J REFUG STUD, V13, P303, DOI [DOI 10.1093/JRS/13.3.303, 10.1093/jrs/13.3.303]; Green TJ, 2005, EUR J CLIN NUTR, V59, P205, DOI 10.1038/sj.ejcn.1602059; Herrmann W, 2008, DTSCH ARZTEBL INT, V105, P680, DOI 10.3238/arztebl.2008.0680; Heseker HB, 2009, BRIT J NUTR, V102, P173, DOI 10.1017/S0007114508149200; Jay J, 2007, EPIDEMIOLOGY, V18, P362; Jiang TN, 2005, J NUTR, V135, P1106, DOI 10.1093/jn/135.5.1106; Kaiser L, 2007, PUBLIC HEALTH NUTR, V10, P574, DOI 10.1017/S1368980007382542; Kemmer TM, 2003, J NUTR, V133, P4143, DOI 10.1093/jn/133.12.4143; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034906; Maplecroft, 2010, MAPL FOOD SEC IND IN; Maplecroft, 2011, MAPL FOOD SEC IND IN; McGillivray G, 2007, ARCH DIS CHILD, V92, P1088, DOI 10.1136/adc.2006.112813; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; McLean ED, 2007, J NUTR, V137, P676, DOI 10.1093/jn/137.3.676; Phillips CB, 2011, MED J AUSTRALIA, V195, P185, DOI 10.5694/j.1326-5377.2011.tb03276.x; Ruston D., 2004, NATL DIET NUTR SURVE, V4, P52; Shams M., 2009, Eastern Mediterranean Health Journal, V15, P1285; Shuangyan Qiu, 2015, INV HLTH CAR CHILDR; Siekmann JH, 2003, J NUTR, V133, p3972S, DOI 10.1093/jn/133.11.3972S; Skull SA, 2003, INTERN MED J, V33, P47, DOI 10.1046/j.1445-5994.2003.00344.x; Thamm M, 1999, Gesundheitswesen, V61 Spec No, pS207; TOOLE MJ, 1992, LANCET, V339, P1214, DOI 10.1016/0140-6736(92)91143-V; United Nations High Commissioner for Refugees, 2011, PROJ GLOB RES NEEDS; United Nations World Food Programme United Nations High Commissioner for Refugees, 2009, MICR POWD MIXME US K; Vanderjagt DJ, 2009, J OBSTET GYNAECOL, V29, P288, DOI 10.1080/01443610902812709; Walker P. F., 2011, Morbidity and Mortality Weekly Report, V60, P343	39	25	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57998	10.1371/journal.pone.0057998	http://dx.doi.org/10.1371/journal.pone.0057998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469126	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900219
J	Chong, HQ; Huang, L; Yeow, JW; Wang, I; Zhang, HF; Song, H; Jiang, RR				Chong, Huiqing; Huang, Lei; Yeow, Jianwei; Wang, Ivy; Zhang, Hongfang; Song, Hao; Jiang, Rongrong			Improving Ethanol Tolerance of Escherichia coli by Rewiring Its Global Regulator cAMP Receptor Protein (CRP)	PLOS ONE			English	Article							NADH OXIDASE; TRANSCRIPTION MACHINERY; CRYSTAL-STRUCTURE; BIOFILM FORMATION; KO11; OVEREXPRESSION; IMMOBILIZATION; FERMENTATION; MUTAGENESIS; IMPROVEMENT	A major challenge in bioethanol fermentation is the low tolerance of the microbial host towards the end product bioethanol. Here we report to improve the ethanol tolerance of E. coli from the transcriptional level by engineering its global transcription factor cAMP receptor protein (CRP), which is known to regulate over 400 genes in E. coli. Three ethanol tolerant CRP mutants (E1-E3) were identified from error-prone PCR libraries. The best ethanol-tolerant strain E2 (M59T) had the growth rate of 0.08 h(-1) in 62 g/L ethanol, higher than that of the control at 0.06 h(-1). The M59T mutation was then integrated into the genome to create variant iE2. When exposed to 150 g/l ethanol, the survival of iE2 after 15 min was about 12%, while that of BW25113 was <0.01%. Quantitative real-time reverse transcription PCR analysis (RT-PCR) on 444 CRP-regulated genes using OpenArray (R) technology revealed that 203 genes were differentially expressed in iE2 in the absence of ethanol, whereas 92 displayed differential expression when facing ethanol stress. These genes belong to various functional groups, including central intermediary metabolism (aceE, acnA, sdhD, sucA), iron ion transport (entH, entD, fecA, fecB), and general stress response (osmY, rpoS). Six up-regulated and twelve down-regulated common genes were found in both iE2 and E2 under ethanol stress, whereas over one hundred common genes showed differential expression in the absence of ethanol. Based on the RT-PCR results, entA, marA or bhsA was knocked out in iE2 and the resulting strains became more sensitive towards ethanol.	[Chong, Huiqing; Zhang, Hongfang; Song, Hao; Jiang, Rongrong] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Huang, Lei] Zhejiang Univ, Dept Chem & Biol Engn, Inst Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Yeow, Jianwei; Wang, Ivy] Life Technol, Syst Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Zhejiang University; Thermo Fisher Scientific	Jiang, RR (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	rrjiang@ntu.edu.sg	Jiang, Rongrong/G-6217-2010; Song, Hao/G-6207-2010	Song, Hao/0000-0001-5553-2539	Singapore Ministry of Education [RG27/11]; Singapore National Research Foundation [NRF-CRP-5-2009-03]; Life Technologies Collaborative Research Compacts (CRC) Program	Singapore Ministry of Education(Ministry of Education, Singapore); Singapore National Research Foundation(National Research Foundation, Singapore); Life Technologies Collaborative Research Compacts (CRC) Program	This work is supported by Singapore Ministry of Education (RG27/11), Singapore National Research Foundation (NRF-CRP-5-2009-03), and Life Technologies Collaborative Research Compacts (CRC) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Aono R, 1998, EXTREMOPHILES, V2, P239, DOI 10.1007/s007920050066; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Basak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051179; Chen K, 2010, BIOTECHNOL LETT, V32, P87, DOI 10.1007/s10529-009-0114-2; Chen TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016228; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eiadpum A, 2012, J BIOSCI BIOENG, V114, P325, DOI 10.1016/j.jbiosc.2012.04.004; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Gonzalez R, 2003, BIOTECHNOL PROGR, V19, P612, DOI 10.1021/bp025658q; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hayashi T, 2012, APPL ENVIRON MICROB, V78, P5622, DOI 10.1128/AEM.00733-12; Hong SH, 2010, MICROB BIOTECHNOL, V3, P717, DOI 10.1111/j.1751-7915.2010.00220.x; Hong SH, 2010, MICROB BIOTECHNOL, V3, P344, DOI 10.1111/j.1751-7915.2010.00164.x; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Huang L, 2008, PROTEIN EXPRES PURIF, V61, P168, DOI 10.1016/j.pep.2008.05.016; Huang L, 2009, APPL MICROBIOL BIOT, V84, P301, DOI 10.1007/s00253-009-1982-z; Jiang RR, 2005, ADV SYNTH CATAL, V347, P1139, DOI 10.1002/adsc.200505063; Jiang RR, 2004, TETRAHEDRON-ASYMMETR, V15, P2939, DOI 10.1016/j.tetasy.2004.07.057; Letti LAJ, 2012, BIOMASS BIOENERG, V44, P80, DOI 10.1016/j.biombioe.2012.04.023; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Klein-Marcuschamer D, 2009, APPL ENVIRON MICROB, V75, P2705, DOI 10.1128/AEM.01888-08; Liu WS, 2012, TOP CATAL, V55, P1146, DOI 10.1007/s11244-012-9893-0; Lountos GT, 2006, BIOCHEMISTRY-US, V45, P9648, DOI 10.1021/bi060692p; Luo LH, 2009, BIOTECHNOL LETT, V31, P1867, DOI 10.1007/s10529-009-0092-4; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Maeda T, 2007, APPL MICROBIOL BIOT, V77, P879, DOI 10.1007/s00253-007-1217-0; Manow R, 2012, J IND MICROBIOL BIOT, V39, P977, DOI 10.1007/s10295-012-1100-6; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Patnaik R, 2008, BIOTECHNOL PROGR, V24, P38, DOI 10.1021/bp0701214; Sandoval NR, 2011, METAB ENG, V13, P214, DOI 10.1016/j.ymben.2010.12.001; Shen CR, 2008, METAB ENG, V10, P312, DOI 10.1016/j.ymben.2008.08.001; Sridhar M, 2002, BIORESOURCE TECHNOL, V83, P199, DOI 10.1016/S0960-8524(01)00221-8; Wackett LP, 2008, CURR OPIN CHEM BIOL, V12, P187, DOI 10.1016/j.cbpa.2008.01.025; Wang JQ, 2012, BIOTECHNOL BIOENG, V109, P3133, DOI 10.1002/bit.24574; Wang L, 2012, APPL MICROBIOL BIOT, V96, P1265, DOI 10.1007/s00253-012-3919-1; Wang L, 2012, APPL MICROBIOL BIOT, V94, P1233, DOI 10.1007/s00253-011-3699-z; Wang L, 2012, J MOL CATAL B-ENZYM, V76, P9, DOI 10.1016/j.molcatb.2011.11.016; Wang LA, 2011, J MOL CATAL B-ENZYM, V69, P120, DOI 10.1016/j.molcatb.2011.01.005; Wang LA, 2010, J BIOTECHNOL, V150, P57, DOI 10.1016/j.jbiotec.2010.07.005; Westfall PJ, 2011, CURR OPIN BIOTECH, V22, P344, DOI 10.1016/j.copbio.2011.04.023; Won HS, 2008, J BIOCHEM, V143, P163, DOI 10.1093/jb/mvm238; Yadav AK, 2011, CRIT REV BIOTECHNOL, V31, P1, DOI 10.3109/07388550903420970; Yomano LP, 1998, J IND MICROBIOL BIOT, V20, P132, DOI 10.1038/sj.jim.2900496; Yu KO, 2012, ENZYME MICROB TECH, V51, P237, DOI 10.1016/j.enzmictec.2012.07.003; Zhang HF, 2012, APPL MICROBIOL BIOT, V94, P1107, DOI 10.1007/s00253-012-4012-5; Zhang HF, 2012, BIOTECHNOL BIOENG, V109, P1165, DOI 10.1002/bit.24411; Zhang HF, 2010, APPL MICROBIOL BIOT, V88, P117, DOI 10.1007/s00253-010-2735-8; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Zhou B, 2008, BIOTECHNOL BIOENG, V100, P627, DOI 10.1002/bit.21800; Zhu J, 2004, APPL MICROBIOL BIOT, V64, P367, DOI 10.1007/s00253-003-1499-9	55	40	49	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57628	10.1371/journal.pone.0057628	http://dx.doi.org/10.1371/journal.pone.0057628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469036	gold, Green Published			2022-12-27	WOS:000315524900135
J	Mahurkar, S; Moldovan, M; Suppiah, V; O'Doherty, C				Mahurkar, Sunil; Moldovan, Max; Suppiah, Vijayaprakash; O'Doherty, Catherine			Identification of Shared Genes and Pathways: A Comparative Study of Multiple Sclerosis Susceptibility, Severity and Response to Interferon Beta Treatment	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; UBIQUITIN-PROTEASOME SYSTEM; NEUROTROPHIC FACTOR; GLATIRAMER ACETATE; OXIDATIVE-STRESS; TYROSINE KINASE; CELL-SURVIVAL; DIFFERENTIATION; RISK; POLYMORPHISMS	Recent genome-wide association studies (GWAS) have successfully identified several gene loci associated with multiple sclerosis (MS) susceptibility, severity or interferon-beta (IFN-beta) response. However, due to the nature of these studies, the functional relevance of these loci is not yet fully understood. We have utilized a systems biology based approach to explore the genetic interactomes of these MS related traits. We hypothesised that genes and pathways associated with the 3 MS related phenotypes might interact collectively to influence the heterogeneity and unpredictable clinical outcomes observed. Individual genetic interactomes for each trait were constructed and compared, followed by prioritization of common interactors based on their frequencies. Pathway enrichment analyses were performed to highlight shared functional pathways. Biologically relevant genes ABL1, GRB2, INPP5D, KIF1B, PIK3R1, PLCG1, PRKCD, SRC, TUBA1A and TUBA4A were identified as common to all 3 MS phenotypes. We observed that the highest number of first degree interactors were shared between MS susceptibility and MS severity (p = 1.34x10(-79)) with UBC as the most prominent first degree interactor for this phenotype pair from the prioritisation analysis. As expected, pairwise comparisons showed that MS susceptibility and severity interactomes shared the highest number of pathways. Pathways from signalling molecules and interaction, and signal transduction categories were found to be highest shared pathways between 3 phenotypes. Finally, FYN was the most common first degree interactor in the MS drugs-gene network. By applying the systems biology based approach, additional significant information can be extracted from GWAS. Results of our interactome analyses are complementary to what is already known in the literature and also highlight some novel interactions which await further experimental validation. Overall, this study illustrates the potential of using a systems biology based approach in an attempt to unravel the biological significance of gene loci identified in large GWAS.	[Mahurkar, Sunil; Suppiah, Vijayaprakash; O'Doherty, Catherine] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Moldovan, Max] Univ New S Wales, Australian Inst Hlth Innovat, Sydney, NSW, Australia	University of South Australia; University of New South Wales Sydney	Suppiah, V (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	vijay.suppiah@unisa.edu.au	Suppiah, Vijay/D-4174-2011; Moldovan, Max/H-7108-2014; O'Doherty, Catherine/A-1212-2011; King, Catherine/F-4007-2013	Suppiah, Vijay/0000-0001-5496-935X; Moldovan, Max/0000-0001-9680-8474; King, Catherine/0000-0002-5761-4746	School of Pharmacy, University of South Australia	School of Pharmacy, University of South Australia	SM is supported by a postgraduate scholarship provided by the School of Pharmacy, University of South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baptista MS, 2012, CELL MOL LIFE SCI, V69, P2691, DOI 10.1007/s00018-012-0946-0; Baranzini SE, 2010, BRAIN, V133, P2603, DOI 10.1093/brain/awq192; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Blanchette F, 2008, J NEUROL, V255, P26, DOI 10.1007/s00415-008-1005-5; Blanco Y, 2006, NEUROSCI LETT, V406, P270, DOI 10.1016/j.neulet.2006.07.043; Blanco Y, 2006, NEUROSCI LETT, V396, P217, DOI 10.1016/j.neulet.2005.11.032; Briggs FBS, 2011, GENES IMMUN, V12, P615, DOI 10.1038/gene.2011.34; Brightbill H, 2009, INT IMMUNOL, V21, P575, DOI 10.1093/intimm/dxp027; Byun E, 2008, ARCH NEUROL-CHICAGO, V65, P337, DOI 10.1001/archneurol.2008.47; Cavanillas ML, 2011, GENES IMMUN, V12, P110, DOI 10.1038/gene.2010.52; Cenit MDC, 2009, MULT SCLER J, V15, P913, DOI 10.1177/1352458509106509; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Comabella M, 2009, ARCH NEUROL-CHICAGO, V66, P972, DOI 10.1001/archneurol.2009.150; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu ZJ, 2007, NUCLEIC ACIDS RES, V35, pW625, DOI 10.1093/nar/gkm295; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Jin HJ, 2011, J BIOL CHEM, V286, P19840, DOI 10.1074/jbc.M110.203687; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Lalive PH, 2008, J NEUROIMMUNOL, V197, P147, DOI 10.1016/j.jneuroim.2008.04.033; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Lee LF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002400; Lindquist S, 2005, J NEUROIMMUNOL, V167, P183, DOI 10.1016/j.jneuroim.2005.06.008; Locke NR, 2009, J IMMUNOL, V183, P975, DOI 10.4049/jimmunol.0803749; Lorenz HM, 2000, APOPTOSIS, V5, P443, DOI 10.1023/A:1009692902805; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Matejuk A, 2003, J NEUROSCI RES, V73, P667, DOI 10.1002/jnr.10689; Menon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018660; Mero IL, 2012, J NEUROIMMUNOL, V244, P107, DOI 10.1016/j.jneuroim.2012.01.011; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Minagar A, 2012, NEUROL RES, V34, P611, DOI 10.1179/1743132812Y.0000000055; Mirowska-Guzel D, 2008, J NEUROIMMUNOL, V193, P170, DOI 10.1016/j.jneuroim.2007.10.013; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Mosteller CF, 1948, AM STAT, V2, P30; Nischwitz S, 2010, J NEUROIMMUNOL, V227, P162, DOI 10.1016/j.jneuroim.2010.06.003; O'Doherty C, 2009, PHARMACOGENOMICS, V10, P1177, DOI [10.2217/pgs.09.41, 10.2217/PGS.09.41]; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Satoh JI, 2009, MULT SCLER J, V15, P531, DOI 10.1177/1352458508101943; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Seiwa C, 2007, J NEUROSCI RES, V85, P954, DOI 10.1002/jnr.21196; Silberman I, 2008, CELL CYCLE, V7, P3847, DOI 10.4161/cc.7.24.7267; Ueda A, 2012, J IMMUNOL, V188, P5247, DOI 10.4049/jimmunol.1102241; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang JH, 2011, GENOME MED, V3, DOI 10.1186/gm217; Yoshimura S, 2010, MULT SCLER J, V16, P1178, DOI 10.1177/1352458510375706	59	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57655	10.1371/journal.pone.0057655	http://dx.doi.org/10.1371/journal.pone.0057655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469041	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000315524900140
J	Masujin, K; Kaku-Ushiki, Y; Miwa, R; Okada, H; Shimizu, Y; Kasai, K; Matsuura, Y; Yokoyama, T				Masujin, Kentaro; Kaku-Ushiki, Yuko; Miwa, Ritsuko; Okada, Hiroyuki; Shimizu, Yoshihisa; Kasai, Kazuo; Matsuura, Yuichi; Yokoyama, Takashi			The N-Terminal Sequence of Prion Protein Consists an Epitope Specific to the Abnormal Isoform of Prion Protein (PrPSc)	PLOS ONE			English	Article							INTERSPECIES TRANSMISSION; MONOCLONAL-ANTIBODY; DISEASE; CONFORMATION; CONVERSION; PEPTIDE; BINDING; MUTANT; MICE; AGGREGATION	The conformation of abnormal prion protein (PrPSc) differs from that of cellular prion protein (PrPC), but the precise characteristics of PrPSc remain to be elucidated. To clarify the properties of native PrPSc, we attempted to generate novel PrPSc-specific monoclonal antibodies (mAbs) by immunizing PrP-deficient mice with intact PrPSc purified from bovine spongiform encephalopathy (BSE)-affected mice. The generated mAbs 6A12 and 8D5 selectivity precipitated PrPSc from the brains of prion-affected mice, sheep, and cattle, but did not precipitate PrPC from the brains of healthy animals. In histopathological analysis, mAbs 6A12 and 8D5 strongly reacted with prion-affected mouse brains but not with unaffected mouse brains without antigen retrieval. Epitope analysis revealed that mAbs 8D5 and 6A12 recognized the PrP subregions between amino acids 31-39 and 41-47, respectively. This indicates that a PrPSc-specific epitope exists in the N-terminal region of PrPSc, and mAbs 6A12 and 8D5 are powerful tools with which to detect native and intact PrPSc. We found that the ratio of proteinase K (PK)-sensitive PrPSc to PK-resistant PrPSc was constant throughout the disease time course.	[Masujin, Kentaro; Miwa, Ritsuko; Okada, Hiroyuki; Shimizu, Yoshihisa; Kasai, Kazuo; Matsuura, Yuichi; Yokoyama, Takashi] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Kaku-Ushiki, Yuko] Nippi Res Inst Biomatrix, Toride, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Yokoyama, T (corresponding author), Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	tyoko@affrc.go.jp	Matsuura, Yuichi/AAF-3170-2021	Matsuura, Yuichi/0000-0003-3383-7918	BSE; Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Health, Labour and Welfare of Japan	BSE; Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-Aid from the BSE and Other Prion Disease Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan, and in part by grants for BSE research from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Giannopoulos PN, 2009, J NEUROSCI, V29, P8743, DOI 10.1523/JNEUROSCI.2294-09.2009; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; Hijazi N, 2005, J BIOL CHEM, V280, P17057, DOI 10.1074/jbc.M411314200; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; Jones M, 2009, BRAIN PATHOL, V19, P293, DOI 10.1111/j.1750-3639.2008.00181.x; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Lane A, 2003, CLIN CHEM, V49, P1774, DOI 10.1373/49.10.1774; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Moroncini G, 2006, NEUROBIOL DIS, V23, P717, DOI 10.1016/j.nbd.2006.06.008; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Petsch B, 2011, J VIROL, V85, P4538, DOI 10.1128/JVI.02467-10; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Serbec VC, 2004, J BIOL CHEM, V279, P3694, DOI 10.1074/jbc.M310868200; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Ushiki-Kaku Y, 2010, J BIOL CHEM, V285, P11931, DOI 10.1074/jbc.M109.058859; Yam AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009316; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Yin SM, 2006, J BIOL CHEM, V281, P10698, DOI 10.1074/jbc.M511819200; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200; Yokoyama T, 2009, J GEN VIROL, V90, P261, DOI 10.1099/vir.0.004754-0; Yokoyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015450; YOKOYAMA WM, 1991, CURRENT PROTOCOLS IM	49	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58013	10.1371/journal.pone.0058013	http://dx.doi.org/10.1371/journal.pone.0058013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469131	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900223
J	Gupta, V; Doshi, N; Mitragotri, S				Gupta, Vivek; Doshi, Nishit; Mitragotri, Samir			Permeation of Insulin, Calcitonin and Exenatide across Caco-2 Monolayers: Measurement Using a Rapid, 3-Day System	PLOS ONE			English	Article							ORAL PEPTIDE DELIVERY; CELL-LINE CACO-2; IN-VITRO; SALMON-CALCITONIN; INTESTINAL EPITHELIUM; COMPLEXATION HYDROGELS; DRUG ABSORPTION; CULTURE-SYSTEM; TRANSPORT; PERMEABILITY	Objectives: Caco-2 monolayers are one of the most widely used in vitro models for prediction of intestinal permeability of therapeutic molecules. However, the conventional Caco-2 monolayer model has several drawbacks including labor-intensive culture process, unphysiological growth conditions, lack of reproducibility and limited throughput. Here, we report on the use of 3-day Caco-2 monolayers for assessing permeability of polypeptide drugs. Methods: The 3-day monolayers were grown in a commercially available transwell set-up, which facilitates rapid development of the Caco-2 monolayers in an intestinal epithelial differentiation mimicking environment. This set-up included use of serum-free medium of defined composition with supplements such as butyric acid, hormones, growth factors, and other metabolites, reported to regulate the differentiation of intestinal epithelial cells in vivo. We measured permeability of 3 different therapeutic polypeptides; insulin, calcitonin, and exenatide across the monolayer. Results: Preliminary validation of the monolayer was carried out by confirming dose-dependent permeation of FITC-insulin and sulforhodamine-B. Transport of insulin, calcitonin, and exenatide measured at different loading concentrations suggests that the permeability values obtained with 3-day cultures resemble more closely the values obtained with ex vivo models compared to permeability values obtained with conventional 21-day cultures. Conclusions: Short-term 3-day Caco-2 monolayers provide new opportunities for developing reproducible and high-throughput models for screening of therapeutic macromolecules for oral absorption.	[Gupta, Vivek; Doshi, Nishit; Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Mitragotri, S (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	samir@engineering.ucsb.edu		Gupta, Vivek/0000-0002-3618-8178	Entrega Inc.; Otis Williams Fellowship; Otis Williams Fellowship at UCSB	Entrega Inc.; Otis Williams Fellowship; Otis Williams Fellowship at UCSB	This work was supported by Entrega Inc. VG acknowledges support from Otis Williams Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The research was funded by Entrega Inc. VG was supported by Otis Williams Fellowship at UCSB. SM is a shareholder and consultant of Entrega Inc. Funding does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anand BS, 2003, J PHARMACOL EXP THER, V304, P781, DOI 10.1124/jpet.102.044313; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Asa D, 2008, COMP BD BIOCOAT INTE, V416, P1; Basson MD, 1996, EXP CELL RES, V225, P301, DOI 10.1006/excr.1996.0180; Brewis Ian A., 1993, Biochemical Society Transactions, V21, p252S; Burton PS, 1996, J PHARM SCI, V85, P1336, DOI 10.1021/js960067d; Camenisch G, 1998, EUR J PHARM SCI, V6, P313, DOI 10.1016/S0928-0987(97)10019-7; Cetin M, 2008, AAPS PHARMSCITECH, V9, P1191, DOI 10.1208/s12249-008-9165-2; Chong SH, 1997, PHARMACEUT RES, V14, P1835, DOI 10.1023/A:1012112820371; Collett A, 1996, PHARMACEUT RES, V13, P216, DOI 10.1023/A:1016082829111; CONRADI RA, 1991, PHARMACEUT RES, V8, P1453, DOI 10.1023/A:1015825912542; Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828; Fasano A, 1998, TRENDS BIOTECHNOL, V16, P152, DOI 10.1016/S0167-7799(97)01170-0; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; GOMEZ G, 1995, AM J PHYSIOL-GASTR L, V268, pG71, DOI 10.1152/ajpgi.1995.268.1.G71; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; HARDIN JA, 1993, AM J PHYSIOL, V264, pG312, DOI 10.1152/ajpgi.1993.264.2.G312; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; HO NFH, 1995, J PHARM SCI, V84, P21, DOI 10.1002/jps.2600840107; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Ichikawa H, 2003, J BIOMED MATER RES A, V67A, P609, DOI 10.1002/jbm.a.10128; Le Ferrec E, 2001, ATLA-ALTERN LAB ANIM, V29, P649, DOI 10.1177/026119290102900604; Lee HJ, 2002, ARCH PHARM RES, V25, P572, DOI 10.1007/BF02976925; Lentz KA, 2000, INT J PHARM, V200, P41, DOI 10.1016/S0378-5173(00)00334-3; Ma EL, 2006, ACTA PHARMACOL SIN, V27, P1382, DOI 10.1111/j.1745-7254.2006.00424.x; Mahato RI, 2003, CRIT REV THER DRUG, V20, P153, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30; Mayfield JA, 2004, AM FAM PHYSICIAN, V70, P489; Morishita M, 2006, DRUG DISCOV TODAY, V11, P905, DOI 10.1016/j.drudis.2006.08.005; Munoz-Torres Manuel, 2004, Treat Endocrinol, V3, P117; Nollevaux G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-20; Sajeesh S, 2010, J CONTROL RELEASE, V147, P377, DOI 10.1016/j.jconrel.2010.08.007; Salamat-Miller N, 2005, INT J PHARMACEUT, V294, P201, DOI 10.1016/j.ijpharm.2005.01.022; Shah RB, 2004, AAPS J, V6; Sinko PJ, 1999, PHARMACEUT RES, V16, P527, DOI 10.1023/A:1018819012405; Soikkeli A, 2010, J BIOMOL SCREEN, V15, P30, DOI 10.1177/1087057109352236; Song KH, 2005, J CONTROL RELEASE, V106, P298, DOI 10.1016/j.jconrel.2005.05.016; SOULEIMANI A, 1993, FEBS LETT, V326, P45, DOI 10.1016/0014-5793(93)81758-R; Thompson C, 2011, PHARM RES-DORDR, V28, P886, DOI 10.1007/s11095-010-0345-x; Whitehead K, 2004, J CONTROL RELEASE, V98, P37, DOI 10.1016/j.jconrel.2004.04.013; Whitehead K, 2008, PHARM RES-DORDR, V25, P1782, DOI 10.1007/s11095-007-9488-9; Woitiski CB, 2011, INT J PHARMACEUT, V412, P123, DOI 10.1016/j.ijpharm.2011.04.003; Wood KM, 2010, ACTA BIOMATER, V6, P48, DOI 10.1016/j.actbio.2009.05.032; Yamashita S, 2002, J PHARM SCI, V91, P669, DOI 10.1002/jps.10050; Yang HT, 2003, ACTA PHARMACOL SIN, V24, P1185; Yang TZ, 2005, J DRUG TARGET, V13, P29, DOI 10.1080/10611860400020191; Youn YS, 2008, EUR J PHARM BIOPHARM, V68, P667, DOI 10.1016/j.ejpb.2007.07.009; Youn YS, 2006, J CONTROL RELEASE, V114, P334, DOI 10.1016/j.jconrel.2006.06.007	49	32	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57136	10.1371/journal.pone.0057136	http://dx.doi.org/10.1371/journal.pone.0057136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23483881	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000066
J	Luo, YH; Widmer, A				Luo, Yonghai; Widmer, Alex			Herkogamy and Its Effects on Mating Patterns in Arabidopsis thaliana	PLOS ONE			English	Article							GENETIC-VARIATION; NATURAL VARIATION; OUTCROSSING RATE; TRAIT; SIZE; POPULATIONS; EVOLUTION; SELECTION; AUTOGAMY; DISPLAY	The evolution of mating systems, which exhibit an extraordinary diversity in flowering plants, is of central interest in plant biology. Herkogamy, the spatial separation of sexual organs within flowers, is a widespread floral mechanism that is thought to be an adaptive trait reducing self-pollination in hermaphroditic plants. In contrast with previous studies of herkogamy that focused on plants with relatively large floral displays, we here characterized herkogamy in Arabidopsis thaliana, a model plant with a strong selfing syndrome. Developmental features, reproductive consequences, and genetic architecture of herkogamy were exploited using naturally variable A. thaliana accessions, under both greenhouse and natural conditions. Our results demonstrate that the degree of herkogamy can strongly influence the mating patterns of A. thaliana: approach herkogamy can effectively promote outcrossing, no herkogamy is also capable of enhancing the opportunity for outcrossing, and reverse herkogamy facilitates efficient self-pollination. In addition, we found that the expression of herkogamy in A. thaliana was environment-dependent and regulated by multiple quantitative trait loci. This study reveals how minor modifications in floral morphology may cause dramatic changes in plant mating patterns, provides new insights into the function of herkogamy, and suggests the way for dissecting the genetic basis of this important character in a model plant.	[Luo, Yonghai; Widmer, Alex] ETH, Inst Integrat Biol IBZ, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Luo, YH (corresponding author), ETH, Inst Integrat Biol IBZ, Zurich, Switzerland.	yonghailuo@gmail.com	Widmer, Alex/B-6841-2009	Widmer, Alex/0000-0001-8253-5137	Competence Center Environment and Sustainability (CCES) of the ETH-Domain	Competence Center Environment and Sustainability (CCES) of the ETH-Domain	This work was supported by the Competence Center Environment and Sustainability (CCES) of the ETH-Domain in the framework of the BioChange project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Bakker EG, 2006, MOL ECOL, V15, P1405, DOI 10.1111/j.1365-294X.2006.02884.x; Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; BELAOUSSOFF S, 1995, EVOLUTION, V49, P545, DOI 10.2307/2410278; Bergelson J, 1998, GENETICS, V148, P1311; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; BREESE E. L., 1959, ANN BOT [LONDON], V23, P331; Brunet J, 1998, FUNCT ECOL, V12, P596, DOI 10.1046/j.1365-2435.1998.00231.x; Button L, 2012, INT J PLANT SCI, V173, P251, DOI 10.1086/663972; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Chen KY, 2007, SCIENCE, V318, P643, DOI 10.1126/science.1148428; Chen KY, 2004, GENETICS, V168, P1563, DOI 10.1534/genetics.103.022558; Darwin C, 1877, EFFECTS CROSS SELF F; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Goodwillie C, 2010, NEW PHYTOL, V185, P311, DOI 10.1111/j.1469-8137.2009.03043.x; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; Herlihy CR, 2007, EVOLUTION, V61, P1661, DOI 10.1111/j.1558-5646.2007.00137.x; HOLTSFORD TP, 1992, EVOLUTION, V46, P216, DOI 10.1111/j.1558-5646.1992.tb01996.x; Kalisz S, 2004, NATURE, V430, P884, DOI 10.1038/nature02776; Karron JD, 2004, HEREDITY, V92, P242, DOI 10.1038/sj.hdy.6800402; Karron JD, 1997, HEREDITY, V79, P365, DOI 10.1038/hdy.1997.169; KLINKHAMER PGL, 1989, OIKOS, V54, P201, DOI 10.2307/3565267; Lendvai G, 2003, HEREDITY, V90, P336, DOI 10.1038/sj.hdy.6800249; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; Medrano M, 2005, ANN BOT-LONDON, V95, P1105, DOI 10.1093/aob/mci129; Medrano M, 2012, PLANT BIOLOGY, V14, P801, DOI 10.1111/j.1438-8677.2012.00569.x; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Motten AF, 2000, AM J BOT, V87, P339, DOI 10.2307/2656629; ORNDUFF R, 1969, Taxon, V18, P121, DOI 10.2307/1218671; Pico FX, 2008, GENETICS, V180, P1009, DOI 10.1534/genetics.108.089581; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; R Core Team, 2021, R LANGUAGE ENV STAT; SHORE JS, 1990, HEREDITY, V64, P105, DOI 10.1038/hdy.1990.13; Sicard A, 2011, ANN BOT-LONDON, V107, P1433, DOI 10.1093/aob/mcr023; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stebbins G. L., 1974, Flowering plants. Evolution above the species level.; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Tantikanjana T, 2009, PLANT CELL, V21, P2642, DOI 10.1105/tpc.109.067801; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2001, JOINMAP R VERSION 3; WEBB CJ, 1986, NEW ZEAL J BOT, V24, P163, DOI 10.1080/0028825X.1986.10409726; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845	45	32	33	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57902	10.1371/journal.pone.0057902	http://dx.doi.org/10.1371/journal.pone.0057902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469099	Green Submitted, gold, Green Published			2022-12-27	WOS:000315561400048
J	Liau, WS; Nasri, U; Elmatari, D; Rothman, J; LaMunyon, CW				Liau, Wei-Siang; Nasri, Ubaydah; Elmatari, Daniel; Rothman, Jason; LaMunyon, Craig W.			Premature Sperm Activation and Defective Spermatogenesis Caused by Loss of spe-46 Function in Caenorhabditis elegans	PLOS ONE			English	Article							FAMILY-MEMBER SPE-4; PROTEIN PHOSPHATASE; MOLECULAR ANALYSIS; MEMBRANE-PROTEIN; GENE-EXPRESSION; SEA-URCHIN; C-ELEGANS; NEMATODE; SPERMIOGENESIS; INITIATION	Given limited resources for motility, sperm cell activation must be precisely timed to ensure the greatest likelihood of fertilization. Like those of most species, the sperm of C. elegans become active only after encountering an external signaling molecule. Activation coincides with spermiogenesis, the final step in spermatogenesis, when the spherical spermatid undergoes wholesale reorganization to produce a pseudopod. Here, we describe a gene involved in sperm activation, spe-46. This gene was identified in a suppressor screen of spe-27(it132ts), a sperm-expressed gene whose product functions in the transduction of the spermatid activation signal. While spe-27(it132ts) worms are sterile at 25 degrees C, the spe-46(hc197)I; spe-27(it132ts)IV double mutants regain partial fertility. Single nucleotide polymorphism mapping, whole genome sequencing, and transformation rescue were employed to identify the spe-46 coding sequence. It encodes a protein with seven predicted transmembrane domains but with no other predicted functional domains or homology outside of nematodes. Expression is limited to spermatogenic tissue, and a transcriptional GFP fusion shows expression corresponds with the onset of the pachytene stage of meiosis. The spe-46(hc197) mutation bypasses the need for the activation signal; mutant sperm activate prematurely without an activation signal in males, and mutant males are sterile. In an otherwise wild-type genome, the spe-46(hc197) mutation induces a sperm defective phenotype. In addition to premature activation, spe-46(hc197) sperm exhibit numerous defects including aneuploidy, vacuolization, protruding spikes, and precocious fusion of membranous organelles. Hemizygous worms [spe-46(hc197)/mnDf111] are effectively sterile. Thus, spe-46 appears to be involved in the regulation of spermatid activation during spermiogenesis, with the null phenotype being an absence of functional sperm and hypomorphic phenotypes being premature spermatid activation and numerous sperm cell defects.	[Liau, Wei-Siang; Nasri, Ubaydah; Elmatari, Daniel; Rothman, Jason; LaMunyon, Craig W.] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	LaMunyon, CW (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	cwlamunyon@csupomona.edu	Rothman, Jason/I-2382-2019	Rothman, Jason/0000-0002-4848-8901; Liau, Wei-Siang/0000-0001-8547-4712	U.S. National Institutes of Health [1 SC3 GM087212]; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM087212] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by U.S. National Institutes of Health award 1 SC3 GM087212. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduengo PM, 1998, J CELL SCI, V111, P3645; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOATMAN DE, 1991, BIOL REPROD, V44, P806, DOI 10.1095/biolreprod44.5.806; BRENNER S, 1974, GENETICS, V77, P71; BURKE DJ, 1983, J MOL BIOL, V171, P1, DOI 10.1016/S0022-2836(83)80312-X; CHRISTEN R, 1982, J BIOL CHEM, V257, P4881; del Castillo-Olivares A, 2009, DEV BIOL, V333, P397, DOI 10.1016/j.ydbio.2009.06.044; Dell'Angelica EC, 2001, CELL, V106, P395, DOI 10.1016/S0092-8674(01)00470-6; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gadella BM, 2000, DEVELOPMENT, V127, P2407; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; Geldziler B, 2005, DEV BIOL, V283, P424, DOI 10.1016/j.ydbio.2005.04.036; Gosney R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-44; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Han X, 2009, GENETICS, V181, P933, DOI 10.1534/genetics.108.096016; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Kaupp UB, 2006, J CELL PHYSIOL, V208, P487, DOI 10.1002/jcp.20669; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kulkarni M, 2012, PLOS GENET, V8, P587, DOI 10.1371/journal.pgen.1002678; L'Hernault Steven W., 1997, Cold Spring Harbor Monograph Series, V33, P271; LHERNAULT SW, 1988, GENETICS, V120, P435; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; Machaca K, 1996, DEV BIOL, V176, P1, DOI 10.1006/dbio.1996.9999; Minniti AN, 1996, GENETICS, V143, P213; Muhlrad PJ, 2002, GENETICS, V161, P143; Muhlrad PJ, 2001, THESIS U ARIZONA TUC; Nance J, 1999, GENETICS, V152, P209; Nance J, 2000, GENETICS, V156, P1623; Neill AT, 2004, REPRODUCTION, V127, P141, DOI 10.1530/rep.1.00085; NELSON GA, 1980, CELL, V19, P457, DOI 10.1016/0092-8674(80)90520-6; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; ROBERTS TM, 1986, J CELL BIOL, V102, P1787, DOI 10.1083/jcb.102.5.1787; ROBERTS TM, 1982, J CELL BIOL, V92, P113, DOI 10.1083/jcb.92.1.113; Sadler PL, 2000, DEVELOPMENT, V127, P355; SCHACKMANN RW, 1981, DEV BIOL, V81, P145, DOI 10.1016/0012-1606(81)90357-2; SEPSENWOL S, 1989, J CELL BIOL, V108, P55, DOI 10.1083/jcb.108.1.55; SHAKES DC, 1989, DEV BIOL, V134, P189, DOI 10.1016/0012-1606(89)90088-2; Smith JR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002375; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Stanfield GM, 2006, CURR BIOL, V16, P252, DOI 10.1016/j.cub.2005.12.041; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; VARKEY JP, 1993, GENETICS, V133, P79; Veljkovic E, 2004, J BIOL CHEM, V279, P49268, DOI 10.1074/jbc.M404470200; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	53	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57266	10.1371/journal.pone.0057266	http://dx.doi.org/10.1371/journal.pone.0057266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483899	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100017
J	Colabardini, AC; Brown, NA; Savoldi, M; Goldman, MHS; Goldman, GH				Colabardini, Ana Cristina; Brown, Neil Andrew; Savoldi, Marcela; Goldman, Maria Helena S.; Goldman, Gustavo Henrique			Functional Characterization of Aspergillus nidulans ypkA, a Homologue of the Mammalian Kinase SGK	PLOS ONE			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; GPI-ANCHORED PROTEINS; SPHINGOLIPID BIOSYNTHESIS; CELL-GROWTH; CERAMIDE SYNTHASES; SIGNALING PATHWAY; MESSENGER-RNA; HEAT-STRESS; PKH-YPK; YEAST	The serum- and glucocorticoid-regulated protein kinase (SGK) is an AGC kinase involved in signal cascades regulated by glucocorticoid hormones and serum in mammals. The Saccharomyces cerevisiae ypk1 and ypk2 genes were identified as SGK homologues and Ypk1 was shown to regulate the balance of sphingolipids between the inner and outer plasma membrane. This investigation characterized the Aspergillus nidulans YPK1 homologue, YpkA, representing the first filamentous fungal YPK1 homologue. Two conditional mutant strains were constructed by replacing the endogenous ypk1 promoter with two different regulatable promoters, alcA (from the alcohol dehydrogenase gene) and niiA (from the nitrate reductase gene). Both constructs confirmed that ypkA was an essential gene in A. nidulans. Repression of ypkA caused decreased radial growth, a delay in conidial germination, deficient polar axis establishment, intense branching during late stages of growth, a lack of asexual spores, and a terminal phenotype. Membrane lipid polarization, endocytosis, eisosomes and vacuolar distribution were also affected by ypkA repression, suggesting that YpkA plays a role in hyphal morphogenesis via coordinating the delivery of cell membrane and wall constituents to the hyphal apex. The A. nidulans Pkh1 homologue pkhA was also shown to be an essential gene, and preliminary genetic analysis suggested that the ypkA gene is not directly downstream of pkhA or epistatic to pkhA, rather, ypkA and pkhA are genetically independent or in parallel. BarA is a homologue of the yeast Lag1 acyl-CoA-dependent ceramide synthase, which catalyzes the condensation of phytosphingosine with a fatty acyl-CoA to form phytoceramide. When barA was absent, ypkA repression was lethal to the cell. Therefore, there appears to be a genetic interaction between ypkA, barA, and the sphingolipid synthesis. Transcriptional profiling of ypkA overexpression and down-regulation revealed several putative YpkA targets associated with the observed phenotypes.	[Goldman, Gustavo Henrique] Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil; [Colabardini, Ana Cristina; Brown, Neil Andrew; Savoldi, Marcela; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmacet Ribeirao Preto, Sao Paulo, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Goldman, GH (corresponding author), Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil.	ggoldman@usp.br	Colabardini, Ana/P-1791-2015; Goldman, Gustavo Henrique/F-1848-2013; Goldman, Maria Helena S./D-1424-2012	Colabardini, Ana/0000-0002-2131-7969; Goldman, Gustavo Henrique/0000-0002-2986-350X; Goldman, Maria Helena S./0000-0002-6786-9320; Brown, Neil/0000-0002-3555-5765	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil for financial support. We also thank Dr. Vicky Sophianopoulou for providing the PilA::GFP and PilB::GFP strains. We would like to thank the reviewers for their suggestions and comments.	Alvarez FJ, 2007, EUKARYOT CELL, V6, P755, DOI 10.1128/EC.00008-07; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Aviram S, 2008, MOL CELL BIOL, V28, P6858, DOI 10.1128/MCB.00367-08; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CHEN P, 1993, MOL GEN GENET, V236, P443, DOI 10.1007/BF00277146; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Flipphi M, 2002, BIOCHEM J, V364, P25, DOI 10.1042/bj3640025; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gelperin D, 2002, GENETICS, V161, P1453; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Govindan B, 1995, J EXP ZOOL, V273, P401, DOI 10.1002/jez.1402730505; GOW NAR, 1994, MICROBIOL-SGM, V140, P3193, DOI 10.1099/13500872-140-12-3193; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; Hollister RD, 1997, NEUROSCIENCE, V79, P1111, DOI 10.1016/S0306-4522(97)00014-6; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; Jacquier N, 2010, J CELL SCI, V123, P2218, DOI 10.1242/jcs.063073; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kanazawa T, 2000, J CELL BIOL, V149, P943, DOI 10.1083/jcb.149.4.943; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Liu K, 2005, BIOCHEM SOC T, V33, P1170, DOI 10.1042/BST0331170; Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200; Maiyar AC, 1996, J BIOL CHEM, V271, P12414, DOI 10.1074/jbc.271.21.12414; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Mouritsen OG, 1997, CURR OPIN STRUC BIOL, V7, P518, DOI 10.1016/S0959-440X(97)80116-9; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Olivera-Couto A, 2012, MOL GENET GENOMICS, V287, P607, DOI 10.1007/s00438-012-0706-8; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; PUNT PJ, 1991, GENE, V104, P119, DOI 10.1016/0378-1119(91)90476-R; PUSHKAREVA MY, 1992, J BIOL CHEM, V267, P15246; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sambrook J., 2001, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Semighini CP, 2002, APPL ENVIRON MICROB, V68, P1351, DOI 10.1128/AEM.68.3.1351-1357.2002; Shimobayashi M, 2010, J BIOL CHEM, V285, P36984, DOI 10.1074/jbc.M110.119180; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; SPRAGUE GF, 1981, J MOL BIOL, V153, P305, DOI 10.1016/0022-2836(81)90280-1; Steinberg G, 2007, NAT REV MICROBIOL, V5, P309, DOI 10.1038/nrmicro1618; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Sutterlin C, 1997, J CELL SCI, V110, P2703; Tanoue D, 2005, ARCH BIOCHEM BIOPHYS, V437, P29, DOI 10.1016/j.abb.2005.02.030; Vangelatos I, 2010, EUKARYOT CELL, V9, P1441, DOI 10.1128/EC.00087-10; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	69	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57630	10.1371/journal.pone.0057630	http://dx.doi.org/10.1371/journal.pone.0057630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472095	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900034
J	Dahlhoff, C; Desmarchelier, C; Sailer, M; Furst, RW; Haag, A; Ulbrich, SE; Hummel, B; Obeid, R; Geisel, J; Bader, BL; Daniel, H				Dahlhoff, Christoph; Desmarchelier, Charles; Sailer, Manuela; Fuerst, Rainer W.; Haag, Alexander; Ulbrich, Susanne E.; Hummel, Bjoern; Obeid, Rima; Geisel, Juergen; Bader, Bernhard L.; Daniel, Hannelore			Hepatic Methionine Homeostasis Is Conserved in C57BL/6N Mice on High-Fat Diet Despite Major Changes in Hepatic One-Carbon Metabolism	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; HOMOCYSTEINE S-METHYLTRANSFERASE; LOW-DENSITY LIPOPROTEIN; HIGH-THROUGHPUT METHOD; LIVER-DISEASE; PHOSPHATIDYLCHOLINE SYNTHESIS; PLASMA HOMOCYSTEINE; ENERGY-EXPENDITURE; INSULIN-RESISTANCE	Obesity is an underlying risk factor in the development of cardiovascular disease, dyslipidemia and non-alcoholic fatty liver disease (NAFLD). Increased hepatic lipid accumulation is a hallmark in the progression of NAFLD and impairments in liver phosphatidylcholine (PC) metabolism may be central to the pathogenesis. Hepatic PC biosynthesis, which is linked to the one-carbon (C1) metabolism by phosphatidylethanolamine N-methyltransferase, is known to be important for hepatic lipid export by VLDL particles. Here, we assessed the influence of a high-fat (HF) diet and NAFLD status in mice on hepatic methyl-group expenditure and C1-metabolism by analyzing changes in gene expression, protein levels, metabolite concentrations, and nuclear epigenetic processes. In livers from HF diet induced obese mice a significant downregulation of cystathionine beta-synthase (CBS) and an increased betaine-homocysteine methyltransferase (BHMT) expression were observed. Experiments in vitro, using hepatoma cells stimulated with peroxisome proliferator activated receptor alpha (PPAR alpha) agonist WY14,643, revealed a significantly reduced Cbs mRNA expression. Moreover, metabolite measurements identified decreased hepatic cystathionine and L-alpha-amino-n-butyrate concentrations as part of the transsulfuration pathway and reduced hepatic betaine concentrations, but no metabolite changes in the methionine cycle in HF diet fed mice compared to controls. Furthermore, we detected diminished hepatic gene expression of de novo DNA methyltransferase 3b but no effects on hepatic global genomic DNA methylation or hepatic DNA methylation in the Cbs promoter region upon HF diet. Our data suggest that HF diet induces a PPARa-mediated downregulation of key enzymes in the hepatic transsulfuration pathway and upregulates BHMT expression in mice to accommodate to enhanced dietary fat processing while preserving the essential amino acid methionine.	[Dahlhoff, Christoph; Desmarchelier, Charles; Sailer, Manuela; Haag, Alexander; Daniel, Hannelore] Tech Univ Munich, Res Ctr Nutr & Food Sci, PhD Grp, Biochem Unit, Freising Weihenstephan, Germany; [Dahlhoff, Christoph; Fuerst, Rainer W.; Ulbrich, Susanne E.; Bader, Bernhard L.] Tech Univ Munich, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Bader, Bernhard L.] Tech Univ Munich, Res Ctr Nutr & Food Sci, Nutr Med Unit, Freising Weihenstephan, Germany; [Fuerst, Rainer W.; Ulbrich, Susanne E.] Tech Univ Munich, Res Ctr Nutr & Food Sci, ZIEL, Physiol Unit, Freising Weihenstephan, Germany; [Hummel, Bjoern; Obeid, Rima; Geisel, Juergen] Univ Hosp Saarland, Clin Chem & Lab Med Cent Lab, Homburg, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Universitatsklinikum des Saarlandes	Bader, BL (corresponding author), Tech Univ Munich, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany.	bernhard.bader@tum.de	Ulbrich, Susanne E/D-1815-2014; Daniel, Hannelore/B-8982-2009; Obeid, Rima/AAR-9906-2020	Ulbrich, Susanne E/0000-0003-0355-3869; 				Anai M, 1999, DIABETES, V48, P158, DOI 10.2337/diabetes.48.1.158; Angulo P, 2007, NUTR REV, V65, pS57, DOI [10.1111/j.1753-4887.2007.tb00329.x, 10.1301/nr.2007.jun.S57-S63]; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bravo E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-60; CERSOSIMO E, 1986, AM J PHYSIOL, V250, pE248, DOI 10.1152/ajpendo.1986.250.3.E248; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DERR RF, 1976, J PHARMACOL EXP THER, V197, P675; DESCHATRETTE J, 1974, BIOCHIMIE, V56, P1603; Desmarchelier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-84; FINKELSTEIN JD, 1986, J NUTR, V116, P985, DOI 10.1093/jn/116.6.985; FINKELSTEIN JD, 1988, J BIOL CHEM, V263, P11750; FINKELSTEIN JD, 1982, ARCH BIOCHEM BIOPHYS, V218, P169, DOI 10.1016/0003-9861(82)90332-0; Fonseca V, 2000, METABOLISM, V49, P736, DOI 10.1053/meta.2000.6256; Furst RW, 2012, J STEROID BIOCHEM, V130, P96, DOI 10.1016/j.jsbmb.2012.01.009; Holm PI, 2003, CLIN CHEM, V49, P286, DOI 10.1373/49.2.286; HONG RW, 1992, ANN SURG, V215, P114, DOI 10.1097/00000658-199202000-00004; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Karimi M, 2006, EPIGENETICS-US, V1, P45; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kirsch SH, 2009, J CHROMATOGR B, V877, P3865, DOI 10.1016/j.jchromb.2009.09.039; Li L, 2006, ANN NUTR METAB, V50, P499, DOI 10.1159/000098141; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Mack I, 2009, AM J PHYSIOL-ENDOC M, V297, pE735, DOI 10.1152/ajpendo.90851.2008; MALAISSE WJ, 1980, MOL CELL ENDOCRINOL, V20, P171, DOI 10.1016/0303-7207(80)90080-5; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nakashima T, 1983, Prog Clin Biol Res, V125, P449; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Noga AA, 2003, J BIOL CHEM, V278, P5952, DOI 10.1074/jbc.M212194200; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Oakes CC, 2006, EPIGENETICS-US, V1, P146, DOI 10.4161/epi.1.3.3392; Oakes Christopher C., 2009, V507, P271, DOI 10.1007/978-1-59745-522-0_20; Obeid R, 2009, FEBS LETT, V583, P1215, DOI 10.1016/j.febslet.2009.03.038; R Core Team, 2020, R LANG ENV STAT COMP; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ratnam S, 2006, AM J PHYSIOL-ENDOC M, V290, pE933, DOI 10.1152/ajpendo.00498.2005; Ratnam S, 2002, J BIOL CHEM, V277, P42912, DOI 10.1074/jbc.M206588200; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Rubio-Aliaga I, 2011, PHYSIOL GENOMICS, V43, P408, DOI 10.1152/physiolgenomics.00179.2010; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Sheikh K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1157, DOI 10.1152/ajpendo.00254.2006; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Sparks JD, 2006, BIOCHEM J, V395, P363, DOI 10.1042/BJ20051966; STABLER SP, 1993, BLOOD, V81, P3404; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; Strang BD, 1998, J DAIRY SCI, V81, P728, DOI 10.3168/jds.S0022-0302(98)75629-2; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; Tang B, 2009, NUTRITION; Teng YW, 2012, J BIOL CHEM, V287, P16187, DOI 10.1074/jbc.M111.303255; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Uekawa A, 2009, J NUTRIGENET NUTRIGE, V2, P29, DOI 10.1159/000165374; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang DQH, 2009, J LIPID RES, V50, pS406, DOI 10.1194/jlr.R800075-JLR200; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Wijekoon EP, 2005, DIABETES, V54, P3245, DOI 10.2337/diabetes.54.11.3245; Williams KT, 2008, J NUTR, V138, P2064, DOI 10.3945/jn.108.094144; YAO ZM, 1988, J BIOL CHEM, V263, P2998	73	29	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57387	10.1371/journal.pone.0057387	http://dx.doi.org/10.1371/journal.pone.0057387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472083	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900021
J	Gadadhar, S; Karande, AA				Gadadhar, Sudarshan; Karande, Anjali A.			Abrin Immunotoxin: Targeted Cytotoxicity and Intracellular Trafficking Pathway	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; RICIN-A-CHAIN; RIBOSOME-INACTIVATING PROTEINS; PHASE-I; ENZYMATIC-ACTIVITY; ABRUS-PRECATORIUS; TOXIC LECTINS; FUSION TOXIN; HUMAN BREAST; RECEPTOR	Background: Immunotherapy is fast emerging as one of the leading modes of treatment of cancer, in combination with chemotherapy and radiation. Use of immunotoxins, proteins bearing a cell-surface receptor-specific antibody conjugated to a toxin, enhances the efficacy of cancer treatment. The toxin Abrin, isolated from the Abrus precatorius plant, is a type II ribosome inactivating protein, has a catalytic efficiency higher than any other toxin belonging to this class of proteins but has not been exploited much for use in targeted therapy. Methods: Protein synthesis assay using (3)[H] L-leucine incorporation; construction and purification of immunotoxin; study of cell death using flow cytometry; confocal scanning microscopy and sub-cellular fractionation with immunoblot analysis of localization of proteins. Results: We used the recombinant A chain of abrin to conjugate to antibodies raised against the human gonadotropin releasing hormone receptor. The conjugate inhibited protein synthesis and also induced cell death specifically in cells expressing the receptor. The conjugate exhibited differences in the kinetics of inhibition of protein synthesis, in comparison to abrin, and this was attributed to differences in internalization and trafficking of the conjugate within the cells. Moreover, observations of sequestration of the A chain into the nucleus of cells treated with abrin but not in cells treated with the conjugate reveal a novel pathway for the movement of the conjugate in the cells. Conclusions: This is one of the first reports on nuclear localization of abrin, a type II RIP. The immunotoxin mAb F1G4-rABRa-A, generated in our laboratory, inhibits protein synthesis specifically on cells expressing the gonadotropin releasing hormone receptor and the pathway of internalization of the protein is distinct from that seen for abrin.	[Gadadhar, Sudarshan; Karande, Anjali A.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Karande, AA (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	anjali@biochem.iisc.ernet.in	Gadadhar, Sudarshan/O-1770-2019; Gadadhar, Sudarshan/C-1319-2019	Gadadhar, Sudarshan/0000-0003-4791-2034; Gadadhar, Sudarshan/0000-0003-4791-2034	Council of Scientific and Industrial Research (CSIR), Government of India; CSIR	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work has been supported by the grant from the Council of Scientific and Industrial Research (CSIR), Government of India. Sudarshan Gadadhar is a recipient of Senior Research Fellowship from the CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagaria A, 2006, J BIOL CHEM, V281, P34465, DOI 10.1074/jbc.M601777200; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Barbieri L, 2004, FEBS LETT, V563, P219, DOI 10.1016/S0014-5793(04)00286-8; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; Battelli MG, 2010, BBA-GEN SUBJECTS, V1800, P1276, DOI 10.1016/j.bbagen.2010.09.006; Battelli MG, 2004, CELL MOL LIFE SCI, V61, P1975, DOI 10.1007/s00018-004-4171-3; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Bora N, 2009, COMP STUDY SENSITIVI; Chen JK, 1997, PROTEIN ENG, V10, P827, DOI 10.1093/protein/10.7.827; Cheung LWT, 2008, FEBS J, V275, P5479, DOI 10.1111/j.1742-4658.2008.06677.x; CLAYTON RN, 1981, ENDOCR REV, V2, P186, DOI 10.1210/edrv-2-2-186; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; EAGLE H, 1955, P SOC EXP BIOL MED, V89, P362; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1982, J BIOL CHEM, V257, P9054; EVENSEN G, 1991, J BIOL CHEM, V266, P6848; GOLDBERG MR, 1995, CLIN CANCER RES, V1, P57; GRIFFITHS GD, 1987, J PATHOL, V151, P221, DOI 10.1002/path.1711510310; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; GROS O, 1985, J IMMUNOL METHODS, V81, P283, DOI 10.1016/0022-1759(85)90213-3; Hapgood JP, 2005, J NEUROENDOCRINOL, V17, P619, DOI 10.1111/j.1365-2826.2005.01353.x; Harrison GS, 2004, ENDOCR-RELAT CANCER, V11, P725, DOI 10.1677/erc.1.00777; Hermanson GT, 1996, BIOCONJUGATE TECHNIQ, P510; HERTLER AA, 1989, J CLIN ONCOL, V7, P1932, DOI 10.1200/JCO.1989.7.12.1932; HUNG CH, 1994, EUR J BIOCHEM, V219, P83, DOI 10.1111/j.1432-1033.1994.tb19917.x; HUNG CH, 1993, J MOL BIOL, V229, P263, DOI 10.1006/jmbi.1993.1029; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Kakar SS, 1995, CANCER LETT, V98, P57, DOI 10.1016/0304-3835(95)90203-1; KAKAR SS, 1992, BIOCHEM BIOPH RES CO, V189, P289, DOI 10.1016/0006-291X(92)91556-6; KAKAR SS, 1994, MOL CELL ENDOCRINOL, V106, P145, DOI 10.1016/0303-7207(94)90196-1; KARANDE AA, 1995, MOL CELL ENDOCRINOL, V114, P51, DOI 10.1016/0303-7207(95)03641-J; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kottler ML, 1997, INT J CANCER, V71, P595, DOI 10.1002/(SICI)1097-0215(19970516)71:4<595::AID-IJC14>3.3.CO;2-L; Kottler ML, 1999, EUR J ENDOCRINOL, V140, P561, DOI 10.1530/eje.0.1400561; Kreitman R J, 2000, Expert Opin Pharmacother, V1, P1117, DOI 10.1517/14656566.1.6.1117; Kreitman RJ, 2003, CURR OPIN MOL THER, V5, P44; Kreitman RJ, 1998, ADV DRUG DELIVER REV, V31, P53, DOI 10.1016/S0169-409X(97)00094-X; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; Luster TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047361; Lyu MA, 2010, NEOPLASIA, V12, P366, DOI 10.1593/neo.91960; Maroui MA, 2011, J VIROL, V85, P13164, DOI 10.1128/JVI.05808-11; McClintock JL, 2010, INVEST OPHTH VIS SCI, V51, P3455, DOI 10.1167/iovs.09-4386; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Narayanan S, 2005, FEBS LETT, V579, P1324, DOI 10.1016/j.febslet.2005.01.038; Narayanan S, 2004, BIOCHEM J, V377, P233, DOI 10.1042/BJ20030797; OLSNES S, 1974, J BIOL CHEM, V249, P803; OLSNES S, 1975, EUR J BIOCHEM, V60, P281, DOI 10.1111/j.1432-1033.1975.tb21001.x; Pai-Scherf LH, 1999, CLIN CANCER RES, V5, P2311; PATI D, 1995, ENDOCRINOLOGY, V136, P75, DOI 10.1210/en.136.1.75; PIRKER R, 1988, J CANCER RES CLIN, V114, P385, DOI 10.1007/BF02128183; Posey JA, 2002, CLIN CANCER RES, V8, P3092; Qu XL, 2004, J BIOCHEM MOL BIOL, V37, P445; REFSNES K, 1974, J BIOL CHEM, V249, P3557; Sampson JH, 2003, J NEURO-ONCOL, V65, P27, DOI 10.1023/A:1026290315809; SANDVIG K, 1978, EUR J BIOCHEM, V82, P13, DOI 10.1111/j.1432-1033.1978.tb11992.x; Sandvig K, 1999, FEBS LETT, V452, P67, DOI 10.1016/S0014-5793(99)00529-3; Schlick JL, 2000, FEBS LETT, V472, P241, DOI 10.1016/S0014-5793(00)01469-1; SOLERRODRIGUEZ AM, 1993, EXP CELL RES, V206, P227, DOI 10.1006/excr.1993.1142; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; TAHIROV TH, 1995, J MOL BIOL, V250, P354, DOI 10.1006/jmbi.1995.0382; THORPE PE, 1987, CANCER RES, V47, P5924; Vrecl M, 1998, MOL ENDOCRINOL, V12, P1818, DOI 10.1210/me.12.12.1818; Vrecl M, 2000, PFLUG ARCH EUR J PHY, V439, pR19, DOI 10.1007/s004240000075; Wang LC, 2004, BIOCHIMIE, V86, P327, DOI 10.1016/j.biochi.2004.03.006; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Yang WH, 2003, ENDOCRINOLOGY, V144, P1456, DOI 10.1210/en.2002-220917	67	30	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58304	10.1371/journal.pone.0058304	http://dx.doi.org/10.1371/journal.pone.0058304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472175	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900121
J	Hariharan, R; Simon, R; Pillai, MR; Taylor, TD				Hariharan, Ramkumar; Simon, Reji; Pillai, M. Radhakrishna; Taylor, Todd D.			Comparative Analysis of DNA Word Abundances in Four Yeast Genomes Using a Novel Statistical Background Model	PLOS ONE			English	Article							REGULATORY SITES; GENES; IDENTIFICATION; DISCOVERY	Previous studies have shown that the identification and analysis of both abundant and rare k-mers or "DNA words of length k'' in genomic sequences using suitable statistical background models can reveal biologically significant sequence elements. Other studies have investigated the uni/multimodal distribution of k-mer abundances or "k-mer spectra'' in different DNA sequences. However, the existing background models are affected to varying extents by compositional bias. Moreover, the distribution of k-mer abundances in the context of related genomes has not been studied previously. Here, we present a novel statistical background model for calculating k-mer enrichment in DNA sequences based on the average of the frequencies of the two (k-1) mers for each k-mer. Comparison of our null model with the commonly used ones, including Markov models of different orders and the single mismatch model, shows that our method is more robust to compositional AT-rich bias and detects many additional, repeat-poor over-abundant k-mers that are biologically meaningful. Analysis of overrepresented genomic k-mers (4 <= k <= 16) from four yeast species using this model showed that the fraction of overrepresented DNA words falls linearly as k increases; however, a significant number of overabundant k-mers exists at higher values of k. Finally, comparative analysis of k-mer abundance scores across four yeast species revealed a mixture of unimodal and multimodal spectra for the various genomic sub-regions analyzed.	[Hariharan, Ramkumar; Simon, Reji; Pillai, M. Radhakrishna] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram, Kerala, India; [Hariharan, Ramkumar; Taylor, Todd D.] RIKEN Quantitat Biol Ctr, Lab MetaSyst Res, Tsurumi Ku, Yokohama, Kanagawa, Japan	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); RIKEN	Taylor, TD (corresponding author), RIKEN Quantitat Biol Ctr, Lab MetaSyst Res, Tsurumi Ku, Yokohama, Kanagawa, Japan.	taylor@riken.jp	Taylor, Todd/A-7121-2009	Taylor, Todd/0000-0003-4247-6253				Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397; Chor B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r108; Csuros M, 2007, TRENDS GENET, V23, P543, DOI 10.1016/j.tig.2007.07.008; Garcia SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016065; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Hampson S, 2002, BIOINFORMATICS, V18, P513, DOI 10.1093/bioinformatics/18.4.513; Herold J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-167; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137; Reinert G, 2000, J COMPUT BIOL, V7, P1, DOI 10.1089/10665270050081360; Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103; Robin S, 2001, J COMPUT BIOL, V8, P349, DOI 10.1089/106652701752236179; Sinha S, 2002, NUCLEIC ACIDS RES, V30, P5549, DOI 10.1093/nar/gkf669; van Helden J, 2000, NUCLEIC ACIDS RES, V28, P1000; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	19	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58038	10.1371/journal.pone.0058038	http://dx.doi.org/10.1371/journal.pone.0058038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472131	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900075
J	Ricciardi, E; Handjaras, G; Bonino, D; Vecchi, T; Fadiga, L; Pietrini, P				Ricciardi, Emiliano; Handjaras, Giacomo; Bonino, Daniela; Vecchi, Tomaso; Fadiga, Luciano; Pietrini, Pietro			Beyond Motor Scheme: A Supramodal Distributed Representation in the Action-Observation Network	PLOS ONE			English	Article							PREMOTOR CORTEX; MIRROR NEURONS; CLASSIFICATION; SELECTION; PARIETAL; BLINDNESS; PATTERNS; REVEALS; IMAGERY; VISION	The representation of actions within the action-observation network is thought to rely on a distributed functional organization. Furthermore, recent findings indicate that the action-observation network encodes not merely the observed motor act, but rather a representation that is independent from a specific sensory modality or sensory experience. In the present study, we wished to determine to what extent this distributed and 'more abstract' representation of action is truly supramodal, i.e. shares a common coding across sensory modalities. To this aim, a pattern recognition approach was employed to analyze neural responses in sighted and congenitally blind subjects during visual and/or auditory presentation of hand-made actions. Multivoxel pattern analyses-based classifiers discriminated action from non-action stimuli across sensory conditions (visual and auditory) and experimental groups (blind and sighted). Moreover, these classifiers labeled as 'action' the pattern of neural responses evoked during actual motor execution. Interestingly, discriminative information for the action/non action classification was located in a bilateral, but left-prevalent, network that strongly overlaps with brain regions known to form the action-observation network and the human mirror system. The ability to identify action features with a multivoxel pattern analyses-based classifier in both sighted and blind individuals and independently from the sensory modality conveying the stimuli clearly supports the hypothesis of a supramodal, distributed functional representation of actions, mainly within the action-observation network.	[Ricciardi, Emiliano; Handjaras, Giacomo; Bonino, Daniela; Pietrini, Pietro] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Lab Clin Biochem & Mol Biol, Pisa, Italy; [Ricciardi, Emiliano] CNR, Fdn G Monasterio Reg Toscana, MRI Lab, I-56100 Pisa, Italy; [Vecchi, Tomaso] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy; [Vecchi, Tomaso] IRCCS Mondino, Brain Connect Ctr, Pavia, Italy; [Fadiga, Luciano] Univ Ferrara, Sect Human Physiol, I-44100 Ferrara, Italy; [Fadiga, Luciano] Italian Inst Technol, RBCS Dept, Genoa, Italy; [Pietrini, Pietro] Pisa Univ Hosp, Clin Psychol Branch, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); University of Pavia; IRCCS Fondazione Casimiro Mondino; University of Ferrara; Istituto Italiano di Tecnologia - IIT; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Ricciardi, E (corresponding author), Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Lab Clin Biochem & Mol Biol, Pisa, Italy.	emiliano.ricciardi@bioclinica.unipi.it	Fadiga, Luciano/AAC-7404-2022; Pietrini, Pietro/Z-4202-2019; Ricciardi, Emiliano/E-6929-2011	Ricciardi, Emiliano/0000-0002-7178-9534; Handjaras, Giacomo/0000-0001-5677-8434; Pietrini, Pietro/0000-0002-6768-5556; fadiga, luciano/0000-0001-5691-5080	European Union; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca; University of Pisa-Faculty of Medicine; Strategic Project Region-University; 'Poeticon++'	European Union(European Commission); Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Pisa-Faculty of Medicine; Strategic Project Region-University; 'Poeticon++'	This work was supported by European Union Grants 'THE: The Hand Embodied' to E. R. and P. P. and 'Poeticon++' to L.F., by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca grant to P.P., by the Young Investigator Award of the University of Pisa-Faculty of Medicine to E.R. and by the Strategic Project Region-University to L.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; Cattaneo L, 2010, CEREB CORTEX, V20, P2252, DOI 10.1093/cercor/bhp291; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Dinstein I, 2008, J NEUROSCI, V28, P11231, DOI 10.1523/JNEUROSCI.3585-08.2008; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Joachims T., 1999, MAKING LARGE SCALE S; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kupers R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00019; Lewis JW, 2011, HUM BRAIN MAPP, V32, P2241, DOI 10.1002/hbm.21185; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lowry R., 1999, CONCEPTS APPL INFERE; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Molenberghs P, 2012, NEUROIMAGE, V59, P608, DOI 10.1016/j.neuroimage.2011.07.080; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Oosterhof NN, 2012, NEUROIMAGE, V63, P262, DOI 10.1016/j.neuroimage.2012.06.045; Oosterhof NN, 2012, J COGNITIVE NEUROSCI, V24, P975, DOI 10.1162/jocn_a_00195; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Ricciardi E, 2011, CURR OPIN NEUROL, V24, P357, DOI 10.1097/WCO.0b013e328348bdbf; Ricciardi E, 2009, J NEUROSCI, V29, P9719, DOI 10.1523/JNEUROSCI.0274-09.2009; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Scholkopf B., 1999, ADV KERNEL METHODS S; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; TAILAIRACH J, 1988, COPLANAR STEREOTAXIC	47	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58632	10.1371/journal.pone.0058632	http://dx.doi.org/10.1371/journal.pone.0058632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472216	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000315637900162
J	Wang, XJ; Wang, JZ; Su, M; Wang, CX; Chen, JZ; Wang, H; Song, L; Zou, YB; Zhang, LF; Zhang, YY; Hui, RT				Wang, Xiaojian; Wang, Jizheng; Su, Ming; Wang, Changxin; Chen, Jingzhou; Wang, Hu; Song, Lei; Zou, Yubao; Zhang, Lianfeng; Zhang, Youyi; Hui, Rutai			TNNI3K, a Cardiac-Specific Kinase, Promotes Physiological Cardiac Hypertrophy in Transgenic Mice	PLOS ONE			English	Article							TROPONIN-I PHOSPHORYLATION; PROTEIN-C PHOSPHORYLATION; HUMAN HEART-MUSCLE; FAILURE; BINDING; OVEREXPRESSION; CARDIOMYOCYTES; EXPRESSION; GENE	Purpose: Protein kinase plays an essential role in controlling cardiac growth and hypertrophic remodeling. The cardiac troponin I-interacting kinase (TNNI3K), a novel cardiac specific kinase, is associated with cardiomyocyte hypertrophy. However, the precise function of TNNI3K in regulating cardiac remodeling has remained controversial. Methods and Results: In a rat model of cardiac hypertrophy generated by transverse aortic constriction, myocardial TNNI3K expression was significantly increased by 1.62 folds (P<0.05) after constriction for 15 days. To investigate the role of TNNI3K in cardiac hypertrophy, we generated transgenic mouse lines with overexpression of human TNNI3K specifically in the heart. At the age of 3 months, the high-copy-number TNNI3K transgenic mice demonstrated a phenotype of concentric hypertrophy with increased heart weight normalized to body weight (1.31 fold, P<0.01). Echocardiography and non-invasive hemodynamic assessments showed enhanced cardiac function. No necrosis or myocyte disarray was observed in the heart of TNNI3K transgenic mice. This concentric hypertrophy maintained up to 12 months of age without cardiac dysfunction. The phospho amino acid analysis revealed that TNNI3K is a protein-tyrosine kinase. The yeast two-hybrid screen and co-immunoprecipitation assay identified cTnI as a target for TNNI3K. Moreover, TNNI3K overexpression induced cTnI phosphorylation at Ser22/Ser23 in vivo and in vitro, suggesting that TNNI3K is a novel upstream regulator for cTnI phosphorylation. Conclusion: TNNI3K promotes a concentric hypertrophy with enhancement of cardiac function via regulating the phosphorylation of cTnI. TNNI3K could be a potential therapeutic target for preventing from heart failure.	[Wang, Xiaojian; Wang, Jizheng; Su, Ming; Wang, Changxin; Chen, Jingzhou; Wang, Hu; Hui, Rutai] Chinese Acad Med Sci, Peking Union Med Coll, FuWai Hosp, Sinogerman Lab Mol Med,State Key Lab Cardiovasc D, Beijing 100730, Peoples R China; [Wang, Xiaojian; Wang, Jizheng; Su, Ming; Wang, Changxin; Chen, Jingzhou; Wang, Hu; Song, Lei; Zou, Yubao; Hui, Rutai] Chinese Acad Med Sci, Peking Union Med Coll, Cardiovasc Inst, Beijing 100730, Peoples R China; [Song, Lei; Zou, Yubao] Chinese Acad Med Sci, Peking Union Med Coll, FuWai Hosp, Dept Cardiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100730, Peoples R China; [Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Zhang, Youyi] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Hui, RT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, FuWai Hosp, Sinogerman Lab Mol Med,State Key Lab Cardiovasc D, Beijing 100730, Peoples R China.	huirutai@sglab.org			Ministry of Science and Technology of China [2007DFC30340]; National Science and Technology Major Projects [2009ZX09501-026]; National Natural Science Foundation of China [30840041, 30700322]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China (2007DFC30340 to RTH); National Science and Technology Major Projects (2009ZX09501-026 to RTH); and the National Natural Science Foundation of China (30840041 to XJW, 30700322 to JZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Catalucci D, 2009, J BIOL CHEM, V284, P28180, DOI 10.1074/jbc.M109.036566; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Juan F, 2008, INT J CARDIOL, V128, P83, DOI 10.1016/j.ijcard.2008.03.006; Kooij V, 2010, J MOL CELL CARDIOL, V48, P954, DOI 10.1016/j.yjmcc.2010.01.002; Lai ZF, 2008, AM J PHYSIOL-HEART C, V295, pH708, DOI 10.1152/ajpheart.00252.2008; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Milano A, 2011, CIRCULATION, V124; Scruggs SB, 2011, ARCH BIOCHEM BIOPHYS, V510, P129, DOI 10.1016/j.abb.2011.02.013; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; VOROTNIKOV A V, 1988, Biokhimiya, V53, P31; Wang H, 2008, J CELL MOL MED, V12, P304, DOI 10.1111/j.1582-4934.2007.00155.x; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Wang L, 2011, CLIN EXP PHARMACOL P, V38, P278, DOI 10.1111/j.1440-1681.2011.05499.x; Wang XJ, 2010, CLIN SCI, V118, P137, DOI 10.1042/CS20080637; Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010; Wheeler FC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000647; Wiltshire SA, 2011, J IMMUNOL, V186, P6398, DOI 10.4049/jimmunol.1100159; Zhao Y, 2003, J MOL MED-JMM, V81, P297, DOI 10.1007/s00109-003-0427-x	33	8	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58570	10.1371/journal.pone.0058570	http://dx.doi.org/10.1371/journal.pone.0058570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472207	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900153
J	Zhang, HT; Ma, H; Xu, Y; Li, L				Zhang, Hongtuan; Ma, Hui; Xu, Yong; Li, Liang			Association of SMAD7 rs12953717 Polymorphism with Cancer: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TGF-BETA; RISK; PUBLICATION; VARIANTS; ALLELES; PATHWAY; 8Q24	Background: Accumulating evidence has suggested that Mothers against decapentaplegic homolog 7 (SMAD7) rs12953717 polymorphism might be related to cancer risk. However, epidemiologic findings have been inconsistent. We therefore performed a meta-analysis to clarify the association between the SMAD7 rs12953717 polymorphism and cancer risk. Methods: A comprehensive search was conducted to identify all eligible studies of SMAD7 rs12953717 polymorphism and cancer risk. We used odds ratios (ORs) to assess the strength of the association, and 95% confidence intervals (CIs) to give a sense of the precision of the estimate. Heterogeneity, publication bias, and sensitivity analysis were also explored. Results: A total of 14 case-control studies, including 16928 cases and 14781 controls, were included in the present meta-analysis. The overall results showed that the variant genotypes were associated with a significantly increased risk of all cancer types (homozygote comparison, OR = 1.23, 95%CI = 1.10-1.38, P < 0.01; heterozygote comparison, OR = 1.12, 95% CI = 1.02-1.22, P = 0.02; recessive model, OR = 1.17, 95% CI = 1.07-1.29, P < 0.01; dominant model, OR = 1.15, 95% CI = 1.06-1.25, P < 0.01; allelic model, OR = 1.12, 95% CI = 1.06-1.18, P < 0.01). Further sensitivity analysis confirmed the significant association. In the subgroup analysis by ethnicity, SMAD7 rs12953717 polymorphism was significantly associated with cancer risk in both Caucasians and Asians. In the subgroup analysis by cancer types, SMAD7 rs12953717 polymorphism was significantly associated with colorectal cancer. Conclusions: Our investigations demonstrate that rs12953717 polymorphism is associated with the susceptibility of cancer. Large-scale and well-designed case-control studies are necessary to validate the risk identified in the present meta-analysis.	[Zhang, Hongtuan; Xu, Yong] Tianjin Med Univ, Dept Urol, Affiliated Hosp 2, Tianjin Key Inst Urol, Tianjin, Peoples R China; [Ma, Hui] Tianjin Med Univ, Dept Epidemiol, Sch Publ Hlth, Tianjin, Peoples R China; [Li, Liang] Tianjin Med Univ, Sch Life Sci, Lab Populat & Quantitat Genet, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Xu, Y (corresponding author), Tianjin Med Univ, Dept Urol, Affiliated Hosp 2, Tianjin Key Inst Urol, Tianjin, Peoples R China.	xymnwk@163.com			Tianjin Province's Natural Science Foundation [09JCYBJC10000]; High technology and Basic Research Program of Tianjin medical university [2009GSI18]	Tianjin Province's Natural Science Foundation; High technology and Basic Research Program of Tianjin medical university	This work was supported by the Tianjin Province's Natural Science Foundation (09JCYBJC10000) and High technology and Basic Research Program of Tianjin medical university (2009GSI18). The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulay JL, 2003, INT J CANCER, V104, P446, DOI 10.1002/ijc.10908; Broderick P, 2008, LEUKEMIA LYMPHOMA, V49, P271, DOI 10.1080/10428190701817290; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cheung WY, 2009, GASTROENTEROL CLIN N, V38, P75, DOI 10.1016/j.gtc.2009.01.009; Curtin K, 2009, CANCER EPIDEM BIOMAR, V18, P616, DOI 10.1158/1055-9965.EPI-08-0690; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Gibson L, 2009, CANCER EPIDEM BIOMAR, V18, P1934, DOI 10.1158/1055-9965.EPI-09-0214; Hirata H, 2009, CANCER-AM CANCER SOC, V115, P4488, DOI 10.1002/cncr.24491; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaklamani Virginia G, 2004, Expert Rev Anticancer Ther, V4, P649, DOI 10.1586/14737140.4.4.649; Korchynskyi O, 1999, INT J CANCER, V82, P197, DOI 10.1002/(SICI)1097-0215(19990719)82:2<197::AID-IJC8>3.0.CO;2-V; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li X, 2011, MOL BIOL REP, V38, P5093, DOI 10.1007/s11033-010-0656-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Passarelli MN, 2011, GENE CHROMOSOME CANC, V50, P875, DOI 10.1002/gcc.20913; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slattery ML, 2010, CANCER RES, V70, P2996, DOI 10.1158/0008-5472.CAN-10-0514; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thompson CL, 2009, CARCINOGENESIS, V30, P982, DOI 10.1093/carcin/bgp086; Wright ME, 2009, CANCER RES, V69, P1429, DOI 10.1158/0008-5472.CAN-08-2343; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018	35	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58170	10.1371/journal.pone.0058170	http://dx.doi.org/10.1371/journal.pone.0058170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472153	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900099
J	Matsubara, Y; Ono, Y; Suzuki, H; Arai, F; Suda, T; Murata, M; Ikeda, Y				Matsubara, Yumiko; Ono, Yukako; Suzuki, Hidenori; Arai, Fumio; Suda, Toshio; Murata, Mitsuru; Ikeda, Yasuo			OP9 Bone Marrow Stroma Cells Differentiate into Megakaryocytes and Platelets	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR NF-E2; IN-VITRO; FUNCTIONAL PLATELETS; MALIGNANT HEMATOPOIESIS; MOUSE; GENERATION; PROTEIN; MEGAKARYOPOIESIS; ACTIVATION	Platelets are essential for hemostatic plug formation and thrombosis. The mechanisms of megakaryocyte (MK) differentiation and subsequent platelet production from stem cells remain only partially understood. The manufacture of megakaryocytes (MKs) and platelets from cell sources including hematopoietic stem cells and pluripotent stem cells have been highlighted for studying the platelet production mechanisms as well as for the development of new strategies for platelet transfusion. The mouse bone marrow stroma cell line OP9 has been widely used as feeder cells for the differentiation of stem cells into MK lineages. OP9 cells are reported to be pre-adipocytes. We previously reported that 3T3-L1 pre-adipocytes differentiated into MKs and platelets. In the present study, we examined whether OP9 cells differentiate into MKs and platelets using MK lineage induction (MKLI) medium previously established to generate MKs and platelets from hematopoietic stem cells, embryonic stem cells, and pre-adipocytes. OP9 cells cultured in MKLI medium had megakaryocytic features, i.e., positivity for surface markers CD41 and CD42b, polyploidy, and distinct morphology. The OP9-derived platelets had functional characteristics, providing the first evidence for the differentiation of OP9 cells into MKs and platelets. We then analyzed gene expressions of critical factors that regulate megakaryopoiesis and thrombopoiesis. The gene expressions of p45NF-E2, FOG, Fli1, GATA2, RUNX1, thrombopoietin, and c-mpl were observed during the MK differentiation. Among the observed transcription factors of MK lineages, p45NF-E2 expression was increased during differentiation. We further studied MK and platelet generation using p45NF-E2-overexpressing OP9 cells. OP9 cells transfected with p45NF-E2 had enhanced production of MKs and platelets. Our findings revealed that OP9 cells differentiated into MKs and platelets in vitro. OP9 cells have critical factors for megakaryopoiesis and thrombopoiesis, which might be involved in a mechanism of this differentiation. p45NF-E2 might also play important roles in the differentiation of OP9 cells into MK lineages cells.	[Matsubara, Yumiko; Murata, Mitsuru] Keio Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Ono, Yukako] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan; [Suzuki, Hidenori] Nippon Med Sch, Dept Morphol & Biomol Res, Tokyo 113, Japan; [Arai, Fumio; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Tokyo, Japan; [Ikeda, Yasuo] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	Keio University; Keio University; Nippon Medical School; Keio University; Waseda University	Matsubara, Y (corresponding author), Keio Univ, Sch Med, Dept Lab Med, Tokyo, Japan.	yumikoma@a7.keio.jp	Suda, Toshio/H-6761-2013; Arai, Fumio/J-5241-2013	Suda, Toshio/0000-0001-7540-1771; Arai, Fumio/0000-0003-1936-4907	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21591250, 22659183]; Japanese Ministry of Health Labor and Welfare	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/) (# 21591250 to Y. Matsubara and # 22659183 to Y. Ikeda and Y. Matsubara) and from the Japanese Ministry of Health Labor and Welfare (http://www.mhlw.go.jp/) for blood coagulation abnormalities (to M. Murata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; Battinelli EM, 2007, CURR OPIN HEMATOL, V14, P419, DOI 10.1097/MOH.0b013e3282bad151; Bieker JJ, 2005, MT SINAI J MED, V72, P333; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; Chang Y, 2007, J THROMB HAEMOST, V5, P318, DOI 10.1111/j.1538-7836.2007.02472.x; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; Colman A, 2009, EMBO REP, V10, P714, DOI 10.1038/embor.2009.142; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Fock EF, 2008, EXP HEMATOL, V36, P78, DOI 10.1016/j.exphem.2007.08.015; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Fujimoto TT, 2003, BLOOD, V102, P4044, DOI 10.1182/blood-2003-06-1773; Gao JA, 2010, J GENET GENOMICS, V37, P475, DOI 10.1016/S1673-8527(09)60067-9; Gaur M, 2006, J THROMB HAEMOST, V4, P436, DOI 10.1111/j.1538-7836.2006.01744.x; Geddis AE, 2010, SEMIN HEMATOL, V47, P212, DOI 10.1053/j.seminhematol.2010.03.001; Gupta P, 2009, J CELL MOL MED, V13, P4349, DOI 10.1111/j.1582-4934.2009.00757.x; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Kerrigan SW, 2004, BLOOD, V104, P1327, DOI 10.1182/blood-2003-10-3633; Kitajima K, 2011, BLOOD, V117, P3748, DOI 10.1182/blood-2010-07-298596; Kuter D J, 1996, Stem Cells, V14 Suppl 1, P88; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsubara Y, 2012, METHODS MOL BIOL, V788, P249, DOI 10.1007/978-1-61779-307-3_17; Matsubara Y, 2010, BIOCHEM BIOPH RES CO, V402, P796, DOI 10.1016/j.bbrc.2010.10.120; Matsubara Y, 2009, BIOCHEM BIOPH RES CO, V378, P716, DOI 10.1016/j.bbrc.2008.11.117; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; Nishikii H, 2008, J EXP MED, V205, P1917, DOI 10.1084/jem.20071482; Niwa A, 2009, J CELL PHYSIOL, V221, P367, DOI 10.1002/jcp.21864; Ono M, 2011, PLATELETS, V22, P196, DOI 10.3109/09537104.2010.541959; Ono Y, 2012, BLOOD, V120, P3812, DOI 10.1182/blood-2012-02-413617; Pang LY, 2005, J CLIN INVEST, V115, P3332, DOI 10.1172/JCI26720; PETERS LL, 1993, NATURE, V362, P768, DOI 10.1038/362768a0; Rao AK, 2003, J THROMB HAEMOST, V1, P671, DOI 10.1046/j.1538-7836.2003.00129.x; Reems JA, 2010, TRANSFUS MED REV, V24, P33, DOI 10.1016/j.tmrv.2009.09.003; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Shivdasani RA, 2001, STEM CELLS, V19, P397, DOI 10.1634/stemcells.19-5-397; SUZUKI H, 1994, J ELECTRON MICROSC, V43, P282; Suzuki H, 2003, BRIT J HAEMATOL, V121, P904, DOI 10.1046/j.1365-2141.2003.04373.x; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200	48	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58123	10.1371/journal.pone.0058123	http://dx.doi.org/10.1371/journal.pone.0058123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469264	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100061
J	Badejo, AC; Badejo, AO; Shin, KH; Chai, YG				Badejo, Abimbola Comfort; Badejo, Adegoke Olugboyega; Shin, Kyung Hoon; Chai, Young Gyu			A Gene Expression Study of the Activities of Aromatic Ring-Cleavage Dioxygenases in Mycobacterium gilvum PYR-GCK to Changes in Salinity and pH during Pyrene Degradation	PLOS ONE			English	Article							QUANTITATIVE PCR; DEGRADING BACTERIA; VANBAALENII PYR-1; CRUDE-OIL; CANCER; QUANTIFICATION; HYDROCARBONS; PHENANTHRENE; SMEGMATIS; CLUSTER	Polycyclic aromatic hydrocarbons (PAHs) are toxic pollutants found in the environment which can be removed through the use of physical and biological agents. The rate of PAH biodegradation is affected by environmental conditions of pH, salinity and temperature. Adaptation of the pyrene degrading bacteria, Mycobacterium gilvum PYR-GCK, to fluctuating environmental conditions during pyrene biodegrading activity was studied using the quantitative real time - Polymerase Chain Reaction (qRT-PCR) technique. Four aromatic ring-cleavage dioxygenase genes: phdF, phdI, pcaG and pcaH; critical to pyrene biodegradation, were studied in pH states of 5.5, 6.5, 7.5 and NaCl concentrations 0 M, 0.17 M, 0.5 M, 0.6 M, 1 M. First, we conducted a residual pyrene study using gas chromatography and flame ionization technologies. Central to a gene expression study is the use of a valid endogenous reference gene, making its determination our next approach, using the geNorm/NormFinder algorithms. Armed with a valid control gene, rpoB, we applied it to a gene expression study, using the comparative critical threshold (2(Delta Delta CT)) quantification method. The pyrene degrading activity of the strain was strongly functional in all the NaCl concentration states, with the least activity found at 1M (similar to 70% degraded after 48 hours of cultivation). The transcripts quantification of three genes backed this observation with high expression levels. The gene expression levels also revealed pH 6.5 as optimal for pyrene degradation and weak degradation activity at pH of 5.5, corroborating the residual pyrene analysis. The expression of these genes as proteins has already been studied in our laboratory using proteomics techniques and this validates our current study.	[Badejo, Abimbola Comfort; Chai, Young Gyu] Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea; [Badejo, Adegoke Olugboyega; Shin, Kyung Hoon] Hanyang Univ, Dept Environm & Marine Sci, Ansan, South Korea	Hanyang University; Hanyang University	Chai, YG (corresponding author), Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea.	ygchai@hanyang.ac.kr	Shin, Kyung-Hoon/AAD-6999-2021	Shin, Kyung-Hoon/0000-0002-3169-4274	National Research Foundation of Korea; Korean Government [2012-0009212]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	The research was supported by the National Research Foundation of Korea Grant funded by the Korean Government (No. 2012-0009212 to YGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M., 1999, BIODEGRADATION BIORE, V2nd, P443; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armstrong B, 2004, ENVIRON HEALTH PERSP, V112, P970, DOI 10.1289/ehp.6895; Arora P. K., 2010, Journal of Bioremediation and Biodegradation, V1, P1000112, DOI 10.4172/2155-6199.1000112; Arora Pankaj K, 2009, BMC Res Notes, V2, P67, DOI 10.1186/1756-0500-2-67; Badejo AC, 2013, BIODEGRADATION, V24, P741, DOI 10.1007/s10532-013-9622-9; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; DeanRoss D, 1996, APPL MICROBIOL BIOT, V46, P307, DOI 10.1007/s002530050822; Desroche N, 2005, J MICROBIOL METH, V60, P325, DOI 10.1016/j.mimet.2004.10.010; Diaz MP, 2002, BIOTECHNOL BIOENG, V79, P145, DOI 10.1002/bit.10318; Diaz MP, 2000, MAR BIOTECHNOL, V2, P522, DOI 10.1007/s101260000037; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gomez M, 1998, MOL MICROBIOL, V29, P617, DOI 10.1046/j.1365-2958.1998.00960.x; GROSSER RJ, 1991, APPL ENVIRON MICROB, V57, P3462, DOI 10.1128/AEM.57.12.3462-3469.1991; HAMMOND EC, 1976, ANN NY ACAD SCI, V271, P116, DOI 10.1111/j.1749-6632.1976.tb23100.x; Higgins J, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-77; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Iwabuchi T, 1998, J BIOL CHEM, V273, P8332, DOI 10.1074/jbc.273.14.8332; Iwagami SG, 2000, APPL ENVIRON MICROB, V66, P1499, DOI 10.1128/AEM.66.4.1499-1508.2000; Kastner M, 1998, APPL ENVIRON MICROB, V64, P359; Kazunga C, 2000, APPL ENVIRON MICROB, V66, P1917, DOI 10.1128/AEM.66.5.1917-1922.2000; Kim SK, 2012, LETT APPL MICROBIOL, V54, P306, DOI 10.1111/j.1472-765X.2012.03209.x; Kim SJ, 2007, J BACTERIOL, V189, P464, DOI 10.1128/JB.01310-06; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kim YH, 2005, MICROB ECOL, V50, P110, DOI 10.1007/s00248-004-0126-3; Kim YH, 2005, APPL MICROBIOL BIOT, V67, P275, DOI 10.1007/s00253-004-1796-y; Kim YH, 2004, J IND MICROBIOL BIOT, V31, P507, DOI 10.1007/s10295-004-0178-x; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Lefebvre O, 2006, WATER RES, V40, P3671, DOI 10.1016/j.watres.2006.08.027; Mumtaz M., 1995, TOX PROF POL AR HYDR; Nozaki M, 1979, Top Curr Chem, V78, P145, DOI 10.1007/BFb0048193; Ofer N, 2012, APPL ENVIRON MICROB, V78, P7483, DOI 10.1128/AEM.01318-12; Pagnout C, 2007, RES MICROBIOL, V158, P175, DOI 10.1016/j.resmic.2006.11.002; Saito A, 2000, J BACTERIOL, V182, P2134, DOI 10.1128/JB.182.8.2134-2141.2000; Schneider J, 1996, APPL ENVIRON MICROB, V62, P13, DOI 10.1128/AEM.62.1.13-19.1996; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker CG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-100; Wang ZD, 1999, ENVIRON SCI TECHNOL, V33, P3100, DOI 10.1021/es990031y	40	34	36	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58066	10.1371/journal.pone.0058066	http://dx.doi.org/10.1371/journal.pone.0058066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469141	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900232
J	Bason, C; Lorini, R; Lunardi, C; Dolcino, M; Giannattasio, A; d'Annunzio, G; Rigo, A; Pedemonte, N; Corrocher, R; Puccetti, A				Bason, Caterina; Lorini, Renata; Lunardi, Claudio; Dolcino, Marzia; Giannattasio, Alessandro; d'Annunzio, Giuseppe; Rigo, Antonella; Pedemonte, Nicoletta; Corrocher, Roberto; Puccetti, Antonio			In Type 1 Diabetes a Subset of Anti-Coxsackievirus B4 Antibodies Recognize Autoantigens and Induce Apoptosis of Pancreatic Beta Cells	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ENTEROVIRUS INFECTION; INSULIN-SECRETION; DEATH; IMMUNOLOGY; CALCIUM; VIRUSES; SERIES; FOCUS; IDENTIFICATION	Type 1 diabetes is characterized by autoimmune destruction of pancreatic beta cells. The role played by autoantibodies directed against beta cells antigens in the pathogenesis of the disease is still unclear. Coxsackievirus B infection has been linked to the onset of type 1 diabetes; however its precise role has not been elucidated yet. To clarify these issues, we screened a random peptide library with sera obtained from 58 patients with recent onset type 1 diabetes, before insulin therapy. We identified an immunodominant peptide recognized by the majority of individual patients'sera, that shares homology with Coxsackievirus B4 VP1 protein and with beta-cell specific autoantigens such as phogrin, phosphofructokinase and voltage-gated L-type calcium channels known to regulate beta cell apoptosis. Antibodies against the peptide affinity-purified from patients' sera, recognized the viral protein and autoantigens; moreover, such antibodies induced apoptosis of the beta cells upon binding the L-type calcium channels expressed on the beta cell surface, suggesting a calcium dependent mechanism. Our results provide evidence that in autoimmune diabetes a subset of anti-Coxsackievirus antibodies are able to induce apoptosis of pancreatic beta cells which is considered the most critical and final step in the development of autoimmune diabetes without which clinical manifestations do not occur.	[Bason, Caterina; Lunardi, Claudio; Corrocher, Roberto] Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy; [Lorini, Renata; Giannattasio, Alessandro; d'Annunzio, Giuseppe] Univ Genoa, Dept Pediat, Genoa, Italy; [Lorini, Renata; Giannattasio, Alessandro; d'Annunzio, Giuseppe] Giannina Gaslini Inst, Genoa, Italy; [Dolcino, Marzia; Puccetti, Antonio] Giannina Gaslini Inst, Clin & Expt Immunol Unit, Genoa, Italy; [Rigo, Antonella] Univ Verona, Sect Hematol, Dept Med, I-37100 Verona, Italy; [Pedemonte, Nicoletta] Giannina Gaslini Inst, Mol Genet Lab, Genoa, Italy; [Puccetti, Antonio] Univ Genoa, Dept Expt Med, Sect Hystol, Genoa, Italy	University of Verona; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Puccetti, A (corresponding author), Giannina Gaslini Inst, Clin & Expt Immunol Unit, Genoa, Italy.	antonio.puccetti@unige.it	Pedemonte, Nicoletta/B-3607-2010; d'Annunzio, Giuseppe/J-7368-2018	Pedemonte, Nicoletta/0000-0002-5161-1720; d'Annunzio, Giuseppe/0000-0002-1856-2277	Ministry of University, Research, Science and Technology (Murst), Italy	Ministry of University, Research, Science and Technology (Murst), Italy	The work was supported by a grant from Ministry of University, Research, Science and Technology (Murst), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Atsumi T, 2007, ENDOCR J, V54, P517, DOI 10.1507/endocrj.K06-205; Cavalieri E, 2011, J TRANSL MED, V21, P9; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Coelho WS, 2012, INT J BIOCHEM CELL B, V44, P150, DOI 10.1016/j.biocel.2011.10.010; Colli ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002267; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Ghazarian L, 2013, CELL MOL LIFE SCI, V70, P239, DOI 10.1007/s00018-012-1042-1; Grieco FA, 2012, CLIN EXP IMMUNOL, V168, P24, DOI 10.1111/j.1365-2249.2011.04556.x; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hober D, 2012, CLIN EXP IMMUNOL, V168, P47, DOI 10.1111/j.1365-2249.2011.04559.x; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; Jackson MW, 2010, J IMMUNOL METHODS, V361, P31, DOI 10.1016/j.jim.2010.07.005; Jaidane H, 2012, CLIN EXP IMMUNOL, V168, P39, DOI 10.1111/j.1365-2249.2011.04558.x; Jaidane H, 2009, DIABETES-METAB RES, V25, P591, DOI 10.1002/dmrr.995; Jaidane H, 2008, DIABETES METAB, V34, P537, DOI 10.1016/j.diabet.2008.05.008; Juntti-Berggren L, 2004, P NATL ACAD SCI USA, V101, P10090, DOI 10.1073/pnas.0403551101; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Lablanche S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.15; Lee MS, 2004, MOL GENET METAB, V83, P82, DOI 10.1016/j.ymgme.2004.08.002; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; McKenzie MD, 2006, INT IMMUNOL, V18, P837, DOI 10.1093/intimm/dxl020; Mercalli A, 2012, DIABETOLOGIA, V55, P2479, DOI 10.1007/s00125-012-2591-4; Merrins MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034036; Oikarinen M, 2012, DIABETES, V61, P687, DOI 10.2337/db11-1157; Oikarinen S, 2011, DIABETES, V60, P276, DOI 10.2337/db10-0186; Pedemonte N, 2007, MOL PHARMACOL, V72, P197, DOI 10.1124/mol.107.034702; Puccetti A, 2010, DISCOV MED, V9, P224; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Richardson SJ, 2011, SEMIN IMMUNOPATHOL, V33, P9, DOI 10.1007/s00281-010-0205-0; Richer MJ, 2009, AUTOIMMUN REV, V8, P611, DOI 10.1016/j.autrev.2009.02.006; Ristow M, 1999, J MOL MED, V77, P96, DOI 10.1007/s001090050311; Ristow M, 1999, DIABETES, V48, P1557, DOI 10.2337/diabetes.48.8.1557; Schulte BM, 2012, DIABETES, V61, P2030, DOI 10.2337/db11-1547; Schulte BM, 2010, VIRAL IMMUNOL, V23, P99, DOI 10.1089/vim.2009.0072; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Stene LC, 2012, CLIN EXP IMMUNOL, V168, P12, DOI 10.1111/j.1365-2249.2011.04555.x; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Thomas HE, 2010, CELL DEATH DIFFER, V17, P577, DOI 10.1038/cdd.2009.165; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Torii S, 2005, TRAFFIC, V6, P1213, DOI 10.1111/j.1600-0854.2005.00353.x; Torii S, 2009, ENDOCR J, V56, P639, DOI 10.1507/endocrj.K09E-157; Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970; Troiano L, 2007, NAT PROTOC, V2, P2719, DOI 10.1038/nprot.2007.405; Tuszkiewicz-Misztal E, 1991, Kinderarztl Prax, V59, P88; Wang L, 1999, ENDOCRINOLOGY, V140, P1200, DOI 10.1210/en.140.3.1200; Wasmeier C, 1996, J BIOL CHEM, V271, P18161, DOI 10.1074/jbc.271.30.18161; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yang SN, 2005, AM J PHYSIOL-ENDOC M, V288, pE16, DOI 10.1152/ajpendo.00042.2004; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	59	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57729	10.1371/journal.pone.0057729	http://dx.doi.org/10.1371/journal.pone.0057729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469060	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900158
J	Lord, CEN; Dauphinee, AN; Watts, RL; Gunawardena, AHLAN				Lord, Christina E. N.; Dauphinee, Adrian N.; Watts, Rebecca L.; Gunawardena, Arunika H. L. A. N.			Unveiling Interactions among Mitochondria, Caspase-Like Proteases, and the Actin Cytoskeleton during Plant Programmed Cell Death (PCD)	PLOS ONE			English	Article							SELF-INCOMPATIBILITY RESPONSE; LACE PLANT; APONOGETON-MADAGASCARIENSIS; PERMEABILITY TRANSITION; CYTOCHROME-C; IN-VIVO; DYNAMICS; REORGANIZATION; EMBRYOGENESIS; ARABIDOPSIS	Aponogeton madagascariensis produces perforations over its leaf surface via programmed cell death (PCD). PCD begins between longitudinal and transverse veins at the center of spaces regarded as areoles, and continues outward, stopping several cells from these veins. The gradient of PCD that exists within a single areole of leaves in an early stage of development was used as a model to investigate cellular dynamics during PCD. Mitochondria have interactions with a family of proteases known as caspases, and the actin cytoskeleton during metazoan PCD; less is known regarding these interactions during plant PCD. This study employed the actin stain Alexa Fluor 488 phalloidin, the actin depolymerizer Latrunculin B (Lat B), a synthetic caspase peptide substrate and corresponding specific inhibitors, as well as the mitochondrial pore inhibitor cyclosporine A (CsA) to analyze the role of these cellular constituents during PCD. Results depicted that YVADase (caspase-1) activity is higher during the very early stages of perforation formation, followed by the bundling and subsequent breakdown of actin. Actin depolymerization using Lat B caused no change in YVADase activity. In vivo inhibition of YVADase activity prevented PCD and actin breakdown, therefore substantiating actin as a likely substrate for caspase-like proteases (CLPs). The mitochondrial pore inhibitor CsA significantly decreased YVADase activity, and prevented both PCD and actin breakdown; therefore suggesting the mitochondria as a possible trigger for CLPs during PCD in the lace plant. To our knowledge, this is the first in vivo study using either caspase-1 inhibitor (Ac-YVAD-CMK) or CsA, following which the actin cytoskeleton was examined. Overall, our findings suggest the mitochondria as a possible upstream activator of YVADase activity and implicate these proteases as potential initiators of actin breakdown during perforation formation via PCD in the lace plant.	[Lord, Christina E. N.; Dauphinee, Adrian N.; Watts, Rebecca L.; Gunawardena, Arunika H. L. A. N.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	Gunawardena, AHLAN (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	arunika.gunawardena@dal.ca	Dauphinee, Adrian/AAI-7757-2021	Dauphinee, Adrian/0000-0002-3363-198X	Natural Sciences and Engineering Research Council (NSERC); Canadian Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpagaus S, 2002, J BIOL CHEM, V277, P1780, DOI 10.1074/jbc.M109416200; Balk J, 2003, PLANT J, V34, P573, DOI 10.1046/j.1365-313X.2003.01748.x; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Bosch M, 2008, MOL PLANT, V1, P879, DOI 10.1093/mp/ssn053; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Contran N, 2007, PROTOPLASMA, V231, P193, DOI 10.1007/s00709-007-0250-2; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Curtis MJ, 2002, PLANT J, V29, P295, DOI 10.1046/j.0960-7412.2001.01213.x; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; Diamond M., 2007, PLANT MITOCHONDRIA, V31, P308; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Giuliani C, 2002, ANN BOT-LONDON, V90, P287, DOI 10.1093/aob/mcf173; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gunawardena AHLAN, 2006, BOT J LINN SOC, V150, P25, DOI 10.1111/j.1095-8339.2006.00487.x; Gunawardena AHLAN, 2004, PLANT CELL, V16, P60, DOI 10.1105/tpc.016188; Gunawardena AHLAN, 2008, J EXP BOT, V59, P445, DOI 10.1093/jxb/erm189; Gunawardena AHLAN, 2007, AM J BOT, V94, P1116, DOI 10.3732/ajb.94.7.1116; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Higaki T, 2007, PLANT CELL PHYSIOL, V48, P1414, DOI 10.1093/pcp/pcm109; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jones A, 2000, TRENDS PLANT SCI, V5, P225, DOI 10.1016/S1360-1385(00)01605-8; Kacprzyk J, 2011, ADV BOT RES, V60, P169, DOI 10.1016/B978-0-12-385851-1.00004-4; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Liu ZQ, 2007, PROTOPLASMA, V232, P61, DOI 10.1007/s00709-007-0269-4; Lord CEN, 2012, EUR J CELL BIOL, V91, P603, DOI 10.1016/j.ejcb.2012.02.002; Lord CEN, 2012, PHYSIOL PLANTARUM, V145, P114, DOI 10.1111/j.1399-3054.2012.01570.x; Lord CEN, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-102; Lord CEN, 2011, PLANTA, V233, P407, DOI 10.1007/s00425-010-1304-9; Mishra S., 2011, BIOTECHNOL BIOINFORM, V1, P1; Piszczek E, 2007, ACTA PHYSIOL PLANT, V29, P391, DOI 10.1007/s11738-007-0086-6; Potten C., 2004, APOPTOSIS LIFE DEATH; Poulter NS, 2008, PLANT PHYSIOL, V146, P1358, DOI 10.1104/pp.107.107052; Poulter NS, 2010, PLANT PHYSIOL, V152, P1274, DOI 10.1104/pp.109.152066; Rogers HJ, 2005, CURR TOP DEV BIOL, V71, P225, DOI 10.1016/S0070-2153(05)71007-3; Sanmartin M, 2005, PLANT PHYSIOL, V137, P841, DOI 10.1104/pp.104.058552; Schwarzerova K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-89; Scott I, 2008, NEW PHYTOL, V177, P90, DOI 10.1111/j.1469-8137.2007.02255.x; Scott Iain, 2007, V31, P1, DOI 10.1002/9780470986592.ch1; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Smertenko AP, 2003, PLANT J, V33, P813, DOI 10.1046/j.1365-313X.2003.01670.x; Staiger CJ, 2003, J EXP BOT, V54, P103, DOI 10.1093/jxb/54.380.103; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; Vacca RA, 2006, PLANT PHYSIOL, V141, P208, DOI 10.1104/pp.106.078683; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Wertman J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-115; Wright H, 2009, AM J BOT, V96, P865, DOI 10.3732/ajb.0800343; Yao N, 2004, PLANT J, V40, P596, DOI 10.1111/j.1365-313X.2004.02239.x	54	24	24	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57110	10.1371/journal.pone.0057110	http://dx.doi.org/10.1371/journal.pone.0057110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483897	Green Published, gold			2022-12-27	WOS:000316936100015
J	Freeman, ED; Larsen, RT; Clegg, K; McMillan, BR				Freeman, Eric D.; Larsen, Randy T.; Clegg, Ken; McMillan, Brock R.			Long-Lasting Effects of Maternal Condition in Free-Ranging Cervids	PLOS ONE			English	Article							WHITE-TAILED DEER; CAUSE-SPECIFIC MORTALITY; GLOBAL CLIMATE-CHANGE; CENTRAL NEW-MEXICO; MULE DEER; REPRODUCTIVE SUCCESS; WINTER WEATHER; ANTLER SIZE; RED DEER; ROE DEER	Causes of phenotypic variation are fundamental to evolutionary ecology because they influence the traits acted upon by natural selection. One such cause of phenotypic variation is a maternal effect, which is the influence of the environment experienced by a female (and her corresponding phenotype) on the phenotype of her offspring (independent of the offspring's genotype). While maternal effects are well documented, the longevity and fitness impact of these effects remains unclear because it is difficult to follow free-living individuals through their reproductive lifetimes. For long-lived species, it has been suggested that maternal effects are masked by environmental variables acting on offspring in years following the period of dependence. Our objective was to use indirect measures of maternal condition to determine if maternal effects have long-lasting influences on male offspring in two species of cervid. Because antlers are sexually selected, we used measures of antler size at time of death, 1.5-21.5 years after gestation to investigate maternal effects. We quantified antler size of 11,000 male elk and mule deer born throughout the intermountain western US (6 states) over nearly 30 years. Maternal condition during development was estimated indirectly using a suite of abiotic variables known to influence condition of cervids (i.e., winter severity, spring and summer temperature, and spring and summer precipitation). Antler size of male cervids was significantly associated with our indirect measure of maternal condition during gestation and lactation. Assuming the correctness of our indirect measure, our findings demonstrate that antler size is a sexually selected trait that is influenced-into adulthood-by maternal condition. This link emphasizes the importance of considering inherited environmental effects when interpreting population dynamics or examining reproductive success of long-lived organisms.	[Freeman, Eric D.; Larsen, Randy T.; McMillan, Brock R.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Clegg, Ken] Private Lands Consulting, Springville, UT USA	Brigham Young University	Freeman, ED (corresponding author), Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA.	edfreeman1@gmail.com						Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Albon Stephen D., 1992, P15; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; ANTHONY RG, 1976, J WILDLIFE MANAGE, V40, P140, DOI 10.2307/3800168; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bender LC, 2008, WILDLIFE BIOL, V14, P70, DOI 10.2981/0909-6396(2008)14[70:RBNCAS]2.0.CO;2; Bender LC, 2007, J WILDLIFE MANAGE, V71, P1118, DOI 10.2193/2006-226; Bernardo J, 1996, AM ZOOL, V36, P83; Bishop CJ, 2005, J WILDLIFE MANAGE, V69, P311, DOI 10.2193/0022-541X(2005)069<0311:MDSAAP>2.0.CO;2; BOWYER RT, 1986, SOUTHWEST NAT, V31, P289, DOI 10.2307/3671833; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; CLUTTONBROCK TH, 1982, BEHAVIOUR, V79, P108, DOI 10.1163/156853982X00201; Dale BW, 2008, J MAMMAL, V89, P1130, DOI 10.1644/07-MAMM-A-137.1; Ericsson G, 2001, ECOLOGY, V82, P1613, DOI 10.1890/0012-9658(2001)082[1613:ARREAS]2.0.CO;2; Festa-Bianchet M, 2000, BEHAV ECOL, V11, P633, DOI 10.1093/beheco/11.6.633; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; Festa-Bianchet M, 1998, BEHAV ECOL, V9, P144, DOI 10.1093/beheco/9.2.144; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; Garroway CJ, 2005, CAN J ZOOL, V83, P1246, DOI 10.1139/Z05-118; Gendreau Y, 2005, BEHAV ECOL SOCIOBIOL, V58, P237, DOI 10.1007/s00265-005-0938-2; GILBERT P F, 1970, Journal of Wildlife Management, V34, P15, DOI 10.2307/3799486; Glover T., 2002, INTRO BIOSTATISTICS; GREEN WCH, 1991, BEHAV ECOL SOCIOBIOL, V29, P373, DOI 10.1007/BF00165963; Hamlin KL, 2000, J WILDLIFE MANAGE, V64, P441, DOI 10.2307/3803242; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Hurley MA, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.4; Huxley JS, 1931, RELATIVE SIZE ANTLER, P819; Jones OR, 2005, P ROY SOC B-BIOL SCI, V272, P2619, DOI 10.1098/rspb.2005.3267; KEISS RE, 1969, J WILDLIFE MANAGE, V33, P175, DOI 10.2307/3799668; Kirkpatrick M, 1989, EVOLUTION MATERNAL C, P485; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; KOJOLA I, 1993, CAN J ZOOL, V71, P753, DOI 10.1139/z93-099; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Leckenby DA, 1986, J RANGE MANAGE, P244; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lomas LA, 2007, J WILDLIFE MANAGE, V71, P884, DOI 10.2193/2006-203; Maestripieri D., 2009, MATERNAL EFFECTS MAM; Marshal JP, 2008, SOUTHWEST NAT, V53, P311, DOI 10.1894/CJ-143.1; Marshal JP, 2005, RANGELAND ECOL MANAG, V58, P360, DOI 10.2111/1551-5028(2005)058[0360:RTAFDA]2.0.CO;2; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; MECH LD, 1991, J MAMMAL, V72, P146, DOI 10.2307/1381989; Merrill EH, 1991, SUMMER RANGE ELK POP, P263; Monteith KL, 2009, J MAMMAL, V90, P651, DOI 10.1644/08-MAMM-A-191R1.1; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nesbitt WH, 1989, RECORDS N AM BIG GAM; OZOGA JJ, 1986, J WILDLIFE MANAGE, V50, P480, DOI 10.2307/3801110; Peek JM, 2002, J WILDLIFE MANAGE, V66, P729, DOI 10.2307/3803138; PICTON HD, 1984, J APPL ECOL, V21, P869, DOI 10.2307/2405052; PICTON HD, 1979, INT J BIOMETEOROL, V23, P115, DOI 10.1007/BF01560091; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Post E, 1997, P ROY SOC B-BIOL SCI, V264, P1317, DOI 10.1098/rspb.1997.0182; Reimers E, 1997, CAN J ZOOL, V75, P648, DOI 10.1139/z97-082; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; SAUER JR, 1983, J WILDLIFE MANAGE, V47, P31, DOI 10.2307/3808049; SCHULTZ SR, 1995, J MAMMAL, V76, P575, DOI 10.2307/1382366; Smith BL, 1998, J MAMMAL, V79, P1038, DOI 10.2307/1383113; SMITH WP, 1987, AM NAT, V130, P310, DOI 10.1086/284712; Team RC, 2012, R LANG ENV STAT COMP; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Vanpe C, 2007, AM NAT, V169, P481, DOI 10.1086/512046; VERME LJ, 1968, J WILDLIFE MANAGE, V32, P566, DOI 10.2307/3798937; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x; WAUTERS LA, 1995, BEHAV ECOL SOCIOBIOL, V37, P189, DOI 10.1007/s002650050180; Weladji RB, 2003, OECOLOGIA, V136, P317, DOI 10.1007/s00442-003-1257-9; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238	73	11	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58373	10.1371/journal.pone.0058373	http://dx.doi.org/10.1371/journal.pone.0058373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472189	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900135
J	Lunghi, C; Alais, D				Lunghi, Claudia; Alais, David			Touch Interacts with Vision during Binocular Rivalry with a Tight Orientation Tuning	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; SPATIAL-FREQUENCY; CATEGORICAL PERCEPTION; TACTILE; DISCRIMINATION; ATTENTION; MOTION; REPRESENTATION; INFORMATION; ACTIVATION	Multisensory integration is a common feature of the mammalian brain that allows it to deal more efficiently with the ambiguity of sensory input by combining complementary signals from several sensory sources. Growing evidence suggests that multisensory interactions can occur as early as primary sensory cortices. Here we present incompatible visual signals (orthogonal gratings) to each eye to create visual competition between monocular inputs in primary visual cortex where binocular combination would normally take place. The incompatibility prevents binocular fusion and triggers an ambiguous perceptual response in which the two images are perceived one at a time in an irregular alternation. One key function of multisensory integration is to minimize perceptual ambiguity by exploiting cross-sensory congruence. We show that a haptic signal matching one of the visual alternatives helps disambiguate visual perception during binocular rivalry by both prolonging the dominance period of the congruent visual stimulus and by shortening its suppression period. Importantly, this interaction is strictly tuned for orientation, with a mismatch as small as 7.5 degrees between visual and haptic orientations sufficient to annul the interaction. These results indicate important conclusions: first, that vision and touch interact at early levels of visual processing where interocular conflicts are first detected and orientation tunings are narrow, and second, that haptic input can influence visual signals outside of visual awareness, bringing a stimulus made invisible by binocular rivalry suppression back to awareness sooner than would occur without congruent haptic input.	[Lunghi, Claudia] Univ Florence, Dept Neurosci, Florence, Italy; [Lunghi, Claudia] CNR, Inst Neurosci, Pisa, Italy; [Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Sydney	Lunghi, C (corresponding author), Univ Florence, Dept Neurosci, Florence, Italy.	c.lunghi@in.cnr.it	Lunghi, Claudia/C-7274-2014	Lunghi, Claudia/0000-0003-3811-5404	Italian Ministry of Universities and Research; EC project "STANIB" (FP7 ERC); Australian Research Council [DP130102336]	Italian Ministry of Universities and Research(Ministry of Education, Universities and Research (MIUR)); EC project "STANIB" (FP7 ERC); Australian Research Council(Australian Research Council)	This research was supported by the Italian Ministry of Universities and Research (PRIN2009), by EC project "STANIB" (FP7 ERC) and the Australian Research Council, Discovery Project #DP130102336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Alais D, 2010, VISION RES, V50, P929, DOI 10.1016/j.visres.2010.03.010; Arabzadeh E, 2008, PSYCHOL SCI, V19, P635, DOI 10.1111/j.1467-9280.2008.02134.x; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen YC, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00212; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Conrad V, 2010, J VISION, V10, DOI 10.1167/10.10.27; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Falchier A, 2002, J NEUROSCI, V22, P5749; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gori M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00055; Goyal MS, 2006, NEUROREPORT, V17, P1381, DOI 10.1097/01.wnr.0000227990.23046.fe; Guzman-Martinez E, 2012, CURR BIOL, V22, P383, DOI 10.1016/j.cub.2012.01.004; Hancock S, 2007, PERCEPTION, V36, P288, DOI 10.1068/p5494; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Holcombe AO, 2008, VISION RES, V48, P1743, DOI 10.1016/j.visres.2008.05.019; Hsiao SS, 2002, BEHAV BRAIN RES, V135, P93, DOI 10.1016/S0166-4328(02)00160-2; HUBEL DH, 1977, NATURE, V269, P328, DOI 10.1038/269328a0; Kang M-S, 2005, PSYCHOLOGIJA, V32; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; Klink PC, 2012, PHILOS T R SOC B, V367, P932, DOI 10.1098/rstb.2011.0358; Koch C., 2007, QUEST CONSCIOUSNESS; Levelt WJM, 1965, BINOCULAR RIVALRY; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Ling S, 2009, PSYCHOL SCI, V20, P1348, DOI 10.1111/j.1467-9280.2009.02446.x; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; MAFFEI L, 1973, VISION RES, V13, P1255, DOI 10.1016/0042-6989(73)90201-0; Maruya K, 2007, PSYCHOL SCI, V18, P1090, DOI 10.1111/j.1467-9280.2007.02030.x; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; MOVSHON JA, 1973, PERCEPTION, V2, P53, DOI 10.1068/p020053; Munhall KG, 2009, CURR BIOL, V19, P735, DOI 10.1016/j.cub.2009.03.019; Newell FN, 2002, COGNITION, V85, P113, DOI 10.1016/S0010-0277(02)00104-X; Paffen CLE, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00105; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PHILLIPS GC, 1984, J OPT SOC AM A, V1, P226, DOI 10.1364/JOSAA.1.000226; RASKIN LA, 1983, PSYCHOL RES-PSYCH FO, V45, P135, DOI 10.1007/BF00308665; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vasconcelos N, 2011, P NATL ACAD SCI USA, V108, P15408, DOI 10.1073/pnas.1102780108; Viviani P, 2007, VIS COGN, V15, P420, DOI 10.1080/13506280600761134; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zhou W, 2010, CURR BIOL, V20, P1356, DOI 10.1016/j.cub.2010.05.059	55	47	47	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58754	10.1371/journal.pone.0058754	http://dx.doi.org/10.1371/journal.pone.0058754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472219	Green Published, gold			2022-12-27	WOS:000315637900166
J	Singer, K; Morris, DL; Oatmen, KE; Wang, TY; DelProposto, J; Mergian, T; Cho, KW; Lumeng, CN				Singer, Kanakadurga; Morris, David L.; Oatmen, Kelsie E.; Wang, Tianyi; DelProposto, Jennifer; Mergian, Taleen; Cho, Kae Won; Lumeng, Carey N.			Neuropeptide Y Is Produced by Adipose Tissue Macrophages and Regulates Obesity-Induced Inflammation	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; METABOLIC SYNDROME; LEUKOCYTE SUBSETS; CHRONIC STRESS; IMMUNE-SYSTEM; WEIGHT-LOSS; LONG-TERM; IN-VITRO; NPY	Neuropeptide Y (NPY) is induced in peripheral tissues such as adipose tissue with obesity. The mechanism and function of NPY induction in fat are unclear. Given the evidence that NPY can modulate inflammation, we examined the hypothesis that NPY regulates the function of adipose tissue macrophages (ATMs) in response to dietary obesity in mice. NPY was induced by dietary obesity in the stromal vascular cells of visceral fat depots from mice. Surprisingly, the induction of Npy was limited to purified ATMs from obese mice. Significant basal production of NPY was observed in cultured bone marrow derived macrophage and dendritic cells (DCs) and was increased with LPS stimulation. In vitro, addition of NPY to myeloid cells had minimal effects on their activation profiles. NPY receptor inhibition promoted DC maturation and the production of IL-6 and TNFa suggesting an anti-inflammatory function for NPY signaling in DCs. Consistent with this, NPY injection into lean mice decreased the quantity of M1-like CD11c(+) ATMs and suppressed Ly6c(hi) monocytes. BM chimeras generated from Npy(-/-) donors demonstrated that hematopoietic NPY contributes to the obesity-induced induction of Npy in fat. In addition, loss of Npy expression from hematopoietic cells led to an increase in CD11c(+) ATMs in visceral fat with high fat diet feeding. Overall, our studies suggest that NPY is produced by a range of myeloid cells and that obesity activates the production of NPY in adipose tissue macrophages with autocrine and paracrine effects.	[Singer, Kanakadurga; Morris, David L.; Oatmen, Kelsie E.; Wang, Tianyi; DelProposto, Jennifer; Mergian, Taleen; Cho, Kae Won; Lumeng, Carey N.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Lumeng, Carey N.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lumeng, CN (corresponding author), Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	clumeng@umich.edu	Morris, David/J-4002-2012	Morris, David/0000-0001-7607-3829; Lumeng, Carey/0000-0003-0303-6204; Singer, Kanakadurga/0000-0001-8278-3800	National Institutes of Health [DK090262]; Endocrine Fellows Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090262, F32DK091976, K08DK078851, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Fellows Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Institutes of Health DK090262 and a grant from the Endocrine Fellows Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2009, J BIOL CHEM, V284, P24715, DOI 10.1074/jbc.M109.035253; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Barnea A, 2001, BRAIN RES, V896, P137, DOI 10.1016/S0006-8993(01)02141-2; Bedoui S, 2003, J IMMUNOL, V171, P3451, DOI 10.4049/jimmunol.171.7.3451; Bedoui S, 2001, J NEUROIMMUNOL, V117, P125, DOI 10.1016/S0165-5728(01)00328-9; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; CHEN SH, 1995, ACTA PHARM SINIC, V16, P149; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Dedoussis GVZ, 2010, EUR J CLIN INVEST, V40, P388, DOI 10.1111/j.1365-2362.2010.02277.x; Dimitrijevic M, 2005, REGUL PEPTIDES, V124, P163, DOI 10.1016/j.regpep.2004.07.012; Dobrian AD, 2010, AM J PHYSL ENDOCRINO; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gelfo F, 2011, PEPTIDES, V32, P1320, DOI 10.1016/j.peptides.2011.03.023; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gundersen C, 2010, OBES REV; HAUSER GJ, 1995, LIFE SCI, V57, P235, DOI 10.1016/0024-3205(95)00266-9; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kakko T, 2011, DIABETES VASC DIS RE, V8, P221, DOI 10.1177/1479164111415882; Kim SJ, 2010, DIABETES, V59, P1739, DOI 10.2337/db09-1618; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; Kos K, 2009, DIABETES OBES METAB, V11, P285, DOI 10.1111/j.1463-1326.2008.00909.x; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Kuo LE, 2008, ANN NY ACAD SCI, V1148, P232, DOI 10.1196/annals.1410.035; Kyrou I, 2006, ANN NY ACAD SCI, V1083, P77, DOI 10.1196/annals.1367.008; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Makinde TO, 2012, EXP MOL PATHOL; Mitic K, 2011, PEPTIDES, V32, P1626, DOI 10.1016/j.peptides.2011.06.007; Mori MA, 2010, DIABETES, V59, P2960, DOI 10.2337/db10-0367; Morris DL, 2012, OBESITY, V20, P1189, DOI 10.1038/oby.2012.7; MYERS AK, 1988, BIOCHEM BIOPH RES CO, V155, P118, DOI 10.1016/S0006-291X(88)81057-X; Nave H, 2004, J NEUROIMMUNOL, V155, P1, DOI 10.1016/j.jneuroim.2004.05.009; Patel HR, 2006, DIABETES, V55, P3091, DOI 10.2337/db05-0624; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Qureshi NU, 1998, REGUL PEPTIDES, V75-6, P215, DOI 10.1016/S0167-0115(98)00071-8; Rasmusson AM, 2010, EXP BIOL MED, V235, P1150, DOI 10.1258/ebm.2010.009334; Robbins CS, 2011, CIRCULATION; Ruohonen ST, 2008, DIABETES, V57, P1517, DOI 10.2337/db07-0722; SCHWARZ H, 1994, J NEUROIMMUNOL, V51, P53, DOI 10.1016/0165-5728(94)90128-7; Segal-Lieberman G, 2003, AM J PHYSIOL-ENDOC M, V284, pE1131, DOI 10.1152/ajpendo.00491.2002; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Silva AP, 2003, REGUL PEPTIDES, V116, P71, DOI 10.1016/S0167-0115(03)00191-5; Stadler J, 2011, ANN ANAT, V193, P486, DOI 10.1016/j.aanat.2011.10.009; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Wheway J, 2007, PEPTIDES, V28, P453, DOI 10.1016/j.peptides.2006.09.030; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang KP, 2008, FASEB J, V22, P2452, DOI 10.1096/fj.07-100735	52	70	70	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57929	10.1371/journal.pone.0057929	http://dx.doi.org/10.1371/journal.pone.0057929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472120	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900063
J	Zammarchi, F; Boutsalis, G; Cartegni, L				Zammarchi, Francesca; Boutsalis, George; Cartegni, Luca			5 ' UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer	PLOS ONE			English	Article							GENE FUSION; MESSENGER-RNAS; C-MYC; EXPRESSION; TRANSLATION; PTEN; TRANSLOCATIONS; TRANSCRIPTS; PROGRESSION; SENESCENCE	ERG, a member of the ETS transcription factor family, is frequently overexpressed in prostate cancer as a result of its fusion to the androgen-responsive Tmprss2 gene. Different genomic rearrangements and alternative splicing events around the junction region lead to multiple combination of Tmprss2:ERG fusion transcripts that correlate with different tumor aggressiveness, but their specific functions and biological activities are still unclear. The complexity of ERG expression pattern is compounded by the use of alternative promoters, splice sites, polyadenylation sites and translation initiation sites in both the native and fusion contexts. Our systematic characterization of native ERG and Tmprss2:ERG variants reveals that their different oncogenic potential is impacted by the status of the Ets domain and the configuration of the 5' UTR region. In particular, expression and activity of functional ERG and Tmprss2:ERG variants are influenced both by translation initiation signals within the different isoforms and by inhibitory upstream Open Reading Frames (uORF) in their 5' UTRs. Stable expression of ERG and Tmprss2:ERG variants promoted cell migration/invasion, induced a block of proliferation and induced a senescence-like state, suggesting a role for these variants in the prostate tumorigenesis process. In addition to Tmprss2:ERG fusion products, a group of related native ERG isoforms is also highly over-expressed in fusion-carrying prostate cancers, and share the same translation initiation site (in ERG exon 4) with the commonly observed Tmprss2 exon1 joined to ERG exon 4 (T1:E4) fusion-derived variant. Usage of this ATG can be preferentially down-regulated by directed antisense-based compounds, possibly representing the basis of a targeted approach that distinguishes between tumor-associated and normal ERG.	[Zammarchi, Francesca; Boutsalis, George; Cartegni, Luca] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA; [Boutsalis, George; Cartegni, Luca] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Cartegni, Luca] Mem Sloan Kettering Canc Ctr, Ctr Expt Therapeut, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Cartegni, L (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, 1275 York Ave, New York, NY 10021 USA.	cartegnl@mskcc.org		Zammarchi, Francesca/0000-0001-9457-2170	DOD grant [PC081477]	DOD grant	Work was supported by DOD grant PC081477. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Buttice G, 1996, ONCOGENE, V13, P2297; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; DUTERQUECOQUILLAUD M, 1993, ONCOGENE, V8, P1865; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; FitzGerald LM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-230; Ghosh AK, 1999, GENE, V235, P85, DOI 10.1016/S0378-1119(99)00206-1; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Jhavar S, 2008, J MOL DIAGN, V10, P50, DOI 10.2353/jmoldx.2008.070085; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Mani RS, 2011, CANCER RES, V71, P5387, DOI 10.1158/0008-5472.CAN-11-0876; McDuff FKE, 2011, CELL SIGNAL, V23, P6, DOI 10.1016/j.cellsig.2010.07.004; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Moulton JD, 2009, MOLECULES, V14, P1304, DOI 10.3390/molecules14031304; Nam RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/cbt.6.1.3489; Owczarek CM, 2004, GENE, V324, P65, DOI 10.1016/j.gene.2003.09.047; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; PRASAD DDK, 1994, ONCOGENE, V9, P669; Rajput AB, 2007, J CLIN PATHOL, V60, P1238, DOI 10.1136/jcp.2006.043810; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Squire JA, 2009, NAT GENET, V41, P509, DOI 10.1038/ng0509-509; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966	38	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e49721	10.1371/journal.pone.0049721	http://dx.doi.org/10.1371/journal.pone.0049721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472063	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900001
J	Zhang, YN; Xia, JG; Zhang, YJ; Qin, Y; Yang, D; Qi, LS; Zhao, WY; Wang, CG; Guo, Z				Zhang, Yuannv; Xia, Jiguang; Zhang, Yujing; Qin, Yao; Yang, Da; Qi, Lishuang; Zhao, Wenyuan; Wang, Chenguang; Guo, Zheng			Pitfalls in Experimental Designs for Characterizing the Transcriptional, Methylational and Copy Number Changes of Oncogenes and Tumor Suppressor Genes	PLOS ONE			English	Article							CANCER STEM-CELLS; OLIGONUCLEOTIDE ARRAYS; EXPRESSION; MUTATIONS; PATHWAYS; DATABASE; IDENTIFICATION; CARCINOMA; PROTEIN; GAIN	Background: It is a common practice that researchers collect a set of samples without discriminating the mutants and their wild-type counterparts to characterize the transcriptional, methylational and/or copy number changes of pre-defined candidate oncogenes or tumor suppressor genes (TSGs), although some examples are known that carcinogenic mutants may express and function completely differently from their wild-type counterparts. Principal Findings: Based on various high-throughput data without mutation information for typical cancer types, we surprisingly found that about half of known oncogenes (or TSGs) pre-defined by mutations were down-regulated (or up-regulated) and hypermethylated (or hypomethylated) in their corresponding cancer types. Therefore, the overall expression and/or methylation changes of genes detected in a set of samples without discriminating the mutants and their wild-type counterparts cannot indicate the carcinogenic roles of the mutants. We also found that about half of known oncogenes were located in deletion regions, whereas all known TSGs were located in deletion regions. Thus, both oncogenes and TSGs may be located in deletion regions and thus deletions can indicate TSGs only if the gene is found to be deleted as a whole. In contrast, amplifications are restricted to oncogenes and thus can be used to support either the dysregulated wild-type gene or its mutant as an oncogene. Conclusions: We demonstrated that using the transcriptional, methylational and/or copy number changes without mutation information to characterize oncogenes and TSGs, which is a currently still widely adopted strategy, will most often produce misleading results. Our analysis highlights the importance of evaluating expression, methylation and copy number changes together with gene mutation data in the same set of samples in order to determine the distinct roles of the mutants and their wild-type counterparts.	[Zhang, Yuannv; Xia, Jiguang; Zhang, Yujing; Qin, Yao; Qi, Lishuang; Zhao, Wenyuan; Wang, Chenguang; Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Yang, Da] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Chengdu 610054, Peoples R China; [Guo, Zheng] Univ Elect Sci & Technol China, Bioinformat Ctr, Chengdu 610054, Peoples R China	Harbin Medical University; University of Texas System; UTMD Anderson Cancer Center; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Guo, Z (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	guoz@ems.hrbmu.edu.cn		Yang, Da/0000-0002-8336-9457	National Natural Science Foundation of China [30970668, 30011901, 81071646, 91029717]; Excellent Youth Foundation of Heilongjiang Province [JC200808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Heilongjiang Province	This work was supported by the National Natural Science Foundation of China (grant No: 30970668, 30011901, 81071646, 91029717) and the Excellent Youth Foundation of Heilongjiang Province (grant No. JC200808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Calza S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-140; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Edwards PAW, 2010, J PATHOL, V220, P244, DOI 10.1002/path.2632; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Furney SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn482; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Greulich H, 2011, TRENDS MOL MED, V17, P283, DOI 10.1016/j.molmed.2011.01.012; Hernandez P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-13; Huan CM, 2005, J BIOL CHEM, V280, P30225, DOI 10.1074/jbc.M502380200; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Klijn C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1143; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Negrotto S, 2011, CANCER RES, V71, P1431, DOI 10.1158/0008-5472.CAN-10-2422; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Roy D, 2011, BLOOD, V118, pE32, DOI 10.1182/blood-2010-12-323659; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Scrima M, 2012, AM J PATHOL, V180, P1202, DOI 10.1016/j.ajpath.2011.11.038; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; Sell S, 2006, TUMOR BIOL, V27, P59, DOI 10.1159/000092323; Sun XF, 2012, MOL BIOL REP, V39, P5631, DOI 10.1007/s11033-011-1369-y; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Viloria CG, 2009, CANCER RES, V69, P4926, DOI 10.1158/0008-5472.CAN-08-4155; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WEINBERG RA, 1994, CA-CANCER J CLIN, V44, P160, DOI 10.3322/canjclin.44.3.160; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Yang YM, 2003, BIOINFORMATICS, V19, P2311, DOI 10.1093/bioinformatics/btg300; Yao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029686; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365	58	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58163	10.1371/journal.pone.0058163	http://dx.doi.org/10.1371/journal.pone.0058163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472150	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900096
J	Stewart, LD; McNair, J; McCallan, L; Gordon, A; Grant, IR				Stewart, Linda D.; McNair, James; McCallan, Lyanne; Gordon, Alan; Grant, Irene R.			Improved Detection of Mycobacterium bovis Infection in Bovine Lymph Node Tissue Using Immunomagnetic Separation (IMS)-Based Methods	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; MAGNETIC SEPARATION; TUBERCULOSIS; IS6110; FECES; PCR	Immunomagnetic separation (IMS) can selectively isolate and concentrate Mycobacterium bovis cells from lymph node tissue to facilitate subsequent detection by PCR (IMS-PCR) or culture (IMS-MGIT). This study describes application of these novel IMS-based methods to test for M. bovis in a survey of 280 bovine lymph nodes (206 visibly lesioned (VL), 74 non-visibly lesioned (NVL)) collected at slaughter as part of the Northern Ireland bovine TB eradication programme. Their performance was evaluated relative to culture. Overall, 174 (62.1%) lymph node samples tested positive by culture, 162 (57.8%) by IMS-PCR (targeting IS6110), and 191 (68.2%) by IMS-MGIT culture. Twelve (6.9%) of the 174 culture positive lymph node samples were not detected by either of the IMS-based methods. However, an additional 79 M. bovis positive lymph node samples (27 (13.1%) VL and 52 (70.3%) NVL) were detected by the IMS-based methods and not by culture. When low numbers of viable M. bovis are present in lymph nodes (e. g. in NVLs of skin test reactor cattle) decontamination prior to culture may adversely affect viability, leading to false negative culture results. In contrast, IMS specifically captures whole M. bovis cells (live, dead or potentially dormant) which are not subject to any deleterious treatment before detection by PCR or MGIT culture. During this study only 2.7% of NVL lymph nodes tested culture positive, whereas 70.3% of the same samples tested M. bovis positive by the IMS-based tests. Results clearly demonstrate that not only are the IMS-based methods more rapid but they have greater detection sensitivity than the culture approach currently used for the detection of M. bovis infection in cattle. Adoption of the IMS-based methods for lymph node testing would have the potential to improve M. bovis detection in clinical samples.	[Stewart, Linda D.; Grant, Irene R.] Queens Univ Belfast, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland; [McNair, James; McCallan, Lyanne] Agri Food & Biosci Inst Northern Ireland, Vet Sci Div, Belfast, Antrim, North Ireland; [Gordon, Alan] Agri Food & Biosci Inst Northern Ireland, Div Biometr, Belfast, Antrim, North Ireland	Queens University Belfast; Agri-Food & Biosciences Institute; Agri-Food & Biosciences Institute	Grant, IR (corresponding author), Queens Univ Belfast, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland.	i.grant@qub.ac.uk	Stewart, Linda/AFS-8631-2022	Grant, Irene/0000-0001-5860-3769; Stewart, Linda/0000-0002-2400-6162	Department of Environment, Food and Rural Affairs, UK [SE3262]	Department of Environment, Food and Rural Affairs, UK(Department for Environment, Food & Rural Affairs (DEFRA))	This research was funded by the Department of Environment, Food and Rural Affairs, UK (Project SE3262), www.defra.gov.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CORNER LA, 1995, NEW ZEAL VET J, V43, P129, DOI 10.1080/00480169.1995.35871; Coros A, 2008, J BACTERIOL, V190, P3408, DOI 10.1128/JB.00009-08; Delahay RJ, 2007, VET J, V173, P287, DOI 10.1016/j.tvjl.2005.11.011; Delahay RJ, 2001, TUBERCULOSIS, V81, P43, DOI 10.1054/tube.2000.0266; Foddai A, 2011, J CLIN MICROBIOL, V49, P2017, DOI 10.1128/JCM.00429-11; Foddai A, 2010, APPL ENVIRON MICROB, V76, P7550, DOI 10.1128/AEM.01432-10; Garbaccio SG, 2010, REV ARGENT MICROBIOL, V42, P247, DOI 10.1590/S0325-75412010000400002; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; McHugh TD, 1997, J CLIN MICROBIOL, V35, P1769, DOI 10.1128/JCM.35.7.1769-1771.1997; Office International des Epizooties, 2010, OIE TERR MAN 2010; Office International des Epizooties, 2009, OIE TERR MAN 2010; Roring S, 1998, VET MICROBIOL, V61, P71, DOI 10.1016/S0378-1135(98)00167-9; Rua-Domenech R. de la, 2006, GVJ - Government Veterinary Journal, V16, P65; Skuce RA, 2010, VET REC, V167, P684, DOI 10.1136/vr.c5108; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; Stewart LD, 2012, J CLIN MICROBIOL, V50, P1598, DOI 10.1128/JCM.05747-11; Sweeney FP, 2007, APPL ENVIRON MICROB, V73, P7471, DOI 10.1128/AEM.00978-07; Sweeney FP, 2006, LETT APPL MICROBIOL, V2, P460; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; THIERRY D, 1990, NUCLEIC ACIDS RES, V18, P188, DOI 10.1093/nar/18.1.188; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Zumarraga MJ, 2005, J VET DIAGN INVEST, V17, P232, DOI 10.1177/104063870501700303	22	20	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58374	10.1371/journal.pone.0058374	http://dx.doi.org/10.1371/journal.pone.0058374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469275	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900082
J	Glowacki, F; Savary, G; Gnemmi, V; Buob, D; Van der Hauwaert, C; Lo-Guidice, JM; Bouye, S; Hazzan, M; Pottier, N; Perrais, M; Aubert, S; Cauffiez, C				Glowacki, Francois; Savary, Gregoire; Gnemmi, Viviane; Buob, David; Van der Hauwaert, Cynthia; Lo-Guidice, Jean-Marc; Bouye, Sebastien; Hazzan, Marc; Pottier, Nicolas; Perrais, Michael; Aubert, Sebastien; Cauffiez, Christelle			Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis	PLOS ONE			English	Article							RENAL FIBROSIS; GENE-EXPRESSION; MICRORNAS; MECHANISMS; SERUM; IDENTIFICATION; PATHOLOGY; INSIGHTS; REVEALS; CANCER	MicroRNAs (miRNAs)are a class of noncoding RNA acting at a post-transcriptional level to control the expression of large sets of target mRNAs. While there is evidence that miRNAs deregulation plays a causative role in various complex disorders, their role in fibrotic kidney diseases is largely unexplored. Here, we found a strong up-regulation of miR-21 in the kidneys of mice with unilateral ureteral obstruction and also in the kidneys of patients with severe kidney fibrosis. In addition, mouse primary fibroblasts derived from fibrotic kidneys exhibited higher miR-21 expression level compared to those derived from normal kidneys. Expression of miR-21 in normal primary kidney fibroblasts was induced upon TGF beta exposure, a key growth factor involved in fibrogenesis. Finally, ectopic expression of miR-21 in primary kidney fibroblasts was sufficient to promote myofibroblast differentiation. As circulating miRNAs have been suggested as promising non-invasive biomarkers, we further assess whether circulating miR-21 levels are associated with renal fibrosis using sera from 42 renal transplant recipients, categorized according to their renal fibrosis severity, evaluated on allograft biopsies (Interstitial Fibrosis/Tubular Atrophy (IF/TA). Circulating miR-21 levels are significantly increased in patients with severe IF/TA grade (IF/TA grade 3: 3.0 +/- 1.0 vs lower grade of fibrosis: 1.5 +/- 1.2; p = 0.001). By contrast, circulating miR-21 levels were not correlated with other renal histological lesions. In a multivariate linear regression model including IF/TA grade and estimated GFR, independent associations were found between circulating miR-21 levels and IF/TA score (beta = 0.307, p = 0.03), and between miR-21 levels and aMDRD (beta = -0.398, p = 0.006). Altogether, these data suggest miR-21 has a key pathogenic role in kidney fibrosis and may represent a novel, predictive and reliable blood marker of kidney fibrosis.	[Glowacki, Francois; Savary, Gregoire; Van der Hauwaert, Cynthia; Lo-Guidice, Jean-Marc; Pottier, Nicolas; Cauffiez, Christelle] Fac Med H Warembourg, EA4483, Dept Biochim & Biol Mol, Lille, France; [Glowacki, Francois; Hazzan, Marc] CHRU, Serv Nephrol, Hop Huriez, Lille, France; [Gnemmi, Viviane; Perrais, Michael; Aubert, Sebastien] Jean Pierre Aubert Res Ctr, Inst Natl Sante & Rech Med, U837, Equipe Mucines Differenciat & Cancerogenese Epith, Lille, France; [Gnemmi, Viviane; Buob, David; Aubert, Sebastien] CHRU, Inst Pathol, Ctr Biol Pathol Genet, Lille, France; [Gnemmi, Viviane; Perrais, Michael; Aubert, Sebastien] Univ Lille 2, Fac Med H Warembourg, Lille, France; [Buob, David; Hazzan, Marc] Univ Lille 2, Fac Med H Warembourg, EA2686, Lille, France; [Bouye, Sebastien] CHRU, Serv Urol, Hop Huriez, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Glowacki, F (corresponding author), Fac Med H Warembourg, EA4483, Dept Biochim & Biol Mol, Lille, France.	francois.glowacki@chru-lille.fr	Cauffiez, Christelle/H-5816-2019; GUIDICE, Jean-Marc LO/O-3177-2017	Cauffiez, Christelle/0000-0003-0951-7973; GUIDICE, Jean-Marc LO/0000-0003-3486-6809; Savary, Gregoire/0000-0001-8021-2676; pottier, nicolas/0000-0001-8913-6286; Hazzan, Marc/0000-0002-9863-8840; Glowacki, Francois/0000-0001-5443-9172; Van der Hauwaert, Cynthia/0000-0001-9549-3722	Conseil Regional du Nord Pas de Calais, Santelys Association [ANR-09-JCJC-0002]	Conseil Regional du Nord Pas de Calais, Santelys Association(Region Hauts-de-France)	This research was supported by the Conseil Regional du Nord Pas de Calais, ANR-09-JCJC-0002, Santelys Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina S, 2011, TRANSL RES, V157, P236, DOI 10.1016/j.trsl.2011.01.011; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Duffield J, DRUG DISOVE IN PRESS; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Fu XN, 2011, EUR J CLIN INVEST, V41, P1245, DOI 10.1111/j.1365-2362.2011.02535.x; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Hesselink DA, 2010, THER DRUG MONIT, V32, P387, DOI 10.1097/FTD.0b013e3181e44244; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Jenkins RH, 2012, BIOCHEM SOC T, V40, P762, DOI 10.1042/BST20120085; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Moore J, 2010, JAMA-J AM MED ASSOC, V303, P1282, DOI 10.1001/jama.2010.356; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Racusen LC, 2010, KIDNEY INT, V78, pS27, DOI 10.1038/ki.2010.419; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Thum T, 2011, J CLIN INVEST, V121, P461, DOI 10.1172/JCI45938; Tili Esmerina, 2007, Future Oncol, V3, P521, DOI 10.2217/14796694.3.5.521; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Villar A.V., 2012, INT J CARDIOL; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Yokoi T, 2011, TOXICOL SCI, V123, P1, DOI 10.1093/toxsci/kfr168; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	47	159	170	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58014	10.1371/journal.pone.0058014	http://dx.doi.org/10.1371/journal.pone.0058014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469132	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900224
J	Halldin, CN; Suarthana, E; Fedan, KB; Lo, YC; Turabelidze, G; Kreiss, K				Halldin, Cara N.; Suarthana, Eva; Fedan, Kathleen B.; Lo, Yi-Chun; Turabelidze, George; Kreiss, Kathleen			Increased Respiratory Disease Mortality at a Microwave Popcorn Production Facility with Worker Risk of Bronchiolitis Obliterans	PLOS ONE			English	Article							DIACETYL; EXPOSURE; VAPORS	Background: Bronchiolitis obliterans, an irreversible lung disease, was first associated with inhalation of butter flavorings (diacetyl) in workers at a microwave popcorn company. Excess rates of lung-function abnormalities were related to cumulative diacetyl exposure. Because information on potential excess mortality would support development of permissible exposure limits for diacetyl, we investigated respiratory-associated mortality during 2000-2011 among current and former workers at this company who had exposure to flavorings and participated in cross-sectional surveys conducted between 2000-2003. Methods: We ascertained workers' vital status through a Social Security Administration search. Causes of death were abstracted from death certificates. Because bronchiolitis obliterans is not coded in the International Classification of Disease 10th revision (ICD-10), we identified respiratory mortality decedents with ICD-10 codes J40-J44 which encompass bronchitis (J40), simple and mucopurulent chronic bronchitis (J41), unspecified chronic bronchitis (J42), emphysema (J43), and other chronic obstructive pulmonary disease (COPD) (J44). We calculated expected number of deaths and standardized mortality ratios (SMRs) with 95% confidence intervals (CI) to determine if workers exposed to diacetyl experienced greater respiratory mortality than expected. Results: We identified 15 deaths among 511 workers. Based on U. S. population estimates, 17.39 deaths were expected among these workers (SMR = 0.86; CI: 0.48-1.42). Causes of death were available for 14 decedents. Four deaths among production and flavor mixing workers were documented to have a multiple cause of 'other COPD' (J44), while 0.98 'other COPD'-associated deaths were expected (SMR = 4.10; CI: 1.12-10.49). Three of the 4 'other COPD'-associated deaths occurred among former workers and workers employed before the company implemented interventions reducing diacetyl exposure in 2001. Conclusion: Workers at the microwave popcorn company experienced normal rates of all-cause mortality but higher rates of COPD-associated mortality, especially workers employed before the company reduced diacetyl exposure. The demonstrated excess in COPD-associated mortality suggests continued efforts to lower flavoring exposure are prudent.	[Halldin, Cara N.; Suarthana, Eva; Lo, Yi-Chun] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA 30333 USA; [Halldin, Cara N.; Suarthana, Eva; Fedan, Kathleen B.; Kreiss, Kathleen] NIOSH, Div Resp Dis Studies, Morgantown, WV 26505 USA; [Lo, Yi-Chun; Turabelidze, George] Missouri Dept Hlth & Senior Serv, Jefferson City, MO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Halldin, CN (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA 30333 USA.	vgx5@cdc.gov		Halldin, Cara/0000-0002-8050-8407	Centers for Disease Control (CDC); National Institute for Occupational Safety and Health (NIOSH); Missouri Department of Health & Senior Services	Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Missouri Department of Health & Senior Services	The Centers for Disease Control (CDC), National Institute for Occupational Safety and Health (NIOSH), and Missouri Department of Health & Senior Services supported the salaries of the authors, and no other funding was obtained. This work was performed by State and Federal Government employees as part of their work; no non-governmental funding supported this work. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of NIOSH or the CDC.	Akpinar-Elci M, 2004, EUR RESPIR J, V24, P298, DOI 10.1183/09031936.04.00013903; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; BANG KM, 1993, CHEST, V103, P536, DOI 10.1378/chest.103.2.536; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P345; Centers for Disease Control and Prevention National Center for Health Statistics, 2009, HLTH DAT INT NAT HLT; Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH), 2010, NIOSH 119 RAT FIL MO; Cox-Ganser J, 2011, J OCCUP ENVIRON HYG, V8, P59, DOI 10.1080/15459624.2011.540168; Ghanei M, 2008, RESP MED, V102, P825, DOI 10.1016/j.rmed.2008.01.016; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hubbs AF, 2002, TOXICOL APPL PHARM, V185, P128, DOI 10.1006/taap.2002.9525; Hubbs AF, 2008, TOXICOL PATHOL, V36, P330, DOI 10.1177/0192623307312694; Kanwal R, 2006, J OCCUP ENVIRON MED, V48, P149, DOI 10.1097/01.jom.0000194152.48728.fb; Kanwal R, 2011, PUBLIC HEALTH REP, V126, P480, DOI 10.1177/003335491112600405; Kim TJ, 2010, AM J IND MED, V53, P857, DOI 10.1002/ajim.20858; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Lockey J., 2002, AM J RESP CRIT CARE, V165, pA461; Lockey JE, 2009, EUR RESPIR J, V34, P63, DOI 10.1183/09031936.00050808; Markopoulou KD, 2002, EUR RESPIR J, V19, P20, DOI 10.1183/09031936.02.00282001; Morgan DL, 2012, TOXICOL PATHOL, V40, P448, DOI 10.1177/0192623311431946; National Institute for Occupational Safety and Health (NIOSH, 2011, DRAFT CRIT REC STAND; NIOSH, 2006, RESP US NOT MEAN NIO; Parmet AJ, 2002, J OCCUP ENVIRON MED, V44, P216, DOI 10.1097/00043764-200203000-00002; Robinson CF, 2006, J OCCUP ENVIRON MED, V48, P662, DOI 10.1097/01.jom.0000229968.74906.8f; Ryan G, 1999, J EPIDEMIOL COMMUN H, V53, P230, DOI 10.1136/jech.53.4.230; Schubauer-Berigan MK, 2011, AM J IND MED, V54, P915, DOI 10.1002/ajim.20999; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; STEENLAND K, 1992, AM J EPIDEMIOL, V136, P855, DOI 10.1093/aje/136.7.855; U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics, 1996, 76200 US DHHS CDCP N; van Rooy FGBGJ, 2007, AM J RESP CRIT CARE, V176, P498, DOI 10.1164/rccm.200611-1620OC; World Health Organization, 1992, INT STAT CLASS DIS R	31	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57935	10.1371/journal.pone.0057935	http://dx.doi.org/10.1371/journal.pone.0057935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469109	Green Published, gold			2022-12-27	WOS:000315524900204
J	Jansen, T; Campbell, A; Brunel, T; Clausen, LW				Jansen, Teunis; Campbell, Andrew; Brunel, Thomas; Clausen, Lotte Worsoe			Spatial Segregation within the Spawning Migration of North Eastern Atlantic Mackerel (Scomber scombrus) as Indicated by Juvenile Growth Patterns	PLOS ONE			English	Article								A comparison of growth data (fish length) with latitude shows that southern juvenile mackerel attain a greater length than those originating from further north before growth ceases during their first winter. A similar significant relationship was found between the growth in the first year (derived from the otolith inner winter ring) and latitude for adult mackerel spawning between 44 degrees N (Bay of Biscay) and 54 degrees N (west of Ireland). These observations are consistent with spatial segregation of the spawning migration; the further north that the fish were hatched, the further north they will tend to spawn. No such relationship was found in mackerel spawning at more northerly latitudes, possibly as a consequence of increased spatial mixing in a more energetic regime with stronger currents. This study provides previously lacking support for spawning segregation behaviour among North East Atlantic mackerel - an important step towards understanding the migratory behaviour of mackerel and hence the spatiotemporal distribution dynamics around spawning time.	[Jansen, Teunis; Clausen, Lotte Worsoe] Tech Univ Denmark, DTU AQUA Natl Inst Aquat Resources, Charlottenlund, Denmark; [Campbell, Andrew] Inst Marine, Fisheries Ecosyst Advisory Serv, Galway, Ireland; [Brunel, Thomas] IMARES, Dept Fisheries, Ijmuiden, Netherlands	Technical University of Denmark; Marine Institute Ireland; Wageningen University & Research	Jansen, T (corresponding author), Tech Univ Denmark, DTU AQUA Natl Inst Aquat Resources, Charlottenlund, Denmark.	Tej@aqua.dtu.dk		Worsoe Clausen, Lotte/0000-0003-1503-6092; Jansen, Teunis/0000-0001-8722-4493	European Commission [FACTS 02466 FP7-KBBE-2009-2]; EURO-BASIN [264933]	European Commission(European CommissionEuropean Commission Joint Research Centre); EURO-BASIN	The research was funded by the European Commission's within the Seventh Framework Programme (FACTS 02466 FP7-KBBE-2009-2) and EURO-BASIN (Grant Agreement #264933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASTONGUAY M, 1991, CAN J FISH AQUAT SCI, V48, P296, DOI 10.1139/f91-041; Dawson W.A., 1991, ICES J MAR SCI, V47, P303; Ehrenbaum E, 1914, RAPP P V REUN CONS P, V18, P1; Hopkins P, 1986, 1986H7 ICES CM; ICES, 1977, 1977H2 ICES CM; ICES, 2019, ICES SCI REPORTS, V1, DOI 10.17895/ices.pub.4982; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Iversen S.A., 2002, ICES J MAR SCI, V215, P382, DOI [10.17895/ices.pub.8877, DOI 10.17895/ICES.PUB.8877]; JAMIESON A, 1987, J CONSEIL, V44, P66; Jansen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038758; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Johnson P. O, 1977, FISH RES TECH REP MA, V77, P1; MACKENZIE K, 1990, J CONSEIL, V46, P155; Mendiola D, 2007, J FISH BIOL, V70, P911, DOI 10.1111/j.1095-8649.2007.01355.x; Naevdal, 1970, FISK DIR SKR SERV HA, V15, P573; Nesbo CL, 2000, P ROY SOC B-BIOL SCI, V267, P281, DOI 10.1098/rspb.2000.0998; Nolan GD, 2012, ICES COOP RES REP, V314, P1; Pitois SG, 2012, MAR ECOL PROG SER, V456, P169, DOI 10.3354/meps09710; Robert D, 2009, MAR ECOL PROG SER, V377, P227, DOI 10.3354/meps07833; SOMDAL O, 1992, SARSIA, V77, P19, DOI 10.1080/00364827.1992.10413489; Teixeira AS, 1985, 1985H68 ICES CM; Uriarte A., 2001, 2001O17 ICES CM; Villamor B, 2004, FISH RES, P121; Zuur Alain F., 2009, P1	24	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58114	10.1371/journal.pone.0058114	http://dx.doi.org/10.1371/journal.pone.0058114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469149	gold, Green Published			2022-12-27	WOS:000315524900240
J	Laporta, J; Peters, TL; Merriman, KE; Vezina, CM; Hernandez, LL				Laporta, Jimena; Peters, Tonia L.; Merriman, Kathryn E.; Vezina, Chad M.; Hernandez, Laura L.			Serotonin (5-HT) Affects Expression of Liver Metabolic Enzymes and Mammary Gland Glucose Transporters during the Transition from Pregnancy to Lactation	PLOS ONE			English	Article							ORGANIC NUTRIENT METABOLISM; CONSCIOUS DOGS; INSULIN LEVELS; ACTIVATION; INFUSION; DISPOSAL; BOVINE; GLUT8; HOMEOSTASIS; INHIBITOR	The aim of this experiment was to demonstrate the ability of feeding serotonin (5-HT; 5-hydroxytryptamine) precursors to increase 5-HT production during the transition from pregnancy to lactation and the effects this has on maternal energy metabolism in the liver and mammary gland. Pregnant rats (n = 45) were fed one of three diets: I) control (CON), II) CON supplemented with 0.2% 5-hydroxytryptophan (5-HTP) or III) CON supplemented with 1.35% L-tryptophan (L-TRP), beginning on d13 of pregnancy through d9 of lactation (d9). Serum (pre and post-partum), milk (daily), liver and mammary gland tissue (d9) were collected. Serum 5-HT was increased in the 5-HTP fed dams beginning on d20 of gestation and remained elevated through d9, while it was only increased on d9 in the L-TRP fed dams. 5-HT levels were increased in mammary gland and liver of both groups. Additionally, 5-HTP fed dams had serum and milk glucose levels similar to the CON, while L-TRP had decreased serum (d9) and milk glucose (all dates evaluated). Feeding 5-HTP resulted in increased mRNA expression of key gluconeogenic and glycolytic enzymes in liver and glucose transporters 1 and 8 (GLUT-1, -8) in the mammary gland. We demonstrated the location of GLUT-8 in the mammary gland both in the epithelial and vascular endothelial cells. Finally, phosphorylated 5' AMP-activated protein kinase (pAMPK), a known regulator of intracellular energy status, was elevated in mammary glands of 5-HTP fed dams. Our results suggest that increasing 5-HT production during the transition from pregnancy to lactation increases mRNA expression of enzymes involved in energy metabolism in the liver, and mRNA abundance and distribution of glucose transporters within the mammary gland. This suggests the possibility that 5-HT may be involved in regulating energy metabolism during the transition from pregnancy to lactation.	[Laporta, Jimena; Peters, Tonia L.; Merriman, Kathryn E.; Hernandez, Laura L.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, LL (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu	Vezina, Chad/GRO-2299-2022; Laporta, Jimena/AAX-3093-2021	Hernandez, Laura/0000-0001-7591-5203; Vezina, Chad/0000-0001-7058-5399	USDA/HATCH [MSN146995]	USDA/HATCH(United States Department of Agriculture (USDA))	This project was funded by USDA/HATCH Funding #MSN146995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; BURNOL AF, 1990, BIOCHEM J, V270, P277, DOI 10.1042/bj2700277; CAMPS M, 1994, ENDOCRINOLOGY, V134, P924, DOI 10.1210/en.134.2.924; Coelho WS, 2012, INT J BIOCHEM CELL B, V44, P150, DOI 10.1016/j.biocel.2011.10.010; Cura AJ, 2010, J BIOL CHEM, V285, P15430, DOI 10.1074/jbc.M110.110593; Ducy P, 2011, CURR OPIN PHARMACOL, V11, P34, DOI 10.1016/j.coph.2011.01.007; GRUMMER RR, 1995, J ANIM SCI, V73, P2820; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hernandez LL, 2008, J DAIRY SCI, V91, P1834, DOI 10.3168/jds.2007-0766; Hernandez LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032598; Hernandez LL, 2012, AM J PHYSIOL-ENDOC M, V302, pE1009, DOI 10.1152/ajpendo.00666.2011; Hernandez LL, 2009, J ENDOCRINOL, V203, P123, DOI 10.1677/JOE-09-0187; Ibberson M, 2002, J BIOL CHEM, V27, P4607; Jeoung Nam Ho, 2010, Korean Diabetes J, V34, P274, DOI 10.4093/kdj.2010.34.5.274; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; KARKALAS J, 1985, J SCI FOOD AGR, V36, P1019, DOI 10.1002/jsfa.2740361018; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; KUHN N J, 1978, Biochemical Society Transactions, V6, P539; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Lesurtel M, 2012, SURG-J R COLL SURG E, V10, P107, DOI 10.1016/j.surge.2011.11.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macheda ML, 2003, CELL TISSUE RES, V311, P91, DOI 10.1007/s00441-002-0661-5; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; McFadden JW, 2009, BIOCHEM BIOPH RES CO, V390, P388, DOI 10.1016/j.bbrc.2009.09.017; Moore MC, 2005, AM J PHYSIOL-ENDOC M, V289, pE225, DOI 10.1152/ajpendo.00614.2004; Moore MC, 2004, AM J PHYSIOL-ENDOC M, V287, pE1057, DOI 10.1152/ajpendo.00313.2004; Moore MC, 2004, DIABETES, V53, P14, DOI 10.2337/diabetes.53.1.14; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Nemeth BA, 2000, PEDIATR RES, V47, P444, DOI 10.1203/00006450-200004000-00006; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Pang WW, 2007, J MAMMARY GLAND BIOL, V12, P211, DOI 10.1007/s10911-007-9054-4; Papadimas GK, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13548; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Sanger GJ, 2008, TRENDS PHARMACOL SCI, V29, P465, DOI 10.1016/j.tips.2008.06.008; Schmidt S, 2009, AM J PHYSIOL-ENDOC M, V296, pE614, DOI 10.1152/ajpendo.91019.2008; Schurmann A, 2002, CELL TISSUE RES, V307, P237, DOI 10.1007/s00441-001-0499-2; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; SUGIMOTO Y, 1990, JPN J PHARMACOL, V54, P93, DOI 10.1254/jjp.54.93; Tudhope SJ, 2012, DIABETES, V61, P49, DOI 10.2337/db11-0870; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Watanabe H, 2011, CURR OPIN LIPIDOL, V22, P186, DOI 10.1097/MOL.0b013e3283462273; YAMADA J, 1989, LIFE SCI, V45, P1931, DOI 10.1016/0024-3205(89)90547-X; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Zhao FQ, 2004, BBA-GENE STRUCT EXPR, V1680, P103, DOI 10.1016/j.bbaexp.2004.09.001	48	31	35	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57847	10.1371/journal.pone.0057847	http://dx.doi.org/10.1371/journal.pone.0057847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469086	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900182
J	Oh, Y; Baldwin, IT; Galis, I				Oh, Youngjoo; Baldwin, Ian T.; Galis, Ivan			A Jasmonate ZIM-Domain Protein NaJAZd Regulates Floral Jasmonic Acid Levels and Counteracts Flower Abscission in Nicotiana attenuata Plants	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; TRANSCRIPTION FACTORS; METHYL JASMONATE; ETHYLENE BURST; JAZ FAMILY; ARABIDOPSIS; EXPRESSION; TOBACCO; DEFENSE; GENE	Jasmonic acid is an important regulator of plant growth, development and defense. The jasmonate-ZIM domain (JAZ) proteins are key regulators in jasmonate signaling ubiquitously present in flowering plants but their functional annotation remains largely incomplete. Recently, we identified 12 putative JAZ proteins in native tobacco, Nicotiana attenuata, and initiated systematic functional characterization of these proteins by reverse genetic approaches. In this report, Nicotiana attenuata plants silenced in the expression of NaJAZd (irJAZd) by RNA interference were used to characterize NaJAZd function. Although NaJAZd transcripts were strongly and transiently up-regulated in the rosette leaves by simulated herbivory treatment, we did not observe strong defense-related phenotypes, such as altered herbivore performance or the constitutive accumulation of defense-related secondary metabolites in irJAZd plants compared to wild type plants, both in the glasshouse and the native habitat of Nicotiana attenuata in the Great Basin Desert, Utah, USA. Interestingly, irJAZd plants produced fewer seed capsules than did wild type plants as a result of increased flower abscission in later stages of flower development. The early-and mid-developmental stages of irJAZd flowers had reduced levels of jasmonic acid and jasmonoyl-L-isoleucine, while fully open flowers had normal levels, but these were impaired in NaMYB305 transcript accumulations. Previously, NaMYB305-silenced plants were shown to have strong flower abscission phenotypes and contained lower NECTARIN 1 transcript levels, phenotypes which are copied in irJAZd plants. We propose that the NaJAZd protein is required to counteract flower abscission, possibly by regulating jasmonic acid and jasmonoyl-L-isoleucine levels and/or expression of NaMYB305 gene in Nicotiana attenuata flowers. This novel insight into the function of JAZ proteins in flower and seed development highlights the diversity of functions played by jasmonates and JAZ proteins.	[Oh, Youngjoo; Baldwin, Ian T.; Galis, Ivan] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Galis, I (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan.	igalis@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Galis, Ivan/F-5734-2011	Baldwin, Ian/0000-0001-5371-2974; Galis, Ivan/0000-0001-9840-8845	Max Planck Society	Max Planck Society(Max Planck Society)	The Max Planck Society was the only funder of this work. The Max Planck Society had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Bhattacharya S, 2012, PLANT J, V71, P587, DOI 10.1111/j.1365-313X.2012.05011.x; Bubner B, 2006, PLANT CELL REP, V25, P668, DOI 10.1007/s00299-005-0111-4; BUNKER TW, 1995, PLANT CELL, V7, P1319, DOI 10.1105/tpc.7.8.1319; Carter C, 2004, TRENDS PLANT SCI, V9, P320, DOI 10.1016/j.tplants.2004.05.008; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Clark DG, 1997, PLANT MOL BIOL, V34, P855, DOI 10.1023/A:1005877809905; Colquhoun TA, 2011, PLANT PHYSIOL, V156, P974, DOI 10.1104/pp.111.176248; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Davies P.J., 2010, PLANT HORMONES, P377, DOI 10.1007/978-1-4020-2686-7; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Habib H, 2007, BIOTECHNOL MOL BIOL, V2, P63; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; Horner HT, 2007, AM J BOT, V94, P12, DOI 10.3732/ajb.94.1.12; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Ismail A, 2012, J EXP BOT, V63, P2127, DOI 10.1093/jxb/err426; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Jones ML, 2008, PLANT SCI, V175, P190, DOI 10.1016/j.plantsci.2008.03.011; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; JONGSMA MA, 1994, PLANTA, V195, P29, DOI 10.1007/BF00206288; Kallenbach M, 2011, NEW PHYTOL, V191, P1054, DOI 10.1111/j.1469-8137.2011.03767.x; Kessler A, 2004, PLANT J, V38, P639, DOI 10.1111/j.1365-313X.2004.02076.x; Kim KC, 2011, GENES GENOM, V33, P229, DOI 10.1007/s13258-010-0174-7; Kistner C, 2005, LOTUS JAPONICUS HANDBOOK, P123, DOI 10.1007/1-4020-3735-X_9; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Liu GY, 2012, PLANT J, V70, P377, DOI 10.1111/j.1365-313X.2011.04875.x; Liu GY, 2009, PLANT CELL, V21, P2672, DOI 10.1105/tpc.108.060079; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Oh Y, 2012, PLANT PHYSIOL, V159, P769, DOI 10.1104/pp.112.193771; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; SABLOWSKI RWM, 1994, EMBO J, V13, P128, DOI 10.1002/j.1460-2075.1994.tb06242.x; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Sehr EM, 2010, PLANT J, V63, P811, DOI 10.1111/j.1365-313X.2010.04283.x; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shimizu-Yumoto H, 2012, POSTHARVEST BIOL TEC, V63, P111, DOI 10.1016/j.postharvbio.2011.08.009; Shoji T, 2000, PLANT CELL PHYSIOL, V41, P831, DOI 10.1093/pcp/pcd001; Shoji T, 2008, PLANT CELL PHYSIOL, V49, P1003, DOI 10.1093/pcp/pcn077; Shyu C, 2012, PLANT CELL, V24, P536, DOI 10.1105/tpc.111.093005; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn Anke, 2008, P61, DOI 10.1007/978-1-4020-8182-8_3; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Doorn WG, 2002, ANN BOT-LONDON, V89, P689, DOI 10.1093/aob/mcf124; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; von Dahl CC, 2007, PLANT J, V51, P293, DOI 10.1111/j.1365-313X.2007.03142.x; Wager A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00041; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wild M, 2012, PLANT CELL, V24, P3307, DOI 10.1105/tpc.112.101428; Wilkinson JQ, 1997, NAT BIOTECHNOL, V15, P444, DOI 10.1038/nbt0597-444; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101; Zhu D, 2012, BIOCHEM BIOPH RES CO, V426, P273, DOI 10.1016/j.bbrc.2012.08.086; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	75	40	48	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57868	10.1371/journal.pone.0057868	http://dx.doi.org/10.1371/journal.pone.0057868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469091	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900187
J	Parzy, E; Bouchaud, V; Massot, P; Voisin, P; Koonjoo, N; Moncelet, D; Franconi, JM; Thiaudiere, E; Mellet, P				Parzy, Elodie; Bouchaud, Veronique; Massot, Philippe; Voisin, Pierre; Koonjoo, Neha; Moncelet, Damien; Franconi, Jean-Michel; Thiaudiere, Eric; Mellet, Philippe			Overhauser-Enhanced MRI of Elastase Activity from In Vitro Human Neutrophil Degranulation	PLOS ONE			English	Article							CYSTIC-FIBROSIS; THERAPEUTIC TARGETS; CATHEPSIN-G; INFLAMMATION; PROTEASES	Background: Magnetic resonance imaging can reveal exquisite anatomical details. However several diseases would benefit from an imaging technique able to specifically detect biochemical alterations. In this context protease activity imaging is one of the most promising areas of research. Methodology/Principal Findings: We designed an elastase substrate by grafting stable nitroxide free radicals on soluble elastin. This substrate generates a high Overhauser magnetic resonance imaging (OMRI) contrast upon digestion by the target proteases through the modulation of its rotational correlation time. The sensitivity is sufficient to generate contrasted images of the degranulation of neutrophils induced by a calcium ionophore from 2610 4 cells per milliliter, well under the physiological neutrophils concentrations. Conclusions/Significance: These ex-vivo experiments give evidence that OMRI is suitable for imaging elastase activity from neutrophil degranulation. Provided that a fast protease-substrate is used these results open the door to better diagnoses of a number of important pathologies (cystic fibrosis, inflammation, pancreatitis) by OMRI or Electron Paramagnetic Resonance Imaging in vivo. It also provides a long-expected method to monitor anti-protease treatments efficiency and help pharmaceutical research.	[Parzy, Elodie; Bouchaud, Veronique; Massot, Philippe; Voisin, Pierre; Koonjoo, Neha; Moncelet, Damien; Franconi, Jean-Michel; Thiaudiere, Eric; Mellet, Philippe] Univ Bordeaux Segalen, CRMSB, UMR 5536, CNRS, Bordeaux, France; [Mellet, Philippe] INSERM, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mellet, P (corresponding author), Univ Bordeaux Segalen, CRMSB, UMR 5536, CNRS, Bordeaux, France.	philippe.mellet@rmsb.u-bordeaux2.fr		Thiaudiere, Eric/0000-0002-9993-4035; Mellet, Philippe/0000-0001-5499-9735	French Agence Nationale de la Recherche [Blanc_09_434420]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the French Agence Nationale de la Recherche; grant number Blanc_09_434420. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieth J. G., 2004, HDB PROTEOLYTIC ENZY, P1517; Bilgin M, 2008, PANCREAS, V36, pE33, DOI 10.1097/mpa.0b013e318150e557; BRAUN NJ, 1987, BIOL CHEM H-S, V368, P299, DOI 10.1515/bchm3.1987.368.1.299; Elborn JS, 2012, EUR RESPIR J, V40, P969, DOI 10.1183/09031936.00194611; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Griese M, 2008, EUR RESPIR J, V32, P783, DOI 10.1183/09031936.00146807; Henriksen PA, 2008, INT J BIOCHEM CELL B, V40, P1095, DOI 10.1016/j.biocel.2008.01.004; Jastrzebska B, 2009, J MED CHEM, V52, P1576, DOI 10.1021/jm801411h; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Krishna MC, 2002, P NATL ACAD SCI USA, V99, P2216, DOI 10.1073/pnas.042671399; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Massot P, 2012, CONTRAST MEDIA MOL I, V7, P45, DOI 10.1002/cmmi.464; Mellet P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005244; Motoo Y, 2007, J PANCREAS, V8, P533; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Peterson-Carmichael SL, 2009, PEDIATR PULM, V44, P503, DOI 10.1002/ppul.21044; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Southan C, 2000, J PEPT SCI, V6, P453, DOI 10.1002/1099-1387(200009)6:9<453::AID-PSC284>3.0.CO;2-Z; Stockley RA, 1999, AM J RESP CRIT CARE, V160, pS49, DOI 10.1164/ajrccm.160.supplement_1.13; Tu C, 2012, NMR BIOMED; Utsumi H, 2006, P NATL ACAD SCI USA, V103, P1463, DOI 10.1073/pnas.0510670103	23	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57946	10.1371/journal.pone.0057946	http://dx.doi.org/10.1371/journal.pone.0057946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469112	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900207
J	Shen, MQ; Broeckling, CD; Chu, EY; Ziegler, G; Baxter, IR; Prenni, JE; Hoekenga, OA				Shen, Miaoqing; Broeckling, Corey D.; Chu, Elly Yiyi; Ziegler, Gregory; Baxter, Ivan R.; Prenni, Jessica E.; Hoekenga, Owen A.			Leveraging Non-Targeted Metabolite Profiling via Statistical Genomics	PLOS ONE			English	Article							WIDE ASSOCIATION; MASS-SPECTROMETRY; QUANTITATIVE RESISTANCE; GENETIC ARCHITECTURE; MAPPING POPULATION; COMPLEX TRAITS; LEAF-BLIGHT; MAIZE; METABOLOMICS; LOCI	One of the challenges of systems biology is to integrate multiple sources of data in order to build a cohesive view of the system of study. Here we describe the mass spectrometry based profiling of maize kernels, a model system for genomic studies and a cornerstone of the agroeconomy. Using a network analysis, we can include 97.5% of the 8,710 features detected from 210 varieties into a single framework. More conservatively, 47.1% of compounds detected can be organized into a network with 48 distinct modules. Eigenvalues were calculated for each module and then used as inputs for genome-wide association studies. Nineteen modules returned significant results, illustrating the genetic control of biochemical networks within the maize kernel. Our approach leverages the correlations between the genome and metabolome to mutually enhance their annotation and thus enable biological interpretation. This method is applicable to any organism with sufficient bioinformatic resources.	[Shen, Miaoqing] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Shen, Miaoqing; Chu, Elly Yiyi; Hoekenga, Owen A.] ARS, USDA, RW Holley Ctr Agr & Hlth, Ithaca, NY USA; [Broeckling, Corey D.; Prenni, Jessica E.] Colorado State Univ, Prote & Metabol Facil, Ft Collins, CO 80523 USA; [Ziegler, Gregory; Baxter, Ivan R.] ARS, USDA, Plant Genet Res Unit, St Louis, MO USA; [Ziegler, Gregory] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); Colorado State University; United States Department of Agriculture (USDA); Donald Danforth Plant Science Center	Hoekenga, OA (corresponding author), ARS, USDA, RW Holley Ctr Agr & Hlth, Ithaca, NY USA.	Owen.Hoekenga@ars.usda.gov	Broeckling, Corey D./ABE-2561-2020; Baxter, Ivan R/A-1052-2009	Broeckling, Corey D./0000-0002-6158-827X; Baxter, Ivan R/0000-0001-6680-1722; Hoekenga, Owen/0000-0003-4427-2000; Prenni, Jessica/0000-0002-0337-8450	US Department of Agriculture's Agricultural Research Service; National Science Foundation (IOS) [1126950]	US Department of Agriculture's Agricultural Research Service; National Science Foundation (IOS)(National Science Foundation (NSF))	Funding was provided to IRB and OAH by the US Department of Agriculture's Agricultural Research Service and by the National Science Foundation (IOS # 1126950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolleddula J, 2012, RAPID COMMUN MASS SP, V26, P1277, DOI 10.1002/rcm.6221; Broeckling CD, 2013, METABOLOMICS, V9, P33, DOI 10.1007/s11306-012-0426-4; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; DiLeo MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026683; Dixon RA, 2003, PHYTOCHEMISTRY, V62, P815, DOI 10.1016/S0031-9422(02)00712-4; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fong C, 2010, BIOINFORMATICS, V26, P560, DOI 10.1093/bioinformatics/btp714; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hansey CN, 2011, CROP SCI, V51, P704, DOI 10.2135/cropsci2010.03.0178; Hoekenga Owen A, 2008, J Biomol Tech, V19, P159; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Huhman DV, 2002, PHYTOCHEMISTRY, V59, P347, DOI 10.1016/S0031-9422(01)00432-0; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Inouye M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002907; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Last RL, 2007, NAT REV MOL CELL BIO, V8, P167, DOI 10.1038/nrm2098; Lei ZT, 2011, J BIOL CHEM, V286, P25435, DOI 10.1074/jbc.R111.238691; Lipka A. E., 2012, BIOINFORMATICS; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; Patterson SD, 2003, NAT BIOTECHNOL, V21, P221, DOI 10.1038/nbt0303-221; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; R Core Team, 2020, R LANG ENV STAT COMP; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tolstikov VV, 2002, ANAL BIOCHEM, V301, P298, DOI 10.1006/abio.2001.5513; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yanes O, 2011, ANAL CHEM, V83, P2152, DOI 10.1021/ac102981k; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang NY, 2010, PLANT PHYSIOL, V154, P1753, DOI 10.1104/pp.110.165787	48	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57667	10.1371/journal.pone.0057667	http://dx.doi.org/10.1371/journal.pone.0057667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469044	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900143
J	Vilela, B; Moreno-Cortes, A; Rabissi, A; Leung, J; Pages, M; Lumbreras, V				Vilela, Belmiro; Moreno-Cortes, Alicia; Rabissi, Agnese; Leung, Jeffrey; Pages, Montserrat; Lumbreras, Victoria			The Maize OST1 Kinase Homolog Phosphorylates and Regulates the Maize SNAC1-Type Transcription Factor	PLOS ONE			English	Article							SNRK2 PROTEIN-KINASES; ABSCISIC-ACID SIGNAL; GENE-EXPRESSION; FUNCTIONAL-ANALYSIS; STOMATAL CLOSURE; STRESS-RESPONSE; SALT TOLERANCE; ABA RESPONSES; PLANT-CELLS; DROUGHT	The Arabidopsis kinase OPEN STOMATA 1 (OST1) plays a key role in regulating drought stress signalling, particularly stomatal closure. We have identified and investigated the functions of the OST1 ortholog in Z. mays (ZmOST1). Ectopic expression of ZmOST1 in the Arabidopsis ost1 mutant restores the stomatal closure phenotype in response to drought. Furthermore, we have identified the transcription factor, ZmSNAC1, which is directly phosphorylated by ZmOST1 with implications on its localization and protein stability. Interestingly, ZmSNAC1 binds to the ABA-box of ZmOST1, which is conserved in SnRK2s activated by ABA and is part of the contact site for the negative-regulating clade A PP2C phosphatases. Taken together, our results indicate that ZmSNAC1 is a substrate of ZmOST1 and delineate a novel osmotic stress transcriptional pathway in maize.	[Vilela, Belmiro; Moreno-Cortes, Alicia; Rabissi, Agnese; Pages, Montserrat; Lumbreras, Victoria] Ctr Res Agr Genom, Bellaterra, Cerdanyola Del, Spain; [Leung, Jeffrey] Ctr Natl Rech Sci, Inst Sci Vegetal, Gif Sur Yvette, France	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lumbreras, V (corresponding author), Ctr Res Agr Genom, Bellaterra, Cerdanyola Del, Spain.	victoria.lumbreras@cragenomica.es	Torrens, Montserrat Pages/B-6329-2012; Moreno-Cortés, Alicia/K-4916-2014; Pages, Montserrat/ABA-6448-2021	Torrens, Montserrat Pages/0000-0001-8431-5605; Moreno-Cortés, Alicia/0000-0002-5470-3188; 	Fundacao para a Ciencia e Tecnologia [SFRH/BD/62070/2009]; European Union Marie-Curie Early Stage Training Fellowships [MEST-CT-2005-020232-2 ADONIS]; Consolider-Ingenio from MCYT (Spain) [2010CSD2007-00036]; MCYT (Spain) [BIO2009-13044]; Comissionat per Universitats i Recerca de la Generalitat de Catalunya [CIRIT2009SGR626]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union Marie-Curie Early Stage Training Fellowships(European Commission); Consolider-Ingenio from MCYT (Spain); MCYT (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comissionat per Universitats i Recerca de la Generalitat de Catalunya(Generalitat de Catalunya)	BV was financed by Fundacao para a Ciencia e Tecnologia PhD grant SFRH/BD/62070/2009 and European Union Marie-Curie Early Stage Training Fellowships MEST-CT-2005-020232-2 ADONIS. This work was supported by Consolider-Ingenio 2010CSD2007-00036 from MCYT (Spain) and grants BIO2009-13044 from MCYT (Spain) and CIRIT2009SGR626 from Comissionat per Universitats i Recerca de la Generalitat de Catalunya to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERBERG RJ, 1992, P NATL ACAD SCI USA, V89, P10183, DOI 10.1073/pnas.89.21.10183; Antoni R, 2011, CURR OPIN PLANT BIOL, V14, P547, DOI 10.1016/j.pbi.2011.06.004; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Blatt MR, 2000, ANNU REV CELL DEV BI, V16, P221, DOI 10.1146/annurev.cellbio.16.1.221; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Droillard MJ, 2002, FEBS LETT, V527, P43, DOI 10.1016/S0014-5793(02)03162-9; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Ellis JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021169; Franz S, 2011, MOL PLANT, V4, P83, DOI 10.1093/mp/ssq064; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huai JL, 2008, PLANT CELL REP, V27, P1861, DOI 10.1007/s00299-008-0608-8; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Joshi-Saha A, 2011, MOL PLANT, V4, P562, DOI 10.1093/mp/ssr055; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kim MJ, 2012, BIOCHEM J, V448, P353, DOI 10.1042/BJ20120244; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Kulik A, 2011, OMICS, V15, P859, DOI 10.1089/omi.2011.0091; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lu M, PLANT CELL REP; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Roelfsema MRG, 2005, NEW PHYTOL, V167, P665, DOI 10.1111/j.1469-8137.2005.01460.x; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Sirichandra C, 2009, FEBS LETT, V583, P2982, DOI 10.1016/j.febslet.2009.08.033; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tsai AYL, 2012, PLANT J, V69, P809, DOI 10.1111/j.1365-313X.2011.04832.x; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Vlad F, 2008, PLANT J, V55, P104, DOI 10.1111/j.1365-313X.2008.03488.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang RS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-216; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Xue GP, 2004, PLANT J, V37, P326, DOI 10.1046/j.1365-313X.2003.01963.x; Yang JP, 2008, PLANT SIGNAL BEHAV, V3, P131, DOI 10.4161/psb.3.2.5040; Ying S, 2011, PLANT CELL REP, V30, P1683, DOI 10.1007/s00299-011-1077-z; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang Y, 2008, ANN APPL BIOL, V153, P401, DOI 10.1111/j.1744-7348.2008.00302.x; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163	83	23	24	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58105	10.1371/journal.pone.0058105	http://dx.doi.org/10.1371/journal.pone.0058105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469147	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900238
J	Bakir-Gungor, B; Sezerman, OU				Bakir-Gungor, Burcu; Sezerman, Osman Ugur			The Identification of Pathway Markers in Intracranial Aneurysm Using Genome-Wide Association Data from Two Different Populations	PLOS ONE			English	Article							SUBARACHNOID HEMORRHAGE; RISK-FACTORS; MISSING HERITABILITY; DISEASE; SNPS; NETWORK; RUPTURE; GROWTH; LOCI; MAP	The identification of significant individual factors causing complex diseases is challenging in genome-wide association studies (GWAS) since each factor has only a modest effect on the disease development mechanism. In this study, we hypothesize that the biological pathways that are targeted by these individual factors show higher conservation within and across populations. To test this hypothesis, we searched for the disease related pathways on two intracranial aneurysm GWAS in European and Japanese case-control cohorts. Even though there were a few significantly conserved SNPs within and between populations, seven of the top ten affected pathways were found significant in both populations. The probability of random occurrence of such an event is 2.44E-36. We therefore claim that even though each individual has a unique combination of factors involved in the mechanism of disease development, most targeted pathways that need to be altered by these factors are, for the most part, the same. These pathways can serve as disease markers. Individuals, for example, can be scanned for factors affecting the genes in marker pathways. Hence, individual factors of disease development can be determined; and this knowledge can be exploited for drug development and personalized therapeutic applications. Here, we discuss the potential avenues of pathway markers in medicine and their translation to preventive and individualized health care.	[Bakir-Gungor, Burcu] Bahcesehir Univ, Dept Genet & Bioinformat, Fac Arts & Sci, Istanbul, Turkey; [Bakir-Gungor, Burcu] TUBITAK, Adv Genom & Bioinformat Res Ctr, UEKAE, Kocaeli, Turkey; [Sezerman, Osman Ugur] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Bahcesehir University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Sabanci University	Bakir-Gungor, B (corresponding author), Bahcesehir Univ, Dept Genet & Bioinformat, Fac Arts & Sci, Istanbul, Turkey.	burcu.gungor@bahcesehir.edu.tr	SEZERMAN, OSMAN U/X-6441-2018	Bakir-Gungor, Burcu/0000-0002-2272-6270; Sezerman, Osman Ugur/0000-0003-0905-6783	Intensified Cooperation (IntenC): Promotion of German-Turkish Higher Education Research Grant of TUBITAK [109S218]	Intensified Cooperation (IntenC): Promotion of German-Turkish Higher Education Research Grant of TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by the Intensified Cooperation (IntenC): Promotion of German-Turkish Higher Education Research Grant # 109S218 of TUBITAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; Bakir-Gungor B, 2012, THESIS SABANCI U IST; Bakir-Gungor B, 2012, NATURE PROTOCOL EXCH; Bakir-Gungor B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026277; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Couzin J, 2007, SCIENCE, V317, P320; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Feigin VL, 2006, STROKE, V37, P305, DOI 10.1161/01.STR.0000200558.38774.d5; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gaal EI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002563; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gieteling EW, 2003, J NEUROL, V250, P418, DOI 10.1007/s00415-003-0997-0; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldstein DB, 2007, SCIENCE, V318, P391; Goldstein DB, 2004, NAT GENET, V36, P1243, DOI 10.1038/ng1204-1243; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofer AM, 2005, J CELL SCI, V118, P855, DOI 10.1242/jcs.01705; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Holtzman DM, 2011, SCI TRANSL MED, V3; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jia PL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S15; Juvela S, 2001, STROKE, V32, P485, DOI 10.1161/01.STR.32.2.485; Juvela S, 2000, STROKE, V31, P392, DOI 10.1161/01.STR.31.2.392; Kholodenko BN, 2009, WIRES SYST BIOL MED, V1, P28, DOI 10.1002/wsbm.16; Krischek B, 2008, NEUROSCIENCE, V154, P1398, DOI 10.1016/j.neuroscience.2008.04.049; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Laaksamo E, 2008, STROKE, V39, P886, DOI 10.1161/STROKEAHA.107.497875; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lindekleiv H, 2012, STROKE J CEREBRAL CI; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Matur Z, 2010, NOROPSIKIYATRI ARS, V47, P162, DOI 10.4274/npa.47.5425; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pera J, 2010, STROKE, V41, P224, DOI 10.1161/STROKEAHA.109.562009; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Roberts N.J., 2012, SCI TRANSL MED, V4; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruigrok YM, 2008, J NEUROL NEUROSUR PS, V79, P722, DOI 10.1136/jnnp.2007.128041; Ruigrok YM, 2010, GENOME MED, V2, DOI 10.1186/gm182; Saccone SF, 2010, NUCLEIC ACIDS RES, V38, pW201, DOI 10.1093/nar/gkq513; Schadt EE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002132; Shriner D, 2007, SCIENCE, V316, P1840; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wilke R. A., 2008, Current Pharmacogenomics & Personalized Medicine, V6, P150; Williams SM, 2007, SCIENCE, V316, P1841; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zhou YL, 2011, ACTA NEUROCHIR SUPPL, V110, P15, DOI 10.1007/978-3-7091-0353-1_3	76	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57022	10.1371/journal.pone.0057022	http://dx.doi.org/10.1371/journal.pone.0057022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483893	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100011
J	Evans, N; Pasman, HR; Alonso, TV; van den Block, L; Miccinesi, G; Van Casteren, V; Donker, G; Bertolissi, S; Zurriaga, O; Deliens, L; Onwuteaka-Philipsen, B				Evans, Natalie; Pasman, H. Roeline; Vega Alonso, Tomas; van den Block, Lieve; Miccinesi, Guido; Van Casteren, Viviane; Donker, Ge; Bertolissi, Stefano; Zurriaga, Oscar; Deliens, Luc; Onwuteaka-Philipsen, Bregje		EUROIMPACT	End-of-Life Decisions: A Cross-National Study of Treatment Preference Discussions and Surrogate Decision-Maker Appointments	PLOS ONE			English	Article							TERMINALLY-ILL PATIENTS; PALLIATIVE CARE; ADVANCE DIRECTIVES; CANCER-PATIENTS; HEALTH-CARE; PROFESSIONALS; FEASIBILITY; NETHERLANDS; DISCLOSURE; PHYSICIANS	Background: Making treatment decisions in anticipation of possible future incapacity is an important part of patient participation in end-of-life decision-making. This study estimates and compares the prevalence of GP-patient end-of-life treatment discussions and patients' appointment of surrogate decision-makers in Italy, Spain, Belgium and the Netherlands and examines associated factors. Methods: A cross-sectional, retrospective survey was conducted with representative GP networks in four countries. GPs recorded the health and care characteristics in the last three months of life of 4,396 patients who died non-suddenly. Prevalences were estimated and logistic regressions were used to examine between country differences and country-specific associated patient and care factors. Results: GP-patient discussion of treatment preferences occurred for 10%, 7%, 25% and 47% of Italian, Spanish, Belgian and of Dutch patients respectively. Furthermore, 6%, 5%, 16% and 29% of Italian, Spanish, Belgian and Dutch patients had a surrogate decision-maker. Despite some country-specific differences, previous GP-patient discussion of primary diagnosis, more frequent GP contact, GP provision of palliative care, the importance of palliative care as a treatment aim and place of death were positively associated with preference discussions or surrogate appointments. A diagnosis of dementia was negatively associated with preference discussions and surrogate appointments. Conclusions: The study revealed a higher prevalence of treatment preference discussions and surrogate appointments in the two northern compared to the two southern European countries. Factors associated with preference discussions and surrogate appointments suggest that delaying diagnosis discussions impedes anticipatory planning, whereas early preference discussions, particularly for dementia patients, and the provision of palliative care encourage participation.	[Evans, Natalie; Pasman, H. Roeline; Deliens, Luc; Onwuteaka-Philipsen, Bregje] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Vega Alonso, Tomas] Minist Hlth, Publ Hlth Directorate, Direcc Gen Salud Publ, Valladolid, Spain; [Vega Alonso, Tomas] Minist Hlth, Publ Hlth Directorate, Direcc Gen Salud Publ, Castille, Spain; [Vega Alonso, Tomas] Minist Hlth, Publ Hlth Directorate, Direcc Gen Salud Publ, Leon, Spain; [van den Block, Lieve; Deliens, Luc] Vrije Universiteit Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Miccinesi, Guido] ISPO, Canc Prevent & Res Inst, Clin & Descript Epidemiol Unit, Florence, Italy; [Van Casteren, Viviane] Inst Sci Sante Publ, WIV ISP Wetenschappelijk Inst Volksgezondheid, Brussels, Belgium; [Donker, Ge] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Bertolissi, Stefano] SIMG, Italian Soc Gen Practice, Florence, France; [Zurriaga, Oscar] Valencian Reg Hlth Adm, Publ Hlth & Res Gen Directorate, Valencia, Spain; [Zurriaga, Oscar] CSISP, Higher Publ Hlth Res Ctr, Valencia, Spain; [Zurriaga, Oscar] Spanish Consortium Res Epidemiol & Publ Hlth, Madrid, Spain	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Institute for Health Services Research	Evans, N (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	n.evans@vumc.nl	Van den Block, Lieve/D-1247-2011; Caraceni, Augusto/C-1012-2017; Evans, Natalie/M-1631-2013; Zurriaga, Oscar/J-3046-2019; Donker, Gé/AAX-8564-2021; miccinesi, guido/AAB-5476-2022; Zurriaga, Oscar/F-9877-2010	Van den Block, Lieve/0000-0002-7770-348X; Caraceni, Augusto/0000-0002-0375-6204; Evans, Natalie/0000-0001-7124-9282; Zurriaga, Oscar/0000-0001-7279-432X; miccinesi, guido/0000-0002-7452-9594; Zurriaga, Oscar/0000-0001-7279-432X; Harding, Richard/0000-0001-9653-8689; Deliens, Luc/0000-0002-8158-2422; Donker, Ge/0000-0001-6314-9249; Brearley, Sarah Grace/0000-0003-4764-3276	Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project (SBO) [SBO IWT 050158]; Vrije Universiteit Brussel, Ghent University; Antwerp University; Scientific Institute for Public Health, Belgium; VU University Medical Centre Amsterdam, the Netherlands; Italian Ministry of Health; European Union [264697]	Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project (SBO); Vrije Universiteit Brussel, Ghent University; Antwerp University; Scientific Institute for Public Health, Belgium; VU University Medical Centre Amsterdam, the Netherlands(Netherlands Government); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission)	Funding for the study came from the Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project (SBO) (contract SBO IWT 050158) (2006-2010), as part of the 'Monitoring Quality of End-of-Life Care (MELC) Study', a collaboration between the Vrije Universiteit Brussel, Ghent University, Antwerp University, the Scientific Institute for Public Health, Belgium, and VU University Medical Centre Amsterdam, the Netherlands. Funding also came from the Italian Ministry of Health through the 'Evaluation, testing and implementation of supportive care, care interventions, integrated programs and improving the quality of care for cancer patients' program 'Integrated Oncology Project n degrees 6, years 2008-2011' led by Massimo Costantini (IRCCS AOU San Martino-IST, Genoa), from the annual budgets of the Autonomous Community of Castilla y Leon and Comunitat Valenciana and from EUROIMPACT: European Intersectorial and Multidisciplinary Palliative Care Research Training, funded by the European Union Seventh Framework Programme (FP7/2007-2013, under grant agreement nu [264697]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi E, 2011, J PALLIAT MED, V14, P323, DOI 10.1089/jpm.2010.0312; Albert SM, 1999, J NEUROL SCI, V169, P108, DOI 10.1016/S0022-510X(99)00227-0; Andorno R, 2009, EUR J HEALTH LAW, V16, P207, DOI 10.1163/157180909X453053; Boerma W., 2003, PROFILES GEN PRACTIC; Borreani C, 2012, J PAIN SYMPTOM MANAG, V43, P739, DOI 10.1016/j.jpainsymman.2011.05.011; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Bravo G, 2003, ALZ DIS ASSOC DIS, V17, P215, DOI 10.1097/00002093-200310000-00004; Cartwright C, 2007, PALLIATIVE MED, V21, P295, DOI 10.1177/0269216307079063; Claessen SJJ, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625184; Conroy S, 2009, CLIN MED, V9, P76, DOI 10.7861/clinmedicine.9-1-76; Costantini A, 2009, J CANCER EDUC, V24, P180, DOI 10.1080/08858190902876262; Costantini M, 2006, ANN ONCOL, V17, P853, DOI 10.1093/annonc/mdl028; Desmedt M, 2002, SUPPORT CARE CANCER, V10, P343, DOI 10.1007/s00520-002-0345-4; Eizenga WH, 2006, HUISARTS WETENSCHAP, V49, P308; ESTAPE J, 1992, ANN ONCOL, V3, P451, DOI 10.1093/oxfordjournals.annonc.a058233; Formiga F, 2004, QJM-INT J MED, V97, P803, DOI 10.1093/qjmed/hch135; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; Havens GAD, 2000, RES NURS HEALTH, V23, P319, DOI 10.1002/1098-240X(200008)23:4<319::AID-NUR8>3.0.CO;2-6; Hoving C, 2010, PATIENT EDUC COUNS, V78, P275, DOI 10.1016/j.pec.2010.01.015; IIS, 2009, AT CUID PAL ORG COM; Janssens RJPA, 2001, PALLIATIVE MED, V15, P481, DOI 10.1191/026921601682553969; Lofmark R, 2006, J PALLIATIVE CARE, V22, P105, DOI 10.1177/082585970602200207; Martin-Matthews A, 2011, CAN J AGING, V30, P339, DOI 10.1017/S0714980811000201; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Menaca A, 2012, CRIT REV ONCOL HEMAT, V82, P387, DOI 10.1016/j.critrevonc.2011.06.002; Miccinesi G, 2005, SOC SCI MED, V60, P1961, DOI 10.1016/j.socscimed.2004.08.061; Morrison RS, 2004, ARCH INTERN MED, V164, P2421, DOI 10.1001/archinte.164.22.2421; Ott B B, 1999, Am J Crit Care, V8, P514; Parker SM, 2007, J PAIN SYMPTOM MANAG, V34, P81, DOI 10.1016/j.jpainsymman.2006.09.035; Pelayo M, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-37; Pool R, 2000, NEGOTIATING GOOD DEA; Proot IM, 2004, PALLIATIVE MED, V18, P53, DOI 10.1191/0268216304pm818oa; Robinson C, 2012, CAN FAM PHYSICIAN, V58, pE229; Sbanotto A, 1998, SUPPORT CARE CANCER, V6, P426, DOI 10.1007/s005200050189; Simon-Lorda P, 2008, BIOETHICS, V22, P346, DOI 10.1111/j.1467-8519.2008.00644.x; Sizoo EM, 2012, EUR J CANCER, V48, P226, DOI 10.1016/j.ejca.2011.11.010; Toscani F, 2006, AM J BIOETHICS, V6, pW6, DOI 10.1080/15265160500394994; van Alphen JE, 2010, BRIT J GEN PRACT, V60, P263, DOI 10.3399/bjgp10X483931; Van den Block L, 2012, NATIONWIDE MONITORIN; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Van den Block L, 2007, JAMA-J AM MED ASSOC, V298, P1638, DOI 10.1001/jama.298.14.1638; Van den Block Lieve, 2007, BMC Palliat Care, V6, P6; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; Vega Alonso A, 2006, GAC SANIT S3, V20, P52; Voltz R, 1998, J PAIN SYMPTOM MANAG, V16, P153, DOI 10.1016/S0885-3924(98)00067-0	45	48	48	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57965	10.1371/journal.pone.0057965	http://dx.doi.org/10.1371/journal.pone.0057965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472122	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000315637900065
J	Kong, XF; Bousfiha, A; Rouissi, A; Itan, Y; Abhyankar, A; Bryant, V; Okada, S; Ailal, F; Bustamante, J; Casanova, JL; Hirst, J; Boisson-Dupuis, S				Kong, Xiao-Fei; Bousfiha, Aziz; Rouissi, Abdelfettah; Itan, Yuval; Abhyankar, Avinash; Bryant, Vanessa; Okada, Satoshi; Ailal, Fatima; Bustamante, Jacinta; Casanova, Jean-Laurent; Hirst, Jennifer; Boisson-Dupuis, Stephanie			A Novel Homozygous p. R1105X Mutation of the AP4E1 Gene in Twins with Hereditary Spastic Paraplegia and Mycobacterial Disease	PLOS ONE			English	Article							SEQUENCING-BASED DISCOVERY; HERMANSKY-PUDLAK-SYNDROME; PROTEIN COMPLEX-4 AP-4; INTELLECTUAL DISABILITY; DEFICIENCY CAUSES; INFECTION; IMMUNITY; IMMUNODEFICIENCY; SUSCEPTIBILITY; LINE	We report identical twins with intellectual disability, progressive spastic paraplegia and short stature, born to a consanguineous family. Intriguingly, both children presented with lymphadenitis caused by the live Bacillus Calmette-Guerin (BCG) vaccine. Two syndromes - hereditary spastic paraplegia (HSP) and mycobacterial disease - thus occurred simultaneously. Whole-exome sequencing (WES) revealed a homozygous nonsense mutation (p.R1105X) of the AP4E1 gene, which was confirmed by Sanger sequencing. The p.R1105X mutation has no effect on AP4E1 mRNA levels, but results in lower levels of AP-4 epsilon protein and of the other components of the AP-4 complex, as shown by western blotting, immunoprecipitation and immunofluorescence. Thus, the C-terminal part of the AP-4e subunit plays an important role in maintaining the integrity of the AP-4 complex. No abnormalities of the IL-12/IFN-gamma axis or oxidative burst pathways were identified. In conclusion, we identified twins with autosomal recessive AP-4 deficiency associated with HSP and mycobacterial disease, suggesting that AP-4 may play important role in the neurological and immunological systems.	[Kong, Xiao-Fei; Itan, Yuval; Abhyankar, Avinash; Bryant, Vanessa; Okada, Satoshi; Casanova, Jean-Laurent; Boisson-Dupuis, Stephanie] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Bousfiha, Aziz; Ailal, Fatima] King Hassan II Univ, Ibn Rochd Hosp, Dept Pediat, Clin Immunol Unit, Casablanca, Morocco; [Rouissi, Abdelfettah] Pediat Sect Liberal, Casablanca, Morocco; [Bustamante, Jacinta; Casanova, Jean-Laurent; Boisson-Dupuis, Stephanie] INSERM, U980, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Bustamante, Jacinta] Univ Paris 05, Necker Med Sch, Paris, France; [Bustamante, Jacinta] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Immunol Hematol Unit, Paris, France; [Hirst, Jennifer] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1TN, England	Rockefeller University; Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Cambridge	Boisson-Dupuis, S (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA.	stbo603@mail.rockefeller.edu	Bryant, Vanessa/S-5333-2019; Casanova, Jean-Laurent/I-3418-2017; Boisson-Dupuis, Stéphanie/I-2040-2017; Bustamante, Jacinta/H-7877-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Okada, Satoshi/B-8901-2011	Bryant, Vanessa/0000-0002-4697-7410; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Bustamante, Jacinta/0000-0002-3439-2482; Okada, Satoshi/0000-0002-4622-5657; Casanova, Jean-Laurent/0000-0002-7782-4169; Kong, Xiao-Fei/0000-0001-9983-2373	Stony Wold-Herbert Fund; Choh-Hao Li Memorial Fund Scholar award; Shanghai Educational Development Foundation; AXA Research Fund; St. Giles Foundation; Jeffrey Modell Foundation; Rockefeller University Center for Clinical and Translational Science from the National Center for Research Resources [8UL1TR000043]; National Center for Advancing Sciences (NCATS), National Institutes of Health, the National Institute of Allergy and Infectious Diseases [5R01AI089970-02, 5R37AI095983-02]; Rockefeller University, and the European Research Council (ERC); JLC from the Jeffrey Modell Foundation in collaboration with Talecris BioTherapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI095983, R01AI089970] Funding Source: NIH RePORTER	Stony Wold-Herbert Fund; Choh-Hao Li Memorial Fund Scholar award; Shanghai Educational Development Foundation; AXA Research Fund(AXA Research Fund); St. Giles Foundation; Jeffrey Modell Foundation; Rockefeller University Center for Clinical and Translational Science from the National Center for Research Resources; National Center for Advancing Sciences (NCATS), National Institutes of Health, the National Institute of Allergy and Infectious Diseases; Rockefeller University, and the European Research Council (ERC); JLC from the Jeffrey Modell Foundation in collaboration with Talecris BioTherapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	XFK was supported by a Stony Wold-Herbert Fund, Choh-Hao Li Memorial Fund Scholar award and the Shanghai Educational Development Foundation, YI is supported by the AXA Research Fund, and VB is supported by the Stony Wold-Herbert Fund. The Laboratory of Human Genetics of Infectious Diseases is supported in part by grants from the St. Giles Foundation, the Jeffrey Modell Foundation, The Rockefeller University Center for Clinical and Translational Science grant number 8UL1TR000043 from the National Center for Research Resources and the National Center for Advancing Sciences (NCATS), National Institutes of Health, the National Institute of Allergy and Infectious Diseases (grant numbers 5R01AI089970-02 and 5R37AI095983-02), The Rockefeller University, and the European Research Council (ERC). JLC has a research grant from the Jeffrey Modell Foundation in collaboration with Talecris BioTherapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Badolato R, 2007, J ALLERGY CLIN IMMUN, V120, P735, DOI 10.1016/j.jaci.2007.08.039; Bauer P, 2012, NEUROGENETICS, V13, P73, DOI 10.1007/s10048-012-0314-0; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Bogunovic D, 2012, SCIENCE; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Bryant VL, 2012, HAPLOINSUFFICI UNPUB; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Cann HM, 1992, CURR OPIN GENET DEV, V2, P393, DOI 10.1016/S0959-437X(05)80148-0; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Dehkordy SF, 2012, J CLIN IMMUNOL, V32, P1, DOI 10.1007/s10875-011-9593-8; Dell'Angelica EC, 1999, J BIOL CHEM, V274, P7278, DOI 10.1074/jbc.274.11.7278; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hirst J, 2012, TRAFFIC; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jung J, 2006, BLOOD, V108, P362, DOI 10.1182/blood-2005-11-4377; Kong XF, 2012, HUM MOL GENET; Kong XF, 2010, BLOOD, V116, P5895, DOI 10.1182/blood-2010-04-280586; Kong XF, 2010, HUM MOL GENET, V19, P434, DOI 10.1093/hmg/ddp507; Lee PPW, 2008, PEDIATR INFECT DIS J, V27, P224, DOI 10.1097/INF.0b013e31815b494c; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Mussaffi H, 2005, EUR RESPIR J, V25, P324, DOI 10.1183/09031936.05.00058604; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; NUNN PP, 1988, BRIT MED BULL, V44, P801, DOI 10.1093/oxfordjournals.bmb.a072284; Ozer HL, 1996, EXP GERONTOL, V31, P303, DOI 10.1016/0531-5565(95)00024-0; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Patel SY, 2008, J CLIN PATHOL, V61, P1006, DOI 10.1136/jcp.2007.051201; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Schule R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787; Shotelersuk V, 2000, AM J MED, V108, P423, DOI 10.1016/S0002-9343(99)00436-2; TUMILOWICZ JJ, 1984, IN VITRO CELL DEV B, V20, P486; Verkerk AJMH, 2009, AM J HUM GENET, V85, P40, DOI 10.1016/j.ajhg.2009.06.004; Yap CC, 2003, MOL CELL NEUROSCI, V24, P283, DOI 10.1016/S1044-7431(03)00164-7	48	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58286	10.1371/journal.pone.0058286	http://dx.doi.org/10.1371/journal.pone.0058286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472171	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900117
J	Mayer-Jochimsen, M; Fast, S; Tintle, NL				Mayer-Jochimsen, Morgan; Fast, Shannon; Tintle, Nathan L.			Assessing the Impact of Differential Genotyping Errors on Rare Variant Tests of Association	PLOS ONE			English	Article							GENETIC ASSOCIATION; SEQUENCING DATA; SAMPLE-SIZE; POWER	Genotyping errors are well-known to impact the power and type I error rate in single marker tests of association. Genotyping errors that happen according to the same process in cases and controls are known as non-differential genotyping errors, whereas genotyping errors that occur with different processes in the cases and controls are known as differential genotype errors. For single marker tests, non-differential genotyping errors reduce power, while differential genotyping errors increase the type I error rate. However, little is known about the behavior of the new generation of rare variant tests of association in the presence of genotyping errors. In this manuscript we use a comprehensive simulation study to explore the effects of numerous factors on the type I error rate of rare variant tests of association in the presence of differential genotyping error. We find that increased sample size, decreased minor allele frequency, and an increased number of single nucleotide variants (SNVs) included in the test all increase the type I error rate in the presence of differential genotyping errors. We also find that the greater the relative difference in case-control genotyping error rates the larger the type I error rate. Lastly, as is the case for single marker tests, genotyping errors classifying the common homozygote as the heterozygote inflate the type I error rate significantly more than errors classifying the heterozygote as the common homozygote. In general, our findings are in line with results from single marker tests. To ensure that type I error inflation does not occur when analyzing next-generation sequencing data careful consideration of study design (e. g. use of randomization), caution in meta-analysis and using publicly available controls, and the use of standard quality control metrics is critical.	[Mayer-Jochimsen, Morgan] Scripps Coll, Dept Math, Claremont, CA 91711 USA; [Fast, Shannon] MIT, Dept Operat Res, Boston, MA USA; [Tintle, Nathan L.] Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA 51250 USA	Claremont Colleges; Scripps College; Massachusetts Institute of Technology (MIT)	Tintle, NL (corresponding author), Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA 51250 USA.	nathan.tintle@dordt.edu		Tintle, Nathan/0000-0003-1447-9107	National Human Genome Research Institute [R15HG004543, R15HG006915]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG006915, R15HG004543] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Human Genome Research Institute (R15HG004543; R15HG006915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2009, STAT APPL GENET MOL, V2, P8; Ahn K, 2007, ANN HUM GENET, V71, P249, DOI 10.1111/j.1469-1809.2006.00318.x; Borchers B, 2009, STAT APPL GENET MOL, P8; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2005, J CLIN INVEST, V115, DOI [10.1172/JCI24756.1408, DOI 10.1172/JCI24756.1408]; Gordon D., 2004, STAT APPL GENET MOL, V3, P26, DOI [10.2202/1544-6115.1085, DOI 10.2202/1544-6115.1085]; Gordon D, 2011, HUM HERED, V71, P113, DOI 10.1159/000325590; Huang L, 2009, AM J HUM GENET, V85, P692, DOI 10.1016/j.ajhg.2009.09.017; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; Kang SJ, 2004, HUM HERED, V58, P139, DOI 10.1159/000083540; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li QZ, 2010, HUM HERED, V69, P219, DOI 10.1159/000291927; Li Y, 2010, AM J HUM GENET, V87, P728, DOI 10.1016/j.ajhg.2010.10.014; Luedtke Alexander, 2011, BMC Proc, V5 Suppl 9, pS119, DOI 10.1186/1753-6561-5-S9-S119; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pan W, 2011, GENET EPIDEMIOL, V35, P381, DOI 10.1002/gepi.20586; Petersen Ashley, 2011, BMC Proc, V5 Suppl 9, pS48, DOI 10.1186/1753-6561-5-S9-S48; Powers S, 2011, HUM HERED, V72, P153, DOI 10.1159/000332222; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Sun YV, 2011, GENET EPIDEMIOL, V35, pS101, DOI 10.1002/gepi.20658; Tintle N, 2011, GENET EPIDEMIOL, V35, pS56, DOI 10.1002/gepi.20650; Tintle NL, 2007, STAT APPL GENET MOL, V6; Wilson AF, 2011, GENET EPIDEMIOL, V35, pS107, DOI 10.1002/gepi.20659; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e56626	10.1371/journal.pone.0056626	http://dx.doi.org/10.1371/journal.pone.0056626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472072	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900010
J	Mutha, PK; Haaland, KY; Sainburg, RL				Mutha, Pratik K.; Haaland, Kathleen Y.; Sainburg, Robert L.			Rethinking Motor Lateralization: Specialized but Complementary Mechanisms for Motor Control of Each Arm	PLOS ONE			English	Article							UNILATERAL BRAIN-DAMAGE; HEMISPHERIC ASYMMETRIES; EVOLUTION; HAND; HYPOTHESIS; HANDEDNESS; COMPONENTS; ADVANTAGES; MOVEMENTS; DOMINANT	Motor lateralization in humans has primarily been characterized as "handedness", resulting in the view that one armhemisphere system is specialized for all aspects of movement while the other is simply a weaker analogue. We have proposed an alternative view that motor lateralization reflects proficiency of each arm for complementary functions that arises from a specialization of each hemisphere for distinct movement control mechanisms. However, before this idea of hemispheric specialization can be accepted, it is necessary to precisely identify these distinct, lateralized mechanisms. Here we show in right-handers that dominant arm movements rely on predictive mechanisms that anticipate and account for the dynamic properties of the arm, while the non-dominant arm optimizes positional stability by specifying impedance around equilibrium positions. In a targeted-reaching paradigm, we covertly and occasionally shifted the hand starting location either orthogonal to or collinear with a particular direction of movement. On trials on which the start positions were shifted orthogonally, we did not notice any strong interlimb differences. However, on trials on which start positions were shifted orthogonally, the dominant arm largely maintained the direction and straightness of its trajectory, while the non-dominant arm deviated towards the previously learned goal position, consistent with the hypothesized control specialization of each arm-hemisphere system. These results bring together two competing theories about mechanisms of movement control, and suggest that they coexist in the brain in different hemispheres. These findings also question the traditional view of handedness, because specialized mechanisms for each arm-hemisphere system were identified within a group of right-handers. It is likely that such hemispheric specialization emerged to accommodate increasing motor complexity during evolution.	[Mutha, Pratik K.; Haaland, Kathleen Y.] NM VA Healthcare Syst, Albuquerque, NM USA; [Mutha, Pratik K.; Haaland, Kathleen Y.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Haaland, Kathleen Y.] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Sainburg, Robert L.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Sainburg, Robert L.] Penn State Univ, Dept Neurol, University Pk, PA 16802 USA	University of New Mexico; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mutha, PK (corresponding author), NM VA Healthcare Syst, Albuquerque, NM USA.	pkm@unm.edu; rls45@psu.edu		Sainburg, Robert/0000-0003-2627-1258	United States National Institutes of Health [R01HD39311, R01HD059783]; VA RD Merit Review [101BX007080, B4125R]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059783] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039311] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA RD Merit Review; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by United States National Institutes of Health grants R01HD39311 and R01HD059783 to R. L. Sainburg, and VA R&D Merit Review (101BX007080) and RR&D (B4125R) grants to K. Y. Haaland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagesteiro LB, 2003, J NEUROPHYSIOL, V90, P1503, DOI 10.1152/jn.00189.2003; Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; CARSON RG, 1990, NEUROPSYCHOLOGIA, V28, P1215, DOI 10.1016/0028-3932(90)90056-T; CARSON RG, 1993, J MOTOR BEHAV, V25, P21, DOI 10.1080/00222895.1993.9941636; CARSON RG, 1995, BRAIN COGNITION, V28, P133, DOI 10.1006/brcg.1995.1161; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; DEAN RS, 1987, NEUROPSYCHOLOGIA, V25, P585, DOI 10.1016/0028-3932(87)90083-2; DELIS DC, 1986, NEUROPSYCHOLOGIA, V24, P205, DOI 10.1016/0028-3932(86)90053-9; Duff SV, 2007, EXP BRAIN RES, V179, P551, DOI 10.1007/s00221-006-0811-1; ELLIOTT D, 1993, CAN J EXP PSYCHOL, V47, P570, DOI 10.1037/h0078856; Elliott D, 1995, CORTEX, V31, P685, DOI 10.1016/S0010-9452(13)80020-2; Federmeier KD, 2008, LANG LINGUIST COMPAS, V2, P1, DOI 10.1111/j.1749-818x.2007.00042.x; Feldman A G, 1998, Motor Control, V2, P189; Feldman AG, 2009, ADV EXP MED BIOL, V629, P699, DOI 10.1007/978-0-387-77064-2_38; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; Gazzaniga MS, 1998, SCI AM, V279, P50, DOI 10.1038/scientificamerican0798-50; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Gentilucci M, 2006, J COGNITIVE NEUROSCI, V18, P1059, DOI 10.1162/jocn.2006.18.7.1059; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Gottlieb G L, 1998, Motor Control, V2, P10; Grimshaw GM, 1998, BRAIN COGNITION, V36, P108, DOI 10.1006/brcg.1997.0949; Haaland KY, 2004, BRAIN, V127, P1145, DOI 10.1093/brain/awh133; HAALAND KY, 1994, BRAIN COGNITION, V24, P104, DOI 10.1006/brcg.1994.1006; HAALAND KY, 1989, NEUROPSYCHOLOGIA, V27, P961, DOI 10.1016/0028-3932(89)90071-7; Harrington DL, 1997, BRAIN DAM B, P111; Herculano-Houzel S, 2010, P NATL ACAD SCI USA, V107, P19008, DOI 10.1073/pnas.1012590107; Hermsdorfer J, 1999, EXP BRAIN RES, V128, P41, DOI 10.1007/s002210050815; Hermsdorfer J, 1996, BRAIN, V119, P1575, DOI 10.1093/brain/119.5.1575; Hinder MR, 2003, J PHYSIOL-LONDON, V549, P953, DOI 10.1113/jphysiol.2002.033845; KUYPERS H. G. J. M., 1964, PROGR BRAIN RES, V11, P178; KUYPERS HGJ, 1970, BRAIN RES, V24, P29, DOI 10.1016/0006-8993(70)90272-6; Latash ML, 2010, MED LITH, V46, P382, DOI 10.3390/medicina46060054; Latash ML, 2010, MOTOR CONTROL, V14, P294; Marzke MW, 2009, J BONE JOINT SURG AM, V91A, P26, DOI 10.2106/JBJS.I.00102; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; Medland SE, 2004, LATERALITY, V9, P287, DOI 10.1080/13576500342000040a; Mutha PK, 2011, BRAIN, V134, P3644, DOI 10.1093/brain/awr275; Mutha PK, 2011, J NEUROSCI, V31, P6972, DOI 10.1523/JNEUROSCI.6432-10.2011; Nirkko AC, 2001, NEUROIMAGE, V13, P825, DOI 10.1006/nimg.2000.0739; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ostry DJ, 2003, EXP BRAIN RES, V153, P275, DOI 10.1007/s00221-003-1624-0; REEVES WH, 1985, INT J NEUROSCI, V28, P291, DOI 10.3109/00207458508985397; Rilling JK, 1999, NEUROREPORT, V10, P1453, DOI 10.1097/00001756-199905140-00012; ROY EA, 1983, HUM MOVEMENT SCI, V2, P271, DOI 10.1016/0167-9457(83)90022-2; ROY EA, 1994, BRAIN COGNITION, V24, P289, DOI 10.1006/brcg.1994.1017; Sainburg R. L., 2010, VISION GOAL DIRECTED, P219; Sainburg RL, 2004, J NEUROPHYSIOL, V92, P1374, DOI 10.1152/jn.00181.2004; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Schaefer SY, 2008, J MOTOR BEHAV, V40, P325, DOI 10.3200/JMBR.40.4.325-336; Schaefer SY, 2009, BRAIN RES, V1298, P78, DOI 10.1016/j.brainres.2009.08.063; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290; Wang JS, 2007, EXP BRAIN RES, V178, P565, DOI 10.1007/s00221-007-0936-x; Weissman DH, 2005, CEREB CORTEX, V15, P870, DOI 10.1093/cercor/bhh187; WINSTEIN CJ, 1995, EXP BRAIN RES, V105, P163; Yadav V, 2011, NEUROSCIENCE, V196, P153, DOI 10.1016/j.neuroscience.2011.08.039; Yeo R. A., 2002, HDB NEUROPSYCHOLOGY, P331	59	74	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58582	10.1371/journal.pone.0058582	http://dx.doi.org/10.1371/journal.pone.0058582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472210	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900156
J	Schoene, D; Lord, SR; Delbaere, K; Severino, C; Davies, TA; Smith, ST				Schoene, Daniel; Lord, Stephen R.; Delbaere, Kim; Severino, Connie; Davies, Thomas A.; Smith, Stuart T.			A Randomized Controlled Pilot Study of Home-Based Step Training in Older People Using Videogame Technology	PLOS ONE			English	Article							FALLS PREVENTION INTERVENTIONS; POSTURAL SWAY; REACTION-TIME; FUNCTIONAL MOBILITY; BALANCE CONFIDENCE; PREDICTING FALLS; TAI CHI; WII FIT; EXERCISE; ADULTS	Background: Stepping impairments are associated with physical and cognitive decline in older adults and increased fall risk. Exercise interventions can reduce fall risk, but adherence is often low. A new exergame involving step training may provide an enjoyable exercise alternative for preventing falls in older people. Purpose: To assess the feasibility and safety of unsupervised, home-based step pad training and determine the effectiveness of this intervention on stepping performance and associated fall risk in older people. Design: Single-blinded two-arm randomized controlled trial comparing step pad training with control (no-intervention). Setting/Participants: Thirty-seven older adults residing in independent-living units of a retirement village in Sydney, Australia. Intervention: Intervention group (IG) participants were provided with a computerized step pad system connected to their TVs and played a step game as often as they liked (with a recommended dose of 2-3 sessions per week for 15-20 minutes each) for eight weeks. In addition, IG participants were asked to complete a choice stepping reaction time (CSRT) task once each week. Main Outcome Measures: CSRT, the Physiological Profile Assessment (PPA), neuropsychological and functional mobility measures were assessed at baseline and eight week follow-up. Results: Thirty-two participants completed the study (86.5%). IG participants played a median 2.75 sessions/week and no adverse events were reported. Compared to the control group, the IG significantly improved their CSRT (F-31,F-1 = 18.203, p < .001), PPA composite scores (F-31,F-1 = 12.706, p = 0.001), as well as the postural sway (F-31,F-1 = 4.226, p = 0.049) and contrast sensitivity (F-31,F-1 = 4.415, p = 0.044) PPA sub-component scores. In addition, the IG improved significantly in their dual-task ability as assessed by a timed up and go test/verbal fluency task (F-31,F-1 = 4.226, p = 0.049). Conclusions: Step pad training can be safely undertaken at home to improve physical and cognitive parameters of fall risk in older people without major cognitive and physical impairments.	[Schoene, Daniel; Lord, Stephen R.; Delbaere, Kim; Severino, Connie; Davies, Thomas A.; Smith, Stuart T.] Neurosci Res Australia, Falls & Balance Res Grp, Sydney, NSW, Australia; [Schoene, Daniel; Lord, Stephen R.; Delbaere, Kim] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Smith, ST (corresponding author), Neurosci Res Australia, Falls & Balance Res Grp, Sydney, NSW, Australia.	s.smith@neura.edu.au	Smith, Stuart T/B-8144-2011; Lord, Stephen R/C-9612-2011; Delbaere, Kim/D-6370-2011; Schoene, Daniel/H-8861-2019	Smith, Stuart T/0000-0002-4735-6026; Delbaere, Kim/0000-0002-5655-0234; Schoene, Daniel/0000-0003-0717-5746; Lord, Stephen R/0000-0002-7111-8802	National Health and Medical Research Council (NHMRC) [568724]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was financially supported by a National Health and Medical Research Council (NHMRC) project grant (grant number 568724) (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angevaren M, 2008, COCHRANE DATABASE SY; Annesi JJ, 1997, PERCEPT MOTOR SKILL, V85, P835, DOI 10.2466/pms.1997.85.3.835; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; Ashworth NL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004017.pub2; Baranowski T, 2008, AM J PREV MED, V34, P74, DOI 10.1016/j.amepre.2007.09.027; Brumels KA, 2008, CLIN KINES, V62, P26; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Cyarto EV, 2008, GERONTOLOGY, V54, P272, DOI 10.1159/000155653; de Bruin ED, 2010, Z GERONTOL GERIATR, V43, P229, DOI 10.1007/s00391-010-0124-7; DEBRUIN ED, 2011, J NOV PHYSIOTHER, V1, P104, DOI DOI 10.4172/2165-7025.1000104; Delbaere K, 2011, J GERONTOL A-BIOL, V66, P674, DOI 10.1093/gerona/glr019; FERNIE GR, 1982, AGE AGEING, V11, P11, DOI 10.1093/ageing/11.1.11; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Graves LEF, 2010, J PHYS ACT HEALTH, V7, P393, DOI 10.1123/jpah.7.3.393; Guderian B, 2010, J SPORT MED PHYS FIT, V50, P436; Hale LA, 2012, ARCH PHYS MED REHAB, V93, P27, DOI 10.1016/j.apmr.2011.08.004; Hsu CL, 2012, OSTEOPOROS INT; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Liu-Ambrose T, 2009, BRIT J SPORT MED, V43, P25, DOI 10.1136/bjsm.2008.055616; Liu-Ambrose T, 2008, J AM GERIATR SOC, V56, P1821, DOI [10.1111/j.1532-5415.2008.01931.x, 10.1111/j.1532-5415.2008.01984.x]; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Maddison R, 2007, PEDIATR EXERC SCI, V19, P334, DOI 10.1123/pes.19.3.334; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Mansfield A, 2010, PHYS THER, V90, P476, DOI 10.2522/ptj.20090070; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Melzer I, 2010, AGING CLIN EXP RES, V22, P360, DOI 10.1007/BF03324940; Nyman SR, 2012, AGE AGEING, V41, P16, DOI 10.1093/ageing/afr103; Nyman SR, 2011, AGE AGEING, V40, P430, DOI 10.1093/ageing/afr016; Pfeifer M, 2001, EXP CLIN ENDOCR DIAB, V109, P87, DOI 10.1055/s-2001-14831; Pijnappels M, 2010, AGE AGEING, V39, P99, DOI 10.1093/ageing/afp200; Plante TG, 2003, COMPUT HUM BEHAV, V19, P495, DOI 10.1016/S0747-5632(02)00074-2; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raudenbush B, 2009, PERCEPT MOTOR SKILL, V108, P439, DOI 10.2466/PMS.108.2.439-448; Rhodes RE, 2009, PSYCHOL HEALTH MED, V14, P631, DOI 10.1080/13548500903281088; Rogers MW, 2003, J GERONTOL A-BIOL, V58, P46; Schoene D, 2012, J AGING PHYS ACTIV, V20, pS186; Schoene D, 2011, ARCH PHYS MED REHAB, V92, P947, DOI 10.1016/j.apmr.2011.01.012; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Shigematsu R, 2008, J GERONTOL A-BIOL, V63, P76, DOI 10.1093/gerona/63.1.76; Taylor D, 2012, J AM GERIATR SOC, V60, P841, DOI 10.1111/j.1532-5415.2012.03928.x; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; Tseng SC, 2009, J GERONTOL A-BIOL, V64, P807, DOI 10.1093/gerona/glp027; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x	49	145	147	7	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57734	10.1371/journal.pone.0057734	http://dx.doi.org/10.1371/journal.pone.0057734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472104	Green Published, gold			2022-12-27	WOS:000315637900043
J	Stark, GV; Long, JP; Ortiz, DI; Gainey, M; Carper, BA; Feng, JY; Miller, SM; Bigger, JE; Vela, EM				Stark, Gregory V.; Long, James P.; Ortiz, Diana I.; Gainey, Melicia; Carper, Benjamin A.; Feng, Jingyu; Miller, Stephen M.; Bigger, John E.; Vela, Eric M.			Clinical Profiles Associated with Influenza Disease in the Ferret Model	PLOS ONE			English	Article							H5N1 VIRUSES; A H5N1; HUMANS	Influenza A viruses continue to pose a threat to human health; thus, various vaccines and prophylaxis continue to be developed. Testing of these products requires various animal models including mice, guinea pigs, and ferrets. However, because ferrets are naturally susceptible to infection with human influenza viruses and because the disease state resembles that of human influenza, these animals have been widely used as a model to study influenza virus pathogenesis. In this report, a statistical analysis was performed to evaluate data involving 269 ferrets infected with seasonal influenza, swine influenza, and highly pathogenic avian influenza (HPAI) from 16 different studies over a five year period. The aim of the analyses was to better qualify the ferret model by identifying relationships among important animal model parameters (endpoints) and variables of interest, which include survival, time-to-death, changes in body temperature and weight, and nasal wash samples containing virus, in addition to significant changes from baseline in selected hematology and clinical chemistry parameters. The results demonstrate that a disease clinical profile, consisting of various changes in the biological parameters tested, is associated with various influenza A infections in ferrets. Additionally, the analysis yielded correlates of protection associated with HPAI disease in ferrets. In all, the results from this study further validate the use of the ferret as a model to study influenza A pathology and to evaluate product efficacy.	[Stark, Gregory V.; Long, James P.; Ortiz, Diana I.; Gainey, Melicia; Carper, Benjamin A.; Feng, Jingyu; Miller, Stephen M.; Bigger, John E.; Vela, Eric M.] Biomed Res Ctr, Columbus, OH USA		Vela, EM (corresponding author), Biomed Res Ctr, Columbus, OH USA.	velae@battelle.org	Carper, Benjamin/L-3433-2017; Ortiz, Diana/M-1690-2019	Carper, Benjamin/0000-0001-5882-2232; 	 [N01-AI-30061/TO 0011/C22]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030061] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was conducted under contract N01-AI-30061/TO 0011/C22.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Cox N., 2002, WHO MANUAL ANIMAL IN; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gainey M. R., 2010, Health, V2, P32, DOI 10.4236/health.2010.21006; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vela EM, 2012, INFLUENZA OTHER RESP, V6, P328, DOI 10.1111/j.1750-2659.2011.00321.x; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; Zeng H, 2012, J VIROLOGY IN PRESS; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	17	20	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58337	10.1371/journal.pone.0058337	http://dx.doi.org/10.1371/journal.pone.0058337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472182	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900128
J	Alemu, AS; Kempker, RR; Tenna, A; Smitson, C; Berhe, N; Fekade, D; Blumberg, HM; Aseffa, A				Alemu, Abere Shiferaw; Kempker, Russell R.; Tenna, Admasu; Smitson, Christopher; Berhe, Nega; Fekade, Daniel; Blumberg, Henry M.; Aseffa, Abraham			High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia	PLOS ONE			English	Article							SERUM; MENINGITIS; NEOFORMANS; CARE	Background: Cryptococcal disease is estimated to be responsible for significant mortality in Sub-Saharan Africa; however, only scarce epidemiology data exists. We sought to evaluate the prevalence of and risk factors for cryptococcal antigenemia in Ethiopia. Methods: Consecutive adult HIV-infected patients from two public HIV clinics in Addis Ababa, Ethiopia were enrolled into the study. A CD4 count <= 200 cells/mu l was required for study participation. Patients receiving anti-retroviral therapy ( ART) were not excluded. A cryptococcal antigen test was performed for all patients along with an interview, physical exam, and medical chart abstraction. Logistic regression analysis was used to assess risk factors for cryptococcal antigenemia. Results: 369 HIV-infected patients were enrolled; mean CD4 123 cells/mu l and 74% receiving ART. The overall prevalence of cryptococcal antigenemia was 8.4%; 11% in patients with a CD4 count,100 cells/mu l, 8.9% with CD4 100 to 150 cells/mu l and 5.7% with CD4150-200 cell/mu l. 84% of patients with cryptococcal antigenemia were receiving ART. In multivariable analysis, increasing age, self reported fever, CD4 count,100 cells/mu l, and site of screening were associated with an increased risk of cryptococcal antigenemia. No individual or combination of clinical symptoms had optimal sensitivity or specificity for cryptococcal antigenemia. Conclusion: Cryptococcal antigenemia is high in Ethiopia and rapid scale up of screening programs is needed. Screening should be implemented for HIV-infected patients with low CD4 counts regardless of symptoms or receipt of ART. Further study into the effect of location and environment on cryptococcal disease is warranted.	[Alemu, Abere Shiferaw] Haramya Univ, Med Lab Technol, Harar, Ethiopia; [Kempker, Russell R.; Smitson, Christopher; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Tenna, Admasu; Fekade, Daniel] Univ Addis Ababa, Dept Med, Div Infect Dis, Addis Ababa, Ethiopia; [Berhe, Nega] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Blumberg, Henry M.] Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Blumberg, Henry M.] Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA USA; [Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Haramaya University; Emory University; Addis Ababa University; Addis Ababa University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Alemu, AS (corresponding author), Haramya Univ, Med Lab Technol, Harar, Ethiopia.	meetabere@gmail.com; rkempke@emory.edu	Blumberg, Henry/W-2156-2019; hlupeni, admire/M-1539-2018; Aseffa, Abraham/J-3248-2016	Blumberg, Henry/0000-0002-3110-2443; Aseffa, Abraham/0000-0002-8028-1150; Mamuye, Admasu Tenna/0000-0002-9882-9989	Emory University Global Health Institute; Armauer Hansen Research Institute	Emory University Global Health Institute; Armauer Hansen Research Institute	The study was supported in part by the Emory University Global Health Institute and the Armauer Hansen Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chowdhary A, 2012, CRIT REV MICROBIOL, V38, P1, DOI 10.3109/1040841X.2011.606426; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; Federal Ministry of Health, 2010, REP PROGR IMPL UN DE; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lindsley MD, 2011, CLIN INFECT DIS, V53, P321, DOI 10.1093/cid/cir379; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	17	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58377	10.1371/journal.pone.0058377	http://dx.doi.org/10.1371/journal.pone.0058377			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469276	gold, Green Submitted, Green Published			2022-12-27	WOS:000315634900083
J	Huda, KMK; Banu, MSA; Pathi, KM; Tuteja, N				Huda, Kazi Md. Kamrul; Banu, Mst. Sufara Akhter; Pathi, Krishna Mohan; Tuteja, Narendra			Reproductive Organ and Vascular Specific Promoter of the Rice Plasma Membrane Ca(2+)ATPase Mediates Environmental Stress Responses in Plants	PLOS ONE			English	Article							THALIANA CULTURED-CELLS; ABSCISIC-ACID; METHYL-JASMONATE; GENE-EXPRESSION; SALICYLIC-ACID; COLD-STRESS; MOLECULAR CHARACTERIZATION; TRANSCRIPTIONAL REGULATION; TRANSGENIC TOBACCO; OSMOTIC-STRESS	Background: Plasma membrane Ca(2+)ATPase is a transport protein in the plasma membrane of cells and helps in removal of calcium (Ca2+) from the cell, hence regulating Ca2+ level within cells. Though plant Ca(2+)ATPases have been shown to be involved in plant stress responses but their promoter regions have not been well studied. Results: The 1478 bp promoter sequence of rice plasma membrane Ca(2+)ATPase contains cis-acting elements responsive to stresses and plant hormones. To identify the functional region, serial deletions of the promoter were fused with the GUS sequence and four constructs were obtained. These were differentially activated under NaCl, PEG cold, methyl viologen, abscisic acid and methyl jasmonate treatments. We demonstrated that the rice plasma membrane Ca(2+)ATPase promoter is responsible for vascular-specific and multiple stress-inducible gene expression. Only full-length promoter showed specific GUS expression under stress conditions in floral parts. High GUS activity was observed in roots with all the promoter constructs. The -1478 to -886 bp flanking region responded well upon treatment with salt and drought. Only the full-length promoter presented cold-induced GUS expression in leaves, while in shoots slight expression was observed for -1210 and -886 bp flanking region. The -1210 bp deletion significantly responded to exogenous methyl viologen and abscisic acid induction. The -1210 and -886 bp flanking region resulted in increased GUS activity in leaves under methyl jasmonate treatments, whereas in shoots the -886 bp and -519 bp deletion gave higher expression. Salicylic acid failed to induce GUS activities in leaves for all the constructs. Conclusions: The rice plasma membrane Ca(2+)ATPase promoter is a reproductive organ-specific as well as vascular-specific. This promoter contains drought, salt, cold, methyl viologen, abscisic acid and methyl jasmonate related cis-elements, which regulated gene expression. Overall, the tissue-specificity and inducible nature of this promoter could grant wide applicability in plant biotechnology.	[Huda, Kazi Md. Kamrul; Banu, Mst. Sufara Akhter; Pathi, Krishna Mohan; Tuteja, Narendra] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Tuteja, N (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Aruna Asaf Ali Marg, New Delhi, India.	narendra@icgeb.res.in		Pathi, Dr. Krishna Mohan/0000-0003-4693-6747	Department of Science and Technology (DST); Department of Biotechnology (DBT), Government of India	Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	Work on signal transduction and plant stress tolerance in NT's laboratory is partially supported by Department of Science and Technology (DST) and Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aviles-Arnaut H, 2012, J INTEGR PLANT BIOL, V54, P15, DOI 10.1111/j.1744-7909.2011.01084.x; Beffagna N, 2005, PLANT CELL PHYSIOL, V46, P1326, DOI 10.1093/pcp/pci142; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Boursiac Y, 2010, PLANT PHYSIOL, V154, P1158, DOI 10.1104/pp.110.159038; Breton G, 2003, PLANT PHYSIOL, V132, P64, DOI 10.1104/pp.102.015255; Cerana M, 2006, PLANT BIOLOGY, V8, P572, DOI 10.1055/s-2006-924111; Chung WS, 2000, PLANT CELL, V12, P1393, DOI 10.1105/tpc.12.8.1393; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Geisler M, 2000, PLANT PHYSIOL, V124, P1814, DOI 10.1104/pp.124.4.1814; Gomez-Porras JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-260; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; Guo HN, 2004, TRANSGENIC RES, V13, P559, DOI 10.1007/s11248-004-2738-2; [郭秀林 Guo Xiulin], 2002, [作物学报, Acta Agronomica Sinica], V28, P537; Guo Y, 2009, PLANT CELL, V21, P3518, DOI 10.1105/tpc.108.064139; Gupta V, 2007, PLANT CELL REP, V26, P1919, DOI 10.1007/s00299-007-0414-8; Hamilton DA, 1998, PLANT MOL BIOL, V38, P663, DOI 10.1023/A:1006083725102; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; He YH, 2001, PLANT MOL BIOL, V47, P595, DOI 10.1023/A:1012211011538; Hehn A, 1998, J GEN VIROL, V79, P1495, DOI 10.1099/0022-1317-79-6-1495; Hirschi KD, 2004, PLANT PHYSIOL, V136, P2438, DOI 10.1104/pp.104.046490; Hong JK, 2009, PLANTA, V229, P249, DOI 10.1007/s00425-008-0824-z; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Imai R, 2005, MOL GENET GENOMICS, V274, P445, DOI 10.1007/s00438-005-0050-3; ISHIKAWA A, 1994, PLANT MOL BIOL, V26, P403, DOI 10.1007/BF00039549; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang Y, 1999, ACTA BOT SIN, V41, P967; Jupin I, 1996, EMBO J, V15, P5679, DOI 10.1002/j.1460-2075.1996.tb00952.x; Kang JH, 2006, PLANT SCI, V171, P435, DOI 10.1016/j.plantsci.2006.05.005; Kanneganti V, 2008, PLANT MOL BIOL, V66, P445, DOI 10.1007/s11103-007-9284-2; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; KIM SR, 1993, PLANT PHYSIOL, V103, P97, DOI 10.1104/pp.103.1.97; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P255, DOI 10.4161/psb.5.3.10550; Li MN, 2007, PLANT PHYSIOL, V144, P1797, DOI 10.1104/pp.107.101600; [刘炜 Liu Wei], 2002, [作物学报, Acta Agronomica Sinica], V28, P227; Lu SY, 1993, CHIN J RICE, V13, P161; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; MASON HS, 1993, PLANT CELL, V5, P241, DOI 10.1105/tpc.5.3.241; MCCUE KF, 1990, TRENDS BIOTECHNOL, V8, P358, DOI 10.1016/0167-7799(90)90225-M; Morsy MR, 2005, GENE, V344, P171, DOI 10.1016/j.gene.2004.09.033; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; Nayyar H, 2003, BIOL PLANTARUM, V47, P541, DOI 10.1023/B:BIOP.0000041059.10703.11; Oettgen P, 2001, CIRC RES, V89, P380, DOI 10.1161/hh1701.095958; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Qudeimat E, 2008, P NATL ACAD SCI USA, V105, P19555, DOI 10.1073/pnas.0800864105; Quiapim AC, 2009, PLANT PHYSIOL, V149, P1211, DOI 10.1104/pp.108.131573; Romani G, 2004, PLANT BIOLOGY, V6, P192, DOI 10.1055/s-2004-817848; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Ruiz-Rivero OJ, 1998, PLANT MOL BIOL, V36, P639, DOI 10.1023/A:1005980028203; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; SCHINDLER U, 1992, PLANT CELL, V4, P1309, DOI 10.1105/tpc.4.10.1309; Schiott M, 2005, PHYSIOL PLANTARUM, V124, P278, DOI 10.1111/j.1399-3054.2005.00512.x; Shao HB, 2008, BIOESSAYS, V30, P634, DOI 10.1002/bies.20770; Shao HB, 2008, MOL MEMBR BIOL, V25, P179, DOI 10.1080/09687680801914508; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shirasawa-Seo N, 2005, J GEN VIROL, V86, P1851, DOI 10.1099/vir.0.80790-0; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Song WY, 2008, INT J BIOL SCI, V4, P116; Sun DL., 1998, CHIN B BOT, V15, P50, DOI 10.3969/j.issn.1674-3466.1998.02.008; Swanson R, 2005, SEX PLANT REPROD, V18, P163, DOI 10.1007/s00497-005-0009-x; TSUCHIYA T, 1994, PLANT MOL BIOL, V26, P1737, DOI 10.1007/BF00019488; Tung CW, 2005, PLANT PHYSIOL, V138, P977, DOI 10.1104/pp.105.060558; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; WIMMERS LE, 1992, P NATL ACAD SCI USA, V89, P9205, DOI 10.1073/pnas.89.19.9205; Wood NT, 2000, PLANT J, V24, P335, DOI 10.1046/j.1365-313x.2000.00881.x; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Xiang CB, 1996, PLANT MOL BIOL, V32, P415, DOI 10.1007/BF00019093; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Youm JW, 2008, PLANTA, V228, P701, DOI 10.1007/s00425-008-0782-5; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zong Hui, 2000, Journal of South China Agricultural University, V21, P63	83	19	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57803	10.1371/journal.pone.0057803	http://dx.doi.org/10.1371/journal.pone.0057803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469243	Green Submitted, Green Published, gold			2022-12-27	WOS:000315897100043
J	Yi, R; Zhu, ZX; Hu, JH; Qian, Q; Dai, JC; Ding, Y				Yi, Rong; Zhu, Zhixuan; Hu, Jihong; Qian, Qian; Dai, Jincheng; Ding, Yi			Identification and Expression Analysis of microRNAs at the Grain Filling Stage in Rice (Oryza sativa L.) via Deep Sequencing	PLOS ONE			English	Article							SMALL RNAS; RESPONSIVE MICRORNAS; SEED DEVELOPMENT; PLANT MICRORNAS; RT-PCR; MIRNAS; REVEALS; GENE; BIOGENESIS; ROLES	MicroRNAs (miRNAs) have been shown to play crucial roles in the regulation of plant development. In this study, high-throughput RNA-sequencing technology was used to identify novel miRNAs, and to reveal miRNAs expression patterns at different developmental stages during rice (Oryza sativa L.) grain filling. A total of 434 known miRNAs (380, 402, 390 and 392 at 5, 7, 12 and 17 days after fertilization, respectively.) were obtained from rice grain. The expression profiles of these identified miRNAs were analyzed and the results showed that 161 known miRNAs were differentially expressed during grain development, a high proportion of which were up-regulated from 5 to 7 days after fertilization. In addition, sixty novel miRNAs were identified, and five of these were further validated experimentally. Additional analysis showed that the predicted targets of the differentially expressed miRNAs may participate in signal transduction, carbohydrate and nitrogen metabolism, the response to stimuli and epigenetic regulation. In this study, differences were revealed in the composition and expression profiles of miRNAs among individual developmental stages during the rice grain filling process, and miRNA editing events were also observed, analyzed and validated during this process. The results provide novel insight into the dynamic profiles of miRNAs in developing rice grain and contribute to the understanding of the regulatory roles of miRNAs in grain filling.	[Yi, Rong; Zhu, Zhixuan; Hu, Jihong; Qian, Qian; Dai, Jincheng; Ding, Yi] Wuhan Univ, Coll Life Sci, Dept Genet, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Ding, Y (corresponding author), Wuhan Univ, Coll Life Sci, Dept Genet, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	yiding@whu.edu.cn	Dai, Jin/GVT-2414-2022	Dai, Jin/0000-0003-3063-746X; Hu, Jihong/0000-0002-2512-4056	National Basic Research Program (973) of China [2013CB126900]; National Natural Science Foundation of China [NSFC 30971740]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (973) of China (2013CB126900) and the National Natural Science Foundation of China (NSFC 30971740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Counce PA, 2006, CROP SCI, V46, P1501, DOI 10.2135/cropsci2005.0240; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duan K, 2005, PLANT MOL BIOL, V57, P785, DOI 10.1007/s11103-005-1803-4; Duan MJ, 2005, PLANT MOL BIOL, V59, P165, DOI 10.1007/s11103-004-7507-3; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Habig JW, 2007, MOL CELL, V25, P792, DOI 10.1016/j.molcel.2007.03.010; Heisel SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002871; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kondou H, 2006, BREEDING SCI, V56, P235, DOI 10.1270/jsbbs.56.235; Lan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-264; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Liu J, 2012, J EXP BOT, V63, P3727, DOI 10.1093/jxb/ers066; Liu YL, 2005, PLANT PHYSIOL, V139, P1545, DOI 10.1104/pp.105.066837; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Sun LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043760; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Suzuki A, 1997, GENE, V198, P393, DOI 10.1016/S0378-1119(97)00344-2; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Uchiumi T, 2010, PLANTA, V232, P579, DOI 10.1007/s00425-010-1197-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vincken QJJP, 2003, PLANT MOL BIOL, V51, P789, DOI 10.1023/A:1022528705590; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xing SP, 2011, PLANT SIGNAL BEHAV, V6, P934, DOI 10.4161/psb.6.7.15668; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	59	66	72	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57863	10.1371/journal.pone.0057863	http://dx.doi.org/10.1371/journal.pone.0057863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469249	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100047
J	Zhang, L; Orloff, MS; Reber, S; Li, SC; Zhao, Y; Eng, C				Zhang, Li; Orloff, Mohammed S.; Reber, Sean; Li, Shengchao; Zhao, Ye; Eng, Charis			cgaTOH: Extended Approach for Identifying Tracts of Homozygosity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANCER; RISK; LOCI; LUNG	Identification of disease variants via homozygosity mapping and investigation of the effects of genome-wide homozygosity regions on traits of biomedical importance have been widely applied recently. Nonetheless, the existing methods and algorithms to identify long tracts of homozygosity (TOH) are not able to provide efficient and rigorous regions for further downstream association investigation. We expanded current methods to identify TOHs by defining "surrogate-TOH'', a region covering a cluster of TOHs with specific characteristics. Our defined surrogate-TOH includes cTOH, viz a common TOH region where at least ten TOHs present; gTOH, whereby a group of highly overlapping TOHs share proximal boundaries; and aTOH, which are allelically-matched TOHs. Searching for gTOH and aTOH was based on a repeated binary spectral clustering algorithm, where a hierarchy of clusters is created and represented by a TOH cluster tree. Based on the proposed method of identifying different species of surrogate-TOH, our cgaTOH software was developed. The software provides an intuitive and interactive visualization tool for better investigation of the high-throughput output with special interactive navigation rings, which will find its applicability in both conventional association studies and more sophisticated downstream analyses. NCBI genome map viewer is incorporated into the system. Moreover, we discuss the choice of implementing appropriate empirical ranges of critical parameters by applying to disease models. This method identifies various patterned clusters of SNPs demonstrating extended homozygosity, thus one can observe different aspects of the multi-faceted characteristics of TOHs.	[Zhang, Li] Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA; [Zhang, Li; Orloff, Mohammed S.; Eng, Charis] Lerner Res Inst, Genom Med Inst, Cleveland, OH USA; [Zhang, Li; Orloff, Mohammed S.; Eng, Charis] Taussig Canc Inst, Cleveland, OH USA; [Zhang, Li] Case Western Reserve Univ, Dept Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Reber, Sean; Zhao, Ye] Kent State Univ, Dept Comp Sci, Kent, OH 44242 USA; [Li, Shengchao] Johns Hopkins Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Inst Nursing Excellence, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Zhang, L (corresponding author), Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA.	zhangl3@ccf.org		Eng, Charis/0000-0002-3693-5145				Aslibekyan S, 2012, PHARMACOGENET GENOM, V22, P191, DOI 10.1097/FPC.0b013e32834fdd41; Assie G, 2008, JAMA-J AM MED ASSOC, V299, P1437, DOI 10.1001/jama.299.12.1437; Bacolod MD, 2008, CANCER RES, V68, P2610, DOI 10.1158/0008-5472.CAN-07-5250; Bhattacharya P, 2002, CANCER LETT, V188, P207, DOI 10.1016/S0304-3835(02)00430-5; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; Ng AY, 2002, ADV NEUR IN, V14, P849; Orloff MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031975; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Purcell S, 2007, AM J HUMAN GENETICS, V81; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Rudan I, 1999, HUM BIOL, V71, P173; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; SIMPSON JL, 1981, AM J OBSTET GYNECOL, V141, P629, DOI 10.1016/S0002-9378(15)33302-0; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111	19	16	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57772	10.1371/journal.pone.0057772	http://dx.doi.org/10.1371/journal.pone.0057772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469237	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100040
J	Borcherding, JA; Chen, HH; Caraballo, JC; Baltrusaitis, J; Pezzulo, AA; Zabner, J; Grassian, VH; Comellas, AP				Borcherding, Jennifer A.; Chen, Haihan; Caraballo, Juan C.; Baltrusaitis, Jonas; Pezzulo, Alejandro A.; Zabner, Joseph; Grassian, Vicki H.; Comellas, Alejandro P.			Coal Fly Ash Impairs Airway Antimicrobial Peptides and Increases Bacterial Growth	PLOS ONE			English	Article							PULMONARY HOST-DEFENSE; EPITHELIAL-CELLS; POLLUTION PARTICLES; PARTICULATE MATTER; LUNG-FUNCTION; AMBIENT AIR; IRON; INFECTION; CLEARANCE; DISEASE	Air pollution is a risk factor for respiratory infections, and one of its main components is particulate matter (PM), which is comprised of a number of particles that contain iron, such as coal fly ash (CFA). Since free iron concentrations are extremely low in airway surface liquid (ASL), we hypothesize that CFA impairs antimicrobial peptides (AMP) function and can be a source of iron to bacteria. We tested this hypothesis in vivo by instilling mice with Pseudomonas aeruginosa (PA01) and CFA and determine the percentage of bacterial clearance. In addition, we tested bacterial clearance in cell culture by exposing primary human airway epithelial cells to PA01 and CFA and determining the AMP activity and bacterial growth in vitro. We report that CFA is a bioavailable source of iron for bacteria. We show that CFA interferes with bacterial clearance in vivo and in primary human airway epithelial cultures. Also, we demonstrate that CFA inhibits AMP activity in vitro, which we propose as a mechanism of our cell culture and in vivo results. Furthermore, PA01 uses CFA as an iron source with a direct correlation between CFA iron dissolution and bacterial growth. CFA concentrations used are very relevant to human daily exposures, thus posing a potential public health risk for susceptible subjects. Although CFA provides a source of bioavailable iron for bacteria, not all CFA particles have the same biological effects, and their propensity for iron dissolution is an important factor. CFA impairs lung innate immune mechanisms of bacterial clearance, specifically AMP activity. We expect that identifying the PM mechanisms of respiratory infections will translate into public health policies aimed at controlling, not only concentration of PM exposure, but physicochemical characteristics that will potentially cause respiratory infections in susceptible individuals and populations.	[Borcherding, Jennifer A.; Caraballo, Juan C.; Pezzulo, Alejandro A.; Zabner, Joseph; Comellas, Alejandro P.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Grassian, Vicki H.] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Chen, Haihan] Univ Iowa, Dept Chem & Biochem Engn, Iowa City, IA 52242 USA; [Baltrusaitis, Jonas] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Comellas, AP (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.	alejandro-comellas@uiowa.edu	Baltrusaitis, Jonas/F-9367-2013; Comellas, Alejandro/AAE-5661-2019; Chen, Haihan/F-3264-2014; Baltrusaitis, Jonas/AAW-6072-2021; Baltrusaitis, Jonas/AAT-3166-2020	Chen, Haihan/0000-0001-6360-2947; Baltrusaitis, Jonas/0000-0001-5634-955X; Pezzulo, Alejandro/0000-0001-7544-5109; Zabner, Joseph/0000-0002-9606-1339; Comellas, Alejandro/0000-0003-1521-7520	National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH) [UL1RR024979]; Center for Health Effects of Environmental Contamination (CHEEC); NIH [KO1HL080966, P30 ES005605]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Health Effects of Environmental Contamination (CHEEC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by Grant Number UL1RR024979 from the National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CTSA or NIH. This publication was also supported by Center for Health Effects of Environmental Contamination (CHEEC) Seed Grants: FY 2010 and NIH Grant: KO1HL080966, and NIH P30 ES005605. The funders had no role in study design, data collection and anlysis, decision to publish, or preparation of the manuscript.	Arbex MA, 2009, J EPIDEMIOL COMMUN H, V63, P777, DOI 10.1136/jech.2008.078360; Baltrusaitis J, 2007, PHYS CHEM CHEM PHYS, V9, P3011, DOI 10.1039/b617697f; Bullen JJ, 2005, FEMS IMMUNOL MED MIC, V43, P325, DOI 10.1016/j.femsim.2004.11.010; Caraballo JC, 2011, AM J PHYSIOL-LUNG C, V300, pL569, DOI 10.1152/ajplung.00109.2010; Chen H, 2012, ENVIRON SCI TECHNOL, V46, P2112, DOI 10.1021/es204102f; Finnerty K, 2007, J TOXICOL ENV HEAL A, V70, P1957, DOI 10.1080/15287390701549229; Ganz T, 2002, J CLIN INVEST, V109, P693, DOI 10.1172/JCI200215218; Ghio AJ, 2012, J TOXICOL ENV HEAL B, V15, P1, DOI 10.1080/10937404.2012.632359; Giere R, 2003, AM MINERAL, V88, P1853, DOI 10.2138/am-2003-11-1228; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; Goss CH, 2004, AM J RESP CRIT CARE, V169, P816, DOI 10.1164/rccm.200306-779OC; Harrod KS, 2005, TOXICOL SCI, V83, P155, DOI 10.1093/toxsci/kfi007; HATCH GE, 1985, ENVIRON RES, V36, P67, DOI 10.1016/0013-9351(85)90008-8; Hygienists ACGIH, 2009, DOC THRESH LIM VAL B, P74; Jones T, 2010, J TOXICOL ENV HEAL A, V73, P341, DOI 10.1080/15287390903442637; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Klein-Patel ME, 2006, TOXICOL SCI, V92, P115, DOI 10.1093/toxsci/kfj214; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; Miyata R, 2011, TOXICOL APPL PHARM, V257, P209, DOI 10.1016/j.taap.2011.09.007; Mukherjee B, 2011, J APPL TOXICOL, V33, P281; Noble RE, 2002, SCI TOTAL ENVIRON, V284, P263, DOI 10.1016/S0048-9697(01)00871-3; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; PANUSH D, 1993, RADIOLOGY, V187, P421, DOI 10.1148/radiology.187.2.8475284; Parameswaran GI, 2011, CHEST, V140, P611, DOI 10.1378/chest.10-2760; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Roberts JR, 2009, J IMMUNOTOXICOL, V6, P49, DOI 10.1080/15476910802630379; SANDSTROM T, 1991, BRIT J IND MED, V48, P771; Shi ZB, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003837; Sigaud S, 2007, TOXICOL APPL PHARM, V223, P1, DOI 10.1016/j.taap.2007.04.014; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Veranth JM, 2000, CHEM RES TOXICOL, V13, P382, DOI 10.1021/tx9901884; Veranth JM, 2000, CHEM RES TOXICOL, V13, P161, DOI 10.1021/tx9902136; Voelkel K, 2003, J BIOSCIENCES, V28, P51, DOI 10.1007/BF02970131; Watson W, 2010, US COAL SUPPLY DEMAN; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983	37	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57673	10.1371/journal.pone.0057673	http://dx.doi.org/10.1371/journal.pone.0057673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469047	gold, Green Published			2022-12-27	WOS:000315524900146
J	Corsi, DJ; Lear, SA; Chow, CK; Subramanian, SV; Boyle, MH; Teo, KK				Corsi, Daniel J.; Lear, Scott A.; Chow, Clara K.; Subramanian, S. V.; Boyle, Michael H.; Teo, Koon K.			Socioeconomic and Geographic Patterning of Smoking Behaviour in Canada: A Cross-Sectional Multilevel Analysis	PLOS ONE			English	Article							HEALTH-RELATED BEHAVIOR; MALE BRITISH DOCTORS; TOBACCO USE; SMOKERS; INEQUALITIES; CESSATION; MORTALITY; CONTEXT	Objective: To describe the socioeconomic and geographic distribution of smoking behaviour in Canada among 19,383 individuals (51% women) aged 15-85 years. Methods: Current smoking and quitting were modeled using standard and multilevel logistic regression. Markers of socioeconomic status (SES) were education and occupation. Geography was defined by Canadian Provinces. Results: The adjusted prevalence of current smoking was 20.2% (95% confidence interval [CI]: 18.8-21.7) and 63.7% (95% CI: 61.1-66.3) of ever smokers had quit. Current smoking decreased and quitting increased with increasing SES. The adjusted prevalence of current smoking was 32.8% (95% CI: 28.4-37.5) among the least educated compared to 11.0% (95% CI: 8.9-13.4) for the highest educated. Among the least educated, 53.0% (95% CI: 46.8-59.2) had quit, rising to 68.7% (95% CI: 62.7-74.1) for the most educated. There was substantial variation in current smoking and quitting at the provincial level; current smoking varied from 17.9% in British Columbia to 26.1% in Nova Scotia, and quitting varied from 57.4% in Nova Scotia to 67.8% in Prince Edward Island. Nationally, increasing education and occupation level were inversely associated with current smoking (odds ratio [OR] 0.64, 95% CI: 0.60-0.68 for education; OR 0.82, 95% CI: 0.77-0.87 for occupation) and positively associated with quitting (OR 1.27, 95% CI: 1.16-1.40 for education; OR 1.20, 95% CI: 1.12-1.27 for occupation). These associations were consistent in direction across provinces although with some variability in magnitude. Conclusion: Our findings indicate that socioeconomic inequalities in smoking have persisted in Canada; current smoking was less likely and quitting was more likely among the better off groups and in certain provinces. Current prevention and cessation policies have not been successful in improving the situation for all areas and groups. Future efforts to reduce smoking uptake and increase cessation in Canada will need consideration of socioeconomic and geographic factors to be successful.	[Corsi, Daniel J.] Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Chow, Clara K.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Boyle, Michael H.] McMaster Univ, Dept Psychiat, Hamilton, ON, Canada; [Boyle, Michael H.] McMaster Univ, Behav Neurosci & Offord Ctr Child Studies, Hamilton, ON, Canada; [Boyle, Michael H.; Teo, Koon K.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Teo, Koon K.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Simon Fraser University; George Institute for Global Health; University of Sydney; Harvard University; Harvard T.H. Chan School of Public Health; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute	Corsi, DJ (corresponding author), Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.	djcorsi@hsph.harvard.edu	Corsi, Daniel J/S-4689-2018	Corsi, Daniel J/0000-0001-7063-3354; Teo, Koon/0000-0002-3731-0956				Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; [Anonymous], 1999, CURBING EPIDEMIC GOV; Baliunas Dolly, 2007, Chronic Dis Can, V27, P154; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Bauld L., 2011, TOBACCO CONTROL INEQ; Beland Yves, 2002, Health Rep, V13, P9; Copley TT, 2006, INDICATORS MONITORIN; Corsi DJ, 2012, AM J PREV MED, V43, P601, DOI 10.1016/j.amepre.2012.08.023; DERBY CA, 1994, AM J PREV MED, V10, P327, DOI 10.1016/S0749-3797(18)30560-9; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; DUNCAN C, 1993, SOC SCI MED, V37, P725, DOI 10.1016/0277-9536(93)90366-C; Duncan C, 1996, SOC SCI MED, V42, P817, DOI 10.1016/0277-9536(95)00181-6; Eriksen M P, 1999, Nicotine Tob Res, V1 Suppl 1, pS79; Ezzati M, 2004, COMP QUANTIFICATION; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Hammond D, 2006, TOB CONTROL, V15, P19, DOI 10.1136/tc.2005.012294; Health Canada, 2010, CAN TOB US MON SURV; Hill SE, 2005, AUST NZ J PUBL HEAL, V29, P279, DOI 10.1111/j.1467-842X.2005.tb00769.x; Hiscock R, 2012, J PUBLIC HEALTH-UK, V34, P390, DOI 10.1093/pubmed/fds012; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Lee DS, 2009, CAN MED ASSOC J, V181, pE55, DOI 10.1503/cmaj.081629; Lindstrom M, 2002, ADDICTION, V97, P205, DOI 10.1046/j.1360-0443.2002.00036.x; Luk R, 2009, ADDICTION, V104, P488, DOI 10.1111/j.1360-0443.2008.02453.x; ONS, 2011, SMOK DRINK AD 2009 R; Osler M, 1998, TOB CONTROL, V7, P262, DOI 10.1136/tc.7.3.262; Pechacek TF, 2003, EVIDENCE BASED CARDI, P103; Peto R, 2012, MORTALITY SMOKING DE; Peto R, 2006, MORTALITY SMOKING DE; Rasbash J., 2010, MLWIN VERSION 2 20; Reid J., 2012, TOBACCO USE CANADA P; Reid JL, 2010, CAN J PUBLIC HEALTH, V101, P73, DOI 10.1007/BF03405567; Reid JL, 2012, TOB US CAN PATT TREN; Shields Margot, 2005, Health Rep, V16, P19; Smith P, 2009, J EPIDEMIOL COMMUN H, V63, P317, DOI 10.1136/jech.2008.078204; Stata Corp, 2012, STAT STAT SOFTW REL; Statistics Canada, 2011, CAN TOB US MON SURV; Statistics Canada, 2005, CCHS CYCL 2 1 2003 P; Statistics Canada, 2010, CAN TOB US MON SURV; Statistics Canada, 2015, CONCORDANCE NATL OCC; Statistics Canada, 2011, RES TEL SERV SURV RT; Stead LF, 2007, TOB CONTROL, V16, pI3, DOI 10.1136/tc.2006.019737; Tomz Michael., 2001, CLARIFY SOFTWARE INT; *US DEP HHS, 1989, RED HLTH CONS SMOK 2; Whitlock G, 1998, TOB CONTROL, V7, P276, DOI 10.1136/tc.7.3.276; World Health Organization, 2019, WHO REPORT GLOBAL TO	46	27	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57646	10.1371/journal.pone.0057646	http://dx.doi.org/10.1371/journal.pone.0057646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23469038	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900137
J	Seron-Ferre, M; Forcelledo, ML; Torres-Farfan, C; Valenzuela, FJ; Rojas, A; Vergara, M; Rojas-Garcia, PP; Recabarren, MP; Valenzuela, GJ				Seron-Ferre, Maria; Luisa Forcelledo, Maria; Torres-Farfan, Claudia; Valenzuela, Francisco J.; Rojas, Auristela; Vergara, Marcela; Rojas-Garcia, Pedro P.; Recabarren, Monica P.; Valenzuela, Guillermo J.			Impact of Chronodisruption during Primate Pregnancy on the Maternal and Newborn Temperature Rhythms	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; FETAL ADRENAL-GLAND; FOR-GESTATIONAL-AGE; CIRCADIAN-RHYTHMS; BODY-TEMPERATURE; MELATONIN; ENTRAINMENT; PINEALECTOMY; FETUS; LIGHT	Disruption of the maternal environment during pregnancy is a key contributor to offspring diseases that develop in adult life. To explore the impact of chronodisruption during pregnancy in primates, we exposed pregnant capuchin monkeys to constant light (eliminating the maternal melatonin rhythm) from the last third of gestation to term. Maternal temperature and activity circadian rhythms were assessed as well as the newborn temperature rhythm. Additionally we studied the effect of daily maternal melatonin replacement during pregnancy on these rhythms. Ten pregnant capuchin monkeys were exposed to constant light from 60% of gestation to term. Five received a daily oral dose of melatonin (250 mu g kg/body weight) at 1800 h (LL+Mel) and the other five a placebo (LL). Six additional pregnant females were maintained in a 14:10 light: dark cycles and their newborns were used as controls (LD). Rhythms were recorded 96 h before delivery in the mother and at 4-6 days of age in the newborn. Exposure to constant light had no effect on the maternal body temperature rhythm however it delayed the acrophase of the activity rhythm. Neither rhythm was affected by melatonin replacement. In contrast, maternal exposure to constant light affected the newborn body temperature rhythm. This rhythm was entrained in control newborns whereas LL newborns showed a random distribution of the acrophases over 24-h. In addition, mean temperature was decreased (34.0 +/- 0.6 vs 36.1 +/- 0.2 degrees C, in LL and control, respectively P<0.05). Maternal melatonin replacement during pregnancy re-synchronized the acrophases and restored mean temperature to the values in control newborns. Our findings demonstrate that prenatal melatonin is a Zeitgeber for the newborn temperature rhythm and supports normal body temperature maintenance. Altogether these prenatal melatonin effects highlight the physiological importance of the maternal melatonin rhythm during pregnancy for the newborn primate.	[Seron-Ferre, Maria; Valenzuela, Francisco J.; Rojas, Auristela] Univ Chile, Fac Med, Programa Fisiopatol, Santiago 7, Chile; [Seron-Ferre, Maria; Luisa Forcelledo, Maria; Vergara, Marcela; Rojas-Garcia, Pedro P.; Recabarren, Monica P.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ciencias Fisiol, Santiago, Chile; [Torres-Farfan, Claudia] Univ Austral Chile, Fac Med, Inst Anat Histol & Patol, Santiago, Chile; [Valenzuela, Guillermo J.] Arrowhead Reg Med Ctr, Dept Womens Hlth, San Bernardino, CA USA	Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad Austral de Chile	Seron-Ferre, M (corresponding author), Univ Chile, Fac Med, Programa Fisiopatol, Santiago 7, Chile.	mseron@med.uchile.cl	Valenzuela-Melgarejo, Dr. Francisco J./ABF-1271-2021		FONDECYT-LINEAS COMPLEMENTARIAS [1998-8980006]; FONDECYT [1090381]; Conicyt Anillo [ACT-1116]	FONDECYT-LINEAS COMPLEMENTARIAS(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS)	Funding came from FONDECYT-LINEAS COMPLEMENTARIAS 1998-8980006, FONDECYT 1090381 and Conicyt Anillo ACT-1116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abeysena C, 2009, AUST NZ J OBSTET GYN, V49, P382, DOI 10.1111/j.1479-828X.2009.01010.x; ALEXANDER G, 1975, BIOL NEONATE, V26, P214, DOI 10.1159/000240732; Barger LK, 2010, PHYSIOL BEHAV, V101, P595, DOI 10.1016/j.physbeh.2010.06.002; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bellavia SL, 2006, PHYSIOL BEHAV, V89, P342, DOI 10.1016/j.physbeh.2006.06.018; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Burgess HJ, 2001, J APPL PHYSIOL, V91, P1214, DOI 10.1152/jappl.2001.91.3.1214; CASSONE VM, 1986, PHYSIOL BEHAV, V36, P1111, DOI 10.1016/0031-9384(86)90488-9; Croteau A, 2006, AM J PUBLIC HEALTH, V96, P846, DOI 10.2105/AJPH.2004.058552; Davis Fred C., 2001, Handbook of Behavioral Neurobiology, V12, P247; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; FULLER CA, 1979, AM J PHYSIOL, V236, pR153, DOI 10.1152/ajpregu.1979.236.3.R153; GLOTZBACH SF, 1994, PEDIATRICS, V94, P482; Jin LZ, 2004, J OCCUP ENVIRON MED, V46, P1144, DOI 10.1097/01.jom.0000145168.21614.21; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Masuda K, 2010, J BIOL RHYTHM, V25, P361, DOI 10.1177/0748730410379382; MATSUMOTO T, 1991, AM J OBSTET GYNECOL, V165, P1777, DOI 10.1016/0002-9378(91)90032-M; MCMILLEN IC, 1989, J ENDOCRINOL, V120, P459, DOI 10.1677/joe.0.1200459; Mendez N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042713; MIRMIRAN M, 1991, EARLY HUM DEV, V26, P121, DOI 10.1016/0378-3782(91)90016-V; Nathanielsz PW, 2006, ILAR J, V47, P73, DOI 10.1093/ilar.47.1.73; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Pennell CE, 2009, EARLY LIFE ORIGINS OF HUMAN HEALTH AND DISEASE, P205, DOI 10.1159/000221166; REDMAN J, 1983, SCIENCE, V219, P1089, DOI 10.1126/science.6823571; REPPERT SM, 1979, PEDIATR RES, V13, P788, DOI 10.1203/00006450-197906000-00015; Schrader JA, 2010, NEUROSCIENCE, V171, P513, DOI 10.1016/j.neuroscience.2010.08.057; Schrader JA, 2012, BRAIN RES, V1480, P53, DOI 10.1016/j.brainres.2012.09.003; Seron-Ferre M, 2012, MOL CELL ENDOCRINOL, V349, P68, DOI 10.1016/j.mce.2011.07.039; SITKA U, 1994, EUR J PEDIATR, V153, P117, DOI 10.1007/BF01959222; Torres-Farfan C, 2006, ENDOCRINOLOGY, V147, P4618, DOI 10.1210/en.2006-0628; Torres-Farfan C, 2004, J PHYSIOL-LONDON, V554, P841, DOI 10.1113/jphysiol.2003.056465; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Torres-Farfan C, 2008, J PHYSIOL-LONDON, V586, P4017, DOI 10.1113/jphysiol.2008.154351; Torres-Farfan C, 2008, AM J PRIMATOL, V70, P93, DOI 10.1002/ajp.20461; Torres-Farfan C, 2006, J PINEAL RES, V41, P58, DOI 10.1111/j.1600-079X.2006.00331.x; YELLON SM, 1988, BIOL REPROD, V39, P1093, DOI 10.1095/biolreprod39.5.1093; Zar JH, 1974, BIOSTATISTICAL ANAL, V22, P310	39	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57710	10.1371/journal.pone.0057710	http://dx.doi.org/10.1371/journal.pone.0057710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469055	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900154
J	Shifrin, H; Nadler-Milbauer, M; Shoham, S; Weinstock, M				Shifrin, Helena; Nadler-Milbauer, Mirela; Shoham, Shai; Weinstock, Marta			Rivastigmine Alleviates Experimentally Induced Colitis in Mice and Rats by Acting at Central and Peripheral Sites to Modulate Immune Responses	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ACETYLCHOLINE-RECEPTOR ALPHA-7; VAGUS NERVE; STIMULATION; MODELS; CELLS; ENDOTOXEMIA; SUPPRESSION; ACTIVATION	The cholinergic anti-inflammatory system and alpha 7 nicotinic receptors in macrophages have been proposed to play a role in neuroimmunomodulation and in the etiology of ulcerative colitis. We investigated the ability of a cholinesterase (ChE) inhibitor rivastigmine, to improve the pathology of ulcerative colitis by increasing the concentration of extracellular acetylcholine in the brain and periphery. In combination with carbachol (10 mu M), rivastigmine (1 mu M) significantly decreased the release of nitric oxide, TNF-alpha, IL-1 beta and IL-6 from lipopolysaccharide-activated RAW 264.7 macrophages and this effect was abolished by alpha 7 nicotinic receptor blockade by bungarotoxin. Rivastigmine (1 mg/kg) but not (0.5 mg/kg), injected subcutaneously once daily in BALB/c mice with colitis induced by 4% dextran sodium sulphate (DSS), reduced the disease activity index (DAI) by 60% and damage to colon structure. Rivastigmine (1 mg/kg) also reduced myeloperoxidase activity and IL-6 by >60%, and the infiltration of CD11b expressing cells by 80%. These effects were accompanied by significantly greater ChE inhibition in cortex, brain stem, plasma and colon than that after 0.5 mg/kg. Co-administration of rivastigmine (1 mg/kg) with the muscarinic antagonist scopolamine significantly increased the number of CD11b expressing cells in the colon but did not change DAI compared to those treated with rivastigmine alone. Rivastigmine 1 and 2 mg given rectally to rats with colitis induced by rectal administration of 30 mg dintrobezene sulfonic acid (DNBS) also caused a dose related reduction in ChE activity in blood and colon, the number of ulcers and area of ulceration, levels of TNF-alpha and in MPO activity. The study revealed that the ChE inhibitor rivastigmine is able to reduce gastro-intestinal inflammation by actions at various sites at which it preserves ACh. These include ACh released from vagal nerve endings that activates alpha7 nicotinic receptors on circulating macrophages and in brainstem neurons.	[Shifrin, Helena; Nadler-Milbauer, Mirela; Shoham, Shai; Weinstock, Marta] Hebrew Univ Jerusalem, Med Ctr, Inst Drug Res, Dept Pharmacol, Jerusalem, Israel	Hebrew University of Jerusalem	Weinstock, M (corresponding author), Hebrew Univ Jerusalem, Med Ctr, Inst Drug Res, Dept Pharmacol, Jerusalem, Israel.	martar@ekmd.huji.ac.il						Bai A, 2007, SCAND J IMMUNOL, V66, P538, DOI 10.1111/j.1365-3083.2007.02011.x; Barnes CA, 2000, NEUROSCIENCE, V99, P17, DOI 10.1016/S0306-4522(00)00180-9; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BRADLEY PP, 1982, BLOOD, V60, P618; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Desreumaux P, 1997, GASTROENTEROLOGY, V113, P118, DOI 10.1016/S0016-5085(97)70116-1; Dmitrieva NA, 2007, J HISTOCHEM CYTOCHEM, V55, P461, DOI 10.1369/jhc.6A7116.2006; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hibi T, 2002, J GASTROENTEROL, V37, P409, DOI 10.1007/s005350200060; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Jubeh TT, 2006, J DRUG TARGET, V14, P155, DOI 10.1080/10611860600648429; Kawashima K, 2003, LIFE SCI, V72, P2101, DOI 10.1016/S0024-3205(03)00068-7; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Kullmann F, 2001, INT J COLORECTAL DIS, V16, P238, DOI 10.1007/s003840100311; Miceli PC, 2003, AUTON NEUROSCI-BASIC, V105, P16, DOI 10.1016/S1566-0702(03)00023-7; Nizri E, 2008, J NEUROIMMUNOL, V203, P12, DOI 10.1016/j.jneuroim.2008.06.018; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Snoek SA, 2010, BRIT J PHARMACOL, V160, P322, DOI 10.1111/j.1476-5381.2010.00699.x; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang RH, 2000, NEUROPHARMACOLOGY, V39, P497, DOI 10.1016/S0028-3908(99)00157-4; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	37	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57668	10.1371/journal.pone.0057668	http://dx.doi.org/10.1371/journal.pone.0057668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469045	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900144
J	Studt, L; Humpf, HU; Tudzynski, B				Studt, Lena; Humpf, Hans-Ulrich; Tudzynski, Bettina			Signaling Governed by G Proteins and cAMP Is Crucial for Growth, Secondary Metabolism and Sexual Development in Fusarium fujikuroi	PLOS ONE			English	Article							G-ALPHA-PROTEIN; GIBBERELLA-FUJIKUROI; CONIDIAL GERMINATION; BOTRYTIS-CINEREA; DIFFERENTIAL PRODUCTION; MAGNAPORTHE-GRISEA; NEUROSPORA-CRASSA; GENE; SUBUNIT; BIOSYNTHESIS	The plant-pathogenic fungus Fusarium fujikuroi is a notorious rice pathogen causing hyper-elongation of infected plants due to the production of gibberellic acids (GAs). In addition to GAs, F. fujikuroi produces a wide range of other secondary metabolites, such as fusarins, fusaric acid or the red polyketides bikaverins and fusarubins. The recent availability of the fungal genome sequence for this species has revealed the potential of many more putative secondary metabolite gene clusters whose products remain to be identified. However, the complex regulation of secondary metabolism is far from being understood. Here we studied the impact of the heterotrimeric G protein and the cAMP-mediated signaling network, including the regulatory subunits of the cAMP-dependent protein kinase (PKA), to study their effect on colony morphology, sexual development and regulation of bikaverins, fusarubins and GAs. We demonstrated that fusarubin biosynthesis is negatively regulated by at least two G alpha subunits, FfG1 and FfG3, which both function as stimulators of the adenylyl cyclase FfAC. Surprisingly, the primary downstream target of the adenylyl cyclase, the PKA, is not involved in the regulation of fusarubins, suggesting that additional, yet unidentified, cAMP-binding protein(s) exist. In contrast, bikaverin biosynthesis is significantly reduced in ffg1 and ffg3 deletion mutants and positively regulated by FfAC and FfPKA1, while GA biosynthesis depends on the active FfAC and FfPKA2 in an FfG1- and FfG3-independent manner. In addition, we provide evidence that G Protein-mediated/cAMP signaling is important for growth in F. fujikuroi because deletion of ffg3, ffac and ffpka1 resulted in impaired growth on minimal and rich media. Finally, sexual crosses of ffg1 mutants showed the importance of a functional FfG1 protein for development of perithecia in the mating strain that carries the MAT1-1 idiomorph.	[Studt, Lena; Humpf, Hans-Ulrich] Univ Munster, Inst Lebensmittelchem, D-48149 Munster, Germany; [Studt, Lena; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany	University of Munster; University of Munster	Tudzynski, B (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany.	tudzynsb@uni-muenster.de	Studt, Lena/AAE-3991-2021; Humpf, Hans-Ulrich/AAV-4845-2020	Humpf, Hans-Ulrich/0000-0003-3296-3058; Studt-Reinhold, Lena/0000-0002-8738-2106	DFG (Deutsche Forschungsgemeinschaft) [GRK1409]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The funding for this project comes from the DFG (Deutsche Forschungsgemeinschaft) Grant Number GRK1409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; Bahn YS, 2006, CURR OPIN MICROBIOL, V9, P572, DOI 10.1016/j.mib.2006.09.003; BARRERO AF, 1991, PHYTOCHEMISTRY, V30, P2259, DOI 10.1016/0031-9422(91)83625-U; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Bolker M, 1998, FUNGAL GENET BIOL, V25, P143, DOI 10.1006/fgbi.1998.1102; Brock NL, 2011, CHEMBIOCHEM, V12, P2667, DOI 10.1002/cbic.201100516; Brown DW, 2012, FUNGAL GENET BIOL, V49, P521, DOI 10.1016/j.fgb.2012.05.010; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chang MH, 2004, GENETICS, V167, P1305, DOI 10.1534/genetics.103.025379; Chen CB, 2005, MOL MICROBIOL, V55, P299, DOI 10.1111/j.1365-2958.2004.04390.x; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Choi YE, 2008, MYCOLOGIA, V100, P701, DOI 10.3852/08-015; Choi YE, 2010, MOL PLANT MICROBE IN, V23, P522, DOI 10.1094/MPMI-23-4-0522; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cook RJ., 1981, FUSARIUM DIS BIOL TA, P104; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Degani O, 2004, APPL ENVIRON MICROB, V70, P5005, DOI 10.1128/AEM.70.8.5005-5009.2004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Fillinger S, 2002, MOL MICROBIOL, V44, P1001, DOI 10.1046/j.1365-2958.2002.02933.x; Fuller KK, 2011, MOL MICROBIOL, V79, P1045, DOI 10.1111/j.1365-2958.2010.07509.x; Gao SJ, 1996, P NATL ACAD SCI USA, V93, P14122, DOI 10.1073/pnas.93.24.14122; Garcia-Martinez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028849; Garcia-Rico RO, 2008, MICROBIOL-SGM, V154, P3567, DOI 10.1099/mic.0.2008/019091-0; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Ito S., 1931, REP HOKKAIDO NATL AG, V27, P1; Ivey FD, 1996, MOL BIOL CELL, V7, P1283, DOI 10.1091/mbc.7.8.1283; Jain S, 2005, FEMS MICROBIOL LETT, V243, P165, DOI 10.1016/j.femsle.2004.12.009; Jain S, 2002, CURR GENET, V41, P407, DOI 10.1007/s00294-002-0322-y; Kays AM, 2000, MOL CELL BIOL, V20, P7693, DOI 10.1128/MCB.20.20.7693-7705.2000; KJAER D, 1971, J CHEM SOC C, P2792, DOI 10.1039/j39710002792; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; KLITTICH CJR, 1988, GENETICS, V118, P417; Kohut G, 2010, J BASIC MICROB, V50, P59, DOI 10.1002/jobm.200900113; Kurosawa E., 1926, T NAT HIST SOC FORMO, V16, P213; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Lee J, 2010, BIOCHEM BIOPH RES CO, V401, P48, DOI 10.1016/j.bbrc.2010.09.005; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Liebmann B, 2003, MOL GENET GENOMICS, V269, P420, DOI 10.1007/s00438-003-0852-0; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Liu SH, 1997, MOL PLANT MICROBE IN, V10, P1075, DOI 10.1094/MPMI.1997.10.9.1075; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Mogensen EG, 2006, EUKARYOT CELL, V5, P103, DOI 10.1128/EC.5.1.103-111.2006; Mukherjee M, 2007, MICROBIOL-SGM, V153, P1734, DOI 10.1099/mic.0.2007/005702-0; NAKAFUKU M, 1987, P NATL ACAD SCI USA, V84, P2140, DOI 10.1073/pnas.84.8.2140; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Proctor RH, 2004, MYCOL RES, V108, P815, DOI 10.1017/S0953756204000577; Regenfelder E, 1997, EMBO J, V16, P1934, DOI 10.1093/emboj/16.8.1934; Reithner B, 2005, FUNGAL GENET BIOL, V42, P749, DOI 10.1016/j.fgb.2005.04.009; Rosen S, 1999, EMBO J, V18, P5592, DOI 10.1093/emboj/18.20.5592; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schumacher J, 2008, MOL PLANT MICROBE IN, V21, P1443, DOI 10.1094/MPMI-21-11-1443; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Seo JA, 2005, GENETICS, V171, P81, DOI 10.1534/genetics.105.042796; Shimizu K, 2003, GENETICS, V165, P1095; Shimizu K, 2001, GENETICS, V157, P591; Studt L, 2012, FUNGAL GENET BIOL, V49, P567, DOI 10.1016/j.fgb.2012.05.005; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Tag A, 2000, MOL MICROBIOL, V38, P658, DOI 10.1046/j.1365-2958.2000.02166.x; TERENZI HF, 1976, J BACTERIOL, V126, P91, DOI 10.1128/JB.126.1.91-99.1976; Tudzynski B, 1996, MICROBIOL-SGM, V142, P533, DOI 10.1099/13500872-142-3-533; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; TURNER GE, 1993, J BIOL CHEM, V268, P14805; Wiemann P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037519; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; YABUTA T., 1939, Journal of the Agricultural Chemical Society of Japan, V15, P257; Yang Q, 1999, GENETICS, V151, P107; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Yu JH, 1996, EMBO J, V15, P5184, DOI 10.1002/j.1460-2075.1996.tb00903.x; Zeilinger S, 2005, APPL ENVIRON MICROB, V71, P1591, DOI 10.1128/AEM.71.3.1591-1597.2005; Zuber S, 2003, GENETICS, V164, P487; Zuber S, 2002, EUKARYOT CELL, V1, P440, DOI 10.1128/EC.1.3.440-447.2002	87	42	46	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58185	10.1371/journal.pone.0058185	http://dx.doi.org/10.1371/journal.pone.0058185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469152	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900243
J	Dai, N; Cao, XJ; Li, MX; Qing, Y; Liao, L; Lu, XF; Zhang, SH; Li, Z; Yang, YX; Wang, D				Dai, Nan; Cao, Xiao-Jing; Li, Meng-Xia; Qing, Yi; Liao, Ling; Lu, Xian-Feng; Zhang, Shi-Heng; Li, Zheng; Yang, Yu-Xin; Wang, Dong			Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							BASE EXCISION-REPAIR; SUBCELLULAR-LOCALIZATION; ANTI-P53 AUTOANTIBODIES; ENDONUCLEASE APE1/REF-1; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; P53; ACTIVATION; PROTEIN; AGENTS	Apurinic/apyrimidinic endonuclease 1 (APE1), which has the dual functions of both DNA repair and redox activity, has been reported to be highly expressed in non-small cell lung cancer (NSCLC), and this appears to be a characteristic related to chemotherapy resistance. In this study, we identified serum APE1 autoantibodies (APE1-AAbs) in NSCLC patients and healthy controls by immunoblotting and investigated the expression of APE1-AAbs by indirect ELISA from the serum of 292 NSCLC patients and 300 healthy controls. In addition, serum APE1-AAbs level alterations of 91 patients were monitored before and after chemotherapy. Our results showed that serum APE1-AAbs can be detected in both NSCLC patients and healthy controls. Serum APE1-AAbs were significantly higher than those of healthy controls and closely related to APE1 antigen levels both in tumor tissues and the peripheral blood. Moreover, the change in levels of serum APE1-AAbs in NSCLC is closely associated with the response to chemotherapy. These results suggest that APE1-AAbs is a potential tumor marker and predictor of therapeutic efficacy in NSCLC.	[Dai, Nan; Li, Meng-Xia; Qing, Yi; Liao, Ling; Lu, Xian-Feng; Zhang, Shi-Heng; Li, Zheng; Yang, Yu-Xin; Wang, Dong] Third Mil Med Univ, Daping Hosp, Ctr Canc, Chongqing, Peoples R China; [Dai, Nan; Li, Meng-Xia; Qing, Yi; Liao, Ling; Lu, Xian-Feng; Zhang, Shi-Heng; Li, Zheng; Yang, Yu-Xin; Wang, Dong] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Cao, Xiao-Jing] Chongqing Hosp Tradit Chinese Med, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Wang, D (corresponding author), Third Mil Med Univ, Daping Hosp, Ctr Canc, Chongqing, Peoples R China.	dongwang64@hotmail.com	Li, Mengxia/AAM-4289-2020; yang, yx/GZM-0464-2022	Li, Mengxia/0000-0003-4443-740X; 	National Natural Science Foundation of China [30872975, 81001000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30872975 and No. 81001000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Atassi MZ, 2008, AUTOIMMUNITY, V41, P123, DOI 10.1080/08916930801929021; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Bharti A, 2007, MASS SPECTROM REV, V26, P451, DOI 10.1002/mas.20125; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Chapman CJ, 2011, CLIN CANCER RES, V17, P1474, DOI 10.1158/1078-0432.CCR-10-1363; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; Desmetz C, 2011, J CELL MOL MED, V15, P2013, DOI 10.1111/j.1582-4934.2011.01355.x; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fan Jerome, 2006, CJEM, V8, P19; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; FOLLI F, 1993, NEW ENGL J MED, V328, P546, DOI 10.1056/NEJM199302253280805; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gullo C, 2006, BBA-REV CANCER, V1765, P223, DOI 10.1016/j.bbcan.2006.01.001; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Iizasa T, 1998, CANCER IMMUNOL IMMUN, V46, P345, DOI 10.1007/s002620050496; Indovina Paola, 2011, Int J Proteomics, V2011, P726869, DOI 10.1155/2011/726869; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karanikas V, 2009, CANCER LETT, V282, P159, DOI 10.1016/j.canlet.2009.03.015; Katsumata Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005330; Kobold S, 2010, HUM IMMUNOL, V71, P643, DOI 10.1016/j.humimm.2010.03.015; Konopa K, 2010, ANN ONCOL, V21, P199, DOI 10.1093/annonc/mdq452; Lubin R, 1995, CLIN CANCER RES, V1, P1463; Luo MH, 2004, ANTICANCER RES, V24, P2127; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macdonald IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040759; Madrid MF, 2005, CANCER LETT, V230, P187, DOI 10.1016/j.canlet.2004.12.017; Messmer BT, 2011, LEUKEMIA RES, V35, P965, DOI 10.1016/j.leukres.2011.04.009; Milne K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003409; Mitsudomi T, 1998, JNCI-J NATL CANCER I, V90, P1563, DOI 10.1093/jnci/90.20.1563; Nagashio R, 2008, LUNG CANCER, V62, P364, DOI 10.1016/j.lungcan.2008.03.026; Neri M, 2003, LUNG CANCER-J IASLC, V39, P165, DOI 10.1016/S0169-5002(02)00449-X; Nesterova M, 2006, BBA-MOL BASIS DIS, V1762, P398, DOI 10.1016/j.bbadis.2005.12.010; Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Postmus PE, 2008, ANN ONCOL, V19, P25, DOI 10.1093/annonc/mdn464; Puglisi F, 2001, ANTICANCER RES, V21, P4041; Qiu J, 2008, J CLIN ONCOL, V26, P5060, DOI 10.1200/JCO.2008.16.2388; Saleh J, 2006, CANCER LETT, V233, P48, DOI 10.1016/j.canlet.2005.02.040; Schena M, 2012, DNA REPAIR AMST; Singh KK, 2005, GENE, V354, P140, DOI 10.1016/j.gene.2005.03.027; Sweasy JB, 2006, CELL CYCLE, V5, P250, DOI 10.4161/cc.5.3.2414; Tan HT, 2009, FEBS J, V276, P6880, DOI 10.1111/j.1742-4658.2009.07396.x; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Tureci O, 2006, CANCER LETT, V236, P64, DOI 10.1016/j.canlet.2005.05.008; Tufman A, 2010, CANCER BIOMARK, V6, P123, DOI 10.3233/CBM-2009-0124; Wang D, 2004, MOL CANCER THER, V3, P679; Wang D, 2009, LUNG CANCER, V66, P298, DOI 10.1016/j.lungcan.2009.02.019; Wang JB, 2010, CANCER CAUSE CONTROL, V21, P959, DOI 10.1007/s10552-010-9523-8; Wu HH, 2010, ONCOGENE, V29, P4330, DOI 10.1038/onc.2010.178; Yoo DG, 2008, LUNG CANCER, V60, P277, DOI 10.1016/j.lungcan.2007.10.015; Zhang Y, 2009, INT J ONCOL, V35, P1069, DOI 10.3892/ijo_00000422; [张云嵩 ZHANG Yunsong], 2007, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V29, P776; Zinkernagel RM, 2000, NAT IMMUNOL, V1, P181, DOI 10.1038/79712	56	38	41	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58001	10.1371/journal.pone.0058001	http://dx.doi.org/10.1371/journal.pone.0058001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472128	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900071
J	De Coster, G; Van Dongen, S; Malaki, P; Muchane, M; Alcantara-Exposito, A; Matheve, H; Lens, L				De Coster, Greet; Van Dongen, Stefan; Malaki, Phillista; Muchane, Muchai; Alcantara-Exposito, Angelica; Matheve, Hans; Lens, Luc			Fluctuating Asymmetry and Environmental Stress: Understanding the Role of Trait History	PLOS ONE			English	Article							DEVELOPMENTAL STABILITY; DIRECTIONAL ASYMMETRY; HABITAT DISTURBANCE; BODY-SIZE; FITNESS; FRAGMENTATION; INSTABILITY; ORNAMENTS; INDICATOR; PATTERNS	While fluctuating asymmetry (FA; small, random deviations from perfect symmetry in bilaterally symmetrical traits) is widely regarded as a proxy for environmental and genetic stress effects, empirical associations between FA and stress are often weak or heterogeneous among traits. A conceptually important source of heterogeneity in relationships with FA is variation in the selection history of the trait(s) under study, i.e. traits that experienced a (recent) history of directional change are predicted to be developmentally less stable, potentially through the loss of canalizing modifiers. Here we applied X-ray photography on museum specimens and live captures to test to what extent the magnitude of FA and FA-stress relationships covary with directional shifts in traits related to the flight apparatus of four East-African rainforest birds that underwent recent shifts in habitat quality and landscape connectivity. Both the magnitude and direction of phenotypic change varied among species, with some traits increasing in size while others decreased or maintained their original size. In three of the four species, traits that underwent larger directional changes were less strongly buffered against random perturbations during their development, and traits that increased in size over time developed more asymmetrically than those that decreased. As we believe that spurious relationships due to biased comparisons of historic (museum specimens) and current (field captures) samples can be ruled out, these results support the largely untested hypothesis that directional shifts may increase the sensitivity of developing traits to random perturbations of environmental or genetic origin.	[De Coster, Greet; Alcantara-Exposito, Angelica; Matheve, Hans; Lens, Luc] Univ Ghent, Terr Ecol Unit, B-9000 Ghent, Belgium; [De Coster, Greet; Van Dongen, Stefan] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Malaki, Phillista; Muchane, Muchai] Natl Museums Kenya, Nairobi, Kenya	Ghent University; University of Antwerp	De Coster, G (corresponding author), Univ Sao Paulo, Dept Ecol, Biosci Inst, Sao Paulo, Brazil.	greet.decoster@ugent.be	De Coster, Greet/C-7237-2008	Lens, Luc/0000-0002-0241-2215	Research Foundation Flanders (FWO) [G.0055.08, G.0149.09]; Flemish Interuniversity Council [02/6/7-338-607]; FWO research community [WO.037.10N]	Research Foundation Flanders (FWO)(FWO); Flemish Interuniversity Council; FWO research community	This study was funded by research grants G.0055.08 (to LL) and G.0149.09 (to SVD) of Research Foundation Flanders (FWO), by Flemish Interuniversity Council project 02/6/7-338-607 (to W. Verheyen) and through contacts facilitated by FWO research community WO.037.10N (to F. Volckaert). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2006, J ORNITHOL, V147, P125; Anciaes M, 2000, J APPL ECOL, V37, P1013, DOI 10.1046/j.1365-2664.2000.00554.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Beentje HJ, 1987, UTAFITI, V1, P23; Callens T, 2011, MOL ECOL, V20, P1829, DOI 10.1111/j.1365-294X.2011.05028.x; Chege J, 2005, J EAST AFR NAT HIST, V94, P231, DOI [10.2982/0012-8317(2005)94[231:VSOFSF]2.0.CO;2, DOI 10.2982/0012-8317(2005)94[231:VSOFSF]2.0.CO;2]; Clarke GM, 1998, HEREDITY, V80, P553, DOI 10.1046/j.1365-2540.1998.00326.x; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Dantas GPM, 2009, IHERINGIA SER ZOOL, V99, P115, DOI 10.1590/S0073-47212009000100017; Delgado-Acevedo J, 2008, CONSERV BIOL, V22, P773, DOI 10.1111/j.1523-1739.2008.00930.x; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Ellegren H, 1997, NATURE, V389, P593, DOI 10.1038/39303; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Freedman AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013088; Goodenough AE, 2012, ANN ZOOL FENN, V49, P81, DOI 10.5735/086.049.0108; Helle S, 2011, ECOL INDIC, V11, P861, DOI 10.1016/j.ecolind.2010.11.004; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hopton ME, 2009, ECOL INDIC, V9, P883, DOI 10.1016/j.ecolind.2008.10.010; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Krist M, 2011, BIOL REV, V86, P692, DOI 10.1111/j.1469-185X.2010.00166.x; Lens L, 2000, ECOL LETT, V3, P516, DOI 10.1046/j.1461-0248.2000.00181.x; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1241, DOI 10.1098/rspb.1999.0769; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1055, DOI 10.1098/rspb.1999.0743; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2002, CONSERV BIOL, V16, P479, DOI 10.1046/j.1523-1739.2002.00516.x; Lens L, 2001, OSTRICH, P44; Lens L, 2008, BIRD CONSERV INT, V18, pS125, DOI 10.1017/S0959270908000336; Lovett J.C., 1985, SWARA, V8, P8; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; MOLLER AP, 1993, J EVOLUTION BIOL, V6, P481, DOI 10.1046/j.1420-9101.1993.6040481.x; MOLLER AP, 1991, P ROY SOC B-BIOL SCI, V245, P1, DOI 10.1098/rspb.1991.0080; MOLLER AP, 1993, J THEOR BIOL, V161, P359, DOI 10.1006/jtbi.1993.1061; MOLLER AP, 1993, GENETICA, V89, P267, DOI 10.1007/BF02424520; Moller AP, 1997, ASYMMETRY DEV STABIL; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PALMER AR, 1994, DEV INSTABILITY ITS, P203; Pelabon C, 2006, J EVOLUTION BIOL, V19, P764, DOI 10.1111/j.1420-9101.2005.01054.x; Pellikka PKE, 2009, INT J APPL EARTH OBS, V11, P221, DOI 10.1016/j.jag.2009.02.002; Polak M., 2003, CAUSES CONSEQUENCES; Polak M, 2007, P ROY SOC B-BIOL SCI, V274, P3133, DOI 10.1098/rspb.2007.1272; Schmeller DS, 2011, J NAT CONSERV, V19, P161, DOI 10.1016/j.jnc.2010.11.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherman E, 2009, APPL HERPETOL, V6, P369, DOI 10.1163/157075309X1252321771605; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Svensson L., 1992, IDENTIFICATION GUIDE; SWADDLE JP, 1994, ANIM BEHAV, V48, P986, DOI 10.1006/anbe.1994.1327; van Dongen S, 1999, J EVOLUTION BIOL, V12, P94, DOI 10.1046/j.1420-9101.1999.00012.x; Van Dongen S, 2009, J EVOLUTION BIOL, V22, P1695, DOI 10.1111/j.1420-9101.2009.01780.x; Vangestel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021569; Vangestel C, 2011, ECOL INDIC, V11, P389, DOI 10.1016/j.ecolind.2010.06.009; Weller B, 2004, BASIC APPL ECOL, V5, P193, DOI 10.1078/1439-1791-00220; Wilder C., 1998, J EAST AFR NAT HIST, V87, P181, DOI [10.2982/0012-8317(1998)87[181:VSACOT]2.0.CO;2, DOI 10.2982/0012-8317(1998)87[181:VSACOT]2.0.CO;2]; Wilson JM, 1996, J HUM EVOL, V30, P529, DOI 10.1006/jhev.1996.0041	57	37	40	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57966	10.1371/journal.pone.0057966	http://dx.doi.org/10.1371/journal.pone.0057966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472123	Green Published, gold			2022-12-27	WOS:000315637900066
J	Huoi, C; Vanhems, P; Nicolle, MC; Michallet, M; Benet, T				Huoi, Catherine; Vanhems, Philippe; Nicolle, Marie-Christine; Michallet, Mauricette; Benet, Thomas			Incidence of Hospital-Acquired Pneumonia, Bacteraemia and Urinary Tract Infections in Patients with Haematological Malignancies, 2004-2010: A Surveillance-Based Study	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; BLOOD-STREAM INFECTIONS; STEM-CELL TRANSPLANTATION; NOSOCOMIAL INFECTIONS; INVASIVE ASPERGILLOSIS; CANCER-PATIENTS; IMMUNOCOMPROMISED PATIENTS; NEUTROPENIC PATIENTS; SINGLE INSTITUTION; PROGNOSTIC-FACTORS	Objective: This study charted incidence trends of hospital-acquired (HA) pneumonia, bacteraemia and urinary tract infections (UTI) in a haematology department. Methods: Prospective surveillance of hospital-acquired infections (HAI) was undertaken in a 42-bed haematology department of a university hospital. All patients hospitalized >= 48 hours between 1 st January 2004 and 31 st December 2010 were included. Definitions of HAI were based on a standardized protocol. The incidence was the number of events per 1000 patient-days at risk; only the first HAI was counted. Multivariate Poisson regression was fitted to assess temporal trends. Results: Among 3 355 patients (58 063 patient-days at risk) included, 1 055 (31%) had HAI. The incidence of HA pneumonia, HA bacteraemia and HA UTI was respectively 3.3, 12.0 and 2.9 per 1000 patient-days at risk. HA bacteraemia incidence increased by 11% (95% confidence interval: +6%, +15%, P<0.001) per year, independently of neutropenia, central venous catheterization (CVC) and haematological disease. The incidences of HA pneumonia and HA UTI were stable. The most frequently isolated pathogens were Aspergillus spp. (59.2%) for pneumonia, coagulase-negative Staphylococcus (44.2%) for bacteraemia and enterobacteria (60%) for UTI. Conclusion: The incidence of bacteraemia increased, indicating that factors other than CVC exposure, including chemotherapy with its impact on the immune system, could explain this trend. Further analytic studies are needed to explore the factors that could explain this trend.	[Huoi, Catherine; Vanhems, Philippe; Nicolle, Marie-Christine; Benet, Thomas] Hosp Civils Lyon, Infect Control & Epidemiol Unit, Edouard Herriot Hosp, Lyon, France; [Vanhems, Philippe; Benet, Thomas] Univ Lyon 1, Epidemiol & Publ Hlth Grp, CNRS, UMR 5558, F-69365 Lyon, France; [Michallet, Mauricette] Hosp Civils Lyon, Dept Haematol, Edouard Herriot Hosp, Lyon, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; CHU Lyon	Benet, T (corresponding author), Hosp Civils Lyon, Infect Control & Epidemiol Unit, Edouard Herriot Hosp, Lyon, France.	thomas.benet@chu-lyon.fr						Al-Tonbary YA, 2011, WORLD J PEDIATR, V7, P60, DOI 10.1007/s12519-010-0212-1; Bailey LC, 2009, SEMIN HEMATOL, V46, P313, DOI 10.1053/j.seminhematol.2009.03.010; Benet T, 2009, J HOSP INFECT, V73, P217, DOI 10.1016/j.jhin.2009.07.018; Benet T, 2007, CLIN INFECT DIS, V45, P682, DOI 10.1086/521378; CARLISLE PS, 1993, INFECT CONT HOSP EP, V14, P320, DOI 10.1086/646750; Comite technique des infections nosocomiales, 1999, 100 REC SURV PREV IN; Cornet M, 2002, J HOSP INFECT, V51, P288, DOI 10.1053/jhin.2002.1258; Crawford J, 2004, CANCER-AM CANCER SOC, V100, P228, DOI 10.1002/cncr.11882; Cullen M, 2009, BRIT J CANCER, V101, pS11, DOI 10.1038/sj.bjc.6605270; De Angelis G, 2010, CLIN MICROBIOL INFEC, V16, P1729, DOI 10.1111/j.1469-0691.2010.03332.x; Dettenkofer M, 2005, CLIN INFECT DIS, V40, P926, DOI 10.1086/428046; Dettenkofer M, 2003, BONE MARROW TRANSPL, V31, P795, DOI 10.1038/sj.bmt.1703920; Engelhart S, 2002, INFECT CONT HOSP EP, V23, P244, DOI 10.1086/502043; Ewig S, 1998, CHEST, V114, P444, DOI 10.1378/chest.114.2.444; Gonzalez-Barca E, 1999, EUR J CLIN MICROBIOL, V18, P539, DOI 10.1007/s100960050345; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Hahn T, 2002, INFECT CONT HOSP EP, V23, P525, DOI 10.1086/502101; Leibovici L, 2006, CANCER-AM CANCER SOC, V107, P1743, DOI 10.1002/cncr.22205; Marena C, 2001, INFECT CONT HOSP EP, V22, P510, DOI 10.1086/501942; Nicolle MC, 2011, HAEMATOL-HEMATOL J, V96, P1685, DOI 10.3324/haematol.2011.044636; PANNUTI C, 1992, CANCER-AM CANCER SOC, V69, P2653, DOI 10.1002/1097-0142(19920601)69:11<2653::AID-CNCR2820691106>3.0.CO;2-8; PANNUTI CS, 1991, J CLIN ONCOL, V9, P77, DOI 10.1200/JCO.1991.9.1.77; Pottecher B, 2000, B CANCER, V87, P557; Pulte D, 2008, JNCI-J NATL CANCER I, V100, P1301, DOI 10.1093/jnci/djn276; Roberts RR, 2010, MED CARE, V48, P1026, DOI 10.1097/MLR.0b013e3181ef60a2; Rupp ME, 2004, HOSP EPIDEMIOLOGY IN, V3rd, P253; Saavedra S, 2002, BONE MARROW TRANSPL, V30, P937, DOI 10.1038/sj.bmt.1703764; Saavedra S, 2002, CLIN MICROBIOL INFEC, V8, P725, DOI 10.1046/j.1469-0691.2002.00458.x; Segal Brahm H, 2007, J Natl Compr Canc Netw, V5, P235; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Thirumala R, 2010, CRIT CARE CLIN, V26, P59, DOI 10.1016/j.ccc.2009.09.007; Urrea M, 2004, AM J INFECT CONTROL, V32, P205, DOI 10.1016/j.ajic.2003.10.013; Velasco E, 2004, EUR J CLIN MICROBIOL, V23, P596, DOI 10.1007/s10096-004-1181-x; Velasco E, 1997, AM J INFECT CONTROL, V25, P458, DOI 10.1016/S0196-6553(97)90067-5; Wayne AS, 2008, JNCI-J NATL CANCER I, V100, P1271, DOI 10.1093/jnci/djn306; Wisplinghoff H, 2003, INFECT CONT HOSP EP, V24, P905, DOI 10.1086/502158; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339	37	22	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58121	10.1371/journal.pone.0058121	http://dx.doi.org/10.1371/journal.pone.0058121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472145	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900090
J	Kok, GD; Bockting, CLH; Burger, H; Hannig, W; Pijnenborg, GHM; Cuijpers, P; Hollon, SD				Kok, Gemma D.; Bockting, Claudi L. H.; Burger, Huibert; Hannig, Wiebke; Pijnenborg, Gerdina H. M.; Cuijpers, Pim; Hollon, Steven D.			Double Trouble: Does Co-Morbid Chronic Somatic Illness Increase Risk for Recurrence in Depression? A Systematic Review	PLOS ONE			English	Review							HEALTH; INTERVIEW; DISORDER; CARE; RECOVERY; DISEASES; IMPACT	Objective: To perform a systematic review, and if possible a meta-analysis, to establish whether depressed patients with comorbid chronic somatic illnesses are a high risk "double trouble" group for depressive recurrence. Method: The databases PubMed, EMbase and PsycINFO were systematically searched until the 4th of December 2012 by using MeSH and free text terms. Additionally, reference lists of retrieved publications and treatment guidelines were reviewed, and experts were consulted. Inclusion criteria were: depression had to be measured at least twice during the study with qualified instruments and the chronic somatic illness had to be assessed by self-report or by a medical professional. Information on depressive recurrence was extracted and additionally risk ratios of recurrence were calculated. Results: The search generated four articles that fulfilled our inclusion criteria. These studies showed no differences in recurrence over one-two-three-and 6.5 years of follow-up for a total of 2010 depressed patients of which 694 patients with a co-morbid chronic somatic illness versus 1316 patients without (Study 1: RR = 0.49, 95% CI, 0.17-1.41 at one year follow-up and RR = 1.37, 95% CI, 0.78-2.41 at two year follow-up; Study 2: RR = 0.94, 95% CI, 0.65-1.36 at two year follow-up; Study 3: RR = 1.15, 95% CI, 0.40-3.27 at one year follow-up; RR = 1.07, 95% CI, 0.48-2.42 at two year follow-up and RR = 0.99, 95% CI, 0.55-1.77 at 6.5 years follow-up; Study 4: RR = 1.16, 95% CI, 0.86-1.57 at three year follow-up). Conclusion: We found no association between a heightened risk for depressive recurrence and co-morbid chronic somatic illnesses. There is a need for more longitudinal studies to justify the current specific treatment advice such as long-term pharmacological maintenance treatment for this presumed "double trouble" group.	[Kok, Gemma D.; Bockting, Claudi L. H.; Pijnenborg, Gerdina H. M.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Hannig, Wiebke] Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany; [Pijnenborg, Gerdina H. M.] GGZ Drenthe, Dept Psychot Disorders, Assen, Netherlands; [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Cuijpers, Pim] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Cuijpers, Pim] Leuphana Univ, Luneburg, Germany; [Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	University of Groningen; University of Groningen; Philipps University Marburg; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leuphana University Luneburg; Vanderbilt University	Bockting, CLH (corresponding author), Univ Groningen, Dept Clin Psychol, Groningen, Netherlands.	c.l.h.bockting@rug.nl	Cuijpers, Pim/G-1703-2013; Bockting, Claudi L/K-3768-2019	Bockting, Claudi L/0000-0002-9220-9244; Cuijpers, Pim/0000-0001-5497-2743				Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2010, PRACT GUID TREATM PA; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BURNAM MA, 1988, MED CARE, V26, P775, DOI 10.1097/00005650-198808000-00004; Deeks J J, 2003, Health Technol Assess, V7, piii; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Evans DL, 2003, BIOL PSYCHIAT, V54, P177, DOI 10.1016/S0006-3223(03)00639-5; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Gerrits MM, 2013, PSYCHOTHER PSYCHOSOM, V82, P64, DOI 10.1159/000338636; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hardeveld F, 2012, PSYCHOL MED, V12, P1; Judd LL, 1997, ARCH GEN PSYCHIAT, V54, P989; Koike AK, 2002, AM J PSYCHIAT, V159, P1738, DOI 10.1176/appi.ajp.159.10.1738; Kovacs M, 1997, DIABETES CARE, V20, P45, DOI 10.2337/diacare.20.1.45; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P991; LYKETSOS CG, 1994, INT J METHOD PSYCH, V4, P143; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; National Institute for Health and Clinical Excellence, 2009, DEPR AD CHRON PHYS H; National Institute for Health and Clinical Excellence, 2010, NAT CLIN PRACT GUID, V91; Noel PH, 2004, ANN FAM MED, V2, P555, DOI 10.1370/afm.143; Reeves BC, 2008, COCHRANE HDB SYSTEMA, P389, DOI [DOI 10.1002/9780470712184.CH13, DOI 10.1002/9780470712184]; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Simon GE, 2005, PSYCHOL MED, V35, P271, DOI 10.1017/S0033291704003071; Tossani E, 2005, SEMIN DIALYSIS, V18, P73, DOI 10.1111/j.1525-139X.2005.18217.x; Wallace RB, 1995, J HUM RESOUR, V30, pS84, DOI 10.2307/146279; Wells GA, NEWCASTLE OTTOWA SCA; WELLS KB, 1993, AM J PSYCHIAT, V150, P632; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645	31	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57510	10.1371/journal.pone.0057510	http://dx.doi.org/10.1371/journal.pone.0057510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099RC	23472087	Green Published, gold			2022-12-27	WOS:000315637900026
J	Patel, M; Cai, QF; Ding, DL; Salvi, R; Hu, ZH; Hu, BH				Patel, Minal; Cai, Qunfeng; Ding, Dalian; Salvi, Richard; Hu, Zihua; Hu, Bo Hua			The miR-183/Taok1 Target Pair Is Implicated in Cochlear Responses to Acoustic Trauma	PLOS ONE			English	Article							APOPTOSIS-RELATED GENES; NOISE-INDUCED APOPTOSIS; OUTER HAIR-CELLS; HEARING-LOSS; INNER-EAR; OXIDATIVE STRESS; PROTEIN-KINASE; MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; EXPOSURE	Acoustic trauma, one of the leading causes of sensorineural hearing loss, induces sensory hair cell damage in the cochlea. Identifying the molecular mechanisms involved in regulating sensory hair cell death is critical towards developing effective treatments for preventing hair cell damage. Recently, microRNAs (miRNAs) have been shown to participate in the regulatory mechanisms of inner ear development and homeostasis. However, their involvement in cochlear sensory cell degeneration following acoustic trauma is unknown. Here, we profiled the expression pattern of miRNAs in the cochlear sensory epithelium, defined miRNA responses to acoustic overstimulation, and explored potential mRNA targets of miRNAs that may be responsible for the stress responses of the cochlea. Expression analysis of miRNAs in the cochlear sensory epithelium revealed constitutive expression of 176 miRNAs, many of which have not been previously reported in cochlear tissue. Exposure to intense noise caused significant threshold shift and apoptotic activity in the cochleae. Gene expression analysis of noise-traumatized cochleae revealed time-dependent transcriptional changes in the expression of miRNAs. Target prediction analysis revealed potential target genes of the significantly downregulated miRNAs, many of which had cell death- and apoptosis-related functions. Verification of the predicted targets revealed a significant upregulation of Taok1, a target of miRNA-183. Moreover, inhibition of miR-183 with morpholino antisense oligos in cochlear organotypic cultures revealed a negative correlation between the expression levels of miR-183 and Taok1, suggesting the presence of a miR-183/Taok1 target pair. Together, miRNA profiling as well as the target analysis and validation suggest the involvement of miRNAs in the regulation of the degenerative process of the cochlea following acoustic overstimulation. The miR-183/Taok1 target pair is likely to play a role in this regulatory process.	[Patel, Minal; Cai, Qunfeng; Ding, Dalian; Salvi, Richard; Hu, Bo Hua] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA; [Hu, Zihua] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Ctr Computat Res, Dept Ophthalmol,Dept Biostat,Dept Med, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hu, BH (corresponding author), SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA.	bhu@buffalo.edu			National Institutes of Health [R01DC010154-01A2]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant R01DC010154-01A2 (to BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Ahn JH, 2005, BIOCHEM BIOPH RES CO, V335, P485, DOI 10.1016/j.bbrc.2005.07.114; Akao Y, 2009, LEUKEMIA RES, V33, P1530, DOI 10.1016/j.leukres.2009.04.019; Belleannee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034996; Bohne BA, 2007, HEARING RES, V223, P61, DOI 10.1016/j.heares.2006.10.004; Cai QF, 2012, NEUROBIOL DIS, V45, P723, DOI 10.1016/j.nbd.2011.10.018; Chan DK, 2007, OTOL NEUROTOL, V28, P417, DOI 10.1097/01.mao.0000247826.28893.7a; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Cho YS, 2004, MOL BRAIN RES, V130, P134, DOI 10.1016/j.molbrainres.2004.07.017; Cosulich S, 1996, CURR BIOL, V6, P1586, DOI 10.1016/S0960-9822(02)70779-3; David EA, 2002, J OTOLARYNGOL, V31, P304, DOI 10.2310/7070.2002.34330; Ding DL, 2002, HEARING RES, V164, P115, DOI 10.1016/S0378-5955(01)00417-8; Elkan-Miller T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018195; Eskiizmir G, 2011, ORL-J OTO-RHIN-LARYN, V73, P24, DOI 10.1159/000321116; Feng S, 2011, NUCL ACIDS RES; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frucht CS, 2011, NEUROSCI LETT, V493, P44, DOI 10.1016/j.neulet.2011.02.017; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Habtemichael N, 2010, MOL CELL NEUROSCI, V45, P297, DOI 10.1016/j.mcn.2010.07.003; Han WJ, 2006, HEARING RES, V211, P85, DOI 10.1016/j.heares.2005.10.004; Harding GW, 2005, HEARING RES, V204, P90, DOI 10.1016/j.heares.2005.01.004; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; HENRY KR, 1981, ARCH OTOLARYNGOL, V107, P92; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hsu CJ, 2000, HEARING RES, V142, P203, DOI 10.1016/S0378-5955(00)00020-4; Hu BH, 2009, NEUROSCIENCE, V161, P915, DOI 10.1016/j.neuroscience.2009.03.072; Hu BH, 2000, ACTA OTO-LARYNGOL, V120, P19, DOI 10.1080/000164800760370774; Hu BH, 2002, HEARING RES, V166, P62, DOI 10.1016/S0378-5955(02)00286-1; Hu BH, 2010, J NEUROSCI RES, V88, P1812, DOI 10.1002/jnr.22333; Hu BH, 2008, HEARING RES, V245, P48, DOI 10.1016/j.heares.2008.08.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Jamesdaniel S, 2011, J PROTEOMICS; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Kanitz A, 2010, WIRES SYST BIOL MED, V2, P245, DOI 10.1002/wsbm.55; KONISHI T, 1979, HEARING RES, V1, P325, DOI 10.1016/0378-5955(79)90004-2; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; Li PF, 2010, J CARDIOVASC TRANSL, V3, P219, DOI 10.1007/s12265-010-9175-9; Lu SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040676; Masaki M, 2003, EUR J BIOCHEM, V270, P76, DOI 10.1046/j.1432-1033.2003.03363.x; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200; Motsch N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042193; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Murillo-Cuesta S, 2012, MOL MED, V18, P260, DOI 10.2119/molmed.2011.00328; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Okumura H, 2011, EXP ANIM TOKYO, V60, P355, DOI 10.1538/expanim.60.355; Patel M, 2012, HEARING RES, V287, P6, DOI 10.1016/j.heares.2012.03.008; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Pirvola U, 2000, J NEUROSCI, V20, P43, DOI 10.1523/JNEUROSCI.20-01-00043.2000; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Raman M, 2007, EMBO J, V26, P2005, DOI 10.1038/sj.emboj.7601668; Ross JS, 2007, AM J CLIN PATHOL, V128, P830, DOI 10.1309/2JK279BU2G743MWJ; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003; SAUNDERS JC, 1985, J ACOUST SOC AM, V78, P833, DOI 10.1121/1.392915; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shruti K, 2011, BIOCH BIOPHYS RES CO; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Tadros SF, 2008, APOPTOSIS, V13, P1303, DOI 10.1007/s10495-008-0266-x; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Thulasingam S, 2011, MOL CELL BIOCH; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van De Water TR, 2004, OTOL NEUROTOL, V25, P627, DOI 10.1097/00129492-200407000-00035; Vecchione A, 2010, ENDOCR-RELAT CANCER, V17, pF37, DOI 10.1677/ERC-09-0163; Vlajkovic SM, 2004, NEUROSCIENCE, V126, P763, DOI 10.1016/j.neuroscience.2004.04.023; Wang J, 2003, J NEUROSCI, V23, P8596; Wang J, 2011, GENE THER; Wang XR, 2010, NEUROREPORT, V21, P611, DOI 10.1097/WNR.0b013e328338864b; Wang Z, 2010, BRAIN RES, V1346, P14, DOI 10.1016/j.brainres.2010.05.059; Wei L, 2010, NEUROSCIENCE, V168, P288, DOI 10.1016/j.neuroscience.2010.03.015; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Wojtala RL, 2011, J BIOL CHEM, V286, P30161, DOI 10.1074/jbc.M111.228320; Wu MF, 2008, CELL BIOL INT, V32, P151, DOI 10.1016/j.cellbi.2007.08.006; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yamamoto H, 2009, NEUROSCIENCE, V158, P1691, DOI 10.1016/j.neuroscience.2008.10.063; Yang WP, 2004, HEARING RES, V196, P69, DOI 10.1016/j.heares.2004.04.015; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043741; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034688	93	27	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58471	10.1371/journal.pone.0058471	http://dx.doi.org/10.1371/journal.pone.0058471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472202	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900148
J	Sariisik, E; Docheva, D; Padula, D; Popov, C; Opfer, J; Schieker, M; Clausen-Schaumann, H; Benoit, M				Sariisik, Ediz; Docheva, Denitsa; Padula, Daniela; Popov, Cvetan; Opfer, Jan; Schieker, Matthias; Clausen-Schaumann, Hauke; Benoit, Martin			Probing the Interaction Forces of Prostate Cancer Cells with Collagen I and Bone Marrow Derived Stem Cells on the Single Cell Level	PLOS ONE			English	Article							SKELETAL METASTASES; SIGNALING PROMOTES; ADHESION FORCES; STROMAL CELLS; INVASION; GROWTH; SPECTROSCOPY; ORGANIZATION	Adhesion of metastasizing prostate carcinoma cells was quantified for two carcinoma model cell lines LNCaP (lymph node-specific) and PC3 (bone marrow-specific). By time-lapse microscopy and force spectroscopy we found PC3 cells to preferentially adhere to bone marrow-derived mesenchymal stem cells (SCP1 cell line). Using atomic force microscopy (AFM) based force spectroscopy, the mechanical pattern of the adhesion to SCP1 cells was characterized for both prostate cancer cell lines and compared to a substrate consisting of pure collagen type I. PC3 cells dissipated more energy (27.6 aJ) during the forced de-adhesion AFM experiments antd showed significantly more adhesive and stronger bonds compared to LNCaP cells (20.1 aJ). The characteristic signatures of the detachment force traces revealed that, in contrast to the LNCaP cells, PC3 cells seem to utilize their filopodia in addition to establish adhesive bonds. Taken together, our study clearly demonstrates that PC3 cells have a superior adhesive affinity to bone marrow mesenchymal stem cells, compared to LNCaP. Semi-quantitative PCR on both prostate carcinoma cell lines revealed the expression of two Col-I binding integrin receptors, alpha 1 beta 1 and alpha 2 beta 1 in PC3 cells, suggesting their possible involvement in the specific interaction to the substrates. Further understanding of the exact mechanisms behind this phenomenon might lead to optimized therapeutic applications targeting the metastatic behavior of certain prostate cancer cells towards bone tissue.	[Sariisik, Ediz; Opfer, Jan; Benoit, Martin] Univ Munich, Chair Biophys & New Mat, Munich, Germany; [Sariisik, Ediz; Padula, Daniela; Opfer, Jan; Clausen-Schaumann, Hauke; Benoit, Martin] Univ Munich, Ctr NanoSci, Munich, Germany; [Docheva, Denitsa; Padula, Daniela; Popov, Cvetan; Schieker, Matthias] Univ Munich, Dept Surg, Munich, Germany; [Sariisik, Ediz; Padula, Daniela; Clausen-Schaumann, Hauke] Munich Univ Appl Sci, Dept Appl Sci & Mechatron, Munich, Germany; [Schieker, Matthias; Clausen-Schaumann, Hauke] Munich Univ Appl Sci, Ctr Appl Tissue Engn & Regenerat Med, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Clausen-Schaumann, H (corresponding author), Univ Munich, Ctr NanoSci, Munich, Germany.	clausen-schaumann@hm.edu; benoit@physik.uni-muenchen.de	Docheva, Denitsa/R-1259-2018; Schieker, Matthias/J-6511-2015; Schieker, Matthias/AGZ-2030-2022; Popov, Cvetan/K-3851-2016; Sarıışık, Ediz/AAG-5723-2019; Clausen-Schaumann, Hauke/W-1830-2017	Docheva, Denitsa/0000-0002-7588-1290; Schieker, Matthias/0000-0002-1230-3653; Schieker, Matthias/0000-0002-1230-3653; Popov, Cvetan/0000-0001-6578-6153; Sarıışık, Ediz/0000-0003-3816-5970; Clausen-Schaumann, Hauke/0000-0002-9413-0310	Ministry of national Education of Turkey; German Excellence Initiative via the "Nanosystems Initiative Munich"; German research foundation	Ministry of national Education of Turkey(Ministry of National Education - Turkey); German Excellence Initiative via the "Nanosystems Initiative Munich"; German research foundation(German Research Foundation (DFG))	Funding provided by the Ministry of national Education of Turkey (http://egitek.meb.gov.tr), German Excellence Initiative via the "Nanosystems Initiative Munich" (http://www.nano-initiative-munich.de/de/research-areas/) and the German research foundation (http://www.dfg.de/gefoerderte_projekte/informationssysteme/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberton P, 2012, STEM CELLS DEV, V21, P846, DOI 10.1089/scd.2011.0150; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964; Benoit M, 2011, METHODS MOL BIOL, V736, P355, DOI 10.1007/978-1-61779-105-5_21; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Chirgwin JM, 2007, J CELL BIOCHEM, V102, P1333, DOI 10.1002/jcb.21556; Cooper CR, 2003, CANCER-AM CANCER SOC, V97, P739, DOI 10.1002/cncr.11181; Cross NA, 2007, BIOCHEM SOC T, V35, P698, DOI 10.1042/BST0350698; Docheva D, 2010, BIOCHEM BIOPH RES CO, V402, P361, DOI 10.1016/j.bbrc.2010.10.034; Dufrene YF, 2011, NAT METHODS, V8, P123, DOI 10.1038/nmeth0211-123; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Hall CL, 2008, NEOPLASIA, V10, P797, DOI 10.1593/neo.08380; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Huang GTJ, 2006, J ENDODONT, V32, P1066, DOI 10.1016/j.joen.2006.05.009; Kiefer JA, 2001, MATRIX BIOL, V20, P429, DOI 10.1016/S0945-053X(01)00159-7; KOUTSILIERIS M, 1995, CRIT REV ONCOL HEMAT, V18, P51, DOI 10.1016/1040-8428(94)00122-A; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Nabha SM, 2008, INT J CANCER, V122, P2482, DOI 10.1002/ijc.23431; Opfer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045896; Popov C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.71; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289; Schmitz J, 2009, SOFT MATTER, V5, P4141, DOI 10.1039/b821853f; Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; te Riet J, 2011, ULTRAMICROSCOPY, V111, P1659, DOI 10.1016/j.ultramic.2011.09.012; Thie M, 1998, HUM REPROD, V13, P3211, DOI 10.1093/humrep/13.11.3211; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	34	23	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57706	10.1371/journal.pone.0057706	http://dx.doi.org/10.1371/journal.pone.0057706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472100	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900039
J	Wang, ZW; van Kleunen, M; During, HJ; Werger, MJA				Wang, Zhengwen; van Kleunen, Mark; During, Heinjo J.; Werger, Marinus J. A.			Root Foraging Increases Performance of the Clonal Plant Potentilla reptans in Heterogeneous Nutrient Environments	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; DIVISION-OF-LABOR; MORPHOLOGICAL PLASTICITY; STOLONIFEROUS HERBS; GLECHOMA-HEDERACEA; SOIL HETEROGENEITY; SHADE-AVOIDANCE; ELEVATED CO2; COSTS; INTEGRATION	Background: Plastic root-foraging responses have been widely recognized as an important strategy for plants to explore heterogeneously distributed resources. However, the benefits and costs of root foraging have received little attention. Methodology/Principal Findings: In a greenhouse experiment, we grew pairs of connected ramets of 22 genotypes of the stoloniferous plant Potentilla reptans in paired pots, between which the contrast in nutrient availability was set as null, medium and high, but with the total nutrient amount kept the same. We calculated root-foraging intensity of each individual ramet pair as the difference in root mass between paired ramets divided by the total root mass. For each genotype, we then calculated root-foraging ability as the slope of the regression of root-foraging intensity against patch contrast. For all genotypes, root-foraging intensity increased with patch contrast and the total biomass and number of offspring ramets were lowest at high patch contrast. Among genotypes, root-foraging intensity was positively related to production of offspring ramets and biomass in the high patch-contrast treatment, which indicates an evolutionary benefit of root foraging in heterogeneous environments. However, we found no significant evidence that the ability of plastic foraging imposes costs under homogeneous conditions (i.e. when foraging is not needed). Conclusions/Significance: Our results show that plants of P. reptans adjust their root-foraging intensity according to patch contrast. Moreover, the results show that the root foraging has an evolutionary advantage in heterogeneous environments, while costs of having the ability of plastic root foraging were absent or very small.	[Wang, Zhengwen] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Wang, Zhengwen; During, Heinjo J.; Werger, Marinus J. A.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands; [Wang, Zhengwen] Univ Bern, Inst Plant Sci, Bern, Switzerland; [van Kleunen, Mark] Univ Konstanz, Dept Biol, Constance, Germany	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Utrecht University; University of Bern; University of Konstanz	Wang, ZW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	wangzw@iae.ac.cn	Wang, Zhengwen/A-8292-2011; van Kleunen, Mark/B-3769-2009	van Kleunen, Mark/0000-0002-2861-3701	Natural Science Foundation of China [30370268, 30870422]; Sino-Swiss Science and Technology Cooperation Program [EG14-092009]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Swiss Science and Technology Cooperation Program	This study was supported by Natural Science Foundation of China grant (30370268, 30870422). Analysis and writing were partly done while ZW was funded by the Sino-Swiss Science and Technology Cooperation Program (EG14-092009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P137; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Cahill JF, 1999, ANN BOT-LONDON, V83, P471, DOI 10.1006/anbo.1999.0841; Chen X, 2011, NEW PHYTOL, V190, P409, DOI 10.1111/j.1469-8137.2010.03639.x; D'Hertefeldt T, 1999, J ECOL, V87, P258, DOI 10.1046/j.1365-2745.1999.00345.x; de Kroon H, 2006, TRENDS ECOL EVOL, V21, P113, DOI 10.1016/j.tree.2005.11.021; De Kroon H, 2003, ECOL STU AN, V168, P215; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; EVANS JP, 1991, OECOLOGIA, V86, P268, DOI 10.1007/BF00317540; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; Fransen B, 2001, J ECOL, V89, P711, DOI 10.1046/j.0022-0477.2001.00589.x; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; Garcia-Palacios P, 2011, J ECOL, V99, P551, DOI 10.1111/j.1365-2745.2010.01765.x; Gleeson SK, 1997, OIKOS, V79, P387, DOI 10.2307/3546023; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; Huber H, 1999, PLANT ECOL, V141, P107, DOI 10.1023/A:1009861521047; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Hutchings MJ, 2003, ECOLOGY, V84, P2322, DOI 10.1890/02-0290; Kembel SW, 2005, AM NAT, V166, P216, DOI 10.1086/431287; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Lamb EG, 2004, FUNCT ECOL, V18, P836, DOI 10.1111/j.0269-8463.2004.00893.x; Lande K, 1983, EVOLUTION, V37, P1210; Louapre P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038288; Maestre FT, 2007, OECOLOGIA, V151, P512, DOI 10.1007/s00442-006-0577-y; Maestre FT, 2005, NEW PHYTOL, V168, P637, DOI 10.1111/j.1469-8137.2005.01547.x; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; Matlaga DP, 2009, AM J BOT, V96, P431, DOI 10.3732/ajb.0800164; McNickle GG, 2009, TRENDS ECOL EVOL, V24, P419, DOI 10.1016/j.tree.2009.03.004; McNickle GG, 2009, P NATL ACAD SCI USA, V106, P4747, DOI 10.1073/pnas.0807971106; Rausher D, 1992, EVOLUTION, V46, P616; Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431, DOI 10.1098/rspb.1999.0656; SAS Institute Inc, 2004, SAS 9 1 2 QUAL TOOLS; Shemesh H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010824; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Steinger T, 2003, J EVOLUTION BIOL, V16, P313, DOI 10.1046/j.1420-9101.2003.00518.x; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Stuefer JF, 2002, J EVOLUTION BIOL, V15, P880, DOI 10.1046/j.1420-9101.2002.00435.x; Stuefer Josef F., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P47, DOI 10.1078/1433-8319-00051; Stuefer JF, 2009, J ECOL, V97, P1020, DOI 10.1111/j.1365-2745.2009.01546.x; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; van Kleunen M, 2000, EVOLUTION, V54, P1947, DOI 10.1111/j.0014-3820.2000.tb01239.x; van Kleunen M, 2007, NEW PHYTOL, V176, P727, DOI 10.1111/j.1469-8137.2007.02296.x; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; Wang ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025401; Weijschede J, 2006, NEW PHYTOL, V172, P655, DOI 10.1111/j.1469-8137.2006.01885.x; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; Yu FH, 2002, ACTA BOT SIN, V44, P468	61	27	28	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58602	10.1371/journal.pone.0058602	http://dx.doi.org/10.1371/journal.pone.0058602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472211	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900157
J	Wen, ZK; Xu, L; Xu, W; Yin, ZN; Gao, XM; Xiong, SD				Wen, Zhenke; Xu, Lin; Xu, Wei; Yin, Zhinan; Gao, Xiaoming; Xiong, Sidong			Interleukin-17 Expression Positively Correlates with Disease Severity of Lupus Nephritis by Increasing Anti-Double-Stranded DNA Antibody Production in a Lupus Model Induced by Activated Lymphocyte Derived DNA	PLOS ONE			English	Article							ERYTHEMATOSUS-LIKE SYNDROME; T-HELPER-CELLS; IL-17; MICE; DIFFERENTIATION; PATHOGENESIS; SUPPRESSION; DEFICIENCY; MECHANISMS; INDUCTION	Lupus nephritis is one of the most serious manifestations and one of the strongest predictors of a poor outcome in systemic lupus erythematosus (SLE). Recent evidence implicated a potential role of interlukin-17 (IL-17) in the pathogenesis of lupus nephritis. However, the correlation between IL-17 expression level and the severity of lupus nephritis still remains incompletely understood. In this study, we found that serum IL-17 expression level was associated with the severity of lupus nephritis, which was evaluated by histopathology of kidney sections and urine protein. Of note, we showed that enforced expression of IL-17 using adenovirus construct that expresses IL-17 could enhance the severity of lupus nephritis, while blockade of IL-17 using neutralizing antibody resulted in decreased severity of lupus nephritis. Consistently, we observed an impaired induction of lupus nephritis in IL-17-deficient mice. Further, we revealed that IL-17 expression level was associated with immune complex deposition and complement activation in kidney. Of interest, we found that IL-17 was crucial for increasing anti-double-stranded DNA (dsDNA) antibody production in SLE. Our results suggested that IL-17 expression level positively correlated with the severity of lupus nephritis, at least in part, because of its contribution to anti-dsDNA antibody production. These findings provided a novel mechanism for how IL-17 expression level correlated with disease pathogenesis and suggested that management of IL-17 expression level was a potential and promising approach for treatment of lupus nephritis.	[Wen, Zhenke; Xu, Lin; Xiong, Sidong] Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xu, Wei; Yin, Zhinan; Gao, Xiaoming; Xiong, Sidong] Soochow Univ, Jiangsu Key Lab Infect & Immun, Inst Biol, Suzhou, Jiangsu, Peoples R China; [Xu, Wei; Yin, Zhinan; Gao, Xiaoming; Xiong, Sidong] Soochow Univ, Jiangsu Key Lab Infect & Immun, Inst Med Sci, Suzhou, Jiangsu, Peoples R China	Fudan University; Soochow University - China; Soochow University - China	Xiong, SD (corresponding author), Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	sdxiongfd@126.com		Wen, Zhenke/0000-0003-0542-0349	National Natural Science Foundation of China [30890141, 81273300]; Major State Basic Research Development Program of China [2013CB530501]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1075]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Shanghai STC grant [10JC1401400]; Mingdao Program for Medical Graduate Student in Fudan University [MDJH2012002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Shanghai STC grant; Mingdao Program for Medical Graduate Student in Fudan University	This work was supported by grants from the National Natural Science Foundation of China (30890141, 81273300), Major State Basic Research Development Program of China (2013CB530501), Program for Changjiang Scholars and Innovative Research Team in University (IRT1075), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Shanghai STC grant (10JC1401400), and Mingdao Program for Medical Graduate Student in Fudan University (MDJH2012002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2008, KIDNEY INT, V73, P172, DOI 10.1038/sj.ki.5002625; Alba P, 2003, ANN RHEUM DIS, V62, P556, DOI 10.1136/ard.62.6.556; Apostolidis SA, 2011, LUPUS, V20, P120, DOI 10.1177/0961203310389100; Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; Chen DY, 2012, LUPUS, V21, P1385, DOI 10.1177/0961203312457718; Chen XQ, 2010, J CLIN IMMUNOL, V30, P221, DOI 10.1007/s10875-009-9365-x; Cohen RA, 2008, CLIN IMMUNOL, V128, P1, DOI 10.1016/j.clim.2008.04.004; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Dong GF, 2003, CHINESE MED J-PEKING, V116, P543; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Kang HK, 2007, J IMMUNOL, V178, P7849, DOI 10.4049/jimmunol.178.12.7849; Kang HK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2682; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Mountz JD, 2011, DISCOV MED, V11, P76; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nicoletti F, 2000, EUR J IMMUNOL, V30, P438; Qiao B, 2005, RHEUMATOLOGY, V44, P1108, DOI 10.1093/rheumatology/keh656; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; SWAAK AJG, 1982, ANN RHEUM DIS, V41, P388, DOI 10.1136/ard.41.4.388; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; Wang Y, 2010, CLIN EXP IMMUNOL, V159, P1, DOI 10.1111/j.1365-2249.2009.04031.x; Wen Z, 2012, LUPUS, V21, P508, DOI 10.1177/0961203311434940; Wen ZK, 2007, RHEUMATOLOGY, V46, P1796, DOI 10.1093/rheumatology/kem275; Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038; Xing Q, 2012, RHEUMATOL INT, V32, P949, DOI 10.1007/s00296-010-1771-0; Zhang WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022659; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016	43	32	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58161	10.1371/journal.pone.0058161	http://dx.doi.org/10.1371/journal.pone.0058161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472149	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900095
J	Winther, TN; Bang-Berthelsen, CH; Heiberg, IL; Pociot, F; Hogh, B				Winther, Thilde Nordmann; Bang-Berthelsen, Claus Heiner; Heiberg, Ida Louise; Pociot, Flemming; Hogh, Birthe			Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B	PLOS ONE			English	Article							E-ANTIGEN SEROCONVERSION; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; SURFACE-ANTIGEN; IMMUNE-SYSTEM; EXPRESSION; CELLS; MANAGEMENT; CLEARANCE	Background and Aim: Children chronically infected with hepatitis B virus (HBV) are at high risk of progressive liver disease. However, no treatment is available that is consistently effective in curing chronic hepatitis B (CHB) in children. Improved understanding of the natural course of disease is warranted. Identification of specific microRNA (miRNA) profiles in children chronically infected with HBV may provide insight into the pathogenesis of CHB and lead to advances in the management of children with CHB. Patients and Methods: MiRNA PCR panels were employed to screen plasma levels of 739 miRNAs in pooled samples from HBeAg positive, HBeAg negative, and healthy children. The three groups' plasma miRNA profiles were compared, and aberrantly expressed miRNAs were identified. The identified miRNAs were then validated. Individual RT-qPCRs were performed on plasma from 34 HBeAg positive, 26 HBeAg negative, and 60 healthy children. Results: A panel of 16 plasma miRNAs were identified as aberrantly expressed in HBeAg positive and HBeAg negative children (p<0.001). Levels of all of the miRNAs were upregulated in HBeAg positive children compared with in HBeAg negative children. A positive correlation was furthermore found between plasma levels of the identified miRNAs and HBV DNA (p<0.001). Conclusion: We are the first to investigate the plasma miRNA profile of children chronically infected with HBV. Our data indicates the existence of a relationship between abundance of circulating miRNAs and immunological stages in the natural course of disease. Certain miRNAs may contribute to the establishment and maintenance of CHB in children. Further studies are warranted to advance understanding of miRNAs in the pathogenesis of CHB, hopefully leading to the identification of future therapeutic targets.	[Winther, Thilde Nordmann; Heiberg, Ida Louise; Hogh, Birthe] Univ Copenhagen, Dept Paediat, Hvidovre Hosp, Copenhagen, Denmark; [Winther, Thilde Nordmann; Bang-Berthelsen, Claus Heiner; Pociot, Flemming] Univ Copenhagen, Glostrup Hosp, Glostrup Res Inst, Diagnost Unit, Glostrup, Denmark; [Winther, Thilde Nordmann; Bang-Berthelsen, Claus Heiner; Pociot, Flemming] Univ Copenhagen, Glostrup Hosp, Glostrup Res Inst, Ctr Noncoding RNA Technol & Hlth, Glostrup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Winther, TN (corresponding author), Univ Copenhagen, Dept Paediat, Hvidovre Hosp, Copenhagen, Denmark.	thildewinther@gmail.com		/0000-0003-4541-2538; Pociot, Flemming/0000-0003-3274-5448	Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Danish Council for Strategic Research [09-067036/DSF]	Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	TNW was the recipient of a PhD scholarship from the Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. CHBB and FP were supported by the Danish Council for Strategic Research (09-067036/DSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Bala S, 2012, HEPATOLOGY; Casalini P, 2009, J BUON, V14, pS17; CHANG MH, 1995, HEPATOLOGY, V22, P1387, DOI 10.1016/0270-9139(95)90141-8; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Guo HY, 2011, HEPATOLOGY, V54, P808, DOI 10.1002/hep.24441; Haber BA, 2009, PEDIATRICS, V124, pE1007, DOI 10.1542/peds.2009-0567; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Iloeje UH, 2012, LIVER INT; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krarup HB, 2008, SCAND J GASTROENTERO, V43, P334, DOI 10.1080/00365520701712198; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mukaide M, 2003, J GASTROEN HEPATOL, V18, P1264, DOI 10.1046/j.1440-1746.2003.03204.x; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ni YH, 2007, GASTROENTEROLOGY, V132, P2340, DOI 10.1053/j.gastro.2007.03.111; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Paganelli M, 2012, J HEPATOL; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Simonetti J, 2010, HEPATOLOGY, V51, P1531, DOI 10.1002/hep.23464; SSI Statens Serum Institut Copenhagen Denmark, CHILDH VACC PROGR DE; TASSOPOULOS NC, 1987, GASTROENTEROLOGY, V92, P1844, DOI 10.1016/0016-5085(87)90614-7; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; World Health Organization, 2012, HEP B; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	43	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58236	10.1371/journal.pone.0058236	http://dx.doi.org/10.1371/journal.pone.0058236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469271	Green Submitted, gold, Green Published			2022-12-27	WOS:000315634900078
J	Czerny, M; Barchichat, I; Meszaros, K; Sodeck, GH; Weber, A; Reineke, D; Englberger, L; Schonhoff, F; Kadner, A; Jenni, H; Schmidli, J; Carrel, TP				Czerny, Martin; Barchichat, Ilan; Meszaros, Katharina; Sodeck, Gottfried H.; Weber, Alberto; Reineke, David; Englberger, Lars; Schoenhoff, Florian; Kadner, Alexander; Jenni, Hansjoerg; Schmidli, Juerg; Carrel, Thierry P.			Long-Term Results after Proximal Thoracic Aortic Redo Surgery	PLOS ONE			English	Article							ASCENDING AORTA; CARDIAC-SURGERY; ROOT; DISSECTION; REOPERATIONS; REPAIR; OUTCOMES	Objective: To evaluate early and mid-term results in patients undergoing proximal thoracic aortic redo surgery. Methods: We analyzed 60 patients (median age 60 years, median logistic EuroSCORE 40) who underwent proximal thoracic aortic redo surgery between January 2005 and April 2012. Outcome and risk factors were analyzed. Results: In hospital mortality was 13%, perioperative neurologic injury was 7%. Fifty percent of patients underwent redo surgery in an urgent or emergency setting. In 65%, partial or total arch replacement with or without conventional or frozen elephant trunk extension was performed. The preoperative logistic EuroSCORE I confirmed to be a reliable predictor of adverse outcome (ROC 0.786, 95%CI 0.64-0.93) as did the new EuroSCORE II model: ROC 0.882 95%CI 0.78-0.98. Extensive individual logistic EuroSCORE I levels more than 67 showed an OR of 7.01, 95%CI 1.43-34.27. A EuroSCORE II larger than 28 showed an OR of 4.44 (95%CI 1.4-14.06). Multivariate logistic regression analysis identified a critical preoperative state (OR 7.96, 95%CI 1.51-38.79) but not advanced age (OR 2.46, 95%CI 0.48-12.66) as the strongest independent predictor of in-hospital mortality. Median follow-up was 23 months (1-52 months). One year and five year actuarial survival rates were 83% and 69% respectively. Freedom from reoperation during follow-up was 100%. Conclusions: Despite a substantial early attrition rate in patients presenting with a critical preoperative state, proximal thoracic aortic redo surgery provides excellent early and mid-term results. Higher EuroSCORE I and II levels and a critical preoperative state but not advanced age are independent predictors of in-hospital mortality. As a consequence, age alone should no longer be regarded as a contraindication for surgical treatment in this particular group of patients.	[Czerny, Martin; Barchichat, Ilan; Meszaros, Katharina; Weber, Alberto; Reineke, David; Englberger, Lars; Schoenhoff, Florian; Kadner, Alexander; Jenni, Hansjoerg; Schmidli, Juerg; Carrel, Thierry P.] Univ Hosp Bern, Dept Cardiovasc Surg, CH-3010 Bern, Switzerland; [Meszaros, Katharina] Med Univ Graz, Dept Cardiac Surg, Graz, Austria; [Sodeck, Gottfried H.] Med Univ Vienna, Dept Emergency Med, Vienna, Austria	University of Bern; University Hospital of Bern; Medical University of Graz; Medical University of Vienna	Czerny, M (corresponding author), Univ Hosp Bern, Dept Cardiovasc Surg, CH-3010 Bern, Switzerland.	martin.czerny@insel.ch	Kadner, Alexander/GYJ-0985-2022; Carrel, Thierry/AAI-5910-2021; Weber, Alberto/CAG-7772-2022; Kadner, Alexander/ADL-0427-2022	Kadner, Alexander/0000-0003-3024-6514; Barchichat, Ilan/0000-0002-7691-5026; Schoenhoff, Florian/0000-0002-3311-4595; Weber, Alberto/0000-0001-6488-9660; Czerny, Martin/0000-0003-4766-9775				Bonser RS, 2011, J AM COLL CARDIOL, V58, P2455, DOI 10.1016/j.jacc.2011.06.067; Czerny M, 2011, ANN THORAC SURG, V92, P1657, DOI 10.1016/j.athoracsur.2011.06.073; Czerny M, 2011, CIRCULATION, V124, P1407, DOI 10.1161/CIRCULATIONAHA.110.010124; Dougenis D, 1997, ANN THORAC SURG, V64, P986, DOI 10.1016/S0003-4975(97)00626-7; Etz CD, 2008, J THORAC CARDIOV SUR, V136, P860, DOI 10.1016/j.jtcvs.2007.11.071; Girardi LN, 2006, ANN THORAC SURG, V82, P1407, DOI 10.1016/j.athoracsur.2006.04.002; Krahenbuhl E, 2012, EUR J CARDIO-THORAC, V41, pe110, DOI 10.1093/ejcts/ezs121; Luciani N, 2011, ANN THORAC SURG, V92, P898, DOI 10.1016/j.athoracsur.2011.04.116; Meszaros K, 2012, ANN THORAC SURG; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Pacini D, 2012, EUR J CARDIO-THORAC, V42, P249, DOI 10.1093/ejcts/ezr304; Park CB, 2011, J THORAC CARDIOV SUR, V142, P278, DOI 10.1016/j.jtcvs.2010.08.055; Park CB, 2011, J THORAC CARDIOV SUR, V142, P602, DOI 10.1016/j.jtcvs.2010.08.086; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; Silva J, 2010, ANN THORAC SURG, V90, P555, DOI 10.1016/j.athoracsur.2010.03.092; Tsagakis K, 2011, EUR J CARDIO-THORAC, V39, P87, DOI 10.1016/j.ejcts.2010.03.070; Tsagakis K, 2010, J THORAC CARDIOV SUR, V140, pS116, DOI 10.1016/j.jtcvs.2010.07.066	17	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57713	10.1371/journal.pone.0057713	http://dx.doi.org/10.1371/journal.pone.0057713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469220	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100031
J	Gahring, LC; Enioutina, EY; Myers, EJ; Spangrude, GJ; Efimova, OV; Kelley, TW; Tvrdik, P; Capecchi, MR; Rogers, SW				Gahring, Lorise C.; Enioutina, Elena Y.; Myers, Elizabeth J.; Spangrude, Gerald J.; Efimova, Olga V.; Kelley, Todd W.; Tvrdik, Petr; Capecchi, Mario R.; Rogers, Scott W.			Nicotinic Receptor Alpha7 Expression Identifies a Novel Hematopoietic Progenitor Lineage	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; CYTOKINE PRODUCTION; HUMAN MONOCYTES; CELLS; INFLAMMATION; NEUROPROTECTION; STIMULATION; RELEASE; PATHWAY; CHOLINE	How inflammatory responses are mechanistically modulated by nicotinic acetylcholine receptors (nAChR), especially by receptors composed of alpha7 (alpha 7) subunits, is poorly defined. This includes a precise definition of cells that express alpha 7 and how these impact on innate inflammatory responses. To this aim we used mice generated through homologous recombination that express an Ires-Cre-recombinase bi-cistronic extension of the endogenous alpha 7 gene that when crossed with a reporter mouse expressing Rosa26-LoxP (yellow fluorescent protein (YFP)) marks in the offspring those cells of the alpha 7 cell lineage (alpha 7(lin+)). In the adult, on average 20-25 percent of the total CD45(+) myeloid and lymphoid cells of the bone marrow (BM), blood, spleen, lymph nodes, and Peyers patches are alpha 7(lin+), although variability between litter mates in this value is observed. This hematopoietic alpha 7(lin+) subpopulation is also found in Sca1(+)cKit(+) BM cells suggesting the alpha 7 lineage is established early during hematopoiesis and the ratio remains stable in the individual thereafter as measured for at least 18 months. Both alpha 7(lin+) and alpha 7(lin-) BM cells can reconstitute the immune system of naive irradiated recipient mice and the alpha 7(lin+):alpha 7(lin-) beginning ratio is stable in the recipient after reconstitution. Functionally the alpha 7(lin+):alpha 7(lin-) lineages differ in response to LPS challenge. Most notable is the response to LPS as demonstrated by an enhanced production of IL-12/23(p40) by the alpha 7(lin+) cells. These studies demonstrate that alpha 7(lin+) identifies a novel subpopulation of bone marrow cells that include hematopoietic progenitor cells that can re-populate an animal's inflammatory/immune system. These findings suggest that alpha 7 exhibits a pleiotropic role in the hematopoietic system that includes both the direct modulation of pro-inflammatory cell composition and later in the adult the role of modulating pro-inflammatory responses that would impact upon an individual's lifelong response to inflammation and infection.	[Gahring, Lorise C.; Rogers, Scott W.] Salt Lake City Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA; [Gahring, Lorise C.; Enioutina, Elena Y.; Myers, Elizabeth J.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT USA; [Gahring, Lorise C.; Enioutina, Elena Y.; Spangrude, Gerald J.; Efimova, Olga V.; Kelley, Todd W.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Spangrude, Gerald J.] Univ Utah, Sch Med, Dept Internal Med, Div Hematol, Salt Lake City, UT USA; [Efimova, Olga V.; Kelley, Todd W.] Univ Utah, Associated Reg & Univ Pathologists, Salt Lake City, UT USA; [Tvrdik, Petr; Capecchi, Mario R.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Tvrdik, Petr; Capecchi, Mario R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT USA; [Rogers, Scott W.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Gahring, LC (corresponding author), Salt Lake City Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA.	Lorise.Gahring@hsc.utah.edu	Tvrdik, Petr/AAK-4398-2021; Enioutina, Elena/AAV-1745-2021	Tvrdik, Petr/0000-0002-8750-9672	National Institutes of Health [R01 DA025057, AG29838, AG017517, RC1-AI 086238]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017517, R01AG029838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grant Support: National Institutes of Health grants R01 DA025057 (LCG and SWR), AG29838 (LCG) and AG017517 (SWR) and RC1-AI 086238 (GJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Canastar A, 2012, J MOL NEUROSCI, V47, P389, DOI 10.1007/s12031-011-9663-7; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; Carlson NG, 1999, J IMMUNOL, V163, P3963; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Deak E, 2010, J CELL MOL MED, V14, P1946, DOI 10.1111/j.1582-4934.2009.00908.x; Djouad F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2153; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-38; Gahring LC, 2010, J BIOL CHEM, V285, P19793, DOI 10.1074/jbc.M110.108803; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; Gallowitsch-Puerta M, 2005, ANN NY ACAD SCI, V1062, P209, DOI 10.1196/annals.1358.024; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Grando SA, 2008, J PHARMACOL SCI, V106, P174, DOI 10.1254/jphs.FM0070087; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Liu RH, 2004, J PHARMACOL EXP THER, V310, P52, DOI 10.1124/jpet.103.065037; Makki N, 2010, DEV BIOL, V341, P499, DOI 10.1016/j.ydbio.2010.02.014; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Meguro-Horike M, 2011, HUM MOL GENET, V20, P3798, DOI 10.1093/hmg/ddr298; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; OKADA S, 1992, BLOOD, V80, P3044; Osborne-Hereford AV, 2008, J NEUROIMMUNOL, V193, P130, DOI 10.1016/j.jneuroim.2007.10.029; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pauly JR, 2004, ANN NY ACAD SCI, V1035, P316, DOI 10.1196/annals.1332.019; Reynolds PR, 2010, AM J RESP CELL MOL, V42, P545, DOI 10.1165/rcmb.2008-0265OC; Rogers SW, 2012, BRAIN BEHAV, V2, P628, DOI 10.1002/brb3.84; Rogers SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036467; Rogers SW, 2012, AM J MED GENET A, V158A, P1135, DOI 10.1002/ajmg.a.35372; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; van der Zanden EP, 2012, NEUROIMMUNOMODULAT, V19, P255, DOI 10.1159/000335185; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339	38	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57481	10.1371/journal.pone.0057481	http://dx.doi.org/10.1371/journal.pone.0057481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469197	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100020
J	Chen, G; Gong, M; Yan, M; Zhang, XM				Chen, Gang; Gong, Ming; Yan, Min; Zhang, Xiaoming			Sevoflurane Induces Endoplasmic Reticulum Stress Mediated Apoptosis in Hippocampal Neurons of Aging Rats	PLOS ONE			English	Article							ER-STRESS; CELL-DEATH; ISOFLURANE; MEMORY; ISCHEMIA; YOUNG; ANESTHETICS; CASPASE-12; EXPOSURE; PATHWAY	Elderly patients are more likely to suffer from postoperative memory impairment for volatile anesthetics could induce aging neurons degeneration and apoptosis while the mechanism was still elusive. Therefore we hypothesized that ER stress mediated hippocampal neurons apoptosis might play an important role in the mechanism of sevoflurane-induced cognitive impairment in aged rats. Thirty 18-month-old male Sprague-Dawley rats were divided into two groups: the sham anesthesia group (exposure to simply humidified 30-50% O-2 balanced by N-2 in an acrylic anesthetizing chamber for 5 hours) and the sevoflurane anesthesia group (received 2% sevoflurane in the same humidified mixed air in an identical chamber for the same time). Spatial memory of rats was assayed by the Morris water maze test. The ultrastructure of the hippocampus was observed by transmission electron microscopy (TEM). The expressions of C/EBP homologous protein (CHOP) and caspase-12 in the hippocampus were observed by immunohistochemistry and real-time PCR analysis. The apoptosis neurons were also assessed by TUNEL assay. The Morris water maze test showed that sevoflurane anesthesia induced spatial memory impairment in aging rats (P<0.05). The apoptotic neurons were condensed and had clumped chromatin with fragmentation of the nuclear membrane, verifying apoptotic degeneration in the sevoflurane group rats by TEM observation. The expressions of CHOP and caspase-12 increased, and the number of TUNEL positive cells of the hippocampus also increased in the sevoflurane group rats (P<0.05). The present results suggested that the long time exposure of sevoflurane could induce neuronal degeneration and cognitive impairment in aging rats. The ER stress mediated neurons apoptosis may play a role in the sevoflurane-induced memory impairment in aging rats.	[Chen, Gang; Gong, Ming; Yan, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xiaoming] Zhejiang Univ, Sch Med, Dept Anat & Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhang, XM (corresponding author), Zhejiang Univ, Sch Med, Dept Anat & Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zxm@zju.edu.cn			National Natural Science Foundation of China [30971124]; Qianjiang Talent Program of Zhejiang Province [2009R10043]; Health Bureau of Zhejiang Province [2008A076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talent Program of Zhejiang Province; Health Bureau of Zhejiang Province	The study is supported by National Natural Science Foundation of China (No. 30971124), Qianjiang Talent Program of Zhejiang Province (2009R10043) and the Health Bureau of Zhejiang Province (2008A076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, P NATL ACAD SCI USA, V105, P1722, DOI 10.1073/pnas.0711651105; Bezerra FJL, 2010, REV BRAS ANESTESIOL, V60, P162, DOI 10.1590/S0034-70942010000200008; Bignami E, 2009, J CARDIOTHOR VASC AN, V23, P594, DOI 10.1053/j.jvca.2009.01.022; Bittner EA, 2011, CAN J ANESTH, V58, P216, DOI 10.1007/s12630-010-9418-x; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Culley DJ, 2007, CURR OPIN ANESTHESIO, V20, P408, DOI 10.1097/ACO.0b013e3282efd18b; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Fradejas N, 2010, J NEUROSCI RES, V88, P1094, DOI 10.1002/jnr.22280; Gupta S, 2001, LIFE SCI, V69, P2957, DOI 10.1016/S0024-3205(01)01404-7; Hudson AE, 2011, BRIT J ANAESTH, V107, P30, DOI 10.1093/bja/aer122; Landoni G, 2012, J CARDIOTHOR VASC AN, V26, P764, DOI 10.1053/j.jvca.2012.04.018; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu XS, 2010, NEUROBIOL LEARN MEM, V94, P461, DOI 10.1016/j.nlm.2010.08.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ogawa S, 2007, ANTIOXID REDOX SIGN, V9, P573, DOI 10.1089/ars.2006.1516; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Perouansky M., 2008, V182, P143, DOI 10.1007/978-3-540-74806-9_7; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Soo KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035413; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Wei HF, 2009, CURR ALZHEIMER RES, V6, P30, DOI 10.2174/156720509787313934; Wiklund A, 2009, NEUROREPORT, V20, P1419, DOI 10.1097/WNR.0b013e328330cd2b; Wong CH, 2006, FOOD CHEM TOXICOL, V44, P1399, DOI 10.1016/j.fct.2006.03.004; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664	37	74	85	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57870	10.1371/journal.pone.0057870	http://dx.doi.org/10.1371/journal.pone.0057870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469093	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900189
J	den Hertog, AL; de Vos, AF; Klatser, PR; Anthony, RM				den Hertog, Alice L.; de Vos, Alex F.; Klatser, Paul R.; Anthony, Richard M.			Early Specific Host Response Associated with Starting Effective Tuberculosis Treatment in an Infection Controlled Placebo Controlled Mouse Study	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUGS; IFN-GAMMA; DIAGNOSIS; PULMONARY; RIFAMPIN	Recently we proposed exploring the potential of treatment stimulated testing as diagnostic method for tuberculosis (TB). An infection controlled placebo controlled mouse study was performed to investigate whether serum cytokine levels changed measurably during the early phase of TB chemotherapy. Serum was collected prior to and during the first 3 weeks of isoniazid (INH) and rifampicin (RIF) chemotherapy, and levels of 23 selected cytokines/chemokines were measured using a liquid bead array. The serum levels of IFN gamma, IP-10, MIG, MCP-1, IL-17 and IL-6 were elevated in the TB infected mice compared to non-infected mice at least at 1 time point measured. In infected mice, IFN gamma, IP-10, MIG and MCP-1 levels decreased within 7 days of treatment with RIF+INH compared to placebo. Treatment of non-infected mice in the absence of tuberculosis infection had no effect on these cytokines. IL-17 and IL-6 had decreased to baseline in all infected mice prior to the initiation of treatment. This study demonstrates that systemic levels of some cytokines, more specifically IFN gamma, IP-10, MIG and MCP-1, rapidly and specifically change upon starting TB chemotherapy only in the presence of infection in a mouse model. Thus, IFN gamma, IP-10, MIG and MCP-1 are promising 'Treat-to-Test' targets for the diagnosis of TB and deserve further investigation in a study on human TB suspects.	[den Hertog, Alice L.; Klatser, Paul R.; Anthony, Richard M.] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands; [de Vos, Alex F.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Anthony, RM (corresponding author), KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands.	r.anthony@kit.nl	Anthony, Richard/AAP-3406-2020	Anthony, Richard/0000-0002-0550-5273; Klatser, Paul/0000-0003-2127-9138; Klatser, Paul/0000-0003-3868-2409	Top Institute Pharma [T4-303]	Top Institute Pharma	This project has been performed under the framework of the Top Institute Pharma Project T4-303 "Therapeutic monitoring of TB, Trachoma and Leishmaniasis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELBAUM PC, 1986, ANTIMICROB AGENTS CH, V29, P576, DOI 10.1128/AAC.29.4.576; Bothamley GH, 2004, CLIN DIAGN LAB IMMUN, V11, P942, DOI 10.1128/CDLI.11.5.942-951.2004; de Steenwinkel JEM, 2012, EUR J CLIN MICROBIOL, V31, P1195, DOI 10.1007/s10096-011-1428-2; den Hertog AL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002207; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lin YG, 1998, INFECT IMMUN, V66, P2319, DOI 10.1128/IAI.66.5.2319-2322.1998; Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429; Pai M, 2007, CLIN INFECT DIS, V44, P74, DOI 10.1086/509927; Pokkali S, 2009, HUM IMMUNOL, V70, P110, DOI 10.1016/j.humimm.2008.11.003; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Rubbo PA, 2012, J CLIN MICROBIOL, V50, P1711, DOI 10.1128/JCM.00117-12; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Smith SG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-35; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Tariq S. M., 2004, JPMA Journal of the Pakistan Medical Association, V54, P88; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Vesely JJK, 1998, PHARMACOTHERAPY, V18, P345	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57997	10.1371/journal.pone.0057997	http://dx.doi.org/10.1371/journal.pone.0057997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469125	Green Published, Green Submitted			2022-12-27	WOS:000315524900218
J	Huang, L; Lange, MD; Yu, YS; Li, S; Su, KH; Zhang, ZX				Huang, Lin; Lange, Miles D.; Yu, Yangsheng; Li, Song; Su, Kaihong; Zhang, Zhixin			Contribution of V-H Replacement Products in Mouse Antibody Repertoire	PLOS ONE			English	Article							SURROGATE LIGHT-CHAIN; B-CELL DEVELOPMENT; V(D)J RECOMBINATION; GENE REPLACEMENT; RECEPTOR; LUPUS; DNA; MECHANISM; EXPRESSION; AUTOANTIBODIES	V-H replacement occurs through RAG-mediated recombination between the cryptic recombination signal sequence (cRSS) near the 3' end of a rearranged V-H gene and the 23-bp RSS from an upstream unrearranged V-H gene. Due to the location of the cRSS, V-H replacement leaves a short stretch of nucleotides from the previously rearranged V-H gene at the newly formed V-D junction, which can be used as a marker to identify V-H replacement products. To determine the contribution of V-H replacement products to mouse antibody repertoire, we developed a Java-based V-H Replacement Footprint Analyzer (V(H)RFA) program and analyzed 17,179 mouse IgH gene sequences from the NCBI database to identify V-H replacement products. The overall frequency of V-H replacement products in these IgH genes is 5.29% based on the identification of pentameric V-H replacement footprints at their V-D junctions. The identified V-H replacement products are distributed similarly in IgH genes using most families of V-H genes, although different families of V-H genes are used differentially. The frequencies of V-H replacement products are significantly elevated in IgH genes derived from several strains of autoimmune prone mice and in IgH genes encoding autoantibodies. Moreover, the identified V-H replacement footprints in IgH genes from autoimmune prone mice or IgH genes encoding autoantibodies preferentially encode positively charged amino acids. These results revealed a significant contribution of V-H replacement products to the diversification of antibody repertoire and potentially, to the generation of autoantibodies in mice.	[Huang, Lin; Lange, Miles D.; Yu, Yangsheng; Li, Song; Su, Kaihong; Zhang, Zhixin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Su, Kaihong; Zhang, Zhixin] Univ Nebraska Med Ctr, Eppley Canc Inst, Omaha, NE USA; [Su, Kaihong] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Zhang, ZX (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.	zhangj@unmc.edu		Zhang, Zhixin/0000-0003-3924-1082	National Institutes of Health [AI074948, AI076475, AR059351]; University of Nebraska Medical Center, Eppley Cancer Institute, Omaha, Nebraska; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074948, R01AI076475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048592, R01AR059351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center, Eppley Cancer Institute, Omaha, Nebraska; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by National Institutes of Health grants AI074948 (ZZ), AI076475 (ZZ), and AR059351 (KS), and by faculty developmental fund for ZZ and KS from University of Nebraska Medical Center, Eppley Cancer Institute, Omaha, Nebraska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Burrows PD, 1997, CURR OPIN IMMUNOL, V9, P239, DOI 10.1016/S0952-7915(97)80142-2; Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2; Cascalho M, 1997, J IMMUNOL, V159, P5795; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; DATTA SK, 1986, ANN NY ACAD SCI, V475, P47, DOI 10.1111/j.1749-6632.1986.tb20855.x; Davila M, 2007, J EXP MED, V204, P3195, DOI 10.1084/jem.20071224; EILAT D, 1988, J IMMUNOL, V141, P1745; Furukawa F, 1997, LUPUS, V6, P193, DOI 10.1177/096120339700600215; Gaffney PM, 2002, RHEUM DIS CLIN N AM, V28, P111, DOI 10.1016/S0889-857X(03)00072-3; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; HANG LM, 1981, J EXP MED, V154, P216, DOI 10.1084/jem.154.1.216; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kalinina O, 2011, P NATL ACAD SCI USA, V108, P7125, DOI 10.1073/pnas.1019389108; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Karasuyama H, 1997, IMMUNOL CELL BIOL, V75, P209, DOI 10.1038/icb.1997.32; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; Koralov SB, 2006, IMMUNITY, V25, P43, DOI 10.1016/j.immuni.2006.04.016; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lutz J, 2006, J IMMUNOL, V177, P7007, DOI 10.4049/jimmunol.177.10.7007; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OKEEFE TL, 1992, EUR J IMMUNOL, V22, P619, DOI 10.1002/eji.1830220302; RADIC MZ, 1993, J IMMUNOL, V150, P4966; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; Rogosch T, 2010, J IMMUNOL, V184, P4947, DOI 10.4049/jimmunol.0900859; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHATZ DG, 1988, CELL, V53, P107, DOI 10.1016/0092-8674(88)90492-8; Sekiguchi DR, 2003, J EXP MED, V197, P27, DOI 10.1084/jem.20020737; SUENAGA R, 1993, CLIN EXP IMMUNOL, V94, P418; Sun Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00392; Swanson PC, 1998, IMMUNITY, V9, P115, DOI 10.1016/S1074-7613(00)80593-2; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Watson LC, 2006, J IMMUNOL, V177, P1120, DOI 10.4049/jimmunol.177.2.1120; Wloch MK, 1997, J IMMUNOL, V158, P4500; Yazici ZA, 1998, J AUTOIMMUN, V11, P477, DOI 10.1006/jaut.1998.0232; Zhang ZX, 2007, TRENDS IMMUNOL, V28, P132, DOI 10.1016/j.it.2007.01.003; Zhang ZX, 2004, IMMUNOL REV, V197, P231, DOI 10.1111/j.0105-2896.2004.0107.x; Zhang ZX, 2003, ANN NY ACAD SCI, V987, P270, DOI 10.1111/j.1749-6632.2003.tb06060.x; Zhang ZX, 2003, IMMUNITY, V19, P21, DOI 10.1016/S1074-7613(03)00170-5	56	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57877	10.1371/journal.pone.0057877	http://dx.doi.org/10.1371/journal.pone.0057877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469094	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900190
J	Jack, H; Canavan, M; Ofori-Atta, A; Taylor, L; Bradley, E				Jack, Helen; Canavan, Maureen; Ofori-Atta, Angela; Taylor, Lauren; Bradley, Elizabeth			Recruitment and Retention of Mental Health Workers in Ghana	PLOS ONE			English	Article							HOSPITAL MANAGEMENT; MEDICAL-STUDENTS; ATTITUDES; PSYCHIATRY; ILLNESS; MODEL	Introduction: The lack of trained mental health workers is a primary contributor to the mental health treatment gap worldwide. Despite the great need to recruit and retain mental health workers in low-income countries, little is known about how these workers perceive their jobs and what drives them to work in mental health care. Using qualitative interviews, we aimed to explore factors motivating mental health workers in order to inform interventions to increase recruitment and retention. Methods: We conducted 28 in-depth, open-ended interviews with staff in Ghana's three public psychiatric hospitals. We used the snowballing method to recruit participants and the constant comparative method for qualitative data analysis, with multiple members of the research team participating in data coding to enhance the validity and reliability of the analysis. The use of qualitative methods allowed us to understand the range and depth of motivating and demotivating factors. Results: Respondents described many factors that influenced their choice to enter and remain in mental health care. Motivating factors included 1) desire to help patients who are vulnerable and in need, 2) positive day-to-day interactions with patients, 3) intellectual or academic interest in psychiatry or behavior, and 4) good relationships with colleagues. Demotivating factors included 1) lack of resources at the hospital, 2) a rigid supervisory hierarchy, 3) lack of positive or negative feedback on work performance, and 4) few opportunities for career advancement within mental health. Conclusions: Because many of the factors are related to relationships, these findings suggest that strengthening the interpersonal and team dynamics may be a critical and relatively low cost way to increase worker motivation. The data also allowed us to highlight key areas for resource allocation to improve both recruitment and retention, including risk pay, adequate tools for patient care, improved hospital work environment, and stigma reduction efforts.	[Jack, Helen; Canavan, Maureen; Taylor, Lauren; Bradley, Elizabeth] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Ofori-Atta, Angela] Univ Ghana, Sch Med, Accra, Ghana	Yale University; University of Ghana	Bradley, E (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	Elizabeth.Bradley@yale.edu	Jack, Helen/AAB-3650-2020	Jack, Helen/0000-0003-2815-4725	Stacey Leondis SY'08 Summer Fellowship; Wendy E. Blanning Memorial Fellowship; Jackson Institute for Global Affairs at Yale University	Stacey Leondis SY'08 Summer Fellowship; Wendy E. Blanning Memorial Fellowship; Jackson Institute for Global Affairs at Yale University	The Stacey Leondis SY'08 Summer Fellowship, Wendy E. Blanning Memorial Fellowship, and the Jackson Institute for Global Affairs at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2007, SOC PSYCH PSYCH EPID, V42, P931, DOI 10.1007/s00127-007-0246-4; [Anonymous], GHAN COUNTR SUMM MEN; [Anonymous], 2008, MENTAL HLTH GAP GLOB; Ballester Dinarte Alexandre, 2005, Sao Paulo Med. J., V123, P72, DOI 10.1590/S1516-31802005000200008; Barke A, 2011, SOC PSYCH PSYCH EPID, V46, P1191, DOI 10.1007/s00127-010-0290-3; Biernacki P, 1981, SNOWBALL SAMPLING PR; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Dieleman Marjolein, 2003, Hum Resour Health, V1, P10, DOI 10.1186/1478-4491-1-10; Executive Board of the World Health Organization, 2012, GLOB BURD MENT DIS N; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Glaser B.G., 1968, DISCOV GROUNDED THEO; Hartwig K, 2008, INT J HEALTH PLAN M, V23, P203, DOI 10.1002/hpm.915; Jenkins R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009049; Kebede S, 2010, INT J QUAL HEALTH C, V22, P39, DOI 10.1093/intqhc/mzp051; Laugharne R, 2009, ACAD PSYCHIATR, V33, P71, DOI 10.1176/appi.ap.33.1.71; Lehmann U, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-19; McCracken G., 1988, LONG INTERVIEW, V13; Minas H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-317; Ndetei DM, 2008, ACAD PSYCHIATR, V32, P154, DOI 10.1176/appi.ap.32.2.154; Ofori-Atta A, 2010, AFRICAN J PSYCHIAT, V13; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rowson M., EQUINET DISCUSSION P, V4, P1; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Saxena S, 2006, WORLD PSYCHIATRY, V5, P179; Smits HL, 2002, INT J QUAL HEALTH C, V14, P439, DOI 10.1093/intqhc/14.6.439; Sofaer S, 1999, QUALITATIVE METHODS; Stilwell B, 2004, B WORLD HEALTH ORGAN, V82, P595; Swanson RC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000385; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Bank Group, 2012, TOT POP; Yasamy M, 2011, PLOS MED, V8, P1421	33	31	32	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57940	10.1371/journal.pone.0057940	http://dx.doi.org/10.1371/journal.pone.0057940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23469111	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900206
J	Toda, H; Sato, Y; Takata, K; Orita, Y; Asano, N; Yoshino, T				Toda, Hiroko; Sato, Yasuharu; Takata, Katsuyoshi; Orita, Yorihisa; Asano, Naoko; Yoshino, Tadashi			Clinicopathologic Analysis of Localized Nasal/Paranasal Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; POOR-PROGNOSIS; DISTINCT TYPES; PHENOTYPE; SURVIVAL	Diffuse large B-cell lymphoma (DLBCL) comprises 2 molecularly distinct subgroups of non-germinal center B-cell-like (non-GCB) and germinal center B-cell-like (GCB) DLBCLs, with the former showing relatively poor prognosis. In the present study, we analyzed the clinicopathological features of 39 patients with localized nasal/paranasal DLBCL. Immunohistochemistry-based subclassification revealed that 11 patients (28%) were of the GCB-type according to Hans' algorithm and 11 (28%) were of the GCB-type according to Choi's algorithm. According to both Hans' and Choi's algorithms, the non-GCB type was predominant. Nevertheless, prognosis was good. Overall survival did not differ significantly between the GCB and non-GCB subgroups (Hans' algorithm: p = 0.57, Choi's algorithm: p = 0.99). Furthermore, the prognosis of localized nasal/paranasal DLBCL was better than that of other localized extranodal DLBCLs. The prognosis of extranodal DLBCL is usually considered poorer than that of nodal DLBCL. However, in our study, no difference was noted between patients with localized nasal/paranasal DLBCL and patients with localized nodal DLBCL. In conclusion, although the non-GCB subtype is thought to show poor prognosis, in our study, the prognosis for localized nasal/paranasal DLBCL patients was good irrespective of subclassification.	[Toda, Hiroko; Sato, Yasuharu; Takata, Katsuyoshi; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008530, Japan; [Orita, Yorihisa] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Okayama 7008530, Japan; [Asano, Naoko] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan	Okayama University; Okayama University; Nagoya University	Sato, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008530, Japan.	satou-y@cc.okayama-u.ac.jp						Al-Abbadi MA, 2006, MODERN PATHOL, V19, P1521, DOI 10.1038/modpathol.3800691; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Camilleri-Broet S, 2006, BLOOD, V107, P190, DOI 10.1182/blood-2005-03-1024; Campo E, 2006, HISTOPATHOLOGY, V48, P481, DOI 10.1111/j.1365-2559.2006.02369.x; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Connor J, 2007, HISTOPATHOLOGY, V51, P697, DOI 10.1111/j.1365-2559.2007.02855.x; DAMORE F, 1991, EUR J CANCER, V27, P1201, DOI 10.1016/0277-5379(91)90081-N; Deckert M, 2011, LEUKEMIA, V25, P1797, DOI 10.1038/leu.2011.169; Habara T, 2012, J CLIN EXP HEMATOP, V52, P91, DOI 10.3960/jslrt.52.91; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hattab EM, 2010, MODERN PATHOL, V23, P235, DOI 10.1038/modpathol.2009.164; Hembury TA, 2002, AM J CLIN PATHOL, V117, P574; Hoefnagel JJ, 2005, BLOOD, V105, P3671, DOI 10.1182/blood-2004-04-1594; Krol ADG, 2003, ANN ONCOL, V14, P131, DOI 10.1093/annonc/mdg004; Li D, 2010, PATHOL RES PRACT, V206, P611, DOI 10.1016/j.prp.2010.04.005; Meyer PN, 2011, J CLIN ONCOL, V29, P200, DOI 10.1200/JCO.2010.30.0368; Moller MB, 2004, BRIT J HAEMATOL, V124, P151, DOI 10.1046/j.1365-2141.2003.04749.x; Mozos A, 2009, MODERN PATHOL, V22, P1210, DOI 10.1038/modpathol.2009.87; Murase T, 2007, BLOOD, V109, P478, DOI 10.1182/blood-2006-01-021253; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pileri SA, 2002, HISTOPATHOLOGY, V41, P482, DOI 10.1046/j.1365-2559.2002.01538.x; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sato Y, 2009, CANCER SCI, V100, P42, DOI 10.1111/j.1349-7006.2008.00995.x; Steidl C, 2011, BLOOD, V118, P2659, DOI 10.1182/blood-2011-05-326538; Vural F, 2008, INT J DERMATOL, V47, P675, DOI 10.1111/j.1365-4632.2008.03693.x; Yamaguchi H, 2011, J CLIN EXP HEMATOP, V51, P1, DOI 10.3960/jslrt.51.1; Yoshida S, 2005, MODERN PATHOL, V18, P398, DOI 10.1038/modpathol.3800266; Zucca E, 2003, J CLIN ONCOL, V21, P20, DOI 10.1200/JCO.2003.11.141	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57677	10.1371/journal.pone.0057677	http://dx.doi.org/10.1371/journal.pone.0057677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469048	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900147
J	Wei, HJ; Qing, YB; Pan, WR; Zhao, HY; Li, HH; Cheng, WM; Zhao, L; Xu, CS; Li, H; Li, S; Ye, L; Wei, TY; Li, XB; Fu, GW; Li, WG; Xin, JG; Zeng, YZ				Wei, Hongjiang; Qing, Yubo; Pan, Weirong; Zhao, Hongye; Li, Honghui; Cheng, Wenmin; Zhao, Lu; Xu, Chengsheng; Li, Hong; Li, Si; Ye, Lei; Wei, Taiyun; Li, Xiaobing; Fu, Guowen; Li, Wengui; Xin, Jige; Zeng, Yangzhi			Comparison of the Efficiency of Banna Miniature Inbred Pig Somatic Cell Nuclear Transfer among Different Donor Cells	PLOS ONE			English	Article							BUFFALOS BUBALUS-BUBALIS; IN-VITRO; CLONED PIGS; CLONING EFFICIENCY; EMBRYOS; FETAL; ADULT; CYCLE; AGE; IMPROVEMENT	Somatic cell nuclear transfer (SCNT) is an important method of breeding quality varieties, expanding groups, and preserving endangered species. However, the viability of SCNT embryos is poor, and the cloned rate of animal production is low in pig. This study aims to investigate the gene function and establish a disease model of Banna miniature inbred pig. SCNT with donor cells derived from fetal, newborn, and adult fibroblasts was performed, and the cloning efficiencies among the donor cells were compared. The results showed that the cleavage and blastocyst formation rates did not significantly differ between the reconstructed embryos derived from the fetal (74.3% and 27.4%) and newborn (76.4% and 21.8%) fibroblasts of the Banna miniature inbred pig (P>0.05). However, both fetal and newborn fibroblast groups showed significantly higher rates than the adult fibroblast group (61.9% and 13.0%; P<0.05). The pregnancy rates of the recipients in the fetal and newborn fibroblast groups (60% and 80%, respectively) were higher than those in the adult fibroblast group. Eight, three, and one cloned piglet were obtained from reconstructed embryos of the fetal, newborn, and adult fibroblasts, respectively. Microsatellite analyses results indicated that the genotypes of all cloning piglets were identical to their donor cells and that the genetic homozygosity of the Banna miniature inbred pig was higher than those of the recipients. Therefore, the offspring was successfully cloned using the fetal, newborn, and adult fibroblasts of Banna miniature inbred pig as donor cells.	[Wei, Hongjiang; Qing, Yubo; Pan, Weirong; Cheng, Wenmin; Xin, Jige; Zeng, Yangzhi] Yunnan Agr Univ, Key Lab Banna Miniature Inbred Pig Yunnan Prov, Kunming, Peoples R China; [Wei, Hongjiang; Zhao, Hongye; Li, Honghui; Zhao, Lu; Xu, Chengsheng; Li, Hong; Li, Si; Ye, Lei; Wei, Taiyun; Li, Xiaobing; Fu, Guowen; Li, Wengui] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China	Yunnan Agricultural University; Yunnan Agricultural University	Wei, HJ (corresponding author), Yunnan Agr Univ, Key Lab Banna Miniature Inbred Pig Yunnan Prov, Kunming, Peoples R China.	hongjiangwei@126.com			Ministry of Science and Technology of China [2011CB944200]; National Natural Science Foundation of China [31060308]; Yunnan Provincial Program for Introducing High-level Scientists [2011HA011]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Program for Introducing High-level Scientists	This study was supported by the Major Research Plan from the Ministry of Science and Technology of China (Grant No. 2011CB944200), the National Natural Science Foundation of China (Grant No. 31060308) and Yunnan Provincial Program for Introducing High-level Scientists (Grant No. 2011HA011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, STEM CELLS, V24, P805, DOI 10.1634/stemcells.2005-0350; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Crabbe JC, 2005, NEUROSCI BIOBEHAV R, V28, P785, DOI 10.1016/j.neubiorev.2004.08.002; Dinnyes A., 2001, Theriogenology, V55, P264; Estrada JL, 2008, CLONING STEM CELLS, V10, P287, DOI 10.1089/clo.2008.0005; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Heidari B, 2010, ZYGOTE, V18, P331, DOI 10.1017/S0967199409990360; Hill JR, 2000, BIOL REPROD, V62, P1135, DOI 10.1095/biolreprod62.5.1135; Hirayama H, 2011, J REPROD DEVELOP, V57, P57, DOI 10.1262/jrd.10-040S; Hoshino Y, 2005, CLONING STEM CELLS, V7, P17, DOI 10.1089/clo.2005.7.17; Hosseini SM, 2008, SMALL RUMINANT RES, V78, P162, DOI 10.1016/j.smallrumres.2008.06.004; Inoue K, 2003, BIOL REPROD, V69, P1394, DOI 10.1095/biolreprod.103.017731; Kasinathan P, 2001, BIOL REPROD, V64, P1487, DOI 10.1095/biolreprod64.5.1487; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kato Y, 2000, J REPROD FERTIL, V120, P231, DOI 10.1530/reprod/120.2.231; Koo DB, 2005, ANIM REPROD SCI, V90, P101, DOI 10.1016/j.anireprosci.2005.01.005; Kurome M, 2008, J REPROD DEVELOP, V54, P254, DOI 10.1262/jrd.20038; Kurome M, 2008, J REPROD DEVELOP, V54, P156, DOI 10.1262/jrd.19165; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lee GS, 2003, THERIOGENOLOGY, V59, P1949, DOI 10.1016/S0093-691X(02)01294-3; Li Y, 2010, REPROD DOMEST ANIM, V45, P608, DOI 10.1111/j.1439-0531.2008.01311.x; Li ZY, 2006, DEV BIOL, V293, P439, DOI 10.1016/j.ydbio.2006.02.016; Machaty Z, 1998, BIOL REPROD, V59, P451, DOI 10.1095/biolreprod59.2.451; Martin M, 2004, THERIOGENOLOGY, V62, P113, DOI 10.1016/j.theriogenology.2003.08.003; Miyoshi K, 2007, MOL REPROD DEV, V74, P1568, DOI 10.1002/mrd.20730; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Pandey A, 2010, CELL REPROGRAM, V12, P357, DOI 10.1089/cell.2009.0083; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 2003, THERIOGENOLOGY, V59, P115, DOI 10.1016/S0093-691X(02)01263-3; Shi DS, 2007, BIOL REPROD, V77, P285, DOI 10.1095/biolreprod.107.060210; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Tian J, 2012, REPROD DOMEST ANIM, V47, P544, DOI 10.1111/j.1439-0531.2011.01915.x; Tian XC, 2003, REPROD BIOL ENDOCRIN, V1, P1; Tomii R, 2009, J REPROD DEVELOP, V55, P121, DOI 10.1262/jrd.20126; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wani NA, 2010, BIOL REPROD, V82, P373, DOI 10.1095/biolreprod.109.081083; Wells DN, 2003, THERIOGENOLOGY, V59, P45, DOI 10.1016/S0093-691X(02)01273-6; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743; Yao Ya-Xin, 2008, Yichuan, V30, P1392, DOI 10.3724/SP.J.1005.2008.01392; Yu P, 2004, TRANSPL P, V36, P2485, DOI 10.1016/j.transproceed.2004.07.055; Zakhartchenko V, 2001, MOL REPROD DEV, V60, P362, DOI 10.1002/mrd.1098; Zeng R, 2005, ANIM GENET, V36, P267, DOI 10.1111/j.1365-2052.2005.01277.x; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	48	30	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57728	10.1371/journal.pone.0057728	http://dx.doi.org/10.1371/journal.pone.0057728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469059	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900157
J	Chou, EY; Murnighan, JK				Chou, Eileen Y.; Murnighan, J. Keith			Life or Death Decisions: Framing the Call for Help	PLOS ONE			English	Article							GENETIC SIMILARITY THEORY; ALTRUISTIC MOTIVATION; HEALTHY BEHAVIOR; PROSPECT-THEORY; FEELING GOOD; EMPATHY; SELECTION; MOOD	Background: Chronic blood shortages in the U. S. would be alleviated by small increases, in percentage terms, of people donating blood. The current research investigated the effects of subtle changes in charity-seeking messages on the likelihood of people responses to a call for help. We predicted that "avoid losses" messages would lead to more helping behavior than "promote gains" messages would. Method: Two studies investigated the effects of message framing on helping intentions and behaviors. With the help and collaboration of the Red Cross, Study 1, a field experiment, directly assessed the effectiveness of a call for blood donations that was presented as either death-preventing (losses) or life-saving (gains), and as being of either more or less urgent need. With the help and collaboration of a local charity, Study 2, a lab experiment, assessed the effects of the gain-versus-loss framing of a donation-soliciting flyer on individuals' expectations of others' monetary donations as well their own volunteering behavior. Study 2 also assessed the effects of three emotional motivators - feelings of empathy, positive affect, and relational closeness. Result: Study 1 indicated that, on a college campus, describing blood donations as a way to "prevent a death" rather than "save a life" boosted the donation rate. Study 2 showed that framing a charity's appeals as helping people to avoid a loss led to larger expected donations, increased intentions to volunteer, and more helping behavior, independent of other emotional motivators. Conclusion: This research identifies and demonstrates a reliable and effective method for increasing important helping behaviors by providing charities with concrete ideas that can effectively increase helping behavior generally and potentially death-preventing behavior in particular.	[Chou, Eileen Y.] Univ Virginia, Frank Batten Sch Leadership & Publ Policy, Charlottesville, VA 22903 USA; [Murnighan, J. Keith] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA	University of Virginia; Northwestern University	Chou, EY (corresponding author), Univ Virginia, Frank Batten Sch Leadership & Publ Policy, Charlottesville, VA 22903 USA.	eileen.chou@virginia.edu						Barton Noelle, 2010, CHRONICLE PHILANTHRO; Batson C. D., 1993, STANFORD ENCY PHILOS, V2, P69; Batson C. D., 2006, SOCIAL PSYCHOL EC, P281; BATSON CD, 1981, J PERS SOC PSYCHOL, V40, P290, DOI 10.1037/0022-3514.40.2.290; BATSON CD, 1983, J PERS SOC PSYCHOL, V45, P706, DOI 10.1037//0022-3514.45.3.706; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; CARLSON M, 1988, J PERS SOC PSYCHOL, V55, P211, DOI 10.1037/0022-3514.55.2.211; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Clark MS, 1978, COG SOC PSYCHOL, P30; DREBEN EK, 1979, J PERS SOC PSYCHOL, V37, P1758; Fazio R.H., 1981, ADV EXPT SOCIAL PSYC, V14, P161, DOI [10.1016/S0065-2601(08)60372-X, DOI 10.1016/S0065-2601(08)60372-X]; Glynn SA, 2003, JAMA-J AM MED ASSOC, V289, P2246, DOI 10.1001/jama.289.17.2246; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; ISEN AM, 1978, J PERS SOC PSYCHOL, V36, P1, DOI 10.1037/0022-3514.36.1.1; ISEN AM, 1972, J PERS SOC PSYCHOL, V21, P384, DOI 10.1037/h0032317; ISEN AM, 1978, SOC PSYCHOL, V41, P346, DOI 10.2307/3033588; Jeong ES, 2011, SOC INFLUENCE, V6, P15, DOI 10.1080/15298868.2010.524369; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lee JA, 2001, J APPL SOC PSYCHOL, V31, P816, DOI 10.1111/j.1559-1816.2001.tb01415.x; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Linville PW, 1993, SOCIAL PSYCHOL HIV I, P35; MAHESWARAN D, 1990, J MARKETING RES, V27, P361, DOI 10.2307/3172593; MEYEROWITZ BE, 1987, J PERS SOC PSYCHOL, V52, P500, DOI 10.1037/0022-3514.52.3.500; Miller DT, 1998, J PERS SOC PSYCHOL, V74, P53, DOI 10.1037/0022-3514.74.1.53; Neuberg SL, 1997, J PERS SOC PSYCHOL, V73, P510; Riley W, 2007, TRANSFUSION, V47, P1180, DOI 10.1111/j.1537-2995.2007.01252.x; Rothman AJ, 1997, PSYCHOL BULL, V121, P3, DOI 10.1037/0033-2909.121.1.3; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; RUSHTON JP, 1989, BEHAV BRAIN SCI, V12, P503, DOI 10.1017/S0140525X00057320; RUSHTON JP, 1984, BEHAV GENET, V14, P179, DOI 10.1007/BF01065540; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Weiner B., 1980, HUMAN MOTIVATION	34	26	27	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57351	10.1371/journal.pone.0057351	http://dx.doi.org/10.1371/journal.pone.0057351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483903	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100020
J	Votier, SC; Bicknell, A; Cox, SL; Scales, KL; Patrick, SC				Votier, Stephen C.; Bicknell, Anthony; Cox, Samantha L.; Scales, Kylie L.; Patrick, Samantha C.			A Bird's Eye View of Discard Reforms: Bird-Borne Cameras Reveal Seabird/Fishery Interactions	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; COMMERCIAL FISHERIES; FORAGING BEHAVIOR; FINE-SCALE; SEABIRDS; PREDATION; FOOD; AVAILABILITY; RESPONSES; DYNAMICS	Commercial capture fisheries produce huge quantities of offal, as well as undersized and unwanted catch in the form of discards. Declines in global catches and legislation to ban discarding will significantly reduce discards, but this subsidy supports a large scavenger community. Understanding the potential impact of declining discards for scavengers should feature in an eco-system based approach to fisheries management, but requires greater knowledge of scavenger/fishery interactions. Here we use bird-borne cameras, in tandem with GPS loggers, to provide a unique view of seabird/fishery interactions. 20,643 digital images (one min 21) from ten bird-borne cameras deployed on central place northern gannets Morus bassanus revealed that all birds photographed fishing vessels. These were large (>15 m) boats, with no small-scale vessels. Virtually all vessels were trawlers, and gannets were almost always accompanied by other scavenging birds. All individuals exhibited an Area-Restricted Search (ARS) during foraging, but only 42% of ARS were associated with fishing vessels, indicating much 'natural' foraging. The proportion of ARS behaviours associated with fishing boats were higher for males (81%) than females (30%), although the reasons for this are currently unclear. Our study illustrates that fisheries form a very important component of the prey-landscape for foraging gannets and that a discard ban, such as that proposed under reforms of the EU Common Fisheries Policy, may have a significant impact on gannet behaviour, particularly males. However, a continued reliance on 'natural' foraging suggests the ability to switch away from scavenging, but only if there is sufficient food to meet their needs in the absence of a discard subsidy.	[Votier, Stephen C.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Votier, Stephen C.; Bicknell, Anthony; Cox, Samantha L.; Patrick, Samantha C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Scales, Kylie L.] Plymouth Marine Lab, Plymouth, Devon, England; [Patrick, Samantha C.] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	University of Exeter; University of Plymouth; Plymouth Marine Laboratory; Centre National de la Recherche Scientifique (CNRS)	Votier, SC (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	stephen.votier@plymouth.ac.uk	Cox, S L/ABD-5059-2021; Scales, Kylie/L-9318-2018; Bicknell, Anthony/G-6809-2016; Votier, Stephen C/G-2348-2014; Cox, S L/AEX-9613-2022	Cox, S L/0000-0002-5409-4458; Scales, Kylie/0000-0003-0843-0956; Bicknell, Anthony/0000-0002-2817-2010; Votier, Stephen C/0000-0002-0976-0167; Cox, S L/0000-0002-5409-4458	EU INTERREG project CHARM-III; Natural Environment Research Council [NE/G001014/1, NE/H007466/1]; Association for the Study of Animal Behaviour; Natural Environment Research Council [pml010005, 1066095, NE/H007199/1] Funding Source: researchfish; NERC [pml010005, NE/G001014/1, NE/H007199/1, NE/H007466/1] Funding Source: UKRI	EU INTERREG project CHARM-III; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Association for the Study of Animal Behaviour; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by EU INTERREG project CHARM-III, Natural Environment Research Council (NE/G001014/1 & NE/H007466/1) and an Association for the Study of Animal Behaviour research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2011, ECOLOGY, V92, P1948, DOI 10.1890/11-0181.1; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; [Anonymous], 2007, SEC2007380 COMM EUR; [Anonymous], 2005, DISCARDS WORLDS MARI; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Bearhop S, 2001, CONDOR, V103, P802, DOI 10.1650/0010-5422(2001)103[0802:AVIGSD]2.0.CO;2; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Enever R, 2007, FISH RES, V86, P143, DOI 10.1016/j.fishres.2007.05.013; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Garthe S, 2011, LIMNOL OCEANOGR, V56, P802, DOI 10.4319/lo.2011.56.3.0802; Granadeiro JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017467; Gremillet D, 2010, FRONT ECOL ENVIRON, V8, P401, DOI 10.1890/10.WB.020; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; HUDSON AV, 1989, IBIS, V131, P225, DOI 10.1111/j.1474-919X.1989.tb02765.x; Huppop O, 2000, MAR ECOL PROG SER, V194, P241, DOI 10.3354/meps194241; Jackson AL, 2008, BIOL LETTERS, V4, P311, DOI 10.1098/rsbl.2008.0038; Montevecchi WA, 2007, MAR ECOL PROG SER, V352, P213, DOI 10.3354/meps07075; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Oro D, 1996, MAR ECOL PROG SER, V132, P43, DOI 10.3354/meps132043; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; R Development Core Team, 2012, R LANG ENV STAT COMP; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2008, MAR ECOL PROG SER, V367, P223, DOI 10.3354/meps07621; Votier SC, 2008, IBIS, V150, P45, DOI 10.1111/j.1474-919X.2008.00804.x; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x	33	86	90	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57376	10.1371/journal.pone.0057376	http://dx.doi.org/10.1371/journal.pone.0057376			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483906	Green Published, Green Accepted, gold			2022-12-27	WOS:000316936100023
J	Azevedo, AS; Goncalves, AJS; Archer, M; Freire, MS; Galler, R; Alves, AMB				Azevedo, Adriana S.; Goncalves, Antonio J. S.; Archer, Marcia; Freire, Marcos S.; Galler, Ricardo; Alves, Ada M. B.			The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against Dengue	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIBODY-RESPONSES; NEUTRALIZING ANTIBODY; ENVELOPE GLYCOPROTEIN; JAPANESE ENCEPHALITIS; PROTEIN VACCINES; IMMUNE-RESPONSE; SUBUNIT VACCINE; TYPE-2 VIRUS; NS1 GENE	The dengue envelope glycoprotein (E) is the major component of virion surface and its ectodomain is composed of domains I, II and III. This protein is the main target for the development of a dengue vaccine with induction of neutralizing antibodies. In the present work, we tested two different vaccination strategies, with combined immunizations in a prime/booster regimen or simultaneous inoculation with a DNA vaccine (pE1D2) and a chimeric yellow fever/dengue 2 virus (YF17D-D2). The pE1D2 DNA vaccine encodes the ectodomain of the envelope DENV2 protein fused to t-PA signal peptide, while the YF17D-D2 was constructed by replacing the prM and E genes from the 17D yellow fever vaccine virus by those from DENV2. Balb/c mice were inoculated with these two vaccines by different prime/booster or simultaneous immunization protocols and most of them induced a synergistic effect on the elicited immune response, mainly in neutralizing antibody production. Furthermore, combined immunization remarkably increased protection against a lethal dose of DENV2, when compared to each vaccine administered alone. Results also revealed that immunization with the DNA vaccine, regardless of the combination with the chimeric virus, induced a robust cell immune response, with production of IFN-c by CD8+ T lymphocytes.	[Azevedo, Adriana S.; Goncalves, Antonio J. S.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil; [Archer, Marcia; Freire, Marcos S.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Alves, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.	ada@ioc.fiocruz.br	Galler, Ricardo/B-3280-2014	Souza Azevedo, Adriana/0000-0001-7401-5107	Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Apoio a Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ; Instituto Nacional de Ciencia e Tecnologia de Vacinas(INCTV)/CNPq	Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ; Instituto Nacional de Ciencia e Tecnologia de Vacinas(INCTV)/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz (FIOCRUZ), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa de Apoio a Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ and Instituto Nacional de Ciencia e Tecnologia de Vacinas(INCTV)/CNPq grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155; Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528; Biswas S, 2001, HUM GENE THER, V12, P1917, DOI 10.1089/104303401753153965; Boyle JS, 1997, INT IMMUNOL, V9, P1897, DOI 10.1093/intimm/9.12.1897; Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8; Chen L, 2007, J VIROL, V81, P11634, DOI 10.1128/JVI.00996-07; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Galler R, 2005, BRAZ J MED BIOL RES, V38, P1835, DOI 10.1590/S0100-879X2005001200012; George Junu A, 2011, Immune Netw, V11, P268, DOI 10.4110/in.2011.11.5.268; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001; Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Haglund K, 2002, J VIROL, V76, P7506, DOI 10.1128/JVI.76.15.7506-7517.2002; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Imoto J, 2007, VACCINE, V25, P1076, DOI 10.1016/j.vaccine.2006.09.059; Inchauspe G, 1997, DNA CELL BIOL, V16, P185, DOI 10.1089/dna.1997.16.185; Julander Justin G., 2011, Antiviral Chemistry & Chemotherapy, V21, P105, DOI 10.3851/IMP1690; Khanam S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-10; Konishi E, 2006, VACCINE, V24, P2200, DOI 10.1016/j.vaccine.2005.11.002; Konishi E, 2003, VACCINE, V21, P1826, DOI 10.1016/S0264-410X(03)00028-8; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Monath T. P., 1997, CLIN VIROLOGY, P1133; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Porter KR, 1998, ARCH VIROL, V143, P997, DOI 10.1007/s007050050348; Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Simmons M, 2001, AM J TROP MED HYG, V65, P420, DOI 10.4269/ajtmh.2001.65.420; Simmons M, 2006, J VIROL, V80, P9577, DOI 10.1128/JVI.00284-06; Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Valdes I, 2009, VIROLOGY, V394, P249, DOI 10.1016/j.virol.2009.08.029; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Wang Z, 2009, CHINESE MED J-PEKING, V122, P2339, DOI 10.3760/cma.j.issn.0366-6999.2009.19.028; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974	57	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58357	10.1371/journal.pone.0058357	http://dx.doi.org/10.1371/journal.pone.0058357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472186	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900132
J	Edwards, CB; Copes, N; Brito, AG; Canfield, J; Bradshaw, PC				Edwards, Clare B.; Copes, Neil; Brito, Andres G.; Canfield, John; Bradshaw, Patrick C.			Malate and Fumarate Extend Lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							DIETARY RESTRICTION; C. ELEGANS; MITOCHONDRIAL RESPIRATION; CALORIC RESTRICTION; ENERGY-METABOLISM; OXIDATIVE STRESS; SKELETAL-MUSCLE; LONGEVITY; PROTEIN; LONG	Malate, the tricarboxylic acid (TCA) cycle metabolite, increased lifespan and thermotolerance in the nematode C. elegans. Malate can be synthesized from fumarate by the enzyme fumarase and further oxidized to oxaloacetate by malate dehydrogenase with the accompanying reduction of NAD. Addition of fumarate also extended lifespan, but succinate addition did not, although all three intermediates activated nuclear translocation of the cytoprotective DAF-16/FOXO transcription factor and protected from paraquat-induced oxidative stress. The glyoxylate shunt, an anabolic pathway linked to lifespan extension in C. elegans, reversibly converts isocitrate and acetyl-CoA to succinate, malate, and CoA. The increased longevity provided by malate addition did not occur in fumarase (fum-1), glyoxylate shunt (gei-7), succinate dehydrogenase flavoprotein (sdha-2), or soluble fumarate reductase F48E8.3 RNAi knockdown worms. Therefore, to increase lifespan, malate must be first converted to fumarate, then fumarate must be reduced to succinate by soluble fumarate reductase and the mitochondrial electron transport chain complex II. Reduction of fumarate to succinate is coupled with the oxidation of FADH(2) to FAD. Lifespan extension induced by malate depended upon the longevity regulators DAF-16 and SIR-2.1. Malate supplementation did not extend the lifespan of long-lived eat-2 mutant worms, a model of dietary restriction. Malate and fumarate addition increased oxygen consumption, but decreased ATP levels and mitochondrial membrane potential suggesting a mild uncoupling of oxidative phosphorylation. Malate also increased NADPH, NAD, and the NAD/NADH ratio. Fumarate reduction, glyoxylate shunt activity, and mild mitochondrial uncoupling likely contribute to the lifespan extension induced by malate and fumarate by increasing the amount of oxidized NAD and FAD cofactors.	[Edwards, Clare B.; Copes, Neil; Brito, Andres G.; Canfield, John; Bradshaw, Patrick C.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Bradshaw, PC (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	pbradsha@cas.usf.edu	Bradshaw, Patrick C./AAR-9189-2020	Bradshaw, Patrick C./0000-0002-4591-6798	University of South Florida; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	University of South Florida; NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by start-up funds to the PI from the University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Meera Nanjundan for helpful advice. We would also like to thank Gabriel Pizzano and Lindsay Cash for help in the preparation of the lifespan assays and Joseph Lofti for help with the respiration experiments. The sir-2.1(ok434) C. elegans strain was obtained from Dr. Sandy Westerheide. All other nematode strains were provided by the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN, USA), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; BEYER RE, 1984, MECH AGEING DEV, V24, P309, DOI 10.1016/0047-6374(84)90116-7; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Braeckman B.P., 2009, INTERMEDIARY METABOL, V1-24, DOI DOI 10.1895/WORMBOOK.1.146.1; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Camarasa C, 2007, YEAST, V24, P391, DOI 10.1002/yea.1467; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; Chuang MH, 2009, BIOORGAN MED CHEM, V17, P7831, DOI 10.1016/j.bmc.2009.09.002; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P132, DOI 10.1159/000089642; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; de Jong L, 2004, GENETICS, V168, P845, DOI 10.1534/genetics.104.028605; Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807; Fei YJ, 2003, J BIOL CHEM, V278, P6136, DOI 10.1074/jbc.M208763200; Fitzgerald VK, 2009, BIOTECHNIQUES, V47, pIX, DOI 10.2144/000113277; Gallo M, 2011, MECH AGEING DEV, V132, P515, DOI 10.1016/j.mad.2011.08.004; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Gonzalez-Cabo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008872; GOODRICK CL, 1980, GERONTOLOGY, V26, P22, DOI 10.1159/000212390; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Harman D, 2009, BIOGERONTOLOGY, V10, P773, DOI 10.1007/s10522-009-9234-2; Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3; Hempenstall S, 2012, MECH AGEING DEV, V133, P37, DOI 10.1016/j.mad.2011.12.002; Hipkiss AR, 2010, EXP GERONTOL, V45, P395, DOI 10.1016/j.exger.2010.03.006; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Holt SJ, 2003, MECH AGEING DEV, V124, P779, DOI 10.1016/S0047-6374(03)00132-5; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kamei Y, 2011, BIOCHEM BIOPH RES CO, V407, P185, DOI 10.1016/j.bbrc.2011.02.136; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887; Kirkwood TBL, 2012, BIOESSAYS, V34, P692, DOI 10.1002/bies.201200014; Knauf F, 2006, BIOCHEM J, V397, P25, DOI 10.1042/BJ20060409; LECLERC J, 1981, ANN NUTR METAB, V25, P20, DOI 10.1159/000176475; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Leiser SF, 2011, AGING CELL, V10, P318, DOI 10.1111/j.1474-9726.2011.00672.x; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Link CD, 2002, METHOD ENZYMOL, V353, P497; LIU FZ, 1995, DEV BIOL, V169, P399, DOI 10.1006/dbio.1995.1156; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Perron JT, 2000, NEUROSCI LETT, V281, P91, DOI 10.1016/S0304-3940(00)00825-9; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Regev-Rudzki N, 2009, MOL MICROBIOL, V72, P297, DOI 10.1111/j.1365-2958.2009.06659.x; Ruzanov P, 2007, EXP GERONTOL, V42, P825, DOI 10.1016/j.exger.2007.04.002; Salminen A, 2010, AGEING RES REV, V9, P211, DOI 10.1016/j.arr.2010.04.003; Schaffer S, 2011, BIOGERONTOLOGY, V12, P195, DOI 10.1007/s10522-010-9310-7; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shoyama T, 2009, EXP GERONTOL, V44, P784, DOI 10.1016/j.exger.2009.09.006; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Stiernagle Theresa, 2006, WormBook, P1; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Tahara EB, 2011, J BIOENERG BIOMEMBR, V43, P483, DOI 10.1007/s10863-011-9377-0; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Tomitsuka E, 2010, ANN NY ACAD SCI, V1201, P44, DOI 10.1111/j.1749-6632.2010.05620.x; Wang JQ, 2010, EXP GERONTOL, V45, P621, DOI 10.1016/j.exger.2010.02.008; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Williams DS, 2009, AGING CELL, V8, P765, DOI 10.1111/j.1474-9726.2009.00527.x; Wu JL, 2008, PHYSIOL RES, V57, P261, DOI 10.33549/physiolres.931161; Wu JL, 2007, PHYSIOL RES, V56, P213, DOI 10.33549/physiolres.930937; Wu JL, 2011, PHYSIOL RES, V60, P329, DOI 10.33549/physiolres.931986; Yuan Y, 2012, J BIOL CHEM; Yuan YY, 2012, J BIOL CHEM, V287, P31414, DOI 10.1074/jbc.M112.377275; Zarse K, 2007, FASEB J, V21, P1271, DOI 10.1096/fj.06-6994com; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang MH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000245	82	56	59	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58345	10.1371/journal.pone.0058345	http://dx.doi.org/10.1371/journal.pone.0058345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472183	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900129
J	Codocedo, JF; Godoy, JA; Poblete, MI; Inestrosa, NC; Huidobro-Toro, JP				Francisco Codocedo, Juan; Alejandro Godoy, Juan; Ines Poblete, Maria; Inestrosa, Nibaldo C.; Pablo Huidobro-Toro, Juan			ATP Induces NO Production in Hippocampal Neurons by P2X(7) Receptor Activation Independent of Glutamate Signaling	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; S-NITROSYLATION; NERVOUS-SYSTEM; RAT CEREBELLUM; L-ARGININE; MODULATION; ASTROCYTES; BRAIN; TRANSMISSION; POTENTIATION	To assess the putative role of adenosine triphosphate (ATP) upon nitric oxide (NO) production in the hippocampus, we used as a model both rat hippocampal slices and isolated hippocampal neurons in culture, lacking glial cells. In hippocampal slices, additions of exogenous ATP or 2'(3')-O-(4-Benzoylbenzoyl) ATP (Bz-ATP) elicited concentration-dependent NO production, which increased linearly within the first 15 min and plateaued thereafter; agonist EC50 values were 50 and 15 mu M, respectively. The NO increase evoked by ATP was antagonized in a concentration-dependent manner by Coomassie brilliant blue G (BBG) or by N-omega-propyl-L-arginine, suggesting the involvement of P2X(7)Rs and neuronal NOS, respectively. The ATP induced NO production was independent of N-methyl-D-aspartic acid (NMDA) receptor activity as effects were not alleviated by DL-2-Amino-5-phosphonopentanoic acid (APV), but antagonized by BBG. In sum, exogenous ATP elicited NO production in hippocampal neurons independently of NMDA receptor activity.	[Francisco Codocedo, Juan; Alejandro Godoy, Juan; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac, Santiago, Chile; [Ines Poblete, Maria; Pablo Huidobro-Toro, Juan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Codocedo, JF (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac, Alameda 340, Santiago, Chile.	jfcodocedo@gmail.com	Godoy, Juan A/F-5398-2018	Godoy, Juan A/0000-0001-9920-6698; Codocedo Henriquez, Juan Francisco/0000-0002-9683-2156	Center for Aging and Regeneration (CARE, CONICYT) [PFB12/2007]; FONDECYT [1110672]; CONICYT	Center for Aging and Regeneration (CARE, CONICYT); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Center for Aging and Regeneration (CARE, CONICYT grant-PFB12/2007) and partially by FONDECYT grant 1110672. JFC was awarded a CONICYT doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Buffo A, 1998, NEUROSCIENCE, V85, P587, DOI 10.1016/S0306-4522(98)00049-9; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Contestabile A, 2000, BRAIN RES REV, V32, P476, DOI 10.1016/S0165-0173(00)00018-7; EAST SJ, 1991, NEUROSCI LETT, V123, P17, DOI 10.1016/0304-3940(91)90147-L; Florenzano F, 2008, PROG NEUROBIOL, V84, P40, DOI 10.1016/j.pneurobio.2007.10.004; Florenzano F, 2002, NEUROSCIENCE, V115, P425, DOI 10.1016/S0306-4522(02)00397-4; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; GORBUNOV N, 1994, J NEUROCHEM, V62, P2205; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jo YH, 2002, J NEUROPHYSIOL, V88, P2501, DOI 10.1152/jn.00352.2002; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kiss JP, 2001, TRENDS NEUROSCI, V24, P211, DOI 10.1016/S0166-2236(00)01745-8; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Li NZ, 2003, J NEUROSCI, V23, P10302; Lorca RA, 2011, EUR J NEUROSCI, V33, P1175, DOI 10.1111/j.1460-9568.2010.07589.x; Lu YF, 1999, J NEUROSCI, V19, P10250; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Murakami K, 2003, NEUROSCIENCE, V117, P37, DOI 10.1016/S0306-4522(02)00804-7; Muramatsu K, 2000, DEV BRAIN RES, V123, P119, DOI 10.1016/S0165-3806(00)00088-2; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; Narcisse L, 2005, GLIA, V49, P245, DOI 10.1002/glia.20110; Selvakumar B, 2009, P NATL ACAD SCI USA, V106, P16440, DOI 10.1073/pnas.0908949106; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Yamada K, 1997, NEUROSCI RES, V28, P93, DOI 10.1016/S0168-0102(97)00032-1; Zhang HQ, 1997, J MED CHEM, V40, P3869, DOI 10.1021/jm970550g; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7	36	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57626	10.1371/journal.pone.0057626	http://dx.doi.org/10.1371/journal.pone.0057626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472093	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900032
J	Mahon, AR; Jerde, CL; Galaska, M; Bergner, JL; Chadderton, WL; Lodge, DM; Hunter, ME; Nico, LG				Mahon, Andrew R.; Jerde, Christopher L.; Galaska, Matthew; Bergner, Jennifer L.; Chadderton, W. Lindsay; Lodge, David M.; Hunter, Margaret E.; Nico, Leo G.			Validation of eDNA Surveillance Sensitivity for Detection of Asian Carps in Controlled and Field Experiments	PLOS ONE			English	Article								In many North American rivers, populations of multiple species of non-native cyprinid fishes are present, including black carp (Mylpharyngodon piceus), grass carp (Ctenopharyngodon idella), bighead carp (Hypophthalmichthys nobilis), silver carp (Hypophthalmichthys molitrix), common carp (Cyprinus carpio), and goldfish (Carassius auratus). All six of these species are found in the Mississippi River basin and tracking their invasion has proven difficult, particularly where abundance is low. Knowledge of the location of the invasion front is valuable to natural resource managers because future ecological and economic damages can be most effectively prevented when populations are low. To test the accuracy of environmental DNA (eDNA) as an early indicator of species occurrence and relative abundance, we applied eDNA technology to the six non-native cyprinid species putatively present in a 2.6 river mile stretch of the Chicago (IL, USA) canal system that was subsequently treated with piscicide. The proportion of water samples yielding positive detections increased with relative abundance of the six species, as indicated by the number of carcasses recovered after poisoning. New markers for black carp, grass carp, and a common carp/goldfish are reported and details of the marker testing to ensure specificity are provided.	[Mahon, Andrew R.; Bergner, Jennifer L.] Cent Michigan Univ, Dept Biol, Inst Great Lakes Res, Mt Pleasant, MI 48859 USA; [Jerde, Christopher L.; Galaska, Matthew; Lodge, David M.] Univ Notre Dame, Environm Change Initiat, Notre Dame, IN 46556 USA; [Jerde, Christopher L.; Galaska, Matthew; Lodge, David M.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Chadderton, W. Lindsay] Notre Dame Environm Change Initiat, Great Lakes Project, Nat Conservancy, Notre Dame, IN USA; [Hunter, Margaret E.; Nico, Leo G.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL USA	Central Michigan University; University of Notre Dame; University of Notre Dame; Nature Conservancy; United States Department of the Interior; United States Geological Survey	Mahon, AR (corresponding author), Cent Michigan Univ, Dept Biol, Inst Great Lakes Res, Mt Pleasant, MI 48859 USA.	mahon2a@cmich.edu	Jerde, Christopher/AAJ-4385-2020; Galaska, Mathew/L-3948-2019; Lodge, David Michael/AAX-1781-2021	Jerde, Christopher/0000-0002-8074-3466; Galaska, Mathew/0000-0002-4257-0170; Mahon, Andrew/0000-0002-5074-8725	Great Lakes Restoration Initiative administered by the US Fish and Wildlife Service (Environmental DNA surveillance - Applied early detection; GLAS [FY10-S-T024-O169-2]; NOAA CSCOR [NA09NOS4780192]; College of Science and Technology at Central Michigan University	Great Lakes Restoration Initiative administered by the US Fish and Wildlife Service (Environmental DNA surveillance - Applied early detection; GLAS; NOAA CSCOR(National Oceanic Atmospheric Admin (NOAA) - USA); College of Science and Technology at Central Michigan University	The Great Lakes Restoration Initiative administered by the US Fish and Wildlife Service (Environmental DNA surveillance - Applied early detection; GLAS#: FY10-S-T024-O169-2), the NOAA CSCOR (#NA09NOS4780192), and the College of Science and Technology at Central Michigan University supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cudmore B., 2004, CANADIAN MANUSCRIPT, V2705, P44; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fuller PL, 1999, NONINDIGENOUS FISHES; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kocovsky PM, 2012, J GREAT LAKES RES, V38, P159, DOI 10.1016/j.jglr.2011.11.015; Kolar C, 2010, MANAGING UNDESIRED I, P1; KOLAR CS, 2007, BIGHEADED CARPS BIOL; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Moy PB, 2011, AM FISH S S, V74, P121; Nico LG, 2011, AM FISH S S, V74, P89; Nico LG, 2005, BLACK CARP BIOL SYNO; Sparks RE, 2011, AM FISH S S, V74, P139; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; TAYLOR J, 1977, Environmental Biology of Fishes, V1, P205, DOI 10.1007/BF00000412; Tetra-Tech Inc, 2010, LITTL CAL RIV RAP RE, P1; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x	20	125	138	2	246	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58316	10.1371/journal.pone.0058316	http://dx.doi.org/10.1371/journal.pone.0058316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472178	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900124
J	Smith, MC; Goddard, ET; Lanfranca, MP; Davido, DJ				Smith, Miles C.; Goddard, Erica T.; Lanfranca, Mirna Perusina; Davido, David J.			hTERT Extends the Life of Human Fibroblasts without Compromising Type I Interferon Signaling	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; LARGE-T-ANTIGEN; HUMAN-PAPILLOMAVIRUS TYPE-16; VESICULAR STOMATITIS-VIRUS; HUMAN-DIPLOID FIBROBLASTS; HUMAN TELOMERASE; GENE-EXPRESSION; CELLULAR SENESCENCE; HUMAN CYTOMEGALOVIRUS; ANTIVIRAL RESPONSES	Primary cells are often used to study viral replication and host-virus interactions as their antiviral pathways have not been altered or inactivated; however, their use is restricted by their short lifespan. Conventional methods to extend the life of primary cultures typically utilize viral oncogenes. Many of these oncogenes, however, perturb or inactivate cellular antiviral pathways, including the interferon (IFN) response. It has been previously shown that expression of the telomerase reverse transcriptase (TERT) gene extends the life of certain cell types. The effect that TERT expression has on the innate antiviral response to RNA-and DNA-containing viruses has not been examined. In the current study, we introduced the human TERT (hTERT) gene into a primary human embryonic lung (HEL-299) cell strain, which is known to respond to the type I IFN, IFN-beta. We show that the resulting HEL-TERT cell line is capable of replicating beyond 100 population doublings without exhibiting signs of senescence. Treatment with IFN-beta resulted in the upregulation of four model IFN stimulated genes (ISGs) in HEL-299 and HEL-TERT cells. Both cell lines supported the replication of herpes simplex virus type 1 (HSV-1) and vesicular stomatitis virus (VSV) and impaired the replication of both viruses upon IFN-beta pretreatment. Introduction of the viral oncoprotein, simian virus 40 (SV40) large T-antigen, which is frequently used to immortalize cells, largely negated this effect. Taken together, our data indicate that expression of hTERT does not alter type 1 IFN signaling and/or the growth of two viruses, making this cell line a useful reagent for studying viral replication and virus-cell interactions.	[Smith, Miles C.; Goddard, Erica T.; Lanfranca, Mirna Perusina; Davido, David J.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Davido, DJ (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	ddavido@ku.edu		Goddard, Erica/0000-0002-4550-665X; Smith, Miles/0000-0003-0651-809X	National Institute of Allergy and Infectious Diseases [R01AI72357]; National Center for Research Resources [P20RR016475]; National Institute of General Medical Sciences from the National Institutes of Health [P20GM103418]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases (R01AI72357), the National Center for Research Resources (P20RR016475), and the National Institute of General Medical Sciences (P20GM103418) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; [Anonymous], CAT SEARCH; Barber GN, 2005, ONCOGENE, V24, P7710, DOI 10.1038/sj.onc.1209042; BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; BRAILOVSKY CA, 1969, INT J CANCER, V4, P194, DOI 10.1002/ijc.2910040209; Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449; Bresnahan WA, 2000, J VIROL, V74, P10816, DOI 10.1128/JVI.74.22.10816-10818.2000; Brockmann D, 2003, CURR TOP MICROBIOL, V272, P97; CAI WZ, 1991, J VIROL, V65, P4078, DOI 10.1128/JVI.65.8.4078-4090.1991; CAI WZ, 1989, J VIROL, V63, P4579, DOI 10.1128/JVI.63.11.4579-4589.1989; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cantalupo PG, 2009, VIROLOGY, V386, P183, DOI 10.1016/j.virol.2008.12.038; Chen QM, 2000, J CELL SCI, V113, P4087; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Conrady CD, 2011, J VIROL, V85, P1625, DOI 10.1128/JVI.01715-10; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Davido DJ, 2005, J VIROL, V79, P1232, DOI 10.1128/JVI.79.2.1232-1243.2005; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOUGLAS JL, 1995, J VIROL, V69, P8061, DOI 10.1128/JVI.69.12.8061-8065.1995; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fields B. N., 2007, FIELDS VIROLOGY; Franco S, 2001, EXP CELL RES, V268, P14, DOI 10.1006/excr.2001.5264; Fridman AL, 2006, J GERONTOL A-BIOL, V61, P879, DOI 10.1093/gerona/61.9.879; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Hardy GAD, 2009, BLOOD, V113, P5497, DOI 10.1182/blood-2008-11-190231; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hou M, 2001, CLIN CHEM, V47, P519; HUDSON JB, 1990, J VIROL, V64, P519, DOI 10.1128/JVI.64.2.519-526.1990; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Hyland PL, 2011, J VIROL; ITO Y, 1977, INFECT IMMUN, V18, P23, DOI 10.1128/IAI.18.1.23-27.1977; Kalamvoki M, 2009, P NATL ACAD SCI USA, V106, P14576, DOI 10.1073/pnas.0906905106; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kulaeva OI, 2003, ONCOGENE, V22, P4118, DOI 10.1038/sj.onc.1206594; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Langford M P, 1981, Methods Enzymol, V78, P339; Li HP, 2005, CELL RES, V15, P262, DOI 10.1038/sj.cr.7290295; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Lindvall C, 2003, CANCER RES, V63, P1743; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Misawa K, 2000, P NATL ACAD SCI USA, V97, P3062, DOI 10.1073/pnas.060489597; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Mossman KL, 2002, J VIROL, V76, P1995, DOI 10.1128/JVI.76.4.1995-1998.2002; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Neumeister P, 2002, INT J BIOCHEM CELL B, V34, P1475, DOI 10.1016/S1357-2725(02)00079-1; Nguyen ML, 2007, J VIROL, V81, P12985, DOI 10.1128/JVI.01485-07; Norman KL, 2001, CYTOKINE GROWTH F R, V12, P271, DOI 10.1016/S1359-6101(00)00024-1; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Paladino P, 2009, J INTERF CYTOK RES, V29, P599, DOI 10.1089/jir.2009.0074; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; RAJAN P, 1995, J VIROL, V69, P785, DOI 10.1128/JVI.69.2.785-795.1995; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rathi AV, 2010, VIROLOGY, V406, P202, DOI 10.1016/j.virol.2010.07.018; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Samaniego LA, 1997, J VIROL, V71, P4614, DOI 10.1128/JVI.71.6.4614-4625.1997; SCHAFFER PA, 1973, VIROLOGY, V52, P57, DOI 10.1016/0042-6822(73)90398-X; SHAY JW, 1993, EXP CELL RES, V209, P45, DOI 10.1006/excr.1993.1283; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; Shou JY, 2002, P NATL ACAD SCI USA, V99, P2830, DOI 10.1073/pnas.052705299; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Smith MC, 2011, ANTIVIR RES, V91, P259, DOI 10.1016/j.antiviral.2011.06.009; Smith MC, 2011, FUTURE VIROL, V6, P421, DOI 10.2217/FVL.11.24; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STEWART WE, 1969, J VIROL, V4, P147, DOI 10.1128/JVI.4.2.147-153.1969; Sundararajan R, 2001, J VIROL, V75, P7506, DOI 10.1128/JVI.75.16.7506-7516.2001; Taylor RT, 2005, J VIROL, V79, P3873, DOI 10.1128/JVI.79.6.3873-3877.2005; Untergasser G, 2002, CANCER RES, V62, P6255; Valls E, 2003, NUCLEIC ACIDS RES, V31, P3114, DOI 10.1093/nar/gkg418; van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; WAZER DE, 1995, P NATL ACAD SCI USA, V92, P3687, DOI 10.1073/pnas.92.9.3687; Xin H, 2004, ONCOGENE, V23, P6209, DOI 10.1038/sj.onc.1207836; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Zhu HF, 2011, J VIROL, V85, P11079, DOI 10.1128/JVI.05098-11	103	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58233	10.1371/journal.pone.0058233	http://dx.doi.org/10.1371/journal.pone.0058233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472163	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900109
J	Yan, DW; Wang, J; Yuan, TT; Hong, LW; Gao, X; Lu, YT				Yan, Da-Wei; Wang, Jing; Yuan, Ting-Ting; Hong, Li-Wei; Gao, Xiang; Lu, Ying-Tang			Perturbation of Auxin Homeostasis by Overexpression of Wild-Type IAA15 Results in Impaired Stem Cell Differentiation and Gravitropism in Roots	PLOS ONE			English	Article							OF-FUNCTION MUTATION; YUCCA FLAVIN MONOOXYGENASES; FUNCTIONAL GENOMIC ANALYSIS; GENE FAMILY-MEMBERS; BOX PROTEIN TIR1; ARABIDOPSIS-THALIANA; AUX/IAA PROTEINS; POSTTRANSCRIPTIONAL REGULATION; GRAVITY VECTOR; DOMAIN-II	Aux/IAAs interact with auxin response factors (ARFs) to repress their transcriptional activity in the auxin signaling pathway. Previous studies have focused on gain-of-function mutations of domain II and little is known about whether the expression level of wild-type Aux/IAAs can modulate auxin homeostasis. Here we examined the perturbation of auxin homeostasis by ectopic expression of wild-type IAA15. Root gravitropism and stem cell differentiation were also analyzed. The transgenic lines were less sensitive to exogenous auxin and exhibited low-auxin phenotypes including failures in gravity response and defects in stem cell differentiation. Overexpression lines also showed an increase in auxin concentration and reduced polar auxin transport. These results demonstrate that an alteration in the expression of wild-type IAA15 can disrupt auxin homeostasis.	[Yan, Da-Wei; Wang, Jing; Yuan, Ting-Ting; Hong, Li-Wei; Gao, Xiang; Lu, Ying-Tang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Lu, YT (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Hubei, Peoples R China.	yingtlu@whu.edu.cn		Yan, Dawei/0000-0002-9048-711X	National Natural Science Foundation of China [90917001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant# 90917001) to YT Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Arase F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043414; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blancaflor EB, 1998, PLANT PHYSIOL, V116, P213, DOI 10.1104/pp.116.1.213; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boonsirichai K, 2003, PLANT CELL, V15, P2612, DOI 10.1105/tpc.015560; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; CONNER TW, 1990, PLANT MOL BIOL, V15, P623, DOI 10.1007/BF00017836; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DAVIES PJ, 1976, PHYSIOL PLANTARUM, V36, P333, DOI 10.1111/j.1399-3054.1976.tb02252.x; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Ding ZJ, 2010, P NATL ACAD SCI USA, V107, P12046, DOI 10.1073/pnas.1000672107; DOLAN L, 1993, DEVELOPMENT, V119, P71; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Eklund DM, 2010, PLANT CELL, V22, P349, DOI 10.1105/tpc.108.064816; Falkenberg B, 2008, J EXP BOT, V59, P2831, DOI 10.1093/jxb/ern144; Fasano JM, 2001, PLANT CELL, V13, P907, DOI 10.1105/tpc.13.4.907; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Fukaki H, 2006, PLANT J, V48, P380, DOI 10.1111/j.1365-313X.2006.02882.x; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gallego-Bartolome J, 2011, PLANT PHYSIOL, V156, P1819, DOI 10.1104/pp.111.173971; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Guilfoyle T J, 1995, ASGSB Bull, V8, P39; Hacham Y, 2012, PLANT SIGNAL BEHAV, V7, P68, DOI 10.4161/psb.7.1.18657; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Hu YQ, 2010, PLANT CELL ENVIRON, V33, P1656, DOI 10.1111/j.1365-3040.2010.02171.x; Ikeda Y, 2009, NAT CELL BIOL, V11, P731, DOI 10.1038/ncb1879; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johannes E, 2001, PLANT PHYSIOL, V127, P119, DOI 10.1104/pp.127.1.119; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kiss JZ, 1996, PHYSIOL PLANTARUM, V97, P237, DOI 10.1034/j.1399-3054.1996.970205.x; Kiss JZ, 2000, CRIT REV PLANT SCI, V19, P551, DOI 10.1016/S0735-2689(01)80008-3; LEE JS, 1984, PLANTA, V160, P536, DOI 10.1007/BF00411142; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Moore I, 2002, CURR BIOL, V12, pR452, DOI 10.1016/S0960-9822(02)00943-0; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Morita MT, 2004, CURR OPIN PLANT BIOL, V7, P712, DOI 10.1016/j.pbi.2004.09.001; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Nakamura A, 2003, PLANT PHYSIOL, V133, P1843, DOI 10.1104/pp.103.030031; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Park JY, 2002, PLANT J, V32, P669, DOI 10.1046/j.1365-313X.2002.01459.x; Plieth C, 2002, PLANT PHYSIOL, V129, P786, DOI 10.1104/pp.011007; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Rahman A, 2010, PLANT CELL, V22, P1762, DOI 10.1105/tpc.110.075317; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Ruzicka K, 2009, P NATL ACAD SCI USA, V106, P4284, DOI 10.1073/pnas.0900060106; SAETHER N, 1991, PLANTA, V184, P491, DOI 10.1007/BF00197897; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Sato A, 2008, PHYSIOL PLANTARUM, V133, P397, DOI 10.1111/j.1399-3054.2008.01055.x; Sato A, 2008, PLANT SIGNAL BEHAV, V3, P496, DOI 10.4161/psb.3.7.5994; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shkolnik-Inbar D, 2010, PLANT CELL, V22, P3560, DOI 10.1105/tpc.110.074641; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Sukumar P, 2009, PLANT PHYSIOL, V150, P722, DOI 10.1104/pp.108.131607; Sun JQ, 2009, PLANT CELL, V21, P1495, DOI 10.1105/tpc.108.064303; Sundberg E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001628; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; TIMPTE C, 1994, GENETICS, V138, P1239; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Toyota M, 2008, PLANT PHYSIOL, V146, P505, DOI 10.1104/pp.107.106450; Toyota Masatsugu, 2010, Seikagaku, V82, P730; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wenzel CL, 2007, PLANT J, V49, P387, DOI 10.1111/j.1365-313X.2006.02977.x; White PJ, 2002, TRENDS PLANT SCI, V7, P8, DOI 10.1016/S1360-1385(01)02219-1; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yang LX, 2005, PLANT CELL PHYSIOL, V46, P1309, DOI 10.1093/pcp/pci140; YOUNG LM, 1990, PLANT PHYSIOL, V92, P792, DOI 10.1104/pp.92.3.792; Zhang WJ, 2011, PLANT J, V68, P1, DOI 10.1111/j.1365-313X.2011.04668.x; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zhou WK, 2010, PLANT CELL, V22, P3692, DOI 10.1105/tpc.110.075721	103	12	12	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58103	10.1371/journal.pone.0058103	http://dx.doi.org/10.1371/journal.pone.0058103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472140	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900085
J	Chehab, JC; Vilakazi-Nhlapo, AK; Vranken, P; Peters, A; Klausner, JD				Chehab, Joel C.; Vilakazi-Nhlapo, Amanda K.; Vranken, Peter; Peters, Annatjie; Klausner, Jeffrey D.			Current Integration of Tuberculosis (TB) and HIV Services in South Africa, 2011	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; ANTIRETROVIRAL THERAPY; IMPLEMENTATION; INFECTION; HIV/AIDS; BARRIERS; TRIAL	Setting: Public Health Facilities in South Africa. Objective: To assess the current integration of TB and HIV services in South Africa, 2011. Design: Cross-sectional study of 49 randomly selected health facilities in South Africa. Trained interviewers administered a standardized questionnaire to one staff member responsible for TB and HIV in each facility on aspects of TB/HIV policy, integration and recording and reporting. We calculated and compared descriptive statistics by province and facility type. Results: Of the 49 health facilities 35 (71%) provided isoniazid preventive therapy (IPT) and 35 (71%) offered antiretroviral therapy (ART). Among assessed sites in February 2011, 2,512 patients were newly diagnosed with HIV infection, of whom 1,913 (76%) were screened for TB symptoms, and 616 of 1,332 (46%) of those screened negative for TB were initiated on IPT. Of 1,072 patients newly registered with TB in February 2011, 144 (13%) were already on ART prior to Tb clinical diagnosis, and 451 (42%) were newly diagnosed with HIV infection. Of those, 84 (19%) were initiated on ART. Primary health clinics were less likely to offer ART compared to district hospitals or community health centers (p<0.001). Conclusion: As of February 2011, integration of TB and HIV services is taking place in public medical facilities in South Africa. Among these services, IPT in people living with HIV and ART in TB patients are the least available.	[Chehab, Joel C.; Vranken, Peter; Peters, Annatjie; Klausner, Jeffrey D.] Ctr Dis Control & Prevent, Pretoria, South Africa; [Vilakazi-Nhlapo, Amanda K.] Natl Dept Hlth, Pretoria, South Africa		Chehab, JC (corresponding author), Ctr Dis Control & Prevent, Pretoria, South Africa.	jchehab06@gmail.com			PEPFAR	PEPFAR	PEPFAR-funded (The U.S. President's Emergency Plan for AIDS Relief implementation) partners did participate in the data collection. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, INT J TUBERC LUNG D, V13, P927; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Bock N, 2004, SEMIN RESP CRIT CARE, V25, P337, DOI 10.1055/s-2004-829505; Bodibe K, 2011, LIV AIDS 481 LESS HC; Breier M, 2007, SHORTAGE MED DOCTORS; Charalambous S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000391010.02774.6f; Chehab JC, 2012, INT J TUBERC LUNG D, V16, P903, DOI 10.5588/ijtld.11.0722; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; Date AA, 2010, B WORLD HEALTH ORGAN, V88, P253, DOI 10.2471/BLT.09.066522; Eldred LJ, 2010, AIDS, V24, pS1, DOI 10.1097/01.aids.0000391009.95149.ec; Gareta D, 2011, TROP MED INT HLTH; Grant AD, 2005, JAMA-J AM MED ASSOC, V293, P2719, DOI 10.1001/jama.293.22.2719; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lester R, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000391021.18284.12; Loveday M, 2011, TROP MED INT HEALTH, V16, P431, DOI 10.1111/j.1365-3156.2010.02721.x; Mosimaneotsile B, 2010, JAIDS-J ACQ IMM DEF, V54, P71, DOI 10.1097/QAI.0b013e3181c3cbf0; Munseri PJ, 2008, INT J TUBERC LUNG D, V12, P1037; Nansera D, 2010, AFR HEALTH SCI, V10, P312; National Department of Health (NDOH), 2010, NAT DEP HLTH STRAT P; NDoH, 2010, GUID TUB PREV THER H; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Republic of South Africa National Department of Health, 2011, HUM RES HLTH S AFR H; Republic of South Africa National Department of Health (NDOH), 2009, 2008 NAT ANT SENT HI; Republic of South Africa National Department of Health (NDOH), 2009, NAT TUB MAN GUID 200; Republic of South Africa National Department of Health (NDOH), 2011, KICK TB CAMP; Shisana O, 2004, SAMJ S AFR MED J, V94, P283; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; The Presidency of the Republic of South Africa, 2011, STAT M S AFR NAT AID; UNAIDS, 2010, GLOB REP UNAIDS REP; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; WHO, 2008, WHO HIV AIDS TB DEP; *WHO, 2002, WHO STRAT FRAM DECR; WHO, 2011, WHO GLOBAL TUBERCULO; Wildschut A, 2008, SHORTAGE NURSES S AF; World Health Organization, 2010, WHO GUID INT TUB CAS; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	40	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57791	10.1371/journal.pone.0057791	http://dx.doi.org/10.1371/journal.pone.0057791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469242	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900047
J	Chen, ZY; Lee, H; Henle, SJ; Cheever, TR; Ekker, SC; Henley, JR				Chen, Zheyan; Lee, Han; Henle, Steven J.; Cheever, Thomas R.; Ekker, Stephen C.; Henley, John R.			Primary Neuron Culture for Nerve Growth and Axon Guidance Studies in Zebrafish (Danio rerio)	PLOS ONE			English	Article							NEURITE OUTGROWTH; CHEMOTROPIC GUIDANCE; COMMISSURAL AXONS; IN-VITRO; MYELIN; RECEPTOR; CONES; OLIGODENDROCYTES; EXPRESSION; PATHWAYS	Zebrafish (Danio rerio) is a widely used model organism in genetics and developmental biology research. Genetic screens have proven useful for studying embryonic development of the nervous system in vivo, but in vitro studies utilizing zebrafish have been limited. Here, we introduce a robust zebrafish primary neuron culture system for functional nerve growth and guidance assays. Distinct classes of central nervous system neurons from the spinal cord, hindbrain, forebrain, and retina from wild type zebrafish, and fluorescent motor neurons from transgenic reporter zebrafish lines, were dissociated and plated onto various biological and synthetic substrates to optimize conditions for axon outgrowth. Time-lapse microscopy revealed dynamically moving growth cones at the tips of extending axons. The mean rate of axon extension in vitro was 21.4 +/- 1.2 mu m hr(-1) s.e.m. for spinal cord neurons, which corresponds to the typical similar to 0.5 mm day(-1) growth rate of nerves in vivo. Fluorescence labeling and confocal microscopy demonstrated that bundled microtubules project along axons to the growth cone central domain, with filamentous actin enriched in the growth cone peripheral domain. Importantly, the growth cone surface membrane expresses receptors for chemotropic factors, as detected by immunofluorescence microscopy. Live-cell functional assays of axon extension and directional guidance demonstrated mammalian brain-derived neurotrophic factor (BDNF)-dependent stimulation of outgrowth and growth cone chemoattraction, whereas mammalian myelin-associated glycoprotein inhibited outgrowth. High-resolution live-cell Ca2+-imaging revealed local elevation of cytoplasmic Ca2+ concentration in the growth cone induced by BDNF application. Moreover, BDNF-induced axon outgrowth, but not basal outgrowth, was blocked by treatments to suppress cytoplasmic Ca2+ signals. Thus, this primary neuron culture model system may be useful for studies of neuronal development, chemotropic axon guidance, and mechanisms underlying inhibition of neural regeneration in vitro, and complement observations made in vivo.	[Chen, Zheyan; Lee, Han; Henley, John R.] Mayo Clin, Coll Med, Mayo Grad Sch, Rochester, MN 55905 USA; [Henle, Steven J.; Cheever, Thomas R.; Henley, John R.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Henley, John R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Henley, JR (corresponding author), Mayo Clin, Coll Med, Mayo Grad Sch, Rochester, MN 55905 USA.	henley.john@mayo.edu		Ekker, Stephen/0000-0003-0726-4212; Henle, Steven/0000-0002-8007-1030; Lee, Han/0000-0002-6633-966X; Henley, John/0000-0003-1846-5941	NIH [NS067311, DA14546]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067311, F32NS080322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants NS067311 to JRH and DA14546 to SCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluni B, 2011, ZEBRAFISH CLASSROOM; Andersen EF, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-27; Andersen Soren S. L., 2001, Methods in Cell Science, V23, P205, DOI 10.1023/A:1016349232389; Ankerhold R, 1998, GLIA, V23, P257, DOI 10.1002/(SICI)1098-1136(199807)23:3<257::AID-GLIA8>3.3.CO;2-B; [Anonymous], 2002, ZEBRAFISH PRACTICAL; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BAIRD DH, 1992, J NEUROSCI, V12, P619; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Balciunas D, 2005, ZEBRAFISH, V1, P335, DOI 10.1089/zeb.2005.1.335; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; BASTMEYER M, 1991, J NEUROSCI, V11, P626; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bingham SM, 2005, J NEUROSCI METH, V149, P42, DOI 10.1016/j.jneumeth.2005.05.002; Carlstrom LP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-82; Chalasani SH, 2007, J NEUROSCI, V27, P973, DOI 10.1523/JNEUROSCI.4132-06.2007; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; Cormie P, 2007, NEUROSCI LETT, V411, P128, DOI 10.1016/j.neulet.2006.10.030; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Driever W, 1996, DEVELOPMENT, V123, P37; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; Ghosh C, 1997, CYTOTECHNOLOGY, V23, P221, DOI 10.1023/A:1007915618413; GRANT P, 1989, DEV BIOL, V133, P502, DOI 10.1016/0012-1606(89)90053-5; GREENSPOON S, 1995, J NEUROSCI, V15, P5956; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hallbook F, 1999, CURR OPIN NEUROBIOL, V9, P616, DOI 10.1016/S0959-4388(99)00011-2; HAMMARBACK JA, 1985, J NEUROSCI RES, V13, P213, DOI 10.1002/jnr.490130115; Henle SJ, 2011, J NEUROSCI, V31, P7016, DOI 10.1523/JNEUROSCI.0216-11.2011; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Jacques-Fricke BT, 2006, J NEUROSCI, V26, P5656, DOI 10.1523/JNEUROSCI.0675-06.2006; Kanungo J, 2011, NEUROTOXICOL TERATOL, V33, P618, DOI 10.1016/j.ntt.2011.08.013; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KUWADA JY, 1990, J NEUROSCI, V10, P1299; Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718; LEIN PJ, 1992, DEV BRAIN RES, V69, P191, DOI 10.1016/0165-3806(92)90159-T; LEMMON V, 1992, J NEUROSCI, V12, P818; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.3.CO;2-W; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lum T, 2001, INT J DEV NEUROSCI, V19, P569, DOI 10.1016/S0736-5748(01)00041-7; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Moon MS, 2005, DEV BIOL, V288, P474, DOI 10.1016/j.ydbio.2005.09.049; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Petzold AM, 2010, ZEBRAFISH, V7, P149, DOI 10.1089/zeb.2010.0660; Rinkwitz S, 2011, PROG NEUROBIOL, V93, P231, DOI 10.1016/j.pneurobio.2010.11.003; ROTHMAN S, 1981, J COMP NEUROL, V195, P141, DOI 10.1002/cne.901950108; Sakowski SA, 2012, J NEUROSCI METH, V205, P277, DOI 10.1016/j.jneumeth.2012.01.007; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; Trousse F, 2001, DEVELOPMENT, V128, P3927; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	72	32	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57539	10.1371/journal.pone.0057539	http://dx.doi.org/10.1371/journal.pone.0057539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469201	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900027
J	Gallagher, JJ; Zhang, XW; Hall, FS; Uhl, GR; Bearer, EL; Jacobs, RE				Gallagher, Joseph J.; Zhang, Xiaowei; Hall, F. Scott; Uhl, George R.; Bearer, Elaine L.; Jacobs, Russell E.			Altered Reward Circuitry in the Norepinephrine Transporter Knockout Mouse	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; TENSOR-BASED MORPHOMETRY; VIVO H-1-NMR SPECTROSCOPY; MANGANESE-ENHANCED MRI; DOPAMINE-TRANSPORTER; IN-VIVO; SEROTONIN TRANSPORTER; ALZHEIMERS-DISEASE; N-ACETYLASPARTATE; EXTRACELLULAR DOPAMINE	Synaptic levels of the monoamine neurotransmitters dopamine, serotonin, and norepinephrine are modulated by their respective plasma membrane transporters, albeit with a few exceptions. Monoamine transporters remove monoamines from the synaptic cleft and thus influence the degree and duration of signaling. Abnormal concentrations of these neuronal transmitters are implicated in a number of neurological and psychiatric disorders, including addiction, depression, and attention deficit/hyperactivity disorder. This work concentrates on the norepinephrine transporter (NET), using a battery of in vivo magnetic resonance imaging techniques and histological correlates to probe the effects of genetic deletion of the norepinephrine transporter on brain metabolism, anatomy and functional connectivity. MRS recorded in the striatum of NET knockout mice indicated a lower concentration of NAA that correlates with histological observations of subtle dysmorphisms in the striatum and internal capsule. As with DAT and SERT knockout mice, we detected minimal structural alterations in NET knockout mice by tensor-based morphometric analysis. In contrast, longitudinal imaging after stereotaxic prefrontal cortical injection of manganese, an established neuronal circuitry tracer, revealed that the reward circuit in the NET knockout mouse is biased toward anterior portions of the brain. This is similar to previous results observed for the dopamine transporter (DAT) knockout mouse, but dissimilar from work with serotonin transporter (SERT) knockout mice where Mn2+ tracings extended to more posterior structures than in wildtype animals. These observations correlate with behavioral studies indicating that SERT knockout mice display anxiety-like phenotypes, while NET knockouts and to a lesser extent DAT knockout mice display antidepressant-like phenotypic features. Thus, the mainly anterior activity detected with manganese-enhanced MRI in the DAT and NET knockout mice is likely indicative of more robust connectivity in the frontal portion of the reward circuit of the DAT and NET knockout mice compared to the SERT knockout mice.	[Gallagher, Joseph J.; Zhang, Xiaowei; Bearer, Elaine L.; Jacobs, Russell E.] CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; [Bearer, Elaine L.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Hall, F. Scott; Uhl, George R.] NIDA, Mol Neurobiol Branch, Intramural Res Program, Baltimore, MD USA	California Institute of Technology; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Jacobs, RE (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA.	rjacobs@caltech.edu	Hall, F. Scott/C-3036-2013; Jacobs, Russell/H-1087-2011	Hall, F. Scott/0000-0002-0822-4063; Jacobs, Russell/0000-0002-1382-8486	Beckman Institute; NIH NINDS [NS062184]; NIMH [MH087660]; NIMGS [P5OGM08273]; NIDA [R01DA18184]; National Institute on Drug Abuse; Harvey Family endowment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018184, ZIADA000165] Funding Source: NIH RePORTER	Beckman Institute; NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMGS; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Harvey Family endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was funded in part by the Beckman Institute, NIH NINDS NS062184, NIMH MH087660, NIMGS P5OGM08273 (ELB), and NIDA R01DA18184 (REJ) and, in part, by the National Institute on Drug Abuse, Intramural Research Program (GRU and FSH), and by the Harvey Family endowment (ELB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Arime Y, 2010, INT J NEUROPSYCHOPH, V13, P59; Arime Y, 2012, NEUROPSYCHO IN PRESS; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Bearer EL, 2007, NEUROIMAGE, V37, P230, DOI 10.1016/j.neuroimage.2007.05.010; Bearer EL, 2009, NEUROIMAGE, V46, P1091, DOI 10.1016/j.neuroimage.2009.03.026; Bonci A, 2003, TRENDS PHARMACOL SCI, V24, P172, DOI 10.1016/S0165-6147(03)00068-3; Bossa M, 2010, NEUROIMAGE, V51, P956, DOI 10.1016/j.neuroimage.2010.02.061; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Canals S, 2008, NEUROIMAGE, V40, P458, DOI 10.1016/j.neuroimage.2007.12.007; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; Caron MG, 1999, BIOL PSYCHIAT, V45, p5S; Carson RP, 2002, J PHARMACOL EXP THER, V301, P410, DOI 10.1124/jpet.301.2.410; Chatham J C, 2001, ILAR J, V42, P189; Dar DE, 2006, EUR J PHARMACOL, V538, P43, DOI 10.1016/j.ejphar.2006.03.048; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Dong H.W., 2008, ALLEN REFERENCE ATLA; Dykstra LA, 2003, FASEB J, V17, pA205; Dzirasa K, 2010, J NEUROSCI, V30, P6387, DOI 10.1523/JNEUROSCI.0764-10.2010; Eschenko O, 2010, MAGN RESON IMAGING, V28, P1165, DOI 10.1016/j.mri.2009.12.022; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gallagher JJ, 2012, NEUROIMAGE, V60, P1856, DOI 10.1016/j.neuroimage.2012.01.132; Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434; Gobert A, 2004, J NEUROSCI METH, V140, P141, DOI 10.1016/j.jneumeth.2004.04.040; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Haenisch B, 2011, PHARMACOL THERAPEUT, V129, P352, DOI 10.1016/j.pharmthera.2010.12.002; Haenisch B, 2009, J NEUROCHEM, V111, P403, DOI 10.1111/j.1471-4159.2009.06345.x; Hall FS, 2011, NEUROSCIENCE, V175, P315, DOI 10.1016/j.neuroscience.2010.11.057; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Hall FS, 2006, NEUROPSYCHOPHARMACOL, V31, pS155; Hall FS, 2004, ANN NY ACAD SCI, V1025, P47, DOI 10.1196/annals.1316.006; Hall FS, 2002, NEUROSCIENCE, V115, P153, DOI 10.1016/S0306-4522(02)00379-2; Haller J, 2002, BRAIN RES BULL, V58, P279, DOI 10.1016/S0361-9230(02)00789-X; Hasan KM, 2001, J MAGN RESON, V152, P41, DOI 10.1006/jmre.2001.2400; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hof PR., 2000, COMP CYTOARCHITECTON; Homberg J, 2008, BEHAV PHARMACOL, V19, P656; Hu YP, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-49; Hua X, 2010, NEUROBIOL AGING, V31, P1463, DOI 10.1016/j.neurobiolaging.2010.04.033; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jokerst JV, 2011, ACCOUNTS CHEM RES, V44, P1050, DOI 10.1021/ar200106e; Jones JD, 2010, PHARMACOL BIOCHEM BE, V94, P580, DOI 10.1016/j.pbb.2009.11.014; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Keller NR, 2004, CIRCULATION, V110, P1191, DOI 10.1161/01.CIR.0000141804.90845.E6; Kochunov P, 2001, J COMPUT ASSIST TOMO, V25, P805, DOI 10.1097/00004728-200109000-00023; Koikkalainen J, 2011, NEUROIMAGE, V56, P1134, DOI 10.1016/j.neuroimage.2011.03.029; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lau JC, 2008, NEUROIMAGE, V42, P19, DOI 10.1016/j.neuroimage.2008.04.252; Leow AD, 2007, IEEE T MED IMAGING, V26, P822, DOI 10.1109/TMI.2007.892646; Li Q, 2003, J NEUROCHEM, V84, P1256, DOI 10.1046/j.1471-4159.2003.01607.x; Lyoo IK, 2002, BIOL PSYCHIAT, V51, P195, DOI 10.1016/S0006-3223(01)01313-0; Madabhushi A, 2005, IEEE T MED IMAGING, V24, P561, DOI 10.1109/TMI.2004.843256; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Mead AN, 2002, EUR J NEUROSCI, V16, P514, DOI 10.1046/j.1460-9568.2002.02104.x; Medvedev IO, 2005, PSYCHOPHARMACOLOGY, V180, P408, DOI 10.1007/s00213-005-2173-y; Meyer JS, 2006, ANN NY ACAD SCI, V1074, P365, DOI 10.1196/annals.1369.036; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; MOFFETT JR, 1995, J NEUROCYTOL, V24, P409, DOI 10.1007/BF01181604; Moriya Y, 2013, SEROTONIN BIOSYNTHES; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Murayama Y, 2006, MAGN RESON IMAGING, V24, P349, DOI 10.1016/j.mri.2005.12.031; Narayana PA, 2010, DRUG ALCOHOL DEPEN, V111, P191, DOI 10.1016/j.drugalcdep.2010.04.012; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Nestler E. J., 2008, MOL NEUROPHARMACOLOG; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Numachi Y, 2007, EUR J PHARMACOL, V572, P120, DOI 10.1016/j.ejphar.2007.06.022; Ordway G. A., 2002, NEUROPSYCHOPHARMACOL, P1051; Ottobrini L, 2011, EUR J NUCL MED MOL I, V38, P949, DOI 10.1007/s00259-010-1687-7; Pautler RG, 2003, MAGNET RESON MED, V50, P33, DOI 10.1002/mrm.10498; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perles-Barbacaru TA, 2011, NEUROIMAGE, V55, P622, DOI 10.1016/j.neuroimage.2010.12.048; Perona MTG, 2008, BEHAV PHARMACOL, V19, P566, DOI 10.1097/FBP.0b013e32830cd80f; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Rommelfanger KS, 2004, J NEUROCHEM, V91, P1116, DOI 10.1111/j.1471-4159.2004.02785.x; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; RUDIN M, 1995, EUR J PHARM SCI, V3, P255, DOI 10.1016/0928-0987(95)00012-3; Sanacora G, 1999, NEUROSCIENTIST, V5, P192, DOI 10.1177/107385849900500316; Sanders JD, 2005, NEUROSCIENCE, V130, P107, DOI 10.1016/j.neuroscience.2004.09.014; Schuff N, 2008, PSYCHIAT RES-NEUROIM, V162, P147, DOI 10.1016/j.pscychresns.2007.04.011; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Sieber-Blum M, 2000, MOL CELL BIOCHEM, V212, P61, DOI 10.1023/A:1007100803568; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, SCHIZOPHRENIA BULL, V34, P595, DOI 10.1093/schbul/sbn056; Solich J, 2011, NEUROCHEM INT, V59, P185, DOI 10.1016/j.neuint.2011.04.012; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 2010, ANN NY ACAD SCI, V1187, P218, DOI 10.1111/j.1749-6632.2009.05276.x; Steen RG, 2005, NEUROPSYCHOPHARMACOL, V30, P1949, DOI 10.1038/sj.npp.1300850; Tao GZ, 2009, J NEUROL SCI, V282, P39, DOI 10.1016/j.jns.2008.12.035; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Torres GE, 2005, J NEUROSCI METH, V143, P63, DOI 10.1016/j.jneumeth.2004.09.012; Valenzuela MJ, 2001, NEUROLOGY, V56, P592, DOI 10.1212/WNL.56.5.592; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; Vielhaber S, 2008, EPILEPSIA, V49, P40, DOI 10.1111/j.1528-1167.2007.01280.x; Vizi ES, 2004, J NEUROSCI, V24, P7888, DOI 10.1523/JNEUROSCI.1506-04.2004; Wang YM, 1999, BIOL PSYCHIAT, V46, P1124, DOI 10.1016/S0006-3223(99)00245-0; Weinberger DR, 2001, BIOL PSYCHIAT, V50, P825, DOI 10.1016/S0006-3223(01)01252-5; Wolf Marina E, 2002, Mol Interv, V2, P146, DOI 10.1124/mi.2.3.146; Woo KV, 2001, CIRCULATION, V104, P173; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Yamashita M, 2006, NEUROPSYCHOPHARMACOL, V31, P2132, DOI 10.1038/sj.npp.1301009; Yanovsky I, 2009, MED IMAGE ANAL, V13, P679, DOI 10.1016/j.media.2009.06.002; Zhang XW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011506; Zhou J, 2004, DRUG FUTURE, V29, P1235, DOI 10.1358/dof.2004.029.12.855246	116	14	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57597	10.1371/journal.pone.0057597	http://dx.doi.org/10.1371/journal.pone.0057597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469209	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000315634900030
J	Tanaka, SS; Nakane, A; Yamaguchi, YL; Terabayashi, T; Abe, T; Nakao, K; Asashima, M; Steiner, KA; Tam, PPL; Nishinakamura, R				Tanaka, Satomi S.; Nakane, Akihiro; Yamaguchi, Yasuka L.; Terabayashi, Takeshi; Abe, Takaya; Nakao, Kazuki; Asashima, Makoto; Steiner, Kirsten A.; Tam, Patrick P. L.; Nishinakamura, Ryuichi			Dullard/Ctdnep1 Modulates WNT Signalling Activity for the Formation of Primordial Germ Cells in the Mouse Embryo	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR; NEGATIVE REGULATOR; GENE-EXPRESSION; AXIS FORMATION; SPECIFICATION; PATHWAY; PROTEIN; MICE; GENERATION; LINEAGE	Dullard/Ctdnep1 is a member of the serine/threonine phosphatase family of the C-terminal domain of eukaryotic RNA polymerase II. Embryos lacking Dullard activity fail to form primordial germ cells (PGCs). In the mouse, the formation of PGCs is influenced by BMP4 and WNT3 activity. Although Dullard is reputed to negatively regulate BMP receptor function, in this study we found mutations in Dullard had no detectable effect on BMP4 and p-Smad activity. Furthermore Dullard mutations did not influence the dosage-dependent inductive effect of Bmp4 in PGC formation. However, Dullard may function as a positive regulator of WNT signalling. Combined loss of one copy each of Dullard and Wnt3 had a synergistic effect on the reduction of PGC numbers in the compound heterozygous embryo. In addition, loss of Dullard function was accompanied by down-regulation of WNT/beta-catenin signalling activity and a reduction in the level of Dishevelled 2 (Dvl2). Therefore, Dullard may play a role in the fine-tuning of WNT signalling activity by modulating the expression of ligands/antagonists and the availability of Dvl2 protein during specification of the germ cell lineage.	[Tanaka, Satomi S.; Nakane, Akihiro; Yamaguchi, Yasuka L.; Terabayashi, Takeshi; Nishinakamura, Ryuichi] Kumamoto Univ, IMEG, Dept Kidney Dev, Kumamoto, Japan; [Abe, Takaya; Nakao, Kazuki] RIKEN Ctr Dev Biol CDB, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan; [Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn SCRC, Tsukuba, Ibaraki, Japan; [Steiner, Kirsten A.; Tam, Patrick P. L.] Childrens Med Res Inst, Embryol Unit, Westmead, NSW, Australia; [Tam, Patrick P. L.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Kumamoto University; RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); Children's Medical Research Institute - Australia; University of Sydney	Tam, PPL (corresponding author), Childrens Med Res Inst, Embryol Unit, Westmead, NSW, Australia.	ptam@cmri.org.au; ryuichi@kumamoto-u.ac.jp	Asashima, Makoto/O-8389-2018; Nakane, Akihiro/GVR-7445-2022	Asashima, Makoto/0000-0002-0012-026X; zhong wei, he gui/0000-0002-3066-3564; Terabayashi, Takeshi/0000-0001-7102-784X	Ministry of Education, Culture, Sports, Science and Technology of Japan [23013018]; Japan Society for Promotion of Science [23570258]; Grants-in-Aid for Scientific Research [23570258, 23013018] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#23013018 to SST), the Japan Society for Promotion of Science (23570258 to SST), and Mr. James Fairfax (to Children's Medical Research Institute). PPLT is a Senior Principal Research Fellow of the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Arnold SJ, 2006, DEV BIOL; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Bosman EA, 2006, DEVELOPMENT, V133, P3399, DOI 10.1242/dev.02497; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chang H, 2001, MECH DEVELOP, V104, P61, DOI 10.1016/S0925-4773(01)00367-7; Chew LJ, 2011, J NEUROSCI, V31, P13921, DOI 10.1523/JNEUROSCI.3343-11.2011; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DUNCAN M, 1992, DEV BIOL, V154, P1, DOI 10.1016/0012-1606(92)90042-F; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Matsui Y, 2005, BIOESSAYS, V27, P136, DOI 10.1002/bies.20178; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; NEUMAN T, 1993, DEV BIOL, V160, P186, DOI 10.1006/dbio.1993.1297; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Rebay I, 2005, TRENDS GENET, V21, P163, DOI 10.1016/j.tig.2005.01.005; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Shirasawa S, 2011, STEM CELLS DEV, V20, P1071, DOI 10.1089/scd.2010.0185; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tamashiro DAA, 2012, DIFFERENTIATION, V83, P282, DOI 10.1016/j.diff.2012.02.010; Tanaka SS, 2010, DEV DYNAM, V239, P2851, DOI 10.1002/dvdy.22417; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Tanaka SS, 2011, DEV GROWTH DIFFER; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamaguchi YL, 2011, DEV DYNAM, V240, P394, DOI 10.1002/dvdy.22528; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173	59	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57428	10.1371/journal.pone.0057428	http://dx.doi.org/10.1371/journal.pone.0057428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469192	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900019
J	Kawedia, JD; Yang, F; Sartor, MA; Gozal, D; Czyzyk-Krzeska, M; Menon, AG				Kawedia, Jitesh D.; Yang, Fan; Sartor, Maureen A.; Gozal, David; Czyzyk-Krzeska, Maria; Menon, Anil G.			Hypoxia and Hypoxia Mimetics Decrease Aquaporin 5 (AQP5) Expression through Both Hypoxia Inducible Factor-1 alpha and Proteasome-Mediated Pathways	PLOS ONE			English	Article							PROTEIN-KINASE-A; WATER CHANNELS; EPITHELIAL SODIUM; FLUID TRANSPORT; PULMONARY-EDEMA; COBALT CHLORIDE; HEME OXYGENASE; FACTOR 1-ALPHA; MESSENGER-RNA; PC12 CELLS	The alveolar epithelium plays a central role in gas exchange and fluid transport, and is therefore critical for normal lung function. Since the bulk of water flux across this epithelium depends on the membrane water channel Aquaporin 5 (AQP5), we asked whether hypoxia had any effect on AQP5 expression. We show that hypoxia causes a significant (70%) decrease in AQP5 expression in the lungs of mice exposed to hypoxia. Hypoxia and the hypoxia mimetic, cobalt, also caused similar decreases in AQP5 mRNA and protein expression in the mouse lung epithelial cell line MLE-12. The action of hypoxia and cobalt on AQP5 transcription was demonstrated by directly quantifying heternonuclear RNA by real-time PCR. Dominant negative mutants of Hypoxia Inducible Factor (HIF-1 alpha) and HIF-1 alpha siRNA blocked the action of cobalt, showing that HIF-1 alpha is a key component in this mechanism. The proteasome inhibitors, lactacystin or proteasome inhibitor-III completely abolished the effect of hypoxia and cobalt both at the protein and mRNA level indicating that the proteasome pathway is probably involved not only for the stability of HIF-1 alpha protein, but for the stability of unidentified transcription factors that regulate AQP5 transcription. These studies reveal a potentially important physiological mechanism linking hypoxic stress and membrane water channels.	[Kawedia, Jitesh D.; Yang, Fan; Menon, Anil G.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA; [Sartor, Maureen A.] Univ Michigan, Dept Biostat, Ann Arbor, MI USA; [Gozal, David] Univ Chicago, Comer Childrens Hosp, Chicago, IL 60637 USA; [Czyzyk-Krzeska, Maria] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH USA; [Czyzyk-Krzeska, Maria] Dept Vet Affairs, VA Res Serv, Cincinnati, OH USA; [Yang, Fan] City Hope Comprehens Canc Ctr, Dept Mol Med, Duarte, CA USA; [Kawedia, Jitesh D.] Univ Texas MD Anderson Canc Ctr, Dept Pharm Res, Houston, TX 77030 USA	University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; University of Chicago; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; City of Hope; University of Texas System; UTMD Anderson Cancer Center	Kawedia, JD (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA.	jdkawedia@mdanderson.org	Gozal, David/ABH-3805-2020; Sartor, Maureen/L-2902-2019; Gozal, David/M-9492-2017	Kawedia, Jitesh/0000-0001-9685-9378	National Institutes of Health NIDCR [DE138283]; National Institutes of Health NIEHS [ES06096]; National Institutes of Health NCI [CA122346, HL69932]; NATIONAL CANCER INSTITUTE [R01CA122346] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Institutes of Health NIDCR DE138283 to AGM, NIEHS ES06096 to MAS, MM and AGM, NCI CA122346 to MC-K, and HL69932 to DG. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1991, J CELL BIOCHEM, V47, P43, DOI 10.1002/jcb.240470106; Abreu-Rodriguez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028385; Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Asikainen TM, 2005, P NATL ACAD SCI USA, V102, P10212, DOI 10.1073/pnas.0504520102; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Borok Z, 2002, J APPL PHYSIOL, V93, P2199, DOI 10.1152/japplphysiol.01171.2001; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chun YS, 2001, J CELL SCI, V114, P4051; Clifton-Koeppel R, 2006, NEWBORN INFANT NURS, V6, P52, DOI 10.1053/j.nainr.2006.03.011; CZYZYKKRZESKA MF, 1994, J BIOL CHEM, V269, P760; DOMENIGHETTI GM, 1994, SCHWEIZ MED WSCHR, V124, P274; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Gabazza EC, 2004, PATHOL INT, V54, P774, DOI 10.1111/j.1440-1827.2004.01754.x; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Groenman FA, 2007, AM J PHYSIOL-LUNG C, V293, pL557, DOI 10.1152/ajplung.00486.2006; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Hardiman KM, 2001, AM J RESP CELL MOL, V25, P538, DOI 10.1165/ajrcmb.25.5.f219; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ji ZY, 2006, CANCER LETT, V244, P182, DOI 10.1016/j.canlet.2005.12.010; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Karyala Saikumar, 2004, Cardiovasc Toxicol, V4, P47, DOI 10.1385/CT:4:1:47; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; KATAYOSE D, 1993, BIOCHEM BIOPH RES CO, V191, P587, DOI 10.1006/bbrc.1993.1258; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kozlowski L, 2001, TUMOR BIOL, V22, P211, DOI 10.1159/000050618; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Krane CM, 1999, MAMM GENOME, V10, P498, DOI 10.1007/s003359901030; LI QQ, 2001, CELL MOL BIOL NOISY, V47; Li RC, 2004, NEUROBIOL DIS, V17, P44, DOI 10.1016/j.nbd.2004.05.006; Li RC, 2006, BRAIN RES, V1096, P173, DOI 10.1016/j.brainres.2006.04.063; Maggiorini M, 2006, CARDIOVASC RES, V72, P41, DOI 10.1016/j.cardiores.2006.07.004; Mairbaurl H, 2002, AM J PHYSIOL-LUNG C, V282, pL659, DOI 10.1152/ajplung.00355; Mairbaurl H, 1997, AM J PHYSIOL-LUNG C, V273, pL797, DOI 10.1152/ajplung.1997.273.4.L797; McCormack T, 1997, J BIOL CHEM, V272, P26103, DOI 10.1074/jbc.272.42.26103; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Mobasheri A, 2006, ANN NY ACAD SCI, V1091, P83, DOI 10.1196/annals.1378.057; MULLERTAUBENBERGER A, 1988, J CELL SCI, V90, P51; Pacary E, 2008, BIOCHEM BIOPH RES CO, V377, P400, DOI 10.1016/j.bbrc.2008.09.145; Palmer BF, 2010, AM J MED SCI, V340, P69, DOI 10.1097/MAJ.0b013e3181d3cdbe; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rassler B, 2007, RESP PHYSL NEUROBIOL; Sartor M, 2004, BIOTECHNIQUES, V36, P790, DOI 10.2144/04365ST02; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Sartori C, 2007, RESP PHYSL NEUROBIOL; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sporer KA, 2001, CHEST, V120, P1628, DOI 10.1378/chest.120.5.1628; Tie L, 2012, CELL PHYSIOL BIOCHEM, V29, P269, DOI 10.1159/000337608; Tomlinson LA, 1999, AM J PHYSIOL-LUNG C, V277, pL881, DOI 10.1152/ajplung.1999.277.5.L881; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; VERKMAN AS, 2000, EXP PHYSL, V85; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; Wenger RH, 2000, J EXP BIOL, V203, P1253; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yamamoto N, 2002, MOL BRAIN RES, V104, P96, DOI 10.1016/S0169-328X(02)00322-4; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yang F, 2003, J BIOL CHEM, V278, P32173, DOI 10.1074/jbc.M305149200; Zee ED, 2006, AM J PHYSIOL-LUNG C, V291, pL102, DOI 10.1152/ajplung.00286.2005; Zemans RL, 2004, CRIT CARE, V8, P469, DOI 10.1186/cc2906; Zhou BY, 2007, AM J PHYSIOL-CELL PH, V292, pC1280, DOI 10.1152/ajpcell.00070.2006	75	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57541	10.1371/journal.pone.0057541	http://dx.doi.org/10.1371/journal.pone.0057541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469202	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100022
J	Ravoori, M; Duggal, J; Gagea, M; Han, L; Singh, S; Liu, P; Wei, W; Ragan, DK; Bankson, JA; Ma, JF; Kundra, V				Ravoori, Murali; Duggal, Jyoti; Gagea, Mihai; Han, Lin; Singh, Sheela; Liu, Ping; Wei, Wei; Ragan, Dustin K.; Bankson, James A.; Ma, Jingfei; Kundra, Vikas			Visualizing the Prostate Gland by MR Imaging in Young and Old Mice	PLOS ONE			English	Article							2-POINT DIXON TECHNIQUE; MOUSE MODEL; FAT; WATER; EFFICIENT; PROTON	Purpose: Prostate imaging requires optimization in young and old mouse models. We tested which MR sequences and field strengths best depict the prostate gland in young and old mice; and, whether prostate MR signal, size, and architecture change with age. Technique: Magnetic resonance imaging (MRI) of the prostate of young (2 months) and old (18 months) male nude mice (n = 6) was performed at 4.7 and 7 T and SCID mice (n = 6) at 7 T field strengths, using T1, fat suppressed T1, DWI, T2, fat suppressed T2, as well as T2-based- and proton density-based Dixon "water only" sequences. Images were ranked for best overall sequence for prostate visualization, prostate delineation, and quality of fat suppression. Prostate volume and signal characteristics were compared and histology was performed. Results: T2-based-Dixon "water only" images ranked best overall for prostate visualization and delineation as well as fat suppression (n = 6, P < 0.001) at both 4.7 T and 7 T in nude and 7T in SCID mice. Evaluated in nude mice, T2-based Dixon "water only" had greater prostate CNR and lower fat SNR at 7 T than 4.7 T (P < 0.001). Prostate volume was less in older than younger mice (n = 6, P < 0.02 nude mice; n = 6, P < 0.002 SCID mice). Prostate T2 FSE as well as proton density-based and T2-based-Dixon "water only" signal intensity was higher in younger than older mice (P < 0.001 nude mice; P < 0.01 SCID mice) both at 4.7 and 7 T. This corresponded to an increase in glandular hyperplasia in older mice by histology (P < 0.01, n = 6). Conclusion: T2-based Dixon "water only" images best depict the mouse prostate in young and old nude mice at 4.7 and 7 T. The mouse prostate decreases in size with age. The decrease in T2 and T2-based Dixon "water only" signal with age corresponds with glandular hyperplasia. Findings suggest age should be an important determinant when choosing models of prostate biology and disease.	[Ravoori, Murali; Duggal, Jyoti; Han, Lin; Singh, Sheela; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Gagea, Mihai] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Sect Body Imaging, Houston, TX 77030 USA; [Liu, Ping; Wei, Wei] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Ragan, Dustin K.; Bankson, James A.; Ma, Jingfei] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kundra, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA.	vkundra@mdanderson.org	Wei, Wei/AGP-5085-2022; wei, wei/HHR-8613-2022; Bankson, James A./J-9798-2014	Bankson, James A./0000-0002-8574-154X	National Cancer Institute Prostate SPORE Grant [CA140388]; National Institutes of Health through M. D. Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA140388] Funding Source: NIH RePORTER	National Cancer Institute Prostate SPORE Grant; National Institutes of Health through M. D. Anderson's Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research supported in part by a grant from the National Cancer Institute Prostate SPORE Grant (CA140388), and by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant (CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christiane L, 2011, PLOS ONE, V6, P1; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Gagea-Iurascu M, 2012, AM COLL LAB, P117, DOI 10.1016/B978-0-12-380920-9.00004-3; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; Hsieh CL, 2005, J MOL ENDOCRINOL, V35, P293, DOI 10.1677/jme.1.01722; Kim CK, 2010, AM J ROENTGENOL, V194, P1461, DOI 10.2214/AJR.09.3654; Kim CK, 2006, J COMPUT ASSIST TOMO, V30, P7, DOI 10.1097/01.rct.0000185384.27765.09; Knoblaugh S, 2011, COMPARATIVE ANATOMY AND HISTOLOGY: A MOUSE AND HUMAN ATLAS, P285; Korteweg MA, 2011, INVEST RADIOL, V46, P370, DOI 10.1097/RLI.0b013e31820df706; Kuhl CK, 2008, RADIOLOGY, V247, P16, DOI 10.1148/radiol.2471061828; Kundra V, 2007, AM J ROENTGENOL, V189, P830, DOI 10.2214/AJR.07.2011; Ma JF, 2005, MAGN RESON IMAGING, V23, P977, DOI 10.1016/j.mri.2005.10.005; Ma JF, 2004, MAGN RESON MED, V52, P415, DOI 10.1002/mrm.20146; Mahdavi SS, 2011, MED IMAGE ANAL, V15, P589, DOI 10.1016/j.media.2011.03.004; Nastiuk KL, 2007, BMC UROL, V7, P1; Rad A M, 2008, Open Magn Reson Rev, V1, P60, DOI 10.2174/1874769800801010060; Ragan DK, 2010, J MAGN RESON IMAGING, V31, P510, DOI 10.1002/jmri.22060; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Umekita Y, 1996, P NATL ACAD SCI USA, V93, P11802, DOI 10.1073/pnas.93.21.11802; Valkenburg Kenneth C, 2011, Prostate Cancer, V2011, P895238, DOI 10.1155/2011/895238; Xiang QS, 1997, JMRI-J MAGN RESON IM, V7, P1002, DOI 10.1002/jmri.1880070612; Yang D, 2005, RADIOLOGY, V235, P950, DOI 10.1148/radiol.2353040108	23	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e55746	10.1371/journal.pone.0055746	http://dx.doi.org/10.1371/journal.pone.0055746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469167	gold, Green Published, Green Submitted			2022-12-27	WOS:000315897100007
J	Sagong, B; Baek, JI; Oh, SK; Na, KJ; Bae, JW; Choi, SY; Jeong, JY; Choi, JY; Lee, SH; Lee, KY; Kim, UK				Sagong, Borum; Baek, Jeong-In; Oh, Se-Kyung; Na, Kyung Jin; Bae, Jae Woong; Choi, Soo Young; Jeong, Ji Yun; Choi, Jae Young; Lee, Sang-Heun; Lee, Kyu-Yup; Kim, Un-Kyung			A Rapid Method for Simultaneous Screening of Multi-Gene Mutations Associated with Hearing Loss in the Korean Population	PLOS ONE			English	Article							MOLECULAR ANALYSIS; MATERNAL PLASMA; GENE-MUTATIONS; FETAL DNA; PDS GENE; DEAFNESS; GJB2; SLC26A4; POLYMORPHISM; PENDRIN	Hearing loss (HL) is a congenital disease with a high prevalence, and patients with hearing loss need early diagnosis for treatment and prevention. The GJB2, MT-RNR1, and SLC26A4 genes have been reported as common causative genes of hearing loss in the Korean population and some mutations of these genes are the most common mutations associated with hearing loss. Accordingly, we developed a method for the simultaneous detection of seven mutations (c.235delC of GJB2, c.439A>G, c.919-2A>G, c.1149+3A>G, c.1229C>T, c.2168A>G of SLC26A4, and m.1555A>G of the MT-RNR1 gene) using multiplex SNaPshot minisequencing to enable rapid diagnosis of hereditary hearing loss. This method was confirmed in patients with hearing loss and used for genetic diagnosis of controls with normal hearing and neonates. We found that 4.06% of individuals with normal hearing and 4.32% of neonates were heterozygous carriers. In addition, we detected that an individual is heterozygous for two different mutations of GJB2 and SLC26A4 gene, respectively and one normal hearing showing the heteroplasmy of m.1555A>G. These genotypes corresponded to those determined by direct sequencing. Overall, we successfully developed a robust and cost-effective diagnosis method that detects common causative mutations of hearing loss in the Korean population. This method will be possible to detect up to 40% causative mutations associated with prelingual HL in the Korean population and serve as a useful genetic technique for diagnosis of hearing loss for patients, carriers, neonates, and fetuses.	[Sagong, Borum; Baek, Jeong-In; Oh, Se-Kyung; Bae, Jae Woong; Kim, Un-Kyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Taegu, South Korea; [Na, Kyung Jin; Lee, Sang-Heun; Lee, Kyu-Yup] Kyungpook Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Taegu, South Korea; [Choi, Soo Young] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Jeong, Ji Yun] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Endocrinol & Metab, Sch Med, Taegu, South Korea; [Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Kyungpook National University; Kyungpook National University; University of Pennsylvania; Kyungpook National University; Kyungpook National University Hospital; Yonsei University; Yonsei University Health System	Lee, KY (corresponding author), Kyungpook Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Taegu, South Korea.	kylee@knu.ac.kr; kimuk@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0028066]; Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea [A111345]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0028066) and by a grant from the Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea. (A111345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JW, 2008, INT J MOL MED, V22, P175, DOI 10.3892/ijmm_00000005; Bae JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042463; Bardien S, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-2; Choung YH, 2002, LARYNGOSCOPE, V112, P1667, DOI 10.1097/00005537-200209000-00026; Cohn ES, 1999, AM J MED GENET, V89, P130, DOI 10.1002/(SICI)1096-8628(19990924)89:3<130::AID-AJMG3>3.0.CO;2-M; Dossena S, 2011, CELL PHYSIOL BIOCHEM, V28, P451, DOI 10.1159/000335107; Dudarewicz M, 2012, PHARMACOL REP, V64, P343, DOI 10.1016/S1734-1140(12)70774-0; Fiorentino F, 2003, MOL HUM REPROD, V9, P399, DOI 10.1093/molehr/gag046; Garcia-Roca P, 2012, ARCH MED RES, V43, P283, DOI 10.1016/j.arcmed.2012.05.005; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Grignani P, 2006, INT J LEGAL MED, V120, P151, DOI 10.1007/s00414-005-0059-5; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Huang CH, 2011, MOL CELL PROBE, V25, P153, DOI 10.1016/j.mcp.2011.03.002; Ishihara K, 2010, HEARING RES, V270, P110, DOI 10.1016/j.heares.2010.08.015; Kato T, 2010, J HUM GENET, V55, P147, DOI 10.1038/jhg.2009.143; Kirchhoff T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035706; Kokotas H, 2010, GENET TEST MOL BIOMA, V14, P189, DOI 10.1089/gtmb.2009.0136; La Neve F, 2008, MEAT SCI, V80, P216, DOI 10.1016/j.meatsci.2007.11.027; Lee KY, 2008, INT J PEDIATR OTORHI, V72, P1301, DOI 10.1016/j.ijporl.2008.05.007; Li Shao-Ying, 2011, Zhonghua Zhong Liu Za Zhi, V33, P605; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Paneto GG, 2011, MITOCHONDRION, V11, P296, DOI 10.1016/j.mito.2010.12.010; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Poon LLM, 2002, CLIN CHEM, V48, P35; Shin JW, 2012, CLIN EXP OTORHINOLAR, V5, pS10, DOI 10.3342/ceo.2012.5.S1.S10; Smith WM, 1998, GENET TEST, V2, P43, DOI 10.1089/gte.1998.2.43; Song MJ, 2012, J HUM GENET, V57, P139, DOI 10.1038/jhg.2011.144; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yang JJ, 2005, HEARING RES, V199, P22, DOI 10.1016/j.heares.2004.08.007; Yoon JS, 2008, J MED GENET, V45, P411, DOI 10.1136/jmg.2007.054635; Zhao Juan, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P518, DOI 10.3760/cma.j.issn.1003-9406.2009.05.008	39	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57237	10.1371/journal.pone.0057237	http://dx.doi.org/10.1371/journal.pone.0057237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469187	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100017
J	de Poorter, C; Baertsoen, K; Lannoy, V; Parmentier, M; Springael, JY				de Poorter, Cedric; Baertsoen, Kevin; Lannoy, Vincent; Parmentier, Marc; Springael, Jean-Yves			Consequences of ChemR23 Heteromerization with the Chemokine Receptors CXCR4 and CCR7	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTORS; DENDRITIC CELLS; HIV-1 CORECEPTOR; DIMERIZATION; CHEMERIN; DESENSITIZATION; ADIPOKINE; LIGAND; HETEROOLIGOMERS; OLIGOMERIZATION	Recent studies have shown that heteromerization of the chemokine receptors CCR2, CCR5 and CXCR4 is associated to negative binding cooperativity. In the present study, we build on these previous results, and investigate the consequences of chemokine receptor heteromerization with ChemR23, the receptor of chemerin, a leukocyte chemoattractant protein structurally unrelated to chemokines. We show, using BRET and HTRF assays, that ChemR23 forms homomers, and provide data suggesting that ChemR23 also forms heteromers with the chemokine receptors CCR7 and CXCR4. As previously described for other chemokine receptor heteromers, negative binding cooperativity was detected between ChemR23 and chemokine receptors, i.e. the ligands of one receptor competed for the binding of a specific tracer of the other. We also showed, using mouse bone marrow-derived dendritic cells prepared from wild-type and ChemR23 knockout mice, that ChemR23-specific ligands cross-inhibited CXCL12 binding on CXCR4 in a ChemR23-dependent manner, supporting the relevance of the ChemR23/CXCR4 interaction in native leukocytes. Finally, and in contrast to the situation encountered for other previously characterized CXCR4 heteromers, we showed that the CXCR4-specific antagonist AMD3100 did not cross-inhibit chemerin binding in cells co-expressing ChemR23 and CXCR4, demonstrating that cross-regulation by AMD3100 depends on the nature of receptor partners with which CXCR4 is co-expressed.	[de Poorter, Cedric; Baertsoen, Kevin; Parmentier, Marc; Springael, Jean-Yves] Univ Libre Brussels, IRIBHM, Brussels, Belgium; [Lannoy, Vincent] Euroscreen SA, Gosselies, Belgium	Universite Libre de Bruxelles	Parmentier, M (corresponding author), Univ Libre Brussels, IRIBHM, Campus Erasme, Brussels, Belgium.	mparment@ulb.ac.be		Parmentier, Marc/0000-0001-8081-4685	Fonds de la Recherche Scientifique Medicale of Belgium; Fondation Medicale Reine Elisabeth; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Interuniversity Attraction Poles Programme - Belgian State - Belgian Science Policy [P6-14]; Walloon region (Programme d'excellence "CIBLES"); European Union [LSHB-CT-2005-518167/INNOCHEM]; Alice et David Van Buuren Foundation	Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; Actions de Recherche Concertees of the Communaute Francaise de Belgique; Interuniversity Attraction Poles Programme - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Walloon region (Programme d'excellence "CIBLES"); European Union(European Commission); Alice et David Van Buuren Foundation	This work was supported by the Fonds de la Recherche Scientifique Medicale of Belgium and the Fondation Medicale Reine Elisabeth, the Actions de Recherche Concertees of the Communaute Francaise de Belgique, the Interuniversity Attraction Poles Programme (P6-14) - Belgian State - Belgian Science Policy, the Walloon region (Programme d'excellence "CIBLES"), the European Union (grant LSHB-CT-2005-518167/INNOCHEM). C.D. was a fellow of the Belgian Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA) and was also supported by the Alice et David Van Buuren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Chakera A, 2008, MOL PHARMACOL, V73, P1362, DOI 10.1124/mol.107.040915; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Finley MJ, 2008, J NEUROIMMUNOL, V197, P114, DOI 10.1016/j.jneuroim.2008.04.021; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Le YY, 2001, CLIN IMMUNOL, V99, P365, DOI 10.1006/clim.2001.5021; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Mellado M, 1999, NATURE, V400, P723, DOI 10.1038/23382; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Toth PT, 2004, J PHARMACOL EXP THER, V310, P8, DOI 10.1124/jpet.103.064956; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011	35	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58075	10.1371/journal.pone.0058075	http://dx.doi.org/10.1371/journal.pone.0058075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469143	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900234
J	Gerez, J; Fuertes, M; Tedesco, L; Silberstein, S; Sevlever, G; Paez-Pereda, M; Holsboer, F; Turjanski, AG; Arzt, E				Gerez, Juan; Fuertes, Mariana; Tedesco, Lucas; Silberstein, Susana; Sevlever, Gustavo; Paez-Pereda, Marcelo; Holsboer, Florian; Turjanski, Adrian G.; Arzt, Eduardo			In Silico Structural and Functional Characterization of the RSUME Splice Variants	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-STRUCTURE PREDICTION; ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; CRYSTAL-STRUCTURE; HYPOXIA; CELLS; SUMO; INVOLVEMENT	RSUME (RWD-containing SUMO Enhancer) is a small protein that increases SUMO conjugation to proteins. To date, four splice variants that codify three RSUME isoforms have been described, which differ in their C-terminal end. Comparing the structure of the RSUME isoforms we found that, in addition to the previously described RWD domain in the N-terminal, all these RSUME variants also contain an intermediate domain. Only the longest RSUME isoform presents a C-terminal domain that is absent in the others. Given these differences, we used the shortest and longest RSUME variants for comparative studies. We found that the C-terminal domain is dispensable for the SUMO-conjugation enhancer properties of RSUME. We also demonstrate that these two RSUME variants are equally induced by hypoxia. The NF-kappa B signaling pathway is inhibited and the HIF-1 pathway is increased more efficiently by the longest RSUME, by means of a greater physical interaction of RSUME267 with the target proteins. In addition, the mRNA and protein levels of these isoforms differ in human glioma samples; while the shortest RSUME isoform is expressed in all the tumors analyzed, the longest variant is expressed in most but not all of them. The results presented here show a degree of redundancy of the RSUME variants on the SUMO pathway. However, the increased inhibition conferred by RSUME267 over the NF-kappa B signaling pathway, the increased activation over the HIF-1 pathway and the different expression of the RSUME isoforms suggest specific roles for each RSUME isoform which may be relevant in certain types of brain tumors that express RSUME, like human pituitary adenomas and gliomas.	[Gerez, Juan; Fuertes, Mariana; Tedesco, Lucas; Silberstein, Susana; Arzt, Eduardo] Max Planck Gesell, Inst Invest Biomed Buenos Aires IBioBA CONICET Pa, Buenos Aires, DF, Argentina; [Silberstein, Susana; Arzt, Eduardo] Univ Buenos Aires, FCEN, Dept Fisiol & Biol Mol, Buenos Aires, DF, Argentina; [Sevlever, Gustavo] FLENI, Dept Neuropatol & Biol Mol, Buenos Aires, DF, Argentina; [Paez-Pereda, Marcelo; Holsboer, Florian; Arzt, Eduardo] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Turjanski, Adrian G.] Univ Buenos Aires, FCEN, INQUIMAE CONICET, Dept Quim Biol,Lab Bioinformat Estruct, Buenos Aires, DF, Argentina	Max Planck Society; University of Buenos Aires; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Arzt, E (corresponding author), Max Planck Gesell, Inst Invest Biomed Buenos Aires IBioBA CONICET Pa, Buenos Aires, DF, Argentina.	earzt@fbmc.fcen.uba.ar	Sevlever, Gustavo/Q-2219-2015	Sevlever, Gustavo/0000-0002-9567-7553; Turjanski, Adrian/0000-0003-2190-137X; Paez-Pereda, Marcelo/0000-0001-6029-0706	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina); Max Planck Society; University of Buenos Aires (UBA, Argentina); National Research Council (CONICET, Argentina)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina)(ANPCyT); Max Planck Society(Max Planck Society); University of Buenos Aires (UBA, Argentina)(University of Buenos Aires); National Research Council (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina), the Max Planck Society, the University of Buenos Aires (UBA, Argentina) and National Research Council (CONICET, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Castro CP, 2003, ENDOCRINOLOGY, V144, P693, DOI 10.1210/en.2002-220891; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Fowkes RC, 2012, ENDOCR-RELAT CANCER, V19, pC1, DOI 10.1530/ERC-11-0297; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hooft RWW, 1996, PROTEINS, V26, P363; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kalli K, 1998, MOL CELL BIOL, V18, P3140, DOI 10.1128/MCB.18.6.3140; Ke J, 2007, J ORAL PATHOL MED, V36, P290, DOI 10.1111/j.1600-0714.2007.00532.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kovalenko OV, 1996, P NATL ACAD SCI USA, V93, P2958, DOI 10.1073/pnas.93.7.2958; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Liberman AC, 2009, FASEB J, V23, P1558, DOI 10.1096/fj.08-121236; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mount DW, 2007, CSH PROTOC, V2007; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Richard DE, 2000, J BIOL CHEM, V275, P26765; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shan B, 2012, ENDOCR-RELAT CANCER, V19, P13, DOI 10.1530/ERC-11-0211; Shima DT, 1996, INVEST OPHTH VIS SCI, V37, P1334; Stone DH, 1998, J PUBLIC HEALTH MED, V20, P111, DOI 10.1093/oxfordjournals.pubmed.a024701; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195	45	11	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57795	10.1371/journal.pone.0057795	http://dx.doi.org/10.1371/journal.pone.0057795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469069	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900167
J	Liu, LL; Wu, J; Ong, SS; Chen, TS				Liu, Lingling; Wu, Jing; Ong, Su Sien; Chen, Taosheng			Cyclin-Dependent Kinase 4 Phosphorylates and Positively Regulates PAX3-FOXO1 in Human Alveolar Rhabdomyosarcoma Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; FUSION GENE; PAX3-FKHR; INHIBITION; IDENTIFICATION; PROLIFERATION; REVEALS; BINDING; TARGET; SITES	Alveolar rhabdomyosarcoma (ARMS) is an aggressive childhood muscle sarcoma with a 5-year survival rate of less than 30%. More than 80% of ARMSs harbor a PAX3-FOXO1 fusion transcription factor. However, expression of PAX3-FOXO1 in muscle cells alone is not sufficient and requires the loss of function of Ink4a/ARF to promote malignant proliferation of muscle cells in vitro or initiate ARMS tumor formation in vivo. This prompted us to examine the signaling pathways required to activate the function of PAX3-FOXO1 and to explore the functional interaction between the Ink4a/ARF and PAX3-FOXO1 signaling pathways. Here we report that inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin (a small molecule selective inhibitor of Cdk4/cyclin D1 that we identified in a screen for compounds that inhibit PAX3-FOXO1) led to inhibition of the transcriptional activity of PAX3-FOXO1 in ARMS cell line Rh30. Consistent with this finding, activation of Cdk4 enhanced the activity of PAX3-FOXO1. In vitro kinase assays revealed that Cdk4 directly phosphorylated PAX3-FOXO1 at Ser(430). Whereas fascaplysin did not affect the protein level of PAX3-FOXO1, it did increase the cytoplasmic level of PAX3-FOXO1 in a portion of cells. Our findings indicate that Cdk4 phosphorylates and positively regulates PAX3-FOXO1 and suggest that inhibition of Cdk4 activity should be explored as a promising avenue for developing therapy for ARMS.	[Liu, Lingling; Wu, Jing; Ong, Su Sien; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Chen, TS (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	taosheng.chen@stjude.org	Chen, Taosheng/I-6351-2013	Chen, Taosheng/0000-0001-6420-3809	American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital; National Cancer Institute [P30CA027165]; St. Baldrick's Foundation [179692]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital, National Cancer Institute grant P30CA027165, and the St. Baldrick's Foundation (Award Number: 179692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstutz R, 2008, CANCER RES, V68, P3767, DOI 10.1158/0008-5472.CAN-07-2447; Aubry C, 2009, BIOORGAN MED CHEM, V17, P6073, DOI 10.1016/j.bmc.2009.06.070; Bouck DC, 2011, J BIOMOL SCREEN, V16, P394, DOI 10.1177/1087057110397889; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dietz KN, 2011, INT J BIOCHEM CELL B, V43, P936, DOI 10.1016/j.biocel.2011.03.010; Dietz KN, 2009, BIOCHEMISTRY-US, V48, P11786, DOI 10.1021/bi9012947; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2005, CANCER RES, V65, P7530, DOI 10.1158/0008-5472.CAN-05-0477; Lin WW, 2008, J BIOL CHEM, V283, P30650, DOI 10.1074/jbc.M806132200; Linardic CM, 2008, CANCER LETT, V270, P10, DOI 10.1016/j.canlet.2008.03.035; Linardic CM, 2007, CANCER RES, V67, P6691, DOI 10.1158/0008-5472.CAN-06-3210; Liu L, 2012, J CAN RES UPDATES, V1, P49; Liu LL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-154; Liu P, 2008, ONCOGENE, V27, P4733, DOI 10.1038/onc.2008.104; Saab R, 2006, MOL CANCER THER, V5, P1299, DOI 10.1158/1535-7163.MCT-05-0383; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; Yan XJ, 2011, EUR J PHARM SCI, V43, P251, DOI 10.1016/j.ejps.2011.04.018; Zeng FY, 2010, BIOCHEM BIOPH RES CO, V391, P1049, DOI 10.1016/j.bbrc.2009.12.017; Zeng FY, 2009, CANCER LETT, V284, P157, DOI 10.1016/j.canlet.2009.04.016	23	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58193	10.1371/journal.pone.0058193	http://dx.doi.org/10.1371/journal.pone.0058193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469153	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900244
J	Mori, S; Tran, V; Nishikawa, K; Kaneda, T; Hamada, Y; Kawaguchi, N; Fujita, M; Takada, YK; Matsuura, N; Zhao, M; Takada, Y				Mori, Seiji; Vu Tran; Nishikawa, Kyoko; Kaneda, Teruya; Hamada, Yoshinosuke; Kawaguchi, Naomasa; Fujita, Masaaki; Takada, Yoko K.; Matsuura, Nariaki; Zhao, Min; Takada, Yoshikazu			A Dominant-Negative FGF1 Mutant (the R50E Mutant) Suppresses Tumorigenesis and Angiogenesis	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; DIRECT BINDING; INTEGRIN ALPHA-V-BETA-3; RECEPTOR; ALPHA-6-BETA-4; EXPRESSION; DOMAIN	Fibroblast growth factor-1 (FGF1) and FGF2 play a critical role in angiogenesis, a formation of new blood vessels from existing blood vessels. Integrins are critically involved in FGF signaling through crosstalk. We previously reported that FGF1 directly binds to integrin alpha v beta 3 and induces FGF receptor-1 (FGFR1)-FGF1-integrin alpha v beta 3 ternary complex. We previously generated an integrin binding defective FGF1 mutant (Arg-50 to Glu, R50E). R50E is defective in inducing ternary complex formation, cell proliferation, and cell migration, and suppresses FGF signaling induced by WT FGF1 (a dominant-negative effect) in vitro. These findings suggest that FGFR and alpha v beta 3 crosstalk through direct integrin binding to FGF, and that R50E acts as an antagonist to FGFR. We studied if R50E suppresses tumorigenesis and angiogenesis. Here we describe that R50E suppressed tumor growth in vivo while WT FGF1 enhanced it using cancer cells that stably express WT FGF1 or R50E. Since R50E did not affect proliferation of cancer cells in vitro, we hypothesized that R50E suppressed tumorigenesis indirectly through suppressing angiogenesis. We thus studied the effect of R50E on angiogenesis in several angiogenesis models. We found that excess R50E suppressed FGF1-induced migration and tube formation of endothelial cells, FGF1-induced angiogenesis in matrigel plug assays, and the outgrowth of cells in aorta ring assays. Excess R50E suppressed FGF1-induced angiogenesis in chick embryo chorioallantoic membrane (CAM) assays. Interestingly, excess R50E suppressed FGF2-induced angiogenesis in CAM assays as well, suggesting that R50E may uniquely suppress signaling from other members of the FGF family. Taken together, our results suggest that R50E suppresses angiogenesis induced by FGF1 or FGF2, and thereby indirectly suppresses tumorigenesis, in addition to its possible direct effect on tumor cell proliferation in vivo. We propose that R50E has potential as an anti-cancer and anti-angiogenesis therapeutic agent ("FGF1 decoy").	[Mori, Seiji; Nishikawa, Kyoko; Kaneda, Teruya; Hamada, Yoshinosuke; Kawaguchi, Naomasa; Matsuura, Nariaki] Osaka Univ, Dept Mol Pathol, Grad Sch Med, Div Hlth Sci, Suita, Osaka, Japan; [Vu Tran; Fujita, Masaaki; Takada, Yoko K.; Zhao, Min; Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA; [Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Sacramento, CA 95817 USA	Osaka University; University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	Japan Society for the Promotion of Science [23590446]; National Institutes of Health [CA13015]; Department of Defense [W81XWH-10-1-0312]; Grants-in-Aid for Scientific Research [23590446] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by A Grant-in-Aid for Scientific Research (Grant No. 23590446) from the Japan Society for the Promotion of Science (to Seiji Mori and Nariaki Matsuura), and National Institutes of Health CA13015 and Department of Defense W81XWH-10-1-0312 (to Yoshikazu Takada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura N, 2006, CANCER RES, V66, P9691, DOI 10.1158/0008-5472.CAN-06-1686; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Brooks PC, 1999, METH MOL B, V129, P257; Dorkin TJ, 1999, ONCOGENE, V18, P2755, DOI 10.1038/sj.onc.1202624; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Giri D, 1999, CLIN CANCER RES, V5, P1063; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; NICOSIA RF, 1990, LAB INVEST, V63, P115; Okunieff P, 2003, ADV EXP MED BIOL, V530, P593; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Schreiber I, 2007, EUR J ENDOCRINOL, V156, P75, DOI 10.1530/eje.1.02312; Storgard Chris, 2004, V294, P123; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thurber GM, 2008, TRENDS PHARMACOL SCI, V29, P57, DOI 10.1016/j.tips.2007.11.004; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273	25	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57927	10.1371/journal.pone.0057927	http://dx.doi.org/10.1371/journal.pone.0057927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469107	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900202
J	Walia, R; Chaconas, G				Walia, Rupali; Chaconas, George			Suggested Role for G4 DNA in Recombinational Switching at the Antigenic Variation Locus of the Lyme Disease Spirochete	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; GENETIC-VARIATION; VLSE; SEQUENCE; PATHWAYS; INFECTIVITY; MUTATIONS; MECHANISM; BACTERIAL; GENOME	Antigenic variation through targeted DNA rearrangements provides a powerful diversity generating mechanism that allows a variety of pathogens to stay one step ahead of acquired immunity in their hosts. The Lyme disease spirochete encodes such a system that is required for persistent infection. The vls locus, carried on a 29 kb linear plasmid (lp28-1) in the type strain B31, carries 15 silent cassettes from which information is unidirectionally transferred into the expression locus, vlsE. Recent studies have surprisingly shown that, with the exception of the RuvAB branch migrase, no other known recombination/repair proteins appear to play a role in the recombinational switching process. In the work presented here we show that G4 DNA can be formed by sequences within the B31 vlsE locus, prompting us to investigate the presence of potential G4-forming DNA throughout the vls locus of several Lyme spirochete strains and species. We found that runs of G, three nucleotides and longer occur at a very high density, with a greater than 100-fold strand-specific distribution in the vls locus of three B. burgdorferi strains as well as in B. afzelii and B. garinii, in spite of the bias for the use of A-T rich codons in Borrelia species. Our findings suggest the possibility that G4 DNA may be a mediator of recombinational switching at the vlsE locus in the Lyme spirochetes.	[Walia, Rupali; Chaconas, George] Univ Calgary, Dept Biochem & Mol Biol, Snyder Inst Chron Dis, Calgary, AB, Canada; [Walia, Rupali; Chaconas, George] Univ Calgary, Dept Microbiol & Infect Dis, Snyder Inst Chron Dis, Calgary, AB, Canada	University of Calgary; University of Calgary	Chaconas, G (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Snyder Inst Chron Dis, Calgary, AB, Canada.	chaconas@ucalgary.ca			Canadian Institutes of Health Research [MOP 53086]; Canada Research Chair in the Molecular Biology of Lyme Borreliosis; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in the Molecular Biology of Lyme Borreliosis; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by grant MOP 53086 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to G.C., who also holds a Canada Research Chair in the Molecular Biology of Lyme Borreliosis (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and a Scientist Award from the Alberta Heritage Foundation for Medical Research (http://www.ahfmr.ab.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankhead T, 2007, MOL MICROBIOL, V65, P1547, DOI 10.1111/j.1365-2958.2007.05895.x; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barbour AG, 2010, BORRELIA MOL BIOL HO, P327; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2011, MOL MICROBIOL, V81, P1136, DOI 10.1111/j.1365-2958.2011.07773.x; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Coutte L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000293; Davis L, 2011, EMBO J, V30, P3878, DOI 10.1038/emboj.2011.342; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Helm RA, 2009, J BACTERIOL, V191, P5613, DOI 10.1128/JB.00535-09; Hill SA, 2000, MOL GEN GENET, V264, P268, DOI 10.1007/s004380000316; Hill SA, 2009, FEMS MICROBIOL REV, V33, P521, DOI 10.1111/j.1574-6976.2009.00171.x; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Indest KJ, 2001, INFECT IMMUN, V69, P7083, DOI 10.1128/IAI.69.11.7083-7090.2001; Kaushik M, 2011, CURR MOL MED, V11, P744, DOI 10.2174/156652411798062421; Kline KA, 2005, J BACTERIOL, V187, P2903, DOI 10.1128/JB.187.8.2903-2907.2005; KOOMEY M, 1987, GENETICS, V117, P391; Kuryavyi V, 2012, STRUCTURE, V20, P2090, DOI 10.1016/j.str.2012.09.013; Lawrenz MB, 2004, INFECT IMMUN, V72, P6577, DOI 10.1128/IAI.72.11.6577-6585.2004; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Liveris D, 2008, INFECT IMMUN, V76, P4009, DOI 10.1128/IAI.00027-08; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6174, DOI 10.1093/nar/gks253; Mehr IJ, 2000, GENETICS, V154, P523; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; Mehr IJ, 1997, MOL MICROBIOL, V23, P1121, DOI 10.1046/j.1365-2958.1997.2971660.x; Morrison LJ, 2009, CELL MICROBIOL, V11, P1724, DOI 10.1111/j.1462-5822.2009.01383.x; Norris S.J., 2010, BORRELIA MOL BIOL HO, P293; Norris SJ, 2006, MOL MICROBIOL, V60, P1319, DOI 10.1111/j.1365-2958.2006.05204.x; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Rohrer MS, 2005, NUCLEIC ACIDS RES, V33, P3363, DOI 10.1093/nar/gki650; Samuels D.S., 2010, BORRELIA MOL BIOL HO; Sannohe Y, 2010, CURR PROTOC NUCL ACI; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; Sechman EV, 2006, MOL MICROBIOL, V61, P185, DOI 10.1111/j.1365-2958.2006.05213.x; Skaar EP, 2002, J BACTERIOL, V184, P919, DOI 10.1128/jb.184.4.919-927.2002; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; Sun D, 2010, METHODS MOL BIOL, V608, P65, DOI 10.1007/978-1-59745-363-9_5; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200; Vink C, 2012, FEMS MICROBIOL REV, V36, P917, DOI 10.1111/j.1574-6976.2011.00321.x; Wang DC, 2003, MOL MICROBIOL, V47, P1407, DOI 10.1046/j.1365-2958.2003.03386.x; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhang JR, 1998, INFECT IMMUN, V66, P3689, DOI 10.1128/IAI.66.8.3689-3697.1998; Zhang JR, 1998, INFECT IMMUN, V66, P3698, DOI 10.1128/IAI.66.8.3698-3704.1998	53	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57792	10.1371/journal.pone.0057792	http://dx.doi.org/10.1371/journal.pone.0057792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469068	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900166
J	Yang, XY; Jing, H; Zhao, K; Sun, RL; Liu, ZZ; Ying, Y; Ci, L; Kuang, Y; Huang, F; Wang, ZG; Fei, J				Yang, Xingyu; Jing, Hua; Zhao, Kai; Sun, Ruilin; Liu, Zhenze; Ying, Yue; Ci, Lei; Kuang, Ying; Huang, Fang; Wang, Zhugang; Fei, Jian			Functional Imaging of Rel Expression in Inflammatory Processes Using Bioluminescence Imaging System in Transgenic Mice	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE-RECEPTORS; FACTOR C-REL; TRANSCRIPTION FACTORS; GENE-EXPRESSION; LPS; ROLES; CELLS; MACROPHAGES; ACTIVATION	c-Rel plays important roles in many inflammatory diseases. Revealing the dynamic expression of c-Rel in disease processes in vivo is critical for understanding c-Rel functions and for developing anti-inflammatory drugs. In this paper, a transgenic mouse line, B6-Tg(c-Rel-luc)(Mlit), which incorporated the transgene firefly luciferase driven by a 14.5-kb fragment containing mouse c-Rel gene Rel promoter, was generated to monitor Rel expression in vivo. Luciferase expression could be tracked in living mice by the method of bioluminescence imaging in a variety of inflammatory processes, including LPS induced sepsis and EAE disease model. The luciferase expression in transgenic mice was comparable to the endogenous Rel expression and could be suppressed by administration of anti-inflammatory drug dexamethasone or aspirin. These results indicate that the B6-Tg(c-Rel-luc)(Mlit) mouse is a valuable animal model to study Rel expression in physiological and pathological processes, and the effects of various drug treatments in vivo.	[Yang, Xingyu; Jing, Hua; Zhao, Kai; Liu, Zhenze; Ying, Yue; Ci, Lei] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Sun, Ruilin; Kuang, Ying; Wang, Zhugang; Fei, Jian] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China; [Huang, Fang] Fudan Univ, Natl Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Fei, J (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	jfei@tongji.edu.cn	Sun, Ruilin/F-9850-2013	Sun, Ruilin/0000-0002-7564-1051	National Key Project [2010CB945501, 2010CB912604]; National Natural Science Foundation of China [81171188]; Science and Technology Commission of Shanghai Municipality [08140900700, 08140901900, 10DZ2251500, 12140902100]; E-Institutes of Shanghai Municipal Education Commission [E03003]	National Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); E-Institutes of Shanghai Municipal Education Commission	This work was supported by the National Key Project [2010CB945501, 2010CB912604]; the National Natural Science Foundation of China (81171188); the Science and Technology Commission of Shanghai Municipality [08140900700, 08140901900, 10DZ2251500, 12140902100]; and the E-Institutes of Shanghai Municipal Education Commission [E03003]. (National Key Project:http://www.973.gov.cn/AreaAppl.aspx; The National Natural Science Foundation of China: http://www.nsfc.gov.cn/nsfc/cen/bzgh_125/index.html; The Science and Technology Commission of Shanghai Municipality: http://www.stcsm.gov.cn/structure/index.htm; The E-Institutes of Shanghai Municipal Education Commission: http://www.shmec.gov.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belguise K, 2007, J CLIN INVEST, V117, P4009, DOI 10.1172/JCI32424; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Chen GB, 2011, J IMMUNOL, V187, P4483, DOI 10.4049/jimmunol.1101757; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Courtine E, 2011, INFECT IMMUN, V79, P1848, DOI 10.1128/IAI.00021-11; Curry Choladda V, 2009, J Hematop, V2, P20, DOI 10.1007/s12308-009-0021-4; de Miguel LS, 1999, EUR J CLIN INVEST, V29, P93, DOI 10.1046/j.1365-2362.1999.00425.x; Donovan CE, 1999, J IMMUNOL, V163, P6827; Ferber IA, 1996, J IMMUNOL, V156, P5; Fullard N, 2012, INT J BIOCHEM CELL B, V44, P851, DOI 10.1016/j.biocel.2012.02.017; Gaspar-Pereira S, 2012, AM J PATHOL, V180, P929, DOI 10.1016/j.ajpath.2011.11.007; Gieling RG, 2010, HEPATOLOGY, V51, P922, DOI 10.1002/hep.23385; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Glezer I, 2003, NEUROPHARMACOLOGY, V45, P1120, DOI 10.1016/S0028-3908(03)00279-X; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Jeon YJ, 2000, IMMUNOPHARMACOLOGY, V48, P173, DOI 10.1016/S0162-3109(00)00199-5; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; KUPRASH DV, 1995, ONCOGENE, V11, P97; Lamhamedi-Cherradi SE, 2003, J IMMUNOL, V171, P4886, DOI 10.4049/jimmunol.171.9.4886; Li LM, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-49; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Reinhard K, 2011, EUR J IMMUNOL, V41, P1388, DOI 10.1002/eji.201041056; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Tian WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005028; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Santos RCV, 2011, INFLAMMATION, V34, P653, DOI 10.1007/s10753-010-9275-3; Wang Y, 2008, J IMMUNOL, V180, P8118, DOI 10.4049/jimmunol.180.12.8118; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	30	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57632	10.1371/journal.pone.0057632	http://dx.doi.org/10.1371/journal.pone.0057632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469037	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900136
J	Tobias, F; Lob, D; Lengert, N; Durante, M; Drossel, B; Taucher-Scholz, G; Jakob, B				Tobias, Frank; Loeb, Daniel; Lengert, Nicor; Durante, Marco; Drossel, Barbara; Taucher-Scholz, Gisela; Jakob, Burkhard			Spatiotemporal Dynamics of Early DNA Damage Response Proteins on Complex DNA Lesions	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; ATM ACTIVATION; FLUORESCENCE RECOVERY; MRE11-RAD50-NBS1 COMPLEX; CHROMATIN RETENTION; 53BP1 RECRUITMENT; CELLULAR-RESPONSE; NUCLEAR PROTEINS; TRACK STRUCTURE	The response of cells to ionizing radiation-induced DNA double-strand breaks (DSB) is determined by the activation of multiple pathways aimed at repairing the injury and maintaining genomic integrity. Densely ionizing radiation induces complex damage consisting of different types of DNA lesions in close proximity that are difficult to repair and may promote carcinogenesis. Little is known about the dynamic behavior of repair proteins on complex lesions. In this study we use live-cell imaging for the spatio-temporal characterization of early protein interactions at damage sites of increasing complexity. Beamline microscopy was used to image living cells expressing fluorescently-tagged proteins during and immediately after charged particle irradiation to reveal protein accumulation at damaged sites in real time. Information on the mobility and binding rates of the recruited proteins was obtained from fluorescence recovery after photobleaching (FRAP). Recruitment of the DNA damage sensor protein NBS1 accelerates with increasing lesion density and saturates at very high damage levels. FRAP measurements revealed two different binding modalities of NBS1 to damage sites and a direct impact of lesion complexity on the binding. Faster recruitment with increasing lesion complexity was also observed for the mediator MDC1, but mobility was limited at very high damage densities due to nuclear-wide binding. We constructed a minimal computer model of the initial response to DSB based on known protein interactions only. By fitting all measured data using the same set of parameters, we can reproduce the experimentally characterized steps of the DNA damage response over a wide range of damage densities. The model suggests that the influence of increasing lesion density accelerating NBS1 recruitment is only dependent on the different binding modes of NBS1, directly to DSB and to the surrounding chromatin via MDC1. This elucidates an impact of damage clustering on repair without the need of invoking extra processing steps.	[Tobias, Frank; Durante, Marco; Taucher-Scholz, Gisela; Jakob, Burkhard] GSI Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany; [Loeb, Daniel; Lengert, Nicor; Durante, Marco; Drossel, Barbara] Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Technical University of Darmstadt	Jakob, B (corresponding author), GSI Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany.	B.Jakob@gsi.de	Durante, Marco/L-4795-2017; Durante, Marco/K-1315-2014; Jakob, Burkhard/D-2047-2013	Durante, Marco/0000-0002-4615-553X; Durante, Marco/0000-0002-4615-553X; Jakob, Burkhard/0000-0003-2404-377X	Bundesministerium fur Bildung und Forschung [02NUK001A, 02S8355]; Deutsche Forschungsgemeinschaft [Graduiertenkolleg 1657]; Helmholtz Graduate School for Hadron and Ion Research (HGS-HIRe)	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Graduate School for Hadron and Ion Research (HGS-HIRe)	This research was partly supported by Bundesministerium fur Bildung und Forschung grants 02NUK001A and 02S8355; Deutsche Forschungsgemeinschaft grant Graduiertenkolleg 1657; Helmholtz Graduate School for Hadron and Ion Research (HGS-HIRe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Calapez A, 2002, J CELL BIOL, V159, P795, DOI 10.1083/jcb.200203046; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; CASH JR, 1990, ACM T MATH SOFTWARE, V16, P201, DOI 10.1145/79505.79507; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Crank J., 1975, MATH DIFFUSION; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Friedland W, 2010, RADIAT RES, V173, P677, DOI 10.1667/RR1965.1; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Hable V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041943; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Jakob B, 2000, RADIAT RES, V154, P398, DOI 10.1667/0033-7587(2000)154[0398:ILCPRR]2.0.CO;2; Jakob B, 2006, NUCL INSTRUM METH B, V245, P292, DOI 10.1016/j.nimb.2005.11.117; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2005, RADIAT RES, V163, P681, DOI 10.1667/RR3374; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Jungmichel S, 2010, CHROMOSOMA, V119, P337, DOI 10.1007/s00412-010-0266-9; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; KRAMER M, 1994, ADV SPACE RES-SERIES, V14, P151, DOI 10.1016/0273-1177(94)90465-0; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; LOBRICH M, 1994, RADIAT RES, V139, P142, DOI 10.2307/3578658; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Meyer B, 2012, THESIS TU DARMSTADT; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Mosconi M, 2011, RADIAT ENVIRON BIOPH, V50, P345, DOI 10.1007/s00411-011-0366-9; Mouri K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005131; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Politi A, 2005, MOL CELL, V19, P679, DOI 10.1016/j.molcel.2005.06.036; Rodgers W, 2002, J IMMUNOL, V168, P2348, DOI 10.4049/jimmunol.168.5.2348; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Scholz M, 2003, RAD EFFECTS POLYM BI, P158; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shimamoto N, 1999, J BIOL CHEM, V274, P15293, DOI 10.1074/jbc.274.22.15293; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Splinter J, 2010, MUTAGENESIS, V25, P289, DOI 10.1093/mutage/geq005; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Sprague BL, 2006, BIOPHYS J, V91, P1169, DOI 10.1529/biophysj.105.073676; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; TAUCHERSCHOLZ G, 2007, GENOME INTEGRITY, V1, P453; Tobias F, 2010, MUTAT RES-REV MUTAT, V704, P54, DOI 10.1016/j.mrrev.2009.11.004; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van Royen ME, 2011, CHROMOSOME RES, V19, P83, DOI 10.1007/s10577-010-9172-5; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	82	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57953	10.1371/journal.pone.0057953	http://dx.doi.org/10.1371/journal.pone.0057953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469115	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400049
J	Jansen, OE; Aarts, GM; Reijnders, PJH				Jansen, Okka E.; Aarts, Geert M.; Reijnders, Peter J. H.			Harbour Porpoises Phocoena phocoena in the Eastern Scheldt: A Resident Stock or Trapped by a Storm Surge Barrier?	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; FEEDING ECOLOGY; CARBON ISOTOPES; MARINE MAMMALS; NORTH-SEA; FOOD-WEB; NITROGEN; DELTA-C-13; TISSUES; DIET	Coastal protection measures are planned and executed worldwide to combat the effects of global warming and climate change, in particular the acceleration of sea level rise, higher storm surge flooding and extensive coastal inundation. The extent to which these defensive measures may impact coastal and estuarine ecosystems is still poorly understood. Since the building of a storm surge barrier, movement of harbour porpoises Phocoena phocoena in and out of the Eastern Scheldt tidal bay (SW-Netherlands) may be limited. To measure residency, porpoises stranded along the Dutch North Sea coast between 2006 and 2008 were sampled for muscle (n = 102) and bone tissue (n = 118), of which 9 muscle (8.8 parts per thousand) and 12 bone samples (10.2 parts per thousand) were collected from animals stranded within the Eastern Scheldt. Stable carbon (delta C-13) was analysed to get insight into the habitat use and residency of porpoises in the Eastern Scheldt. Our data showed significantly higher delta C-13 values in the muscle of porpoises stranded within the Eastern Scheldt (mu = -17.7%, SD = 0.4 parts per thousand) compared to animals stranded along the Dutch coast (mu = 218.3 parts per thousand, SD = 0.5 parts per thousand). This suggests that most porpoises stranded in the Eastern Scheldt foraged there for a longer period. The distinct delta C-13 signature of animals from the Eastern Scheldt was not observed in bone tissue, suggesting a relatively recent shift in habitat use rather than life-long residency of porpoises within the Eastern Scheldt. The high number of strandings within the Eastern Scheldt suggests a higher mortality rate compared to the Dutch coastal zone. Our study indicates that along with other changes in the physical environment, the storm surge barrier may play an important role in determining the residency of porpoises in the Eastern Scheldt, and that the area might act as an ecological trap for porpoises entering it.	[Jansen, Okka E.; Aarts, Geert M.; Reijnders, Peter J. H.] Wageningen UR, IMARES, Dept Ecosyst, Den Burg, Netherlands; [Jansen, Okka E.; Aarts, Geert M.; Reijnders, Peter J. H.] Wageningen Univ, Dept Aquat Ecol & Waterqual Management, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Jansen, OE (corresponding author), Wageningen UR, IMARES, Dept Ecosyst, Den Burg, Netherlands.	okka.jansen@wur.nl		Aarts, Geert/0000-0003-3196-4235; reijnders, peter/0000-0002-3783-8283	Dutch Ministry of Agriculture, Nature and Food Quality (LNV), BO Project [4308201019]; NWO-ZKO (The Netherlands Organisation for Scientific Research under the Sea and Coastal Research programme)	Dutch Ministry of Agriculture, Nature and Food Quality (LNV), BO Project; NWO-ZKO (The Netherlands Organisation for Scientific Research under the Sea and Coastal Research programme)	This work was funded by the Dutch Ministry of Agriculture, Nature and Food Quality (LNV), BO Project 4308201019. G. Aarts is funded by the NWO-ZKO (The Netherlands Organisation for Scientific Research under the Sea and Coastal Research programme) grant Effects of underwater noise on fish and marine mammals in the North Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes C, 2009, ESTUAR COAST SHELF S, V81, P368, DOI 10.1016/j.ecss.2008.11.011; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bosello F, 2012, CLIMATIC CHANGE, V112, P63, DOI 10.1007/s10584-011-0340-1; Camphuysen Kees (C. J.), 2011, Lutra, V54, P39; Camphuysen Kees C. J., 2008, Lutra, V51, P87; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Christensen JT, 2008, MAR ECOL PROG SER, V368, P1, DOI 10.3354/meps07635; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Das K, 2003, MAR ECOL PROG SER, V263, P287, DOI 10.3354/meps263287; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Geelhoed S, 2011, C10311 IM; Hallegatte S, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015604; Harrod C, 2005, OECOLOGIA, V144, P673, DOI 10.1007/s00442-005-0161-x; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; IPCC, 1990, STRAT AD SEA LEV RIS; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Jansen OE, 2012, MAR BIOL RES, V8, P829, DOI 10.1080/17451000.2012.692164; Kabat P, 2005, NATURE, V438, P283, DOI 10.1038/438283a; Kurle CM, 2002, MAR ECOL PROG SER, V236, P289, DOI 10.3354/meps236289; McCullagh P, 1989, GEN LINEAR MODELS; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Middelburg JJ, 2007, MAR CHEM, V106, P127, DOI 10.1016/j.marchem.2006.02.007; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; NIENHUIS PH, 1994, HYDROBIOLOGIA, V283, P1; O'Regan HJ, 2008, J HUM EVOL, V55, P617, DOI 10.1016/j.jhevol.2008.05.001; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2020, R LANG ENV STAT COMP; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Reijnders PJH, 2009, MARINE MAMMALS; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Scheidat M, 2012, J SEA RES, V69, P1, DOI 10.1016/j.seares.2011.12.004; SEALY J, 1995, ANTIQUITY, V69, P290, DOI 10.1017/S0003598X00064693; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Zanderink Frank, 2010, Zoogdier, V21, P12	40	2	4	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56932	10.1371/journal.pone.0056932	http://dx.doi.org/10.1371/journal.pone.0056932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483892	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100010
J	Manu, KA; Shanmugam, MK; Ong, TH; Subramaniam, A; Siveen, KS; Perumal, E; Samy, RP; Bist, P; Lim, LHK; Kumar, AP; Hui, KM; Sethi, G				Manu, Kanjoormana Aryan; Shanmugam, Muthu K.; Ong, Tina H.; Subramaniam, Aruljothi; Siveen, Kodappully Sivaraman; Perumal, Ekambaram; Samy, Ramar Perumal; Bist, Pradeep; Lim, Lina H. K.; Kumar, Alan Prem; Hui, Kam M.; Sethi, Gautam			Emodin Suppresses Migration and Invasion through the Modulation of CXCR4 Expression in an Orthotopic Model of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; NF-KAPPA-B; CANCER-CELL-MIGRATION; NECROSIS-FACTOR-ALPHA; ALOE-EMODIN; METASTASIS; DEGRADATION; CHEMOTAXIS; ACTIVATION; ADHESION	Accumulating evidence(s) indicate that CXCL12-CXCR4 signaling cascade plays an important role in the process of invasion and metastasis that accounts for more than 80% of deaths in hepatocellular carcinoma (HCC) patients. Thus, identification of novel agents that can downregulate CXCR4 expression and its associated functions have a great potential in the treatment of metastatic HCC. In the present report, we investigated an anthraquinone derivative, emodin for its ability to affect CXCR4 expression as well as function in HCC cells. We observed that emodin downregulated the expression of CXCR4 in a dose-and time-dependent manner in HCC cells. Treatment with pharmacological proteasome and lysosomal inhibitors did not have substantial effect on emodin-induced decrease in CXCR4 expression. When investigated for the molecular mechanism(s), it was observed that the suppression of CXCR4 expression was due to downregulation of mRNA expression, inhibition of NFkB activation, and abrogation of chromatin immunoprecipitation activity. Inhibition of CXCR4 expression by emodin further correlated with the suppression of CXCL12-induced migration and invasion in HCC cell lines. In addition, emodin treatment significantly suppressed metastasis to the lungs in an orthotopic HCC mice model and CXCR4 expression in tumor tissues. Overall, our results show that emodin exerts its anti-metastatic effect through the downregulation of CXCR4 expression and thus has the potential for the treatment of HCC.	[Manu, Kanjoormana Aryan; Shanmugam, Muthu K.; Subramaniam, Aruljothi; Siveen, Kodappully Sivaraman; Kumar, Alan Prem; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Ong, Tina H.; Hui, Kam M.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore, Singapore; [Subramaniam, Aruljothi; Perumal, Ekambaram] Bharathiar Univ, Dept Biotechnol, Mol Toxicol Lab, Coimbatore, Tamil Nadu, India; [Samy, Ramar Perumal; Lim, Lina H. K.] Natl Univ Singapore, Dept Microbiol, Infect Dis Programme, Singapore 117548, Singapore; [Bist, Pradeep; Lim, Lina H. K.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Bist, Pradeep; Sethi, Gautam] Natl Univ Singapore, Program Immunol, Singapore 117548, Singapore; [Kumar, Alan Prem] Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, Singapore 117548, Singapore; [Kumar, Alan Prem] Curtin Univ Technol, Fac Hlth Sci, Sch Biomed Sci, Perth, WA, Australia; [Kumar, Alan Prem] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	National University of Singapore; National Cancer Centre Singapore (NCCS); Bharathiar University; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Curtin University; University of North Texas System; University of North Texas Denton	Hui, KM (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore, Singapore.	cmrhkm@nccs.com.sg; phcgs@nus.edu.sg	R., Ponalagusamy/B-5250-2014; BIST, PRADEEP/AAG-7986-2019; Kumar, Alan Prem/ABE-7492-2020; Perumal, Ekambaram/R-9319-2018; Ong, Hooi Tin/J-7710-2017; Muralidharan, Aruljothi/Y-1546-2019; Aryan, Manu/C-6609-2015; Muralidharan, Aruljothi/AAN-9475-2020; Sethi, Gautam/F-2372-2011	R., Ponalagusamy/0000-0002-9868-3764; Kumar, Alan Prem/0000-0002-3754-5712; Siveen, Kodappully Sivaraman/0000-0003-4669-1890; Perumal, Ekambaram/0000-0003-2159-8198; Lim, Lina/0000-0002-2935-2275; Sethi, Gautam/0000-0002-8677-8475; Kanjoormana Aryan, Manu/0000-0002-4437-6486; Hui, Kam/0000-0003-1820-1399	Singapore Ministry of Health's National Medical Research Council; National Medical Research Council of Singapore; Biomedical Research Council of Singapore; Singapore Millennium Foundation; National Medical Research Council of Singapore [R-713-000-124-213]; Ministry of Education, Singapore [MOE2012-T2-2-139]; Cancer Science Institute of Singapore, Experimental Therapeutics I Program [R-713-001-011-271]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation(Singapore Millennium Foundation); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Ministry of Education, Singapore(Ministry of Education, Singapore); Cancer Science Institute of Singapore, Experimental Therapeutics I Program	This research work was supported by grant funding from Singapore Ministry of Health's National Medical Research Council under its Exploratory/Developmental Grant (EDG) funding scheme to GS. KMH was supported by grant funding from the National Medical Research Council of Singapore, Biomedical Research Council of Singapore, and the Singapore Millennium Foundation. APK was supported by grants from the National Medical Research Council of Singapore [Grant R-713-000-124-213], Ministry of Education, Singapore [MOE2012-T2-2-139] and Cancer Science Institute of Singapore, Experimental Therapeutics I Program [Grant R-713-001-011-271]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya M, 2007, TUMOR BIOL, V28, P123, DOI 10.1159/000102979; Bachelder RE, 2002, CANCER RES, V62, P7203; Benovic JL, 2004, CANCER CELL, V6, P429, DOI 10.1016/j.ccr.2004.10.017; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Chua AW, 2010, BIOCH PHARM; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Huang F, 2010, WORLD J GASTROENTERO, V16, P1832, DOI 10.3748/wjg.v16.i15.1832; Huang Q, 2004, BIOCHEM PHARMACOL, V68, P361, DOI 10.1016/j.bcp.2004.03.032; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Kulbe H, 2005, CANCER RES, V65, P10355, DOI 10.1158/0008-5472.CAN-05-0957; Kumar A, 1998, ONCOGENE, V17, P913, DOI 10.1038/sj.onc.1201998; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Lin HM, 2011, J GASTROEN HEPATOL, V26, P28, DOI 10.1111/j.1440-1746.2010.06502.x; Lin ML, 2010, MOL CARCINOGEN, V49, P783, DOI 10.1002/mc.20652; Liu H, 2008, CELL MOL IMMUNOL, V5, P373, DOI 10.1038/cmi.2008.46; Nasuhara Y, 1999, J BIOL CHEM, V274, P19965, DOI 10.1074/jbc.274.28.19965; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ok S, 2012, IMMUNOPHARMACOL IMMU; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Rajendran P, 2011, CLIN CANCER RES, V17, P1425, DOI 10.1158/1078-0432.CCR-10-1123; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Subik K, 2012, BONE, V50, P813, DOI 10.1016/j.bone.2011.12.022; Tabolacci C, 2010, LIFE SCI, V87, P316, DOI 10.1016/j.lfs.2010.07.003; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Xia Qi-song, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P85; Xiang Zuo-lin, 2010, Zhonghua Zhong Liu Za Zhi, V32, P344; Xiang ZL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-176; Xiang ZL, 2009, CANCER J, V15, P519, DOI 10.1097/PPO.0b013e3181c6aa6b	36	53	56	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57015	10.1371/journal.pone.0057015	http://dx.doi.org/10.1371/journal.pone.0057015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472074	Green Published, gold			2022-12-27	WOS:000315637900012
J	Mehrparvar, M; Zytynska, SE; Weisser, WW				Mehrparvar, Mohsen; Zytynska, Sharon E.; Weisser, Wolfgang W.			Multiple Cues for Winged Morph Production in an Aphid Metacommunity	PLOS ONE			English	Article							PEA APHID; LIFE-HISTORY; HOST-PLANT; 2 STRAINS; METAPOPULATION STRUCTURE; PHENOTYPIC PLASTICITY; CLONAL VARIATION; ALATE PRODUCTION; DISPERSAL; HOMOPTERA	Environmental factors can lead individuals down different developmental pathways giving rise to distinct phenotypes (phenotypic plasticity). The production of winged or unwinged morphs in aphids is an example of two alternative developmental pathways. Dispersal is paramount in aphids that often have a metapopulation structure, where local subpopulations frequently go extinct, such as the specialized aphids on tansy (Tanacetum vulgare). We conducted various experiments to further understand the cues involved in the production of winged dispersal morphs by the two dominant species of the tansy aphid metacommunity, Metopeurum fuscoviride and Macrosiphoniella tanacetaria. We found that the ant-tended M. fuscoviride produced winged individuals predominantly at the beginning of the season while the untended M. tanacetaria produced winged individuals throughout the season. Winged mothers of both species produced winged offspring, although in both species winged offspring were mainly produced by unwinged females. Crowding and the presence of predators, effects already known to influence wing production in other aphid species, increased the percentage of winged offspring in M. tanacetaria, but not in M. fuscoviride. We find there are also other factors (i.e. temporal effects) inducing the production of winged offspring for natural aphid populations. Our results show that the responses of each aphid species are due to multiple wing induction cues.	[Mehrparvar, Mohsen; Zytynska, Sharon E.; Weisser, Wolfgang W.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany	Technical University of Munich	Mehrparvar, M (corresponding author), Tech Univ Munich, Dept Ecol & Ecosyst Management, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany.	mohsen.mehrparvar@tum.de	Zytynska, Sharon/C-9089-2011; Weisser, Wolfgang W/B-9718-2014	Zytynska, Sharon/0000-0002-0174-3303; Weisser, Wolfgang W/0000-0002-2757-8959; Mehrparvar, Mohsen/0000-0002-6051-5845	Iranian Ministry of Science, Research and Technology; Deutsche Forschungsgemeinschaft (DFG) [WE 3081/2-3]	Iranian Ministry of Science, Research and Technology; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	MM was supported financially by the Iranian Ministry of Science, Research and Technology (www.msrt.ir). This study was partly supported by grant WE 3081/2-3 of the Deutsche Forschungsgemeinschaft (DFG) to WWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balog A, 2013, EUR J ENTOMOL, V110, P153, DOI 10.14411/eje.2013.021; Begon M, 2006, ECOLOGY INDIVIDUALS, V4th; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Braendle C, 2005, HEREDITY, V94, P435, DOI 10.1038/sj.hdy.6800633; Braendle C, 2001, J INSECT BEHAV, V14, P497, DOI 10.1023/A:1011124122873; Brisson JA, 2010, PHILOS T R SOC B, V365, P605, DOI 10.1098/rstb.2009.0255; DEBARRO PJ, 1992, ENTOMOL EXP APPL, V65, P205, DOI 10.1007/BF02343853; Dixon AFG, 1999, P ROY SOC B-BIOL SCI, V266, P1549, DOI 10.1098/rspb.1999.0814; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; El-Ziady S., 1960, Proceedings of the Royal Entomological Society of London (A), V35, P30; EL-ZIADY S., 1956, Proceedings of the Royal Entomological Society of London, V31, P61; Flatt T, 2000, ECOLOGY, V81, P3522, DOI 10.1890/0012-9658(2000)081[3522:TEOMAO]2.0.CO;2; GROETERS FR, 1989, EVOL ECOL, V3, P327, DOI 10.1007/BF02285263; Hatano E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011188; Hazell SP, 2005, ECOL ENTOMOL, V30, P293, DOI 10.1111/j.0307-6946.2005.00703.x; JOHNSON B, 1966, ENTOMOL EXP APPL, V9, P213, DOI 10.1111/j.1570-7458.1966.tb02352.x; JOHNSON BRUCE, 1965, ENTOMOL EXP APPL, V8, P49, DOI 10.1007/BF00304538; Kawada K., 1987, World Crop Pests, V2A, P255; KLEINJAN JE, 1975, ENTOMOL EXP APPL, V18, P384, DOI 10.1007/BF00628368; Kunert G, 2005, ECOL LETT, V8, P596, DOI 10.1111/j.1461-0248.2005.00754.x; Kunert G, 2005, B ENTOMOL RES, V95, P125, DOI 10.1079/BER2004342; Kunert G, 2003, OECOLOGIA, V135, P304, DOI 10.1007/s00442-003-1185-8; LAMB RJ, 1987, ENTOMOL EXP APPL, V45, P195, DOI 10.1007/BF00305648; LAMBERS DHR, 1966, ANNU REV ENTOMOL, V11, P47, DOI 10.1146/annurev.en.11.010166.000403; LEES AD, 1967, J INSECT PHYSIOL, V13, P289, DOI 10.1016/0022-1910(67)90155-2; Lees AD, 1966, ADV INSECT PHYSL, V3, P207, DOI [DOI 10.1016/S0065-2806(08)60188-5, 10.1016/S0065-2806(08)60188-5]; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Loxdale HD, 2011, BIOL J LINN SOC, V104, P838, DOI 10.1111/j.1095-8312.2011.01761.x; MACKAY PA, 1975, CAN ENTOMOL, V107, P1161, DOI 10.4039/Ent1071161-11; Massonnet B, 2002, MOL ECOL, V11, P2511, DOI 10.1046/j.1365-294X.2002.01633.x; MITTLER TE, 1969, ENTOMOL EXP APPL, V12, P703, DOI 10.1007/BF00297096; Miura T, 2004, ECOL RES, V19, P141, DOI 10.1111/j.1440-1703.2003.00618.x; Mondor EB, 2005, OECOLOGIA, V142, P104, DOI 10.1007/s00442-004-1710-4; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; Plantegenest M, 1999, EVOL ECOL, V13, P229, DOI 10.1023/A:1006635616637; Poethke HJ, 2010, AM NAT, V175, P577, DOI 10.1086/651595; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; SEIBERT TF, 1992, ANN ENTOMOL SOC AM, V85, P173, DOI 10.1093/aesa/85.2.173; SHAW MJP, 1970, ANN APPL BIOL, V65, P191, DOI 10.1111/j.1744-7348.1970.tb04578.x; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Sloggett JJ, 2002, OIKOS, V98, P323, DOI 10.1034/j.1600-0706.2002.980213.x; SMITH MAH, 1989, ENTOMOL EXP APPL, V51, P125, DOI 10.1007/BF00186729; SUTHERLAND OR, 1969, J INSECT PHYSIOL, V15, P1385, DOI 10.1016/0022-1910(69)90199-1; SUTHERLAND OR, 1970, J INSECT PHYSIOL, V16, P1349, DOI 10.1016/0022-1910(70)90134-4; SUTHERLAND OR, 1969, J INSECT PHYSIOL, V15, P2179, DOI 10.1016/0022-1910(69)90083-3; TAYLOR AD, 1990, ECOLOGY, V71, P429, DOI 10.2307/1940297; TSUJI H, 1987, JPN J APPL ENTOMOL Z, V31, P36, DOI 10.1303/jjaez.31.36; TSUMUKI H, 1990, APPL ENTOMOL ZOOL, V25, P215, DOI 10.1303/aez.25.215; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; WEISSER WW, 1994, EUR J ENTOMOL, V91, P71; Weisser WW, 2000, ENTOMOL EXP APPL, V97, P83, DOI 10.1023/A:1004096312093; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Williams IS, 2007, APHIDS AS CROP PESTS, P69, DOI 10.1079/9780851998190.0069; Williams IS, 2000, J APPL ECOL, V37, P40, DOI 10.1046/j.1365-2664.2000.00465.x; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449	55	31	31	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58323	10.1371/journal.pone.0058323	http://dx.doi.org/10.1371/journal.pone.0058323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472179	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900125
J	Singh, N; Bharti, PK; Singh, MP; Mishra, S; Shukla, MM; Sharma, RK; Singh, RK				Singh, Neeru; Bharti, Praveen K.; Singh, Mrigendra P.; Mishra, Sweta; Shukla, Man M.; Sharma, Ravendra K.; Singh, Rajesh K.			Comparative Evaluation of Bivalent Malaria Rapid Diagnostic Tests versus Traditional Methods in Field with Special Reference to Heat Stability Testing in Central India	PLOS ONE			English	Article							LABORATORY COMPARATIVE-EVALUATION; PF-PLDH/PAN-PLDH; FALCIPARUM; TANZANIA; PERFORMANCE; PREVALENCE; INTENSITY; INFECTION; PARASITES; ANTIGEN	Background: Malaria presents a diagnostic challenge in areas where both Plasmodium falciparum and P. vivax are co-endemic. Bivalent Rapid Diagnostic tests (RDTs) showed promise as diagnostic tools for P. falciparum and P. vivax. To assist national malaria control programme in the selection of RDTs, commercially available seven malaria RDTs were evaluated in terms of their performance with special reference to heat stability. Methodology/Principal Findings: This study was undertaken in four forested districts of central India (July, 2011- March, 2012). All RDTs were tested simultaneously in field along with microscopy as gold standard. These RDTs were stored in their original packing at 25 degrees C before transport to the field or they were stored at 35 degrees C and 45 degrees C upto 100 days for testing the performance of RDTs at high temperature. In all 2841 patients with fever were screened for malaria of which 26% were positive for P. falciparum, and 17% for P. vivax. The highest sensitivity of any RDT for P. falciparum was 98% (95% CI; 95.9-98.8) and lowest sensitivity was 76% (95% CI; 71.7-79.6). For P. vivax highest and lowest sensitivity for any RDT was 80% (95% CI; 94.9 - 83.9) and 20% (95% CI; 15.6-24.5) respectively. Heat stability experiments showed that most RDTs for P. falciparum showed high sensitivity at 45 degrees C upto 90 days. While for P. vivax only two RDTs maintained good sensitivity upto day 90 when compared with RDTs kept at room temperature. Agreement between observers was excellent for positive and negative readings for both P. falciparum and P. vivax (Kappa >0.6-0.9). Conclusion: This is first field evaluation of RDTs regarding their temperature stability. Although RDTs are useful as diagnostic tool for P. falciparum and P. vivax even at high temperature, the quality of RDTs should be regulated and monitored more closely.	[Singh, Neeru; Bharti, Praveen K.; Mishra, Sweta; Sharma, Ravendra K.] Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India; [Singh, Neeru; Singh, Mrigendra P.; Shukla, Man M.] Natl Inst Malaria Res Field Unit Jabalpur, Jabalpur, Madhya Pradesh, India; [Singh, Rajesh K.] Madhya Pradesh Tech Assistance Support Team TAS, BDA Colony, Bhopal, Madhya Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Singh, N (corresponding author), Reg Med Res Ctr Tribals, Nagpur Rd, Jabalpur, Madhya Pradesh, India.	neeru.singh@gmail.com		Singh, Mrigendra/0000-0003-4336-4413	Department of Health; FW, Government of Madhya Pradesh; UKaid from the Department for International Development	Department of Health; FW, Government of Madhya Pradesh; UKaid from the Department for International Development	We acknowledge and sincerely appreciate the support and inspiration received from the Department of Health and FW, Government of Madhya Pradesh. The Madhya Pradesh Technical Assistance and Support Team (TAST) deserve special appreciation for their logistic support.; This document is an output from a project funded by UKaid from the Department for International Development. The views expressed do not necessarily reflect the department's official policies.	Albertini A, 2012, TROP MED INT HEALTH, V17, P147, DOI 10.1111/j.1365-3156.2011.02904.x; [Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2009, MAL MICR QUAL ASS MA; [Anonymous], 2009, MAL RAP DIAGN TEST P; Ashley EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-241; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Barbe B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-326; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Bharti PK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-126; Bodker R, 2006, AM J TROP MED HYG, V74, P716; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; [Directorate of National Vector Borne Disease Control Programme National Drug Policy on Malaria], 2010, NAT DRUG POL MAL 201; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Heutmekers M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-204; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Jain V, 2008, AM J TROP MED HYG, V79, P636; Jorgensen P, 2006, AM J TROP MED HYG, V74, P750, DOI 10.4269/ajtmh.2006.74.750; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Makler MT, 2009, AM J TROP MED HYG, V81, P921, DOI 10.4269/ajtmh.2009.09-0202; Maltha J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-7; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-171; Marsh K, 1996, LANCET, V347, P1327; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; PREMJI Z, 1994, T ROY SOC TROP MED H, V88, P418, DOI 10.1016/0035-9203(94)90409-X; Richter J, 2004, PARASITOL RES, V94, P384, DOI 10.1007/s00436-004-1213-6; Schachterle SE, 2011, J CLIN MICROBIOL, V49, P3885, DOI 10.1128/JCM.01157-11; SHIFF CJ, 1993, T ROY SOC TROP MED H, V87, P646, DOI 10.1016/0035-9203(93)90273-S; Singh J., 1944, Indian Medical Gazette, V79, P102; Singh N, 2004, J INFECTION, V48, P364, DOI 10.1016/j.jinf.2004.01.007; Singh N, 2011, T ROY SOC TROP MED H, V105, P133, DOI 10.1016/j.trstmh.2010.11.002; Singh N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-191; SOWUNMI A, 1993, T ROY SOC TROP MED H, V87, P422, DOI 10.1016/0035-9203(93)90022-I; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; WHO, 2003, MAL RAP DIAGN MAK IT; WHO, 2010, GUID TREATM MAL, V2nd	38	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58080	10.1371/journal.pone.0058080	http://dx.doi.org/10.1371/journal.pone.0058080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472135	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900080
J	Stamm, M; Staritzbichler, R; Khafizov, K; Forrest, LR				Stamm, Marcus; Staritzbichler, Rene; Khafizov, Kamil; Forrest, Lucy R.			Alignment of Helical Membrane Protein Sequences Using AlignMe	PLOS ONE			English	Article							ACID SUBSTITUTION MATRICES; REMOTE HOMOLOGY DETECTION; TRANSMEMBRANE PROTEINS; STRUCTURE PREDICTION; SECONDARY STRUCTURE; GAP PENALTIES; RECOGNITION; TOPOLOGY; BENCHMARK; ACCURACY	Few sequence alignment methods have been designed specifically for integral membrane proteins, even though these important proteins have distinct evolutionary and structural properties that might affect their alignments. Existing approaches typically consider membrane-related information either by using membrane-specific substitution matrices or by assigning distinct penalties for gap creation in transmembrane and non-transmembrane regions. Here, we ask whether favoring matching of predicted transmembrane segments within a standard dynamic programming algorithm can improve the accuracy of pairwise membrane protein sequence alignments. We tested various strategies using a specifically designed program called AlignMe. An updated set of homologous membrane protein structures, called HOMEP2, was used as a reference for optimizing the gap penalties. The best of the membrane-protein optimized approaches were then tested on an independent reference set of membrane protein sequence alignments from the BAliBASE collection. When secondary structure (S) matching was combined with evolutionary information (using a position-specific substitution matrix (P)), in an approach we called AlignMePS, the resultant pairwise alignments were typically among the most accurate over a broad range of sequence similarities when compared to available methods. Matching transmembrane predictions (T), in addition to evolutionary information, and secondary-structure predictions, in an approach called AlignMePST, generally reduces the accuracy of the alignments of closely-related proteins in the BAliBASE set relative to AlignMePS, but may be useful in cases of extremely distantly related proteins for which sequence information is less informative. The open source AlignMe code is available at https://sourceforge.net/projects/alignme/, and at http://www.forrestlab.org, along with an online server and the HOMEP2 data set.	[Stamm, Marcus; Staritzbichler, Rene; Khafizov, Kamil; Forrest, Lucy R.] Max Planck Inst Biophys, Computat Struct Biol Grp, Frankfurt, Germany	Max Planck Society	Forrest, LR (corresponding author), Max Planck Inst Biophys, Computat Struct Biol Grp, Frankfurt, Germany.	lucy.forrest@biophys.mpg.de	Khafizov, Kamil/E-5368-2011; Forrest, Lucy/E-8113-2016	Khafizov, Kamil/0000-0001-5524-0296; Forrest, Lucy/0000-0003-1855-7985; Staritzbichler, Rene/0000-0002-6719-2997	German Research Foundation (DFG) Collaborative Research Center 807	German Research Foundation (DFG) Collaborative Research Center 807(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG; www.dfg.de/en) Collaborative Research Center 807 "Transport and Communication across Biological Membranes". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2001, CURR OPIN STRUC BIOL, V11, P540, DOI 10.1016/S0959-440X(00)00246-3; Bahr A, 2001, NUCLEIC ACIDS RES, V29, P323, DOI 10.1093/nar/29.1.323; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bernsel A, 2008, PROTEINS, V71, P1387, DOI 10.1002/prot.21825; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; Cline M, 2002, BIOINFORMATICS, V18, P306, DOI 10.1093/bioinformatics/18.2.306; Dayhoff M.O., 1978, MODEL EVOLUTIONARY C; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dong E, 2008, GENE, V422, P41, DOI 10.1016/j.gene.2008.06.006; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; Edgar RC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-396; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hill JR, 2011, BIOINFORMATICS, V27, pI15, DOI 10.1093/bioinformatics/btr230; Hill JR, 2012, BIOINFORMATICS; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Jimenez-Morales D, 2008, IEEE ENG MED BIO, P1347, DOI 10.1109/IEMBS.2008.4649414; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kauko A, 2008, J MOL BIOL, V380, P170, DOI 10.1016/j.jmb.2008.04.052; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Koehler J, 2009, PROTEINS, V76, P13, DOI 10.1002/prot.22315; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Lolkema JS, 2005, MOL MEMBR BIOL, V22, P177, DOI 10.1080/09687860500063324; Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516; Lolkema JS, 1998, FEMS MICROBIOL REV, V22, P305, DOI 10.1016/S0168-6445(98)00018-7; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Muller T, 2002, MOL BIOL EVOL, V19, P8, DOI 10.1093/oxfordjournals.molbev.a003985; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Ostermeier C, 1997, CURR OPIN STRUC BIOL, V7, P697, DOI 10.1016/S0959-440X(97)80080-2; Pedersen J, 1998, PROTEINS, V29, P2; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; Raghava GPS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-47; Remmert M, 2011, NAT METHODS; ROSE GD, 1978, NATURE, V272, P586, DOI 10.1038/272586a0; Saigo H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-246; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shafrir Y, 2004, BIOINFORMATICS, V20, P758, DOI 10.1093/bioinformatics/btg482; Shu NJ, 2011, BIOINFORMATICS, V27, P1702, DOI 10.1093/bioinformatics/btr235; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tang CL, 2003, J MOL BIOL, V334, P1043, DOI 10.1016/j.jmb.2003.10.025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	72	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57731	10.1371/journal.pone.0057731	http://dx.doi.org/10.1371/journal.pone.0057731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469223	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900038
J	Wu, ZG; Zhou, P; Li, XX; Wang, H; Luo, DL; Qiao, HY; Ke, X; Huang, J				Wu, Zhigang; Zhou, Peng; Li, Xiaoxin; Wang, Hui; Luo, Delun; Qiao, Huaiyao; Ke, Xiao; Huang, Jian			Structural Characterization of a Recombinant Fusion Protein by Instrumental Analysis and Molecular Modeling	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ELECTROSPRAY MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; MONOCLONAL-ANTIBODY; SAMPLE PREPARATION; DEAMIDATION SITES; MEMBRANE-PROTEIN; IDENTIFICATION; RECEPTOR; NEOVASCULARIZATION	Conbercept is a genetically engineered homodimeric protein for the treatment of wet age-related macular degeneration (wet AMD) that functions by blocking VEGF-family proteins. Its huge, highly variable architecture makes characterization and development of a functional assay difficult. In this study, the primary structure, number of disulfide linkages and glycosylation state of conbercept were characterized by high-performance liquid chromatography, mass spectrometry, and capillary electrophoresis. Molecular modeling was then applied to obtain the spatial structural model of the conbercept-VEGF-A complex, and to study its inter-atomic interactions and dynamic behavior. This work was incorporated into a platform useful for studying the structure of conbercept and its ligand binding functions.	[Wu, Zhigang; Luo, Delun; Qiao, Huaiyao; Ke, Xiao] Chengdu Kanghong Biotechnol Inc, Chengdu, Peoples R China; [Zhou, Peng; Huang, Jian] Univ Elect Sci & Technol China, Ctr Bioinformat, Chengdu 610054, Peoples R China; [Li, Xiaoxin] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Wang, Hui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China	University of Electronic Science & Technology of China; Peking University; Beijing Institute of Microbiology & Epidemiology	Wu, ZG (corresponding author), Chengdu Kanghong Biotechnol Inc, Chengdu, Peoples R China.	wuzhigang@cnkh.com; hj@uestc.edu.cn	Huang, Jian/G-8437-2011; wu, zhi/GXH-3041-2022	Huang, Jian/0000-0003-3282-8892; Zhou, Peng/0000-0001-5681-9937	973 projects [2011CB510200]; National Natural Science Foundation of China [61071177]; Program for New Century Excellent Talents in University [NCET-12-0088]	973 projects(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The authors acknowledge the following funding supports: the 973 projects 2011CB510200, the National Natural Science Foundation of China No. 61071177 and the Program for New Century Excellent Talents in University (NCET-12-0088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 1996, ARCH OPHTHALMOL-CHIC, V114, P66, DOI 10.1001/archopht.1996.01100130062010; Ahn J, 2010, J CHROMATOGR B, V878, P403, DOI 10.1016/j.jchromb.2009.12.013; Argueso P, 2003, INVEST OPHTH VIS SCI, V44, P86, DOI 10.1167/iovs.02-0181; Bongers J, 2011, J CHROMATOGR A, V1218, P8140, DOI 10.1016/j.chroma.2011.08.089; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Chelius D, 2005, ANAL CHEM, V77, P6004, DOI 10.1021/ac050672d; CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2000, RECENT PROG HORM RES, V55, P15; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Gaza-Bulseco G, 2008, ANAL CHEM, V80, P9491, DOI 10.1021/ac801617u; Gorman JJ, 2002, MASS SPECTROM REV, V21, P183, DOI 10.1002/mas.10025; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Gupta K, 2010, ANAL CHEM, V82, P8313, DOI 10.1021/ac101867e; HJERTEN S, 1987, J CHROMATOGR, V387, P127, DOI 10.1016/S0021-9673(01)94519-4; Krokhin OV, 2006, ANAL CHEM, V78, P6645, DOI 10.1021/ac061017o; KRUEGER DE, 1980, SURV OPHTHALMOL, V24, P614, DOI 10.1016/0039-6257(80)90122-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li CY, 2006, BIOCHEMISTRY-US, V45, P12117, DOI 10.1021/bi060627f; Li XJ, 2008, J AM SOC MASS SPECTR, V19, P855, DOI 10.1016/j.jasms.2008.02.011; MaAuley A, 2008, PROTEIN SCI, V17, P95, DOI 10.1110/ps.073134408; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Mack S, 2009, ELECTROPHORESIS, V30, P4049, DOI 10.1002/elps.200800690; Makino Y, 2000, J BIOCHEM-TOKYO, V128, P175, DOI 10.1093/oxfordjournals.jbchem.a022738; Manabe T, 1997, ELECTROPHORESIS, V18, P92, DOI 10.1002/elps.1150180118; Manabe T, 1997, ELECTROPHORESIS, V18, P1159, DOI 10.1002/elps.1150180723; MILLER JW, 1994, AM J PATHOL, V145, P574; Miller JW, 1997, AM J PATHOL, V151, P13; Mundt AA, 2001, ANAL BIOCHEM, V299, P147, DOI 10.1006/abio.2001.5416; Raju TS, 1996, BIOTECHNOL APPL BIOC, V24, P191; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shinkai A, 1998, J BIOL CHEM, V273, P31283, DOI 10.1074/jbc.273.47.31283; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Spiess C, 1997, J BIOL CHEM, V272, P22125, DOI 10.1074/jbc.272.35.22125; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Takemoto L, 2001, CURR EYE RES, V22, P148, DOI 10.1076/ceyr.22.2.148.5524; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timm V, 2010, J CHROMATOGR B, V878, P777, DOI 10.1016/j.jchromb.2010.01.036; Wei Z, 2005, DEV BIOLOGICALS, V122, P29; Wu Jiang, 2008, V446, P1, DOI 10.1007/978-1-60327-084-7_1; Xie HW, 2009, ANAL CHEM, V81, P5699, DOI 10.1021/ac900468j; Yang YZ, 2009, J CHROMATOGR A, V1216, P3767, DOI 10.1016/j.chroma.2009.02.059; Yeung YA, 2010, CANCER RES, V70, P3269, DOI 10.1158/0008-5472.CAN-09-4580; Zeng R, 1999, ACTA BIOCH BIOPH SIN, V31, P695; Zhang W, 2002, ANAL BIOCHEM, V311, P1, DOI 10.1016/S0003-2697(02)00394-9; Zhou P, 2009, J COMPUT CHEM, V30, P940, DOI 10.1002/jcc.21109	51	40	45	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57642	10.1371/journal.pone.0057642	http://dx.doi.org/10.1371/journal.pone.0057642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469213	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900032
J	Chang, FC; Lai, TS; Chiang, CK; Chen, YM; Wu, MS; Chu, TS; Wu, KD; Lin, SL				Chang, Fan-Chi; Lai, Tai-Shuan; Chiang, Chih-Kang; Chen, Yung-Ming; Wu, Ming-Shiou; Chu, Tzong-Shinn; Wu, Kwan-Dun; Lin, Shuei-Liong			Angiopoietin-2 Is Associated with Albuminuria and Microinflammation in Chronic Kidney Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ENDOTHELIAL GROWTH-FACTOR; GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RECEPTOR TIE-2; PLASMA ANGIOPOIETIN-1; RENAL-FUNCTION; TNF-ALPHA; MORTALITY	Although cardiovascular disease (CVD) is the leading cause of mortality in patients with chronic kidney disease (CKD), the pathophysiology is not thoroughly understood. Given that elevated albuminuria or circulating angiopoietin-2 associates with CVD and mortality in CKD patients, we were intrigued by the relationship between albuminuria and angiopoietin-2. A total of 416 patients with CKD stages 3 to 5 were stratified by urine albumin-creatinine ratio as normoalbuminuria (<30 mg/g), microalbuminuria (30-300 mg/g), or macroalbuminuria (>300 mg/g). The levels of plasma angiopoietin-2 and vascular endothelial growth factor (VEGF) increased, and soluble Tie-2 decreased in the subgroups of albuminuria; whereas angiopoietin-1 did not change. Linear regression showed a positive correlation between urine albumin-creatinine ratio (ACR) and plasma angiopoietin-2 (correlation coefficient r = 0.301, 95% confidence interval 0.211-0.386, P<0.0001), but not between ACR and VEGF or soluble Tie-2. Multivariate linear regression analysis showed that plasma angiopoietin-2 was independently associated with ACR (P = 0.025). Furthermore, plasma angiopoietin-2 was positively correlated with high sensitive C-reactive protein (r = 0.114, 95% confidence interval 0.018-0.208, P = 0.020). In conclusion, plasma angiopoietin-2 was associated with albuminuria and markers of systemic microinflammation in CKD patients. Although previous evidence has shown that angiopoietin-2 destabilizes vasculature and induces inflammation in different scenarios, further study will be required to delineate the role of angiopoietin-2 in albuminuria and microinflammation in CKD patients.	[Chang, Fan-Chi; Lai, Tai-Shuan; Chiang, Chih-Kang; Chen, Yung-Ming; Wu, Ming-Shiou; Chu, Tzong-Shinn; Wu, Kwan-Dun; Lin, Shuei-Liong] Natl Taiwan Univ Hosp, Dept Med, Div Renal, Taipei, Taiwan; [Chang, Fan-Chi; Lin, Shuei-Liong] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10764, Taiwan; [Lai, Tai-Shuan] Natl Taiwan Univ Hosp, Dept Internal Med, Bei Hu Branch, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chu, TS (corresponding author), Natl Taiwan Univ Hosp, Dept Med, Div Renal, Taipei, Taiwan.	tschu@ntu.edu.tw	Lin, Shuei-Liong/AGR-2002-2022; Chang, Fan-Chi/GOK-2657-2022	Lin, Shuei-Liong/0000-0002-1041-5571; CHU, TZONG-SHINN/0000-0002-5291-2509; Lai, Tai-Shuan/0000-0002-0552-372X; CHEN, YUNG-MING/0000-0002-9241-1258; WU, MING-SHIOU/0000-0002-1674-443X; WU, KWAN-DUN/0000-0002-3339-1509; CHIANG, CHIH-KANG/0000-0001-9021-4616	National Science Council [99-2628-B-002-013, 101-2321-B-002-060]; Mrs. Hsiu-Chin Lee Kidney Research Foundation	National Science Council(Ministry of Science and Technology, Taiwan); Mrs. Hsiu-Chin Lee Kidney Research Foundation	This study was supported by the National Science Council (99-2628-B-002-013, S. L. L., 101-2321-B-002-060, S. L. L.) ( http://web1.nsc.gov.tw/), and Mrs. Hsiu-Chin Lee Kidney Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Bureau W, 2006, AM J PHYSIOL-HEART C, V291, pH948, DOI 10.1152/ajpheart.00734.2005; Chong AY, 2004, J AM COLL CARDIOL, V43, P423, DOI 10.1016/j.jacc.2003.08.042; Cirillo M, 2004, KIDNEY INT, V65, P2290, DOI 10.1111/j.1523-1755.2004.00652.x; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; Kielstein JT, 2005, AM J KIDNEY DIS, V46, P186, DOI 10.1053/j.ajkd.2005.05.009; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lee KW, 2004, CIRCULATION, V110, P2355, DOI 10.1161/01.CIR.0000138112.90641.7F; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lim HS, 2004, DIABETES CARE, V27, P2918, DOI 10.2337/diacare.27.12.2918; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Nadar SK, 2005, J INTERN MED, V258, P336, DOI 10.1111/j.1365-2796.2005.01550.x; Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7; Pasceri V, 2001, CIRCULATION, V103, P2531; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Tennent GA, 2008, ATHEROSCLEROSIS, V196, P248, DOI 10.1016/j.atherosclerosis.2007.05.010; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Watts GF, 2001, KIDNEY INT, V60, P182, DOI 10.1046/j.1523-1755.2001.00785.x; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Zhang RX, 2010, HYPERTENSION, V55, P953, DOI 10.1161/HYPERTENSIONAHA.109.140608	37	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e54668	10.1371/journal.pone.0054668	http://dx.doi.org/10.1371/journal.pone.0054668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469160	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100002
J	Zhang, RY; Zhao, Y; Chu, MJ; Wu, C; Jin, GF; Dai, JC; Wang, C; Hu, LM; Gou, JW; Qian, C; Bai, JL; Wu, TC; Hu, ZB; Lin, DX; Shen, HB; Chen, F				Zhang, Ruyang; Zhao, Yang; Chu, Minjie; Wu, Chen; Jin, Guangfu; Dai, Juncheng; Wang, Cheng; Hu, Lingmin; Gou, Jianwei; Qian, Chen; Bai, Jianling; Wu, Tangchun; Hu, Zhibin; Lin, Dongxin; Shen, Hongbing; Chen, Feng			Pathway Analysis for Genome-Wide Association Study of Lung Cancer in Han Chinese Population	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SUSCEPTIBILITY LOCUS; CELL-PROLIFERATION; NICOTINE; APOPTOSIS; MULTIPLE; COMPLEX; ROLES; MET; RAC	Genome-wide association studies (GWAS) have identified a number of genetic variants associated with lung cancer risk. However, these loci explain only a small fraction of lung cancer hereditability and other variants with weak effect may be lost in the GWAS approach due to the stringent significance level after multiple comparison correction. In this study, in order to identify important pathways involving the lung carcinogenesis, we performed a two-stage pathway analysis in GWAS of lung cancer in Han Chinese using gene set enrichment analysis (GSEA) method. Predefined pathways by BioCarta and KEGG databases were systematically evaluated on Nanjing study (Discovery stage: 1,473 cases and 1,962 controls) and the suggestive pathways were further to be validated in Beijing study (Replication stage: 858 cases and 1,115 controls). We found that four pathways (achPathway, metPathway, At1rPathway and rac1Pathway) were consistently significant in both studies and the P values for combined dataset were 0.012, 0.010, 0.022 and 0.005 respectively. These results were stable after sensitivity analysis based on gene definition and gene overlaps between pathways. These findings may provide new insights into the etiology of lung cancer.	[Zhang, Ruyang; Zhao, Yang; Chu, Minjie; Jin, Guangfu; Dai, Juncheng; Wang, Cheng; Hu, Lingmin; Gou, Jianwei; Qian, Chen; Bai, Jianling; Hu, Zhibin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhang, Ruyang; Zhao, Yang; Chu, Minjie; Jin, Guangfu; Dai, Juncheng; Wang, Cheng; Hu, Lingmin; Gou, Jianwei; Qian, Chen; Bai, Jianling; Hu, Zhibin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Minist Educ MOE, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Wu, Chen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, Chen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Wu, Chen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Wu, Tangchun] Inst Occupat Med, Wuhan, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth,Tonji Med Coll, Wuhan 430074, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing Medical University; Huazhong University of Science & Technology; Nanjing Medical University	Chen, F (corresponding author), Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn		Chen, Feng/0000-0002-2699-7190; Zhang, Ruyang/0000-0003-3861-4297; Lin, Dongxin/0000-0002-8723-8868; Wu, Chen/0000-0003-4954-1011	China National High-Tech Research and Development Program Grant [2009AA022705]; National Key Basic Research Program Grant [2011CB503805]; National Natural Science Foundation of China [81072389, 30901232, 30730080, 30972541, 30901233]; Research Found for the Doctoral Program of Higher Education of China [20113234110002]; Jiangsu Natural Science Foundation [BK2011028]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [11KJA330001, 10KJA33034]; US National Institutes of Health Grant [U19 CA148127]; Research and Innovation Project for College Graduates of Jiangsu Province [CXZZ11_0733]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	China National High-Tech Research and Development Program Grant; National Key Basic Research Program Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Found for the Doctoral Program of Higher Education of China; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Innovation Project for College Graduates of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work is founded by the China National High-Tech Research and Development Program Grant (2009AA022705) and partly funded by the National Key Basic Research Program Grant (2011CB503805) and the National Natural Science Foundation of China (81072389, 30901232, 30730080, 30972541 and 30901233), the Research Found for the Doctoral Program of Higher Education of China (20113234110002), Jiangsu Natural Science Foundation (BK2011028), Natural Science Foundation of the Jiangsu Higher Education Institutions of China (11KJA330001 and 10KJA33034), the US National Institutes of Health Grant (U19 CA148127), the Research and Innovation Project for College Graduates of Jiangsu Province (CXZZ11_0733), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Biernacka JM, 2012, INT J NEUROPSYCHOPH, P1; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chung RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036662; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; Cucina A, 2008, J SURG RES, V150, P227, DOI 10.1016/j.jss.2007.10.019; Cui J, 2007, ACTA PHARMACOL SIN, V28, P601, DOI 10.1111/j.1745-7254.2007.00579.x; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Fehringer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031816; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Guo HD, 2010, INT J DIGIT EARTH, V3, P1, DOI 10.1080/17538941003650702; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Imai N, 2007, LAB INVEST, V87, P189, DOI 10.1038/labinvest.3700504; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Li MC, 2008, LUNG CANCER, V62, P145, DOI 10.1016/j.lungcan.2008.03.002; Liu B, 2010, CARCINOGENESIS, V31, P1405, DOI 10.1093/carcin/bgq126; Lu J, 2009, FASEB J, V23, P3459, DOI 10.1096/fj.09-136549; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; MANECKJEE R, 1994, CELL GROWTH DIFFER, V5, P1033; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Menashe I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029396; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Paliwal A, 2010, CANCER RES, V70, P2779, DOI 10.1158/0008-5472.CAN-09-4550; Pedroso I, 2010, METHODS MOL BIOL, V628, P373, DOI 10.1007/978-1-60327-367-1_20; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Pickel L, 2010, CANC BIOLTHER, P9; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Puri Neelu, 2008, J Carcinog, V7, P9; To CTT, 1998, ONCOL REP, V5, P1013; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007040; Zech T, 2008, CELL, V134, P18, DOI 10.1016/j.cell.2008.06.039; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhang MF, 2012, HUM GENET, V131, P615, DOI [10.1007/s00439-011-1107-5, 10.1007/S00439-011-11047-8]; Zhang MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022760	58	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57763	10.1371/journal.pone.0057763	http://dx.doi.org/10.1371/journal.pone.0057763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469231	Green Published, gold			2022-12-27	WOS:000315897100037
J	Chen, H; Dorrigan, A; Saad, S; Hare, DJ; Cortie, MB; Valenzuela, SM				Chen, Hui; Dorrigan, Alisha; Saad, Sonia; Hare, Dominic J.; Cortie, Michael B.; Valenzuela, Stella M.			In Vivo Study of Spherical Gold Nanoparticles: Inflammatory Effects and Distribution in Mice	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CELLULAR UPTAKE; COLLOIDAL GOLD; SIZE; TOXICITY; CELLS; BIODISTRIBUTION; MECHANISMS; EXPRESSION; ALPHA	Objectives: Gold nanoparticles (AuNPs) of 21 nm have been previously well characterized in vitro for their capacity to target macrophages via active uptake. However, the short-term impact of such AuNPs on physiological systems, in particular resident macrophages located in fat tissue in vivo, is largely unknown. This project investigated the distribution, organ toxicity and changes in inflammatory cytokines within the adipose tissue after mice were exposed to AuNPs. Methods: Male C57BL/6 mice were injected intraperitoneally (IP) with a single dose of AuNPs (7.85 mu g AuNPs/g). Body weight and energy intake were recorded daily. Tissues were collected at 1 h, 24 h and 72 h post-injection to test for organ toxicity. AuNP distribution was examined using electron microscopy. Proinflammatory cytokine expression and macrophage number within the abdominal fat pad were determined using real-time PCR. Results: At 72 hours post AuNP injection, daily energy intake and body weight were found to be similar between Control and AuNP treated mice. However, fat mass was significantly smaller in AuNP-treated mice. Following IP injection, AuNPs rapidly accumulated within the abdominal fat tissue and some were seen in the liver. A reduction in TNF alpha and IL-6 mRNA levels in the fat were observed from 1 h to 72 h post AuNP injection, with no observable changes in macrophage number. There was no detectable toxicity to vital organs (liver and kidney). Conclusion: Our 21 nm spherical AuNPs caused no measurable organ or cell toxicity in mice, but were correlated with significant fat loss and inhibition of inflammatory effects. With the growing incidence of obesity and obesity-related diseases, our findings offer a new avenue for the potential development of gold nanoparticles as a therapeutic agent in the treatment of such disorders.	[Chen, Hui; Dorrigan, Alisha; Valenzuela, Stella M.] Univ Technol Sydney, Fac Sci, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia; [Cortie, Michael B.] Univ Technol Sydney, Inst Nanoscale Technol, Sydney, NSW 2007, Australia; [Saad, Sonia] Univ Sydney, Kolling Inst Med Res, Renal Res Grp, Sydney, NSW 2006, Australia; [Hare, Dominic J.] Univ Technol Sydney, Elemental Bioimaging Facil, Sydney, NSW 2007, Australia	University of Technology Sydney; University of Technology Sydney; University of Sydney; Kolling Institute of Medical Research; University of Technology Sydney	Valenzuela, SM (corresponding author), Univ Technol Sydney, Fac Sci, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia.	stella.valenzuela@uts.edu.au	Chen, Hui/R-6137-2019; Hare, Dominic/AAM-7725-2020; Hare, Dominic/H-2481-2011; Saad, Sonia/D-2914-2015; Chen, Hui/D-2005-2014; Valenzuela, Stella/R-6387-2019; Cortie, Michael B/F-2920-2011	Chen, Hui/0000-0001-6883-3752; Hare, Dominic/0000-0002-5922-7643; Chen, Hui/0000-0001-6883-3752; Valenzuela, Stella/0000-0001-5934-6047; Saad, Sonia/0000-0001-8067-8046; Cortie, Michael/0000-0003-3202-6398	Faculty of Science, UTS; Centre for Health Technology UTS; Institute for Nanoscale Technology, UTS	Faculty of Science, UTS; Centre for Health Technology UTS; Institute for Nanoscale Technology, UTS	The work presented in this paper was financially supported by Faculty of Science, UTS, Centre for Health Technology UTS and the Institute for Nanoscale Technology, UTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter S, 2012, EXPERT OPIN DRUG DEL, V9, P1225, DOI 10.1517/17425247.2012.716824; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; ANTONOVYCH TT, 1981, ANN CLIN LAB SCI, V11, P386; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Balasubramanian SK, 2010, BIOMATERIALS, V31, P2034, DOI 10.1016/j.biomaterials.2009.11.079; Bastus NG, 2009, MOL IMMUNOL, V46, P743, DOI 10.1016/j.molimm.2008.08.277; Brown C. L., 2008, Inflammopharmacology, V16, P133, DOI 10.1007/s10787-007-0017-6; CHAMPION GD, 1990, BAILLIERE CLIN RHEUM, V4, P491, DOI 10.1016/S0950-3579(05)80005-6; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; CLARK P, 1989, J RHEUMATOL, V16, P442; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Cortie MB, 2004, GOLD BULL, V37, P12, DOI 10.1007/BF03215512; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Dykman LA, 2004, BIOL BULL+, V31, P75, DOI 10.1023/B:BIBU.0000014358.98422.9c; Edgar J. A., 2009, GOLD SCI APPL, P369; Fischer HC, 2007, CURR OPIN BIOTECH, V18, P565, DOI 10.1016/j.copbio.2007.11.008; Goel R, 2009, NANOMEDICINE-UK, V4, P401, DOI [10.2217/nnm.09.21, 10.2217/NNM.09.21]; GOTTLIEB NL, 1972, ARTHRITIS RHEUM, V15, P582, DOI 10.1002/art.1780150604; Hare D, 2009, METALLOMICS, V1, P53, DOI 10.1039/b816188g; HORTON RJ, 1983, SCAND J RHEUMATOL, P100; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074; Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698; Kean W. F., 2008, Inflammopharmacology, V16, P112, DOI 10.1007/s10787-007-0021-x; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; Lanone S, 2006, CURR MOL MED, V6, P651, DOI 10.2174/156652406778195026; Lasagna-Reeves C, 2010, BIOCHEM BIOPH RES CO, V393, P649, DOI 10.1016/j.bbrc.2010.02.046; Libutti SK, 2010, CLIN CANCER RES, V16, P6139, DOI 10.1158/1078-0432.CCR-10-0978; MASCARENHAS BR, 1972, ARTHRITIS RHEUM-US, V15, P391, DOI 10.1002/art.1780150410; Mironava T, 2010, NANOTOXICOLOGY, V4, P120, DOI 10.3109/17435390903471463; Nimi N, 2011, GOLD BULL, V44, P15, DOI 10.1007/s13404-010-0001-6; Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pernodet N, 2006, SMALL, V2, P766, DOI 10.1002/smll.200500492; Pissuwan D, 2007, GOLD BULL, V40, P121, DOI 10.1007/BF03215568; Pissuwan D, 2007, J NANOPART RES, V9, P1109, DOI 10.1007/s11051-007-9212-z; Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006; Pissuwan D, 2010, TRENDS BIOTECHNOL, V28, P207, DOI 10.1016/j.tibtech.2009.12.004; Pompa PP, 2011, NANO RES, V4, P405, DOI 10.1007/s12274-011-0095-z; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Saad S, 2009, NEPHROL DIAL TRANSPL, V24, P1130, DOI 10.1093/ndt/gfn614; Sadauskas E, 2009, NANOMED-NANOTECHNOL, V5, P162, DOI 10.1016/j.nano.2008.11.002; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Thakor AS, 2011, NANO LETT, V11, P4029, DOI 10.1021/nl202559p; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Ujfalussy I, 2003, Z RHEUMATOL, V62, P155, DOI 10.1007/s00393-003-0458-2; WALZ DT, 1983, AM J MED, V75, P90, DOI 10.1016/0002-9343(83)90481-3; Willette AA, 2012, DIABETES CARE; Yildirimer L, 2011, NANO TODAY, V6, P585, DOI 10.1016/j.nantod.2011.10.001; Zhang XD, 2010, INT J NANOMED, V5, P771, DOI 10.2147/IJN.S8428	60	151	151	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58208	10.1371/journal.pone.0058208	http://dx.doi.org/10.1371/journal.pone.0058208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469154	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900245
J	Chen, MJ; Cheng, HL; Chiou, YY				Chen, Mei-Ju; Cheng, Hong-Lin; Chiou, Yuan-Yow			Risk Factors for Renal Scarring and Deterioration of Renal Function in Primary Vesico-Ureteral Reflux Children: A Long-Term Follow-Up Retrospective Cohort Study	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; CHRONIC KIDNEY-DISEASE; DAMAGE; ADOLESCENTS; FAILURE	Background and Purpose: The aim was to identify the risk factors for renal scarring and deteriorating renal function in children with primary vesico-ureteral reflux (VUR). Materials and Methods: Patients with primary VUR admitted to the National Cheng Kung University Hospital were retrospectively analyzed. The outcomes were renal scarring, assessed by technetium-99 m dimercaptosuccinic acid scanning, and renal function, assessed by estimated glomerular filtration rate. Univariate and multivariate models were applied to identify the corresponding independent predictors. Results: A total of 173 patients with primary VUR were recruited. The median age of VUR diagnosis was 10.0 months (IQR: 4.0-43.0 months). After adjusting for confounding factors, it was found that older age of VUR diagnosis (>= 5 years vs. <1 year, adjusted OR = 2.78, 95% CI = 1.00-7.70, p = 0.049), higher grade of VUR (high grade [IV-V] vs. none, adjusted OR = 15.17, 95% CI = 5.33-43.19, p<0.0001; low grade [I-III] vs. none, adjusted OR = 5.72, 95% CI = 2.43-13.45, p<0.0001), and higher number of UTI (>= 2 vs. 0, adjusted OR = 3.21, 95% CI = 1.06-9.76, p = 0.039) were risk factors for renal scarring, whereas a younger age of VUR diagnosis (>= 5 years vs. <1 year, adjusted HR = 0.16, 95% CI: 0.05-0.51, p = 0.002), renal scarring (yes vs. no, adjusted HR = 3.66, 95% CI: 1.32-10.16, p = 0.013), and APN (yes vs. no, adjusted HR = 3.10, 95% CI: 1.05-9.14, p = 0.041) were risk factors for developing chronic kidney disease stage 2 or higher. Conclusions: Our findings expand on the current knowledge of risk factors for renal scarring and deteriorating renal function, and this information can be used to modify the management and treatment of VUR.	[Chen, Mei-Ju] Chung Hwa Univ Med Technol, Dept Long Term Care, Rende Shiang, Tainan County, Taiwan; [Cheng, Hong-Lin] Natl Cheng Kung Univ Hosp, Dept Urol, Tainan 70428, Taiwan; [Chiou, Yuan-Yow] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan; [Chiou, Yuan-Yow] Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70428, Taiwan	Chung Hua University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Chiou, YY (corresponding author), Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan.	yuanyow@mail.ncku.edu.tw						Alsaywid BS, 2010, J UROLOGY, V184, P1598, DOI 10.1016/j.juro.2010.04.021; Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Caione P, 2004, BJU INT, V93, P1309, DOI 10.1111/j.1464-410X.04866.x; Chiou YY, 2001, RADIOLOGY, V221, P366, DOI 10.1148/radiol.2212010146; Conway PH, 2007, JAMA-J AM MED ASSOC, V298, P179, DOI 10.1001/jama.298.2.179; Faust WC, 2009, J UROLOGY, V181, P290, DOI 10.1016/j.juro.2008.09.039; Hogg RJ, 2003, PEDIATRICS, V111, P1416, DOI 10.1542/peds.111.6.1416; Howard RG, 2001, BRIT J RADIOL, V74, P331, DOI 10.1259/bjr.74.880.740331; LEWITT SB, 1981, J UROLOGY, V125, P277; Novak TE, 2009, J UROLOGY, V182, P1678, DOI 10.1016/j.juro.2009.02.085; Silva JMP, 2006, PEDIATR NEPHROL, V21, P1285, DOI 10.1007/s00467-006-0166-7; Silva JMP, 2006, PEDIATR NEPHROL, V21, P981, DOI 10.1007/s00467-006-0151-1; Polito C, 2007, J UROLOGY, V178, P1043, DOI 10.1016/j.juro.2007.05.061; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Silva ACSE, 2007, PEDIATR NEPHROL, V22, P459, DOI 10.1007/s00467-006-0349-2; Silva JMP, 2009, NEPHROLOGY, V14, P198, DOI 10.1111/j.1440-1797.2008.01046.x; Soylu A, 2008, PEDIATR NEPHROL, V23, P2227, DOI 10.1007/s00467-008-0907-x; Swerkersson S, 2007, J UROLOGY, V178, P647, DOI 10.1016/j.juro.2007.04.004; Tepmongkol Supatporn, 2002, Journal of the Medical Association of Thailand, V85, pS203; Vachvanichsanong P, 2008, NEPHROLOGY, V13, P38, DOI 10.1111/j.1440-1797.2007.00906.x; Yoneda A, 2002, J UROLOGY, V168, P1704, DOI 10.1016/S0022-5347(05)64393-5	21	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57954	10.1371/journal.pone.0057954	http://dx.doi.org/10.1371/journal.pone.0057954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469116	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900210
J	Neuman, BW; Kiss, G; Al-Mulla, HMN; Dokland, T; Buchmeier, MJ; Weikl, TR; Schley, D				Neuman, Benjamin W.; Kiss, Gabriella; Al-Mulla, Hawaa M. N.; Dokland, Terje; Buchmeier, Michael J.; Weikl, Thomas R.; Schley, David			Direct Observation of Membrane Insertion by Enveloped Virus Matrix Proteins by Phosphate Displacement	PLOS ONE			English	Article							VESICLE; FISSION; BINDING; HELICES; ESCRT	Enveloped virus release is driven by poorly understood proteins that are functional analogs of the coat protein assemblies that mediate intracellular vesicle trafficking. We used differential electron density mapping to detect membrane integration by membrane-bending proteins from five virus families. This demonstrates that virus matrix proteins replace an unexpectedly large portion of the lipid content of the inner membrane face, a generalized feature likely to play a role in reshaping cellular membranes.	[Neuman, Benjamin W.; Al-Mulla, Hawaa M. N.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Kiss, Gabriella] Emory Univ, Sch Med, Atlanta, GA USA; [Dokland, Terje] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Buchmeier, Michael J.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Buchmeier, Michael J.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Weikl, Thomas R.] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Schley, David] Pirbright Inst, Pirbright, Surrey, England	University of Reading; Emory University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Irvine; University of California System; University of California Irvine; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Neuman, BW (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	b.w.neuman@reading.ac.uk	Weikl, Thomas/G-8572-2016	Weikl, Thomas/0000-0002-0911-5328; Dokland, Terje/0000-0001-5655-4123; Neuman, Benjamin/0000-0003-1240-8954	Pacific Southwest Regional Center of Excellence [AI-065359]; UK Biotechnology and Biological Sciences Research Council [IAH1717]; United States Department of Agriculture [2006-35204-17456]; UK Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001717] Funding Source: researchfish; BBSRC [BBS/E/I/00001717] Funding Source: UKRI	Pacific Southwest Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United States Department of Agriculture(United States Department of Agriculture (USDA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Support was provided by the Pacific Southwest Regional Center of Excellence AI-065359, The UK Biotechnology and Biological Sciences Research Council IAH1717, the United States Department of Agriculture 2006-35204-17456 and a UK Medical Research Council capacity building studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2003, VIROLOGY, V314, P488, DOI 10.1016/S0042-6822(03)00485-9; Borbat PP, 2001, SCIENCE, V291, P266, DOI 10.1126/science.291.5502.266; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Frank J, 2006, 3 DIMENSIONAL ELECT; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; JACOBS RE, 1989, BIOCHEMISTRY-US, V28, P3421, DOI 10.1021/bi00434a042; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Langer JD, 2007, FEBS LETT, V581, P2083, DOI 10.1016/j.febslet.2007.03.020; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Linke GT, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051602; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marsh D, 2010, EUR BIOPHYS J BIOPHY, V39, P513, DOI 10.1007/s00249-009-0512-3; Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021; Neuman BW, 2005, J VIROL, V79, P3822, DOI 10.1128/JVI.79.6.3822-3830.2005; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Rutherford E, 1911, PHILOS MAG, V6, P1; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Spilman MS, 2009, J GEN VIROL, V90, P527, DOI 10.1099/vir.0.007674-0; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Volpon L, 2010, P NATL ACAD SCI USA, V107, P5441, DOI 10.1073/pnas.0909877107	23	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57916	10.1371/journal.pone.0057916	http://dx.doi.org/10.1371/journal.pone.0057916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469104	Green Accepted, Green Published, gold			2022-12-27	WOS:000315524900199
J	Philipson, CW; Bassaganya-Riera, J; Viladomiu, M; Pedragosa, M; Guerrant, RL; Roche, JK; Hontecillas, R				Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; Guerrant, Richard L.; Roche, James K.; Hontecillas, Raquel			The Role of Peroxisome Proliferator-Activated Receptor gamma in Immune Responses to Enteroaggregative Escherichia coli Infection	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FECAL CALPROTECTIN; EPITHELIAL-CELLS; T-CELLS; BACTERIAL; IL-17; INFLAMMATION; MALNUTRITION; EXPRESSION; PROTECTION	Background: Enteroaggregative Escherichia coli (EAEC) is recognized as an emerging cause of persistent diarrhea and enteric disease worldwide. Mucosal immunity towards EAEC infections is incompletely understood due in part to the lack of appropriate animal models. This study presents a new mouse model and investigates the role of peroxisome proliferator-activated receptor gamma (PPAR gamma) in the modulation of host responses to EAEC in nourished and malnourished mice. Methods/Principal Findings: Wild-type and T cell-specific PPAR gamma null C57BL/6 mice were fed protein-deficient diets at weaning and challenged with 5 x 10(9) cfu EAEC strain JM221 to measure colonic gene expression and immune responses to EAEC. Antigen-specific responses to E. coli antigens were measured in nourished and malnourished mice following infection and demonstrated the immunosuppressive effects of malnutrition at the cellular level. At the molecular level, both pharmacological blockade and deletion of PPAR gamma in T cells resulted in upregulation of TGF-beta, IL-6, IL-17 and anti-microbial peptides, enhanced Th17 responses, fewer colonic lesions, faster clearance of EAEC, and improved recovery. The beneficial effects of PPAR gamma blockade on weight loss and EAEC clearance were abrogated by neutralizing IL-17 in vivo. Conclusions: Our studies provide in vivo evidence supporting the beneficial role of mucosal innate and effector T cell responses on EAEC burden and suggest pharmacological blockade of PPAR gamma as a novel therapeutic intervention for EAEC infection.	[Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; Hontecillas, Raquel] Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA; [Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; Hontecillas, Raquel] Virginia Tech, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA USA; [Bassaganya-Riera, Josep] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA; [Guerrant, Richard L.; Roche, James K.] Univ Virginia, Ctr Global Hlth, Div Infect Dis & Int Hlth, Charlottesville, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Virginia	Hontecillas, R (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA.	rmagarzo@vt.edu	Philipson, Casandra/AAY-5746-2021; Viladomiu, Monica/GNM-6447-2022		National Institutes of Health [5R01AT004308]; National Institute of Allergy and Infectious Diseases [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported in part by National Institutes of Health 5R01AT004308 to JB-R, National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi JA, 2001, CLIN INFECT DIS, V32, P1706, DOI 10.1086/320756; Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Al Jarousha AMK, 2011, INDIAN J PEDIATR, V78, P165, DOI 10.1007/s12098-010-0249-0; Aslani MM, 2011, INT J INFECT DIS, V15, pE136, DOI 10.1016/j.ijid.2010.10.002; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Boll EJ, 2012, CELL MICROBIOL, V14, P120, DOI 10.1111/j.1462-5822.2011.01706.x; Cennimo D, 2009, J MED MICROBIOL, V58, P403, DOI 10.1099/jmm.0.005793-0; Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Cooper AM, 2009, EUR J IMMUNOL, V39, P649, DOI 10.1002/eji.200839090; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Edwards LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027030; Fagerberg UL, 2007, J PEDIATR GASTR NUTR, V45, P414, DOI 10.1097/MPG.0b013e31810e75a9; Fleckenstein JM, 2001, J CLIN INVEST, V107, P27, DOI 10.1172/JCI11792; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; HEDGES S, 1992, INFECT IMMUN, V60, P1295, DOI 10.1128/IAI.60.4.1295-1301.1992; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Huang DB, 2006, CLIN INFECT DIS, V43, P556, DOI 10.1086/505869; Hughes S, 2006, PARASITE IMMUNOL, V28, P577, DOI 10.1111/j.1365-3024.2006.00897.x; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jiang ZD, 2003, J INFECT DIS, V188, P506, DOI 10.1086/377102; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Khan MAS, 2004, IMMUNOLOGY, V112, P651, DOI 10.1111/j.1365-2567.2004.01923.x; Kim TG, 2011, EXP DERMATOL, V20, P855, DOI 10.1111/j.1600-0625.2011.01343.x; Kouhkan Azam, 2004, Iran J Allergy Asthma Immunol, V3, P189; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lim JH, 2009, EXP MOL MED, V41, P757, DOI 10.3858/emm.2009.41.10.082; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Manz M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-5; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Mrabet-Dahbi S, 2009, EXP DERMATOL, V18, P437, DOI 10.1111/j.1600-0625.2009.00878.x; Murray J, 1997, BLOOD, V90, P2772, DOI 10.1182/blood.V90.7.2772.2772_2772_2783; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ogawa H, 2012, BIOCHEM BIOPH RES CO, V420, P114, DOI 10.1016/j.bbrc.2012.02.124; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubino SJ, 2012, TRENDS IMMUNOL, V33, P112, DOI 10.1016/j.it.2012.01.003; Shastri YM, 2008, AM J MED, V121, P1099, DOI 10.1016/j.amjmed.2008.06.034; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sibartie S, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-54; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takahashi N, 2008, J EXP MED, V205, P1755, DOI 10.1084/jem.20080588; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Weintraub A, 2007, J MED MICROBIOL, V56, P4, DOI 10.1099/jmm.0.46930-0; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036	64	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57812	10.1371/journal.pone.0057812	http://dx.doi.org/10.1371/journal.pone.0057812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469071	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900168
J	Tang, DD; Hu, L; Li, H; Zhang, QL; Chen, AT				Tang, Dandan; Hu, Li; Li, Hong; Zhang, Qinglin; Chen, Antao			The Neural Dynamics of Conflict Adaptation within a Look-to-Do Transition	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL MECHANISMS; TRAUMATIC BRAIN-INJURY; INDUCED BEHAVIORAL-ADJUSTMENT; STROOP TASK; SEQUENTIAL MODULATIONS; PREFRONTAL CORTEX; RESPONSE CONFLICT; EXECUTIVE CONTROL; DECISION-MAKING	Background: For optimal performance in conflict situations, conflict adaptation (conflict detection and adjustment) is necessary. However, the neural dynamics of conflict adaptation is still unclear. Methods: In the present study, behavioral and electroencephalography (EEG) data were recorded from seventeen healthy participants during performance of a color-word Stroop task with a novel look-to-do transition. Within this transition, participants looked at the Stroop stimuli but no responses were required in the 'look' trials; or made manual responses to the Stroop stimuli in the 'do' trials. Results: In the 'look' trials, the amplitude modulation of N450 occurred exclusively in the right-frontal region. Subsequently, the amplitude modulation of sustained potential (SP) emerged in the posterior parietal and right-frontal regions. A significantly positive correlation between the modulation of reconfiguration in the 'look' trials and the behavioral conflict adaptation in the 'do' trials was observed. Specially, a stronger information flow from right-frontal region to posterior parietal region in the beta band was observed for incongruent condition than for congruent condition. In the 'do' trials, the conflict of 'look' trials enhanced the amplitude modulations of N450 in the right-frontal and posterior parietal regions, but decreased the amplitude modulations of SP in these regions. Uniquely, a stronger information flow from centro-parietal region to right-frontal region in the theta band was observed for il condition than for cl condition. Conclusion: All these findings showed that top-down conflict adaptation is implemented by: (1) enhancing the sensitivity to conflict detection and the adaptation to conflict resolution; (2) modulating the effective connectivity between parietal region and right-frontal region.	[Tang, Dandan; Hu, Li; Zhang, Qinglin; Chen, Antao] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Fac Psychol, Chongqing, Peoples R China; [Li, Hong; Chen, Antao] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Liaoning, Peoples R China	Southwest University - China; Liaoning Normal University	Chen, AT (corresponding author), Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Fac Psychol, Chongqing, Peoples R China.	xscat@swu.edu.cn			National Natural Science Foundation of China [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-11-0698]; Fundamental Research Funds for the Central Universities [SWU1009001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding support was provided by the National Natural Science Foundation of China (31170980, 81271477), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), the New Century Excellent Talents in University (NCET-11-0698), and the Fundamental Research Funds for the Central Universities (SWU1009001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2007, PSYCHON B REV, V14, P742, DOI 10.3758/BF03196831; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Chen AT, 2011, INT J PSYCHOPHYSIOL, V80, P129, DOI 10.1016/j.ijpsycho.2011.02.012; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Donohue SE, 2011, COGN AFFECT BEHAV NE, P1; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T., 2007, HYPNOSIS CONSCIOUS S, P29; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Freitas AL, 2007, PSYCHOL SCI, V18, P1040, DOI 10.1111/j.1467-9280.2007.02022.x; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hazeltine E, 2011, J EXP PSYCHOL HUMAN, V37, P1898, DOI 10.1037/a0024662; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hu L, 2012, NEUROIMAGE, V62, P217, DOI 10.1016/j.neuroimage.2012.03.094; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Iyer A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000444; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; Lamers MJM, 2011, Q J EXP PSYCHOL, V64, P1056, DOI 10.1080/17470218.2010.523792; Larson MJ, 2012, DEV NEUROPSYCHOL, V37, P343, DOI 10.1080/87565641.2011.650337; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2012, NEUROPSYCHOLOGIA, V50, P426, DOI 10.1016/j.neuropsychologia.2011.12.021; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Liu PD, 2012, J COGN PSYCHOL, V24, P457, DOI 10.1080/20445911.2011.651080; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Mayr U, 2009, PSYCHOL RES-PSYCH FO, V73, P794, DOI 10.1007/s00426-008-0191-1; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2006, PSYCHON B REV, V13, P112, DOI 10.3758/BF03193821; Peng WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034163; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Posner M., 1975, INFORM PROCESSING CO; Posner MI, 1998, ROYAL SOC, V353, P1915; Purmann S, 2009, PSYCHON B REV, V16, P350, DOI 10.3758/PBR.16.2.350; Roelofs A, 2006, P NATL ACAD SCI USA, V103, P13884, DOI 10.1073/pnas.0606265103; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Verguts T, 2008, PSYCHOL REV, V115, P518, DOI 10.1037/0033-295X.115.2.518; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; West R, 2000, CEREB CORTEX, V10, P748, DOI 10.1093/cercor/10.8.748; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	72	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57912	10.1371/journal.pone.0057912	http://dx.doi.org/10.1371/journal.pone.0057912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23469102	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900197
J	den Adel, B; van der Graaf, LM; Strijkers, GJ; Lamb, HJ; Poelmann, RE; van der Weerd, L				den Adel, Brigit; van der Graaf, Linda M.; Strijkers, Gustav J.; Lamb, Hildo J.; Poelmann, Robert E.; van der Weerd, Louise			Self-Gated CINE MRI for Combined Contrast-Enhanced Imaging and Wall-Stiffness Measurements of Murine Aortic Atherosclerotic Lesions	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; HIGH-RESOLUTION MRI; IN-VIVO; IRON-OXIDE; HYPERTENSIVE PATIENTS; APOLIPOPROTEIN-E; DEFICIENT MICE; MOUSE; PLAQUE; HEART	Background: High-resolution contrast-enhanced imaging of the murine atherosclerotic vessel wall is difficult due to unpredictable flow artifacts, motion of the thin artery wall and problems with flow suppression in the presence of a circulating contrast agent. Methods and Results: We applied a 2D-FLASH retrospective-gated CINE MRI method at 9.4T to characterize atherosclerotic plaques and vessel wall distensibility in the aortic arch of aged ApoE(-/-) mice after injection of a contrast agent. The method enabled detection of contrast enhancement in atherosclerotic plaques in the aortic arch after I. V. injection of micelles and iron oxides resulting in reproducible plaque enhancement. Both contrast agents were taken up in the plaque, which was confirmed by histology. Additionally, the retrospective-gated CINE method provided images of the aortic wall throughout the cardiac cycle, from which the vessel wall distensibility could be calculated. Reduction in plaque size by statin treatment resulted in lower contrast enhancement and reduced wall stiffness. Conclusions: The retrospective-gated CINE MRI provides a robust and simple way to detect and quantify contrast enhancement in atherosclerotic plaques in the aortic wall of ApoE(-/-) mice. From the same scan, plaque-related changes in stiffness of the aortic wall can be determined. In this mouse model, a correlation between vessel wall stiffness and atherosclerotic lesions was found.	[den Adel, Brigit; van der Graaf, Linda M.; Lamb, Hildo J.; Poelmann, Robert E.; van der Weerd, Louise] Leiden Univ Med Ctr, Leiden, Netherlands; [Strijkers, Gustav J.] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Eindhoven University of Technology	den Adel, B (corresponding author), Leiden Univ Med Ctr, Leiden, Netherlands.	b.den_adel@lumc.nl	Lamb, Hildo/ABE-1171-2021; van der Weerd, Louise/B-5421-2014	Lamb, Hildo/0000-0002-6969-2418; van der Weerd, Louise/0000-0002-5997-2125; Strijkers, Gustav/0000-0001-6700-5058	Dutch Heart Foundation [NHS2006T106]; Life Science Health Priority Network of Excellence [LSHB-CT-2005-512146]; Netherlands Science Foundation (NWO) [JPA3, 700.58.801]	Dutch Heart Foundation(Netherlands Heart Foundation); Life Science Health Priority Network of Excellence; Netherlands Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch Heart Foundation (grant NHS2006T106), http://www.hartstichting.nl/wetenschappers/subsidiewijzer/; LSHB-CT-2005-512146 Life Science Health Priority Network of Excellence, JPA3 (ec.europa.eu) and Athena 700.58.801 from the Netherlands Science Foundation (NWO), www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; Asmar RG, 1997, J HYPERTENS, V15, pS99, DOI 10.1097/00004872-199715022-00010; Bergwerff M, 1998, CIRC RES, V82, P221; Boekhorst BCMT, 2010, MOL IMAGING BIOL, V12, P635, DOI 10.1007/s11307-010-0323-z; Burtea C, 2011, CONTRAST MEDIA MOL I, V6, P236, DOI 10.1002/cmmi.423; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; den Adel B, 2012, ATHEROSCLEROSIS, V225, P274, DOI 10.1016/j.atherosclerosis.2012.07.028; den Adel B, 2013, CONTRAST MEDIA MOL I, V8, P63, DOI 10.1002/cmmi.1496; Faraci FM, 1999, CIRC RES, V85, P1214; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Hartley CJ, 1997, AM J PHYSIOL-HEART C, V273, pH494, DOI 10.1152/ajpheart.1997.273.1.H494; Heijman E, 2007, NMR BIOMED, V20, P439, DOI 10.1002/nbm.1110; Herold V, 2009, MAGN RESON MATER PHY, V22, P159, DOI 10.1007/s10334-008-0160-0; John S, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.06.027; Klug G, 2009, FRONT BIOSCI-LANDMRK, V14, P2546, DOI 10.2741/3396; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; LEHMANN ED, 1995, CLIN SCI, V89, P247, DOI 10.1042/cs0890247; Li ZY, 2006, J BIOMECH, V39, P2611, DOI 10.1016/j.jbiomech.2005.08.022; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Metafratzi ZM, 2002, J CARDIOV MAGN RESON, V4, P481, DOI 10.1081/JCMR-120016386; Miraux S, 2009, MAGN RESON MED, V62, P1099, DOI 10.1002/mrm.22139; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Morris JB, 2008, ARTERIOSCL THROM VAS, V28, P265, DOI 10.1161/ATVBAHA.107.151175; Morrison TM, 2009, J VASC SURG, V49, P1029, DOI 10.1016/j.jvs.2008.11.056; Mulder Willem J M, 2007, Top Magn Reson Imaging, V18, P409; Mulder WJM, 2007, MAGN RESON MED, V58, P1164, DOI 10.1002/mrm.21315; Mulder WJM, 2004, BIOCONJUGATE CHEM, V15, P799, DOI 10.1021/bc049949r; Nahrendorf M, 2000, J CARDIOV MAGN RESON, V2, P171, DOI 10.3109/10976640009146565; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Parczyk M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-72; PLUMP AS, 1995, ANNU REV NUTR, V15, P495, DOI 10.1146/annurev.nu.15.070195.002431; Rensen SS, 2008, CIRCULATION, V118, P828, DOI 10.1161/CIRCULATIONAHA.107.743690; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Shaaban AM, 2000, AM J ROENTGENOL, V174, P1657, DOI 10.2214/ajr.174.6.1741657; Van der Heiden K, 2008, ATHEROSCLEROSIS, V196, P542, DOI 10.1016/j.atherosclerosis.2007.05.030; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; Wang YX, 2000, AM J PHYSIOL-HEART C, V278, pH428, DOI 10.1152/ajpheart.2000.278.2.H428; Wiesmann F, 2003, MAGN RESON MED, V50, P69, DOI 10.1002/mrm.10500; Yamakoshi Y, 2011, CHEM COMMUN, V47, P8835, DOI 10.1039/c1cc10924c; Yu HY, 2006, MAGN RESON MED, V56, P876, DOI 10.1002/mrm.21034	40	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57299	10.1371/journal.pone.0057299	http://dx.doi.org/10.1371/journal.pone.0057299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472079	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900017
J	Romo, CM; Tylianakis, JM				Romo, Cecilia M.; Tylianakis, Jason M.			Elevated Temperature and Drought Interact to Reduce Parasitoid Effectiveness in Suppressing Hosts	PLOS ONE			English	Article							CLIMATE-CHANGE; BIOLOGICAL-CONTROL; WATER-STRESS; HERBIVORE INTERACTIONS; TERRESTRIAL INSECTS; TROPHIC LEVELS; GLOBAL-CHANGE; RESPONSES; APHID; CONSEQUENCES	Climate change affects the abundance, distribution and activity of natural enemies that are important for suppressing herbivore crop pests. Moreover, higher mean temperatures and increased frequency of climatic extremes are expected to induce different responses across trophic levels, potentially disrupting predator-prey interactions. Using field observations, we examined the response of an aphid host-parasitoid system to variation in temperature. Temperature was positively associated with attack rates by parasitoids, but also with a non-significant trend towards increased attack rates by higher-level hyperparasitoids. Elevated hyperparasitism could partly offset any benefit of climate warming to parasitoids, and would suggest that higher trophic levels may hamper predictions of predator-prey interactions. Additionally, the mechanisms affecting host-parasitoid dynamics were examined using controlled laboratory experiments that simulated both temperature increase and drought. Parasitoid fitness and longevity responded differently when exposed to each climatic variable in isolation, compared to the interaction of both variables at once. Although temperature increase or drought tended to positively affect the ability of parasitoids to control aphid populations, these effects were significantly reversed when the drivers were expressed in concert. Additionally, separate warming and drought treatments reduced parasitoid longevity, and although temperature increased parasitoid emergence success and drought increased offspring production, combined temperature and drought produced the lowest parasitoid emergence. The non-additive effects of different climate drivers, combined with differing responses across trophic levels, suggest that predicting future pest outbreaks will be more challenging than previously imagined.	[Romo, Cecilia M.; Tylianakis, Jason M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	Romo, CM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	ceciro@gmail.com	Tylianakis, Jason/B-6634-2011	Tylianakis, Jason/0000-0001-7402-5620; Romo, Cecilia/0000-0001-9592-3665	University of Canterbury; Rutherford Discovery Fellowship	University of Canterbury; Rutherford Discovery Fellowship	C.M.R. was funded by University of Canterbury Doctoral and College of Science scholarships and J.M.T. is funded by a Rutherford Discovery Fellowship administered by the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2007, J KANSAS ENTOMOL SOC, V80, P156, DOI 10.2317/0022-8567(2007)80[156:EOLEWO]2.0.CO;2; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, AR4 CLIM CHANG 2007; AYRES MP, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P75; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bannerman JA, 2011, ECOL ENTOMOL, V36, P490, DOI 10.1111/j.1365-2311.2011.01292.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bezemer TM, 1998, OIKOS, V82, P212, DOI 10.2307/3546961; Binzer A, 2012, PHILOS T R SOC B, V367, P2935, DOI 10.1098/rstb.2012.0230; Blande JD, 2004, J CHEM ECOL, V30, P1781, DOI 10.1023/B:JOEC.0000042401.52088.54; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; de Sassi C, 2012, PHILOS T R SOC B, V367, P3033, DOI 10.1098/rstb.2012.0233; de Sassi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040557; Denis D, 2011, ECOL MODEL, V222, P1604, DOI 10.1016/j.ecolmodel.2011.02.023; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Gilbert N, 1996, CAN ENTOMOL, V128, P1, DOI 10.4039/Ent1281-1; GODFRAY HCJ, 1994, J ANIM ECOL, V63, P1, DOI 10.2307/5577; Hale BK, 2003, ECOL ENTOMOL, V28, P666, DOI 10.1111/j.1365-2311.2003.00563.x; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Heimpel GE, 1996, ECOLOGY, V77, P2410, DOI 10.2307/2265742; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hogervorst PAM, 2007, ENTOMOL EXP APPL, V122, P223, DOI 10.1111/j.1570-7458.2006.00505.x; Hoover JK, 2004, GLOBAL CHANGE BIOL, V10, P1197, DOI 10.1111/j.1529-8817.2003.00796.x; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Inbar M, 2001, OIKOS, V94, P228, DOI 10.1034/j.1600-0706.2001.940203.x; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; Johnson SN, 2011, J ECOL, V99, P57, DOI 10.1111/j.1365-2745.2010.01748.x; Khan MAM, 2010, ENTOMOL EXP APPL, V137, P229, DOI 10.1111/j.1570-7458.2010.01059.x; Klapwijk MJ, 2010, GLOBAL CHANGE BIOL, V16, P102, DOI 10.1111/j.1365-2486.2009.01918.x; MacGILLIVRAY M. E., 1957, CANADIAN ENT, V89, P43; Massad TJ, 2010, ARTHROPOD-PLANT INTE, V4, P181, DOI 10.1007/s11829-010-9102-7; MILLER JC, 1994, ENVIRON ENTOMOL, V23, P1304, DOI 10.1093/ee/23.5.1304; Mody K, 2009, ECOL ENTOMOL, V34, P133, DOI 10.1111/j.1365-2311.2008.01053.x; Mullan B., 2005, CHANGES DROUGHT RISK; Mullan B, 2008, CLIMATE CHANGE EFFEC, P156; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Pritchard J, 2007, GLOBAL CHANGE BIOL, V13, P1616, DOI 10.1111/j.1365-2486.2007.01401.x; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Schooler SS, 2011, BIOL CONTROL, V58, P167, DOI 10.1016/j.biocontrol.2011.05.018; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Sullivan DJ, 1999, ANNU REV ENTOMOL, V44, P291, DOI 10.1146/annurev.ento.44.1.291; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Van Nouhuys S, 2004, J ANIM ECOL, V73, P526, DOI 10.1111/j.0021-8790.2004.00827.x; Venables WN., 2002, MODERN APPL STAT S 4; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Vollhardt IMG, 2010, ENTOMOL EXP APPL, V137, P1, DOI 10.1111/j.1570-7458.2010.01025.x; WAAGE JK, 1982, PARASITOLOGY, V84, P241, DOI 10.1017/S003118200005366X; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wu GM, 2011, ENVIRON ENTOMOL, V40, P737, DOI 10.1603/EN11018; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	64	84	90	1	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58136	10.1371/journal.pone.0058136	http://dx.doi.org/10.1371/journal.pone.0058136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472147	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900093
J	Wang, YJ; Sun, MA; Bao, HX; White, AP				Wang, Yejun; Sun, Ming'an; Bao, Hongxia; White, Aaron P.			T3_MM: A Markov Model Effectively Classifies Bacterial Type III Secretion Signals	PLOS ONE			English	Article							MESSENGER-RNA; PROTEIN; SALMONELLA; PREDICTION; EFFECTORS	Motivation: Type III Secretion Systems (T3SSs) play important roles in the interaction between gram-negative bacteria and their hosts. T3SSs function by translocating a group of bacterial effector proteins into the host cytoplasm. The details of specific type III secretion process are yet to be clarified. This research focused on comparing the amino acid composition within the N-terminal 100 amino acids from type III secretion (T3S) signal sequences or non-T3S proteins, specifically whether each residue exerts a constraint on residues found in adjacent positions. We used these comparisons to set up a statistic model to quantitatively model and effectively distinguish T3S effectors. Results: In this study, the amino acid composition (Aac) probability profiles conditional on its sequentially preceding position and corresponding amino acids were compared between N-terminal sequences of T3S and non-T3S proteins. The profiles are generally different. A Markov model, namely T3_MM, was consequently designed to calculate the total Aac conditional probability difference, i.e., the likelihood ratio of a sequence being a T3S or a non-T3S protein. With T3_MM, known T3S and non-T3S proteins were found to well approximate two distinct normal distributions. The model could distinguish validated T3S and non-T3S proteins with a 5-fold cross-validation sensitivity of 83.9% at a specificity of 90.3%. T3_MM was also shown to be more robust, accurate, simple, and statistically quantitative, when compared with other T3S protein prediction models. The high effectiveness of T3_MM also indicated the overall Aac difference between N-termini of T3S and non-T3S proteins, and the constraint of Aac exerted by its preceding position and corresponding Aac. Availability: An R package for T3_MM is freely downloadable from: http://biocomputer.bio.cuhk.edu.hk/softwares/T3_MM. T3_MM web server: http://biocomputer.bio.cuhk.edu.hk/T3DB/T3_MM.php.	[Wang, Yejun; Bao, Hongxia] Haerbin Med Univ, Genom Res Ctr, Harbin, Peoples R China; [Sun, Ming'an] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [White, Aaron P.] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	Harbin Medical University; Chinese University of Hong Kong; University of Saskatchewan	Wang, YJ (corresponding author), Haerbin Med Univ, Genom Res Ctr, Harbin, Peoples R China.	yejun.wang@gmail.com; Aaron.White@usask.ca	Sun, Mingan/D-7141-2019	Sun, Mingan/0000-0002-4661-3027				Arnold R, 2010, MICROBES INFECT, V12, P346, DOI 10.1016/j.micinf.2010.02.003; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal-Bayard J, 2010, J BIOL CHEM, V285, P16360, DOI 10.1074/jbc.M110.100669; Enninga J, 2009, CELL MICROBIOL, V11, P1462, DOI 10.1111/j.1462-5822.2009.01360.x; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Izore T, 2011, STRUCTURE, V19, P603, DOI 10.1016/j.str.2011.03.015; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Karavolos MH, 2005, J BACTERIOL, V187, P1559, DOI 10.1128/JB.187.5.1559-1567.2005; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lindeberg M, 2009, TRENDS MICROBIOL, V17, P304, DOI 10.1016/j.tim.2009.04.001; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Wang YJ, 2008, CANCER LETT, V263, P67, DOI 10.1016/j.canlet.2007.12.022; Wang YJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-66; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47	30	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58173	10.1371/journal.pone.0058173	http://dx.doi.org/10.1371/journal.pone.0058173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472154	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900100
J	Dona, V; Ventura, M; Sali, M; Cascioferro, A; Provvedi, R; Palu, G; Delogu, G; Manganelli, R				Dona, Valentina; Ventura, Marcello; Sali, Michela; Cascioferro, Alessandro; Provvedi, Roberta; Palu, Giorgio; Delogu, Giovanni; Manganelli, Riccardo			The PPE Domain of PPE17 Is Responsible for Its Surface Localization and Can Be Used to Express Heterologous Proteins on the Mycobacterial Surface	PLOS ONE			English	Article							TUBERCULOSIS; PE; SECRETION; SYSTEM; IMMUNOGENICITY; PE-PGRS33; MARINUM	PPE represent a peculiar family of mycobacterial proteins characterized by a 180 aminoacids conserved N-terminal domain. Several PPE genes are co-transcribed with a gene encoding for a protein belonging to another family of mycobacterial specific proteins named PE. Only one PE-PPE couple has been extensively characterized so far (PE25-PPE41) and it was shown that these two proteins form a heterodimer and that this interaction is essential for PPE41 stability and translocation through the mycobacterial cell wall. In this study we characterize the PE11-PPE17 couple. In contrast with what was found for PE25-PPE41, we show that PPE17 is not secreted but surface exposed. Moreover, we demonstrate that the presence of PE11 is not necessary for PPE17 stability or for its localization on the mycobacterial surface. Finally, we show that the PPE domain of PPE17 targets the mycobacterial cell wall and that this domain can be used as a fusion partner to expose heterologous proteins on the mycobacterial surface.	[Dona, Valentina; Ventura, Marcello; Cascioferro, Alessandro; Palu, Giorgio; Manganelli, Riccardo] Univ Padua, Dept Mol Med, Padua, Italy; [Sali, Michela; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Provvedi, Roberta] Univ Padua, Dept Biol, Padua, Italy	University of Padua; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua	Manganelli, R (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	riccardo.manganelli@unipd.it	Manganelli, Riccardo/A-7361-2009; Cascioferro, Alessandro/E-3445-2017	Manganelli, Riccardo/0000-0003-0940-7336; Cascioferro, Alessandro/0000-0001-7751-7348; SALI, Michela/0000-0003-3609-2990; PROVVEDI, ROBERTA/0000-0003-1164-9676; Delogu, Giovanni/0000-0003-0182-8267	European Community [201762]; Ministero dell'Universita e della Ricerca Scientifica, Progetti di Interesse Nazionale [2008Y8RZTF]	European Community(European Commission); Ministero dell'Universita e della Ricerca Scientifica, Progetti di Interesse Nazionale	This work was supported by the European Community's Seventh Framework Programme (FP7/2007 2013) under grant agreement no201762 and by Ministero dell'Universita e della Ricerca Scientifica, Progetti di Interesse Nazionale 2008 (code number 2008Y8RZTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Daleke MH, 2012, P NATL ACAD SCI US; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Li ZM, 1999, INFECT IMMUN, V67, P4780, DOI 10.1128/IAI.67.9.4780-4786.1999; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sali M, 2008, MICROBES INFECT, V10, P605, DOI 10.1016/j.micinf.2008.02.012; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Song H, 2008, TUBERCULOSIS EDINB; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sultana R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016745	29	20	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57517	10.1371/journal.pone.0057517	http://dx.doi.org/10.1371/journal.pone.0057517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469198	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100021
J	Janssens, L; Brumagne, S; McConnell, AK; Claeys, K; Pijnenburg, M; Burtin, C; Janssens, W; Decramer, M; Troosters, T				Janssens, Lotte; Brumagne, Simon; McConnell, Alison K.; Claeys, Kurt; Pijnenburg, Madelon; Burtin, Chris; Janssens, Wim; Decramer, Marc; Troosters, Thierry			Proprioceptive Changes Impair Balance Control in Individuals with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							POSTURAL CONTROL; EXERCISE; DIAPHRAGM; VIBRATION; STABILITY; MOBILITY; COPD	Introduction: Balance deficits are identified as important risk factors for falling in individuals with chronic obstructive pulmonary disease (COPD). However, the specific use of proprioception, which is of primary importance during balance control, has not been studied in individuals with COPD. The objective was to determine the specific proprioceptive control strategy during postural balance in individuals with COPD and healthy controls, and to assess whether this was related to inspiratory muscle weakness. Methods: Center of pressure displacement was determined in 20 individuals with COPD and 20 age/gender-matched controls during upright stance on an unstable support surface without vision. Ankle and back muscle vibration were applied to evaluate the relative contribution of different proprioceptive signals used in postural control. Results: Individuals with COPD showed an increased anterior-posterior body sway during upright stance (p = 0.037). Compared to controls, individuals with COPD showed an increased posterior body sway during ankle muscle vibration (p = 0.047), decreased anterior body sway during back muscle vibration (p = 0.025), and increased posterior body sway during simultaneous ankle-muscle vibration (p = 0.002). Individuals with COPD with the weakest inspiratory muscles showed the greatest reliance on ankle muscle input when compared to the stronger individuals with COPD (p = 0.037). Conclusions: Individuals with COPD, especially those with inspiratory muscle weakness, increased their reliance on ankle muscle proprioceptive signals and decreased their reliance on back muscle proprioceptive signals during balance control, resulting in a decreased postural stability compared to healthy controls. These proprioceptive changes may be due to an impaired postural contribution of the inspiratory muscles to trunk stability. Further research is required to determine whether interventions such as proprioceptive training and inspiratory muscle training improve postural balance and reduce the fall risk in individuals with COPD.	[Janssens, Lotte; Brumagne, Simon; Claeys, Kurt; Pijnenburg, Madelon; Burtin, Chris; Decramer, Marc; Troosters, Thierry] Univ Louvain, KU Leuven, Dept Rehabil Sci, Louvain, Belgium; [McConnell, Alison K.] Brunel Univ, Ctr Sports Med & Human Performance, Uxbridge UB8 3PH, Middx, England; [Claeys, Kurt] Catholic Univ Coll Bruges Ostend, Dept Hlth Care, Brugge, Belgium; [Burtin, Chris; Janssens, Wim; Decramer, Marc; Troosters, Thierry] Katholieke Univ Leuven Hosp, Resp Rehabil & Resp Div, Louvain, Belgium	KU Leuven; Brunel University; Catholic College Bruges-Ostend; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Janssens, L (corresponding author), Univ Louvain, KU Leuven, Dept Rehabil Sci, Louvain, Belgium.	Lotte.Janssens@faber.kuleuven.be	McConnell, Alison/ABB-1170-2020; Janssens, Lotte/T-1845-2017; McConnell, Alison K/G-5810-2014; Claeys, Kurt/AAW-3505-2020; burtin, chris/B-3343-2015; burtin, chris/F-8813-2013	Janssens, Lotte/0000-0002-6133-4915; McConnell, Alison K/0000-0002-3160-673X; Brumagne, Simon/0000-0002-0251-9338; Janssens, Wim/0000-0003-1830-2982; Claeys, Kurt/0000-0002-2794-3071	Research Foundation - Flanders (FWO) [1.5.104.03, G.0674.09, G.0598.09N, G.0871.13N]	Research Foundation - Flanders (FWO)(FWO)	This work was supported by the Research Foundation - Flanders (FWO) grants 1.5.104.03, G.0674.09, G.0598.09N and G.0871.13N. Lotte Janssens is PhD fellow of the FWO and Madelon Pijnenburg is PhD fellow of Agency for Innovation by Science and Technology - Flanders (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum JHJ, 1998, GAIT POSTURE, V8, P214, DOI 10.1016/S0966-6362(98)00027-7; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Beauchamp MK, 2009, RESP MED, V103, P1885, DOI 10.1016/j.rmed.2009.06.008; Beauchamp MK, 2012, CHEST, V141, P1496, DOI 10.1378/chest.11-1708; Bischoff-Ferrari HA, 2006, OSTEOPOROSIS INT, V17, P656, DOI 10.1007/s00198-005-0030-9; Brumagne S, 2008, GAIT POSTURE, V28, P657, DOI 10.1016/j.gaitpost.2008.04.015; Butcher Scott J, 2004, J Cardiopulm Rehabil, V24, P274, DOI 10.1097/00008483-200407000-00013; Chang AT, 2008, J CARDIOPULM REHABIL, V28, P142, DOI 10.1097/01.HCR.0000314209.17300.cc; Cordo PJ, 2005, EXP BRAIN RES, V167, P324, DOI 10.1007/s00221-005-0034-x; David P, 2012, EUR J APPL PHYSIOL, V112, P145, DOI 10.1007/s00421-011-1954-8; Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030; El-Kady MA, 2006, HEARING RES, V212, P109, DOI 10.1016/j.heares.2005.05.018; Engel R, 2011, J ALTERN COMPLEM MED, V17, P797, DOI 10.1089/acm.2010.0517; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Hall LM, 2010, J NEUROPHYSIOL, V103, P968, DOI 10.1152/jn.00479.2009; Hamaoui A, 2010, NEUROSCI LETT, V475, P141, DOI 10.1016/j.neulet.2010.03.064; Hodges PW, 2000, J PHYSIOL-LONDON, V522, P165, DOI 10.1111/j.1469-7793.2000.t01-1-00165.xm; Hodges PW, 2002, EXP BRAIN RES, V144, P293, DOI 10.1007/s00221-002-1040-x; Janssens L, 2010, SPINE, V35, P1088, DOI 10.1097/BRS.0b013e3181bee5c3; Kantor E, 2001, NEUROSCI LETT, V308, P128, DOI 10.1016/S0304-3940(01)01986-3; Kiers H, 2012, EUR J APPL PHYSIOL, V112, P1577, DOI 10.1007/s00421-011-2124-8; Kuznetsov NA, 2012, J MOTOR BEHAV, V44, P241, DOI 10.1080/00222895.2012.688894; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Lawlor DA, 2003, BRIT MED J, V327, P712, DOI 10.1136/bmj.327.7417.712; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; Polkey MI, 1996, AM J RESP CRIT CARE, V154, P1310, DOI 10.1164/ajrccm.154.5.8912741; ROCHESTER DF, 1983, MED CLIN N AM, V67, P573, DOI 10.1016/S0025-7125(16)31190-7; Roig M, 2011, RESP MED, V105, P461, DOI 10.1016/j.rmed.2010.08.015; Roig M, 2009, RESP MED, V103, P1257, DOI 10.1016/j.rmed.2009.03.022; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Smith MD, 2010, GAIT POSTURE, V31, P456, DOI 10.1016/j.gaitpost.2010.01.022	31	55	56	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57949	10.1371/journal.pone.0057949	http://dx.doi.org/10.1371/journal.pone.0057949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469255	Green Published, gold, Green Accepted			2022-12-27	WOS:000315897100052
J	Jiao, GZ; Cao, XY; Cui, W; Lian, HY; Miao, YL; Wu, XF; Han, D; Tan, JH				Jiao, Guang-Zhong; Cao, Xin-Yan; Cui, Wei; Lian, Hua-Yu; Miao, Yi-Long; Wu, Xiu-Fen; Han, Dong; Tan, Jing-He			Developmental Potential of Prepubertal Mouse Oocytes Is Compromised Due Mainly to Their Impaired Synthesis of Glutathione	PLOS ONE			English	Article							IN-VITRO MATURATION; SPERM NUCLEAR DECONDENSATION; EMBRYO DEVELOPMENT; INTRACELLULAR GLUTATHIONE; MALE PRONUCLEUS; BOVINE OOCYTES; GOAT OOCYTES; PIG OOCYTES; GONADOTROPIN REGULATION; OOPLASMIC MATURATION	Although oocytes from prepubertal animals are found less competent than oocytes from adults, the underlying mechanisms are poorly understood. Using the mouse oocyte model, this paper has tested the hypothesis that the developmental potential of prepubertal oocytes is compromised due mainly to their impaired potential for glutathione synthesis. Oocytes from prepubertal and adult mice, primed with or without eCG, were matured in vitro and assessed for glutathione synthesis potential, oxidative stress, Ca2+ reserves, fertilization and in vitro development potential. In unprimed mice, abilities for glutathione synthesis, activation, male pronuclear formation, blastocyst formation, cortical granule migration and polyspermic block were all compromised significantly in prepubertal compared to adult oocytes. Cysteamine and cystine supplementation to maturation medium significantly promoted oocyte glutathione synthesis and blastocyst development but difference due to maternal age remained. Whereas reactive oxygen species (ROS) levels increased, Ca2+ storage decreased significantly in prepubertal oocytes. Levels of both catalytic and modifier subunits of the gamma-glutamylcysteine ligase were significantly lower in prepubertal than in adult oocytes. Maternal eCG priming improved all the parameters and eliminated the age difference. Together, the results have confirmed our hypothesis by showing that prepubertal oocytes have a decreased ability to synthesize glutathione leading to an impaired potential to reduce ROS and to form male pronuclei and blastocysts. The resulting oxidative stress decreases the intracellular Ca2+ store resulting in impaired activation at fertilization, and damages the microfilament network, which affects cortical granule redistribution leading to polyspermy.	[Jiao, Guang-Zhong; Cao, Xin-Yan; Cui, Wei; Lian, Hua-Yu; Miao, Yi-Long; Wu, Xiu-Fen; Han, Dong; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	Cui, Wei/F-2192-2016	Cui, Wei/0000-0001-7281-3471	National Basic Research Program of China [2012CB944403, 2007CB947403]; China National Natural Science Foundation [31272444, 30972096, 30771556]; China National Project of Transgenics [2009ZX08008-006B]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China National Project of Transgenics	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2007CB947403), the China National Natural Science Foundation (Nos. 31272444, 30972096 and 30771556) and the China National Project of Transgenics (Nos. 2009ZX08008-006B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeydeera LR, 1998, BIOL REPROD, V58, P213, DOI 10.1095/biolreprod58.1.213; Ajduk A, 2008, REPROD BIOLOGY, V8, P3, DOI 10.1016/S1642-431X(12)60001-1; Bai J, 2008, THERIOGENOLOGY, V70, P758, DOI 10.1016/j.theriogenology.2008.04.053; CALVIN HI, 1986, GAMETE RES, V14, P265, DOI 10.1002/mrd.1120140310; Chang HY, 2004, J CELL SCI, V117, P6289, DOI 10.1242/jcs.01567; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Damiani P, 1996, MOL REPROD DEV, V45, P521, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;521::AID-MRD15&gt;3.0.CO;2-Z; de Matos DG, 2003, MOL REPROD DEV, V64, P214, DOI 10.1002/mrd.10243; de Matos DG, 2000, THERIOGENOLOGY, V53, P761, DOI 10.1016/S0093-691X(99)00278-2; deMatos DG, 1997, BIOL REPROD, V57, P1420, DOI 10.1095/biolreprod57.6.1420; El Mouatassim S, 1999, MOL HUM REPROD, V5, P720, DOI 10.1093/molehr/5.8.720; EPPIG JJ, 1992, J REPROD FERTIL, V95, P119, DOI 10.1530/jrf.0.0950119; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Furnus CC, 1998, MOL REPROD DEV, V51, P76, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;76::AID-MRD9&gt;3.0.CO;2-T; Gandolfi F, 1998, MOL REPROD DEV, V49, P168, DOI 10.1002/(SICI)1098-2795(199802)49:2&lt;168::AID-MRD7&gt;3.0.CO;2-N; GARDINER CS, 1995, ARCH BIOCHEM BIOPHYS, V321, P6, DOI 10.1006/abbi.1995.1361; GARDINER CS, 1995, ARCH BIOCHEM BIOPHYS, V318, P30, DOI 10.1006/abbi.1995.1200; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; ISSELS RD, 1988, BIOCHEM PHARMACOL, V37, P881, DOI 10.1016/0006-2952(88)90176-1; Izquierdo D, 1999, THERIOGENOLOGY, V52, P847, DOI 10.1016/S0093-691X(99)00177-6; Khatir H, 1996, MOL REPROD DEV, V45, P231, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;231::AID-MRD17&gt;3.0.CO;2-3; Khatir H, 1998, THERIOGENOLOGY, V50, P1201, DOI 10.1016/S0093-691X(98)00220-9; Khatir H, 1998, THERIOGENOLOGY, V50, P917, DOI 10.1016/S0093-691X(98)00196-4; Koeman J, 2003, THERIOGENOLOGY, V60, P879, DOI 10.1016/S0093-691X(03)00090-6; Ledda S, 1997, J REPROD FERTIL, V109, P73, DOI 10.1530/jrf.0.1090073; LOHUIS MM, 1995, THERIOGENOLOGY, V43, P51, DOI 10.1016/0093-691X(94)00016-N; Luderer U, 2001, REPROD TOXICOL, V15, P495, DOI 10.1016/S0890-6238(01)00157-5; Madgwick S, 2005, J CELL SCI, V118, P3849, DOI 10.1242/jcs.02506; Marchal R, 2001, THERIOGENOLOGY, V56, P17, DOI 10.1016/S0093-691X(01)00539-8; MARTINO A, 1995, THERIOGENOLOGY, V43, P473, DOI 10.1016/0093-691X(94)00040-2; MEISTER A, 1986, J AM COLL NUTR, V5, P137; NASRESFAHANI MH, 1990, DEVELOPMENT, V109, P501; OBrien JK, 1996, REPROD FERT DEVELOP, V8, P1029, DOI 10.1071/RD9961029; OBrien JK, 1997, THERIOGENOLOGY, V47, P1433, DOI 10.1016/S0093-691X(97)00134-9; Ozawa M, 2010, J CELL PHYSIOL, V222, P294, DOI 10.1002/jcp.21949; PERREAULT SD, 1984, DEV BIOL, V101, P160, DOI 10.1016/0012-1606(84)90126-X; PERREAULT SD, 1988, DEV BIOL, V125, P181, DOI 10.1016/0012-1606(88)90070-X; PERREAULT SD, 1987, BIOL REPROD, V36, P239, DOI 10.1095/biolreprod36.1.239; PINKERT CA, 1989, J REPROD FERTIL, V87, P63, DOI 10.1530/jrf.0.0870063; Ptak G, 1999, BIOL REPROD, V61, P1568, DOI 10.1095/biolreprod61.6.1568; REVEL F, 1995, J REPROD FERTIL, V103, P115, DOI 10.1530/jrf.0.1030115; Salamone DF, 2001, BIOL REPROD, V64, P1761, DOI 10.1095/biolreprod64.6.1761; SEIDEL GE, 1971, J DAIRY SCI, V54, P923, DOI 10.3168/jds.S0022-0302(71)85945-3; Sha W, 2010, FERTIL STERIL, V93, P1650, DOI 10.1016/j.fertnstert.2009.03.003; Sirard MA, 2007, THERIOGENOLOGY, V68, pS71, DOI 10.1016/j.theriogenology.2007.05.053; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; Squier TC, 2000, FRONT BIOSCI-LANDMRK, V5, pD504, DOI 10.2741/Squier; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Sutovsky P, 1997, BIOL REPROD, V56, P1503, DOI 10.1095/biolreprod56.6.1503; Takahashi T, 2009, BIOL REPROD, V80, P493, DOI 10.1095/biolreprod.108.072017; Tsai-Turton M, 2005, AM J PHYSIOL-ENDOC M, V289, pE391, DOI 10.1152/ajpendo.00531.2004; Urdaneta A, 2004, ZYGOTE, V12, P277, DOI 10.1017/S0967199404002874; Velilla E, 2004, MOL REPROD DEV, V68, P507, DOI 10.1002/mrd.20111; Wakai T, 2012, J CELL PHYSIOL, V227, P705, DOI 10.1002/jcp.22778; Wu YG, 2007, CELL RES, V17, P722, DOI 10.1038/cr.2007.66; Yanagimachi R, 1994, PHYSL REPRODUCTION, V1, P189; YOSHIDA M, 1993, BIOL REPROD, V49, P89, DOI 10.1095/biolreprod49.1.89; YOSHIDA M, 1993, MOL REPROD DEV, V35, P76, DOI 10.1002/mrd.1080350113; Zhou P, 2008, REPRODUCTION, V135, P605, DOI 10.1530/REP-08-0003; Zhou P, 2010, BIOL REPROD, V82, P759, DOI 10.1095/biolreprod.109.082206	61	49	51	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58018	10.1371/journal.pone.0058018	http://dx.doi.org/10.1371/journal.pone.0058018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469259	gold, Green Published, Green Submitted			2022-12-27	WOS:000315897100056
J	Olesen, SS; Graversen, C; Bouwense, SAW; van Goor, H; Wilder-Smith, OHG; Drewes, AM				Olesen, Soren S.; Graversen, Carina; Bouwense, Stefan A. W.; van Goor, Harry; Wilder-Smith, Oliver H. G.; Drewes, Asbjorn M.			Quantitative Sensory Testing Predicts Pregabalin Efficacy in Painful Chronic Pancreatitis	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; POSTHERPETIC NEURALGIA; CENTRAL SENSITIZATION; NEUROPATHIC PAIN; MEDICAL JOURNALS; DOUBLE-BLIND; GABAPENTIN; HYPERALGESIA; MODULATION; ONSET	Background: A major problem in pain medicine is the lack of knowledge about which treatment suits a specific patient. We tested the ability of quantitative sensory testing to predict the analgesic effect of pregabalin and placebo in patients with chronic pancreatitis. Methods: Sixty-four patients with painful chronic pancreatitis received pregabalin (150-300 mg BID) or matching placebo for three consecutive weeks. Analgesic effect was documented in a pain diary based on a visual analogue scale. Responders were defined as patients with a reduction in clinical pain score of 30% or more after three weeks of study treatment compared to baseline recordings. Prior to study medication, pain thresholds to electric skin and pressure stimulation were measured in dermatomes T10 (pancreatic area) and C5 (control area). To eliminate inter-subject differences in absolute pain thresholds an index of sensitivity between stimulation areas was determined (ratio of pain detection thresholds in pancreatic versus control area, ePDT ratio). Pain modulation was recorded by a conditioned pain modulation paradigm. A support vector machine was used to screen sensory parameters for their predictive power of pregabalin efficacy. Results: The pregabalin responders group was hypersensitive to electric tetanic stimulation of the pancreatic area (ePDT ratio 1.2 (0.9-1.3)) compared to non-responders group (ePDT ratio: 1.6 (1.5-2.0)) (P = 0.001). The electrical pain detection ratio was predictive for pregabalin effect with a classification accuracy of 83.9% (P = 0.007). The corresponding sensitivity was 87.5% and specificity was 80.0%. No other parameters were predictive of pregabalin or placebo efficacy. Conclusions: The present study provides first evidence that quantitative sensory testing predicts the analgesic effect of pregabalin in patients with painful chronic pancreatitis. The method can be used to tailor pain medication based on patient's individual sensory profile and thus comprises a significant step towards personalized pain medicine.	[Olesen, Soren S.; Graversen, Carina; Drewes, Asbjorn M.] Aarhus Univ Hosp, Aalborg Hosp, Dept Gastroenterol, Mech Sense, Aalborg, Denmark; [Graversen, Carina] Aarhus Univ Hosp, Aalborg Hosp, Dept Radiol, Mech Sense, Aalborg, Denmark; [Graversen, Carina] Univ Gottingen, Univ Med Ctr Gottingen, Bernstein Ctr Computat Neurosci, Dept Neurorehabil Engn, D-37073 Gottingen, Germany; [Bouwense, Stefan A. W.; van Goor, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Pain & Nocicept Neurosci Res Grp, NL-6525 ED Nijmegen, Netherlands; [Wilder-Smith, Oliver H. G.] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Care, Pain & Nocicept Neurosci Res Grp, NL-6525 ED Nijmegen, Netherlands; [Wilder-Smith, Oliver H. G.; Drewes, Asbjorn M.] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Gottingen; Radboud University Nijmegen; Radboud University Nijmegen; Aalborg University	Olesen, SS (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Dept Gastroenterol, Mech Sense, Aalborg, Denmark.	sso@mech-sense.com	Bouwense, Stefan/P-6468-2015; Drewes, Asbjørn/AAR-7479-2021	Bouwense, Stefan/0000-0002-7600-9429; Drewes, Asbjørn/0000-0001-7465-964X; Schou Olesen, Soren/0000-0003-3916-3168; Graversen, Carina/0000-0001-8392-058X	Pfizer Research and Development; Danish Agency for Science, Technology and Innovation: Det Strategiske Forskningsrad [10-092786]	Pfizer Research and Development; Danish Agency for Science, Technology and Innovation: Det Strategiske Forskningsrad	This research was supported by a free grant from Pfizer Research and Development and the Danish Agency for Science, Technology and Innovation: Det Strategiske Forskningsrad; grant No. 10-092786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, BRIT MED J, V286, P1489, DOI 10.1136/bmj.286.6376.1489; Arendt-Nielsen L, 2000, Prog Brain Res, V129, P343; Arendt-Nielsen L, 2011, CLIN J PAIN; Attal N, 2004, NEUROLOGY, V62, P218, DOI 10.1212/01.WNL.0000103237.62009.77; Bockbrader HN, 2010, J CLIN PHARMACOL, V50, P941, DOI 10.1177/0091270009352087; Bouwense SAW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042096; Bouwense SAW, 2011, REGION ANESTH PAIN M, V36, P531, DOI 10.1097/AAP.0b013e31822e0d4a; Buscher HG, 2006, EUR J PAIN, V10, P363, DOI 10.1016/j.ejpain.2005.06.006; Cathcart S, 2009, PAIN RES MANAG, V14, P433, DOI 10.1155/2009/523098; CHEN ACN, 1989, PAIN, V37, P143, DOI 10.1016/0304-3959(89)90126-7; Dimcevski G, 2007, GASTROENTEROLOGY, V132, P1546, DOI 10.1053/j.gastro.2007.01.037; Edwards RR, 2006, ANESTHESIOLOGY, V104, P1243, DOI 10.1097/00000542-200606000-00020; Fehrenbacher JC, 2003, PAIN, V105, P133, DOI 10.1016/S0304-3959(03)00173-8; Fink K, 2002, NEUROPHARMACOLOGY, V42, P229, DOI 10.1016/S0028-3908(01)00172-1; Fujisawa M, 1999, J OROFAC PAIN, V13, P97; Gardner TB, 2010, PANCREAS, V39, P498, DOI 10.1097/MPA.0b013e3181c5c693; Gottrup H, 2004, ANESTHESIOLOGY, V101, P1400; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Houghton LA, 2007, GUT, V56, P1218, DOI 10.1136/gut.2006.110858; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; Lee Y, 2010, METHODS MOL BIOL, V620, P347, DOI 10.1007/978-1-60761-580-4_11; McQuay HJ, 2012, PAIN, V153, P1364, DOI 10.1016/j.pain.2012.01.024; Mullady DK, 2011, GUT, V60, P77, DOI 10.1136/gut.2010.213835; Olesen AE, 2012, BASIC CLIN PHARMACOL, V111, P385, DOI 10.1111/j.1742-7843.2012.00914.x; Olesen SS, 2011, ALIMENT PHARM THER, V34, P878, DOI 10.1111/j.1365-2036.2011.04802.x; Olesen SS, 2011, GASTROENTEROLOGY, V141, P536, DOI 10.1053/j.gastro.2011.04.003; Olesen SS, 2010, CLIN GASTROENTEROL H, V8, P724, DOI 10.1016/j.cgh.2010.03.005; Olesen SS, 2012, REGIONAL ANESTHESIA; Pasricha PJ, 2012, NAT REV GASTRO HEPAT, V9, P140, DOI 10.1038/nrgastro.2011.274; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Rojas J, 2009, INVEST OPHTH VIS SCI, V50, P2384, DOI 10.1167/iovs.08-2670; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Stacey BR, 2008, J PAIN, V9, P1006, DOI 10.1016/j.jpain.2008.05.014; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vranken JH, 2008, PAIN, V136, P150, DOI 10.1016/j.pain.2007.06.033; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021	37	77	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57963	10.1371/journal.pone.0057963	http://dx.doi.org/10.1371/journal.pone.0057963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469256	Green Published, gold			2022-12-27	WOS:000315897100053
J	Adair, BD; Xiong, JP; Alonso, JL; Hyman, BT; Arnaout, MA				Adair, Brian D.; Xiong, Jian-Ping; Alonso, Jose Luis; Hyman, Bradley T.; Arnaout, M. Amin			EM Structure of the Ectodomain of Integrin CD11b/CD18 and Localization of Its Ligand-Binding Site Relative to the Plasma Membrane	PLOS ONE			English	Article							DEPENDENT ADHESION SITE; CRYSTAL-STRUCTURE; A-DOMAIN; CONFORMATIONAL-CHANGES; EXTRACELLULAR SEGMENT; I-DOMAIN; ACTIVATION; ALPHA(IIB)BETA(3); ALPHA-V-BETA-3; RECEPTOR	One-half of the integrin alpha-subunit Propeller domains contain and extra vWFA domain (alpha A domain), which mediates integrin binding to extracellular physiologic ligands via its metal-ion-dependent adhesion site (MIDAS). We used electron microscopy to determine the 3D structure of the alpha A-containing ectodomain of the leukocyte integrin CD11b/CD18 (alpha M beta 2) in its inactive state. A well defined density for alpha A was observed within a bent ectodomain conformation, while the structure of the ectodomain in complex with the Fab fragment of mAb107, which binds at the MIDAS face of CD11b and stabilizes the inactive state, further revealed that alpha A is restricted to a relatively small range of orientations relative to the Propeller domain. Using Fab 107 as probe in fluorescent lifetime imaging microscopy (FLIM) revealed that alpha A is positioned relatively far from the membrane surface in the inactive state, and a systematic orientation search revealed that the MIDAS face would be accessible to extracellular ligand in the inactive state of the full-length cellular integrin. These studies are the first to define the 3D EM structure of an alpha A-containing integrin ectodomain and to position the ligand-binding face of alpha A domain in relation to the plasma membrane, providing new insights into current models of integrin activation.	[Adair, Brian D.; Xiong, Jian-Ping; Arnaout, M. Amin] Massachusetts Gen Hosp, Struct Biol Program, Charlestown, MA USA; [Adair, Brian D.; Xiong, Jian-Ping; Alonso, Jose Luis; Hyman, Bradley T.; Arnaout, M. Amin] Harvard Univ, Sch Med, Charlestown, MA USA; [Alonso, Jose Luis; Arnaout, M. Amin] Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Charlestown, MA USA; [Hyman, Bradley T.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Hyman, Bradley T.] Massachusetts Gen Hosp, Inst Neurodegenerat Dis, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Struct Biol Program, Charlestown, MA USA.	aarnaout1@partners.org	Alonso, José Luis/ABF-5483-2021		National Institutes of Health [DK48549, DK50305, DK068253]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050305, R01DK048549, K01DK068253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants DK48549, DK50305 and DK068253 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Calzada MJ, 2002, J BIOL CHEM, V277, P39899, DOI 10.1074/jbc.M205886200; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Coutinho A, 2007, BIOPHYS CHEM, V130, P76, DOI 10.1016/j.bpc.2007.07.007; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gupta V, 2007, BLOOD, V109, P3513, DOI 10.1182/blood-2005-11-056689; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kendall T, 2011, J BIOL CHEM, V286, P30981, DOI 10.1074/jbc.M111.254797; Lau TL, 2009, EMBO J; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 2002, J IMMUNOL, V168, P1219, DOI 10.4049/jimmunol.168.3.1219; Mahalingam B, 2011, J IMMUNOL, V187, P6393, DOI 10.4049/jimmunol.1102394; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Peter K, 1998, BLOOD, V92, P3240, DOI 10.1182/blood.V92.9.3240.421k21_3240_3249; Rocco M, 2008, STRUCTURE, V16, P954, DOI 10.1016/j.str.2008.02.019; San Sebastian E, 2006, J AM CHEM SOC, V128, P3554, DOI 10.1021/ja054142a; Schwarz M, 2004, J PHARMACOL EXP THER, V308, P1002, DOI 10.1124/jpet.103.058883; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Stewart MP, 1996, J IMMUNOL, V156, P1810; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	46	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57951	10.1371/journal.pone.0057951	http://dx.doi.org/10.1371/journal.pone.0057951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469114	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900209
J	Chanclon, B; Luque, RM; Cordoba-Chacon, J; Gahete, MD; Pozo-Salas, AI; Castano, JP; Gracia-Navarro, F; Martinez-Fuentes, AJ				Chanclon, Belen; Luque, Raul M.; Cordoba-Chacon, Jose; Gahete, Manuel D.; Pozo-Salas, Ana I.; Castano, Justo P.; Gracia-Navarro, Francisco; Martinez-Fuentes, Antonio J.			Role of Endogenous Cortistatin in the Regulation of Ghrelin System Expression at Pancreatic Level under Normal and Obese Conditions	PLOS ONE			English	Article							O-ACYLTRANSFERASE; BETA-CELLS; ACYLATED PEPTIDE; INSULIN-RELEASE; GENE; IDENTIFICATION; SOMATOSTATIN; RECEPTOR; ACTH; RATS	Ghrelin-system components [native ghrelin, In1-ghrelin, Ghrelin-O-acyltransferase enzyme (GOAT) and receptors (GHS-Rs)] are expressed in a wide variety of tissues, including the pancreas, where they exert different biological actions including regulation of neuroendocrine secretions, food intake and pancreatic function. The expression of ghrelin system is regulated by metabolic conditions (fasting/obesity) and is associated with the progression of obesity and insulin resistance. Cortistatin (CORT), a neuropeptide able to activate GHS-R, has emerged as an additional link in gut-brain interplay. Indeed, we recently reported that male CORT deficient mice (cort-/-) are insulin-resistant and present a clear dysregulation in the stomach ghrelin-system. The present work was focused at analyzing the expression pattern of ghrelin-system components at pancreas level in cort-/- mice and their control littermates (cort+/+) under low- or high-fat diet. Our data reveal that all the ghrelin-system components are expressed at the mouse pancreatic level, where, interestingly, In1-ghrelin was expressed at higher levels than native-ghrelin. Thus, GOAT mRNA levels were significantly lower in cort-/- mice compared with controls while native ghrelin, In1-ghrelin and GHS- R transcript levels remained unaltered under normal metabolic conditions. Moreover, under obese condition, a significant increase in pancreatic expression of native-ghrelin, In1-ghrelin and GHS- R was observed in obese cort+/+ but not in cort-/- mice. Interestingly, insulin expression and release was elevated in obese cort+/+, while these changes were not observed in obese cort-/- mice. Altogether, our results indicate that the ghrelin-system expression is clearly regulated in the pancreas of cort+/+ and cort-/- under normal and/or obesity conditions suggesting that this system may play relevant roles in the endocrine pancreas. Most importantly, our data demonstrate, for the first time, that endogenous CORT is essential for the obesity-induced changes in insulin expression/secretion observed in mice, suggesting that CORT is a key regulatory component of the pancreatic function.	[Martinez-Fuentes, Antonio J.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; CIBER Fisiopatol Obesidad & Nutr, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Martinez-Fuentes, AJ (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain.	bc2mafua@uco.es	Castaño, Justo P/A-7124-2010; Gahete, Manuel D./C-4969-2009; Cordoba-Chacon, Jose/AAH-5753-2019; Martinez-Fuentes, Antonio J/F-8198-2016; Raul, Luque Huertas/M-6948-2018	Castaño, Justo P/0000-0002-3145-7287; Gahete, Manuel D./0000-0002-4578-2179; Cordoba-Chacon, Jose/0000-0001-8787-2706; Chanclon Garcia, Belen/0000-0001-7170-9699; Luque, Raul M./0000-0002-7585-1913; Gracia Navarro, Francisco/0000-0003-2128-4228	Fundacion Alfonso Martin Escudero; Sara Borrell Grant Program [CD11/00276]; Ministerio de Educacion y Ciencia e Innovacion [RYC-2007-00186, BFU2007-60180-BFI, BFU2008-01136/BFI, BFU2010-19300]; Junta de Andalucia [BIO-0139/CTS-5051]	Fundacion Alfonso Martin Escudero; Sara Borrell Grant Program; Ministerio de Educacion y Ciencia e Innovacion(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by Fundacion Alfonso Martin Escudero (to JCC), Sara Borrell Grant Program (CD11/00276 to MDG), Ministerio de Educacion y Ciencia e Innovacion: RYC-2007-00186, BFU2007-60180-BFI, BFU2008-01136/BFI, BFU2010-19300 and Junta de Andalucia BIO-0139/CTS-5051 (RML; JPC; FGN; AJMF). CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WJ, 2010, CELL PHYSIOL BIOCHEM, V26, P707, DOI 10.1159/000322338; Bando M, 2012, AM J PHYSIOL-ENDOC M, V302, pE403, DOI 10.1152/ajpendo.00341.2011; Broglio F, 2008, MOL CELL ENDOCRINOL, V286, P123, DOI 10.1016/j.mce.2007.12.012; Cordoba-Chacon J, 2011, ENDOCRINOLOGY, V152, P4800, DOI 10.1210/en.2011-1542; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Favaro E, 2012, DIABETOLOGIA, V55, P1058, DOI 10.1007/s00125-011-2423-y; Gahete MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023302; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Granata R, 2012, FASEB J; Granata R, 2010, J MOL ENDOCRINOL, V45, P107, DOI 10.1677/JME-10-0019; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Kineman RD, 2007, J MOL ENDOCRINOL, V38, P511, DOI 10.1677/JME-06-0026; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Luque RM, 2006, AM J PHYSIOL-ENDOC M, V291, pE395, DOI 10.1152/ajpendo.00038.2006; Luque RM, 2007, ENDOCRINOLOGY, V148, P5998, DOI 10.1210/en.2007-0946; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Sakata I, 2009, AM J PHYSIOL-ENDOC M, V297, pE134, DOI 10.1152/ajpendo.90859.2008; Seim I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-298; Seim I, 2011, MOL CELL ENDOCRINOL, V340, P3, DOI 10.1016/j.mce.2011.05.002; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Ueberberg B, 2009, HORM METAB RES, V41, P814, DOI 10.1055/s-0029-1233462; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veldhuis JD, 2010, INT J PEPT, V2010; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	35	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57834	10.1371/journal.pone.0057834	http://dx.doi.org/10.1371/journal.pone.0057834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469081	gold, Green Published			2022-12-27	WOS:000315524900177
J	Frankel, LK; Sallans, L; Limbach, PA; Bricker, TM				Frankel, Laurie K.; Sallans, Larry; Limbach, Patrick A.; Bricker, Terry M.			Oxidized Amino Acid Residues in the Vicinity of Q(A) and Pheo(D1) of the Photosystem II Reaction Center: Putative Generation Sites of Reducing-Side Reactive Oxygen Species	PLOS ONE			English	Article							MASS-SPECTROMETRY; THYLAKOID MEMBRANES; EXTRINSIC PROTEINS; CRYSTAL-STRUCTURE; SINGLET OXYGEN; EPR; ELECTROPHORESIS; IDENTIFICATION; RESOLUTION; ELONGATUS	Under a variety of stress conditions, Photosystem II produces reactive oxygen species on both the reducing and oxidizing sides of the photosystem. A number of different sites including the Mn4O5Ca cluster, P-680, Pheo(D1), Q(A), Q(B) and cytochrome b(559) have been hypothesized to produce reactive oxygen species in the photosystem. In this communication using Fourier-transform ion cyclotron resonance mass spectrometry we have identified several residues on the D1 and D2 proteins from spinach which are oxidatively modified and in close proximity to Q(A) (D1 residues F-239, (241)Q, E-242 and the D2 residues P-238, T-239, E-242 and M-247) and Pheo(D1) (D1 residues E-130, L-133 and F-135). These residues may be associated with reactive oxygen species exit pathways located on the reducing side of the photosystem, and their modification may indicate that both Q(A) and Pheo(D1) are sources of reactive oxygen species on the reducing side of Photosystem II.	[Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA; [Sallans, Larry; Limbach, Patrick A.] Univ Cincinnati, Dept Chem, Rieveschl Labs Mass Spectrometry, Cincinnati, OH 45221 USA	Louisiana State University System; Louisiana State University; University of Cincinnati	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA.	btbric@lsu.edu	Limbach, Patrick/A-9188-2009	Limbach, Patrick/0000-0003-1526-4546	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-98ER20310]; National Institutes of Health [RR019900, GM58843]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM058843, R01GM058843] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-FG02-98ER20310 to T.M.B and L.K.F., which supported the protein chemistry aspects and data analysis for this manuscript, and the National Institutes of Health Grants RR019900 and GM58843 to P.A.L., which supported the mass spectrometry experiments of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANYEV G, 1994, PHOTOSYNTH RES, V41, P327, DOI 10.1007/BF00019410; Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; Bricker TM, 1998, PHOTOSYNTH RES, V56, P157, DOI 10.1023/A:1006068615220; BRICKER TM, 1996, OXYGENIC PHOTOSYNTHE, P113; CALHOUN DB, 1983, BIOCHEMISTRY-US, V22, P1526, DOI 10.1021/bi00276a002; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; Dorlet P, 2001, J BIOL CHEM, V276, P22313, DOI 10.1074/jbc.M102475200; Dreaden TM, 2011, J BIOL CHEM, V286, P22632, DOI 10.1074/jbc.M110.212928; DURRANT JR, 1990, BIOCHIM BIOPHYS ACTA, V1017, P167, DOI 10.1016/0005-2728(90)90148-W; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frankel LK, 2012, BIOCHEMISTRY-US, V51, P6371, DOI 10.1021/bi300650n; Furman OS, 2010, ENVIRON SCI TECHNOL, V44, P6423, DOI 10.1021/es1013714; GHANOTAKIS DF, 1983, FEBS LETT, V153, P231, DOI 10.1016/0014-5793(83)80154-9; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HIDEG E, 1994, PHOTOSYNTH RES, V39, P191, DOI 10.1007/BF00029386; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kasson TMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042220; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Kruk J, 1999, PHOTOSYNTH RES, V62, P273, DOI 10.1023/A:1006374319191; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Liu K, 2004, PHOTOSYNTH RES, V81, P41, DOI 10.1023/B:PRES.0000028340.44043.6c; *LLC, SOFTW PYMOL MOL GRAP; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; Merry SAP, 1998, BIOCHEMISTRY-US, V37, P17439, DOI 10.1021/bi980502d; Nakamura T, 2004, PROTEOMICS, V4, P2558, DOI 10.1002/pmic.200300812; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; RABILLOUD T, 1995, ELECTROPHORESIS, V16, P1414, DOI 10.1002/elps.11501601234; Renzone Giovanni, 2007, Current Proteomics, V4, P1; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2010, BIOCHEMISTRY-US, V49, P36, DOI 10.1021/bi9017818; Sander J, 2010, J BIOL CHEM, V285, P29851, DOI 10.1074/jbc.M110.127142; Schey KL, 2000, ACCOUNTS CHEM RES, V33, P299, DOI 10.1021/ar9800744; Schoneich C, 2006, FREE RADICAL BIO MED, V41, P1507, DOI 10.1016/j.freeradbiomed.2006.08.013; Sharma J, 1997, J BIOL CHEM, V272, P33158, DOI 10.1074/jbc.272.52.33158; Sharma J, 1997, J BIOL CHEM, V272, P33153, DOI 10.1074/jbc.272.52.33153; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Sun G, 2004, ELECTROPHORESIS, V25, P959, DOI 10.1002/elps.200305800; SUNDBY C, 1993, J BIOL CHEM, V268, P25476; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Whitmarsh J., 1996, OXYGENIC PHOTOSYNTHE, P249, DOI 10.1007/0-306-48127-8_13; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yamashita A, 2008, J BIOL CHEM, V283, P28380, DOI 10.1074/jbc.M710465200; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	54	22	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58042	10.1371/journal.pone.0058042	http://dx.doi.org/10.1371/journal.pone.0058042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469138	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900229
J	Kasai, A; Sano, T; Harada, T				Kasai, Atsushi; Sano, Teruo; Harada, Takeo			Scion on a Stock Producing siRNAs of Potato Spindle Tuber Viroid (PSTVd) Attenuates Accumulation of the Viroid	PLOS ONE			English	Article							GRAFT TRANSMISSION; MESSENGER-RNA; GENE-EXPRESSION; DEGRADATION; PROTEIN; INFECTION; PREVENTS; ORGANS	Plants can attenuate the replication of plant viruses and viroids by RNA silencing induced by virus and viroid infection. In higher plants, silencing signals such as small interfering RNAs (siRNAs) produced by RNA silencing can be transported systemically through phloem, so it is anticipated that antiviral siRNA signals produced in a stock would have the potential to attenuate propagation of viruses or viroids in the scion. To test whether this is indeed the case, we prepared transgenic tobacco (Nicotiana benthamiana) expressing a hairpin RNA (hpRNA) of Potato spindle tuber viroid (PSTVd) in companion cells by using a strong companion cell-specific promoter. A grafting experiment of the wild type tobacco scion on the top of the transgenic tobacco stock revealed that accumulation of PSTVd challenge-inoculated into the scion was apparently attenuated compared to the control grafted plants. These results indicate that genetically modified rootstock expressing viroid-specific siRNAs can attenuate viroid accumulation in a non-genetically modified scion grafted on the stock.	[Kasai, Atsushi; Sano, Teruo; Harada, Takeo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan	Hirosaki University	Harada, T (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan.	tharada@cc.hirosaki-u.ac.jp			Japan Science and Technology Agency; Hirosaki University	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Hirosaki University	This work was supported by the Adaptable and Seamless Technology Transfer Program through target-derived R&D of the Japan Science and Technology Agency, and by a Grant for Institutional Research at Hirosaki University. The funders of this works had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMA K, 1992, PLANT CELL REP, V12, P7, DOI 10.1007/BF00232413; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Carbonell A, 2008, VIROLOGY, V371, P44, DOI 10.1016/j.virol.2007.09.031; Crete P, 2001, PLANT J, V28, P493, DOI 10.1046/j.1365-313X.2001.01171.x; Csorba T, 2010, PLANT J, V62, P463, DOI 10.1111/j.1365-313X.2010.04163.x; Di Serio F, 2011, VIRUS TAXONOMY; Di Serio F, 2010, J VIROL, V84, P2477, DOI 10.1128/JVI.02336-09; Diermann N, 2010, BIOL CHEM, V391, P1379, DOI 10.1515/BC.2010.148; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Gomez G, 2007, PLANT J, V51, P1041, DOI 10.1111/j.1365-313X.2007.03203.x; Haque AKMN, 2007, GENE, V396, P321, DOI 10.1016/j.gene.2007.04.003; Harada T, 2010, SCI HORTIC-AMSTERDAM, V125, P545, DOI 10.1016/j.scienta.2010.05.013; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Itaya A, 2001, MOL PLANT MICROBE IN, V14, P1332, DOI 10.1094/MPMI.2001.14.11.1332; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Kalantidis K, 2007, J VIROL, V81, P12872, DOI 10.1128/JVI.00974-07; Kasai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016895; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Martinez de Alba AE, 2003, J VIROL, V77, P9685, DOI 10.1128/JVI.77.17.9685-9694.2003; Matsuda Y, 2002, PROTOPLASMA, V220, P51, DOI 10.1007/s00709-002-0027-6; Navarro B, 2012, PLANT J, V70, P991, DOI 10.1111/j.1365-313X.2012.04940.x; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; SANO T, 1992, P NATL ACAD SCI USA, V89, P10104, DOI 10.1073/pnas.89.21.10104; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Schwind N, 2009, MOL PLANT PATHOL, V10, P459, DOI [10.1111/j.1364-3703.2009.00546.x, 10.1111/J.1364-3703.2009.00546.X]; Shaharuddin NA, 2006, FEBS LETT, V580, P6579, DOI 10.1016/j.febslet.2006.11.005; Sonoda S, 2000, PLANT J, V21, P1, DOI 10.1046/j.1365-313x.2000.00645.x; TANAKA A, 1990, NUCLEIC ACIDS RES, V18, P6767, DOI 10.1093/nar/18.23.6767; Tournier B, 2006, PLANT J, V47, P383, DOI 10.1111/j.1365-313X.2006.02796.x; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Wang Y, 2011, VIROLOGY, V413, P72, DOI 10.1016/j.virol.2011.01.021; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614	38	31	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57736	10.1371/journal.pone.0057736	http://dx.doi.org/10.1371/journal.pone.0057736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469061	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900159
J	Araujo, SBL; Rorato, AC; Perez, DM; Pie, MR				Lino Araujo, Sabrina Borges; Rorato, Ana C.; Perez, Daniela M.; Pie, Marcio R.			A Spatially Explicit Model of Synchronization in Fiddler Crab Waving Displays	PLOS ONE			English	Article							COUPLED LOGISTIC MAP; REPRODUCTIVE-CYCLES; POPULATION-DYNAMICS; VISUAL CONTROL; FEMALE CHOICE; COURTSHIP; EVOLUTION; BRACHYURA; SIGNAL; HETEROGENEITY	Fiddler crabs (Uca spp., Decapoda: Ocypodidae) are commonly found forming large aggregations in intertidal zones, where they perform rhythmic waving displays with their greatly enlarged claws. While performing these displays, fiddler crabs often synchronize their behavior with neighboring males, forming the only known synchronized visual courtship displays involving reflected light and moving body parts. Despite being one of the most conspicuous aspects of fiddler crab behavior, little is known about the mechanisms underlying synchronization of male displays. In this study we develop a spatially explicit model of fiddler crab waving displays using coupled logistic map equations. We explored two alternative models in which males either direct their attention at random angles or preferentially toward neighbors. Our results indicate that synchronization is possible over a fairly large region of parameter space. Moreover, our model was capable of generating local synchronization neighborhoods, as commonly observed in fiddler crabs under natural conditions.	[Lino Araujo, Sabrina Borges; Rorato, Ana C.; Pie, Marcio R.] Univ Fed Parana, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil; [Rorato, Ana C.; Perez, Daniela M.; Pie, Marcio R.] Univ Fed Parana, Lab Dinam Evolut & Sistemas Complexos, Dept Zool, BR-80060000 Curitiba, Parana, Brazil; [Perez, Daniela M.; Pie, Marcio R.] Univ Fed Parana, Programa Posgrad Zool, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana	Araujo, SBL (corresponding author), Univ Fed Parana, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil.	araujosbl@gmail.com	Pie, Marcio/B-7684-2008; Araujo, Sabrina Borges Lino/I-9274-2012	Araujo, Sabrina Borges Lino/0000-0002-8759-8310; Rorato Vitor, Ana Claudia/0000-0002-1532-2016; M. Perez, Daniela/0000-0002-8560-0368	CAPES [0004428/2010]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SBLA thanks CAPES for PRODOC No 0004428/2010 grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Aizawa N, 1998, MAR BIOL, V131, P523, DOI 10.1007/s002270050344; Allen BJ, 2007, FUNCT ECOL, V21, P154, DOI 10.1111/j.1365-2435.2006.01219.x; Anteneodo C, 2006, PHYSICA D, V223, P270, DOI 10.1016/j.physd.2006.10.001; Araujo SBL, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.022903; Araujo SBL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061908; Backwell P, 1998, NATURE, V391, P31, DOI 10.1038/34076; Backwell P, 2006, ACTA ETHOL, V9, P22, DOI 10.1007/s10211-005-0009-8; Backwell PRY, 1999, ETHOLOGY, V105, P415, DOI 10.1046/j.1439-0310.1999.00387.x; Bascompte J., 1998, MODELING SPATIOTEMPO; BUCK J, 1978, AM NAT, V112, P471, DOI 10.1086/283291; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; CHRISTY JH, 1984, BIOL REV, V59, P483, DOI 10.1111/j.1469-185X.1984.tb00412.x; CHRISTY JH, 1978, SCIENCE, V199, P453, DOI 10.1126/science.199.4327.453; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; DOHERTY JA, 1982, ANIM BEHAV, V30, P352, DOI 10.1016/S0003-3472(82)80046-8; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; GORDON H. R. S., 1958, ANIMAL BEHAVIOUR, V6, P238, DOI 10.1016/0003-3472(58)90057-5; Greenfield MD, 1997, P ROY SOC B-BIOL SCI, V264, P1355, DOI 10.1098/rspb.1997.0188; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; GREENFIELD MD, 1993, NATURE, V364, P618, DOI 10.1038/364618a0; GREENFIELD MD, 1994, AM ZOOL, V34, P605; GYLLENBERG M, 1993, MATH BIOSCI, V118, P25, DOI 10.1016/0025-5564(93)90032-6; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Hemmi JM, 2003, NATURE, V421, P160, DOI 10.1038/nature01247; How MJ, 2009, J COMP PHYSIOL A, V195, P55, DOI 10.1007/s00359-008-0382-7; Kendall BE, 1998, THEOR POPUL BIOL, V54, P11, DOI 10.1006/tpbi.1998.1365; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Knell RJ, 2004, P ROY SOC B-BIOL SCI, V271, P523, DOI 10.1098/rspb.2003.2641; LAND M, 1995, J COMP PHYSIOL A, V177, P91, DOI 10.1007/BF00243401; LAND M, 1995, J COMP PHYSIOL A, V177, P81, DOI 10.1007/BF00243400; LANGDON JW, 1985, MAR BEHAV PHYSIOL, V11, P315, DOI 10.1080/10236248509387056; Layne JE, 1998, J EXP BIOL, V201, P2253; LLOYD AL, 1995, J THEOR BIOL, V173, P217, DOI 10.1006/jtbi.1995.0058; Matsumasa M, 2005, ANIM BEHAV, V69, P569, DOI 10.1016/j.anbehav.2004.06.017; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Milner RNC, 2012, BIOL LETTERS, V8, P176, DOI 10.1098/rsbl.2011.0926; Milner RNC, 2010, BIOL LETTERS, V6, P755, DOI 10.1098/rsbl.2010.0384; Murai M, 2006, BEHAV ECOL SOCIOBIOL, V60, P736, DOI 10.1007/s00265-006-0217-x; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Neda Z, 2000, PHYS REV E, V61, P6987, DOI 10.1103/PhysRevE.61.6987; Ott E., 1993, CHAOS DYNAMICAL SYST; Perez DM, 2012, BIOL J LINN SOC, V106, P307, DOI 10.1111/j.1095-8312.2012.01860.x; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Pope Denise S., 2005, P252, DOI 10.1017/CBO9780511610363.016; Pope DS, 2000, BEHAV ECOL SOCIOBIOL, V47, P432, DOI 10.1007/s002650050687; Reaney LT, 2008, CURR BIOL, V18, pR62, DOI 10.1016/j.cub.2007.11.047; Rosenberg MS, 2002, BIOL J LINN SOC, V75, P147, DOI 10.1046/j.1095-8312.2002.00012.x; Rosenberg MS, 2001, J CRUSTACEAN BIOL, V21, P839, DOI 10.1651/0278-0372(2001)021[0839:TSATOF]2.0.CO;2; SALMON M, 1978, Z TIERPSYCHOL, V48, P251; SALMON M, 1968, AM ZOOL, V8, P623; Smolka J, 2009, J EXP BIOL, V212, P3522, DOI 10.1242/jeb.032359; Sole R, 2000, SIGNS LIFE COMPLEXIT; Strogatz S.H., 2003, SYNC EMERGING SCI SP; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Viscido SV, 2002, ANIM BEHAV, V63, P735, DOI 10.1006/anbe.2001.1935; Zeil J, 2006, J COMP PHYSIOL A, V192, P1, DOI 10.1007/s00359-005-0048-7; Zeil J, 1997, VISION RES, V37, P3417, DOI 10.1016/S0042-6989(97)00106-5; Zeil J, 2001, J EXP BIOL, V204, P2561; ZEIL J, 1986, J COMP PHYSIOL A, V159, P801, DOI 10.1007/BF00603733; Zeil J, 1996, J EXP BIOL, V199, P1569; Zhang QB, 2003, OIKOS, V102, P146, DOI 10.1034/j.1600-0706.2003.12169.x; ZUCKER N, 1978, BIOL BULL, V155, P410, DOI 10.2307/1540961	67	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57362	10.1371/journal.pone.0057362	http://dx.doi.org/10.1371/journal.pone.0057362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483905	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100022
J	Bayet-Robert, M; Morvan, D				Bayet-Robert, Mathilde; Morvan, Daniel			Metabolomics Reveals Metabolic Targets and Biphasic Responses in Breast Cancer Cells Treated by Curcumin Alone and in Association with Docetaxel	PLOS ONE			English	Article							DIETARY CURCUMIN; INDUCED APOPTOSIS; DNA-DAMAGE; KAPPA-B; PHASE-I; GLUTATHIONE; SPECTROSCOPY; EXPRESSION; MECHANISM; ACID	Background: Curcumin (CUR) has deserved extensive research due to its anti-inflammatory properties, of interest in human diseases including cancer. However, pleiotropic even paradoxical responses of tumor cells have been reported, and the mechanisms of action of CUR remain uncompletely elucidated. Methodology/Principal Findings: H-1-NMR spectroscopy-based metabolomics was applied to get novel insight into responses of MCF7 and MDA-MB-231 breast cancer cells to CUR alone, and MCF7 cells to CUR in cotreatment with docetaxel (DTX). In both cell types, a major target of CUR was glutathione metabolism. Total glutathione (GSx) increased at low dose CUR (<= 10 mg.l(-1) -28 mu M-) (up to + 121% in MCF7 cells, P < 0.01, and + 138% in MDA-MB-231 cells, P < 0.01), but decreased at high dose (>= 25 mg.l(-1) 70 mu M-) (-49%, in MCF7 cells, P < 0.02, and -56% in MDA-MB-231 cells, P < 0.025). At high dose, in both cell types, GSx-related metabolites decreased, including homocystein, creatine and taurine (-60 to -80%, all, P < 0.05). Together with glutathione-S-transferase actvity, data established that GSx biosynthesis was upregulated at low dose, and GSx consumption activated at high dose. Another major target, in both cell types, was lipid metabolism involving, at high doses, accumulation of polyunsaturated and total free fatty acids (between x4.5 and x11, P < 0.025), and decrease of glycerophospho-ethanolamine and -choline (about -60%, P < 0.025). Multivariate statistical analyses showed a metabolic transition, even a biphasic behavior of some metabolites including GSx, between low and high doses. In addition, CUR at 10 mg.l(-1) in cotreatment with DTX induced modifications in glutathione metabolism, lipid metabolism, and glucose utilization. Some of these changes were biphasic depending on the duration of exposure to CUR. Conclusions/Significance: Metabolomics reveals major metabolic targets of CUR in breast cancer cells, and biphasic responses that challenge the widely accepted beneficial effects of the phytochemical.	[Bayet-Robert, Mathilde; Morvan, Daniel] Univ Auvergne UDA, F-63001 Clermont Ferrand, France; [Morvan, Daniel] Comprehens Canc Ctr Jean Perrin, F-63011 Clermont Ferrand, France	UNICANCER; Centre Jean Perrin	Bayet-Robert, M (corresponding author), Univ Auvergne UDA, 49 Blvd Francois Mitterrand, F-63001 Clermont Ferrand, France.	Mathilde.BAYET-ROBERT@wanadoo.fr; Daniel.MORVAN@udamail.fr						Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Banerjee M, 2010, FEBS J, V277, P3437, DOI 10.1111/j.1742-4658.2010.07750.x; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Bayet-Robert M, 2010, BIOCHEM PHARMACOL, V80, P1170, DOI 10.1016/j.bcp.2010.07.007; Bayet-Robert M, 2010, MAGN RESON MED, V63, P1172, DOI 10.1002/mrm.22303; Bayet-Robert M, 2010, CANCER BIOL THER, V9, P8, DOI 10.4161/cbt.9.1.10392; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Birringer M, 2011, PHARM RES-DORDR, V28, P2680, DOI 10.1007/s11095-011-0551-1; Biswas SK, 2005, ANTIOXID REDOX SIGN, V7, P32, DOI 10.1089/ars.2005.7.32; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Cao J, 2006, TOXICOL SCI, V91, P476, DOI 10.1093/toxsci/kfj153; Chan WH, 2005, ANN NY ACAD SCI, V1042, P372, DOI 10.1196/annals.1338.057; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Dorai T, 2001, PROSTATE, V47, P293, DOI 10.1002/pros.1074; Erlank H, 2011, FREE RADICAL BIO MED, V51, P2319, DOI 10.1016/j.freeradbiomed.2011.09.033; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j; Garg R, 2008, CARCINOGENESIS, V29, P1022, DOI 10.1093/carcin/bgn064; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Hayeshi R, 2007, FOOD CHEM TOXICOL, V45, P286, DOI 10.1016/j.fct.2006.07.027; Hininger I, 2004, MUTAT RES-GEN TOX EN, V558, P75, DOI 10.1016/j.mrgentox.2003.11.004; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; HUANG MT, 1994, CANCER RES, V54, P5841; Hurd TR, 2012, J BIOL CHEM, V287, P35153, DOI 10.1074/jbc.M112.400002; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Karunagaran D, 2005, CURR CANCER DRUG TAR, V5, P117, DOI 10.2174/1568009053202081; Kim AN, 2010, FREE RADICAL BIO MED, V49, P323, DOI 10.1016/j.freeradbiomed.2010.04.015; Kuhad A, 2007, J AGR FOOD CHEM, V55, P10150, DOI 10.1021/jf0723965; LAVOIE S, 2009, J NEUROCHEM, V108, P1410, DOI DOI 10.1111/j.1471-4159.2009.05908.x; Lee YK, 2009, ANN NY ACAD SCI, V1171, P489, DOI 10.1111/j.1749-6632.2009.04699.x; Massimi M, 2012, BBA-GEN SUBJECTS, V1820, P1, DOI 10.1016/j.bbagen.2011.10.005; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; Shao ZM, 2002, INT J CANCER, V98, P234, DOI 10.1002/ijc.10183; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Somasundaram S, 2002, CANCER RES, V62, P3868; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Tan GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027683; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	45	46	48	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57971	10.1371/journal.pone.0057971	http://dx.doi.org/10.1371/journal.pone.0057971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472124	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900067
J	Fu, RH; Wang, YC; Liu, SP; Chu, CL; Tsai, RT; Ho, YC; Chang, WL; Chiu, SC; Harn, HJ; Shyu, WC; Lin, SZ				Fu, Ru-Huei; Wang, Yu-Chi; Liu, Shih-Ping; Chu, Ching-Liang; Tsai, Rong-Tzong; Ho, Yu-Chen; Chang, Wen-Lin; Chiu, Shao-Chih; Harn, Horng-Jyh; Shyu, Woei-Cherng; Lin, Shinn-Zong			Acetylcorynoline Impairs the Maturation of Mouse Bone Marrow-Derived Dendritic Cells via Suppression of I kappa B Kinase and Mitogen-Activated Protein Kinase Activities	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; GENE-EXPRESSION; HERBAL MEDICINE; LPS; SURVIVAL; BIOLOGY; ENDOCYTOSIS; INDUCTION; ALKALOIDS; CCR7	Background: Dendritic cells (DCs) are major modulators in the immune system. One active field of research is the manipulation of DCs as pharmacological targets to screen novel biological modifiers for the treatment of inflammatory and autoimmune disorders. Acetylcorynoline is the major alkaloid component derived from Corydalis bungeana herbs. We assessed the capability of acetylcorynoline to regulate lipopolysaccharide (LPS)-stimulated activation of mouse bone marrow-derived DCs. Methodology/Principal Findings: Our experimental data showed that treatment with up to 20 mu M acetylcorynoline does not cause cytotoxicity in cells. Acetylcorynoline significantly inhibited the secretion of tumor necrosis factor-alpha, interleukin-6, and interleukin-12p70 by LPS-stimulated DCs. The expression of LPS-induced major histocompatibility complex class II, CD40, and CD86 on DCs was also decreased by acetylcorynoline, and the endocytic capacity of LPS-stimulated DCs was restored by acetylcorynoline. In addition, LPS-stimulated DC-elicited allogeneic T-cell proliferation was blocked by acetylcorynoline, and the migratory ability of LPS-stimulated DCs was reduced by acetylcorynoline. Moreover, acetylcorynoline significantly inhibits LPS-induced activation of IkB kinase and mitogen-activated protein kinase. Importantly, administration of acetylcorynoline significantly attenuates 2,4-dinitro-1-fluorobenzene-induced delayed-type hypersensitivity. Conclusions/Significance: Acetylcorynoline may be one of the potent immunosuppressive agents through the blockage of DC maturation and function.	[Fu, Ru-Huei; Ho, Yu-Chen; Chang, Wen-Lin; Chiu, Shao-Chih; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Fu, Ru-Huei; Liu, Shih-Ping; Chiu, Shao-Chih; Harn, Horng-Jyh; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Wang, Yu-Chi] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Liu, Shih-Ping] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chu, Ching-Liang] Natl Taiwan Univ, Grad Inst Immunol, Taipei 10764, Taiwan; [Tsai, Rong-Tzong] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Yunlin, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Industrial Technology Research Institute - Taiwan; China Medical University Taiwan; National Taiwan University; Chung Shan Medical University; China Medical University Taiwan	Fu, RH (corresponding author), China Med Univ, Grad Inst Immunol, Taichung, Taiwan.	rhfu@mail.cmu.edu.tw; shinnzong@yahoo.com.tw	Lin, Shinn-Zong/AAX-2379-2020	Chu, Ching-Liang/0000-0002-8463-526X; Fu, Ru-Huei/0000-0001-9367-1759; Liu, Shih-Ping/0000-0002-5803-4460	National Science Council (Taiwan) [NSC 98-2320-B-039-043-MY2]; China Medical University [CMU98-CT-31]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Taiwan Department of Health Clinical Trial and Research Center of Excellence	This work was supported in part by the National Science Council (Taiwan) (NSC 98-2320-B-039-043-MY2), China Medical University (CMU98-CT-31), and the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 1999, J IMMUNOL, V163, P5786; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Chen YW, 2007, INT IMMUNOPHARMACOL, V7, P1102, DOI 10.1016/j.intimp.2007.04.007; Chen Y, 2010, PLANTA MED, V76, P1424, DOI 10.1055/s-0029-1240909; deLuca LS, 2012, NAT REV IMMUNOL, V12, P339, DOI 10.1038/nri3193; Fang F, 2010, J IMMUNOL, V184, P6084, DOI 10.4049/jimmunol.0902561; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fu RH, 2013, J SCI FOOD AGR, V93, P76, DOI 10.1002/jsfa.5733; Fu RH, 2011, BIOTECHNOL LETT, V33, P903, DOI 10.1007/s10529-011-0528-5; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gommerman JL, 2011, IMMUNOL REV, V244, P85, DOI 10.1111/j.1600-065X.2011.01056.x; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Huang RY, 2010, J IMMUNOL, V184, P6815, DOI 10.4049/jimmunol.0903991; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Kim JS, 2005, IMMUNOLOGY, V115, P375, DOI 10.1111/j.1365-2567.2005.02156.x; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li CY, 2011, J CELL PHYSIOL, V226, P2338, DOI 10.1002/jcp.22576; Lin MK, 2011, IMMUNOBIOLOGY, V216, P1103, DOI 10.1016/j.imbio.2011.05.002; Liu C, 2011, INT J BIOL SCI, V7, P168, DOI 10.7150/ijbs.7.168; Liu Y, 2007, TRANSPLANTATION, V84, P1517, DOI 10.1097/01.tp.0000289990.55668.0d; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mitsui S, 2010, J PHARMACOL EXP THER, V333, P954, DOI 10.1124/jpet.109.162305; Murakami M, 2011, CURR OPIN RHEUMATOL, V23, P273, DOI 10.1097/BOR.0b013e3283456797; Nhiem NX, 2011, ARCH PHARM RES, V34, P1593, DOI 10.1007/s12272-011-1002-6; Niu LL, 2011, J SEP SCI, V34, P987, DOI 10.1002/jssc.201000785; Nouri-Shirazi M, 2003, IMMUNOLOGY, V109, P365, DOI 10.1046/j.1365-2567.2003.01655.x; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Thobe BM, 2007, J CELL PHYSIOL, V210, P667, DOI 10.1002/jcp.20860; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uto T, 2011, INT IMMUNOPHARMACOL, V11, P1932, DOI 10.1016/j.intimp.2011.08.003; Wei H. L., 1997, Yaoxue Xuebao, V32, P331; Xie C, 2004, PHYTOCHEMISTRY, V65, P3041, DOI 10.1016/j.phytochem.2004.09.009; Yoon MS, 2006, MOL PHARMACOL, V70, P1033, DOI 10.1124/mol.106.024547; Yu QG, 2004, J IMMUNOL, V172, P6047, DOI 10.4049/jimmunol.172.10.6047; Yu YL, 2009, EUR J IMMUNOL, V39, P2482, DOI 10.1002/eji.200839039	42	21	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58398	10.1371/journal.pone.0058398	http://dx.doi.org/10.1371/journal.pone.0058398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472193	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900139
J	Hu, H; Gao, J; He, J; Yu, B; Zheng, P; Huang, ZQ; Mao, XB; Yu, J; Han, GQ; Chen, DW				Hu, Hong; Gao, Jie; He, Jun; Yu, Bing; Zheng, Ping; Huang, Zhiqing; Mao, Xiangbing; Yu, Jie; Han, Guoquan; Chen, Daiwen			Codon Optimization Significantly Improves the Expression Level of a Keratinase Gene in Pichia pastoris	PLOS ONE			English	Article							BACILLUS-LICHENIFORMIS; ESCHERICHIA-COLI; KERA GENE; YEAST; PROTEIN; SEQUENCE; FERMENTATION; PURIFICATION; CHICKENS; PROMOTER	The main keratinase (kerA) gene from the Bacillus licheniformis S90 was optimized by two codon optimization strategies and expressed in Pichia pastoris in order to improve the enzyme production compared to the preparations with the native kerA gene. The results showed that the corresponding mutations (synonymous codons) according to the codon bias in Pichia pastoris were successfully introduced into keratinase gene. The highest keratinase activity produced by P. pastoris pPICZ alpha A-kerAwt, pPICZ alpha A-kerAopti1 and pPICZ alpha A-kerAopti2 was 195 U/ml, 324 U/ml and 293 U/ml respectively. In addition, there was no significant difference in biomass concentration, target gene copy numbers and relative mRNA expression levels of every positive strain. The molecular weight of keratinase secreted by recombinant P. pastori was approx. 39 kDa. It was optimally active at pH 7.5 and 50 degrees C. The recombinant keratinase could efficiently degrade both alpha-keratin (keratin azure) and beta-keratin (chicken feather meal). These properties make the P. pastoris pPICZ alpha A-kerAopti1 a suitable candidate for industrial production of keratinases.	[Hu, Hong; Gao, Jie; He, Jun; Yu, Bing; Zheng, Ping; Huang, Zhiqing; Mao, Xiangbing; Yu, Jie; Han, Guoquan; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University	Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	dwchen@sicau.edu.cn			Feed Biotechnology Project of Sichuan Province of China [2010GZ0193]	Feed Biotechnology Project of Sichuan Province of China	This research was granted by Feed Biotechnology Project of Sichuan Province of China with grant number 2010GZ0193. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON SGE, 1991, MOL BIOL EVOL, V8, P530; Bai JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022577; Boettner M, 2007, J BIOTECHNOL, V130, P1, DOI 10.1016/j.jbiotec.2007.02.019; [陈惠 Chen Hui], 2005, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V21, P171; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Hu H, 2013, BIOTECHNOL LETT, V35, P239, DOI 10.1007/s10529-012-1064-7; Hu XY, 1996, PROTEIN EXPRES PURIF, V7, P289, DOI 10.1006/prep.1996.0041; Huang H, 2008, APPL MICROBIOL BIOT, V78, P95, DOI 10.1007/s00253-007-1290-4; Jia HY, 2012, J MOL CATAL B-ENZYM, V78, P72, DOI 10.1016/j.molcatb.2012.02.009; Kublanov IV, 2009, APPL ENVIRON MICROB, V75, P286, DOI 10.1128/AEM.00607-08; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; Li K, 2012, VACCINE, V30, P2273, DOI 10.1016/j.vaccine.2012.01.075; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; LIN XA, 1995, APPL ENVIRON MICROB, V61, P1469, DOI 10.1128/AEM.61.4.1469-1474.1995; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Macedo AJ, 2005, APPL ENVIRON MICROB, V71, P594, DOI 10.1128/AEM.71.1.594-596.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porres JM, 2002, BIOTECHNOL LETT, V24, P631, DOI 10.1023/A:1015083007746; Potvin G, 2012, BIOCHEM ENG J, V64, P91, DOI 10.1016/j.bej.2010.07.017; Radha S, 2007, J APPL MICROBIOL, V103, P1301, DOI 10.1111/j.1365-2672.2007.03372.x; Radha S, 2009, PROTEIN EXPRES PURIF, V64, P24, DOI 10.1016/j.pep.2008.10.008; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Son HJ, 2008, BIOTECHNOL LETT, V30, P461, DOI 10.1007/s10529-007-9567-3; SPANJAARD RA, 1988, P NATL ACAD SCI USA, V85, P7967, DOI 10.1073/pnas.85.21.7967; Stark CR, 2009, J APPL POULTRY RES, V18, P30, DOI 10.3382/japr.2008-00038; Wang JJ, 2006, J APPL POULTRY RES, V15, P544, DOI 10.1093/japr/15.4.544; Waterham HR, 1997, GENE, V186, P37, DOI 10.1016/S0378-1119(96)00675-0; WILLIAMS CM, 1990, APPL ENVIRON MICROB, V56, P1509, DOI 10.1128/AEM.56.6.1509-1515.1990; Yao B, 1998, SCI CHINA SER C, V28, P237; ZHANG SP, 1991, GENE, V105, P61, DOI 10.1016/0378-1119(91)90514-C; Zhu T, 2009, J APPL MICROBIOL, V107, P954, DOI 10.1111/j.1365-2672.2009.04279.x	38	50	57	6	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58393	10.1371/journal.pone.0058393	http://dx.doi.org/10.1371/journal.pone.0058393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472192	Green Submitted, Green Published, gold			2022-12-27	WOS:000315637900138
J	Ely, CR; Hall, JS; Schmutz, JA; Pearce, JM; Terenzi, J; Sedinger, JS; Ip, HS				Ely, Craig R.; Hall, Jeffrey S.; Schmutz, Joel A.; Pearce, John M.; Terenzi, John; Sedinger, James S.; Ip, Hon S.			Evidence that Life History Characteristics of Wild Birds Influence Infection and Exposure to Influenza A Viruses	PLOS ONE			English	Article							GEESE BRANTA-CANADENSIS; WHITE-FRONTED GEESE; AVIAN INFLUENZA; CANADA GEESE; PACIFIC FLYWAY; AQUATIC BIRDS; SURVEILLANCE; ANTIBODIES; PREVALENCE; WATERFOWL	We report on life history characteristics, temporal, and age-related effects influencing the frequency of occurrence of avian influenza (AI) viruses in four species of migratory geese breeding on the Yukon-Kuskokwim Delta, Alaska. Emperor geese (Chen canagica), cackling geese (Branta hutchinsii), greater white-fronted geese (Anser albifrons), and black brant (Branta bernicla), were all tested for active infection of AI viruses upon arrival in early May, during nesting in June, and while molting in July and August, 2006-2010 (n = 14,323). Additionally, prior exposure to AI viruses was assessed via prevalence of antibodies from sera samples collected during late summer in 2009 and 2010. Results suggest that geese are uncommonly infected by low pathogenic AI viruses while in Alaska. The percent of birds actively shedding AI viruses varied annually, and was highest in 2006 and 2010 (1-3%) and lowest in 2007, 2008, and 2009 (<0.70%). Contrary to findings in ducks, the highest incidence of infected birds was in late spring when birds first arrived from staging and wintering areas. Despite low prevalence, most geese were previously exposed to AI viruses, as indicated by high levels of seroprevalence during late summer (47%-96% across species; n = 541). Seroprevalence was >95% for emperor geese, a species that spends part of its life cycle in Asia and is endemic to Alaska and the Bering Sea region, compared to 40-60% for the other three species, whose entire life cycles are within the western hemisphere. Birds <45 days of age showed little past exposure to AI viruses, although antibodies were detected in samples from 5-week old birds in 2009. Seroprevalence of known age black brant revealed that no birds <4 years old had seroconverted, compared to 49% of birds >= 4 years of age.	[Ely, Craig R.; Schmutz, Joel A.; Pearce, John M.; Terenzi, John] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Hall, Jeffrey S.; Ip, Hon S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Sedinger, James S.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Nevada System of Higher Education (NSHE); University of Nevada Reno	Ely, CR (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA.	cely@usgs.gov		Hall, Jeffrey/0000-0001-5599-2826; Ip, Hon/0000-0003-4844-7533	U.S. Fish and Wildlife Service; U.S. Geological Survey; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700007C]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was funded by the U.S. Fish and Wildlife Service, the U.S. Geological Survey, and in part by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Contract No. HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Michael G., 1992, P365; Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Brown Justin D., 2008, V436, P85, DOI 10.1007/978-1-59745-279-3_11; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; De Marco MA, 2005, AVIAN PATHOL, V34, P480, DOI 10.1080/03079450500368185; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Dusek RJ, 2009, AVIAN DIS, V53, P222, DOI 10.1637/8462-082908-Reg.1; Ellstrom P, 2008, VACCINE, V26, P4414, DOI 10.1016/j.vaccine.2008.06.027; Ely C. R., 2008, VOGELWELT, V129, P310; Ely CR, 1996, AUK, V113, P889, DOI 10.2307/4088866; Ely Craig R., 1994, Transactions of the North American Wildlife and Natural Resources Conference, V59, P91; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fischer JB, 2011, NEST POPULATION SIZE; Flint PL, 2009, CONDOR, V111, P591, DOI 10.1525/cond.2009.090100; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Garamszegi LZ, 2007, P ROY SOC B-BIOL SCI, V274, P2003, DOI 10.1098/rspb.2007.0124; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grindstaff JL, 2008, J EXP BIOL, V211, P654, DOI 10.1242/jeb.012344; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Harris MT, 2010, J WILDLIFE DIS, V46, P981, DOI 10.7589/0090-3558-46.3.981; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hill NJ, 2010, AVIAN DIS, V54, P426, DOI 10.1637/8912-043009-Reg.1; Hoye BJ, 2012, P ROY SOC B-BIOL SCI, V279, P529, DOI 10.1098/rspb.2011.0958; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Hupp JW, 2008, ARCTIC, V61, P23; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Kistler WM, 2012, J WILDLIFE DIS, V48, P1097, DOI 10.7589/2011-02-046; Kleijn D, 2010, P ROY SOC B-BIOL SCI, V277, P2041, DOI 10.1098/rspb.2010.0026; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Kraus RHS, 2013, MOL ECOL, V22, P41, DOI 10.1111/mec.12098; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Mowbray TB, 2002, BIRDS N AM; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2006, VACCINE, V24, P6729, DOI 10.1016/j.vaccine.2006.05.060; NETTLES VF, 1985, AVIAN DIS, V29, P733, DOI 10.2307/1590665; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen M, 1980, WILD GEESE WORLD THE; Pasick J, 2009, REV SCI TECH OIE, V28, P349, DOI 10.20506/rst.28.1.1875; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Pearce JM, 2011, MOL ECOL, V20, P1015, DOI 10.1111/j.1365-294X.2010.04908.x; Poole A, 1994, BIRDS N AM, V97; Purchase HG, 1989, LAB MANUAL ISOLATION; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Reed A., 1998, BIRDS N AM; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; SAS Institute Inc, 1999, SAS STAT US GUID; Schamber JL, 2007, J FIELD ORNITHOL, V78, P74, DOI 10.1111/j.1557-9263.2006.00087.x; Siembieda JL, 2010, VECTOR-BORNE ZOONOT, V10, P793, DOI 10.1089/vbz.2009.0095; Sokal R.R., 1984, BIOMETRY; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2009, AVIAN DIS, V53, P276, DOI 10.1637/8520-111708-Reg.1; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; U.S. Avian Influenza Interagency Working Group, 2006, EARL DET SYST HIGHL; United States Geological Survey, 2007, LIST SPEC AFF H5N1 A; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Webster RG, 2007, J WILDLIFE DIS, V43, pS1; Yasue M, 2006, BIOSCIENCE, V56, P923, DOI 10.1641/0006-3568(2006)56[923:TEOHAI]2.0.CO;2; Zhou EM, 1998, AVIAN DIS, V42, P517, DOI 10.2307/1592678	77	23	24	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57614	10.1371/journal.pone.0057614	http://dx.doi.org/10.1371/journal.pone.0057614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469210	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900031
J	Matser, A; Vanhommerig, J; van der Loeff, MFS; Geskus, RB; de Vries, HJC; Prins, JM; Prins, M; Bruisten, SM				Matser, Amy; Vanhommerig, Joost; van der Loeff, Maarten F. Schim; Geskus, Ronald B.; de Vries, Henry J. C.; Prins, Jan M.; Prins, Maria; Bruisten, Sylvia M.			HIV-Infected Men Who Have Sex with Men Who Identify Themselves as Belonging to Subcultures Are at Increased Risk for Hepatitis C Infection	PLOS ONE			English	Article							POSITIVE MEN; VIRUS-INFECTION; COMMUNITY; AMSTERDAM; EPIDEMIC	Background: Hepatitis C virus (HCV) emerged as sexually transmitted infection among HIV-infected men who have sex with men (MSM). We studied whether HCV circulated in identifiable high-risk MSM subcultures and performed phylogenetic analysis. Methods: HIV-infected MSM were recruited at the sexually transmitted infections (STI) outpatient clinic and a university HIV clinic in Amsterdam, the Netherlands, 2008-2009. Participants completed a detailed questionnaire and were tested for HCV antibodies and RNA, with NS5B regions sequenced for analysis of clusters. Results: Among 786 participants, the median age was 43 (IQR 37-48) years, and 93 (11.8%) were HCV-positive. Seropositivity was associated with belonging to subcultures identified as leather (aOR 2.60; 95% CI 1.56-4.33), rubber/lycra (aOR 2.15; 95% CI 1.10-4.21), or jeans (aOR 2.23; 95% CI 1.41-3.54). The two largest HCV-RNA monophyletic clusters were compared; MSM in cluster I (genotype 1a, n = 13) reported more partners (P = 0.037) than MSM in cluster II (genotype 4d, n = 14), but demographics, subculture characteristics and other risk behaviors did not differ significantly between the two clusters. Discussion: HCV infection is associated with identifiable groups of leather/rubber/lycra/jeans subcultures among HIV-infected MSM. Separate epidemiological HCV transmission networks were not revealed. Active HCV screening and treatment within specific subcultures may reduce HCV spread among all MSM.	[Matser, Amy; Vanhommerig, Joost; van der Loeff, Maarten F. Schim; Geskus, Ronald B.; de Vries, Henry J. C.; Prins, Maria; Bruisten, Sylvia M.] Publ Hlth Serv Amsterdam, Amsterdam, Netherlands; [Matser, Amy] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Hlth Care, Utrecht, Netherlands; [Vanhommerig, Joost] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim; de Vries, Henry J. C.; Prins, Jan M.; Prins, Maria] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Bruisten, Sylvia M.] Univ Amsterdam, Dept Expt Virol, Amsterdam, Netherlands	Public Health Service Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Matser, A (corresponding author), Publ Hlth Serv Amsterdam, Amsterdam, Netherlands.	amatser@ggd.amsterdam.nl	Vanhommerig, Joost W/E-5753-2016; Prins, Jan M./AAF-4945-2020; de Vries, Henry/K-5963-2012; Geskus, Ronald B/H-3684-2019	de Vries, Henry/0000-0001-9784-547X; Geskus, Ronald B/0000-0002-2740-3155; Prins, Jan/0000-0002-5415-8933; Matser, Amy/0000-0003-4291-1905	Netherlands Organisation for Health Research (ZonMw) [125010008]; Public Health Service RD grant; AIDS foundation HIV/AIDS [2008026]	Netherlands Organisation for Health Research (ZonMw)(Netherlands Organization for Health Research and Development); Public Health Service RD grant; AIDS foundation HIV/AIDS	This study is funded by the Netherlands Organisation for Health Research (ZonMw) [grant number 125010008]. Joost Vanhommerig was supported by Public Health Service R&D grant 2011 and AIDS foundation HIV/AIDS [Grant number 2008026]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia MAM, 1996, J CLIN MICROBIOL, V34, P2665, DOI 10.1128/JCM.34.11.2665-2669.1996; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fierer DS, 2008, J INFECT DIS, V198, P683, DOI 10.1086/590430; Gambotti L, 2005, Euro Surveill, V10, P115, DOI 10.2807/esm.10.05.00535-en; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Graham M, 1998, J HOMOSEXUAL, V35, P163, DOI 10.1300/J082v35n03_07; Heiligenberg M, 2012, SEX TRANSM DIS, V39, P8, DOI 10.1097/OLQ.0b013e3182354e81; Heymans R, 2012, J INFECT DIS, V206, P596, DOI 10.1093/infdis/jis399; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; Moser CM, 2006, J HOMOSEXUAL, V50, P90; Moskowitz DA, 2011, AIDS BEHAV, V15, P557, DOI 10.1007/s10461-009-9636-9; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; R Development Core Team, 2012, R LANG ENV STAT COMP; Serpaggi J, 2006, AIDS, V20, P233, DOI 10.1097/01.aids.0000200541.40633.56; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson EC, 2009, AIDS, V23, P89, DOI 10.1097/QAD.0b013e32831940a3; Turner JM, 2006, SEX TRANSM INFECT, V82, P298, DOI 10.1136/sti.2005.018366; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2011, SEX TRANSM DIS, V38, P102, DOI 10.1097/OLQ.0b013e3181ec9de5; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; van Rooijen MS, 2012, PREVALENCE INCIDENCE; VANLIESHOUT M, 1995, J HOMOSEXUAL, V29, P19, DOI 10.1300/J082v29n01_02	33	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57740	10.1371/journal.pone.0057740	http://dx.doi.org/10.1371/journal.pone.0057740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099PY	23469226	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900039
J	Leymarie, O; Jouvion, G; Herve, PL; Chevalier, C; Lorin, V; Lecardonnel, J; Da Costa, B; Delmas, B; Escriou, N; Le Goffic, R				Leymarie, Olivier; Jouvion, Gregory; Herve, Pierre-Louis; Chevalier, Christophe; Lorin, Valerie; Lecardonnel, Jerome; Da Costa, Bruno; Delmas, Bernard; Escriou, Nicolas; Le Goffic, Ronan			Kinetic Characterization of PB1-F2-Mediated Immunopathology during Highly Pathogenic Avian H5N1 Influenza Virus Infection	PLOS ONE			English	Article							A VIRUS; PB1-F2 PROTEIN; PANDEMIC INFLUENZA; MITOCHONDRIAL-MEMBRANE; HIGH VIRULENCE; HOST IMMUNE; RESPONSES; IDENTIFICATION; HEMAGGLUTININ; CONTRIBUTES	The PB1-F2 protein encoded by influenza A viruses can contribute to virulence, a feature that is dependent of its sequence polymorphism. Whereas PB1-F2 from some H1N1 viruses were shown to exacerbate the inflammatory response within the airways, the contribution of PB1-F2 to highly pathogenic avian influenza virus (HPAIV) virulence in mammals remains poorly described. Using a H5N1 HPAIV strain isolated from duck and its PB1-F2 knocked-out mutant, we characterized the dynamics of PB1-F2-associated host response in a murine model of lethal pneumonia. The mean time of death was 10 days for the two viruses, allowing us to perform global transcriptomic analyses and detailed histological investigations of the infected lungs at multiple time points. At day 2 post-infection (pi), while no histopathological lesion was observed, PB1-F2 expression resulted in a significant inhibition of cellular pathways involved in macrophage activation and in a transcriptomic signature suggesting that it promotes damage to the epithelial barrier. At day 4 pi, the gene profile associated with PB1-F2 expression revealed dysfunctions in NK cells activity. At day 8 pi, PB1-F2 expression was strongly associated with increased transcription of genes encoding chemokines and cytokines implicated in the recruitment of granulocytes, as well as expression of a number of genes encoding enzymes expressed by neutrophils. These transcriptomic data were fully supported by the histopathological analysis of the mice lungs which evidenced more severe inflammatory lesions and enhanced recruitment of neutrophils in the context of PB1-F2 expression, and thus provided a functional corroboration to the insight obtained in this work. In summary, our study shows that PB1-F2 of H5N1 HPAIV markedly influences the expression of the host transcriptome in a different way than its H1N1 counterparts: H5N1 PB1-F2 first delays the initial immune response but increases the pulmonary inflammatory response during the late stages of infection.	[Leymarie, Olivier; Chevalier, Christophe; Da Costa, Bruno; Delmas, Bernard; Le Goffic, Ronan] INRA, Domaine Vilvert, Unite Virol & Immunol Mol, UR 892, Jouy En Josas, France; [Jouvion, Gregory] Inst Pasteur, Dept Infect & Epidemiol, Unite Histopathol Humaine & Modeles Anim, Paris, France; [Herve, Pierre-Louis; Lorin, Valerie; Escriou, Nicolas] Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, Paris, France; [Herve, Pierre-Louis; Lorin, Valerie; Escriou, Nicolas] CNRS, URA30I5, Paris, France; [Herve, Pierre-Louis; Lorin, Valerie; Escriou, Nicolas] Univ Paris Diderot, EA 302, Paris, France; [Lecardonnel, Jerome] INRA, CRB GADIE, Domaine Vilvert, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Escriou, N (corresponding author), Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, Paris, France.	nicolas.escriou@pasteur.fr; ronan.legoffic@jouy.inra.fr	LE GOFFIC, Ronan/B-7649-2008; Escriou, Nicolas/A-2392-2016; LE GOFFIC, Ronan/M-3099-2019; Chevalier, Christophe/C-2575-2009; Jouvion, Grégory/AAL-2620-2021; Chevalier, Christophe/AAK-4461-2020; Chevalier, Christophe/AAW-5560-2020; Hervé, Pierre-Louis/M-9935-2017	LE GOFFIC, Ronan/0000-0002-2012-0064; Escriou, Nicolas/0000-0002-1224-6839; LE GOFFIC, Ronan/0000-0002-2012-0064; Chevalier, Christophe/0000-0003-3231-9027; Hervé, Pierre-Louis/0000-0002-6015-4154; Leymarie, Olivier/0000-0001-8670-3089	Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'') [dim100157]; "DIM Malinf'' doctoral fellowships awarded by the "Conseil regional d'Ile-de-France''	Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'')(Region Ile-de-France); "DIM Malinf'' doctoral fellowships awarded by the "Conseil regional d'Ile-de-France''	This work was funded by the Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'', Grant#: dim100157). OL and PLH were supported by "DIM Malinf'' doctoral fellowships awarded by the "Conseil regional d'Ile-de-France''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Dudek SE, 2011, BIOL CHEM, V392, P1135, DOI [10.1515/BC-2011-174, 10.1515/BC.2011.174]; Fragiadaki M, 2011, MOL BIOL CELL, V22, P1836, DOI 10.1091/mbc.E10-08-0669; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Guo HL, 2011, J LEUKOCYTE BIOL, V89, P189, DOI 10.1189/jlb.0610319; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Henkel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011112; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ivan FX, 2012, FUNCT INTEGR GENOMIC, V12, P105, DOI 10.1007/s10142-011-0247-y; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Marjuki H, 2010, ARCH VIROL, V155, P925, DOI 10.1007/s00705-010-0666-4; Mazur I, 2008, CELL MICROBIOL; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Meunier I, 2012, J VIROL, V86, P4271, DOI 10.1128/JVI.07243-11; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Pena L, 2012, J VIROL; Pope SM, 2005, J BIOL CHEM, V280, P13952, DOI 10.1074/jbc.M406037200; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, VIRULENCE, V2, P542, DOI 10.4161/viru.2.6.17812; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wilson CB, 2008, J IMMUNOL, V181, P2303, DOI 10.4049/jimmunol.181.4.2303; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	53	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57894	10.1371/journal.pone.0057894	http://dx.doi.org/10.1371/journal.pone.0057894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469251	Green Published, Green Submitted, gold			2022-12-27	WOS:000315897100048
J	Zhang, F; Xu, X; Zhang, Y; Zhou, B; He, ZS; Zhai, QW				Zhang, Fang; Xu, Xiang; Zhang, Yi; Zhou, Ben; He, Zhishui; Zhai, Qiwei			Gene Expression Profile Analysis of Type 2 Diabetic Mouse Liver	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; BLOOD-GLUCOSE; OBESITY; INFLAMMATION; METABOLISM; PATHOGENESIS; NETWORK; CANCER; RATS	Liver plays a key role in glucose metabolism and homeostasis, and impaired hepatic glucose metabolism contributes to the development of type 2 diabetes. However, the precise gene expression profile of diabetic liver and its association with diabetes and related diseases are yet to be further elucidated. In this study, we detected the gene expression profile by high-throughput sequencing in 9-week-old normal and type 2 diabetic db/db mouse liver. Totally 12132 genes were detected, and 2627 genes were significantly changed in diabetic mouse liver. Biological process analysis showed that the upregulated genes in diabetic mouse liver were mainly enriched in metabolic processes. Surprisingly, the downregulated genes in diabetic mouse liver were mainly enriched in immune-related processes, although all the altered genes were still mainly enriched in metabolic processes. Similarly, KEGG pathway analysis showed that metabolic pathways were the major pathways altered in diabetic mouse liver, and downregulated genes were enriched in immune and cancer pathways. Analysis of the key enzyme genes in fatty acid and glucose metabolism showed that some key enzyme genes were significantly increased and none of the detected key enzyme genes were decreased. In addition, FunDo analysis showed that liver cancer and hepatitis were most likely to be associated with diabetes. Taken together, this study provides the digital gene expression profile of diabetic mouse liver, and demonstrates the main diabetes-associated hepatic biological processes, pathways, key enzyme genes in fatty acid and glucose metabolism and potential hepatic diseases.	[Zhang, Fang; Xu, Xiang; Zhang, Yi; Zhou, Ben; He, Zhishui; Zhai, Qiwei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhai, QW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	qwzhai@sibs.ac.cn	Zhou, Ben/R-9844-2019; Zhou, Ben/AAB-5808-2020; Zhou, Ben/G-1850-2017	Zhou, Ben/0000-0001-7177-2882; Zhou, Ben/0000-0001-7177-2882; Zhai, Qiwei/0000-0002-9617-7403; Zhang, Fang/0000-0002-7000-554X	National Natural Science Foundation of China [30825009, 30970619, 31030022, 31200591, 81021002]; National Basic Research Program of China (973 Program) [2009CB918403]; Program of Shanghai Subject Chief Scientist [11XD1405800]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-09]; Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2011KIP511]; SA-SIBS Scholarship Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program of Shanghai Subject Chief Scientist; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; SA-SIBS Scholarship Program	This study was supported by grants from National Natural Science Foundation of China (30825009, 30970619, 31030022, 31200591 and 81021002), National Basic Research Program of China (973 Program, 2009CB918403), Program of Shanghai Subject Chief Scientist (11XD1405800), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-09), Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2011KIP511), and SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Agius L, 2010, MINI-REV MED CHEM, V10, P1175, DOI 10.2174/1389557511009011175; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Demir M, 2008, EUR J GASTROEN HEPAT, V20, P668, DOI 10.1097/MEG.0b013e3282f55e1e; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhahbi Joseph M, 2003, Diabetes Technol Ther, V5, P411, DOI 10.1089/152091503765691910; DUNAWAY GA, 1978, J BIOL CHEM, V253, P7460; Ender, 2010, COLLIN ADO COLLINEAR; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; FOLEY JE, 1992, DIABETES CARE, V15, P773, DOI 10.2337/diacare.15.6.773; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liaskou E, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/949157; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marzban L, 2002, ENDOCRINOLOGY, V143, P4636, DOI 10.1210/en.2002-220732; Matschinsky FM, 2006, DIABETES, V55, P1; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; McCormack JG, 2001, CURR PHARM DESIGN, V7, P1451, DOI 10.2174/1381612013397393; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Neyrinck AM, 2009, BIOCHEM BIOPH RES CO, V385, P351, DOI 10.1016/j.bbrc.2009.05.070; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; RABITZSCH G, 1995, CLIN CHEM, V41, P966; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sangiorgio L, 2000, DIABETES RES CLIN PR, V48, P147, DOI 10.1016/S0168-8227(99)00135-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Soverini V, 2011, ACTA DIABETOL, V48, P337, DOI 10.1007/s00592-011-0293-x; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Suh YH, 2005, J MOL ENDOCRINOL, V34, P299, DOI 10.1677/jme.1.01679; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; van Lunteren E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007832; van Poelje PD, 2007, CURR OPIN DRUG DISC, V10, P430; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yang G, 2010, INT J IMPOT RES, V22, P310, DOI 10.1038/ijir.2010.21; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou HR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S16	69	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57766	10.1371/journal.pone.0057766	http://dx.doi.org/10.1371/journal.pone.0057766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469233	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100038
J	Dufour, S; Lavertu, G; Dufour-Beausejour, S; Juneau-Fecteau, A; Calakos, N; Deschenes, M; Vallee, R; De Koninck, Y				Dufour, Suzie; Lavertu, Guillaume; Dufour-Beausejour, Sophie; Juneau-Fecteau, Alexandre; Calakos, Nicole; Deschenes, Martin; Vallee, Real; De Koninck, Yves			A Multimodal Micro-Optrode Combining Field and Single Unit Recording, Multispectral Detection and Photolabeling Capabilities	PLOS ONE			English	Article							NEURONS	Microelectrodes have been very instrumental and minimally invasive for in vivo functional studies from deep brain structures. However they are limited in the amount of information they provide. Here, we describe a, aluminum-coated, fibre optic-based glass microprobe with multiple electrical and optical detection capabilities while retaining tip dimensions that enable single cell measurements (diameter <= 10 mu m). The probe enables optical separation from individual cells in transgenic mice expressing multiple fluorescent proteins in distinct populations of neurons within the same deep brain nucleus. It also enables color conversion of photoswitchable fluorescent proteins, which can be used for post-hoc identification of the recorded cells. While metal coating did not significantly improve the optical separation capabilities of the microprobe, the combination of metal on the outside of the probe and of a hollow core within the fiber yields a microelectrode enabling simultaneous single unit and population field potential recordings. The extended range of functionalities provided by the same microprobe thus opens several avenues for multidimensional structural and functional interrogation of single cells and their surrounding deep within the intact nervous system.	[Dufour, Suzie; Lavertu, Guillaume; Dufour-Beausejour, Sophie; Juneau-Fecteau, Alexandre; Deschenes, Martin; De Koninck, Yves] Inst Univ Sante Mentale Quebec, Unite Neurosci Cellulaires & Mol, Quebec City, PQ, Canada; [Dufour, Suzie; Vallee, Real; De Koninck, Yves] Univ Laval, Ctr Opt Photon & Laser, Quebec City, PQ G1K 7P4, Canada; [Dufour, Suzie; Lavertu, Guillaume; Dufour-Beausejour, Sophie; Juneau-Fecteau, Alexandre; Deschenes, Martin; De Koninck, Yves] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Calakos, Nicole] Duke Univ, Med Ctr, Ctr Translat Neurosci, Durham, NC USA	Laval University; Laval University; Laval University; Duke University	De Koninck, Y (corresponding author), Inst Univ Sante Mentale Quebec, Unite Neurosci Cellulaires & Mol, Quebec City, PQ, Canada.	yves.dekoninck@crulrg.ulaval.ca	Vallee, Real/ABD-1571-2021; Juneau-Fecteau, Alexandre/AAT-3820-2020; De Koninck, Yves/C-2659-2008	Juneau-Fecteau, Alexandre/0000-0002-0517-5278; De Koninck, Yves/0000-0002-5779-9330; Vallee, Real/0000-0002-8437-2463; Dufour-Beausejour, Sophie/0000-0003-4236-3566	Canadian Institutes for Health Research [MOP 12942]; CIHR (Canadian Institutes of Health Research); NINDS (National Institute of Neurological Disorders and Stroke) [NS054840, NS064577]; Tourette Syndrome Association, NARSAD (National Alliance for Research in Schizophrenia and Affective Disorders); Klingenstein Fund; Chercheur National of the Fonds de la recherche en sante du Quebec (FRSQ); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064577, K02NS054840] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); NINDS (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Tourette Syndrome Association, NARSAD (National Alliance for Research in Schizophrenia and Affective Disorders); Klingenstein Fund(Klingenstein Philanthropies); Chercheur National of the Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Canadian Institutes for Health Research grant MOP 12942 to Y.D.K. Y.D.K. was a Chercheur National of the Fonds de la recherche en sante du Quebec (FRSQ). Y.L., A.J.F, S. D. B and S. D. were the recipients of a Studentship from the CIHR (Canadian Institutes of Health Research) Neurophysics Training program grant. N.C. was supported by grants from NINDS (National Institute of Neurological Disorders and Stroke) (NS054840, NS064577, and American Recovery and Reinvestment Act supplement), Tourette Syndrome Association, NARSAD (National Alliance for Research in Schizophrenia and Affective Disorders), and The Klingenstein Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazelot M, 2010, J PHYSIOL-LONDON, V588, P2077, DOI 10.1113/jphysiol.2009.185918; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; LeChasseur Y, 2011, NAT METHODS, V8, P319, DOI 10.1038/NMETH.1572; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; ROBINSON DA, 1968, PR INST ELECTR ELECT, V56, P1065, DOI 10.1109/PROC.1968.6458; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sheeba JH, 2008, BIOPHYS J, V95, P2722, DOI 10.1529/biophysj.108.134635; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Zhang ZW, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00021	15	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57703	10.1371/journal.pone.0057703	http://dx.doi.org/10.1371/journal.pone.0057703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469053	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900152
J	Ooms, M; Letko, M; Binka, M; Simon, V				Ooms, Marcel; Letko, Michael; Binka, Mawuena; Simon, Viviana			The Resistance of Human APOBEC3H to HIV-1 NL4-3 Molecular Clone Is Determined by a Single Amino Acid in Vif	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTIDINE DEAMINASE APOBEC3H; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; VARIANTS; PROTEIN; LOCALIZATION; EVOLUTION; INFECTION; DNA	Some human APOBEC3 cytidine deaminases have antiviral activity against HIV-1 and other retroviruses. The single deaminase domain APOBEC3H (A3H) enzyme is highly polymorphic and multiple A3H haplotypes have been identified. A3H haplotype II (A3H-hapII) possesses the strongest activity against HIV-1. There remains, however, uncertainty regarding the extent to which A3H-hapII is sensitive to HIV-1 Vif mediated degradation. We tested, therefore, the two different reference Vif proteins widely used in previous studies. We show that A3H-hapII is resistant to NL4-3 Vif while it is efficiently degraded by LAI Vif. Co-immunoprecipitation assays demonstrate that LAI Vif, but not NL4-3 Vif associates with A3H-hapII. Chimeras between NL4-3 and LAI Vif identify the amino acid responsible for the differential degradation activity: A histidine at position 48 in Vif confers activity against A3H-hapII, while an asparagine abolishes its anti-A3H activity. Furthermore, the amino acid identity at position 48 only affects the degradation of A3H-hapII, whereas recognition of and activity against human A3D, A3F and A3G are only minimally affected. NL4-3 encoding 48H replicates better than NL4-3 WT (48N) in T cell-lines stably expressing A3H hapII, whereas there is no fitness difference in the absence of APOBEC3. These studies provide an explanation for the conflicting reports regarding A3H resistance to Vif mediated degradation.	[Ooms, Marcel; Letko, Michael; Binka, Mawuena; Simon, Viviana] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Simon, Viviana] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Simon, Viviana] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Simon, V (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	viviana.simon@mssm.edu	simon, viviana/A-9131-2008	simon, viviana/0000-0002-6416-5096; Binka, Mawuena/0000-0002-9370-1708; Ooms, Marcel/0000-0002-0750-5832	NIH [R01 AI089246, AI064001, T32A107647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089246, R01AI064001] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by NIH grants R01 AI089246 and AI064001 (VS) as well as a Public Health Service Institutional Research Training Award T32A107647 (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Binka M, 2012, J VIROL, V86, P49, DOI 10.1128/JVI.06082-11; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; GONCALVES J, 1994, J VIROL, V68, P704, DOI 10.1128/JVI.68.2.704-712.1994; Gourraud PA, 2011, HUM IMMUNOL, V72, P207, DOI 10.1016/j.humimm.2010.12.008; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Li MMH, 2010, J VIROL, V84, P88, DOI 10.1128/JVI.01344-09; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Ooms M, 2010, J VIROL, V84, P7961, DOI 10.1128/JVI.00754-10; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; Wang XJ, 2011, J VIROL, V85, P3142, DOI 10.1128/JVI.02049-10; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09; Zhou T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-31	30	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57744	10.1371/journal.pone.0057744	http://dx.doi.org/10.1371/journal.pone.0057744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469063	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900161
J	Yu, RJ; Hsieh, MH; Wang, HLS; Liu, CM; Liu, CC; Hwang, TJ; Chien, YL; Hwu, HG; Tseng, WYI				Yu, Rongjun; Hsieh, Ming H.; Wang, Hsiao-Lan Sharon; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Chien, Yi-Ling; Hwu, Hai-Gwo; Tseng, Wen-Yih Isaac			Frequency Dependent Alterations in Regional Homogeneity of Baseline Brain Activity in Schizophrenia	PLOS ONE			English	Article							RESTING-STATE FMRI; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; PREFRONTAL CORTEX; BOLD SIGNAL; PHYSIOLOGICAL CONDITION; VOLUME REDUCTION; WORKING-MEMORY; HYPOFRONTALITY	Low frequency oscillations are essential in cognitive function impairment in schizophrenia. While functional connectivity can reveal the synchronization between distant brain regions, the regional abnormalities in task-independent baseline brain activity are less clear, especially in specific frequency bands. Here, we used a regional homogeneity (ReHo) method combined with resting-state functional magnetic resonance imaging to investigate low frequency spontaneous neural activity in the three different frequency bands (slow-5: 0.01-0.027 Hz; slow-4: 0.027-0.08 Hz; and typical band: 0.01-0.08 Hz) in 69 patients with schizophrenia and 62 healthy controls. Compared with controls, schizophrenia patients exhibited decreased ReHo in the precentral gyrus, middle occipital gyrus, and posterior insula, whereas increased ReHo in the medial prefrontal cortex and anterior insula. Significant differences in ReHo between the two bands were found in fusiform gyrus and superior frontal gyrus (slow-4> slow-5), and in basal ganglia, parahippocampus, and dorsal middle prefrontal gyrus (slow-5> slow-4). Importantly, we identified significant interaction between frequency bands and groups in the inferior occipital gyrus and caudate body. This study demonstrates that ReHo changes in schizophrenia are widespread and frequency dependent.	[Yu, Rongjun] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Hsieh, Ming H.; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Chien, Yi-Ling; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Hsieh, Ming H.; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Chien, Yi-Ling; Hwu, Hai-Gwo] Coll Med, Taipei, Taiwan; [Hsieh, Ming H.; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Chien, Yi-Ling; Hwu, Hai-Gwo] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Wang, Hsiao-Lan Sharon; Tseng, Wen-Yih Isaac] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan; [Hwu, Hai-Gwo; Tseng, Wen-Yih Isaac] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Tseng, Wen-Yih Isaac] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan	California Institute of Technology; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hwu, HG (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan.	haigohwu@ntu.edu.tw; wytseng@ntu.edu.tw	Hwang, TJ/K-4768-2019; Yu, Rongjun/AAV-2615-2020; Hsieh, Ming H./B-2970-2010	Yu, Rongjun/0000-0003-0123-1524; Tseng, Wen-Yih Isaac/0000-0002-2314-6868; LIU, CHIH-MIN/0000-0001-7016-8990; HWU, HAI-GWO/0000-0002-2582-2807; LIU, CHEN-CHUNG/0000-0002-9290-110X; Hsieh, Ming H./0000-0002-3585-7843; CHIEN, YI-LING/0000-0002-3477-3015; Hwang, Tzung-Jeng/0000-0001-7894-9484	National Health Research Institute, Taiwan [NHRI-EX101-10145NI]; National Science Council, Taiwan [NSC100-3112-B-002-016]; National Taiwan University [97HM00273]	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was supported in part by the National Health Research Institute, Taiwan (NHRI-EX101-10145NI), National Science Council, Taiwan (NSC100-3112-B-002-016), and National Taiwan University (97HM00273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth H, 2002, AM J PSYCHIAT, V159, P1497, DOI 10.1176/appi.ajp.159.9.1497; Bermann KF, 1998, BIOL PSYCHIAT, V43, p67S, DOI 10.1016/S0006-3223(98)90674-6; Bhugra D, 2005, PLOS MED, V2, P372, DOI 10.1371/journal.pmed.0020151; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blow N, 2008, NAT METHODS, V5, P981, DOI 10.1038/nmeth1108-981; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Brown GG, 2010, CURR TOP BEHAV NEURO, V4, P181, DOI 10.1007/7854_2010_54; BUCHSBAUM MS, 1987, AM J PSYCHIAT, V144, P122, DOI 10.1176/ajp.144.1.122; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; Cao Qing-jiu, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P261; Carter CS, 1998, AM J PSYCHIAT, V155, P1285, DOI 10.1176/ajp.155.9.1285; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Cochran S, 2005, SCHIZOPHRENIA BULL, V31, P296; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FRITH CD, 1995, BRIT J PSYCHIAT, V167, P343, DOI 10.1192/bjp.167.3.343; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; Hill KE, 2002, SCHIZOPHR RES, V53, P112; Honey GD, 2004, SCHIZOPHRENIA NEUROI, P237; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Kane JM, 1996, NEW ENGL J MED, V334, P34, DOI 10.1056/NEJM199601043340109; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Mitchell RLC, 2004, BRIT J PSYCHIAT, V184, P223, DOI 10.1192/bjp.184.3.223; Moran LV, 2011, SCHIZOPHRENIA BULL, V37, P659, DOI 10.1093/schbul/sbr056; Narr KL, 2005, BIOL PSYCHIAT, V58, P32, DOI 10.1016/j.biopsych.2005.03.043; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onitsuka T, 2007, SCHIZOPHR RES, V92, P197, DOI 10.1016/j.schres.2007.01.027; PAULMAN RG, 1990, BIOL PSYCHIAT, V27, P377, DOI 10.1016/0006-3223(90)90549-H; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Saze T, 2007, EUR ARCH PSY CLIN N, V257, P473, DOI 10.1007/s00406-007-0750-2; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sun YM, 2011, BRAIN RES, V1413, P98, DOI 10.1016/j.brainres.2011.06.065; Takahashi T, 2004, PSYCHIAT RES-NEUROIM, V131, P185, DOI 10.1016/j.pscychresns.2004.05.006; Takahashi T, 2009, SCHIZOPHR RES, V108, P49, DOI 10.1016/j.schres.2008.12.029; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI [10.1093/cercor/bhm069, 10.1093/cercor/hhm069]; Tan HY, 2006, AM J PSYCHIAT, V163, P1969, DOI 10.1176/appi.ajp.163.11.1969; TAYLOR MA, 1984, AM J PSYCHIAT, V141, P196; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Vercammen A, 2010, BIOL PSYCHIAT, V67, P912, DOI 10.1016/j.biopsych.2009.11.017; Whalley HC, 2008, J AFFECT DISORDERS, V109, P99, DOI 10.1016/j.jad.2007.11.009; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Wynn JK, 2008, PSYCHIAT RES-NEUROIM, V164, P97, DOI 10.1016/j.pscychresns.2008.01.005; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou SY, 2005, PSYCHIAT RES-NEUROIM, V139, P127, DOI 10.1016/j.pscychresns.2005.05.005; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	73	55	61	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57516	10.1371/journal.pone.0057516	http://dx.doi.org/10.1371/journal.pone.0057516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483911	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100027
J	Bartolommei, G; Moncelli, MR; Tadini-Buoninsegni, F				Bartolommei, Gianluca; Moncelli, Maria Rosa; Tadini-Buoninsegni, Francesco			A Method to Measure Hydrolytic Activity of Adenosinetriphosphatases (ATPases)	PLOS ONE			English	Article							RETICULUM CA-ATPASE; SARCOPLASMIC-RETICULUM; INORGANIC-PHOSPHATE; PUMP CYCLE; PHOSPHORUS; NA,K-ATPASE; CA2+-ATPASE; TRANSPORT; STATE; NA+,K+-ATPASE	The detection of small amounts (nanomoles) of inorganic phosphate has a great interest in biochemistry. In particular, phosphate detection is useful to evaluate the rate of hydrolysis of phosphatases, that are enzymes able to remove phosphate from their substrate by hydrolytic cleavage. The hydrolysis rate is correlated to enzyme activity, an extremely important functional parameter. Among phosphatases there are the cation transporting adenosinetriphosphatases (ATPases), that produce inorganic phosphate by cleavage of the gamma-phosphate of ATP. These membrane transporters have many fundamental physiological roles and are emerging as potential drug targets. ATPase hydrolytic activity is measured to test enzyme functionality, but it also provides useful information on possible inhibitory effects of molecules that interfere with the hydrolytic process. We have optimized a molybdenum-based protocol that makes use of potassium antimony (III) oxide tartrate (originally employed for phosphate detection in environmental analysis) to allow its use with phosphatase enzymes. In particular, the method was successfully applied to native and recombinant ATPases to demonstrate its reliability, validity, sensitivity and versatility. Our method introduces significant improvements to well-established experimental assays, which are currently employed for ATPase activity measurements. Therefore, it may be valuable in biochemical and biomedical investigations of ATPase enzymes, in combination with more specific tests, as well as in high throughput drug screening.	[Bartolommei, Gianluca; Moncelli, Maria Rosa; Tadini-Buoninsegni, Francesco] Univ Florence, Dept Chem Ugo Schiff, Sesto Fiorentino, Italy	University of Florence	Bartolommei, G (corresponding author), Univ Florence, Dept Chem Ugo Schiff, Sesto Fiorentino, Italy.	gianluca.bartolommei@unifi.it	Tadini-Buoninsegni, Francesco/CAJ-5745-2022	TADINI-BUONINSEGNI, Francesco/0000-0001-5594-2554	Ente Cassa di Risparmio di Firenze [2009.0749]; Italian Ministry of Education, University and Research [20083YM37E]	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ente Cassa di Risparmio di Firenze (2009.0749) (http://www.entecarifirenze.it) and the Italian Ministry of Education, University and Research (PRIN Project 20083YM37E) (http://hubmiur.pubblica.istruzione.it/web/ricerca/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGINSKI E S, 1975, Annals of Clinical and Laboratory Science, V5, P399; Bartolommei G, 2008, BIOPHYS J, V95, P1813, DOI 10.1529/biophysj.108.133546; Bartolommei G, 2011, J BIOL CHEM, V286, P38383, DOI 10.1074/jbc.M111.287276; Bartolommei G, 2010, BIOPHYS J, V99, P2087, DOI 10.1016/j.bpj.2010.07.050; Billington RA, 2004, BIOCHEM J, V378, P275, DOI 10.1042/BJ20031284; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; D'Angelo E, 2001, J ENVIRON QUAL, V30, P2206, DOI 10.2134/jeq2001.2206; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DRYER RL, 1957, J BIOL CHEM, V225, P177; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; ERNSTER L, 1956, Methods Biochem Anal, V3, P1; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORBUSH B, 1988, J BIOL CHEM, V263, P7961; Gemma S, 2012, J MED CHEM, V55, P10387, DOI 10.1021/jm300831b; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Jorgensen P L, 1974, Methods Enzymol, V32, P277; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan J.H., 2004, HDB ATPASES BIOCH CE, P63; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Katewa SD, 2003, ANAL BIOCHEM, V323, P180, DOI 10.1016/j.ab.2003.08.024; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lin SH, 2000, ANAL BIOCHEM, V287, P303, DOI 10.1006/abio.2000.4828; Liu YY, 2009, J MOL BIOL, V391, P858, DOI 10.1016/j.jmb.2009.06.044; LOWRY OH, 1946, J BIOL CHEM, V162, P421; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lupfert C, 2001, BIOPHYS J, V81, P2069, DOI 10.1016/S0006-3495(01)75856-0; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matula J, 2011, PLANT SOIL ENVIRON, V57, P1, DOI 10.17221/185/2010-PSE; Mesquita RBR, 2011, ANAL CHIM ACTA, V701, P15, DOI 10.1016/j.aca.2011.06.002; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Noske R, 2010, BBA-BIOENERGETICS, V1797, P1540, DOI 10.1016/j.bbabio.2010.03.021; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Osmond, 1887, B SOC CHIM FR, V47, P745; Peinelt C, 2004, BIOPHYS J, V86, P815, DOI 10.1016/S0006-3495(04)74157-0; Power MH, 1953, STANDARD METHODS CLI; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SCHWARTZ A, 1971, METHOD PHARMACOL, V1, P368; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Taylor AE, 1914, J BIOL CHEM, V18, P215; U.S. Environmental Protection Agency, 2005, STAND OP PROC PART P; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019	46	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58615	10.1371/journal.pone.0058615	http://dx.doi.org/10.1371/journal.pone.0058615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472215	Green Submitted, gold, Green Published			2022-12-27	WOS:000315637900161
J	Shali, S; Wushou, A; Liu, ET; Jia, L; Yao, RM; Su, YG; Ge, JB				Shali, Shalaimaiti; Wushou, Alimujiang; Liu, Entao; Jia, Lin; Yao, Ruiming; Su, Yangang; Ge, Junbo			Time Course of Current of Injury Is Related to Acute Stability of Active-Fixation Pacing Leads in Rabbits	PLOS ONE			English	Article							PACEMAKER; PERFORMANCE; ELECTRODES; UNIPOLAR	Background: Magnitude of current of injury (COI) consequent to pacemaker lead fixation is recognized as a predictor of acute lead stability. It is unclear whether dynamic monitoring of COI after lead fixation provides additional information beyond a single assessment performed at the time of fixation. Objectives: This study was aimed to test the hypothesis that the time course of COI is related to acute lead stability. Methods and Results: Active fixation leads with fixed screw were anchored to either Langendorff-perfused rabbit hearts endocardially or in vivo hearts epicardially in manners of contact the helix with no rotation, half rotation and full rotation, respectively. Intracardiac electrogram (EGM) was monitored dynamically from onset to resolution of COI, and magnitudes of intrinsic R wave and COI, including ST-segment elevation, ST/R and intracardiac EGM duration (IED), were measured. A digital force gauge was applied to assess lead stability. In vitro, COI in contacted leads was significantly smaller than those in half rotated (p < 0.05) and fully rotated leads (p < 0.05), and presented most precipitous recovery to baseline (1.5+/-1.1 min, p < 0.05). Half-rotated and fully rotated leads manifested the same magnitude of COI right after placement. However, the time course of COI was significantly longer in fully rotated leads than that in half rotated leads (26.5+/-2.8 min vs. 5.6+/-2.0 min, p < 0.05). Similar findings were observed in vivo. The time course of COI was significantly correlated with the force needed to detach the lead from myocardium (r = 0. 72, n = 48, p < 0.001). Conclusions: Time course of COI is related to acute lead stability in rabbits. One might be misled by a single assessment of COI magnitude right after lead placement, whereas persistence of COI is likely to be a useful indicator of adequate lead stability.	[Shali, Shalaimaiti; Yao, Ruiming; Su, Yangang; Ge, Junbo] Fudan Univ, Zhong Shan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai 200433, Peoples R China; [Wushou, Alimujiang] Xi An Jiao Tong Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Head & Neck Surg Oncol, Xian, Peoples R China; [Liu, Entao; Jia, Lin] Medtron Shanghai Co Ltd, Dept Cardiac Rhythm Dis Management, Shanghai, Peoples R China	Fudan University; Xi'an Jiaotong University	Su, YG (corresponding author), Fudan Univ, Zhong Shan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai 200433, Peoples R China.	su.yangang@zs-hospital.sh.cn; jbge@zs-hospital.sh.cn						Albouaini K, 2009, HEART, V95, P2030, DOI 10.1136/hrt.2009.171835; Avramovitch N, 2004, HEART RHYTHM, V71, P219; CHAUHAN A, 1994, PACE, V17, P2012, DOI 10.1111/j.1540-8159.1994.tb03791.x; Cheng A, 2010, J AM COLL CARDIOL, V56, P1651, DOI 10.1016/j.jacc.2010.06.037; DEBUITLEIR M, 1990, AM J CARDIOL, V65, P999, DOI 10.1016/0002-9149(90)91003-O; DECAPRIO V, 1977, CIRCULATION, V56, P750, DOI 10.1161/01.CIR.56.5.750; Efimov IR, 1997, J CARDIOVASC ELECTR, V8, P1031, DOI 10.1111/j.1540-8167.1997.tb00627.x; GROSSI EA, 1993, ANN THORAC SURG, V56, P156, DOI 10.1016/0003-4975(93)90422-E; MYERS GH, 1978, PACE, V1, P90, DOI 10.1111/j.1540-8159.1978.tb03445.x; PARSONNET V, 1979, CIRCULATION, V60, P590, DOI 10.1161/01.CIR.60.3.590; Redfearn DP, 2007, PACE, V30, P1438, DOI 10.1111/j.1540-8159.2007.00889.x; Sambelashvili AT, 2004, AM J PHYSIOL-HEART C, V286, pH2183, DOI 10.1152/ajpheart.00637.2003; Saxonhouse SJ, 2005, J AM COLL CARDIOL, V45, P412, DOI 10.1016/j.jacc.2004.10.045; VARRIALE P, 1978, PACE, V1, P335, DOI 10.1111/j.1540-8159.1978.tb03488.x; Yusu S, 2012, INT HEART J, V53, P113, DOI 10.1536/ihj.53.113	15	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57727	10.1371/journal.pone.0057727	http://dx.doi.org/10.1371/journal.pone.0057727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472103	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900042
J	Skeeles, LE; Fleming, JL; Mahler, KL; Toland, AE				Skeeles, Laura E.; Fleming, Jessica L.; Mahler, Kimberly L.; Toland, Amanda Ewart			The Impact of 3 ' UTR Variants on Differential Expression of Candidate Cancer Susceptibility Genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BINDING-SITES; WEB TOOL; GENOME; LOCI; IDENTIFICATION; PREDICTION	Variants in regulatory regions are predicted to play an important role in disease susceptibility of common diseases. Polymorphisms mapping to microRNA (miRNA) binding sites have been shown to disrupt the ability of miRNAs to target genes resulting in differential mRNA and protein expression. Skin tumor susceptibility 5 (Skts5) was identified as a locus conferring susceptibility to chemically-induced skin cancer in NIH/Ola by SPRET/Outbred F1 backcrosses. To determine if polymorphisms between the strains which mapped to putative miRNA binding sites in the 3' untranslated region (3'UTR) of genes at Skts5 influenced expression, we conducted a systematic evaluation of 3'UTRs of candidate genes across this locus. Nine genes had polymorphisms in their 3'UTRs which fit the linkage data and eight of these contained polymorphisms suspected to interfere with or introduce miRNA binding. 3'UTRs of six genes, Bcap29, Dgkb, Hbp1, Pik3cg, Twistnb, and Tspan13 differentially affected luciferase expression, but did not appear to be differentially regulated by the evaluated miRNAs predicted to bind to only one of the two isoforms. 3'UTRs from four additional genes chosen from the locus that fit less stringent criteria were evaluated. Ifrd1 and Etv1 showed differences and contained polymorphisms predicted to disrupt or create miRNA binding sites but showed no difference in regulation by the miRNAs tested. In summary, multiple 3'UTRs with putative functional variants between susceptible and resistant strains of mice influenced differential expression independent of predicted miRNA binding.	[Skeeles, Laura E.; Fleming, Jessica L.; Mahler, Kimberly L.; Toland, Amanda Ewart] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Toland, Amanda Ewart] Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Toland, AE (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	Amanda.toland@osumc.edu	Toland, Amanda Ewart/E-4202-2011	Toland, Amanda/0000-0002-0271-1792	American Cancer Society [MGO RSG-07-083]; National Cancer Institute [CA134461]; OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA134461] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part from MGO RSG-07-083 from the American Cancer Society, CA134461 from the National Cancer Institute and the OSU Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036694; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chin L, 2008, CANCER RES, V69, P5970; Emerson JJ, 2010, PHILOS T R SOC B, V365, P2581, DOI 10.1098/rstb.2010.0005; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Knight JC, 2012, J INTERN MED, V271, P379, DOI 10.1111/j.1365-2796.2011.02508.x; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Landi D, 2012, MUTAGENESIS, V27, P205, DOI 10.1093/mutage/ger055; Liu XG, 2010, THROMB RES, V126, P130, DOI 10.1016/j.thromres.2010.04.010; Mahler KL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-626; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Nagase H, 2003, CANCER RES, V63, P4849; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 2001, CANCER RES, V61, P1305; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sotiriou S, 2009, NEUROSCI LETT, V461, P196, DOI 10.1016/j.neulet.2009.06.034; Tsao D, 2011, NUCLEIC ACIDS RES, V39, P6201, DOI 10.1093/nar/gkr165	30	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58609	10.1371/journal.pone.0058609	http://dx.doi.org/10.1371/journal.pone.0058609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472213	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900159
J	van Steenbeek, FG; Spee, B; Penning, LC; Kummeling, A; van Gils, IHM; Grinwis, GCM; Van Leenen, D; Holstege, FCP; Vos-Loohuis, M; Rothuizen, J; Leegwater, PAJ				van Steenbeek, Frank G.; Spee, Bart; Penning, Louis C.; Kummeling, Anne; van Gils, Ingrid H. M.; Grinwis, Guy C. M.; Van Leenen, Dik; Holstege, Frank C. P.; Vos-Loohuis, Manon; Rothuizen, Jan; Leegwater, Peter A. J.			Altered Subcellular Localization of Heat Shock Protein 90 Is Associated with Impaired Expression of the Aryl Hydrocarbon Receptor Pathway in Dogs	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNTS; DUCTUS VENOSUS; IRISH WOLFHOUNDS; LIVER DEVELOPMENT; GENE-EXPRESSION; MOUSE; MICE; ARNT; ANGIOGENESIS; CLOSURE	The aryl hydrocarbon receptor (AHR) mediates biological responses to toxic chemicals. An unexpected role for AHR in vascularization was suggested when mice lacking AHR displayed impaired closure of the ductus venosus after birth, as did knockout mice for aryl hydrocarbon receptor interacting protein (AIP) and aryl hydrocarbon receptor nuclear translocator (ARNT). The resulting intrahepatic portosystemic shunts (IHPSS) are frequently diagnosed in specific dog breeds, such as the Irish wolfhound. We compared the expression of components of the AHR pathway in healthy Irish wolfhounds and dogs with IHPSS. To this end, we analyzed the mRNA expression in the liver of AHR, AIP, ARNT, and other genes involved in this pathway, namely, those for aryl hydrocarbon receptor nuclear translocator 2 (ARNT2), hypoxia inducible factor 1alpha (HIF1A), heat shock protein 90AA1 (HSP90AA1), cytochromes P450 (CYP1A1, CYP1A2, and CYP1B1), vascular endothelial growth factor A (VEGFA), nitric oxide synthesase 3 (NOS3), and endothelin (EDN1). The observed low expression of AHR mRNA in the Irish wolfhounds is in associated with a LINE-1 insertion in intron 2, for which these dogs were homozygous. Down regulation in Irish wolfhounds was observed for AIP, ARNT2, CYP1A2, CYP1B1 and HSP90AA1 expression, whereas the expression of HIF1A was increased. Immunohistochemistry revealed lower levels of AHR, HIF1A, and VEGFA protein in the nucleus and lower levels of ARNT and HSP90AA1 protein in the cytoplasm of the liver cells of Irish wolfhounds. The impaired expression of HSP90AA1 could trigger the observed differences in mRNA and protein levels and therefore explain the link between two very different functions of AHR: regulation of the closure of the ductus venosus and the response to toxins.	[van Steenbeek, Frank G.; Spee, Bart; Penning, Louis C.; Kummeling, Anne; van Gils, Ingrid H. M.; Vos-Loohuis, Manon; Rothuizen, Jan; Leegwater, Peter A. J.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Van Leenen, Dik; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	van Steenbeek, FG (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	f.g.vansteenbeek@uu.nl	Kummeling, Anne/GNW-3198-2022; Penning, Louis/AAC-7524-2019; Holstege, Frank/AAM-9944-2021; van Steenbeek, F.G./AFL-0046-2022; Fiumefreddo, Andrea/T-2977-2019	van Steenbeek, F.G./0000-0001-5460-6540; Leegwater, Peter/0000-0002-4100-015X; Grinwis, Guy/0000-0002-1583-9648	European Commission [LUPA-GA-201370]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was partly funded by the European Commission (LUPA-GA-201370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding has been received for this study.	Adeagbo ASO, 2004, BRIT J PHARMACOL, V142, P727, DOI 10.1038/sj.bjp.0705849; ADEAGBO ASO, 1990, J PHARMACOL EXP THER, V252, P875; Baragatti B, 2011, AM J PHYSIOL-HEART C, V300, pH892, DOI 10.1152/ajpheart.00907.2010; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Bustin S, 2012, VET J, V191, P279, DOI 10.1016/j.tvjl.2011.06.044; Court MH, 1999, CLIN TECH SMALL AN P, V14, P38, DOI 10.1016/S1096-2867(99)80025-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Jurka J, 1996, J MOL EVOL, V43, P685, DOI 10.1007/BF02202117; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; Kerr MG, 1999, VET REC, V144, P693, DOI 10.1136/vr.144.25.693; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Lamb CR, 2004, VET REC, V155, P699, DOI 10.1136/vr.155.22.699; Lin BC, 2008, MOL PHARMACOL, V74, P1367, DOI 10.1124/mol.108.047068; LOHSE CL, 1977, AM J VET RES, V38, P839; Maltepe E, 2000, BIOCHEM BIOPH RES CO, V273, P231, DOI 10.1006/bbrc.2000.2928; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maniatis T., 1982, MOL CLONING LAB MANU; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; MEYER HP, 1995, VET REC, V136, P13, DOI 10.1136/vr.136.1.13; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Nukaya M, 2009, P NATL ACAD SCI US; Peng L, 2012, DRUG METAB DISPOS, V40, P1198, DOI 10.1124/dmd.112.045088; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Sekine H, 2006, J BIOL CHEM, V281, P37507, DOI 10.1074/jbc.M606910200; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Steenbeek FG, 2009, J VET INTERN MED, V23, P950, DOI 10.1111/j.1939-1676.2009.0319.x; van Steenbeek FG, 2012, MAMM GENOME, V23, P76, DOI 10.1007/s00335-011-9364-0; VANDENINGH TSGAM, 1995, VET QUART, V17, P70, DOI 10.1080/01652176.1995.9694536; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Walisser JA, 2004, J BIOL CHEM, V279, P16326, DOI 10.1074/jbc.M400784200; Wondimu A, 2012, LAB INVEST, V92, P110, DOI 10.1038/labinvest.2011.134; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57973	10.1371/journal.pone.0057973	http://dx.doi.org/10.1371/journal.pone.0057973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472125	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900068
J	Yamashita, Y; Akatsuka, S; Shinjo, K; Yatabe, Y; Kobayashi, H; Seko, H; Kajiyama, H; Kikkawa, F; Takahashi, T; Toyokuni, S				Yamashita, Yoriko; Akatsuka, Shinya; Shinjo, Kanako; Yatabe, Yasushi; Kobayashi, Hiroharu; Seko, Hiroshi; Kajiyama, Hiroaki; Kikkawa, Fumitaka; Takahashi, Takashi; Toyokuni, Shinya			Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; C-MET; TYROSINE KINASE; POOR-PROGNOSIS; AMPLIFICATION; OVEREXPRESSION; CANCER; EXPRESSION; MUTATIONS; RECEPTOR	Clear cell adenocarcinoma of the ovary (OCC) is a chemo-resistant tumor with a relatively poor prognosis and is frequently associated with endometriosis. Although it is assumed that oxidative stress plays some role in the malignant transformation of this tumor, the characteristic molecular events leading to carcinogenesis remain unknown. In this study, an array-based comparative genomic hybridization (CGH) analysis revealed Met gene amplification in 4/13 OCC primary tumors and 2/8 OCC cell lines. Amplification of the AKT2 gene, which is a downstream component of the Met/PI3K signaling pathway, was also observed in 5/21 samples by array-based CGH analysis. In one patient, both the Met and AKT2 genes were amplified. These findings were confirmed using fluorescence in situ hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemistry. In total, 73 OCC cases were evaluated using real-time quantitative PCR; 37.0% demonstrated Met gene amplification (>4 copies), and 8.2% had AKT2 amplification. Furthermore, stage 1 and 2 patients with Met gene amplification had significantly worse survival than patients without Met gene amplification (p<0.05). Met knockdown by shRNA resulted in reduced viability of OCC cells with Met amplification due to increased apoptosis and cellular senescence, suggesting that the Met signaling pathway plays an important role in OCC carcinogenesis. Thus, we believe that targeted inhibition of the Met pathway may be a promising treatment for OCC.	[Yamashita, Yoriko; Akatsuka, Shinya; Shinjo, Kanako; Kobayashi, Hiroharu; Seko, Hiroshi; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4648601, Japan; [Yamashita, Yoriko] Nagoya City Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Shinjo, Kanako; Kobayashi, Hiroharu; Kajiyama, Hiroaki; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4648601, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan; [Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya City University; Nagoya University; Aichi Cancer Center; Nagoya University	Yamashita, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4648601, Japan.	k46581a@nucc.cc.nagoya-u.ac.jp	Takahashi, Takashi/I-7262-2014; YATABE, Yasushi/J-6461-2014; Yamashita, Yoriko/B-9810-2011; KIKKAWA, Fumitaka/I-7341-2014; Toyokuni, Shinya/ABE-7714-2021; Toyokuni, Shinya/C-1358-2010	Takahashi, Takashi/0000-0003-0615-7001; YATABE, Yasushi/0000-0003-1788-559X; Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109	Japan Society of the Promotion of Science, Tokyo, Japan; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Japan Society of the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid from the Japan Society of the Promotion of Science, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043403; Bachleitner-Hofmann T, 2008, MOL CANCER THER, V7, P3499, DOI 10.1158/1535-7163.MCT-08-0374; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Christensen JG, 2003, CANCER RES, V63, P7345; Dent J, 2003, BRIT J CANCER, V88, P1578, DOI 10.1038/sj.bjc.6600896; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HOULDSWORTH J, 1990, CANCER RES, V50, P6417; Hu Q, 2010, LAB INVEST, V90, P360, DOI 10.1038/labinvest.2009.140; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Koon EC, 2008, INT J GYNECOL CANCER, V18, P976, DOI 10.1111/j.1525-1438.2007.01135.x; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Kuo KT, 2010, CLIN CANCER RES, V16, P1997, DOI 10.1158/1078-0432.CCR-09-2105; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; LIU YP, 2007, J JISHOU UNIV, V28, P1; Lo Muzio L, 2006, TUMOR BIOL, V27, P115, DOI 10.1159/000092716; Mandai M, 2009, INT J CLIN ONCOL, V14, P383, DOI 10.1007/s10147-009-0935-y; Miller CT, 2006, ONCOGENE, V25, P409, DOI 10.1038/sj.onc.1209057; Moumen A, 2007, DEVELOPMENT, V134, P1443, DOI 10.1242/dev.02820; Nakajima M, 1999, CANCER, V85, P1894; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Nakazawa K, 2005, J PATHOL, V206, P356, DOI 10.1002/path.1779; Ogawa S, 2000, GYNECOL ONCOL, V77, P298, DOI 10.1006/gyno.2000.5765; Rahman MT, 2012, CANCER-AM CANCER SOC, V118, P2846, DOI 10.1002/cncr.26598; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Suehiro Y, 2000, ONCOLOGY-BASEL, V59, P50, DOI 10.1159/000012137; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Yamamoto S, 2012, HISTOPATHOLOGY, V60, P1073, DOI 10.1111/j.1365-2559.2011.04163.x; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70; Yamashita Y, 2006, PATHOL INT, V56, P659, DOI 10.1111/j.1440-1827.2006.02026.x; Yamashita Y, 2011, AM J CLIN PATHOL, V135, P556, DOI 10.1309/AJCPCTDC5PY3LXBP; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	43	57	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57724	10.1371/journal.pone.0057724	http://dx.doi.org/10.1371/journal.pone.0057724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469222	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900037
J	Lacorte, GA; Felix, GMF; Pinheiro, RRB; Chaves, AV; Almeida, G; Neves, FS; Leite, LO; Santos, FR; Braga, EM				Lacorte, Gustavo A.; Felix, Gabriel M. F.; Pinheiro, Rafael R. B.; Chaves, Anderson V.; Almeida-Neto, Gilberto; Neves, Frederico S.; Leite, Lemuel O.; Santos, Fabricio R.; Braga, Erika M.			Exploring the Diversity and Distribution of Neotropical Avian Malaria Parasites - A Molecular Survey from Southeast Brazil	PLOS ONE			English	Article							BLOOD PARASITES; SPATIAL VARIATION; FOREST BIRDS; PREVALENCE; PLASMODIUM; INFECTION; HEMATOZOA; COMMUNITY; GENERA	Southeast Brazil is a neotropical region composed of a mosaic of different tropical habitats and mountain chains, which allowed for the formation of bird-rich communities with distinct ecological niches. Although this region has the potential to harbor a remarkable variety of avian parasites, there is a lack of information about the diversity of malarial parasites. We used molecular approaches to characterize the lineage diversity of Plasmodium and Haemoproteus in bird communities from three different habitats in southeast Brazil based on the prevalence, richness and composition of lineages. We observed an overall prevalence of 35.3%, with a local prevalence ranging from 17.2% to 54.8%. Moreover, no significant association between prevalence and habitat type could be verified (p>0.05). We identified 89 Plasmodium and 22 Haemoproteus lineages, with 86% of them described for the first time here, including an unusual infection of a non-columbiform host by a Haemoproteus (Haemoproteus) parasite. The composition analyses of the parasite communities showed that the lineage composition from Brazilian savannah and tropical dry forest was similar, but it was different from the lineage composition of Atlantic rainforest, reflecting the greater likeness of the former habitats with respect to seasonality and forest density. No significant effects of habitat type on lineage richness were observed based on GLM analyses. We also found that sites whose samples had a greater diversity of bird species showed a greater diversity of parasite lineages, providing evidence that areas with high bird richness also have high parasite richness. Our findings point to the importance of the neotropical region (southeast Brazil) as a major reservoir of new haemosporidian lineages.	[Lacorte, Gustavo A.; Felix, Gabriel M. F.; Pinheiro, Rafael R. B.; Almeida-Neto, Gilberto; Braga, Erika M.] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Chaves, Anderson V.; Neves, Frederico S.; Santos, Fabricio R.] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Leite, Lemuel O.] Univ Estadual Montes Claros, Ctr Ciencias Biol & Saude, Montes Claros, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros	Braga, EM (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.	embraga@icb.ufmg.br	Chaves, Anderson Vieira/AAB-2717-2019; Pinheiro, Rafael/C-9721-2016; Lacorte, Gustavo Augusto/AAS-1968-2021; Neves, Frederico/E-5777-2013; Félix, Gabriel/B-5187-2016; PINHEIRO, RÔMULO PEDROZA/J-9992-2012; Leite, Lemuel/E-2460-2016; Braga, Erika Martins/A-6776-2008; Santos, Fabrício Rodrigues/H-2370-2011	Chaves, Anderson Vieira/0000-0002-0934-1763; Pinheiro, Rafael/0000-0003-2342-8483; Lacorte, Gustavo Augusto/0000-0002-6866-348X; Neves, Frederico/0000-0002-2691-3743; PINHEIRO, RÔMULO PEDROZA/0000-0002-0623-3003; Braga, Erika Martins/0000-0001-5550-7157; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Felix, Gabriel/0000-0002-3901-4333	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [INCT 573899/2008-8]; FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) [INCT APQ-0084/08]; FAPEMIG PRONEX Historia Natural; FAPEMIG-Vale Edital; CAPES -Edital Parasitologia Basica	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG PRONEX Historia Natural(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG-Vale Edital; CAPES -Edital Parasitologia Basica	This study was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (INCT 573899/2008-8), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) (INCT APQ-0084/08), FAPEMIG PRONEX Historia Natural, FAPEMIG-Vale Edital 2010 and CAPES -Edital Parasitologia Basica-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; BEAUDOIN R L, 1971, Journal of Wildlife Diseases, V7, P5; Belo NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017654; Belo NO, 2012, PARASITOLOG IN PRESS; BENNETT G F, 1976, Journal of Wildlife Diseases, V12, P454; Bensch S, 2003, J PARASITOL, V89, P388, DOI 10.1645/0022-3395(2003)089[0388:TASVOH]2.0.CO;2; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bonneaud C, 2009, J TROP ECOL, V25, P439, DOI 10.1017/S0266467409006178; Braga EM, 2011, MEM I OSWALDO CRUZ, V106, P3, DOI 10.1590/S0074-02762011000900002; Dimitrov D, 2010, ACTA PARASITOL, V55, P201, DOI 10.2478/s11686-010-0029-z; Drummond GM, 2005, BIODIVERSIDADE MINAS, V2th; Dunn JC, 2011, BEHAV ECOL SOCIOBIOL, V65, P1459, DOI 10.1007/s00265-011-1156-8; Durrant KL, 2006, ORNITHOL MONOGR, P98; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fallon SM, 2003, J PARASITOL, V89, P1044, DOI 10.1645/GE-3157; Fecchio A, 2011, EMU, V111, P132, DOI 10.1071/MU10063; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Green Phil, 1994, PHRAP; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2011, J WILDLIFE DIS, V47, P849, DOI 10.7589/0090-3558-47.4.849; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2004, MAP BIOM BRAS; Ishtiaq F, 2007, J WILDLIFE DIS, V43, P382, DOI 10.7589/0090-3558-43.3.382; Jarvi SI, 2002, J PARASITOL, V88, P153, DOI 10.1645/0022-3395(2002)088[0153:PDUTPO]2.0.CO;2; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; Marini MA, 2005, CONSERV BIOL, V19, P665, DOI 10.1111/j.1523-1739.2005.00706.x; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Matta NE, 2004, MEM I OSWALDO CRUZ, V99, P271, DOI 10.1590/S0074-02762004000300005; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Merino S, 2008, AUSTRAL ECOL, V33, P329, DOI 10.1111/j.1442-9993.2008.01820.x; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; Munro HJ, 2009, ORNITOL NEOTROP, V20, P461; Ots I, 1998, OECOLOGIA, V116, P441, DOI 10.1007/s004420050608; Outlaw DC, 2011, P NATL ACAD SCI USA, V108, P13183, DOI 10.1073/pnas.1109153108; Perkins SL, 2000, P ROY SOC B-BIOL SCI, V267, P2345, DOI 10.1098/rspb.2000.1290; R Core Team, 2018, R LANG ENV STAT COMP; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; Rosa-Freitas MG, 1998, MEM I OSWALDO CRUZ, V93, P651, DOI 10.1590/S0074-02761998000500016; RubioPalis Y, 1997, J MED ENTOMOL, V34, P499, DOI 10.1093/jmedent/34.5.499; Sambrook J., 2001, MOL CLONING LAB MANU; Santiago-Alarcon D, 2010, INT J PARASITOL, V40, P463, DOI 10.1016/j.ijpara.2009.10.003; Sebaio F, 2010, BIRD CONSERV INT, V20, P432, DOI 10.1017/S0959270910000110; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; Sick H., 1993, BIRDS BRAZIL NATURAL; Sorci G, 1997, J EVOLUTION BIOL, V10, P731, DOI 10.1007/s000360050051; Szymanski MM, 2005, J PARASITOL, V91, P768, DOI 10.1645/GE-417R1.1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valkinas G., 2005, AVIAN MALARIA PARASI; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Wiersch SC, 2007, J ORNITHOL, V148, P17, DOI 10.1007/s10336-006-0094-0	59	75	76	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57770	10.1371/journal.pone.0057770	http://dx.doi.org/10.1371/journal.pone.0057770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469235	gold, Green Published			2022-12-27	WOS:000315897100039
J	Lee, DH; Park, JK; Kwon, JH; Yuk, SS; Erdene-Ochir, TO; Jang, YH; Seong, BL; Lee, JB; Park, SY; Choi, IS; Song, CS				Lee, Dong-Hun; Park, Jae-Keun; Kwon, Jung-Hoon; Yuk, Seong-Su; Erdene-Ochir, Tseren-Ochir; Jang, Yo-Han; Seong, Baik-Lin; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon			Efficacy of Single Dose of a Bivalent Vaccine Containing Inactivated Newcastle Disease Virus and Reassortant Highly Pathogenic Avian Influenza H5N1 Virus against Lethal HPAI and NDV Infection in Chickens	PLOS ONE			English	Article							LIVE ATTENUATED VACCINE; PROTECTIVE EFFICACY; REVERSE GENETICS; OUTBREAKS; CHINA; EPIDEMIOLOGY; CHALLENGE; ECOLOGY; DUCKS	Highly pathogenic avian influenza (HPAI) and Newcastle disease (ND) are 2 devastating diseases of poultry, which cause great economic losses to the poultry industry. In the present study, we developed a bivalent vaccine containing antigens of inactivated ND and reassortant HPAI H5N1 viruses as a candidate poultry vaccine, and we evaluated its immunogenicity and protective efficacy in specific pathogen-free chickens. The 6: 2 reassortant H5N1 vaccine strain containing the surface genes of the A/Chicken/Korea/ES/2003(H5N1) virus was successfully generated by reverse genetics. A polybasic cleavage site of the hemagglutinin segment was replaced by a monobasic cleavage site. We characterized the reverse genetics-derived reassortant HPAI H5N1 clade 2.5 vaccine strain by evaluating its growth kinetics in eggs, minimum effective dose in chickens, and cross-clade immunogenicity against HPAI clade 1 and 2. The bivalent vaccine was prepared by emulsifying inactivated ND (La Sota strain) and reassortant HPAI viruses with Montanide ISA 70 adjuvant. A single immunization with this vaccine induced high levels of hemagglutination-inhibiting antibody titers and protected chickens against a lethal challenge with the wild-type HPAI and ND viruses. Our results demonstrate that the bivalent, inactivated vaccine developed in this study is a promising approach for the control of both HPAI H5N1 and ND viral infections.	[Lee, Dong-Hun; Park, Jae-Keun; Kwon, Jung-Hoon; Yuk, Seong-Su; Erdene-Ochir, Tseren-Ochir; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon] Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea; [Jang, Yo-Han; Seong, Baik-Lin] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea	Konkuk University; Yonsei University	Song, CS (corresponding author), Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea.	songcs@konkuk.ac.kr	Lee, Dong-hun/H-5082-2019; Youk, Sungsu/AAC-2316-2019; Tseren Ochir, Erdene Ochir/AAH-4980-2019	Youk, Sungsu/0000-0002-3106-3712; Tseren Ochir, Erdene Ochir/0000-0003-3237-7307; Lee, Dong-Hun/0000-0002-0820-7378	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [610001-03-1-SU000]; KBNP Inc.; Green Cross Veterinary Products Co., Ltd.; Daesung Microbiological Labs Co., Ltd.; Choong Ang vaccine laboratories co. Ltd.	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; KBNP Inc.; Green Cross Veterinary Products Co., Ltd.; Daesung Microbiological Labs Co., Ltd.; Choong Ang vaccine laboratories co. Ltd.	This work was supported by a grant (No. 610001-03-1-SU000) from the Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge technical advice and support by KBNP Inc., Green Cross Veterinary Products Co., Ltd., Daesung Microbiological Labs Co., Ltd., Choong Ang vaccine laboratories co. Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexander D.J., 1997, DIS POULTRY, P541; Butler D, 2005, NATURE, V434, P810, DOI 10.1038/4344810a; Engelhardt OG, 2012, INFLUENZA OTHER RESP; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Han GZ, 2008, J VIROL, V82, P6782, DOI 10.1128/JVI.00370-08; Jeon WJ, 2008, J VET SCI, V9, P295, DOI 10.4142/jvs.2008.9.3.295; Jung EJ, 2010, EXP MOL MED, V42, P116, DOI 10.3858/emm.2010.42.2.013; Ke GM, 2001, J VIROL METHODS, V97, P1, DOI 10.1016/S0166-0934(01)00296-8; Lee YJ, 2004, AVIAN PATHOL, V33, P482, DOI 10.1080/03079450400003700; Liang R, 2002, VET MICROBIOL, V87, P193, DOI 10.1016/S0378-1135(02)00050-0; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Mase M, 2002, J CLIN MICROBIOL, V40, P3826, DOI 10.1128/JCM.40.10.3826-3830.2002; Neumann Gabriele, 2012, Methods Mol Biol, V865, P193, DOI 10.1007/978-1-61779-621-0_12; OIE, 2010, WORLD AN HLTH INF DA; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROTT R, 1992, VET MICROBIOL, V33, P303, DOI 10.1016/0378-1135(92)90058-2; Shi HY, 2007, VACCINE, V25, P7379, DOI 10.1016/j.vaccine.2007.08.011; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Tian GB, 2005, VIROLOGY, V341, P153, DOI 10.1016/j.virol.2005.07.011; Tian GB, 2010, AVIAN DIS, V54, P287, DOI 10.1637/8707-031709-ResNote.1; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 2006, VIROLOGY, V351, P303, DOI 10.1016/j.virol.2006.01.044; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; World Organisation for Animal Health (OIE), 2009, OIE TERR MAN	26	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58186	10.1371/journal.pone.0058186	http://dx.doi.org/10.1371/journal.pone.0058186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469269	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100066
J	Shanks, RMQ; Lahr, RM; Stella, NA; Arena, KE; Brothers, KM; Kwak, DH; Liu, XY; Kalivoda, EJ				Shanks, Robert M. Q.; Lahr, Roni M.; Stella, Nicholas A.; Arena, Kristin E.; Brothers, Kimberly M.; Kwak, Daniel H.; Liu, Xinyu; Kalivoda, Eric J.			A Serratia marcescens PigP Homolog Controls Prodigiosin Biosynthesis, Swarming Motility and Hemolysis and Is Regulated by cAMP-CRP and HexS	PLOS ONE			English	Article							VIRULENCE FACTOR EXPRESSION; GGDEF/EAL DOMAIN PROTEIN; SP ATCC 39006; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; BIOSURFACTANT PRODUCTION; ANTIBIOTIC BIOSYNTHESIS; STAPHYLOCOCCUS-AUREUS; MUTATIONAL ANALYSIS; 2-COMPONENT SYSTEM	Swarming motility and hemolysis are virulence-associated determinants for a wide array of pathogenic bacteria. The broad host-range opportunistic pathogen Serratia marcescens produces serratamolide, a small cyclic amino-lipid, that promotes swarming motility and hemolysis. Serratamolide is negatively regulated by the transcription factors HexS and CRP. Positive regulators of serratamolide production are unknown. Similar to serratamolide, the antibiotic pigment, prodigiosin, is regulated by temperature, growth phase, HexS, and CRP. Because of this co-regulation, we tested the hypothesis that a homolog of the PigP transcription factor of the atypical Serratia species ATCC 39006, which positively regulates prodigiosin biosynthesis, is also a positive regulator of serratamolide production in S. marcescens. Mutation of pigP in clinical, environmental, and laboratory strains of S. marcescens conferred pleiotropic phenotypes including the loss of swarming motility, hemolysis, and severely reduced prodigiosin and serratamolide synthesis. Transcriptional analysis and electrophoretic mobility shift assays place PigP in a regulatory pathway with upstream regulators CRP and HexS. The data from this study identifies a positive regulator of serratamolide production, describes novel roles for the PigP transcription factor, shows for the first time that PigP directly regulates the pigment biosynthetic operon, and identifies upstream regulators of pigP. This study suggests that PigP is important for the ability of S. marcescens to compete in the environment.	[Shanks, Robert M. Q.; Lahr, Roni M.; Stella, Nicholas A.; Arena, Kristin E.; Brothers, Kimberly M.; Kalivoda, Eric J.] Univ Pittsburgh, Dept Ophthalmol, Ctr Eye, Charles T Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA; [Kwak, Daniel H.; Liu, Xinyu] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shanks, RMQ (corresponding author), Univ Pittsburgh, Dept Ophthalmol, Ctr Eye, Charles T Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA.	shanksrm@upmc.edu	Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Lahr, Roni/0000-0002-7469-4565; Brothers, Kimberly/0000-0003-2055-9760	National Institutes of Health (NIH) [AI085570]; Research to Prevent Blindness Career Development Award; NIH [EY08098]; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health (NIH) grant AI085570 and a Research to Prevent Blindness Career Development Award to RS and support from NIH grant EY08098, the Eye and Ear Foundation of Pittsburgh, and unrestricted funds from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON C, 1992, INFECT IMMUN, V60, P4740, DOI 10.1128/IAI.60.11.4740-4746.1992; ALLISON C, 1992, MOL MICROBIOL, V6, P1583; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BRAUN V, 1991, CRIT REV MICROBIOL, V18, P115, DOI 10.3109/10408419109113511; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Carpinella MC, 2011, PHYTOMEDICINE, V18, P994, DOI 10.1016/j.phymed.2011.03.003; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640; Dwivedi D, 2008, J NAT PROD, V71, P637, DOI 10.1021/np7007126; Fender JE, 2012, APPL ENVIRON MICROB, V78, P6225, DOI 10.1128/AEM.01778-12; Fineran PC, 2005, MICROBIOL-SGM, V151, P3833, DOI 10.1099/mic.0.28251-0; Fineran PC, 2005, MOL MICROBIOL, V56, P1495, DOI 10.1111/j.1365-2958.2005.04660.x; Fineran PC, 2007, J BACTERIOL, V189, P7653, DOI 10.1128/JB.00671-07; Fraser GM, 2002, MICROBIOL-SGM, V148, P2191, DOI 10.1099/00221287-148-7-2191; GERBER NN, 1974, CRIT REV MICROBIOL, V3, P469; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Gristwood T, 2008, MOL MICROBIOL, V69, P418, DOI 10.1111/j.1365-2958.2008.06291.x; Gristwood Tamzin, 2011, J Bacteriol, V193, P1076, DOI 10.1128/JB.00352-10; Gristwood T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-112; Haddix PL, 2008, J BACTERIOL, V190, P7453, DOI 10.1128/JB.00909-08; Horng YT, 2002, MOL MICROBIOL, V45, P1655, DOI 10.1046/j.1365-2958.2002.03117.x; Horng YT, 2010, INT J MED MICROBIOL, V300, P304, DOI 10.1016/j.ijmm.2010.01.003; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Hume E, 2004, Arch Soc Esp Oftalmol, V79, P475; Hume EBH, 1999, CURR EYE RES, V19, P525, DOI 10.1076/ceyr.19.6.525.5283; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Kalivoda EJ, 2010, RES MICROBIOL, V161, P158, DOI 10.1016/j.resmic.2009.12.004; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kowalski RP, 2010, ACTA OPHTHALMOL, V88, pe120, DOI 10.1111/j.1755-3768.2010.01897.x; Lai HC, 2005, J BACTERIOL, V187, P3407, DOI 10.1128/JB.187.10.3407-3414.2005; Laupland KB, 2008, EUR J CLIN MICROBIOL, V27, P89, DOI 10.1007/s10096-007-0400-7; Li H, 2005, MICROBIOL IMMUNOL, V49, P303, DOI 10.1111/j.1348-0421.2005.tb03734.x; Liaw SJ, 2003, J MED MICROBIOL, V52, P19, DOI 10.1099/jmm.0.05024-0; Lin CS, 2010, INFECT IMMUN, V78, P4870, DOI 10.1128/IAI.00661-10; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; MATSUYAMA T, 1995, J BACTERIOL, V177, P987, DOI 10.1128/jb.177.4.987-991.1995; MATSUYAMA T, 1986, J GEN MICROBIOL, V132, P865; MATSUYAMA T, 1989, FEMS MICROBIOL LETT, V61, P243, DOI 10.1016/0378-1097(89)90204-8; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Miller J.H., 1972, EXPT MOL GENETICS; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; OREAR J, 1992, J BACTERIOL, V174, P6125, DOI 10.1128/JB.174.19.6125-6137.1992; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; Ramsay Joshua P, 2012, Commun Integr Biol, V5, P96; Reimmann C, 2002, MICROBIOL-SGM, V148, P923, DOI 10.1099/00221287-148-4-923; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; RIUS N, 1994, APPL ENVIRON MICROB, V60, P2152, DOI 10.1128/AEM.60.6.2152-2154.1994; ROSENBERG M, 1986, ADV MICROB ECOL, V9, P353; ROSENBERG M, 1986, INFECT IMMUN, V51, P932, DOI 10.1128/IAI.51.3.932-935.1986; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005; Shanks RMQ, 2012, RES MICROBI IN PRESS; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Shanks RMQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036398; Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Stella NA, 2012, ADV MICROBI IN PRESS; Sunaga S, 2004, MICROBIOL IMMUNOL, V48, P723, DOI 10.1111/j.1348-0421.2004.tb03597.x; Tanikawa T, 2006, MICROBIOL IMMUNOL, V50, P587, DOI 10.1111/j.1348-0421.2006.tb03833.x; Ulrich RL, 2004, J BACTERIOL, V186, P4350, DOI 10.1128/JB.186.13.4350-4360.2004; Verhamme KMC, 2007, INFECT CONT HOSP EP, V28, P389, DOI 10.1086/511702; Vining LC, 1990, ANN REV MICROBIOL, V44; Walker KE, 1999, MOL MICROBIOL, V32, P825, DOI 10.1046/j.1365-2958.1999.01401.x; Wang WB, 2008, INFECT IMMUN, V76, P2051, DOI 10.1128/IAI.01557-07; WASSERMAN H, 1961, J AM CHEM SOC, V83, P4107, DOI 10.1021/ja01480a046; Wilf NM, 2012, MICROBIOL-SGM, V158, P648, DOI 10.1099/mic.0.055780-0; Wilf NM, 2011, ENVIRON MICROBIOL, V13, P2649, DOI 10.1111/j.1462-2920.2011.02532.x; Williamson NR, 2008, ENVIRON MICROBIOL, V10, P1202, DOI 10.1111/j.1462-2920.2007.01536.x; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531	73	38	41	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57634	10.1371/journal.pone.0057634	http://dx.doi.org/10.1371/journal.pone.0057634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469212	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000315897100028
J	Wen, XP; Liang, Y; Zhu, J; Wu, TC				Wen, Xiaopiao; Liang, Yuan; Zhu, Jiang; Wu, Tangchun			The Effects of Housework on the Health of Retired Older Adults: A Preliminary Investigation from the Tongji-Dongfeng Cohort Study, China	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; HOUSEHOLD LABOR; GENDER INEQUALITY; LEISURE-TIME; PAID WORK; POPULATION; MEN; PERSPECTIVE; EQUALITY	Background: The aim of the current study was to explore the relationship between housework and health of retired older adults, and to provide new evidences and clues for the effects of housework on health. Methodology/Principal Findings: The data came from the baseline survey of the Tongji-Dongfeng Cohort Study with 25,501 participants. The independent variable was housework including child care, elder care, grocery shopping & cooking, and washing clothes & cleaning house. The dependent variable was self-reported two-week illness. Age, education, marital status, smoking and drinking were used as potential confounding variables. There are gender differences in the four types of housework, with higher prevalence among women than among men. The prevalence of two-week illness in women was higher than that in men. After adjusting for potential confounding variables, the four types of housework had almost no significant effects on two-week illness, except for washing clothes & cleaning house with a negative effect for women (OR = 1.17, 95% CI 1.06-1.29). Conclusions/Significance: The association of housework with health, especially of child care, elder care, and grocery shopping & cooking without significance and of washing clothes & cleaning house with significance for women, would provide a valuable clue for in-depth study of housework, namely the effects of housework on health would be subdivided into the dimensions of psychological and social activity besides physical activity, and it may not be suitable to simply classify housework as a kind of exercise.	[Wen, Xiaopiao; Liang, Yuan] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Dept Social Med & Hlth Management, Wuhan 430074, Peoples R China; [Zhu, Jiang] Dongfeng Motor Corp, Dongfeng Cent Hosp, Dept Hlth Care, Shiyan, Peoples R China; [Zhu, Jiang] Hubei Univ Med, Shiyan, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Dongfeng Motor; Hubei University of Medicine; Huazhong University of Science & Technology	Liang, Y (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Dept Social Med & Hlth Management, Wuhan 430074, Peoples R China.	liangyuan217@163.com; wut@mails.tjmu.edu.cn			Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program [2011CB503800]; Natural Scientific Foundation of China [NSFC-81172751]; Dongfeng Motor Corporation, DMC, China	Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Dongfeng Motor Corporation, DMC, China	Huazhong University of Science and Technology Foundation for Educational Development and Research; National Basic Research Program (Grant 2011CB503800); Natural Scientific Foundation of China (NSFC-81172751) and the Dongfeng Motor Corporation, DMC, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailshire JA, 2011, J AM GERIATR SOC, V59, P2241, DOI 10.1111/j.1532-5415.2011.03723.x; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Baxter J, 1997, J COMP FAM STUD, V28, P220; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Bianchi SM, 2000, SOC FORCES, V79, P191, DOI 10.2307/2675569; Bird CE, 1999, J HEALTH SOC BEHAV, V40, P32, DOI 10.2307/2676377; Bittman M, 2003, AM J SOCIOL, V109, P186, DOI 10.1086/378341; BLAIR SN, 1992, ANNU REV PUBL HEALTH, V13, P99, DOI 10.1146/annurev.pu.13.050192.000531; Borrell C, 2004, SOC SCI MED, V58, P1869, DOI 10.1016/S0277-9536(03)00408-8; Fuwa M, 2007, SOC SCI RES, V36, P512, DOI 10.1016/j.ssresearch.2006.04.005; Geist C, 2011, J MARRIAGE FAM, V73, P832, DOI 10.1111/j.1741-3737.2011.00850.x; GLASS J, 1994, J HEALTH SOC BEHAV, V35, P179, DOI 10.2307/2137364; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; Hook JL, 2010, AM J SOCIOL, V115, P1480, DOI 10.1086/651384; Huang HQ, 2007, J E CHINA NORMAL U P, V39, P86; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Khawaja M, 2007, AM J PUBLIC HEALTH, V97, P860, DOI 10.2105/AJPH.2005.080374; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Liu AL, 2007, CHIN J PREV CONTR CH, V15, P84; Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669; Robinson J, 1992, SOCIAL SCI Q, V73, P845; Ruppanner LE, 2010, SOC SCI RES, V39, P963, DOI 10.1016/j.ssresearch.2010.04.002; Sayer LC, 2009, SOC INDIC RES, V93, P215, DOI 10.1007/s11205-008-9376-7; Sesso HD, 2000, CIRCULATION, V102, P975, DOI 10.1161/01.CIR.102.9.975; Shi J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-277; Szinovacz ME, 2000, J MARRIAGE FAM, V62, P78, DOI 10.1111/j.1741-3737.2000.00078.x; Tao Wenting, 2010, Clin Pract Epidemiol Ment Health, V6, P36, DOI 10.2174/1745017901006010036; Tao YL, 2011, COLLECTION WOMENS ST, V106, P13; Thebaud S, 2010, GENDER SOC, V24, P330, DOI 10.1177/0891243210369105; Voicu M, 2009, EUR SOCIOL REV, V25, P365, DOI 10.1093/esr/jcn054; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; [Wang Zhiyun 王志云], 2010, [心理科学进展, Advances in Psychological Science], V18, P1668; WILSON PWF, 1986, AM HEART J, V111, P1177, DOI 10.1016/0002-8703(86)90022-0; Zins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026531	34	9	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e57232	10.1371/journal.pone.0057232	http://dx.doi.org/10.1371/journal.pone.0057232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103EI	23469186	Green Published, gold			2022-12-27	WOS:000315897100016
J	Zhao, Y; Qin, W; Zhang, JP; Hu, ZY; Tong, JW; Ding, CB; Peng, ZG; Zhao, LX; Song, DQ; Jiang, JD				Zhao, Ye; Qin, Wei; Zhang, Jing-Pu; Hu, Zhan-Ying; Tong, Jun-Wei; Ding, Cun-Bao; Peng, Zong-Gen; Zhao, Li-Xun; Song, Dan-Qing; Jiang, Jian-Dong			HCV IRES-Mediated Core Expression in Zebrafish	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RIBOSOME ENTRY SITE; AMINO-ACID SUBSTITUTIONS; HUMAN LIVER; HEPATOCELLULAR-CARCINOMA; TRANSGENIC ZEBRAFISH; RESISTANCE MUTATIONS; INTERNAL INITIATION; LIPID-ACCUMULATION; GENE-EXPRESSION	The lack of small animal models for hepatitis C virus has impeded the discovery and development of anti-HCV drugs. HCV-IRES plays an important role in HCV gene expression, and is an attractive target for antiviral therapy. In this study, we report a zebrafish model with a biscistron expression construct that can co-transcribe GFP and HCV-core genes by human hepatic lipase promoter and zebrafish liver fatty acid binding protein enhancer. HCV core translation was designed mediated by HCV-IRES sequence and gfp was by a canonical cap-dependent mechanism. Results of fluorescence image and in situ hybridization indicate that expression of HCV core and GFP is liver-specific; RT-PCR and Western blotting show that both core and gfp expression are elevated in a time-dependent manner for both transcription and translation. It means that the HCV-IRES exerted its role in this zebrafish model. Furthermore, the liver-pathological impact associated with HCV-infection was detected by examination of gene markers and some of them were elevated, such as adiponectin receptor, heparanase, TGF-beta, PDGF-alpha, etc. The model was used to evaluate three clinical drugs, ribavirin, IFN alpha-2b and vitamin B12. The results show that vitamin B12 inhibited core expression in mRNA and protein levels in dose-dependent manner, but failed to impact gfp expression. Also VB12 down-regulated some gene transcriptions involved in fat liver, liver fibrosis and HCV-associated pathological process in the larvae. It reveals that HCV-IRES responds to vitamin B12 sensitively in the zebrafish model. Ribavirin did not disturb core expression, hinting that HCV-IRES is not a target site of ribavirin. IFNa-2b was not active, which maybe resulted from its degradation in vivo for the long time. These findings demonstrate the feasibility of the zebrafish model for screening of anti-HCV drugs targeting to HCV-IRES. The zebrafish system provides a novel evidence of using zebrafish as a HCV model organism.	[Zhao, Ye; Qin, Wei; Zhang, Jing-Pu; Hu, Zhan-Ying; Tong, Jun-Wei; Ding, Cun-Bao; Peng, Zong-Gen; Zhao, Li-Xun; Song, Dan-Qing] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Zhao, Ye; Qin, Wei; Zhang, Jing-Pu; Hu, Zhan-Ying; Tong, Jun-Wei; Ding, Cun-Bao; Peng, Zong-Gen; Zhao, Li-Xun; Song, Dan-Qing; Jiang, Jian-Dong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Zhang, JP (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	zjp5577@126.com; jiang.jdong@163.com	Peng, Zong-Gen/GVU-2327-2022; Hu, Zhanying/AAE-8790-2019	Peng, Zong-Gen/0000-0001-7662-6892; Hu, Zhanying/0000-0002-4169-7778; Zhao, Ye/0000-0002-2852-7432	National Natural Science Foundation of China [30772681]; National Science and Technology Major Special Project on Major New Drug Innovation [2012ZX09301002-001-021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Special Project on Major New Drug Innovation	This study was supported by The National Natural Science Foundation of China (No. 30772681), and National Science and Technology Major Special Project on Major New Drug Innovation (Item Number: 2012ZX09301002-001-021) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2010, LIVER INT, V30, P1259, DOI 10.1111/j.1478-3231.2010.02283.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Dash S, 2005, LIVER INT, V25, P580, DOI 10.1111/j.1478-3231.2005.01082.x; Ding CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022921; Dumas E, 2003, NUCLEIC ACIDS RES, V31, P1275, DOI 10.1093/nar/gkg199; Fujino T, 2010, HEPATOL RES, V40, P923, DOI 10.1111/j.1872-034X.2010.00700.x; Fukuhara T, 2010, HEPATOL RES, V40, P171, DOI 10.1111/j.1872-034X.2009.00575.x; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kohjima M, 2007, INT J MOL MED, V20, P351; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Li DS, 2004, J VIROL, V78, P12075, DOI 10.1128/JVI.78.21.12075-12081.2004; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liua S, 2011, ANTIVIR RES, V89, P54; Locker N, 2007, EMBO J, V26, P795, DOI 10.1038/sj.emboj.7601549; Lott WB, 2001, P NATL ACAD SCI USA, V98, P4916, DOI 10.1073/pnas.081072798; Lukavsky PJ, 2009, VIRUS RES, V139, P166, DOI 10.1016/j.virusres.2008.06.004; Mee CJ, 2010, GASTROENTEROLOGY, V138, P1134, DOI 10.1053/j.gastro.2009.11.047; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Paulsen RB, 2010, P NATL ACAD SCI USA, V107, P7263, DOI 10.1073/pnas.0911896107; Qiu P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp251; Rekha RD, 2008, TOXICOLOGY, V243, P11, DOI 10.1016/j.tox.2007.09.007; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Reynolds JE, 1996, RNA, V2, P867; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Singaravelu R, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-5; SMITH DB, 1995, J GEN VIROL, V76, P1749, DOI 10.1099/0022-1317-76-7-1749; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Suzuki T, 2007, ADV DRUG DELIVER REV, V59, P1200, DOI 10.1016/j.addr.2007.04.014; Tachi Y, 2010, LIVER INT, V30, P554, DOI 10.1111/j.1478-3231.2009.02164.x; Takyar SS, 2002, J MOL BIOL, V319, P1, DOI 10.1016/S0022-2836(02)00300-5; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992; van Deursen D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-99; Wang WY, 2000, BIOORG MED CHEM LETT, V10, P1151, DOI 10.1016/S0960-894X(00)00217-1; Wang Z, 2000, CHIN J HEPATOL, V8, P224; Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Zhang J, 2002, VIROLOGY, V293, P141, DOI 10.1006/viro.2001.1270	48	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e56985	10.1371/journal.pone.0056985	http://dx.doi.org/10.1371/journal.pone.0056985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469178	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100011
J	Edan, RA; Luqmani, YA; Masocha, W				Edan, Rawan Abdulhameed; Luqmani, Yunus A.; Masocha, Willias			COL-3, a Chemically Modified Tetracycline, Inhibits Lipopolysaccharide-Induced Microglia Activation and Cytokine Expression in the Brain	PLOS ONE			English	Article							P38 MAP KINASE; NEURODEGENERATIVE DISEASES; NITRIC-OXIDE; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; NEONATAL-RAT; MAST-CELLS; MINOCYCLINE; NEUROTOXICITY; NEUROINFLAMMATION	Microglia activation results in release of proinflammatory molecules including cytokines, which contribute to neuronal damage in the central nervous system (CNS) if not controlled. Tetracycline antibiotics such as minocycline inhibit microglial activation and cytokine expression during CNS inflammation. In the present study we found that administration of chemically modified tetracycline-3 (COL-3), inhibits lipopolysaccharide (LPS)-induced microglial and p38 MAPK activation, as well as the increase in TNF-alpha, but not IL-1 beta expression, in the brains of BALB/c mice. COL-3 has been described to have no antibacterial activity. We observed that COL-3 had no activity against a Gram-negative bacteria, Escherichia coli; however surprisingly, COL-3 had antibacterial activity against a Gram-positive bacteria Staphylococcus aureus, with a minimum inhibitory concentration of 1 mg/ml. Our data show that COL-3 has some antibacterial activity against S. aureus, inhibits LPS-induced neuroinflammation, and displays potential as a therapeutic agent for treatment of conditions involving CNS inflammation.	[Edan, Rawan Abdulhameed; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Dept Pharmaceut Chem, Safat, Kuwait; [Edan, Rawan Abdulhameed; Masocha, Willias] Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat, Kuwait	Kuwait University; Kuwait University	Masocha, W (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat, Kuwait.	masocha@hsc.edu.kw		Masocha, Willias/0000-0003-3132-5935	Kuwait University Research Sector [YM05/10, GM01/01, GM01/05]	Kuwait University Research Sector	This work was supported by grants YM05/10, GM01/01 and GM01/05 from Kuwait University Research Sector. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya MR, 2004, DRUG RESIST UPDATE, V7, P195, DOI 10.1016/j.drup.2004.04.002; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; An HZ, 2002, IMMUNOLOGY, V106, P38, DOI 10.1046/j.1365-2567.2002.01401.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Blum D, 2004, NEUROBIOL DIS, V17, P359, DOI 10.1016/j.nbd.2004.07.012; Bu XN, 2007, NEUROCHEM INT, V51, P459, DOI 10.1016/j.neuint.2007.04.028; Cazalis J, 2009, INFLAMMATION, V32, P130, DOI 10.1007/s10753-009-9111-9; Chen J, 2001, CURR MED CHEM, V8, P253, DOI 10.2174/0929867013373615; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Chu Quincy S C, 2007, Invest New Drugs, V25, P359, DOI 10.1007/s10637-006-9031-6; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dezube BJ, 2006, J CLIN ONCOL, V24, P1389, DOI 10.1200/JCO.2005.04.2614; Eklund KK, 1999, ANN NY ACAD SCI, V878, P689, DOI 10.1111/j.1749-6632.1999.tb07763.x; Fan LW, 2005, J NEUROSCI RES, V82, P71, DOI 10.1002/jnr.20623; Fan LW, 2005, NEUROSCIENCE, V133, P159, DOI 10.1016/j.neuroscience.2005.02.016; Fingleton Barbara, 2003, Curr Opin Investig Drugs, V4, P1460; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; GOLUB LM, 1991, CRIT REV ORAL BIOL M, V2, P297, DOI 10.1177/10454411910020030201; Greenwald RA, 1998, BONE, V22, P33, DOI 10.1016/S8756-3282(97)00221-4; Guo G, 2007, NEUROCHEM RES, V32, P2160, DOI 10.1007/s11064-007-9408-8; Hart AD, 2012, BRAIN BEHAV IMMUN, V26, P754, DOI 10.1016/j.bbi.2011.11.006; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Kaneko YS, 2005, J NEUROCHEM, V94, P393, DOI 10.1111/j.1471-4159.2005.03209.x; Kim SS, 2004, ARCH PHARM RES, V27, P314, DOI 10.1007/BF02980066; Lai AY, 2006, GLIA, V53, P809, DOI 10.1002/glia.20335; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Liu Y, 2001, CURR MED CHEM, V8, P243, DOI 10.2174/0929867013373525; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lokeshwar BL, 2002, INT J CANCER, V98, P297, DOI 10.1002/ijc.10168; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Maruyama M, 2000, BRAIN RES, V887, P350, DOI 10.1016/S0006-8993(00)03063-8; Masocha W, 2009, J NEUROIMMUNOL, V214, P78, DOI 10.1016/j.jneuroim.2009.06.022; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Roy SK, 2011, PHARMACOL RES, V64, P580, DOI 10.1016/j.phrs.2011.06.012; Sandler C, 2005, INFLAMM RES, V54, P304, DOI 10.1007/s00011-005-1358-5; Shao J, 2012, J NEUROIMMUNOL; Skaletz-Rorowski A, 2005, CARDIOVASC RES, V67, P142, DOI 10.1016/j.cardiores.2005.03.009; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Suk K, 2004, NEUROSCI LETT, V366, P167, DOI 10.1016/j.neulet.2004.05.038; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Terayama R, 2008, NEUROSCIENCE, V153, P1245, DOI 10.1016/j.neuroscience.2008.03.041; Tian DH, 2000, J NEUROSCI, V20, P6478, DOI 10.1523/JNEUROSCI.20-17-06478.2000; Tikka TM, 2002, BRAIN, V125, P722, DOI 10.1093/brain/awf068; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311; Yang LP, 2007, MOL VIS, V13, P1083; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhao F, 2009, TOXICOL SCI, V107, P156, DOI 10.1093/toxsci/kfn213	59	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57827	10.1371/journal.pone.0057827	http://dx.doi.org/10.1371/journal.pone.0057827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469077	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900173
J	Mun, J; Tam, C; Chan, G; Kim, JH; Evans, D; Fleiszig, S				Mun, James; Tam, Connie; Chan, Gary; Kim, Jong Hun; Evans, David; Fleiszig, Suzanne			MicroRNA-762 Is Upregulated in Human Corneal Epithelial Cells in Response to Tear Fluid and Pseudomonas aeruginosa Antigens and Negatively Regulates the Expression of Host Defense Genes Encoding RNase7 and ST2	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; RECEPTOR; RESISTANCE	Mucosal surfaces regulate defenses against infection and excessive inflammation. We previously showed that human tears upregulated epithelial expression of genes encoding RNase7 and ST2, which inhibited Pseudomonas aeruginosa invasion of human corneal epithelial cells. Here, microRNA microarrays were used to show that a combination of tear fluid exposure (16 h) then P. aeruginosa antigens (3 h) upregulated miR-762 and miR-1207, and down-regulated miR-92 and let-7b (all > 2-fold) in human corneal epithelial cells compared to P. aeruginosa antigens alone. RT-PCR confirmed miR-762 upregulation, 3-fold in tear-antigen exposed cells. Without tears or antigens, an antagomir reduced miR-762 expression relative to scrambled controls by similar to 50%, increased expression of genes encoding RNase7 (similar to 80 %), ST2 (similar to 58%) and Rab5a (similar to 75%), without affecting P. aeruginosa internalization. However, P. aeruginosa invasion was increased. 3-fold by a miR-762 mimic which reduced RNase7 and ST2 gene expression. Tear fluid alone also induced miR-762 expression similar to 4-fold, which was reduced by the miR-762 antagomir. Combination of tear fluid and miR-762 antagomir increased RNase7 and ST2 gene expression. These data show that mucosal fluids, such as tears, can modulate epithelial microRNA expression to regulate innate defense genes, and that miR-762 negatively regulates RNase7, ST2 and Rab5a genes. Since RNase7 and ST2 inhibit P. aeruginosa internalization, and are upregulated by tear fluid, other tear-induced mechanisms must counteract inhibitory effects of miR-762 to regulate resistance to bacteria. These data also suggest a complex relationship between tear induction of miR-762, its modulation of innate defense genes, and P. aeruginosa internalization.	[Mun, James; Tam, Connie; Evans, David; Fleiszig, Suzanne] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Mun, James; Fleiszig, Suzanne] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Chan, Gary] Univ Calif Berkeley, Program Bioengn, Berkeley, CA 94720 USA; [Kim, Jong Hun] Univ Calif Berkeley, Program Mol & Cell Biol, Berkeley, CA 94720 USA; [Evans, David] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Fleiszig, Suzanne] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA; [Fleiszig, Suzanne] Univ Calif Berkeley, Grad Grp Infect Dis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Touro University California; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fleiszig, S (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	fleiszig@berkeley.edu		Fleiszig, Suzanne/0000-0001-6324-3462; Tam, Connie/0000-0002-1566-7508; Evans, David/0000-0002-6885-2053	Bill and Melinda Gates Foundation; National Eye Institute [R01-EY011221]; NATIONAL EYE INSTITUTE [R01EY011221] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a Grand Challenges Explorations Grant from the Bill and Melinda Gates Foundation (SF, DE), and the National Eye Institute R01-EY011221 (SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros Victor, 2004, Methods Mol Biol, V265, P131; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Campbell EL, 2011, J IMMUNOL, V187, P3475, DOI 10.4049/jimmunol.1100150; Chen YQ, 2012, J NEPHROL, V25, P566, DOI 10.5301/jn.5000034; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Hazlett LD, 2010, INVEST OPHTH VIS SCI, V51, P1524, DOI 10.1167/iovs.09-3983; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Huang X, 2007, INVEST OPHTH VIS SCI, V48, P4626, DOI 10.1167/iovs.07-0316; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kiehne K, 2007, SCAND J GASTROENTERO, V42, P1063, DOI 10.1080/00365520701320489; Knop Erich, 2007, Chem Immunol Allergy, V92, P36, DOI 10.1159/000099252; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kwong MSF, 2007, INFECT IMMUN, V75, P2325, DOI 10.1128/IAI.01404-06; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Liew FY, 2005, IMMUNOL LETT, V96, P27, DOI 10.1016/j.imlet.2004.07.008; Maltseva IA, 2007, EXP EYE RES, V85, P142, DOI 10.1016/j.exer.2007.04.001; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; McNamara NA, 1999, EXP EYE RES, V69, P483, DOI 10.1006/exer.1999.0722; Mun JJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00008; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Otri AM, 2010, BRIT J OPHTHALMOL, V94, P1523, DOI 10.1136/bjo.2009.178236; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Roberts RL, 2000, J LEUKOCYTE BIOL, V68, P627; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Ryan D, 2006, MOL VIS, V12, P1175; Spencer JD, 2011, KIDNEY INT, V80, P175, DOI 10.1038/ki.2011.109; Tiffany John M, 2008, Dev Ophthalmol, V41, P1, DOI 10.1159/000131066; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64	38	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57850	10.1371/journal.pone.0057850	http://dx.doi.org/10.1371/journal.pone.0057850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469087	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900183
J	Munier, A; Marzouk, D; Abravanel, F; El-Daly, M; Taylor, S; Mamdouh, R; Eldin, WS; El-Arab, HE; Sos, DG; Momen, M; Okasha, O; Le Fouler, L; El-Hosini, M; Izopet, J; Rafik, M; Albert, M; Abdel-Hamid, M; Mohamed, MK; Delarocque-Astagneau, E; Fontanet, A				Munier, Aline; Marzouk, Diaa; Abravanel, Florence; El-Daly, Mai; Taylor, Sylvia; Mamdouh, Rasha; Eldin, Waleed Salah; El-Arab, Hanan Ezz; Sos, Dalia Gaber; Momen, Mohamed; Okasha, Omar; Le Fouler, Lenaig; El-Hosini, Mostafa; Izopet, Jacques; Rafik, Mona; Albert, Matthew; Abdel-Hamid, Mohamed; Mohamed, Mostafa Kamal; Delarocque-Astagneau, Elisabeth; Fontanet, Arnaud			Frequent Transient Hepatitis C viremia without Seroconversion among Healthcare Workers in Cairo, Egypt	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; OCCUPATIONAL-EXPOSURE; NEEDLESTICK INJURIES; BLOOD EXPOSURES; RISK-FACTORS; HCV-VIREMIA; VIRUS; INFECTION; ABSENCE; TRANSMISSION	Backgrounds: With 10% of the general population aged 15-59 years chronically infected with hepatitis C virus (HCV), Egypt is the country with the highest HCV prevalence worldwide. Healthcare workers (HCWs) are therefore at particularly high risk of HCV infection. Our aim was to study HCV infection risk after occupational blood exposure among HCWs in Cairo. Methodology/Principal Findings: The study was conducted in 2008-2010 at Ain Shams University Hospital, Cairo. HCWs reporting an occupational blood exposure at screening, having neither anti-HCV antibodies (anti-HCV) nor HCV RNA, and exposed to a HCV RNA positive patient, were enrolled in a 6-month prospective cohort with follow-up visits at weeks 2, 4, 8, 12 and 24. During follow-up, anti-HCV, HCV RNA and ALT were tested. Among 597 HCWs who reported a blood exposure, anti-HCV prevalence at screening was 7.2%, not different from that of the general population of Cairo after age-standardization (11.6% and 10.4% respectively, p = 0.62). The proportion of HCV viremia among index patients was 37%. Of 73 HCWs exposed to HCV RNA from index patients, nine (12.3%; 95% CI, 5.8-22.1%) presented transient viremia, the majority of which occurred within the first two weeks after exposure. None of the workers presented seroconversion or elevation of ALT. Conclusions/Significance: HCWs of a general University hospital in Cairo were exposed to a highly viremic patient population. They experienced frequent occupational blood exposures, particularly in early stages of training. These exposures resulted in transient viremic episodes without established infection. These findings call for further investigation of potential immune protection against HCV persistence in this high risk group.	[Munier, Aline; Taylor, Sylvia; Le Fouler, Lenaig; Delarocque-Astagneau, Elisabeth; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Marzouk, Diaa; Eldin, Waleed Salah; El-Arab, Hanan Ezz; Sos, Dalia Gaber; Momen, Mohamed; Okasha, Omar; El-Hosini, Mostafa; Mohamed, Mostafa Kamal] Ain Shams Univ, Fac Med, Dept Community Environm & Occupat Med, Cairo, Egypt; [Abravanel, Florence; Izopet, Jacques] Ctr Physiopathol Toulouse Purpan, INSERM, U1043, Toulouse, France; [Abravanel, Florence; Izopet, Jacques] Hop Purpan, CHU Toulouse, Virol Lab, Inst Federatif Biol Purpan, Toulouse, France; [El-Daly, Mai; Abdel-Hamid, Mohamed] Natl Hepatol & Trop Med Res Inst, Viral Hepatitis Res Lab, Cairo, Egypt; [El-Daly, Mai] Minoufiya Univ, Natl Liver Inst, Minoufiya, Egypt; [Mamdouh, Rasha; Rafik, Mona] Aim Shams Univ, Fac Med, Cairo, Egypt; [Albert, Matthew] Inst Pasteur, Lab Dendrit Cell Immunobiol, Paris, France; [Albert, Matthew] INSERM, U818, Paris, France; [Abdel-Hamid, Mohamed] Minia Fac Med, Dept Microbiol, Al Minya, Egypt; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Chaire Sante & Dev, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Egyptian Knowledge Bank (EKB); Ain Shams University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Ain Shams University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Egyptian Knowledge Bank (EKB); Minia University; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Munier, A (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.	aline.munier@pasteur.fr	IZOPET, Jacques/L-5756-2014; Ez-elarab, Hanan/C-9470-2019; ABRAVANEL, Florence/AAC-2993-2021; mohamed, mostafa/AFE-7371-2022; El-Daly, Mai/C-4704-2013; Abrvaanel, florence/K-3776-2014; delarocque-astagneau, elisabeth/E-4706-2016; Rafik, Mona/C-1650-2015	Ez-elarab, Hanan/0000-0002-4362-0715; ABRAVANEL, Florence/0000-0002-1753-1065; mohamed, mostafa/0000-0002-1421-2667; delarocque-astagneau, elisabeth/0000-0002-5129-9300; Rafik, Mona/0000-0002-8782-5552; El-Daly, Mai/0000-0002-3864-523X; Momen, Mohamed/0000-0002-7166-9831; , arnaud/0000-0002-5239-6110; mamdouh, rasha/0000-0002-8986-6032; Okasha, Omar/0000-0001-6401-707X	Agence nationale de recherches sur le Sida et les Hepatites virales, France [ANRS 12171]	Agence nationale de recherches sur le Sida et les Hepatites virales, France(ANRS)	This work was supported by the Agence nationale de recherches sur le Sida et les Hepatites virales, France, grant number ANRS 12171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid M, 1997, J Hum Virol, V1, P58; Abdelwahab S, 2012, T ROY SOC TROP MED H, V106, P98, DOI 10.1016/j.trstmh.2011.10.003; Abdelwahab SF, 2012, CLIN VACCINE IMMUNOL, V19, P780, DOI 10.1128/CVI.00050-12; Al-Sherbiny M, 2005, AM J TROP MED HYG, V73, P44; Deuffic-Burban S, 2011, J CLIN VIROL, V52, P4, DOI 10.1016/j.jcv.2011.05.016; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Hashem M, 2011, J INFECT DIS, V203, P854, DOI 10.1093/infdis/jiq123; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; Jagger J, 2002, JAMA-J AM MED ASSOC, V288, P1469, DOI 10.1001/jama.288.12.1469; Kamal SM, 2004, J VIROL, V78, P12252, DOI 10.1128/JVI.78.22.12252-12258.2004; Kermode M, 2004, INT J INFECT DIS, V8, P325, DOI 10.1016/j.ijid.2004.03.005; Kubitschke A, 2007, EUR J CLIN INVEST, V37, P54, DOI 10.1111/j.1365-2362.2007.01753.x; Lee R, 2009, J HOSP INFECT, V72, P285, DOI 10.1016/j.jhin.2009.03.016; Meyer MF, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-58; Mir O, 2011, CLIN MICROBIOL INFEC, V17, P464, DOI 10.1111/j.1469-0691.2010.03321.x; Morand P, 2001, CLIN INFECT DIS, V33, P727, DOI 10.1086/322619; Oh HS, 2005, J HOSP INFECT, V60, P269, DOI 10.1016/j.jhin.2004.11.026; Post JJ, 2004, J INFECT DIS, V189, P1846, DOI 10.1086/383279; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Puro V, 2001, INFECT CONT HOSP EP, V22, P206, DOI 10.1086/501890; Riviere Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-76; Schmid K, 2007, J HOSP INFECT, V65, P124, DOI 10.1016/j.jhin.2006.10.002; Talaat M, 2006, AM J INFECT CONTROL, V34, P193, DOI 10.1016/j.ajic.2005.05.028; Talaat M, 2003, AM J INFECT CONTROL, V31, P469, DOI 10.1016/j.ajic.2003.03.003; Talaat M, 2003, TROP MED INT HEALTH, V8, P234, DOI 10.1046/j.1365-3156.2003.01015.x; Yazdanpanah Y, 2005, CLIN INFECT DIS, V41, P1423, DOI 10.1086/497131	28	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57835	10.1371/journal.pone.0057835	http://dx.doi.org/10.1371/journal.pone.0057835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469082	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900178
J	Pannekoek, WJ; Linnemann, JR; Brouwer, PM; Bos, JL; Rehmann, H				Pannekoek, Willem-Jan; Linnemann, Jelena R.; Brouwer, Patricia M.; Bos, Johannes L.; Rehmann, Holger			Rap1 and Rap2 Antagonistically Control Endothelial Barrier Resistance	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; GTP-BINDING PROTEINS; CELL-CELL CONTACTS; N-TERMINAL KINASE; BIOCHEMICAL-CHARACTERIZATION; INTERACTING KINASE; PUTATIVE EFFECTOR; DOWN-REGULATION; CAMP ANALOG; VE-CADHERIN	Rap1 and Rap2 are closely related proteins of the Ras family of small G-proteins. Rap1 is well known to regulate cell-cell adhesion. Here, we have analysed the effect of Rap-mediated signalling on endothelial permeability using electrical impedance measurements of HUVEC monolayers and subsequent determination of the barrier resistance, which is a measure for the ease with which ions can pass cell junctions. In line with its well-established effect on cell-cell junctions, depletion of Rap1 decreases, whereas activation of Rap1 increases barrier resistance. Despite its high sequence homology with Rap1, depletion of Rap2 has an opposite, enhancing, effect on barrier resistance. This effect can be mimicked by depletion of the Rap2 specific activator RasGEF1C and the Rap2 effector MAP4K4, establishing Rap2 signalling as an independent pathway controlling barrier resistance. As simultaneous depletion or activation of both Rap1 and Rap2 results in a barrier resistance comparable to control cells, Rap1 and Rap2 control barrier resistance in a reciprocal manner. This Rap1-antagonizing effect of Rap2 is established independent of junctional actin formation. These data establish that endothelial barrier resistance is determined by the combined antagonistic actions of Rap1 and Rap2.	[Pannekoek, Willem-Jan; Linnemann, Jelena R.; Brouwer, Patricia M.; Bos, Johannes L.; Rehmann, Holger] Univ Med Ctr Utrecht, Mol Canc Res Ctr, Biomed Genet & Canc Genom Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Rehmann, H (corresponding author), Univ Med Ctr Utrecht, Mol Canc Res Ctr, Biomed Genet & Canc Genom Ctr, Utrecht, Netherlands.	h.rehmann@umcutrecht.nl			Section of Chemical Sciences of the Netherlands Organization for Scientific Research (NOW-CW)	Section of Chemical Sciences of the Netherlands Organization for Scientific Research (NOW-CW)	H.R. is supported by the Section of Chemical Sciences of the Netherlands Organization for Scientific Research (NOW-CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Farmer PJ, 2001, AM J PHYSIOL-LUNG C, V280, pL732, DOI 10.1152/ajplung.2001.280.4.L732; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hippenstiel S, 2002, CIRC RES, V91, P618, DOI 10.1161/01.RES.0000036603.61868.F9; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; LANGELER EG, 1991, AM J PHYSIOL, V260, pC1052, DOI 10.1152/ajpcell.1991.260.5.C1052; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Lorenowicz MJ, 2008, EUR J CELL BIOL, V87, P779, DOI 10.1016/j.ejcb.2008.05.004; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Nonaka H, 2008, BIOCHEM BIOPH RES CO, V377, P573, DOI 10.1016/j.bbrc.2008.10.038; OHMSTEDE CA, 1990, P NATL ACAD SCI USA, V87, P6527, DOI 10.1073/pnas.87.17.6527; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Paganini S, 2006, BIOCHIMIE, V88, P285, DOI 10.1016/j.biochi.2005.08.007; Pannekoek WJ, 2011, CELL SIGNAL, V23, P2056, DOI 10.1016/j.cellsig.2011.07.022; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; PIZON V, 1988, ONCOGENE, V3, P201; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Ryu J, 2008, J NEUROSCI, V28, P8178, DOI 10.1523/JNEUROSCI.1944-08.2008; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Tsygankova OM, 2010, MOL CELL BIOL, V30, P3262, DOI 10.1128/MCB.01345-09; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Vuchak LA, 2011, CELL ADHES MIGR, V5, P323, DOI 10.4161/cam.5.4.17041; Wittchen Erika S, 2011, Small GTPases, V2, P65; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yaman E, 2009, FEBS J, V276, P4607, DOI 10.1111/j.1742-4658.2009.07166.x; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	53	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57903	10.1371/journal.pone.0057903	http://dx.doi.org/10.1371/journal.pone.0057903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469100	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900195
J	Sasakawa, K				Sasakawa, Koji			A Novel Technique for Identifying the Instar of Field-Collected Insect Larvae	PLOS ONE			English	Article							GROUND BEETLES COLEOPTERA; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; RIBOSOMAL DNA; CARABIDAE; IDENTIFICATION; MITOCHONDRIAL; CHARACTERS	Many field studies of insects have focused on the adult stage alone, likely because immature stages are unknown in most insect species. Molecular species identification (e.g., DNA barcoding) has helped ascertain the immature stages of many insects, but larval developmental stages (instars) cannot be identified. The identification of the growth stages of collected individuals is indispensable from both ecological and taxonomic perspectives. Using a larval-adult body size relationship across species, I present a novel technique for identifying the instar of field-collected insect larvae that are identified by molecular species identification technique. This method is based on the assumption that classification functions derived from discriminant analyses, performed with larval instar as a response variable and adult and larval body sizes as explanatory variables, can be used to determine the instar of a given larval specimen that was not included in the original data set, even at the species level. This size relationship has been demonstrated in larval instars for many insects (Dyar's rule), but no attempt has been made to include the adult stage. Analysis of a test data set derived from the beetle family Carabidae (Coleoptera) showed that classification functions obtained from data sets derived from related species had a correct classification rate of 81-100%. Given that no reliable method has been established to identify the instar of field-collected insect larvae, these values may have sufficient accuracy as an analytical method for field-collected samples. The chief advantage of this technique is that the instar can be identified even when only one specimen is available per species if classification functions are determined for groups to which the focal species belongs. Similar classification functions should be created for other insect groups. By using those functions together with molecular species identification, future studies could include larval stages as well as adults.	Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan	University of Tokyo	Sasakawa, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan.	cksasa@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [20-11227]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by the Japan Society for the Promotion of Science (JSPS) (the Research Fellowship for Young Scientists; no. 20-11227). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andujar C, 2010, ZOOTAXA, P47; Beutel RG, 2005, SYST ENTOMOL, V30, P510, DOI 10.1111/j.1365-3113.2005.00293.x; Bousquet Y, 2010, ILLUSTRATED IDENTIFI; Casale Achille, 2007, Subterranean Biology, V5, P35; Chandra G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-138; Emden F. I. van., 1942, Transactions of the Royal Entomological Society of London, V92, P1; Foltan P, 2005, MOL ECOL, V14, P4147, DOI 10.1111/j.1365-294X.2005.02732.x; Grebennikov VV, 2008, INVERTEBR SYST, V22, P479, DOI 10.1071/IS07051; Gullan P.J., 2010, INSECTS OUTLINE ENTO; Habu A., 1961, Bulletin of the National Institute of Agricultural Sciences Tokyo (Ser C), V13, P207; Hayashi M, 2010, ENTOMOL SCI, V13, P417, DOI 10.1111/j.1479-8298.2010.00404.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holland JM, 2002, AGROECOLOGY OF CARABID BEETLES, P1; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Klimes P, 2010, J APPL ENTOMOL, V134, P659, DOI 10.1111/j.1439-0418.2009.01463.x; Lawrence JF, 2011, ANN ZOOL, V61, P1, DOI 10.3161/000345411X576725; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Luff ML, 2005, P 11 EUR CAR M ARH D, P183; Luff ML, 1993, CARABIDAE COLEOPTERA; Lundgren JG, 2009, RELATIONSHIPS NATURA; Maddison DR, 1999, SYST ENTOMOL, V24, P103, DOI 10.1046/j.1365-3113.1999.00088.x; Ober KA, 2002, MOL PHYLOGENET EVOL, V24, P228, DOI 10.1016/S1055-7903(02)00251-8; Ober KA, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.6301; R Core Team, 2021, R LANGUAGE ENV STAT; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rehn AC, 2003, SYST ENTOMOL, V28, P181, DOI 10.1046/j.1365-3113.2003.00210.x; Rencher AC, 2002, METHODS MULTIVARIATE; Ribera I, 2005, J ZOOL SYST EVOL RES, V43, P284, DOI 10.1111/j.1439-0469.2005.00324.x; Ruiz C, 2009, MOL PHYLOGENET EVOL, V50, P44, DOI 10.1016/j.ympev.2008.09.023; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Solodovnikov AY, 2007, J ZOOL SYST EVOL RES, V45, P120, DOI 10.1111/j.1439-0469.2006.00387.x; Zetto Brandmayr T., 1998, PHYLOGENY AND CLASSI, P449	32	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57836	10.1371/journal.pone.0057836	http://dx.doi.org/10.1371/journal.pone.0057836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469083	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900179
J	Shafeeq, S; Kuipers, OP; Kloosterman, TG				Shafeeq, Sulman; Kuipers, Oscar P.; Kloosterman, Tomas G.			Cellobiose-Mediated Gene Expression in Streptococcus pneumoniae: A Repressor Function of the Novel GntR-Type Regulator BguR	PLOS ONE			English	Article							CARBOHYDRATE PHOSPHOTRANSFERASE SYSTEMS; BACILLUS-SUBTILIS; VIRULENCE FACTORS; GENOME SEQUENCE; STRAIN R6; METABOLISM; OPERON; COLONIZATION; BACTERIA; DISEASE	The human pathogen Streptococcus pneumoniae has the ability to use the carbon-and energy source cellobiose due to the presence of a cellobiose-utilizing gene cluster (cel locus) in its genome. This system is regulated by the cellobiose-dependent transcriptional activator CelR, which has been previously shown to contribute to pneumococcal virulence. To get a broader understanding of the response of S. pneumoniae to cellobiose, we compared the pneumococcal transcriptome during growth on glucose as the main carbon source to that with cellobiose as the main carbon source. The expression of various carbon metabolic genes was altered, including a PTS operon (which we here denote as the bgu operon) that has high similarity with the cel locus. In contrast to the cel locus, the bgu operon is conserved in all sequenced strains of S. pneumoniae, indicating an important physiological function in the lifestyle of pneumococci. We next characterized the transcriptional regulation of the bgu operon in more detail. Its expression was increased in the presence of cellobiose, and decreased in the presence of glucose. A novel GntR-type transcriptional regulator (which we here denote as BguR) was shown to act as a transcriptional repressor of the bgu operon and its repressive effect was relieved in the presence of cellobiose. BguR-dependent repression was demonstrated to be mediated by a 20-bp DNA operator site (5'-AAAAATGTCTAGACAAATTT-3') present in PbguA, as verified by promoter truncation experiments. In conclusion, we have identified a new cellobiose-responsive PTS operon, together with its transcriptional regulator in S. pneumoniae.	[Shafeeq, Sulman; Kuipers, Oscar P.; Kloosterman, Tomas G.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009; Shafeeq, Sulman/P-4473-2014	Kuipers, Oscar/0000-0001-5596-7735; Shafeeq, Sulman/0000-0003-1152-526X	HEC (Higher Education commission) Pakistan; EU [HEALTH-F3-2009-222983]; HEC-NUFFIC overseas scholarship program	HEC (Higher Education commission) Pakistan(Higher Education Commission of Pakistan); EU(European Commission); HEC-NUFFIC overseas scholarship program	SS is supported by the HEC-NUFFIC overseas scholarship program by HEC (Higher Education commission) Pakistan and TGK was supported by the EU-funded Pneumopath project HEALTH-F3-2009-222983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boianelli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047393; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Buckwalter CM, 2012, TRENDS MICROBIOLOGY; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kilic AO, 2004, J BACTERIOL, V186, P4246, DOI 10.1128/JB.186.13.4246-4253.2004; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lengeler JW, 2009, CONTRIB MICROBIOL, V16, P65, DOI 10.1159/000219373; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Matsuura Y, 1998, J NUTR SCI VITAMINOL, V44, P423, DOI 10.3177/jnsv.44.423; McAllister LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032385; McGeer A, 2003, NAT MED, V9, P390, DOI 10.1038/nm0403-390; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Neelakanta G, 2009, APPL ENVIRON MICROB, V75, P2284, DOI 10.1128/AEM.02621-08; Nieto C, 1997, J BIOL CHEM, V272, P30860, DOI 10.1074/jbc.272.49.30860; Nieto C, 2001, J BIOL CHEM, V276, P14946, DOI 10.1074/jbc.M010911200; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Obaro S, 2002, J MED MICROBIOL, V51, P98, DOI 10.1099/0022-1317-51-2-98; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; Sadaie Y, 2008, FEMS MICROBIOL LETT, V279, P103, DOI 10.1111/j.1574-6968.2007.01018.x; Shafeeq S, 2012, MICROBIOL-SGM, V158, P2917, DOI 10.1099/mic.0.062919-0; Shafeeq S, 2011, MICROBIOL-SGM, V157, P2854, DOI 10.1099/mic.0.051359-0; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tyx RE, 2011, J BACTERIOL, V193, P3512, DOI 10.1128/JB.01410-10; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Zeng L, 2009, J BACTERIOL, V191, P2153, DOI 10.1128/JB.01641-08; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	46	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57586	10.1371/journal.pone.0057586	http://dx.doi.org/10.1371/journal.pone.0057586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469031	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900130
J	Clambey, ET; Collins, B; Young, MH; Eberlein, J; David, A; Kappler, JW; Marrack, P				Clambey, Eric T.; Collins, Bernard; Young, Mary H.; Eberlein, Jens; David, Alexandria; Kappler, John W.; Marrack, Philippa			The Ikaros Transcription Factor Regulates Responsiveness to IL-12 and Expression of IL-2 Receptor Alpha in Mature, Activated CD8 T Cells	PLOS ONE			English	Article							FATE DECISIONS; MEMORY; EFFECTOR; GENE; DIFFERENTIATION; GENERATION; MICE; BET; INTERLEUKIN-12; LYMPHOCYTE	The Ikaros family of transcription factors is critical for normal T cell development while limiting malignant transformation. Mature CD8 T cells express multiple Ikaros family members, yet little is known about their function in this context. To test the functions of this gene family, we used retroviral transduction to express a naturally occurring, dominant negative (DN) isoform of Ikaros in activated CD8 T cells. Notably, expression of DN Ikaros profoundly enhanced the competitive advantage of activated CD8 T cells cultured in IL-12, such that by 6 days of culture, DN Ikaros-transduced cells were 100-fold more abundant than control cells. Expression of a DN isoform of Helios, a related Ikaros-family transcription factor, conferred a similar advantage to transduced cells in IL-12. While DN Ikaros-transduced cells had higher expression of the IL-2 receptor alpha chain, DN Ikaros-transduced cells achieved their competitive advantage through an IL-2 independent mechanism. Finally, the competitive advantage of DN Ikaros-transduced cells was manifested in vivo, following adoptive transfer of transduced cells. These data identify the Ikaros family of transcription factors as regulators of cytokine responsiveness in activated CD8 T cells, and suggest a role for this family in influencing effector and memory CD8 T cell differentiation.	[Clambey, Eric T.; Young, Mary H.; Eberlein, Jens; David, Alexandria; Kappler, John W.; Marrack, Philippa] Univ Colorado, Integrated Dept Immunol, Aurora, CO USA; [Clambey, Eric T.; Collins, Bernard; Young, Mary H.; David, Alexandria; Kappler, John W.; Marrack, Philippa] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO USA; [Clambey, Eric T.; Eberlein, Jens] Univ Colorado, Dept Anesthesiol, Aurora, CO USA; [Clambey, Eric T.] Univ Colorado, Mucosal Inflammat Program, Aurora, CO USA; [Collins, Bernard; Marrack, Philippa] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO USA; [Eberlein, Jens] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado, Dept Med, Aurora, CO USA; [Kappler, John W.] Univ Colorado, Dept Pharmacol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Clambey, ET (corresponding author), Univ Colorado, Integrated Dept Immunol, Anschutz Med Campus, Aurora, CO USA.	eric.clambey@ucdenver.edu	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	National Institutes of Health [AI-17134, AI-18785, AI-22295, AI-52225]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI018785, R56AI017134, R01AI018785, R37AI017134, R37AI018785, R01AI017134, R01AI052225, P01AI022295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work supported by National Institutes of Health grants AI-17134, AI-18785, AI-22295 and AI-52225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinheiro AAD, 2007, J LEUKOCYTE BIOL, V81, P1102, DOI 10.1189/jlb.0906583; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Berg RE, 2002, EUR J IMMUNOL, V32, P2807, DOI 10.1002/1521-4141(2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fallarino F, 1996, J IMMUNOL, V156, P1095; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Grossel MJ, 1999, J BIOL CHEM, V274, P29960, DOI 10.1074/jbc.274.42.29960; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Manders PM, 2005, P NATL ACAD SCI USA, V102, P7418, DOI 10.1073/pnas.0501585102; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Quintana FJ, 2012, NAT IMMUNOL; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Rao JB, 1996, J IMMUNOL, V156, P3357; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Roberts KG, 2011, CURR OPIN PEDIATR, V23, P34, DOI 10.1097/MOP.0b013e3283426260; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schmidt CS, 2002, J IMMUNOL, V168, P5521, DOI 10.4049/jimmunol.168.11.5521; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Thaventhiran JE, 2012, P NATL ACAD SCI US; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thomas RM, 2010, J BIOL CHEM, V285, P2545, DOI 10.1074/jbc.M109.038794; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Umetsu SE, 2009, J IMMUNOL, V183, P5518, DOI 10.4049/jimmunol.0901284; Urban JA, 2004, J IMMUNOL, V173, P4470, DOI 10.4049/jimmunol.173.7.4470; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Welsh RM, 2009, IMMUNITY, V31, P178, DOI 10.1016/j.immuni.2009.08.005; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Yap WH, 2005, FEBS LETT, V579, P4470, DOI 10.1016/j.febslet.2005.07.018; Zhang L, 2011, MOL THER, V19, P751, DOI 10.1038/mt.2010.313; Zhang Z, 2007, BLOOD, V109, P2190, DOI 10.1182/blood-2005-01-031930; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	70	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57435	10.1371/journal.pone.0057435	http://dx.doi.org/10.1371/journal.pone.0057435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23483882	gold, Green Submitted, Green Published			2022-12-27	WOS:000315561400042
J	San Martin, A; Ceballo, S; Ruminot, I; Lerchundi, R; Frommer, WB; Barros, LF				San Martin, Alejandro; Ceballo, Sebastian; Ruminot, Ivan; Lerchundi, Rodrigo; Frommer, Wolf B.; Felipe Barros, Luis			A Genetically Encoded FRET Lactate Sensor and Its Use To Detect the Warburg Effect in Single Cancer Cells	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER MCT4; ASTROCYTIC GLYCOLYSIS; METABOLIC TRANSFORMATION; ENERGY-METABOLISM; MITOCHONDRIAL; STIMULATION; GLUCOSE; EXPRESSION; NEURONS; PROTEIN	Lactate is shuttled between and inside cells, playing metabolic and signaling roles in healthy tissues. Lactate is also a harbinger of altered metabolism and participates in the pathogenesis of inflammation, hypoxia/ischemia, neurodegeneration and cancer. Many tumor cells show high rates of lactate production in the presence of oxygen, a phenomenon known as the Warburg effect, which has diagnostic and possibly therapeutic implications. In this article we introduce Laconic, a genetically-encoded Forster Resonance Energy Transfer (FRET)-based lactate sensor designed on the bacterial transcription factor LldR. Laconic quantified lactate from 1 mu M to 10 mM and was not affected by glucose, pyruvate, acetate, betahydroxybutyrate, glutamate, citrate, alpha-ketoglutarate, succinate, malate or oxalacetate at concentrations found in mammalian cytosol. Expressed in astrocytes, HEK cells and T98G glioma cells, the sensor allowed dynamic estimation of lactate levels in single cells. Used in combination with a blocker of the monocarboxylate transporter MCT, the sensor was capable of discriminating whether a cell is a net lactate producer or a net lactate consumer. Application of the MCT-block protocol showed that the basal rate of lactate production is 3-5 fold higher in T98G glioma cells than in normal astrocytes. In contrast, the rate of lactate accumulation in response to mitochondrial inhibition with sodium azide was 10 times lower in glioma than in astrocytes, consistent with defective tumor metabolism. A ratio between the rate of lactate production and the rate of azide-induced lactate accumulation, which can be estimated reversibly and in single cells, was identified as a highly sensitive parameter of the Warburg effect, with values of 4.1 +/- 0.5 for T98G glioma cells and 0.07 +/- 0.007 for astrocytes. In summary, this article describes a genetically-encoded sensor for lactate and its use to measure lactate concentration, lactate flux, and the Warburg effect in single mammalian cells.	[San Martin, Alejandro; Ceballo, Sebastian; Ruminot, Ivan; Lerchundi, Rodrigo; Felipe Barros, Luis] Ctr Estudios Cient, Valdivia, Chile; [San Martin, Alejandro; Ceballo, Sebastian; Ruminot, Ivan; Lerchundi, Rodrigo] Univ Austral Chile, Valdivia, Chile; [Frommer, Wolf B.] Carnegie Inst Sci, Stanford, CA USA	Universidad Austral de Chile; Carnegie Institution for Science	Barros, LF (corresponding author), Ctr Estudios Cient, Valdivia, Chile.	fbarros@cecs.cl	Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017; Ceballo, Sebastian/B-2372-2016; Ceballo, Sebastian/M-2902-2019	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Ceballo, Sebastian/0000-0001-7710-421X; San Martin, Alejandro/0000-0002-5608-5117	Fondecyt [1100936]; Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT; Gobierno Regional de Los RIos; National Institutes of Health (NIDDK) [1RO1DK079109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT; Gobierno Regional de Los RIos; National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Partly supported by Fondecyt grant 1100936. The Centro de Estudios CientIficos (CECs) is funded by the Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT and the Gobierno Regional de Los RIos. WBF was supported by a grant from the National Institutes of Health (NIDDK; 1RO1DK079109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera L, 2008, J BACTERIOL, V190, P2997, DOI [10.1128/JB.02013-07, 10.1128/JB.00815-08]; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; Bittner CX, 2011, J NEUROSCI, V31, P4709, DOI 10.1523/JNEUROSCI.5311-10.2011; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; BROWN MA, 1994, ARCH BIOCHEM BIOPHYS, V313, P22, DOI 10.1006/abbi.1994.1353; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gao C, 2012, J BACTERIOL, V194, P2687, DOI 10.1128/JB.06579-11; Gao YG, 2008, NUCLEIC ACIDS RES, V36, P7110, DOI 10.1093/nar/gkn827; Georgi T, 2008, J BACTERIOL, V190, P963, DOI 10.1128/JB.01147-07; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Hashimoto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002915; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hussien R, 2011, PHYSIOL GENOMICS, V43, P255, DOI 10.1152/physiolgenomics.00177.2010; Jolivet R, 2010, J CEREBR BLOOD F MET, V30, P1982, DOI 10.1038/jcbfm.2010.132; KAUPPINEN RA, 1982, BIOCHIM BIOPHYS ACTA, V681, P286, DOI 10.1016/0005-2728(82)90033-0; Lager I, 2006, J BIOL CHEM, V281, P30875, DOI 10.1074/jbc.M605257200; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Loaiza A, 2003, J NEUROSCI, V23, P7337; Marcillac F, 2011, GLIA, V59, P1987, DOI 10.1002/glia.21240; Maughan DW, 2005, MOL CELL PROTEOMICS, V4, P1541, DOI 10.1074/mcp.M500053-MCP200; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Shimizu H, 2007, NEURON, V54, P59, DOI 10.1016/j.neuron.2007.03.014; SIESS EA, 1978, H-S Z PHYSIOL CHEM, V359, P785, DOI 10.1515/bchm2.1978.359.2.785; Sotelo-Hitschfeld T, 2012, GLIA, V60, P674, DOI 10.1002/glia.22304; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	52	203	207	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57712	10.1371/journal.pone.0057712	http://dx.doi.org/10.1371/journal.pone.0057712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469056	Green Submitted, gold, Green Published			2022-12-27	WOS:000315561400045
J	Collino, S; Montoliu, I; Martin, FPJ; Scherer, M; Mari, D; Salvioli, S; Bucci, L; Ostan, R; Monti, D; Biagi, E; Brigidi, P; Franceschi, C; Rezzi, S				Collino, Sebastiano; Montoliu, Ivan; Martin, Francois-Pierre J.; Scherer, Max; Mari, Daniela; Salvioli, Stefano; Bucci, Laura; Ostan, Rita; Monti, Daniela; Biagi, Elena; Brigidi, Patrizia; Franceschi, Claudio; Rezzi, Serge			Metabolic Signatures of Extreme Longevity in Northern Italian Centenarians Reveal a Complex Remodeling of Lipids, Amino Acids, and Gut Microbiota Metabolism	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; EPOXYEICOSATRIENOIC ACIDS; RHEUMATOID-ARTHRITIS; CALORIC RESTRICTION; CROHNS-DISEASE; FATTY-ACIDS; PLASMA; SPECTROSCOPY; POPULATION; IDENTIFICATION	The aging phenotype in humans has been thoroughly studied but a detailed metabolic profiling capable of shading light on the underpinning biological processes of longevity is still missing. Here using a combined metabonomics approach compromising holistic 1 H-NMR profiling and targeted MS approaches, we report for the first time the metabolic phenotype of longevity in a well characterized human aging cohort compromising mostly female centenarians, elderly, and young individuals. With increasing age, targeted MS profiling of blood serum displayed a marked decrease in tryptophan concentration, while an unique alteration of specific glycerophospholipids and sphingolipids are seen in the longevity phenotype. We hypothesized that the overall lipidome changes specific to longevity putatively reflect centenarians' unique capacity to adapt/respond to the accumulating oxidative and chronic inflammatory conditions characteristic of their extreme aging phenotype. Our data in centenarians support promotion of cellular detoxification mechanisms through specific modulation of the arachidonic acid metabolic cascade as we underpinned increased concentration of 8,9-EpETrE, suggesting enhanced cytochrome P450 (CYP) enzyme activity. Such effective mechanism might result in the activation of an anti-oxidative response, as displayed by decreased circulating levels of 9-HODE and 9-oxoODE, markers of lipid peroxidation and oxidative products of linoleic acid. Lastly, we also revealed that the longevity process deeply affects the structure and composition of the human gut microbiota as shown by the increased extrection of phenylacetylglutamine (PAG) and p-cresol sulfate (PCS) in urine of centenarians. Together, our novel approach in this representative Italian longevity cohort support the hypothesis that a complex remodeling of lipid, amino acid metabolism, and of gut microbiota functionality are key regulatory processes marking exceptional longevity in humans.	[Collino, Sebastiano; Martin, Francois-Pierre J.; Scherer, Max; Rezzi, Serge] Nestle Inst Hlth Sci SA, Prote & Metabon, Lausanne, Switzerland; [Montoliu, Ivan] Nestec Ltd, Appl Math, Nestle Res Ctr, Lausanne, Switzerland; [Mari, Daniela] Univ Milan, Dept Med Sci, Milan, Italy; [Mari, Daniela] Geriatr Unit Ca Grande Fdn Maggiore Policlin Hosp, Milan, Italy; [Salvioli, Stefano; Bucci, Laura; Ostan, Rita; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Salvioli, Stefano; Bucci, Laura; Ostan, Rita; Franceschi, Claudio] Univ Bologna, Interdept Ctr L Galvani, Bologna, Italy; [Monti, Daniela] Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy; [Biagi, Elena; Brigidi, Patrizia] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy	Nestle SA; Nestle SA; University of Milan; University of Bologna; University of Bologna; University of Florence; University of Bologna	Collino, S (corresponding author), Nestle Inst Hlth Sci SA, Prote & Metabon, Campus EPFL, Lausanne, Switzerland.	sebastiano.collino@rd.nestle.com	Salvioli, Stefano/K-6663-2016; Franceschi, Claudio/L-4484-2017; Monti, Daniela/G-9556-2012; Ostan, Rita/K-3074-2018; Mari, Daniela/K-5663-2016	Salvioli, Stefano/0000-0002-6191-1225; Franceschi, Claudio/0000-0001-9841-6386; Monti, Daniela/0000-0001-8651-8123; Ostan, Rita/0000-0002-0299-2811; Mari, Daniela/0000-0002-6950-0789; Martin, Francois-Pierre/0000-0003-1373-5367; Brigidi, Patrizia/0000-0001-8375-6150; Collins, Steve/0000-0002-3997-3374	University of Florence; MIUR	University of Florence; MIUR(Ministry of Education, Universities and Research (MIUR))	The authors are grateful to CEPS and ANNFAS no-profit associations and to Dr. Daniela Follo and Alessandro Ghezzo for the recruitment of DS persons. This research was funded by University of Florence to D. Monti and MIUR (PRIN2006) to D. Monti, CF, and D. Mari. The funding sources have not been involved in the design, analysis or interpretation of the results.	Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Atmon G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/j.mad.2004.08.026; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Baur P, 2011, J PROTEOME RES; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burkle Alexander, 2007, Immun Ageing, V4, P4, DOI 10.1186/1742-4933-4-4; BYRNE GI, 1986, J INTERFERON RES, V6, P389, DOI 10.1089/jir.1986.6.389; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Campbell WB, 2000, TRENDS PHARMACOL SCI, V21, P125, DOI 10.1016/S0165-6147(00)01472-3; Cevenini E, 2008, EXPERT OPIN BIOL TH, V8, P1393, DOI 10.1517/14712598.8.9.1393 ; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Davinelli S, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-9; De Benedictis G, 1998, EUR J HUM GENET, V6, P534, DOI 10.1038/sj.ejhg.5200222; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Dillon EL, 2009, J CLIN ENDOCR METAB, V94, P1630, DOI 10.1210/jc.2008-1564; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Fuchs B, 2005, CLIN BIOCHEM, V38, P925, DOI 10.1016/j.clinbiochem.2005.06.006; Gaskins AJ, 2010, AM J CLIN NUTR, V92, P1461, DOI 10.3945/ajcn.110.000026; Guigoz Y, 2008, CURR OPIN CLIN NUTR, V11, P13, DOI 10.1097/MCO.0b013e3282f2bfdf; GUPTA N, 2011, INFLAMM BOWEL DIS; Hsieh CC, 2004, MECH AGEING DEV, V125, P785, DOI 10.1016/j.mad.2004.07.008; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; Jira W, 1997, CHEM PHYS LIPIDS, V87, P81, DOI 10.1016/S0009-3084(97)00030-3; Jira W, 1998, CHEM PHYS LIPIDS, V91, P1, DOI 10.1016/S0009-3084(97)00095-9; Kummerow FA, 2001, J NUTR BIOCHEM, V12, P602, DOI 10.1016/S0955-2863(01)00181-4; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Maeba R, 2007, J ATHEROSCLER THROMB, V14, P12, DOI 10.5551/jat.14.12; Magni E, 1996, EUR J NEUROL, V3, P198, DOI 10.1111/j.1468-1331.1996.tb00423.x; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Oostendorp M, 2006, CLIN CHEM, V52, P1395, DOI 10.1373/clinchem.2006.069112; Passarino G, 2002, EXP GERONTOL, V37, P1283, DOI 10.1016/S0531-5565(02)00140-7; Patterson D, 2011, MECH AGEING DEV; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pereira SP, 1996, CLIN SCI, V91, P509, DOI 10.1042/cs0910509; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Radmark O, 2003, ARTERIOSCL THROM VAS, V23, P1140, DOI 10.1161/01.ATV.0000082460.58448.01; Rezzi S, 2007, J PROTEOME RES, V6, P4469, DOI 10.1021/pr070431h; Rezzi S, 2009, EXP GERONTOL, V44, P356, DOI 10.1016/j.exger.2009.02.008; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Schieke SM, 2007, CELL METAB, V5, P233, DOI 10.1016/j.cmet.2007.03.005; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212; Siddiqui N, 2003, J LIPID RES, V44, P2406, DOI 10.1194/jlr.D300017-JLR200; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Suliman ME, 2005, AM J CLIN NUTR, V82, P342, DOI 10.1093/ajcn/82.2.342; TAKATA S, 1994, AM J PATHOL, V145, P541; Wang YL, 2007, J PROTEOME RES, V6, P1846, DOI 10.1021/pr060685n; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Wijeyesekera A, 2012, J PROTEOME RES, V11, P2224, DOI 10.1021/pr2010154; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yeboah J, 2010, ARTERIOSCL THROM VAS, V30, P628, DOI 10.1161/ATVBAHA.109.199281	59	175	176	4	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e56564	10.1371/journal.pone.0056564	http://dx.doi.org/10.1371/journal.pone.0056564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483888	Green Published, gold			2022-12-27	WOS:000316936100006
J	Jensen, TJ; Zwiefelhofer, T; Tim, RC; Dzakula, Z; Kim, SK; Mazloom, AR; Zhu, ZY; Tynan, J; Lu, T; McLennan, G; Palomaki, GE; Canick, JA; Oeth, P; Deciu, C; van den Boom, D; Ehrich, M				Jensen, Taylor J.; Zwiefelhofer, Tricia; Tim, Roger C.; Dzakula, Zeljko; Kim, Sung K.; Mazloom, Amin R.; Zhu, Zhanyang; Tynan, John; Lu, Tim; McLennan, Graham; Palomaki, Glenn E.; Canick, Jacob A.; Oeth, Paul; Deciu, Cosmin; van den Boom, Dirk; Ehrich, Mathias			High-Throughput Massively Parallel Sequencing for Fetal Aneuploidy Detection from Maternal Plasma	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; DOWN-SYNDROME; DNA METHYLATION; LIGATION	Background: Circulating cell-free (ccf) fetal DNA comprises 3-20% of all the cell-free DNA present in maternal plasma. Numerous research and clinical studies have described the analysis of ccf DNA using next generation sequencing for the detection of fetal aneuploidies with high sensitivity and specificity. We sought to extend the utility of this approach by assessing semi-automated library preparation, higher sample multiplexing during sequencing, and improved bioinformatic tools to enable a higher throughput, more efficient assay while maintaining or improving clinical performance. Methods: Whole blood (10mL) was collected from pregnant female donors and plasma separated using centrifugation. Ccf DNA was extracted using column-based methods. Libraries were prepared using an optimized semi-automated library preparation method and sequenced on an Illumina HiSeq2000 sequencer in a 12-plex format. Z-scores were calculated for affected chromosomes using a robust method after normalization and genomic segment filtering. Classification was based upon a standard normal transformed cutoff value of z = 3 for chromosome 21 and z = 3.95 for chromosomes 18 and 13. Results: Two parallel assay development studies using a total of more than 1900 ccf DNA samples were performed to evaluate the technical feasibility of automating library preparation and increasing the sample multiplexing level. These processes were subsequently combined and a study of 1587 samples was completed to verify the stability of the process-optimized assay. Finally, an unblinded clinical evaluation of 1269 euploid and aneuploid samples utilizing this high-throughput assay coupled to improved bioinformatic procedures was performed. We were able to correctly detect all aneuploid cases with extremely low false positive rates of 0.09%, <0.01%, and 0.08% for trisomies 21, 18, and 13, respectively. Conclusions: These data suggest that the developed laboratory methods in concert with improved bioinformatic approaches enable higher sample throughput while maintaining high classification accuracy.	[Jensen, Taylor J.; Zwiefelhofer, Tricia; Tim, Roger C.; Dzakula, Zeljko; Kim, Sung K.; Mazloom, Amin R.; Zhu, Zhanyang; Tynan, John; Lu, Tim; Oeth, Paul; Deciu, Cosmin] Sequenom Inc, Res & Dev, Ctr Mol Med, San Diego, CA USA; [McLennan, Graham; van den Boom, Dirk; Ehrich, Mathias] Sequenom Inc, Res & Dev, San Diego, CA USA; [Palomaki, Glenn E.; Canick, Jacob A.] Brown Univ, Women & Infants Hosp, Alpert Med Sch, Providence, RI USA	Sequenom; Sequenom; Brown University; Women & Infants Hospital Rhode Island	Ehrich, M (corresponding author), Sequenom Inc, Res & Dev, San Diego, CA USA.	mehrich@sequenom.com			Sequenom, Inc.	Sequenom, Inc.	This study was funded by Sequenom, Inc. The funding organization had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Canick JA, 2012, PRENATAL DIAG, V32, P730, DOI 10.1002/pd.3892; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Della Ragione F, 2010, J MOL DIAGN, V12, P797, DOI 10.2353/jmoldx.2010.090199; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Faas BHW, 2012, EXPERT OPIN BIOL TH, V12, pS19, DOI 10.1517/14712598.2012.670632; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Patsalis PC, 2012, EXPERT OPIN BIOL TH, V12, pS155, DOI 10.1517/14712598.2012.674108; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922	27	77	116	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57381	10.1371/journal.pone.0057381	http://dx.doi.org/10.1371/journal.pone.0057381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483908	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100025
J	Chen, J; Zhang, LC; Xing, YM; Wang, YQ; Xing, XK; Zhang, DW; Liang, HQ; Guo, SX				Chen, Juan; Zhang, Li-Chun; Xing, Yong-Mei; Wang, Yun-Qiang; Xing, Xiao-Ke; Zhang, Da-Wei; Liang, Han-Qiao; Guo, Shun-Xing			Diversity and Taxonomy of Endophytic Xylariaceous Fungi from Medicinal Plants of Dendrobium (Orchidaceae)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SEQUENCE; TREES; TAXOL	Dendrobium spp. are traditional Chinese medicinal plants, and the main effective ingredients (polysaccharides and alkaloids) have pharmacologic effects on gastritis infection, cancer, and anti-aging. Previously, we confirmed endophytic xylariaceous fungi as the dominant fungi in several Dendrobium species of tropical regions from China. In the present study, the diversity, taxonomy, and distribution of culturable endophytic xylariaceous fungi associated with seven medicinal species of Dendrobium (Orchidaceae) were investigated. Among the 961 endophytes newly isolated, 217 xylariaceous fungi (morphotaxa) were identified using morphological and molecular methods. The phylogenetic tree constructed using nuclear ribosomal internal transcribed spacer (ITS), large subunit of ribosomal DNA (LSU), and beta-tubulin sequences divided these anamorphic xylariaceous isolates into at least 18 operational taxonomic units (OTUs). The diversity of the endophytic xylariaceous fungi in these seven Dendrobium species was estimated using Shannon and evenness indices, with the results indicating that the dominant Xylariaceae taxa in each Dendrobium species were greatly different, though common xylariaceous fungi were found in several Dendrobium species. These findings implied that different host plants in the same habitats exhibit a preference and selectivity for their fungal partners. Using culture-dependent approaches, these xylariaceous isolates may be important sources for the future screening of new natural products and drug discovery.	[Chen, Juan; Zhang, Li-Chun; Xing, Yong-Mei; Xing, Xiao-Ke; Zhang, Da-Wei; Liang, Han-Qiao; Guo, Shun-Xing] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Chen, Juan; Zhang, Li-Chun; Xing, Yong-Mei; Xing, Xiao-Ke; Zhang, Da-Wei; Liang, Han-Qiao; Guo, Shun-Xing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Yun-Qiang] Bot Garden Xishuangbanna S Med, Jinghong, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Guo, SX (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	sxguo2006@yahoo.com.cn			National Natural Science Foundation of China [30900004, 31070300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This investigation was supported by National Natural Science Foundation of China (30900004 and 31070300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly AH, 2011, FUNGAL DIVERS, V50, P3, DOI 10.1007/s13225-011-0116-y; Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Bayman P, 1997, NEW PHYTOL, V135, P143, DOI 10.1046/j.1469-8137.1997.00618.x; Bayman P., 2006, SOIL BIOL, P153; Botella L, 2011, FUNGAL DIVERS, V47, P9, DOI 10.1007/s13225-010-0061-1; CALLAN BE, 1990, MYCOTAXON, V36, P343; CALLAN BE, 1993, MYCOTAXON, V46, P141; Chareprasert Sukanyanee, 2012, Prog Mol Subcell Biol, V53, P229, DOI 10.1007/978-3-642-23342-5_12; Chen J, 2011, WORLD J MICROB BIOT, V27, P1009, DOI 10.1007/s11274-010-0544-y; Chen SC, 1999, NATIVE ORCHIDS CHINA, P1; Chen Xiao-Mei, 2005, Zhongguo Zhongyao Zazhi, V30, P253; Davis EC, 2003, AM J BOT, V90, P1661, DOI 10.3732/ajb.90.11.1661; de Errasti A, 2010, FUNGAL DIVERS, V41, P29, DOI 10.1007/s13225-009-0012-x; Dearnaley JDW, 2007, MYCORRHIZA, V17, P475, DOI 10.1007/s00572-007-0138-1; Debbab A, 2012, FUNGAL DIVERS, V57, P45, DOI 10.1007/s13225-012-0191-8; Debbab A, 2011, FUNGAL DIVERS, V49, P1, DOI 10.1007/s13225-011-0114-0; Edwards RL, 2003, REC RES DEV PLANT S, V1, P1; Ganley RJ, 2004, P NATL ACAD SCI USA, V101, P10107, DOI 10.1073/pnas.0401513101; Guedegbe HJ, 2009, MYCOL RES, V113, P1039, DOI 10.1016/j.mycres.2009.06.008; Guo LD, 2003, MYCOL RES, V107, P680, DOI 10.1017/S0953756203007834; Hacioglu N, 2011, AFR J MICROBIOL RES, V5, P728; Hamilton CE, 2012, FUNGAL DIVERS, V54, P39, DOI 10.1007/s13225-012-0156-y; Hsieh HM, 2005, MYCOLOGIA, V97, P844, DOI 10.3852/mycologia.97.4.844; Hsieh HM, 2010, MOL PHYLOGENET EVOL, V54, P957, DOI 10.1016/j.ympev.2009.12.015; Kirk PM., 2008, DICT FUNGI, V10th ed; Klaiklay S, 2012, ARCH PHARM RES, V35, P1127, DOI 10.1007/s12272-012-0701-y; Ko TWK, 2011, FUNGAL DIVERS, V50, P113, DOI 10.1007/s13225-011-0130-0; Lacap DC, 2003, FUNGAL DIVERS, V12, P53; Liu KH, 2010, BIOTECHNOL LETT, V32, P689, DOI 10.1007/s10529-010-0201-4; Martos F, 2012, MOL ECOL, V21, P5098, DOI 10.1111/j.1365-294X.2012.05692.x; Nylander JAA., 2004, BIOINFORMATICS; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Okane I, 2008, MYCOSCIENCE, V49, P359, DOI 10.1007/s10267-008-0440-6; Okane I, 2012, MYCOSCIENCE, V53, P122, DOI 10.1007/s10267-011-0149-9; Pelaez F, 2008, FUNGAL DIVERS, V31, P111; PETRINI L, 1985, Sydowia, V38, P216; Promputtha I, 2007, MICROB ECOL, V53, P579, DOI 10.1007/s00248-006-9117-x; Purahong W, 2011, FUNGAL DIVERS, V47, P1, DOI 10.1007/s13225-010-0083-8; Radic N, 2012, PHYTOMEDICINE, V19, P1270, DOI 10.1016/j.phymed.2012.09.007; ROGERS J D, 1985, Sydowia, V38, P255; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sieber Thomas N., 2007, Fungal Biology Reviews, V21, P75, DOI 10.1016/j.fbr.2007.05.004; Silva GH, 2010, PHYTOCHEM LETT, V3, P164, DOI 10.1016/j.phytol.2010.07.001; Siriwach R, 2011, J ANTIBIOT, V64, P217, DOI 10.1038/ja.2010.160; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 1996, MICROBIOL-UK, V142, P435, DOI 10.1099/13500872-142-2-435; Sun X, 2011, FUNGAL DIVERS, V47, P85, DOI 10.1007/s13225-010-0086-5; Suwannasai N, 2012, IMA FUNGUS, V3, P125, DOI 10.5598/imafungus.2012.03.02.04; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang AMC, 2009, FUNGAL DIVERS, V34, P127; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yuan ZQ, 2009, BIOL PLANTARUM, V53, P155, DOI 10.1007/s10535-009-0024-0; Yuan ZL, 2009, WORLD J MICROB BIOT, V25, P295, DOI 10.1007/s11274-008-9893-1	58	28	40	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58268	10.1371/journal.pone.0058268	http://dx.doi.org/10.1371/journal.pone.0058268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472167	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900113
J	He, P; Li, PT; Hua, Q; Liu, Y; Staufenbiel, M; Li, RN; Shen, Y				He, Ping; Li, Pengtao; Hua, Qian; Liu, Yuan; Staufenbiel, Matthias; Li, Rena; Shen, Yong			Chronic Administration of Anti-Stroke Herbal Medicine TongLuoJiuNao Reduces Amyloidogenic Processing of Amyloid Precursor Protein in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; NF-KAPPA-B; BETA-SECRETASE; GINSENOSIDE RG1; HEME OXYGENASE-1; TRANSGENIC MICE; MEMORY DEFICITS; RECEPTOR PLAYS; EXPRESSION; CLEAVAGE	Composed of Ginsenoside Rg1 and Geniposide, the herbal medicine TongLuoJiuNao (TLJN) injection liquid has anti-inflammatory properties and can improve learning and memory in mice. Recently, TLJN has been used to treat the patients with cerebral ischemic stroke and vascular dementia, which significantly increase the risk of developing Alzheimer's disease (AD) in the early human beings. Although beneficial effects of TLJN have been reported in the vascular-associated brain disorders, the roles of TLJN in AD brains are still not clear. In this study, we chronically administered TLJN in amyloid precursor protein (APP) Swedish mutant transgenic mice (APP23) from 6 months old of age, which is at the onset of A beta plaques, to 12 months old. We found that TLJN significantly decreased A beta production and deposition in the brain of APP23 mice. Furthermore, we observed that TLJN down-regulated the levels and activity of beta-secretase 1 (BACE1) protein as well as the expression levels of gamma-secretase complex components: PS1, nicastrin and anterior pharynx-defective 1 (APH1) but not presenilin enhancer 2 (PEN2). The results suggest an inhibitory effect of TLJN on amyloidogenic APP processing by down-regulating the cleavage enzymes BACE1 and gamma-secretase.	[He, Ping; Shen, Yong] Roskamp Inst, Ctr Adv Therapeut Strategies Brain Disorders, Sarasota, FL USA; [Li, Pengtao; Hua, Qian; Liu, Yuan] Beijing Univ Chinese Med, Dept Pathol, Sch Preclin Med, Beijing, Peoples R China; [Staufenbiel, Matthias] Novartis Pharm Ltd, Nervous Syst Res, Basel, Switzerland; [Li, Rena] Roskamp Inst, Ctr Hormone Adv Sci & Educ, Sarasota, FL USA	Beijing University of Chinese Medicine; Novartis	Shen, Y (corresponding author), Roskamp Inst, Ctr Adv Therapeut Strategies Brain Disorders, Sarasota, FL USA.	yshen@rfdn.org			Alzheimer Association [IIRG-09-61521, IIRG-07-59510]; AHAF [G2006-118, A2008-642]; State Key Development Program for Basic Research of China [2012CB518602]; Production of New Medicine Program of Ministry of Science and Technology of China [2008ZX09101-027]; National Natural Science Foundation of China [81072901];  [NIH/NIA025888];  [NIH/NIAR01AG032441]; NATIONAL INSTITUTE ON AGING [R01AG032441] Funding Source: NIH RePORTER	Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); AHAF; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Production of New Medicine Program of Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by grants from NIH/NIA025888 (YS), NIH/NIAR01AG032441 (RL), Alzheimer Association: IIRG-09-61521 (YS) and IIRG-07-59510 (RL); AHAF: G2006-118 (RL) and A2008-642 (PH), The State Key Development Program for Basic Research of China: 2012CB518602 (PTL), Production of New Medicine Program of Ministry of Science and Technology of China: 2008ZX09101-027 (PTL) and National Natural Science Foundation of China: 81072901 (QH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao HY, 2005, ARCH PHARM RES, V28, P335, DOI 10.1007/BF02977802; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Best JD, 2005, J PHARMACOL EXP THER, V313, P902, DOI 10.1124/jpet.104.081174; Chang Y, 2008, EUR J PHARMACOL, V578, P28, DOI 10.1016/j.ejphar.2007.09.023; Chen F, 2006, FASEB J, V20, P1269, DOI 10.1096/fj.05-5530fje; Chen LM, 2012, EUR J PHARMACOL, V675, P15, DOI 10.1016/j.ejphar.2011.11.039; Choi K, 2007, NEUROSCI LETT, V421, P37, DOI 10.1016/j.neulet.2007.05.017; Choo MK, 2008, ONCOL REP, V19, P595; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Duarte AI, 2005, FREE RADICAL BIO MED, V39, P876, DOI 10.1016/j.freeradbiomed.2005.05.002; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gu Z, 2007, CHANGCHUN MED SCH CH; Guo LX, 2012, ACTA PHARMACOL SIN, V33, P237, DOI 10.1038/aps.2011.146; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He P, 2013, PLOS ONE; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; He P, 2012, FASEB J, V26, P334, DOI 10.1096/fj.11-192716; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hua Q, 2008, BIOL PHARM BULL, V31, P633, DOI 10.1248/bpb.31.633; Hua QA, 2010, J ETHNOPHARMACOL, V129, P306, DOI 10.1016/j.jep.2010.03.024; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jazwa A, 2010, CURR DRUG TARGETS, V11, P1517, DOI 10.2174/1389450111009011517; Ji HF, 2008, ACTA PHARMACOL SIN, V29, P143, DOI 10.1111/j.1745-7254.2008.00752.x; Joo SS, 2008, BIOL PHARM BULL, V31, P1392, DOI 10.1248/bpb.31.1392; Kim BH, 2009, PLANTA MED, V75, P321, DOI 10.1055/s-0028-1112218; Kim YJ, 2008, BIOL PHARM BULL, V31, P826, DOI 10.1248/bpb.31.826; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lee SY, 2009, BIOSCI BIOTECH BIOCH, V73, P811, DOI 10.1271/bbb.80637; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li XJ, 2012, J ETHNOPHARMACOL, V141, P927, DOI 10.1016/j.jep.2012.03.042; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu JH, 2009, ACTA PHARMACOL SIN, V30, P159, DOI 10.1038/aps.2008.25; Liu Ying, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P956; Liu Y, 2011, J ETHNOPHARMACOL, V137, P1035, DOI 10.1016/j.jep.2011.07.031; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Selkoe DJ, 2003, NEUROCHEM RES, V28, P1705, DOI 10.1023/A:1026065122854; Shi C, 2012, BBA-GEN SUBJECTS, V1820, P453, DOI 10.1016/j.bbagen.2011.12.005; Shi YQ, 2010, J ALZHEIMERS DIS, V19, P977, DOI 10.3233/JAD-2010-1296; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Siemers ER, 2007, CLIN NEUROPHARMACOL, V30, P317, DOI 10.1097/WNF.0b013e31805b7660; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sommer B, 1998, MOL PSYCHIATR, V3, P284, DOI 10.1038/sj.mp.4000397; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Van Dooren T, 2006, AM J PATHOL, V168, P245, DOI 10.2353/ajpath.2006.050752; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2007, NEURON, V54, P671, DOI 10.1016/j.neuron.2007.05.018; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Wang YH, 2009, J ASIAN NAT PROD RES, V11, P604, DOI 10.1080/10286020902843152; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yin F, 2012, CNS NEUROL DISORD-DR; Yin F, 2010, BIOL PHARM BULL, V33, P1841, DOI 10.1248/bpb.33.1841; Yin F, 2010, ACTA PHARMACOL SIN, V31, P540, DOI 10.1038/aps.2010.28; Zhang C, 2010, J ALZHEIMERS DIS, V22, P683, DOI 10.3233/JAD-2010-100816; Zhang X, 2012, NEUROSCIENCE, V220, P191, DOI 10.1016/j.neuroscience.2012.06.027; Zhang ZG, 2008, MOL ENDOCRINOL, V22, P186, DOI 10.1210/me.2007-0119; Zhao HF, 2009, BRAIN RES, V1256, P111, DOI 10.1016/j.brainres.2008.12.031; Zhu W., 2007, HUBEI MED SCH CHINES, V5, P4	72	19	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58181	10.1371/journal.pone.0058181	http://dx.doi.org/10.1371/journal.pone.0058181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472157	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900103
J	Rotem-Bamberger, S; Katz, C; Friedler, A				Rotem-Bamberger, Shahar; Katz, Chen; Friedler, Assaf			Regulation of ASPP2 Interaction with p53 Core Domain by an Intramolecular Autoinhibitory Mechanism	PLOS ONE			English	Article							NF-KAPPA-B; BCL-2 FAMILY PROTEINS; DESIGNED PEPTIDE; SH3 DOMAINS; CELL-DEATH; RESCUE; CANCER; 53BP2; MUTANTS; PROLINE	ASPP2 is a key protein in regulating apoptosis both in p53-dependent and-independent pathways. The C-terminal part of ASPP2 contains four ankyrin repeats and an SH3 domain (Ank-SH3) that mediate the interactions of ASPP2 with apoptosis related proteins such as p53, Bcl-2 and the p65 subunit of NF kappa B. p53 core domain (p53CD) binds the n-src loop and the RT loop of ASPP2 SH3. ASPP2 contains a disordered proline rich domain (ASPP2 Pro) that forms an intramolecular autoinhibitory interaction with the Ank-SH3 domains. Here we show how this intramolecular interaction affects the intermolecular interactions of ASPP2 with p53, Bcl-2 and NFkB. We used biophysical methods to obtain better understanding of the relationship between ASPP2 and its partners for getting a comprehensive view on ASPP2 pathways. Fluorescence anisotropy competition experiments revealed that both ASPP2 Pro and p53CD competed for binding the n-src loop of the ASPP2 SH3, indicating regulation of p53CD binding to this loop by ASPP2 Pro. Peptides derived from the ASPP2-binding interface of Bcl-2 did not compete with p53CD or NFkB peptides for binding the ASPP2 n-src loop. However, p53CD displaced the NF kappa B peptide (residues 303-332) from its complex with ASPP2 Ank-SH3, indicating that NF kappa B 303-332 and p53CD bind a partly overlapping site in ASPP2 SH3, mostly in the RT loop. These results are in agreement with previous docking studies, which showed that ASPP2 Ank-SH3 binds Bcl-2 and NF kappa B mostly via distinct sites from p53. However they show some overlap between the binding sites of p53CD and NF kappa B in ASPP2 Ank-SH3. Our results provide experimental evidence that the intramolecular interaction in ASPP2 regulates its binding to p53CD and that ASPP2 Ank-SH3 binds Bcl-2 and NF kappa B via distinct sites.	[Rotem-Bamberger, Shahar; Katz, Chen; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Friedler, A (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	assaf.friedler@mail.huji.ac.il			Israeli Ministry of Health; European Research Council under the European Community/ERC [203413]	Israeli Ministry of Health; European Research Council under the European Community/ERC(European Research Council (ERC))	AF was supported by a grant from the Israeli Ministry of Health and by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement nu 203413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Benyamini H, 2011, J MOL RECOGNIT, V24, P266, DOI 10.1002/jmr.1048; Benyamini H, 2009, PROTEINS, V77, P602, DOI 10.1002/prot.22473; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bouchet BP, 2006, CRIT REV ONCOL HEMAT, V58, P190, DOI 10.1016/j.critrevonc.2005.10.005; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Friedler A, 2004, J MOL BIOL, V336, P187, DOI 10.1016/j.jmb.2003.12.005; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Kampa KM, 2009, CELL CYCLE, V8, P2871, DOI 10.4161/cc.8.18.9474; Katz C, 2008, P NATL ACAD SCI USA, V105, P12277, DOI 10.1073/pnas.0711269105; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu WK, 2010, ONKOLOGIE, V33, P500, DOI 10.1159/000319692; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Rotem S, 2007, BIOCHEM SOC T, V35, P966, DOI 10.1042/BST0350966; Rotem S, 2008, J BIOL CHEM, V283, P18990, DOI 10.1074/jbc.M708717200; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Saksela K, 2012, FEBS LETT; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Takahashi N, 2005, GENES CELLS, V10, P803, DOI 10.1111/j.1365-2443.2005.00878.x; Tidow H, 2007, J MOL BIOL, V371, P948, DOI 10.1016/j.jmb.2007.05.024; Tidow H, 2006, J BIOL CHEM, V281, P32526, DOI 10.1074/jbc.M604725200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yang JP, 1999, ONCOGENE, V18, P5177, DOI 10.1038/sj.onc.1202904; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhao J, 2010, HEPATOLOGY, V51, P142, DOI 10.1002/hep.23247	39	15	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58470	10.1371/journal.pone.0058470	http://dx.doi.org/10.1371/journal.pone.0058470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472201	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900147
J	Xu, J; Deng, XY; Tang, M; Li, L; Xiao, LB; Yang, LF; Zhong, JF; Bode, AM; Dong, ZG; Tao, YG; Cao, Y				Xu, Juan; Deng, Xiyun; Tang, Min; Li, Lili; Xiao, Lanbo; Yang, Lifang; Zhong, Juanfang; Bode, Ann M.; Dong, Zigang; Tao, Yongguang; Cao, Ya			Tyrosylprotein Sulfotransferase-1 and Tyrosine Sulfation of Chemokine Receptor 4 Are Induced by Epstein-Barr Virus Encoded Latent Membrane Protein 1 and Associated with the Metastatic Potential of Human Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SQUAMOUS-CELL CARCINOMA; NF-KAPPA-B; GENE-EXPRESSION; POSTTRANSLATIONAL MODIFICATIONS; NUCLEAR TRANSLOCATION; CANCER METASTASIS; TUMOR INVASION	The latent membrane protein 1 (LMP1), which is encoded by the Epstein-Barr virus (EBV), is an important oncogenic protein that is closely related to carcinogenesis and metastasis of nasopharyngeal carcinoma (NPC), a prevalent cancer in China. We previously reported that the expression of the functional chemokine receptor CXCR4 is associated with human NPC metastasis. In this study, we show that LMP1 induces tyrosine sulfation of CXCR4 through tyrosylprotein sulfotransferase-1 (TPST-1), an enzyme that is responsible for catalysis of tyrosine sulfation in vivo, which is likely to contribute to the highly metastatic character of NPC. LMP1 could induce tyrosine sulfation of CXCR4 and its associated cell motility and invasiveness in a NPC cell culture model. In contrast, the expression of TPST-1 small interfering RNA reversed LMP1-induced tyrosine sulfation of CXCR4. LMP1 conveys signals through the epidermal growth factor receptor (EGFR) pathway, and EGFR-targeted siRNA inhibited the induction of TPST-1 by LMP1. We used a ChIP assay to show that EGFR could bind to the TPST-1 promoter in vivo under the control of LMP1. A reporter gene assay indicated that the activity of the TPST-1 promoter could be suppressed by deleting the binding site between EGFR and TPST-1. Finally, in human NPC tissues, the expression of TPST-1 and LMP1 was directly correlated and clinically, the expression of TPST-1 was associated with metastasis. These results suggest the up-regulation of TPST-1 and tyrosine sulfation of CXCR4 by LMP1 might be a potential mechanism contributing to NPC metastasis.	[Xu, Juan; Deng, Xiyun; Tang, Min; Li, Lili; Xiao, Lanbo; Yang, Lifang; Zhong, Juanfang; Tao, Yongguang; Cao, Ya] Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Hunan, Peoples R China; [Xu, Juan; Deng, Xiyun; Tang, Min; Xiao, Lanbo; Yang, Lifang; Zhong, Juanfang; Tao, Yongguang; Cao, Ya] Cent S Univ, Xiangya Sch Med, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha, Hunan, Peoples R China; [Xu, Juan; Deng, Xiyun; Tang, Min; Xiao, Lanbo; Yang, Lifang; Zhong, Juanfang; Tao, Yongguang; Cao, Ya] Cent S Univ, Xiangya Sch Med, Minist Educ, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Yang, Lifang; Cao, Ya] Cent S Univ, Xiangya Sch Med, Affiliated Hosp 1, Mol Imaging Ctr, Changsha, Hunan, Peoples R China; [Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Central South University; Central South University; Central South University; Central South University; University of Minnesota System	Tao, YG (corresponding author), Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Hunan, Peoples R China.	taoyong@csu.edu.cn; ycao98@vip.sina.com	Li, Lili/Q-5750-2018	Li, Lili/0000-0002-0292-5889	National Basic Research Program of China [2009CB521801, 2011CB504300]; National Nature Science Foundation of China [30771966, 30930101, 81171881]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2009CB521801, 2011CB504300) and the National Nature Science Foundation of China (30771966, 30930101, 81171881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1985, J BIOL CHEM, V260, P6434; Barretina J, NAT GENET, V42, P715; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; Bundgaard Jens R., 2008, V446, P47, DOI 10.1007/978-1-60327-084-7_4; Cabioglu N, 2007, ANN ONCOL, V18, P1021, DOI 10.1093/annonc/mdm060; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Deng L, 2003, CELL RES, V13, P187, DOI 10.1038/sj.cr.7290163; Ding L, 2005, INT J BIOCHEM CELL B, V37, P1881, DOI 10.1016/j.biocel.2005.04.012; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Feijun L, 2002, PROG BIOCHEM BIOPHYS, V29, P567; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Hu JY, 2005, CLIN CANCER RES, V11, P4658, DOI 10.1158/1078-0432.CCR-04-1798; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; King AD, 2000, HEAD NECK-J SCI SPEC, V22, P275; KOBAYASHI T, 1993, INT J CANCER, V55, P448, DOI 10.1002/ijc.2910550321; Kondo S, 2006, CANCER RES, V66, P9870, DOI 10.1158/0008-5472.CAN-06-1679; Krohn A, 2009, CANCER LETT, V280, P65, DOI 10.1016/j.canlet.2009.02.005; Kucia M, 2004, J MOL HISTOL, V35, P233; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lee HJ, 2009, INT J ONCOL, V34, P473, DOI 10.3892/ijo_00000172; Lee Y, 2009, ONCOGENE; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; Li J, 2007, CANCER BIOL THER, V6, P1997, DOI 10.4161/cbt.6.12.5160; Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Moore KL, 2009, P NATL ACAD SCI USA, V106, P14741, DOI 10.1073/pnas.0908376106; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Morris MA, 2009, FUTURE ONCOL, V5, P811, DOI [10.2217/fon.09.53, 10.2217/FON.09.53]; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murono S, 2001, P NATL ACAD SCI USA, V98, P6905, DOI 10.1073/pnas.121016998; Nakayama T, 2002, J VIROL, V76, P3072, DOI 10.1128/JVI.76.6.3072-3077.2002; Ouyang YB, 1998, J BIOL CHEM, V273, P24770, DOI 10.1074/jbc.273.38.24770; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Sasaki K, 2009, ONCOL REP, V21, P65, DOI 10.3892/or_00000190; Seibert C, 2008, BIOCHEMISTRY-US, V47, P11251, DOI 10.1021/bi800965m; Shair KHY, 2012, J VIROL, V86, P5352, DOI 10.1128/JVI.07035-11; Song X, 2005, VIRUS RES, V113, P89, DOI 10.1016/j.virusres.2005.04.019; Taichman RS, 2002, CANCER RES, V62, P1832; Tao YG, 2005, EXP CELL RES, V303, P240, DOI 10.1016/j.yexcr.2004.09.030; Tao YG, 2004, SCI CHINA SER C, V47, P258, DOI 10.1360/03yc0039; Tao YG, 2004, CELL SIGNAL, V16, P781, DOI 10.1016/j.cellsig.2003.12.001; Toruner GA, 2004, CANCER GENET CYTOGEN, V154, P27, DOI 10.1016/j.cancergencyto.2004.01.026; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang ZL, 2010, EUR J CANCER, V46, P2996, DOI 10.1016/j.ejca.2010.07.008; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	53	24	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e56114	10.1371/journal.pone.0056114	http://dx.doi.org/10.1371/journal.pone.0056114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472069	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900007
J	Yang, HY; Lu, KC; Lee, HS; Huang, SM; Lin, YF; Wu, CC; Salter, DM; Su, SL				Yang, Hsin-Yi; Lu, Kuo-Cheng; Lee, Herng-Sheng; Huang, Shih-Ming; Lin, Yuh-Feng; Wu, Chia-Chao; Salter, Donald M.; Su, Sui-Lung			Role of the Functional Toll-Like Receptor-9 Promoter Polymorphism (-1237T/C) in Increased Risk of End-Stage Renal Disease: A Case-Control Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; NUTRITIONAL-STATUS; PROSPECTIVE COHORT; HUMAN TLR9; GENE; TOLL-LIKE-RECEPTOR-9; MORTALITY; CPG; INTERLEUKIN-6	Inflammation induced by infectious and noninfectious triggers in the kidney may lead to end stage renal disease (ESRD). Toll-like receptor 9 (TLR-9) a receptor for CpG DNA is involved in activation of immune cells in renal disease and may contribute to chronic inflammatory disease progression through an interleukin-6 (IL-6) dependent pathway. Previous studies indicate that -1237T/C confers regulatory effects on TLR-9 transcription. To date the effect of TLR-9 polymorphisms on ESRD remains unknown. We performed a case-control study and genotyped 630 ESRD patients and 415 controls for -1237T/C, -1486T/C and 1635G/A by real-time PCR assays and assessed plasma concentration of IL-6 by ELISA. Haplotype association analysis was performed using the Haploview package. A luciferase reporter assay and real-time PCR were used to test the function of the -1237T/C promoter polymorphism. A significant association between -1237T/C in TLR-9 and ESRD was identified. The TCA, TTA and CCA haplotype of TLR-9 were associated with ESRD. ESRD patients carrying -1237TC had a higher mean plasma IL-6 level when compared with -1237TT. The TLR-9 transcriptional activity of the variant -1237CC allele is higher than the -1237TT allele. The results indicate that in a Han Chinese population the presence of the C allele of 1237T/C in the TLR-9 gene increases susceptibility towards development of ESRD. In vitro studies demonstrate that -1237T/C may be involved in the development of ESRD through transcriptional modulation of TLR-9.	[Yang, Hsin-Yi; Su, Sui-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lu, Kuo-Cheng] Fu Jen Catholic Univ, Sch Med, Cardinal Tien Hosp, Div Nephrol,Dept Med, New Taipei City, Taiwan; [Lee, Herng-Sheng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Lin, Yuh-Feng] Taipei Med Univ, Grad Inst Clin Med, Shuang Ho Hosp, Div Nephrol,Dept Med, New Taipei City, Taiwan; [Lin, Yuh-Feng; Wu, Chia-Chao] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Salter, Donald M.] Univ Edinburgh, Ctr Mol Med, MRC IGMM, Edinburgh, Midlothian, Scotland	National Defense Medical Center; Cardinal Tien Hospital; Fu Jen Catholic University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; University of Edinburgh	Su, SL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	a131419@gmail.com		Wu, Chia-Chao/0000-0002-8772-011X; Su, Sui-Lung/0000-0003-3122-1116	National Science Council; National Defense Medical Center; Tri-Service General Hospital; Cardinal Tien Hospital, Taiwan, ROC [NSC99-2314-B-016-001, NSC 99-2815-C-016-002-B, TSGH-C100-007-009-10-S03, CTH- NC10007, MAB101-29]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Center; Tri-Service General Hospital; Cardinal Tien Hospital, Taiwan, ROC	This study was supported by grants from the National Science Council, National Defense Medical Center, Tri-Service General Hospital and Cardinal Tien Hospital, Taiwan, ROC (NSC99-2314-B-016-001, NSC 99-2815-C-016-002-B, TSGH-C100-007-009-10-S03, CTH- NC10007, MAB101-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler S, 2006, ETHNIC DIS, V16; Anders HJ, 2004, FASEB J, V18, P534, DOI 10.1096/fj.03-0646fje; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028256; Dalpke A, 2002, BIODRUGS, V16, P419, DOI 10.2165/00063030-200216060-00003; De Jager PL, 2006, ARTHRITIS RHEUM, V54, P1279, DOI 10.1002/art.21755; Eleftheriadis Theodoros, 2009, Inflammation & Allergy Drug Targets, V8, P191; Faresjo T, 2010, INT J ENV RES PUB HE, V7, P325, DOI 10.3390/ijerph7010325; Gama-Axelsson T, 2012, CLIN J AM SOC NEPHRO, V7, P1446, DOI 10.2215/CJN.10251011; Giachelia M, 2012, LEUKEMIA LYMPHOMA, V53, P411, DOI 10.3109/10428194.2011.621566; Hamann L, 2004, J IMMUNOL METHODS, V285, P281, DOI 10.1016/j.jim.2003.12.005; Hasuike Y, 2009, AM J NEPHROL, V30, P389, DOI 10.1159/000235687; Holla LI, 2010, J CLIN PERIODONTOL, V37, P152, DOI 10.1111/j.1600-051X.2009.01523.x; Jansen MAM, 2001, J AM SOC NEPHROL, V12, P157, DOI 10.1681/ASN.V121157; Kikuchi K, 2005, J AUTOIMMUN, V24, P347, DOI 10.1016/j.jaut.2005.03.002; Koc M, 2011, NEPHROL DIAL TRANSPL, V26, P955, DOI 10.1093/ndt/gfq500; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Krayenbuehl PA, 2010, EUR J GASTROEN HEPAT, V22, P835, DOI 10.1097/MEG.0b013e3283322067; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Lange NE, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-26; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Ljungman P, 2009, THROMB RES, V124, P57, DOI 10.1016/j.thromres.2008.10.009; Lu KC, 2011, TOHOKU J EXP MED, V225, P109, DOI 10.1620/tjem.225.109; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Ng MW, 2005, RHEUMATOLOGY, V44, P1456, DOI 10.1093/rheumatology/kei120; Novak N, 2007, ALLERGY, V62, P766, DOI 10.1111/j.1398-9995.2007.01358.x; Pahl MV, 2010, NEPHROL DIAL TRANSPL, V25, P205, DOI 10.1093/ndt/gfp397; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Schwartz DA, 2005, CLIN INFECT DIS, V41, pS403, DOI 10.1086/431985; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Smith KD, 2009, CURR OPIN NEPHROL HY, V18, P189, DOI 10.1097/MNH.0b013e32832a1d5f; Soriano-Sarabia N, 2008, JAIDS-J ACQ IMM DEF, V49, P128, DOI 10.1097/QAI.0b013e318184fb41; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Summers SA, 2010, AM J PATHOL, V177, P2234, DOI 10.2353/ajpath.2010.100153; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wu JF, 2012, J INFECT DIS, V206, P662, DOI 10.1093/infdis/jis420; Xu CJ, 2009, MOL BIOL REP, V36, P2245, DOI 10.1007/s11033-008-9440-z; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS169, DOI 10.1681/ASN.2006080910	46	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58444	10.1371/journal.pone.0058444	http://dx.doi.org/10.1371/journal.pone.0058444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472199	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900145
J	Young-Gqamana, B; Brignol, N; Chang, HH; Khanna, R; Soska, R; Fuller, M; Sitaraman, SA; Germain, DP; Giugliani, R; Hughes, DA; Mehta, A; Nicholls, K; Boudes, P; Lockhart, DJ; Valenzano, KJ; Benjamin, ER				Young-Gqamana, Brandy; Brignol, Nastry; Chang, Hui-Hwa; Khanna, Richie; Soska, Rebecca; Fuller, Maria; Sitaraman, Sheela A.; Germain, Dominique P.; Giugliani, Roberto; Hughes, Derralynn A.; Mehta, Atul; Nicholls, Kathy; Boudes, Pol; Lockhart, David J.; Valenzano, Kenneth J.; Benjamin, Elfrida R.			Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb(3)) in Fabry Transgenic Mice and in the Plasma of Fabry Patients	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; MOUSE KIDNEY GLYCOSPHINGOLIPIDS; LYSOSOMAL ALPHA-GALACTOSIDASE; PHARMACOLOGICAL CHAPERONE; IN-VITRO; DISEASE; GLOBOTRIAOSYLCERAMIDE; URINARY; STORAGE; BIOMARKER	Fabry disease (FD) results from mutations in the gene (GLA) that encodes the lysosomal enzyme alpha-galactosidase A (alpha-Gal A), and involves pathological accumulation of globotriaosylceramide (GL-3) and globotriaosylsphingosine (lyso-Gb(3)). Migalastat hydrochloride (GR181413A) is a pharmacological chaperone that selectively binds, stabilizes, and increases cellular levels of alpha-Gal A. Oral administration of migalastat HCl reduces tissue GL-3 in Fabry transgenic mice, and in urine and kidneys of some FD patients. A liquid chromatography-tandem mass spectrometry method was developed to measure lyso-Gb(3) in mouse tissues and human plasma. Oral administration of migalastat HCl to transgenic mice reduced elevated lyso-Gb(3) levels up to 64%, 59%, and 81% in kidney, heart, and skin, respectively, generally equal to or greater than observed for GL-3. Furthermore, baseline plasma lyso-Gb(3) levels were markedly elevated in six male FD patients enrolled in Phase 2 studies. Oral administration of migalastat HCl (150 mg QOD) reduced urine GL-3 and plasma lyso-Gb(3) in three subjects (range: 15% to 46% within 48 weeks of treatment). In contrast, three showed no reductions in either substrate. These results suggest that measurement of tissue and/or plasma lyso-Gb(3) is feasible and may be warranted in future studies of migalastat HCl or other new potential therapies for FD.	[Young-Gqamana, Brandy] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Brignol, Nastry; Chang, Hui-Hwa; Khanna, Richie; Soska, Rebecca; Sitaraman, Sheela A.; Boudes, Pol; Lockhart, David J.; Valenzano, Kenneth J.; Benjamin, Elfrida R.] Amicus Therapeut, Cranbury, NJ USA; [Fuller, Maria] South Australia Pathol Womens & Childrens Hosp, Lysosomal Dis Res Unit, Adelaide, SA, Australia; [Germain, Dominique P.] Univ Versailles St Quentin Yvelines, Hop Raymond Poincare, Assistance Publ Hop Paris, Div Med Genet, Garches, France; [Giugliani, Roberto] Porto Alegre Fed Univ Rio Grande Sul, Clin Hosp, Med Genet Serv, Porto Alegre, RS, Brazil; [Hughes, Derralynn A.; Mehta, Atul] Royal Free Hosp, Dept Acad Haematol, Lysosomal Storage Disorders Unit, London, England; [Hughes, Derralynn A.; Mehta, Atul] UCL, Sch Med, London, England; [Nicholls, Kathy] Royal Melbourne Hosp, Dept Nephrol, Parkville, Vic 3050, Australia	University of Cape Town; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Universidade Federal do Rio Grande do Sul; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; UCL Medical School; Royal Melbourne Hospital	Benjamin, ER (corresponding author), Amicus Therapeut, Cranbury, NJ USA.	ebenjamin@amicusrx.com	Giugliani, Roberto/G-4790-2015; GERMAIN, Dominique P./AAD-6747-2020; Mehta, Atul/GPC-7364-2022; Hughes, Derralynn/J-8012-2013; Nicholls, Kathleen/N-5002-2017	Giugliani, Roberto/0000-0001-9655-3686; Hughes, Derralynn/0000-0003-4531-9173; GERMAIN, Dominique/0000-0002-8355-007X; Nicholls, Kathleen/0000-0002-1297-8722	Amicus Therapeutics; Genzyme; Shire HGT; Amicus; Actelion; Protalix	Amicus Therapeutics; Genzyme(Sanofi-AventisGenzyme Corporation); Shire HGT; Amicus; Actelion; Protalix	Brandy Young-Gqamana is a former employee of Amicus Therapeutics. Nastry Brignol, Hui-Hwa Chang, Richie Khanna, Rebecca Soska, Sheela A. Sitaraman, Pol Boudes, David J. Lockhart, Kenneth J. Valenzano, and Elfrida R. Benjamin are employed by Amicus Therapeutics and are shareholders in the company. Maria Fuller was a collaborator with Amicus Therapeutics. All other authors were investigators on the Phase 2 clinical studies of migalastat HCl. Dominique P. Germain has received research funding, consultancy fees, and travel expenses from Genzyme and Shire HGT. Roberto Giugliani is a consultant and investigator for Actelion, Amicus, BioMarin, Genzyme and Shire HGT. Derralynn A. Hughes is a consultant for Amicus, Shire HGT, Genzyme, Actelion, has been on a Speaker's Bureau for Amicus, Shire HGT, Genzyme, and Actelion, and has received grants from Amicus, Shire HGT, and Genzyme. Atul Mehta has received honoraria, research funding, consultancy fees, and travel expenses from Shire HGT, Genzyme, Actelion, Protalix, and Amicus. Kathy Nicholls has received travel and research support and speaker's honoraria from Amicus, Shire HGT and Genzyme. Amicus Therapeutics funded the research and any publication fees. The alpha-Gal A (Fabrazyme) used in this study is a product produced by Genzyme. Maria Fuller is employed by SA Pathology, Adelaide. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all of the PLOS ONE policies on sharing data and materials.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Aerts JMFG, 2011, J INHERIT METAB DIS, V34, P605, DOI 10.1007/s10545-011-9308-6; [Anonymous], 2014, METABOLIC MOL BASES; Asano N, 2000, EUR J BIOCHEM, V267, P4179, DOI 10.1046/j.1432-1327.2000.01457.x; Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Auray-Blais C, 2008, MOL GENET METAB, V93, P331, DOI 10.1016/j.ymgme.2007.10.001; Auray-Blais C, 2012, ANAL CHEM, V84, P2745, DOI 10.1021/ac203433e; Auray-Blais C, 2010, CLIN CHIM ACTA, V411, P1906, DOI 10.1016/j.cca.2010.07.038; Bekri Soumeya, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P289, DOI 10.2174/187152506778520718; Benjamin ER, 2009, J INHERIT METAB DIS, V32, P424, DOI 10.1007/s10545-009-1077-0; Benjamin ER, 2012, MOL THER, V20, P717, DOI 10.1038/mt.2011.271; Boutin M, 2012, CLIN CHIM ACTA, V414, P273, DOI 10.1016/j.cca.2012.09.026; BOYD B, 1989, NEPHRON, V51, P207, DOI 10.1159/000185286; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Durant B, 2011, J LIPID RES, V52, P1742, DOI 10.1194/jlr.M017178; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fan JQ, 2003, METHOD ENZYMOL, V363, P412; Germain DP, 2009, INT J CLIN PHARM TH, V47, pS111; Germain DP, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-91; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; GROSS SK, 1991, J LIPID RES, V32, P157; Hughes DA, 2008, ACTA PAEDIATR, V97, P41, DOI 10.1111/j.1651-2227.2008.00649.x; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Ishii S, 2009, J PHARMACOL EXP THER, V328, P723, DOI 10.1124/jpet.108.149054; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; Kruger R, 2012, J CHROMATOGR B, V883, P128, DOI 10.1016/j.jchromb.2011.11.020; MCCLUER RH, 1981, J BIOL CHEM, V256, P3112; MCCLUER RH, 1983, ENDOCRINOLOGY, V113, P251, DOI 10.1210/endo-113-1-251; Ogawa K, 2009, MOL GENET METAB, V96, P91, DOI 10.1016/j.ymgme.2008.10.017; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Park J, 2003, P NATL ACAD SCI USA, V100, P3450, DOI 10.1073/pnas.0537900100; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; Rombach SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047805; Schiffmann R, 2003, MUSCLE NERVE, V28, P703, DOI 10.1002/mus.10497; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Shin SH, 2007, BIOCHEM BIOPH RES CO, V359, P168, DOI 10.1016/j.bbrc.2007.05.082; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148; Takenaka T, 2000, P NATL ACAD SCI USA, V97, P7515, DOI 10.1073/pnas.120177997; Togawa T, 2010, BIOCHEM BIOPH RES CO, V399, P716, DOI 10.1016/j.bbrc.2010.08.006; Togawa T, 2010, MOL GENET METAB, V100, P257, DOI 10.1016/j.ymgme.2010.03.020; Valenzano KJ, 2011, ASSAY DRUG DEV TECHN, V9, P213, DOI 10.1089/adt.2011.0370; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; West M, 2009, J AM SOC NEPHROL, V20, P1132, DOI 10.1681/ASN.2008080870; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Wu XY, 2011, HUM MUTAT, V32, P965, DOI 10.1002/humu.21530; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111	53	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57631	10.1371/journal.pone.0057631	http://dx.doi.org/10.1371/journal.pone.0057631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472096	Green Published, gold			2022-12-27	WOS:000315637900035
J	De Vos, S; Bossier, P; Van Stappen, G; Vercauteren, I; Sorgeloos, P; Vuylsteke, M				De Vos, Stephanie; Bossier, Peter; Van Stappen, Gilbert; Vercauteren, Ilse; Sorgeloos, Patrick; Vuylsteke, Marnik			A first AFLP-Based Genetic Linkage Map for Brine Shrimp Artemia franciscana and Its Application in Mapping the Sex Locus	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; MICROSATELLITE MARKERS; LITOPENAEUS-VANNAMEI; CHROMOSOME EVOLUTION; PENAEUS-MONODON; DAPHNIA-PULEX; LARGE GENOMES; DNA-CONTENT; CRUSTACEA; ISOPODA	We report on the construction of sex-specific linkage maps, the identification of sex-linked markers and the genome size estimation for the brine shrimp Artemia franciscana. Overall, from the analysis of 433 AFLP markers segregating in a 112 full-sib family we identified 21 male and 22 female linkage groups (2n = 42), covering 1,041 and 1,313 cM respectively. Fifteen putatively homologous linkage groups, including the sex linkage groups, were identified between the female and male linkage map. Eight sex-linked AFLP marker alleles were inherited from the female parent, supporting the hypothesis of a WZ-ZZ sex-determining system. The haploid Artemia genome size was estimated to 0.93 Gb by flow cytometry. The produced Artemia linkage maps provide the basis for further fine mapping and exploring of the sex-determining region and are a possible marker resource for mapping genomic loci underlying phenotypic differences among Artemia species.	[De Vos, Stephanie; Bossier, Peter; Van Stappen, Gilbert; Sorgeloos, Patrick] Univ Ghent, Dept Anim Prod, ARC, Lab Aquaculture, B-9000 Ghent, Belgium; [De Vos, Stephanie; Vercauteren, Ilse; Vuylsteke, Marnik] VIB, Dept Plant Syst Biol, Ghent, Belgium; [De Vos, Stephanie; Vercauteren, Ilse; Vuylsteke, Marnik] Univ Ghent, Dept Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Vuylsteke, M (corresponding author), VIB, Dept Plant Syst Biol, Ghent, Belgium.	marnik.vuylsteke@psb.vib-ugent.be	Bossier, Peter GM/A-8118-2008	Bossier, Peter GM/0000-0002-6165-9111	Ghent University	Ghent University(Ghent University)	The authors acknowledge the support of Ghent University for the Bijzonder Onderzoeksfonds (BOF) of Stephanie De Vos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzopoulos T.J., 1999, INT J SALT LAKE RES, V8, P10; ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; Alcivar-Warren A., 2012, PLASTICITY SHRIMP GE; Asem A, 2010, LAT AM J AQUAT RES, V38, P501, DOI 10.3856/vol38-issue3-fulltext-14; BADARACCO G, 1995, J MOL EVOL, V41, P150, DOI 10.1007/BF00170666; Benzie JAH, 2009, REV AQUACULT, V1, P232, DOI 10.1111/j.1753-5131.2009.01018.x; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Bossier P, 2004, AQUACULTURE, V231, P93, DOI 10.1016/j.aquaculture.2003.11.001; BOWEN ST, 1965, GENETICS, V52, P695; Browne RAB, 1991, TAXONOMY POPULATION; Camargo WN, 2002, HYDROBIOLOGIA, V468, P245, DOI 10.1023/A:1015209223336; CARETTONI D, 1994, BIOCHEM J, V299, P623, DOI 10.1042/bj2990623; Mendonca MAC, 2010, J HISTOCHEM CYTOCHEM, V58, P229, DOI 10.1369/jhc.2009.954727; Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007; CRUCES J, 1986, GENE, V44, P341, DOI 10.1016/0378-1119(86)90200-3; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Foley BR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-568; Ford AT, 2008, AQUAT TOXICOL, V88, P316, DOI 10.1016/j.aquatox.2008.04.013; Genet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-314; Gomez-Uchida D, 2003, J CRUSTACEAN BIOL, V23, P486, DOI 10.1651/0278-0372(2003)023[0486:AAAAOG]2.0.CO;2; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Hodgson R, 1999, WORKSH MOL DIAGN SHR; Jeffery NW, 2012, POLAR BIOL, V35, P959, DOI 10.1007/s00300-011-1137-4; JUCHAULT P, 1995, HEREDITY, V75, P466, DOI 10.1038/hdy.1995.163; Kappas I, 2004, MAR BIOL, V146, P103, DOI 10.1007/s00227-004-1420-9; Kayim M, 2010, J ANIM VET ADV, V9, P1223; Lavens P., 1996, 361 FAO; LEGER P, 1986, OCEANOGR MAR BIOL, V24, P521; Li YT, 2003, AQUACULTURE, V219, P143, DOI 10.1016/S0044-8486(02)00355-1; Li YT, 2006, AQUACULTURE, V258, P198, DOI 10.1016/j.aquaculture.2006.04.027; Li ZX, 2006, AQUACULTURE, V261, P463, DOI 10.1016/j.aquaculture.2006.07.002; Libertini A, 2008, EUR J ENTOMOL, V105, P53, DOI 10.14411/eje.2008.007; Maneeruttanarungroj C, 2006, ANIM GENET, V37, P363, DOI 10.1111/j.1365-2052.2006.01493.x; Maniatsi S, 2011, MOL PHYLOGENET EVOL, V58, P353, DOI 10.1016/j.ympev.2010.11.029; Mantovani B, 2008, HEREDITY, V100, P496, DOI 10.1038/hdy.2008.3; Munoz J, 2009, MOL ECOL RESOUR, V9, P547, DOI 10.1111/j.1755-0998.2008.02360.x; Pannell JR, 2008, GENET RES, V90, P73, DOI 10.1017/S0016672307008981; Parnes S, 2003, GENET RES, V82, P107, DOI 10.1017/S0016672303006372; Parraguez M, 2009, HEREDITAS, V146, P93, DOI 10.1111/j.1601-5223.2009.02109.x; Perez F, 2004, AQUACULTURE, V242, P105, DOI 10.1016/j.aquaculture.2004.09.002; Rees DJ, 2008, GENOME, V51, P159, DOI 10.1139/g07-108; Rees DJ, 2007, GENOME, V50, P151, DOI 10.1139/G06-155; RHEINSMI.EL, 1974, COMP BIOCHEM PHYSIOL, V48, P343, DOI 10.1016/0305-0491(74)90269-7; Robbins HM, 2010, J EXP BIOL, V213, P1464, DOI 10.1242/jeb.041772; Routtu J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-508; Sagi E.D, 2009, AQUACULTURE EUROPE, V34, P30; SEIDLER RJ, 1971, J BACTERIOL, V106, P608, DOI 10.1128/JB.106.2.608-614.1971; Shuster SM, 1999, J HERED, V90, P304, DOI 10.1093/jhered/90.2.304; Siegismund HR, 2002, J HERED, V93, P432, DOI 10.1093/jhered/93.6.432; Staelens J, 2008, GENETICS, V179, P917, DOI 10.1534/genetics.107.080150; STEFANI R, 1963, CARYOLOGIA, V16, P625, DOI 10.1080/00087114.1963.10796102; Stillman JH, 2008, INTEGR COMP BIOL, V48, P852, DOI 10.1093/icb/icn096; Tomaszkiewicz M, 2010, J CRUSTACEAN BIOL, V30, P757, DOI 10.1651/09-3219.1; Triantaphyllidis GV, 1997, MAR BIOL, V129, P477, DOI 10.1007/s002270050188; Vainola R, 1998, HEREDITY, V81, P621, DOI 10.1046/j.1365-2540.1998.00442.x; VALVERDE JR, 1994, J MOL EVOL, V39, P400, DOI 10.1007/BF00160272; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; VAUGHN JC, 1977, BIOCHEM BIOPH RES CO, V79, P525, DOI 10.1016/0006-291X(77)90189-9; Ventura T, 2011, HEREDITY, V107, P456, DOI 10.1038/hdy.2011.32; Ventura T, 2012, BIOTECHNOL ADV, V30, P1543, DOI 10.1016/j.biotechadv.2012.04.008; Vergilino R, 2009, BIOL J LINN SOC, V97, P68, DOI 10.1111/j.1095-8312.2008.01185.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Wang W, 2012, RUSS J GENET+, V48, P422, DOI 10.1134/S102279541204014X; Weeks SC, 2010, J EVOLUTION BIOL, V23, P1100, DOI 10.1111/j.1420-9101.2010.01963.x; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; You EM, 2010, ANIM GENET, V41, P365, DOI 10.1111/j.1365-2052.2009.02014.x; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8; Zhou Y, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-95	70	29	29	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57585	10.1371/journal.pone.0057585	http://dx.doi.org/10.1371/journal.pone.0057585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469207	Green Published, gold			2022-12-27	WOS:000315634900029
J	Fang, SL; Fan, TC; Fu, HW; Chen, CJ; Hwang, CS; Hung, TJ; Lin, LY; Chang, MDT				Fang, Shun-lung; Fan, Tan-chi; Fu, Hua-Wen; Chen, Chien-Jung; Hwang, Chi-Shin; Hung, Ta-Jen; Lin, Lih-Yuan; Chang, Margaret Dah-Tsyr			A Novel Cell-Penetrating Peptide Derived from Human Eosinophil Cationic Protein	PLOS ONE			English	Article							MAJOR BASIC-PROTEIN; SURFACE GLYCOSAMINOGLYCANS; TRYPTOPHAN FLUORESCENCE; MEMBRANE; DELIVERY; BINDING; BIOSYNTHESIS; ANTENNAPEDIA; ENDOCYTOSIS; MOLECULES	Cell-penetrating peptides (CPPs) are short peptides which can carry various types of molecules into cells; however, although most CPPs rapidly penetrate cells in vitro, their in vivo tissue-targeting specificities are low. Herein, we describe cell-binding, internalization, and targeting characteristics of a newly identified 10-residue CPP, denoted ECP32-41, derived from the core heparin-binding motif of human eosinophil cationic protein (ECP). Besides traditional emphasis on positively charged residues, the presence of cysteine and tryptophan residues was demonstrated to be essential for internalization. ECP32-41 entered Beas-2B and wild-type CHO-K1 cells, but not CHO cells lacking of cell-surface glycosaminoglycans (GAGs), indicating that binding of ECP32-41 to cell-surface GAGs was required for internalization. When cells were cultured with GAGs or pre-treated with GAG-digesting enzymes, significant decreases in ECP32-41 internalization were observed, suggesting that cell-surface GAGs, especially heparan sulfate proteoglycans were necessary for ECP32-41 attachment and penetration. Furthermore, treatment with pharmacological agents identified two forms of energy-dependent endocytosis, lipid-raft endocytosis and macropinocytosis, as the major ECP32-41 internalization routes. ECP32-41 was demonstrated to transport various cargoes including fluorescent chemical, fluorescent protein, and peptidomimetic drug into cultured Beas-2B cells in vitro, and targeted broncho-epithelial and intestinal villi tissues in vivo. Hence this CPP has the potential to serve as a novel vehicle for intracellular delivery of biomolecules or medicines, especially for the treatment of pulmonary or gastrointestinal diseases.	[Fang, Shun-lung; Fu, Hua-Wen; Chen, Chien-Jung; Hwang, Chi-Shin; Hung, Ta-Jen; Lin, Lih-Yuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Fan, Tan-chi] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Fu, Hua-Wen; Lin, Lih-Yuan] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Hwang, Chi-Shin] Taipei City Hosp, Zhongxiao Branch, Dept Neurol, Taipei, Taiwan; [Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; National Tsing Hua University; Taipei City Hospital; National Tsing Hua University	Chang, MDT (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	dtchang@life.nthu.edu.tw		Lin, Lih-Yuan/0000-0001-9827-3434; Fu, Hua-Wen/0000-0002-6346-2785	National Science Council, Taiwan [NSC101-2622-B-007-001-CC1, NSC101-2325-B-007-002-]; National Tsing Hua University [101N2051E1]; Chang-Gung Memorial Hospital-National Tsing Hua University Joint Research Program [100N2710E1, 100N2711E1]; Veterans General Hospitals, University System of Taiwan, Joint Research Program [VGHUST101-G6-2-1, VGHUST101-G6-2-2]; Apex Biotechnology Corporation, Taiwan; Graduate Students Study Abroad Program of National Science Council of Taiwan [100IPFA0400015]; Apex Biotechnology Corporation	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University; Chang-Gung Memorial Hospital-National Tsing Hua University Joint Research Program; Veterans General Hospitals, University System of Taiwan, Joint Research Program; Apex Biotechnology Corporation, Taiwan; Graduate Students Study Abroad Program of National Science Council of Taiwan; Apex Biotechnology Corporation	This work was supported by the National Science Council, Taiwan (grant numbers NSC101-2622-B-007-001-CC1 and NSC101-2325-B-007-002-), Toward World-Class Project of National Tsing Hua University (grant number 101N2051E1), Chang-Gung Memorial Hospital-National Tsing Hua University Joint Research Program (grant numbers 100N2710E1 and 100N2711E1), and Veterans General Hospitals, University System of Taiwan, Joint Research Program (grant numbers VGHUST101-G6-2-1 and VGHUST101-G6-2-2). CJC was awarded a scholarship by Apex Biotechnology Corporation, Taiwan, and TJH was supported by the Graduate Students Study Abroad Program of National Science Council of Taiwan (grant number 100IPFA0400015). The financial funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Apex Biotechnology Corporation provided graduate student scholarship. The funders do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abes R, 2007, BIOCHEM SOC T, V35, P775, DOI 10.1042/BST0350775; Beer AJ, 2006, CLIN CANCER RES, V12, P3942, DOI 10.1158/1078-0432.CCR-06-0266; Bitler BG, 2010, RECENT PAT ANTI-CANC, V5, P99, DOI 10.2174/157489210790936252; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chang KC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-6; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Deshayes S, 2006, BBA-BIOMEMBRANES, V1758, P1846, DOI 10.1016/j.bbamem.2006.08.010; EGESTEN A, 1986, J HISTOCHEM CYTOCHEM, V34, P1399, DOI 10.1177/34.11.3772075; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fan TC, 2008, J BIOL CHEM, V283, P25468, DOI 10.1074/jbc.M803516200; Fan TC, 2007, TRAFFIC, V8, P1778, DOI 10.1111/j.1600-0854.2007.00650.x; Garcia-Mayoral MF, 2010, BIOPHYS J, V98, P2702, DOI 10.1016/j.bpj.2010.02.039; Fotin-Mleczek M, 2005, CURR PHARM DESIGN, V11, P3613, DOI 10.2174/138161205774580778; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; GRASSEL S, 1995, MOL CELL BIOCHEM, V145, P61, DOI 10.1007/BF00925714; Jha D, 2011, BIOCONJUGATE CHEM, V22, P319, DOI 10.1021/bc100045s; Kamide K, 2010, INT J MOL MED, V25, P41, DOI 10.3892/ijmm_00000311; Kersemans V, 2008, CURR PHARM DESIGN, V14, P2415, DOI 10.2174/138161208785777432; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Letoha T, 2010, BBA-BIOMEMBRANES, V1798, P2258, DOI 10.1016/j.bbamem.2010.01.022; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Maiolo JR, 2005, BBA-BIOMEMBRANES, V1712, P161, DOI 10.1016/j.bbamem.2005.04.010; MIYAMOTO MM, 1988, P NATL ACAD SCI USA, V85, P7627, DOI 10.1073/pnas.85.20.7627; Nishimura S, 2008, J BIOL CHEM, V283, P11752, DOI 10.1074/jbc.M708849200; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; Rosenberg HF, 2008, CURR PHARM BIOTECHNO, V9, P135, DOI 10.2174/138920108784567236; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; Rydberg HA, 2012, BIOCHEMISTRY; Sanchez D, 2011, BIOCHIMIE, V93, P331, DOI 10.1016/j.biochi.2010.10.005; Sarko D, 2010, MOL PHARMACEUT, V7, P2224, DOI 10.1021/mp100223d; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Stewart KM, 2008, ORG BIOMOL CHEM, V6, P2242, DOI 10.1039/b719950c; Tjelle TE, 1996, J CELL SCI, V109, P2905; Torrent M, 2008, BIOCHEMISTRY-US, V47, P3544, DOI 10.1021/bi702065b; Torrent M, 2009, BIOCHEM J, V421, P425, DOI 10.1042/BJ20082330; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vives E, 2008, BBA-REV CANCER, V1786, P126, DOI 10.1016/j.bbcan.2008.03.001; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wollack JW, 2010, BIOORG MED CHEM LETT, V20, P161, DOI 10.1016/j.bmcl.2009.11.026; Xie WL, 2010, J PEPT SCI, V16, P105, DOI 10.1002/psc.1205; Zhang WY, 2005, BIOCHEMISTRY-US, V44, P10110, DOI 10.1021/bi050341v; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	51	55	59	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57318	10.1371/journal.pone.0057318	http://dx.doi.org/10.1371/journal.pone.0057318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469189	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900014
J	Rutchick, AM; Slepian, ML				Rutchick, Abraham M.; Slepian, Michael L.			Handling Ibuprofen Increases Pain Tolerance and Decreases Perceived Pain Intensity in a Cold Pressor Test	PLOS ONE			English	Article							PLACEBO ANALGESIA; RANDOMIZED-TRIAL; GOAL ACTIVATION; COPING STYLE; BEHAVIOR; AGGRESSION; PERCEPTION; RESPONSES; VALIDATION; REDUCE	Pain contributes to health care costs, missed work and school, and lower quality of life. Extant research on psychological interventions for pain has focused primarily on developing skills that individuals can apply to manage their pain. Rather than examining internal factors that influence pain tolerance (e. g., pain management skills), the current work examines factors external to an individual that can increase pain tolerance. Specifically, the current study examined the nonconscious influence of exposure to meaningful objects on the perception of pain. Participants (N = 54) completed a cold pressor test, examined either ibuprofen or a control object, then completed another cold pressor test. In the second test, participants who previously examined ibuprofen reported experiencing less intense pain and tolerated immersion longer (relative to baseline) than those who examined the control object. Theoretical and applied implications of these findings are discussed.	[Rutchick, Abraham M.] Calif State Univ Northridge, Dept Psychol, Northridge, CA 91330 USA; [Slepian, Michael L.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	California State University System; California State University Northridge; Tufts University	Rutchick, AM (corresponding author), Calif State Univ Northridge, Dept Psychol, Northridge, CA 91330 USA.	abraham.rutchick@csun.edu			College of Social and Behavioral Sciences at California State University, Northridge	College of Social and Behavioral Sciences at California State University, Northridge	This research was funded by an internal grant from the College of Social and Behavioral Sciences at California State University, Northridge (www.csun.edu/csbs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADER R, 1975, PSYCHOSOM MED, V37, P333, DOI 10.1097/00006842-197507000-00007; Bargh JA, 2006, EUR J SOC PSYCHOL, V36, P147, DOI 10.1002/ejsp.336; Bargh JA, 2012, TRENDS COGN SCI, V16, P593, DOI 10.1016/j.tics.2012.10.002; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bastian B, 2011, PSYCHOL SCI, V22, P334, DOI 10.1177/0956797610397058; BEERS TM, 1979, J CONSULT CLIN PSYCH, V47, P179, DOI 10.1037/0022-006X.47.1.179; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 1997, PROG NEUROBIOL, V52, P109, DOI 10.1016/S0301-0082(97)00006-3; Benedetti F, 1998, PAIN, V75, P313, DOI 10.1016/S0304-3959(98)00010-4; Benedetti F, 1999, EUR J NEUROSCI, V11, P625, DOI 10.1046/j.1460-9568.1999.00465.x; BERKOWITZ L, 1967, J PERS SOC PSYCHOL, V7, P202, DOI 10.1037/h0025008; BIERI D, 1990, PAIN, V41, P139, DOI 10.1016/0304-3959(90)90018-9; Cepeda MS, 2003, PROG PAIN RES MANAG, V24, P601; Dijksterhuis A, 2000, J EXP SOC PSYCHOL, V36, P531, DOI 10.1006/jesp.2000.1427; Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V74, P865, DOI 10.1037/0022-3514.74.4.865; Dixon KE, 2004, PAIN, V112, P188, DOI 10.1016/j.pain.2004.08.017; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Ferguson MJ, 2007, PERS SOC PSYCHOL B, V33, P1632, DOI 10.1177/0146167207307493; Forster J, 2007, PERS SOC PSYCHOL REV, V11, P211, DOI 10.1177/1088868307303029; Forys KL, 2007, HEALTH PSYCHOL, V26, P22, DOI 10.1037/0278-6133.26.1.22; Geers AL, 2005, J PERS SOC PSYCHOL, V89, P143, DOI 10.1037/0022-3514.89.2.143; GIL KM, 1987, PAIN, V29, P209, DOI 10.1016/0304-3959(87)91037-2; Gray K, 2012, SOC PSYCHOL PERS SCI, V3, P639, DOI 10.1177/1948550611433470; Gray K, 2008, PSYCHOL SCI, V19, P1260, DOI 10.1111/j.1467-9280.2008.02208.x; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Jackson T, 2005, J PAIN, V6, P228, DOI 10.1016/j.jpain.2004.12.004; Jackson T, 2002, PSYCHOL HEALTH MED, V7, P215; Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003; Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527; Klinesmith J, 2006, PSYCHOL SCI, V17, P568, DOI 10.1111/j.1467-9280.2006.01745.x; Lerman SF, 2012, J CLIN PSYCHOL MED S; LYERLY SB, 1964, J ABNORM SOC PSYCH, V68, P321, DOI 10.1037/h0044351; Meier BP, 2008, J EXP SOC PSYCHOL, V44, P1383, DOI 10.1016/j.jesp.2008.05.005; Mussweiler T, 2000, J PERS SOC PSYCHOL, V79, P507, DOI 10.1037/0022-3514.79.4.507; Paquet C, 2005, PAIN, V115, P355, DOI 10.1016/j.pain.2005.03.024; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; Rutchick AM, 2010, EUR J SOC PSYCHOL, V40, P704, DOI 10.1002/ejsp.753; Schaffer SD, 2004, AM J NURS, V104, P75, DOI 10.1097/00000446-200408000-00044; Shalev I, 2011, PERSPECT PSYCHOL SCI, V6, P488, DOI 10.1177/1745691611416993; Slepian ML, 2010, J EXP SOC PSYCHOL, V46, P696, DOI 10.1016/j.jesp.2010.03.009; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; Staats P, 1998, J PAIN SYMPTOM MANAG, V15, P235, DOI 10.1016/S0885-3924(97)00363-1; Turk DC, 2005, PROF PSYCHOL-RES PR, V36, P602, DOI 10.1037/0735-7028.36.6.602; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Williams LE, 2009, EMOTION, V9, P847, DOI 10.1037/a0017745; Zhong CB, 2010, PSYCHOL SCI, V21, P619, DOI 10.1177/0956797610366090	47	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e56175	10.1371/journal.pone.0056175	http://dx.doi.org/10.1371/journal.pone.0056175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099PY	23469170	Green Published, gold			2022-12-27	WOS:000315634900005
J	Wen, L; Dong, SK; Li, YY; Li, XY; Shi, JJ; Wang, YL; Liu, DM; Ma, YS				Wen, Lu; Dong, Shikui; Li, Yuanyuan; Li, Xiaoyan; Shi, Jianjun; Wang, Yanlong; Liu, Demei; Ma, Yushou			Effect of Degradation Intensity on Grassland Ecosystem Services in the Alpine Region of Qinghai-Tibetan Plateau, China	PLOS ONE			English	Article							ORGANIC-CARBON; BIODIVERSITY; DYNAMICS; NITROGEN; BIOMASS; SOILS; MANAGEMENT; DIVERSITY; STORAGE; VALUES	The deterioration of alpine grassland has great impact on ecosystem services in the alpine region of Qinghai-Tibetan Plateau. However, the effect of grassland degradation on ecosystem services and the consequence of grassland deterioration on economic loss still remains a mystery. So, in this study, we assessed four types of ecosystem services following the Millennium Ecosystem Assessment classification, along a degradation gradient. Five sites of alpine grassland at different levels of degradation were investigated in Guoluo Prefecture of Qinghai Province, China. The species composition, aboveground biomass, soil total organic carbon (TOC), and soil total nitrogen (TN) were tested to evaluate major ecological services of the alpine grassland. We estimated the value of primary production, carbon storage, nitrogen recycling, and plant diversity. The results show the ecosystem services of alpine grassland varied along the degradation gradient. The ecosystem services of degraded grassland (moderate, heavy and severe) were all significantly lower than non-degraded grassland. Interestingly, the lightly degraded grassland provided more economic benefit from carbon maintenance and nutrient sequestration compared to non-degraded. Due to the destruction of the alpine grassland, the economic loss associated with decrease of biomass in 2008 was $198/ha. Until 2008, the economic loss caused by carbon emissions and nitrogen loss on severely degraded grassland was up to $8 033/ha and $13 315/ha, respectively. Urgent actions are required to maintain or promote the ecosystem services of alpine grassland in the Qinghai-Tibetan Plateau.	[Wen, Lu; Dong, Shikui; Li, Yuanyuan; Li, Xiaoyan] Beijing Normal Univ, Environm Sch, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China; [Shi, Jianjun; Wang, Yanlong; Ma, Yushou] Qinghai Univ, Qinghai Acad Anim Sci & Vet Med, Xining, Peoples R China; [Liu, Demei] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining, Peoples R China	Beijing Normal University; Qinghai University; Chinese Academy of Sciences	Dong, SK (corresponding author), Beijing Normal Univ, Environm Sch, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	dongshikui@sina.com	li, yuanyuan/GZA-4435-2022		Ministry of Science and Technology, China [2012BAC01B02]; Ministry of Environmental Protection, China [201209033, 50939001]; Engagement Fund for the Outstanding Doctoral Dissertation of Beijing Normal University [2009018]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Ministry of Environmental Protection, China; Engagement Fund for the Outstanding Doctoral Dissertation of Beijing Normal University	This study was financially supported by the grants from the Ministry of Science and Technology, China (2012BAC01B02), the Ministry of Environmental Protection, China (201209033), and 50939001 and the Engagement Fund for the Outstanding Doctoral Dissertation of Beijing Normal University (2009018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; [蔡晓布 CAI XiaoBu], 2008, [生态学报, Acta Ecologica Sinica], V28, P1034; Cao GM, 2004, SOIL BIOL BIOCHEM, V36, P237, DOI 10.1016/j.soilbio.2003.09.010; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Dong SK, 2010, FRONT EARTH SCI-PRC, V4, P42, DOI 10.1007/s11707-010-0010-z; [董锁成 Dong Suocheng], 2002, [自然资源学报, Journal of Natural Resources], V17, P713; Fischer M, 2008, MT RES DEV, V28, P148, DOI 10.1659/mrd.0964; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Ingraham MW, 2008, ECOL ECON, V67, P608, DOI 10.1016/j.ecolecon.2008.01.012; Lange GM, 2009, OCEAN COAST MANAGE, V52, P521, DOI 10.1016/j.ocecoaman.2009.08.005; Li X., 1995, GRASSL CHINA, V4, P64; Li X., 1995, GRASSLAND CHINA, V4, P51; Lin Chaofeng, 2007, Chinese Journal of Applied and Environmental Biology, V13, P788; Liu Min-chao, 2005, Journal of Plant Resources and Environment, V14, P40; [刘敏超 Liu Minchao], 2005, [环境科学学报, Acta Scientiae Circumstantiae], V25, P1280; [刘敏超 LIU Minchao], 2006, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V15, P405; Liu Wei, 2005, Grassland of China, V27, P9; Liu XiaoNi, 2008, Acta Prataculturae Sinica, V17, P1; [鲁春霞 Lu Chunxia], 2004, [生态学报, Acta Ecologica Sinica], V24, P2749; Miller D.J., 2005, GRASSLANDS WORLD PLA, P305; Quetier F, 2010, REG ENVIRON CHANGE, V10, P119, DOI 10.1007/s10113-009-0099-3; Rodionov A, 2007, EUR J SOIL SCI, V58, P1260, DOI 10.1111/j.1365-2389.2007.00919.x; Rounsevell MDA, 2010, BIODIVERS CONSERV, V19, P2823, DOI 10.1007/s10531-010-9838-5; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Shang Z., 2007, FRONT AGR CHINA, V1, P197, DOI [10.1007/s11703-007-0034-7, DOI 10.1007/S11703-007-0034-7]; Song GH, 2005, BIOGEOCHEMISTRY, V74, P47, DOI 10.1007/s10533-004-2222-3; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tong Chuan, 2006, Shengtaixue Zazhi, V25, P259; Wang Bing, 2008, Forest Research, V21, P268; Wang CT, 2009, LAND DEGRAD DEV, V20, P187, DOI 10.1002/ldr.879; Wang G., 2001, J DESERT RES, V21, P101, DOI DOI 10.3321/J.ISSN:1000-694X.2001.02.001; Wei XR, 2009, BIOGEOCHEMISTRY, V96, P149, DOI 10.1007/s10533-009-9350-8; Wiesmeier M, 2009, SOIL TILL RES, V104, P299, DOI 10.1016/j.still.2009.04.005; Wright AL, 2004, SOIL BIOL BIOCHEM, V36, P1809, DOI 10.1016/j.soilbio.2004.05.004; [谢高地 Xie Gaodi], 2003, [山地学报, Journal of Mountain Science], V21, P50; Yan Van, 2006, Wuhan University Journal of Natural Sciences, V11, P958, DOI 10.1007/BF02830194; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Yashiro Y, 2010, J PLANT ECOL, V3, P89, DOI 10.1093/jpe/rtq011; Yu Ge, 2007, Yingyong Shengtai Xuebao, V18, P47; Zhang JF., 2008, PRUATACULTURE ANIMAL, V01, P30; Zhao HL, 2009, CATENA, V77, P187, DOI 10.1016/j.catena.2008.12.007; Zhu L, 2012, SOIL SCI SOC AM J; Zuo XA, 2009, ENVIRON GEOL, V58, P1227, DOI 10.1007/s00254-008-1617-1	47	104	113	20	238	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58432	10.1371/journal.pone.0058432	http://dx.doi.org/10.1371/journal.pone.0058432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469278	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900086
J	Zaade, D; Schmitz, J; Benke, E; Klare, S; Seidel, K; Kirsch, S; Goldin-Lang, P; Zollmann, FS; Unger, T; Funke-Kaiser, H				Zaade, Daniela; Schmitz, Jennifer; Benke, Eileen; Klare, Sabrina; Seidel, Kerstin; Kirsch, Sebastian; Goldin-Lang, Petra; Zollmann, Frank S.; Unger, Thomas; Funke-Kaiser, Heiko			Distinct Signal Transduction Pathways Downstream of the (P)RR Revealed by Microarray and ChIP-chip Analyses	PLOS ONE			English	Article							LEUKEMIA ZINC-FINGER; VACUOLAR H+-ATPASE; ANGIOTENSIN-II PRODUCTION; (PRO)RENIN RECEPTOR; PROMYELOCYTIC-LEUKEMIA; RENIN/PRORENIN RECEPTOR; PRORENIN RECEPTOR; RENIN RECEPTOR; CELL-PROLIFERATION; GENE-EXPRESSION	The (pro) renin receptor ((P)RR) signaling is involved in different pathophysiologies ranging from cardiorenal end-organ damage via diabetic retinopathy to tumorigenesis. We have previously shown that the transcription factor promyelocytic leukemia zinc finger (PLZF) is an adaptor protein of the (P) RR. Furthermore, recent publications suggest that major functions of the (P) RR are mediated ligand-independently by its transmembrane and intracellular part, which acts as an accessory protein of V-ATPases. The transcriptome and recruitmentome downstream of the V-ATPase function and PLZF in the context of the (P) RR are currently unknown. Therefore, we performed a set of microarray and chromatin-immunoprecipitation (ChIP)-chip experiments using siRNA against the (P) RR, stable overexpression of PLZF, the PLZF translocation inhibitor genistein and the specific V-ATPase inhibitor bafilomycin to dissect transcriptional pathways downstream of the (P) RR. We were able to identify distinct and overlapping genetic signatures as well as novel real-time PCR-validated target genes of the different molecular functions of the (P) RR. Moreover, bioinformatic analyses of our data confirm the role of (P)RRs signal transduction pathways in cardiovascular disease and tumorigenesis.	[Zaade, Daniela; Schmitz, Jennifer; Benke, Eileen; Klare, Sabrina; Seidel, Kerstin; Kirsch, Sebastian; Goldin-Lang, Petra; Zollmann, Frank S.; Unger, Thomas; Funke-Kaiser, Heiko] Charite, CCR, Inst Pharmacol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Funke-Kaiser, H (corresponding author), Charite, CCR, Inst Pharmacol, D-13353 Berlin, Germany.	heikofunkekaiser@me.com	/GPG-3365-2022	SEIDEL, KERSTIN/0000-0002-9166-7032				Agnihotri S, 2009, ONCOGENE, V28, P3033, DOI 10.1038/onc.2009.159; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603; Batenburg WW, 2012, CLIN SCI, V123, P121, DOI 10.1042/CS20120042; Bernardo MV, 2007, BIOCHEM BIOPH RES CO, V359, P317, DOI 10.1016/j.bbrc.2007.05.085; Biswas KB, 2010, HYPERTENS RES, V33, P1053, DOI 10.1038/hr.2010.136; Bowman EJ, 2003, J BIOL CHEM, V278, P44147, DOI 10.1074/jbc.M306595200; Brown MJ, 2008, CIRCULATION, V118, P773, DOI 10.1161/CIRCULATIONAHA.108.787630; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Clavreul N, 2011, AM J PHYSIOL-RENAL, V300, pF1310, DOI 10.1152/ajprenal.00119.2010; Collett NP, 2010, SEMIN ONCOL, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; COOK M, 1995, P NATL ACAD SCI USA, V92, P2249, DOI 10.1073/pnas.92.6.2249; Costoya JA, 2001, CURR OPIN HEMATOL, V8, P212, DOI 10.1097/00062752-200107000-00006; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Danser AHJ, 2007, NEPHROL DIAL TRANSPL, V22, P1288, DOI 10.1093/ndt/gfl846; Danser AHJ, 2005, HYPERTENSION, V46, P1069, DOI 10.1161/01.HYP.0000186329.92187.2e; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; De La Fuente R, 2011, REPRODUCTION, V142, P221, DOI 10.1530/REP-10-0380; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Ebihara Akio, 2012, Front Biosci (Elite Ed), V4, P1150; Funke-Kaiser H, 2010, HYPERTENS RES, V33, P98, DOI 10.1038/hr.2009.206; Gorski JJ, 2011, NUCLEIC ACIDS RES, V39, P9536, DOI 10.1093/nar/gkr679; He M, 2009, EUR J PHARMACOL, V606, P155, DOI 10.1016/j.ejphar.2008.12.050; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ichihara A, 2011, J RENIN-ANGIO-ALDO S, V12, P638, DOI 10.1177/1470320311429227; Ikeda R, 2005, J BIOL CHEM, V280, P8523, DOI 10.1074/jbc.M409442200; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Juillerat-Jeanneret L, 2004, BRIT J CANCER, V90, P1059, DOI 10.1038/sj.bjc.6601646; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Liu JL, 2010, ADV EXP MED BIOL, V685, P111; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; McDonald GA, 2003, AM J PHYSIOL-RENAL, V285, pF59, DOI 10.1152/ajprenal.00157.2002; Melnyk RA, 2009, AM J NEPHROL, V30, P232, DOI 10.1159/000220260; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2006, EXPERT OPIN INV DRUG, V15, P1131, DOI 10.1517/13543784.15.10.1131; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Petrie K, 2008, ONCOGENE, V27, P5260, DOI 10.1038/onc.2008.159; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Rezgui D, 2009, J MOL ENDOCRINOL, V42, P341, DOI 10.1677/JME-08-0154; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Rusin A, 2010, ACTA BIOCHIM POL, V57, P23; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Schefe JH, 2008, J HYPERTENS, V26, P1787, DOI 10.1097/HJH.0b013e3283060f2e; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Seidel K, 2011, BRAIN PATHOL, V21, P31, DOI 10.1111/j.1750-3639.2010.00427.x; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Sennoune SR, 2012, CURR PROTEIN PEPT SC, V13, P152; Shi J, 2009, INT J CANCER, V125, P1558, DOI 10.1002/ijc.24449; Sihn G, 2010, KIDNEY INT, V78, P246, DOI 10.1038/ki.2010.151; Soucy NV, 2006, TOXICOL SCI, V90, P230, DOI 10.1093/toxsci/kfj077; Spalice A, 2009, ACTA PAEDIATR, V98, P421, DOI 10.1111/j.1651-2227.2008.01160.x; SPINOZZI F, 1994, LEUKEMIA RES, V18, P431, DOI 10.1016/0145-2126(94)90079-5; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tsuzuki S, 2002, BLOOD, V99, P3404, DOI 10.1182/blood.V99.9.3404; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uraoka M, 2009, BIOCHEM BIOPH RES CO, V390, P1202, DOI 10.1016/j.bbrc.2009.10.121; Varela MC, 2006, EUR J MED GENET, V49, P298, DOI 10.1016/j.ejmg.2005.12.002; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035632; Yoshikawa A, 2011, HYPERTENS RES, V34, P599, DOI 10.1038/hr.2010.284	69	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57674	10.1371/journal.pone.0057674	http://dx.doi.org/10.1371/journal.pone.0057674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23469216	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900034
J	Bishnu, B; Bhaduri, S; Kumar, AMV; Click, ES; Chadha, VK; Satyanarayana, S; Nair, SA; Gupta, D; Ahmed, QT; Sarkar, S; Paul, D; Dewan, P				Bishnu, Bipra; Bhaduri, Sudipto; Kumar, Ajay M. V.; Click, Eleanor S.; Chadha, Vineet Kumar; Satyanarayana, Srinath; Nair, Sreenivas Achutan; Gupta, Devesh; Ahmed, Quazi T.; Sarkar, Silajit; Paul, Durba; Dewan, Puneet			What Are the Reasons for Poor Uptake of HIV Testing among Patients with TB in an Eastern India District?	PLOS ONE			English	Article							TUBERCULOSIS PATIENTS; MISSED OPPORTUNITIES; IMPLEMENTATION	Background: National policy in India recommends HIV testing of all patients with TB. In West Bengal state, only 28% of patients with TB were tested for HIV between April-June, 2010. We conducted a cross-sectional survey to understand patient, provider and health system related factors associated with low uptake of HIV testing among patients with TB. Methods: We reviewed TB and HIV program records to assess the HIV testing status of patients registered for anti-TB treatment from July-September 2010 in South-24-Parganas district, West Bengal, assessed availability of HIV testing kits and interviewed a random sample of patients with TB and providers. Results: Among 1633 patients with TB with unknown HIV status at the time of diagnosis, 435 (26%) were tested for HIV within the intensive phase of TB treatment. Patients diagnosed with and treated for TB at facilities with co-located HIV testing services were more likely to get tested for HIV than at facilities without [RR = 1.27, (95% CI 1.20-3.35)]. Among 169 patients interviewed, 67 reported they were referred for HIV testing, among whom 47 were tested. During interviews, providers attributed the low proportion of patients with TB being referred and tested for HIV to inadequate knowledge among providers about the national policy, belief that patients will not test for HIV even if they are referred, shortage of HIV testing kits, and inadequate supervision by both programs. Discussion: In West Bengal, poor uptake of HIV testing among patients with TB was associated with absence of HIV testing services at sites providing TB care services and to poor referral practices among providers. Comprehensive strategies to change providers' beliefs and practices, decentralization of HIV testing to all TB care centers, and improved HIV test kit supply chain management may increase the proportion of patients with TB who are tested for HIV.	[Bishnu, Bipra; Nair, Sreenivas Achutan; Ahmed, Quazi T.; Sarkar, Silajit; Paul, Durba; Dewan, Puneet] WHO, Country Off, Off World Hlth Org WHO Representat India, New Delhi, India; [Bhaduri, Sudipto] Govt West Bengal, Minist Hlth & Family Welf, Dist TB Ctr, Kolkata, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath] South East Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India; [Click, Eleanor S.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Chadha, Vineet Kumar] Natl TB Inst, Bangalore, Karnataka, India; [Gupta, Devesh] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India	World Health Organization; Centers for Disease Control & Prevention - USA	Bishnu, B (corresponding author), WHO, Country Off, Off World Hlth Org WHO Representat India, New Delhi, India.	bsinha008@gmail.com		Satyanarayana, Srinath/0000-0002-5420-2551; Nair, Sreenivas/0000-0002-2586-6797; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Union from Global Fund Round 9 India TB Project funds; WHO-India from USAID funds	Union from Global Fund Round 9 India TB Project funds; WHO-India from USAID funds(United States Agency for International Development (USAID)World Health Organization)	Funding support was provided in part by the Union from Global Fund Round 9 India TB Project funds and the remaining part by WHO-India from USAID funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Central TB Division, 2005, TECHN OP GUID TUB CO; Central TB Division, 2010, UN ACC TB CAR; Central TB Division Ministry of Health and Family Welfare, 2011, REV NAT TB CONTR PRO; Friedland G, 2007, J INFECT DIS, V196, pS114, DOI 10.1086/518664; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Kuo AM, 2005, AIDS PATIENT CARE ST, V19, P239, DOI 10.1089/apc.2005.19.239; Nabbuye-Sekandi J, 2010, INT J TUBERC LUNG D, V14, P896; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization and Central TB Division, 2009, NAT FRAM JOINT HIV T; National AIDS Control Organization ICMR-National Institute of Medical Statistics, 2018, HIV EST 2017 TECHN R; Okot-Chono R, 2009, INT J TUBERC LUNG D, V13, P955; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Strauss A, 1997, GROUNDED THEORY PRAC; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; van der Werf MJ, 2005, INT J TUBERC LUNG D, V9, P733; Vanden Driessche K, 2009, TRAINING HLTH CARE W, V23, DOI [10.1186/1478-4491-7-23, DOI 10.1186/1478-4491-7-23]; WHO, 2004, INT POL COLL TB HIV; WHO, 2010, GLOB TUB CONTR 2010; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Yi SY, 2009, AIDS CARE, V21, P529, DOI 10.1080/09540120802270268	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e55229	10.1371/journal.pone.0055229	http://dx.doi.org/10.1371/journal.pone.0055229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469163	Green Published, gold			2022-12-27	WOS:000315897100004
J	Wei, HF; Huang, J; Yang, J; Zhang, XJ; Lin, LW; Xue, ES; Chen, ZK				Wei, Hongfen; Huang, Jing; Yang, Jing; Zhang, Xiujuan; Lin, Liwu; Xue, Ensheng; Chen, Zhikui			Ultrasound Exposure Improves the Targeted Therapy Effects of Galactosylated Docetaxel Nanoparticles on Hepatocellular Carcinoma Xenografts	PLOS ONE			English	Article							ASIALOGLYCOPROTEIN RECEPTOR; IN-VIVO; MOLECULAR-WEIGHT; GENE-TRANSFER; CANCER; LIPOSOMES; DELIVERY; CELLS; PROLIFERATION; INHIBITION	Purpose: The distribution of targeted nanoparticles in tumor tissue is affected by a combination of various factors such as the physicochemical properties of the nanoparticles, tumor hemoperfusion and tumor vascular permeability. In this study, the impact of the biological effects of ultrasound on nanoparticle targeting to liver carcinoma was explored. Methods: The copolymer MePEG-PLGA was used to prepare the galactosylated docetaxel nanoparticles (GDN), and the physical and chemical properties as well as the acute toxicity were then assayed. The impact of ultrasound exposure (UE) on tumor hemoperfusion was observed by contrast-enhanced ultrasonography (CEUS), and the distribution of docetaxel in tumors and liver were detected by high performance liquid chromatography (HPLC). In the GDN combined with UE treatment group, the mice were injected intravenously with GDN, followed by ultrasound exposure on the human hepatocellular carcinoma xenografts. Twenty-eight days post-administration, the tumor growth inhibition rate was calculated, and the expression of Survivin and Ki67 in tumor tissues were determined by immunohistochemistry assay and quantitative real-time PCR. Results: The mean size of prepared liver-targeting nanoparticles GDN was 209.3 nm, and the encapsulation efficiency was 72.28%. The median lethal dose of GDN was detected as 219.5 mg/kg which was about four times higher than that of docetaxel. After ultrasound exposure, the tumor peak - base intensity difference value, examined by CEUS, increased significantly. The drug content in the tumor was 1.96 times higher than in the GDN treated control. In vivo, GDN intravenous injection combined with ultrasound exposure therapy achieved the best anti-tumor effect with a tumor growth inhibition rate of 74.2%, and the expression of Survivin and Ki67 were significantly decreased as well. Conclusion: Ultrasound exposure can improve targeting nanoparticles accumulation in the tumor, and achieve a synergism antitumor effect on the hepatocellular carcinoma xenografts.	[Wei, Hongfen; Zhang, Xiujuan; Lin, Liwu; Xue, Ensheng; Chen, Zhikui] Fujian Med Univ, Affiliated Union Hosp, Dept Ultrasonog, Fuzhou, Peoples R China; [Wei, Hongfen] Zhejiang Univ, Affiliated Sir Run Run Shaw Hosp, Dept Ultrasonog, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Jing] Peoples Hosp Zhuhai City, Dept Ultrasonog, Zhuhai, Peoples R China; [Yang, Jing] Fujian Med Univ, Affiliated Union Hosp, Dept Pharm, Fuzhou, Peoples R China	Fujian Medical University; Zhejiang University; Fujian Medical University	Chen, ZK (corresponding author), Fujian Med Univ, Affiliated Union Hosp, Dept Ultrasonog, Fuzhou, Peoples R China.	jimchen2003@163.com			Key Laboratory Fund at the Affiliated Union Hospital, Fujian Medical University; Medical Innovation Foundation by Fujian Provincial Department of Health [2012-CXB-15]	Key Laboratory Fund at the Affiliated Union Hospital, Fujian Medical University; Medical Innovation Foundation by Fujian Provincial Department of Health	This research was financially supported in part by the Key Laboratory Fund at the Affiliated Union Hospital, Fujian Medical University and the Medical Innovation Foundation Grant provided by Fujian Provincial Department of Health (2012-CXB-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Bergh J, 2012, J CLIN ONCOL, V30, P921, DOI 10.1200/JCO.2011.35.7376; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; Chen ZK, 2012, MED ONCOL, V29, P62, DOI 10.1007/s12032-010-9762-2; Dong L, 2008, J BIOMED MATER RES A, V84A, P777, DOI 10.1002/jbm.a.31328; Fang Chao, 2006, Yaoxue Xuebao, V41, P305; Gan HK, 2012, CANC RES; Guhagarkar SA, 2010, INT J PHARMACEUT, V401, P113, DOI 10.1016/j.ijpharm.2010.09.012; Jeong YI, 2005, INT J PHARMACEUT, V296, P151, DOI 10.1016/j.ijpharm.2005.02.027; Kawakami S, 1998, BIOCHEM BIOPH RES CO, V252, P78, DOI 10.1006/bbrc.1998.9602; Lee SH, 2011, ISLETS, V3, P358, DOI 10.4161/isl.3.6.17923; Lentacker I, 2010, J CONTROL RELEASE, V148, pE113, DOI 10.1016/j.jconrel.2010.07.085; Li LL, 2010, ACS NANO, V4, P6874, DOI 10.1021/nn100918a; Lin F, 2012, CELL PROLIFERAT, V45, P207, DOI 10.1111/j.1365-2184.2012.00812.x; Managit C, 2005, J PHARM SCI-US, V94, P2266, DOI 10.1002/jps.20443; Negishi Y, 2010, MOL PHARMACEUT, V7, P217, DOI 10.1021/mp900214s; Ning YX, 2012, ONCOL REP, V27, P1857, DOI 10.3892/or.2012.1739; Niu G, 2012, J CONTROL RELEASE, V161, P18, DOI 10.1016/j.jconrel.2012.04.043; Oeffinger BE, 2004, ULTRASONICS, V42, P343, DOI 10.1016/j.ultras.2003.11.011; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng DJ, 2007, CANCER GENE THER, V14, P66, DOI 10.1038/sj.cgt.7700985; Pouleau HB, 2012, INT J ONCOL, V40, P923, DOI 10.3892/ijo.2011.1260; Preusser M, 2012, HISTOPATHOLOGY, V60, P885, DOI 10.1111/j.1365-2559.2011.04134.x; Rottenberg S, 2012, CANCER RES, V72, P2350, DOI 10.1158/0008-5472.CAN-11-4201; Suzuki R, 2010, J CONTROL RELEASE, V142, P245, DOI 10.1016/j.jconrel.2009.10.027; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Thaci B, 2012, CANCER GENE THER, V19, P431, DOI 10.1038/cgt.2012.21; van Zuylen L, 2001, INVEST NEW DRUG, V19, P125, DOI 10.1023/A:1010618632738; Xu ZH, 2009, BIOMATERIALS, V30, P226, DOI 10.1016/j.biomaterials.2008.09.014; Yata Y, 2010, HEPATOL RES, V40, P304, DOI 10.1111/j.1872-034X.2009.00598.x; Zhang Y, 2007, J CONTROL RELEASE, V117, P281, DOI 10.1016/j.jconrel.2006.11.006; Zheng WY, 2011, DRUG DISCOV THER, V5, P293, DOI 10.5582/ddt.2011.v5.6.293	32	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2013	8	3							e58133	10.1371/journal.pone.0058133	http://dx.doi.org/10.1371/journal.pone.0058133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103EI	23469265	Green Published, gold, Green Submitted			2022-12-27	WOS:000315897100062
J	Anderson, KE; Kielkowska, A; Durrant, TN; Juvin, V; Clark, J; Stephens, LR; Hawkins, PT				Anderson, Karen E.; Kielkowska, Anna; Durrant, Tom N.; Juvin, Veronique; Clark, Jonathan; Stephens, Len R.; Hawkins, Phillip T.			Lysophosphatidylinositol-Acyltransferase-1 (LPIAT1) Is Required to Maintain Physiological Levels of PtdIns and PtdInsP(2) in the Mouse	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LYSOPHOSPHOLIPID ACYLTRANSFERASES; CAENORHABDITIS-ELEGANS; PHOSPHATIDYLINOSITOL; MEMBRANE; PHOSPHOINOSITIDES; TISSUES; MBOA-7; MICE	We disrupted the gene encoding lysophosphatidylinositol-acyltransferase-1 (LPIAT1) in the mouse with the aim of understanding its role in determining cellular phosphoinositide content. LPIAT1(-/-) mice were born at lower than Mendelian ratios and exhibited a severe developmental brain defect. We compared the phospholipid content of livers and brains from LPIAT1(-/-) and LPIAT1(+/+) littermates by LC-ESI/MS. In accord with previous studies, the most abundant molecular species of each phosphoinositide class (PtdIns, PtdInsP, PtdInsP(2) and PtdInsP(3)) possessed a C38:4 complement of fatty-acyl esters (C18:0 and C20:4 are usually assigned to the sn-1 and sn-2 positions, respectively). LPIAT1(-/-) liver and brain contained relatively less of the C38:4 species of PtdIns, PtdInsP and PtdInsP(2) (dropping from 95-97% to 75-85% of the total species measured for each lipid class) and relatively more of the less abundant species (PtdInsP(3) less abundant species were below our quantification levels). The increases in the less abundant PtdIns and PtdInsP(2) species did not compensate for the loss in C38:4 species, resulting in a 26-44% reduction in total PtdIns and PtdInsP(2) levels in both brain and liver. LPIAT1(-/-) brain and liver also contained increased levels of C18:0 lyso-PtdIns (300% and 525% respectively) indicating a defect in the reacylation of this molecule. LPIAT1(-/-) brain additionally contained significantly reduced C38:4 PC and PE levels (by 47% and 55% respectively), possibly contributing to the phenotype in this organ. The levels of all other molecular species of PC, PE, PS and PA measured in the brain and liver were very similar between LPIAT1(-/-) and LPIAT1(+/+) samples. These results suggest LPIAT1 activity plays a non-redundant role in maintaining physiological levels of PtdIns within an active deacylation/reacylation cycle in mouse tissues. They also suggest that this pathway must act in concert with other, as yet unidentified, mechanisms to achieve the enrichment observed in C38:4 molecular species of phosphoinositides.	[Anderson, Karen E.; Durrant, Tom N.; Juvin, Veronique; Stephens, Len R.; Hawkins, Phillip T.] Babraham Inst, Inositide Lab, Cambridge, England; [Kielkowska, Anna; Clark, Jonathan] Babraham Biosci Technol Ltd, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Stephens, LR (corresponding author), Babraham Inst, Inositide Lab, Babraham Res Campus, Cambridge, England.	len.stephens@babraham.ac.uk; phillip.hawkins@babraham.ac.uk	Jones, Beryl/N-5842-2019; Walton, Alexander/W-5786-2019	Jones, Beryl/0000-0003-2925-0807; Walton, Alexander/0000-0001-8635-873X; Anderson, Karen/0000-0002-7394-6660; Hawkins, Phillip/0000-0002-6979-0464; Corby-Harris, Vanessa/0000-0001-7680-0328; stephens, len/0000-0002-2771-3487; Durrant, Tom N/0000-0002-0503-9364	Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG [BB/J004456/1]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BB/I003916/1, BBS/E/B/000C0415] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by the Biotechnology and Biological Sciences Research Council United Kingdom Signalling ISPG BB/J004456/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER A, 1990, LIPIDS, V25, P473, DOI 10.1007/BF02538091; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fan YY, 2012, J LIPID RES, V53, P1287, DOI 10.1194/jlr.M024216; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Lee HC, 2012, GENES CELLS, V17, P748, DOI 10.1111/j.1365-2443.2012.01624.x; Lung M, 2009, J BIOL CHEM, V284, P31062, DOI 10.1074/jbc.M109.050617; Milne SB, 2005, J LIPID RES, V46, P1796, DOI 10.1194/jlr.D500010-JLR200; PALMER FBS, 1986, BIOCHEM CELL BIOL, V64, P117, DOI 10.1139/o86-019; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shulga YV, 2010, BIOCHEMISTRY-US, V49, P312, DOI 10.1021/bi901551e; Steinhauer J, 2009, MOL BIOL CELL, V20, P5224, DOI 10.1091/mbc.E09-05-0382; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; VADNAL RE, 1989, BIOCHEM BIOPH RES CO, V163, P995, DOI 10.1016/0006-291X(89)92320-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708	27	215	222	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58425	10.1371/journal.pone.0058425	http://dx.doi.org/10.1371/journal.pone.0058425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	24358254	gold, Green Published			2022-12-27	WOS:000315637900141
J	Shen, HM; Wu, XM; Zhu, YZ; Sun, HL				Shen, Hongmei; Wu, Xinmin; Zhu, Yuzhong; Sun, Hualing			Intravenous Administration of Achyranthes Bidentata Polypeptides Supports Recovery from Experimental Ischemic Stroke in Vivo	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; NEURONAL DAMAGE; NEUROPROTECTION; CALCIUM; SENSORIMOTOR; GLUTAMATE; NMDA; APOPTOSIS; CELLS; PATHOPHYSIOLOGY	Background: Achyranthes bidentata Blume (A. bidentata) is a commonly prescribed Chinese medicinal herb. A. bidentata polypeptides (ABPP) is an active composite constituent, separated from the aqueous extract of A. bidentata. Our previous studies have found that ABPP have the neuroprotective function in vitro and in rat middle cerebral artery occlusion (MCAO) model in attenuating the brain infract area induced by focal ischemia-reperfusion. However, the ultimate goal of the stroke treatment is the restoration of behavioral function. Identifying behavioral deficits and therapeutic treatments in animal models of ischemic stroke is essential for potential translational applications. Methodology and Principal Findings: The effect of ABPP on motor, sensory, and cognitive function in an ischemic stroke model with MCAO was investigated up to day 30. The function recovery monitored by the neurological deficit score, grip test, body asymmetry, beam-balancing task, and the Morris Water Maze. In this study, systemic administration of ABPP by i.v after MCAO decreased the neurological deficit score, ameliorated the forepaw muscle strength, and diminished the motor and sensory asymmetry on 7th and 30th day after MCAO. MCAO has been observed to cause prolonged disturbance of spatial learning and memory in rats using the MWM, and ABPP treatment could improve the spatial learning and memory function, which is impaired by MCAO in rats, on 30th day after MCAO. Then, the viable cells in CA1 region of hippocampus were counted by Nissl staining, and the neuronal cell death were significantly suppressed in the ABPP treated group. Conclusion: ABPP could improve the recovery of sensory, motor and coordination, and cognitive function in MCAO-induced ischemic rats. And this recovery had a good correlation to the less of neuronal injury in brain.	[Shen, Hongmei] Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China; Nantong Univ, Inst Naut Med, Nantong, Peoples R China	Nantong University; Nantong University	Shen, HM (corresponding author), Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China.	hmshen1971@gmail.com	sun, hualin/AAX-6391-2021		National Natural Science Foundation of China [81073079, K2009013]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The National Natural Science Foundation of China (Grant No. 81073079, K2009013) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) supported Hongmei Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blandini F, 1996, FUNCT NEUROL, V11, P3; Borlongan CV, 1998, NEUROREPORT, V9, P3615, DOI 10.1097/00001756-199811160-00012; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; BUCHAN A, 1990, J NEUROSCI, V10, P311; Buckmaster PS, 2002, EPILEPSY RES, V48, P43, DOI 10.1016/S0920-1211(01)00318-7; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Cespedes-Rubio A, 2010, J NEUROSCI RES, V88, P3621, DOI 10.1002/jnr.22511; CHOI DW, 1989, ANN NY ACAD SCI, V568, P219; Dhar-Mascareno M, 2005, FREE RADICAL BIO MED, V38, P1311, DOI 10.1016/j.freeradbiomed.2005.01.017; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; EIMERL S, 1994, J NEUROCHEM, V62, P1223; Feigin VL, 2007, STROKE, V38, P1734, DOI 10.1161/STROKEAHA.107.487132; Gagliardi RJ, 2000, ARQ NEURO-PSIQUIAT, V58, P583, DOI 10.1590/S0004-282X2000000300030; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Gerriets T, 2003, J NEUROSCI METH, V122, P201, DOI 10.1016/S0165-0270(02)00322-9; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; GOLDSTEIN LB, 1993, J NEUROSCI METH, V48, P35, DOI 10.1016/S0165-0270(05)80005-6; Gong X, 2002, PHYTOMEDICINE, V9, P478, DOI 10.1078/09447110260571760; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Harvey AL, 1999, TRENDS PHARMACOL SCI, V20, P196, DOI 10.1016/S0165-6147(99)01346-2; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kirino T, 1986, No To Shinkei, V38, P1157; Kitagawa K, 1998, STROKE, V29, P2616, DOI 10.1161/01.STR.29.12.2616; Liu HT, 1999, P NATL ACAD SCI USA, V96, P12096, DOI 10.1073/pnas.96.21.12096; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Reglodi D, 2003, BRAIN RES BULL, V59, P459, DOI 10.1016/S0361-9230(02)00962-0; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Shen HM, 2010, J NEUROSCI RES, V88, P669, DOI 10.1002/jnr.22221; Shen HM, 2008, BRAIN RES BULL, V77, P274, DOI 10.1016/j.brainresbull.2008.08.002; Shen YT, 2011, NEUROCHEM RES, V36, P2186, DOI 10.1007/s11064-011-0543-x; Thomalla G, 2006, STROKE, V37, P852, DOI 10.1161/01.STR.0000204120.79399.72; Yonemori F, 1996, J CEREBR BLOOD F MET, V16, P973, DOI 10.1097/00004647-199609000-00022	44	61	65	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57055	10.1371/journal.pone.0057055	http://dx.doi.org/10.1371/journal.pone.0057055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469228	Green Submitted, gold, Green Published			2022-12-27	WOS:000315561400025
J	Yao, XL; Fu, BJ; Lu, YH; Sun, FX; Wang, S; Liu, M				Yao, Xueling; Fu, Bojie; Lu, Yihe; Sun, Feixiang; Wang, Shuai; Liu, Min			Comparison of Four Spatial Interpolation Methods for Estimating Soil Moisture in a Complex Terrain Catchment	PLOS ONE			English	Article							SEMIARID LOESS PLATEAU; LINEAR-REGRESSION; VARIABILITY; WATER; PREDICTION; SURFACE; MODEL; SCALE; SCATTEROMETER; INFORMATION	Many spatial interpolation methods perform well for gentle terrains when producing spatially continuous surfaces based on ground point data. However, few interpolation methods perform satisfactorily for complex terrains. Our objective in the present study was to analyze the suitability of several popular interpolation methods for complex terrains and propose an optimal method. A data set of 153 soil water profiles (1 m) from the semiarid hilly gully Loess Plateau of China was used, generated under a wide range of land use types, vegetation types and topographic positions. Four spatial interpolation methods, including ordinary kriging, inverse distance weighting, linear regression and regression kriging were used for modeling, randomly partitioning the data set into 2/3 for model fit and 1/3 for independent testing. The performance of each method was assessed quantitatively in terms of mean-absolute-percentage-error, root-mean-square-error, and goodness-of-prediction statistic. The results showed that the prediction accuracy differed significantly between each method in complex terrain. The ordinary kriging and inverse distance weighted methods performed poorly due to the poor spatial autocorrelation of soil moisture at small catchment scale with complex terrain, where the environmental impact factors were discontinuous in space. The linear regression model was much more suitable to the complex terrain than the former two distance-based methods, but the predicted soil moisture changed too sharply near the boundary of the land use types and junction of the sunny (southern) and shady (northern) slopes, which was inconsistent with reality because soil moisture should change gradually in short distance due to its mobility in soil. The most optimal interpolation method in this study for the complex terrain was the hybrid regression kriging, which produced a detailed, reasonable prediction map with better accuracy and prediction effectiveness.	[Yao, Xueling; Fu, Bojie; Lu, Yihe; Sun, Feixiang; Wang, Shuai; Liu, Min] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Fu, BJ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bfu@rcees.ac.cn	Fu, Bojie/B-1493-2009; Wang, Shuai/B-2334-2017	Wang, Shuai/0000-0003-1595-9858; Feng, Haiyang/0000-0002-2169-2347; Shen, Wen-Hui/0000-0001-7988-6382	National Natural Science Foundation of China [40930528]; State Forestry Administration [201004058]; CAS/SAFEA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration; CAS/SAFEA(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (No. 40930528), State Forestry Administration (No. 201004058) and the CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergel C, 2008, HYDROL EARTH SYST SC, V12, P1323, DOI 10.5194/hess-12-1323-2008; Bai Tian-lu, 2009, Shengtaixue Zazhi, V28, P2508; Baskan O, 2009, CLAY MINER, V44, P181, DOI 10.1180/claymin.2009.044.2.181; Bi HX, 2008, J AM WATER RESOUR AS, V44, P1121, DOI 10.1111/j.1752-1688.2008.00236.x; Bi HX, 2009, INT J SEDIMENT RES, V24, P63, DOI 10.1016/S1001-6279(09)60016-0; Carre F, 2002, GEODERMA, V110, P241, DOI 10.1016/S0016-7061(02)00233-1; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; Dorigo WA, 2011, HYDROL EARTH SYST SC, V15, P1675, DOI 10.5194/hess-15-1675-2011; Dripps WR, 2007, HYDROGEOL J, V15, P433, DOI 10.1007/s10040-007-0160-6; Fritsch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020682; Gilbert B, 1997, LANDSCAPE URBAN PLAN, V37, P235, DOI 10.1016/S0169-2046(97)80007-2; Govaerts A, 2010, QUANT GEO G, V16, P219, DOI 10.1007/978-90-481-2322-3_20; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Kravchenko A, 1999, AGRON J, V91, P393, DOI 10.2134/agronj1999.00021962009100030007x; Lesch SM, 2008, GEODERMA, V148, P130, DOI 10.1016/j.geoderma.2008.09.014; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Li Y, 2010, GEODERMA, V159, P63, DOI 10.1016/j.geoderma.2010.06.017; Lin GF, 2004, J HYDROL, V288, P288, DOI 10.1016/j.jhydrol.2003.10.008; Liu W, 2010, AGR WATER MANAGE, V97, P1133, DOI 10.1016/j.agwat.2010.01.001; Liu Y, 2012, GEOMORPHOLOGY, V138, P404, DOI 10.1016/j.geomorph.2011.10.009; Minasny B, 2007, GEODERMA, V140, P324, DOI 10.1016/j.geoderma.2007.04.028; Minet J, 2011, HYDROL EARTH SYST SC, V15, P1323, DOI 10.5194/hess-15-1323-2011; Moran MS, 2004, CAN J REMOTE SENS, V30, P805, DOI 10.5589/m04-043; Perry MA, 2008, HYDROL EARTH SYST SC, V12, P39, DOI 10.5194/hess-12-39-2008; Qiu Y, 2003, CATENA, V54, P173, DOI 10.1016/S0341-8162(03)00064-X; Sigua GC, 2008, J SOIL SEDIMENT, V8, P193, DOI 10.1007/s11368-008-0003-7; Stacey KF, 2006, GEODERMA, V135, P107, DOI 10.1016/j.geoderma.2005.11.008; Sun W, 2012, J PLANT NUTR SOIL SC, V175, P212, DOI 10.1002/jpln.201100005; Tabari H, 2011, METEOROL ATMOS PHYS, V110, P135, DOI 10.1007/s00703-010-0110-z; Tischler M, 2007, ENVIRON MODELL SOFTW, V22, P891, DOI 10.1016/j.envsoft.2006.05.022; Toth E, 2008, CEREAL RES COMMUN, V36, P307; Tramblay Y, 2010, J HYDROL, V387, P176, DOI 10.1016/j.jhydrol.2010.04.006; Vanita Pandey, 2010, International Journal of Geosciences, V1, P87; Wagner W, 1999, REMOTE SENS ENVIRON, V70, P191, DOI 10.1016/S0034-4257(99)00036-X; Wang M, 2012, PLOS ONE, V7; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang ZQ, 2009, J GEOGR SCI, V19, P707, DOI 10.1007/s11442-009-0707-7; Wu J, 2006, GEODERMA, V134, P187, DOI 10.1016/j.geoderma.2005.11.002; Yao XL, 2012, J SOIL SEDIMENT, V12, P694, DOI 10.1007/s11368-012-0481-5; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Zeng C, 2011, ACTA AGR SCAND B-S P, V61, P1, DOI 10.1080/09064710903352589; Zhang CL, 2008, INT FED INFO PROC, V258, P719; Zhang CL, 2009, INT FED INFO PROC, V293, P285; Zhao PP, 2010, ACTA AGR SCAND B-S P, V60, P117, DOI 10.1080/09064710802676377; Zhu Q, 2010, PEDOSPHERE, V20, P594, DOI 10.1016/S1002-0160(10)60049-5; Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433; Zribi M, 2003, REMOTE SENS ENVIRON, V86, P30, DOI 10.1016/S0034-4257(03)00065-8	48	126	136	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54660	10.1371/journal.pone.0054660	http://dx.doi.org/10.1371/journal.pone.0054660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23483879	Green Submitted, gold, Green Published			2022-12-27	WOS:000314021500101
J	Anderson, KE; Sheehan, TH; Mott, BM; Maes, P; Snyder, L; Schwan, MR; Walton, A; Jones, BM; Corby-Harris, V				Anderson, Kirk E.; Sheehan, Timothy H.; Mott, Brendon M.; Maes, Patrick; Snyder, Lucy; Schwan, Melissa R.; Walton, Alexander; Jones, Beryl M.; Corby-Harris, Vanessa			Microbial Ecology of the Hive and Pollination Landscape: Bacterial Associates from Floral Nectar, the Alimentary Tract and Stored Food of Honey Bees (Apis mellifera)	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GUT BACTERIA; SYMBIONTS; COMMUNITIES; EVOLUTION; MICROFLORA; DIVERSITY; POLLEN; ANTS; MICROORGANISMS	Nearly all eukaryotes are host to beneficial or benign bacteria in their gut lumen, either vertically inherited, or acquired from the environment. While bacteria core to the honey bee gut are becoming evident, the influence of the hive and pollination environment on honey bee microbial health is largely unexplored. Here we compare bacteria from floral nectar in the immediate pollination environment, different segments of the honey bee (Apis mellifera) alimentary tract, and food stored in the hive (honey and packed pollen or "beebread''). We used cultivation and sequencing to explore bacterial communities in all sample types, coupled with culture-independent analysis of beebread. We compare our results from the alimentary tract with both culture-dependent and culture-independent analyses from previous studies. Culturing the foregut (crop), midgut and hindgut with standard media produced many identical or highly similar 16S rDNA sequences found with 16S rDNA clone libraries and next generation sequencing of 16S rDNA amplicons. Despite extensive culturing with identical media, our results do not support the core crop bacterial community hypothesized by recent studies. We cultured a wide variety of bacterial strains from 6 of 7 phylogenetic groups considered core to the honey bee hindgut. Our results reveal that many bacteria prevalent in beebread and the crop are also found in floral nectar, suggesting frequent horizontal transmission. From beebread we uncovered a variety of bacterial phylotypes, including many possible pathogens and food spoilage organisms, and potentially beneficial bacteria including Lactobacillus kunkeei, Acetobacteraceae and many different groups of Actinobacteria. Contributions of these bacteria to colony health may include general hygiene, fungal and pathogen inhibition and beebread preservation. Our results are important for understanding the contribution to pollinator health of both environmentally vectored and core microbiota, and the identification of factors that may affect bacterial detection and transmission, colony food storage and disease susceptibility.	[Anderson, Kirk E.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Anderson, Kirk E.; Sheehan, Timothy H.; Mott, Brendon M.; Maes, Patrick; Snyder, Lucy; Schwan, Melissa R.; Walton, Alexander; Jones, Beryl M.; Corby-Harris, Vanessa] USDA ARS Carl Hayden Bee Res Ctr, Tucson, AZ USA; [Sheehan, Timothy H.; Maes, Patrick] Univ Arizona, Dept Microbiol, Tucson, AZ USA; [Mott, Brendon M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Walton, Alexander] Iowa State Univ, Dept Ecol & Evolut, Ames, IA USA; [Jones, Beryl M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	University of Arizona; University of Arizona; Arizona State University; Arizona State University-Tempe; Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Anderson, KE (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.	kirk.anderson@ars.usda.gov	Jones, Beryl/N-5842-2019; Walton, Alexander/W-5786-2019	Jones, Beryl/0000-0003-2925-0807; Walton, Alexander/0000-0001-8635-873X; Anderson, Karen/0000-0002-7394-6660; Hawkins, Phillip/0000-0002-6979-0464; Corby-Harris, Vanessa/0000-0001-7680-0328; stephens, len/0000-0002-2771-3487; Durrant, Tom N/0000-0002-0503-9364	Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BB/I003916/1, BBS/E/B/000C0415] Funding Source: researchfish	Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided entirely by the USA tax-payer supported operating budget of the Agricultural Research Service-U.S. Department of Agriculture Carl Hayden Bee Research Center, Tucson AZ. There were no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Aween MM, 2012, J FOOD SCI, V77, pM364, DOI 10.1111/j.1750-3841.2012.02776.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Bottacini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044229; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Bution ML, 2008, MICRON, V39, P897, DOI 10.1016/j.micron.2007.11.008; Chen YP, 2010, APIDOLOGIE, V41, P364, DOI 10.1051/apido/2010021; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1988, J INSECT PHYSIOL, V34, P85, DOI 10.1016/0022-1910(88)90158-8; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; DAESCHEL MA, 1987, FEMS MICROBIOL LETT, V46, P357, DOI 10.1111/j.1574-6968.1987.tb02472.x; Dawkins R, 2004, BIOL PHILOS, V19, P377, DOI 10.1023/B:BIPH.0000036180.14904.96; DeSantis TZ, 2006, APPL ENV MICROBIOL; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Endo A, 2011, INT J SYST EVOL MICR; Endo A, 2009, SYST APPL MICROBIOL, V32, P593, DOI 10.1016/j.syapm.2009.08.002; Engel, 2013, INT J SYST EVOL MICR, DOI 10.109.; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Feldhaar Heike, 2009, Journal of Biology (London), V8, P31, DOI 10.1186/jbiol129; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1983, J INVERTEBR PATHOL, V42, P187, DOI 10.1016/0022-2011(83)90061-7; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gordon DM, 2001, MICROBIOL-SGM, V147, P1079, DOI 10.1099/00221287-147-5-1079; GOTELLI NJ, 2002, ECOSIM NULL MODELS S; Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hendriksma HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059589; Garcia AH, 2011, J BIOSCIENCES, V36, P939, DOI 10.1007/s12038-011-9107-0; Holldobler B., 2008, SUPERORGANISM BEAUTY; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; INGLIS GD, 1993, MICROBIAL ECOL, V26, P125, DOI 10.1007/BF00177048; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jojima Y, 2004, INT J SYST EVOL MICR, V54, P2263, DOI 10.1099/ijs.0.02911-0; Judd T. M., 2011, SOCIAL INSECTS STRUC; Kacaniova M, 2004, FOLIA MICROBIOL, V49, P169, DOI 10.1007/BF02931394; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOPER GM, 1980, APIDOLOGIE, V11, P63, DOI 10.1051/apido:19800108; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; Microbiome F, 2013, UNEXPECTED DIVERSITY, DOI [10.1128/mBio.00602-12, DOI 10.1128/MBI0.00602-12.EDIT0R]; Millet V, 2000, LETT APPL MICROBIOL, V30, P136, DOI 10.1046/j.1472-765X.2000.00684.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neveling DP, 2012, CURR MICROBIOL; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Ohkuma M., 2001, RIKEN REV, V41, P69; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2009, J APICULT RES, V48, P233, DOI 10.3896/IBRA.1.48.4.02; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P209, DOI 10.1051/apido:19660302; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Promnuan Y, 2009, WORLD J MICROB BIOT, V25, P1685, DOI 10.1007/s11274-009-0051-1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Rangberg A, 2012, INTEGR COMP BIOL, V52, P89, DOI 10.1093/icb/ics089; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rosengaus RB, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.31; RUIZARGU.T, 1973, J GEN MICROBIOL, V76, P211, DOI 10.1099/00221287-76-1-211; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Shamala TR, 2000, LETT APPL MICROBIOL, V30, P453, DOI 10.1046/j.1472-765X.2000.00746.x; SUZUKI I, 1991, MILCHWISSENSCHAFT, V46, P635; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Turner J. Scott, 2005, American Entomologist, V51, P36; Turner JS, 2004, BIOL PHILOS, V19, P327, DOI 10.1023/B:BIPH.0000036115.65522.a1; Vasquez A, 2011, MICROBIOLOGY TODAY, V38, P226; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; VIDAVER AK, 1982, ANNU REV MICROBIOL, V36, P495, DOI 10.1146/annurev.mi.36.100182.002431; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	106	215	222	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e83125	10.1371/journal.pone.0083125	http://dx.doi.org/10.1371/journal.pone.0083125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358254	gold, Green Published, Green Submitted			2022-12-27	WOS:000328737700049
J	Ren, GL; Huang, GY; Zheng, H; Fang, Y; Ma, HH; Xu, MC; Zhang, HB; Zhang, WY; Zhao, YG; Sun, DY; Hu, WK; Liu, J				Ren, Guang-Li; Huang, Guang-Yu; Zheng, Hong; Fang, Ying; Ma, Heng-Hao; Xu, Man-Chun; Zhang, Hong-Bin; Zhang, Wei-Yun; Zhao, Ya-Gang; Sun, Da-Yong; Hu, Wen-Kui; Liu, Jian			Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and lLong-Term-siRNA Treatment	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SHORT HAIRPIN RNA; NONPARENCHYMAL LIVER-CELLS; DENDRITIC CELLS; POLYMERASE-II; EXPRESSION; REPLICATION; INFECTION; INTERFERENCE; INHIBITION	Background: Currently, no licensed therapy can thoroughly eradicate hepatitis B virus (HBV) from the body, including interferon alpha and inhibitors of HBV reverse-transcription. Small interfering RNA (siRNA) seem to be a promising tool for treating HBV, but had no effect on the pre-existing HBV covalently closed circular DNA. Because it is very difficult to thoroughly eradicate HBV with unique siRNAs, upgrading the immune response is the best method for fighting HBV infection. Here, we aim to explore the immune response of transgenic mice to HBV vaccination after long-term treatment with siRNAs and develop a therapeutic approach that combines siRNAs with immunopotentiators. Methodology/Principal Findings: To explore the response of transgenic mice to hepatitis B vaccine, innate and acquired immunity were detected after long-term treatment with siRNAs and vaccination. Antiviral cytokines and level of anti-hepatitis B surface antigen antibody (HBsAg-Ab) were measured after three injections of hepatitis B vaccine. Results: Functional analyses indicated that toll-like receptor-mediated innate immune responses were reinforced, and antiviral cytokines were significantly increased, especially in the pSilencer4.1/HBV groups. Analysis of CD80+/CD86+ dendritic cells in the mouse liver indicated that dendritic cell antigen presentation was strengthened. Furthermore, the siRNA-treated transgenic mice could produce detectable HBsAg-Ab after vaccination, especially in the CpG oligonucleotide vaccine group. Conclusions/Significance: For the first time, our studies demonstrate that siRNAs with CpG HBV vaccine could strengthen the immune response and break the immune tolerance status of transgenic mice to HBV. Thus, siRNAs and HBV vaccine could provide a sharp double-edged sword against chronic HBV infection.	[Ren, Guang-Li; Ma, Heng-Hao; Xu, Man-Chun; Zhang, Hong-Bin; Zhang, Wei-Yun; Hu, Wen-Kui; Liu, Jian] Gen Hosp GuangZhou Mil Command PLA, Dept Pediat, Guangzhou, Guangdong, Peoples R China; [Ren, Guang-Li] S China Univ Technol, Inst Biochem, Guangzhou, Guangdong, Peoples R China; [Ren, Guang-Li] HuaBo Biopharmceut Inst GuangZhou, Guangzhou, Guangdong, Peoples R China; [Huang, Guang-Yu] Third Mil Med Univ, Dept Infect Dis, Southwest Hosp, Chongqing, Peoples R China; [Zheng, Hong] Fourth Mil Med Univ, Dent Hosp, Dept Oral Orthopaed, Xian 710032, Peoples R China; [Fang, Ying] Guangzhou Med Univ, Dept Stomatol, Guangzhou, Guangdong, Peoples R China; [Zhao, Ya-Gang; Sun, Da-Yong] Gen Hosp GuangZhou Mil Command PLA, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Hu, Wen-Kui; Liu, Jian] Gen Hosp GuangZhou Mil Command PLA, Dept Gerontol & Deanery, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; South China University of Technology; Army Medical University; Air Force Military Medical University; Guangzhou Medical University; Southern Theater Command General Hospital; Southern Theater Command General Hospital	Ren, GL (corresponding author), Gen Hosp GuangZhou Mil Command PLA, Dept Pediat, Guangzhou, Guangdong, Peoples R China.	guangliren@hotmail.com			China postdoctoral Science Foundation [20100470917, 201003353]; Natural Science Foundation of Guangzhou province [8451001002000762]; Guangdong province & GuangZhou Science and Technology Program Funds [12C19732961131678, 20120314]	China postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangzhou province; Guangdong province & GuangZhou Science and Technology Program Funds	This research was funded by China postdoctoral Science Foundation [20100470917; 201003353]; Natural Science Foundation of Guangzhou province [8451001002000762]; and Guangdong province & GuangZhou Science and Technology Program Funds [12C19732961131678, 20120314]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Carmona S, 2009, MOL PHARMACEUT, V6, P706, DOI 10.1021/mp800157x; Chen CC, 2009, MOL THER, V17, P352, DOI 10.1038/mt.2008.245; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Durantel D, 2012, J HEPATOL, V57, P486, DOI 10.1016/j.jhep.2012.06.019; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kakazu E, 2009, HEPATOLOGY, V50, P1936, DOI 10.1002/hep.23248; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Nassanian H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000767; Park SG, 2005, GASTROENTEROLOGY, V128, P2042, DOI 10.1053/j.gastro.2005.03.002; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Ren GL, 2005, BIOCHEM BIOPH RES CO, V335, P1051, DOI 10.1016/j.bbrc.2005.07.170; Ren GL, 2007, ANTIVIR THER, V12, P865; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Starkey JL, 2009, J GEN VIROL, V90, P115, DOI 10.1099/vir.0.004408-0; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Wen WH, 2007, HEPATOLOGY, V46, P84, DOI 10.1002/hep.21663; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu Zhe, 2007, J Infect, V55, pe1, DOI 10.1016/j.jinf.2007.01.003; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhang JC, 2009, J VIROL METHODS, V161, P30, DOI 10.1016/j.jviromet.2009.05.009	31	25	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57525	10.1371/journal.pone.0057525	http://dx.doi.org/10.1371/journal.pone.0057525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472088	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900027
J	Wang, PH; Gu, ZH; Wan, DH; Zhu, WB; Qiu, W; Weng, SP; Yu, XQ; He, JG				Wang, Pei-Hui; Gu, Zhi-Hua; Wan, Ding-Hui; Zhu, Wei-Bin; Qiu, Wei; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			Litopenaeus vannamei Sterile-Alpha and Armadillo Motif Containing Protein (LvSARM) Is Involved in Regulation of Penaeidins and antilipopolysaccharide factors	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE GENES; TOLL SIGNALING PATHWAY; SHRIMP PENAEUS-MONODON; BLACK TIGER SHRIMP; INNATE IMMUNITY; CAENORHABDITIS-ELEGANS; DROSOPHILA; SARM; INFECTION; RECEPTORS	The Toll-like receptor (TLR)-mediated NF-kappa B pathway is tightly controlled because overactivation may result in severe damage to the host, such as in the case of chronic inflammatory diseases and cancer. In mammals, sterile-alpha and armadillo motif-containing protein (SARM) plays an important role in negatively regulating this pathway. While Caenorhabditis elegans SARM is crucial for an efficient immune response against bacterial and fungal infections, it is still unknown whether Drosophila SARM participates in immune responses. Here, Litopenaeus vannamei SARM (LvSARM) was cloned and functionally characterized. LvSARM shared signature domains with and exhibited significant similarities to mammalian SARM. Real-time quantitative PCR analysis indicated that the expression of LvSARM was responsive to Vibrio alginolyticus and white spot syndrome virus (WSSV) infections in the hemocyte, gill, hepatopancreas and intestine. In Drosophila S2 cells, LvSARM was widely distributed in the cytoplasm and could significantly inhibit the promoters of the NF-kappa B pathway-controlled antimicrobial peptide genes (AMPs). Silencing of LvSARM using dsRNA-mediated RNA interference increased the expression levels of Penaeidins and antilipopolysaccharide factors, which are L. vannamei AMPs, and increased the mortality rate after V. alginolyticus infection. Taken together, our results reveal that LvSARM may be a novel component of the shrimp Toll pathway that negatively regulates shrimp AMPs, particularly Penaeidins and antilipopolysaccharide factors.	[Wang, Pei-Hui; Gu, Zhi-Hua; Wan, Ding-Hui; Zhu, Wei-Bin; Qiu, Wei; Weng, Shao-Ping; He, Jian-Guo] Sch Life Sci, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	Wang, PH (corresponding author), Sch Life Sci, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	wph326@gmail.com; lsshjg@mail.sysu.edu.cn	YU, XiaoQiang/GRJ-1077-2022; Wang, Pei-Hui/F-7682-2014; YU, XIAO-QIANG/AAL-1797-2021	Wang, Pei-Hui/0000-0001-6853-2423; YU, XIAO-QIANG/0000-0003-1419-9009; Munthe, Else/0000-0003-3859-1582	National Natural Science Foundation of China [U1131002]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest [201103034]; Foundation of Administration of Ocean and Fisheries of Guangdong Province [A201101B02]; Open Project of the State Key Laboratory of Biocontrol [SKLBC09K04]; Foundation of Science and Technology Bureau of Guangdong Province [2011A 020102002, 2009A 020102002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; Foundation of Administration of Ocean and Fisheries of Guangdong Province; Open Project of the State Key Laboratory of Biocontrol; Foundation of Science and Technology Bureau of Guangdong Province	This research was supported by the National Natural Science Foundation of China under Grant No. U1131002, the National High Technology Research and Development Program of China (973 Program) 2012CB114401, the China Agriculture Research System, the Special Fund for Agro-scientific Research in the Public Interest 201103034, the Foundation of Administration of Ocean and Fisheries of Guangdong Province A201101B02, the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04) and the Foundation of Science and Technology Bureau of Guangdong Province (2011A 020102002 and 2009A 020102002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Bachere E, 2000, AQUACULTURE, V191, P3, DOI 10.1016/S0044-8486(00)00413-0; Belinda LWC, 2008, MOL IMMUNOL, V45, P1732, DOI 10.1016/j.molimm.2007.09.030; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cuthbertson BJ, 2008, DEV COMP IMMUNOL, V32, P167, DOI 10.1016/j.dci.2007.06.009; de la Vega E, 2008, MOL IMMUNOL, V45, P1916, DOI 10.1016/j.molimm.2007.10.039; de Lorgeril J, 2008, MOL IMMUNOL, V45, P3438, DOI 10.1016/j.molimm.2008.04.002; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho SH, 2009, FISH SHELLFISH IMMUN, V27, P73, DOI 10.1016/j.fsi.2009.05.001; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kadowaki T, 2011, IN VIVO, V25, P741; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Labreuche Y, 2009, DEV COMP IMMUNOL, V33, P806, DOI 10.1016/j.dci.2009.02.005; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2009, CURR TOP MICROBIOL, V328, P197; Li CY, 2010, FISH SHELLFISH IMMUN, V29, P1044, DOI 10.1016/j.fsi.2010.08.020; Li CY, 2010, FISH SHELLFISH IMMUN, V28, P1, DOI 10.1016/j.fsi.2009.09.003; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang KCHC, 2010, DEV COMP IMMUNOL, V34, P49, DOI 10.1016/j.dci.2009.08.003; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Woramongkolchai N, 2011, DEV COMP IMMUNOL, V35, P530, DOI 10.1016/j.dci.2010.12.016; Yuan SC, 2010, J IMMUNOL, V184, P6874, DOI 10.4049/jimmunol.0903675; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013	51	112	112	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e52088	10.1371/journal.pone.0052088	http://dx.doi.org/10.1371/journal.pone.0052088			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405063	Green Submitted, Green Published, gold			2022-12-27	WOS:000315153400006
J	Li, SH; Arguelles, L; Jiang, F; Chen, WJ; Jin, XM; Yan, CH; Tian, Y; Hong, XM; Qian, C; Zhang, J; Wang, XB; Shen, XM				Li, Shenghui; Arguelles, Lester; Jiang, Fan; Chen, Wenjuan; Jin, Xingming; Yan, Chonghuai; Tian, Ying; Hong, Xiumei; Qian, Ceng; Zhang, Jun; Wang, Xiaobin; Shen, Xiaoming			Sleep, School Performance, and a School-Based Intervention among School-Aged Children: A Sleep Series Study in China	PLOS ONE			English	Article							DAYTIME SLEEPINESS; ACADEMIC-PERFORMANCE; RISK-FACTORS; DURATION; DISTURBANCES; ADOLESCENTS; PREVALENCE; DISRUPTION; DISORDERS; CHILDHOOD	Background: Sufficient sleep during childhood is essential to ensure a transition into a healthy adulthood. However, chronic sleep loss continues to increase worldwide. In this context, it is imperative to make sleep a high-priority and take action to promote sleep health among children. The present series of studies aimed to shed light on sleep patterns, on the longitudinal association of sleep with school performance, and on practical intervention strategy for Chinese school-aged children. Methods and Findings: A serial sleep researches, including a national cross-sectional survey, a prospective cohort study, and a school-based sleep intervention, were conducted in China from November 2005 through December 2009. The national cross-sectional survey was conducted in 8 cities and a random sample of 20,778 children aged 9.0 +/- 1.61 years participated in the survey. The five-year prospective cohort study included 612 children aged 6.8 +/- 0.31 years. The comparative cross-sectional study (baseline: n = 525, aged 10.80 +/- 0.41; post-intervention follow-up: n = 553, aged 10.81 +/- 0.33) was undertaken in 6 primary schools in Shanghai. A battery of parent and teacher reported questionnaires were used to collect information on children's sleep behaviors, school performance, and sociodemographic characteristics. The mean sleep duration was 9.35 +/- 0.77 hours. The prevalence of daytime sleepiness was 64.4% (sometimes: 37.50%; frequently: 26.94%). Daytime sleepiness was significantly associated with impaired attention, learning motivation, and particularly, academic achievement. By contrast, short sleep duration only related to impaired academic achievement. After delaying school start time 30 minutes and 60 minutes, respectively, sleep duration correspondingly increased by 15.6 minutes and 22.8 minutes, respectively. Moreover, intervention significantly improved the sleep duration and daytime sleepiness. Conclusions: Insufficient sleep and daytime sleepiness commonly existed and positively associated with the impairment of school performance, especially academic achievement, among Chinese school-aged children. The effectiveness of delaying school staring time emphasized the benefits of optimal school schedule regulation to children's sleep health.	[Li, Shenghui; Yan, Chonghuai; Zhang, Jun] Shanghai Jiao Tong Univ, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Li, Shenghui; Tian, Ying; Qian, Ceng] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Northwestern Univ, Feinberg Sch Med, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL 60611 USA; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Childrens Mem Hosp, Chicago, IL 60614 USA; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Childrens Mem Res Ctr, Chicago, IL USA; [Jiang, Fan; Chen, Wenjuan; Jin, Xingming] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200030, Peoples R China; [Wang, Xiaobin; Shen, Xiaoming] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Childhood Origins Dis, Baltimore, MD USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Shanghai Jiao Tong University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Li, SH (corresponding author), Shanghai Jiao Tong Univ, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China.	Lsh9907@163.com; Shenxm9907@126.com	Jiang, Fan/AHA-6297-2022; Jiang, Fan/AGX-9052-2022; CHEN, Haiyong/G-6787-2014; Devreese, Bart/B-2011-2009	Jiang, Fan/0000-0003-0634-101X; Anthony, Arguelles Arias/0000-0003-4359-733X; Fickers, Patrick/0000-0002-2600-5833; CHEN, Haiyong/0000-0002-4889-2752; Devreese, Bart/0000-0002-9764-2581	MOE - Shanghai Key Laboratory of Children's Environmental Health [06DZ22024]; Key Discipline in Public Health of Shanghai Municipal Education Commission; National Natural Science Foundation of China [81072314, 30700670, 81172685]; Innovation Program of Shanghai Municipal Education Commission [13YZ034]; New Bairenjihua in Shanghai Jiaotong University School of Medicine; Shanghai public health academic leader project [GWDTR201222]	MOE - Shanghai Key Laboratory of Children's Environmental Health; Key Discipline in Public Health of Shanghai Municipal Education Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); New Bairenjihua in Shanghai Jiaotong University School of Medicine; Shanghai public health academic leader project	This study was funded by Grants from MOE - Shanghai Key Laboratory of Children's Environmental Health (06DZ22024), the Key Discipline in Public Health of Shanghai Municipal Education Commission, National Natural Science Foundation of China (81072314, 30700670, 81172685), Innovation Program of Shanghai Municipal Education Commission (13YZ034), 2009 New Bairenjihua in Shanghai Jiaotong University School of Medicine, and 2012 Shanghai public health academic leader project (GWDTR201222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe DW, 2010, J ADOLESCENT HEALTH, V47, P523, DOI 10.1016/j.jadohealth.2010.03.005; Bruni O, 2006, SLEEP MED, V7, P43, DOI 10.1016/j.sleep.2005.09.003; Calhoun SL, 2011, SLEEP, V34, P503, DOI 10.1093/sleep/34.4.503; Clinkinbeard SS, 2011, J YOUTH ADOLESCENCE, V40, P916, DOI 10.1007/s10964-010-9594-6; Colten HR, 2006, SLEEP DISORDERS SLEE; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dexter Donn, 2003, WMJ, V102, P44; Gaina A, 2007, J PEDIATR-US, V151, P518, DOI 10.1016/j.jpeds.2007.04.036; Grandner MA, 2012, SLEEP MED REV, V16, P199, DOI 10.1016/j.smrv.2012.02.001; Gruber R, 2010, SLEEP MED, V11, P289, DOI 10.1016/j.sleep.2009.09.007; Heussler HS, 2005, MED J AUSTRALIA, V182, P484, DOI 10.5694/j.1326-5377.2005.tb06793.x; Holley S, 2010, BEHAV SLEEP MED, V8, P16, DOI 10.1080/15402000903425462; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Institute of M. Sleep disorders sleep deprivation, 2006, UNM PUBL HLTH PROBL; Jiang Fan, 2002, Zhonghua Yi Xue Za Zhi, V82, P736; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Li Sheng-hui, 2007, Zhonghua Er Ke Za Zhi, V45, P176; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Li SH, 2010, SLEEP MED, V11, P907, DOI 10.1016/j.sleep.2010.03.018; Li YC, 2008, SLEEP MED, V9, P142, DOI 10.1016/j.sleep.2007.01.018; Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Matricciani L, 2011, SLEEP, V34, P651, DOI 10.1093/sleep/34.5.651; Matricciani LA, 2012, PEDIATRICS, V129, P548, DOI 10.1542/peds.2011-2039; Mindell JA, 2003, CLIN GUIDE PEDIAT SL; Mindell JA, 2011, SLEEP MED, V12, P203, DOI 10.1016/j.sleep.2011.01.003; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Owens JA, 2000, SLEEP, V23, P1043; Owens JA, 2010, ARCH PEDIAT ADOL MED, V164, P608, DOI 10.1001/archpediatrics.2010.96; Perez-Chada D, 2007, SLEEP, V30, P1698, DOI 10.1093/sleep/30.12.1698; Ravid S, 2009, DEV NEUROPSYCHOL, V34, P574, DOI 10.1080/87565640903133533; Ravikiran SR, 2011, INDIAN PEDIATR, V48, P221, DOI 10.1007/s13312-011-0049-2; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Spruyt K, 2005, J SLEEP RES, V14, P163, DOI 10.1111/j.1365-2869.2005.00458.x; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Teufel J. A., 2007, American Journal of Health Studies, V22, P10; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Yang J., 2007, CHINA J SCH DOCTOR, V21, P379	42	150	156	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67928	10.1371/journal.pone.0067928	http://dx.doi.org/10.1371/journal.pone.0067928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	24349428	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300017
J	Jiang, FS; Li, WP; Huang, YF; Chen, YT; Jin, B; Chen, NP; Ding, ZS; Ding, XH				Jiang, Fusheng; Li, Weiping; Huang, Yanfen; Chen, Yitao; Jin, Bo; Chen, Nipi; Ding, Zhishan; Ding, Xinghong			Antioxidant, Antityrosinase and Antitumor Activity Comparison: The Potential Utilization of Fibrous Root Part of Bletilla striata (Thunb.) Reichb.f.	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; TYROSINASES; PREVENTION; EXTRACTS; SEQUENCE; ORCHIDS; AGENTS; PLANT	This study was carried out to evaluate the utilization probability of the fibrous root part (FRP) of Bletilla striata, which was usually discarded and harvesting pseudobulb part (PSP). The chemical composition, total phenolic content, DPPH radical scavenging activity, Ferric-reducing antioxidant power and tyrosinase inhibition activity were compared between FRP and PSP. Antioxidant and pro-oxidant effect as well as antitumor effect of the extract of FRP and PSP were analyzed by in vitro cell system as well. Thin layer chromatography and high performance liquid chromatography analysis indicated that the chemical compositions in the two parts were similar, but the content in FRP was much higher than PSP. Meanwhile, the FRP extracts showed higher phenolic content, stronger DPPH scavenging activity, Ferric-reducing antioxidant capacity and tyrosinase inhibition activity. Sub-fraction analysis revealed that the distribution characteristic of phenolic components and other active constituents in FRP and PSP were consistent, and mainly deposited in chloroform and acetoacetate fractions. Especially, the chloroform sub-fraction (sch) of FRP showed extraordinary DPPH scavenging activity and tyrosinase inhibition activity, with IC50 0.848 mg/L and 4.3 mg/L, respectively. Besides, tyrosinase inhibition activity was even stronger than the positive compound arbutin (31.8 mg/L). Moreover, In vitro cell system analysis confirmed that FRP extract exerts comparable activity with PSP, especially, the sub-fraction sch of FRP showed better antioxidant activity at low dosage and stronger per-oxidant activity at high dosage, and both sch of FRP and PSP can dose-dependent induce HepG2 cells apoptosis, which implied tumor therapeutic effect. Considering that an additional 0.3 kg FRP would be obtained when producing 1.0 kg PSP, our work demonstrated that FRP is very potential to be used together with PSP.	[Jiang, Fusheng; Huang, Yanfen; Chen, Yitao; Jin, Bo; Chen, Nipi; Ding, Zhishan] Zhejiang Chinese Med Univ, Inst Biotechnol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Weiping] Zhejiang Chinese Med Univ, Dept Med Chem, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Ding, Xinghong] Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Ding, XH (corresponding author), Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China.	xinghongding@163.com	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022; Sinnaeve, Davy/F-2293-2013; Rokni-Zadeh, Hassan/B-8098-2008	Madder, Annemieke/0000-0003-0179-7608; Sinnaeve, Davy/0000-0003-2556-5895; Rokni-Zadeh, Hassan/0000-0001-5503-0344; Dai, Haibin/0000-0002-5768-2714; Martins, Jose/0000-0001-7350-2253; De Vleeschouwer, Matthias/0000-0001-6889-1928; Rozenski, Jef/0000-0001-9624-5536	Public Welfare Technology Research Projects of Zhejiang Province [2011C22047]; New-Shoot Talented Man Plan Project of Zhejiang Province [2010R4100581/4CE2011R4100191/4CE2012R410038]	Public Welfare Technology Research Projects of Zhejiang Province; New-Shoot Talented Man Plan Project of Zhejiang Province	This research was supported by the Public Welfare Technology Research Projects of Zhejiang Province (No. 2011C22047, http://www.zjkjt.gov.cn/) and New-Shoot Talented Man Plan Project of Zhejiang Province (No. 2010R4100581/4CE2011R4100191/4CE2012R410038, http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Canadanovic-Brunet JM, 2009, INT J FOOD SCI TECH, V44, P269, DOI 10.1111/j.1365-2621.2007.01680.x; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Ding ZS, 2008, MOLECULES, V13, P220, DOI 10.3390/molecules13020220; Duan XW, 2007, MOLECULES, V12, P759, DOI 10.3390/12040759; Gan RY, 2010, J MED PLANTS RES, V4, P2438; Kaji H, 2009, J CLIN PHARM THER, V34, P197, DOI 10.1111/j.1365-2710.2008.00993.x; Kong JM, 2003, ACTA PHARMACOL SIN, V24, P7; Lei TC, 1999, CHINESE TRADITIONAL, V30, P336; Liang QY, 2006, J GUANGXI MED U, V23, P36; Lin SQ, 1994, THESIS NATL CHENG KU; Luo Y, 2010, J BIOMED MATER RES A, V94A, P193, DOI 10.1002/jbm.a.32711; Maisuthisakul P, 2009, FOOD CHEM, V117, P332, DOI 10.1016/j.foodchem.2009.04.010; Mao XL, 2011, CENTRAL S PHARM, V9, P604; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Marxen K, 2007, SENSORS-BASEL, V7, P2080, DOI 10.3390/s7102080; Morita H, 2005, BIOORG MED CHEM LETT, V15, P1051, DOI 10.1016/j.bmcl.2004.12.026; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Gutierrez RMP, 2010, J MED PLANTS RES, V4, P592; PONNAZHAGAN S, 1994, J INVEST DERMATOL, V102, P744, DOI 10.1111/1523-1747.ep12376924; [黄海云 Rui Haiyun], 2003, [南京师大学报. 自然科学版, Journal of Nanjing Normal University. Natural Science], V26, P94; Shi J, 2009, THESIS HAINAN U HAIN; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Smit N, 2009, INT J MOL SCI, V10, P5326, DOI 10.3390/ijms10125326; Sun DF, 2006, CHINESE WILD PLANT R, V25, P34; Sun F, 2007, J DALIAN I LIGHT IND, V26, P97; TAKAGI S, 1983, PHYTOCHEMISTRY, V22, P1011, DOI 10.1016/0031-9422(83)85044-4; VanGelder CWG, 1997, PHYTOCHEMISTRY, V45, P1309, DOI 10.1016/S0031-9422(97)00186-6; VIDENSEK N, 1990, J NAT PROD, V53, P1609, DOI 10.1021/np50072a039; Wang CM, 2006, BIOTECHNOL LETT, V28, P539, DOI 10.1007/s10529-006-0011-x; Wazir D, 2011, J PLANT BIOCHEM BIOT, V20, P234, DOI 10.1007/s13562-011-0051-8; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Yang Y, 2009, ASIA PACIFIC TRADITI, V5, P23; Zhang HH, 2010, FREE RADICAL BIO MED, V49, P2010, DOI 10.1016/j.freeradbiomed.2010.09.031; Zhu JY, 2011, THESIS FUJIAN U TRAD	35	73	82	6	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58004	10.1371/journal.pone.0058004	http://dx.doi.org/10.1371/journal.pone.0058004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	24098758	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900220
